PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dahiya, S; Liu, YJ; Nonnemacher, MR; Dampier, W; Wigdahl, B				Dahiya, Satinder; Liu, Yujie; Nonnemacher, Michael R.; Dampier, Will; Wigdahl, Brian			CCAAT Enhancer Binding Protein and Nuclear Factor of Activated T Cells Regulate HIV-1 LTR via a Novel Conserved Downstream Site in Cells of the Monocyte-Macrophage Lineage	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LONG-TERMINAL REPEAT; I-HYPERSENSITIVE SITES; ALPHA C/EBP-ALPHA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SWI/SNF COMPLEX; LOCATED DOWNSTREAM; NFAT; BETA	Transcriptional control of the human immunodeficiency virus type 1 (HIV-1) promoter, the long terminal repeat (LTR), is achieved by interactions with cis-acting elements present both upstream and downstream of the start site. In silico transcription factor binding analysis of the HIV-1 subtype B LTR sequences revealed a potential downstream CCAAT enhancer binding protein (C/EBP) binding site. This binding site (+ 158 to+ 172), designated DS3, was found to be conserved in 67% of 3,858 unique subtype B LTR sequences analyzed in terms of nucleotide sequence as well as physical location in the LTR. DS3 was found to be well represented in other subtypes as well. Interestingly, DS3 overlaps with a previously identified region that bind members of the nuclear factor of activated T cells (NFAT) family of proteins. NFATc2 exhibited a higher relative affinity for DS3 as compared with members of the C/EBP family (C/EBP alpha and beta). DS3 was able to compete efficiently with the low-affinity upstream C/EBP binding site I with respect to C/EBP binding, suggesting utilization of both NFAT and C/EBP. Moreover, cyclosporine A treatment, which has been shown to prevent dephosphorylation and nuclear translocation of NFAT isoforms, resulted in enhanced C/EBP alpha binding. The interactions at DS3 were also validated in an integrated HIV-1 LTR in chronically infected U1 cells. A binding knockout of DS3 demonstrated reduced HIV-1 LTR-directed transcription under both basal and interleukin-6-stimulated conditions only in cells of the monocyte-macrophage lineage cells and not in cells of T-cell origin. Thus, the events at DS3 positively regulate the HIV-1 promoter in cells of the monocyte-macrophage lineage.	[Wigdahl, Brian] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Ctr Mol Virol & Translat Neurosci, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Wigdahl, B (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	bwigdahl@drexelmed.edu	Dahiya, Satinder/AAO-8399-2021	Dahiya, Satinder/0000-0002-2189-4846	Public Health Service, National Institutes of Health through National Institute of Neurological Disorders and Stroke [NS32092, NS46263]; National Institute of Drug Abuse [DA19807]; National Institute of Mental Health Comprehensive NeuroAIDS Core Center (CNAC) [1P30 MH-092177-01A]; Ruth L. Kirschstein National Research Service Award [5T32MH079785]; Department of Microbiology and Immunology; Institute for Molecular Medicine and Infectious Disease; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, T32MH079785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032092, R01NS046263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019807] Funding Source: NIH RePORTER	Public Health Service, National Institutes of Health through National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health Comprehensive NeuroAIDS Core Center (CNAC); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology and Immunology; Institute for Molecular Medicine and Infectious Disease; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These studies were funded in part by the Public Health Service, National Institutes of Health through grants from National Institute of Neurological Disorders and Stroke, NS32092 and NS46263, the National Institute of Drug Abuse, DA19807 (Dr. Brian Wigdahl, Principal Investigator), the National Institute of Mental Health Comprehensive NeuroAIDS Core Center (CNAC) Developmental Grant, 1P30 MH-092177-01A (Nonnemacher, PI), and under the Ruth L. Kirschstein National Research Service Award 5T32MH079785. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Dr. Michael Nonnemacher was also supported by faculty development funds provided by the Department of Microbiology and Immunology and the Institute for Molecular Medicine and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; Avots A, 1999, IMMUNITY, V10, P515, DOI 10.1016/S1074-7613(00)80051-5; Bert AG, 2007, MOL CELL BIOL, V27, P2870, DOI 10.1128/MCB.02323-06; Buckner AE, 2002, VIRUS RES, V89, P53, DOI 10.1016/S0168-1702(02)00110-7; Carey MF, 2009, COLD SPRING HARB PRO, V2009; Cockerill PN, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe15; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahiya S, 2012, J GEN VIROL, V93, P1151, DOI 10.1099/vir.0.041186-0; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Ding YP, 2010, J IMMUNOL, V184, P2593, DOI 10.4049/jimmunol.0902378; El Kharroubi A, 1998, MOL CELL BIOL, V18, P2535, DOI 10.1128/MCB.18.5.2535; ElKharroubi A, 1996, MOL CELL BIOL, V16, P2958; ELKHARROUBI A, 1994, J BIOL CHEM, V269, P19916; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Grant C, 2006, VIROLOGY, V348, P354, DOI 10.1016/j.virol.2005.12.024; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Huang J, 2006, J VIROL, V80, P1098, DOI 10.1128/JVI.80.3.1098-1109.2006; Iida S, 2008, GENES CELLS, V13, P313, DOI 10.1111/j.1365-2443.2008.01173.x; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Lee ES, 2002, VIROLOGY, V299, P20, DOI 10.1006/viro.2002.1500; Li L, 2012, ADV VIROL, V2012, DOI 10.1155/2012/123605; Liu XJ, 2002, J BIOL CHEM, V277, P39312, DOI 10.1074/jbc.M205107200; Liu Y, 2009, FUTURE MICROBIOL, V4, P299, DOI 10.2217/FMB.09.4; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Maitra U, 2009, MOL CELL BIOL, V29, P5989, DOI 10.1128/MCB.00541-09; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Nonnemacher MR, 2003, BIOMED PHARMACOTHER, V57, P34, DOI 10.1016/S0753-3322(02)00334-7; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; PERKINS ND, 1994, J VIROL, V68, P6820, DOI 10.1128/JVI.68.10.6820-6823.1994; Qi XP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213389; Ranjbar S, 2006, PLOS PATHOG, V2, P1176, DOI 10.1371/journal.ppat.0020130; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ravimohan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042801; ROEBUCK KA, 1993, J CLIN INVEST, V92, P1336, DOI 10.1172/JCI116707; Romanchikova N, 2003, IMMUNOBIOLOGY, V208, P361, DOI 10.1078/0171-2985-00283; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Steinberg XP, 2012, BIOCHEMISTRY-US, V51, P952, DOI 10.1021/bi201593q; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tesmer VM, 1996, J MOL BIOL, V262, P327, DOI 10.1006/jmbi.1996.0516; TESMER VM, 1993, P NATL ACAD SCI USA, V90, P7298, DOI 10.1073/pnas.90.15.7298; Tripathy MK, 2011, EPIGENOMICS-UK, V3, P487, DOI [10.2217/EPI.11.61, 10.2217/epi.11.61]; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834; Yang TTC, 2006, J BIOL CHEM, V281, P11541, DOI 10.1074/jbc.M511214200; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347	66	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88116	10.1371/journal.pone.0088116	http://dx.doi.org/10.1371/journal.pone.0088116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551078	Green Submitted, gold, Green Published			2022-12-27	WOS:000331271500029
J	Alshaarawi, S; Shatriah, I; Zunaina, E; Hitam, WHW				Alshaarawi, Salem; Shatriah, Ismail; Zunaina, Embong; Hitam, Wan Hazabbah Wan			Assessment of the Optic Nerve Head Parameters Using Heidelberg Retinal Tomography III in Preterm Children	PLOS ONE			English	Article							FULL-TERM INFANTS; BIRTH-WEIGHT; POSTNATAL-GROWTH; DISC MORPHOLOGY; FIBER LAYER; CUP; PROGRESSION; GESTATION; RATIO; BORN	Background: Variations in optic nerve head morphology and abnormal retinal vascular pattern have been described in preterm children using digital image analysis of fundus photograph, optical coherence tomograph and serial funduscopy. We aimed to compare the optic nerve head parameters in preterm and term Malay children using Heidelberg Retinal Tomograph III. Design: A cross sectional study. Methodology/Principal Findings: Thirty-two preterm Malay children who were born at up to 32 weeks postconception, and 32 term Malay children aged 8-16 years old were recruited into this cross sectional study, which was conducted in the Hospital Universiti Sains Malaysia, Malaysia from January to December 2011. Their optic nerves were scanned and analyzed using a Heidelberg Retinal Tomography (HRT) III (Heidelberg Engineering, Germany). Preterm children showed an increased rim volume (SD) (0.56 (0.26) vs 0.44 (0.18) mm(3), respectively), smaller cup shape (SD) (0.18 (0.07) vs 0.25 (0.06) mm, respectively), increased height variation contour (SD) (0.44 (0.14) vs 0.35 (0.08) mm, respectively), and increased cup depth (SD) (0.24 (0.11) vs 0.17 (0.05) mm(3), respectively) when compared to their normal peers (p, 0.05). There were no significant differences in the mean disc area, cup area, cup to disc ratio or rim area between the preterm and term children (p. 0.05) in our study. Conclusions/Significance: Preterm children exhibit different characteristics of optic nerve head parameters with HRT III analysis. Increased cup depth in preterm children suggests a need for close observation and monitoring. It may raise suspicion of pediatric glaucoma when proper documentation of intraocular pressure and clinical funduscopy are unsuccessful in uncooperative children.	[Alshaarawi, Salem; Shatriah, Ismail; Zunaina, Embong; Hitam, Wan Hazabbah Wan] Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kubang Kerian, Kelantan, Malaysia	Universiti Sains Malaysia	Shatriah, I (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kubang Kerian, Kelantan, Malaysia.	shatriah@usm.my	Embong, Zunaina/C-7386-2018; Wan Hitam, Wan Hazabbah/M-3262-2016; Shatriah, Ismail/D-3637-2016	Shatriah, Ismail/0000-0002-4753-4814; Zunaina, Embong/0000-0001-5394-6105; Wan Hitam, Wan Hazabbah/0000-0002-3737-1820	Universiti Sains Malaysia [1001/PPSP/812104]	Universiti Sains Malaysia(Universiti Sains Malaysia)	This study was supported by a Research University Grant (1001/PPSP/812104) from Universiti Sains Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowd C, 2009, INVEST OPHTH VIS SCI, V50, P691, DOI 10.1167/iovs.08-2136; De Silva DJ, 2006, INVEST OPHTH VIS SCI, V47, P4683, DOI 10.1167/iovs.06-0152; Durmus M, 2009, EUR J OPHTHALMOL, V19, P55, DOI 10.1177/112067210901900108; FLEDELIUS H, 1978, ACTA OPHTHALMOL, V56, P563; Hellstrom A, 1997, INVEST OPHTH VIS SCI, V38, P1184; Hellstrom A, 2000, EYE, V14, P324, DOI 10.1038/eye.2000.81; Huynh SC, 2007, AM J OPHTHALMOL, V143, P518, DOI 10.1016/j.ajo.2006.09.050; Huynh SC, 2006, INVEST OPHTH VIS SCI, V47, P3276, DOI 10.1167/iovs.06-0072; Jacobson L, 2003, BRIT J OPHTHALMOL, V87, P1345, DOI 10.1136/bjo.87.11.1345; Jayasundera T, 2005, CLIN EXP OPHTHALMOL, V33, P259, DOI 10.1111/j.1442-9071.2005.01000.x; Kandasamy Y, 2012, BRIT J OPHTHALMOL, V96, P662, DOI 10.1136/bjophthalmol-2011-300950; Larsson E, 2011, ACTA OPHTHALMOL, V89, P755, DOI 10.1111/j.1755-3768.2009.01818.x; McLoone E, 2006, BRIT J OPHTHALMOL, V90, P465, DOI 10.1136/bjo.2005.078519; Meyer T, 2001, OPHTHAL PHYSL OPT, V21, P139, DOI 10.1046/j.1475-1313.2001.00551.x; Pang Y, 2009, OPTOMETRY VISION SCI, V86, P1346, DOI 10.1097/OPX.0b013e3181be0712; Park HJ, 2011, J PEDIAT OPHTH STRAB, V48, P151, DOI 10.3928/01913913-20100719-06; RIMMER S, 1993, AM J OPHTHALMOL, V116, P748, DOI 10.1016/S0002-9394(14)73476-2; Samarawickrama C, 2010, BRIT J OPHTHALMOL, V94, P871, DOI 10.1136/bjo.2009.158279; Samarawickrama C, 2009, OPHTHALMOLOGY, V116, P1112, DOI 10.1016/j.ophtha.2008.12.061; Tong L, 2007, INVEST OPHTH VIS SCI, V48, P4939, DOI 10.1167/iovs.07-0585; Wikstrand MH, 2010, PEDIATR RES, V67, P325, DOI 10.1203/PDR.0b013e3181ca9f43	21	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88056	10.1371/journal.pone.0088056	http://dx.doi.org/10.1371/journal.pone.0088056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551076	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000331266000022
J	Buchanan, AM; Dow, DE; Massambu, CG; Nyombi, B; Shayo, A; Musoke, R; Feng, S; Bartlett, JA; Cunningham, CK; Schimana, W				Buchanan, Ann M.; Dow, Dorothy E.; Massambu, Charles G.; Nyombi, Balthazar; Shayo, Aisa; Musoke, Rahma; Feng, Sheng; Bartlett, John A.; Cunningham, Coleen K.; Schimana, Werner			Progress in the Prevention of Mother to Child Transmission of HIV in Three Regions of Tanzania: A Retrospective Analysis	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PREGNANT-WOMEN; ZIDOVUDINE; NEVIRAPINE; LAMIVUDINE; RECOMMENDATIONS; COMBINATION; MORTALITY; BOTSWANA; REGIMENS	Background: Mother to child transmission (MTCT) of HIV-1 remains an important problem in sub-Saharan Africa where most new pediatric HIV-1 infections occur. Early infant diagnosis of HIV-1 using dried blood spot (DBS) PCR among exposed infants provides an opportunity to assess current MTCT rates. Methods: We conducted a retrospective data analysis on mother-infant pairs from all PMTCT programs in three regions of northern Tanzania to determine MTCT rates from 2008-2010. Records of 3,016 mother-infant pairs were assessed to determine early transmission among HIV-exposed infants in the first 75 days of life. Results: Of 2,266 evaluable infants in our cohort, 143 had a positive DBS PCR result at <= 75 days of life, for an overall transmission rate of 6.3%. Transmission decreased substantially over the period of study as more effective regimens became available. Transmission rates were tightly correlated to maternal regimen: 14.9% (9.5, 20.3) of infants became infected when women received no therapy; 8.8% (6.9, 10.7) and 3.6% (2.4, 4.8) became infected when women received single-dose nevirapine (sdNVP) or combination prophylaxis, respectively; the lowest MTCT rates occurred when women were on HAART, with 2.1% transmission (0.3, 3.9). Treatment regimens changed dramatically over the study period, with an increase in combination prophylaxis and a decrease in the use of sdNVP. Uptake of DBS PCR more than tripled over the period of study for the three regions surveyed. Conclusions: Our study demonstrates significant reductions in MTCT of HIV-1 in three regions of Tanzania coincident with increased use of more effective PMTCT interventions. The changes we demonstrate for the period of 2008-2010 occurred prior to major changes in WHO PMTCT guidelines.	[Buchanan, Ann M.; Dow, Dorothy E.; Shayo, Aisa; Musoke, Rahma; Bartlett, John A.; Cunningham, Coleen K.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Buchanan, Ann M.; Dow, Dorothy E.] Duke Univ, Med Ctr, Div Infect Dis, Dept Pediat, Durham, NC USA; [Buchanan, Ann M.; Bartlett, John A.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Massambu, Charles G.] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Nyombi, Balthazar] Kilimanjaro Christian Med Ctr Clin Lab, Moshi, Tanzania; [Feng, Sheng] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Bartlett, John A.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC USA; [Schimana, Werner] Elizabeth Glaser Pediat AIDS Fdn, Dar Es Salaam, Tanzania	Kilimanjaro Christian Medical Centre; Duke University; Duke University; Kilimanjaro Christian Medical Centre; Duke University; Duke University	Buchanan, AM (corresponding author), Kilimanjaro Christian Med Ctr, Moshi, Tanzania.	ann.buchanan@duke.edu	Dow, Dorothy/H-8164-2019		President's Emergency Plan for AIDS Relief (PEPFAR) through the National Institute of Allergy and Infectious Diseases (NIAID) [NOT-A1-10-023 (3UO1 A1069484 A4S2)]; Duke Clinical Trials Unit and Clinical Research Sites [U01 AI069484]; Duke Center for AIDS Research [5P30 AI064518]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [T32 HD060558 to DED]; HRSA [T84HS21123]; NIH [P30AI064518, D43CA153722, D43TW06732]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060558] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW009985, D43TW006732] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, U01AI069484] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the National Institute of Allergy and Infectious Diseases (NIAID); Duke Clinical Trials Unit and Clinical Research Sites; Duke Center for AIDS Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through a supplement to the National Institute of Allergy and Infectious Diseases (NIAID): NOT-A1-10-023 (3UO1 A1069484 A4S2); the Duke Clinical Trials Unit and Clinical Research Sites (U01 AI069484 to CKC, JAB, and AMB); the Duke Center for AIDS Research (5P30 AI064518 to CKC and AMB); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant to the Division of Infectious Diseases, Department of Pediatrics, Duke University Medical Center (T32 HD060558 to DED); and HRSA grant T84HS21123 and NIH grants P30AI064518, D43CA153722, and D43TW06732 to JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anoje C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-184; [Anonymous], 2020, HIGH POSS COST COVID; [Anonymous], NAT GUID MAN HIV AID; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coutsoudis A, 2000, ANN NY ACAD SCI, V918, P136; Dabis F, 2005, AIDS, V19, P309; Dao H, 2007, AM J OBSTET GYNECOL, V197, pS42, DOI 10.1016/j.ajog.2007.03.001; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V58, P353, DOI 10.1097/QAI.0b013e31822d4063; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Jamieson DJ, 2007, AM J OBSTET GYNECOL, V197, pS26, DOI 10.1016/j.ajog.2007.03.087; Jaspan HB, 2003, CURR HIV RES, V1, P321, DOI 10.2174/1570162033485221; Kouanda S, 2010, AIDS CARE, V22, P843, DOI 10.1080/09540120903499204; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; Marazzi MC, 2010, AIDS, V24, P2819, DOI 10.1097/QAD.0b013e32833ff58c; Ministry of Health and Social Welfare National AIDS Control Programme (NACP), 2012, TANZ EL MOTH CHILD T; Ministry of Health and Social Welfare United Republic of Tanzania, 2011, PREV MOTH TO CHILD T; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Olayinka BA, 2000, J PAEDIATR CHILD H, V36, P313, DOI 10.1046/j.1440-1754.2000.00528.x; Saba J, 2002, LANCET, V359, P1178; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Simpson BJ, 2000, PEDIATR INFECT DIS J, V19, P618, DOI 10.1097/00006454-200007000-00007; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; UNAIDS, 2012, GLOBAL REPORT UNAIDS	26	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88679	10.1371/journal.pone.0088679	http://dx.doi.org/10.1371/journal.pone.0088679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551134	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000054
J	Tsvetkova, M; Macy, MW				Tsvetkova, Milena; Macy, Michael W.			The Social Contagion of Generosity	PLOS ONE			English	Article							INDIRECT RECIPROCITY; GENERALIZED EXCHANGE; THRESHOLD MODELS; EVOLUTION; NETWORKS; COOPERATION; DIFFUSION; BEHAVIOR; GRATITUDE; DILEMMAS	Why do people help strangers when there is a low probability that help will be directly reciprocated or socially rewarded? A possible explanation is that these acts are contagious: those who receive or observe help from a stranger become more likely to help others. We test two mechanisms for the social contagion of generosity among strangers: generalized reciprocity (a recipient of generosity is more likely to pay it forward) and third-party influence (an observer of generous behavior is more likely to emulate it). We use an online experiment with randomized trials to test the two hypothesized mechanisms and their interaction by manipulating the extent to which participants receive and observe help. Results show that receiving help can increase the willingness to be generous towards others, but observing help can have the opposite effect, especially among those who have not received help. These results suggest that observing widespread generosity may attenuate the belief that one's own efforts are needed.	[Tsvetkova, Milena; Macy, Michael W.] Cornell Univ, Dept Sociol, Ithaca, NY 14850 USA; [Macy, Michael W.] Cornell Univ, Dept Informat Sci, Ithaca, NY USA	Cornell University; Cornell University	Tsvetkova, M (corresponding author), Cornell Univ, Dept Sociol, Ithaca, NY 14850 USA.	mvt9@cornell.edu	Tsvetkova, Milena/AAE-9386-2021	Tsvetkova, Milena/0000-0002-3552-108X	National Science Foundation [SES-1260348, SES-1303526]; Divn Of Social and Economic Sciences [1303526] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by grants SES-1260348 and SES-1303526 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Bearman P, 1997, AM J SOCIOL, V102, P1383, DOI 10.1086/231087; Ben-Ner A, 2004, J ECON BEHAV ORGAN, V53, P333, DOI 10.1016/j.jebo.2002.12.001; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bohannon J, 2011, SCIENCE, V334, P307, DOI 10.1126/science.334.6054.307; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; BOYD R, 1989, SOC NETWORKS, V11, P213, DOI 10.1016/0378-8733(89)90003-8; Christakis N.A., 2009, CONNECTED SURPRISING; Cialdini R.B., 2008, INFLUENCE SCI PRACTI; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; DIEKMANN A, 1985, J CONFLICT RESOLUT, V29, P605, DOI 10.1177/0022002785029004003; Ekeh P., 1974, SOCIAL EXCHANGE THEO; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; GRANOVETTER M, 1983, J MATH SOCIOL, V9, P165, DOI 10.1080/0022250X.1983.9989941; GRANOVETTER M, 1986, J ECON BEHAV ORGAN, V7, P83, DOI 10.1016/0167-2681(86)90023-5; Greiner B, 2005, J ECON PSYCHOL, V26, P711, DOI 10.1016/j.joep.2004.04.003; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Jordan JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066199; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Lopez-Pintado D, 2008, RATION SOC, V20, P399, DOI 10.1177/1043463108096787; Malinowski B, 1920, MAN, V20, P97, DOI 10.2307/2840430; Mallough R., 2013, EXTRA LARGE SIZED OR; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Memmott M, 2013, 55 CUSTOMERS PAY NEX; Molm LD, 2007, AM J SOCIOL, V113, P205, DOI 10.1086/517900; Murphy K, 2013, MAAM YOUR BURGER HAS; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2007, P R SOC B, V274, P605, DOI 10.1098/rspb.2006.0125; OLIVER P, 1985, AM J SOCIOL, V91, P522, DOI 10.1086/228313; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pfeiffer T, 2005, P ROY SOC B-BIOL SCI, V272, P1115, DOI 10.1098/rspb.2004.2988; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Ross J., 2010, HUMAN FACTORS COMPUT, DOI [10.1145/1753846.1753873, DOI 10.1145/1753846.1753873]; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Stanca L, 2009, J ECON PSYCHOL, V30, P190, DOI 10.1016/j.joep.2008.07.010; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Tsvetkova M, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500057; UEHARA E, 1990, AM J SOCIOL, V96, P521, DOI 10.1086/229571; Valente TW, 1996, SOC NETWORKS, V18, P69, DOI 10.1016/0378-8733(95)00256-1; Weber JM, 2008, J PERS SOC PSYCHOL, V95, P1340, DOI 10.1037/a0012454; YAMAGISHI T, 1993, SOC PSYCHOL QUART, V56, P235, DOI 10.2307/2786661	44	66	66	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87275	10.1371/journal.pone.0087275	http://dx.doi.org/10.1371/journal.pone.0087275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551053	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000331266000011
J	Skule, C; Ulleberg, P; Lending, HD; Berge, T; Egeland, J; Brennen, T; Landro, NI				Skule, Cecilie; Ulleberg, Pal; Lending, Hilde Dallavara; Berge, Torkil; Egeland, Jens; Brennen, Tim; Landro, Nils Inge			Depressive Symptoms in People with and without Alcohol Abuse: Factor Structure and Measurement Invariance of the Beck Depression Inventory (BDI-II) Across Groups	PLOS ONE			English	Article							OF-FIT INDEXES; SUBSTANCE	This study explored differences in the factor structure of depressive symptoms in patients with and without alcohol abuse, and differences in the severity of depressive symptoms between the two groups. In a sample of 358 patients without alcohol problems and 167 patients with comorbid alcohol problems, confirmatory factor analysis revealed that the same factor structures, Beck et al.'s two-factor Somatic Affective-Cognitive (SA-C) model, and Buckley et al.'s three-factor Cognitive-Affective-Somatic (C-A-S) model, demonstrated the best fit to the data in both groups. The SA-C model was preferred due to its more parsimonious nature. Evidence for strict measurement invariance across the two groups for the SA-C model was found. MIMIC (multiple-indicator-multiple-cause) modeling showed that the level of depressive symptoms was found to be highest on both factors in the group with comorbid alcohol problems. The magnitude of the differences in latent mean scores suggested a moderate difference in the level of depressive symptoms between the two groups. It is argued that patients with comorbid depression and alcohol abuse should be offered parallel and adequate treatment for both conditions.	[Skule, Cecilie; Lending, Hilde Dallavara; Berge, Torkil] Diakonhjemmet Hosp, Community Mental Hlth Ctr Vinderen, Oslo, Norway; [Ulleberg, Pal; Egeland, Jens; Brennen, Tim; Landro, Nils Inge] Univ Oslo, Dept Psychol, Oslo, Norway; [Egeland, Jens] Vestfold Mental Hlth Care Trust, Tonsberg, Norway	Diakonhjemmet Hospital; University of Oslo	Skule, C (corresponding author), Diakonhjemmet Hosp, Community Mental Hlth Ctr Vinderen, Oslo, Norway.	cecilie9@diakonsyk.no	Brennen, Tim/ABE-8954-2020	Brennen, Tim/0000-0003-1434-2661	Regional Competence Centre for Double Diagnoses, South Eastern Norway; Community Mental Health Center, Vinderen, Diakonhjemmet Hospital, Oslo	Regional Competence Centre for Double Diagnoses, South Eastern Norway; Community Mental Health Center, Vinderen, Diakonhjemmet Hospital, Oslo	The research was funded by the Regional Competence Centre for Double Diagnoses, South Eastern Norway, and the research fund in the Community Mental Health Center, Vinderen, Diakonhjemmet Hospital, Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babor T.F., 2001, ALCOHOL USE DISORDER; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis L, 2008, CURR OPIN PSYCHIATR, V21, P14, DOI 10.1097/YCO.0b013e3282f32408; Dum M, 2008, ADDICT BEHAV, V33, P381, DOI 10.1016/j.addbeh.2007.09.017; Hesse M, 2004, ADDICT BEHAV, V29, P1137, DOI 10.1016/j.addbeh.2004.03.006; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson ME, 2006, ASSESSMENT, V66, P17; Kessler RC, 1996, AM J ORTHOPSYCHIAT, V66, P17, DOI 10.1037/h0080151; Loehlin JC, 1998, LATENT VARIABLE MODE; Muthen B., 2010, MPLUS USERS GUIDE; Ostacher MJ, 2007, PSYCHIAT CLIN N AM, V30, P69, DOI 10.1016/j.psc.2006.12.009; Palfai TP, 2007, J STUD ALCOHOL DRUGS, V68, P673, DOI 10.15288/jsad.2007.68.673; Quilty LC, 2010, PSYCHOL ASSESSMENT, V22, P603, DOI 10.1037/a0019698; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Seignourel PJ, 2008, DRUG ALCOHOL DEPEN, V93, P271, DOI 10.1016/j.drugalcdep.2007.10.016; Vanheule S, 2008, ASSESSMENT, V15, P177, DOI 10.1177/1073191107311261; Ward LC, 2006, PSYCHOL ASSESSMENT, V18, P81, DOI 10.1037/1040-3590.18.1.81	22	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88321	10.1371/journal.pone.0088321	http://dx.doi.org/10.1371/journal.pone.0088321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533075	Green Published, gold			2022-12-27	WOS:000331262600033
J	Teixeira, H; Rodriguez-Echeverria, S; Nabais, C				Teixeira, Helena; Rodriguez-Echeverria, Susana; Nabais, Cristina			Genetic Diversity and Differentiation of Juniperus thurifera in Spain and Morocco as Determined by SSR	PLOS ONE			English	Article							WESTERN MEDITERRANEAN BASIN; GLACIAL REFUGIA; PLANT; POLYPLOIDY; DISTANCES; GENOTYPE; EXAMPLE; L.	Juniperus thurifera L. is an important tree endemic to the western Mediterranean basin that it is able to grow in semi-arid climates. It nowadays exhibits a disjunct distribution pattern, occurring in North Africa, Spain, France and the Italian Alps. The Strait of Gibraltar has acted as an efficient barrier against gene flow between African and European populations, which are considered different subspecies by some authors. We aimed at describing the intraspecific genetic diversity of J. thurifera in populations from the Iberian Peninsula and Morocco and the phylogeographical relationships among these populations. The ploidy level of J. thurifera was examined and eleven nuclear microsatellites (nSSRs) developed for J. thurifera were assessed for genotyping this species. Six nSSRs were polymorphic and subsequently used to assess the genetic diversity and structure of the studied populations. Genotyping of the tetraploid J. thurifera using nuclear microsatellites supports the separation of Moroccan and Spanish populations into two genetically differentiated groups that correspond to the proposed subspecies africana and thurifera. High values of within population genetic diversity were found, that accounted for 90% of the total genetic variance, while population structure was weak. The estimators of genetic diversity were higher in populations of Spain than in populations of Morocco pointing for a possible loss of genetic diversity during the spread of this species to Africa from Europe.	[Teixeira, Helena; Rodriguez-Echeverria, Susana; Nabais, Cristina] Univ Coimbra, Ctr Ecol Func, Dept Ciencias Vida, Coimbra, Portugal	Universidade de Coimbra	Rodriguez-Echeverria, S (corresponding author), Univ Coimbra, Ctr Ecol Func, Dept Ciencias Vida, Coimbra, Portugal.	susanare@ci.uc.pt	Rodríguez-Echeverría, Susana/I-1730-2015	Rodríguez-Echeverría, Susana/0000-0002-2058-3229; Nabais, Cristina/0000-0001-6901-8776; Teixeira, Helena/0000-0001-9032-4575	MEDIATIC [PTDC/AAC-CLI/103361/2008]; Fundacao para a Ciencia e Tecnologia (FCT) from the Portuguese Government	MEDIATIC; Fundacao para a Ciencia e Tecnologia (FCT) from the Portuguese Government(Portuguese Foundation for Science and Technology)	This work was supported by the project MEDIATIC (PTDC/AAC-CLI/103361/2008) funded by the Fundacao para a Ciencia e Tecnologia (FCT) from the Portuguese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2011, JUNIPERUS WORLD GENU; Adams RP, 2003, BIOCHEM SYST ECOL, V31, P375, DOI 10.1016/S0305-1978(02)00157-6; Assoumane A, 2013, TREE GENET GENOMES, V9, P93, DOI 10.1007/s11295-012-0537-0; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Carrion JS, 2003, GLOBAL ECOL BIOGEOGR, V12, P119, DOI 10.1046/j.1466-822X.2003.00013.x; Castro S, 2013, PLANT SCI, V207, P72, DOI 10.1016/j.plantsci.2013.02.012; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; DeSoto L, 2012, EUR J FOREST RES, V131, P905, DOI 10.1007/s10342-011-0564-7; DeSoto L, 2010, APPL VEG SCI, V13, P15, DOI 10.1111/j.1654-109X.2009.01045.x; Douaihy B, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr003; Dzialuk A, 2011, ANN FOREST SCI, V68, P1341, DOI 10.1007/s13595-011-0150-7; Escribano-Avila G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046993; EXCOFFIER L, 1992, GENETICS, V131, P479; Farjon A, 2005, MONOGRAPH CUPRESSACE; Garcia-Verdugo C, 2013, MOL ECOL, V22, P1546, DOI 10.1111/mec.12194; GAUQUELIN T, 1988, Ecologia Mediterranea, V14, P31; Gauquelin T, 1999, BIODIVERS CONSERV, V8, P1479, DOI 10.1023/A:1008966808796; Geleta N, 2006, BIODIVERS CONSERV, V15, P3251, DOI 10.1007/s10531-005-0313-7; Jaramillo-Correa JP, 2010, MOL ECOL, V19, P5452, DOI 10.1111/j.1365-294X.2010.04912.x; Jimenez JF, 2003, ISR J PLANT SCI, V51, P11, DOI 10.1560/ABR5-A6MP-5XEG-V0WF; Kloda JM, 2008, HEREDITY, V100, P253, DOI 10.1038/sj.hdy.6801044; Maire R., 1987, FLORE AFRIQUE NORD, V16; MANTEL N, 1967, CANCER RES, V27, P209; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Obbard DJ, 2006, HEREDITY, V97, P296, DOI 10.1038/sj.hdy.6800862; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pfeiffer T, 2011, J HERED, V102, P479, DOI 10.1093/jhered/esr024; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Renau-Morata B, 2005, AM J BOT, V92, P875, DOI 10.3732/ajb.92.5.875; Romo A., 2005, Dendrobiology, V54, P41; Romo A, 2007, ANN BOT FENN, V44, P72; Romo A, 2013, TREE GENET GENOMES, V9, P587, DOI 10.1007/s11295-012-0581-9; Sampson JF, 2012, BIOL J LINN SOC, V105, P218, DOI 10.1111/j.1095-8312.2011.01787.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Telleria JL, 2013, J ORNITHOL; Terrab A, 2008, MOL PHYLOGENET EVOL, V48, P94, DOI 10.1016/j.ympev.2008.03.018	39	57	57	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88996	10.1371/journal.pone.0088996	http://dx.doi.org/10.1371/journal.pone.0088996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533164	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600124
J	Veldhuis, L; van Grieken, A; Renders, CM; HiraSing, RA; Raat, H				Veldhuis, Lydian; van Grieken, Amy; Renders, Carry M.; HiraSing, Remy A.; Raat, Hein			Parenting Style, the Home Environment, and Screen Time of 5-Year-Old Children; The 'Be Active, Eat Right' Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; FAMILY ENVIRONMENT; CHILDHOOD OBESITY; TELEVISION; OVERWEIGHT; ASSOCIATION; BEDROOM; TV; ADOLESCENTS; PREVENTION	Introduction: The global increase in childhood overweight and obesity has been ascribed partly to increases in children's screen time. Parents have a large influence on their children's screen time. Studies investigating parenting and early childhood screen time are limited. In this study, we investigated associations of parenting style and the social and physical home environment on watching TV and using computers or game consoles among 5-year-old children. Methods: This study uses baseline data concerning 5-year-old children (n = 3067) collected for the 'Be active, eat right' study. Results: Children of parents with a higher score on the parenting style dimension involvement, were more likely to spend >30 min/day on computers or game consoles. Overall, families with an authoritative or authoritarian parenting style had lower percentages of children's screen time compared to families with an indulgent or neglectful style, but no significant difference in OR was found. In families with rules about screen time, children were less likely to watch TV>2 hrs/day and more likely to spend >30 min/day on computers or game consoles. The number of TVs and computers or game consoles in the household was positively associated with screen time, and children with a TV or computer or game console in their bedroom were more likely to watch TV>2 hrs/day or spend >30 min/day on computers or game consoles. Conclusion: The magnitude of the association between parenting style and screen time of 5-year-olds was found to be relatively modest. The associations found between the social and physical environment and children's screen time are independent of parenting style. Interventions to reduce children's screen time might be most effective when they support parents specifically with introducing family rules related to screen time and prevent the presence of a TV or computer or game console in the child's room.	[Veldhuis, Lydian; HiraSing, Remy A.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Veldhuis, Lydian; van Grieken, Amy; Raat, Hein] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Renders, Carry M.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Inst Hlth Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Veldhuis, L (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	lidyveldhuis@hotmail.com	van Grieken, Amy/N-1583-2014	van Grieken, Amy/0000-0001-6767-9159; Renders, Carry/0000-0001-6688-1312	Netherlands Organization for Health Research and Development [50-50110-98-355]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development [grant number 50-50110-98-355]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Mejia AM, 2007, INT J OBESITY, V31, P644, DOI 10.1038/sj.ijo.0803455; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Barkin S, 2006, ARCH PEDIAT ADOL MED, V160, P395, DOI 10.1001/archpedi.160.4.395; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barradas DT, 2007, J PEDIATR-US, V151, P369, DOI 10.1016/j.jpeds.2007.04.069; Barradas DT, 2007, J PEDIAT, V151, pe361; Bulk-Bunschoten AMW, 2005, OVERBRUGGINGSPLAN VO; Centraal Bureau voor de Statistiek [Statistics Netherlands], 2004, ALLOCHTONEN IN NEDER; Centraal Bureau voor de Statistiek [Statistics Netherlands], 2004, STANDAARD ONDERWIJSI; Crowder JS, 2012, PREV MED, V55, P623, DOI 10.1016/j.ypmed.2012.10.005; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; Davison K K, 2001, Obes Rev, V2, P159, DOI 10.1046/j.1467-789x.2001.00036.x; Davison KK, 2005, J PEDIATR-US, V147, P436, DOI 10.1016/j.jpeds.2005.05.002; De Bourdeaudhuij I, 2009, PUBLIC HEALTH NUTR, V12, P259, DOI 10.1017/S1368980008002930; de Jong E, 2013, INT J OBESITY, V37, P47, DOI 10.1038/ijo.2011.244; Dennison BA, 2002, PEDIATRICS, V109, P1028, DOI 10.1542/peds.109.6.1028; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Golan M, 2004, OBES RES, V12, P357, DOI 10.1038/oby.2004.45; Gubbels JS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-18; Hardy LL, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-24; Hesketh K, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-60; Huver RME, 2010, J ADOLESCENCE, V33, P395, DOI 10.1016/j.adolescence.2009.07.012; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Jago R, 2008, PREV MED, V47, P525, DOI 10.1016/j.ypmed.2008.07.016; Jago R, 2011, PEDIATRICS, V128, pE572, DOI [10.1542/peds.2010-3664, 10.1542/peds.2011-1818]; Liu RX, 2003, COMPUT METH PROG BIO, V71, P141, DOI 10.1016/S0169-2607(02)00058-5; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Loprinzi PD, 2012, OBESITY FACTS, V5, P420, DOI 10.1159/000341097; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Power TG, 2013, CHILD OBES, V9, pS87, DOI 10.1089/chi.2013.0038; Reilly JJ, 2008, P NUTR SOC, V67, P317, DOI 10.1017/S0029665108008604; Renders CM, 2006, AANPAK OVERGEWICHT I; Saelens BE, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00001; Salmon J, 2005, OBES RES, V13, P1939, DOI 10.1038/oby.2005.239; Sleddens EFC, 2013, FOOD PARENTING PRACT; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Spurrier NJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-31; Steinberg L, 2006, J RES ADOLESCENCE, V16, P47, DOI 10.1111/j.1532-7795.2006.00119.x; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Taylor A, 2011, APPETITE, V57, P700, DOI 10.1016/j.appet.2011.08.014; van der Horst K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-142; van der Horst K, 2007, HEALTH EDUC RES, V22, P295, DOI 10.1093/her/cyl080; van Zutphen M, 2007, J PAEDIATR CHILD H, V43, P458, DOI 10.1111/j.1440-1754.2007.01111.x; Vandewater EA, 2007, PEDIATRICS, V119, pE1006, DOI 10.1542/peds.2006-1804; Velde SJT, 2011, INT J PEDIATR OBES, V6, pE364, DOI 10.3109/17477166.2010.490264; Veldhuis L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-177; World Health Organization, 2011, FACTSHEET NO 311 OBE	49	43	45	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88486	10.1371/journal.pone.0088486	http://dx.doi.org/10.1371/journal.pone.0088486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533092	Green Published, gold			2022-12-27	WOS:000331262600050
J	Xie, GQ; Zou, JP; Zhao, L; Wu, MJ; Wang, SG; Zhang, F; Tang, B				Xie, Guoqiang; Zou, Jiaping; Zhao, Lina; Wu, Mengjing; Wang, Shigui; Zhang, Fan; Tang, Bin			Inhibitional Effects of Metal Zn2+ on the Reproduction of Aphis medicaginis and Its Predation by Harmonia axyridis	PLOS ONE			English	Article							REAL-TIME PCR; XENOPUS-LAEVIS VITELLOGENIN; LITURA F LEPIDOPTERA; CHIRONOMIDAE DIPTERA; MOLECULAR-CLONING; REFERENCE GENES; SEWAGE-SLUDGE; DAPHNIA-MAGNA; BLOOD PROTEIN; ZINC	Background: Contamination, including metals, can disturb the reproductive processes of many organisms, including both prey and predatory insects. However, there is virtually no information on the effects of high level Zinc (Zn) pollution on aphids and ladybirds. The high concentrations of Zn2+ or Zn pollution inhibit reproduction in the phytophagous aphid, Aphis medicaginis, and the predatory ladybird Harmonia axyridis could provide important information. Results: It was observed in this study that Zn concentrations in Vicia faba (broad bean) seeds and seedlings in all Zn2+ treatments were significantly higher than that in the control group, and increased with increasing Zn2+ concentrations in the solution. The rate of reproduction in A. medicaginis declined significantly (p<0.05) over time in the five groups fed on broad bean seedlings treated with different concentrations of Zn2+ solution compared with the control group. These results showed that higher concentrations of Zn2+ significantly inhibited the reproductive capacity of A. medicaginis. We also cloned and identified a gene encoding vitellogenin (Vg) from A. medicaginis, which has an important role in vitellogenesis, and therefore, reproduction was affected by exposure to Zn2+. Expression of AmVg was reduced with increasing exposure to Zn2+ and also in the F-1-F-3 generations of aphids exposed to different Zn2+ concentrations. Predation by H. axyridis was also reduced in aphids exposed to high-levels of Zn2+. Similarly, ovipositioning by H. axyridis was also reduced. Conclusions: Our results suggest that Zn2+ can significantly affect the reproductive capacity of both A. medicaginis and its predator H. axyridis, the former through effects on the expression of AmVg and the latter through avoidance of aphids containing high levels of Zn2+.	[Xie, Guoqiang; Zou, Jiaping; Zhao, Lina; Wu, Mengjing; Wang, Shigui; Tang, Bin] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China; [Zhang, Fan; Tang, Bin] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China	Hangzhou Normal University; Beijing Academy of Agriculture & Forestry	Tang, B (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China.	tbzm611@yahoo.com			National Basic Research Program of China [2012CB127605, 2009CB119206]; Special Fund for Agro-scientific Research in the Public Interest [201303024]; National Natural Science Foundation of China [31071731, 31000880]; The Project of Zhejiang Key Scientific and Technological Innovation Team [2010R50039]; Program for Excellent Young Teachers in Hangzhou Normal University [JTAS 2011-01-031]; Hangzhou Normal University High-level Talents Start-up Fund [YS05203105]	National Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Project of Zhejiang Key Scientific and Technological Innovation Team; Program for Excellent Young Teachers in Hangzhou Normal University; Hangzhou Normal University High-level Talents Start-up Fund	This work was supported by National Basic Research Program of China (Grant No. 2012CB127605 and 2009CB119206), Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303024), National Natural Science Foundation of China (Grant Nos. 31071731 and 31000880), The Project of Zhejiang Key Scientific and Technological Innovation Team (Grant No. 2010R50039), the Program for Excellent Young Teachers in Hangzhou Normal University (Grant No. JTAS 2011-01-031) and Hangzhou Normal University High-level Talents Start-up Fund (Grant No. YS05203105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2007, AM NAT, V170, P37, DOI 10.1086/518183; Armstrong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053186; Augustyniak M, 2005, COMP BIOCHEM PHYS C, V141, P412, DOI 10.1016/j.cbpc.2005.09.007; Augustyniak M, 2005, SECOTOX ADV TRENDS E, P103; Augustyniak M, 2008, J INSECT PHYSIOL, V54, P41, DOI 10.1016/j.jinsphys.2007.08.002; Augustyniak M, 2006, COMP BIOCHEM PHYS C, V144, P242, DOI 10.1016/j.cbpc.2006.09.003; Augustyniak M, 2009, J INSECT PHYSIOL, V55, P735, DOI 10.1016/j.jinsphys.2009.04.009; Barata C, 2000, AQUAT TOXICOL, V48, P195, DOI 10.1016/S0166-445X(99)00038-7; Cervera A, 2005, J INSECT PHYSIOL, V51, P895, DOI 10.1016/j.jinsphys.2005.04.005; Cervera A, 2004, J INSECT PHYSIOL, V50, P737, DOI 10.1016/j.jinsphys.2004.06.001; [柴世伟 Chai Shiwei], 2004, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V43, P90; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chen GR, 2010, CONSERVATION UTILIZA, V2, P41; CRAWFORD LA, 1995, J APPL ECOL, V32, P528, DOI 10.2307/2404650; De Schamphelaere KAC, 2004, AQUAT TOXICOL, V70, P233, DOI 10.1016/j.aquatox.2004.09.008; DEBISTHOVEN LGJ, 1992, HYDROBIOLOGIA, V239, P141, DOI 10.1007/BF00007671; Denslow ND, 1999, ECOTOXICOLOGY, V8, P385, DOI 10.1023/A:1008986522208; ETMAN AAM, 1979, J AUST ENTOMOL SOC, V18, P363; Gao HH, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4401; Green ID, 2003, AGR ECOSYST ENVIRON, V99, P171, DOI 10.1016/S0167-8809(03)00147-6; Gunson A. J., 2001, ARTISANAL MINING PEO; Hayford BL, 2005, J KANSAS ENTOMOL SOC, V78, P89, DOI 10.2317/0405.20.1; Hu C., 2007, CHINESE AGR SCI B, V23; Hwang DS, 2009, ANN NY ACAD SCI, V1163, P417, DOI 10.1111/j.1749-6632.2008.03631.x; KAGEYAMA Y, 1994, INSECT BIOCHEM MOLEC, V24, P599, DOI 10.1016/0965-1748(94)90096-5; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Marchal Elisabeth, 2013, BMC Res Notes, V6, P237, DOI 10.1186/1756-0500-6-237; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; Martinez EA, 2004, ENVIRON TOXICOL CHEM, V23, P662, DOI 10.1897/02-512; Martinez EA, 2001, ENVIRON TOXICOL CHEM, V20, P2475, DOI [10.1897/1551-5028(2001)020&lt;2475:IOMDIC&gt;2.0.CO;2, 10.1002/etc.5620201112]; Martinez EA, 2002, ARCH ENVIRON CON TOX, V42, P286, DOI 10.1007/s00244-001-0190-0; Maryanski M, 2002, ECOTOXICOLOGY, V11, P127, DOI 10.1023/A:1014425113481; Matsuura H, 1997, APPL ENTOMOL ZOOL, V32, P167, DOI 10.1303/aez.32.167; Merrington G, 1997, SCI TOTAL ENVIRON, V205, P245, DOI 10.1016/S0048-9697(97)00202-7; [莫争 Mo Zheng], 2002, [环境化学, Environmental Chemistry], V21, P110; MONTORZI M, 1994, BIOCHEM BIOPH RES CO, V200, P1407, DOI 10.1006/bbrc.1994.1607; Mousavi SK, 2003, SCI TOTAL ENVIRON, V307, P93; Nota B, 2011, ENVIRON POLLUT, V159, P1343, DOI 10.1016/j.envpol.2011.01.014; Nursita AI, 2005, ECOTOX ENVIRON SAFE, V60, P306, DOI 10.1016/j.ecoenv.2004.05.001; Oves M, 2012, TOXICITY HEAVY METAL, V1, P1; PAN ML, 1969, SCIENCE, V165, P393, DOI 10.1126/science.165.3891.393; Polkki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038832; Pokhrel LR, 2012, ENVIRON SCI TECHNOL, V46, P7755, DOI 10.1021/es204055c; Polidori C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070529; [秦厚国 Qin Houguo], 2004, [中国生态农业学报, Chinese journal of eco-agriculture], V12, P40; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Ruohomaki K, 1996, J APPL ECOL, V33, P773, DOI 10.2307/2404947; Sandifer RD, 1996, CHEMOSPHERE, V33, P2475, DOI 10.1016/S0045-6535(96)00348-7; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Shu YH, 2009, ECOTOX ENVIRON SAFE, V72, P2130, DOI 10.1016/j.ecoenv.2009.06.004; Siddique HR, 2009, ECOTOX ENVIRON SAFE, V72, P1652, DOI 10.1016/j.ecoenv.2009.06.010; Son J, 2011, PROTEOMICS, V11, P2294, DOI 10.1002/pmic.200900690; Stewart AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027578; STIFANI S, 1988, BIOCHEM J, V250, P467, DOI 10.1042/bj2500467; Sun Hong-Xia, 2007, Acta Entomologica Sinica, V50, P178; Swevers L., 2005, P87; TELFER WH, 1954, J GEN PHYSIOL, V37, P539, DOI 10.1085/jgp.37.4.539; Tiu SHK, 2009, GEN COMP ENDOCR, V160, P36, DOI 10.1016/j.ygcen.2008.10.014; Tufail M, 2010, INSECT MOL BIOL, V19, P787, DOI 10.1111/j.1365-2583.2010.01035.x; Tylko G, 2005, MICROSC RES TECHNIQ, V66, P239, DOI 10.1002/jemt.20164; Tylko G, 2003, FOLIA BIOL-KRAKOW, V51, P125; Vogt C, 2007, J ENVIRON SCI HEAL A, V42, P1, DOI 10.1080/10934520601015255; WAHLI W, 1978, DEV BIOL, V67, P371, DOI 10.1016/0012-1606(78)90207-5; Wallace RA, 1985, DEV BIOL COMPREHENSI, P127; [王宏镔 Wang Hongbin], 2005, [生态学报, Acta Ecologica Sinica], V25, P596; Warchalowska-Sliwa E, 2005, ENVIRON POLLUT, V133, P373, DOI 10.1016/j.envpol.2004.05.013; Xia Qiang, 2006, Acta Entomologica Sinica, V49, P387; Yang SL, 2013, ENVIRON POLLUT, V177, P64, DOI 10.1016/j.envpol.2013.01.044; Ye GY, 2008, INSECT MOL BIOL, V17, P227, DOI 10.1111/j.1365-2583.2008.00795.x; Zhang Ao, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P131; Zhuang P, 2009, ENVIRON GEOCHEM HLTH, V31, P707, DOI 10.1007/s10653-009-9248-3; Zygmunt PMS, 2006, ENVIRON TOXICOL CHEM, V25, P2709, DOI 10.1897/05-580R.1; 夏嫱, 2005, [科学通报, Chinese Science Bulletin], V50, P2613	75	16	16	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87639	10.1371/journal.pone.0087639	http://dx.doi.org/10.1371/journal.pone.0087639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533059	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600017
J	Perez, OM; Brinkhof, MWG; Egger, M; Frosner, G; Herzog, C; Zwahlen, M				Mayorga Perez, Orlando; Brinkhof, Martin W. G.; Egger, Matthias; Froesner, Gert; Herzog, Christian; Zwahlen, Marcel			Decreasing Risk of Hepatitis A Infection in Leon, Nicaragua: Evidence from Cross-Sectional and Longitudinal Seroepidemiology Studies	PLOS ONE			English	Article							UNIVERSAL VACCINATION; COST-EFFECTIVENESS; VIRUS; SEROPREVALENCE; CHILDREN; EPIDEMIOLOGY; TRANSMISSION; IMMUNIZATION; PREVALENCE; ANTIBODIES	Nicaragua is highly endemic for hepatitis A. We aimed to provide an estimate of the change in the age-specific risk of hepatitis A virus (HAV) infection based on serological data from cross-sectional and longitudinal samples collected in Leon, Nicaragua, in 1995/96 (n = 979) and 2003 (n = 494). Methods: The observed age-specific prevalence of anti-HAV antibodies was correlated to the age-specific risk of infection by calculating the probability of freedom from infection at a specific age. Results: The proportion of seropositive children aged 1.5 to 6 years was 42% in 2003 compared to 67% in 1995/96. Estimated annual risk of infection for a 3-year old child was 30% (95% CI: 27.0%, 33.1%) in 1995 and 15.5% (95% CI: 12.4%, 19.0%) in 2003. There was good agreement between estimates based on cross-sectional and longitudinal data. The age-specific geometric mean of the quantified anti-HAV antibody levels assessed in 2003 was highest at age 4 and decreased steadily up to age 40. Conclusions: The substantially lower risk of HAV infection in 2003 than in 1995 for young children indicates a beginning transition from high to intermediate endemicity in Leon, Nicaragua. Consecutive age-stratified serosurveys are useful to assess changes in risk of infection following public health interventions. The decreasing age-specific GMC of anti-HAV antibodies during adulthood in a country with endemic HAV indirectly suggests that ongoing HAV exposure in the community has marginal boosting effect on antibody levels once protective immunity has been established by natural infection.	[Mayorga Perez, Orlando] Natl Autonomous Univ, Fac Med Sci, Dept Microbiol & Parasitol, Leon, Nicaragua; [Brinkhof, Martin W. G.; Egger, Matthias; Zwahlen, Marcel] Univ Bern, ISPM, Bern, Switzerland; [Froesner, Gert] Univ Munich, Max von Pettenkofer Inst, Munich, Germany; [Herzog, Christian] Crucell Switzerland AG, Bern, Switzerland	University of Bern; University of Munich; Johnson & Johnson	Zwahlen, M (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	zwahlen@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022; Herzog, Christian/AAF-2665-2020	Zwahlen, Marcel/0000-0002-6772-6346; Brinkhof, Martin/0000-0002-9319-665X; Egger, Matthias/0000-0001-7462-5132; Herzog, Christian/0000-0003-3706-5011				ADES AE, 1993, AM J EPIDEMIOL, V137, P1022, DOI 10.1093/oxfordjournals.aje.a116758; Andre FE, 2006, CURR TOP MICROBIOL, V304, P95; [Anonymous], 2012, Wkly Epidemiol Rec, V87; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P201; Barkai G, 2009, PEDIATR INFECT DIS J, V28, P391, DOI 10.1097/INF.0b013e318190655c; Bell BP, 1998, J INFECT DIS, V178, P1579, DOI 10.1086/314518; Brinkhof MWG, 2013, VACCINE, V31, P1490, DOI 10.1016/j.vaccine.2013.01.011; Dagan R, 2005, JAMA-J AM MED ASSOC, V294, P202, DOI 10.1001/jama.294.2.202; de Almeida LM, 2002, T ROY SOC TROP MED H, V96, P605, DOI 10.1016/S0035-9203(02)90325-1; Hanafiah KM, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-57; Jacobsen KH, 2005, INT J EPIDEMIOL, V34, P600, DOI 10.1093/ije/dyi062; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150; Laubereau B, 2000, SCHWEIZ MED WSCHR, V130, P143; Lopez E, 2007, J GASTROENTEROL, V42, P152, DOI 10.1007/s00535-006-1984-x; Ministerio de Salud MINSA, 2007, IND BAS SAL; Ott JJ, 2013, INT J INFECT DIS, V17, pE939, DOI 10.1016/j.ijid.2013.04.012; Perez OM, 2003, J INFECT DIS, V188, P671, DOI 10.1086/377309; Perez OM, 1996, AM J TROP MED HYG, V55, P17, DOI 10.4269/ajtmh.1996.55.1.TM0550010017; Pichichero ME, 2009, PEDIATRICS, V124, P1633, DOI 10.1542/peds.2008-3645; Quezada A, 2008, REV PANAM SALUD PUBL, V23, P303, DOI 10.1590/S1020-49892008000500002; Sartori AMC, 2012, VACCINE, V30, P7489, DOI 10.1016/j.vaccine.2012.10.056; Tanaka J, 2000, VACCINE, V18, pS57, DOI 10.1016/S0264-410X(99)00466-1; Van Damme P, 2005, JAMA-J AM MED ASSOC, V294, P246, DOI 10.1001/jama.294.2.246; Victor JC, 2006, AM J EPIDEMIOL, V163, P204, DOI 10.1093/aje/kwj029; Vizzotti C, 2014, PEDIATR INFECT DIS J, V33, P84, DOI 10.1097/INF.0000000000000042; Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012; World Health Organization, 2011, IMM VACC BIOL IMM BA	28	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e87643	10.1371/journal.pone.0087643	http://dx.doi.org/10.1371/journal.pone.0087643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523871	Green Published, gold			2022-12-27	WOS:000331258100020
J	Pascoe, B; Dams, L; Wilkinson, TS; Harris, LG; Bodger, O; Mack, D; Davies, AP				Pascoe, Ben; Dams, Lucy; Wilkinson, Tom S.; Harris, Llinos G.; Bodger, Owen; Mack, Dietrich; Davies, Angharad P.			Dormant Cells of Staphylococcus aureus Are Resuscitated by Spent Culture Supernatant	PLOS ONE			English	Article							PROMOTING FACTORS; MICROCOCCUS-LUTEUS; PSEUDOMONAS-AERUGINOSA; PLANKTONIC CELLS; BACTERIAL-GROWTH; SER/THR KINASE; RESISTANCE; VIRULENCE; BIOFILM; EPIDERMIDIS	We describe the first in vitro model of dormancy in Staphylococcus aureus, showing that cells are generated which can be resuscitated by addition of spent medium supernatant taken from cultures of the same organism. Over 30 days, culturable counts in dormant cultures of S. aureus SH1000 fell from 10(6)-10(7) cfu/ml to <10 cfu/ml as measured by the Most Probable Number method in liquid culture, while total counts as determined by microscopy, and supported by data from RT-qPCR, remained around 10(6)-10(7) cells/ml. Supplementing cultures with 25-50% spent medium resulted in a >600-fold increase in bacterial growth. Resuscitation was a specific effect, greatly reduced by boiling or addition of trypsin to the spent supernatant. Supernatant also effected a reduction in lag phase of dormant cultures. SEM demonstrated the presence of small coccoid cells in dormant cultures. The results are similar to those seen with resuscitation promoting factors (Rpfs) in actinobacteria. This is the first time resuscitation has been demonstrated in Staphylococcus aureus, which is an important human pathogen. A better understanding of control and reactivation of dormant cells could lead to major improvements in managing staphylococcal infections; resuscitation could be an important step in restoring susceptibility to antibiotic treatment.	[Pascoe, Ben; Dams, Lucy; Wilkinson, Tom S.; Harris, Llinos G.; Bodger, Owen; Mack, Dietrich; Davies, Angharad P.] Swansea Univ Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Mack, Dietrich; Davies, Angharad P.] Publ Hlth Wales Microbiol Swansea, Swansea, W Glam, Wales; [Mack, Dietrich] Inst Med Diagnost GmbH, Bioscientia Lab Ingelheim, Mainz, Germany	Swansea University	Davies, AP (corresponding author), Swansea Univ Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	angharad.p.davies@swansea.ac.uk	Wilkinson, Thomas S/C-5237-2013; Pascoe, Ben/C-2253-2009; Harris, Llinos/AAQ-9477-2021; Pascoe, Ben/AAD-2728-2019; Harris, Llinos G/AAR-5927-2021	Wilkinson, Thomas S/0000-0003-0397-6079; Pascoe, Ben/0000-0001-6376-5121; Harris, Llinos G/0000-0002-0295-3038; Davies, Angharad/0000-0003-4190-8894; Bodger, Owen/0000-0002-4022-9964	Bill and Melinda Gates Foundation [51957]; Wales Office for Research and Development [HA09/010]; MRC [G0801929] Funding Source: UKRI; Medical Research Council [G0801929] Funding Source: researchfish; Health and Care Research Wales [HA-09-010] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wales Office for Research and Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Health and Care Research Wales	This work was funded by the Bill and Melinda Gates Foundation (Grant ID 51957) and the Wales Office for Research and Development (project number HA09/010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000; Cafiso V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029573; Cerca F, 2011, J MED MICROBIOL, V60, P1717, DOI 10.1099/jmm.0.031922-0; Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905; Cohen-Gonsaud M, 2004, TRENDS BIOCHEM SCI, V29, P7, DOI 10.1016/j.tibs.2003.10.009; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Davies AP, 2008, TUBERCULOSIS, V88, P462, DOI 10.1016/j.tube.2008.01.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P803, DOI 10.1093/jac/30.6.803; EVANS DJ, 1991, J ANTIMICROB CHEMOTH, V27, P177, DOI 10.1093/jac/27.2.177; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; HUSSAIN M, 1991, J MED MICROBIOL, V34, P143, DOI 10.1099/00222615-34-3-143; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Kana BD, 2010, FEMS IMMUNOL MED MIC, V58, P39, DOI 10.1111/j.1574-695X.2009.00606.x; Kaprelyants AS, 2012, PROTEIN PEPTIDE LETT, V19, P1026; Kell DB, 2000, CURR OPIN MICROBIOL, V3, P238, DOI 10.1016/S1369-5274(00)00082-5; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lorenz U, 2000, FEMS IMMUNOL MED MIC, V29, P145, DOI 10.1111/j.1574-695X.2000.tb01517.x; Mukamolova GV, 1999, ARCH MICROBIOL, V172, P9, DOI 10.1007/s002030050733; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Mukamolova GV, 2002, MOL MICROBIOL, V46, P611, DOI 10.1046/j.1365-2958.2002.03183.x; MUKAMOLOVA GV, 1995, ANTON LEEUW INT J G, V67, P289, DOI 10.1007/BF00873692; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Pieper R, 2006, PROTEOMICS, V6, P4246, DOI 10.1002/pmic.200500764; Pinto D, 2013, MICROBIOL-SGM, V159, P1390, DOI 10.1099/mic.0.067850-0; Ravagnani A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-39; Reischl U, 2000, J CLIN MICROBIOL, V38, P2429; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Sakata N, 2005, CURR MICROBIOL, V50, P47, DOI 10.1007/s00284-004-4381-9; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shah IM, 2010, MOL MICROBIOL, V75, P1232, DOI 10.1111/j.1365-2958.2010.07046.x; Shleeva MO, 2011, TUBERCULOSIS, V91, P146, DOI 10.1016/j.tube.2010.12.006; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; TAYLOR J, 1962, J APPL BACTERIOL, V25, P54, DOI 10.1111/j.1365-2672.1962.tb01119.x; Wai SN, 2000, ARCH MICROBIOL, V173, P307, DOI 10.1007/s002030000142; Wivagg CN, 2012, ANTIMICROB AGENTS CH, V56, P1591, DOI 10.1128/AAC.06027-11	53	22	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e85998	10.1371/journal.pone.0085998	http://dx.doi.org/10.1371/journal.pone.0085998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523858	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100007
J	Salvaris, M; Haggard, P				Salvaris, Mathew; Haggard, Patrick			Decoding Intention at Sensorimotor Timescales	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SINGLE-TRIAL EEG; EVENT-RELATED DESYNCHRONIZATION; SPATIAL FILTERS; MOVEMENT; IMAGERY; COMMUNICATION; PERFORMANCE; POTENTIALS; SELECTION	The ability to decode an individual's intentions in real time has long been a 'holy grail' of research on human volition. For example, a reliable method could be used to improve scientific study of voluntary action by allowing external probe stimuli to be delivered at different moments during development of intention and action. Several Brain Computer Interface applications have used motor imagery of repetitive actions to achieve this goal. These systems are relatively successful, but only if the intention is sustained over a period of several seconds; much longer than the timescales identified in psychophysiological studies for normal preparation for voluntary action. We have used a combination of sensorimotor rhythms and motor imagery training to decode intentions in a single-trial cued-response paradigm similar to those used in human and non-human primate motor control research. Decoding accuracy of over 0.83 was achieved with twelve participants. With this approach, we could decode intentions to move the left or right hand at sub-second timescales, both for instructed choices instructed by an external stimulus and for free choices generated intentionally by the participant. The implications for volition are considered.	[Salvaris, Mathew; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England	University of London; University College London	Salvaris, M (corresponding author), UCL, Inst Cognit Neurosci, London, England.	m.salvaris@ucl.ac.uk		Haggard, Patrick/0000-0001-7798-793X	Big Questions in Free Will grant from the Templeton Foundation; ESRC grant [RES062-23-2183]; Leverhulme Trust Major Research Fellowship; EU project VERE	Big Questions in Free Will grant from the Templeton Foundation; ESRC grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust Major Research Fellowship; EU project VERE	This research was supported by a Big Questions in Free Will grant from the Templeton Foundation. Patrick Haggard was supported by ESRC grant (RES062-23-2183), by a Leverhulme Trust Major Research Fellowship, and by EU project VERE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Dennett Daniel, 1993, CONSCIOUSNESS EXPLAI; Donchin E, 2009, LECT NOTES ARTIF INT, V5638, P724, DOI 10.1007/978-3-642-02812-0_82; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Filevich E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00202; Fleming SM, 2009, CEREB CORTEX, V19, P2352, DOI 10.1093/cercor/bhn252; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Macmillan N. A., 2004, DETECTION THEORY USE; Morash V, 2008, CLIN NEUROPHYSIOL, V119, P2570, DOI 10.1016/j.clinph.2008.08.013; Muller KR, 2008, J NEUROSCI METH, V167, P82, DOI 10.1016/j.jneumeth.2007.09.022; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Naeem M, 2006, J NEURAL ENG, V3, P208, DOI 10.1088/1741-2560/3/3/003; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; OConnor T., 2011, OXFORD HDB FREE WILL; PFURTSCHELLER G, 1988, ELECTROEN CLIN NEURO, V70, P190, DOI 10.1016/0013-4694(88)90119-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Schneider L, 2013, J COGNITIVE NEUROSCI, V25, P822, DOI 10.1162/jocn_a_00360; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; WISE SP, 1986, PROG BRAIN RES, V64, P117; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	39	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e85100	10.1371/journal.pone.0085100	http://dx.doi.org/10.1371/journal.pone.0085100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523855	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100004
J	Zhu, WY; He, JY; Chen, DD; Zhang, BJ; Xu, LY; Ma, HJ; Liu, XG; Zhang, YK; Le, HB				Zhu, Wangyu; He, Jianying; Chen, Dongdong; Zhang, Bingjie; Xu, Liyun; Ma, Haijie; Liu, XiaoGuang; Zhang, YongKui; Le, Hanbo			Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PLASMA MICRORNAS; SERUM; FAMILY; MARKERS; SIGNATURE; DIAGNOSIS; PROFILES; SURVIVAL; ZEB1	Background: Altered expression of miRNA expression contributes to human carcinogenesis. This study was designed to detect aberrant miRNA expressions as a potential biomarker for early detection and prognosis prediction of non-small cell lung cancer (NSCLC). Methods: miRNA array was used to profile differentially expressed miRNAs and Taqman-based quantitative RT-PCR assays were used to analyze levels of miR-29c, miR-93, and miR-429 expression in NSCLC tissue samples, corresponding normal tissue samples, and serum samples from 70 NSCLC patients as well as in serum samples from 48 healthy controls. Results: Levels of miR-29c and miR-93 expression were upregulated in NSCLC tissues, while serum levels of miR-29c were also upregulated, but levels of serum miR-429 were decreased in NSCLC. Moreover, the levels of miR-429 expression in NSCLC tissues were associated with those in serum samples. Receiver operating characteristic (ROC) curve analysis showed that at the optimal cut-off point, the areas under the ROC curve for serum levels of miR-29c and miR-429 were 0.723 and 0.727, respectively, levels which are higher than that of carcinoma embryonic antigen (0.534) in diagnosis of stage I NSCLC. In addition, serum levels of miR-429 were associated with poor overall survival of NSCLC patients. Both univariate and multivariate analyses showed that serum miR-429 level was an independent prognostic predictor for NSCLC. Conclusions: The results of the current study suggest that detection of serum miR-29c and miR-429 expression should be further evaluated as a novel, non-invasive biomarker for early stage NSCLC.	[Zhu, Wangyu; He, Jianying; Chen, Dongdong; Xu, Liyun; Zhang, YongKui; Le, Hanbo] Zhoushan Hosp, Dept Joint Immunogen Lab, Zhoushan, Zhejiang, Peoples R China; [Zhang, Bingjie; Ma, Haijie; Liu, XiaoGuang] Zhoushan Hosp, Dept Cardiothorac Surg, Zhoushan, Zhejiang, Peoples R China		Zhang, YK (corresponding author), Zhoushan Hosp, Dept Joint Immunogen Lab, Zhoushan, Zhejiang, Peoples R China.	zyk801801@126.com; zslehanbo@163.com			Natural Science Foundation of Zhejiang Province [Y2110960]; Science and Technology Bureau of Zhoushan [10137, 2011C12039]; Medical Bureau of Zhejiang Province [2011KYB165]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Science and Technology Bureau of Zhoushan; Medical Bureau of Zhejiang Province	This study was supported in part by grants from Natural Science Foundation of Zhejiang Province (Y2110960), the Science and Technology Bureau of Zhoushan (10137 and 2011C12039), and from the Medical Bureau of Zhejiang Province (2011KYB165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi F, 2012, ECANCERMEDICALSCIENC, V6, DOI 10.3332/ecancer.2012.246; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen ZH, 2012, PROSTATE, V72, P1443, DOI 10.1002/pros.22495; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Keller A, 2011, RNA BIOL, V8, P506, DOI 10.4161/rna.8.3.14994; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Le HB, 2012, MED ONCOL, V29, P3190, DOI 10.1007/s12032-012-0303-z; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Savita U, 2013, BIOCHEM BIOPH RES CO, V434, P841, DOI 10.1016/j.bbrc.2013.04.025; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393; Zou YC, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/4/047101	31	130	138	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e87780	10.1371/journal.pone.0087780	http://dx.doi.org/10.1371/journal.pone.0087780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523873	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100022
J	Jang, M; Lee, MJ; Lee, JM; Bae, CS; Kim, SH; Ryu, JH; Cho, IH				Jang, Minhee; Lee, Min Jung; Lee, Jin Moo; Bae, Chun-Sik; Kim, Sung-Hoon; Ryu, Jong Hoon; Cho, Ik-Hyun			Oriental Medicine Kyung-Ok-Ko Prevents and Alleviates Dehydroepiandrosterone-Induced Polycystic Ovarian Syndrome in Rats	PLOS ONE			English	Article							DRIED REHMANNIAE RADIX; GENE-EXPRESSION; SYNDROME PCOS; T-CELLS; WOMEN; METFORMIN; MICE; INFLAMMATION; ADOLESCENTS; INFERTILITY	Kyung-Ok-Ko (KOK), a traditional herbal prescription composed of Rehmannia glutinosa Liboschitz var. purpurae, Lycium chinense, Aquillaria agallocha, Poria cocos, Panax ginseng, and honey, has been widely used in traditional Oriental medicine as a vitalizing medicine or as the prescription for patients with age-associated disorders such as amnesia and stroke. However, the potential protective value of KOK for the treatment of polycystic ovarian syndrome (PCOS) is largely unknown. We investigated whether pre-administration (daily from 2 hours before PCOS induction) and post-administration (daily after induction of PCOS) of KOK (0.5, 1.0, and 2.0 g/kg/day, p.o.) could have a protective effect in a dehydroepiandrosterone (DHEA, s. c.)-induced PCOS rat model. Pre-administration of KOK significantly decreased the elevated body weight and ovary weight, elevated size and number of follicular cysts, elevated level of serum glucose, and estradiol after DHEA injection. KOK reduced the elevated percentage of CD8 (+) T lymphocytes in lymph nodes, the elevated mRNA expression of CD11b and CD3 in ovaries, and infiltration of macrophages in ovarian tissue with PCOS. KOK diminished the increased mRNA expression of pro-inflammatory cytokines (IL-1 beta, IL-6, TNF-alpha), chemokines (IL-8, MCP-1), and iNOS in the ovaries, and increased the reduced mRNA expression of growth factors (EGF, TGF-b) by DHEA injection. Post-administration of KOK also improved the DHEA-induced PCOS-like symptoms, generally similar to those evident from pre-administration of KOK. KOK may effectively prevent and improve DHEA-induced PCOS via anti-inflammatory action, indicating its preventive and therapeutic potential for suppressing PCOS.	[Jang, Minhee; Lee, Min Jung; Cho, Ik-Hyun] Kyung Hee Univ, Dept Convergence Med Sci, Seoul, South Korea; [Jang, Minhee; Lee, Min Jung; Kim, Sung-Hoon] Kyung Hee Univ, Dept Canc Prevent Mat Dev, Seoul, South Korea; [Lee, Jin Moo] Kyung Hee Univ, Coll Korean Med, Dept Gynecol, Seoul, South Korea; [Bae, Chun-Sik] Chonnam Natl Univ, Coll Vet Med, Kwangju, South Korea; [Bae, Chun-Sik] Chonnam Natl Univ, Anim Med Inst, Kwangju, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Inst Korean Med, Seoul, South Korea; [Ryu, Jong Hoon] Kyung Hee Univ, Coll Pharm, Dept Oriental Pharmaceut Sci, Seoul, South Korea; [Ryu, Jong Hoon] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Chonnam National University; Chonnam National University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Cho, IH (corresponding author), Kyung Hee Univ, Dept Convergence Med Sci, Seoul, South Korea.	ihcho@khu.ac.kr	Cho, Ik-Hyun/A-9348-2014	Lee, Minjung/0000-0003-4206-6713; kim, sunghoon/0000-0002-1570-3230	Kwang Dong Pharmaceutical Co., Ltd; National Research Foundation of Korea (NRF); Korea government (MSIP) [2007-0054931]	Kwang Dong Pharmaceutical Co., Ltd; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP)	Original study was supported by supported by grant from the Kwang Dong Pharmaceutical Co., Ltd. And study for revision was supported by supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2007-0054931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato G, 2003, OBSTET GYNECOL, V101, P1177, DOI 10.1016/S0029-7844(03)00233-3; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Benson S, 2008, BRAIN BEHAV IMMUN, V22, P177, DOI 10.1016/j.bbi.2007.07.003; Cai M, 2011, J ETHNOPHARMACOL, V138, P723, DOI 10.1016/j.jep.2011.10.016; Carmina E, 1999, J CLIN ENDOCR METAB, V84, P1897, DOI 10.1210/jc.84.6.1897; Cho IH, 2012, J GINSENG RES, V36, P342, DOI 10.5142/jgr.2012.36.4.342; Diamanti-Kandarakis E, 2007, Minerva Endocrinol, V32, P35; Elia E, 2006, MOL HUM REPROD, V12, P475, DOI 10.1093/molehr/gal057; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Ropelato MG, 2009, J CLIN ENDOCR METAB, V94, P3602, DOI 10.1210/jc.2009-0402; Glintborg D, 2009, CLIN ENDOCRINOL, V71, P652, DOI 10.1111/j.1365-2265.2009.03523.x; Goodarzi MO, 2011, FERTIL STERIL, V95, P1736, DOI 10.1016/j.fertnstert.2011.01.015; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Hahn S, 2005, EUR J ENDOCRINOL, V153, P853, DOI 10.1530/eje.1.02024; Hatzirodos N, 2011, FASEB J, V25, P2256, DOI 10.1096/fj.11-181099; Huh J, 1610, DONGUIBOGAM; Ibanez L, 2006, FERTIL STERIL, V86, pS24, DOI 10.1016/j.fertnstert.2006.03.006; Jang M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/237207; Johnson N, 2011, AUST NZ J OBSTET GYN, V51, P125, DOI 10.1111/j.1479-828X.2010.01274.x; 이소연, 2008, [The Korea Journal of Herbology, 대한본초학회지], V23, P123; Kousta E, 1997, HUM REPROD UPDATE, V3, P359, DOI 10.1093/humupd/3.4.359; Krinke G.J., 2000, LAB RAT; KUBO M, 1994, BIOL PHARM BULL, V17, P1282, DOI 10.1248/bpb.17.1282; Lee E. S., 2002, KOR J HERBOL, V17, P101; Lee JC, 2003, AM J CHINESE MED, V31, P885, DOI 10.1142/S0192415X03001636; Lee SM, 2012, J ETHNOPHARMACOL, V141, P368, DOI 10.1016/j.jep.2012.02.048; Legro RS, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu FX, 2002, CLIN EXP IMMUNOL, V128, P10, DOI 10.1046/j.1365-2249.2002.01780.x; Luchetti CG, 2004, J REPROD IMMUNOL, V64, P59, DOI 10.1016/j.jri.2004.04.002; Maharjan R, 2011, J AYURVEDA INTEGR ME, V1, P273; Manneras L, 2008, ENDOCRINOLOGY, V149, P3559, DOI 10.1210/en.2008-0053; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; MEIKLE AW, 1992, J STEROID BIOCHEM, V42, P293, DOI 10.1016/0960-0760(92)90132-3; Musso C, 2005, CLIN ENDOCRINOL, V63, P73, DOI 10.1111/j.1365-2265.2005.02302.x; Nestler JE, 2002, FERTIL STERIL, V77, P209, DOI 10.1016/S0015-0282(01)02963-6; Norman RJ, 2006, ENDOCRINE, V30, P35, DOI 10.1385/ENDO:30:1:35; Obradovic S, 2001, PHARMAZIE, V56, P235; Park Hyun-Jung, 2011, Exp Neurobiol, V20, P137, DOI 10.5607/en.2011.20.3.137; Raja-Khan N, 2011, AM J PHYSIOL-ENDOC M, V301, pE1, DOI 10.1152/ajpendo.00667.2010; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rios JL, 2011, PLANTA MED, V77, P681, DOI 10.1055/s-0030-1270823; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Safadi FF, 2000, ENDOCRINE, V12, P81, DOI 10.1385/ENDO:12:1:81; Sander V, 2006, REPRODUCTION, V131, P591, DOI 10.1530/rep.1.00941; Sapino A, 2003, AM J PATHOL, V163, P1313, DOI 10.1016/S0002-9440(10)63490-6; Schindler AE, 2009, MATURITAS, V65, pS3, DOI 10.1016/j.maturitas.2009.10.011; Sekiya N, 2003, PHYTOTHER RES, V17, P160, DOI 10.1002/ptr.1097; Shin BumYoung, 2009, Journal of Traditional Medicines, V26, P35; Solano ME, 2011, J REPROD IMMUNOL, V92, P33, DOI 10.1016/j.jri.2011.09.003; Taylor AE, 1997, J CLIN ENDOCR METAB, V82, P2248, DOI 10.1210/jc.82.7.2248; Wu RJ, 2004, HUM REPROD UPDATE, V10, P119, DOI 10.1093/humupd/dmh011; Yan G, 2000, J WOMEN HEALTH GEN-B, V9, P275, DOI 10.1089/152460900318461; Ye Y, 2010, J ETHNOPHARMACOL, V129, P387, DOI 10.1016/j.jep.2010.04.009; Yokozawa T, 2004, AM J CHINESE MED, V32, P829, DOI 10.1142/S0192415X04002442; Zhang R, 2010, J ETHNOPHARMACOL, V130, P299, DOI 10.1016/j.jep.2010.05.007; Zhang Y, 2004, EUR J PHARMACOL, V504, P39, DOI 10.1016/j.ejphar.2004.09.051	59	34	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87623	10.1371/journal.pone.0087623	http://dx.doi.org/10.1371/journal.pone.0087623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520334	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600025
J	Paulsen, SJ; Larsen, LK; Hansen, G; Chelur, S; Larsen, PJ; Vrang, N				Paulsen, Sarah Juel; Larsen, Leif Kongskov; Hansen, Gitte; Chelur, Shekar; Larsen, Philip Just; Vrang, Niels			Expression of the Fatty Acid Receptor GPR120 in the Gut of Diet-Induced-Obese Rats and Its Role in GLP-1 Secretion	PLOS ONE			English	Article							PANCREATIC BETA-CELLS	Stimulation of the G protein coupled receptor GPR120 has been shown to have anti-inflammatory and insulin-sensitizing effects, to promote glucagon like peptide-1 (GLP-1) secretion, and to play a key role in sensing dietary fat and control energy balance. In a search for differentially expressed genes potentially involved in food intake and body-weight regulation we identified GPR120 to be differentially regulated in the intestine of selectively bred diet induced obese (DIO) and diet resistant (DR) rats. Subsequently we investigated the effect of GPR120 receptor stimulation with the long chain fatty acid alpha linolenic acid (ALA) on GLP-1 secretion in rats. Independent of diet (high or low fat), GPR120 expression showed a two-fold increase in the intestine of DIO compared to DR rats. In situ hybridization revealed a broad expression of GPR120 in the gut mucosa in both intestinal epithelial and endocrine cells. Using double in situ hybridization GPR120 mRNA did not appear to be enriched in preproglucagon expressing L-cells. In line with the anatomical data, ALA administration did not increase circulating GLP-1 levels. Our data shows a widespread expression of GPR120 in the gut epithelium and can not confirm a major role for GPR120 in the regulation of GLP-1 secretion. The broad expression of GPR120 in the gut epithelium supports reports indicating a putative role of GPR120 as a sensor of dietary fat.	[Paulsen, Sarah Juel; Hansen, Gitte; Vrang, Niels] Gubra, Dept Histol, Horsholm, Denmark; [Larsen, Leif Kongskov] Vipergen Aps, Dept Mol Biol, Copenhagen, Denmark; [Chelur, Shekar] Aurigene Discovery Technol Ltd, Dept Preclin Biol, Bengaluru, India; [Larsen, Philip Just] Sanofi Aventis, Dept Diabet Res & Translat Sci, Frankfurt, Germany	Aurigene Discovery Technologies Limited; Sanofi-Aventis	Vrang, N (corresponding author), Gubra, Dept Histol, Horsholm, Denmark.	niels@gubra.dk		Chelur, Shekar/0000-0001-7017-4063				Duca F.A., 2012, INT J OBES LOND; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Paulsen SJ, 2008, BRAIN RES, V1199, P1, DOI 10.1016/j.brainres.2007.12.074; Sykaras AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042373; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P515, DOI 10.1007/s00210-007-0250-y; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Waguri T, 2013, BIOMED RES-TOKYO, V34, P69, DOI 10.2220/biomedres.34.69; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200	14	49	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88227	10.1371/journal.pone.0088227	http://dx.doi.org/10.1371/journal.pone.0088227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520357	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600048
J	Shin, HY; Kim, H; Kwon, MJ; Hwang, DH; Lee, K; Kim, BG				Shin, Hae Young; Kim, Hyosil; Kwon, Min Jung; Hwang, Dong Hoon; Lee, KiYoung; Kim, Byung Gon			Molecular and Cellular Changes in the Lumbar Spinal Cord following Thoracic Injury: Regulation by Treadmill Locomotor Training	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GENE-EXPRESSION; PRESYNAPTIC FUNCTION; SYNAPTIC PLASTICITY; RECOVERY; ACTIVATION; ARC/ARG3.1; MICROGLIA; CELLS; SYNAPTOGENESIS	Traumatic spinal cord injury (SCI) often leads to debilitating loss of locomotor function. Neuroplasticity of spinal circuitry underlies some functional recovery and therefore represents a therapeutic target to improve locomotor function following SCI. However, the cellular and molecular mechanisms mediating neuroplasticity below the lesion level are not fully understood. The present study performed a gene expression profiling in the rat lumbar spinal cord at 1 and 3 weeks after contusive SCI at T9. Another group of rats received treadmill locomotor training (TMT) until 3 weeks, and gene expression profiles were compared between animals with and without TMT. Microarray analysis showed that many inflammationrelated genes were robustly upregulated in the lumbar spinal cord at both 1 and 3 weeks after thoracic injury. Notably, several components involved in an early complement activation pathway were concurrently upregulated. In line with the microarray finding, the number of microglia substantially increased not only in the white matter but also in the gray matter. C3 and complement receptor 3 were intensely expressed in the ventral horn after injury. Furthermore, synaptic puncta near ventral motor neurons were frequently colocalized with microglia after injury, implicating complement activation and microglial cells in synaptic remodeling in the lumbar locomotor circuitry after SCI. Interestingly, TMT did not influence the injury-induced upregulation of inflammation-related genes. Instead, TMT restored pre-injury expression patterns of several genes that were downregulated by injury. Notably, TMT increased the expression of genes involved in neuroplasticity (Arc, Nrcam) and angiogenesis (Adam8, Tie1), suggesting that TMT may improve locomotor function in part by promoting neurovascular remodeling in the lumbar motor circuitry.	[Shin, Hae Young; Kwon, Min Jung; Hwang, Dong Hoon; Kim, Byung Gon] Ajou Univ, Sch Med, Dept Brain Sci, Suwon 441749, South Korea; [Shin, Hae Young; Kim, Hyosil; Kwon, Min Jung; Hwang, Dong Hoon; Lee, KiYoung; Kim, Byung Gon] Ajou Univ, Sch Med, Dept Biomed Sci, Grad Program Neurosci, Suwon 441749, South Korea; [Kim, Hyosil; Lee, KiYoung] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon 441749, South Korea; [Kim, Byung Gon] Ajou Univ, Sch Med, Dept Neurol, Suwon 441749, South Korea	Ajou University; Ajou University; Ajou University; Ajou University	Lee, K (corresponding author), Ajou Univ, Sch Med, Dept Biomed Sci, Grad Program Neurosci, Suwon 441749, South Korea.	kiylee@ajou.ac.kr; kimbg@ajou.ac.kr	Kim, Byung Gon/L-6884-2019	Kim, Byung Gon/0000-0003-2233-9569	National Research Foundation of Korea (NRF); Korea government (MSIP) [NRF-2009-0069522, NRF2009- 0081466, NRF-2012R1A5A2051429, NRF-2013R1A2A2A04013317]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2009-0069522, NRF2009- 0081466, and NRF-2012R1A5A2051429 to BGK; NRF-2013R1A2A2A04013317 to KYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2011, J SPINAL CORD MED, V34, P488, DOI 10.1179/2045772311Y.0000000028; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Battistuzzo CR, 2012, J NEUROTRAUM, V29, P1600, DOI 10.1089/neu.2011.2199; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Cowell RM, 2003, J NEUROSCI, V23, P9459; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; Di Giovanni S, 2004, FASEB J, V18, P153, DOI 10.1096/fj.04-2694fje; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dobkin BH, 2004, ANN NY ACAD SCI, V1038, P148, DOI 10.1196/annals.1315.024; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Edgerton VR, 2012, EUR J PHYS REHAB MED, V48, P99; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Frigon A, 2006, PROG BRAIN RES, V157, P231, DOI 10.1016/S0079-6123(06)57016-5; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Ghasemlou N, 2010, J NEUROSCI, V30, P13750, DOI 10.1523/JNEUROSCI.2998-10.2010; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Guaiquil VH, 2010, J MOL MED, V88, P497, DOI 10.1007/s00109-010-0591-8; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Hashimoto M, 2005, ACTA NEUROPATHOL, V109, P165, DOI 10.1007/s00401-004-0926-z; HOLNESS CL, 1993, BLOOD, V81, P1607; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Kiryushko D, 2003, J BIOL CHEM, V278, P12325, DOI 10.1074/jbc.M211628200; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MacKay-Lyons M, 2002, PHYS THER, V82, P69, DOI 10.1093/ptj/82.1.69; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mahoney ET, 2009, J COMP NEUROL, V512, P243, DOI 10.1002/cne.21902; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Norton JA, 2008, BRAIN, V131, P1478, DOI 10.1093/brain/awn050; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pajoohesh-Ganji A, 2012, BRAIN RES, V1475, P96, DOI 10.1016/j.brainres.2012.07.058; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Roy RR, 2012, ARCH PHYS MED REHAB, V93, P1487, DOI 10.1016/j.apmr.2012.04.034; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schafer DP, 2010, BIOCHEM SOC T, V38, P476, DOI 10.1042/BST0380476; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Singh H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029319; Singh H, 2011, BIOCHEM SOC T, V39, P1592, DOI 10.1042/BST20110699; Slavik JM, 1999, IMMUNOL RES, V19, P1, DOI 10.1007/BF02786473; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tan AM, 2012, EXP NEUROL, V235, P142, DOI 10.1016/j.expneurol.2011.08.026; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0	66	24	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88215	10.1371/journal.pone.0088215	http://dx.doi.org/10.1371/journal.pone.0088215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520355	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600046
J	Lai, QT; Ma, SW; Ge, J; Huang, ZX; Huang, X; Jiang, XT; Li, YY; Zhang, MX; Zhang, XY; Sun, J; Abbott, WGH; Hou, JL				Lai, Qintao; Ma, Shiwu; Ge, Jun; Huang, Zuxiong; Huang, Xuan; Jiang, Xiaotao; Li, Yongyin; Zhang, Mingxia; Zhang, Xiaoyong; Sun, Jian; Abbott, William G. H.; Hou, Jinlin			TCR gamma delta(+)CD4(-)CD8(-) T Cells Suppress the CD8(+) T-Cell Response to Hepatitis B Virus Peptides, and Are Associated with Viral Control in Chronic Hepatitis B	PLOS ONE			English	Article							E-ANTIGEN; INTRAEPITHELIAL LYMPHOCYTES; HBEAG SEROCONVERSION; EFFECTOR FUNCTIONS; TGF-BETA; HLA-E; LIVER; HBV; IDENTIFICATION; SEROCLEARANCE	The immune mechanisms underlying failure to achieve hepatitis B e antigen (HBeAg) seroconversion associated with viral control in chronic hepatitis B (CHB) remain unclear. Here we investigated the role of CD4(-) CD8(-) T (double-negative T; DNT) cells including TCR alpha beta(+) DNT (alpha beta DNT) and TCR gamma delta(+) DNT (gamma delta DNT) cells. Frequencies of circulating DNT cell subsets were measured by flow cytometry in a retrospective cohort of 51 telbivudine-treated HBeAg-positive CHB patients, 25 immune tolerant carriers (IT), 33 inactive carriers (IC), and 37 healthy controls (HC). We found that gamma delta DNT cell frequencies did not significantly change during treatment, being lower at baseline (P = 0.019) in patients with HBeAg seroconversion after 52 weeks of antiviral therapy (n = 20) than in those without (n = 31), and higher in the total CHB and IT than IC and HC groups (P<0.001). alpha beta DNT cell frequencies were similar for all groups. In vitro, gamma delta DNT cells suppressed HBV core peptide-stimulated interferon-gamma and tumor necrosis factor-a production in TCR alpha beta(+) CD8(+) T cells, which may require cell-cell contact, and could be partially reversed by anti-NKG2A. These findings suggest that gamma delta DNT cells limit CD8(+) T cell response to HBV, and may impede HBeAg seroconversion in CHB.	[Lai, Qintao; Ma, Shiwu; Ge, Jun; Huang, Zuxiong; Huang, Xuan; Jiang, Xiaotao; Li, Yongyin; Zhang, Mingxia; Zhang, Xiaoyong; Sun, Jian; Abbott, William G. H.; Hou, Jinlin] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China; [Lai, Qintao; Ma, Shiwu; Ge, Jun; Huang, Zuxiong; Huang, Xuan; Jiang, Xiaotao; Li, Yongyin; Zhang, Mingxia; Zhang, Xiaoyong; Sun, Jian; Abbott, William G. H.; Hou, Jinlin] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Ma, Shiwu] Kunming Gen Hosp PLA, Dept Infect Dis, Kunming, Peoples R China; [Jiang, Xiaotao] Southern Med Univ, Auckland City Hosp, Basic Med Sch, Dept Immunol, Auckland, New Zealand; [Abbott, William G. H.] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand	Southern Medical University - China; Southern Medical University - China; Kunming General Hospital; Auckland City Hospital; Auckland City Hospital	Hou, JL (corresponding author), Southern Med Univ, Nanfang Hosp, Hepatol Unit, 1838 North Guangzhou Ave, Guangzhou, Guangdong, Peoples R China.	jlhousmu@163.com	, sunjian/Y-6548-2019	Jiang, Xiaotao/0000-0001-7571-1593	National Natural Science Foundation of China [30730082, 81270025]; Major Science and Technology Special Project of China [2012ZX10002-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Special Project of China	This study was supported by grants from the National Natural Science Foundation of China ( No. 30730082 and No. 81270025), Major Science and Technology Special Project of China (2012ZX10002-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Ballester JC, 2012, CYTOM PART B-CLIN CY, V82B, P238, DOI 10.1002/cyto.b.21020; Angelini DF, 2011, J LEUKOCYTE BIOL, V89, P75, DOI 10.1189/jlb.0710413; Ashour HM, 2006, J IMMUNOL, V177, P8331, DOI 10.4049/jimmunol.177.12.8331; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Chang JJ, 2007, HEPATOLOGY, V46, P1332, DOI 10.1002/hep.21844; Chang JJ, 2005, J VIROL, V79, P3038, DOI 10.1128/JVI.79.5.3038-3051.2005; Chen M, 2008, J INFECT DIS, V198, P1643, DOI 10.1086/593065; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Golden-Mason L, 2011, HEPATOLOGY, V54, P1559, DOI 10.1002/hep.24556; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Heydtmann M, 2006, J IMMUNOL, V177, P729, DOI 10.4049/jimmunol.177.1.729; Iwaszko M, 2011, ARCH IMMUNOL THER EX, V59, P353, DOI 10.1007/s00005-011-0137-y; Kuhl AA, 2009, IMMUNOLOGY, V128, P580, DOI 10.1111/j.1365-2567.2009.03162.x; Lau GKK, 2012, J HEPATOL, V56, P753, DOI 10.1016/j.jhep.2011.12.006; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee BO, 2011, IMMUNOLOGY, V134, P434, DOI 10.1111/j.1365-2567.2011.03502.x; Li FL, 2013, GASTROENTEROLOGY, V144, P392, DOI 10.1053/j.gastro.2012.10.039; Li XY, 2011, J IMMUNOL, V186, P6693, DOI 10.4049/jimmunol.1002776; Liang MF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-69; Locke NR, 2006, J IMMUNOL, V176, P6553, DOI 10.4049/jimmunol.176.11.6553; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Ma SW, 2012, J HEPATOL, V56, P775, DOI 10.1016/j.jhep.2011.10.020; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Morsy MA, 2005, LAB INVEST, V85, P285, DOI 10.1038/labinvest.3700219; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Rehermann B, 1996, J CLIN INVEST, V97, P1655, DOI 10.1172/JCI118592; Reignat S, 2002, J EXP MED, V195, P1089, DOI 10.1084/jem.20011723; Reijnders JGP, 2010, GASTROENTEROLOGY, V139, P491, DOI 10.1053/j.gastro.2010.03.059; Ren GX, 2012, AIDS, V26, P2145, DOI 10.1097/QAD.0b013e328359b7ae; Rossol S, 1997, J CLIN INVEST, V99, P3025, DOI 10.1172/JCI119498; Seo N, 1999, J IMMUNOL, V163, P242; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; van der Molen RG, 2004, HEPATOLOGY, V40, P738, DOI 10.1002/hep.20366; Voelkl S, 2011, EUR J IMMUNOL, V41, P739, DOI 10.1002/eji.201040982; Wu JF, 2010, GASTROENTEROLOGY, V138, P165, DOI 10.1053/j.gastro.2009.09.018; Yang HI, 2012, CLIN GASTROENTEROL H, V10, P527, DOI 10.1016/j.cgh.2011.12.019; Ye J, 2013, J IMMUNOL, V190, P2403, DOI 10.4049/jimmunol.1202369; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	44	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88475	10.1371/journal.pone.0088475	http://dx.doi.org/10.1371/journal.pone.0088475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551107	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500041
J	Lee, KY; Lin, SW; Sun, HY; Kuo, CH; Tsai, MS; Wu, BR; Tang, SY; Liu, WC; Chang, SY; Hung, CC				Lee, Kuan-Yeh; Lin, Shu-Wen; Sun, Hsin-Yun; Kuo, Ching-Hua; Tsai, Mao-Song; Wu, Bing-Ru; Tang, Sue-Yo; Liu, Wen-Chun; Chang, Sui-Yuan; Hung, Chien-Ching			Therapeutic Drug Monitoring and Pharmacogenetic Study of HIV-Infected Ethnic Chinese Receiving Efavirenz-Containing Antiretroviral Therapy with or without Rifampicin-Based Anti-Tuberculous Therapy	PLOS ONE			English	Article							POPULATION PHARMACOKINETICS; PLASMA-CONCENTRATIONS; BODY-WEIGHT; CYP2B6; POLYMORPHISMS; ADULTS; INDIVIDUALS; FREQUENCIES; NELFINAVIR; REGIMENS	Objectives: Plasma efavirenz concentrations in HIV-infected patients with tuberculosis (TB) may be affected by cytochrome P450 (CYP) 2B6 single-nucleotide polymorphisms and concurrent rifampicin use. We aimed to investigate the effects of CYP2B6 G516T polymorphisms and concomitant rifampicin use on the plasma efavirenz concentrations in HIV-infected Taiwanese. Methods: HIV-infected patients with or without TB who had received combination antiretroviral therapy containing efavirenz (600 mg daily) for two weeks or greater were enrolled for determinations of CYP2B6 G516T polymorphism and plasma efavirenz concentrations with the use of polymerase-chain-reaction restriction fragment-length polymorphism and high-performance liquid chromatography, respectively. Results: From October 2009 to August 2012, 171 HIV-infected patients, including 18 with TB, were enrolled 113 (66.1%) with CYP2B6 G516G, 55 (32.2%) GT, and 3 (1.8%) TT genotype. Patients receiving rifampicin had a significantly lower median plasma efavirenz concentration than the control group (2.16 vs 2.92 mg/L, P = 0.003); however, all patients achieved target plasma concentration (>1 mg/L). Patients with GT or TT genotype had a significantly higher plasma concentration than those with GG genotype (2.50 vs 3.47 mg/L for GT genotype and 8.78 mg/L for TT genotype, P<0.001). Plasma efavirenz concentration >4 mg/L was noted in 38 (22.2%) patients, which was associated with a lower weight (per 10-kg increase, odds ratio, 0.52; 95% confidence interval, 0.33-0.83) and GT or TT genotype (odds ratio, 4.35; 95% confidence interval, 1.97-9.59) in multivariate analysis. Conclusions: Despite combination with rifampicin, sufficient plasma efavirenz concentrations can be achieved in HIV-infected Taiwanese with TB who receive efavirenz 600 mg daily. Carriage of CYP2B6 516 GT and TT genotypes and a lower weight are associated with higher plasma efavirenz concentrations.	[Lee, Kuan-Yeh] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Lin, Shu-Wen; Tang, Sue-Yo] Natl Taiwan Univ, Grad Inst Clin Pharm, Taipei 10764, Taiwan; [Lin, Shu-Wen; Kuo, Ching-Hua] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lin, Shu-Wen; Sun, Hsin-Yun; Kuo, Ching-Hua; Liu, Wen-Chun; Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Sun, Hsin-Yun; Liu, Wen-Chun; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Kuo, Ching-Hua] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Wu, Bing-Ru; Chang, Sui-Yuan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chang, Sui-Yuan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chang, SY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	sychang@ntu.edu.tw; hcc0401@ntu.edu.tw		Hung, Chien-Ching/0000-0001-7345-0836; CHANG, SUI-YUAN/0000-0002-6009-6724; LIN, SHU-WEN/0000-0002-9940-0850; Wu, Bing-RU/0000-0002-0557-9440; KUO, CHING-HUA/0000-0001-5722-0360; SUN, HSIN-YUN/0000-0003-0074-7721	Centers for Disease Control, Taiwan; Institute for Biotechnology and Medicine Industry, Taiwan	Centers for Disease Control, Taiwan; Institute for Biotechnology and Medicine Industry, Taiwan	This study was supported by grants from the Centers for Disease Control, Taiwan and Institute for Biotechnology and Medicine Industry, Taiwan. The funding sources played no role in study design and conduct, data collection, analysis or interpretation, writing of the manuscript, or the decision to submit it for publication.	BENEDEK IH, 1998, PHARMACOKINETIC INTE; Borand L, 2013, ANTIVIR THER, V18, P419, DOI 10.3851/IMP2483; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; Cohen K, 2009, ANTIVIR THER, V14, P687; Food and Drug Administration, 2013, SUST LAB UPD DOS ADJ; Gatanaga H, 2007, CLIN INFECT DIS, V45, P1230, DOI 10.1086/522175; Guan S, 2006, EUR J PHARM SCI, V29, P14, DOI 10.1016/j.ejps.2006.04.004; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Haas DW, 2004, AIDS, V18, P2391; Hiratsuka M, 2002, EUR J CLIN PHARMACOL, V58, P417, DOI 10.1007/s00228-002-0499-5; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Kwara A, 2008, J CLIN PHARMACOL, V48, P1032, DOI 10.1177/0091270008321790; Kwara A, 2011, AIDS, V25, P388, DOI 10.1097/QAD.0b013e3283427e05; Lopez-Cortes LF, 2002, CLIN PHARMACOKINET, V41, P681, DOI 10.2165/00003088-200241090-00004; Luetkemeyer AF, 2013, CLIN INFECT DIS, V57, P586, DOI 10.1093/cid/cit246; Manosuthi W, 2009, ANTIMICROB AGENTS CH, V53, P4545, DOI 10.1128/AAC.00492-09; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Pfister M, 2003, ANTIMICROB AGENTS CH, V47, P130, DOI 10.1128/AAC.47.1.130-137.2003; Poeta J, 2011, J ANTIMICROB CHEMOTH, V66, P2601, DOI 10.1093/jac/dkr360; Ramachandran G, 2006, J CHROMATOGR B, V835, P131, DOI 10.1016/j.jchromb.2006.03.014; Ramachandran G, 2009, ANTIMICROB AGENTS CH, V53, P863, DOI 10.1128/AAC.00899-08; Stohr W, 2008, ANTIVIR THER, V13, P675; Uttayamakul S, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-8; Wyen C, 2011, J ANTIMICROB CHEMOTH, V66, P2092, DOI 10.1093/jac/dkr272	27	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88497	10.1371/journal.pone.0088497	http://dx.doi.org/10.1371/journal.pone.0088497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551111	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500043
J	Machen, A; Drake, T; Wang, YF				Machen, Alexandra; Drake, Tim; Wang, Yun F. (Wayne)			Same Day Identification and Full Panel Antimicrobial Susceptibility Testing of Bacteria from Positive Blood Culture Bottles Made Possible by a Combined Lysis-Filtration Method with MALDI-TOF VITEK Mass Spectrometry and the VITEK2 System	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; RAPID IDENTIFICATION; MICROORGANISMS; BIOTYPER; IMPACT	Rapid identification and antimicrobial susceptibility testing of microorganisms causing bloodstream infections or sepsis have the potential to improve patient care. This proof-of-principle study evaluates the Lysis-Filtration Method for identification as well as antimicrobial susceptibility testing of bacteria directly from positive blood culture bottles in a clinical setting. A total of 100 non-duplicated positive blood cultures were tested and 1012 microorganism-antimicrobial combinations were assessed. An aliquot of non-charcoal blood culture broth was incubated with lysis buffer briefly before being filtered and washed. Microorganisms recovered from the filter membrane were first identified by using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight VITEK (R) Mass Spectrometry (VITEK MS). After quick identification from VITEK MS, filtered microorganisms were inoculated to VITEK (R) 2 system for full panel antimicrobial susceptibility testing analysis. Of 100 bottles tested, the VITEK MS resulted in 94.0% correct organism identification to the species level. Compared to the conventional antimicrobial susceptibility testing methods, direct antimicrobial susceptibility testing from VITEK (R) 2 resulted in 93.5% (946/1012) category agreement of antimicrobials tested, with 3.6% (36/1012) minor error, 1.7% (7/1012) major error, and 1.3% (13/1012) very major error of antimicrobials. The average time to identification and antimicrobial susceptibility testing was 11.4 hours by using the Lysis-Filtration method for both VITEK MS and VITEK (R) 2 compared to 56.3 hours by using conventional methods (p<0.00001). Thus, the same-day results of microorganism identification and antimicrobial susceptibility testing directly from positive blood culture can be achieved and can be used for appropriate antibiotic therapy and antibiotic stewardship.	[Machen, Alexandra; Wang, Yun F. (Wayne)] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Drake, Tim; Wang, Yun F. (Wayne)] Grady Hlth Syst, Dept Pathol & Lab Med, Atlanta, GA 30303 USA	Emory University	Wang, YF (corresponding author), Grady Hlth Syst, Dept Pathol & Lab Med, Atlanta, GA 30303 USA.	yfwang@emory.edu						Buchan BW, 2012, J CLIN MICROBIOL, V50, P346, DOI 10.1128/JCM.05021-11; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Clerc O, 2013, CLIN INFECT DIS, V56, P1101, DOI 10.1093/cid/cis1204; Drancourt M, 2010, CLIN MICROBIOL INFEC, V16, P1620, DOI 10.1111/j.1469-0691.2010.03290.x; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Fothergill A, 2013, J CLIN MICROBIOL, V51, P805, DOI 10.1128/JCM.02326-12; Gray TJ, 2013, DIAGN MICR INFEC DIS, V77, P110, DOI 10.1016/j.diagmicrobio.2013.06.016; Hayek SS, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.16; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Neville SA, 2011, J CLIN MICROBIOL, V49, P2980, DOI 10.1128/JCM.00431-11; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Perez KK, 2013, ARCH PATHOL LAB MED, V137, P1247, DOI 10.5858/arpa.2012-0651-OA; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Romero-Gomez MP, 2012, J INFECTION, V65, P513, DOI 10.1016/j.jinf.2012.08.013; Schneiderhan W, 2013, CLIN CHEM, V59, P1649, DOI 10.1373/clinchem.2012.198218; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Szabados F, 2011, CLIN MICROBIOL INFEC, V17, P192, DOI 10.1111/j.1469-0691.2010.03229.x; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589; Wang Yun F, 2011, MLO Med Lab Obs, V43, P41; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Wimmer JL, 2012, J CLIN MICROBIOL, V50, P2452, DOI 10.1128/JCM.00409-12	23	101	110	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87870	10.1371/journal.pone.0087870	http://dx.doi.org/10.1371/journal.pone.0087870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551067	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500022
J	Chattopadhyay, C; Grimm, EA; Woodman, SE				Chattopadhyay, Chandrani; Grimm, Elizabeth A.; Woodman, Scott E.			Simultaneous Inhibition of the HGF/MET and Erk1/2 Pathways Affect Uveal Melanoma Cell Growth and Migration	PLOS ONE			English	Article							C-MET; FACTOR RECEPTOR; EXPRESSION; MUTATIONS; LINES; GNAQ; HGF	Purpose: Nearly all primary uveal melanoma (UM) that metastasize involve the liver. Hepatocyte growth factor (HGF) is proposed to be an important microenvironmental element in attracting/supporting UM metastasis through activation of MET. The majority (>85%) of UM express mutations in the G-alpha proteins, that drive the MEK-ERK1/2 pathway. Thus, we proposed that the combination of MET and MEK inhibition would inhibit the growth and migration of G-alpha protein mutant versus non-mutant UM cells. Methods: Western-blots demonstrated the relative protein levels of ERK1/2 and MET in UM cells. Cells were treated with the small molecule inhibitors AZD6244 (MEKi) and/or MK-8033 (METi) and downstream markers evaluated. Further studies determined the effect of combination MEKi and METi treatment on cell growth, apoptosis and migration. Results: All G-alpha protein mutant UM cell lines express MET mRNA and protein. The level of mRNA expression correlates with protein expression. MEKi, but not METi treatment results in markedly reduced ERK1/2 phosphorylation. Either MEKi or METi treatment alone results in reduced cell proliferation, but only modest induction of apoptosis. The combination MEKi+ METi results in significant reduction of proliferation in G-alpha protein mutant cells. UM cell migration was blocked by METi, but not MEKi treatment. Conclusions: MET protein expression showed no correlation with G-alpha protein mutation status. Combining MEKi with METi treatment has added benefit to either treatment alone in reducing G-alpha protein mutant UM cell growth. Combining METi with MEKi treatment adds the effect of limiting uveal melanoma cell migration.	[Chattopadhyay, Chandrani; Grimm, Elizabeth A.; Woodman, Scott E.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Woodman, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	swoodman@mdanderson.org		Woodman, Scott/0000-0002-1157-6991	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Miriam and James Mulva Foundation for Melanoma Research; SPORE Development Award, NCI [P50 CA093459]; NATIONAL CANCER INSTITUTE [P50CA093459, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Miriam and James Mulva Foundation for Melanoma Research; SPORE Development Award, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Miriam and James Mulva Foundation for Melanoma Research (CC and EAG). SEW is partly supported by a SPORE Development Award, NCI (P50 CA093459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MH, 2010, INVEST OPHTH VIS SCI, V51, P3333, DOI 10.1167/iovs.09-4801; Chattopadhyay C, 2012, INT J CANCER, V131, pE56, DOI 10.1002/ijc.26487; Chen PW, 1997, J IMMUNOTHER, V20, P265, DOI 10.1097/00002371-199707000-00003; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Economou MA, 2005, INVEST OPHTH VIS SCI, V46, P4372, DOI 10.1167/iovs.05-0322; Folberg R, 2008, INVEST OPHTH VIS SCI, V49, P4697, DOI 10.1167/iovs.08-2324; Fujita S, 1997, JPN J CLIN ONCOL, V27, P378, DOI 10.1093/jjco/27.6.378; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Janssen CS, 2008, BRIT J CANCER, V99, P1673, DOI 10.1038/sj.bjc.6604731; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Khalili JS, 2012, CLIN CANC RES; Maat W, 2008, INVEST OPHTH VIS SCI, V49, P23, DOI 10.1167/iovs.07-0722; Mallikarjuna K, 2007, CURR EYE RES, V32, P281, DOI 10.1080/02713680601161220; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Surriga O VR, 2013, CANC RES S1, V73; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Topcu-Yilmaz P, 2010, MELANOMA RES, V20, P126, DOI 10.1097/CMR.0b013e328335a916; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; van den Bosch T, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/360136; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Woodman SE, 2012, CANCER J, V18, P148, DOI 10.1097/PPO.0b013e31824bd256; Woodman SE HB, 2010, ARVO ANN M FT LAUD F; Wu XQ, 2012, MELANOMA RES, V22, P123, DOI 10.1097/CMR.0b013e3283507ffd; Yeh I GK, 2011, CANC RES S1, V71	27	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e83957	10.1371/journal.pone.0083957	http://dx.doi.org/10.1371/journal.pone.0083957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551032	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000003
J	Faigle, R; Sharrief, A; Marsh, EB; Llinas, RH; Urrutia, VC				Faigle, Roland; Sharrief, Anjail; Marsh, Elisabeth B.; Llinas, Rafael H.; Urrutia, Victor C.			Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; AMERICAN-HEART-ASSOCIATION; ACUTE CEREBRAL INFARCTION; INTENSIVE-CARE; UNIT ADMISSION; DIABETES-MELLITUS; BLOOD-PRESSURE; RISK; MANAGEMENT; SMOKING	Background and Purpose: Intravenous (IV) tissue plasminogen activator (tPA) is the only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA patients are typically monitored in an intensive care unit (ICU) for at least 24 hours. However, rigorous evidence to support this practice is lacking. This study evaluates factors that predict ICU needs after IV thrombolysis. Methods: A retrospective chart review was performed for 153 patients who received intravenous tPA for acute ischemic stroke. Data on stroke risk factors, physiologic parameters on presentation, and stroke severity were collected. The timing and nature of an intensive care intervention, if needed, was recorded. Using multivariable logistic regression, we determined factors associated with requiring ICU care. Results: African American race (Odds Ratio [OR] 8.05, 95% Confidence Interval [CI] 2.65-24.48), systolic blood pressure, and National Institutes of Health Stroke Scale (NIHSS) (OR 1.20 per point increase, 95% CI 1.09-1.31) were predictors of utilization of ICU resources. Patients with an NIHSS >= 10 had a 7.7 times higher risk of requiring ICU resources compared to patients who presented with an NIHSS<10 (p<0.001). Most patients with ICU needs developed them prior to the end of tPA infusion (81.0%, 95% CI 68.8-93.1). Only 7% of patients without ICU needs by the end of the tPA infusion went on to require ICU care later on. These patients were more likely to have diabetes mellitus and had significantly higher NIHSS compared to patients without further ICU needs (mean NIHSS 17.3, 95% CI 11.5-22.9 vs. 9.2, 95% CI 7.7-9.6). Conclusion: Race, NIHSS, and systolic blood pressure predict ICU needs following tPA for acute ischemic stroke. We propose that patients without ICU needs by the end of the tPA infusion might be safely monitored in a non-ICU setting if NIHSS at presentation is low.	[Faigle, Roland; Sharrief, Anjail; Marsh, Elisabeth B.; Llinas, Rafael H.; Urrutia, Victor C.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Sharrief, Anjail] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA	Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston	Urrutia, VC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	vurruti1@jhmi.edu	Faigle, Roland/ABB-9082-2020; Urrutia, Victor/AAH-6683-2021	Faigle, Roland/0000-0002-9074-1915; Urrutia, Victor/0000-0002-4995-6949; Marsh, Elisabeth/0000-0002-2385-5074; Llinas, Rafael/0000-0002-9161-2699	R25-NIH/NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery	R25-NIH/NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery	RF is supported by an R25 Grant-NIH/NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; BROTT T, 1989, STROKE, V20, P871, DOI 10.1161/01.STR.20.7.871; Bui JQH, 2011, J NEUROSURG, V115, P1236, DOI 10.3171/2011.8.JNS11105; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Demaerschalk BM, 2010, AM J MANAG CARE, V16, P525; Ernst R, 2000, STROKE, V31, P2552, DOI 10.1161/01.STR.31.11.2552; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; Hacke W, 2004, LANCET, V363, P768; Howard G, 2013, JAMA INTERN MED, V173, P46, DOI 10.1001/2013.jamainternmed.857; HOWARD RS, 2003, J NEUROL NEUROSUR PS, V74, P2, DOI DOI 10.1136/JNNP.74.SUPPL_3.III2; Howard VJ, 2011, ANN NEUROL, V69, P619, DOI 10.1002/ana.22385; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; KITTNER SJ, 1990, JAMA-J AM MED ASSOC, V264, P1267, DOI 10.1001/jama.264.10.1267; Kufner A, 2013, STROKE, V44, P407, DOI 10.1161/STROKEAHA.112.662148; Lewandowski CA, 1999, STROKE, V30, P2598, DOI 10.1161/01.STR.30.12.2598; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Manolio TA, 1996, STROKE, V27, P1479, DOI 10.1161/01.STR.27.9.1479; Mensah G. A., 2004, ATLAS HEART DIS STRO; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; OPPENHEIMER SM, 1985, BRIT MED J, V291, P1014, DOI 10.1136/bmj.291.6501.1014-a; Ovbiagele B, 2005, NEUROLOGY, V65, P293, DOI 10.1212/01.WNL.0000168163.72351.f3; Rocco A, 2013, STROKE, V44, P2134, DOI 10.1161/STROKEAHA.111.675918; Rockman CB, 2013, J VASC SURG, V57, P327, DOI 10.1016/j.jvs.2012.08.118; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schneider AT, 2004, STROKE, V35, P1552, DOI 10.1161/01.STR.0000129335.28301.f5; Smith G, 1999, BRIT MED J, V318, P1544, DOI 10.1136/bmj.318.7197.1544; TAYLOR WAS, 1995, J NEUROSURG, V82, P48, DOI 10.3171/jns.1995.82.1.0048; Wang M Y, 2000, J Stroke Cerebrovasc Dis, V9, P64, DOI 10.1053/jscd.2000.0090064; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; WOLF PA, 1988, JAMA-J AM MED ASSOC, V259, P1025, DOI 10.1001/jama.259.7.1025	31	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88652	10.1371/journal.pone.0088652	http://dx.doi.org/10.1371/journal.pone.0088652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533130	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600088
J	Lyngdoh, S; Shrotriya, S; Goyal, SP; Clements, H; Hayward, MW; Habib, B				Lyngdoh, Salvador; Shrotriya, Shivam; Goyal, Surendra P.; Clements, Hayley; Hayward, Matthew W.; Habib, Bilal			Prey Preferences of the Snow Leopard (Panthera uncia): Regional Diet Specificity Holds Global Significance for Conservation	PLOS ONE			English	Article							TROPHIC CASCADES; LARGE CARNIVORES; PREDATION; NEPAL; YELLOWSTONE; LIVESTOCK; WOLVES	The endangered snow leopard is a large felid that is distributed over 1.83million km(2) globally. Throughout its range it relies on a limited number of prey species in some of the most inhospitable landscapes on the planet where high rates of human persecution exist for both predator and prey. We reviewed 14 published and 11 unpublished studies pertaining to snow leopard diet throughout its range. We calculated prey consumption in terms of frequency of occurrence and biomass consumed based on 1696 analysed scats from throughout the snow leopard's range. Prey biomass consumed was calculated based on the Ackerman's linear correction factor. We identified four distinct physiographic and snow leopard prey type zones, using cluster analysis that had unique prey assemblages and had key prey characteristics which supported snow leopard occurrence there. Levin's index showed the snow leopard had a specialized dietary niche breadth. The main prey of the snow leopard were Siberian ibex (Capra sibrica), blue sheep (Pseudois nayaur), Himalayan tahr (Hemitragus jemlahicus), argali (Ovis ammon) and marmots (Marmota spp). The significantly preferred prey species of snow leopard weighed 55 +/- 5 kg, while the preferred prey weight range of snow leopard was 36-76 kg with a significant preference for Siberian ibex and blue sheep. Our meta-analysis identified critical dietary resources for snow leopards throughout their distribution and illustrates the importance of understanding regional variation in species ecology; particularly prey species that have global implications for conservation.	[Lyngdoh, Salvador; Shrotriya, Shivam; Goyal, Surendra P.; Habib, Bilal] Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttarakhand, India; [Clements, Hayley; Hayward, Matthew W.] Nelson Mandela Metropolitan Univ, Port Elizabeth, South Africa; [Hayward, Matthew W.] Bangor Univ, Coll Nat Sci, Bangor, Gwynedd, Wales; [Hayward, Matthew W.] Australian Wildlife Conservancy, Nichols Point, Australia; [Hayward, Matthew W.] Nelson Mandela Metropolitan Univ, Ctr African Conservat Ecol, Port Elizabeth, South Africa	Wildlife Institute of India; Nelson Mandela University; Bangor University; Nelson Mandela University	Habib, B (corresponding author), Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttarakhand, India.	bh@wii.gov.in	Hayward, Matt W./F-3569-2010; Clements, Hayley/H-8549-2019; Lyngdoh, Salvador/AAA-3918-2020	Hayward, Matt W./0000-0002-5574-1653; Clements, Hayley/0000-0002-7015-6532; Lyngdoh, Salvador/0000-0001-9809-0347; Habib, Bilal/0000-0003-0040-6214; Shrotriya, Shivam/0000-0003-0420-5815				ACKERMAN BB, 1984, J WILDLIFE MANAGE, V48, P147, DOI 10.2307/3808462; Anderberg M. R., 1973, CLUSTER ANAL APPL; [Anonymous], 1999, WALKERS MAMMALS WORL; Anwar MB, 2011, EUR J WILDLIFE RES, V57, P1077, DOI 10.1007/s10344-011-0521-2; Aryal A, 2009, FINAL REPORT DEMOGRA; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Bagchi S, 2004, LIVING LARGE CARNIVO; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Birkhofer K, 2012, GLOBAL ECOL BIOGEOGR, V21, P100, DOI 10.1111/j.1466-8238.2011.00654.x; Boitani L, 2012, TECH ECOL CONSERVAT, P1, DOI 10.1093/acprof:oso/9780199558520.001.0001; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Clements H, 2013, J ZOOLOGY IN PRESS; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; Devkota BP, 2010, PREY DENSITY D UNPUB; Diaz-Ruiz F, 2013, MAMMAL REV, V43, P59, DOI 10.1111/j.1365-2907.2011.00206.x; Habib B, 2008, STATUS MAMMALS WAKHA; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2012, J ZOOL, V286, P221, DOI 10.1111/j.1469-7998.2011.00871.x; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Hayward MW, 2011, ACTA OECOL, V37, P314, DOI 10.1016/j.actao.2011.03.003; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; JACKSON R, 1989, NATL GEOGR RES, V5, P161; JACKSON R.M., 2008, IUCN 2012 IUCN RED L; Jackson R. M., 1996, THESIS U LONDON, P233; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Jun W, 2012, RES SNOW LEOPARD PAN; Khatoon R, 2010, DIET SELECTION SNOW; Krebs J.R., 1978, P23; Lovari S, 2009, ANIM CONSERV, V12, P559, DOI 10.1111/j.1469-1795.2009.00285.x; Lozano J, 2006, J BIOGEOGR, V33, P1076, DOI 10.1111/j.1365-2699.2006.01474.x; MacArthur R.H., 1972, pvii; McCarthy T, 2003, SNOW LEOPARD SURVIVA; MILLS MGL, 1992, WILDLIFE 2001 : POPULATIONS, P1112; OLI MK, 1994, J MAMMAL, V75, P998, DOI 10.2307/1382482; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Rege JEO, 2000, P 3 INT C YAK PROD C, P69; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Sathyakumar S., 2009, DEV SPATIAL DATABASE; Schaller G. B., 1977, MOUNTAIN MONARCHS WI; Schaller G. B., 1972, SERENGETI LION STUDY; SCHALLER GB, 1988, BIOL CONSERV, V45, P179, DOI 10.1016/0006-3207(88)90138-3; Sharma, 2010, SNOW LEOPARD CONSERV; Sharma S., 2007, FELID BIOL CONSERVAT, P87; Sharma Sandeep, 2006, P184; Shawl T, 2010, INVESTIGATION UNPUB; Shehzad W, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0UMAL.P0NE.0032104; Shrestha B., 2008, PREY ABUNDANCE PREY; Suryawanshi KR, 2013, J APPL ECOL, P1; Wegge P, 2012, WILDLIFE BIOL, V18, P131, DOI 10.2981/11-049; WINEMILLER KO, 1990, ECOL MONOGR, V60, P27, DOI 10.2307/1943025; Winterbach HEK, 2013, MAMMAL REV, V43, P89, DOI 10.1111/j.1365-2907.2011.00209.x	59	75	80	7	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88349	10.1371/journal.pone.0088349	http://dx.doi.org/10.1371/journal.pone.0088349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533080	Green Published, gold			2022-12-27	WOS:000331262600038
J	Shen, ZZ; Pan, X; Miao, LF; Ye, HQ; Chavanas, S; Davrinche, C; McVoy, M; Luo, MH				Shen, Zhang-Zhou; Pan, Xing; Miao, Ling-Feng; Ye, Han-Qing; Chavanas, Stephane; Davrinche, Christian; McVoy, Michael; Luo, Min-Hua			Comprehensive Analysis of Human Cytomegalovirus MicroRNA Expression during Lytic and Quiescent Infection	PLOS ONE			English	Article							INTRINSIC IMMUNE DEFENSE; EARLY GENE-EXPRESSION; DENDRITIC CELLS; RT-PCR; LATENCY; REACTIVATION; VIRUS; IDENTIFICATION; RECOGNITION; TARGET	Background: Human cytomegalovirus (HCMV) encodes microRNAs (miRNAs) that function as post-transcriptional regulators of gene expression during lytic infection in permissive cells. Some miRNAs have been shown to suppress virus replication, which could help HCMV to establish or maintain latent infection. However, HCMV miRNA expression has not been comprehensively examined and compared using cell culture systems representing permissive (lytic) and semi-permissive vs. non-permissive (latent-like) infection. Methods: Viral miRNAs levels and expression kinetics during HCMV infection were determined by miRNA-specific stem-loop RT-PCR. HCMV infected THP-1 (non-permissive), differentiated THP-1 (d-THP-1, semi-permissive) and human embryo lung fibroblasts (HELs, fully-permissive) were examined. The impact of selected miRNAs on HCMV infection (gene expression, genome replication and virus release) was determined by Western blotting, RT-PCR, qPCR, and plaque assay. Results: Abundant expression of 15 HCMV miRNAs was observed during lytic infection in HELs; highest peak inductions (11- to 1502-fold) occurred at 48 hpl. In d-THP-1s, fourteen mRNAs were detected with moderate induction (3- to 288-fold), but kinetics of expression was generally delayed for 24 h relative to HELs. In contrast, only three miRNAs were induced to low levels (3- to 4-fold) during quiescent infection in THP-1s. Interestingly, miR-UL70-3p was poorly induced in HEL (1.5-fold), moderately in THP-1s (4-fold), and strongly (58-fold) in d-THP-1s, suggesting a potentially specific role for miR-UL70-3p in THP-1s and d-THP-1s. MiR-US33, -UL22A and -UL70 were further evaluated for their impact on HCMV replication in HELs. Ectopic expression of miR-UL22A and miR-UL70 did not affect HCMV replication in HELs, whereas miR-US33 inhibited HCMV replication and reduced levels of HCMV US29 mRNA, confirming that US29 is a target of miR-US33. Conclusions: Viral miRNA expression kinetics differs between permissive, semi-permissive and quiescent infections, and miR-US33 down-regulates HCMV replication. These results suggest that miR-US33 may function to impair entry into lytic replication and hence promote establishment of latency.	[Shen, Zhang-Zhou; Pan, Xing; Miao, Ling-Feng; Ye, Han-Qing; Luo, Min-Hua] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Chavanas, Stephane; Davrinche, Christian] Univ Toulouse 3, INSERM, CNRS, U1043,U5282, F-31062 Toulouse, France; [McVoy, Michael] Virginia Commonwealth Univ, Sch Med, Dept Pediat, Richmond, VA USA	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Virginia Commonwealth University	Luo, MH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	luomh@wh.iov.cn	Chavanas, stephane/K-1183-2014	chavanas, stephane/0000-0003-4323-2656	National Program on Key Basic Research Project (973 program) [2011CB504804, 2012CB519003]; National Natural Science Foundation of China [81071350, 81271850, 31170155, 31000090]; Scientific Innovation Project of the Chinese Academy of Sciences [XDB02050500, XDA0104107]	National Program on Key Basic Research Project (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Innovation Project of the Chinese Academy of Sciences	This work was supported by the National Program on Key Basic Research Project (973 program 2011CB504804 and 2012CB519003), the National Natural Science Foundation of China (81071350, 81271850, 31170155, and 31000090), and the Scientific Innovation Project of the Chinese Academy of Sciences (XDB02050500, XDA0104107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CG, 2013, J VIROL; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Beisser PS, 2001, J VIROL, V75, P5949, DOI 10.1128/JVI.75.13.5949-5957.2001; Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Casavant NC, 2006, J VIROL, V80, P8390, DOI 10.1128/JVI.00505-06; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dhuruvasan K, 2011, VIRUS RES, V157, P180, DOI 10.1016/j.virusres.2010.10.011; DREW WL, 1988, REV INFECT DIS, V10, pS468; Duan YL, 2012, ACTA BIOCH BIOPH SIN, V44, P597, DOI 10.1093/abbs/gms041; Dunn W, 2005, CELL MICROBIOL, V7, P1684, DOI 10.1111/j.1462-5822.2005.00598.x; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Goodrum F, 2012, CELL MICROBIOL, V14, P644, DOI 10.1111/j.1462-5822.2012.01774.x; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Huang YJ, 2013, J BIOSCIENCES, V38, P479, DOI 10.1007/s12038-013-9353-4; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Jayarama V, 2006, TRANSFUSION, V46, P1580, DOI 10.1111/j.1537-2995.2006.00926.x; Keyes LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052827; Lee CH, 1999, MOL CELLS, V9, P37; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Liang DG, 2011, CELL RES, V21, P793, DOI 10.1038/cr.2011.5; Lin XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016224; Meier JL, 1997, J VIROL, V71, P1246, DOI 10.1128/JVI.71.2.1246-1255.1997; Mercorelli B, 2011, PHARMACOL THERAPEUT, V131, P309, DOI 10.1016/j.pharmthera.2011.04.007; Michelini Z, 2010, METHODS MOL BIOL, V614, P101, DOI 10.1007/978-1-60761-533-0_6; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Qin Q, 2013, J VIROL; Qin Zhi-feng, 2012, Virologica Sinica, V27, P120, DOI 10.1007/s12250-012-3232-2; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Saffert RT, 2006, J VIROL, V80, P3863, DOI 10.1128/JVI.80.8.3863-3871.2006; Saffert RT, 2007, J VIROL, V81, P9109, DOI 10.1128/JVI.00827-07; Sanchez V, 2012, VIROLOGY, V433, P64, DOI 10.1016/j.virol.2012.07.015; SINCLAIR JH, 1992, J GEN VIROL, V73, P433, DOI 10.1099/0022-1317-73-2-433; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Sinclair J, 2010, BBA-GENE REGUL MECH, V1799, P286, DOI 10.1016/j.bbagrm.2009.08.001; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; STAGNO S, 1980, NEW ENGL J MED, V302, P1073, DOI 10.1056/NEJM198005083021908; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Stern-Ginossar N, 2009, J VIROL, V83, P10684, DOI 10.1128/JVI.01292-09; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tirabassi R, 2011, J VIROL, V85, P11938, DOI 10.1128/JVI.05443-11; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tuddenham L, 2011, BBA-GENE REGUL MECH, V1809, P613, DOI 10.1016/j.bbagrm.2011.04.002; TURTINEN LW, 1994, MICROB PATHOGENESIS, V16, P373, DOI 10.1006/mpat.1994.1037; WEINSHENKER BG, 1988, J IMMUNOL, V140, P1625; Wen L, 1996, Zhonghua Fu Chan Ke Za Zhi, V31, P714; Yee LF, 2007, VIROLOGY, V363, P174, DOI 10.1016/j.virol.2007.01.036; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100	59	41	47	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88531	10.1371/journal.pone.0088531	http://dx.doi.org/10.1371/journal.pone.0088531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533100	Green Published, gold			2022-12-27	WOS:000331262600058
J	Worm, BS; Krag, M; Jensen, K				Worm, Bjarne Skjodt; Krag, Mette; Jensen, Kenneth			Ultrasound-Guided Nerve Blocks - Is Documentation and Education Feasible Using Only Text and Pictures?	PLOS ONE			English	Article							HIGH-RESOLUTION SONOGRAPHY; REGIONAL ANESTHESIA; SYSTEM	Purpose: With the advancement of ultrasound-guidance for peripheral nerve blocks, still pictures from representative ultrasonograms are increasingly used for clinical procedure documentation of the procedure and for educational purposes in textbook materials. However, little is actually known about the clinical and educational usefulness of these still pictures, in particular how well nerve structures can be identified compared to real-time ultrasound examination. We aimed to quantify gross visibility or ultrastructure using still picture sonograms compared to real time ultrasound for trainees and experts, for large or small nerves, and discuss the clinical or educational relevance of these findings. Materials and Methods: We undertook a clinical study to quantify the maximal gross visibility or ultrastructure of seven peripheral nerves identified by either real time ultrasound (clinical cohort, n=635) or by still picture ultrasonograms (clinical cohort, n=112). In addition, we undertook a study on test subjects (n=4) to quantify interobserver variations and potential bias among expert and trainee observers. Results: When comparing real time ultrasound and interpretation of still picture sonograms, gross identification of large nerves was reduced by 15% and 40% by expert and trainee observers, respectively, while gross identification of small nerves was reduced by 29% and 66%. Identification of within-nerve ultrastructure was even less. For all nerve sizes, trainees were unable to identify any anatomical structure in 24 to 34%, while experts were unable to identify anything in 9 to 10%. Conclusion: Exhaustive ultrasonography experience and real time ultrasound measurements seem to be keystones in obtaining optimal nerve identification. In contrast the use of still pictures appears to be insufficient for documentation as well as educational purposes. Alternatives such as video clips or enhanced picture technology are encouraged instead of still pictures extracted from basic ultrasonograms.	[Worm, Bjarne Skjodt; Krag, Mette; Jensen, Kenneth] Copenhagen Univ Hosp Bispebjerg, Dept Anaesthesia & Intens Care, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Worm, BS (corresponding author), Copenhagen Univ Hosp Bispebjerg, Dept Anaesthesia & Intens Care, Copenhagen, Denmark.	bsworm@gmail.com		Krag, Mette/0000-0002-5246-8727				Beekman R, 2004, EUR J NEUROL, V11, P305, DOI 10.1111/j.1468-1331.2004.00773.x; Brasseur JL, 2004, EUR RADIOL, V14, P1770, DOI 10.1007/s00330-004-2401-6; Bretholz A, 2012, PEDIATR EMERG CARE, V28, P506, DOI 10.1097/PEC.0b013e3182586f42; Cataldo R, 2012, BMC ANESTHESIOL, V12, DOI 10.1186/1471-2253-12-33; Choquet O, 2012, CURR OPIN ANESTHESIO, V25, P596, DOI 10.1097/ACO.0b013e328356bb40; Jensen K, 2011, REG ANESTH PAIN MED, V36, pE171; Luyet C, 2010, ANESTHESIOLOGY RES P, V6, P1; Marhofer P, 2008, ULTRASOUND GUIDANCE; Moore DL, 2012, PEDIATR ANESTH, V22, P847, DOI 10.1111/j.1460-9592.2012.03888.x; Neal JM, 2010, REGION ANESTH PAIN M, V35, pS1, DOI 10.1097/AAP.0b013e3181d22fe0; Peer S, 2008, MED RADIOL DIAGN IMA, P1, DOI 10.1007/978-3-540-49084-5_1; SILVESTRI E, 1995, RADIOLOGY, V197, P291, DOI 10.1148/radiology.197.1.7568840; Valentin L, 2009, MINIMUM TRAINING REQ; Walsted M, 2011, REG ANESTH PAIN MED, V36, pE171; Westacott DJ, 2011, HIP INT, V21, P637, DOI 10.5301/HIP.2011.8759	15	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e86966	10.1371/journal.pone.0086966	http://dx.doi.org/10.1371/journal.pone.0086966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533051	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600009
J	Aronson, D; Nakhleh, M; Zeidan-Shwiri, T; Mutlak, M; Lavie, P; Lavie, L				Aronson, Doron; Nakhleh, Morad; Zeidan-Shwiri, Tawfiq; Mutlak, Michael; Lavie, Peretz; Lavie, Lena			Clinical Implications of Sleep Disordered Breathing in Acute Myocardial Infarction	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; CORONARY-ARTERY-DISEASE; PULMONARY-HYPERTENSION; CARDIOVASCULAR-DISEASE; HEART-FAILURE; OXIDATIVE STRESS; APNEA SYNDROME; ASSOCIATION; HEALTH; IMPACT	Background: Sleep disordered breathing (SDB), characterized by nightly intermittent hypoxia, is associated with multiple pathophysiologic alterations that may adversely affect patients with acute myocardial infarction (AMI). This prospective study investigated whether the metabolic perturbations associated with SDB are present when these patients develop AMI and if they affect clinical outcomes. Methods: We prospectively enrolled 180 AMI patients. SDB was defined as oxygen desaturation index (ODI) >5 events/hour based on a Watch Pat-100 sleep study. Blood samples were obtained for high-sensitivity C-reactive protein (hs-CRP) and markers of oxidative stress (lipid peroxides [PD] and serum paraoxonase-1 [PON-1] (arylesterase activity). Echocardiography was performed to evaluate cardiac dimensions and pulmonary artery systolic pressure. Results: SDB was present in 116 (64%) patients. Hs-CRP levels, PD and PON-1 were similar in patients with and without SDB. Echocardiography revealed higher left atrial dimension (4.1 +/- 0.5 vs 3.8 +/- 0.5 cm; P = 0.003) and a significant positive correlation between ODI and pulmonary artery systolic pressure (r = 0.41, P<0.0001). After a median follow up of 68 months, no significant differences were observed between the study groups with regard to clinical outcomes, including death, heart failure, myocardial infarction and unstable angina. Conclusion: There is a high prevalence of previously undiagnosed SDB among patients with AMI. SDB in the setting of AMI is associated with higher pulmonary artery systolic pressure. SDB was not associated with adverse clinical outcomes.	[Aronson, Doron; Nakhleh, Morad; Zeidan-Shwiri, Tawfiq; Mutlak, Michael] Rambam Med Ctr, Dept Cardiol, Haifa, Israel; [Lavie, Peretz; Lavie, Lena] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Lloyd Rigler Sleep Apnea Res Lab, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Aronson, D (corresponding author), Rambam Med Ctr, Dept Cardiol, Haifa, Israel.	daronson@tx.technion.ac.il	Lavie, Peretz/AAC-2736-2020; Aronson, Doron/F-3390-2010		internal departmental sources; LEDLER Foundation	internal departmental sources; LEDLER Foundation	The study was funded by internal departmental sources and by the LEDLER Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Berger S, 2013, AM J RESP CRIT CARE, V187, P90, DOI 10.1164/rccm.201206-1144OC; Burke A, 2003, PROG CARDIOVASC DIS, V46, P79, DOI 10.1016/S0033-0620(03)00076-8; Chami HA, 2008, CIRCULATION, V117, P2599, DOI 10.1161/CIRCULATIONAHA.107.717892; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; ELSAADANI M, 1989, J LIPID RES, V30, P627; FRANKLIN KA, 1995, LANCET, V345, P1085, DOI 10.1016/S0140-6736(95)90820-X; Golbin Jason M, 2008, Proc Am Thorac Soc, V5, P200, DOI 10.1513/pats.200708-143MG; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Haendeler J, 2004, CIRCULATION, V110, P856, DOI 10.1161/01.CIR.0000138743.09012.93; Hamilton GS, 2008, SLEEP, V31, P809, DOI 10.1093/sleep/31.6.809; Hui DS, 2004, CHEST, V125, P1768, DOI 10.1378/chest.125.5.1768; Kim SH, 2008, AM J CARDIOL, V101, P1663, DOI 10.1016/j.amjcard.2008.01.056; Konecny T, 2010, J AM COLL CARDIOL, V56, P742, DOI 10.1016/j.jacc.2010.04.032; Lavie L, 2004, SLEEP, V27, P123; Lavie L, 2010, CHEST, V137, P511, DOI 10.1378/chest.09-2657; Lavie L, 2009, PROG CARDIOVASC DIS, V51, P303, DOI 10.1016/j.pcad.2008.08.003; Lee CH, 2009, CHEST, V135, P1488, DOI 10.1378/chest.08-2336; Marin JM, 1998, SLEEP, V21, P809; McNicholas WT, 2009, PROG CARDIOVASC DIS, V51, P392, DOI 10.1016/j.pcad.2008.10.005; Mehra R, 2006, SLEEP MED, V7, P521, DOI 10.1016/j.sleep.2006.03.012; Mooe T, 1996, CHEST, V109, P659, DOI 10.1378/chest.109.3.659; Mooe T, 1996, AM J MED, V101, P251, DOI 10.1016/S0002-9343(96)00122-2; Mutlak D, 2012, AM J CARDIOL, V109, P1254, DOI 10.1016/j.amjcard.2011.12.035; Nakashima H, 2006, EUR HEART J, V27, P2317, DOI 10.1093/eurheartj/ehl219; Pittman SD, 2004, SLEEP, V27, P923, DOI 10.1093/sleep/27.5.923; Sajkov D, 2009, PROG CARDIOVASC DIS, V51, P363, DOI 10.1016/j.pcad.2008.06.001; Kuniyoshi FHS, 2008, J AM COLL CARDIOL, V52, P343, DOI 10.1016/j.jacc.2008.04.027; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Steiner S, 2010, CHEST, V137, P516, DOI 10.1378/chest.09-1136; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tkacova R, 1998, CIRCULATION, V98, P2269, DOI 10.1161/01.CIR.98.21.2269; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18; Yumino D, 2007, AM J CARDIOL, V99, P26, DOI 10.1016/j.amjcard.2006.07.055; Zeidan-Shwiri T, 2011, HEART RHYTHM, V8, P657, DOI 10.1016/j.hrthm.2010.12.030	37	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88878	10.1371/journal.pone.0088878	http://dx.doi.org/10.1371/journal.pone.0088878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523943	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100092
J	Blamires, SJ; Sahni, V; Dhinojwala, A; Blackledge, TA; Tso, IM				Blamires, Sean J.; Sahni, Vasav; Dhinojwala, Ali; Blackledge, Todd A.; Tso, I-Min			Nutrient Deprivation Induces Property Variations in Spider Gluey Silk	PLOS ONE			English	Article							VISCOUS CAPTURE THREADS; WESTERN BLACK-WIDOW; MECHANICAL-PROPERTIES; WEB ARCHITECTURE; STICKINESS; PERFORMANCE; DROPLETS; ELASTICITY; EVOLUTION; PROTEINS	Understanding the mechanisms facilitating property variability in biological adhesives may promote biomimetic innovations. Spider gluey silks such as the spiral threads in orb webs and the gumfoot threads in cobwebs, both of which comprise of an axial thread coated by glue, are biological adhesives that have variable physical and chemical properties. Studies show that the physical and chemical properties of orb web gluey threads change when spiders are deprived of food. It is, however, unknown whether gumfoot threads undergo similar property variations when under nutritional stress. Here we tested whether protein deprivation induces similar variations in spiral and gumfoot thread morphology and stickiness. We manipulated protein intake for the orb web spider Nephila clavipes and the cobweb spider Latrodectus hesperus and measured the diameter, glue droplet volume, number of droplets per mm, axial thread width, thread stickiness and adhesive energy of their gluey silks. We found that the gluey silks of both species were stickier when the spiders were deprived of protein than when the spiders were fed protein. In N. clavipes a concomitant increase in glue droplet volume was found. Load-extension curves showed that protein deprivation induced glue property variations independent of the axial thread extensions in both species. We predicted that changes in salt composition of the glues were primarily responsible for the changes in stickiness of the silks, although changes in axial thread properties might also contribute. We, additionally, showed that N. clavipes' glue changes color under protein deprivation, probably as a consequence of changes to its biochemical composition.	[Blamires, Sean J.; Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Sahni, Vasav; Dhinojwala, Ali] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA; [Blackledge, Todd A.] Univ Akron, Dept Biol, Integrated Biosci Program, Akron, OH 44325 USA	Tunghai University; University System of Ohio; University of Akron; University System of Ohio; University of Akron	Tso, IM (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	spider@thu.edu.tw			National Science Council, Taiwan (SJB, IMT); Experimental Biology Traveling Fellowship (SJB); National Science Foundation, USA; Austen Bioinnovation Institute, University of Akron; Direct For Mathematical & Physical Scien [1105370] Funding Source: National Science Foundation	National Science Council, Taiwan (SJB, IMT); Experimental Biology Traveling Fellowship (SJB); National Science Foundation, USA(National Science Foundation (NSF)); Austen Bioinnovation Institute, University of Akron; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Council, Taiwan (SJB, IMT), a Journal of Experimental Biology Traveling Fellowship (SJB), the National Science Foundation, USA, and the Austen Bioinnovation Institute, University of Akron (VS, AD, TAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x; Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x; Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001; Blackledge TA, 2007, ANIM BEHAV, V73, P855, DOI 10.1016/j.anbehav.2006.10.014; Blamires SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054558; Blamires SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031626; BONTHRONE KM, 1992, P ROY SOC B-BIOL SCI, V248, P141, DOI 10.1098/rspb.1992.0054; Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487; Boutry C, 2013, J EXP BIOL, V216, P3606, DOI 10.1242/jeb.084236; Brubaker CE, 2012, LANGMUIR, V28, P2200, DOI 10.1021/la300044v; Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292; CRAIG CL, 1994, EVOLUTION, V48, P287, DOI [10.2307/2410093, 10.1111/j.1558-5646.1994.tb01312.x]; Craig CL, 2003, SPIDERWEBS SILK TRAC; Foelix R., 2011, BIOL SPIDERS, V3; Gay C, 2002, INTEGR COMP BIOL, V42, P1123, DOI 10.1093/icb/42.6.1123; Guinea GV, 2010, BIOMACROMOLECULES, V11, P1174, DOI 10.1021/bm901285c; Harmer AMT, 2011, J R SOC INTERFACE, V8, P457, DOI 10.1098/rsif.2010.0454; Higgins L, 1999, PHYSIOL ENTOMOL, V24, P263, DOI 10.1046/j.1365-3032.1999.00135.x; Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e; Koch AL, 1997, MICROBIOL MOL BIOL R, V61, P305, DOI 10.1128/.61.3.305-318.1997; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002; Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Opell BD, 2010, J EXP BIOL, V213, P339, DOI 10.1242/jeb.036947; OPELL BD, 1989, J ARACHNOL, V17, P112; Opell BD, 2008, J EXP ZOOL PART A, V309A, P11, DOI 10.1002/jez.426; Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682; Opell BD, 2013, J EXP BIOL, V216, P3023, DOI 10.1242/jeb.084822; Opell BD, 2011, J EXP BIOL, V214, P2988, DOI 10.1242/jeb.055996; Opell BD, 2009, J EXP ZOOL PART A, V311A, P217, DOI 10.1002/jez.526; OSAKI S, 1989, Acta Arachnologica, V38, P21, DOI 10.2476/asjaa.38.21; Perry DJ, 2010, BIOMACROMOLECULES, V11, P3000, DOI 10.1021/bm1007585; Peters H.M., 1987, P187; Pouchkina NN, 2003, INSECT BIOCHEM MOLEC, V33, P229, DOI 10.1016/S0965-1748(02)00207-2; Pugno NM, 2013, SMALL, V9, P2747, DOI 10.1002/smll.201201343; Putthanarat S, 2004, POLYMER, V45, P1933, DOI 10.1016/j.polymer.2004.01.020; Sahni V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2099; Sahni V, 2012, LANGMUIR, V28, P2206, DOI 10.1021/la203275x; Sahni V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00041; Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019; Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420; Tarakanova A, 2012, J R SOC INTERFACE, V9, P3240, DOI 10.1098/rsif.2012.0473; Tillinghast E.K., 1987, P203; Torres FG, 2014, MAT SCI ENG C-MATER, V34, P341, DOI 10.1016/j.msec.2013.09.030; Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0; VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0; Wu CC, 2013, J EXP BIOL, V216, P3342, DOI 10.1242/jeb.083618; Zax DB, 2004, BIOMACROMOLECULES, V5, P732, DOI 10.1021/bm034309x; Zevenbergen JM, 2008, ANIM BEHAV, V76, P823, DOI 10.1016/j.anbehav.2008.05.008	51	19	19	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88487	10.1371/journal.pone.0088487	http://dx.doi.org/10.1371/journal.pone.0088487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523902	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100051
J	Jagtap, JC; Dawood, P; Shah, RD; Chandrika, G; Natesh, K; Shiras, A; Hegde, AS; Ranade, D; Shastry, P				Jagtap, Jayashree C.; Dawood, Parveen; Shah, Reecha D.; Chandrika, Goparaju; Natesh, Kumar; Shiras, Anjali; Hegde, Amba S.; Ranade, Deepak; Shastry, Padma			Expression and Regulation of Prostate Apoptosis Response-4 (Par-4) in Human Glioma Stem Cells in Drug-Induced Apoptosis	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; PANCREATIC-CANCER CELLS; TUMOR-SUPPRESSOR PAR-4; INDUCED RAPID DEATH; NF-KAPPA-B; DOWN-REGULATION; SENSITIZES; INDUCTION; INACTIVATION; RESISTANCE	Gliomas are the most common and aggressive of brain tumors in adults. Cancer stem cells (CSC) contribute to chemoresistance in many solid tumors including gliomas. The function of prostate apoptosis response-4 (Par-4) as a proapoptotic protein is well documented in many cancers; however, its role in CSC remains obscure. In this study, we aimed to explore the role of Par-4 in drug-induced cytotoxicity using human glioma stem cell line -HNGC-2 and primary culture (G1) derived from high grade glioma. We show that among the panel of drugs-lomustine, carmustine, UCN-01, oxaliplatin, temozolomide and tamoxifen (TAM) screened, only TAM induced cell death and up-regulated Par-4 levels significantly. TAMinduced apoptosis was confirmed by PARP cleavage, Annexin V and propidium iodide staining and caspase-3 activity. Knock down of Par-4 by siRNA inhibited cell death by TAM, suggesting the role of Par-4 in induction of apoptosis. We also demonstrate that the mechanism involves break down of mitochondrial membrane potential, down regulation of Bcl-2 and reduced activation of Akt and ERK 42/44. Secretory Par-4 and GRP-78 were significantly expressed in HNGC-2 cells on exposure to TAM and specific antibodies to these molecules inhibited cell death suggesting that extrinsic Par-4 is important in TAM-induced apoptosis. Interestingly, TAM decreased the expression of neural stem cell markers - Nestin, Bmi1, Vimentin, Sox2, and Musashi in HNGC-2 cell line and G1 cells implicating its potential as a stemness inhibiting drug. Based on these data and our findings that enhanced levels of Par-4 sensitize the resistant glioma stem cells to drug-induced apoptosis, we propose that Par-4 may be explored for evaluating anti-tumor agents in CSC.	[Jagtap, Jayashree C.; Dawood, Parveen; Shah, Reecha D.; Chandrika, Goparaju; Natesh, Kumar; Shiras, Anjali; Hegde, Amba S.; Shastry, Padma] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Ranade, Deepak] DY Patil Med Coll, Dept Neurosurg, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical College, Hospital & Research Centre	Shastry, P (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	padma@nccs.res.in			Indian Council of Medical Research (ICMR) [REF-53/6/2010 -BMS]; Council of Scientific and Industrial Research (CSIR)	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The project is funded by Indian Council of Medical Research (ICMR), REF-53/6/2010 -BMS. PD and RS are research assistants in the Indian Council of Medical Research (ICMR) project. GC and KN are research fellows supported by Council of Scientific and Industrial Research (CSIR), INDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JV, 2013, CANCER CELL, V24, P30, DOI 10.1016/j.ccr.2013.05.007; Azmi AS, 2008, MOL CANCER THER, V7, P2884, DOI 10.1158/1535-7163.MCT-08-0438; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Batista LFZ, 2007, CANCER RES, V67, P11886, DOI 10.1158/0008-5472.CAN-07-2964; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Benzina S, 2008, CANCER LETT, V264, P63, DOI 10.1016/j.canlet.2008.01.023; Block M, 2012, INT J ONCOL, V41, P1845, DOI 10.3892/ijo.2012.1591; Boehrer S, 2002, CANCER RES, V62, P1768; Boehrer S, 2002, LEUKEMIA LYMPHOMA, V43, P1737, DOI 10.1080/1042819021000006510; Burikhanov R, 2013, CANCER RES, V73, P1011, DOI 10.1158/0008-5472.CAN-12-3212; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chakraborty M, 2001, CANCER RES, V61, P7255; Chaudhry P, 2012, MOL CELL BIOL, V32, P826, DOI 10.1128/MCB.06321-11; Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Cook J, 1999, ONCOGENE, V18, P1205, DOI 10.1038/sj.onc.1202416; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; Diaz-Meco MT, 1999, J BIOL CHEM, V274, P19606, DOI 10.1074/jbc.274.28.19606; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; El-Guendy N, 2003, EXP CELL RES, V283, P51, DOI 10.1016/S0014-4827(02)00016-2; Franchitto A, 2010, AM J PATHOL, V177, P1779, DOI 10.2353/ajpath.2010.091171; Hui AM, 2004, CANCER RES, V64, P9115, DOI 10.1158/0008-5472.CAN-04-2740; Irby RB, 2013, EXPERT OPIN THER TAR, V17, P77, DOI 10.1517/14728222.2013.731047; Joshi J, 2008, EMBO J, V27, P2181, DOI 10.1038/emboj.2008.149; Kallio A, 2005, APOPTOSIS, V10, P1395, DOI 10.1007/s10495-005-2137-z; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee JW, 2007, CANCER LETT, V257, P252, DOI 10.1016/j.canlet.2007.08.004; Lee TJ, 2010, J CELL BIOCHEM, V109, P885, DOI 10.1002/jcb.22504; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lu C, 2008, MOL CELL BIOCHEM, V312, P71, DOI 10.1007/s11010-008-9722-8; Matsuoka H, 2009, EXP CELL RES, V315, P2022, DOI 10.1016/j.yexcr.2009.04.009; Meng QH, 2005, ACTA PHARMACOL SIN, V26, P492, DOI 10.1111/j.1745-7254.2005.00087.x; Moreno-Bueno G, 2007, CANCER RES, V67, P1927, DOI 10.1158/0008-5472.CAN-06-2687; Nalca A, 1999, J BIOL CHEM, V274, P29976, DOI 10.1074/jbc.274.42.29976; Parney IF, 2003, CANCER J, V9, P149, DOI 10.1097/00130404-200305000-00003; Patel S, 2012, INT J RADIAT ONCOL, V82, P739, DOI 10.1016/j.ijrobp.2010.12.053; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Qiu GF, 1999, ONCOGENE, V18, P623, DOI 10.1038/sj.onc.1202344; Rah B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044039; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sabioni P, 2008, PROG NEURO-PSYCHOPH, V32, P1927, DOI 10.1016/j.pnpbp.2008.09.023; Sai K, 2012, J NEURO-ONCOL, V107, P487, DOI 10.1007/s11060-011-0786-z; Shiras A, 2003, NEOPLASIA, V5, P520, DOI 10.1016/S1476-5586(03)80036-2; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Shrestha-Bhattarai T, 2010, ONCOGENE, V29, P3873, DOI 10.1038/onc.2010.141; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spence AM, 2004, J NEURO-ONCOL, V70, P91, DOI 10.1023/B:NEON.0000040837.68411.97; Tait MJ, 2007, BRIT J NEUROSURG, V21, P496, DOI 10.1080/02688690701449251; Tan JX, 2014, TOXICOL LETT, V224, P7, DOI 10.1016/j.toxlet.2013.10.008; Thayyullathil Faisal, 2013, J Mol Signal, V8, P2, DOI 10.1186/1750-2187-8-2; Vetterkind S, 2005, INT J ONCOL, V26, P159; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang BD, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-98; XIAO HG, 1994, J NEUROSURG, V81, P734, DOI 10.3171/jns.1994.81.5.0734; Yakisich Juan Sebastian, 2012, DRUGS THERAPY STUDIE, V2; Zheng AP, 2007, ENDOCRINOLOGY, V148, P2764, DOI 10.1210/en.2006-1269	56	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88505	10.1371/journal.pone.0088505	http://dx.doi.org/10.1371/journal.pone.0088505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523904	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100053
J	Oey, M; Ross, IL; Hankamer, B				Oey, Melanie; Ross, Ian L.; Hankamer, Ben			Gateway-Assisted Vector Construction to Facilitate Expression of Foreign Proteins in the Chloroplast of Single Celled Algae	PLOS ONE			English	Article							CHLAMYDOMONAS; TRANSFORMATION	With a rising world population, demand will increase for food, energy and high value products. Renewable production systems, including photosynthetic microalgal biotechnologies, can produce biomass for foods, fuels and chemical feedstocks and in parallel allow the production of high value protein products, including recombinant proteins. Such high value recombinant proteins offer important economic benefits during startup of industrial scale algal biomass and biofuel production systems, but the limited markets for individual recombinant proteins will require a high throughput pipeline for cloning and expression in microalgae, which is currently lacking, since genetic engineering of microalgae is currently complex and laborious. We have introduced the recombination based Gateway (R) system into the construction process of chloroplast transformation vectors for microalgae. This simplifies the vector construction and allows easy, fast and flexible vector design for the high efficiency protein production in microalgae, a key step in developing such expression pipelines.	[Oey, Melanie; Ross, Ian L.; Hankamer, Ben] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Hankamer, B (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	b.hankamer@uq.edu.au	Hankamer, Ben D/C-9688-2015; Oey, Melanie/H-3873-2016; Oey, Melanie/N-9517-2019; Ross, Ian/A-8622-2011	Hankamer, Ben D/0000-0001-9284-4929; Oey, Melanie/0000-0001-9290-0580; Oey, Melanie/0000-0001-9290-0580; Ross, Ian/0000-0002-2389-4292	Australian Research Council [DP110101699, DP130100346]	Australian Research Council(Australian Research Council)	Financial support for this work has been derived from the Australian Research Council through the award of grants DP110101699 and DP130100346. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERTHOLD DA, 1995, J BIOL CHEM, V270, P29293, DOI 10.1074/jbc.270.49.29293; Bock R, 2001, J MOL BIOL, V312, P425, DOI 10.1006/jmbi.2001.4960; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Chen HC, 2013, PLANT BIOTECHNOL J, V11, P818, DOI 10.1111/pbi.12073; Daniell Henry, 2006, Biotechnology Journal, V1, P1071, DOI 10.1002/biot.200600145; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; Franklin S, 2002, PLANT J, V30, P733, DOI 10.1046/j.1365-313X.2002.01319.x; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gregory JA, 2013, APPL ENVIRON MICROB, V79, P3917, DOI 10.1128/AEM.00714-13; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Surzycki R, 2009, BIOLOGICALS, V37, P133, DOI 10.1016/j.biologicals.2009.02.005; Tran M, 2013, P NATL ACAD SCI USA, V110, pE15, DOI 10.1073/pnas.1214638110; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000	17	19	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e86841	10.1371/journal.pone.0086841	http://dx.doi.org/10.1371/journal.pone.0086841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523866	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100015
J	Zhang, G; Bogdanova, N; Gao, T; Song, JJ; Cragg, MS; Glennie, MJ; Sheikh, KA				Zhang, Gang; Bogdanova, Nataliia; Gao, Tong; Song, Julia J.; Cragg, Mark S.; Glennie, Martin J.; Sheikh, Kazim A.			Fc gamma Receptor-Mediated Inflammation Inhibits Axon Regeneration	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; PERIPHERAL-NERVE INJURY; ANTIGANGLIOSIDE ANTIBODIES; ANTI-GD1A ANTIBODY; CLINICAL RECOVERY; SCIATIC-NERVE; IGG SUBCLASS; MICE; GANGLIOSIDES; EXPRESSION	Anti-glycan/ganglioside antibodies are the most common immune effectors found in patients with Guillain-Barre Syndrome, which is a peripheral autoimmune neuropathy. We previously reported that disease-relevant anti-glycan autoantibodies inhibited axon regeneration, which echo the clinical association of these antibodies and poor recovery in Guillain-Barre Syndrome. However, the specific molecular and cellular elements involved in this antibody-mediated inhibition of axon regeneration are not previously defined. This study examined the role of Fc gamma receptors and macrophages in the antibody-mediated inhibition of axon regeneration. A well characterized antibody passive transfer sciatic nerve crush and transplant models were used to study the anti-ganglioside antibody-mediated inhibition of axon regeneration in wild type and various mutant and transgenic mice with altered expression of specific Fc gamma receptors and macrophage/microglia populations. Outcome measures included behavior, electrophysiology, morphometry, immunocytochemistry, quantitative real-time PCR, and western blotting. We demonstrate that the presence of autoantibodies, directed against neuronal/axonal cell surface gangliosides, in the injured mammalian peripheral nerves switch the proregenerative inflammatory environment to growth inhibitory milieu by engaging specific activating Fc gamma receptors on recruited monocyte-derived macrophages to cause severe inhibition of axon regeneration. Our data demonstrate that the antibody orchestrated Fc gamma receptor-mediated switch in inflammation is one mechanism underlying inhibition of axon regeneration. These findings have clinical implications for nerve repair and recovery in antibody-mediated immune neuropathies. Our results add to the complexity of axon regeneration in injured peripheral and central nervous systems as adverse effects of B cells and autoantibodies on neural injury and repair are increasingly recognized.	[Zhang, Gang; Bogdanova, Nataliia; Gao, Tong; Song, Julia J.; Sheikh, Kazim A.] Univ Texas Med Sch Houston, Dept Neurol, Houston, TX 77030 USA; [Cragg, Mark S.; Glennie, Martin J.] Univ Southampton, Fac Med, Canc Sci Div, Antibody & Vaccine Grp, Southampton SO9 5NH, Hants, England	University of Texas System; University of Texas Health Science Center Houston; University of Southampton	Sheikh, KA (corresponding author), Univ Texas Med Sch Houston, Dept Neurol, Houston, TX 77030 USA.	kazim.sheikh@uth.tmc.edu	Cragg, Mark S/E-5965-2010	Cragg, Mark S/0000-0003-2077-089X	National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01 NS42888, R01 NS54962]; GBS/CIDP Foundation International; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054962, R01NS042888] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); GBS/CIDP Foundation International; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurological Disorders and Stroke (NIH/NINDS; grant R01 NS42888 and R01 NS54962) and GBS/CIDP Foundation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankeny DP, 2010, TRENDS IMMUNOL, V31, P332, DOI 10.1016/j.it.2010.06.006; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Cajal S., 1928, DEGENERATION REGENER; Carpo M, 1999, J NEUROL SCI, V168, P78, DOI 10.1016/S0022-510X(99)00173-2; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Goodfellow JA, 2005, J NEUROSCI, V25, P1620, DOI 10.1523/JNEUROSCI.4279-04.2005; Goodyear CS, 1999, J CLIN INVEST, V104, P697, DOI 10.1172/JCI6837; Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758; Halstead SK, 2005, ANN NEUROL, V58, P203, DOI 10.1002/ana.20546; Halstead SK, 2008, J PERIPHER NERV SYST, V13, P228, DOI 10.1111/j.1529-8027.2008.00181.x; Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Kaida K, 2007, J NEUROIMMUNOL, V182, P212, DOI 10.1016/j.jneuroim.2006.09.013; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Koga M, 2003, NEUROLOGY, V60, P1514, DOI 10.1212/01.WNL.0000061615.77865.83; Kuwabara S, 1998, NEUROLOGY, V51, P1656, DOI 10.1212/WNL.51.6.1656; Kuwabara S, 1998, ANN NEUROL, V44, P202, DOI 10.1002/ana.410440210; Lehmann HC, 2007, J NEUROSCI, V27, P27, DOI 10.1523/JNEUROSCI.4017-06.2007; LETOURNEUR O, 1991, J IMMUNOL, V147, P2652; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Lopez PH, 2010, J NEUROSCI, V30, P9533, DOI 10.1523/JNEUROSCI.2281-10.2010; Lopez PHH, 2008, BRAIN, V131, P1926, DOI 10.1093/brain/awn074; Lunn MPT, 2000, J NEUROCHEM, V75, P404, DOI 10.1046/j.1471-4159.2000.0750404.x; Ma CHE, 2011, J CLIN INVEST, V121, P4332, DOI 10.1172/JCI58675; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; NYLAND H, 1980, NEW ENGL J MED, V302, P120; Press R, 2001, J NEUROL SCI, V190, P41, DOI 10.1016/S0022-510X(01)00580-9; Sahenk Z, 1999, ANN NEUROL, V45, P16, DOI 10.1002/1531-8249(199901)45:1<16::AID-ART5>3.0.CO;2-F; SCHWARTZ M, 1982, J NEUROCHEM, V38, P1192, DOI 10.1111/j.1471-4159.1982.tb07890.x; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Sheikh KA, 1998, ANN NY ACAD SCI, V845, P307, DOI 10.1111/j.1749-6632.1998.tb09683.x; Sheikh KA, 2010, F1000 BIOL REP, V2, P21; Su KH, 2004, J IMMUNOL, V172, P7186, DOI 10.4049/jimmunol.172.11.7186; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; ULVESTAD E, 1994, J NEUROL SCI, V121, P125, DOI 10.1016/0022-510X(94)90340-9; van der Pol WL, 2000, NEUROLOGY, V54, P1661, DOI 10.1212/WNL.54.8.1661; van Sorge NM, 2005, J NEUROIMMUNOL, V162, P157, DOI 10.1016/j.jneuroim.2005.01.016; VASS K, 1993, LAB INVEST, V69, P275; VEDELER CA, 1992, J NEUROSCI RES, V31, P654, DOI 10.1002/jnr.490310409; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; YUKI N, 1992, MUSCLE NERVE, V15, P899, DOI 10.1002/mus.880150806; YUKI N, 1993, MUSCLE NERVE, V16, P642, DOI 10.1002/mus.880160610; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhang Y, 2011, DISCOV MED, V11, P395	51	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88703	10.1371/journal.pone.0088703	http://dx.doi.org/10.1371/journal.pone.0088703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523933	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100082
J	Chen, YC; Wang, LY; Chang, YJ; Yang, CP; Wu, TJ; Lin, FR; Liu, SY; Wei, TS				Chen, Yen-Chun; Wang, Lien-Yen; Chang, Yu-Jun; Yang, Chao-Pin; Wu, Tsung-Ju; Lin, Fung-Ru; Liu, Sen-Yung; Wei, Ta-Sen			Potential Risk of Malposition of Nasogastric Tube Using Nose-Ear-Xiphoid Measurement	PLOS ONE			English	Article							ASPIRATION PNEUMONIA; PLACEMENT; PREDICTORS; PH; COMPLICATION	Background: Correct placement of nasogastric tubes provide proper functionality and maximize benefit and minimize risk. The Nose-Ear-Xiphoid (NEX) body surface estimate method is a long-lasting technique, and this study was conducted to evaluate the correlation between NEX method and the secure insertion depth of nasogastric tube. Materials and Methods: Thirty patients with nasogastric tube insertion who received whole body positron emission tomography with computerized tomography scan (PET-CT) were recruited. All data were gathered in the image center, which included Nose-Ear (NE), Ear-Xiphoid (EX), Nose-Ear-Xiphoid (NEX), glabella-xiphoid (GX) and glabella-umbilicus (GU) lengths. The distances of the inserted portion of the nasogastric tube between the cardiac and the nostril were measured by multiplanar reconstruction algorithm. Results: Only one patient successfully placed all side-holes into the stomach while using NEX method to estimate inserting depth. Twenty-nine patients (96.7%) failed to place correctly. Fourteen participants had one or more side-holes in both the esophagus and the stomach sides. Fifteen patients could not pass through any side-hole across the gastroesophageal junction. They had shorter EX distances (p = 0.02), but no difference among the NE distances. Body height had the highest statistical correlation with nasogastric tube length (adjusted R-2 = 0.459), as compared with the NEX, GX and GU body surface methods. Conclusion: This study suggests that NEX method is inappropriate for adult patients to estimate the ideal inserting length of nasogastric tube. Physicians should realize these underinsertions with any side-hole above the gastroesophageal junctions may increase the potential risk of complications.	[Chen, Yen-Chun; Yang, Chao-Pin; Wu, Tsung-Ju; Liu, Sen-Yung; Wei, Ta-Sen] Changhua Christian Hosp, Dept Phys Med & Rehabil, Changhua, Taiwan; [Wang, Lien-Yen; Lin, Fung-Ru] Changhua Christian Hosp, Dept Nucl Med, Changhua, Taiwan; [Chang, Yu-Jun] Changhua Christian Hosp, Lab Epidemiol & Biostat, Changhua, Taiwan; [Liu, Sen-Yung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University	Liu, SY (corresponding author), Changhua Christian Hosp, Dept Phys Med & Rehabil, Changhua, Taiwan.	sunyunykimo@yahoo.com.tw; 10945@cch.org.tw		Chang, Yu-Jun/0000-0002-1433-6002; Wu, Tsung Ju/0000-0002-3428-4887				ASKENASI R, 1984, ANN EMERG MED, V13, P146, DOI 10.1016/S0196-0644(84)80594-6; Dennis M, 2005, LANCET, V365, P2005, DOI 10.1016/S0140-6736(05)66691-3; Dornan T, 2006, CORE CLIN SKILLS OSC, P241; ELGAMEL A, 1993, HEART LUNG, V22, P224; Ellett Marsha L Cirgin, 2004, Gastroenterol Nurs, V27, P253, DOI 10.1097/00001610-200411000-00002; Gharpure V, 2000, CRIT CARE MED, V28, P2962, DOI 10.1097/00003246-200008000-00046; Grap MJ, 2005, AM J CRIT CARE, V14, P325; Jin P, 2011, J CHIN MOD NURS, V7; John EH, 2011, GUYTON HALL TXB MED, P763; Klasner AE, 2002, ANN EMERG MED, V39, P268, DOI 10.1067/mem.2002.120124; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Langmore SE, 2002, DYSPHAGIA, V17, P298, DOI 10.1007/s00455-002-0072-5; Lee SD, 2004, J CLIN GASTROENTEROL, V38, P861, DOI 10.1097/00004836-200411000-00005; Levin AL., 1921, JAMA-J AM MED ASSOC, V76, P1007; Liang HL, 2004, MOD J INTEGR TRADIT, V13, P1485; METHENY N, 1994, NURS RES, V43, P282; METHENY N, 1993, NURS RES, V42, P324; Metheny NA, 1997, JPEN-PARENTER ENTER, V21, P279, DOI 10.1177/0148607197021005279; Metheny NA, 2001, AM J NURS, V101, P36, DOI 10.1097/00000446-200105000-00017; NEUMANN MJ, 1995, J CLIN GASTROENTEROL, V20, P293, DOI 10.1097/00004836-199506000-00007; Newton M, 2000, J CLIN GASTROENTEROL, V30, P264, DOI 10.1097/00004836-200004000-00012; O'Keefe S, 2012, NUTR CLIN PRACT, V27, P76, DOI 10.1177/0884533611432935; Proehl JA, 2011, J EMERG NURS, V37, P357, DOI 10.1016/j.jen.2011.04.011; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; SCALZO A J, 1992, Journal of Emergency Medicine, V10, P581, DOI 10.1016/0736-4679(92)90142-G; Thomsen TW, 2006, NEW ENGL J MED, V354, DOI 10.1056/NEJMvcm050183; TORRES A, 1992, ANN INTERN MED, V116, P540, DOI 10.7326/0003-4819-116-7-540; WALD P, 1986, ANN EMERG MED, V15, P80, DOI 10.1016/S0196-0644(86)80493-0	28	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88046	10.1371/journal.pone.0088046	http://dx.doi.org/10.1371/journal.pone.0088046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520344	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600035
J	Kroger, A; Hof, K; Krick, C; Siniatchkin, M; Jarczok, T; Freitag, CM; Bender, S				Kroeger, Anne; Hof, Katharina; Krick, Christoph; Siniatchkin, Michael; Jarczok, Tomasz; Freitag, Christine M.; Bender, Stephan			Visual Processing of Biological Motion in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Event Related Potential-Study	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; DEVELOPMENTAL-CHANGES; EVOKED POTENTIALS; SPECTRUM DISORDER; ASPERGER SYNDROME; TIME-COURSE; PERCEPTION; BRAIN; METHYLPHENIDATE; SYMPTOMS	Attention-deficit/hyperactivity disorder (ADHD) is often accompanied by problems in social behaviour, which are sometimes similar to some symptoms of autism-spectrum disorders (ASD). However, neuronal mechanisms of ASD-like deficits in ADHD have rarely been studied. The processing of biological motion-recently discussed as a marker of social cognition-was found to be disrupted in ASD in several studies. Thus in the present study we tested if biological motion processing is disrupted in ADHD. We used 64-channel EEG and spatio-temporal source analysis to assess event-related potentials associated with human motion processing in 21 children and adolescents with ADHD and 21 matched typically developing controls. On the behavioural level, all subjects were able to differentiate between human and scrambled motion. But in response to both scrambled and biological motion, the N200 amplitude was decreased in subjects with ADHD. After a spatio-temporal dipole analysis, a human motion specific activation was observable in occipital-temporal regions with a reduced and more diffuse activation in ADHD subjects. These results point towards neuronal determined alterations in the processing of biological motion in ADHD.	[Kroeger, Anne; Hof, Katharina; Siniatchkin, Michael; Jarczok, Tomasz; Freitag, Christine M.; Bender, Stephan] Goethe Univ Hosp Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Krick, Christoph] Saarland Univ Hosp, Dept Neuroradiol, Homburg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Universitatsklinikum des Saarlandes	Kroger, A (corresponding author), Goethe Univ Hosp Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany.	Anne.Kroeger@kgu.de	Bender, Stephan/AAT-1266-2021	Freitag, Christine Margarete/0000-0001-9676-4782	foundation of Marie Christine Held and Erika Hecker; German Research foundation "Deutsche Forschungsgemeinschaft'' [FR2069/2-1]; LOEWE-Program "Neuronal Coordination Research Focus Frankfurt'' (NeFF)	foundation of Marie Christine Held and Erika Hecker; German Research foundation "Deutsche Forschungsgemeinschaft''(German Research Foundation (DFG)); LOEWE-Program "Neuronal Coordination Research Focus Frankfurt'' (NeFF)	There were no industrial funders. This work was supported by the foundation of Marie Christine Held and Erika Hecker to AK, the German Research foundation "Deutsche Forschungsgemeinschaft'' to CMF (FR2069/2-1), and by the LOEWE-Program "Neuronal Coordination Research Focus Frankfurt'' (NeFF) to CMF and SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; [Anonymous], 2000, DSM 4 TR DIAGN STAT; Arbeitsgruppe Kinder Jugendlichen und Familiendiagnsotik, 1998, CBCL 4 18 ELTERNFRAG; Berridge CW, 2011, BIOL PSYCHIAT, V69, pE101, DOI 10.1016/j.biopsych.2010.06.023; Bolte S, 2000, DIAGNOSTICA, V46, P149, DOI 10.1026//0012-1924.46.3.149; Bolte S., 2006, FRAGEBOGEN SOZIALEN; Bolte S., 2006, DIAGNOSTISCHES INTER; Bulheller S, 2003, RAVENSS PROGR MATRIC; Dopfner M, 2008, DIAGNOSTIK SYSTEM PS, V3; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Freitag CM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-6; Greene RW, 1997, J CONSULT CLIN PSYCH, V65, P758, DOI 10.1037/0022-006X.65.5.758; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grossmann T, 2007, EUR J NEUROSCI, V25, P909, DOI 10.1111/j.1460-9568.2007.05379.x; Grzadzinski R, 2011, J AUTISM DEV DISORD, V41, P1178, DOI 10.1007/s10803-010-1135-3; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Herrington JD, 2007, RES AUTISM SPECT DIS, V1, P14, DOI 10.1016/j.rasd.2006.07.002; Hirai M, 2005, COGNITIVE BRAIN RES, V22, P301, DOI 10.1016/j.cogbrainres.2004.08.008; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; Hirai M, 2009, NEUROSCIENCE, V161, P311, DOI 10.1016/j.neuroscience.2009.03.026; Hirai M, 2008, J VISION, V8, DOI 10.1167/8.16.2; Hoffmann M, 1999, VISION RES, V39, P437, DOI 10.1016/S0042-6989(98)00186-2; Hucker HO, 2002, COLOURED PROGR MATRI; Jokisch D, 2005, BEHAV BRAIN RES, V157, P195, DOI 10.1016/j.bbr.2004.06.025; Kaiser MD, 2012, DEV COGN NEUROS-NETH, V2, P25, DOI 10.1016/j.dcn.2011.05.005; Kaiser MD, 2012, SOC NEUROSCI-UK, V7, P301, DOI 10.1080/17470919.2011.614003; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Kochhar P, 2011, CHILD CARE HLTH DEV, V37, P103, DOI 10.1111/j.1365-2214.2010.01123.x; Krakowski AI, 2011, NEUROIMAGE, V56, P373, DOI 10.1016/j.neuroimage.2011.01.058; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; Kroger A, 2011, EUR CHILD ADOLES PSY, V20, P561, DOI 10.1007/s00787-011-0221-1; KUBOVA Z, 1995, VISION RES, V35, P197, DOI 10.1016/0042-6989(94)00138-C; McKay LS, 2012, NEUROIMAGE, V59, P1524, DOI 10.1016/j.neuroimage.2011.08.033; Miller LE, 2013, COGNITION, V128, P140, DOI 10.1016/j.cognition.2013.03.013; Mulligan A, 2009, J AUTISM DEV DISORD, V39, P197, DOI 10.1007/s10803-008-0621-3; Nackaerts E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044473; Niedeggen M, 1999, COGNITIVE BRAIN RES, V8, P95, DOI 10.1016/S0926-6410(99)00009-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pavlova M, 2004, CEREB CORTEX, V14, P181, DOI 10.1093/cercor/bhg117; Pavlova M, 2009, J COGNITIVE NEUROSCI, V21, P837, DOI 10.1162/jocn.2009.21050; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Prieto EA, 2007, NEUROIMAGE, V37, P1384, DOI 10.1016/j.neuroimage.2007.03.080; Reiersen AM, 2008, J AM ACAD CHILD PSY, V47, P662, DOI 10.1097/CHI.0b013e31816bff88; Reiersen AM, 2007, J CHILD PSYCHOL PSYC, V48, P464, DOI 10.1111/j.1469-7610.2006.01720.x; Santosh P, 2004, EUR CHILD ADOLESC PS, V13; Schendan HE, 2007, J COGNITIVE NEUROSCI, V19, P734, DOI 10.1162/jocn.2007.19.5.734; Schneider S., 2009, KINDER DIPS DIAGNOST, V2nd; Senderecka M, 2012, INT J PSYCHOPHYSIOL, V85, P106, DOI 10.1016/j.ijpsycho.2011.05.006; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Storebo OJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037280; Storebo OJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008223.pub2; Taylor MJ, 1999, CLIN NEUROPHYSIOL, V110, P910, DOI 10.1016/S1388-2457(99)00006-1; Taylor MJ, 1995, J PSYCHOPHYSIOL, V9, P283; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Tse J, 2007, J AUTISM DEV DISORD, V37, P1960, DOI 10.1007/s10803-006-0343-3; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Urban KR, 2013, MED HYPOTHESES, V81, P988, DOI 10.1016/j.mehy.2013.09.009; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Williams LM, 2008, BIOL PSYCHIAT, V63, P917, DOI 10.1016/j.biopsych.2007.11.022; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yano M, 2007, TRENDS PHARMACOL SCI, V28, P588, DOI 10.1016/j.tips.2007.10.004	65	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88585	10.1371/journal.pone.0088585	http://dx.doi.org/10.1371/journal.pone.0088585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520402	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600093
J	Shen, MZ; Wang, L; Yang, GD; Gao, L; Wang, B; Guo, XW; Zeng, C; Xu, Y; Shen, LL; Cheng, K; Xia, YS; Li, XM; Wang, HC; Fan, L; Wang, XM				Shen, Mingzhi; Wang, Lin; Yang, Guodong; Gao, Lei; Wang, Bo; Guo, Xiaowang; Zeng, Chao; Xu, Yong; Shen, Liangliang; Cheng, Ke; Xia, Yuesheng; Li, Xiumin; Wang, Haichang; Fan, Li; Wang, Xiaoming			Baicalin Protects the Cardiomyocytes from ER Stress-Induced Apoptosis: Inhibition of CHOP through Induction of Endothelial Nitric Oxide Synthase	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CARDIOVASCULAR-DISEASE; MEDIATED INHIBITION; HEART; DAMAGE; CELL; OVEREXPRESSION; COORDINATION; ANGIOGENESIS; REPERFUSION	Baicalin, the main active ingredient of the Scutellaria root, exerts anti-oxidant and anti-apoptotic effects in cardiovascular diseases. However, the therapeutic mechanism of baicalin remains unknown. Cultured neonatal rat cardiomyocytes were pre-treated with baicalin (0-50 mu M) for 24 h, and subsequently treated with tunicamycin (100 ng/ml). Cell viability was detected by MTT assay, and cell damage was determined by LDH release and TUNEL assay. The expression of CHOP, JNK, caspase-3, eNOS was analyzed by western blot. NO was measured by DAF-FM staining. As a result, treatment with baicalin significantly reduced apoptosis induced by ER stress inducer tunicamycin in cardiomyocytes. Molecularly, baicalin ameliorated tunicamycin-induced ER stress by downregulation of CHOP. In addition, baicalin inverted tunicamycin-induced decreases of eNOS mRNA and protein levels, phospho eNOS and NO production through CHOP pathway. However, the protective effects of baicalin were significantly decreased in cardiomyocytes treated with L-NAME, which suppressed activation of nitric oxide synthase. In conclusion, our results implicate that baicalin could protect cardiomyocytes from ER stress-induced apoptosis via CHOP/eNOS/NO pathway, and suggest the therapeutic values of baicalin against ER stress-associated cardiomyocyte apoptosis.	[Shen, Mingzhi; Wang, Lin; Wang, Bo; Guo, Xiaowang; Cheng, Ke; Xia, Yuesheng; Li, Xiumin; Wang, Xiaoming] Fourth Mil Med Univ, Xijing Hosp, Dept Geriatr, Xian 710032, Peoples R China; [Shen, Mingzhi; Zeng, Chao; Wang, Haichang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Shen, Mingzhi; Xu, Yong] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Cardiol, Sanya, Peoples R China; [Yang, Guodong; Shen, Liangliang] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Gao, Lei] PLA, Guangzhou Command, Wuhan Gen Hosp, Dept Urol, Wuhan, Peoples R China; [Fan, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Air Force Military Medical University; Chinese People's Liberation Army General Hospital	Wang, HC (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China.	wanghc@fmmu.edu.cn; fanli301@sina.com; xmwang@fmmu.edu.cn	li, xiu/GXV-1745-2022	Wang, Xiaoming/0000-0002-9671-6358	National Science Foundation of China (NSFC) [30770847, 81070127, 81270169]; Military Healthcare Project of China [13BJZ34]; Science and Technology Research Project of Shaanxi Province [2012K19-05-02]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Military Healthcare Project of China; Science and Technology Research Project of Shaanxi Province	This work was supported by the National Science Foundation of China (NSFC: 30770847, NSFC: 81070127, NSFC: 81270169), the Military Healthcare Project of China (13BJZ34) and the Science and Technology Research Project of Shaanxi Province (2012K19-05-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar E, 2010, DIABETOLOGIA, V53, P2177, DOI 10.1007/s00125-010-1833-6; Burger D, 2006, CARDIOVASC RES, V72, P51, DOI 10.1016/j.cardiores.2006.06.026; Chaube R, 2012, BBA-MOL CELL BIOL L, V1821, P313, DOI 10.1016/j.bbalip.2011.10.015; Chen LL, 2007, CARDIOVASC PATHOL, V16, P221, DOI 10.1016/j.carpath.2007.02.007; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Jones SP, 2004, AM J PHYSIOL-HEART C, V286, pH276, DOI 10.1152/ajpheart.00129.2003; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Liu AH, 2008, CELL PHYSIOL BIOCHEM, V22, P177, DOI 10.1159/000149795; Liu B, 2012, NEURO-ONCOLOGY, V14, P994, DOI 10.1093/neuonc/nos138; Liu M, 2013, SHOCK; Loinard C, 2012, CIRCULATION, V125, P1014, DOI 10.1161/CIRCULATIONAHA.111.041830; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047900; Mao W, 2007, AM J PHYSIOL-HEART C, V293, pH1636, DOI 10.1152/ajpheart.01377.2006; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Woo AYH, 2005, CARDIOVASC RES, V65, P244, DOI 10.1016/j.cardiores.2004.09.027; Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349; Zhang KQ, 2011, CARDIOVASC RES, V89, P426, DOI 10.1093/cvr/cvq296; Zhou BR, 2012, FREE RADICAL RES, V46, P1458, DOI 10.3109/10715762.2012.726355; Zhu JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035523	31	44	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88389	10.1371/journal.pone.0088389	http://dx.doi.org/10.1371/journal.pone.0088389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520378	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600069
J	Yang, H; Li, JW; Yang, JP; Wang, H; Zou, JL; He, JJ				Yang, Hu; Li, Jinwen; Yang, Jingping; Wang, Hua; Zou, Junliang; He, Junjun			Effects of Nitrogen Application Rate and Leaf Age on the Distribution Pattern of Leaf SPAD Readings in the Rice Canopy	PLOS ONE			English	Article							PHOTON FLUX-DENSITY; WHEAT CANOPY; CARBON GAIN; PHOTOSYNTHESIS; LIGHT; CHLOROPHYLL; LEAVES; IRRADIANCE; ALLOCATION; ACCLIMATION	A Soil-Plant Analysis Development (SPAD) chlorophyll meter can be used as a simple tool for evaluating N concentration of the leaf and investigating the combined effects of nitrogen rate and leaf age on N distribution. We conducted experiments in a paddy field over two consecutive years (2008-2009) using rice plants treated with six different N application levels. N distribution pattern was determined by SPAD readings based on the temporal dynamics of N concentrations in individual leaves. At 62 days after transplantation (DAT) in 2008 and DAT 60 in 2009, leaf SPAD readings increased from the upper to lower in the rice canopy that received N levels of 150 to 375 kg ha 21 The differences in SPAD readings between the upper and lower leaf were larger under higher N application rates. However, as plants grew, this atypical distribution of SPAD readings in canopy leaf quickly reversed to the general order. In addition, temporal dynamics of the leaf SPAD readings (N concentrations) were fitted to a piecewise function. In our model, changes in leaf SPAD readings were divided into three stages: growth, functioning, and senescence periods. The leaf growth period lasted approximately 6 days, and cumulative growing days were not affected by N application rates. The leaf functioning period was represented with a relatively stable SPAD reading related to N application rate, and cumulative growing days were extended with increasing N application rates. A quadratic equation was utilized to describe the relationship between SPAD readings and leaf age during the leaf senescence period. The rate of decrease in SPAD readings increased with the age of leaves, but the rate was slowed by N application. As leaves in the lower canopy were physiologically older than leaves in the upper canopy, the rate of decrease in SPAD readings was faster in the lower leaves.	[Yang, Hu; Yang, Jingping; Wang, Hua; Zou, Junliang; He, Junjun] Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Protect, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Jinwen] Shanghai Acad Environm Sci, Shanghai, Peoples R China	Zhejiang University	Yang, JP (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Inst Environm Protect, Hangzhou 310003, Zhejiang, Peoples R China.	jpyang@zju.edu.cn			National Natural Science Foundation of China [60574046, 10601051]; Zhejiang Natural Science Foundation [Y507005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	The research was financially supported by National Natural Science Foundation of China (No. 60574046, 10601051) and Zhejiang Natural Science Foundation (No. Y507005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1994, ECOLOGY, V75, P1482, DOI 10.2307/1937471; Anten NPR, 1998, OECOLOGIA, V113, P314, DOI 10.1007/s004420050382; ANTEN NPR, 1995, OECOLOGIA, V101, P504, DOI 10.1007/BF00329431; Bertheloot J, 2008, PLANT PHYSIOL, V148, P1707, DOI 10.1104/pp.108.124156; Bond BJ, 1999, OECOLOGIA, V120, P183, DOI 10.1007/s004420050847; Chang LiYing, 2007, Acta Agronomica Sinica, V33, P1108; Dreccer MF, 2000, ANN BOT-LONDON, V86, P821, DOI 10.1006/anbo.2000.1244; ELLSWORTH DS, 1993, OECOLOGIA, V96, P169, DOI 10.1007/BF00317729; Esfahani M, 2008, PADDY WATER ENVIRON, V6, P181, DOI 10.1007/s10333-007-0094-6; FIELD C, 1983, OECOLOGIA, V56, P341, DOI 10.1007/BF00379710; HIKOSAKA K, 1994, OECOLOGIA, V97, P451, DOI 10.1007/BF00325881; HIROSE T, 1989, ECOLOGY, V70, P1610, DOI 10.2307/1938094; HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Jung S, 2003, J AM OIL CHEM SOC, V80, P1169, DOI 10.1007/s11746-003-0837-3; [李东升 Li Dongsheng], 2006, [仪器仪表学报, Chinese Journal of Scientific Instrument], V27, P403; Lotscher M, 2003, ANN BOT-LONDON, V92, P679, DOI 10.1093/aob/mcg188; Mae T, 1981, PLANT CELL PHYSL, V22, P1061; Milroy SP, 2001, ANN BOT-LONDON, V87, P325, DOI 10.1006/anbo.2000.1344; Monsi TM, 1953, JAP J BOT, V14, P22; Murchie EH, 2002, PLANT PHYSIOL, V130, P1999, DOI 10.1104/pp.011098; OKADA K, 1992, PLANT CELL PHYSIOL, V33, P1183; Pandey S, 2005, PHOTOSYNTHETICA, V43, P85, DOI 10.1007/s11099-005-5090-8; PENG SB, 1995, COMMUN SOIL SCI PLAN, V26, P927, DOI 10.1080/00103629509369344; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; SADRAS VO, 1993, OECOLOGIA, V95, P488, DOI 10.1007/BF00317432; Shiratsuchi H, 2006, FIELD CROP RES, V95, P291, DOI 10.1016/j.fcr.2005.04.005; Vos J, 2001, EUR J AGRON, V14, P209, DOI 10.1016/S1161-0301(00)00090-3; Wang SH, 2006, FIELD CROP RES, V96, P224, DOI 10.1016/j.fcr.2005.07.008; Wyka T, 2008, PHOTOSYNTH RES, V95, P87, DOI 10.1007/s11120-007-9238-1; Yashida S, 1969, PLANT SOIL, V31, P48	31	32	37	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88421	10.1371/journal.pone.0088421	http://dx.doi.org/10.1371/journal.pone.0088421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520386	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600077
J	Douzi, B; Spinelli, S; Blangy, S; Roussel, A; Durand, E; Brunet, YR; Cascales, E; Cambillau, C				Douzi, Badreddine; Spinelli, Silvia; Blangy, Stephanie; Roussel, Alain; Durand, Eric; Brunet, Yannick R.; Cascales, Eric; Cambillau, Christian			Crystal Structure and Self-Interaction of the Type VI Secretion Tail-Tube Protein from Enteroaggregative Escherichia coli	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; EFFECTOR TSE1; SYSTEM; BACTERIOPHAGE-T4; APPARATUS; INSIGHTS; REVEALS; COMPLEX; TUBULES; CELLS	The type VI secretion system (T6SS) is a widespread machine used by bacteria to control their environment and kill or disable bacterial species or eukaryotes through toxin injection. The T6SS comprises a central tube formed of stacked hexamers of hemolysin co-regulated proteins (Hcp) and terminated by a trimeric valine-glycine repeat protein G (VgrG) component, the cell puncturing device. A contractile tail sheath, formed by the TssB and TssC proteins, surrounds this tube. This syringe-like machine has been compared to an inverted phage, as both Hcp and VgrG share structural homology with tail components of Caudovirales. Here we solved the crystal structure of a tryptophan-substituted double mutant of Hcp1 from enteroaggregative Escherichia coli and compared it to the structures of other Hcps. Interestingly, we observed that the purified Hcp native protein is unable to form tubes in vitro. To better understand the rationale for observation, we measured the affinity of Hcp1 hexamers with themselves by surface plasmon resonance. The intra-hexamer interaction is weak, with a K-D value of 7.2 mu M. However, by engineering double cysteine mutants at defined positions, tubes of Hcp1 gathering up to 15 stacked hexamers formed in oxidative conditions. These results, together with those available in the literature regarding TssB and TssC, suggest that assembly of the T6SS tube differs significantly from that of Sipho- or Myoviridae.	[Douzi, Badreddine; Spinelli, Silvia; Blangy, Stephanie; Roussel, Alain; Durand, Eric; Cambillau, Christian] Aix Marseille Univ, UMR 7257, Marseille, France; [Douzi, Badreddine; Spinelli, Silvia; Blangy, Stephanie; Roussel, Alain; Durand, Eric; Cambillau, Christian] Ctr Natl Rech Sci, UMR 7257, Marseille, France; [Brunet, Yannick R.; Cascales, Eric] Aix Marseille Univ, Ctr Natl Rech Sci, Inst Microbiol Mediterranee, Lab Ingn Systemes Macromol,UMR7255, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Cambillau, C (corresponding author), Aix Marseille Univ, UMR 7257, Campus Luminy,Case 932, Marseille, France.	cambillau@afmb.univ-mrs.fr	Douzi, Badreddine/ABA-4540-2021; Durand, Eric/E-6739-2017; CASCALES, ERIC/G-7420-2011; douzi, Badreddine/Z-5707-2019	Douzi, Badreddine/0000-0003-3140-4713; Durand, Eric/0000-0002-0577-8220; CASCALES, ERIC/0000-0003-0611-9179; 	CNRS; AMU; Fondation de la Recherche Medicale [FRM DEQ2011-0421282]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Fondation pour la Recherche Medicale [SPF20101221116]; Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]	CNRS(Centre National de la Recherche Scientifique (CNRS)); AMU; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); French Infrastructure for Integrated Structural Biology (FRISBI); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR))	Work in C.C. laboratory is supported by the CNRS, AMU and by grants from the Fondation de la Recherche Medicale (FRM DEQ2011-0421282) and the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01. E.D. is supported by a post-doctoral fellowship from the Fondation pour la Recherche Medicale (SPF20101221116). Work in E. C. laboratory is supported by the CNRS, the Aix-Marseille Universite and funded by a grant from the Agence Nationale de la Recherche (ANR-10-JCJC-1303-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksyuk AA, 2011, STRUCTURE, V19, P1885, DOI 10.1016/j.str.2011.09.012; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Brunet YR, EMBO REPORT IN PRESS; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; DeLano W.L., PYMOL MOL GRAPHICS S; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Durand E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.390153; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanamaru S, 2005, J MOL BIOL, V346, P1013, DOI 10.1016/j.jmb.2004.12.042; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Osipiuk Jerzy, 2011, Journal of Structural and Functional Genomics, V12, P21, DOI 10.1007/s10969-011-9107-1; Pell LG, 2013, J MOL BIOL, V425, P2436, DOI 10.1016/j.jmb.2013.03.035; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Silverman JM, 2013, MOL CELL; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Siponen M, 2009, J BACTERIOL, V191, P728, DOI 10.1128/JB.01363-08; Vincentelli R, 2011, METHODS, V55, P65, DOI 10.1016/j.ymeth.2011.08.010; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zhang H, 2012, FEBS LETT, V586, P3193, DOI 10.1016/j.febslet.2012.06.036; Zoued A, 2013, J BIOL CHEM	48	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e86918	10.1371/journal.pone.0086918	http://dx.doi.org/10.1371/journal.pone.0086918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551044	Green Published, gold			2022-12-27	WOS:000331271500011
J	Guo, XB; Zhang, Y; Hu, WH; Tan, HZ; Wang, XQ				Guo, Xiaobo; Zhang, Ye; Hu, Wenhao; Tan, Haizhu; Wang, Xueqin			Inferring Nonlinear Gene Regulatory Networks from Gene Expression Data Based on Distance Correlation	PLOS ONE			English	Article							MUTUAL INFORMATION; TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; COVARIANCE; COMPENDIUM; ALGORITHM; PROFILES	Nonlinear dependence is general in regulation mechanism of gene regulatory networks (GRNs). It is vital to properly measure or test nonlinear dependence from real data for reconstructing GRNs and understanding the complex regulatory mechanisms within the cellular system. A recently developed measurement called the distance correlation (DC) has been shown powerful and computationally effective in nonlinear dependence for many situations. In this work, we incorporate the DC into inferring GRNs from the gene expression data without any underling distribution assumptions. We propose three DC-based GRNs inference algorithms: CLR-DC, MRNET-DC and REL-DC, and then compare them with the mutual information (MI)-based algorithms by analyzing two simulated data: benchmark GRNs from the DREAM challenge and GRNs generated by SynTReN network generator, and an experimentally determined SOS DNA repair network in Escherichia coli. According to both the receiver operator characteristic (ROC) curve and the precision-recall (PR) curve, our proposed algorithms significantly outperform the MI-based algorithms in GRNs inference.	[Guo, Xiaobo; Zhang, Ye; Hu, Wenhao; Wang, Xueqin] Sun Yat Sen Univ, Sch Math & Computat Sci, Dept Stat Sci, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Xiaobo; Zhang, Ye; Wang, Xueqin] Sun Yat Sen Univ, Southern China Res Ctr Stat Sci, Guangzhou 510275, Guangdong, Peoples R China; [Tan, Haizhu; Wang, Xueqin] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Tan, Haizhu] Shantou Univ, Coll Med, Dept Phys & Informat, Shantou, Peoples R China; [Guo, Xiaobo; Wang, Xueqin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shantou University; Sun Yat Sen University	Wang, XQ (corresponding author), Sun Yat Sen Univ, Sch Math & Computat Sci, Dept Stat Sci, Guangzhou 510275, Guangdong, Peoples R China.	wangxq88@mail.sysu.edu.cn			NSFC for Excellent Young Scholar [11322108]; NCET [12-0559]; NSFC [11001280]; Major State Basic Research Development Program [2012CB517900]	NSFC for Excellent Young Scholar; NCET(Program for New Century Excellent Talents in University (NCET)); NSFC(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China)	Xueqin Wang's research is partially supported by NSFC for Excellent Young Scholar (11322108), NCET (12-0559), NSFC (11001280), and Major State Basic Research Development Program (2012CB517900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Brunel H, 2010, BIOINFORMATICS, V26, P1811, DOI 10.1093/bioinformatics/btq273; Butte A J, 2000, Pac Symp Biocomput, P418; Carrera J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp022; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Emmert-Streib F, 2010, IET SYST BIOL, V4, P277, DOI 10.1049/iet-syb.2010.0028; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Gorfine M, 2012, COMMENT DETECTING NO; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schurmann T, 2002, CONDMAT0203436 ARXIV; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simoes RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033624; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Thomas MC, 2006, ELEMENTS INFORM THEO; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626	28	30	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87446	10.1371/journal.pone.0087446	http://dx.doi.org/10.1371/journal.pone.0087446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551058	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500017
J	Liew, SY; Looi, CY; Paydar, M; Cheah, FK; Leong, KH; Wong, WF; Mustafa, MR; Litaudon, M; Awang, K				Liew, Sook Yee; Looi, Chung Yeng; Paydar, Mohammadjavad; Cheah, Foo Kit; Leong, Kok Hoong; Wong, Won Fen; Mustafa, Mohd Rais; Litaudon, Marc; Awang, Khalijah			Subditine, a New Monoterpenoid Indole Alkaloid from Bark of Nauclea subdita (Korth.) Steud. Induces Apoptosis in Human Prostate Cancer Cells	PLOS ONE			English	Article							ALPHA-INDUCED APOPTOSIS; MEDICINAL-PLANTS; BCL-X; P53; OFFICINALIS; ORIENTALIS; INDUCTION; OVEREXPRESSION; ACTIVATION; EXPRESSION	In this study, a new apoptotic monoterpenoid indole alkaloid, subditine (1), and four known compounds were isolated from the bark of Nauclea subdita. Complete H-1- and C-13- NMR data of the new compound were reported. The structures of isolated compounds were elucidated with various spectroscopic methods such as 1D- and 2D- NMR, IR, UV and LCMS. All five compounds were screened for cytotoxic activities on LNCaP and PC-3 human prostate cancer cell- lines. Among the five compounds, the new alkaloid, subditine (1), demonstrated the most potent cell growth inhibition activity and selective against LNCaP with an IC50 of 12.24 +/- 0.19 mu M and PC-3 with an IC50 of 13.97 +/- 0.32 mu M, compared to RWPE human normal epithelial cell line (IC50 = 30.48 +/- 0.08 mu M). Subditine (1) treatment induced apoptosis in LNCaP and PC-3 as evidenced by increased cell permeability, disruption of cytoskeletal structures and increased nuclear fragmentation. In addition, subditine (1) enhanced intracellular reactive oxygen species (ROS) production, as reflected by increased expression of glutathione reductase (GR) to scavenge damaging free radicals in both prostate cancer cell-lines. Excessive ROS could lead to disruption of mitochondrial membrane potential (MMP), release of cytochrome c and subsequent caspase 9, 3/7 activation. Further Western blot analyses showed subditine (1) induced down-regulation of Bcl-2 and Bcl-xl expression, whereas p53 was upregulated in LNCaP (p53-wild-type), but not in PC-3 (p53-null). Overall, our data demonstrated that the new compound subditine (1) exerts anti-proliferative effect on LNCaP and PC-3 human prostate cancer cells through induction of apoptosis.	[Liew, Sook Yee; Awang, Khalijah] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Looi, Chung Yeng; Paydar, Mohammadjavad; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Cheah, Foo Kit; Leong, Kok Hoong] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Litaudon, Marc] Ctr Natl Rech Sci, Inst Chim Subst Nat, Gif Sur Yvette, France	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Centre National de la Recherche Scientifique (CNRS)	Awang, K (corresponding author), Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia.	khalijah@um.edu.my	Looi, Chung Yeng/A-2623-2013; Mustafa, Mohamed R/B-1647-2009; Liew, Sook Yee/R-1175-2016; Leong, Kok Hoong/D-9505-2012; Paydar, Mohammadjavad/V-4800-2018; AWANG, KHALIJAH/B-8781-2010; Leong, Kok Hoong/J-1956-2015; Wong, Won Fen/D-3087-2012	Looi, Chung Yeng/0000-0002-4830-3495; Mustafa, Mohamed R/0000-0002-7864-5189; Liew, Sook Yee/0000-0002-1941-2780; Leong, Kok Hoong/0000-0002-7317-6117; Paydar, Mohammadjavad/0000-0002-0569-7017; AWANG, KHALIJAH/0000-0001-5971-6570; Leong, Kok Hoong/0000-0002-7317-6117; Wong, Won Fen/0000-0003-1082-1956	University of Malaya Research Grant; University of Malaya High Impact Research Grant [UM.C/625/1/HIR/MOHE/SC/37, HIR: E00002-20001]; French National Center for Scientific Research CNRS [57-02-03-1007]; Postgraduate Research Funds of University of Malaya [PV050/2012A]	University of Malaya Research Grant; University of Malaya High Impact Research Grant; French National Center for Scientific Research CNRS(Centre National de la Recherche Scientifique (CNRS)); Postgraduate Research Funds of University of Malaya	The work was funded by University of Malaya Research Grant RP001/2012; University of Malaya High Impact Research Grant UM.C/625/1/HIR/MOHE/SC/37 and HIR: E00002-20001; French National Center for Scientific Research CNRS grant 57-02-03-1007; and Postgraduate Research Funds of University of Malaya (PV050/2012A). This work was carried out within the framework of an official agreement between the CNRS and the University of Malaya (Malaysia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu P, 1998, HETEROCYCLES, V48, P885, DOI 10.3987/COM-97-8091; Ahmad R, 2010, AFR J BIOTECHNOL, V9, P7948; Arbab IA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/856029; Atta-Ur-Rahman, 1982, BIOSYNTHESIS INDOLE; AU TY, 1973, J CHEM SOC PERK T 1, P13, DOI 10.1039/p19730000013; Awang K, 2007, BIOORGAN MED CHEM, V15, P5997, DOI 10.1016/j.bmc.2007.05.049; Awang K, 2010, BIOORGAN MED CHEM, V18, P7873, DOI 10.1016/j.bmc.2010.09.044; BATCHILY F, 1985, ANN PHARM FR, V43, P513; Bum EN, 2009, EPILEPSY BEHAV, V15, P434, DOI 10.1016/j.yebeh.2009.05.014; Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; Costello LC, 2000, ONCOLOGY-BASEL, V59, P269, DOI 10.1159/000012183; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; ERDELMEIER CAJ, 1992, PLANTA MED, V58, P43, DOI 10.1055/s-2006-961387; Fan Long, 2010, Yaoxue Xuebao, V45, P747; Fatin R. J., 2012, Current Research Journal of Biological Sciences, V4, P600; FRITSCHE M, 1993, ONCOGENE, V8, P307; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gummadi VR, 2013, BIOORG MED CHEM LETT, V23, P4911, DOI 10.1016/j.bmcl.2013.06.071; HOTELLIER F, 1975, PHYTOCHEMISTRY, V14, P1407, DOI 10.1016/S0031-9422(00)98638-2; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Kim JY, 2013, INT J MOL MED, V31, P1388, DOI 10.3892/ijmm.2013.1333; Krajewska M, 1996, AM J PATHOL, V148, P1567; Lebedeva I, 2000, CANCER RES, V60, P6052; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Li QQ, 2010, J PHARM PHARMACOL, V62, P1018, DOI 10.1111/j.2042-7158.2010.01135.x; Liew SY, 2012, MOLECULES, V17, P4028, DOI 10.3390/molecules17044028; Liew SY, 2011, ACTA CRYSTALLOGR E, V67, pO1727, DOI 10.1107/S1600536811022768; Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166; Looi CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056643; Looi CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023640; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Mukhtar MR, 2012, MOLECULES, V17, P267, DOI 10.3390/molecules17010267; Phil, 1989, TREE FLORA MALAYA MA; PHILLIPSON JD, 1974, PHYTOCHEMISTRY, V13, P973, DOI 10.1016/S0031-9422(00)91432-8; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Qureshi AK, 2011, CHEM PHARM BULL, V59, P291, DOI 10.1248/cpb.59.291; RAFFO AJ, 1995, CANCER RES, V55, P4438; Rokhlin OW, 2000, ONCOGENE, V19, P1959, DOI 10.1038/sj.onc.1203453; SAINSBURY M, 1975, PHYTOCHEMISTRY, V14, P2691, DOI 10.1016/0031-9422(75)85251-4; SAINSBURY M, 1976, J CHEM SOC PERK T 1, P2416, DOI 10.1039/p19760002416; Sichaem J, 2010, FITOTERAPIA, V81, P830, DOI 10.1016/j.fitote.2010.05.004; Smith ML, 1996, MUTAT RES-REV GENET, V340, P109, DOI 10.1016/S0165-1110(96)90043-3; Sun JY, 2008, PHYTOCHEMISTRY, V69, P1405, DOI 10.1016/j.phytochem.2008.01.008; ZECHES M, 1985, J NAT PROD, V48, P42, DOI 10.1021/np50037a007; Zhang ZZ, 2001, J NAT PROD, V64, P1001, DOI 10.1021/np010042g	47	33	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87286	10.1371/journal.pone.0087286	http://dx.doi.org/10.1371/journal.pone.0087286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551054	Green Published, gold, Green Accepted			2022-12-27	WOS:000331271500016
J	Petvises, S; O'Neill, HC				Petvises, Sawang; O'Neill, Helen C.			Characterisation of Dendritic Cells Arising from Progenitors Endogenous to Murine Spleen	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TERM RECONSTITUTING SUBSET; ANTIGEN-PRESENTING CELLS; STROMAL CULTURES; GM-CSF; DISTINCT; PRECURSORS; DIFFERENTIATION; IDENTIFICATION; POPULATIONS	Heterogeneity amongst dendritic cell (DC) subsets leads to a spectrum of immune response capacity against pathogens. Several DC subsets in spleen have been described which differ in terms of phenotype and function. We have previously reported a distinct population of CD11c(lo)CD11b(hi)MHC-II(-)CD8(-) dendritic-like "L-DC'' in murine spleen, which can also be generated in splenic stromal longterm cultures. Here, the ontogeny of L-DC development in perinatal mice has been compared with other known splenic DC subsets. Flow cytometric analysis has revealed the presence of L-DC at embryonic age (E) 18.5 spleen, while plasmacytoid (p) DC and conventional (c) DC appear at 2 and 4 days following birth. Co-cultures of E18.5 spleen above splenic stroma also showed production of only L-DC, while spleen cells from D0 through D5 neonates showed production of both L-DC and cDC-like cells. Addition of an M-CSFR inhibitor to co-cultures revealed that while the development of cDC-like cells depended on M-CSF, many L-DC developed independently of M-CSF. Furthermore, purified hematopoietic stem cells (HSC) and multipotential progenitors (MPP) isolated from neonatal D1 spleen are capable of developing into L-DC in co-cultures. These studies reveal a lineage of dendritic-like cells developing in the spleen microenvironment, and which appear to arise from endogenous progenitors laid down in spleen during embryogenesis.	[Petvises, Sawang; O'Neill, Helen C.] Australian Natl Univ, Res Sch Biol, Div Biomed Sci, Canberra, ACT, Australia	Australian National University	O'Neill, HC (corresponding author), Australian Natl Univ, Res Sch Biol, Div Biomed Sci, Canberra, ACT, Australia.	Helen.ONeill@anu.edu.au	O'NEILL, Helen/AAW-8921-2021; O'NEILL, Helen/C-9137-2009	O'NEILL, Helen/0000-0002-9506-284X; O'NEILL, Helen/0000-0002-9506-284X	National Health and Medical Research Council of Australia [585443]; Royal Thai Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Thai Government	This work was supported by project grant #585443 to H.C.O. from the National Health and Medical Research Council of Australia. S.P. was supported by a graduate scholarship from the Royal Thai Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand JY, 2006, DEVELOPMENT, V133, P3619, DOI 10.1242/dev.02510; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Despars G, 2004, EXP HEMATOL, V32, P1182, DOI 10.1016/j.exphem.2004.08.013; Despars G, 2006, IN VITRO CELL DEV-AN, V42, P208; Despars G, 2006, STEM CELLS, V24, P1496, DOI 10.1634/stemcells.2005-0530; Dor FJMF, 2006, EXP HEMATOL, V34, P1573, DOI 10.1016/j.exphem.2006.06.016; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hinton RA, 2012, INT J MED BIOL FRONT, V18, P1; Hinton RA, 2012, J LEUKOCYTE BIOL, V91, P341, DOI 10.1189/jlb.0611302; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2010, METHODS MOL BIOL, V595, P177, DOI 10.1007/978-1-60761-421-0_11; Naik SH, 2010, METHODS MOL BIOL, V595, P167, DOI 10.1007/978-1-60761-421-0_10; Ni KP, 1997, BRIT J HAEMATOL, V97, P710, DOI 10.1046/j.1365-2141.1997.00135.x; O'Neill HC, 2004, STEM CELLS, V22, P475, DOI 10.1634/stemcells.22-4-475; O'Neill HC, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/954275; Onai N, 2010, METHODS MOL BIOL, V595, P195, DOI 10.1007/978-1-60761-421-0_13; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Papathanasiou P, 2009, STEM CELLS, V27, P3082, DOI 10.1002/stem.232; Papathanasiou P, 2009, STEM CELLS, V27, P2498, DOI 10.1002/stem.170; Periasamy P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00073; Periasamy P, 2013, EXP HEMATOL, V41, P281, DOI 10.1016/j.exphem.2012.11.003; Periasamy P, 2013, J LEUKOCYTE BIOL, V93, P63, DOI 10.1189/jlb.0512260; Periasamy P, 2009, EXP HEMATOL, V37, P1060, DOI 10.1016/j.exphem.2009.06.001; Quah B, 2004, INT IMMUNOL, V16, P567, DOI 10.1093/intimm/dxh060; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tan JKH, 2012, J CELL MOL MED, V16, P1924, DOI 10.1111/j.1582-4934.2011.01490.x; Tan JKH, 2011, J CELL MOL MED, V15, P1189, DOI 10.1111/j.1582-4934.2010.01089.x; Tan JKH, 2010, J CELL MOL MED, V14, P2144, DOI 10.1111/j.1582-4934.2009.00923.x; Tan JKH, 2010, BLOOD, V115, P3678, DOI 10.1182/blood-2009-06-227108; Wilson HL, 2000, P NATL ACAD SCI USA, V97, P4784, DOI 10.1073/pnas.080278897; Wolber FM, 2002, EXP HEMATOL, V30, P1010, DOI 10.1016/S0301-472X(02)00881-0; Wu L, 2001, BLOOD, V98, P3376, DOI 10.1182/blood.V98.12.3376; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; YANAI N, 1991, CELL STRUCT FUNCT, V16, P87, DOI 10.1247/csf.16.87	40	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88311	10.1371/journal.pone.0088311	http://dx.doi.org/10.1371/journal.pone.0088311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551086	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500033
J	Roy, CL; Fieberg, J; Scharenbroich, C; Herwig, CM				Roy, Charlotte L.; Fieberg, John; Scharenbroich, Christopher; Herwig, Christine M.			Thinking Like a Duck: Fall Lake Use and Movement Patterns of Juvenile Ring-Necked Ducks before Migration	PLOS ONE			English	Article							AMERICAN BLACK DUCKS; HUNTING DISTURBANCE; DIVING DUCKS; EXPERIMENTAL REFUGES; DANISH WETLANDS; KEOKUK-POOL; WATERFOWL; SURVIVAL; BIRDS; DISPERSAL	The post-fledging period is one of the least studied portions of the annual cycle in waterfowl. Yet, recruitment into the breeding population requires that young birds have sufficient resources to survive this period. We used radio-telemetry and generalized estimating equations to examine support for four hypotheses regarding the drivers of landscape scale habitat use and movements made by juvenile ring-necked ducks between the pre-fledging period and departure for migration. Our response variables included the probability of movement, distances moved, and use of different lake types: brood-rearing lakes, staging lakes, and lakes with low potential for disturbance. Birds increased their use of staging areas and lakes with low potential for disturbance (i.e., without houses or boat accesses, >100 m from roads, or big lakes with areas where birds could sit undisturbed) throughout the fall, but these changes began before the start of the hunting season and their trajectory was not changed by the onset of hunting. Males and females moved similar distances and had similar probabilities of movements each week. However, females were more likely than males to use brood-rearing lakes later in the fall. Our findings suggest juvenile ring-necked ducks require different lake types throughout the fall, and managing solely for breeding habitat will be insufficient for meeting needs during the post-fledging period. Maintaining areas with low potential for disturbance and areas suitable for staging will ensure that ring-necked ducks have access to habitat throughout the fall.	[Roy, Charlotte L.] Minnesota Dept Nat Resources, Wetland Wildlife Populat & Res Grp, Bemidji, MN 56601 USA; [Fieberg, John] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Scharenbroich, Christopher; Herwig, Christine M.] Minnesota Dept Nat Resources, Bemidji, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Roy, CL (corresponding author), Minnesota Dept Nat Resources, Wetland Wildlife Populat & Res Grp, Bemidji, MN 56601 USA.	charlotte.roy@state.mn.us	Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021	Wildlife Restoration Program for Wildlife Research-Species and Habitat Initiatives [W-71-R-2]	Wildlife Restoration Program for Wildlife Research-Species and Habitat Initiatives	Funding was provided by Wildlife Restoration Program for Wildlife Research-Species and Habitat Initiatives W-71-R-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afton Alan D., 1992, P62; ALEXANDER WC, 1987, WILSON BULL, V99, P38; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; BAKER RR, 1993, ORNIS SCAND, V24, P71, DOI 10.2307/3676413; Barton K, 2012, MUMIN MULT INF R PAC; BELL DV, 1985, BIOL CONSERV, V33, P65, DOI 10.1016/0006-3207(85)90005-9; Bellrose F.C., 1994, ECOLOGY MANAGEMENT W; BELLROSE FC, 1954, J WILDLIFE MANAGE, V18, P160, DOI 10.2307/3797710; BREWER R, 1975, IBIS, V117, P521, DOI 10.1111/j.1474-919X.1975.tb04248.x; BURGESS HH, 1969, J WILDLIFE MANAGE, V33, P843, DOI 10.2307/3799315; Cleland David T., 1997, P181; CONROY MJ, 1983, J WILDLIFE MANAGE, V47, P127, DOI 10.2307/3808059; Cooch E., 2007, PROGRAM MARK GENTLE; COWARDIN LM, 1969, J WILDLIFE MANAGE, V33, P829, DOI 10.2307/3799314; CRONAN JOHN M., 1957, AUK, V74, P459; Dennis D.G., 1974, Canadian Wildl Serv Rep Ser, VNo. 29, P58; Dennis DG, 1984, WATERFOWL STUDIES ON, P43; Dooley JL, 2010, J WILDLIFE MANAGE, V74, P1815, DOI 10.2193/2009-284; EADIE JM, 1985, CONDOR, V87, P528, DOI 10.2307/1367952; ESRI, 2010, ARCGIS DESKT REL 10; Evans DM, 2002, IBIS, V144, P2, DOI 10.1046/j.0019-1019.2001.00001.x; Evans DM, 2001, BIOL CONSERV, V98, P315, DOI 10.1016/S0006-3207(00)00170-1; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Fieberg J, 2009, J APPL ECOL, V46, P1018, DOI 10.1111/j.1365-2664.2009.01692.x; FRAZER C, 1990, J WILDLIFE MANAGE, V54, P451, DOI 10.2307/3809658; Gollop J. B., 1954, GUIDE AGING DUCK BRO; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Gwinner E, 1996, J EXP BIOL, V199, P39; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hastie T. J, 1993, STAT MODELS S, P249; HAVERA SP, 1992, WILDLIFE SOC B, V20, P290; Joe M, 2002, J APPL STAT, V29, P373, DOI 10.1080/02664760120108836; Kenow KP, 2003, J FIELD ORNITHOL, V74, P179, DOI 10.1648/0273-8570-74.2.179; Kirby RE, 1999, J WILDLIFE MANAGE, V63, P403, DOI 10.2307/3802526; Korschgen CE, 1996, J FIELD ORNITHOL, V67, P392; KORSCHGEN CE, 1985, WILDLIFE SOC B, V13, P290; Lake BC, 2008, IBIS, V150, P527, DOI 10.1111/j.1474-919X.2008.00814.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lindmeier J. P., 1961, Journal of Wildlife Management, V25, P430, DOI 10.2307/3798834; Madsen J, 1998, J APPL ECOL, V35, P386, DOI 10.1046/j.1365-2664.1998.00314.x; Madsen J, 1998, J APPL ECOL, V35, P398, DOI 10.1046/j.1365-2664.1998.00315.x; Madsen J, 1995, WILDLIFE BIOL, V1, P193, DOI 10.2981/wlb.1995.0025; Mendall HL, 1958, BULLETIN, V60; Minnesota Department of Natural Resources, 2006, LONG RANG DUCK REC P; Mitchell GW, 2010, CONDOR, V112, P644, DOI 10.1525/cond.2010.090136; Molenberghs G., 2005, MODELS DISCRETE LONG; MORTON ML, 1991, ORNIS SCAND, V22, P98, DOI 10.2307/3676540; Nicolai CA, 2012, J ANIM ECOL, V81, P788, DOI 10.1111/j.1365-2656.2012.01952.x; OWEN M, 1973, Wildfowl, V24, P123; Pan W, 2001, BIOMETRIKA, V83, P551; Parker GR, 1998, CAN FIELD NAT, V112, P586; Pearce JM, 2009, WATERBIRDS, V32, P133, DOI 10.1675/063.032.0116; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramenofsky M, 2007, BIOSCIENCE, V57, P135, DOI 10.1641/B570208; RAPPOLE JH, 1987, WILSON BULL, V99, P475; Regehr HM, 2003, WILSON BULL, V115, P423, DOI 10.1676/03-031; Regehr HM, 2001, CONDOR, V103, P408, DOI 10.1650/0010-5422(2001)103[0408:PFBOMH]2.0.CO;2; Rivera JHV, 1998, CONDOR, V100, P69, DOI 10.2307/1369898; Rodriguez A, 2001, OIKOS, V95, P383, DOI 10.1034/j.1600-0706.2001.950303.x; Rohwer FC, 1988, CURRENT ORNITHOLOGY, V5, P187; Roy CL, 2013, J WILDLIFE MANAGE, V77, P947, DOI 10.1002/jwmg.559; Roy CL, 2012, BIRDS N AM ONLINE; SEDINGER JS, 1984, J WILDLIFE MANAGE, V48, P1128, DOI 10.2307/3801773; SEDINGER JS, 1984, AUK, V101, P295, DOI 10.1093/auk/101.2.295; SEDINGER JS, 1995, ECOLOGY, V76, P2404, DOI 10.2307/2265816; THORNBURG DD, 1973, J WILDLIFE MANAGE, V37, P382, DOI 10.2307/3800129; Vaananen VM, 2001, WILDLIFE BIOL, V7, P3; WALSBERG GE, 1986, AUK, V103, P1; Whitaker DM, 2010, AUK, V127, P471, DOI 10.1525/auk.2010.127.3.471; WILTSCHKO W, 1978, OIKOS, V30, P177, DOI 10.2307/3543477; Wingfield J.C., 1990, P232; ZICUS MC, 1989, CONDOR, V91, P807, DOI 10.2307/1368064	72	8	8	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88597	10.1371/journal.pone.0088597	http://dx.doi.org/10.1371/journal.pone.0088597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551123	Green Submitted, gold, Green Published			2022-12-27	WOS:000331271500051
J	Jeganmohan, S; Tucker, C; Cadotte, MW				Jeganmohan, Shajini; Tucker, Caroline; Cadotte, Marc W.			Colonization Rates in a Metacommunity Altered by Competition	PLOS ONE			English	Article							TRADE-OFF; SPECIES COEXISTENCE; COMMUNITY ECOLOGY; K-SELECTION; ENVIRONMENTS; MICROCOSMS; DISPERSAL; BEHAVIOR; SCALES; DEAD	Competition and colonization are two mechanisms that are important for determining coexistence and species diversity in spatially structured habitats. However, these mechanisms may not be independent as species can exhibit behavioral or physiological changes in response to competition that alters their colonization rates. This study examines the effect of interspecific interactions on the colonization rates of four microscopic species (three ciliates and a rotifer) in aquatic microcosms. Two species showed significant reductions in the time to colonize patches when confronted with a competitor, one was a good disperser (Colpidium striatum) and the other was the slowest disperser (Philodina spp.). These results indicate that species' colonization rates in a metacommunity can vary depending on the presence of competitors. Thus, we suggest that predictions based on heuristic tradeoffs between competition and colonization should consider effects of common biotic interactions such as competition.	[Jeganmohan, Shajini; Tucker, Caroline; Cadotte, Marc W.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada; [Tucker, Caroline; Cadotte, Marc W.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; University of Toronto	Cadotte, MW (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.	mcadotte@utsc.utoronto.ca	Cadotte, Marc/AAG-8147-2020	Cadotte, Marc/0000-0002-5816-7693; TUCKER, CAROLINE/0000-0002-4871-2010	Natural Sciences and Engineering Research Council of Canada (NSERC [386151]; Canada Foundation for Innovation and the Ontario Research Fund	Natural Sciences and Engineering Research Council of Canada (NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation and the Ontario Research Fund	The authors wish to thank generous funding from Natural Sciences and Engineering Research Council of Canada (NSERC #386151 to MWC) and from the Canada Foundation for Innovation and the Ontario Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2007, SOIL BIOL BIOCHEM, V39, P700, DOI 10.1016/j.soilbio.2006.09.008; Adler FR, 2006, ECOL LETT, V9, P907, DOI 10.1111/j.1461-0248.2006.00943.x; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Barraquand F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028924; Cadotte MW, 2007, P ROY SOC B-BIOL SCI, V274, P2739, DOI 10.1098/rspb.2007.0925; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; Cadotte MW, 2006, AM NAT, V168, P704, DOI 10.1086/508296; Chevin LM, 2012, PLOS BIOL, V8, P1; Davis LA, 2006, MOL ECOL, V15, P2141, DOI 10.1111/j.1365-294X.2006.02914.x; Durrett R, 2012, J MATH BIOL, V64, P657, DOI 10.1007/s00285-011-0444-2; FENCHEL T, 1982, MAR ECOL PROG SER, V9, P25, DOI 10.3354/meps009025; Hennessy JM, 1978, TOPOTACTIC MOVEMENT; Holyoak M, 2008, P NATL ACAD SCI USA, V105, P19060, DOI 10.1073/pnas.0800483105; HORN HS, 1972, ECOLOGY, V53, P749, DOI 10.2307/1934797; Jennings H. S., 1899, AM J PSYCHOL, V10, P503; JONES JM, 1976, AM NAT, V110, P320, DOI 10.1086/283069; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; LAWLER SP, 1993, AM NAT, V141, P675, DOI 10.1086/285499; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; NOYMEIR I, 1993, ECOL APPL, V3, P32, DOI 10.2307/1941787; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; R Core Team, 2020, R LANG ENV STAT COMP; SALT GW, 1987, HYDROBIOLOGIA, V147, P271, DOI 10.1007/BF00025754; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; SIH A, 1994, ECOLOGY, V75, P1199, DOI 10.2307/1937446; Snyder RE, 2011, P ROY SOC B-BIOL SCI, V278, P739, DOI 10.1098/rspb.2010.1549; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Warren PH, 2006, INVAD NAT SPRING SER, P343, DOI 10.1007/1-4020-4925-0_16; Yu DW, 2001, AM NAT, V158, P49, DOI 10.1086/320865	29	4	4	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88344	10.1371/journal.pone.0088344	http://dx.doi.org/10.1371/journal.pone.0088344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551094	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000032
J	Shuang, Q; Zhang, MY; Yuan, YB				Shuang, Qing; Zhang, Mingyuan; Yuan, Yongbo			Performance and Reliability Analysis of Water Distribution Systems under Cascading Failures and the Identification of Crucial Pipes	PLOS ONE			English	Article							VULNERABILITY; OPTIMIZATION; CENTRALITY; MODEL	As a mean of supplying water, Water distribution system (WDS) is one of the most important complex infrastructures. The stability and reliability are critical for urban activities. WDSs can be characterized by networks of multiple nodes (e. g. reservoirs and junctions) and interconnected by physical links (e. g. pipes). Instead of analyzing highest failure rate or highest betweenness, reliability of WDS is evaluated by introducing hydraulic analysis and cascading failures (conductive failure pattern) from complex network. The crucial pipes are identified eventually. The proposed methodology is illustrated by an example. The results show that the demand multiplier has a great influence on the peak of reliability and the persistent time of the cascading failures in its propagation in WDS. The time period when the system has the highest reliability is when the demand multiplier is less than 1. There is a threshold of tolerance parameter exists. When the tolerance parameter is less than the threshold, the time period with the highest system reliability does not meet minimum value of demand multiplier. The results indicate that the system reliability should be evaluated with the properties of WDS and the characteristics of cascading failures, so as to improve its ability of resisting disasters.	[Shuang, Qing; Zhang, Mingyuan; Yuan, Yongbo] Dalian Univ Technol, Dept Construct Management, Dalian, Liaoning, Peoples R China	Dalian University of Technology	Zhang, MY (corresponding author), Dalian Univ Technol, Dept Construct Management, Dalian, Liaoning, Peoples R China.	myzhang@dlut.edu.cn	ZHANG, Mingyuan/AAJ-4616-2020		National Natural Science Foundation of China [51208081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China under Grant No. 51208081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; BAO YX, 1990, J HYDRAUL ENG-ASCE, V116, P1119, DOI 10.1061/(ASCE)0733-9429(1990)116:9(1119); Bompard E, 2009, LECT NOTES COMPUT SC, V5508, P144, DOI 10.1007/978-3-642-03552-4_13; Bondy J. A, 2008, GRAPH THEORY APPL; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Buldyrev SV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016112; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Chai CL, 2011, J LOSS PREVENT PROC, V24, P688, DOI 10.1016/j.jlp.2011.05.011; Crucitti P, 2004, PHYSICA A, V338, P92, DOI 10.1016/j.physa.2004.02.029; Duenas-Osorio L, 2009, STRUCT SAF, V31, P157, DOI 10.1016/j.strusafe.2008.06.007; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Islam MS, 2014, J WATER RES PLAN MAN, V140, P468, DOI 10.1061/(ASCE)WR.1943-5452.0000349; Islam MS, 2011, URBAN WATER J, V8, P351, DOI 10.1080/1573062X.2011.617829; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Mays L.W., 2000, WATER DISTRIBUTION S; Mishkovski I, 2011, COMMUN NONLINEAR SCI, V16, P341, DOI 10.1016/j.cnsns.2010.03.018; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; OSTFELD A, 1993, RELIAB ENG SYST SAFE, V42, P5, DOI 10.1016/0951-8320(93)90049-5; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Puust R, 2010, URBAN WATER J, V7, P25, DOI 10.1080/15730621003610878; Ren H, 2008, IEEE T CIRCUITS-II, V55, P927, DOI 10.1109/TCSII.2008.924365; Rosas-Casals M, 2007, INT J BIFURCAT CHAOS, V17, P2465, DOI 10.1142/S0218127407018531; Rossman L.A., 2000, EPANET 2 USERS MANUA; Simonsen I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218701; Sole RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026102; SU YC, 1987, J HYDRAUL ENG-ASCE, V113, P1539, DOI 10.1061/(ASCE)0733-9429(1987)113:12(1539); Tolson BA, 2004, J WATER RES PL-ASCE, V130, P63, DOI 10.1061/(ASCE)0733-9496(2004)130:1(63); WAGNER JM, 1988, J WATER RES PL-ASCE, V114, P276, DOI 10.1061/(ASCE)0733-9496(1988)114:3(276); Wang JW, 2011, SAFETY SCI, V49, P807, DOI 10.1016/j.ssci.2010.10.003; Wang JW, 2009, SAFETY SCI, V47, P1332, DOI 10.1016/j.ssci.2009.02.002; Wang WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026101; Wu JJ, 2007, PHYSICA A, V386, P407, DOI 10.1016/j.physa.2007.08.034; Xia YX, 2008, IEEE T CIRCUITS-II, V55, P65, DOI 10.1109/TCSII.2007.908954; Yazdani A, 2011, CHAOS, V21, DOI 10.1063/1.3540339; Zhuang BY, 2013, J HYDRAUL ENG, V139, P527, DOI 10.1061/(ASCE)HY.1943-7900.0000676	37	36	36	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88445	10.1371/journal.pone.0088445	http://dx.doi.org/10.1371/journal.pone.0088445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551102	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000037
J	Song, T; Gu, H				Song, Tao; Gu, Hong			Discriminative Motif Discovery via Simulated Evolution and Random Under-Sampling	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; SEQUENCE; DNA; ALIGNMENT; IDENTIFY; DATABASE	Conserved motifs in biological sequences are closely related to their structure and functions. Recently, discriminative motif discovery methods have attracted more and more attention. However, little attention has been devoted to the data imbalance problem, which is one of the main reasons affecting the performance of the discriminative models. In this article, a simulated evolution method is applied to solve the multi-class imbalance problem at the stage of data preprocessing, and at the stage of Hidden Markov Models (HMMs) training, a random under-sampling method is introduced for the imbalance between the positive and negative datasets. It is shown that, in the task of discovering targeting motifs of nine subcellular compartments, the motifs found by our method are more conserved than the methods without considering data imbalance problem and recover the most known targeting motifs from Minimotif Miner and InterPro. Meanwhile, we use the found motifs to predict protein subcellular localization and achieve higher prediction precision and recall for the minority classes.	[Song, Tao; Gu, Hong] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology	Gu, H (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Liaoning, Peoples R China.	guhong@dlut.edu.cn			Specialized Research Fund for the Doctoral Program of Higher Education [20120041110008]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20120041110008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly M., 2005, NEURAL NETW, P1; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bailey TL, 2008, COMP GENOMICS, P271; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Chawla N. V., 2004, P OCEAN DRILLING PRO, V6, P1, DOI [DOI 10.2973/ODP.PROC.IR.207.2004, DOI 10.1145/1007730.1007733]; Chawla NV, 2011, ARXIV11061813; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Daniels NM, 2012, BIOINFORMATICS, V28, P1216, DOI 10.1093/bioinformatics/bts110; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Eddy S R, 1995, J Comput Biol, V2, P9, DOI 10.1089/cmb.1995.2.9; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Estabrooks A, 2004, COMPUT INTELL-US, V20, P18, DOI 10.1111/j.0824-7935.2004.t01-1-00228.x; Fauteux F, 2008, BIOINFORMATICS, V24, P2303, DOI 10.1093/bioinformatics/btn444; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; GOPALAKRISHNAN PS, 1991, IEEE T INFORM THEORY, V37, P107, DOI 10.1109/18.61108; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huggins P, 2011, BIOINFORMATICS, V27, P2361, DOI 10.1093/bioinformatics/btr412; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Khreich W, 2010, PATTERN RECOGN LETT, V31, P91, DOI 10.1016/j.patrec.2009.09.023; Kumar A, 2010, BIOINFORMATICS, V26, pi287, DOI 10.1093/bioinformatics/btq199; Kumar A, 2009, BIOINFORMATICS, V25, P1602, DOI 10.1093/bioinformatics/btp265; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; Lin TH, 2011, J COMPUT BIOL, V18, P1709, DOI 10.1089/cmb.2011.0193; Lin TH, 2011, IEEE ACM T COMPUT BI, V8, P441, DOI 10.1109/TCBB.2009.82; Mease D, 2007, J MACH LEARN RES, V8, P409; Mehdi AM, 2013, BIOINFORMATICS, V29, P39, DOI 10.1093/bioinformatics/bts654; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Nair R, 2002, PROTEIN SCI, V11, P2836, DOI 10.1110/ps.0207402; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Rifkin R, 2004, J MACH LEARN RES, V5, P101; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Scott MS, 2005, PLOS COMPUT BIOL, V1, P518, DOI 10.1371/journal.pcbi.0010066; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; Vens C, 2011, BIOINFORMATICS, V27, P1231, DOI 10.1093/bioinformatics/btr110; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010	46	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87670	10.1371/journal.pone.0087670	http://dx.doi.org/10.1371/journal.pone.0087670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551063	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000016
J	Zhang, W; Pan, LQ; Tu, K; Zhang, Q; Liu, M				Zhang, Wei; Pan, Leiqing; Tu, Kang; Zhang, Qiang; Liu, Ming			Comparison of Spectral and Image Morphological Analysis for Egg Early Hatching Property Detection Based on Hyperspectral Imaging	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; HATCHABILITY; PREDICTION; STORAGE; SYSTEM	The use of non-destructive methods to detect egg hatching properties could increase efficiency in commercial hatcheries by saving space, reducing costs, and ensuring hatching quality. For this purpose, a hyperspectral imaging system was built to detect embryo development and vitality using spectral and morphological information of hatching eggs. A total of 150 green shell eggs were used, and hyperspectral images were collected for every egg on day 0, 1, 2, 3 and 4 of incubation. After imaging, two analysis methods were developed to extract egg hatching characteristic. Firstly, hyperspectral images of samples were evaluated using Principal Component Analysis (PCA) and only one optimal band with 822 nm was selected for extracting spectral characteristics of hatching egg. Secondly, an image segmentation algorithm was applied to isolate the image morphologic characteristics of hatching egg. To investigate the applicability of spectral and image morphological analysis for detecting egg early hatching properties, Learning Vector Quantization neural network (LVQNN) was employed. The experimental results demonstrated that model using image morphological characteristics could achieve better accuracy and generalization than using spectral characteristic parameters, and the discrimination accuracy for eggs with embryo development were 97% at day 3, 100% at day 4. In addition, the recognition results for eggs with weak embryo development reached 81% at day 3, and 92% at day 4. This study suggested that image morphological analysis was a novel application of hyperspectral imaging technology to detect egg early hatching properties.	[Zhang, Wei; Pan, Leiqing; Tu, Kang; Zhang, Qiang] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Liu, Ming] China Natl Res Inst Food & Fermentat Ind, Beijing, Peoples R China	Nanjing Agricultural University	Tu, K (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China.	Kangtu@njau.edu.cn			National Sci-Tech Support program [2012BAD28B01]; Jiangsu University [CXZZ12_0275]	National Sci-Tech Support program; Jiangsu University	This work was supported by National Sci-Tech Support program (2012BAD28B01) and Jiangsu University student research innovation project (CXZZ12_0275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariana DP, 2010, COMPUT ELECTRON AGR, V74, P137, DOI 10.1016/j.compag.2010.07.008; Elibol O, 2002, POULTRY SCI, V81, P945, DOI 10.1093/ps/81.7.945; Fan FH, 2013, J FOOD ENG, V118, P426, DOI 10.1016/j.jfoodeng.2013.04.015; Huang L, 2013, FOOD RES INT, V54, P821, DOI 10.1016/j.foodres.2013.08.011; Iqbal A, 2013, J FOOD ENG, V117, P42, DOI 10.1016/j.jfoodeng.2013.02.001; Joseph M, 1997, WORLD POULTRY, V13, P80; Kashaninejad M, 2009, J FOOD ENG, V91, P602, DOI 10.1016/j.jfoodeng.2008.10.012; Lawrence K.C., 2006, INT J POULTRY SCI, V5, P964; Lawrence KC, 2008, SENS INSTRUM FOOD QU, V2, P116, DOI DOI 10.1007/S11694-008-9039-Z; Li JB, 2011, COMPUT ELECTRON AGR, V78, P38, DOI 10.1016/j.compag.2011.05.010; Li XY, 2009, J ANHUI AGR SCI, V37, P15253; Liu L, 2013, FOOD BIOPROCESS TECH, V6, P2503, DOI 10.1007/s11947-012-0933-3; Polder G, 2003, J NEAR INFRARED SPEC, V11, P193, DOI 10.1255/jnirs.366; Qin AK, 2005, PATTERN RECOGN, V38, P773, DOI 10.1016/j.patcog.2004.11.011; Qin JW, 2013, J FOOD ENG, V118, P157, DOI 10.1016/j.jfoodeng.2013.04.001; Qin JW, 2009, J FOOD ENG, V93, P183, DOI 10.1016/j.jfoodeng.2009.01.014; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; Smith D. P., 2008, International Journal of Poultry Science, V7, P1001; Wang XT, 2009, POULTRY SCI, V88, P1735, DOI 10.3382/ps.2008-00434; Wold JP, 1996, J FOOD SCI, V61, P74, DOI 10.1111/j.1365-2621.1996.tb14728.x; Wu D, 2013, FOOD BIOPROCESS TECH, V6, P2943, DOI 10.1007/s11947-012-0928-0; Zakaria AH, 2009, POULTRY SCI, V88, P2712, DOI 10.3382/ps.2009-00069; Zhang QY, 2005, SENSOR ACTUAT B-CHEM, V110, P370, DOI 10.1016/j.snb.2005.02.017; Zhang Wei, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P149; Zhang Wei, 2012, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V43, P140; Zou XB, 2010, CHEMOMETR INTELL LAB, V104, P265, DOI 10.1016/j.chemolab.2010.08.019	26	16	17	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88659	10.1371/journal.pone.0088659	http://dx.doi.org/10.1371/journal.pone.0088659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551130	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000050
J	Bird, MS; Day, JA				Bird, Matthew S.; Day, Jenny A.			Wetlands in Changed Landscapes: The Influence of Habitat Transformation on the Physico-Chemistry of Temporary Depression Wetlands	PLOS ONE			English	Article							INVASIVE ALIEN PLANTS; STREAM MACROINVERTEBRATE COMMUNITIES; CAPE FLORISTIC REGION; LAND-USE; WATER-QUALITY; SOUTH-AFRICA; FRAGMENTED LANDSCAPE; WESTERN CAPE; LAKES; SEDIMENT	Temporary wetlands dominate the wet season landscape of temperate, semi-arid and arid regions, yet, other than their direct loss to development and agriculture, little information exists on how remaining wetlands have been altered by anthropogenic conversion of surrounding landscapes. This study investigates relationships between the extent and type of habitat transformation around temporary wetlands and their water column physico-chemical characteristics. A set of 90 isolated depression wetlands (seasonally inundated) occurring on coastal plains of the south-western Cape mediterranean-climate region of South Africa was sampled during the winter/spring wet season of 2007. Wetlands were sampled across habitat transformation gradients according to the areal cover of agriculture, urban development and alien invasive vegetation within 100 and 500 m radii of each wetland edge. We hypothesized that the principal drivers of physico-chemical conditions in these wetlands (e.g. soil properties, basin morphology) are altered by habitat transformation. Multivariate multiple regression analyses (distance-based Redundancy Analysis) indicated significant associations between wetland physico-chemistry and habitat transformation (overall transformation within 100 and 500 m, alien vegetation cover within 100 and 500 m, urban cover within 100 m); although for significant regressions the amount of variation explained was very low (range: similar to 2 to similar to 5.5%), relative to that explained by purely spatio-temporal factors (range: similar to 35.5 to similar to 43%). The nature of the relationships between each type of transformation in the landscape and individual physico-chemical variables in wetlands were further explored with univariate multiple regressions. Results suggest that conservation of relatively narrow (similar to 100 m) buffer strips around temporary wetlands is likely to be effective in the maintenance of natural conditions in terms of physico-chemical water quality.	[Bird, Matthew S.] Nelson Mandela Metropolitan Univ, DST NRF Res Chair Shallow Water Ecosyst, Port Elizabeth, South Africa; [Day, Jenny A.] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa	Nelson Mandela University; University of Cape Town	Bird, MS (corresponding author), Nelson Mandela Metropolitan Univ, DST NRF Res Chair Shallow Water Ecosyst, Port Elizabeth, South Africa.	matthew.bird@nmmu.ac.za	Bird, Matthew/AAB-5127-2020	Bird, Matthew/0000-0001-9163-1008	National Research Foundation (NRF); Water Research Commission (WRC, Pretoria)	National Research Foundation (NRF); Water Research Commission (WRC, Pretoria)	Funding for this project was provided by the National Research Foundation (NRF, Pretoria www.nrf.ac.za) and the Water Research Commission (WRC, Pretoria www.wrc.org.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka M, 2010, FRESHWATER BIOL, V55, P909, DOI 10.1111/j.1365-2427.2009.02334.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Angeler DG, 2007, ECOL APPL, V17, P1105, DOI 10.1890/06-1040; AZOUS AL, 1997, WETLANDS URBANIZATIO; Batzer Darold P., 2006, P242; Bird MS, 2013, HYDROBIOLOGIA, V720, P19, DOI 10.1007/s10750-013-1618-2; Bird MS, 2013, HYDROBIOLOGIA, V711, P115, DOI 10.1007/s10750-013-1470-4; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Blinn DW, 2004, HYDROBIOLOGIA, V528, P229, DOI 10.1007/s10750-004-2350-8; Brooks RT, 2002, J FRESHWATER ECOL, V17, P485, DOI 10.1080/02705060.2002.9663924; Bruland GL, 2003, WETL ECOL MANAG, V11, P141, DOI 10.1023/A:1024244408577; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Carrino-Kyker SR, 2007, WETLANDS, V27, P749, DOI 10.1672/0277-5212(2007)27[749:SPCOTN]2.0.CO;2; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clenaghan C, 1998, FRESHWATER BIOL, V40, P175, DOI 10.1046/j.1365-2427.1998.00330.x; Colburn E. A., 2004, VERNAL POOLS NATURAL; Cook RD, 1982, RESIDUALS INFLUENCE; Crosbie B, 1999, CAN J FISH AQUAT SCI, V56, P1781, DOI 10.1139/cjfas-56-10-1781; Davies BR, 2008, HYDROBIOLOGIA, V597, P7, DOI 10.1007/s10750-007-9227-6; De Roeck ER, 2008, THESIS CATHOLIC U LE; de Szalay FA, 2000, FRESHWATER BIOL, V45, P295, DOI 10.1111/j.1365-2427.2000.00623.x; Declerck S, 2006, BIOL CONSERV, V131, P523, DOI 10.1016/j.biocon.2006.02.024; Enright WD, 2000, PHYS CHEM EARTH PT B, V25, P237, DOI 10.1016/S1464-1909(00)00010-1; Ewart-Smith J., 2006, K8652 WRC SANBI; Faulkner Stephen, 2004, Urban Ecosystems, V7, P89, DOI 10.1023/B:UECO.0000036269.56249.66; Gardiner AJC, 1988, THESIS U CAPE TOWN C; Gorgens AHM, 2004, S AFR J SCI, V100, P27; Gorley C.K., 2006, GETTING STARTED PRIM; Harrison A. D., 1962, Transactions of the Royal Society of South Africa, V36, P213; Heijnis CE, 1999, BIODIVERS CONSERV, V8, P471, DOI 10.1023/A:1008807628092; Hitchcock A, 2006, VELD FLORA, V92, P40; Hitchcock A., 2008, VELD FLORA, V94, P31; HOLM S, 1979, SCAND J STAT, V6, P65; Hopkins S, 2006, THESIS U W CAPE S AF; Houlahan JE, 2004, LANDSCAPE ECOL, V19, P677, DOI 10.1023/B:LAND.0000042912.87067.35; LARSEN WA, 1972, TECHNOMETRICS, V14, P781, DOI 10.2307/1267305; Le Maitre DC, 2000, WATER SA, V26, P397; Leavitt PR, 2006, LIMNOL OCEANOGR, V51, P2262, DOI 10.4319/lo.2006.51.5.2262; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leps J, 2003, MULTIVARIATE ANAL EC; Lofman S, 2001, SCAND J FOREST RES, V16, P44, DOI 10.1080/028275801300004406; Lombard AT, 1997, CONSERV BIOL, V11, P1101, DOI 10.1046/j.1523-1739.1997.96043.x; Lougheed VL, 2001, CAN J FISH AQUAT SCI, V58, P1603, DOI 10.1139/cjfas-58-8-1603; Magnusson AK, 2006, ARCH HYDROBIOL, V165, P537, DOI 10.1127/0003-9136/2006/0165-0537; MANSFIELD ER, 1987, AM STAT, V41, P107, DOI 10.2307/2684221; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McDowell C., 1989, VELD FLORA, V75, P36; MEFFE C, 1997, PRINCIPLES CONSERVAT; MIDGLEY J, 1992, WATER SA, V18, P93; Mlambo MC, 2011, AFR J AQUAT SCI, V36, P299, DOI 10.2989/16085914.2011.636903; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Naveh Z, 2007, LANDSCAPE ECOL, V22, P1437, DOI 10.1007/s10980-007-9171-x; PEDERSEN ER, 1986, HYDROBIOLOGIA, V139, P13, DOI 10.1007/BF00770238; Pham SV, 2008, LIMNOL OCEANOGR, V53, P728, DOI 10.4319/lo.2008.53.2.0728; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAUBENHEIMER CM, 1991, HYDROBIOLOGIA, V224, P167, DOI 10.1007/BF00008466; Rebelo A. G., 2006, VEGETATION S AFRICA, P53, DOI DOI 10.1007/S; REBELO AG, 1992, T ROY SOC S AFR, V48, P55, DOI 10.1080/00359199209520256; Rhazi L, 2001, CR ACAD SCI III-VIE, V324, P165, DOI 10.1016/S0764-4469(00)01286-5; RICHARDS C, 1993, FRESHWATER BIOL, V29, P285, DOI 10.1111/j.1365-2427.1993.tb00764.x; Richardson DM, 2004, S AFR J SCI, V100, P45; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Schell JM, 2001, HYDROBIOLOGIA, V445, P37, DOI 10.1023/A:1017574316867; Semlitsch RD, 1998, CONSERV BIOL, V12, P1129, DOI 10.1046/j.1523-1739.1998.98166.x; SILBERBAUER M J, 1991, Southern African Journal of Aquatic Sciences, V17, P82; Skagen SK, 2008, WETLANDS, V28, P594, DOI 10.1672/07-84.1; Somerfield PJ, 2002, J ANIM ECOL, V71, P581, DOI 10.1046/j.1365-2656.2002.00624.x; tersBraak C. J. F., 2002, CANOCO WINDOWS VERSI; Turner R, 2006, VELD FLORA, V92, P140; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Williams DD., 2006, BIOL TEMPORARY WATER; WITKOWSKI ETF, 1987, J ECOL, V75, P1159, DOI 10.2307/2260320	73	16	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88935	10.1371/journal.pone.0088935	http://dx.doi.org/10.1371/journal.pone.0088935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533161	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600119
J	Dong, CX; Ge, PF; Ren, XL; Zhao, XF; Wang, J; Fan, HQ; Yin, SA				Dong, Caixia; Ge, Pengfei; Ren, Xiaolan; Zhao, Xianfeng; Wang, Jie; Fan, Haoqiang; Yin, Shi-an			The Micronutrient Status of Children Aged 24-60 Months Living in Rural Disaster Areas One Year after the Wenchuan Earthquake	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; BRAIN; PREVALENCE; NUTRITION; TODDLERS; INFANTS; HEALTH	Objective: In order to evaluate micronutrient status of children aged 24-60 months living in rural disaster areas after one year of the earthquake in Wenchuan. Design: After one year of Wenchuan Earthquake, using PPS sampling methods, a total of 270 children from six-randomized townships near seismic center, in each township sample size consisted of 30 to 50 children, were sampled for evaluating Z-score of children's growth status, anemia prevalence, vitamin A, vitamin D, vitamin B-12, folic acid status. Final sample consisted of 152 boys and 118 girls, and blood samples were drawn from 206 children. Results: The stunting (HAZ<2SD) and wasting (WHZ<2SD) were respectively 14.7% and 0.7%. Prevalence of anemia was 17.3% and percentage of iron deficiency was 45.7%. The prevalence of vitamin A deficiency and marginal deficiency was 15.4% and 30.3%, respectively. The sum of vitamin D deficiency and marginal deficiency was near 90%. Percentages of Zinc deficiency including marginal and deficiency were 65.5%. Percentages of vitamin B12 marginal and deficiency were 8.6% and 10.6% and the prevalence of marginal deficiency was significantly higher in boys than in girls. Folic acid deficiency was not found in surveyed children using serum folic acid level < 16.9 ng/ml. Conclusion: In areas affected by Earthquake, preschool children had higher stunting prevalence and a relatively higher prevalence suffered from micronutrient deficiencies, including iron-deficiency anemia, and deficiencies of iron, zinc, vitamin A and vitamin B12.	[Dong, Caixia; Ge, Pengfei; Ren, Xiaolan; Fan, Haoqiang] Gansu Ctr Dis Control & Prevent, Dept Chron Dis, Lanzhou, Gansu, Peoples R China; [Zhao, Xianfeng; Wang, Jie; Yin, Shi-an] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Dept Maternal & Child Nutr, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Yin, SA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Dept Maternal & Child Nutr, Beijing, Peoples R China.	shianyin@126.com			UNICEF in China	UNICEF in China	This survey was partly supported by UNICEF in China, however, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; Bwibo NO, 2003, J NUTR, V133, p3936S, DOI 10.1093/jn/133.11.3936S; Gao Mei-zhe, 2006, Zhonghua Er Ke Za Zhi, V44, P7; Gordon CM, 2008, ARCH PEDIAT ADOL MED, V162, P505, DOI 10.1001/archpedi.162.6.505; Huang C, 2010, J NUTR, V140, P1874, DOI 10.3945/jn.110.121293; Krebs NF, 2007, J NUTR, V137, p511S, DOI 10.1093/jn/137.2.511S; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Nishikiori N, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-73; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; Qin Y, 2009, ASIA PAC J CLIN NUTR, V18, P15; Rosales FJ, 2009, NUTR NEUROSCI, V12, P190, DOI 10.1179/147683009X423454; Rosales FJ, 2008, NUTR NEUROSCI, V11, P135, DOI 10.1179/147683008X301522; Singh Meharban, 2004, Indian Journal of Pediatrics, V71, P59, DOI 10.1007/BF02725658; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang Li-juan, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P696; Wang ZX, 2004, BRIT J NUTR, V91, P121, DOI 10.1079/BJN20031030; WHO, 2000, M PREV CRS IMM STRAT, P2; World Health Organization, 2002, WORLD HLTH REP; World Health Organization, 1995, PHYS STAT US INT ANT; Yin S, 2011, VITAMINS S, V85, P97; Yin SA, 2008, 2002 CHINA NUTR HLTH; YOUNG H, 1995, DISASTERS, V19, P26, DOI 10.1111/j.1467-7717.1995.tb00330.x; Zhao Xian-feng, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P691; Zhu ZW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-126	26	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88444	10.1371/journal.pone.0088444	http://dx.doi.org/10.1371/journal.pone.0088444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533089	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600047
J	Gutmann, MU; Laparra, V; Hyvarinen, A; Malo, J				Gutmann, Michael U.; Laparra, Valero; Hyvarinen, Aapo; Malo, Jesus			Spatio-Chromatic Adaptation via Higher-Order Canonical Correlation Analysis of Natural Images	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; INDEPENDENT COMPONENT ANALYSIS; RECEPTIVE-FIELD PROPERTIES; 2-STAGE LINEAR RECOVERY; COLOR APPEARANCE; SPECTRAL DESCRIPTIONS; CHROMATIC MECHANISMS; SPATIAL STRUCTURE; STRIATE CORTEX; CONSTANCY	Independent component and canonical correlation analysis are two general-purpose statistical methods with wide applicability. In neuroscience, independent component analysis of chromatic natural images explains the spatio-chromatic structure of primary cortical receptive fields in terms of properties of the visual environment. Canonical correlation analysis explains similarly chromatic adaptation to different illuminations. But, as we show in this paper, neither of the two methods generalizes well to explain both spatio-chromatic processing and adaptation at the same time. We propose a statistical method which combines the desirable properties of independent component and canonical correlation analysis: It finds independent components in each data set which, across the two data sets, are related to each other via linear or higher-order correlations. The new method is as widely applicable as canonical correlation analysis, and also to more than two data sets. We call it higher-order canonical correlation analysis. When applied to chromatic natural images, we found that it provides a single (unified) statistical framework which accounts for both spatio-chromatic processing and adaptation. Filters with spatio-chromatic tuning properties as in the primary visual cortex emerged and corresponding-colors psychophysics was reproduced reasonably well. We used the new method to make a theory-driven testable prediction on how the neural response to colored patterns should change when the illumination changes. We predict shifts in the responses which are comparable to the shifts reported for chromatic contrast habituation.	[Gutmann, Michael U.; Hyvarinen, Aapo] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Gutmann, Michael U.; Hyvarinen, Aapo] Univ Helsinki, Helsinki Inst Informat Technol, Helsinki, Finland; [Laparra, Valero; Malo, Jesus] Univ Valencia, Image Proc Lab, Valencia, Spain; [Hyvarinen, Aapo] Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland; [Hyvarinen, Aapo] ATR, Cognit Mech Labs, Kyoto, Japan	University of Helsinki; University of Helsinki; University of Valencia; University of Helsinki	Gutmann, MU (corresponding author), Univ Helsinki, Dept Math & Stat, Helsinki, Finland.	michael.gutmann@helsinki.fi	Malo, Jesus/K-9235-2017; Laparra, Valero/I-2705-2015; Laparra, Valero/AAD-1937-2019	Malo, Jesus/0000-0002-5684-8591; Laparra, Valero/0000-0001-7531-9890; Laparra, Valero/0000-0001-7531-9890; Hyvarinen, Aapo/0000-0002-5806-4432	Academy of Finland; Finnish Centre-of-Excellence in Algorithmic Data Analysis; Finnish Centre-of-Excellence in Inverse Problems Research; Finnish Centre-of-Excellence in Computational Inference Research COIN [251170]; Spanish CICYT research [TEC2009-13696, TIN2012-38102-C03-01]; Computational Science Program; LASTU	Academy of Finland(Academy of Finland); Finnish Centre-of-Excellence in Algorithmic Data Analysis; Finnish Centre-of-Excellence in Inverse Problems Research; Finnish Centre-of-Excellence in Computational Inference Research COIN; Spanish CICYT research(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Computational Science Program; LASTU	MUG and AH acknowledge financial support by the Academy of Finland, Computational Science Program, LASTU, the Finnish Centre-of-Excellence in Algorithmic Data Analysis, the Finnish Centre-of-Excellence in Inverse Problems Research, and the Finnish Centre-of-Excellence in Computational Inference Research COIN (251170). VL and JM acknowledge financial support from the Spanish CICYT research projects TEC2009-13696 and TIN2012-38102-C03-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AB, 2007, NEURAL COMPUT, V19, P2610, DOI 10.1162/neco.2007.19.10.2610; Akaho S, 2001, P INT M PSYCH SOC IM; Amari S, 1996, ADV NEUR IN, V8, P757; Archambeau C., 2009, ADV NEURAL INFORM PR, P73; ATICK JJ, 1993, VISION RES, V33, P123, DOI 10.1016/0042-6989(93)90065-5; Bach FR, 2002, J MACHINE LEARNING R, V3, P1; Bethge M, 2006, J OPT SOC AM A, V23, P1253, DOI 10.1364/JOSAA.23.001253; Bornschein J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003062; BRENEMAN EJ, 1987, J OPT SOC AM A, V4, P1115, DOI 10.1364/JOSAA.4.001115; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; Chakrabarti A, 2011, PROC CVPR IEEE, P193, DOI 10.1109/CVPR.2011.5995660; CLARKE RJ, 1981, IEE PROC-F, V128, P359, DOI 10.1049/ip-f-1.1981.0061; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Coates Adam, 2011, P 14 INT C ART INT S, P215, DOI DOI 10.1177/1753193410390845; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Dayan P, 2001, COMPUTATIONAL NEUROS; Doi E, 2003, NEURAL COMPUT, V15, P397, DOI 10.1162/089976603762552960; DZMURA M, 1993, J OPT SOC AM A, V10, P2166, DOI 10.1364/JOSAA.10.002166; DZMURA M, 1993, J OPT SOC AM A, V10, P2148, DOI 10.1364/JOSAA.10.002148; Fairchild M. D., 2005, COLOR APPEARANCE MOD; GuerreroCusumano JL, 1996, INFORM SCIENCES, V92, P33, DOI 10.1016/0020-0255(96)00036-9; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; Gutmann MU, 2011, LECT NOTES COMPUT SC, V6791, P323, DOI 10.1007/978-3-642-21735-7_40; HANCOCK PJB, 1992, NETWORK-COMP NEURAL, V3, P61, DOI 10.1088/0954-898X/3/1/008; Hastie T., 2009, UNSUPERVISED LEARNIN; Hoyer PO, 2000, NETWORK-COMP NEURAL, V11, P191, DOI 10.1088/0954-898X/11/3/302; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Hyvarinen A, 2009, COMPUT IMAGING VIS, V39, P1; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Karhunen J, 2007, NEUROCOMPUTING, V70, P2969, DOI 10.1016/j.neucom.2006.10.144; Karhunen J, 2013, NEUROCOMPUTING, V113, P153, DOI 10.1016/j.neucom.2013.01.018; Kim T.-H., 2004, FINANC RES LETT, V1, P56, DOI [DOI 10.1016/S1544-6123(03)00003-5, 10.1016/S1544-6123(03)00003-5]; Laparra V, 2012, NEURAL COMPUT, V24, P2751, DOI 10.1162/NECO_a_00336; Lee TW, 2002, VISION RES, V42, P2095, DOI 10.1016/S0042-6989(02)00122-0; LENNIE P, 1990, J NEUROSCI, V10, P649; LUO MR, 1991, COLOR RES APPL, V16, P166, DOI 10.1002/col.5080160307; Luo MR, 1999, COLOR RES APPL, V24, P295, DOI 10.1002/(SICI)1520-6378(199908)24:4<295::AID-COL10>3.0.CO;2-K; Malo J, 2010, NEURAL COMPUT, V22, P3179, DOI 10.1162/NECO_a_00046; MARIMONT DH, 1992, J OPT SOC AM A, V9, P1905, DOI 10.1364/JOSAA.9.001905; MartinezVerdu F, 1997, VISION RES, V37, P1829, DOI 10.1016/S0042-6989(96)00327-6; Melzer T, 2003, PATTERN RECOGN, V36, P1961, DOI 10.1016/S0031-3203(03)00058-X; Miller G., 1955, INFORM THEORY PSYCHO, P95; Moroney N., 2002, P COL IM C, P23; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; Nadarajah S, 2005, ACTA APPL MATH, V89, P53, DOI 10.1007/s10440-005-9003-4; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Puertas G., 2010, ADV NEURAL INF PROCE, V23, P1939; Rehn M, 2007, J COMPUT NEUROSCI, V22, P135, DOI 10.1007/s10827-006-0003-9; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Ruderman DL, 1998, J OPT SOC AM A, V15, P2036, DOI 10.1364/JOSAA.15.002036; Tailby C, 2008, J NEUROSCI, V28, P1131, DOI 10.1523/JNEUROSCI.4682-07.2008; Tailor DR, 2000, VISION RES, V40, P2671, DOI 10.1016/S0042-6989(00)00105-X; Thomas MC, 2006, ELEMENTS INFORM THEO; Tuia D, 2013, IEEE T GEOSCI REMOTE, V51, P329, DOI 10.1109/TGRS.2012.2200045; Wachtler T, 2001, J OPT SOC AM A, V18, P65, DOI 10.1364/JOSAA.18.000065; WEBSTER MA, 1991, NATURE, V349, P235, DOI 10.1038/349235a0; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; Witten D, 2009, BIOSTATISTICS, V10	58	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e86481	10.1371/journal.pone.0086481	http://dx.doi.org/10.1371/journal.pone.0086481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533049	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600007
J	Goto, R; Arai, K; Kitada, H; Ogoshi, K; Hamashima, C				Goto, Rei; Arai, Kohei; Kitada, Hirotsugu; Ogoshi, Kazuei; Hamashima, Chisato			Labor Resource Use for Endoscopic Gastric Cancer Screening in Japanese Primary Care Settings: A Work Sampling Study	PLOS ONE			English	Article							EFFICIENCY; TIME	Objective: Endoscopic gastric cancer is screened in primary care settings, but how much resources are required to deliver this service remains unknown. This study determines how much time and human resources are used for endoscopic gastric cancer and for each component of the procedure. Materials and Methods: Upper endoscopic procedures were prospectively observed using a work sampling technique. This study analyzed data from patients who underwent upper endoscopic gastric cancer screening at primary care clinics that provide this service. The main outcome measurements were time intervals and total time intervals that considered the numbers of simultaneously engaged workers and were calculated as the product of time intervals and the number of workers, and the labor cost of individual components of each procedure. Results: We observed 44 upper endoscopic procedures at four outpatient clinics. Pre-procedure (preparation and premedication), procedure (from intubation to extubation) and post-procedure (recovery and cleaning) accounted for 34.1%, 10.6% and 54.4% of the total time, respectively. Of the overall total time intervals (mean: 4453 person-seconds), 29.3%, 14.4% and 55.7% of the total time was devoted to pre-procedure, procedure and post-procedure, respectively. The post-procedure was the most time-and labor-consuming component from the viewpoints of both total time and labor cost. Conclusions: Most of the time taken to complete endoscopic gastric cancer screening is consumed by preparation, premedication and post-procedures in which nurses play key roles.	[Goto, Rei] Kyoto Univ, Grad Sch Econ, Kyoto, Japan; [Goto, Rei] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan; [Arai, Kohei] Gunma Univ, Fac Social & Informat Studies, Gunma, Japan; [Kitada, Hirotsugu] Hosei Univ, Fac Business Adm, Tokyo, Japan; [Ogoshi, Kazuei] Niigata Canc Ctr Hosp, Niigata, Japan; [Hamashima, Chisato] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan	Kyoto University; Kyoto University; Gunma University; Hosei University; National Cancer Center - Japan	Goto, R (corresponding author), Kyoto Univ, Grad Sch Econ, Kyoto, Japan.	goto.rei.7w@kyoto-u.ac.jp	Hamashima, Chisato/AAI-3061-2021	Arai, Kohei/0000-0003-2989-4936	Ministry of Health, Labor and Welfare of Japan [22-21]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grant-in-Aid for Cancer Control from Ministry of Health, Labor and Welfare of Japan (Grant number 22-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aft L.S., 2000, WORK MEASUREMENT MET; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Foundation for Promotion of Cancer Research, 2011, 2011 CANC STAT JAP; Groover P., 2007, WORK SYSTEMS METHODS; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Harewood GC, 2008, GASTROINTEST ENDOSC, V68, P1043, DOI 10.1016/j.gie.2008.03.1116; Ikegami N, 1999, HEALTH AFFAIR, V18, P56, DOI 10.1377/hlthaff.18.3.56; Japan Medical Association Research Institute, 2012, DYN AN BAS TKC IND M; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Ministry of Health Labour and Welfare, 2011, CHING KOZ KIH TOUK T; Ogoshi K, 2010, ENDOSCOPIC FORUM, V26, P5; Sawada A, 1997, NURS ETHICS, V4, P245; Tipping MD, 2010, J HOSP MED, V5, P353, DOI 10.1002/jhm.647; Yong E, 2006, GASTROINTEST ENDOSC, V64, P760, DOI 10.1016/j.gie.2006.02.047	14	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88113	10.1371/journal.pone.0088113	http://dx.doi.org/10.1371/journal.pone.0088113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523875	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100024
J	Machado-de-Sousa, JP; Osorio, FD; Jackowski, AP; Bressan, RA; Chagas, MHN; Torro-Alves, N; DePaula, ALD; Crippa, JAS; Hallak, JEC				Machado-de-Sousa, Joao Paulo; Osorio, Flavia de Lima; Jackowski, Andrea P.; Bressan, Rodrigo A.; Chagas, Marcos H. N.; Torro-Alves, Nelson; DePaula, Andre L. D.; Crippa, Jose A. S.; Hallak, Jaime E. C.			Increased Amygdalar and Hippocampal Volumes in Young Adults with Social Anxiety	PLOS ONE			English	Article							DEPRESSION; DISORDER; METAANALYSIS; PHOBIA	Background: Functional neuroimaging studies have consistently shown abnormal limbic activation patterns in socially anxious individuals, but structural data on the amygdala and hippocampus of these patients are scarce. This study explored the existence of structural differences in the whole brain, amygdala, and hippocampus of subjects with clinical and subthreshold social anxiety compared to healthy controls. We hypothesized that there would be volumetric differences across groups, without predicting their direction (i.e. enlargement or reduction). Methods: Subjects classified as having social anxiety disorder (n = 12), subthreshold social anxiety (n = 12) and healthy controls (n = 14) underwent structural magnetic resonance imaging scans. The amygdala and hippocampus were defined a priori as regions of interest and volumes were calculated by manual tracing. Whole brain volume was calculated using voxel-based morphometry. Results: The bilateral amygdala and left hippocampus were enlarged in socially anxious individuals relative to controls. The volume of the right hippocampus was enlarged in subthreshold social anxiety participants relative to controls. No differences were found across groups in respect to total brain volume. Conclusions: Our results show amygdalar and hippocampal volume alterations in social anxiety, possibly associated with symptom severity. The time course of such alterations and the cellular and molecular bases of limbic plasticity in social anxiety should be further investigated.	[Machado-de-Sousa, Joao Paulo; Osorio, Flavia de Lima; Chagas, Marcos H. N.; DePaula, Andre L. D.; Crippa, Jose A. S.; Hallak, Jaime E. C.] Univ Sao Paulo, Dept Neurosci & Behav, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP, Brazil; [Jackowski, Andrea P.; Bressan, Rodrigo A.] Fed Univ Sao Paulo UNIFESP, Dept Psychiat, Sao Paulo, Brazil; [Torro-Alves, Nelson] Fed Univ Paraiba UFPB, Dept Psychol, Joao Pessoa, PB, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal da Paraiba	Machado-de-Sousa, JP (corresponding author), Univ Sao Paulo, Dept Neurosci & Behav, Ribeirao Preto Med Sch, BR-14049 Ribeirao Preto, SP, Brazil.	joaopmachado@usp.br	Alves, Nelson/AAG-1137-2020; Alves, Nelson T/D-2350-2014; Bressan, Rodrigo A/E-9178-2010; Chagas, Marcos Hortes N. H/D-9850-2012; Osório, Flávia L./T-5001-2019; Jackowski, Andrea P/D-8616-2012; Osório, Flávia L./H-6079-2012; de Souza Crippa, José Alexandre/A-1215-2008	Alves, Nelson/0000-0003-3678-5762; Alves, Nelson T/0000-0003-3678-5762; Bressan, Rodrigo A/0000-0002-0868-4449; Chagas, Marcos Hortes N. H/0000-0003-3752-7984; Jackowski, Andrea P/0000-0001-8842-5406; L. Osorio, Flavia/0000-0003-1396-555X	National Institute for Translational Medicine (INCT-TM) of the Brazilian Council for Scientific and Technological Development (CNPq); Research Support Center for Applied Neuroscience (NAPNA) of the Sao Paulo Research Foundation (NAPNA)	National Institute for Translational Medicine (INCT-TM) of the Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Center for Applied Neuroscience (NAPNA) of the Sao Paulo Research Foundation (NAPNA)	This research was supported by the National Institute for Translational Medicine (INCT-TM)(www.ufrgs.br/inct-tm) of the Brazilian Council for Scientific and Technological Development (CNPq) and by the Research Support Center for Applied Neuroscience (NAPNA)(www.napnausp.org.br) of the Sao Paulo Research Foundation (NAPNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista CA, 2012, J AFFECT DISORDERS, V136, P857, DOI 10.1016/j.jad.2011.09.022; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Chagas MHN, 2010, REV BRAS PSIQUIATR, V32, P444, DOI 10.1590/S1516-44462010005000029; Crippa JAS, 2008, PERSPECT PSYCHIATR C, V44, P241, DOI 10.1111/j.1744-6163.2008.00183.x; Crum RM, 2001, AM J PSYCHIAT, V158, P1693, DOI 10.1176/appi.ajp.158.10.1693; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; First M. B., 1997, STRUCTURED CLIN INTE; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Frodl T, 2003, BIOL PSYCHIAT, V53, P338, DOI 10.1016/S0006-3223(02)01474-9; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; Liao W, 2010, PLOS ONE, V22; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; POTTS NLS, 1994, PSYCHIAT RES, V52, P35, DOI 10.1016/0165-1781(94)90118-X; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Sheline YI, 1998, NEUROREPORT, V13, P2436; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Syal S, 2012, METAB BRAIN DIS, V27, P299, DOI 10.1007/s11011-012-9299-5; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013	26	52	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88523	10.1371/journal.pone.0088523	http://dx.doi.org/10.1371/journal.pone.0088523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523911	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100060
J	Zhang, LM; Yu, DS; Shi, XZ; Xu, SX; Xing, SH; Zhao, YC				Zhang, Liming; Yu, Dongsheng; Shi, Xuezheng; Xu, Shengxiang; Xing, Shihe; Zhao, Yongcong			Effects of Soil Data and Simulation Unit Resolution on Quantifying Changes of Soil Organic Carbon at Regional Scale with a Biogeochemical Process Model	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NITROUS-OXIDE EVOLUTION; METHANE EMISSIONS; RAINFALL EVENTS; RICE FIELDS; PADDY SOILS; DNDC MODEL; CHINA; DYNAMICS; STORAGE	Soil organic carbon (SOC) models were often applied to regions with high heterogeneity, but limited spatially differentiated soil information and simulation unit resolution. This study, carried out in the Tai-Lake region of China, defined the uncertainty derived from application of the DeNitrification-DeComposition (DNDC) biogeochemical model in an area with heterogeneous soil properties and different simulation units. Three different resolution soil attribute databases, a polygonal capture of mapping units at 1:50,000 (P5), a county-based database of 1:50,000 (C5) and county-based database of 1:14,000,000 (C14), were used as inputs for regional DNDC simulation. The P5 and C5 databases were combined with the 1:50,000 digital soil map, which is the most detailed soil database for the Tai-Lake region. The C14 database was combined with 1:14,000,000 digital soil map, which is a coarse database and is often used for modeling at a national or regional scale in China. The soil polygons of P5 database and county boundaries of C5 and C14 databases were used as basic simulation units. Results project that from 1982 to 2000, total SOC change in the top layer (0-30 cm) of the 2.3 M ha of paddy soil in the Tai-Lake region was +1.48 Tg C, -3.99 Tg C and -15.38 Tg C based on P5, C5 and C14 databases, respectively. With the total SOC change as modeled with P5 inputs as the baseline, which is the advantages of using detailed, polygon-based soil dataset, the relative deviation of C5 and C14 were 368% and 1126%, respectively. The comparison illustrates that DNDC simulation is strongly influenced by choice of fundamental geographic resolution as well as input soil attribute detail. The results also indicate that improving the framework of DNDC is essential in creating accurate models of the soil carbon cycle.	[Zhang, Liming; Xing, Shihe] Fujian Agr & Forestry Univ, Coll Resource & Environm, Fuzhou, Peoples R China; [Zhang, Liming; Yu, Dongsheng; Shi, Xuezheng; Xu, Shengxiang; Zhao, Yongcong] Chinese Acad Sci, State Key Lab Soil & Sustainable Agr, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Soil Science, CAS	Yu, DS (corresponding author), Chinese Acad Sci, State Key Lab Soil & Sustainable Agr, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China.	dshyu@issas.ac.cn; fafuxsh@126.com			National Natural Science Foundation of China [41001126]; National Basic Research Program of China (973 Program) [2010CB950702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The work was funded by National Natural Science Foundation of China (No. 41001126), and the National Basic Research Program of China (973 Program) (2010CB950702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassu Y, 2012, ENG GEOL, V124, P1, DOI 10.1016/j.enggeo.2011.09.007; Ardo J, 2003, J ARID ENVIRON, V54, P633, DOI 10.1006/jare.2002.1105; Arnold R.W., 1995, ADV SOIL SCI SOILS G, P57; Barrett K., 2008, SPSS INTERMEDIATE ST, V3rd ed.; BURKE IC, 1995, ECOL APPL, V5, P793, DOI 10.2307/1941987; Cai ZC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002046; Cerri CEP, 2007, AGR ECOSYST ENVIRON, V122, P58, DOI 10.1016/j.agee.2007.01.008; China Meteorological Administration, 2011, CHIN MET DAT DAIL VA; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192, DOI 10.2136/sssaj1993.03615995005700010034x; Gong Z, 1999, CHINESE SOIL TAXONOM, P5; Gou J, 1999, ADV ATMOS SCI, V16, P581; Huang Y, 2009, AGR FOREST METEOROL, V149, P106, DOI 10.1016/j.agrformet.2008.07.013; Institute of Soil Science, 1986, SOIL ATL CHIN; JENKINSON DS, 1977, SOIL SCI, V123, P298, DOI 10.1097/00010694-197705000-00005; Lal R, 2006, ENCY SOIL SCI, DOI [10.1081/E-ESS-120042696, DOI 10.1081/E-ESS-120042696]; Li CS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002045; Li CS, 1996, GLOBAL BIOGEOCHEM CY, V10, P297, DOI 10.1029/96GB00470; Li CS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015370; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; LI CS, 1994, GLOBAL BIOGEOCHEM CY, V8, P237, DOI 10.1029/94GB00767; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9777, DOI 10.1029/92JD00510; Li CS, 2007, IEEE C COMP VIS PATT, P1; LI QK, 1992, PADDY SOIL CHINA; Liu Qing, 2009, Acta Pedologica Sinica, V46, P1059; Liu QH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002731; Liu YH, 2006, SCI TOTAL ENVIRON, V372, P203, DOI 10.1016/j.scitotenv.2006.09.022; Ll CS, 2007, SOIL SCI PLANT NUTR, V53, P344, DOI 10.1111/j.1747-0765.2007.00133.x; Lu R, 1982, AGR CHEM MANUAL; National Soil Survey Office of China, 1993, SOILS CHIN, V1-6; Neufeldt H, 2006, AGR ECOSYST ENVIRON, V112, P233, DOI 10.1016/j.agee.2005.08.024; Pathak H, 2005, BIOGEOSCIENCES, V2, P113, DOI 10.5194/bg-2-113-2005; Qiu J.J., 2005, AGR SCI CHINA, V37, P1166; Ray BD, 1998, ADV SOIL S, P169; Shi XZ, 2010, CLIMATIC CHANGE, V102, P579, DOI 10.1007/s10584-009-9704-1; Shi XZ, 2006, SOIL SCI SOC AM J, V70, P78, DOI 10.2136/sssaj2004.0318; Shirato Y, 2005, SOIL SCI PLANT NUTR, V51, P183, DOI 10.1111/j.1747-0765.2005.tb00022.x; Smith P, 1997, GEODERMA, V81, P153, DOI 10.1016/S0016-7061(97)00087-6; Soil Survey Staff, 2010, KEYS SOIL TAX; Studdert GA, 2011, SOIL TILL RES, V117, P191, DOI 10.1016/j.still.2011.10.006; Tang HJ, 2010, AGR SCI CHINA, V9, P704, DOI 10.1016/S1671-2927(09)60146-2; Tang HJ, 2006, GEODERMA, V134, P200, DOI 10.1016/j.geoderma.2005.10.005; Tonitto C, 2007, NUTR CYCL AGROECOSYS, V78, P65, DOI 10.1007/s10705-006-9074-2; Wang LG, 2008, GEODERMA, V147, P47, DOI 10.1016/j.geoderma.2008.07.009; Whitmore AP, 1997, GEODERMA, V81, P137, DOI 10.1016/S0016-7061(97)00086-4; Wu TY, 2004, SOIL TILL RES, V77, P59, DOI 10.1016/j.still.2003.10.002; XU Q, 1980, PADDY SOIL TAI LAKE; Xu SX, 2013, CATENA, V104, P67, DOI 10.1016/j.catena.2012.10.017; Xu SX, 2012, CATENA, V92, P113, DOI 10.1016/j.catena.2011.12.005; Yu DS, 2013, SOIL SCI SOC AM J, V77, P664, DOI 10.2136/sssaj2012.0036; Yu DS, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003825; Yu YQ, 2012, GLOBAL PLANET CHANGE, V82-83, P115, DOI 10.1016/j.gloplacha.2011.12.005; Zhang F, 2006, BIOGEOSCIENCES, V3, P451, DOI 10.5194/bg-3-451-2006; Zhang L, 2009, BIOGEOSCIENCES, V6, P739, DOI 10.5194/bg-6-739-2009; Zhang LM, 2012, SOIL TILL RES, V121, P1, DOI 10.1016/j.still.2012.01.010; Zhao YC, 2006, SOIL SCI SOC AM J, V70, P1377, DOI 10.2136/sssaj2004.0165; Zhong B, 2011, PEDOSPHERE, V21, P491, DOI 10.1016/S1002-0160(11)60151-3; [No title captured]	58	21	21	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88622	10.1371/journal.pone.0088622	http://dx.doi.org/10.1371/journal.pone.0088622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523922	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100071
J	Guo, ZCV; Hires, SA; Li, N; O'Connor, DH; Komiyama, T; Ophir, E; Huber, D; Bonardi, C; Morandell, K; Gutnisky, D; Peron, S; Xu, NL; Cox, J; Svoboda, K				Guo, Zengcai V.; Hires, S. Andrew; Li, Nuo; O'Connor, Daniel H.; Komiyama, Takaki; Ophir, Eran; Huber, Daniel; Bonardi, Claudia; Morandell, Karin; Gutnisky, Diego; Peron, Simon; Xu, Ning-long; Cox, James; Svoboda, Karel			Procedures for Behavioral Experiments in Head-Fixed Mice	PLOS ONE			English	Article							OBJECT LOCALIZATION; WATER RESTRICTION; MOTOR CORTEX; SENSORIMOTOR SYSTEM; MOUSE; WHISKER; TOUCH; FOOD; RAT; SOMATOSENSATION	The mouse is an increasingly prominent model for the analysis of mammalian neuronal circuits. Neural circuits ultimately have to be probed during behaviors that engage the circuits. Linking circuit dynamics to behavior requires precise control of sensory stimuli and measurement of body movements. Head-fixation has been used for behavioral research, particularly in non-human primates, to facilitate precise stimulus control, behavioral monitoring and neural recording. However, choice-based, perceptual decision tasks by head-fixed mice have only recently been introduced. Training mice relies on motivating mice using water restriction. Here we describe procedures for head-fixation, water restriction and behavioral training for head-fixed mice, with a focus on active, whisker-based tactile behaviors. In these experiments mice had restricted access to water (typically 1 ml/day). After ten days of water restriction, body weight stabilized at approximately 80% of initial weight. At that point mice were trained to discriminate sensory stimuli using operant conditioning. Head-fixed mice reported stimuli by licking in go/no-go tasks and also using a forced choice paradigm using a dual lickport. In some cases mice learned to discriminate sensory stimuli in a few trials within the first behavioral session. Delay epochs lasting a second or more were used to separate sensation (e. g. tactile exploration) and action (i.e. licking). Mice performed a variety of perceptual decision tasks with high performance for hundreds of trials per behavioral session. Up to four months of continuous water restriction showed no adverse health effects. Behavioral performance correlated with the degree of water restriction, supporting the importance of controlling access to water. These behavioral paradigms can be combined with cellular resolution imaging, random access photostimulation, and whole cell recordings.	[Guo, Zengcai V.; Hires, S. Andrew; Li, Nuo; O'Connor, Daniel H.; Komiyama, Takaki; Ophir, Eran; Huber, Daniel; Gutnisky, Diego; Peron, Simon; Xu, Ning-long; Cox, James; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA; [Huber, Daniel; Bonardi, Claudia; Morandell, Karin] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland	Howard Hughes Medical Institute; University of Geneva	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	svobodak@janelia.hhmi.org	Xu, Ning-long/U-8665-2019; Hires, Samuel/E-4717-2015; Huber, Daniel/C-2932-2013	Xu, Ning-long/0000-0002-1651-401X; Peron, Simon/0000-0001-8265-6940; Komiyama, Takaki/0000-0001-9609-4600; Morandell, Karin/0000-0001-7147-8165; Gutnisky, Diego/0000-0002-8578-0039; Huber, Daniel/0000-0002-0744-7679	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding provided by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051789; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; ARMARIO A, 1983, REV ESP FISIOL, V39, P267; Bekkevold CM, 2013, J AM ASSOC LAB ANIM, V52, P233; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; HAINES H, 1967, PHYSIOL ZOOL, V40, P424, DOI 10.1086/physzool.40.4.30158460; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Heiderstadt KM, 2000, LAB ANIM, V34, P20, DOI 10.1258/002367700780578028; Hires SA, 2013, ELIFE, V2, DOI 10.7554/eLife.01350; Histed MH, 2012, J NEUROPHYSIOL, V107, P758, DOI 10.1152/jn.00609.2011; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kleinfeld D, 2011, NEURON, V72, P455, DOI 10.1016/j.neuron.2011.10.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Pammer L, 2013, J NEUROSCI, V33, P6726, DOI 10.1523/JNEUROSCI.4316-12.2013; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Romo R, 2013, PROG NEUROBIOL, V103, P1, DOI 10.1016/j.pneurobio.2013.03.003; Sachidhanandam S, 2013, NAT NEUROSCI; Sanders JI, 2012, J NEUROPHYSIOL, V108, P3416, DOI 10.1152/jn.00669.2012; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Slotnick B, 2005, CURR PROTOC NEUROSCI; Slotnick B, 2009, J EXP ANAL BEHAV, V91, P253, DOI 10.1901/jeab.2009.91-253; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Toth LA, 2000, CONTEMP TOP LAB ANIM, V39, P9; TREICHLER RF, 1962, J COMP PHYSIOL PSYCH, V55, P346, DOI 10.1037/h0047676; Tucci V, 2006, BEHAV BRAIN RES, V173, P22, DOI 10.1016/j.bbr.2006.05.031; Turner RS, 2000, J NEUROSCI, V20, P7096, DOI 10.1523/JNEUROSCI.20-18-07096.2000; Vincent Stella Burnham, 1912, Behavior Monographs Cambridge Mass, V1; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yamada H, 2010, J NEUROSCI METH, V191, P83, DOI 10.1016/j.jneumeth.2010.06.011; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	52	130	131	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88678	10.1371/journal.pone.0088678	http://dx.doi.org/10.1371/journal.pone.0088678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520413	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600104
J	Kohler, T; Ouertatani-Sakouhi, H; Cosson, P; van Delden, C				Koehler, Thilo; Ouertatani-Sakouhi, Hajer; Cosson, Pierre; van Delden, Christian			QsrO a Novel Regulator of Quorum-Sensing and Virulence in Pseudomonas aeruginosa	PLOS ONE			English	Article							GENE-EXPRESSION; DICTYOSTELIUM-DISCOIDEUM; BACTERIAL VIRULENCE; SOCIAL EVOLUTION; HOST; MUTANTS; SYSTEM; IDENTIFICATION; BIOSYNTHESIS; POPULATIONS	In Pseudomonas aeruginosa, the production of many secreted virulence factors is controlled by a quorum-sensing (QS) circuit, constituted of transcriptional activators (LasR, RhlR, PqsR) and their cognate signaling molecules (3-oxo-C12-HSL, C4-HSL, PQS). QS is a cooperative behavior that is beneficial to a population but can be exploited by "QS-cheaters'', individuals which do not respond to the QS-signal, but can use public goods produced by QS-cooperators. In order to identify QS-deficient clones we designed a genetic screening based on a lasB-lacZ fusion. We isolated one clone (PT1617) deficient in QS-dependent gene expression and virulence factor production despite wild type lasR, rhlR and pqsR alleles. Whole genome sequencing of PT1617 revealed a 3,552 bp deletion encompassing ORFs PA2228-PA2229-PA2230 and the pslA gene. However, complementation of PT1617 by plasmid-encoded copies of these ORFs, did not restore QS. Unexpectedly, gene expression levels of ORFs PA2228, PA2227 (vqsM) and PA2222, located adjacent to the deletion, were 10 to 100 fold higher in mutant PT1617 than in PAO1. When expressed from a constitutive promoter on a plasmid, PA2226, alone was found to be sufficient to confer a QS-negative phenotype on PAO1 as well as on PA14. Co-expression of PA2226 and PA2225 in PAO1 further prevented induction of the type III secretion system. In summary, we have identified a novel genetic locus including ORF2226 termed qsrO (QS-repressing ORF), capable of down-regulating all three known QS-systems in P. aeruginosa.	[Koehler, Thilo; van Delden, Christian] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Ouertatani-Sakouhi, Hajer; Cosson, Pierre] Univ Geneva, Dept Physiol & Metab, Geneva, Switzerland; [Koehler, Thilo; van Delden, Christian] Univ Hosp Geneva, Infect Dis Serv, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	van Delden, C (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland.	Christian.vandelden@hcuge.ch	Köhler, Thilo/AAN-9498-2021		Swiss National Science Foundation [320030_120011, 32473B_140929]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grant nos. 320030_120011 and 32473B_140929 from the Swiss National Science Foundation to CVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Cabrol SN, 2003, J BACTERIOL, V185, P7222, DOI 10.1128/JB.185.24.7222-7230.2003; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; De Kievit T, 1999, J BACTERIOL, V181, P2175, DOI 10.1128/JB.181.7.2175-2184.1999; Denervaud V, 2004, J CLIN MICROBIOL, V42, P554, DOI 10.1128/JCM.42.2.554-562.2004; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dong YH, 2005, MOL MICROBIOL, V58, P552, DOI 10.1111/j.1365-2958.2005.04851.x; Dong YH, 2005, MOL MICROBIOL, V56, P1287, DOI 10.1111/j.1365-2958.2005.04612.x; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Dumas JL, 2006, FEMS MICROBIOL LETT, V254, P217, DOI 10.1111/j.1574-6968.2005.00008.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fletcher MP, 2007, NAT PROTOC, V2, P1254, DOI 10.1038/nprot.2007.158; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Juhas M, 2004, MICROBIOL-SGM, V150, P831, DOI 10.1099/mic.0.26906-0; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Lequette Y, 2006, J BACTERIOL, V188, P3365, DOI 10.1128/JB.188.9.3365-3370.2006; Mashburn-Warren L, 2008, MOL MICROBIOL, V69, P491, DOI 10.1111/j.1365-2958.2008.06302.x; Olivares J, 2012, ENVIRON MICROBIOL, V14, P1968, DOI 10.1111/j.1462-2920.2012.02727.x; Ouahrani-Bettache S, 1999, BIOTECHNIQUES, V26, P620, DOI 10.2144/99264bm05; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Schuster M, 2013, ANN REV MICROBIOL; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Van Delden C, 1998, INFECT IMMUN, V66, P4499; Vinckx T, 2010, MICROBIOL-SGM, V156, P678, DOI 10.1099/mic.0.031971-0; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; WEST SEH, 1994, J BACTERIOL, V176, P7532, DOI 10.1128/JB.176.24.7532-7542.1994; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Wilder CN, 2011, ISME J, V5, P1332, DOI 10.1038/ismej.2011.13; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yuan YQ, 2012, J BACTERIOL, V194, P5171, DOI 10.1128/JB.00792-12	48	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87814	10.1371/journal.pone.0087814	http://dx.doi.org/10.1371/journal.pone.0087814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551066	Green Published, gold			2022-12-27	WOS:000331266000018
J	Keller-Costa, T; Jousset, A; van Overbeek, L; van Elsas, JD; Costa, R				Keller-Costa, Tina; Jousset, Alexandre; van Overbeek, Leo; van Elsas, Jan Dirk; Costa, Rodrigo			The Freshwater Sponge Ephydatia fluviatilis Harbours Diverse Pseudomonas Species (Gammaproteobacteria, Pseudomonadales) with Broad-Spectrum Antimicrobial Activity	PLOS ONE			English	Article							BACTERIAL SYMBIONT; BIOLOGICAL-CONTROL; BIOFILM FORMATION; SP NOV.; RHIZOSPHERE; COMMUNITY; GENOME; SPP.; BRASSICACEARUM; TRANSMISSION	Bacteria are believed to play an important role in the fitness and biochemistry of sponges (Porifera). Pseudomonas species (Gammaproteobacteria, Pseudomonadales) are capable of colonizing a broad range of eukaryotic hosts, but knowledge of their diversity and function in freshwater invertebrates is rudimentary. We assessed the diversity, structure and antimicrobial activities of Pseudomonas spp. in the freshwater sponge Ephydatia fluviatilis. Polymerase Chain Reaction - Denaturing Gradient Gel Electrophoresis (PCR-DGGE) fingerprints of the global regulator gene gacA revealed distinct structures between sponge-associated and free-living Pseudomonas communities, unveiling previously unsuspected diversity of these assemblages in freshwater. Community structures varied across E. fluviatilis specimens, yet specific gacA phylotypes could be detected by PCR-DGGE in almost all sponge individuals sampled over two consecutive years. By means of whole-genome fingerprinting, 39 distinct genotypes were found within 90 fluorescent Pseudomonas isolates retrieved from E. fluviatilis. High frequency of in vitro antibacterial (49%), antiprotozoan (35%) and anti-oomycetal (32%) activities was found among these isolates, contrasting less-pronounced basidiomycetal (17%) and ascomycetal (8%) antagonism. Culture extracts of highly predation-resistant isolates rapidly caused complete immobility or lysis of cells of the protozoan Colpoda steinii. Isolates tentatively identified as P. jessenii, P. protegens and P. oryzihabitans showed conspicuous inhibitory traits and correspondence with dominant sponge-associated phylotypes registered by cultivation-independent analysis. Our findings suggest that E. fluviatilis hosts both transient and persistent Pseudomonas symbionts displaying antimicrobial activities of potential ecological and biotechnological value.	[Keller-Costa, Tina] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Algarve, Portugal; [Jousset, Alexandre] Univ Utrecht, Dept Ecol & Biodivers, Utrecht, Netherlands; [van Overbeek, Leo] Wageningen Univ & Res Ctr, Plant Res Int, Wageningen, Netherlands; [Keller-Costa, Tina; van Elsas, Jan Dirk; Costa, Rodrigo] Univ Groningen, Ctr Ecol & Evolutionary Studies, Dept Microbial Ecol, Groningen, Netherlands; [Costa, Rodrigo] Univ Algarve, Ctr Marine Sci CCMAR, Microbial Ecol & Evolut Res Grp, Faro, Algarve, Portugal	Universidade do Algarve; Utrecht University; Wageningen University & Research; University of Groningen; Universidade do Algarve	Costa, R (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Dept Microbial Ecol, Groningen, Netherlands.	rscosta@ualg.pt	da Silva Costa, Rodrigo/N-7274-2013; Costa, Tina Keller/M-6165-2013; Jousset, Alexandre/C-7607-2011	da Silva Costa, Rodrigo/0000-0002-5932-4101; Costa, Tina Keller/0000-0003-3702-9192; 	European Regional Development Fund (ERDF) through the COMPETE (Operational Competitiveness Programme); national funds through FCT (Foundation for Science and Technology) [PEst-C/MAR/LA0015/2011]; FCT-funded project [PTDC/BIA-MIC/3865/2012]; Federation of European Microbiological Societies (FEMS); Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIC/3865/2012] Funding Source: FCT	European Regional Development Fund (ERDF) through the COMPETE (Operational Competitiveness Programme); national funds through FCT (Foundation for Science and Technology); FCT-funded project; Federation of European Microbiological Societies (FEMS); Fundação para a Ciência e a Tecnologia	This research was partially supported by the European Regional Development Fund (ERDF) through the COMPETE (Operational Competitiveness Programme) and national funds through FCT (Foundation for Science and Technology), under the project "PEst-C/MAR/LA0015/2011''. Further financial support was obtained from the FCT-funded project PTDC/BIA-MIC/3865/2012. Tina Keller-Costa received a mobility grant from the Federation of European Microbiological Societies (FEMS) to perform field and laboratory work in Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2004, MOL PLANT MICROBE IN, V17, P872, DOI 10.1094/MPMI.2004.17.8.872; Adesina MF, 2007, SOIL BIOL BIOCHEM, V39, P2818, DOI 10.1016/j.soilbio.2007.06.004; [Anonymous], 1988, NEW KEY FRESHWATER S; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Berg G, 2000, CAN J MICROBIOL, V46, P1128, DOI 10.1139/cjm-46-12-1128; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; BRAEKMAN JC, 1986, PURE APPL CHEM, V58, P357, DOI 10.1351/pac198658030357; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P969, DOI 10.1094/MPMI.2001.14.8.969; Clardy J, 2009, CURR BIOL, V19, pR437, DOI 10.1016/j.cub.2009.04.001; Costa R, 2007, ENVIRON MICROBIOL, V9, P2260, DOI 10.1111/j.1462-2920.2007.01340.x; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; Costa R, 2006, SOIL BIOL BIOCHEM, V38, P2434, DOI 10.1016/j.soilbio.2006.03.003; Costa R, 2013, MICROB ECOL, V65, P232, DOI 10.1007/s00248-012-0102-2; Davis A.R., 1989, Bioorganic Marine Chemistry, V3, P85; de Bruijn I, 2007, MOL MICROBIOL, V63, P417, DOI 10.1111/j.1365-2958.2006.05525.x; de Souza JT, 2003, ENVIRON MICROBIOL, V5, P1328, DOI 10.1111/j.1462-2920.2003.00438.x; Dembitsky VM, 2003, CHEM PHYS LIPIDS, V123, P117, DOI 10.1016/S0009-3084(03)00020-3; Deora A, 2008, J BASIC MICROB, V48, P71, DOI 10.1002/jobm.200700350; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Ferguson HW, 2004, J FISH DIS, V27, P249, DOI 10.1111/j.1365-2761.2004.00537.x; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Gernert C, 2005, MICROB ECOL, V50, P206, DOI 10.1007/s00248-004-0172-x; GILBERT JJ, 1976, ARCH HYDROBIOL, V78, P268; GOULD WD, 1985, APPL ENVIRON MICROB, V49, P28, DOI 10.1128/AEM.49.1.28-32.1985; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hardoim CCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053029; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Jorgensen C. B., 1946, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V109, P69; Jousset A, 2006, APPL ENVIRON MICROB, V72, P7083, DOI 10.1128/AEM.00557-06; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Jousset A, 2009, ISME J, V3, P666, DOI 10.1038/ismej.2009.26; Jung SW, 2008, J APPL MICROBIOL, V105, P186, DOI 10.1111/j.1365-2672.2008.03733.x; Kaluzhnaya OV, 2011, WORLD J MICROB BIOT, V27, P1955, DOI 10.1007/s11274-011-0654-1; Kang YH, 2012, HYDROBIOLOGIA, V683, P151, DOI 10.1007/s10750-011-0951-6; Kelly SR, 2003, AQUAT MICROB ECOL, V31, P175, DOI 10.3354/ame031175; Kim BS, 2000, PEST MANAG SCI, V56, P1029, DOI 10.1002/1526-4998(200012)56:12<1029::AID-PS238>3.0.CO;2-Q; Lalaouna D, 2012, APPL ENVIRON MICROB, V78, P1658, DOI 10.1128/AEM.06769-11; Leps J, 2003, MULTIVARIATE ANAL EC; Lipko IA, 2012, MOL BIOL+, V46, P609, DOI 10.1134/S0026893312040073; Loper JE, 2007, EUR J PLANT PATHOL, V119, P265, DOI 10.1007/s10658-007-9179-8; Manconi R, 2008, HYDROBIOLOGIA, V595, P27, DOI 10.1007/s10750-007-9000-x; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Michaud L, 2012, FEMS MICROBIOL ECOL, V82, P391, DOI 10.1111/j.1574-6941.2012.01394.x; Milling A, 2004, PLANT SOIL, V266, P23; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Neidig N, 2011, MICROB ECOL, V61, P853, DOI 10.1007/s00248-011-9821-z; Nishimori E, 2000, INT J SYST EVOL MICR, V50, P83, DOI 10.1099/00207713-50-1-83; Nylander J. A. A., 2008, MRMODELTEST 2 3; Parfenova VV, 2008, BIOL BULL+, V35, P374, DOI 10.1134/S1062359008040079; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Reiswig HM, 2010, AQUAT ECOL SER, P91, DOI 10.1016/B978-0-12-374855-3.00004-2; Rico A, 2011, CURR OPIN MICROBIOL, V14, P31, DOI 10.1016/j.mib.2010.12.008; Saeidi N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.55; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; SINGH BN, 1945, BRIT J EXP PATHOL, V26, P316; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x; Vagelas IK, 2007, NEMATOLOGY, V9, P363, DOI 10.1163/156854107781352061; van den Broek D, 2003, MOL PLANT MICROBE IN, V16, P1003, DOI 10.1094/MPMI.2003.16.11.1003; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Weltner W, 1909, SUSSWASSERFAUNA DEUT, P177; WILKINSON CR, 1980, HYDROBIOLOGIA, V75, P241, DOI 10.1007/BF00006488; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	82	26	29	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88429	10.1371/journal.pone.0088429	http://dx.doi.org/10.1371/journal.pone.0088429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533086	gold, Green Published			2022-12-27	WOS:000331262600044
J	Nasu, D; Matsuo, T; Kadota, K				Nasu, Daiki; Matsuo, Tomoyuki; Kadota, Koji			Two Types of Motor Strategy for Accurate Dart Throwing	PLOS ONE			English	Article							OVERARM THROWS; BALL RELEASE; TASK; VARIABILITY; COORDINATION; CEREBELLAR; KINEMATICS; MOVEMENT; NOISE; PATH	This study investigated whether expert dart players utilize hand trajectory patterns that can compensate for the inherent variability in their release timing. In this study, we compared the timing error and hand trajectory patterns of expert players with those of novices. Eight experts and eight novices each made 60 dart throws, aiming at the bull's-eye. The movements of the dart and index finger were captured using seven 480-Hz cameras. The data were interpolated using a cubic spline function and analyzed by the millisecond. The estimated vertical errors on the dartboard were calculated as a time-series by using the state variables of the index finger (position, velocity, and direction of motion). This time-series error represents the hand trajectory pattern. Two variables assessing the performance outcome in the vertical plane and two variables related to the timing control were quantified on the basis of the time-series error. The results revealed two typical types of motor strategies in the expert group. The timing error of some experts was similar to that of novices; however, these experts had a longer window of time in which to release an accurately thrown dart. These subjects selected hand trajectory patterns that could compensate for the timing error. Other experts did not select the complementary hand trajectories, but greatly reduced their error in release timing.	[Nasu, Daiki; Matsuo, Tomoyuki; Kadota, Koji] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan	Osaka University	Nasu, D (corresponding author), Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan.	d.nasu12@skill.hss.osaka-u.ac.jp		Matsuo, Tomoyuki/0000-0002-9356-7406; Nasu, Daiki/0000-0001-9692-6892	Osaka University	Osaka University	This work was supported by Osaka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso FJ, 2005, J BIOMECH, V38, P1085, DOI 10.1016/j.jbiomech.2004.05.031; CALVIN WH, 1983, J THEOR BIOL, V104, P121, DOI 10.1016/0022-5193(83)90405-8; Chowdhary AG, 1999, J THEOR BIOL, V201, P219, DOI 10.1006/jtbi.1999.1024; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Cohen RG, 2012, J NEUROPHYSIOL, V107, P618, DOI 10.1152/jn.00568.2011; CORDO P, 1994, J NEUROPHYSIOL, V71, P1848, DOI 10.1152/jn.1994.71.5.1848; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fleisig G, 2009, SPORT BIOMECH, V8, P10, DOI 10.1080/14763140802629958; Hore J, 2005, J NEUROPHYSIOL, V93, P3189, DOI 10.1152/jn.01268.2004; Hore J, 1999, EXP BRAIN RES, V125, P302, DOI 10.1007/s002210050686; Hore J, 2002, ANN NY ACAD SCI, V978, P1, DOI 10.1111/j.1749-6632.2002.tb07551.x; Hore J, 1996, J NEUROPHYSIOL, V75, P1013, DOI 10.1152/jn.1996.75.3.1013; Hore J, 1996, J NEUROPHYSIOL, V76, P3693, DOI 10.1152/jn.1996.76.6.3693; HORE J, 1995, EXP BRAIN RES, V103, P277; Hore J, 2011, J NEUROPHYSIOL, V106, P2024, DOI 10.1152/jn.00059.2011; Jegede E, 2005, J SPORT SCI, V23, P805, DOI 10.1080/02640410400021393; Kudo K, 2000, J MOTOR BEHAV, V32, P337, DOI 10.1080/00222890009601384; MCDONALD PV, 1989, J MOTOR BEHAV, V21, P245; Muller H, 1999, J HUM MOVEMENT STUD, V36, P103; Nagengast AJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000857; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; NEWELL KM, 1993, VARIABILITY AND MOTOR CONTROL, P1; Seydell A, 2008, J NEUROSCI, V28, P4356, DOI 10.1523/JNEUROSCI.0647-08.2008; Smeets JBJ, 2002, EXP BRAIN RES, V144, P268, DOI 10.1007/s00221-002-1072-2; Sternad D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002159; Timmann D, 2001, J NEUROPHYSIOL, V86, P2690, DOI 10.1152/jn.2001.86.6.2690; Wolpert DM, 2012, CURR OPIN NEUROBIOL, V22, P996, DOI 10.1016/j.conb.2012.05.003; Yang JF, 2005, EXP BRAIN RES, V163, P137, DOI 10.1007/s00221-004-2149-x	28	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88536	10.1371/journal.pone.0088536	http://dx.doi.org/10.1371/journal.pone.0088536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533102	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600060
J	Vijil, C; Hermansson, C; Jeppsson, A; Bergstrom, G; Hulten, LM				Vijil, Carolina; Hermansson, Cecilia; Jeppsson, Anders; Bergstrom, Goran; Hulten, Lillemor Mattsson			Arachidonate 15-Lipoxygenase Enzyme Products Increase Platelet Aggregation and Thrombin Generation	PLOS ONE			English	Article							HUMAN MACROPHAGES; ISCHEMIC-STROKE; ATHEROSCLEROSIS; ATHEROTHROMBOSIS; EXPRESSION; DISEASE; INFLAMMATION; ACTIVATION; MECHANISMS; PLAQUES	Atherosclerotic cardiovascular diseases are the leading causes of morbidity and mortality worldwide. We have previously shown that arachidonate 15-lipoxygenase B (ALOX15B) is highly expressed in atherosclerotic carotid plaques, and elucidation of mechanisms downstream of activated lipoxygenases may be relevant to our understanding of the genesis of atherosclerotic diseases. We examined 120 carotid plaques from patients with symptomatic carotid artery stenosis and showed that the extent of ALOX15B staining was significantly increased in carotid plaques with thrombosis. Impedance aggregometry analyses showed that the ALOX15B enzyme products 15-HETE and 15-HPETE increased platelet aggregation. By using a calibrated automatic thrombin assay, we showed that the ALOX15B products also increased both peak levels of thrombin and the total endogenous thrombin potential. Moreover, platelet aggregation was increased by addition of cell lysates from ischemic human macrophages, whereas platelet aggregation was reduced after knockdown of ALOX15B in human macrophages. Our data show that ALOX15B expression in human carotid plaques is associated with thrombus formation and that enzyme products of ALOX15B increase platelet aggregation and thrombin generation. We therefore propose that activated ALOX15B in macrophages may play a role in the induction of atherothrombotic events by increasing platelet aggregation and thrombin generation.	[Vijil, Carolina; Hulten, Lillemor Mattsson] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden; [Hermansson, Cecilia; Jeppsson, Anders; Bergstrom, Goran; Hulten, Lillemor Mattsson] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden; [Jeppsson, Anders] Sahlgrens Univ Hosp, Dept Cardiothorac Surg, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Hulten, LM (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden.	Lillemor.Mattsson@wlab.gu.se		Bergstrom, Goran/0000-0003-4289-5722	Swedish Research Council; Swedish Heart Lung Foundation; Laboratory Medicine Sahlgrenska University Hospital Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Laboratory Medicine Sahlgrenska University Hospital Sweden	This study was supported by the Swedish Research Council, Swedish Heart Lung Foundation, and Laboratory Medicine Sahlgrenska University Hospital Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Carcaillon L, 2011, ARTERIOSCL THROM VAS, V31, P1445, DOI 10.1161/ATVBAHA.111.223453; Danielsson KN, 2008, ATHEROSCLEROSIS, V199, P34, DOI 10.1016/j.atherosclerosis.2007.10.027; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HEMKER HC, 1993, THROMB HAEMOSTASIS, V70, P617; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Magnusson LU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043142; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Owens AP, 2012, CURR ATHEROSCLER REP, V14, P394, DOI 10.1007/s11883-012-0269-5; Rydberg EK, 2004, ARTERIOSCL THROM VAS, V24, P2040, DOI 10.1161/01.ATV.0000144951.08072.0b; Seet RCS, 2011, STROKE, V42, P2326, DOI 10.1161/STROKEAHA.111.618835; SETTY BNY, 1992, BLOOD, V80, P2765; Sibbing D, 2010, THROMB HAEMOSTASIS, V103, P151, DOI 10.1160/TH09-05-0284; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Yigitkanli K, 2013, ANN NEUROL, V73, P129, DOI 10.1002/ana.23734	29	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88546	10.1371/journal.pone.0088546	http://dx.doi.org/10.1371/journal.pone.0088546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533104	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600062
J	Senner, NR; Hochachka, WM; Fox, JW; Afanasyev, V				Senner, Nathan R.; Hochachka, Wesley M.; Fox, James W.; Afanasyev, Vsevolod			An Exception to the Rule: Carry-Over Effects Do Not Accumulate in a Long-Distance Migratory Bird	PLOS ONE			English	Article							RED KNOTS; HABITAT QUALITY; CONSEQUENCES; SURVIVAL; FITNESS; WINTER; TRANSITION; ARRIVAL; LIMOSA; NORTH	Recent years have seen a growing consensus that events during one part of an animal's annual cycle can detrimentally affect its future fitness. Notably, migratory species have been shown to commonly display such carry-over effects, facing severe time constraints and physiological stresses that can influence events across seasons. However, to date, no study has examined a full annual cycle to determine when these carry-over effects arise and how long they persist within and across years. Understanding when carry-over effects are created and how they persist is critical to identifying those periods and geographic locations that constrain the annual cycle of a population and determining how selection is acting upon individuals throughout the entire year. Using three consecutive years of migration tracks and four consecutive years of breeding success data, we tested whether carry-over effects in the form of timing deviations during one migratory segment of the annual cycle represent fitness costs that persist or accumulate across the annual cycle for a long-distance migratory bird, the Hudsonian godwit, Limosa haemastica. We found that individual godwits could migrate progressively later than population mean over the course of an entire migration period, especially southbound migration, but that these deviations did not accumulate across the entire year and were not consistently detected among individuals across years. Furthermore, neither the accumulation of lateness during previous portions of the annual cycle nor arrival date at the breeding grounds resulted in individuals suffering reductions in their breeding success or survival. Given their extreme life history, such a lack of carry-over effects suggests that strong selection exists on godwits at each stage of the annual cycle and that carry-over effects may not be able to persist in such a system, but also emphasizes that high-quality stopover and wintering sites are critical to the maintenance of long-distance migratory populations.	[Senner, Nathan R.; Hochachka, Wesley M.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Fox, James W.; Afanasyev, Vsevolod] British Antarctic Survey, Cambridge CB3 0ET, England	Cornell University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Senner, NR (corresponding author), Univ Groningen, Anim Ecol Grp, Groningen, Netherlands.	n.r.senner@rug.nl	Hochachka, Wesley M./J-9768-2012	Hochachka, Wesley M./0000-0002-0595-7827	National Science Foundation [1110444]; David and Lucile Packard Foundation; U.S. Fish and Wildlife Service NMBCA [4474, 4073]; Faucett Family Foundation; Cornell University internal grants; Arctic Audubon Society; Ducks Unlimited Canada; American Museum of Natural History; Natural Environment Research Council [bas010011] Funding Source: researchfish; NERC [bas010011] Funding Source: UKRI	National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); U.S. Fish and Wildlife Service NMBCA; Faucett Family Foundation; Cornell University internal grants; Arctic Audubon Society; Ducks Unlimited Canada; American Museum of Natural History; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	National Science Foundation (# 1110444); David and Lucile Packard Foundation (www.packard.org); U.S. Fish and Wildlife Service NMBCA (# 4474 and 4073); Faucett Family Foundation (http://faucett-family-foundation.idilogic.aidpage.com/prn-index.htm); Cornell University internal grants; Arctic Audubon Society (http://www.arcticaudubon.org/grants.html); Ducks Unlimited Canada (http://www.ducks.ca/our-science/graduate-fellowships/); American Museum of Natural History (http://www. amnh.org/our-research/vertebrate-zoology/ornithology/grants).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2006, ARDEA, V94, P347; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; Battley PF, 2012, J AVIAN BIOL, V43, P21, DOI 10.1111/j.1600-048X.2011.05473.x; Bety J, 2004, BEHAV ECOL SOCIOBIOL, V57, P1, DOI 10.1007/s00265-004-0840-3; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Buehler DM, 2010, AUK, V127, P394, DOI 10.1525/auk.2010.09017; Chen HY, 2012, CURR BIOL, V22, P2140, DOI 10.1016/j.cub.2012.09.021; Conklin JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054535; Conklin JR, 2012, J AVIAN BIOL, V43, P252, DOI 10.1111/j.1600-048X.2012.05606.x; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crossland A, 2013, NZ BIRDS ONLINE; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Guglielmo C, 2001, J EXP BIOL, V204, P2683; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; Harrison XA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077783; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hoerling M, 2013, J CLIMATE, V26, P2811, DOI 10.1175/JCLI-D-12-00270.1; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Lok T, 2013, AM NAT, V181, P520, DOI 10.1086/669679; Lourenco PM, 2011, J ORNITHOL, V152, P1023, DOI 10.1007/s10336-011-0692-3; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; McNamara JM, 1998, J AVIAN BIOL, V29, P416, DOI 10.2307/3677160; Miller MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1133, DOI 10.1098/rspb.2008.0015; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Norris DR, 2006, BIOL LETTERS, V2, P148, DOI 10.1098/rsbl.2005.0397; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Piersma T, 2003, FUNCT ECOL, V17, P356, DOI 10.1046/j.1365-2435.2003.00741.x; Piersma Theunis, 2006, Stilt, V50, P3; Reneerkens J, 2002, PHYSIOL BIOCHEM ZOOL, V75, P200, DOI 10.1086/340853; Sheehy J, 2010, CONSERV LETT, V3, P192, DOI 10.1111/j.1755-263X.2010.00100.x; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Vecchi GA, 2013, J CLIMATE, V26, P5337, DOI 10.1175/JCLI-D-12-00464.1; Vezina F, 2012, FUNCT ECOL, V26, P500, DOI 10.1111/j.1365-2435.2011.01955.x; Villarini G, 2012, NAT CLIM CHANGE, V2, P604, DOI 10.1038/NCLIMATE1530; Walker B. M., 2011, BIRDS N AM ONLINE; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1	43	75	79	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e86588	10.1371/journal.pone.0086588	http://dx.doi.org/10.1371/journal.pone.0086588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523862	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000331258100011
J	Shanthanagouda, AH; Guo, BS; Ye, RR; Chao, L; Chiang, MWL; Singaram, G; Cheung, NKM; Zhang, G; Au, DWT				Shanthanagouda, Admane H.; Guo, Bao-Sheng; Ye, Rui R.; Chao, Liang; Chiang, Michael W. L.; Singaram, Gopalakrishnan; Cheung, Napo K. M.; Zhang, Ge; Au, Doris W. T.			Japanese Medaka: A Non-Mammalian Vertebrate Model for Studying Sex and Age-Related Bone Metabolism In Vivo	PLOS ONE			English	Article							ORYZIAS-LATIPES; HORMONE LEVELS; FAS LIGAND; ESTROGENS; TELEOST; RECEPTOR; OSTEOCLASTOGENESIS; OSTEOPOROSIS; OSTEOBLASTS; MINIREVIEW	Background: In human, a reduction in estrogen has been proposed as one of the key contributing factors for postmenopausal osteoporosis. Rodents are conventional models for studying postmenopausal osteoporosis, but the major limitation is that ovariectomy is needed to mimic the estrogen decline after menopause. Interestingly, in medaka fish (Oryzias latipes), we observed a natural drop in plasma estrogen profile in females during aging and abnormal spinal curvature was apparent in old fish, which are similar to postmenopausal women. It is hypothesized that estrogen associated disorders in bone metabolism might be predicted and prevented by estrogen supplement in aging O. latipes, which could be corresponding to postmenopausal osteoporosis in women. Principal findings: In O. latipes, plasma estrogen was peaked at 8 months old and significantly declined after 10, 11 and 22 months in females. Spinal bone mineral density (BMD) and micro-architecture by microCT measurement progressively decreased and deteriorated from 8 to 10, 12 and 14 months old, which was more apparent in females than the male counterparts. After 10 months old, O. latipes were supplemented with 17 alpha-ethinylestradiol (EE2, a potent estrogen mimic) at 6 and 60 ng/mg fish weight/day for 4 weeks, both reduction in spinal BMD and deterioration in bone micro-architecture were significantly prevented. The estrogenic effect of EE2 in O. latipes was confirmed by significant up-regulation of four key estrogen responsive genes in the liver. In general, bone histomorphometric analyses indicated significantly lowered osteoblasts and osteoclasts numbers and surfaces on vertebrae of EE2-fed medaka. Significance: We demonstrate osteoporosis development associated with natural drop in estrogen level during aging in female medaka, which could be attenuated by estrogen treatment. This small size fish is a unique alternative non-mammalian vertebrate model for studying estrogen-related molecular regulation in postmenopausal skeletal disorders in vivo without ovariectomy.	[Shanthanagouda, Admane H.; Ye, Rui R.; Chiang, Michael W. L.; Singaram, Gopalakrishnan; Cheung, Napo K. M.; Au, Doris W. T.] City Univ Hong Kong, Dept Biol & Chem, State Key Lab Marine Pollut, Hong Kong, Hong Kong, Peoples R China; [Guo, Bao-Sheng; Chao, Liang; Zhang, Ge] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; Hong Kong Baptist University	Zhang, G (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China.	zhangge@hkbu.edu.hk; bhdwtau@cityu.edu.hk	Gopalakrishnan, Singaram/AEB-6454-2022; Guo, Baosheng/ABD-4800-2021; GUO, Baosheng/M-6023-2013; Zhang, Ge/K-9118-2019; Zhang, Ge/N-4150-2013	Guo, Baosheng/0000-0002-4510-5418; Zhang, Ge/0000-0002-7807-7695; Zhang, Ge/0000-0002-7807-7695; Chiang, Michael W. L./0000-0001-7661-5560; Admane Holeyappa, shanthanagouda/0000-0002-9907-1129; AU, Wai Ting Doris/0000-0003-4490-5971	CityU Seed Grant [7003024]; University Grants Committee, Area of Excellence Grant [AoE/P-04/04]; State Key Laboratory in Marine Pollution and Hong Kong General Research Fund [HKBU479111]	CityU Seed Grant; University Grants Committee, Area of Excellence Grant; State Key Laboratory in Marine Pollution and Hong Kong General Research Fund	The work described in this paper was supported by grants from the CityU Seed Grant (Project No. 7003024), the University Grants Committee, Area of Excellence Grant (AoE/P-04/04), the State Key Laboratory in Marine Pollution and Hong Kong General Research Fund (HKBU479111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005; Au DWT, 2004, MAR POLLUT BULL, V48, P817, DOI 10.1016/j.marpolbul.2004.02.032; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Chatani M, 2011, DEV BIOL, V360, P96, DOI 10.1016/j.ydbio.2011.09.013; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Ding L, 2010, PLOS ONE, V5; Faienza MF, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/575936; Gopalakrishnan S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-78; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Imai Y, 2010, MOL ENDOCRINOL, V24, P877, DOI 10.1210/me.2009-0238; Inohaya K, 2000, DEV GENES EVOL, V210, P570, DOI 10.1007/s004270000094; Inohaya K, 2007, DEV DYNAM, V236, P3031, DOI 10.1002/dvdy.21329; Khajuria DK, 2013, J ORTHOP SCI, V18, P832, DOI 10.1007/s00776-013-0433-y; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Kinoshita M, 2009, MEDAKA BIOL MANAGEME, P165; Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011; Kraenzlin M., 2007, BONEKEY, V4, P191, DOI [10.1138/20070266, DOI 10.1138/20070266]; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Lerner UH, 2000, MATRIX BIOL, V19, P107, DOI 10.1016/S0945-053X(00)00052-4; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Naruse K, 2011, MEDAKA MODEL ORGANOG, P81; Padilla Stephanie, 2009, Curr Protoc Toxicol, VChapter 1, DOI 10.1002/0471140856.tx0110s39; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Prestwood KM, 2000, J CLIN ENDOCR METAB, V85, P4462, DOI 10.1210/jc.85.12.4462; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; STEGER RW, 1982, EXP AGING RES, V8, P203, DOI 10.1080/03610738208260367; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P91, DOI 10.1016/S0048-9697(98)00335-0; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348; To TT, 2012, DEVELOPMENT, V139, P141, DOI 10.1242/dev.071035; TURNER RT, 1994, ENDOCR REV, V15, P275, DOI 10.1210/er.15.3.275; Turner RT, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P855, DOI 10.1016/B978-0-12-373884-4.00057-4; Wagner TU, 2003, ADV SPACE RES-SERIES, V32, P1459, DOI 10.1016/S0273-1177(03)90381-4; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Yasutake J, 2004, MECH DEVELOP, V121, P883, DOI 10.1016/j.mod.2004.03.008; Zhang XW, 2008, ENVIRON SCI TECHNOL, V42, P6762, DOI 10.1021/es800591t; Zhao RQ, 2012, INT J MED SCI, V9, P825, DOI 10.7150/ijms.5180; Zhou SH, 2003, MOL ENDOCRINOL, V17, P56, DOI 10.1210/me.2002-0210	43	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88165	10.1371/journal.pone.0088165	http://dx.doi.org/10.1371/journal.pone.0088165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523879	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100028
J	Yoon, H; Choi, YL; Song, JY; Do, I; Kang, SY; Ko, YH; Song, S; Kim, BG				Yoon, Heejei; Choi, Yoon-La; Song, Ji-Young; Do, Ingu; Kang, So Young; Ko, Young-Hyeh; Song, Sangyong; Kim, Byoung-Gie			Targeted Inhibition of FAK, PYK2 and BCL-XL Synergistically Enhances Apoptosis in Ovarian Clear Cell Carcinoma Cell Lines	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; BREAST-CANCER CELLS; DOWN-REGULATION; MEDIATED APOPTOSIS; MCL-1; ABT-737; RESISTANCE; MECHANISMS; EXPRESSION; SURVIVAL	Ovarian clear cell carcinoma (OCCC) displays a higher resistance to first line chemotherapy, requiring the development of new therapeutics. We previously identified a frequent chromosomal gain at 8q24 that harbors the focal-adhesion kinase (FAK) gene; the potential of this gene as a therapeutic target remains to be evaluated in OCCCs. We first examined the dependence of OCCCs on FAK and the PI3K/AKT signaling pathway. FAK was overexpressed in 20% of 67 OCCC samples, and this overexpression was correlated with its copy number gain. FAK copy number gains and mutations in PIK3CA accounted for about 40% of OCCC samples, suggesting that the FAK/PI3K/AKT axis is an attractive candidate for targeted therapeutics. We, therefore, treated ovarian cancer cell lines, including OCCC subtypes, with the FAK inhibitors PF-562,271 (PF271), and PF-573,228 (PF228). Ovarian cancer cells were more sensitive to PF271 than PF228. We then searched for single agents that exhibited a synergistic effect on cell death in combination with PF271. We found that co-treatment of PF271 with ABT-737, a BCL-2/BCL-XL antagonist, was profoundly effective at inducing apoptosis. RMGI and OVISE cells were more sensitive to ABT-737 than OVMANA and SKOV3 cells, which have PIK3CA mutations. Mechanistically, PF271 treatment resulted in the transient down-regulation of the anti-apoptotic protein MCL1 via the PI3K/AKT pathway. Therefore, PF271/ABT-737 treatment led to the inhibition of the anti-apoptotic proteins MCL1 and BCL-XL/BCL-2. We suggest that pharmacological inhibition of BCL-XL and FAK/PYK2 can be a potential therapeutic strategy for the treatment of OCCC.	[Yoon, Heejei; Choi, Yoon-La; Song, Ji-Young; Ko, Young-Hyeh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea; [Choi, Yoon-La; Kang, So Young; Ko, Young-Hyeh; Song, Sangyong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Do, Ingu; Ko, Young-Hyeh] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Canc Res Inst, Seoul, South Korea; [Kim, Byoung-Gie] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, BG (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea.	bgkim@skku.edu			Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [A092255]; Samsung Biomedical Research Institute [SBRI SP1-B2-021-2, SBRI SP1-B2-022-2]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A0920010]	Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea; Samsung Biomedical Research Institute(Samsung); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A092255), the Samsung Biomedical Research Institute grants (#SBRI SP1-B2-021-2 and #SBRI SP1-B2-022-2) and the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A0920010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Brotin E, 2010, INT J CANCER, V126, P885, DOI 10.1002/ijc.24787; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Dodier P, 2006, GYNECOL ONCOL, V100, P254, DOI 10.1016/j.ygyno.2005.08.028; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Golubovskaya V, 2002, J BIOL CHEM, V277, P38978, DOI 10.1074/jbc.M205002200; Golubovskaya VM, 2003, MOL CANCER RES, V1, P755; Guessous F, 2012, MOL CANCER THER, V11, P288, DOI 10.1158/1535-7163.MCT-11-0490; Halder J, 2005, CLIN CANCER RES, V11, P8829, DOI 10.1158/1078-0432.CCR-05-1728; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Litvak V, 2000, J BIOL CHEM, V275, P32736, DOI 10.1074/jbc.M004200200; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Okumura K, 2008, CLIN CANCER RES, V14, P8132, DOI 10.1158/1078-0432.CCR-08-1665; Rahmani M, 2012, CANC RES; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Schultze A, 2010, EXPERT OPIN INV DRUG, V19, P777, DOI 10.1517/13543784.2010.489548; Shigemasa K, 2002, JPN J CANCER RES, V93, P542, DOI 10.1111/j.1349-7006.2002.tb01289.x; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Smith CS, 2005, MELANOMA RES, V15, P357, DOI 10.1097/00008390-200510000-00003; Sung CO, 2013, CANC GENETICS; Tamagiku Y, 2004, BIOCHEM BIOPH RES CO, V323, P445, DOI 10.1016/j.bbrc.2004.08.115; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005	40	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88587	10.1371/journal.pone.0088587	http://dx.doi.org/10.1371/journal.pone.0088587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523919	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100068
J	Jeong, W; Kim, J; Bazer, FW; Song, G				Jeong, Wooyoung; Kim, Jinyoung; Bazer, Fuller W.; Song, Gwonhwa			Proliferation-Stimulating Effect of Colony Stimulating Factor 2 on Porcine Trophectoderm Cells Is Mediated by Activation of Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase	PLOS ONE			English	Article							FACTOR GM-CSF; UTERINE EPITHELIAL-CELLS; FACTOR GENE-EXPRESSION; GROWTH-FACTOR; EMBRYO DEVELOPMENT; EARLY-PREGNANCY; BETA-RECEPTOR; IMPLANTATION; BLASTOCYST; BIOLOGY	Colony-stimulating factor 2 (CSF2), also known as granulocyte macrophage colony-stimulating factor, facilitates mammalian embryonic development and implantation. However, biological functions and regulatory mechanisms of action of porcine endometrial CSF2 in peri-implantation events have not been elucidated. The aim of present study was to determine changes in cellular activities induced by CSFs and to access CSF2-induced intracellular signaling in porcine primary trophectoderm (pTr) cells. Differences in expression of CSF2 mRNA in endometrium from cyclic and pregnant gilts were evaluated. Endometrial CSF2 mRNA expression increases during the peri-implantation period, Days 10 to 14 of pregnancy, as compared to the estrous cycle. pTr cells obtained in Day 12 of pregnancy were cultured in the presence or absence of CSF2 (20 ng/ml) and LY294002 (20 mu M), U0126 (20 mu M), rapamycin (20 nM), and SB203580 (20 mu M). CSF2 in pTr cell culture medium at 20 ng/ml significantly induced phosphorylation of AKT1, ERK1/2, MTOR, p70RSK and RPS6 protein, but not STAT3 protein. Also, the PI3K specific inhibitor (LY294002) abolished CSF2-induced increases in p-ERK1/2 and p-MTOR proteins, as well as CSF2-induced phosphorylation of AKT1. Changes in proliferation and migration of pTr cells in response to CSF2 were examined in dose- and time-response experiments. CSF2 significantly stimulated pTr cell proliferation and, U0126, rapamycin and LY294002 blocked this CSF2-induced proliferation of pTr cells. Collectively, during the peri-implantation phase of pregnancy in pigs, endometrial CSF2 stimulates proliferation of trophectoderm cells by activation of the PI3K-and ERK1/2 MAPK-dependent MTOR signal transduction cascades.	[Jeong, Wooyoung; Song, Gwonhwa] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea; [Kim, Jinyoung] Dankook Univ, Dept Anim Resources Sci, Cheonan, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Korea University; Dankook University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Song, G (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea.	ghsong@korea.ac.kr	Song, Gwonhwa/H-3647-2015; Bazer, Fuller/AAF-4317-2021; gwonhwa, song/H-3208-2015	Bazer, Fuller/0000-0002-5823-5086; 	Next-Generation BioGreen 21 Program [PJ008142]; Rural Development Administration; Basic Science Research Program through National Research Foundation of Korea, Republic of Korea [NRF-26 2013R1A1A3012164]; National Research Initiative Competitive Grant from United States Department of Agriculture National Institute of Food and Agriculture, United States of America [2006-35203-17283]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Basic Science Research Program through National Research Foundation of Korea, Republic of Korea; National Research Initiative Competitive Grant from United States Department of Agriculture National Institute of Food and Agriculture, United States of America	This research was funded by the grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration and by the Basic Science Research Program (No. NRF-26 2013R1A1A3012164) through the National Research Foundation of Korea, Republic of Korea, and also by the National Research Initiative Competitive Grant No. 2006-35203-17283 from the United States Department of Agriculture National Institute of Food and Agriculture, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN GC, 1992, DEV BIOL, V151, P352, DOI 10.1016/0012-1606(92)90175-G; BALDWIN GC, 1991, BLOOD, V78, P609, DOI 10.1182/blood.V78.3.609.bloodjournal783609; Bazer FW, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-23; Bazer Fuller W, 2011, Front Biosci (Schol Ed), V3, P745, DOI 10.2741/s184; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; Behr B, 2005, J ASSIST REPROD GEN, V22, P25, DOI 10.1007/s10815-005-0817-9; Burghardt RC, 1997, J REPROD FERTIL, P151; Burton GJ, 2007, PLACENTA, V28, pS64, DOI 10.1016/j.placenta.2007.01.007; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; CLARK DA, 1994, CELL IMMUNOL, V154, P143, DOI 10.1006/cimm.1994.1064; CRAINIE M, 1990, BIOL REPROD, V43, P999, DOI 10.1095/biolreprod43.6.999; DANTZER V, 1985, ANAT EMBRYOL, V172, P281, DOI 10.1007/BF00318976; de Moraes AAS, 1999, J REPROD IMMUNOL, V42, P135, DOI 10.1016/S0165-0378(98)00075-8; deMoraes AAS, 1997, BIOL REPROD, V57, P1060, DOI 10.1095/biolreprod57.5.1060; Diaz-Cueto L, 2001, ARCH MED RES, V32, P619, DOI 10.1016/S0188-4409(01)00326-5; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Emond V, 2000, BIOL REPROD, V62, P1728, DOI 10.1095/biolreprod62.6.1728; Emond V, 2004, BIOL REPROD, V70, P54, DOI 10.1095/biolreprod.103.018689; Emond V, 1998, BIOL REPROD, V58, P143, DOI 10.1095/biolreprod58.1.143; Fernandez-Serra M, 2004, DEV BIOL, V268, P384, DOI 10.1016/j.ydbio.2003.12.029; Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025; Fitzgerald JS, 2005, CHEM IMMUNOL ALLERGY, V88, P181, DOI 10.1159/000087834; Fortin M, 1997, AM J REPROD IMMUNOL, V38, P129; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; GEISERT RD, 1982, BIOL REPROD, V27, P925, DOI 10.1095/biolreprod27.4.925; GEISERT RD, 1982, BIOL REPROD, V27, P941, DOI 10.1095/biolreprod27.4.941; Geisert RD, 1997, J REPROD FERTIL, P133; Giacomini G, 1995, HUM REPROD, V10, P3259, DOI 10.1093/oxfordjournals.humrep.a135899; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; GUILLOMOT M, 1995, J REPROD FERTIL, P39; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; IMAKAWA K, 1993, ENDOCRINOLOGY, V132, P1869, DOI 10.1210/en.132.4.1869; Jaeger LA, 2005, ENDOCRINOLOGY, V146, P3933, DOI 10.1210/en.2005-0090; Ka H, 2001, ENDOCRINOLOGY, V142, P2303, DOI 10.1210/en.142.6.2303; Kanzaki H, 1991, Growth Factors, V5, P69, DOI 10.3109/08977199109000272; Karagenc L, 2005, REPROD BIOMED ONLINE, V10, P511, DOI 10.1016/S1472-6483(10)60829-2; KEYS JL, 1990, AM J ANAT, V188, P221, DOI 10.1002/aja.1001880302; Kim J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105080; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275; Lim HJ, 2002, VITAM HORM, V64, P43, DOI 10.1016/S0083-6729(02)64002-6; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Michael DD, 2006, AM J REPROD IMMUNOL, V56, P63, DOI 10.1111/j.1600-0897.2006.00390.x; MIYAJIMA A, 1993, BLOOD, V82, P1960; O'Leary S, 2004, REPRODUCTION, V128, P237, DOI 10.1530/rep.1.00160; PERRY JS, 1981, J REPROD FERTIL, V62, P321; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Pollard JW, 1997, MOL REPROD DEV, V46, P54, DOI 10.1002/(SICI)1098-2795(199701)46:1&lt;54::AID-MRD9&gt;3.0.CO;2-Q; RAPOPORT AP, 1992, BLOOD REV, V6, P43, DOI 10.1016/0268-960X(92)90007-D; ROBERTSON SA, 1994, CRIT REV IMMUNOL, V14, P239, DOI 10.1615/CritRevImmunol.v14.i3-4.30; Robertson SA, 1996, BIOL REPROD, V54, P183, DOI 10.1095/biolreprod54.1.183; Robertson SA, 1999, BIOL REPROD, V60, P251, DOI 10.1095/biolreprod60.2.251; ROBERTSON SA, 1992, BIOL REPROD, V46, P1069, DOI 10.1095/biolreprod46.6.1069; Robertson SA, 2001, BIOL REPROD, V64, P1206, DOI 10.1095/biolreprod64.4.1206; Robertson SA, 2007, CYTOKINE GROWTH F R, V18, P287, DOI 10.1016/j.cytogfr.2007.04.008; Schafer-Somi S, 2003, ANIM REPROD SCI, V75, P73, DOI 10.1016/S0378-4320(02)00222-1; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; Sjoblom C, 2002, BIOL REPROD, V67, P1817, DOI 10.1095/biolreprod.101.001503; Sjoblom C, 1999, HUM REPROD, V14, P3069, DOI 10.1093/humrep/14.12.3069; Song G, 2011, REPRODUCTION, V141, P127, DOI 10.1530/REP-10-0348; Spandorfer SD, 1998, AM J REPROD IMMUNOL, V40, P377; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102; Stroband H W, 1990, J Reprod Fertil Suppl, V40, P261; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tortorella C, 2006, J GERONTOL A-BIOL, V61, P1111, DOI 10.1093/gerona/61.11.1111; Tremellen KP, 1998, BIOL REPROD, V58, P1217, DOI 10.1095/biolreprod58.5.1217; Wang YC, 2004, DEV DYNAM, V231, P72, DOI 10.1002/dvdy.20114; Zhao Y, 1999, AM J REPROD IMMUNOL, V42, P303; ZHAO Y, 1994, J CLIN ENDOCR METAB, V79, P662, DOI 10.1210/jc.79.2.662	74	20	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88731	10.1371/journal.pone.0088731	http://dx.doi.org/10.1371/journal.pone.0088731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520418	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600109
J	Li, Y; Wang, JJ; Gao, S; Liu, Q; Bai, J; Zhao, XQ; Hao, YH; Ding, HH; Zhu, F; Yang, DL; Zhao, XP				Li, Yuan; Wang, Jiu-Jun; Gao, Shan; Liu, Qian; Bai, Jia; Zhao, Xue-Qi; Hao, You-Hua; Ding, Hong-Hui; Zhu, Fan; Yang, Dong-Liang; Zhao, Xi-Ping			Decreased Peripheral Natural Killer Cells Activity in the Immune Activated Stage of Chronic Hepatitis B	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; FUNCTIONAL DICHOTOMY; INFECTION; FREQUENCY; CLEARANCE; HISTORY; INNATE; PHASE	Background & Aims: The natural course of chronic hepatitis B virus (HBV) infection is characterized by different immune responses, ranging from immune tolerant (IT) to immune activated (IA) stages. In our study, we investigated the natural killer (NK) cells activity in patients at different immunological stages of chronic HBV infection. Methods: Blood samples obtained from 57 HBeAg positive patients with chronic hepatitis B (CHB), including 15 patients in the immune tolerant (IT) stage, 42 patients in the immune activated (IA) stage, and 18 healthy individuals (HI). The analyses included flow cytometry to detect NK cells, the determination of cytokine levels as well as of surface receptor expression and cytotoxicity. Results: NK cells in peripheral blood were significantly lower in patients in the IA stage of CHB compared to HI (p<0.05). Patients in the IA stage of CHB had lower levels of NK cells activating receptor NKp30 and NKG2D expression, cytokine interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) production, as compared to patients in the IT stage and HI, respectively (p<0.05). Cytotoxicity of NK cells was lower in patients in the IA stage of CHB compared to patients in the IT stage and HI, respectively (p<0.05). The level of IFN-gamma but not level of TNF-alpha and cytotoxicity of NK cells was inversely correlated with serum HBV load in patients with CHB. Peripheral NK cells activity did not correlate with ALT level. Conclusion: NK cells activity was lower in CHB patients, especially in those in the IA stage.	[Li, Yuan; Wang, Jiu-Jun; Gao, Shan; Liu, Qian; Bai, Jia; Zhao, Xue-Qi; Zhao, Xi-Ping] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430074, Peoples R China; [Hao, You-Hua; Ding, Hong-Hui; Zhu, Fan; Yang, Dong-Liang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Clin Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhao, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Infect Dis, Wuhan 430074, Peoples R China.	xpzhao@tjh.tjmu.edu.cn			National Science Fund of China (NSFC) [30771911]; National Key Basic Research Program of China [2009CB522502]; National Science and Technology Major Project [2008ZX10002-014, 2008ZX10002-009, 2012ZX10002007-003]	National Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project	This work was supported by grants from the National Science Fund of China (NSFC) (grant number 30771911), the National Key Basic Research Program of China (grant number 2009CB522502) and the National Science and Technology Major Project (grant numbers 2008ZX10002-014, 2008ZX10002-009, 2012ZX10002007-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Iwaszko M, 2011, ARCH IMMUNOL THER EX, V59, P353, DOI 10.1007/s00005-011-0137-y; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Lai CL, 2007, J VIRAL HEPATITIS, V14, P6, DOI 10.1111/j.1365-2893.2007.00909.x; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Mantegani P, 2010, IMMUNOLOGY, V129, P220, DOI 10.1111/j.1365-2567.2009.03171.x; Meier UC, 2005, J VIROL, V79, P12365, DOI 10.1128/JVI.79.19.12365-12374.2005; Mondelli MU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00351; Mondelli MU, 2010, EUR J CLIN INVEST, V40, P851, DOI 10.1111/j.1365-2362.2010.02332.x; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rehermann B, 2007, J HEPATOL, V46, P508, DOI 10.1016/j.jhep.2007.01.002; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Zarife MAS, 2009, J MED VIROL, V81, P49, DOI 10.1002/jmv.21340; Sprengers D, 2006, J MED VIROL, V78, P561, DOI 10.1002/jmv.20576; Sun C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002594; Tian Z, 2013, HEPATOLOGY, V57, P1564; Tjwa ETTL, 2011, J HEPATOL, V54, P209, DOI 10.1016/j.jhep.2010.07.009; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049135; Zhao PW, 2013, CLIN EXP PHARMACOL P, V40, P190, DOI 10.1111/1440-1681.12048; Zou Y, 2010, J IMMUNOL, V184, P466, DOI 10.4049/jimmunol.0900687; Zou ZS, 2009, HEPATOL RES, V39, P1198, DOI 10.1111/j.1872-034X.2009.00571.x	39	19	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e86927	10.1371/journal.pone.0086927	http://dx.doi.org/10.1371/journal.pone.0086927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520324	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600015
J	Williamson, H; Phillips, R; Sarfo, S; Wansbrough-Jones, M; Small, P				Williamson, Heather; Phillips, Richard; Sarfo, Stephen; Wansbrough-Jones, Mark; Small, Pamela			Genetic Diversity of PCR-Positive, Culture-Negative and Culture-Positive Mycobacterium ulcerans Isolated from Buruli Ulcer Patients in Ghana	PLOS ONE			English	Article							CAUSATIVE AGENT; EVOLUTION; DIAGNOSIS; GENOME; FISH	Culture of Mycobacterium ulcerans from Buruli ulcer patients has very low sensitivity. Thus confirmation of M. ulcerans infection is primarily based on PCR directed against IS2404. In this study we compare the genotypes obtained by variable number of tandem repeat analysis of DNA from IS2404-PCR positive cultures with that obtained from IS2404 positive, culture-negative tissue. A significantly greater genetic heterogeneity was found among culture-negative samples compared with that found in cultured strains but a single genotype is over-represented in both sample sets. This study provides evidence that both the focal location of bacteria in a lesion as well as differences in the ability to culture a particular genotype may underlie the low sensitivity of culture. Though preliminary, data from this work also suggests that mycobacteria previously associated with fish disease (M. pseudoshottsii) may be pathogenic for humans.	[Williamson, Heather; Small, Pamela] Univ Tennessee, Knoxville, TN 37996 USA; [Phillips, Richard; Sarfo, Stephen] KNUST, KATH, Kumasi, Ghana; [Wansbrough-Jones, Mark] Univ London, London, England	University of Tennessee System; University of Tennessee Knoxville; Kwame Nkrumah University Science & Technology; University of London	Small, P (corresponding author), Univ Tennessee, Knoxville, TN 37996 USA.	psmall@utk.edu	Phillips, Richard Odame/ABD-5394-2021	Phillips, Richard Odame/0000-0001-8992-0222	NIH National Institute of Allergy and Infectious Diseases Grant Award [1 R03 AI026719-01A1]; Division of International Training and Research Fogarty International Center; Ecology of Emerging Infectious Disease (EID) Grant Award [1 R01 TW007550]; FOGARTY INTERNATIONAL CENTER [R01TW007550] Funding Source: NIH RePORTER; MRC [MR/J01477X/1] Funding Source: UKRI; Medical Research Council [MR/J01477X/1] Funding Source: researchfish	NIH National Institute of Allergy and Infectious Diseases Grant Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of International Training and Research Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Ecology of Emerging Infectious Disease (EID) Grant Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported in part by NIH National Institute of Allergy and Infectious Diseases Grant Award 1 R03 AI026719-01A1, and Division of International Training and Research Fogarty International Center, Ecology of Emerging Infectious Disease (EID) Grant Award 1 R01 TW007550 on Buruli ulcer Disease ecology and disease transmission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doig KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-258; Hilty M, 2006, J BACTERIOL, V188, P1462, DOI 10.1128/JB.188.4.1462-1465.2006; Huys G, 2000, J CLIN MICROBIOL, V38, P3675, DOI 10.1128/JCM.38.10.3675-3680.2000; JACKSON K, 1995, J CLIN MICROBIOL, V33, P2250, DOI 10.1128/JCM.33.9.2250-2253.1995; Phillips R, 2005, J CLIN MICROBIOL, V43, P3650, DOI 10.1128/JCM.43.8.3650-3656.2005; Pidot SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000663; Ranger BS, 2006, INFECT IMMUN, V74, P6037, DOI 10.1128/IAI.00970-06; Rhodes MW, 2005, INT J SYST EVOL MICR, V55, P1139, DOI 10.1099/ijs.0.63343-0; Roltgen K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001904; Roltgen K, 2012, INFECT GENET EVOL, V12, P522, DOI 10.1016/j.meegid.2012.01.018; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751; Rondini S, 2006, J PATHOL, V208, P119, DOI 10.1002/path.1864; Stinear T, 2000, J CLIN MICROBIOL, V38, P1482, DOI 10.1128/JCM.38.4.1482-1487.2000; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Stragier P, 2007, SYST APPL MICROBIOL, V30, P525, DOI 10.1016/j.syapm.2007.06.001; Tobias NJ, 2013, J BACTERIOL, V195, P556, DOI 10.1128/JB.02132-12; Trott KA, 2004, COMPARATIVE MED, V54, P309; Ucko M, 2005, J CLIN MICROBIOL, V43, P892, DOI 10.1128/JCM.43.2.892-895.2005; Williamson HR, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000205; Willson SJ, 2013, INFECT ECOL EPIDEMIO, V3, DOI [10.3402/iee.v3i0.19946, DOI 10.3402/IEE.V3I0.19946.EPUB]; Yeboah-Manu D, 2011, AM J TROP MED HYG, V85, P900, DOI 10.4269/ajtmh.2011.11-0362	21	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88007	10.1371/journal.pone.0088007	http://dx.doi.org/10.1371/journal.pone.0088007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520343	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600034
J	Jiang, SZ; Xia, R; Jiang, Y; Wang, L; Gao, FB				Jiang, Shize; Xia, Rui; Jiang, Yong; Wang, Lei; Gao, Fabao			Vascular Endothelial Growth Factors Enhance the Permeability of the Mouse Blood-brain Barrier	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DRUG-DELIVERY; TUMOR ANGIOGENESIS; REAL-TIME; VEGF; RECEPTOR; CELLS; RATS; DISRUPTION; EXPRESSION	The blood-brain barrier (BBB) impedes entry of many drugs into the brain, limiting clinical efficacy. A safe and efficient method for reversibly increasing BBB permeability would greatly facilitate central nervous system (CNS) drug delivery and expand the range of possible therapeutics to include water soluble compounds, proteins, nucleotides, and other large molecules. We examined the effect of vascular endothelial growth factor (VEGF) on BBB permeability in Kunming (KM) mice. Human VEGF165 was administered to treatment groups at two concentrations (1.6 or 3.0 mu g/mouse), while controls received equal-volume saline. Changes in BBB permeability were measured by parenchymal accumulation of the contrast agent Gd-DTPA as assessed by 7 T magnetic resonance imaging (MRI). Mice were then injected with Evans blue, sacrificed 0.5 h later, and perfused transcardially. Brains were removed, fixed, and sectioned for histological study. Both VEGF groups exhibited a significantly greater signal intensity from the cerebral cortex and basal ganglia than controls (P<0.001). Evans blue fluorescence intensity was higher in the parenchyma and lower in the cerebrovasculature of VEGF-treated animals compared to controls. No significant brain edema was observed by diffusion weighted MRI (DWI) or histological staining. Exogenous application of VEGF can increase the permeability of the BBB without causing brain edema. Pretreatment with VEGF may be a feasible method to facilitate drug delivery into the CNS.	[Jiang, Shize; Xia, Rui; Wang, Lei; Gao, Fabao] Sichuan Univ, West China Hosp, Dept Radiol, Mol Imaging Lab, Chengdu, Sichuan, Peoples R China; [Jiang, Yong] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Gao, FB (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, Mol Imaging Lab, Chengdu, Sichuan, Peoples R China.	gaofabao@yahoo.com			National Natural Science Foundation of China [81130027, 81071204]; National Basic Research Program of China [2011CB935800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81130027; 81071204) (http://www.nsfc.gov.cn/), and the National Basic Research Program of China (973 Program, 2011CB935800) (http://www.973.gov.cn/English/Index. aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abulrob A, 2011, METHODS MOL BIOL, V763, P423, DOI 10.1007/978-1-61779-191-8_29; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Blanchette M, 2009, NEUROSURGERY, V65, P344, DOI 10.1227/01.NEU.0000349762.17256.9E; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Carman AJ, 2011, J NEUROSCI, V31, P13272, DOI 10.1523/JNEUROSCI.3337-11.2011; Cho CW, 2002, PHARMACEUT RES, V19, P1123, DOI 10.1023/A:1019837923906; Choi JJ, 2011, P NATL ACAD SCI USA, V108, P16539, DOI 10.1073/pnas.1105116108; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gaillard PJ, 2012, CURR PHARM BIOTECHNO, V13, P2328; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; IDE A. GORDON, 1939, AMER JOUR ROENTGENOL AND RADIUM THERAP, V42, P891; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kim J, 2011, NANO LETT, V11, P694, DOI 10.1021/nl103812a; Lafuente JV, 2006, J NEURAL TRANSM, V113, P487, DOI 10.1007/s00702-005-0407-0; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Mani N, 2003, J CEREBR BLOOD F MET, V23, P1420, DOI 10.1097/01.WCB.0000090620.86921.9C; Na JH, 2011, BIOMATERIALS, V32, P5252, DOI 10.1016/j.biomaterials.2011.03.076; O'Reilly MA, 2012, INT J HYPERTHER, V28, P386, DOI 10.3109/02656736.2012.666709; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Pardridge W. M., 2001, BRAIN DRUG TARGETING, DOI DOI 10.1017/CBO9780511549571.002; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2002, NAT REV DRUG DISCOV, V1, P131, DOI 10.1038/nrd725; Pardridge WM, 2002, DRUG DISCOV TODAY, V7, P5, DOI 10.1016/S1359-6446(01)02082-7; Patel MM, 2009, CNS DRUGS, V23, P35, DOI 10.2165/0023210-200923010-00003; RAPOPORT SI, 1971, SCIENCE, V173, P1026, DOI 10.1126/science.173.4001.1026; Serrano ID, 2012, MINI-REV MED CHEM, V12, P301, DOI 10.2174/138955712799829302; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; Stumpf WE, 2012, PROG HISTOCHEM CYTO, V47, P1, DOI 10.1016/j.proghi.2011.12.001; Tang T, 2007, BRAIN RES, V1175, P134, DOI 10.1016/j.brainres.2007.08.028; Tiligada E, 2011, CNS NEUROSCI THER, V17, P620, DOI 10.1111/j.1755-5949.2010.00212.x; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Wang B, 2013, ADV EXP MED BIOL, V765, P307, DOI 10.1007/978-1-4614-4989-8_43; Wang W, 1996, AM J PHYSIOL-CELL PH, V271, pC1973, DOI 10.1152/ajpcell.1996.271.6.C1973; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang JP, 2010, J INVEST SURG, V23, P149, DOI 10.3109/08941930903469482; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao LM, 1998, J CARDIOVASC PHARM, V32, P1, DOI 10.1097/00005344-199807000-00001	46	63	70	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e86407	10.1371/journal.pone.0086407	http://dx.doi.org/10.1371/journal.pone.0086407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551038	Green Submitted, gold, Green Published			2022-12-27	WOS:000331271500007
J	Mirza, ZA; Sanap, RV; Bhosale, H				Mirza, Zeeshan A.; Sanap, Rajesh V.; Bhosale, Harshal			Preliminary Review of Indian Eumenophorinae (Araneae: Theraphosidae) with Description of a New Genus and Five New Species from the Western Ghats	PLOS ONE			English	Article							IDIOPIDAE; POCOCK; MYGALOMORPHAE; HISTORY; FAMILY	The theraphosid spider genera Heterophrictus Pocock, 1900 and Neoheterophrictus Siliwal & Raven, 2012 are rediagnosed in this paper and a new genus, Sahydroaraneus gen. nov. is described from Southern Western Ghats. Four new species (two each of Heterophrictus and Neoheterophrictus) and one of Sahydroaraneus gen. nov. are described from the Western Ghats. Plesiophrictus mahabaleshwari Tikader, 1977 is removed from the synonymy of Heterophrictus milleti Pocock, 1900 and is treated as a junior synonym of Heterophrictus blatteri (Gravely, 1935). Plesiophrictus bhori Gravely, 1915 is transferred to the genus Neoheterophrictus, Neoheterophrictus bhori (Gravely, 1915) new combination. The genus, Sahydroaraneus gen. nov., resembles tarantula belonging to the genus, Neoheterophrictus but differs with respect to structure of tibial apophysis and spermathecae. Detailed ultra-structure of setae type of the Indian Eumenophorinae is presented for the first time along with notes on their biogeography. Common elements among Africa, Madagascar and India like the Eumenophorinae and several other mygalomorph spiders advocate mygalomorphae as an important group for evolutionary investigation due to their inability for long distance dispersal rendering the members restrictive in distribution.	[Mirza, Zeeshan A.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Wildlife Conservat Soc India Program, Postgrad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India; [Sanap, Rajesh V.] Indian Inst Ecol & Environm, Postgrad Program Ecol & Environm, New Delhi, India; [Bhosale, Harshal] Fergusson Coll, Dept Environm Sci, Postgrad Program Environm Sci, Pune, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mirza, ZA (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Wildlife Conservat Soc India Program, Postgrad Program Wildlife Biol & Conservat, Bangalore, Karnataka, India.	snakeszeeshan@gmail.com	Mirza, Zeeshan/J-7888-2013	Mirza, Zeeshan/0000-0003-1685-9816	The Newby Trust Limited, London	The Newby Trust Limited, London	The study was partly funded by The Newby Trust Limited, London through a travel grant to visit the Natural History Museum to ZAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bond JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038753; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; COYLE FA, 1985, J ARACHNOL, V13, P291; COYLE FA, 1983, J ARACHNOL, V11, P283; Dippenaar-Schoeman A.S., 2002, PLANT PROTECTION RES, V13; DUNLOP J. A., 2008, REV IBERICA ARACNOLO, V15, P9; Dutta SK, 2004, CURR SCI INDIA, V86, P211; Galon RC, 2005, B BRI ARA SOC, V13, P175; Gravely F. H., 1915, Records of the Indian Museum, V11; GRAVELY F. H., 1935, REC INDIAN MUS, V37, P69; Hedges SB, 2003, NATURE, V425, P669, DOI 10.1038/425669a; Hirst Stanley, 1909, Records of the Indian Museum, V3; Kunte K, 2012, INVERTEBRATES W GHAT; Guadanucci JPL, 2011, J ARACHNOL, V39, P523, DOI 10.1636/A10-53.1; Mirza Zeeshan A., 2012, Revista Iberica de Aracnologia, V21, P9; Mirza ZA, 2012, J ARACHNOL, V40, P85, DOI 10.1636/A11-37.1; Mirza Zeeshan A., 2011, Journal of Threatened Taxa, V3, P2109; Mirza Zeeshan A., 2010, Journal of Threatened Taxa, V2, P789; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Platnick N.I., 2013, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001]; Pocock R. I., 1897, Proceedings of the Zoological Society of London, P724; Pocock RI, 1900, FAUNA BRIT INDIA INC, P1; Raven R, 2007, ZOOS PRINT J, V22, P2853; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Raven Robert J., 2005, Zootaxa, V1004, P15; Sanap Rajesh V., 2013, Taprobanica, V5, P6; Sanap Rajesh V., 2011, Acta Zoologica Lituanica, V21, P96, DOI 10.2478/v10043-011-0019-x; Schmidt G, 1993, B ACCA GIO SCI NAT, V26, P311; Siliwal Manju, 2012, Journal of Threatened Taxa, V4, P3233; Siliwal Manju, 2011, Journal of Threatened Taxa, V3, P2229; Siliwal M, 2010, ZOOKEYS, P71, DOI 10.3897/zookeys.46.347; Siliwal Manju, 2009, Journal of Threatened Taxa, V1, P331; Siliwal Manju, 2009, Journal of Threatened Taxa, V1, P533; Simon Eugene, 1903, P669; Smith A, 1995, TARANTULA SPIDERS; Smith AM, 1990, BABOON SPIDERS TARAN; Smith AM, 2004, J BRIT TARANTULA SOC, V19, P48; Smith AM, 1987, TARANTULA CLASSIFICA; Smith Andrew M., 2006, Journal of the British Tarantula Society, V21, P83; Smith MA, 2001, FIELD GUIDE TH UNPUB; Subramanyam K., 1974, ECOLOGY BIOGEOGRAPHY, P178, DOI 10.1007/978-94-010-2331-3_7; Tikader B.K., 1977, Journal of the Bombay Natural History Society, V74, P306; Vol Fabian, 2002, Journal of the British Tarantula Society, V18, P21	45	8	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87928	10.1371/journal.pone.0087928	http://dx.doi.org/10.1371/journal.pone.0087928			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551072	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500025
J	Latino, DARS; Aires-de-Sousa, J				Latino, Diogo A. R. S.; Aires-de-Sousa, Joao			Automatic NMR-Based Identification of Chemical Reaction Types in Mixtures of Co-Occurring Reactions	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CLASSIFICATION; ELUCIDATION; PREDICTION; SHIFTS	The combination of chemoinformatics approaches with NMR techniques and the increasing availability of data allow the resolution of problems far beyond the original application of NMR in structure elucidation/verification. The diversity of applications can range from process monitoring, metabolic profiling, authentication of products, to quality control. An application related to the automatic analysis of complex mixtures concerns mixtures of chemical reactions. We encoded mixtures of chemical reactions with the difference between the 1 H NMR spectra of the products and the reactants. All the signals arising from all the reactants of the co-occurring reactions were taken together (a simulated spectrum of the mixture of reactants) and the same was done for products. The difference spectrum is taken as the representation of the mixture of chemical reactions. A data set of 181 chemical reactions was used, each reaction manually assigned to one of 6 types. From this dataset, we simulated mixtures where two reactions of different types would occur simultaneously. Automatic learning methods were trained to classify the reactions occurring in a mixture from the 1 H NMR-based descriptor of the mixture. Unsupervised learning methods (self-organizing maps) produced a reasonable clustering of the mixtures by reaction type, and allowed the correct classification of 80% and 63% of the mixtures in two independent test sets of different similarity to the training set. With random forests (RF), the percentage of correct classifications was increased to 99% and 80% for the same test sets. The RF probability associated to the predictions yielded a robust indication of their reliability. This study demonstrates the possibility of applying machine learning methods to automatically identify types of co-occurring chemical reactions from NMR data. Using no explicit structural information about the reactions participants, reaction elucidation is performed without structure elucidation of the molecules in the mixtures.	[Latino, Diogo A. R. S.; Aires-de-Sousa, Joao] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE,CQFB, Caparica, Portugal; [Latino, Diogo A. R. S.] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, CCMM, Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa	Latino, DARS (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE,CQFB, Caparica, Portugal.	latino@fc.ul.pt; joao@airesdesousa.com	Aires-de-Sousa, Joao/C-7826-2013; Aires-de-Sousa, Joao/AAA-9274-2020; Latino, Diogo/D-7476-2013	Aires-de-Sousa, Joao/0000-0002-5887-2966; Aires-de-Sousa, Joao/0000-0002-5887-2966; Latino, Diogo/0000-0002-7622-3249	FCTMES (Fundacao para a Ciencia e a Tecnologia), Ministerio da Ciencia, Tecnologia e Ensino Superior, Lisbon Portugal [PEst-C/EQB/LA0006/2011]	FCTMES (Fundacao para a Ciencia e a Tecnologia), Ministerio da Ciencia, Tecnologia e Ensino Superior, Lisbon Portugal	FCTMES (Fundacao para a Ciencia e a Tecnologia), Ministerio da Ciencia, Tecnologia e Ensino Superior, Lisbon Portugal (through grant no. PEst-C/EQB/LA0006/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-de-Sousa J, 2002, CHEMOMETR INTELL LAB, V61, P167, DOI 10.1016/S0169-7439(01)00171-X; Alonso-Salces RM, 2010, FOOD CHEM, V118, P956, DOI 10.1016/j.foodchem.2008.09.061; Aursand M, 2007, J AGR FOOD CHEM, V55, P38, DOI 10.1021/jf061754l; Ballard M, 2011, ENRGY PROCED, V4, P291, DOI 10.1016/j.egypro.2011.01.054; Beckonert O, 2003, NMR BIOMED, V16, P1, DOI 10.1002/nbm.797; Bernstein MA, 2007, MAGN RESON CHEM, V45, P564, DOI 10.1002/mrc.2007; Binev Y, 2004, J CHEM INF COMP SCI, V44, P946, DOI 10.1021/ci034229k; Binev Y, 2004, J CHEM INF COMP SCI, V44, P940, DOI 10.1021/ci034228s; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brougham DF, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/158094; Cho HW, 2008, EXPERT SYST APPL, V35, P967, DOI 10.1016/j.eswa.2007.08.050; Ebbels TMD, 2007, J PROTEOME RES, V6, P4407, DOI 10.1021/pr0703021; Foley DA, 2011, J ORG CHEM, V76, P9630, DOI 10.1021/jo201212p; Kalelkar S, 2002, J COMB CHEM, V4, P622, DOI 10.1021/cc020031l; Khajeh M, 2010, MAGN RESON CHEM, V48, P516, DOI 10.1002/mrc.2610; Kohonen T., 1988, SELF ORG ASS MEMORY; Latino DARS, 2007, ANAL CHEM, V79, P854, DOI 10.1021/ac060979s; Lloyd GV, 2009, CHEMOM INTELL LAB SY, V98, P49; McKenzie JS, 2011, PROG NUCL MAG RES SP, V59, P336, DOI 10.1016/j.pnmrs.2011.04.003; Mix A, 2010, ORGANOMETALLICS, V29, P442, DOI 10.1021/om900919F; R. D. C. Team, 2004, R LANG ENV STAT COMP; Shey JY, 2002, TETRAHEDRON LETT, V43, P1725, DOI 10.1016/S0040-4039(02)00061-8; Suna T, 2007, NMR BIOMED, V20, P658, DOI 10.1002/nbm.1123; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Sykes BD, 2011, J BIOMOL NMR, V49, P163, DOI 10.1007/s10858-011-9479-3; Vallikivi I, 2004, J MOL CATAL B-ENZYM, V32, P15, DOI 10.1016/j.molcatb.2004.09.002; Gomez MV, 2010, CHEM COMMUN, V46, P4514, DOI 10.1039/b924936b; Wongravee K, 2010, ANAL CHEM, V82, P628, DOI 10.1021/ac9020566; Zupan J, 1999, NEURAL NETWORKS CHEM	29	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88499	10.1371/journal.pone.0088499	http://dx.doi.org/10.1371/journal.pone.0088499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551112	Green Submitted, gold, Green Published			2022-12-27	WOS:000331266000042
J	Fermin, S; Bastin, C; Salmon, E; Goriz, JM; Ramirez, J; Phillips, C				Segovia, Fermin; Bastin, Christine; Salmon, Eric; Goriz, Juan Manuel; Ramirez, Javier; Phillips, Christophe			Combining PET Images and Neuropsychological Test Data for Automatic Diagnosis of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; VECTOR MACHINE; BRAIN ATROPHY; MCI PATIENTS; CLASSIFICATION; PATTERNS; OPTIMIZATION; VALIDATION; DEMENTIA	In recent years, several approaches to develop computer aided diagnosis (CAD) systems for dementia have been proposed. Some of these systems analyze neurological brain images by means of machine learning algorithms in order to find the patterns that characterize the disorder, and a few combine several imaging modalities to improve the diagnostic accuracy. However, they usually do not use neuropsychological testing data in that analysis. The purpose of this work is to measure the advantages of using not only neuroimages as data source in CAD systems for dementia but also neuropsychological scores. To this aim, we compared the accuracy rates achieved by systems that use neuropsychological scores beside the imaging data in the classification step and systems that use only one of these data sources. In order to address the small sample size problem and facilitate the data combination, a dimensionality reduction step (implemented using three different algorithms) was also applied on the imaging data. After each image is summarized in a reduced set of image features, the data sources were combined and classified using three different data combination approaches and a Support Vector Machine classifier. That way, by testing different dimensionality reduction methods and several data combination approaches, we aim not only highlighting the advantages of using neuropsychological scores in the classification, but also implementing the most accurate computer system for early dementia detention. The accuracy of the CAD systems were estimated using a database with records from 46 subjects, diagnosed with MCI or AD. A peak accuracy rate of 89% was obtained. In all cases the accuracy achieved using both, neuropsychological scores and imaging data, was substantially higher than the one obtained using only the imaging data.	[Segovia, Fermin; Bastin, Christine; Salmon, Eric] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Goriz, Juan Manuel; Ramirez, Javier] Univ Granada, Dept Signal Theory Networking & Commun, Granada, Spain; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium	University of Liege; University of Granada; University of Liege	Fermin, S (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	fsegovia@ulg.ac.be	Salmon, Eric/AAE-4901-2020; Gorriz, Juan Manuel/C-2385-2012; Román, Fermín Segovia/M-3306-2014; Ramírez, Javier/B-1836-2012; Phillips, Christophe/M-3025-2017	Salmon, Eric/0000-0003-2520-9241; Gorriz, Juan Manuel/0000-0001-7069-1714; Román, Fermín Segovia/0000-0003-1940-8834; Ramírez, Javier/0000-0002-6229-2921; Phillips, Christophe/0000-0002-4990-425X; Bastin, Christine/0000-0002-4556-9490	University of Liege; "Fonds de la Recherche Scientifique'' (FRS-FNRS); "Stichting Alzheimer Onderzoek/Fondation Recherche Alzheimer'' (SAO-FRA); Inter University Attraction Pole [P7/11]	University of Liege(University of Liege); "Fonds de la Recherche Scientifique'' (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); "Stichting Alzheimer Onderzoek/Fondation Recherche Alzheimer'' (SAO-FRA); Inter University Attraction Pole(Belgian Federal Science Policy Office)	This work was supported by the University of Liege, the "Fonds de la Recherche Scientifique'' (FRS-FNRS), the "Stichting Alzheimer Onderzoek/Fondation Recherche Alzheimer'' (SAO-FRA), and the Inter University Attraction Pole P7/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2007, J CLIN EXP NEUROPSYC, V29, P477, DOI 10.1080/13803390600775339; Artero S, 2006, DEMENT GERIATR COGN, V22, P465, DOI 10.1159/000096287; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Canu E, 2010, J ALZHEIMERS DIS, V19, P963, DOI 10.3233/JAD-2010-1295; Chincarini A, 2011, NEUROIMAGE, V58, P469, DOI 10.1016/j.neuroimage.2011.05.083; Cortes C., 2010, ICML, P239; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Duin RPW, 2000, INT C PATT RECOG, P1, DOI 10.1109/ICPR.2000.906006; Dukart J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055415; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Garraux G, 2013, NEUROIMAGE-CLIN, V2, P883, DOI 10.1016/j.nicl.2013.06.004; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Good P, 2000, PERMUTATION TESTS PR; Gu┬nen M., 2008, P 25 INT C MACH LEAR, P352, DOI DOI 10.1145/1390156.1390201; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Horn JF, 2009, ARTIF INTELL MED, V47, P147, DOI 10.1016/j.artmed.2009.05.001; Igel C, 2007, IEEE ACM T COMPUT BI, V4, P216, DOI [10.1109/TCBB.2007.070208, 10.1109/tcbb.2007.070208]; Illan IA, 2011, INFORM SCIENCES, V181, P903, DOI 10.1016/j.ins.2010.10.027; Ivanoiu A, 2005, J NEUROL, V252, P47, DOI 10.1007/s00415-005-0597-2; Jhoo JH, 2010, PSYCHIAT RES-NEUROIM, V183, P237, DOI 10.1016/j.pscychresns.2010.03.006; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lee WJ, 2007, LECT NOTES COMPUT SC, V4472, P22; Lopez M, 2009, ELECTRON LETT, V45, P389, DOI 10.1049/el.2009.0176; LOPEZ M, 2009, NEUROSCIENCE LETT; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; NOBLE WS, 2004, KERNEL METHODS COMPU, P71; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Phillips CL, 2011, NEUROIMAGE, V56, P797, DOI 10.1016/j.neuroimage.2010.05.083; Schrouff J., 2013, NEUROINFORMATICS; Segovia F, 2012, FRONT ARTIF INTEL AP, V243, P2241, DOI 10.3233/978-1-61499-105-2-2241; Segovia F, 2012, NEUROCOMPUTING, V75, P64, DOI 10.1016/j.neucom.2011.03.050; Signorini M, 1999, NEUROIMAGE, V9, P63, DOI 10.1006/nimg.1998.0381; STOECKEL J, 2001, P 4 INT C MED IM COM, P666; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vapnik V., 1999, NATURE STAT LEARNING; Vapnik V., 1998, STAT LEARNING THEORY; Varma M, 2009, P 26 ANN INT C MACH, P1065; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Wang SG, 2011, EXPERT SYST APPL, V38, P8696, DOI 10.1016/j.eswa.2011.01.077; Webb A. R., 2003, STAT PATTERN RECOGNI; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Woods RP, 2000, BIOMED EN S, P465; Yang JJ, 2009, IEEE I CONF COMP VIS, P436, DOI 10.1109/ICCV.2009.5459172; ZWEIG MH, 1993, CLIN CHEM, V39, P561	55	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88687	10.1371/journal.pone.0088687	http://dx.doi.org/10.1371/journal.pone.0088687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551135	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000055
J	Wang, XX; Liu, W; Wu, L; Zhan, R; Jin, BY; Qian, LJ				Wang Xinxing; Liu Wei; Wu Lei; Zhan Rui; Jin Baoying; Qian Lingjia			A Neuroendocrine Mechanism of Co-Morbidity of Depression-Like Behavior and Myocardial Injury in Rats	PLOS ONE			English	Article							CHRONIC MILD STRESS; HEART-DISEASE; CARDIOVASCULAR-DISEASE; CARDIAC MITOCHONDRIA; MAJOR DEPRESSION; CONTROLLED-TRIAL; MODEL; ANHEDONIA; ANTIDEPRESSANT; INHIBITORS	Depression is generally a recurrent psychiatric disorder. Evidence shows that depression and cardiovascular diseases are common comorbid conditions, but the specific pathological mechanisms remain unclear. The purpose of this study is to determine the effects of depression induced by chronic unpredictable mild stress (CUMS) on myocardial injury and to further elucidate the biological mechanism of depression. Rats were used as a model. The CUMS procedure lasted for a total of 8 weeks. After 4 weeks of CUMS, treated rats exhibited a reduced sucrose preference and changes in scores on an open field test, body weight and content of 5-HT in the brain as compared with the values of these variables in controls. These changes indicated depression-like changes in CUMS rats and demonstrated the feasibility of the depression model. In addition, pathological changes in the myocardium and increased cardiomyocyte apoptosis demonstrated that myocardial injury had occurred after 6 weeks of CUMS and had increased significantly by the end of 8 weeks of CUMS. Plasma serotonin (5-HT), norepinephrine (NE) and epinephrine (E), all depression-related neuroendocrine factors, were measured by HPLC-ECD techniques, and the content of plasma corticosterone (GC) was evaluated by an I-125-cortisol radioactivity immunoassay in control and CUMS rats. The results indicated that 5-HT had decreased, whereas NE, E and GC had increased in CUMS rats, and these factors might be associated with depression-induced myocardial injury. The effects of 5-HT, NE and GC on the survival rate of cultured cardiomyocytes were determined using an orthogonal design. The results showed that 5-HT was a more important factor affecting cell survival than GC or NE. The results suggested that normal blood levels of 5-HT had a cytoprotective effect. The neuroendocrine disorders characterized by decreased 5-HT combined with increased GC and NE mediated the occurrence of depression-induced myocardial injury.	[Wang Xinxing; Zhan Rui; Qian Lingjia] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Liu Wei; Wu Lei] Inst Hlth & Environm Med, Tianjin, Peoples R China; [Jin Baoying] Tianjin Occupat Dis Prevent Hosp Hosp Workers, Tianjin, Peoples R China	Academy of Military Medical Sciences - China	Wang, XX (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	wxxchf@gmail.com; jinbaoying@sohu.com; newjia@vip.sina.com	Wang, Xinxing/AAU-6356-2021		National Natural Science Foundation of China [81372124, 81000584, 31071022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant numbers 81372124, 81000584, 31071022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baune B.T., 2012, CITATION TRANSL PSYC, V2, P1; Bhuiyan MS, 2013, J PHARMACOL SCI, V121, P177, DOI 10.1254/jphs.12R13CP; Bot M, 2011, J PSYCHOSOM RES, V71, P13, DOI 10.1016/j.jpsychores.2010.11.006; Bott-Flugel L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018048; Bravo L, 2012, ANESTHESIOLOGY, V117, P613, DOI 10.1097/ALN.0b013e3182657b3e; Carreira RS, 2008, J BIOENERG BIOMEMBR, V40, P95, DOI 10.1007/s10863-008-9133-2; Chen Li-ping, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P113; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; COLEMAN R, 1987, GERONTOLOGY, V33, P19, DOI 10.1159/000212850; DAquila PS, 1997, PHYSIOL BEHAV, V62, P421, DOI 10.1016/S0031-9384(97)00042-5; DAQUILA PS, 1994, PHYSIOL BEHAV, V56, P861, DOI 10.1016/0031-9384(94)90316-6; Delui MH, 2013, OPEN CARDIOVASC MED, V7, P99, DOI 10.2174/1874192401307010099; Goldstein I, 2012, EUR NEUROPSYCHOPHARM, V22, P72, DOI 10.1016/j.euroneuro.2011.05.007; Grippo AJ, 2002, NEUROSCI BIOBEHAV R, V26, P941, DOI 10.1016/S0149-7634(03)00003-4; Grippo AJ, 2003, PHYSIOL BEHAV, V78, P703, DOI 10.1016/S0031-9384(03)00050-7; Grippo AJ, 2002, AM J PHYSIOL-REG I, V282, pR1333, DOI 10.1152/ajpregu.00614.2001; Hadoke PWF, 2009, BRIT J PHARMACOL, V156, P689, DOI 10.1111/j.1476-5381.2008.00047.x; Hayes D, 2004, AM J MANAG CARE, V10, pS179; Jasinska AJ, 2012, TRENDS NEUROSCI, V35, P395, DOI 10.1016/j.tins.2012.01.001; Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7; Kapfhammer HP, 2011, PSYCHIAT DANUB, V23, P412; Keedwell PA, 2012, BIOL PSYCHIAT, V72, P296, DOI 10.1016/j.biopsych.2012.01.022; Kong HL, 2010, ACTA PHARMACOL SIN, V31, P687, DOI 10.1038/aps.2010.52; Kotter T, 2013, GMS Z MED AUSBILDUNG, V30, pDoc22; Kowey PR, 2011, DRUGS R&D, V11, P1, DOI 10.2165/11587660-000000000-00000; Lee HA, 2012, KOREAN J PHYSIOL PHA, V16, P327, DOI 10.4196/kjpp.2012.16.5.327; Lin EHB, 2012, ANN FAM MED, V10, P6, DOI 10.1370/afm.1343; Liu WH, 2012, PSYCHIAT RES, V200, P361, DOI 10.1016/j.psychres.2012.07.025; Lu FH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-50; Lundberg J, 2012, INT J NEUROPSYCHOPH, V15, P1167, DOI 10.1017/S1461145711001945; McMakin DL, 2012, J AM ACAD CHILD PSY, V51, P404, DOI 10.1016/j.jaac.2012.01.011; Meijer WEE, 2004, EUR J CLIN PHARMACOL, V60, P57, DOI 10.1007/s00228-004-0726-3; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morgan JK, 2013, NEUROBIOL DIS, V52, P66, DOI 10.1016/j.nbd.2012.03.039; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Palekar N, 2013, J NEUROPSYCH CLIN N, V25, pE1, DOI 10.1176/appi.neuropsych.12040082; Passarelli C, 2010, INT J MOL MED, V26, P95, DOI 10.3892/ijmm_00000439; Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221; Redfors B, 2013, VASC HEALTH RISK MAN, V9, P149, DOI 10.2147/VHRM.S40163; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Santra Ranjita, 2012, Indian J Psychol Med, V34, P391, DOI 10.4103/0253-7176.108230; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Serebruany VL, 2003, CIRCULATION, V108, P939, DOI 10.1161/01.CIR.0000085163.21752.0A; Serotonin Cowen P, S AFRICAN J PSYCHIAT, P94; Spasojevic N, 2012, INDIAN J EXP BIOL, V50, P771; Strik JTMH, 2000, PSYCHOSOM MED, V62, P783, DOI 10.1097/00006842-200011000-00007; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; Torchinsky A, 2003, AM J REPROD IMMUNOL, V49, P159, DOI 10.1034/j.1600-0897.2003.01174.x; Troost J, 2011, BRIT J CLIN PHARMACO, V72, P247, DOI 10.1111/j.1365-2125.2011.03988.x; Wang SZ, 2011, J PHYS CHEM LETT, V2, P1, DOI 10.1021/jz101423s; Wang XX, 2012, STRESS, V15, P545, DOI 10.3109/10253890.2011.644603; Wang XX, 2010, CELL STRESS CHAPERON, V15, P771, DOI 10.1007/s12192-010-0185-y; Wang XX, 2009, CELL STRESS CHAPERON, V14, P639, DOI 10.1007/s12192-009-0116-y; Wasserman D, 2010, EUR PSYCHIAT, V25, P278, DOI 10.1016/j.eurpsy.2009.12.016; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Williams MS, 2012, WORLD J PSYCHIATR, V2, P114, DOI 10.5498/wjp.v2.i6.114; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Yu Ling, 2010, Shengli Xuebao, V62, P14; Yubero-Lahoz S, 2012, EUR J PHARMACOL, V674, P337, DOI 10.1016/j.ejphar.2011.10.033; Zahl PH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-62; Zhang WY, 2012, J PHARMACEUT BIOMED, V70, P534, DOI 10.1016/j.jpba.2012.04.032	63	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88427	10.1371/journal.pone.0088427	http://dx.doi.org/10.1371/journal.pone.0088427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551098	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000035
J	Yasuoka, H; Yamaguchi, Y; Feghali-Bostwick, CA				Yasuoka, Hidekata; Yamaguchi, Yukie; Feghali-Bostwick, Carol A.			The Membrane-Associated Adaptor Protein DOK5 Is Upregulated in Systemic Sclerosis and Associated with IGFBP-5-Induced Fibrosis	PLOS ONE			English	Article							PULMONARY-FIBROSIS; CONTRIBUTE; IGFBP-5; KINASE	Systemic sclerosis (SSc) is characterized by excessive fibrosis of the skin and internal organs due to fibroblast proliferation and excessive production of extracellular matrix (ECM). We have shown that insulin-like growth factor binding protein (IGFBP)-5 plays an important role in the development of fibrosis in vitro, ex vivo, and in vivo. We identified a membrane-associated adaptor protein, downstream of tyrosine kinase/docking protein (DOK)5, as an IGFBP-5-regulated target gene using gene expression profiling of primary fibroblasts expressing IGFBP-5. DOK5 is a tyrosine kinase substrate associated with intracellular signaling. Our objective was to determine the role of DOK5 in the pathogenesis of SSc and specifically in IGFBP-5-induced fibrosis. DOK5 mRNA and protein levels were increased in vitro by endogenous and exogenous IGFBP-5 in primary human fibroblasts. DOK5 upregulation required activation of the mitogen-activated protein kinase (MAPK) signaling cascade. Further, IGFBP-5 triggered nuclear translocation of DOK5. DOK5 protein levels were also increased in vivo in mouse skin and lung by IGFBP-5. To determine the effect of DOK5 on fibrosis, DOK5 was expressed ex vivo in human skin in organ culture. Expression of DOK5 in human skin resulted in a significant increase in dermal thickness. Lastly, levels of DOK5 were compared in primary fibroblasts and lung tissues of patients with SSc and healthy donors. Both DOK5 mRNA and protein levels were significantly increased in fibroblasts and skin tissues of patients with SSc compared with those of healthy controls, as well as in lung tissues of SSc patients. Our findings suggest that IGFBP-5 induces its pro-fibrotic effects, at least in part, via DOK5. Furthermore, IGFBP-5 and DOK5 are both increased in SSc fibroblasts and tissues and may thus be acting in concert to promote fibrosis.	[Yasuoka, Hidekata; Yamaguchi, Yukie; Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Feghali-Bostwick, Carol A.] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Yasuoka, Hidekata] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of South Carolina; Keio University	Feghali-Bostwick, CA (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.	feghalib@musc.edu	Yasuoka, Hidekata/AAC-6277-2019	Yamaguchi, Yukie/0000-0002-0297-6627	NIH [R01 AR050840, P30 DK072506, K24 AR060297]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050840, K24AR060297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01 AR050840, P30 DK072506, and K24 AR060297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Brissett M, 2012, ARTHRITIS RHEUM-US, V64, P272, DOI 10.1002/art.30647; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Feghali CA, 1999, ARTHRITIS RHEUM-US, V42, P1451, DOI 10.1002/1529-0131(199907)42:7<1451::AID-ANR19>3.0.CO;2-6; Feghali-Bostwick C, 2003, ARTHRITIS RHEUM, V48, P1956, DOI 10.1002/art.11173; Fu G, 2008, BIOPHYS CHEM, V136, P13, DOI 10.1016/j.bpc.2008.03.009; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Hamaguchi Y, 2008, J RHEUMATOL, V35, P2363, DOI 10.3899/jrheum.080340; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Hsu E, 2008, AM J PATHOL, V172, P1580, DOI 10.2353/ajpath.2008.071021; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Shi L, 2006, CELL SIGNAL, V18, P1995, DOI 10.1016/j.cellsig.2006.03.007; Silver RM., 2005, ARTHRITIS ALLIED CON, P1633; Wen JY, 2009, J MOL CELL CARDIOL, V47, P761, DOI 10.1016/j.yjmcc.2009.09.015; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Yamaguchi Y, 2011, J CELL MOL MED, V15, P957, DOI 10.1111/j.1582-4934.2010.01063.x; Yasuoka H, 2006, AM J PATHOL, V169, P1633, DOI 10.2353/ajpath.2006.060501; Yasuoka H, 2006, ARTHRITIS RHEUM-US, V54, P3001, DOI 10.1002/art.22084; Yasuoka H, 2009, AM J RESP CELL MOL, V41, P179, DOI 10.1165/rcmb.2008-0211OC; Yasuoka Hidekata, 2008, Open Rheumatol J, V2, P17, DOI 10.2174/1874312900802010017; Yasuoka H, 2009, AM J PATHOL, V175, P605, DOI 10.2353/ajpath.2009.080991	22	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87754	10.1371/journal.pone.0087754	http://dx.doi.org/10.1371/journal.pone.0087754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551065	Green Published, gold, Green Accepted			2022-12-27	WOS:000331266000017
J	Kesselheim, AS; Xu, S; Avorn, J				Kesselheim, Aaron S.; Xu, Shuai; Avorn, Jerry			Clinicians' Contributions to the Development of Coronary Artery Stents: A Qualitative Study of Transformative Device Innovation	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ANGIOPLASTY; INDUSTRY; PATENTS; CARE; ACT	Background: Medical device innovation remains poorly understood, and policymakers disagree over how to incentivize early development. We sought to elucidate the components of transformative health care innovation by conducting an in-depth case study of development of a key medical device: coronary artery stents. Methods and Findings: We conducted semi-structured interviews with the innovators whose work contributed to the development of coronary artery stents who we identified based on a review of the regulatory, patent, and medical literature. Semi-structured interviews with each participant covered the interviewee's personal involvement in coronary artery stent development, the roles of institutions and other individuals in the development process, the interplay of funding and intellectual property in the interviewee's contribution, and finally reflections on lessons arising from the experience. Transcripts were analyzed using standard coding techniques and the constant comparative method of qualitative data analysis. Conclusions: We found that the first coronary artery stents emerged from three teams: Julio Palmaz and Richard Schatz, Cesare Gianturco and Gary Roubin, and Ulrich Sigwart. First, these individual physician-inventors saw the need for coronary artery stents in their clinical practice. In response, they developed prototypes with the support of academic medical centers leading to early validation studies. Larger companies entered afterwards with engineering support. Patents became paramount once the technology diffused. The case of coronary stents suggests that innovation policy should focus on supporting early physician-inventors at academic centers.	[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Robert Wood Johnson Foundation Investigator Award in Health Policy Research; Greenwall Faculty Scholarship in Bioethics; career development award from the Agency for Healthcare Research Quality [K08HS18465-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation Investigator Award in Health Policy Research(Robert Wood Johnson Foundation (RWJF)); Greenwall Faculty Scholarship in Bioethics; career development award from the Agency for Healthcare Research Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant from the Robert Wood Johnson Foundation Investigator Award in Health Policy Research to Dr. Kesselheim. Dr. Kesselheim is also supported by a Greenwall Faculty Scholarship in Bioethics and a career development award from the Agency for Healthcare Research & Quality (K08HS18465-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DC, 2009, HEALTH AFFAIR, V28, pW68, DOI 10.1377/hlthaff.28.1.w68; [Anonymous], 2004, MEDSCAPE RADIOL 0506; [Anonymous], 2011, ECONOMIST; Azoulay P, 2007, NEW ENGL J MED, V357, P2049, DOI 10.1056/NEJMsa067417; Bar-Shalom A, 2002, MILBANK Q, V80, P637, DOI 10.1111/1468-0009.00027; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Chatterji AK, 2008, HEALTH AFFAIR, V27, P1532, DOI 10.1377/hlthaff.27.6.1532; CONSTAS MA, 1992, AM EDUC RES J, V29, P253, DOI 10.3102/00028312029002253; Erdin Nils, 2008, J Diabetes Sci Technol, V2, P971; FDA, 2004, INN STAGN CHALL OPP; Feder B.J., 2007, NY TIMES; Fuchs VR, 2001, HLTH AFF, P2030; Geddes LA, 1993, CATHETER INTRO; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; KAHN A, 1991, MED INN CR, V2, P89; Kesselheim AS, 2011, NEW ENGL J MED, V365, P1167, DOI 10.1056/NEJMp1109168; Kramer DB, 2012, NEW ENGL J MED, V367, P1277, DOI 10.1056/NEJMp1207800; Krucoff MW, 2012, JACC-CARDIOVASC INTE, V5, P790, DOI 10.1016/j.jcin.2012.03.023; Malakoff D., 2012, SCI INSIDER; Mike V, 1996, SOC SCI MED, V42, P1247, DOI 10.1016/0277-9536(95)00222-7; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Monagan D, 2007, JOURNEY HEART; MUELLER RL, 1995, AM HEART J, V129, P146, DOI 10.1016/0002-8703(95)90055-1; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; National Research Council, 2001, INN INV MED DEV WORK; Paulsen E, 2012, HILL            0606; Peterson ED, 2000, AM HEART J, V139, P198, DOI 10.1067/mhj.2000.103848; Privitera MB, 2009, IEEE ENG MED BIO, P5595, DOI 10.1109/IEMBS.2009.5333492; Roberts E. B., 1988, NEW MEDICAL DEVICES, P35; Ruygrok PN, 1996, CIRCULATION, V94, P882, DOI 10.1161/01.CIR.94.5.882; Schmookler J., 1966, INVENTION EC GROWTH; SERRUYS PW, 1991, NEW ENGL J MED, V324, P13, DOI 10.1056/NEJM199101033240103; Shih C, 2008, HEALTH AFFAIR, V27, P1566, DOI 10.1377/hlthaff.27.6.1566; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; Sigwart U, 1997, SCI MED, V4, P16; Wallace S, 1996, CARDIOVASC INTER RAD, V19, P59; WILLMS DG, 1990, MED ANTHROPOL Q, V4, P391, DOI 10.1525/maq.1990.4.4.02a00020; Xu S, 2012, CIRC-CARDIOVASC QUAL, V5, P743, DOI 10.1161/CIRCOUTCOMES.112.967398	38	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88664	10.1371/journal.pone.0088664	http://dx.doi.org/10.1371/journal.pone.0088664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533133	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600091
J	Saxena, RK; von Wettberg, E; Upadhyaya, HD; Sanchez, V; Songok, S; Saxena, K; Kimurto, P; Varshney, RK				Saxena, Rachit K.; von Wettberg, Eric; Upadhyaya, Hari D.; Sanchez, Vanessa; Songok, Serah; Saxena, Kulbhushan; Kimurto, Paul; Varshney, Rajeev K.			Genetic Diversity and Demographic History of Cajanus spp. Illustrated from Genome-Wide SNPs	PLOS ONE			English	Article							WILD RELATIVES; SSR MARKERS; MAP; DOMESTICATION; IMPROVEMENT; EVOLUTION; CHICKPEA; DROUGHT; WHEAT	Understanding genetic structure of Cajanus spp. is essential for achieving genetic improvement by quantitative trait loci (QTL) mapping or association studies and use of selected markers through genomic assisted breeding and genomic selection. After developing a comprehensive set of 1,616 single nucleotide polymorphism (SNPs) and their conversion into cost effective KASPar assays for pigeonpea (Cajanus cajan), we studied levels of genetic variability both within and between diverse set of Cajanus lines including 56 breeding lines, 21 landraces and 107 accessions from 18 wild species. These results revealed a high frequency of polymorphic SNPs and relatively high level of cross-species transferability. Indeed, 75.8% of successful SNP assays revealed polymorphism, and more than 95% of these assays could be successfully transferred to related wild species. To show regional patterns of variation, we used STRUCTURE and Analysis of Molecular Variance (AMOVA) to partition variance among hierarchical sets of landraces and wild species at either the continental scale or within India. STRUCTURE separated most of the domesticated germplasm from wild ecotypes, and separates Australian and Asian wild species as has been found previously. Among Indian regions and states within regions, we found 36% of the variation between regions, and 64% within landraces or wilds within states. The highest level of polymorphism in wild relatives and landraces was found in Madhya Pradesh and Andhra Pradesh provinces of India representing the centre of origin and domestication of pigeonpea respectively.	[Saxena, Rachit K.; Upadhyaya, Hari D.; Songok, Serah; Saxena, Kulbhushan; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [von Wettberg, Eric] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [von Wettberg, Eric] Kushlan Inst Trop Sci, Fairchild Trop Bot Garden, Miami, FL USA; [Sanchez, Vanessa] Florida Int Univ, Dept Earth & Environm, Miami, FL 33199 USA; [Songok, Serah; Kimurto, Paul] Egerton Univ, Egerton, Kenya	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); State University System of Florida; Florida International University; State University System of Florida; Florida International University; Egerton University	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org	von Wettberg, Eric/C-1115-2016; Updhayaya, Hari/C-4858-2014; Varshney, Rajeev K/C-5295-2014; Kimurto, Paul/ABC-3322-2021	von Wettberg, Eric/0000-0002-2724-0317; Updhayaya, Hari/0000-0002-5166-6844; Varshney, Rajeev K/0000-0002-4562-9131; 	United States Agency for International Development (USAID)- India Mission and Department of Agriculture and Co-opeartion, Ministry of Agriculture Government of India; Florida International University and Fairchild Tropical Botanic Garden;  [USDA-NIFA-NNF 2011-38420-20053]	United States Agency for International Development (USAID)- India Mission and Department of Agriculture and Co-opeartion, Ministry of Agriculture Government of India(United States Agency for International Development (USAID)); Florida International University and Fairchild Tropical Botanic Garden; 	We thank United States Agency for International Development (USAID)- India Mission and Department of Agriculture and Co-opeartion, Ministry of Agriculture, Government of India for financial support for the research work to RKV and support from Florida International University and Fairchild Tropical Botanic Garden to EvW. VS is thankful for financial support from USDA-NIFA-NNF 2011-38420-20053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium.	[Anonymous], 2008, BIOLOGIST; Bharathi Mudaraddi, 2013, African Journal of Biotechnology, V12, P3797; Bohra A., 2010, J PLANT BIOL, V37, P83; Bohra A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-56; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Cuesta-Marcos A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-707; Deulvot C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-468; Durstewitz G, 2010, GENOME, V53, P948, DOI 10.1139/G10-079; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Friesen ML, 2010, CURR OPIN PLANT BIOL, V13, P119, DOI 10.1016/j.pbi.2009.11.003; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gepts P, 2004, PLANT PHYSIOL, V134, P1295, DOI 10.1104/pp.103.038885; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HAWKES JG, 1991, BIOL J LINN SOC, V43, P3, DOI 10.1111/j.1095-8312.1991.tb00578.x; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Kassa MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039563; Khera P, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.06.0019; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Maesen L. J. G. van der, 1990, The pigeonpea., P15; Maesen L. J. G. van der, 1980, Miscellaneous Papers, Landbouwhogeschool Wageningen, P257; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Neelam K, 2013, MOL BREEDING, V31, P233, DOI 10.1007/s11032-012-9773-0; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Panguluri SK, 2006, GENET RESOUR CROP EV, V53, P523, DOI 10.1007/s10722-004-2031-5; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Rachit KS, 2012, DNA RES, V19, P449, DOI 10.1093/dnares/dss025; RATNAPARKHE MB, 1995, THEOR APPL GENET, V91, P893, DOI 10.1007/BF00223897; Roorkiwal M, 2013, PLANT GENOME-US, V6, P2, DOI [10.3835/plantgenome2013.05.0017, DOI 10.3835/plantgenome2013.05.0017]; Saxena K. B., 2008, Tropical Plant Biology, V1, P159, DOI 10.1007/s12042-008-9014-1; Saxena RK, 2010, PLANT BREEDING, V129, P142, DOI 10.1111/j.1439-0523.2009.01680.x; Saxena RK, 2011, FUNCT INTEGR GENOMIC, V11, P651, DOI 10.1007/s10142-011-0227-2; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Yang SY, 2011, J GENET, V90, P103, DOI 10.1007/s12041-011-0050-5; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z	51	36	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88568	10.1371/journal.pone.0088568	http://dx.doi.org/10.1371/journal.pone.0088568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533111	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600069
J	Yamamoto, R; Yamamoto, Y; Imai, S; Fukutomi, R; Ozawa, Y; Abe, M; Matuo, Y; Saito, K				Yamamoto, Rie; Yamamoto, Yasuko; Imai, Shinjiro; Fukutomi, Ryuta; Ozawa, Yoshio; Abe, Masako; Matuo, Yushi; Saito, Kuniaki			Effects of Various Phytochemicals on Indoleamine 2,3-Dioxygenase 1 Activity: Galanal Is a Novel, Competitive Inhibitor of the Enzyme	PLOS ONE			English	Article							FACTOR-KAPPA-B; TRYPTOPHAN CATABOLISM; PUNGENT PRINCIPLE; INTERFERON-GAMMA; DENDRITIC CELLS; T-CELL; MECHANISM; TARGET; LIPOPOLYSACCHARIDE; IDENTIFICATION	Indoleamine 2,3-dioxygenase (IDO) 1, that catalyzes the first and rate-limiting step in the degradation of L-tryptophan, has an important immunomodulatory function. The activity of IDO1 increases in various inflammatory diseases, including tumors, autoimmune diseases, and different kinds of inflammation. We evaluated the suppressive effect of plant extracts or phytochemicals on IDO1 induction and activity; sixteen kinds of plants extracts and fourteen kinds of phytochemicals were examined. As a result, the methanol extracts of Myoga flower buds, which are traditional Japanese foods, and labdane-type diterpene galanal derived from Myoga flowers significantly suppressed IDO1 activity. The Lineweaver-Burk plot analysis indicated that galanal is a competitive inhibitor. Galanal attenuated L-kynurenine formation with an IC50 value of 7.7 mu M in the assay system using recombinant human IDO1, and an IC50 value of 45 nM in the cell-based assay. Further, mechanistic analysis revealed that galanal interfered with the transcriptional function of the nuclear factor-kappa B and the interferon-c signaling pathway. These effects of galanal are important for immune response. Because the inhibitory effect of galanal on IDO1 activity was stronger than that of 1-methyl tryptophan, a tryptophan analog, galanal may have great potential as the novel drug for various immune-related diseases.	[Yamamoto, Rie; Yamamoto, Yasuko; Matuo, Yushi; Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Yamamoto, Rie; Yamamoto, Yasuko; Matuo, Yushi; Saito, Kuniaki] Kyoto Univ, Fac Med, Kyoto, Japan; [Imai, Shinjiro] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Shizuoka 4228526, Japan; [Fukutomi, Ryuta] Nisshin Pharma Inc, Hlth Care Res Ctr, Chiyoda Ku, Tokyo, Japan; [Ozawa, Yoshio; Abe, Masako] Takasaki Univ Hlth & Welf, Takasaki, Gunma, Japan	Kyoto University; Kyoto University; University of Shizuoka	Yamamoto, Y (corresponding author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.	yamamoto-y@hs.med.kyoto-u.ac.jp						Abe M, 2002, BIOSCI BIOTECH BIOCH, V66, P2698, DOI 10.1271/bbb.66.2698; Abe M, 2008, BIOSCI BIOTECH BIOCH, V72, P2681, DOI 10.1271/bbb.80347; Banerjee T, 2008, ONCOGENE, V27, P2851, DOI 10.1038/sj.onc.1210939; Boasso A, 2009, AMINO ACIDS, V37, P89; Bridewell DJA, 2013, AUST J CHEM, V66, P40, DOI 10.1071/CH12393; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Cerejo M, 2012, J BIOMOL SCREEN, V17, P1362, DOI 10.1177/1087057112452595; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fujigaki H, 2006, J IMMUNOL, V176, P372, DOI 10.4049/jimmunol.176.1.372; Fujigaki H, 2006, J BIOCHEM, V139, P655, DOI 10.1093/jb/mvj072; Fujigaki S, 1998, ARCH BIOCHEM BIOPHYS, V358, P329, DOI 10.1006/abbi.1998.0861; Fujigaki S, 2001, EUR J IMMUNOL, V31, P2313, DOI 10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; Hoshi M, 2009, LEUKEMIA RES, V33, P39, DOI 10.1016/j.leukres.2008.05.023; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Huang Q, 2011, EUR J MED CHEM, V46, P5680, DOI 10.1016/j.ejmech.2011.08.044; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Jeong Y, 2007, LING AKT, V104, P1; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar S, 2008, J MED CHEM, V51, P7325, DOI 10.1021/jm8013053; Lancellotti S, 2011, CURR MED CHEM, V18, P2205, DOI 0929-8673/11 $58.00+.00; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Liu XD, 2009, STUD FUZZ SOFT COMP, V244, P3; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Matsuno K, 2010, BIOORG MED CHEM LETT, V20, P5126, DOI 10.1016/j.bmcl.2010.07.025; Meininger D, 2011, BBA-PROTEINS PROTEOM, V1814, P1947, DOI 10.1016/j.bbapap.2011.07.023; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Myint AM, 2012, J NEURAL TRANSM, V119, P245, DOI 10.1007/s00702-011-0741-3; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palafox D, 2010, TRANSPLANT REV-ORLAN, V24, P160, DOI 10.1016/j.trre.2010.04.003; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Prendergast GC, NOVEL ISOLATED INDOL; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; SAITO K, 1993, BIOCHEM J, V291, P11, DOI 10.1042/bj2910011; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Smith JR, 2012, BIOORGAN MED CHEM, V20, P1354, DOI 10.1016/j.bmc.2011.10.068; Soliman H, 2010, CANCER J, V16, P354, DOI 10.1097/PPO.0b013e3181eb3343; Sun T, 2010, MOL CELL BIOCHEM, V342, P29, DOI 10.1007/s11010-010-0465-y; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang DD, 2012, INT J ONCOL, V40, P929, DOI 10.3892/ijo.2011.1295; Yue EW, 2009, J MED CHEM, V52, P7364, DOI 10.1021/jm900518f	45	23	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88789	10.1371/journal.pone.0088789	http://dx.doi.org/10.1371/journal.pone.0088789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533148	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600106
J	Cardoso-Silva, CB; Costa, EA; Mancini, MC; Balsalobre, TWA; Canesin, LEC; Pinto, LR; Carneiro, MS; Garcia, AAF; de Souza, AP; Vicentini, R				Cardoso-Silva, Claudio Benicio; Costa, Estela Araujo; Mancini, Melina Cristina; Almeida Balsalobre, Thiago Willian; Costa Canesin, Lucas Eduardo; Pinto, Luciana Rossini; Carneiro, Monalisa Sampaio; Franco Garcia, Antonio Augusto; de Souza, Anete Pereira; Vicentini, Renato			De Novo Assembly and Transcriptome Analysis of Contrasting Sugarcane Varieties	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAG; LONG NONCODING RNAS; SNP DISCOVERY; FUNCTION ANNOTATION; RUST RESISTANCE; MATURING STEM; SEQ DATA; GENE; IDENTIFICATION; ORGANIZATION	Sugarcane is an important crop and a major source of sugar and alcohol. In this study, we performed de novo assembly and transcriptome annotation for six sugarcane genotypes involved in bi-parental crosses. The de novo assembly of the sugarcane transcriptome was performed using short reads generated using the Illumina RNA-Seq platform. We produced more than 400 million reads, which were assembled into 72,269 unigenes. Based on a similarity search, the unigenes showed significant similarity to more than 28,788 sorghum proteins, including a set of 5,272 unigenes that are not present in the public sugarcane EST databases; many of these unigenes are likely putative undescribed sugarcane genes. From this collection of unigenes, a large number of molecular markers were identified, including 5,106 simple sequence repeats (SSRs) and 708,125 single-nucleotide polymorphisms (SNPs). This new dataset will be a useful resource for future genetic and genomic studies in this species.	[Cardoso-Silva, Claudio Benicio; Costa, Estela Araujo; Mancini, Melina Cristina; Almeida Balsalobre, Thiago Willian; Costa Canesin, Lucas Eduardo; de Souza, Anete Pereira; Vicentini, Renato] Univ Campinas UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, Campinas, SP, Brazil; [Pinto, Luciana Rossini] Ctr Avancado Pesquisa Tecnol Agronegocio Cana IAC, Ribeirao Preto, SP, Brazil; [Carneiro, Monalisa Sampaio] Univ Fed Sao Carlos, Dept Biotecnol & Prod Vegetal & Anim, Ctr Ciencias Agr, Araras, SP, Brazil; [Franco Garcia, Antonio Augusto] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [de Souza, Anete Pereira] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Vicentini, R (corresponding author), Univ Campinas UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, Campinas, SP, Brazil.	shinapes@unicamp.br	Garcia, Antonio A F/A-4538-2010; Carneiro, Monalisa S/B-7920-2013; DE SOUZA, ANETE PEREIRA/B-8663-2012; Vicentini, Renato/C-5967-2012; Carneiro, Monalisa/AAD-8283-2021; Cardoso da Silva, Cláudio Benício/J-2326-2015; da Silva, Luciana Rossini Pinto Machado/AAT-6921-2021	Garcia, Antonio A F/0000-0003-0634-3277; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Carneiro, Monalisa/0000-0002-9835-7205; Cardoso da Silva, Cláudio Benício/0000-0002-4592-0113; da Silva, Luciana Rossini Pinto Machado/0000-0002-7369-7609; Almeida Balsalobre, Thiago Willian/0000-0002-7488-0536; Vicentini, Renato/0000-0002-0527-1083	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/52197-4, 2008/58031-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://www.fapesp.br) for the financial support grants 2008/52197-4 (AS) and 2008/58031-0 (RV) and for the graduate scholarships to CBCS, EAC, MCM, and TWB, and to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ, http://www.cnpq.br) for the research fellowships to AAG, APS, and RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bellodi N, 1995, COOPERATIVE PRODUTOR, P16; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; Bower NI, 2005, PLANT SCI, V168, P761, DOI 10.1016/j.plantsci.2004.10.006; Carson DL, 2002, PLANT CELL REP, V20, P1075, DOI 10.1007/s00299-002-0444-1; Carson DL, 2000, CROP SCI, V40, P1769, DOI 10.2135/cropsci2000.4061769x; Casu RE, 2004, PLANT MOL BIOL, V54, P503, DOI 10.1023/B:PLAN.0000038255.96128.41; Casu RE, 2003, PLANT MOL BIOL, V52, P371, DOI 10.1023/A:1023957214644; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Daugrois JH, 1996, THEOR APPL GENET, V92, P1059, DOI 10.1007/BF00224049; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Domingues DS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-137; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Garrison E, 2012, QUANT METHODS, P1; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRIVET L, 1994, HEREDITY, V73, P500, DOI 10.1038/hdy.1994.148; Guo XL, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks967; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Henry R, 2010, GENETICS GENOMICS BR, P300; Hoffmann H.P., 2008, CCA UFSCAR TECH B, V1, P30; HOGARTH DM, 1993, FIELD CROP RES, V34, P187, DOI 10.1016/0378-4290(93)90006-9; IRVINE JE, 1975, CROP SCI, V15, P671, DOI 10.2135/cropsci1975.0011183X001500050017x; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Kistner C, 2005, LOTUS JAPONICUS HANDBOOK, P123, DOI 10.1007/1-4020-3735-X_9; Landell M.G.A., 2005, IAC B TECNICO, P33; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Ma HM, 2004, THEOR APPL GENET, V108, P851, DOI 10.1007/s00122-003-1510-y; Mancini MC, 2012, SUGAR TECH, V14, P119, DOI 10.1007/s12355-012-0141-5; Marconi Thiago G, 2011, BMC Res Notes, V4, P264, DOI 10.1186/1756-0500-4-264; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; McCormick AJ, 2006, NEW PHYTOL, V171, P759, DOI 10.1111/j.1469-8137.2006.01785.x; Metzgar D, 2000, GENOME RES, V10, P72; Ming R, 1998, GENETICS, V150, P1663; Ministerio da Agricultura, 2013, AC SAFR BRAS CAN DE; Moore PH, 1996, INTENSIVE SUGARCANE, P544; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pinto LR, 2004, GENOME, V47, P795, DOI [10.1139/g04-055, 10.1139/G04-055]; Ramu P, 2009, THEOR APPL GENET, V119, P1193, DOI 10.1007/s00122-009-1120-4; Sabino J, 1997, COOPERATIVE PRODUTOR, V1; Sun J, 2013, FEBS LETT, V587, P976, DOI 10.1016/j.febslet.2013.02.036; TAI PYP, 1981, FIELD CROP RES, V4, P261, DOI 10.1016/0378-4290(81)90077-0; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; U.S. Department of Agriculture, 2013, SUG WORLD MARK TRAD; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Vettore AL, 2001, GENET MOL BIOL, V24, P1, DOI 10.1590/S1415-47572001000100002; Vicentini R, 2012, TROP PLANT BIOL, V5, P199, DOI 10.1007/s12042-012-9103-z; Vincentz M, 2004, PLANT PHYSIOL, V134, P951, DOI 10.1104/pp.103.033878; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4	69	83	86	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88462	10.1371/journal.pone.0088462	http://dx.doi.org/10.1371/journal.pone.0088462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523899	gold, Green Submitted, Green Published			2022-12-27	WOS:000331258100048
J	Jeong, YH; Kim, Y; Song, H; Chung, YS; Park, SB; Kim, HS				Jeong, Yeon-Hui; Kim, Yongju; Song, Heebum; Chung, Young Sun; Park, Seung Bum; Kim, Hee-Sun			Anti-Inflammatory Effects of alpha-Galactosylceramide Analogs in Activated Microglia: Involvement of the p38 MAPK Signaling Pathway	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELL-ACTIVATION; NF-KAPPA-B; NKT CELLS; SYSTEMIC INFLAMMATION; SPHINGOSINE BACKBONE; PROTEIN-KINASE; LIPOPOLYSACCHARIDE; NEURODEGENERATION; DISEASES	Microglial activation plays a pivotal role in the development and progression of neurodegenerative diseases. Thus, anti-inflammatory agents that control microglial activation can serve as potential therapeutic agents for neurodegenerative diseases. Here, we designed and synthesized alpha-galactosylceramide (alpha-GalCer) analogs to exert anti-inflammatory effects in activated microglia. We performed biological evaluations of 25 alpha-GalCer analogs and observed an interesting preliminary structure-activity relationship in their inhibitory influence on NO release and TNF-alpha production in LPS-stimulated BV2 microglial cells. After identification of 4d and 4e as hit compounds, we further investigated the underlying mechanism of their anti-inflammatory effects using RT-PCR analysis. We confirmed that 4d and 4e regulate the expression of iNOS, COX-2, IL-1 beta, and IL-6 at the mRNA level and the expression of TNF-alpha at the post-transcriptional level. In addition, both 4d and 4e inhibited LPS-induced DNA binding activities of NF-kappa B and AP-1 and phosphorylation of p38 MAPK without affecting other MAP kinases. When we examined the anti-inflammatory effect of a p38 MAPK-specific inhibitor, SB203580, on microglial activation, we observed an identical inhibitory pattern as that of 4d and 4e, not only on NO and TNF-alpha production but also on the DNA binding activities of NF-kB and AP-1. Taken together, these results suggest that p38 MAPK plays an important role in the anti-inflammatory effects of 4d and 4e via the modulation of NF-kappa B and AP-1 activities.	[Jeong, Yeon-Hui; Kim, Hee-Sun] Ewha Womans Univ, Sch Med, Dept Mol Med, Seoul, South Korea; [Jeong, Yeon-Hui; Kim, Hee-Sun] Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Global Res Program Top5, Seoul, South Korea; [Kim, Yongju; Song, Heebum; Park, Seung Bum] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Chung, Young Sun] Korea Soongsil Cyber Univ, Dept Counseling Psychol, Seoul, South Korea; [Park, Seung Bum] Seoul Natl Univ, Dept Biophys & Chem Biol, BioMAX Inst, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU)	Park, SB (corresponding author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.	sbpark@snu.ac.kr; hskimp@ewha.ac.kr	KIM, YONGJU/AAE-3387-2022; Park, Seung Bum/N-1901-2014	Park, Seung Bum/0000-0003-1753-1433; KIM, YONGJU/0000-0002-5862-5228	MRC [2012R1A5A2A32671866]; Basic Science Research Program [2010-0004008]; Bio & Medical Technology Development Program [2012M3A9C4048780]; Global Frontier Project Grant [2013M3A6A4044245]; Basic Research Laboratory [2010-0019766]; National Research Foundation of Korea	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Basic Science Research Program; Bio & Medical Technology Development Program; Global Frontier Project Grant; Basic Research Laboratory; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the MRC Grant (2012R1A5A2A32671866), and the Basic Science Research Program (2010-0004008) to HS Kim, and the Bio & Medical Technology Development Program (2012M3A9C4048780), a Global Frontier Project Grant (2013M3A6A4044245), and the Basic Research Laboratory (2010-0019766) to SB Park, funded by the National Research Foundation of Korea. YK and HS are grateful for a BK21 Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JL, 2001, PROGR MED CHEM, V38, P1, DOI 10.1016/S0079-6468(08)70091-2; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Bachstetter AD, 2010, AGING DIS, V1, P199; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bocchni V, 1992, J NEUROSCI RES, V6, P16; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Cuny GD, 2009, CURR PHARM DESIGN, V15, P3919, DOI 10.2174/138161209789649330; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Fujio M, 2006, J AM CHEM SOC, V128, P9022, DOI 10.1021/ja062740z; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hayakawa Y, 2003, P NATL ACAD SCI USA, V100, P9464, DOI 10.1073/pnas.1630663100; Hung LC, 2007, BIOCHEM PHARMACOL, V73, P1957, DOI 10.1016/j.bcp.2007.03.006; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; JOSEPH CK, 1994, J BIOL CHEM, V269, P17606; Jung JS, 2013, BBA-MOL CELL BIOL L, V1831, P1016, DOI 10.1016/j.bbalip.2013.01.020; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim Y, 2013, J MED CHEM, V56, P7100, DOI 10.1021/jm400949h; Kim Y, 2012, ACS MED CHEM LETT, V3, P151, DOI 10.1021/ml200278u; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee KM, 2012, BIOMOL THER, V20, P492, DOI 10.4062/biomolther.2012.20.5.492; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Nakagawa R, 2000, ONCOL RES, V12, P51, DOI 10.3727/096504001108747521; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Park JS, 2009, J NEUROIMMUNOL, V209, P40, DOI 10.1016/j.jneuroim.2009.01.020; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Van Kaer L, 2005, NAT REV IMMUNOL, V5, P31, DOI 10.1038/nri1531; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Woo MS, 2003, MOL BRAIN RES, V113, P86, DOI 10.1016/S0169-328X(03)00095-0; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	44	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e87030	10.1371/journal.pone.0087030	http://dx.doi.org/10.1371/journal.pone.0087030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523867	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100016
J	Wu, W; Zheng, LM; Chen, HY; Jia, DS; Li, F; Wei, TY				Wu, Wei; Zheng, Limin; Chen, Hongyan; Jia, Dongsheng; Li, Fan; Wei, Taiyun			Nonstructural Protein NS4 of Rice Stripe Virus Plays a Critical Role in Viral Spread in the Body of Vector Insects	PLOS ONE			English	Article							SMALL BROWN PLANTHOPPER; RNA INTERFERENCE; SUBCELLULAR-LOCALIZATION; NUCLEOTIDE-SEQUENCE; DWARF-VIRUS; TENUIVIRUS; REPLICATION; INFECTION; PROTOTYPE; SYSTEM	Rice stripe virus (RSV), a tenuivirus, is transmitted by small brown planthopper (SBPH) in a persistent-propagative manner. In this study, sequential infection of RSV in the internal organs of SBPH after ingestion of virus indicated that RSV initially infected the midgut epithelium, and then progressed to the visceral muscle tissues, through which RSV spread to the entire alimentary canal. Finally, RSV spread into the salivary glands and reproductive system. During viral infection, the nonstructural protein NS4 of RSV formed cytoplasmic inclusions in various tissues of viruliferous SBPH. We demonstrated that the ribonucleoprotein particles of RSV were closely associated with NS4-specific inclusions in the body of viruliferous SBPH through a direct interaction between NS4 and nucleoprotein of RSV. Moreover, the knockdown of NS4 expression due to RNA interference induced by dsRNA from NS4 gene significantly prevented the spread of RSV in the bodies of SBPHs without a significant effect on viral replication in continuous cell culture derived from SBPH. All these results suggest that the nonstructural protein NS4 of RSV plays a critical role in viral spread by the vector insects.	[Wu, Wei; Zheng, Limin; Chen, Hongyan; Jia, Dongsheng; Wei, Taiyun] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Plant Virol, Inst Plant Virol, Fuzhou, Fujian, Peoples R China; [Wu, Wei; Li, Fan] Yunnan Agr Univ, Key Lab Agr Biodivers Pest Management, Chinas Minist Educ, Kunming, Yunnan, Peoples R China	Fujian Agriculture & Forestry University; Yunnan Agricultural University	Li, F (corresponding author), Yunnan Agr Univ, Key Lab Agr Biodivers Pest Management, Chinas Minist Educ, Kunming, Yunnan, Peoples R China.	fanlikm@126.com; weitaiyun@fjau.edu.cn	zheng, limin/HGB-2510-2022		National Basic Research Program of China [2014CB138400]; Specialized Research Fund for the Ministry of Agriculture [201003031, 201303021]; National 863 Program of China [2012AA101505]; National Natural Science Foundation of China [31130044, 31200118, 31171821]; Natural Science Foundation of Fujian Province [2012J01087]	National Basic Research Program of China(National Basic Research Program of China); Specialized Research Fund for the Ministry of Agriculture; National 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by grants from the programs for the National Basic Research Program of China (2014CB138400), the Specialized Research Fund for the Ministry of Agriculture (201003031, 201303021), the National 863 Program of China (2012AA101505), the National Natural Science Foundation of China (31130044, 31200118, 31171821), and the Natural Science Foundation of Fujian Province (2012J01087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar ED, 2009, ANNU REV ENTOMOL, V54, P447, DOI 10.1146/annurev.ento.54.110807.090454; Chen HY, 2011, VIRUS RES, V160, P389, DOI 10.1016/j.virusres.2011.04.028; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chen Q, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003032; Deng JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-310; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jia DS, 2012, J GEN VIROL, V93, P2299, DOI 10.1099/vir.0.042424-0; Jia DS, 2012, J VIROL, V86, P5800, DOI 10.1128/JVI.07121-11; KAKUTANI T, 1990, J GEN VIROL, V71, P1427, DOI 10.1099/0022-1317-71-7-1427; KAKUTANI T, 1991, J GEN VIROL, V72, P465, DOI 10.1099/0022-1317-72-2-465; Li S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026585; Liang DL, 2005, VIRUS GENES, V31, P211, DOI 10.1007/s11262-005-1798-6; Lin Hanxin, 1999, Virologica Sinica, V14, P343; Ma YY, 2013, J GEN VIROL, V94, P1421, DOI 10.1099/vir.0.050104-0; Rocha JJE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019087; Shimizu T, 2011, PLANT BIOTECHNOL J, V9, P503, DOI 10.1111/j.1467-7652.2010.00571.x; Suzuki Yoshihiko, 1992, Annals of the Phytopathological Society of Japan, V58, P480, DOI 10.3186/jjphytopath.58.480; TAKAHASHI M, 1993, J GEN VIROL, V74, P769, DOI 10.1099/0022-1317-74-4-769; TAKAHASHI Y, 1991, PLANT DIS, V75, P458, DOI 10.1094/PD-75-0458; TORIYAMA S, 1994, J GEN VIROL, V75, P3569, DOI 10.1099/0022-1317-75-12-3569; TORIYAMA S, 1986, MICROBIOL SCI, V3, P347; Tsai JH, 1996, FLA ENTOMOL, V79, P563, DOI 10.2307/3496069; Wei TY, 2009, J GEN VIROL, V90, P1025, DOI 10.1099/vir.0.006858-0; Wei TY, 2006, J VIROL, V80, P8593, DOI 10.1128/JVI.00537-06; Wu AZ, 2001, CHINESE SCI BULL, V46, P1819, DOI 10.1007/BF02900559; Xiong RY, 2008, J VIROL, V82, P12304, DOI 10.1128/JVI.01696-08; Xiong RY, 2009, VIROLOGY, V387, P29, DOI 10.1016/j.virol.2009.01.045; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046238; Yao M, 2012, J GEN VIROL, V93, P194, DOI 10.1099/vir.0.033902-0; Yuan ZJ, 2011, VIRUS RES, V159, P62, DOI 10.1016/j.virusres.2011.04.023; Zhang KaiYu, 2008, Scientia Agricultura Sinica, V41, P4063	35	32	36	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88636	10.1371/journal.pone.0088636	http://dx.doi.org/10.1371/journal.pone.0088636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523924	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100073
J	Harper, DM; Irons, BB; Alexander, NM; Comes, JC; Smith, MS; Heutinck, MA; Handley, SM; Ahern, DA				Harper, Diane M.; Irons, Billy B.; Alexander, Natalie M.; Comes, Johanna C.; Smith, Melissa S.; Heutinck, Melinda A.; Handley, Sandra M.; Ahern, Debra A.			Quantifying the Decisional Satisfaction to Accept or Reject the Human Papillomavirus (HPV) Vaccine: A Preference for Cervical Cancer Prevention	PLOS ONE			English	Article							INFECTION; VALIDATION; DECADE; RISK	Objective: Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination. Study Design: This is a prospective survey conducted at an urban college where women 18-26 years old completed a decisional satisfaction survey about their HPV vaccine experience. Results: Regardless of the decision to accept or reject HPV vaccination, the decisional satisfaction was very high (mean 5-item score = 21.2 (SD 3.8)). Women without HPV vaccination were decisionally neutral significantly more often than those already vaccinated; 22% were decisionally neutral for the option to accept HPV vaccination at that visit. Cervical cancer prevention was preferred significantly more often than genital wart prevention in all analyses. Conclusions: Targeting those who are decisionally neutral about HPV vaccination may result in a higher uptake of HPV vaccination.	[Harper, Diane M.; Irons, Billy B.; Alexander, Natalie M.; Ahern, Debra A.] Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64108 USA; [Harper, Diane M.] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA; [Harper, Diane M.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Alexander, Natalie M.] Kansas City Univ Med & Biosci, Dept Family Med, Kansas City, MO USA; [Harper, Diane M.; Irons, Billy B.; Comes, Johanna C.; Smith, Melissa S.; Heutinck, Melinda A.; Handley, Sandra M.; Ahern, Debra A.] Univ Missouri, Student Hlth & Wellness, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Kansas City University of Medicine & Biosciences; University of Missouri System; University of Missouri Kansas City	Harper, DM (corresponding author), Univ Missouri, Sch Med, Dept Community & Family Med, Kansas City, MO 64108 USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				Bogaards JA, 2011, LANCET INFECT DIS, V11, P896, DOI 10.1016/S1473-3099(11)70324-3; Boone T.L., 2004, J PSYCHOL HUM SEX, V16, P51, DOI [10.1300/J056v16n01_04, DOI 10.1300/J056V16N01_04]; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; BRINTON LA, 1987, J NATL CANCER I, V79, P23; Cohen MJ, 2013, MED DECIS MAKING, V33, P1026, DOI 10.1177/0272989X13487946; Collins SI, 2005, INT J CANCER, V114, P498, DOI 10.1002/ijc.20732; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Hall J, 2002, HEALTH ECON, V11, P457, DOI 10.1002/hec.694; Harper DM, 2010, DISCOV MED, V10, P7; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114; Hopfer S, 2011, QUAL HEALTH RES, V21, P262, DOI 10.1177/1049732310383868; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; LEY C, 1991, JNCI-J NATL CANCER I, V83, P997, DOI 10.1093/jnci/83.14.997; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Oteng B, 2011, SEX TRANSM INFECT, V87, P52, DOI 10.1136/sti.2009.041392; Sadique MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054149; Sim JA, 2011, PUBLIC HEALTH, V125, P505, DOI 10.1016/j.puhe.2011.05.005; StatSoft Inc, 2010, STATISTICA DAT AN SO; Steinberg L, 2009, AM PSYCHOL, V64, P583, DOI 10.1037/a0014763; Stokley S, 2013, MMWR-MORBID MORTAL W, V62, P591; Sturm LA, 2005, J DEV BEHAV PEDIATR, V26, P441, DOI 10.1097/00004703-200512000-00009; Trottier H, 2006, AM J MANAG CARE, V12, pS462; Williams WW, 2013, MMWR-MORBID MORTAL W, V62, P66	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88493	10.1371/journal.pone.0088493	http://dx.doi.org/10.1371/journal.pone.0088493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551110	Green Submitted, gold, Green Published			2022-12-27	WOS:000331271500042
J	Mason, JM; Thomas, KS; Crook, AM; Foster, KA; Chalmers, JR; Nunn, AJ; Williams, HC				Mason, James M.; Thomas, Kim S.; Crook, Angela M.; Foster, Katharine A.; Chalmers, Joanne R.; Nunn, Andrew J.; Williams, Hywel C.			Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials	PLOS ONE			English	Article							LOWER-LIMB CELLULITIS; RECURRENT ERYSIPELAS; PENICILLIN	Background: Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. We assessed the cost-effectiveness of prophylactic antibiotic treatment to prevent the recurrence of cellulitis using low dose penicillin V in patients following a first episode (6 months prophylaxis) and more recurrent cellulitis (12 months prophylaxis, or 6 months in those declining 12 months). Methods: Within-trial cost-effectiveness analysis was conducted using the findings of two randomised placebo-controlled multicentre trials (PATCH I and PATCH II), in which patients recruited in the UK and Ireland were followed-up for up to 3 years. Incremental cost, reduction in recurrence, cost per recurrence prevented and cost/QALY were estimated. National unit and reference costs for England in 2010 were applied to resource use, exploring NHS and societal perspectives. A total of 397 patients from the two trials contributed to the analysis. Results: There was a 29% reduction in the number of recurrences occurring within the trial (IRR: 0.71 95%CI: 0.53 to 0.90, p = 0.02), corresponding to an absolute reduction of recurrence of 0.31 recurrences/patient (95%CI: 0.05 to 0.59, p = 0.02). Incremental costs of prophylaxis suggested a small cost saving but were not statistically significant, comparing the two groups. If a decision-maker is willing to pay up to 25,000 pound/QALY then there is a 66% probability of antibiotic prophylaxis being cost-effective from an NHS perspective, rising to 76% probability from a secondary, societal perspective. Conclusion: Following first episode or recurrent cellulitis of the leg, prophylactic low dose penicillin is a very low cost intervention which, on balance, is effective and cost-effective at preventing subsequent attacks. Antibiotic prophylaxis reduces cellulitis recurrence by nearly a third but is not associated with a significant increase in costs.	[Mason, James M.] Univ Durham, Durham Clin Trials Unit, Stockton On Tees, England; [Thomas, Kim S.; Foster, Katharine A.; Chalmers, Joanne R.; Williams, Hywel C.] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England; [Crook, Angela M.; Nunn, Andrew J.] MRC, Clin Trials Unit, London, England	Durham University; University of Nottingham; Medical Research Council Clinical Trials Unit	Mason, JM (corresponding author), Univ Durham, Durham Clin Trials Unit, Queens Campus, Stockton On Tees, England.	j.m.mason@durham.ac.uk	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; williams, hywel/0000-0002-5646-3093; Nunn, Andrew/0000-0002-9158-4595; Chalmers, Joanne/0000-0002-2281-7367; Thomas, Kim/0000-0001-7785-7465	Action Medical Research; Bupa Foundation; National Institute for Health Research [NF-SI-0611-10246] Funding Source: researchfish; Alzheimer&quot;s Society [1651] Funding Source: researchfish	Action Medical Research; Bupa Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); Alzheimer&quot;s Society	PATCH I was funded by Action Medical Research; PATCH II was funded by the Bupa Foundation. Neither funder had any role in the study design; data collection, analysis, and interpretation of data; in the writing of this report; or in the decision to submit the article for publication.	[Anonymous], 2008, UPD GUID METH TECHN; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; BERNARD P, 1989, ARCH DERMATOL, V125, P779, DOI 10.1001/archderm.125.6.779; British Medical Association Royal Pharmaceutical Society of Great Britain, 2010, BRIT NATL FORMULARY; CHAKROUN M, 1994, MED MALADIES INFECT, V24, P894, DOI 10.1016/S0399-077X(05)80579-7; Cox NH, 2006, BRIT J DERMATOL, V155, P947, DOI 10.1111/j.1365-2133.2006.07419.x; Cox NH, 1998, J ROY SOC MED, V91, P634, DOI 10.1177/014107689809101206; CREST, 2005, GUID MAN CELL AD; Curtis L., 2012, UNIT COSTS HLTH SOCI; Department of Health, 2012, NHS HOSP TRUST REF C; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Goettsch WG, 2006, J EUR ACAD DERMATOL, V20, P834, DOI 10.1111/j.1468-3083.2006.01657.x; Hospital Episode Statistics, 2011, HESONLINE INP DAT PR; Jeng A, 2010, MEDICINE, V89, P217, DOI 10.1097/MD.0b013e3181e8d635; JORUPRONSTROM C, 1987, INFECTION, V15, P105, DOI 10.1007/BF01650206; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; KREMER M, 1991, J INFECTION, V22, P37, DOI 10.1016/0163-4453(91)90898-3; Levell NJ, 2011, BRIT J DERMATOL, V164, P1326, DOI 10.1111/j.1365-2133.2011.10275.x; NHS Information Centre, 2012, HRG4 2010 11 REF COS; Office of National Statistics, 2011, ANN SURV HOURS EARN; SJOBLOM AC, 1993, INFECTION, V21, P390, DOI 10.1007/BF01728920; Soo JK, 2008, BRIT J DERMATOL, V158, P1350, DOI 10.1111/j.1365-2133.2007.08423.x; Thomas KS, 2013, NEW ENGL J MED, V368, P1695, DOI 10.1056/NEJMoa1206300	24	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e82694	10.1371/journal.pone.0082694	http://dx.doi.org/10.1371/journal.pone.0082694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551029	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000331271500002
J	Glynn, P; Onal, B; Hund, TJ				Glynn, Patric; Onal, Birce; Hund, Thomas J.			Cycle Length Restitution in Sinoatrial Node Cells: A Theory for Understanding Spontaneous Action Potential Dynamics	PLOS ONE			English	Article							MATHEMATICAL-MODEL; ELECTRICAL ALTERNANS; HEART-FAILURE; FUNNY CURRENT; DYSFUNCTION; PACEMAKING; INSIGHTS; CA2+; MECHANISM; CURRENTS	Normal heart rhythm (sinus rhythm) is governed by the sinoatrial node, a specialized and highly heterogeneous collection of spontaneously active myocytes in the right atrium. Sinoatrial node dysfunction, characterized by slow and/or asynchronous pacemaker activity and even failure, is associated with cardiovascular disease (e.g. heart failure, atrial fibrillation). While tremendous progress has been made in understanding the molecular and ionic basis of automaticity in sinoatrial node cells, the dynamics governing sinoatrial nodel cell synchrony and overall pacemaker function remain unclear. Here, a well-validated computational model of the mouse sinoatrial node cell is used to test the hypothesis that sinoatrial node cell dynamics reflect an inherent restitution property (cycle length restitution) that may give rise to a wide range of behavior from regular periodicity to highly complex, irregular activation. Computer simulations are performed to determine the cycle length restitution curve in the computational model using a newly defined voltage pulse protocol. The ability of the restitution curve to predict sinoatrial node cell dynamics (e.g., the emergence of irregular spontaneous activity) and susceptibility to termination is evaluated. Finally, ionic and tissue level factors (e.g. ion channel conductances, ion concentrations, cell-to-cell coupling) that influence restitution and sinoatrial node cell dynamics are explored. Together, these findings suggest that cycle length restitution may be a useful tool for analyzing cell dynamics and dysfunction in the sinoatrial node.	[Glynn, Patric; Onal, Birce; Hund, Thomas J.] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Glynn, Patric; Onal, Birce; Hund, Thomas J.] Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [Hund, Thomas J.] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hund, TJ (corresponding author), Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	Thomas.Hund@osumc.edu			National Institutes of Health (NIH) [HL 096805, HL114893]; James S. McDonnell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114893, R00HL096805] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) [grant numbers HL 096805, HL114893 to TJH] and the James S. McDonnell Foundation [to TJH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhein S, 2010, N-S ARCH PHARMACOL, V381, P221, DOI 10.1007/s00210-009-0473-1; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; GUEVARA MR, 1992, AM J PHYSIOL, V262, pH1268, DOI 10.1152/ajpheart.1992.262.4.H1268; Hund TJ, 2000, BIOPHYS J, V79, P3095, DOI 10.1016/S0006-3495(00)76544-1; Hund TJ, 2001, BIOPHYS J, V81, P3324, DOI 10.1016/S0006-3495(01)75965-6; Kharche S, 2011, AM J PHYSIOL-HEART C, V301, pH945, DOI 10.1152/ajpheart.00143.2010; Kjolbye AL, 2007, BASIC CLIN PHARMACOL, V101, P215, DOI 10.1111/j.1742-7843.2007.00123.x; Koval OM, 2012, CIRCULATION, V126, P2084, DOI 10.1161/CIRCULATIONAHA.112.105320; Kurata Y, 2003, AM J PHYSIOL-HEART C, V285, pH2804, DOI 10.1152/ajpheart.01050.2002; Kurata Y, 2002, AM J PHYSIOL-HEART C, V283, pH2074, DOI 10.1152/ajpheart.00900.2001; Kurata Y, 2012, AM J PHYSIOL-HEART C, V302, pH2285, DOI 10.1152/ajpheart.00221.2011; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lakatta EG, 2009, J MOL CELL CARDIOL, V47, P157, DOI 10.1016/j.yjmcc.2009.03.022; Lamas GA, 2000, AM HEART J, V140, P541, DOI 10.1067/mhj.2000.109652; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; MICHAELS DC, 1989, CIRC RES, V65, P1350, DOI 10.1161/01.RES.65.5.1350; NOLASCO JB, 1968, J APPL PHYSIOL, V25, P191, DOI 10.1152/jappl.1968.25.2.191; NOMA A, 1974, JPN J PHYSIOL, V24, P617; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; Sanders P, 2004, CIRCULATION, V110, P897, DOI 10.1161/01.CIR.0000139336.69955.AB; SAXON LA, 1993, AM HEART J, V125, P1306, DOI 10.1016/0002-8703(93)90999-P; SENAMI M, 1981, JPN J PHYSIOL, V31, P225; SMITH JM, 1988, CIRCULATION, V77, P110, DOI 10.1161/01.CIR.77.1.110; Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833; Weiss JN, 2011, CIRC RES, V108, P98, DOI 10.1161/CIRCRESAHA.110.223586; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Wolf RM, 2013, AM J PHYSIOL-HEART C, V304, pH1253, DOI 10.1152/ajpheart.00734.2012; Wolf RM, 2010, AM J PHYSIOL-HEART C, V299, pH1505, DOI 10.1152/ajpheart.00503.2010	31	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89049	10.1371/journal.pone.0089049	http://dx.doi.org/10.1371/journal.pone.0089049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533169	gold, Green Submitted, Green Published			2022-12-27	WOS:000331262600131
J	Islam, M; Sharma, S; Teknos, TN				Islam, Mozaffarul; Sharma, Smita; Teknos, Theodoros N.			RhoC Regulates Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma by Overexpressing IL-6 and Phosphorylation of STAT3	PLOS ONE			English	Article							NF-KAPPA-B; DISTANT METASTASES; LUNG-CANCER; EXPRESSION; NANOG; IDENTIFICATION; ACTIVATION; GTPASE; MARKER; RESISTANCE	In this study we investigated the correlation between RhoC expression and cancer stem cells (CSCs) formation in head and neck squamous cell carcinoma (HNSCC). The inhibition of RhoC function was achieved using shRNA. The expression of stem cell surface markers, ALDH and CD44 were significantly low in two RhoC depleted HNSCC cell carcinoma cell lines. Furthermore, a striking reduction in tumorsphere formation was achieved in RhoC knockdown lines. The mRNA expression of RhoC in RhoC knockdown adherent and tumorspheres are dramatically down regulated as compared with the scrambled control. The mRNA expression of stem cell transcription factors; nanog, oct3/4 (Pouf1), and sox2 were significantly depleted in RhoC knockdown clones. Further, the phosphorylation of STAT3(ser727), and STAT3(tyr705) were significantly down regulated in RhoC knockdown clones. The overexpression of STAT3 in RhoC knockdown did not show any change in expression patterns of either-STAT3(tyr705) or stem cell transcription factors, signifying the role of RhoC in STAT3 activation and thus the expression of nanog, oct3/4 and sox2 in HNSCC. The expression of Inter leukin-6 (IL-6) in RhoC knockdown HNSCC cell lines was dramatically low as compared to the scrambled control. Further, we have shown a rescue in STAT3 phosphorylation by IL-6 stimulation in RhoC knockdown lines. This study is the first of its kind to establish the involvement of RhoC in STAT3 phosphorylation and hence in promoting the activation of core cancer stem cells (CSCs) transcription factors. These findings suggest that RhoC may be a novel target for HNSCC therapy.	[Islam, Mozaffarul; Teknos, Theodoros N.] Ohio State Univ, Wexner Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Islam, Mozaffarul; Sharma, Smita; Teknos, Theodoros N.] Ohio State Univ, Ctr Comprehens Canc, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Islam, M (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA.	Mozaffarul.Islam@osumc.edu			The Ohio State University Comprehensive Cancer Center; Slomin Family Foundation (Florida, USA); NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	The Ohio State University Comprehensive Cancer Center; Slomin Family Foundation (Florida, USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by The Ohio State University Comprehensive Cancer Center and the Slomin Family Foundation (Florida, USA) to Ted Teknos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS American Cancer Society, 2013, CANC FACTS FIG, P1; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; BJORDAL K, 1995, BRIT J CANCER, V71, P592, DOI 10.1038/bjc.1995.115; Brown ML, 2002, MED CARE, V40, P104; Buhard O, 2012, CELL MOL LIFE SCI; CAREY TE, 1983, OTOLARYNG HEAD NECK, V91, P482, DOI 10.1177/019459988309100503; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen YW, 2010, MOL CANCER THER, V9, P2879, DOI 10.1158/1535-7163.MCT-10-0504; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Davis SJ, 2010, ARCH OTOLARYNGOL, V136, P1260, DOI 10.1001/archoto.2010.219; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta M, 2012, LEUKEMIA, V26, P1356, DOI 10.1038/leu.2011.340; Gupta M, 2012, CANC RES S1, V72; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hassan KA, 2013, CLIN CANC RES; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Islam M, 2013, ORAL ONCOL, V49, P778, DOI 10.1016/j.oraloncology.2013.04.003; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kleer CG, 2006, CLIN CANCER RES, V12, P4485, DOI 10.1158/1078-0432.CCR-06-0376; KRAUSE CJ, 1981, ARCH OTOLARYNGOL, V107, P703; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liu CA, 2004, ONCOGENE, V23, P8731, DOI 10.1038/sj.onc.1208106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043664; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Mannelli G, 2012, CANCER TREAT REV, V38, P515, DOI 10.1016/j.ctrv.2011.11.007; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Rosenthal DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040979; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schmalbach CE, 2004, ARCH OTOLARYNGOL, V130, P295, DOI 10.1001/archotol.130.3.295; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Takeda T, 1998, J ENDOCRINOL, V159, P323, DOI 10.1677/joe.0.1590323; Takes RP, 2012, ORAL ONCOL, V48, P775, DOI 10.1016/j.oraloncology.2012.03.013; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; van Golen KL, 2000, CANCER RES, V60, P5832; van Golen KL, 2000, NEOPLASIA, V2, P418, DOI 10.1038/sj.neo.7900115; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yi JS, 2012, J SURG ONCOL, V106, P708, DOI 10.1002/jso.23185	48	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88527	10.1371/journal.pone.0088527	http://dx.doi.org/10.1371/journal.pone.0088527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533098	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600056
J	Joshy, G; Korda, RJ; Bauman, A; Van Der Ploeg, HP; Chey, T; Banks, E				Joshy, Grace; Korda, Rosemary J.; Bauman, Adrian; Van Der Ploeg, Hidde P.; Chey, Tien; Banks, Emily			Investigation of Methodological Factors Potentially Underlying the Apparently Paradoxical Findings on Body Mass Index and All-Cause Mortality	PLOS ONE			English	Article							REVERSE CAUSALITY; OBESITY; OVERWEIGHT; ASSOCIATION; WEIGHT; COHORT; VARIABLES; DISEASE; HEIGHT; RISK	Introduction: Findings regarding the association between overweight and all-cause mortality range from significantly lower to higher risk, compared with body-mass-index (BMI) within the "normal'' range. Methods: We examined empirically potential methodological explanations for these apparently conflicting results using questionnaire and linked mortality data from 246,314 individuals aged >= 45 years in the Australian 45 and Up Study (11,127 deaths; median follow-up 3.9 years). Hazard ratios (HR) for all-cause mortality associated with BMI were modelled according to different methods of accounting for illness at baseline, finer versus broader gradations of BMI and choice of reference group, adjusting for potential confounders. Results: In analyses using the broad World Health Organization (WHO) categories, the all-cause mortality HR was significantly lower in the overweight category (25.0-29.99 kg/m(2)), than the normal weight (18.5-24.99 kg/m(2)) category. However, in analyses accounting for baseline illness, which excluded those with pre-existing illness at baseline, ever-smokers and the first 2 years of follow up, absolute age-standardised mortality rates varied up to two-fold between finer BMI categories within the WHO normal weight category; rates were lowest at 22.5-24.99 kg/m(2) and mortality HRs increased steadily for BMI above (p(trend) <0.02) and below (p(trend) < 0.003) this reference category. Hence, the breadth of the BMI categories used and whether or not baseline illness is accounted for explain the apparent discrepancies between reported BMI-mortality associations. Conclusion: Using fine BMI categories and the category with the lowest absolute rates as the reference group and accounting for the potential confounding effects of baseline illness is likely to yield the most reliable risk estimates for establishing the independent relationship of BMI to all-cause mortality. These results and those of other studies indicate that a BMI of 22.5-24.99 kg/m(2), not the broad "overweight'' category of 25-29.99 kg/m(2), was associated with the most favourable mortality risk.	[Joshy, Grace; Korda, Rosemary J.; Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Korda, Rosemary J.] Australian Natl Univ, Australian Ctr Econ Res Hlth, Canberra, ACT, Australia; [Bauman, Adrian; Van Der Ploeg, Hidde P.; Chey, Tien] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Van Der Ploeg, Hidde P.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Banks, Emily] Sax Inst, Sydney, NSW, Australia	Australian National University; Australian National University; University of Sydney; Vrije Universiteit Amsterdam; University of Sydney	Joshy, G (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	grace.joshy@anu.edu.au	van der Ploeg, Hidde/ABD-6402-2021; van der Ploeg, Hidde P/B-2599-2013	van der Ploeg, Hidde P/0000-0002-3719-5249; Korda, Rosemary/0000-0002-9390-2171; Joshy, Grace/0000-0002-0718-6368; Banks, Emily/0000-0002-4617-1302	Australian National Health; Medical Research Council (NHMRC) [585402]; NHMRC	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This specific project was supported by Australian National Health and Medical Research Council (NHMRC) Project Grant number 585402. Emily Banks is supported by the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; [Anonymous], 2011, SAS VERS 9 3 COMP PR; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Canchola AJ, 2003, COX REGRESSION USING; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Chalise P, 2010, TIME SCALES COX MODE; CONNOR RJ, 1972, J AM STAT ASSOC, V67, P601, DOI 10.2307/2284446; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Fay MP, 1997, STAT MED, V16, P791; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flanders WD, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.84; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Froslie KF, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-103; Gill TP, 1997, BRIT MED BULL, V53, P359, DOI 10.1093/oxfordjournals.bmb.a011618; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Harrell FE, 2001, REGRESSION MODELING; Heymsfield SB, 2013, JAMA-J AM MED ASSOC, V309, P87, DOI 10.1001/jama.2012.185445; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Obesity Task Force, 2013, GLOB PREV AD OB; LAGAKOS SW, 1988, STAT MED, V7, P257, DOI 10.1002/sim.4780070126; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mestel R, 2013, LOS ANGELES TIMES; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reuters, 2009, FEW EXTR POUNDS CAN; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Tobias DK, 2013, OBESITY, V21, P1746, DOI 10.1002/oby.20602; Turner Elizabeth L, 2010, Epidemiol Perspect Innov, V7, P9, DOI 10.1186/1742-5573-7-9; Vittinghoff E, 2012, REGRESSION METHODS B; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; World Health Organization, 1999, OB PREV MAN GLOB EP	41	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88641	10.1371/journal.pone.0088641	http://dx.doi.org/10.1371/journal.pone.0088641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533128	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600086
J	Quattrociocchi, W; Caldarelli, G; Scala, A				Quattrociocchi, Walter; Caldarelli, Guido; Scala, Antonio			Self-Healing Networks: Redundancy and Structure	PLOS ONE			English	Article								We introduce the concept of self-healing in the field of complex networks modelling; in particular, self-healing capabilities are implemented through distributed communication protocols that exploit redundant links to recover the connectivity of the system. We then analyze the effect of the level of redundancy on the resilience to multiple failures; in particular, we measure the fraction of nodes still served for increasing levels of network damages. Finally, we study the effects of redundancy under different connectivity patterns-from planar grids, to small-world, up to scale-free networks-on healing performances. Small-world topologies show that introducing some long-range connections in planar grids greatly enhances the resilience to multiple failures with performances comparable to the case of the most resilient (and least realistic) scale-free structures. Obvious applications of self-healing are in the important field of infrastructural networks like gas, power, water, oil distribution systems.	[Quattrociocchi, Walter] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Quattrociocchi, Walter; Caldarelli, Guido; Scala, Antonio] LIMS, London, England; [Quattrociocchi, Walter; Caldarelli, Guido; Scala, Antonio] IMT Alti Studi Lucca, Lucca, Italy; [Caldarelli, Guido; Scala, Antonio] CNR Uos Sapienza, ISC, Rome, Italy	Northeastern University; IMT School for Advanced Studies Lucca; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Scala, A (corresponding author), LIMS, London, England.	antonio.scala@cnr.it	Scala, Antonio/H-9153-2019; Caldarelli, Guido/AAB-8206-2022; Scala, Antonio/A-2098-2012; Scala, Antonio/GRS-5823-2022; Quattrociocchi, Walter/L-4550-2016; Caldarelli, Guido/A-5274-2010	Scala, Antonio/0000-0002-3414-2686; Scala, Antonio/0000-0002-3414-2686; Quattrociocchi, Walter/0000-0002-4374-9324; Caldarelli, Guido/0000-0001-9377-3616	London Institute of Mathematical Sciences; CNR-ISC, US [HDTRA1-11-1-0048]; CNR-PNR National Project "Crisis-Lab"; EU FET project MULTIPLEX [317532]; IMT Lucca Institute for Advanced Studies	London Institute of Mathematical Sciences; CNR-ISC, US; CNR-PNR National Project "Crisis-Lab"; EU FET project MULTIPLEX; IMT Lucca Institute for Advanced Studies	Funding for this work was provided by the authors' institutions (London Institute of Mathematical Sciences, IMT Lucca Institute for Advanced Studies, CNR-ISC), US grant HDTRA1-11-1-0048, CNR-PNR National Project "Crisis-Lab,'' and EU FET project MULTIPLEX nr.317532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Aoki T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.208702; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B., 2003, INTERNET MATH, V1, P1, DOI [DOI 10.1080/15427951.2004.10129080, 10.1080/15427951.2004.10129080]; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Caldarelli G, 2007, SCALE FREE NETWORKS; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; D'Agostino G, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/68006; Das Sarma A, 2012, IEEE CONF COMPUT, P226, DOI 10.1109/INFCOMW.2012.6193496; ENEL, 2011, COMMUNICATION; Flocchini P, 2008, J PARALLEL DISTR COM, V68, P976, DOI 10.1016/j.jpdc.2008.03.002; Flocchini P, 2012, IEEE T COMPUT, V61, P408, DOI 10.1109/TC.2010.228; Katifori E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048704; KAWAMURA R, 1994, IEEE J SEL AREA COMM, V12, P120, DOI 10.1109/49.265711; Li HT, 2010, ELECTRON J QUAL THEO, P1, DOI 10.1080/09575146.2010.515944; Murakami K, 1998, IEEE ACM T NETWORK, V6, P207, DOI 10.1109/90.664269; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Pandurangan G, 2011, PODC 11: PROCEEDINGS OF THE 2011 ACM SYMPOSIUM PRINCIPLES OF DISTRIBUTED COMPUTING, P301; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Ramchurn SD, 2012, COMMUN ACM, V55, P86, DOI 10.1145/2133806.2133825; Santoro N., 2006, DESIGN ANAL DISTRIBU, V56; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Sudhakar TD, 2011, EUR T ELECTR POWER, V21, P635, DOI 10.1002/etep.467; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; Velazquez E., 2010, Proceedings of the 2010 Sixth International Conference on Mobile Ad-hoc and Sensor Networks (MSN 2010), P161, DOI 10.1109/MSN.2010.31; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Wilson D. B., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P296, DOI 10.1145/237814.237880; Yazdani A, 2011, CHAOS, V21, DOI 10.1063/1.3540339; Yuan WJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022818	34	62	63	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87986	10.1371/journal.pone.0087986	http://dx.doi.org/10.1371/journal.pone.0087986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533065	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000331262600023
J	Yu, HX; Ji, R; Ye, WF; Chen, HD; Lai, WX; Fu, Q; Lou, YG				Yu, Haixin; Ji, Rui; Ye, Wenfeng; Chen, Hongdan; Lai, Wenxiang; Fu, Qiang; Lou, Yonggen			Transcriptome Analysis of Fat Bodies from Two Brown Planthopper (Nilaparvata lugens) Populations with Different Virulence Levels in Rice	PLOS ONE			English	Article							HOST-PLANT RESISTANCE; YEAST-LIKE SYMBIOTES; AMINO-ACID; LAODELPHAX-STRIATELLUS; INSECTICIDE RESISTANCE; BODY TRANSCRIPTOME; IDENTIFICATION; QUANTIFICATION; DELPHACIDAE; METABOLISM	Background: The brown planthopper (BPH), Nilaparvata lugens (Stal), one of the most serious rice insect pests in Asia, can quickly overcome rice resistance by evolving new virulent populations. The insect fat body plays essential roles in the life cycles of insects and in plant-insect interactions. However, whether differences in fat body transcriptomes exist between insect populations with different virulence levels and whether the transcriptomic differences are related to insect virulence remain largely unknown. Methodology/Principal Findings: In this study, we performed transcriptome-wide analyses on the fat bodies of two BPH populations with different virulence levels in rice. The populations were derived from rice variety TN1 (TN1 population) and Mudgo (M population). In total, 33,776 and 32,332 unigenes from the fat bodies of TN1 and M populations, respectively, were generated using Illumina technology. Gene ontology annotations and Kyoto Encyclopedia of Genes and Genomes (KEGG) orthology classifications indicated that genes related to metabolism and immunity were significantly active in the fat bodies. In addition, a total of 339 unigenes showed homology to genes of yeast-like symbionts (YLSs) from 12 genera and endosymbiotic bacteria Wolbachia. A comparative analysis of the two transcriptomes generated 7,860 differentially expressed genes. GO annotations and enrichment analysis of KEGG pathways indicated these differentially expressed transcripts might be involved in metabolism and immunity. Finally, 105 differentially expressed genes from YLSs and Wolbachia were identified, genes which might be associated with the formation of different virulent populations. Conclusions/Significance: This study was the first to compare the fat-body transcriptomes of two BPH populations having different virulence traits and to find genes that may be related to this difference. Our findings provide a molecular resource for future investigations of fat bodies and will be useful in examining the interactions between the fat body and virulence variation in the BPH.	[Yu, Haixin; Ji, Rui; Ye, Wenfeng; Chen, Hongdan; Lou, Yonggen] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Lai, Wenxiang; Fu, Qiang] China Natl Rice Res Inst, Res & Dev Ctr Rice Prod Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Fu, Q (corresponding author), China Natl Rice Res Inst, Res & Dev Ctr Rice Prod Technol, Hangzhou, Zhejiang, Peoples R China.	fuqiang@caas.cn; yglou@zju.edu.cn	Ye, Wenfeng/ACL-7903-2022	Ye, Wenfeng/0000-0003-0750-3236; Ji, Rui/0000-0003-2920-5766	National Basic Research Program of China [2010CB126200]; China Agriculture Research System [CARS-01-25]	National Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System	The study was jointly sponsored by the National Basic Research Program of China (2010CB126200; http://www.most.gov.cn/index.htm), and the China Agriculture Research System (CARS-01-25; http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Attardo GM, 2006, INSECT MOL BIOL, V15, P411, DOI 10.1111/j.1365-2583.2006.00649.x; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512; Chen YH, 2011, J INSECT PHYSIOL, V57, P1375, DOI 10.1016/j.jinsphys.2011.07.002; Cheng DJ, 2006, ARCH INSECT BIOCHEM, V61, P10, DOI 10.1002/arch.20090; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; CLARIDGE MF, 1984, ENTOMOL EXP APPL, V36, P107, DOI 10.1007/BF00569950; Dong SZ, 2011, CURR MICROBIOL, V62, P1133, DOI 10.1007/s00284-010-9830-z; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; DREYER DL, 1987, PLANT CELL ENVIRON, V10, P353; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Feitosa FM, 2006, J INSECT SCI, V6; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Foyer CH, 2007, INT J PEST MANAGE, V53, P175, DOI 10.1080/09670870701469146; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Jiang ZH, 2005, OBES RES, V13, P1898, DOI 10.1038/oby.2005.233; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Keeley L.L., 1985, P211; KRAMER KJ, 1987, ARCH INSECT BIOCHEM, V6, P279, DOI 10.1002/arch.940060406; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lu Zhong-Xian, 2004, Journal of Asia-Pacific Entomology, V7, P317, DOI 10.1016/S1226-8615(08)60233-2; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; NODA H, 1995, INSECT BIOCHEM MOLEC, V25, P639, DOI 10.1016/0965-1748(94)00107-S; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; Pang K, 2012, INSECT SCI, V19, P477, DOI 10.1111/j.1744-7917.2011.01486.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; SAKAI T, 1976, Applied Entomology and Zoology, V11, P82; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Shia AKH, 2009, J CELL SCI, V122, P4505, DOI 10.1242/jcs.049155; Shrestha S, 2010, J INSECT PHYSIOL, V56, P324, DOI 10.1016/j.jinsphys.2009.11.008; Shufran K. A., 1995, Insect Science and its Application, V16, P27; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SOGAWA K, 1970, Applied Entomology and Zoology, V5, P145; Suh SO, 2001, MOL BIOL EVOL, V18, P995, DOI 10.1093/oxfordjournals.molbev.a003901; Tang M, 2010, APPL ENVIRON MICROB, V76, P1740, DOI 10.1128/AEM.02240-09; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wilkinson TL, 2001, PHYSIOL ENTOMOL, V26, P86, DOI 10.1046/j.1365-3032.2001.00214.x; Yang Lu, 2012, Open Access Insect Physiology, V4, P19; Yang ZF, 2006, B ENTOMOL RES, V96, P53, DOI 10.1079/BER2005400; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang Jue-feng, 2007, Zhongguo Shuidao Kexue, V21, P551; Zhang ZJ, 2013, GENOMICS, V101, P296, DOI 10.1016/j.ygeno.2013.02.005	50	17	18	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88528	10.1371/journal.pone.0088528	http://dx.doi.org/10.1371/journal.pone.0088528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533099	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600057
J	Adekeye, A; Haeri, M; Solessio, E; Knox, BE				Adekeye, Adeseye; Haeri, Mohammad; Solessio, Eduardo; Knox, Barry E.			Ablation of the Proapoptotic Genes Chop or Ask1 Does Not Prevent or Delay Loss of Visual Function in a P23H Transgenic Mouse Model of Retinitis Pigmentosa	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NEURONAL CELL-DEATH; B-WAVE; TARGETED DISRUPTION; IN-VIVO; RHODOPSIN; MICE; ER; APOPTOSIS	The P23H mutation in rhodopsin (Rho(P23H)) is a prevalent cause of autosomal dominant retinitis pigmentosa. We examined the role of the ER stress proteins, Chop and Ask1, in regulating the death of rod photoreceptors in a mouse line harboring the Rho(P23H) rhodopsin transgene (GHL(+)). We used knockout mice models to determine whether Chop and Ask1 regulate rod survival or retinal degeneration. Electrophysiological recordings showed similar retinal responses and sensitivities for GHL(+), GHL(+)/Chop(-/-) and GHL(+)/Ask1(-/-) animals between 4-28 weeks, by which time all three mouse lines exhibited severe loss of retinal function. Histologically, ablation of Chop and Ask1 did not rescue photoreceptor loss in young animals. However, in older mice, a regional protective effect was observed in the central retina of GHL(+)/Chop(-/-) and GHL(+)/Ask1(-/-), a region that was severely degenerated in GHL(+) mice. Our results show that in the presence of the Rho(P23H) transgene, the rate of decline in retinal sensitivity is similar in Chop or Ask1 ablated and wild-type retinas, suggesting that these proteins do not play a major role during the acute phase of photoreceptor loss in GHL(+) mice. Instead they may be involved in regulating secondary pathological responses such as inflammation that are upregulated during later stages of disease progression.	[Knox, Barry E.] SUNY Upstate Med Univ, Ctr Vis Res, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Ctr Vis Res, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Ctr Vis Res, Dept Ophthalmol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Knox, BE (corresponding author), SUNY Upstate Med Univ, Ctr Vis Res, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.	knoxb@upstate.edu			National Institutes of Health [EY-11256, EY-12975]; NATIONAL EYE INSTITUTE [R01EY012975, R01EY011256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institutes of Health grants EY-11256, EY-12975 (B.E.K.), Research to Prevent Blindness (Unrestricted Grant to SUNY UMU Department of Ophthalmology) and the Lions of CNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; Choudhury S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.34; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Fribley A, 2009, METHODS MOL BIOL, V559, P191, DOI 10.1007/978-1-60327-017-5_14; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; GOTO Y, 1995, INVEST OPHTH VIS SCI, V36, P62; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; GRONDAHL J, 1987, CLIN GENET, V31, P255; Haeri M, 2013, BIOPHYS J, V104, P300, DOI 10.1016/j.bpj.2012.11.3835; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kong L, 2010, NEUROBIOL DIS, V38, P446, DOI 10.1016/j.nbd.2010.03.005; Kroeger H, 2012, INVEST OPHTH VIS SCI, V53, P7590, DOI 10.1167/iovs.12-10221; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nashine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063205; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; PERLMAN I, 1983, BRIT J OPHTHALMOL, V67, P443, DOI 10.1136/bjo.67.7.443; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; Robson JG, 2004, VISION RES, V44, P3253, DOI 10.1016/j.visres.2004.09.002; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; TIAN N, 1995, VISION RES, V35, P1359, DOI 10.1016/0042-6989(95)98715-L; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tso M O, 1997, Trans Am Ophthalmol Soc, V95, P467; TSO MO, 1997, T AM OPHTHAL SOC, V95, P479; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; URANO F, 2000, SCIENCE, V287, P664, DOI [DOI 10.1126/SCIENCE.287.5453.664, 10.1126/science.287.5453.664, DOI 10.1126/science.287.5453.664]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	63	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e83871	10.1371/journal.pone.0083871	http://dx.doi.org/10.1371/journal.pone.0083871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523853	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100002
J	Lanzi, S; Codecasa, F; Cornacchia, M; Maestrini, S; Salvadori, A; Brunani, A; Malatesta, D				Lanzi, Stefano; Codecasa, Franco; Cornacchia, Mauro; Maestrini, Sabrina; Salvadori, Alberto; Brunani, Amelia; Malatesta, Davide			Fat Oxidation, Hormonal and Plasma Metabolite Kinetics during a Submaximal Incremental Test in Lean and Obese Adults	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; INSULIN-RESISTANCE; LIPID OXIDATION; ADIPOSE-TISSUE; INDIRECT CALORIMETRY; SUBSTRATE OXIDATION; BODY-FAT; EXERCISE; ACTIVATION; OVERWEIGHT	This study aimed to compare fat oxidation, hormonal and plasma metabolite kinetics during exercise in lean (L) and obese (O) men. Sixteen L and 16 O men [ Body Mass Index (BMI): 22.9 +/- 0.3 and 39.0 +/- 1.4 kg center dot m(-2)] performed a submaximal incremental test (Incr) on a cycle-ergometer. Fat oxidation rates (FORs) were determined using indirect calorimetry. A sinusoidal model, including 3 independent variables (dilatation, symmetry, translation), was used to describe fat oxidation kinetics and determine the intensity (Fat(max)) eliciting maximal fat oxidation. Blood samples were drawn for the hormonal and plasma metabolite determination at each step of Incr. FORs (mgFFM(-1) min(-1)) were significantly higher from 20 to 30% of peak oxygen uptake (VO2peak) in O than in L and from 65 to 85% VO2peak in L than in O (p <= 0.05). FORs were similar in O and in L from 35 to 60% VO2peak. Fat(max) was 17% significantly lower in O than in L (p<0.01). Fat oxidation kinetics were characterized by similar translation, significantly lower dilatation and left-shift symmetry in O compared with L (p<0.05). During whole exercise, a blunted lipolysis was found in O [lower glycerol/fat mass (FM) in O than in L (p <= 0.001)], likely associated with higher insulin concentrations in O than in L (p<0.01). Non-esterified fatty acids (NEFA) were significantly higher in O compared with L (p<0.05). Despite the blunted lipolysis, O presented higher NEFA availability, likely due to larger amounts of FM. Therefore, a lower Fat(max), a left-shifted and less dilated curve and a lower reliance on fat oxidation at high exercise intensities suggest that the difference in the fat oxidation kinetics is likely linked to impaired muscular capacity to oxidize NEFA in O. These results may have important implications for the appropriate exercise intensity prescription in training programs designed to optimize fat oxidation in O.	[Lanzi, Stefano; Malatesta, Davide] Univ Lausanne, ISSUL, Lausanne, Switzerland; [Lanzi, Stefano; Malatesta, Davide] Univ Lausanne, Dept Physiol, Fac Biol & Med, Lausanne, Switzerland; [Codecasa, Franco; Cornacchia, Mauro; Salvadori, Alberto] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Pulm Rehabil Dept, Verbania, Italy; [Maestrini, Sabrina] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Molecolar Biol Lab, Verbania, Italy; [Brunani, Amelia] San Giuseppe Hosp, Ist Auxol Italiano Piancavallo, Dept Rehabil Med, Verbania, Italy	University of Lausanne; University of Lausanne; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Lanzi, S (corresponding author), ISSUL, Dept Physiol, Fac Biol & Med, Batiment Geopolis, Lausanne, Switzerland.	Stefano.Lanzi@unil.ch	Malatesta, Davide/G-5812-2012	Malatesta, Davide/0000-0003-3905-5642; Lanzi, Stefano/0000-0003-1089-6309; Amelia, Brunani/0000-0003-3059-544X				Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015; Ara I, 2011, INT J OBESITY, V35, P99, DOI 10.1038/ijo.2010.123; Baumgartner RN, 1998, J APPL PHYSIOL, V84, P257, DOI 10.1152/jappl.1998.84.1.257; Bordenave S, 2008, DIABETES METAB, V34, P162, DOI 10.1016/j.diabet.2007.11.006; Braun B, 2004, J APPL PHYSIOL, V97, P991, DOI 10.1152/japplphysiol.00231.2004; Brun JF, 2012, J ENDOCRINOL INVEST, V35, P686, DOI 10.3275/8466; Cheneviere X, 2009, MED SCI SPORT EXER, V41, P1615, DOI 10.1249/MSS.0b013e31819e2f91; Day JR, 2003, J APPL PHYSIOL, V95, P1901, DOI 10.1152/japplphysiol.00024.2003; de Glisezinski I, 2009, J PHYSIOL-LONDON, V587, P3393, DOI 10.1113/jphysiol.2009.168906; De Glisezinski I, 1998, AM J PHYSIOL-ENDOC M, V275, pE951, DOI 10.1152/ajpendo.1998.275.6.E951; Dessi-Fulgheri P, 1997, J HYPERTENS, V15, P1695, DOI 10.1097/00004872-199715120-00074; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Frayn KN, 2010, ACTA PHYSIOL, V199, P509, DOI 10.1111/j.1748-1716.2010.02128.x; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Galitzky J, 2001, J LIPID RES, V42, P536; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Goodpaster BH, 2002, OBES RES, V10, P575, DOI 10.1038/oby.2002.78; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; Houmard JA, 2012, EXERC SPORT SCI REV, V40, P204, DOI 10.1097/JES.0b013e31825d53fc; Kanaley JA, 2001, EUR J APPL PHYSIOL, V85, P68, DOI 10.1007/s004210100404; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Larsen S, 2009, DIABETOLOGIA, V52, P1400, DOI 10.1007/s00125-009-1353-4; LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MAURIEGE P, 1991, J LIPID RES, V32, P1625; Mittendorfer B, 2004, AM J PHYSIOL-ENDOC M, V286, pE354, DOI 10.1152/ajpendo.00301.2003; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Nordby P, 2006, SCAND J MED SCI SPOR, V16, P209, DOI 10.1111/j.1600-0838.2005.00480.x; Perez-Martin A, 2001, DIABETES METAB, V27, P466; Piccoli A, 1998, INT J OBESITY, V22, P97, DOI 10.1038/sj.ijo.0800551; ROMIJN JA, 1992, AM J PHYSIOL, V263, pE64, DOI 10.1152/ajpendo.1992.263.1.E64; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Solomon TPJ, 2008, J APPL PHYSIOL, V104, P1313, DOI 10.1152/japplphysiol.00890.2007; Stich V, 1999, INT J OBESITY, V23, P374, DOI 10.1038/sj.ijo.0800829; Stich V, 2000, AM J PHYSIOL-REG I, V279, pR499, DOI 10.1152/ajpregu.2000.279.2.R499; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; van Aggel-Leijssen DPC, 2001, AM J CLIN NUTR, V73, P523; van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004; Venables MC, 2008, MED SCI SPORT EXER, V40, P495, DOI 10.1249/MSS.0b013e31815f256f; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wong T, 2006, J CLIN ENDOCR METAB, V91, P678, DOI 10.1210/jc.2005-1148; Wood RE, 2010, MED SCI SPORT EXER, V42, P470, DOI 10.1249/MSS.0b013e3181b666ad; World Health Organization, 2006, DEF DIAGN DIAB MELL	45	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88707	10.1371/journal.pone.0088707	http://dx.doi.org/10.1371/journal.pone.0088707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523934	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100083
J	Li, JJ; Chen, CM; Gu, YJ; Di, GH; Wu, J; Liu, GY; Shao, ZM				Li, Jun-jie; Chen, Canming; Gu, Yajia; Di, Genhong; Wu, Jiong; Liu, Guangyu; Shao, ZhiMin			The Role of Mammographic Calcification in the Neoadjuvant Therapy of Breast Cancer Imaging Evaluation	PLOS ONE			English	Article							INTERNATIONAL EXPERT PANEL; CLINICAL EXAMINATION; PRIMARY CHEMOTHERAPY; SYSTEMIC TREATMENT; PREOPERATIVE CHEMOTHERAPY; PHYSICAL-EXAMINATION; TUMOR RESPONSE; ACCURACY; SONOGRAPHY; MRI	Introduction: Investigate the patterns of mammographically detected calcifications before and after neoadjuvant chemotherapy (NACT) to determine their value for efficacy evaluation and surgical decision making. Methods: 187 patients with malignant mammographic calcifications were followed to record the appearances and changes in the calcifications and to analyze their responses to NACT. Results: Patients with calcifications had higher rates of hormonal receptor (HR) positive tumors (74.3% versus 64.6%) and HER2 positive tumors (51.3% versus 33.4%, p = 0.004) and a similar pathologic complete response (pCR) rate compared to patients without calcifications (35.4% versus 29.8%). After NACT, the range of calcification decreased in 40% of patients, increased in 7.5% and remained stable in 52.5%; the calcification density decreased in 15% of patients, increased in 7.5% and remained stable in 77.5%; none of these change patterns were related to tumor response rate. No significant correlation was observed between the calcification appearance (morphology, distribution, range, diameter or density) and tumor subtypes or pCR rates. Among patients with malignant calcifications, 54 showed calcifications alone, 40 occurred with an architectural distortion (AD) and 93 with a mass. Calcifications were observed inside the tumor in 44% of patients and outside in 56%, with similar pCR rates and patterns of change. Conclusions: Calcification appearance did not clearly change after NACT, and calcification patterns were not related to pCR rate, suggesting that mammogram may not accurate to evaluate tumor response changes. Microcalcifications visible after NACT is essential for determining the extent of excision, patients with calcifications that occurred outside of the mass still had the opportunity for breast conservation.	[Li, Jun-jie; Chen, Canming; Di, Genhong; Wu, Jiong; Liu, Guangyu; Shao, ZhiMin] Fudan Univ, Ctr Canc, Dept Breast Surg, Shanghai 200433, Peoples R China; [Li, Jun-jie; Chen, Canming; Gu, Yajia; Di, Genhong; Wu, Jiong; Liu, Guangyu; Shao, ZhiMin] Fudan Univ, Inst Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Gu, Yajia] Fudan Univ, Ctr Canc, Dept Diagnost Radiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Shao, ZM (corresponding author), Fudan Univ, Ctr Canc, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com		Di, Genhong/0000-0003-1171-7907				Adwani A, 2000, EUR J SURG ONCOL, V26, P98, DOI 10.1053/ejso.1999.0748; American College of Radiology, 2003, BREAST IM REP DAT SY; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Chagpar AB, 2006, ANN SURG, V243, P257, DOI 10.1097/01.sla.0000197714.14318.6f; Chen AM, 2004, J CLIN ONCOL, V22, P2303, DOI 10.1200/JCO.2004.09.062; Chen XS, 2010, ANN ONCOL, V21, P961, DOI 10.1093/annonc/mdq041; Croshaw R, 2011, ANN SURG ONCOL, V18, P3160, DOI 10.1245/s10434-011-1919-5; Esserman LE, 2006, BREAST J, V12, P86, DOI 10.1111/j.1075-122X.2006.00195.x; Fadul Dalia, 2004, Breast J, V10, P141, DOI 10.1111/j.1075-122X.2004.21365.x; Ferranti C, 1992, Radiol Med, V84, P26; Fiorentino C, 2001, BREAST CANCER RES TR, V69, P143, DOI 10.1023/A:1012277325168; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; FRAPPART L, 1984, HUM PATHOL, V15, P880, DOI 10.1016/S0046-8177(84)80150-1; Herrada J, 1997, CLIN CANCER RES, V3, P1565; Hieken TJ, 2001, AM J SURG, V182, P351, DOI 10.1016/S0002-9610(01)00726-7; HORTOBAGYI GN, 1994, CANCER-AM CANCER SOC, V74, P416, DOI 10.1002/cncr.2820741329; HORTOBAGYI GN, 1988, CANCER, V62, P2507, DOI 10.1002/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D; Kaufmann M, 2007, ANN ONCOL, V18, P1927, DOI 10.1093/annonc/mdm201; Kaufmann M, 2003, J CLIN ONCOL, V21, P2600, DOI 10.1200/JCO.2003.01.136; Keune JD, 2010, AM J SURG, V199, P477, DOI 10.1016/j.amjsurg.2009.03.012; Kini VR, 1999, INT J RADIAT ONCOL, V43, P341, DOI 10.1016/S0360-3016(98)00395-2; Kuerer HM, 2001, AM J SURG, V182, P601, DOI 10.1016/S0002-9610(01)00793-0; Londero V, 2004, EUR RADIOL, V14, P1371, DOI 10.1007/s00330-004-2246-z; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mauriac L, 1999, ANN ONCOL, V10, P47, DOI 10.1023/A:1008337009350; MOSKOVIC EC, 1993, CLIN RADIOL, V47, P339, DOI 10.1016/S0009-9260(05)81451-5; Noguera JJ, 2007, RADIOLOGIA-MADRID, V49, P37, DOI 10.1016/S0033-8338(07)73714-1; Peintinger F, 2006, ANN SURG ONCOL, V13, P1443, DOI 10.1245/s10434-006-9086-9; Redden MH, 2013, SURG CLIN N AM, V93, P493, DOI 10.1016/j.suc.2013.01.006; Rosen EL, 2003, AM J ROENTGENOL, V181, P1275, DOI 10.2214/ajr.181.5.1811275; Rouzier R, 2001, J CLIN ONCOL, V19, P3828, DOI 10.1200/JCO.2001.19.18.3828; SEGEL MC, 1988, RADIOLOGY, V169, P49, DOI 10.1148/radiology.169.1.3420282; Shin HJ, 2011, BRIT J RADIOL, V84, P612, DOI 10.1259/bjr/74430952; Shin HC, 2013, ANN SURG ONCOL, V20, P2582, DOI 10.1245/s10434-013-2909-6; Smart CR, 1997, CA-CANCER J CLIN, V47, P134, DOI 10.3322/canjclin.47.3.134; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; Vinnicombe SJ, 1996, RADIOLOGY, V198, P333, DOI 10.1148/radiology.198.2.8596827; W. Fraser Symmans, 2009, PATHOLOGIC RESPONSE; Weatherall PT, 2001, J MAGN RESON IMAGING, V13, P868, DOI 10.1002/jmri.1124; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Yeh E, 2005, AM J ROENTGENOL, V184, P868, DOI 10.2214/ajr.184.3.01840868	41	13	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88853	10.1371/journal.pone.0088853	http://dx.doi.org/10.1371/journal.pone.0088853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523942	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100091
J	Liang, B; Guo, Y; Li, YH; Kong, H				Liang, Bin; Guo, Yang; Li, Yunhui; Kong, Hong			Association between IL-10 Gene Polymorphisms and Susceptibility of Tuberculosis: Evidence Based on a Meta-Analysis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; PULMONARY TUBERCULOSIS; INTERLEUKIN-10 POLYMORPHISMS; TNF-ALPHA; CYTOKINES; DISEASE	Background: A number of observational studies have been conducted to investigate the association of IL-10 gene polymorphisms with tuberculosis (TB) susceptibility. However, the results of different studies were inconsistent. The aim of this study was to investigate the relationship between IL-10 -1082G/A, -819T/C, and -592A/C polymorphisms and TB risk by meta-analysis. Methods: A literature search was conducted among six English databases (PubMed, Embase, Web of Science, Science Direct, SpringerLink and EBSCO) and two Chinese databases (Wanfang and Chinese National Knowledge Infrastructure databases) to identify studies involving association between IL-10 21082G/A, 2819T/C, and 2592A/C polymorphisms and TB susceptibility before May. 2013. Statistical analysis was performed using Revman 5.0 and Stata 12.0. Results: A total of 31 studies with 6,559 cases and 7,768 controls were included in this meta-analysis. The results showed that three polymorphisms (-1082G/A, -819T/C, and -592A/C) in the IL-10 gene were not associated with the risk of TB in general population. In the subgroup analysis by ethnicity, IL-10 -1082G/A polymorphism was associated with TB risk in Europeans (AA+ AG vs. GG: OR = 0.57, 95% CI = 0. 0.37-0.89, P = 0.01) and Americans (AA+ AG vs. GG: OR = 0.39, 95% CI = 0.27-0.57, P<0.01), and IL-10 -819T/C (C allele vs. T allele: OR = 0.83, 95% CI = 0.72-0.96, P = 0.01) and -592A/C (CC+AC vs. AA: OR = 0.65, 95% CI = 0.49-0.85, P = 0.002) polymorphisms were significantly associated with TB risk in Asians. Conclusion: This meta-analysis provides strong evidence that IL-10-1082G/A polymorphism was associated with TB risk in Europeans and Americans, and IL-10 -819T/C and -592A/C polymorphisms could be risk factors for TB in Asians. Additional well designed large studies were required for the validation of our results.	[Liang, Bin] China Med Univ, High Vocat Technol Coll, Dept Clin Lab, Shenyang, Peoples R China; [Guo, Yang] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang, Peoples R China; [Li, Yunhui] 202 Hosp, Dept Clin Lab, Shenyang, Peoples R China; [Kong, Hong] China Med Univ, Shengjing Hosp, Dept Clin Lab, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Liang, B (corresponding author), China Med Univ, High Vocat Technol Coll, Dept Clin Lab, Shenyang, Peoples R China.	liangbin_cmu@126.com			Liaoning Natural Science Fund, Liaoning Province, China [201102257]	Liaoning Natural Science Fund, Liaoning Province, China	This study was supported by Liaoning Natural Science Fund, Liaoning Province, China (Topic No: 201102257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirzargar AA, 2006, EUR CYTOKINE NETW, V17, P84; Anand SP, 2007, INDIAN J MED RES, V126, P135; Ansari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027848; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Ates O, 2008, J CLIN IMMUNOL, V28, P232, DOI 10.1007/s10875-007-9155-2; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Ben-Selma W, 2011, MICROBES INFECT, V13, P837, DOI 10.1016/j.micinf.2011.04.009; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Garcia-Elorriaga G, 2013, ASIAN PAC J TROP MED, V6, P505, DOI 10.1016/S1995-7645(13)60086-3; Henao MI, 2006, TUBERCULOSIS, V86, P11, DOI 10.1016/j.tube.2005.03.001; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Knight Julian, 2001, Curr Infect Dis Rep, V3, P427, DOI 10.1007/BF03160478; Liang L, 2011, FEMS IMMUNOL MED MIC, V62, P84, DOI 10.1111/j.1574-695X.2011.00791.x; Liu XX, 2009, MODERN PREV MED, V36, P1827; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; [马志明 MA Zhiming], 2007, [广东医学, Guangdong Medical Journal], V28, P1243; Maurer M, 2000, J NEUROIMMUNOL, V104, P98, DOI 10.1016/S0165-5728(99)00256-8; Meenagh A, 2002, HUM IMMUNOL, V63, P1055, DOI 10.1016/S0198-8859(02)00440-8; Meenakshi P, 2013, SCAND J IMMUNOL, V78, P92, DOI 10.1111/sji.12055; Meilang QuCuo, 2012, Modern Preventive Medicine, V39, P3607; Mhmoud N, 2013, TROP MED INT HEALTH, V18, P1119, DOI 10.1111/tmi.12141; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Mosaad YM, 2010, SCAND J IMMUNOL, V72, P358, DOI 10.1111/j.1365-3083.2010.02426.x; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Oh JH, 2007, RESPIROLOGY, V12, P594, DOI 10.1111/j.1440-1843.2007.01108.x; Oral HB, 2006, CYTOKINE, V35, P143, DOI 10.1016/j.cyto.2006.07.015; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pan F, 2012, MOL BIOL REP, V39, P7143, DOI 10.1007/s11033-012-1546-7; Scola L, 2003, MECH AGEING DEV, V124, P569, DOI 10.1016/S0047-6374(03)00038-1; Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011; Shin HD, 2005, EXP MOL MED, V37, P128, DOI 10.1038/emm.2005.17; Sunder SR, 2012, HUM IMMUNOL, V73, P605, DOI 10.1016/j.humimm.2012.03.012; Taype CA, 2010, INFECT GENET EVOL, V10, P495, DOI 10.1016/j.meegid.2010.02.011; Thye T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005420; Trajkov Dejan, 2009, Indian J Tuberc, V56, P117; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Ulger M, 2013, MIKROBIYOL BUL, V47, P250; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wu F, 2008, J OCCUP HEALTH, V50, P445, DOI 10.1539/joh.L8006; Yang Hui, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P155; Zembrzuski VM, 2010, TUBERCULOSIS, V90, P44, DOI 10.1016/j.tube.2009.11.002; Zhang J, 2011, INT J TUBERC LUNG D, V15, P594, DOI 10.5588/ijtld.09.0703	49	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88448	10.1371/journal.pone.0088448	http://dx.doi.org/10.1371/journal.pone.0088448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523896	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100045
J	Wang, GW; Xu, TZ; Feng, T				Wang, Gang Wei; Xu, Tian Zhou; Feng, Tao			Lie Symmetry Analysis and Explicit Solutions of the Time Fractional Fifth-Order KdV Equation	PLOS ONE			English	Article							PARTIAL-DIFFERENTIAL-EQUATIONS; CONSERVATION-LAWS; OPTIMAL SYSTEMS; WAVE-EQUATIONS; ORDER; INVARIANCE; REDUCTION; BURGERS	In this paper, using the Lie group analysis method, we study the invariance properties of the time fractional fifth-order KdV equation. A systematic research to derive Lie point symmetries to time fractional fifth-order KdV equation is performed. In the sense of point symmetry, all of the vector fields and the symmetry reductions of the fractional fifth-order KdV equation are obtained. At last, by virtue of the sub-equation method, some exact solutions to the fractional fifth-order KdV equation are provided.	[Wang, Gang Wei; Xu, Tian Zhou] Beijing Inst Technol, Sch Math & Stat, Beijing 100081, Peoples R China; [Feng, Tao] Yanshan Univ, Sch Elect Engn, Qinhuangdao, Peoples R China	Beijing Institute of Technology; Yanshan University	Wang, GW (corresponding author), Beijing Inst Technol, Sch Math & Stat, Beijing 100081, Peoples R China.	pukai1121@163.com	Wang, Gangwei/A-1791-2015	Wang, Gangwei/0000-0002-5005-5099	National Natural Science Foundation of China [11171022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project is supported by the National Natural Science Foundation of China (Grant No. 11171022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, MATH SCI ENG; Bluman GW., 1989, SYMMETRIES DIFFERENT, Vvol. 81; Buckwar E, 1998, J MATH ANAL APPL, V227, P81, DOI 10.1006/jmaa.1998.6078; Chen Y, 2008, APPL MATH COMPUT, V200, P87, DOI 10.1016/j.amc.2007.10.050; Craddock M, 2007, J DIFFER EQUATIONS, V232, P652, DOI 10.1016/j.jde.2006.07.011; Craddock M, 2012, J DIFFER EQUATIONS, V252, P56, DOI 10.1016/j.jde.2011.09.024; Daftardar-Gejji V, 2007, APPL MATH COMPUT, V189, P541, DOI 10.1016/j.amc.2006.11.129; Djordjevic VD, 2008, J COMPUT APPL MATH, V222, P701, DOI 10.1016/j.cam.2007.12.013; El-Sayed AMA, 2006, PHYS LETT A, V359, P175, DOI 10.1016/j.physleta.2006.06.024; Gazizov RK, 2013, COMPUT MATH APPL, V66, P576, DOI 10.1016/j.camwa.2013.05.006; Gazizov RK, 2009, PHYS SCRIPTA, VT136, DOI 10.1088/0031-8949/2009/T136/014016; Gazizov R.K., 2007, VESTN USATU, V9, P21; Guo SM, 2012, PHYS LETT A, V376, P407, DOI 10.1016/j.physleta.2011.10.056; He JH, 2000, INT J NONLINEAR MECH, V35, P37, DOI 10.1016/S0020-7462(98)00085-7; Hu SA, 2011, ADV VIB ENG, V10, P187; Ibragimov N., 1994, CRC HDB LIE GROUP AN, V1; Jafari H, 2006, APPL MATH COMPUT, V180, P488, DOI 10.1016/j.amc.2005.12.031; Jefferson GF, 2013, COMMUN NONLINEAR SCI, V18, P2340, DOI 10.1016/j.cnsns.2012.12.022; Johnpillai AG, 2013, APPL MATH LETT, V26, P376, DOI 10.1016/j.aml.2012.10.012; Johnpillai AG, 2011, COMMUN NONLINEAR SCI, V16, P1207, DOI 10.1016/j.cnsns.2010.06.025; Johnpillai AG, 2010, APPL MATH COMPUT, V216, P3761, DOI 10.1016/j.amc.2010.05.043; Jumarie G, 2006, COMPUT MATH APPL, V51, P1367, DOI 10.1016/j.camwa.2006.02.001; Jumarie G, 2010, APPL MATH LETT, V23, P1444, DOI 10.1016/j.aml.2010.08.001; Kiryakova V., 1994, PITMAN RES NOTES MAT, V301; Kumar S, 2012, COMMUN NONLINEAR SCI, V17, P1529, DOI 10.1016/j.cnsns.2011.09.003; Li X, 2010, J PHYS A, V43, P11; Liang YJ, 2013, SIGNAL PROCESS, V93, P242, DOI 10.1016/j.sigpro.2012.07.035; Lie S, 1881, ARCH MATH, V6, P328, DOI DOI 10.1016/0167-2789(90)90123-7; Listopadova V, 2013, NONLINEAR ANAL-REAL, V14, P202, DOI 10.1016/j.nonrwa.2012.05.013; Liu HZ, 2013, STUD APPL MATH, V131, P317, DOI 10.1111/sapm.12011; Liu HZ, 2013, J DIFFER EQUATIONS, V254, P2289, DOI 10.1016/j.jde.2012.12.004; Liu HZ, 2010, J MATH ANAL APPL, V368, P551, DOI 10.1016/j.jmaa.2010.03.026; Lu B, 2012, PHYS LETT A, V376, P2045, DOI 10.1016/j.physleta.2012.05.013; Miller K.S., 1993, INTRO FRACTIONAL CAL; Naz R, 2013, COMMUN NONLINEAR SCI, V18, P826, DOI 10.1016/j.cnsns.2012.09.011; Odibat Z, 2008, APPL MATH LETT, V21, P194, DOI 10.1016/j.aml.2007.02.022; Olver PJ., 1986, APPL LIE GROUP DIFFE, DOI DOI 10.1007/978-1-4684-0274-2; Ovsiannikov L.V., 1982, GROUP ANAL DIFFERENT; Park K. D, 2010, ANAL FRACTIONAL DIFF; Podlubny I, 1999, FRACTIONAL DIFFERENT, P47; Sahadevan R, 2012, J MATH ANAL APPL, V393, P341, DOI 10.1016/j.jmaa.2012.04.006; Sinkala W, 2008, J DIFFER EQUATIONS, V244, P2820, DOI 10.1016/j.jde.2008.02.044; Vaneeva O, 2012, COMMUN NONLINEAR SCI, V17, P611, DOI 10.1016/j.cnsns.2011.06.038; Wang GW, 2013, COMMUN NONLINEAR SCI, V18, P2321, DOI 10.1016/j.cnsns.2012.11.032; Wang GW, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-232; Wang GW, 2013, NONLINEAR D IN PRESS, DOI [10.1007/s11071-013-1150-y, DOI 10.1007/S11071-013-1150-Y.IN]; Wu GC, 2010, PHYS LETT A, V374, P2506, DOI 10.1016/j.physleta.2010.04.034; Zhang S, 2011, PHYS LETT A, V375, P1069, DOI 10.1016/j.physleta.2011.01.029	48	31	31	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88336	10.1371/journal.pone.0088336	http://dx.doi.org/10.1371/journal.pone.0088336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523885	Green Submitted, gold, Green Published			2022-12-27	WOS:000331258100034
J	Ashton, JR; Clark, DP; Moding, EJ; Ghaghada, K; Kirsch, DG; West, JL; Badea, CT				Ashton, Jeffrey R.; Clark, Darin P.; Moding, Everett J.; Ghaghada, Ketan; Kirsch, David G.; West, Jennifer L.; Badea, Cristian T.			Dual-Energy Micro-CT Functional Imaging of Primary Lung Cancer in Mice Using Gold and Iodine Nanoparticle Contrast Agents: A Validation Study	PLOS ONE			English	Article							DOSE HELICAL CT; TUMOR VASCULATURE; PERMEABILITY; NANOPROBE; DISEASES; NODULES; SIZE	Purpose: To provide additional functional information for tumor characterization, we investigated the use of dual-energy computed tomography for imaging murine lung tumors. Tumor blood volume and vascular permeability were quantified using gold and iodine nanoparticles. This approach was compared with a single contrast agent/single-energy CT method. Ex vivo validation studies were performed to demonstrate the accuracy of in vivo contrast agent quantification by CT. Methods: Primary lung tumors were generated in LSL-Kras(G12D);p53(FL/FL) mice. Gold nanoparticles were injected, followed by iodine nanoparticles two days later. The gold accumulated in tumors, while the iodine provided intravascular contrast. Three dual-energy CT scans were performed-two for the single contrast agent method and one for the dual contrast agent method. Gold and iodine concentrations in each scan were calculated using a dual-energy decomposition. For each method, the tumor fractional blood volume was calculated based on iodine concentration, and tumor vascular permeability was estimated based on accumulated gold concentration. For validation, the CT-derived measurements were compared with histology and inductively-coupled plasma optical emission spectroscopy measurements of gold concentrations in tissues. Results: Dual-energy CT enabled in vivo separation of gold and iodine contrast agents and showed uptake of gold nanoparticles in the spleen, liver, and tumors. The tumor fractional blood volume measurements determined from the two imaging methods were in agreement, and a high correlation (R-2 = 0.81) was found between measured fractional blood volume and histology-derived microvascular density. Vascular permeability measurements obtained from the two imaging methods agreed well with ex vivo measurements. Conclusions: Dual-energy CT using two types of nanoparticles is equivalent to the single nanoparticle method, but allows for measurement of fractional blood volume and permeability with a single scan. As confirmed by ex vivo methods, CT-derived nanoparticle concentrations are accurate. This method could play an important role in lung tumor characterization by CT.	[Ashton, Jeffrey R.; Clark, Darin P.; Badea, Cristian T.] Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC 27708 USA; [Moding, Everett J.; Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Ghaghada, Ketan] Texas Childrens Hosp, Edward B Singleton Dept Pediat Radiol, Houston, TX 77030 USA; [Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Ashton, Jeffrey R.; Clark, Darin P.; West, Jennifer L.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Duke University; Baylor College of Medicine; Duke University; Duke University	Badea, CT (corresponding author), Duke Univ, Med Ctr, Ctr Vivo Microscopy, Durham, NC 27708 USA.	cristian.badea@duke.edu	Badea, Cristian T/M-3323-2019; West, Jennifer L/A-4582-2008; Badea, Cristian/B-6681-2011	Badea, Cristian T/0000-0002-1850-2522; West, Jennifer L/0000-0001-8550-2875; Badea, Cristian/0000-0002-1850-2522; Ashton, Jeffrey/0000-0001-8993-8457	National Institutes of Health/National Center for Research Resources National Biomedical Technology Resource Center [P41 EB015897]; National Cancer Institute [U54 CA151668]; NIH/NCI [R21 CA175839]; NIH/National Institute of Allergy and Infectious Diseases [K02 AI093866]; Medical Scientist Training Program Training Grant [T32 GM007171]; NATIONAL CANCER INSTITUTE [U54CA151668, F30CA177220, R35CA197616, P30CA014236, R21CA175839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources National Biomedical Technology Resource Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Scientist Training Program Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from an National Institutes of Health/National Center for Research Resources National Biomedical Technology Resource Center grant (P41 EB015897)(CTB), and from National Cancer Institute U54 CA151668 (JLW). Other support was provided by NIH/NCI R21 CA175839 and NIH/National Institute of Allergy and Infectious Diseases K02 AI093866 (DGK). JRA is supported by a Medical Scientist Training Program Training Grant (T32 GM007171) and a Duke Institutional Fellowship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton JR, 2013, CONTRAST ME IN PRESS; Au JT, 2013, AM J ROENTGENOL, V200, P1347, DOI 10.2214/AJR.12.8933; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Badea C, 2004, MED PHYS, V31, P3324, DOI 10.1118/1.1812604; Badea C, 2011, P SPIE, V7961; Badea CT, 2008, P SOC PHOTO-OPT INS, V6913, P91342, DOI 10.1117/12.772303; Badea CT, 2012, AM J PHYSIOL-LUNG C, V302, pL1088, DOI 10.1152/ajplung.00359.2011; Badea CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034496; Badea CT, 2011, P SPIE INT SOC OPTIC, P7961; Bourin M, 1997, CLIN PHARMACOKINET, V32, P180, DOI 10.2165/00003088-199732030-00002; Clark D, 2012, IMAGE PROCESSING, V8314; Clark DP, 2013, PHYS MED BIOL, V58, P1683, DOI 10.1088/0031-9155/58/6/1683; Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473; Danila D, 2013, NANOMEDICINE; Duncan B, 2010, J CONTROL RELEASE, V148, P122, DOI 10.1016/j.jconrel.2010.06.004; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fink C, 2011, J THORAC ONCOL, V6, pS1139; Fornaro J, 2011, INSIGHTS IMAGING, V2, P149, DOI 10.1007/s13244-010-0057-0; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Ghann WE, 2012, LANGMUIR, V28, P10398, DOI 10.1021/la301694q; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Hainfeld JF, 2011, BRIT J RADIOL, V84, P526, DOI 10.1259/bjr/42612922; Hainfeld JF, 2010, PHYS MED BIOL, V55, P3045, DOI 10.1088/0031-9155/55/11/004; Haiss W, 2007, ANAL CHEM, V79, P4215, DOI 10.1021/ac0702084; Hermosillo G, 2002, INT J COMPUT VISION, V50, P329, DOI 10.1023/A:1020830525823; Hodnett PA, 2012, RADIOL CLIN N AM, V50, P895, DOI 10.1016/j.rcl.2012.06.005; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karathanasis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005843; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Kennedy LC, 2011, SMALL, V7, P169, DOI 10.1002/smll.201000134; Kim D, 2010, ACS NANO, V4, P3689, DOI 10.1021/nn901877h; Kirsch DG, 2010, INT J RADIAT ONCOL, V76, P973, DOI 10.1016/j.ijrobp.2009.11.038; Kramer BS, 2011, J MED SCREEN, V18, P109, DOI 10.1258/jms.2011.011055; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Markowitz SB, 2007, CHEST, V131, P1028, DOI 10.1378/chest.05-3014; Meert AP, 2002, BRIT J CANCER, V87, P694, DOI 10.1038/sj.bjc.6600551; Moding EJ, 2013, INT J RADIAT ONCOL, V85, P1353, DOI 10.1016/j.ijrobp.2012.09.027; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Rygh CB, 2011, CLIN CANCER RES, V17, P550, DOI 10.1158/1078-0432.CCR-10-2049; Schmid-Bindert G, 2012, EUR RADIOL, V22, P93, DOI 10.1007/s00330-011-2230-3; Song L, 2013, ADV HEALTHC MATER, V2, P275, DOI 10.1002/adhm.201200112; Tateishi U, 2005, RADIOLOGY, V235, P1084, DOI 10.1148/radiol.2353042072; Toy R, 2013, ACS NANO, V7, P3118, DOI 10.1021/nn3053439; Zheng JZ, 2010, CONTRAST MEDIA MOL I, V5, P147, DOI 10.1002/cmmi.378	47	64	66	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88129	10.1371/journal.pone.0088129	http://dx.doi.org/10.1371/journal.pone.0088129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520351	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600042
J	Chen, ZH; Pereira, MA; Seielstad, M; Koh, WP; Tai, ES; Teo, YY; Liu, JJ; Hsu, C; Wang, RW; Odegaard, AO; Thyagarajan, B; Koratkar, R; Yuan, JM; Gross, MD; Stram, DO				Chen, Zhanghua; Pereira, Mark A.; Seielstad, Mark; Koh, Woon-Puay; Tai, E. Shyong; Teo, Yik-Ying; Liu, Jianjun; Hsu, Chris; Wang, Renwei; Odegaard, Andrew O.; Thyagarajan, Bharat; Koratkar, Revati; Yuan, Jian-Min; Gross, Myron D.; Stram, Daniel O.			Joint Effects of Known Type 2 Diabetes Susceptibility Loci in Genome-Wide Association Study of Singapore Chinese: The Singapore Chinese Health Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; LARGE-SCALE ASSOCIATION; BODY-MASS INDEX; RISK LOCI; INSULIN-RESISTANCE; METABOLIC SYNDROME; VARIANTS; SMOKING; OBESITY; EPIDEMIOLOGY	Background: Genome-wide association studies (GWAS) have identified genetic factors in type 2 diabetes (T2D), mostly among individuals of European ancestry. We tested whether previously identified T2D-associated single nucleotide polymorphisms (SNPs) replicate and whether SNPs in regions near known T2D SNPs were associated with T2D within the Singapore Chinese Health Study. Methods: 2338 cases and 2339 T2D controls from the Singapore Chinese Health Study were genotyped for 507,509 SNPs. Imputation extended the genotyped SNPs to 7,514,461 with high estimated certainty (r(2).0.8). Replication of known index SNP associations in T2D was attempted. Risk scores were computed as the sum of index risk alleles. SNPs in regions +/- 100 kb around each index were tested for associations with T2D in conditional fine-mapping analysis. Results: Of 69 index SNPs, 20 were genotyped directly and genotypes at 35 others were well imputed. Among the 55 SNPs with data, disease associations were replicated (at p<0.05) for 15 SNPs, while 32 more were directionally consistent with previous reports. Risk score was a significant predictor with a 2.03 fold higher risk CI (1.69-2.44) of T2D comparing the highest to lowest quintile of risk allele burden (p = 5.72 x 10(-14)). Two improved SNPs around index rs10923931 and 5 new candidate SNPs around indices rs10965250 and rs1111875 passed simple Bonferroni corrections for significance in conditional analysis. Nonetheless, only a small fraction (2.3% on the disease liability scale) of T2D burden in Singapore is explained by these SNPs. Conclusions: While diabetes risk in Singapore Chinese involves genetic variants, most disease risk remains unexplained. Further genetic work is ongoing in the Singapore Chinese population to identify unique common variants not already seen in earlier studies. However rapid increases in T2D risk have occurred in recent decades in this population, indicating that dynamic environmental influences and possibly gene by environment interactions complicate the genetic architecture of this disease.	[Chen, Zhanghua; Hsu, Chris; Stram, Daniel O.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Pereira, Mark A.; Odegaard, Andrew O.; Thyagarajan, Bharat; Koratkar, Revati; Gross, Myron D.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Seielstad, Mark] Univ Calif San Francisco, Dept Epidemiol & Biostat, Dept Lab Med, San Francisco, CA 94143 USA; [Seielstad, Mark] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Koh, Woon-Puay; Tai, E. Shyong] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore; [Koh, Woon-Puay; Tai, E. Shyong; Teo, Yik-Ying; Liu, Jianjun] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Liu, Jianjun] ASTAR, Genome Inst Singapore, Human Genet, Singapore, Singapore; [Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Dept Epidemiol, Inst Canc, Pittsburgh, PA 15261 USA	University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, ZH (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	zhanghuc@usc.edu; gross001@umn.edu; daniel.stram@med.usc.edu	Seielstad, Mark/T-7841-2019; Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019; Yuan, Jian-Min/0000-0002-4620-3108; Pereira, Mark/0000-0002-6704-5276; Tai, E Shyong/0000-0003-2929-8966; Seielstad, Mark/0000-0001-5783-1401	Genetic and Environmental Determinants of Type 2 Diabetes in Chinese Singaporeans [R01 DK080720]; National Medical Research Council of Singapore under the Individual Research Grants Scheme; Genome Institute of Singapore; National Medical Research Council of Singapore; Agency for Science, Technology and Research, Singapore; U.S. NIH/NCI [RO1 CA55069, R35 CA53890, R01 CA80205, R01 CA144034]; NATIONAL CANCER INSTITUTE [R35CA053890, R01CA144034, R01CA080205, R01CA055069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080720] Funding Source: NIH RePORTER	Genetic and Environmental Determinants of Type 2 Diabetes in Chinese Singaporeans; National Medical Research Council of Singapore under the Individual Research Grants Scheme(National Medical Research Council, Singapore); Genome Institute of Singapore; National Medical Research Council of Singapore(National Medical Research Council, Singapore); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); U.S. NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by Genetic and Environmental Determinants of Type 2 Diabetes in Chinese Singaporeans, R01 DK080720, U.S. NIH. Additional support came from the National Medical Research Council of Singapore under the Individual Research Grants Scheme, the Genome Institute of Singapore, National Medical Research Council of Singapore under its Individual Research Grant and Clinician Scientist Award Scheme, and from the Agency for Science, Technology and Research, Singapore. The Singapore Chinese Health Study was supported by U.S. NIH/NCI grants: RO1 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2003, J DIABETES COMPLICAT, V17, P39, DOI 10.1016/S1056-8727(02)00190-3; Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chege MP, 2010, RISK FACTORS TYPE 2; Chen CC, 2008, METABOLISM, V57, P544, DOI 10.1016/j.metabol.2007.11.018; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Department of Statistics S, 2013, POP TRENDS 2013; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Fujimoto WY, 1996, DIABETIC MED, V13, pS7; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haag M, 2005, MED SCI MONITOR, V11, pRA359; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hindorff LA, CATALOG PUBLISHED GE; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Jowett JB, 2009, TWIN RES HUM GENET, V12, P44, DOI 10.1375/twin.12.1.44; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ko GTC, 2007, INT J OBESITY, V31, P254, DOI 10.1038/sj.ijo.0803389; Ko GTC, 2001, EUR J EPIDEMIOL, V17, P289, DOI 10.1023/A:1017935707807; Ko GTC, 2001, POSTGRAD MED J, V77, P240, DOI 10.1136/pmj.77.906.240; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maskarinec G, 2009, ETHNIC DIS, V19, P49; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Misra A, 2007, NUTRITION, V23, P696, DOI 10.1016/j.nut.2007.06.008; Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Satagopan JM, 2003, GENET EPIDEMIOL, V25, P149, DOI 10.1002/gepi.10260; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steffes M, 2005, CLIN CHEM, V51, P753, DOI 10.1373/clinchem.2004.042143; Stram Daniel O., 2005, Human Genomics, V2, P144; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Takeuchi T, 2009, DIABETES METAB, V35, P32, DOI 10.1016/j.diabet.2008.06.006; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang HS, 2006, COMPUT STAT DATA AN, V51, P457, DOI 10.1016/j.csda.2006.04.034; Weijnen CF, 2002, DIABETIC MED, V19, P41, DOI 10.1046/j.1464-5491.2002.00624.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zheng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034829; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	83	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87762	10.1371/journal.pone.0087762	http://dx.doi.org/10.1371/journal.pone.0087762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520337	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000331254600028
J	Xu, YM; Chen, HH; Li, F; Deng, F; Liu, XB; Yang, HC; Qi, LG; Guo, JH; Liu, TB				Xu, Yan-Min; Chen, Hong-Hui; Li, Fu; Deng, Fang; Liu, Xiao-Bo; Yang, Hai-Chen; Qi, Li-Guo; Guo, Jin-Hong; Liu, Tie-Bang			Prevalence and Correlates of Cigarette Smoking among Chinese Schizophrenia Inpatients Receiving Antipsychotic Mono-Therapy	PLOS ONE			English	Article							TOBACCO SMOKING; ALCOHOL-CONSUMPTION; GENERAL-POPULATION; GENDER-DIFFERENCES; BIPOLAR DISORDER; ASSOCIATION; PREDICTORS; MEDICATION; MORTALITY; SYMPTOMS	Objective: To investigate the prevalence rate of cigarette smoking and its socio-demographic and clinical correlates in Chinese schizophrenia inpatients receiving antipsychotic mono-therapy. Methods: This study was a cross-sectional, two-site, hospital-based survey. Four hundred and twenty-nine schizophrenia patients (male/female: 66.9% vs. 33.1%) were consecutively recruited from psychosis inpatient wards of two large specialty psychiatric hospitals in mainland China. Patients were assessed using a cigarette smoking questionnaire, the Positive and Negative Symptom Scale, the Simpson Angus Scale, the Barnes Akathisia Rating Scale, and the Abnormal Involuntary Movement Scale. Socio-demographic and other clinical data were also collected. We calculated the prevalence of current smoking in our sample as well as its indirectly standardized prevalence ratio (ISPR) using data from the 2010 Global Adult Tobacco Survey in China. Results: The prevalence rate of current smoking was 40.6% in our sample, and 57.5% in males and 6.3% in females. The ISPRs of all patients, men and women were 1.11(95% CI: 0.95 similar to 1.29), 1.07(95% CI = 0.91 similar to 1.24) and 4.64(95% CI = 2.12 similar to 8.82), respectively. The overall and male-specific prevalence of current smoking did not differ significantly between patients and the general population. In multiple logistic regression analysis, male sex, older age, poor marital status, alcohol use, use of first-generation antipsychotics, longer duration of illness, more frequent hospitalizations, and more severe negative symptoms were independently associated with current smoking. Conclusion: Male Chinese inpatients with schizophrenia who received a mono-therapy of antipsychotics were not more likely to smoke than the general population. Cigarette smoking is more common in schizophrenia patients with more severe illness.	[Xu, Yan-Min] Shenzhen Univ, Normal Coll, Dept Psychol, Shenzhen, Peoples R China; [Xu, Yan-Min; Yang, Hai-Chen; Qi, Li-Guo; Guo, Jin-Hong; Liu, Tie-Bang] Shenzhen Mental Hlth Ctr, Shenzhen Kangning Hosp, Shenzhen Inst Mental Hlth, Shenzhen, Peoples R China; [Chen, Hong-Hui; Li, Fu; Deng, Fang; Liu, Xiao-Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Mental Hlth Ctr, Wuhan 430074, Peoples R China; [Chen, Hong-Hui] Wuhan Municipal, Hlth & Family Planning Commiss, Wuhan, Peoples R China	Shenzhen University; Huazhong University of Science & Technology	Chen, HH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Mental Hlth Ctr, Wuhan 430074, Peoples R China.	Dr.Chen_Honghui@hotmail.com; liutbsz@gmail.com			Wuhan Planning Project of Science and Technology [200860923434]	Wuhan Planning Project of Science and Technology	This work was supported by grant from Wuhan Planning Project of Science and Technology (grant number: 200860923434) (HH Chen, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes M, 2006, AUST NZ J PSYCHIAT, V40, P575, DOI 10.1111/j.1440-1614.2006.01841.x; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; Challis GB, 1999, CAN J PSYCHIAT, V44, P711; China CDC, 2010, GLOB AD TOB SURV GAT; Cho HJ, 2008, SOC SCI MED, V66, P609, DOI 10.1016/j.socscimed.2007.10.005; Chong SA, 1996, AUST NZ J PSYCHIAT, V30, P350, DOI 10.3109/00048679609064998; Curkendall SM, 2004, J CLIN PSYCHIAT, V65, P715; de Leon J, 2002, SCHIZOPHR RES, V56, P47, DOI 10.1016/S0920-9964(01)00217-1; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; De Leon J, 2007, ALCOHOL ALCOHOLISM, V42, P252, DOI 10.1093/alcalc/agm029; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; deLeon J, 1996, SCHIZOPHRENIA BULL, V22, P405, DOI 10.1093/schbul/22.3.405; Diaz FJ, 2009, BIPOLAR DISORD, V11, P154, DOI 10.1111/j.1399-5618.2009.00664.x; Dickerson F, 2013, PSYCHIAT SERV, V64, P44, DOI [10.1176/appi.ps.201200143, 10.1176/appi.ps.001432012]; Ekinci O, 2012, DUNSEN ADAM, V25, P321, DOI 10.5350/DAJPN2012250404; Fan B, 1990, SHANGHAI ARCH PSYCHI, V2, P65; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; GOFF DC, 1992, AM J PSYCHIAT, V149, P1189; Hart CL, 2008, ADDICTION, V103, P1979, DOI 10.1111/j.1360-0443.2008.02373.x; He Y.L., 1997, J CLIN PSYCHIAT, V7, P353; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Hooman S, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-5; Hou YZ, 2011, J PSYCHIATR RES, V45, P1551, DOI 10.1016/j.jpsychires.2011.07.011; Hvidtfeldt UA, 2010, EUR J PUBLIC HEALTH, V20, P376, DOI 10.1093/eurpub/ckp153; Janno S, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-5; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; Kao YC, 2011, PSYCHIAT RES, V190, P193, DOI 10.1016/j.psychres.2011.05.016; Kelly C, 1999, AM J PSYCHIAT, V156, P1751; Kelly C., 2000, ADV PSYCHIAT TREATME, V6, P327, DOI [10.1192/apt.6.5.37, DOI 10.1192/apt.6.5.327, DOI 10.1192/APT.6.5.327]; Kelly DL, 2011, SCHIZOPHRENIA BULL, V37, P832, DOI 10.1093/schbul/sbp152; Kobayashi M, 2010, INT J PSYCHIAT MED, V40, P247, DOI 10.2190/PM.40.3.b; Kumari V, 2005, NEUROSCI BIOBEHAV R, V29, P1021, DOI 10.1016/j.neubiorev.2005.02.006; Leonard Sherry, 2007, J Dual Diagn, V3, P43, DOI 10.1300/J374v03n03_05; Levin ED, 2007, BIOCHEM PHARMACOL, V74, P1182, DOI 10.1016/j.bcp.2007.07.019; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Liao DL, 2002, NEUROPSYCHOBIOLOGY, V45, P172, DOI 10.1159/000063666; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Llerena A, 2003, SCHIZOPHR RES, V60, P311, DOI 10.1016/S0920-9964(02)00508-X; Lowe EJ, 2010, ANN PHARMACOTHER, V44, P727, DOI 10.1345/aph.1M398; Ma XH, 2010, PSYCHIAT RES, V178, P461, DOI 10.1016/j.psychres.2009.08.014; Maki P, 2005, BRIT MED BULL, V73-74, P1, DOI 10.1093/bmb/ldh046; MASTERSON E, 1984, BRIT J PSYCHIAT, V145, P429, DOI 10.1192/bjp.145.4.429; McCool RM, 2003, J SUBST ABUSE TREAT, V25, P43, DOI 10.1016/S0740-5472(03)00065-5; Menzies V, 2002, J AM PSYCHIAT NURSES, V8, P51; Meszaros ZS, 2011, AM J ADDICTION, V20, P462, DOI 10.1111/j.1521-0391.2011.00150.x; Pan ZF, 2004, HEALTH PROMOT INT, V19, P309, DOI 10.1093/heapro/dah304; Parry O, 2002, HEALTH PROMOT INT, V17, P309, DOI 10.1093/heapro/17.4.309; Patkar AA, 2002, J NERV MENT DIS, V190, P604, DOI 10.1097/00005053-200209000-00005; Qian JC, 2010, B WORLD HEALTH ORGAN, V88, P769, DOI 10.2471/BLT.09.064709; Quednow BB, 2012, P NATL ACAD SCI USA, V109, P6271, DOI 10.1073/pnas.1118051109; Rajji TK, 2006, BRIT J PSYCHIAT, V195, P286; REY MJ, 1989, INT CLIN PSYCHOPHARM, V4, P95, DOI 10.1097/00004850-198904000-00001; Rothman KJ, 1979, EPIDEMIOLOGIC ANAL P; Ryan H, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/918368; Sagud M, 2009, PSYCHIAT DANUB, V21, P371; SANDYK R, 1991, INT J NEUROSCI, V57, P259, DOI 10.3109/00207459109150699; [司天梅 Si Tianmei], 2004, [中国心理卫生杂志, Chinese Mental Health Journal], V18, P45; SIMPSON GM, 1970, ACTA PSYCHIAT SCAND, P11; Smith RC, 2002, NEUROPSYCHOPHARMACOL, V27, P479, DOI 10.1016/S0893-133X(02)00324-X; Steinberg ML, 2004, TOB CONTROL, V13, P206; Steinert T, 1996, FORTSCHR NEUROL PSYC, V64, P212, DOI 10.1055/s-2007-996388; Tang YL, 2007, J PSYCHIAT RES, V41, P43, DOI 10.1016/j.jpsychires.2005.10.009; Tang YL, 2007, SCHIZOPHR RES, V97, P88, DOI 10.1016/j.schres.2007.05.025; Tohen M, 2004, BRIT J PSYCHIAT, V184, P337, DOI 10.1192/bjp.184.4.337; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Uzun O, 2003, DRUG ALCOHOL DEPEN, V70, P187, DOI 10.1016/S0376-8716(02)00362-9; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Wang CY, 2010, AUST NZ J PSYCHIAT, V44, P456, DOI 10.3109/00048670903493348; Weiser M, 2004, AM J PSYCHIAT, V161, P1219, DOI 10.1176/appi.ajp.161.7.1219; Winterer G, 2010, CURR OPIN PSYCHIATR, V23, P112, DOI 10.1097/YCO.0b013e3283366643; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Xiang YT, 2009, ALCOHOL CLIN EXP RES, V33, P1111, DOI 10.1111/j.1530-0277.2009.00933.x; Xiao Z, 1990, SHANGHAI ARCH PSYCHI, V2, P66; Zammit S, 2003, AM J PSYCHIAT, V160, P2216, DOI 10.1176/appi.ajp.160.12.2216; Zhang M, 1998, HDB PSYCHISTRIC SCAL; Zhang XY, 2013, PSYCHOL MED, V43, P1651, DOI 10.1017/S0033291712002590; Zhang XY, 2012, J CLIN PSYCHIAT, V73, P1025, DOI 10.4088/JCP.11m07422; Zhang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030937; Zhang XY, 2011, PROG NEURO-PSYCHOPH, V35, P1765, DOI 10.1016/j.pnpbp.2011.06.006; Zhang XY, 2010, SCHIZOPHR RES, V119, P110, DOI 10.1016/j.schres.2009.11.012	81	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88478	10.1371/journal.pone.0088478	http://dx.doi.org/10.1371/journal.pone.0088478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520390	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600081
J	Yan, T; Rizak, JD; Yang, SC; Li, H; Huang, BH; Ma, YY; Hu, XT				Yan, Ting; Rizak, Joshua Dominic; Yang, ShangChuan; Li, Hao; Huang, BaiHui; Ma, YuanYe; Hu, XinTian			Acute Morphine Treatments Alleviate Tremor in 1Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Monkeys	PLOS ONE			English	Article							PARKINSONIAN RESTING TREMOR; VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA; DOPAMINERGIC AGENTS; RHESUS-MONKEYS; MITOCHONDRIAL DYSFUNCTION; MOTOR COMPLICATIONS; DYSKINETIC RESPONSE; PRIMATE MODELS; NEURAL SYSTEMS	Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder associated with decreased striatal dopamine levels. Morphine has been found to elevate dopamine levels, which indicates a potential therapeutic effect in PD treatment that has not been investigated previously. To evaluate this hypothesis, an investigation of the acute effects of morphine on PD symptoms was carried out in male rhesus PD monkeys that had been induced with MPTP. All MPTP induced monkeys displayed progressive and irreversible PD motor symptoms. The behavioral response of these animals to morphine and L-Dopa were quantified with the Kurlan scale. It was found that L-Dopa alleviated bradykinesia, but did not significantly improve tremor. In contrast, acute morphine alleviated tremor significantly. These results suggested that, compared to L-Dopa, morphine has different therapeutic effects in PD therapy and may act through different biological mechanisms to alleviate PD symptoms.	[Yan, Ting; Rizak, Joshua Dominic; Yang, ShangChuan; Li, Hao; Huang, BaiHui; Ma, YuanYe; Hu, XinTian] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Kunming, Yunnan, Peoples R China; [Ma, YuanYe; Hu, XinTian] Chinese Acad Sci, Kunming Inst Zool, Kunming Primate Res Ctr, Kunming, Yunnan, Peoples R China; [Ma, YuanYe; Hu, XinTian] Yunnan Key Lab Primate Biomed Res, Kunming, Yunnan, Peoples R China; [Yan, Ting; Rizak, Joshua Dominic; Li, Hao; Huang, BaiHui] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, YY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Kunming, Yunnan, Peoples R China.	yuanma0716@vip.sina.com; xthu@mail.kiz.ac.cn	Li, Hao/GPS-9834-2022		Strategic Priority Research Program of the Chinese Academy of Science [XDB02020000]; 973 program [2012CB825500, 2012CBA01304, 2011CB707800]; 863 program [2012AA020701, KSCX2-EW-J-23, KSCX2-EW-R-11]; National Science Foundation of China NSFC [91332120, 31271167, 31070963, 31271168, 81271495, 31070965]	Strategic Priority Research Program of the Chinese Academy of Science(Chinese Academy of Sciences); 973 program(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); National Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC))	This research was supported by the Strategic Priority Research Program of the Chinese Academy of Science XDB02020000, 973 program 2012CB825500, 2012CBA01304 and 2011CB707800, the 863 program 2012AA020701, KSCX2-EW-J-23 and KSCX2-EW-R-11, the National Science Foundation of China NSFC 91332120, 31271167, 31070963, 31271168, 81271495 and 31070965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bekheet SHM, 2010, TISSUE CELL, V42, P266, DOI 10.1016/j.tice.2010.06.001; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; BENAZZOUZ A, 1992, EXP BRAIN RES, V90, P116; Benninger DH, 2009, J NEUROL, V256, P256, DOI 10.1007/s00415-009-0092-2; Berg D, 1999, J NEURAL TRANSM, V106, P725, DOI 10.1007/s007020050192; Bergman H, 2002, MOVEMENT DISORD, V17, pS28, DOI 10.1002/mds.10140; Bergman H, 1998, MOVEMENT DISORD, V13, P29; Bezard E, 1997, BRAIN RES, V766, P107, DOI 10.1016/S0006-8993(97)00531-3; BJORNDAL N, 1980, PSYCHOPHARMACOLOGY, V69, P133, DOI 10.1007/BF00427638; Bontempi B, 1997, J NEUROSCI, V17, P8596; Boutrel B, 2008, BRIT J PHARMACOL, V154, P343, DOI 10.1038/bjp.2008.133; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Charron G, 2011, BRAIN, V134, P2321, DOI 10.1093/brain/awr166; Collier TJ, 2003, EXP NEUROL, V183, P258, DOI 10.1016/S0014-4886(03)00246-2; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Vries RLA, 2013, MOL CELL NEUROSCI, V55, P37, DOI 10.1016/j.mcn.2012.07.008; De Vries TJ, 2002, J NEUROSCI, V22, P3321; DEVINE DP, 1994, J NEUROSCI, V14, P1978; Elsworth JD, 2000, NEUROSCIENCE, V95, P399; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fricchione G, 2005, MED SCI MONITOR, V11, pMS54; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Guatteo E, 2013, EXP NEUROL; HANTRAYE P, 1993, NEUROSCIENCE, V53, P169, DOI 10.1016/0306-4522(93)90295-Q; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Hoehn MM, 2001, NEUROLOGY, V57, pS11; Hudzik TJ, 2000, EUR J PHARMACOL, V396, P101, DOI 10.1016/S0014-2999(00)00209-0; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; JENNER P, 1989, J NEUROL NEUROSUR PS, P22; JOHNSON SW, 1992, J NEUROSCI, V12, P483; KALIVAS PW, 1988, J NEUROCHEM, V50, P1498, DOI 10.1111/j.1471-4159.1988.tb03036.x; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Liu N, 2005, BRAIN RES, V1053, P137, DOI 10.1016/j.brainres.2005.06.037; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Mounayar S, 2007, BRAIN, V130, P2898, DOI 10.1093/brain/awm208; Muller T, 2013, CLIN NEUROPHARMACOL, V36, P84, DOI 10.1097/WNF.0b013e31828f3385; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Nakagawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024865; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; PARE D, 1990, NEUROSCIENCE, V35, P217, DOI 10.1016/0306-4522(90)90077-H; Perfeito R, 2012, FREE RADICAL BIO MED, V53, P1791, DOI 10.1016/j.freeradbiomed.2012.08.569; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Samadi P, 2005, NEUROBIOL DIS, V19, P266, DOI 10.1016/j.nbd.2005.01.006; Samadi P, 2004, NEUROBIOL DIS, V16, P246, DOI 10.1016/j.nbd.2004.02.002; Samadi P, 2003, NEUROPHARMACOLOGY, V45, P954, DOI 10.1016/S0028-3908(03)00249-1; Samadi P, 2006, TRENDS PHARMACOL SCI, V27, P512, DOI 10.1016/j.tips.2006.08.002; SCHNEIDER JS, 1990, BRAIN RES, V519, P122, DOI 10.1016/0006-8993(90)90069-N; SMITH RD, 1993, NEUROSCIENCE, V52, P7, DOI 10.1016/0306-4522(93)90176-G; Stefano GB, 2010, CNS NEUROSCI THER, V16, pe124, DOI 10.1111/j.1755-5949.2009.00114.x; VERMEULEN RJ, 1995, PSYCHOPHARMACOLOGY, V118, P451, DOI 10.1007/BF02245946; Vingerhoets FJG, 1997, ANN NEUROL, V41, P58, DOI 10.1002/ana.410410111; Winger G, 2001, DRUG ALCOHOL DEPEN, V62, P181, DOI 10.1016/S0376-8716(00)00166-6; Xu CL, 2012, PHARMACOL BIOCHEM BE, V100, P413, DOI 10.1016/j.pbb.2011.09.014	59	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88404	10.1371/journal.pone.0088404	http://dx.doi.org/10.1371/journal.pone.0088404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520383	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600074
J	Pernet, F; Lagarde, F; Jeannee, N; Daigle, G; Barret, J; Le Gall, P; Quere, C; D'orbcastel, ER				Pernet, Fabrice; Lagarde, Franck; Jeannee, Nicolas; Daigle, Gaetan; Barret, Jean; Le Gall, Patrik; Quere, Claudie; D'orbcastel, Emmanuelle Roque			Spatial and Temporal Dynamics of Mass Mortalities in Oysters Is Influenced by Energetic Reserves and Food Quality	PLOS ONE			English	Article							CRASSOSTREA-GIGAS; PACIFIC OYSTERS; OSTREID HERPESVIRUS-1; PERKINSUS-MARINUS; HEMOCYTE PARAMETERS; DISEASE; INFECTION; IMPACT; OSHV-1; EPIDEMIOLOGY	Although spatial studies of diseases on land have a long history, far fewer have been made on aquatic diseases. Here, we present the first large-scale, high-resolution spatial and temporal representation of a mass mortality phenomenon cause by the Ostreid herpesvirus (OsHV-1) that has affected oysters (Crassostrea gigas) every year since 2008, in relation to their energetic reserves and the quality of their food. Disease mortality was investigated in healthy oysters deployed at 106 locations in the Thau Mediterranean lagoon before the start of the epizootic in spring 2011. We found that disease mortality of oysters showed strong spatial dependence clearly reflecting the epizootic process of local transmission. Disease initiated inside oyster farms spread rapidly beyond these areas. Local differences in energetic condition of oysters, partly driven by variation in food quality, played a significant role in the spatial and temporal dynamics of disease mortality. In particular, the relative contribution of diatoms to the diet of oysters was positively correlated with their energetic reserves, which in turn decreased the risk of disease mortality.	[Pernet, Fabrice; Lagarde, Franck; Barret, Jean; Le Gall, Patrik; D'orbcastel, Emmanuelle Roque] IFREMER, Lab Environm Ressource Languedoc Roussill, Bd Jean Monnet, Sete, France; [Pernet, Fabrice; Quere, Claudie] Technopole Brestiroise, UMR LEMAR Ifremer CNRS UBO IRD, Plouzane, France; [Daigle, Gaetan] Univ Laval, Dept Math & Stat, Quebec City, PQ G1K 7P4, Canada	Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Laval University	Pernet, F (corresponding author), IFREMER, Lab Environm Ressource Languedoc Roussill, Bd Jean Monnet, Sete, France.	fabrice.pernet@ifremer.fr	lagarde, franck/AAD-6400-2022; Pernet, Fabrice/B-4051-2008; Lagarde, Franck/AAC-4490-2022	Pernet, Fabrice/0000-0001-8886-0184; Lagarde, Franck/0000-0002-3468-9593; roque d'orbcastel, emmanuelle/0000-0002-0954-0033; Le Gall, Patrik/0000-0002-9166-3648	France Agrimer; Region Languedoc-Roussillon; Conseil General de l'Herault; GIGASSAT; ANR-AGROBIOSPHERE [ANR-12-AGRO-0001-01]	France Agrimer; Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Conseil General de l'Herault(Region Occitanie); GIGASSAT; ANR-AGROBIOSPHERE(French National Research Agency (ANR))	This work was supported by grants from France Agrimer, Region Languedoc-Roussillon and Conseil General de l'Herault and is part of the GIGASSAT project funded by ANR-AGROBIOSPHERE No. ANR-12-AGRO-0001-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EFSA J, V8, P1894, DOI DOI 10.2903/J.EFSA.2010.1894; Beldomenico PM, 2008, P ROY SOC B-BIOL SCI, V275, P1753, DOI 10.1098/rspb.2008.0147; Beldomenico PM, 2009, EPIDEMICS-NETH, V1, P162, DOI 10.1016/j.epidem.2009.05.002; Binias C, 2014, MAR ECOL-EVOL PERSP, V35, P67, DOI 10.1111/maec.12087; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Clegg TA, 2011, PREV VET MED, V102, P255, DOI 10.1016/j.prevetmed.2011.07.014; COMPS M, 1977, CR ACAD SCI D NAT, V285, P1139; COX DR, 1972, J R STAT SOC B, V34, P187; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; de Montaudouin X, 2012, ESTUAR COAST SHELF S, V110, P54, DOI 10.1016/j.ecss.2012.02.005; Degremont L, 2013, AQUACULTURE, V416, P129, DOI 10.1016/j.aquaculture.2013.09.011; Degremont L, 2011, AQUACULTURE, V317, P94, DOI 10.1016/j.aquaculture.2011.04.029; Delaporte M, 2003, J EXP BIOL, V206, P3053, DOI 10.1242/jeb.00518; Delaporte M, 2007, J EXP MAR BIOL ECOL, V353, P45, DOI 10.1016/j.jembe.2007.09.003; Delaporte M, 2006, LIPIDS, V41, P567, DOI 10.1007/s11745-006-5006-9; Delaporte M, 2006, AQUACULTURE, V254, P571, DOI 10.1016/j.aquaculture.2005.10.006; Dupuy C, 2000, MAR ECOL PROG SER, V205, P171, DOI 10.3354/meps205171; Fleury E, 2013, RESCO RESEAU OBSERVA, P98; Flye-Sainte-Marie J, 2007, J EXP MAR BIOL ECOL, V349, P378, DOI 10.1016/j.jembe.2007.05.029; Ford SE, 1996, J SHELLFISH RES, V15, P45; Ford SE, 2012, J MAR RES, V70, P253, DOI 10.1357/002224012802851850; Genard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064534; Geovariances, 2008, ISATIS TECHN REF; Gestal C, 2008, REV FISH SCI, V16, P133, DOI 10.1080/10641260802325518; Gray BR, 2009, ECOTOXICOLOGY, V18, P259, DOI 10.1007/s10646-008-0279-9; Gustafson LL, 2007, PREV VET MED, V78, P35, DOI 10.1016/j.prevetmed.2006.09.006; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Jolivel A, 2012, ANAL STAT DONNEES MO, P67; Kang CK, 2006, MAR ECOL PROG SER, V315, P113, DOI 10.3354/meps315113; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Kristoffersen AB, 2009, PREV VET MED, V90, P127, DOI 10.1016/j.prevetmed.2009.04.003; Krkosek M, 2010, AQUACULT ENV INTERAC, V1, P21, DOI 10.3354/aei0004; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lazure P., 1992, Vie et Milieu, V42, P137; Legendre P., 2012, NUMERICAL ECOLOGY; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Martenot C, 2011, VIRUS RES, V160, P25, DOI 10.1016/j.virusres.2011.04.012; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; Moller AP, 1998, OIKOS, V83, P301, DOI 10.2307/3546841; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Oliver LM, 1998, DIS AQUAT ORGAN, V34, P51, DOI 10.3354/dao034051; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Paul-Pont I, 2013, DIS AQUAT ORGAN, V105, P127, DOI 10.3354/dao02615; Pepin JF, 2008, J VIROL METHODS, V149, P269, DOI 10.1016/j.jviromet.2008.01.022; Pernet F, 2012, AQUACULT ENV INTERAC, V2, P215, DOI 10.3354/aei00041; Pernet F, 2012, J SEA RES, V68, P20, DOI 10.1016/j.seares.2011.11.004; Pernet F, 2010, MAR ECOL PROG SER, V401, P129, DOI 10.3354/meps08407; Petton B, 2013, AQUACULT ENV INTERAC, V3, P257, DOI 10.3354/aei00070; Renault T., 2011, B OIE, V4, P51; Salama NKG, 2013, J FISH DIS, V36, P323, DOI 10.1111/jfd.12065; Salama NKG, 2011, AQUACULT ENV INTERAC, V2, P61, DOI 10.3354/aei00030; SAMAIN JF, 2008, SUMMER MORTALITY PAC; Sauvage C, 2009, VIRUS RES, V142, P181, DOI 10.1016/j.virusres.2009.02.013; Schikorski D, 2011, VIRUS RES, V155, P28, DOI 10.1016/j.virusres.2010.07.031; Schikorski D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-27; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Souchu P, 2001, MAR ECOL PROG SER, V218, P141, DOI 10.3354/meps218141; Soudant P, 2013, J INVERTEBR PATHOL, V114, P196, DOI 10.1016/j.jip.2013.06.001; Thieltges DW, 2007, OECOLOGIA, V150, P569, DOI 10.1007/s00442-006-0557-2; Townsend AK, 2010, P ROY SOC B-BIOL SCI, V277, P2875, DOI 10.1098/rspb.2010.0480; Viljugrein H, 2009, DIS AQUAT ORGAN, V88, P35, DOI 10.3354/dao02151; Wang XQ, 2012, FISH SHELLFISH IMMUN, V33, P1016, DOI 10.1016/j.fsi.2012.08.026; Wang Z, 2012, J MAR RES, V70, P279, DOI 10.1357/002224012802851931; White DL, 1998, J SHELLFISH RES, V17, P1473	66	65	66	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88469	10.1371/journal.pone.0088469	http://dx.doi.org/10.1371/journal.pone.0088469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551106	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500040
J	Zou, JY; Crews, FT				Zou, Jian Y.; Crews, Fulton T.			Release of Neuronal HMGB1 by Ethanol through Decreased HDAC Activity Activates Brain Neuroimmune Signaling	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; NF-KAPPA-B; CHROMATIN PROTEIN HMGB1; RECEPTOR 4; INDUCED NEUROINFLAMMATION; ALCOHOL-DRINKING; SLICE CULTURES; SPINAL-CORD; INDUCTION; CELLS	Neuroimmune gene induction is involved in many brain pathologies including addiction. Although increased expression of proinflammatory cytokines has been found in ethanol-treated mouse brain and rat brain slice cultures as well as in postmortem human alcoholic brain, the mechanisms remain elusive. High-mobility group box 1 (HMGB1) protein is a nuclear protein that has endogenous cytokine-like activity. We previously found increased HMGB1 in post-mortem alcoholic human brain as well as in ethanol treated mice and rat brain slice cultures. The present study investigated the mechanisms for ethanol-induced release of HMGB1 and neuroimmune activation in a model of rat hippocampal-entorhinal cortex (HEC) brain slice cultures. Ethanol exposure triggered dose-dependent HMGB1 release, predominantly from neuronal cells. Inhibitors of histone deacetylases (HDACs) promoted nucleocytoplasmic mobilization of HDAC1/4 and HMGB1 resulting in increased total HMGB1 and acetylated HMGB1 release. Similarly, ethanol treatment was found to induce the translocation of HDAC1/4 and HMGB1 proteins from nuclear to cytosolic fractions. Furthermore, ethanol treatment reduced HDAC1/4 mRNA and increased acetylated HMGB1 release into the media. These results suggest decreased HDAC activity may be critical in regulating acetylated HMGB1 release from neurons in response to ethanol. Ethanol and HMGB1 treatment increased mRNA expression of proinflammatory cytokines TNF alpha and IL-1 beta as well as toll-like receptor 4 (TLR4). Targeting HMGB1 or microglial TLR4 by using siRNAs to HMGB1 and TLR4, HMGB1 neutralizing antibody, HMGB1 inhibitor glycyrrhizin and TLR4 antagonist as well as inhibitor of microglial activation all blocked ethanol-induced expression of proinflammatory cytokines TNFa and IL-1 beta. These results support the hypothesis that ethanol alters HDACs that regulate HMGB1 release and that danger signal HMGB1 as endogenous ligand for TLR4 mediates ethanol-induced brain neuroimmune signaling through activation of microglial TLR4. These findings provide new therapeutic targets for brain neuroimmune activation and alcoholism.	[Zou, Jian Y.; Crews, Fulton T.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Crews, FT (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27514 USA.	ftcrews@med.unc.edu	Crews, Fulton/T-1181-2019	Crews, Fulton/0000-0003-2393-4976	National Institute on Alcohol Abuse and Alcoholism [AA020023, AA020024, AA020022, AA019767, AA11605, AA007573]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U54AA019767, T32AA007573, U24AA020024, U24AA020022, P60AA011605, U01AA020023, P50AA011605] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the National Institute on Alcohol Abuse and Alcoholism [AA020023, AA020024, AA020022, AA019767, AA11605 and AA007573]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Loeches S, 2012, GLIA, V60, P948, DOI 10.1002/glia.22327; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Botia B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047527; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Crews FT, 2012, BIOL PSYCHIAT; Crews FT, 2013, BIOL PSYCHIAT, V73, P602, DOI 10.1016/j.biopsych.2012.09.030; Crews FT, 2012, ALCOHOL RES-CURR REV, V34, P355; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Guldal CG, 2012, ACTA NEUROPATHOLOGIC; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kelley KW, 2011, BRAIN BEHAV IMMUN, V25, pS13, DOI 10.1016/j.bbi.2010.12.013; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Klune JR, 2008, J LEUKOCYTE BIOL, V83, P558, DOI 10.1189/jlb.0607406; Kutuzova GD, 2001, J IMMUNOL, V167, P482, DOI 10.4049/jimmunol.167.1.482; Liu JA, 2011, P NATL ACAD SCI USA, V108, P4465, DOI 10.1073/pnas.1019020108; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lo Coco D, 2007, NEUROSCI LETT, V412, P73, DOI 10.1016/j.neulet.2006.10.063; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Ma Lijuan, 2012, Immune Netw, V12, P148, DOI 10.4110/in.2012.12.4.148; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; OMARA NB, 1994, ANN PHARMACOTHER, V28, P210; Pascual M, 2012, NEUROPHARMACOLOGY, V62, P2309, DOI 10.1016/j.neuropharm.2012.01.011; Pascual M, 2011, BRAIN BEHAV IMMUN, V25, pS80, DOI 10.1016/j.bbi.2011.02.012; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-130; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Sakharkar AJ, 2012, ALCOHOL CLIN EXP RES, V36, P61, DOI 10.1111/j.1530-0277.2011.01581.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Yang HN, 2010, P NATL ACAD SCI USA, V107, P12611, DOI 10.1073/pnas.1006542107; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015; Zou J, 2006, CELL MOL NEUROBIOL, V26, P385, DOI 10.1007/s10571-006-9045-9; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077; Zou J, 2012, GLIA, V60, P661, DOI 10.1002/glia.22302; Zou J, 2010, ALCOHOL CLIN EXP RES, V34, P777, DOI 10.1111/j.1530-0277.2010.01150.x; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	56	131	134	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87915	10.1371/journal.pone.0087915	http://dx.doi.org/10.1371/journal.pone.0087915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551070	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500024
J	Foley, MH; Forcier, T; McAndrew, E; Gonzalez, M; Chen, HB; Juelg, B; Walker, BD; Irvine, DJ				Foley, Maria Hottelet; Forcier, Talitha; McAndrew, Elizabeth; Gonzalez, Michael; Chen, Huabiao; Juelg, Boris; Walker, Bruce D.; Irvine, Darrell J.			High Avidity CD8(+) T Cells Efficiently Eliminate Motile HIV-Infected Targets and Execute a Locally Focused Program of Anti-Viral Function	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNOLOGICAL SYNAPSE; ANTIGEN SENSITIVITY; LYMPHOCYTE RESPONSE; RHESUS MACAQUES; REPLICATION; ACTIVATION; SIV; POLYFUNCTIONALITY; TRANSMISSION	The dissemination of HIV from an initial site of infection is facilitated by motile HIV-infected CD4(+) T-cells. However, the impact of infected target cell migration on antigen recognition by HIV-specific CD8(+) T-cells is unclear. Using a 3D in vitro model of tissue, we visualized dynamic interactions between HIV-infected or peptide-pulsed CD4(+) T-cells and HIV-specific CD8(+) T-cells. CTLs engaged motile HIV-infected targets, but similar to 50% of targets broke contact and escaped. In contrast, immobilized target cells were readily killed, indicating target motility directly inhibits CD8(+) T-cell function. Strong calcium signals occurred in CTLs killing a motile target but calcium signaling was weak or absent in CTLs which permitted target escape. Neutralization of adhesion receptors LFA-1 and CD58 inhibited CD8(+) T-cell function within the 3D matrix, demonstrating that efficient motile target lysis as dependent on adhesive engagement of targets. Antigen sensitivity (a convolution of antigen density, TCR avidity and CD8 coreceptor binding) is also critical for target recognition. We modulated this parameter (known as functional avidity but referred to here as "avidity'' for the sake of simplicity) by exploiting common HIV escape mutations and measured their impact on CTL function at the single-cell level. Targets pulsed with low avidity mutant antigens frequently escaped while CTLs killed targets bearing high avidity antigen with near-perfect efficiency. CTLs engaged, arrested, and killed an initial target bearing high avidity antigen within minutes, but serial killing was surprisingly rare. CD8 cells remained committed to their initial dead target for hours, accumulating TCR signals that sustained secretion of soluble antiviral factors. These data indicate that high-avidity CD8(+) T-cells execute an antiviral program in the precise location where antigen has been sensed: CTL effector functions are spatiotemporally coordinated with an early lytic phase followed by a sustained stationary secretory phase to control local viral infection.	[Foley, Maria Hottelet; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Foley, Maria Hottelet; Forcier, Talitha; McAndrew, Elizabeth; Chen, Huabiao; Juelg, Boris; Walker, Bruce D.; Irvine, Darrell J.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Foley, Maria Hottelet; Forcier, Talitha; McAndrew, Elizabeth; Chen, Huabiao; Juelg, Boris; Walker, Bruce D.; Irvine, Darrell J.] Harvard Univ, Cambridge, MA 02138 USA; [Foley, Maria Hottelet; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Forcier, Talitha; Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Gonzalez, Michael; Walker, Bruce D.; Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Irvine, DJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	djirvine@mit.edu	Juelg, Boris/ABA-1955-2020	Juelg, Boris/0000-0002-4687-9626; Forcier, Talitha/0000-0002-7933-5086	Ragon Institute; NIH [AI030914, AI074415, AI060354]; Harvard Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI030914, P01AI074415] Funding Source: NIH RePORTER	Ragon Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Ragon Institute and the NIH (AI030914; AI074415; and AI060354), as well as the Harvard Center for AIDS Research. DJI and BDW are investigators of the HHMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Brown A, 2005, J LEUKOCYTE BIOL, V78, P675, DOI 10.1189/jlb.0505237; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Cerottini J C, 1974, Adv Immunol, V18, P67, DOI 10.1016/S0065-2776(08)60308-9; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Cocchi F, 2000, P NATL ACAD SCI USA, V97, P13812, DOI 10.1073/pnas.240469997; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Coppieters K, 2012, J CLIN INVEST, V122, P119, DOI 10.1172/JCI59285; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Friedl Peter, 2004, Methods Mol Biol, V239, P77; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Genesca M, 2007, J IMMUNOL, V179, P4732, DOI 10.4049/jimmunol.179.7.4732; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; ISAAZ S, 1995, EUR J IMMUNOL, V25, P1071, DOI 10.1002/eji.1830250432; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Jenkins MR, 2009, CELL DEATH DIFFER, V16, P537, DOI 10.1038/cdd.2008.176; Kang SS, 2011, J EXP MED, V208, P747, DOI 10.1084/jem.20101295; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Petrovas C, 2004, CURR HIV RES, V2, P153, DOI 10.2174/1570162043484960; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; ROTHSTEIN TL, 1978, J IMMUNOL, V121, P1652; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; SHAW S, 1986, NATURE, V323, P262, DOI 10.1038/323262a0; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; TSOMIDES TJ, 1994, J EXP MED, V180, P1283, DOI 10.1084/jem.180.4.1283; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Weigelin B, 2010, BIOCHEM PHARMACOL, V80, P2087, DOI 10.1016/j.bcp.2010.09.004; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; ZAGURY D, 1975, EUR J IMMUNOL, V5, P818, DOI 10.1002/eji.1830051205; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	63	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87873	10.1371/journal.pone.0087873	http://dx.doi.org/10.1371/journal.pone.0087873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551068	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000019
J	Huang, RY; Lin, YF; Kao, SY; Shieh, YS; Chen, JS				Huang, Ren-Yeong; Lin, Yuh-Feng; Kao, Sen-Yeong; Shieh, Yi-Shing; Chen, Jin-Shuen			A Retrospective Case-Control Analysis of the Outpatient Expenditures for Western Medicine and Dental Treatment Modalities in CKD Patients in Taiwan	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ERYTHROPOIESIS-STIMULATING AGENTS; STAGE RENAL-DISEASE; HEALTH-CARE-SYSTEM; INCREASED RISK; ORAL-HEALTH; POPULATION; COST; ASSOCIATION; DIALYSIS	Background: To determine if expenditures for dentistry (DENT) correlate with severity of chronic kidney disease (CKD). Methods: A total of 10,457 subjects were enrolled from January 2008 to December 2010, divided into three groups: healthy control (HC) group (n = 1,438), high risk (HR) group (n = 3,392), and CKD group (n = 5,627). Five stages were further categorized for the CKD group. OPD utilization and expenditures for western medicine (WM), DENT, and TCM (traditional Chinese medicine) were analyzed retrospectively (2000-2008) using Taiwan's National Health Insurance Research Database. Three major areas were analyzed among groups CKD, HR and HC in this study: 1) demographic data and medical history; 2) utilization (visits/person/year) and expenditures (9-year cumulative expenditure, expenditure/person/year) for OPD services in WM, DENT, and TCM; and 3) utilization and expenditures for dental OPD services, particularly in dental filling, root canal and periodontal therapy. Results: OPD utilization and expenditures of WM increased significantly for the CKD group compared with the HR and HC groups, and increased steadily along with the severity of CKD stages. However, overall DENT and TCM utilization and expenditures did not increase for the CKD group. In comparison among different CKD stages, the average expenditures and utilization for DENT including restorative filling and periodontal therapy, but not root canal therapy, showed significant decreases according to severity of CKD stage, indicating less DENT OPD utilization with progression of CKD. Conclusions: Patients with advanced CKD used DENT OPD service less frequently. However, the connection between CKD and DENT service utilization requires further study.	[Huang, Ren-Yeong] Natl Def Med Ctr, Triserv Gen Hosp, Sch Dent, Dept Periodontol, Taipei, Taiwan; [Lin, Yuh-Feng; Chen, Jin-Shuen] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Lin, Yuh-Feng] Shuang Ho Hosp, Dept Med, Div Nephrol, New Taipei City, Taiwan; [Lin, Yuh-Feng] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Kao, Sen-Yeong] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Shieh, Yi-Shing] Natl Def Med Ctr, Triserv Gen Hosp, Sch Dent, Dept Oral Diag, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chen, JS (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	dgschen@ndmctsgh.edu.tw	Huang, Ren-Yeong/N-2202-2019	Kao, Senyeong/0000-0002-0209-240X	National Science Council of Taiwan [DOH97-HP-1101, DOH-98-1110, DOH99-HP-1106, DOH100-HP-1102, DOH101-HP-1103, DOH102-HP-1103]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study is based in part on data from the NHIRD provided by the Bureau of NHI, Department of Health, and managed by National Health Research Institutes in Taiwan and supported by the National Science Council of Taiwan under grant DOH97-HP-1101, DOH-98-1110, DOH99-HP-1106, DOH100-HP-1102, DOH101-HP-1103, and DOH102-HP-1103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar H, 2011, CLIN J AM SOC NEPHRO, V6, P218, DOI 10.2215/CJN.05470610; Bessette RW, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-65; Chang JM, 2012, CLIN EXP NEPHROL, V16, P187, DOI 10.1007/s10157-012-0592-8; Chang RE, 2011, SOC SCI MED, V73, P153, DOI 10.1016/j.socscimed.2011.05.007; Chen LP, 2006, AM J KIDNEY DIS, V47, P815, DOI 10.1053/j.ajkd.2006.01.018; Chen LP, 2011, AM J KIDNEY DIS, V57, P276, DOI 10.1053/j.ajkd.2010.09.016; Chiang HH, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-78; Chou CY, 2009, PUBLIC HEALTH NUTR, V12, P723, DOI 10.1017/S1368980008003339; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fisher MA, 2008, J PERIODONTOL, V79, P1670, DOI 10.1902/jop.2008.070569 ; Fisher MA, 2008, AM J KIDNEY DIS, V51, P45, DOI 10.1053/j.ajkd.2007.09.018; Frankenfield DL, 2012, AM J KIDNEY DIS, V59, P670, DOI 10.1053/j.ajkd.2011.10.047; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grima DT, 2012, PHARMACOECONOMICS, V30, P981, DOI 10.2165/11599390-000000000-00000; Grubbs V, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-16; Grubbs V, 2011, CLIN J AM SOC NEPHRO, V6, P711, DOI 10.2215/CJN.08270910; Hassan Y, 2009, ANN PHARMACOTHER, V43, P1598, DOI 10.1345/aph.1M187; Hidalgo G, 2013, AM J KIDNEY DIS, V62, P1087, DOI 10.1053/j.ajkd.2013.06.013; Higashiyama A, 2009, HYPERTENS RES, V32, P450, DOI 10.1038/hr.2009.51; Hsu YH, 2011, NEPHROLOGY, V16, P751, DOI 10.1111/j.1440-1797.2011.01489.x; Huang CS, 2013, J FORMOS MED ASSOC, V112, P527, DOI 10.1016/j.jfma.2013.06.011; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Keller JJ, 2012, J CLIN PERIODONTOL, V39, P507, DOI 10.1111/j.1600-051X.2012.01879.x; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Khan S, 2008, J EVAL CLIN PRACT, V14, P422, DOI 10.1111/j.1365-2753.2007.00883.x; Kuo CF, 2012, SCAND J RHEUMATOL, V41, P44, DOI 10.3109/03009742.2011.618145; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levin A, 2009, NEPHROL DIAL TRANSPL, V24, P2714, DOI 10.1093/ndt/gfp180; Liang CH, 2011, INT NURS REV, V58, P463, DOI 10.1111/j.1466-7657.2011.00913.x; Lin C, 2013, LARYNGOSCOPE, V123, P767, DOI 10.1002/lary.23669; Lin MY, 2010, NEPHROL DIAL TRANSPL, V25, P3230, DOI 10.1093/ndt/gfq158; Lo Presti R, 2007, NUTRITION, V23, P598, DOI 10.1016/j.nut.2007.04.012; Lu CT, 1996, J ORAL PATHOL MED, V25, P245, DOI 10.1111/j.1600-0714.1996.tb01379.x; Luciano Eduardo de Paiva, 2012, J Bras Nefrol, V34, P226; Plantinga LC, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110052; Proctor R, 2005, J DENT RES, V84, P199, DOI 10.1177/154405910508400301; Rohn Edward J, 2006, J Dent Educ, V70, P1038; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; Schiller B, 2008, HEMODIAL INT, V12, P441, DOI 10.1111/j.1542-4758.2008.00308.x; Shelley D, 2011, J URBAN HEALTH, V88, P651, DOI 10.1007/s11524-011-9555-8; Summers SA, 2007, AM J MED, V120, P568, DOI 10.1016/j.amjmed.2006.12.007; Thorman R, 2009, SCAND J UROL NEPHROL, V43, P154, DOI 10.1080/00365590802464817; Trivedi H, 2010, ADV CHRONIC KIDNEY D, V17, P265, DOI 10.1053/j.ackd.2010.03.007; Uhlig K, 2010, AM J KIDNEY DIS, V55, P773, DOI 10.1053/j.ajkd.2010.02.340; Vekeman Francis, 2010, J Med Econ, V13, P673, DOI 10.3111/13696998.2010.529032; Vesterinen M, 2007, QUINTESSENCE INT, V38, P211; Wang TF, 2013, QUAL LIFE RES, V22, P811, DOI 10.1007/s11136-012-0205-8; White CA, 2007, KIDNEY INT, V71, P312, DOI 10.1038/sj.ki.5002037; Wiebe N, 2012, CLIN J AM SOC NEPHRO, V7, P24, DOI 10.2215/CJN.07350711; Wish J, 2009, KIDNEY BLOOD PRESS R, V32, P110, DOI 10.1159/000213166; Wish JB, 2007, MAYO CLIN PROC, V82, P1371, DOI 10.4065/82.11.1371; Wu JC, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10268; Wu MY, 2012, AM J KIDNEY DIS, V60, P548, DOI 10.1053/j.ajkd.2012.03.018; Yang M, 2011, ADV CHRONIC KIDNEY D, V18, P400, DOI 10.1053/j.ackd.2011.10.001; Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292; Yuen HK, 2010, SPEC CARE DENT, V30, P151, DOI 10.1111/j.1754-4505.2010.00146.x; Yuh DY, 2013, J PERIODONTOL, V84, P1528, DOI 10.1902/jop.2013.120580	58	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88418	10.1371/journal.pone.0088418	http://dx.doi.org/10.1371/journal.pone.0088418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533085	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600043
J	McCarthy, RC; Kosman, DJ				McCarthy, Ryan C.; Kosman, Daniel J.			Glial Cell Ceruloplasmin and Hepcidin Differentially Regulate Iron Efflux from Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED FORM; RAT-BRAIN; FERROXIDASE ACTIVITY; MOLECULAR-MECHANISM; OXIDATIVE STRESS; IN-VITRO; FERROPORTIN; EXPRESSION; BARRIER	We have used an in vitro model system to probe the iron transport pathway across the brain microvascular endothelial cells (BMVEC) of the blood-brain barrier (BBB). This model consists of human BMVEC (hBMVEC) and C6 glioma cells (as an astrocytic cell line) grown in a transwell, a cell culture system commonly used to quantify metabolite flux across a cell-derived barrier. We found that iron efflux from hBMVEC through the ferrous iron permease ferroportin (Fpn) was stimulated by secretion of the soluble form of the multi-copper ferroxidase, ceruloplasmin (sCp) from the co-cultured C6 cells. Reciprocally, expression of sCp mRNA in the C6 cells was increased by neighboring hBMVEC. In addition, data indicate that C6 cell-secreted hepcidin stimulates internalization of hBMVEC Fpn but only when the end-feet projections characteristic of this glia-derived cell line are proximal to the endothelial cells. This hepcidin-dependent loss of Fpn correlated with knock-down of iron efflux from the hBMVEC; this result was consistent with the mechanism by which hepcidin regulates iron efflux in mammalian cells. In summary, the data support a model of iron trafficking across the BBB in which the capillary endothelium induce the underlying astrocytes to produce the ferroxidase activity needed to support Fpn-mediated iron efflux. Reciprocally, astrocyte proximity modulates the effective concentration of hepcidin at the endothelial cell membrane and thus the surface expression of hBMVEC Fpn. These results are independent of the source of hBMVEC iron (transferrin or non-transferrin bound) indicating that the model developed here is broadly applicable to brain iron homeostasis.	[McCarthy, Ryan C.; Kosman, Daniel J.] Univ Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), Univ Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14222 USA.	camkos@buffalo.edu			National Institutes of Health [DK053820]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053820, R01DK053820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant DK053820 from the National Institutes of Health to DJK and a fellowship from the American Heart Association to RCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; BAKKER GR, 1986, J BIOL CHEM, V261, P3182; Boveri M, 2005, GLIA, V51, P187, DOI 10.1002/glia.20189; BRALET J, 1992, BIOCHEM PHARMACOL, V43, P979, DOI 10.1016/0006-2952(92)90602-F; Christie R, 2001, AM J PATHOL, V158, P1065, DOI 10.1016/S0002-9440(10)64053-9; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Demeuse P, 2002, J NEUROSCI METH, V121, P21, DOI 10.1016/S0165-0270(02)00225-X; Diaz-Coranguez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060655; Dringen R, 2007, NEUROCHEM RES, V32, P1884, DOI 10.1007/s11064-007-9375-0; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Easton AS, 2002, BRAIN RES, V953, P157, DOI 10.1016/S0006-8993(02)03281-X; Ebrahimi KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072177; Ebrahimi KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040287; Fung E, 2013, MOL PHARMACOL, V83, P681, DOI 10.1124/mol.112.083428; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P109, DOI 10.1167/iovs.10-6113; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hurst RD, 1996, J CELL PHYSIOL, V167, P81, DOI 10.1002/(SICI)1097-4652(199604)167:1<81::AID-JCP9>3.3.CO;2-F; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Marksteiner J, 2008, MOL PSYCHIATR, V13, P939, DOI 10.1038/sj.mp.4002072; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Moos T, 2000, CELL MOL NEUROBIOL, V20, P77, DOI 10.1023/A:1006948027674; MOOS T, 1995, DEV BRAIN RES, V87, P203, DOI 10.1016/0165-3806(95)00077-Q; Moos T, 2006, J NEUROCHEM, V98, P1946, DOI 10.1111/j.1471-4159.2006.04023.x; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Preza GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058934; Qian ZM, 2007, J CELL BIOCHEM, V102, P1225, DOI 10.1002/jcb.21352; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Raha AA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-55; Roberts BR, 2012, J NEUROCHEM, V120, P149, DOI 10.1111/j.1471-4159.2011.07500.x; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Schikorski T, 1997, J NEUROSCI, V17, P5858; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; Skjorringe T, 2012, FRONT PHARMACOL, V3; Slany A, 2010, J PROTEOME RES, V9, P6, DOI 10.1021/pr900057t; Stankiewicz JM, 2009, CURR OPIN CLIN NUTR, V12, P22, DOI 10.1097/MCO.0b013e32831ba07c; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Takayama G, 2007, TISSUE ENG, V13, P159, DOI 10.1089/ten.2006.0143; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Villarroel P, 2012, BIOL TRACE ELEM RES, V150, P496, DOI 10.1007/s12011-012-9522-6; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Wang SM, 2010, CELL MOL LIFE SCI, V67, P123, DOI 10.1007/s00018-009-0167-3; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; XU J, 1994, J ANAT, V184, P227; Yang WM, 2011, CELL MOL NEUROBIOL, V31, P93, DOI 10.1007/s10571-010-9558-0; Zechel S, 2006, J NEUROSCI RES, V84, P790, DOI 10.1002/jnr.20991	66	71	74	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89003	10.1371/journal.pone.0089003	http://dx.doi.org/10.1371/journal.pone.0089003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533165	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600125
J	Kasneci, E; Sippel, K; Aehling, K; Heister, M; Rosenstiel, W; Schiefer, U; Papageorgiou, E				Kasneci, Enkelejda; Sippel, Katrin; Aehling, Kathrin; Heister, Martin; Rosenstiel, Wolfgang; Schiefer, Ulrich; Papageorgiou, Elena			Driving with Binocular Visual Field Loss? A Study on a Supervised On-Road Parcours with Simultaneous Eye and Head Tracking	PLOS ONE			English	Article							HEMIANOPIA; MOVEMENTS; GLAUCOMA; PERFORMANCE; PEOPLE; COORDINATION; PATTERNS	Post-chiasmal visual pathway lesions and glaucomatous optic neuropathy cause binocular visual field defects (VFDs) that may critically interfere with quality of life and driving licensure. The aims of this study were (i) to assess the on-road driving performance of patients suffering from binocular visual field loss using a dual-brake vehicle, and (ii) to investigate the related compensatory mechanisms. A driving instructor, blinded to the participants' diagnosis, rated the driving performance (passed/failed) of ten patients with homonymous visual field defects (HP), including four patients with right (HR) and six patients with left homonymous visual field defects (HL), ten glaucoma patients (GP), and twenty age and gender-related ophthalmologically healthy control subjects (C) during a 40-minute driving task on a pre-specified public onroad parcours. In order to investigate the subjects' visual exploration ability, eye movements were recorded by means of a mobile eye tracker. Two additional cameras were used to monitor the driving scene and record head and shoulder movements. Thus this study is novel as a quantitative assessment of eye movements and an additional evaluation of head and shoulder was performed. Six out of ten HP and four out of ten GP were rated as fit to drive by the driving instructor, despite their binocular visual field loss. Three out of 20 control subjects failed the on-road assessment. The extent of the visual field defect was of minor importance with regard to the driving performance. The site of the homonymous visual field defect (HVFD) critically interfered with the driving ability: all failed HP subjects suffered from left homonymous visual field loss (HL) due to right hemispheric lesions. Patients who failed the driving assessment had mainly difficulties with lane keeping and gap judgment ability. Patients who passed the test displayed different exploration patterns than those who failed. Patients who passed focused longer on the central area of the visual field than patients who failed the test. In addition, patients who passed the test performed more glances towards the area of their visual field defect. In conclusion, our findings support the hypothesis that the extent of visual field per se cannot predict driving fitness, because some patients with HVFDs and advanced glaucoma can compensate for their deficit by effective visual scanning. Head movements appeared to be superior to eye and shoulder movements in predicting the outcome of the driving test under the present study scenario.	[Kasneci, Enkelejda; Sippel, Katrin; Rosenstiel, Wolfgang] Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Dept Comp Engn, Tubingen, Germany; [Aehling, Kathrin; Heister, Martin; Schiefer, Ulrich; Papageorgiou, Elena] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Tubingen, Germany; [Schiefer, Ulrich] Univ Appl Sci Aalen, Competence Ctr Vis Res, Study Course Ophthalm Opt Audiol, Aalen, Germany; [Papageorgiou, Elena] Univ Leicester, Leicester Royal Infirm, Dept Ophthalmol, Leicester, Leics, England	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hochschule Aalen; University of Leicester	Kasneci, E (corresponding author), Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Dept Comp Engn, Tubingen, Germany.	enkelejda.kasneci@uni-tuebingen.de		Papageorgiou, Eleni/0000-0003-1931-4168; Sippel, Katrin/0000-0003-4433-8938	PFIZER Pharma GmbH, Berlin, Germany; MSD, SHARP & DOHME GmbH, Haar, Germany	PFIZER Pharma GmbH, Berlin, Germany; MSD, SHARP & DOHME GmbH, Haar, Germany	PFIZER Pharma GmbH, Berlin, Germany, and MSD, SHARP & DOHME GmbH, Haar, Germany provided financial support to this study. This funding was used for compensation of the recruited subjects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulhorn E, 1977, DOCUM OPHTHAL P SERI, V14, P17; BARNES GR, 1979, J PHYSIOL-LONDON, V287, P127, DOI 10.1113/jphysiol.1979.sp012650; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Bowers AR, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/176806; Bowers AR, 2010, INVEST OPHTH VIS SCI, V51, P6605, DOI 10.1167/iovs.10-5310; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Cheong AMY, 2008, OPTOMETRY VISION SCI, V85, P26, DOI 10.1097/OPX.0b013e31815ed6fd; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Einhauser W, 2007, NETWORK-COMP NEURAL, V18, P267, DOI 10.1080/09548980701671094; Elgin J, 2010, AM J OCCUP THER, V64, P268, DOI 10.5014/ajot.64.2.268; FULLER JH, 1992, EXP BRAIN RES, V92, P152; GUITTON D, 1987, J NEUROPHYSIOL, V58, P427, DOI 10.1152/jn.1987.58.3.427; Hamel J, 2012, JOVE-J VIS EXP, DOI 10.3791/4427; Hardiess G, 2010, VISION RES, V50, P1158, DOI 10.1016/j.visres.2010.04.004; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; HERMANBENZUR P, 1976, J NEUROL SCI, V28, P301, DOI 10.1016/0022-510X(76)90023-X; ISHIAI S, 1987, NEUROPSYCHOLOGIA, V25, P675, DOI 10.1016/0028-3932(87)90058-3; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; Karnath H-O, 2006, NEUROPSYCHOLOGIE; Kooijman Aart C, 2008, Vis Impair Res, V10, P1, DOI 10.1080/13882350802053582; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; MCCLOSKEY LW, 1994, AGE AGEING, V23, P267, DOI 10.1093/ageing/23.4.267; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; MEERWALDT JD, 1982, J NEUROL NEUROSUR PS, V45, P586, DOI 10.1136/jnnp.45.7.586; Niehorster DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056615; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; Pambakian ALM, 2000, J NEUROL NEUROSUR PS, V69, P751, DOI 10.1136/jnnp.69.6.751; Papageorgiou E, 2012, VISION RES, V65, P25, DOI 10.1016/j.visres.2012.06.004; Parker WT, 2011, CURR EYE RES, V36, P270, DOI 10.3109/02713683.2010.548893; Pflugshaupt T, 2009, VISION RES, V49, P237, DOI 10.1016/j.visres.2008.10.021; Proudlock FA, 2007, PROG RETIN EYE RES, V26, P486, DOI 10.1016/j.preteyeres.2007.03.004; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; R Core Team, 2018, R LANG ENV STAT COMP; SZLYK JP, 1993, OPTOMETRY VISION SCI, V70, P1031, DOI 10.1097/00006324-199312000-00007; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Szlyk JP, 2002, J REHABIL RES DEV, V39, P483; Tafaj E, 2014, P S EYE TRACK RES AP; Tafaj E, 2012, P S EYE TRACK RES AP, P285, DOI DOI 10.1145/2168556.2168617; Tafaj E, 2013, LECT NOTES COMPUT SC, V8131, P442, DOI 10.1007/978-3-642-40728-4_56; Tant MLM, 2002, VISION RES, V42, P1339, DOI 10.1016/S0042-6989(02)00044-5; Tant MLM, 2002, NEUROPSYCHOL REHABIL, V12, P419, DOI 10.1080/09602010244000183; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P1220, DOI 10.1167/iovs.10-6296; Wood JM, 2009, INVEST OPHTH VIS SCI, V50, P577, DOI 10.1167/iovs.08-2506; ZANGEMEISTER WH, 1982, EXP NEUROL, V75, P389, DOI 10.1016/0014-4886(82)90169-8; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A	50	83	83	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e87470	10.1371/journal.pone.0087470	http://dx.doi.org/10.1371/journal.pone.0087470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523869	Green Published, gold			2022-12-27	WOS:000331258100018
J	Carrel, M; Eron, JJ; Emch, M; Hurt, CB				Carrel, Margaret; Eron, Joseph J., Jr.; Emch, Michael; Hurt, Christopher B.			Spatial Epidemiology of Recently Acquired HIV Infections across Rural and Urban Areas of North Carolina	PLOS ONE			English	Article							ANTIRETROVIRAL-DRUG-RESISTANCE; UNITED-STATES; TIME TRENDS; PREVALENCE; SURVEILLANCE; INDIVIDUALS; MUTATIONS; THERAPY	Transmission of HIV continues in the United States (US), despite prevention efforts aimed at education and treatment. Concurrently, drug resistance in HIV, particularly in patients being infected with HIV for the first time, poses a threat to the continued success of treatment for HIV positive individuals. In North Carolina, nearly one in five individuals with acute HIV infection (AHI) is infected with a drug-resistant strain, a phenomenon known as transmitted drug resistance (TDR). Few studies of AHI or TDR take into account both the spatial aspects of residence at time of infection and the genetic characteristics of the viruses, and questions remain about how viruses are transmitted across space and the rural-urban divide. Using AHI strains from North Carolina, we examined whether differences exist in the spatial patterns of AHI versus AHI with TDR, as well as whether the genetic characteristics of these HIV infections vary by rural-urban status and across Health Service Areas. The highest amounts of TDR were detected in persons under age 30, African Americans, and men who have sex with men (MSM) - similar to the populations where the highest numbers of AHI without TDR are observed. Nearly a quarter of patients reside in rural areas, and there are no significant differences between rural and urban residence among individuals infected with drug resistant or drug susceptible viruses. We observe similar levels of genetic distance between HIV found in rural and urban areas, indicating that viruses are shared across the rural-urban divide. Genetic differences are observed, however, across Health Service Areas, suggesting that local areas are sites of genetic differentiation in viruses being transmitted to newly infected individuals. These results indicate that future efforts to prevent HIV transmission need to be spatially targeted, focusing on local-level transmission in risky populations, in addition to statewide anti- HIV efforts.	[Carrel, Margaret] Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52240 USA; [Eron, Joseph J., Jr.; Hurt, Christopher B.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; [Emch, Michael] Univ N Carolina, Dept Geog, Chapel Hill, NC USA	University of Iowa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carrel, M (corresponding author), Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52240 USA.	margaret-carrel@uiowa.edu			NIH NICHD [R24HD050924]; National Institute for Allergy and Infectious Diseases [5P30AI50410]; National Center for Advancing Translational Sciences [8KL2TR000084]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000084, KL2TR001109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MC and ME were supported by NIH NICHD R24HD050924. www.nichd.nih.gov. JE was supported by National Institute for Allergy and Infectious Diseases, 5P30AI50410. www.niaid.nih.gov. CBH was supported by National Center for Advancing Translational Sciences, 8KL2TR000084. www.ncats.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral SO, 2006, SEX TRANSM DIS, V33, pS1, DOI 10.1097/01.olq.0000223249.04456.76; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; CDC, 2013, HIV SURV REP; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Dennis AM, 2011, CLIN INFECT DIS, V53, P480, DOI 10.1093/cid/cir434; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Gupta RK, 2012, LANCET; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Hurt CB, 2013, SEX TRANSM DIS, V40, P213, DOI 10.1097/OLQ.0b013e318284e3d2; Hurt CB, 2009, ANTIVIR THER, V14, P673; Lieb S, 2011, AIDS BEHAV, V15, P596, DOI 10.1007/s10461-010-9820-y; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Masquelier BND, 2005, JAIDS-J ACQ IMM DEF, V40, P505, DOI 10.1097/01.qai.0000186361.42834.61; McKellar MS, 2013, AIDS RES HUM RETROV, V29, P121, DOI [10.1089/aid.2012.0064, 10.1089/AID.2012.0064]; Oster AM, 2011, AIDS, V25, P2157, DOI 10.1097/QAD.0b013e32834bfde9; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR, P1; Pilcher CD, 2001, AIDS, V15, P837, DOI 10.1097/00002030-200105040-00004; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Prejean J, 2012, J COMMUNITY HLTH, P1; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Ross L, 2007, HIV CLIN TRIALS, V8, P1, DOI 10.1310/hct0801-1; Soeters HM, 2013, AIDS, V27, P2873, DOI 10.1097/01.aids.0000433240.78739.30; Southern HIV/AIDS Strategy Initiative, 2012, SASI UPD CONT HIV CR; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05; Z Gant, 2012, Open AIDS J, V6, P1, DOI 10.2174/1874613601206010001	36	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88512	10.1371/journal.pone.0088512	http://dx.doi.org/10.1371/journal.pone.0088512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520392	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600083
J	Giordano, A; Cogan, NOI; Kaur, S; Drayton, M; Mouradov, A; Panter, S; Schrauf, GE; Mason, JG; Spangenberg, GC				Giordano, Andrea; Cogan, Noel O. I.; Kaur, Sukhjiwan; Drayton, Michelle; Mouradov, Aidyn; Panter, Stephen; Schrauf, Gustavo E.; Mason, John G.; Spangenberg, German C.			Gene Discovery and Molecular Marker Development, Based on High-Throughput Transcript Sequencing of Paspalum dilatatum Poir	PLOS ONE			English	Article							MICROSATELLITE MARKERS; MEDICAGO-TRUNCATULA; GENOME RELATIONS; SSR-MARKERS; EST-SSRS; PLANT; BARLEY; TRANSFERABILITY; WHEAT; RICE	Background: Paspalum dilatatum Poir. (common name dallisgrass) is a native grass species of South America, with special relevance to dairy and red meat production. P. dilatatum exhibits higher forage quality than other C4 forage grasses and is tolerant to frost and water stress. This species is predominantly cultivated in an apomictic monoculture, with an inherent high risk that biotic and abiotic stresses could potentially devastate productivity. Therefore, advanced breeding strategies that characterise and use available genetic diversity, or assess germplasm collections effectively are required to deliver advanced cultivars for production systems. However, there are limited genomic resources available for this forage grass species. Results: Transcriptome sequencing using second-generation sequencing platforms has been employed using pooled RNA from different tissues (stems, roots, leaves and inflorescences) at the final reproductive stage of P. dilatatum cultivar Primo. A total of 324,695 sequence reads were obtained, corresponding to c. 102 Mbp. The sequences were assembled, generating 20,16(contigs of a combined length of 9,336,138 nucleotides. The contigs were BLAST analysed against the fully sequenced grass species of Oryza sativa subsp. japonica, Brachypodium distachyon, the closely related Sorghum bicolor and foxtail millet (Setaria italica) genomes as well as against the UniRef 90 protein database allowing a comprehensive gene ontology analysis to be performed. The contigs generated from the transcript sequencing were also analysed for the presence of simple sequence repeats (SSRs). A total of 2,33(SSR motifs were identified within 1,98(contigs and corresponding primer pairs were designed. Empirical validation of a cohort of 96 SSRs was performed, with 34% being polymorphic between sexual and apomictic biotypes. Conclusions: The development of genetic and genomic resources for P. dilatatum will contribute to gene discovery and expression studies. Association of gene function with agronomic traits will significantly enable molecular breeding and advance germplasm enhancement.	[Giordano, Andrea; Cogan, Noel O. I.; Kaur, Sukhjiwan; Drayton, Michelle; Mouradov, Aidyn; Panter, Stephen; Mason, John G.; Spangenberg, German C.] AgriBio, Ctr AgriBiosci, Dept Environm & Primary Ind, Bundoora, Vic, Australia; [Giordano, Andrea; Cogan, Noel O. I.; Drayton, Michelle; Mouradov, Aidyn; Panter, Stephen; Spangenberg, German C.] Mol Plant Breeding Cooperat Res Ctr, Bundoora, Vic, Australia; [Giordano, Andrea; Cogan, Noel O. I.; Drayton, Michelle; Mouradov, Aidyn; Panter, Stephen; Mason, John G.; Spangenberg, German C.] Dairy Futures Cooperat Res Ctr, Bundoora, Vic, Australia; [Giordano, Andrea; Mason, John G.; Spangenberg, German C.] La Trobe Univ, Bundoora, Vic, Australia; [Schrauf, Gustavo E.] Univ Buenos Aires, Fac Agron, Buenos Aires, DF, Argentina	La Trobe University; La Trobe University; University of Buenos Aires	Spangenberg, GC (corresponding author), AgriBio, Ctr AgriBiosci, Dept Environm & Primary Ind, Bundoora, Vic, Australia.	german.spangenberg@depi.vic.gov.au	Giordano, Andrea M/J-8535-2015	Giordano, Andrea M/0000-0001-5652-4282; Cogan, Noel/0000-0003-1074-8998; Mouradov, Aidyn/0000-0003-2945-3751	Victorian Department of Primary Industries; Dairy Futures Cooperative Research Centre; Molecular Plant Breeding Cooperative Research Centre	Victorian Department of Primary Industries; Dairy Futures Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Molecular Plant Breeding Cooperative Research Centre	This work was supported by funding from the Victorian Department of Primary Industries, the Dairy Futures Cooperative Research Centre and the Molecular Plant Breeding Cooperative Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2005, J HERED, V96, P644, DOI 10.1093/jhered/esi097; AKASHI R, 1992, PLANT SCI, V82, P219, DOI 10.1016/0168-9452(92)90223-9; AKKAYA MS, 1992, GENETICS, V132, P1131; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; BENNETT HW, 1966, CROP SCI, V6, P52, DOI 10.2135/cropsci1966.0011183X000600010016x; Blom CWPM, 1996, TRENDS ECOL EVOL, V11, P290, DOI 10.1016/0169-5347(96)10034-3; BURSON BL, 1978, CAN J GENET CYTOL, V20, P365, DOI 10.1139/g78-041; BURSON BL, 1993, EUPHYTICA, V67, P71, DOI 10.1007/BF00022727; BURSON BL, 1973, CROP SCI, V13, P739, DOI 10.2135/cropsci1973.0011183X001300060045x; BURTON GLENN W., 1962, CROP SCI, V2, P495, DOI 10.2135/cropsci1962.0011183X000200060016x; Burton GW, 1943, J HERED, V34, P15, DOI 10.1093/oxfordjournals.jhered.a105214; Cardle L, 2000, GENETICS, V156, P847; Castillo A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-97; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; CHASE AGNES, 1929, CONTRIB U S NATION HERB, V28, P1; Christin PA, 2009, GENOME BIOL EVOL, V1, P221, DOI 10.1093/gbe/evp020; Cidade FW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-50; Clayton W.D., 1983, GENETIC RESOURCES FO, P39; COLE RJ, 1977, J AGR FOOD CHEM, V25, P1197, DOI 10.1021/jf60213a061; DAVIES LJ, 1992, CAN J PLANT SCI, V72, P773, DOI 10.4141/cjps92-093; DAVIES LJ, 1991, NEW ZEAL J AGR RES, V34, P249; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Gao LF, 2003, MOL BREEDING, V12, P245, DOI 10.1023/A:1026346121217; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; HACKER JB, 1974, AUST J AGR RES, V25, P45, DOI 10.1071/AR9740045; Harlan J., 1983, GENET RESOURC FORAGE, V3, P3; Hayman DL, 1956, I AGR SCI J, V22, P292; Holt EC, 1956, TEXAS AGR EXPT STATI, V829, P14; Hougaard BK, 2008, GENETICS, V179, P2299, DOI 10.1534/genetics.108.090084; Hutton EM, 1968, SOME CONCEPTS METHOD, P79; Jackson MB, 1999, PLANT BIOLOGY, V1, P274, DOI 10.1055/s-2007-978516; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Li X, 2011, CROP PASTURE SCI, V62, P218, DOI 10.1071/CP10352; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzgar D, 2000, GENOME RES, V10, P72; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miz RB, 2006, GENET RESOUR CROP EV, V53, P541, DOI 10.1007/s10722-005-1290-0; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park YJ, 2009, MOLECULES, V14, P4546, DOI 10.3390/molecules14114546; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; ROBINSON DL, 1988, COMMUN SOIL SCI PLAN, V19, P529, DOI 10.1080/00103628809367957; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schrauf GE, 2003, TROP GRASSLANDS, V37, P182; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Souza-Chies TT, 2006, GENETICA, V126, P15, DOI 10.1007/s10709-005-1428-1; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tang JF, 2006, EUPHYTICA, V151, P87, DOI 10.1007/s10681-006-9131-6; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Vaio M, 2007, PLANT SYST EVOL, V265, P109, DOI 10.1007/s00606-006-0506-x; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang LY, 2005, THEOR APPL GENET, V111, P677, DOI 10.1007/s00122-005-2041-5; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	74	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e85050	10.1371/journal.pone.0085050	http://dx.doi.org/10.1371/journal.pone.0085050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520314	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600004
J	Piecha, M; Juras, G; Krol, P; Sobota, G; Polak, A; Bacik, B				Piecha, Magdalena; Juras, Grzegorz; Krol, Piotr; Sobota, Grzegorz; Polak, Anna; Bacik, Bogdan			The Effect of a Short-Term and Long-Term Whole-Body Vibration in Healthy Men upon the Postural Stability	PLOS ONE			English	Article							MUSCLE VIBRATION; TENDON VIBRATION; HUMAN BALANCE; FREQUENCY; STRENGTH; EXERCISE; PERFORMANCE; ADAPTATION; RESPONSES; MOVEMENT	The study aimed to establish the short-term and long-term effects of whole-body vibration on postural stability. The sample consisted of 28 male subjects randomly allocated to four comparative groups, three of which exercised on a vibration platform with parameters set individually for the groups. The stabilographic signal was recorded before the test commenced, after a single session of whole-body vibration, immediately after the last set of exercises of the 4-week whole-body vibration training, and one week after the training ended. The subjects were exposed to vibrations 3 times a week for 4 weeks. Long-term vibration training significantly shortened the rambling and trembling paths in the frontal plane. The path lengths were significantly reduced in the frontal plane one week after the training end date. Most changes in the values of the center of pressure (COP) path lengths in the sagittal and frontal plane were statistically insignificant. We concluded that long-term vibration training improves the postural stability of young healthy individuals in the frontal plane.	[Piecha, Magdalena; Krol, Piotr; Polak, Anna] Jerzy Kukuczka Acad Phys Educ, Dept Physiotherapy Basics, Katowice, Poland; [Juras, Grzegorz; Sobota, Grzegorz; Bacik, Bogdan] Jerzy Kukuczka Acad Phys Educ, Dept Human Motor Behav, Katowice, Poland	Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Piecha, M (corresponding author), Jerzy Kukuczka Acad Phys Educ, Dept Physiotherapy Basics, Katowice, Poland.	magdapiecha@wp.pl	Król, Piotr/W-7308-2019; Sobota, Grzegorz/W-1150-2018; Stania, Magdalena/X-2502-2018	Król, Piotr/0000-0001-7673-4375; Sobota, Grzegorz/0000-0002-8281-0431; Stania, Magdalena/0000-0001-6535-6858; Bacik, Bogdan/0000-0002-9894-3474; Juras, Grzegorz/0000-0001-8081-8854				Adamcova N, 2007, GAIT POSTURE, V25, P99, DOI 10.1016/j.gaitpost.2006.01.008; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Capicikova N, 2006, PHYSIOL RES, V55, pS129, DOI 10.33549/physiolres.930000.55.S1.129; Cochrane DJ, 2011, INT J SPORTS MED, V32, P75, DOI 10.1055/s-0030-1268010; Cochrane DJ, 2011, J SPORT SCI MED, V10, P19; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; de Freitas PB, 2009, HUM MOVEMENT SCI, V28, P515, DOI 10.1016/j.humov.2009.02.001; Dolny DG, 2008, CURR SPORT MED REP, V7, P152, DOI 10.1097/01.CSMR.0000319708.18052.a1; Duclos C, 2007, NEUROIMAGE, V34, P774, DOI 10.1016/j.neuroimage.2006.06.050; EKLUND G, 1966, EXP NEUROL, V16, P80, DOI 10.1016/0014-4886(66)90088-4; Fort A, 2012, J STRENGTH COND RES, V26, P926, DOI 10.1519/JSC.0b013e31822e02a5; Fransson PA, 2000, GAIT POSTURE, V12, P14, DOI 10.1016/S0966-6362(00)00052-7; Gomez S, 2009, GAIT POSTURE, V30, P93, DOI 10.1016/j.gaitpost.2009.03.009; Gyulai G, 2013, ACTA PHYSIOL HUNG, V100, P37, DOI 10.1556/APhysiol.99.2012.005; Horak FB, 1997, GAIT POSTURE, V6, P76, DOI 10.1016/S0966-6362(97)00018-0; Jackson SW, 2003, EUR J APPL PHYSIOL, V88, P380, DOI 10.1007/s00421-002-0701-6; Jordan MJ, 2005, J STRENGTH COND RES, V19, P459, DOI 10.1519/13293.1; Kawanabe Kazuhiro, 2007, Keio Journal of Medicine, V56, P28, DOI 10.2302/kjm.56.28; Kouzaki M, 2000, J APPL PHYSIOL, V89, P1420, DOI 10.1152/jappl.2000.89.4.1420; Krol P, 2011, J SPORT SCI MED, V10, P169; Kuczynski M, 2001, HUM MOVEMENT SCI, V2, P33; Massion J, 1998, NEUROSCI BIOBEHAV R, V22, P465, DOI 10.1016/S0149-7634(97)00031-6; Milton J, 2009, PLOS ONE, V4, P1; Milton JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007427; Moezy A, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038554; Patel M, 2009, CLIN NEUROPHYSIOL, V120, P601, DOI 10.1016/j.clinph.2008.11.026; Piecha M, 2013, ACTA BIOENG BIOMECH, V15, P29, DOI 10.5277/abb130304; Polonyova A, 2001, PHYSIOL RES, V50, P405; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Salavati M, 2007, GAIT POSTURE, V26, P214, DOI 10.1016/j.gaitpost.2006.09.001; Schuhfried O, 2005, CLIN REHABIL, V19, P834, DOI 10.1191/0269215505cr919oa; Slomka K, 2013, GAIT POSTURE, V37, P210, DOI 10.1016/j.gaitpost.2012.07.005; Tahayori B, 2012, MOTOR CONTROL, V16, P144, DOI 10.1123/mcj.16.2.144; THOMAS DP, 1959, J ANAT, V93, P524; Thompson C, 2007, CLIN NEUROPHYSIOL, V118, P2456, DOI 10.1016/j.clinph.2007.08.013; Tihanyi J, 2010, ACTA PHYSIOL HUNG, V97, P172, DOI 10.1556/APhysiol.97.2010.2.3; Torvinen S, 2002, MED SCI SPORT EXER, V34, P1523, DOI 10.1097/00005768-200209000-00020; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Vuillerme N, 2002, NEUROSCI LETT, V333, P131, DOI 10.1016/S0304-3940(02)00999-0; Wierzbicka MM, 1998, J NEUROPHYSIOL, V79, P143, DOI 10.1152/jn.1998.79.1.143; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Zatsiorsky VM, 1999, MOTOR CONTROL, V3, P28, DOI 10.1123/mcj.3.1.28; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	44	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88295	10.1371/journal.pone.0088295	http://dx.doi.org/10.1371/journal.pone.0088295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520362	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600053
J	Shin, IJ; Son, SU; Park, H; Kim, Y; Park, SH; Swanberg, K; Shin, JY; Ha, SK; Cho, Y; Bang, SY; Lew, JH; Cho, SH; Maeng, S				Shin, Im-Joon; Son, Sung Un; Park, Hyunwoo; Kim, Yoorim; Park, Sung Hyun; Swanberg, Kelley; Shin, Joo-Yeon; Ha, Sang-Kyu; Cho, Yoonju; Bang, Soo-Yong; Lew, Jae-Hwan; Cho, Seung-Hun; Maeng, Sungho			Preclinical Evidence of Rapid-Onset Antidepressant-Like Effect in Radix Polygalae Extract	PLOS ONE			English	Article							TAIL SUSPENSION TEST; CHRONIC MILD STRESS; AMPA RECEPTOR; ANIMAL-MODELS; TENUIFOLIA; KETAMINE; NMDA; ANTAGONIST; DEPRESSION; TENUIGENIN	Radix Polygalae (the root of Polygala tenuifolia) is a herb widely used in traditional Asian medicine that is thought to exert a variety of neuropsychiatric effects. Radix Polygalae extract can protect against N-methyl D-aspartate (NMDA) neurotoxicity and induce brain-derived neurotrophic factor (BDNF) expression, suggesting modulatory roles at glutamatergic synapses and possible antidepressant action. In accordance with this hypothesis, Radix Polygalae extract demonstrated antidepressant-like effects in 8-week-old male C57Bl/6 mice by decreasing behavioral despair in the forced swim and tail suspension tasks and increasing hedonic-like behavior in the female urine sniffing test 30 minutes after a single oral administration of 0.1 mg/kg. Reduced latency to acquire a food pellet in the novely suppressed feeding paradigm, without change in anxiety-like behaviors suggested a rapid-onset nature of the antidepressant-like effect. In addition, it decreased the number of failed escapes in the learned helplessness paradigm after two oral administrations 24 hours and 30 minutes before the first test. Finally, it reversed anhedonia as measured by saccharin preference in mice exposed to the chronic stress model after two administrations of 0.1 mg/kg, in contrast to the repeated administration generally needed for similar effect by monoamergic antidepressants. Immobility reduction in tail suspension task was blocked by the alpha-amino-3-hydroxy- 5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist NBQX, a pattern previously demonstrated by ketamine and other ketamine-like rapid-onset antidepressants. Also similarly to ketamine, Radix Polygalae appeared to acutely decrease phosphorylation of GluR1 serine-845 in the hippocampus while leaving the phosphorylation of hippocampal mTOR serine 2448 unchanged. These findings serve as preclinical evidence that Radix Polygalae extract exerts rapid-onset antidepressant effects by modulating glutamatergic synapses in critical brain circuits of depression and may be worthy of further evaluation as a safe substitute to other rapid-onset antidepressants known to have unacceptable side effects.	[Shin, Im-Joon; Cho, Yoonju] Kyung Hee Univ, Coll Oriental Med, Dept Appl Korean Med, Seoul, South Korea; [Son, Sung Un; Park, Hyunwoo; Kim, Yoorim; Park, Sung Hyun; Swanberg, Kelley; Shin, Joo-Yeon; Ha, Sang-Kyu; Bang, Soo-Yong; Lew, Jae-Hwan; Maeng, Sungho] Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med, Yongin, South Korea; [Cho, Seung-Hun] Kyung Hee Univ, Coll Oriental Med, Dept Neuropsychiat, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University	Maeng, S (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med, Yongin, South Korea.	jethrot@hotmail.com	Maeng, Sungho/N-2905-2018; Cho, Seung-Hun/F-1294-2010; Swanberg, Kelley M./AAC-6427-2021	Maeng, Sungho/0000-0002-9347-7902; Cho, Seung-Hun/0000-0002-0627-768X; Swanberg, Kelley M./0000-0002-1254-190X	Kyung Hee University [KHU-20101838]; National Research Foundation of Korea (NRF); Korea government [MEST] [2012-0005755]	Kyung Hee University; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government [MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the Kyung Hee University in 2010 (KHU-20101838) and by the National Research Foundation of Korea (NRF) grant funded by the Korea government [MEST] (No. 2012-0005755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bettio LE, 2012, BEHAV BRAIN RES; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Bradley SR, 2012, PHARMACOL BIOCHEM BE, V101, P35, DOI 10.1016/j.pbb.2011.11.006; Burgdorf J, 2013, NEUROPSYCHOPHARMACOL, V38, P729, DOI 10.1038/npp.2012.246; Calabrese JR, 2000, J CLIN PSYCHIAT, V61, P841, DOI 10.4088/JCP.v61n1106; Chang H.M., 1986, WORLD SCI, P593, DOI [10.1142/9789814503143_0070, DOI 10.1142/9789814503143_0070]; Chen YJ, 2010, EUR J PHARMACOL, V645, P1, DOI 10.1016/j.ejphar.2010.06.034; Chen YJ, 2012, NEUROCHEM RES, V37, P771, DOI 10.1007/s11064-011-0671-3; Cheng MC, 2006, J NAT PROD, V69, P1305, DOI 10.1021/np060207r; Chung IW, 1992, J KOREAN NEUROPSYCHI, V31, P856; CORSSEN G, 1969, Proceedings of the Institute of Medicine of Chicago, V27, P341; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Denk MC, 2011, AM J PSYCHIAT, V168, P751, DOI 10.1176/appi.ajp.2011.11010128; Der-Avakian A, 2012, TRENDS NEUROSCI, V35, P68, DOI 10.1016/j.tins.2011.11.005; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Dwyer JM, 2012, INT J NEUROPSYCHOPH, V15, P429, DOI 10.1017/S1461145711001702; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Farber NB, 2003, ANN NY ACAD SCI, V1003, P119, DOI 10.1196/annals.1300.008; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Garcia-Gutierrez MS, 2010, BRIT J PHARMACOL, V160, P1773, DOI 10.1111/j.1476-5381.2010.00819.x; Gibbons RD, 2012, ARCH GEN PSYCHIAT; Gourley SL, 2012, PSYCHOPHARMACOLOGY, V219, P805, DOI 10.1007/s00213-011-2403-4; 이지용, 2004, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V18, P544; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Hu Y, 2010, PHARM BIOL, V48, P794, DOI 10.3109/13880200903280034; Hu Y, 2010, NEUROCHEM INT, V56, P461, DOI 10.1016/j.neuint.2009.12.004; Hu Y, 2009, PHARMAZIE, V64, P605, DOI 10.1691/ph.2009.9580; Ibrahim L, 2012, J CLIN PSYCHOPHARM, V32, P551, DOI 10.1097/JCP.0b013e31825d70d6; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kawashima K, 2004, BIOL PHARM BULL, V27, P1317, DOI 10.1248/bpb.27.1317; KEITH SJ, 1993, PSYCHOPHARMACOL BULL, V29, P427; Lee HJ, 2004, AM J CHINESE MED, V32, P599, DOI 10.1142/S0192415X04002235; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee Young Jong, 2005, [The Korea Journal of Herbology, 대한본초학회지], V20, P115; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liu P, 2010, PHYTOMEDICINE, V17, P794, DOI 10.1016/j.phymed.2010.01.004; Lv J, 2009, ACTA PHYSIOL, V196, P419, DOI 10.1111/j.1748-1716.2009.01961.x; Maeng Sungho, 2007, Curr Psychiatry Rep, V9, P467, DOI 10.1007/s11920-007-0063-1; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; MATTHEWS K, 1995, PHYSIOL BEHAV, V57, P241, DOI 10.1016/0031-9384(94)00286-E; MORYL E, 1993, PHARMACOL TOXICOL, V72, P394, DOI 10.1111/j.1600-0773.1993.tb01351.x; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; Palucha-Poniewiera A, 2010, PSYCHOPHARMACOLOGY, V212, P523, DOI 10.1007/s00213-010-1978-5; Papp M, 1996, EUR J PHARMACOL, V316, P145, DOI 10.1016/S0014-2999(96)00675-9; Pomierny-Chamiolo L, 2010, PHARMACOL REP, V62, P1186, DOI 10.1016/S1734-1140(10)70381-9; Pryce CR, 2011, PHARMACOL THERAPEUT, V132, P242, DOI 10.1016/j.pharmthera.2011.06.006; Sanacora G, 2007, BIOL PSYCHIAT, V61, P822, DOI 10.1016/j.biopsych.2006.08.037; Shimazaki T, 2007, EUR J PHARMACOL, V575, P94, DOI 10.1016/j.ejphar.2007.08.006; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sui Zhi-Yan, 2012, Clin Psychopharmacol Neurosci, V10, P155, DOI 10.9758/cpn.2012.10.3.155; Sun XL, 2007, BIOL PHARM BULL, V30, P1727, DOI 10.1248/bpb.30.1727; Sun Yan, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1199; Wilkinson P, 2012, COCHRANE DB SYST REV, V11; Willner P, 1996, PHYSIOL BEHAV, V60, P129, DOI 10.1016/0031-9384(95)02256-2; Xie WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045575; Yang C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/175619; Zarate CA, 2004, AM J PSYCHIAT, V161, P171, DOI 10.1176/appi.ajp.161.1.171; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhang H, 2008, PHYTOMEDICINE, V15, P587, DOI 10.1016/j.phymed.2007.12.004	68	44	46	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88617	10.1371/journal.pone.0088617	http://dx.doi.org/10.1371/journal.pone.0088617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520403	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600094
J	Sundar, IK; Yao, HW; Huang, YD; Lyda, E; Sime, PJ; Sellix, MT; Rahman, I				Sundar, Isaac K.; Yao, Hongwei; Huang, Yadi; Lyda, Elizabeth; Sime, Patricia J.; Sellix, Michael T.; Rahman, Irfan			Serotonin and Corticosterone Rhythms in Mice Exposed to Cigarette Smoke and in Patients with COPD: Implication for COPD-Associated Neuropathogenesis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIRCADIAN-RHYTHM; CHRONIC-BRONCHITIS; PLASMA-CORTICOSTERONE; TRANSPORTER GENE; OXIDATIVE STRESS; NEUROPEPTIDE-Y; DEPRESSION; LUNG; ANXIETY	The circadian timing system controls daily rhythms of physiology and behavior, and disruption of clock function can trigger stressful life events. Daily exposure to cigarette smoke (CS) can lead to alteration in diverse biological and physiological processes. Smoking is associated with mood disorders, including depression and anxiety. Patients with chronic obstructive pulmonary disease (COPD) have abnormal circadian rhythms, reflected by daily changes in respiratory symptoms and lung function. Corticosterone (CORT) is an adrenal steroid that plays a considerable role in stress and anti-inflammatory responses. Serotonin (5-hydroxytryptamine; 5HT)is a neurohormone, which plays a role in sleep/wake regulation and affective disorders. Secretion of stress hormones (CORT and 5HT) is under the control of the circadian clock in the suprachiasmatic nucleus. Since smoking is a contributing factor in the development of COPD, we hypothesize that CS can affect circadian rhythms of CORT and 5HT secretion leading to sleep and mood disorders in smokers and patients with COPD. We measured the daily rhythms of plasma CORT and 5HT in mice following acute (3 d), sub-chronic (10 d) or chronic (6 mo) CS exposure and in plasma from non-smokers, smokers and patients with COPD. Acute and chronic CS exposure affected both the timing (peak phase) and amplitude of the daily rhythm of plasma CORT and 5HT in mice. Acute CS appeared to have subtle time-dependent effects on CORT levels but more pronounced effects on 5HT. As compared with CORT, plasma 5HT was slightly elevated in smokers but was reduced in patients with COPD. Thus, the effects of CS on plasma 5HT were consistent between mice and patients with COPD. Together, these data reveal a significant impact of CS exposure on rhythms of stress hormone secretion and subsequent detrimental effects on cognitive function, depression-like behavior, mood/anxiety and sleep quality in smokers and patients with COPD.	[Sundar, Isaac K.; Yao, Hongwei; Huang, Yadi; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Lyda, Elizabeth; Sime, Patricia J.] Univ Rochester, Med Ctr, Dept Med Pulm, Rochester, NY 14642 USA; [Sellix, Michael T.] Univ Rochester, Med Ctr, Dept Med, Div Endocrinol & Metab, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012; Yao, Hongwei/G-6444-2010	Sundar, Isaac K/0000-0001-6742-3460; 	National Institutes of Health [1R01HL097751, 1R01HL092842]; National Institute of Environmental Health Sciences Environmental Health Science Center [P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092842, R01HL097751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences Environmental Health Science Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health 1R01HL097751 (to IR), 1R01HL092842 (to IR) and National Institute of Environmental Health Sciences Environmental Health Science Center grant P30-ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2011, EUR RESPIR REV, V20, P183, DOI 10.1183/09059180.00004311; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; ALTLAND PD, 1978, ENVIRON RES, V15, P160, DOI 10.1016/0013-9351(78)90089-0; Antoniu SA, 2011, EXPERT REV RESP MED, V5, P333, DOI [10.1586/ers.11.30, 10.1586/ERS.11.30]; Atkinson HC, 1997, ENDOCRINOLOGY, V138, P3842, DOI 10.1210/en.138.9.3842; Ban Y, 2007, ATHEROSCLEROSIS, V195, P153, DOI 10.1016/j.atherosclerosis.2006.09.005; Bando H, 2007, J NEUROSCI, V27, P4359, DOI 10.1523/JNEUROSCI.4131-06.2007; BARNES PJ, 1985, AM J MED, V79, P5, DOI 10.1016/0002-9343(85)90080-4; Borsboom GJJM, 1999, AM J RESP CRIT CARE, V159, P1163, DOI 10.1164/ajrccm.159.4.9703106; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI [10.1007/s00213-010-1832-9, 10.1007/s00213-010-2097-z]; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Chen H, 2005, NEUROPSYCHOPHARMACOL, V30, P713, DOI 10.1038/sj.npp.1300597; Chen H, 2008, BRAIN RES, V1228, P81, DOI 10.1016/j.brainres.2008.06.067; Chen H, 2007, AM J PHYSIOL-ENDOC M, V293, pE1564, DOI 10.1152/ajpendo.00442.2007; Chen H, 2006, AM J RESP CRIT CARE, V173, P1248, DOI 10.1164/rccm.200506-977OC; Ciarleglio CM, 2011, NEUROSCIENCE, V197, P8, DOI 10.1016/j.neuroscience.2011.09.036; Di Marco F, 2006, RESP MED, V100, P1767, DOI 10.1016/j.rmed.2006.01.026; Dome P, 2010, NEUROSCI BIOBEHAV R, V34, P295, DOI 10.1016/j.neubiorev.2009.07.013; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Dupont LL, 2013, PULM PHARM THER; Eddahibi S, 2003, CIRCULATION, V108, P1839, DOI 10.1161/01.CIR.0000091409.53101.E8; ESSMAN WB, 1975, PSYCHOL REP, V37, P112, DOI 10.2466/pr0.1975.37.1.112; Gebel S, 2006, TOXICOL SCI, V93, P422, DOI 10.1093/toxsci/kfl071; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gierisch JM, 2012, J GEN INTERN MED, V27, P351, DOI 10.1007/s11606-011-1915-2; Hadden H, 2012, J APPL PHYSIOL, V113, P385, DOI 10.1152/japplphysiol.00244.2012; Hanania NA, 2011, AM J RESP CRIT CARE, V183, P604, DOI 10.1164/rccm.201003-0472OC; Hida A, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-7; Hwang JW, 2011, J IMMUNOL, V187, P987, DOI 10.4049/jimmunol.1001861; Hwang JW, 2013, FASEB J; Ishii T, 2011, J HUM GENET, V56, P41, DOI 10.1038/jhg.2010.133; ISHIKAWA M, 1995, PHYSIOL BEHAV, V57, P41, DOI 10.1016/0031-9384(94)00192-8; Kalynchuk LE, 2004, BEHAV NEUROSCI, V118, P1365, DOI 10.1037/0735-7044.118.6.1365; Kim Chung Mi, 2003, Korean Journal of Internal Medicine, V18, P76; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lau WKW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031617; Lau WKW, 2012, FREE RADICAL RES, V46, P1413, DOI 10.3109/10715762.2012.721928; Launay JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007959; Laurin C, 2012, AM J RESP CRIT CARE, V185, P918, DOI 10.1164/rccm.201105-0939PP; Lewis D A, 2001, Curr Opin Pulm Med, V7, P105, DOI 10.1097/00063198-200103000-00008; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Lutfy K, 2012, J NEUROCHEM, V120, P1108, DOI 10.1111/j.1471-4159.2011.07633.x; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; MCNICHOLAS WT, 1984, BRIT MED J, V289, P878, DOI 10.1136/bmj.289.6449.878; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Murphy JM, 2003, AM J PSYCHIAT, V160, P1663, DOI 10.1176/appi.ajp.160.9.1663; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Mykletun A, 2008, EUR PSYCHIAT, V23, P77, DOI 10.1016/j.eurpsy.2007.10.005; Papi Alberto, 2006, Proc Am Thorac Soc, V3, P245, DOI 10.1513/pats.200512-125SF; Prosser RA, 2003, BRAIN RES, V966, P110, DOI 10.1016/S0006-8993(02)04206-3; Rabe KF, 2007, AM J RESP CRIT CARE, V175, P1222, DOI 10.1164/rccm.200704-586UP; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Rosen CJ, 2009, NEW ENGL J MED, V360, P957, DOI 10.1056/NEJMp0810058; Sekiduka-Kumano T, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-159; Soldin OP, 2011, STEROIDS, V76, P653, DOI 10.1016/j.steroids.2011.02.042; Sollars PJ, 2002, J BIOL RHYTHM, V17, P428, DOI 10.1177/074873002237137; Spengler CM, 2000, AM J RESP CRIT CARE, V162, P1038, DOI 10.1164/ajrccm.162.3.9911107; Stinn W, 2013, TOXICOL SCI, V131, P596, DOI 10.1093/toxsci/kfs312; Tafet GE, 2001, COGN AFFECT BEHAV NE, V1, P388, DOI 10.3758/CABN.1.4.388; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thomas A, 1993, Pneumologie, V47, P526; Tsai CL, 2007, CHRONOBIOL INT, V24, P699, DOI 10.1080/07420520701535753; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wagena EJ, 2004, EUR J EPIDEMIOL, V19, P147, DOI 10.1023/B:EJEP.0000017825.07470.41; Wagena EJ, 2005, PSYCHOSOM MED, V67, P656, DOI 10.1097/01.psy.0000171197.29484.6b; Wilson Ian, 2006, Int J Chron Obstruct Pulmon Dis, V1, P61, DOI 10.2147/copd.2006.1.1.61; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang MWB, 2011, GEN HOSP PSYCHIAT, V33, P217, DOI 10.1016/j.genhosppsych.2011.03.009	74	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87999	10.1371/journal.pone.0087999	http://dx.doi.org/10.1371/journal.pone.0087999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520342	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600033
J	Van Sinderen, ML; Steinberg, GR; Jorgensen, SB; To, SQ; Knower, KC; Clyne, CD; Honeyman, J; Chow, JD; Herridge, KA; Jones, MEE; Simpson, ER; Boon, WC				Van Sinderen, Michelle L.; Steinberg, Gregory R.; Jorgensen, Sebastian B.; To, Sarah Q.; Knower, Kevin C.; Clyne, Colin D.; Honeyman, Jane; Chow, Jenny D.; Herridge, Kerrie A.; Jones, Margaret E. E.; Simpson, Evan R.; Boon, Wah Chin			Hepatic Glucose Intolerance Precedes Hepatic Steatosis in the Male Aromatase Knockout (ArKO) Mouse	PLOS ONE			English	Article							INSULIN-RESISTANCE; RECEPTOR-ALPHA; SKELETAL-MUSCLE; ADIPOSE-TISSUE; OB/OB MICE; DEFICIENT; EXPRESSION; ESTRADIOL; LIVER; GENE	Estrogens are known to play a role in modulating metabolic processes within the body. The Aromatase knockout (ArKO) mice have been shown to harbor factors of Metabolic syndrome with central adiposity, hyperinsulinemia and male-specific hepatic steatosis. To determine the effects of estrogen ablation and subsequent replacement in males on whole body glucose metabolism, three-and six-month-old male ArKO mice were subjected to whole body glucose, insulin and pyruvate tolerance tests and analyzed for ensuing metabolic changes in liver, adipose tissue, and skeletal muscle. Estrogen-deficient male ArKO mice showed increased gonadal adiposity which was significantly reduced upon 17b-estradiol (E2) treatment. Concurrently, elevated ArKO serum leptin levels were significantly reduced upon E2 treatment and lowered serum adiponectin levels were restored to wild type levels. Three-month-old male ArKO mice were hyperglycemic, and both glucose and pyruvate intolerant. These phenotypes continued through to 6 months of age, highlighting a loss of glycemic control. ArKO livers displayed changes in gluconeogenic enzyme expression, and in insulin signaling pathways upon E2 treatment. Liver triglycerides were increased in the ArKO males only after 6 months of age, which could be reversed by E2 treatment. No differences were observed in insulin-stimulated ex vivo muscle glucose uptake nor changes in ArKO adipose tissue and muscle insulin signaling pathways. Therefore, we conclude that male ArKO mice develop hepatic glucose intolerance by the age of 3 months which precedes the sex-specific development of hepatic steatosis. This can be reversed upon the administration of exogenous E2.	[Van Sinderen, Michelle L.; To, Sarah Q.; Knower, Kevin C.; Clyne, Colin D.; Chow, Jenny D.; Herridge, Kerrie A.; Jones, Margaret E. E.; Simpson, Evan R.; Boon, Wah Chin] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Boon, Wah Chin] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Van Sinderen, Michelle L.; Chow, Jenny D.; Jones, Margaret E. E.; Boon, Wah Chin] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Steinberg, Gregory R.; Jorgensen, Sebastian B.; Honeyman, Jane] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Steinberg, Gregory R.; Jorgensen, Sebastian B.; Honeyman, Jane] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Steinberg, Gregory R.] McMaster Univ, Div Endocrinol & Metab, Dept Med, Hamilton, ON, Canada	Prince Henry's Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; McMaster University	Boon, WC (corresponding author), Prince Henrys Inst Med Res, Clayton, Vic, Australia.	wah.chin.boon@florey.edu.au		Steinberg, Gregory/0000-0001-5425-8275; To, Sarah Quynh Giao/0000-0002-7198-484X; Jones, Margaret/0000-0002-0678-3187	Australian National Health and Medical Research Council [338510, 494813, 628553, 441100]; Monash Postgraduate Scholarship; Fred P Archer Fellowship; Victorian Government through the Operational Infrastructure Scheme; Cancer Council of Victoria Postdoctoral Cancer Research Fellowship; PHI audit [13-33]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash Postgraduate Scholarship; Fred P Archer Fellowship; Victorian Government through the Operational Infrastructure Scheme; Cancer Council of Victoria Postdoctoral Cancer Research Fellowship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); PHI audit	This research was supported by Australian National Health and Medical Research Council project grants ID 338510, 494813, and 628553 and program grant 441100. MLS was supported by Monash Postgraduate Scholarship; WCB was supported by a Fred P Archer Fellowship. The authors acknowledge the support of the Victorian Government through the Operational Infrastructure Scheme. SQT was supported by the Cancer Council of Victoria Postdoctoral Cancer Research Fellowship and PHI audit # 13-33. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Boren J, 2013, J INTERN MED, V274, P25, DOI 10.1111/joim.12071; Borthwick EB, 2001, HORM METAB RES, V33, P721, DOI 10.1055/s-2001-19136; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Carani C, 1997, NEW ENGL J MED, V337, P91, DOI 10.1056/NEJM199707103370204; Chow JDY, 2011, J ENDOCRINOL, V210, P323, DOI 10.1530/JOE-10-0462; Denzer C, 2009, J CLIN ENDOCR METAB, V94, P3872, DOI 10.1210/jc.2009-1125; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Galic S., 2009, MOL CELL ENDOCRINOL; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Hamden K, 2008, STEROIDS, V73, P495, DOI 10.1016/j.steroids.2007.12.026; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HARRISON SA, 2004, CLIN LIVER DIS, V8, pR12; Harrison Stephen A, 2004, Clin Liver Dis, V8, P715, DOI 10.1016/j.cld.2004.04.011; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Herrmann BL, 2005, HORM METAB RES, V37, P178, DOI 10.1055/s-2005-861292; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hu P, 2008, J BIOL CHEM, V283, P6752, DOI 10.1074/jbc.M705937200; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Jones MEE, 2001, J STEROID BIOCHEM, V79, P3, DOI 10.1016/S0960-0760(01)00136-4; Jorgensen SB, 2009, AM J PHYSIOL-ENDOC M, V297, pE57, DOI 10.1152/ajpendo.90744.2008; Kim JY, 2010, LIFE SCI, V87, P358, DOI 10.1016/j.lfs.2010.07.009; Lonardo A, 2005, ALIMENT PHARM THER, V22, P64, DOI 10.1111/j.1365-2036.2005.02600.x; Loria P, 2005, ALIMENT PHARM THER, V22, P31, DOI 10.1111/j.1365-2036.2005.02592.x; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Muller G, 2003, BIOCHIMIE, V85, P1245, DOI 10.1016/j.biochi.2003.10.004; Muthusamy T, 2009, METABOLISM, V58, P1581, DOI 10.1016/j.metabol.2009.05.010; Nemoto Y, 2000, J CLIN INVEST, V105, P1819, DOI 10.1172/JCI9575; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; RIBAS V, 2009, AM J PHYSL ENDOCRINO; Robertson KM, 1999, P NATL ACAD SCI USA, V96, P7986, DOI 10.1073/pnas.96.14.7986; Ruhl CE, 2004, CLIN LIVER DIS, V8, pvii; Ruhl Constance E, 2004, Clin Liver Dis, V8, P501, DOI 10.1016/j.cld.2004.04.008; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Takeda K, 2003, J ENDOCRINOL, V176, P237, DOI 10.1677/joe.0.1760237; Yki-Jarvinen H, 2010, DIGEST DIS, V28, P203, DOI 10.1159/000282087	45	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87230	10.1371/journal.pone.0087230	http://dx.doi.org/10.1371/journal.pone.0087230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520329	Green Published, gold			2022-12-27	WOS:000331254600020
J	van Dinteren, R; Arns, M; Jongsma, MLA; Kessels, RPC				van Dinteren, Rik; Arns, Martijn; Jongsma, Marijtje L. A.; Kessels, Roy P. C.			P300 Development across the Lifespan: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							EVENT-RELATED POTENTIALS; COGNITIVE FUNCTION; EXECUTIVE FUNCTION; EVOKED-POTENTIALS; BRAIN POTENTIALS; PROCESSING-SPEED; AGING BRAIN; AGE; MEMORY; LATENCY	Background: The P300 component of the event-related potential is a large positive waveform that can be extracted from the ongoing electroencephalogram using a two-stimuli oddball paradigm, and has been associated with cognitive information processing (e. g. memory, attention, executive function). This paper reviews the development of the auditory P300 across the lifespan. Methodology/Principal Findings: A systematic review and meta-analysis on the P300 was performed including 75 studies (n = 2,811). Scopus was searched for studies using healthy subjects and that reported means of P300 latency and amplitude measured at Pz and mean age. These findings were validated in an independent, existing cross-sectional dataset including 1,572 participants from ages 6-87. Curve-fitting procedures were applied to obtain a model of P300 development across the lifespan. In both studies logarithmic Gaussian models fitted the latency and amplitude data best. The P300 latency and amplitude follow a maturational path from childhood to adolescence, resulting in a period that marks a plateau, after which degenerative effects begin. We were able to determine ages that mark a maximum (in P300 amplitude) or trough (in P300 latency) segregating maturational from degenerative stages. We found these points of deflection occurred at different ages. Conclusions/Significance: It is hypothesized that latency and amplitude index different aspects of brain maturation. The P300 latency possibly indexes neural speed or brain efficiency. The P300 amplitude might index neural power or cognitive resources, which increase with maturation.	[van Dinteren, Rik; Arns, Martijn] Res Inst Brainclin, Nijmegen, Netherlands; [van Dinteren, Rik; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behaviour, NL-6525 ED Nijmegen, Netherlands; [Arns, Martijn] Univ Utrecht, Dept Expt Psychol, Nijmegen, Netherlands; [Jongsma, Marijtje L. A.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med Psychol, Nijmegen, Netherlands	Radboud University Nijmegen; Utrecht University; Radboud University Nijmegen; Radboud University Nijmegen	van Dinteren, R (corresponding author), Res Inst Brainclin, Nijmegen, Netherlands.	rik@brainclinics.com	Kessels, Roy P.C./D-1902-2010	Kessels, Roy P.C./0000-0001-9500-9793; Arns, Martijn/0000-0002-0610-7613; van Dinteren, Rik/0000-0002-1673-4741	BRAINnet	BRAINnet	The authors acknowledge that data and support was provided by BRAINnet; www.BRAINnet.net, under the governance of the BRAINnet Foundation. BRAINnet is the scientific network that coordinates access to the Brain Resource International Database for independent scientific purposes. Data-analysis and reporting were unconstrained. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Altenmuller EO, 1998, ELECTROENCEPHALOGRAP; Arns Martijn, 2008, Journal of Integrative Neuroscience, V7, P421, DOI 10.1142/S0219635208001897; Ashford JW, 2011, J ALZHEIMERS DIS, V26, P229, DOI 10.3233/JAD-2011-0061; Beauchamp MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024981; Brickman AM, 2012, NEUROBIOL AGING, V33, P1699, DOI 10.1016/j.neurobiolaging.2011.06.001; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Clark CR, 2006, ARCH CLIN NEUROPSYCH, V21, P449, DOI 10.1016/j.acn.2006.06.005; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COURCHESNE E, 1984, ELECTROEN CLIN NEURO, V59, P238, DOI 10.1016/0168-5597(84)90063-7; Daffner KR, 2011, J COGNITIVE NEUROSCI, V23, P1298, DOI 10.1162/jocn.2010.21540; Davatzikos C, 2002, CEREB CORTEX, V12, P767, DOI 10.1093/cercor/12.7.767; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DUNCANJOHNSON CC, 1981, SCIENCE, V214, P938, DOI 10.1126/science.7302571; Ehlers CL, 2001, J STUD ALCOHOL, V62, P562, DOI 10.15288/jsa.2001.62.562; Fjell AM, 2003, CLIN NEUROPHYSIOL, V114, P799, DOI 10.1016/S1388-2457(03)00030-0; Friedman D, 1997, EVOKED POTENTIAL, V104, P498, DOI 10.1016/S0168-5597(97)00036-1; Frodl T, 2001, CLIN NEUROPHYSIOL, V112, P1773, DOI 10.1016/S1388-2457(01)00587-9; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Huster RJ, 2011, BRAIN STRUCT FUNCT, V215, P225, DOI 10.1007/s00429-010-0289-2; Kirk RE, 1996, EDUC PSYCHOL MEAS, V56, P746, DOI 10.1177/0013164496056005002; Kraemer HC, 1998, PSYCHOL METHODS, V3, P23, DOI 10.1037/1082-989X.3.1.23; Kuba M, 2012, VISION RES, V62, P9, DOI 10.1016/j.visres.2012.03.014; Li L, 2013, NEUROBIOL AGING, V34, P477, DOI 10.1016/j.neurobiolaging.2012.02.025; Muller BW, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-63; Niedermeyer E., 1999, ELECTROENCEPHALOGRAP; O'Connell RG, 2012, NEUROBIOL AGING, V33, P2448, DOI 10.1016/j.neurobiolaging.2011.12.021; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Patel Salil H, 2005, Int J Med Sci, V2, P147; Paul RH, 2007, INT J NEUROSCI, V117, P549, DOI 10.1080/00207450600773665; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; POLICH J, 1990, INT J PSYCHOPHYSIOL, V9, P237, DOI 10.1016/0167-8760(90)90056-J; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P334, DOI 10.1111/j.1469-8986.1996.tb01058.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; RITTER W, 1969, SCIENCE, V164, P326, DOI 10.1126/science.164.3877.326; Rossini PM, 2007, PROG NEUROBIOL, V83, P375, DOI 10.1016/j.pneurobio.2007.07.010; Rozhkov V P, 2009, Neurosci Behav Physiol, V39, P851, DOI 10.1007/s11055-009-9210-y; Sachs G, 2004, PSYCHIAT RES-NEUROIM, V131, P249, DOI 10.1016/j.pscychresns.2004.05.005; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Sangal B, 1998, CLIN EEG NEUROSCI, V29, P1, DOI [10.1177/155005949802900105, DOI 10.1177/155005949802900105]; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Shajahan PM, 1997, PSYCHOL MED, V27, P579, DOI 10.1017/S0033291796004692; SNYDER E, 1976, BEHAV BIOL, V16, P319, DOI 10.1016/S0091-6773(76)91447-4; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tsai ML, 2012, J FORMOS MED ASSOC, V111, P245, DOI 10.1016/j.jfma.2011.01.009; Turner RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059202; van Beijsterveldt CEM, 2002, BIOL PSYCHOL, V61, P111, DOI 10.1016/S0301-0511(02)00055-8; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Verleger R, 2010, CLIN NEUROPHYSIOL, V121, P1371, DOI 10.1016/j.clinph.2010.01.038; Vermeij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046210; Walhovd KB, 2001, NEUROREPORT, V12, P3149, DOI 10.1097/00001756-200110080-00033; Walhovd KB, 2008, PSYCHOPHYSIOLOGY, V45, P545, DOI 10.1111/j.1469-8986.2008.00661.x; West R, 2010, CORTEX, V46, P550, DOI 10.1016/j.cortex.2009.08.001; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475	61	210	215	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87347	10.1371/journal.pone.0087347	http://dx.doi.org/10.1371/journal.pone.0087347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551055	Green Submitted, gold, Green Published			2022-12-27	WOS:000331266000012
J	Muller, J; Rana, NA; Serth, K; Kakuda, S; Haltiwanger, RS; Gossler, A				Mueller, Julia; Rana, Nadia A.; Serth, Katrin; Kakuda, Shinako; Haltiwanger, Robert S.; Gossler, Achim			O-fucosylation of the Notch Ligand mDLL1 by POFUT1 Is Dispensable for Ligand Function	PLOS ONE			English	Article							FACTOR-LIKE REPEATS; PROTEIN O-FUCOSYL-TRANSFERASE-1; FUCOSE; FRINGE; GLYCOSYLTRANSFERASE; RECEPTOR; EXPRESSION; GENE; LOCALIZATION; COMPONENT	Fucosylation of Epidermal Growth Factor-like (EGF) repeats by protein O-fucosyltransferase 1 (POFUT1 in vertebrates, OFUT1 in Drosophila) is pivotal for NOTCH function. In Drosophila OFUT1 also acts as chaperone for Notch independent from its enzymatic activity. NOTCH ligands are also substrates for POFUT1, but in Drosophila OFUT1 is not essential for ligand function. In vertebrates the significance of POFUT1 for ligand function and subcellular localization is unclear. Here, we analyze the importance of O-fucosylation and POFUT1 for the mouse NOTCH ligand Delta-like 1 (DLL1). We show by mass spectral glycoproteomic analyses that DLL1 is O-fucosylated at the consensus motif (CXXXX)-X-2((S/T) under bar )C-3 (where C-2 and C-3 are the second and third conserved cysteines within the EGF repeats) found in EGF repeats 3, 4, 7 and 8. A putative site with only three amino acids between the second cysteine and the hydroxy amino acid within EGF repeat 2 is not modified. DLL1 proteins with mutated O-fucosylation sites reach the cell surface and accumulate intracellularly. Likewise, in presomitic mesoderm cells of POFUT1 deficient embryos DLL1 is present on the cell surface, and in mouse embryonic fibroblasts lacking POFUT1 the same relative amount of overexpressed wild type DLL1 reaches the cell surface as in wild type embryonic fibroblasts. DLL1 expressed in POFUT1 mutant cells can activate NOTCH, indicating that POFUT1 is not required for DLL1 function as a Notch ligand.	[Mueller, Julia; Serth, Katrin; Gossler, Achim] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Rana, Nadia A.; Kakuda, Shinako; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Hannover Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	robert.haltiwanger@stonybrook.edu; Gossler.Achim@mh-hannover.de			DFG (Deutsche Forschungsgemeinschaft) [GO449/10]; NIH (National Institutes of Health) [GM061126]; Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy''; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy''; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by DFG (Deutsche Forschungsgemeinschaft) grant GO449/10 to AG, NIH (National Institutes of Health) grant GM061126 to RSH and by funding of the Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shareffi E, 2013, GLYCOBIOLOGY, V23, P188, DOI 10.1093/glycob/cws140; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Gridley T, 1997, MOL CELL NEUROSCI, V9, P103, DOI 10.1006/mcne.1997.0610; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, J BIOCHEM, V144, P1, DOI 10.1093/jb/mvn016; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Radtke F, 2005, BIOESSAYS, V27, P1117, DOI 10.1002/bies.20315; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; THOMAS U, 1991, DEVELOPMENT, V111, P749; VASSIN H, 1987, GENETICS, V116, P433; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yao D, 2011, BLOOD, V117, P5652, DOI 10.1182/blood-2010-12-326074; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	42	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88571	10.1371/journal.pone.0088571	http://dx.doi.org/10.1371/journal.pone.0088571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533113	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600071
J	Rudenko, L; Kiseleva, I; Naykhin, AN; Erofeeva, M; Stukova, M; Donina, S; Petukhova, G; Pisareva, M; Krivitskaya, V; Grudinin, M; Buzitskaya, Z; Isakova-Sivak, I; Kuznetsova, S; Larionova, N; Desheva, J; Dubrovina, I; Nikiforova, A; Victor, JC; Neuzil, K; Flores, J; Tsvetnitsky, V; Kiselev, O				Rudenko, Larisa; Kiseleva, Irina; Naykhin, Anatoly N.; Erofeeva, Marianna; Stukova, Marina; Donina, Svetlana; Petukhova, Galina; Pisareva, Maria; Krivitskaya, Vera; Grudinin, Michael; Buzitskaya, Zhanna; Isakova-Sivak, Irina; Kuznetsova, Svetlana; Larionova, Natalie; Desheva, Julia; Dubrovina, Irina; Nikiforova, Alexandra; Victor, John C.; Neuzil, Kathy; Flores, Jorge; Tsvetnitsky, Vadim; Kiselev, Oleg			Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo-Controlled, Randomized Double-Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine	PLOS ONE			English	Article							ADULTS; ANTIBODIES; H1N1	Introduction: Live attenuated influenza vaccines (LAIVs) are being developed to protect humans against future epidemics and pandemics. This study describes the results of a double-blinded randomized placebo-controlled phase I clinical trial of cold-adapted and temperature sensitive H7N3 live attenuated influenza vaccine candidate in healthy seronegative adults. Objective: The goal of the study was to evaluate the safety, tolerability, immunogenicity and potential shedding and transmission of H7N3 LAIV against H7 avian influenza virus of pandemic potential. Methods and Findings: Two doses of H7N3 LAIV or placebo were administered to 40 randomly divided subjects (30 received vaccine and 10 placebo). The presence of influenza A virus RNA in nasal swabs was detected in 60.0% and 51.7% of subjects after the first and second vaccination, respectively. In addition, vaccine virus was not detected among placebo recipients demonstrating the absence of person-to-person transmission. The H7N3 live attenuated influenza vaccine demonstrated a good safety profile and was well tolerated. The two-dose immunization resulted in measurable serum and local antibody production and in generation of antigen-specific CD4(+) and CD8(+) memory T cells. Composite analysis of the immune response which included hemagglutinin inhibition assay, microneutralization tests, and measures of IgG and IgA and virus-specific T cells showed that the majority (86.2%) of vaccine recipients developed serum and/or local antibodies responses and generated CD4(+) and CD8(+) memory T cells. Conclusions: The H7N3 LAIV was safe and well tolerated, immunogenic in healthy seronegative adults and elicited production of antibodies broadly reactive against the newly emerged H7N9 avian influenza virus.	[Rudenko, Larisa; Kiseleva, Irina; Naykhin, Anatoly N.; Donina, Svetlana; Petukhova, Galina; Isakova-Sivak, Irina; Kuznetsova, Svetlana; Larionova, Natalie; Desheva, Julia; Dubrovina, Irina] Russian Acad Med Sci, Inst Expt Med, Dept Virol, St Petersburg P-22, Russia; [Erofeeva, Marianna] Inst Influenza, Dept Epidemiol & Prophylaxis, St Petersburg, Russia; [Stukova, Marina; Pisareva, Maria; Grudinin, Michael; Buzitskaya, Zhanna; Kiselev, Oleg] Inst Influenza, Dept Mol Virol, St Petersburg, Russia; [Krivitskaya, Vera] Inst Influenza, Dept Biotechnol, St Petersburg, Russia; [Nikiforova, Alexandra] Microgen, Dept Preclin Trials, Moscow, Russia; [Victor, John C.; Neuzil, Kathy; Flores, Jorge; Tsvetnitsky, Vadim] Program Appropriate Technol Hlth, Seattle, WA USA	Institute of Experimental Medicine; Russian Academy of Medical Sciences	Kiseleva, I (corresponding author), Russian Acad Med Sci, Inst Expt Med, Dept Virol, St Petersburg P-22, Russia.	irina.v.kiseleva@mail.ru	Grudinin, Mikhail/J-2048-2018; Marina, Stukova/S-4001-2016; Rudenko, Larisa/AAN-9226-2020; Buzitskaya, Zhanna/I-8743-2018; Desheva, Yulia/I-1493-2013; Kiseleva, Irina/E-6555-2014; Larionova, Natalie N.V./J-5004-2018; Petukhova, Galina/C-4646-2016; Isakova-Sivak, Irina/C-1034-2014; Pisareva, Maria/AAV-1692-2021; Rudenko, Larisa G/B-5169-2015	Grudinin, Mikhail/0000-0001-5283-7505; Marina, Stukova/0000-0002-2127-3820; Rudenko, Larisa/0000-0002-0107-9959; Buzitskaya, Zhanna/0000-0002-8394-102X; Desheva, Yulia/0000-0001-9794-3520; Kiseleva, Irina/0000-0002-3892-9873; Larionova, Natalie N.V./0000-0003-1171-3383; Petukhova, Galina/0000-0001-9312-4739; Isakova-Sivak, Irina/0000-0002-2801-1508; Pisareva, Maria/0000-0002-1499-9957; Rudenko, Larisa G/0000-0002-0107-9959; Victor, John/0000-0002-7970-6588; Donina, Svetlana/0000-0002-6502-8341	Program for Appropriate Technologies in Health (PATH)	Program for Appropriate Technologies in Health (PATH)	The study was supported by Program for Appropriate Technologies in Health (PATH) (http://sites.path.org/vaccinedevelopment/influenza/). Some funders (VT, JCV, KN, JF) participated in designing the experiments and critically reviewed the manuscript.	ALEXANDROVA GI, 1977, VOP VIRUSOL+, V4, P387; [Anonymous], 2003, EMEACPMPBWP228901; Chirkova TV, 2011, CLIN VACCINE IMMUNOL, V18, P1710, DOI 10.1128/CVI.05116-11; Desheva JA, 2007, P INT C OPT CONTR IN, P591; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kageyama T, 2013, EURO SURVEILL, V18; Kiseleva I, 2010, INFLUENZA OTHER RESP, V4, P1, DOI 10.1111/j.1750-2659.2009.00118.x; Mallory RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013755; Meijer A, 2006, J VIROL METHODS, V132, P113, DOI 10.1016/j.jviromet.2005.10.001; Metreveli G, 2010, AVIAN DIS, V54, P453, DOI 10.1637/8691-031309-ResNote.1; Naikhin AN, 1997, VOP VIRUSOL+, V42, P212; Petukhova G, 2012, INFLUENZA OTHER RESP, V6, P119, DOI 10.1111/j.1750-2659.2011.00279.x; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rudenko L, 2008, INFLUENZA OTHER RESP, V2, P203, DOI 10.1111/j.1750-2659.2008.00064.x; Rudenko L, 2013, VACCINE, V31, P4702, DOI 10.1016/j.vaccine.2013.08.040; Rudenko L, 2011, VACCINE, V29, pA40, DOI 10.1016/j.vaccine.2011.04.122; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; WHO, 2009, WHO REC ASS QUAL SAF; WHO, 1979, WHO TECHN REP SER; World Health Organization, 2002, WHO MAN AN INFL DIAG	24	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87962	10.1371/journal.pone.0087962	http://dx.doi.org/10.1371/journal.pone.0087962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533064	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600022
J	Studtmann, K; Olschlager-Schutt, J; Buck, F; Richter, D; Sala, C; Bockmann, J; Kindler, S; Kreienkamp, HJ				Studtmann, Katrin; Oelschlaeger-Schuett, Janin; Buck, Friedrich; Richter, Dietmar; Sala, Carlo; Bockmann, Juergen; Kindler, Stefan; Kreienkamp, Hans-Juergen			A Non-Canonical Initiation Site Is Required for Efficient Translation of the Dendritically Localized Shank1 mRNA	PLOS ONE			English	Article							OPEN READING FRAMES; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; DELETION SYNDROME; PROTEIN-SYNTHESIS; GENE-EXPRESSION; REGION; IDENTIFICATION; DISRUPTION; MECHANISMS	Local protein synthesis in dendrites enables neurons to selectively change the protein complement of individual postsynaptic sites. Though it is generally assumed that this mechanism requires tight translational control of dendritically transported mRNAs, it is unclear how translation of dendritic mRNAs is regulated. We have analyzed here translational control elements of the dendritically localized mRNA coding for the postsynaptic scaffold protein Shank1. In its 5' region, the human Shank1 mRNA exhibits two alternative translation initiation sites (AUG(+1) and AUG(+214)), three canonical upstream open reading frames (uORFs1-3) and a high GC content. In reporter assays, fragments of the 5'UTR with high GC content inhibit translation, suggesting a contribution of secondary structures. uORF3 is most relevant to translation control as it overlaps with the first in frame start codon (AUG(+1)), directing translation initiation to the second in frame start codon (AUG(+214)). Surprisingly, our analysis points to an additional uORF initiated at a non-canonical ACG start codon. Mutation of this start site leads to an almost complete loss of translation initiation at AUG(+1), demonstrating that this unconventional uORF is required for Shank1 synthesis. Our data identify a novel mechanism whereby initiation at a non-canonical site allows for translation of the main Shank1 ORF despite a highly structured 5'UTR.	[Studtmann, Katrin; Oelschlaeger-Schuett, Janin; Kindler, Stefan; Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Buck, Friedrich] Univ Klinikum Hamburg Eppendorf, Inst Klin Chem, Hamburg, Germany; [Richter, Dietmar] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol Hamburg, Hamburg, Germany; [Sala, Carlo] CNR, Inst Neurosci, I-20133 Milan, Italy; [Bockmann, Juergen] Univ Ulm, Inst Anat, D-89069 Ulm, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Consiglio Nazionale delle Ricerche (CNR); Ulm University	Kreienkamp, HJ (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany.	Kreienkamp@uke.de	; Sala, Carlo/A-2493-2009	Kreienkamp, Hans-Jurgen/0000-0002-8871-9970; Sala, Carlo/0000-0003-0662-9523	Deutsche Forschungsgemeinschaft [FOR885, Bo1718-4]; Fritz-Thyssen-Stiftung; Comitato Telethon Fondazione Onlus [GGP11095]; Fondazione CARIPLO [2012-0593]; Ministry of Health in the ERA-NET NEURON and PNR-CNR Aging Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz-Thyssen-Stiftung; Comitato Telethon Fondazione Onlus(Fondazione Telethon); Fondazione CARIPLO(Fondazione Cariplo); Ministry of Health in the ERA-NET NEURON and PNR-CNR Aging Program	Financial support was provided by Deutsche Forschungsgemeinschaft (www.dfg.de; FOR885 and Bo1718-4 to H-JK); the Fritz-Thyssen-Stiftung (to DR and SK); and by Comitato Telethon Fondazione Onlus, grant GGP11095 (to CS), Fondazione CARIPLO project number 2012-0593, Ministry of Health in the frame of ERA-NET NEURON and PNR-CNR Aging Program 2012-2014 (to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; Chua JJE, 2012, SCI REP-UK, V2, DOI 10.1038/srep00484; Darnell JC, CELL, V146, P247; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; HANN SR, 1994, BIOCHIMIE, V76, P880, DOI 10.1016/0300-9084(94)90190-2; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kindler S, 2012, RESULTS PROBL CELL D, V54, P61, DOI 10.1007/978-3-642-21649-7_5; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pedersen SK, 2002, BIOCHEM J, V363, P37, DOI 10.1042/0264-6021:3630037; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sawallisch C, 2009, J BIOL CHEM, V284, P9225, DOI 10.1074/jbc.M808425200; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	40	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88518	10.1371/journal.pone.0088518	http://dx.doi.org/10.1371/journal.pone.0088518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533096	gold, Green Submitted, Green Published			2022-12-27	WOS:000331262600054
J	Grabner, DS; Mohamed, FAMM; Nachev, M; Meabed, EMH; Sabry, AHA; Sures, B				Grabner, Daniel S.; Mohamed, Faten A. M. M.; Nachev, Milen; Meabed, Eman M. H.; Sabry, Abdel Hameed A.; Sures, Bernd			Invasion Biology Meets Parasitology: A Case Study of Parasite Spill-Back with Egyptian Fasciola gigantica in the Invasive Snail Pseudosuccinea columella	PLOS ONE			English	Article							NILE DELTA; INTERMEDIATE FORMS; HEPATICA; IDENTIFICATION; EPIDEMIOLOGY; TRANSMISSION; MOLLUSCA; VECTORS	The liver fluke Fasciola gigantica is a trematode parasite of ruminants and humans that occurs naturally in Africa and Asia. Cases of human fascioliasis, attributable at least in part to F. gigantica, are significantly increasing in the last decades. The introduced snail species Galba truncatula was already identified to be an important intermediate host for this parasite and the efficient invader Pseudosuccinea columella is another suspect in this case. Therefore, we investigated snails collected in irrigation canals in Fayoum governorate in Egypt for prevalence of trematodes with focus on P. columella and its role for the transmission of F. gigantica. Species were identified morphologically and by partial sequencing of the cytochrome oxidase subunit I gene (COI). Among all 689 snails found at the 21 sampling sites, P. columella was the most abundant snail with 296 individuals (42.96%) and it was also the most dominant species at 10 sites. It was not found at 8 sites. Molecular detection by PCR and sequencing of the ITS1-5.8S-ITS2 region of the ribosomal DNA (rDNA) revealed infections with F. gigantica (3.38%), Echinostoma caproni (2.36%) and another echinostome (7.09%) that could not be identified further according to its sequence. No dependency of snail size and trematode infection was found. Both high abundance of P. columella in the Fayoum irrigation system and common infection with F. gigantica might be a case of parasite spill-back (increased prevalence in local final hosts due to highly susceptible introduced intermediate host species) from the introduced P. columella to the human population, explaining at least partly the observed increase of reported fascioliasis-cases in Egypt. Eichhornia crassipes, the invasive water hyacinth, which covers huge areas of the irrigation canals, offers safe refuges for the amphibious P. columella during molluscicide application. As a consequence, this snail dominates snail communities and efficiently transmits F. gigantica.	[Grabner, Daniel S.; Nachev, Milen; Sures, Bernd] Univ Duisburg Essen, Essen, Germany; [Grabner, Daniel S.; Nachev, Milen; Sures, Bernd] Univ Duisburg Essen, Ctr Water & Environm Res, Essen, Germany; [Mohamed, Faten A. M. M.; Meabed, Eman M. H.; Sabry, Abdel Hameed A.] Fayoum Univ, Dept Parasitol, Fac Med, Al Fayyum, Egypt	University of Duisburg Essen; University of Duisburg Essen; Egyptian Knowledge Bank (EKB); Fayoum University	Grabner, DS (corresponding author), Univ Duisburg Essen, Essen, Germany.	daniel.grabner@uni-due.de	Sures, Bernd/B-6652-2013	Sures, Bernd/0000-0001-6865-6186; Grabner, Daniel/0000-0002-1251-7096; Meabed, Eman/0000-0003-1673-4327	Integrated Water Technologies (IWaTec); Centre for Water and Environmental Research (ZWU); Fayoum University in Egypt; German Academic Exchange Service (DAAD); Federal Foreign Office; Open Access program of the German Research Foundation (Deutsche Forschungsgemeinschaft)	Integrated Water Technologies (IWaTec); Centre for Water and Environmental Research (ZWU); Fayoum University in Egypt; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Federal Foreign Office; Open Access program of the German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was conducted in the framework of the Integrated Water Technologies (IWaTec) joint project between the Centre for Water and Environmental Research (ZWU) at the University of Duisburg-Essen and the Fayoum University in Egypt. IWaTec is funded by the German Academic Exchange Service (DAAD) and financed by the Federal Foreign Office. This publication has been supported by the Open Access program of the German Research Foundation (Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Madyan Ahmed A., 2004, Journal of the Egyptian Society of Parasitology, V34, P807; Ahmed Amer H., 1999, Journal of the Egyptian Society of Parasitology, V29, P687; Amer S, 2011, PARASITOL INT, V60, P5, DOI 10.1016/j.parint.2010.09.003; [Anonymous], 2004, WATERBORNE ZOONOSES; Ashrafi K, 2006, PARASITOL INT, V55, P249, DOI 10.1016/j.parint.2006.06.003; Bargues M.D., 1996, PARASSITOLOGIA, V38, P251, DOI DOI 10.1016/S0035-9203(99)90289-4; Bargues MD, 2005, J HELMINTHOL, V79, P257, DOI 10.1079/JOH2005297; Brown DS, 1994, FRESHWATER SNAILS AF, DOI 10.1201/9781482295184; Caron Y, 2011, VET PARASITOL, V178, P93, DOI 10.1016/j.vetpar.2010.12.020; Coles GC, 2008, T ROY SOC TROP MED H, V102, P619, DOI 10.1016/j.trstmh.2008.01.009; Curtale F, 2003, J TROP PEDIATRICS, V49, P264, DOI 10.1093/tropej/49.5.264; Curtale F., 2000, Research and Reviews in Parasitology, V60, P129; Dar Y, 2012, PARASITE, V19, P177, DOI 10.1051/parasite/2012192177; Dar Y. D., 2005, Journal of the Egyptian Society of Parasitology, V35, P477; DAWOOD IK, 1965, B WORLD HEALTH ORGAN, V32, P269; Kock Kenné N. de, 2008, Koedoe, V50, P49; DEKOCK KN, 1989, ONDERSTEPOORT J VET, V56, P271; El Shazly Atef M., 2002, Journal of the Egyptian Society of Parasitology, V32, P109; El-Sayad M. H., 1997, Journal of the Egyptian Society of Parasitology, V27, P163; Esteban JG, 2003, AM J TROP MED HYG, V69, P429, DOI 10.4269/ajtmh.2003.69.429; FARAG HF, 1995, T ROY SOC TROP MED H, V89, P36, DOI 10.1016/0035-9203(95)90648-7; Fayad YH, 2001, BIOL INTEGRATED CONT; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fried B, 1996, ADV PARASIT, V38, P311, DOI 10.1016/S0065-308X(08)60037-8; Gopal B, 1987, AQUATIC PLANT STUDIE, V1, P484; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; KENDALL SB, 1965, ANN TROP MED PARASIT, V59, P10, DOI 10.1080/00034983.1965.11686275; LOKER ES, 1995, PARASITOL TODAY, V11, P120, DOI 10.1016/0169-4758(95)80174-X; Lotfy WM, 2002, VET PARASITOL, V103, P323, DOI 10.1016/S0304-4017(01)00613-6; MADSEN H, 1989, ACTA TROP, V46, P139, DOI 10.1016/0001-706X(89)90030-2; Marcilla A, 2002, MOL CELL PROBE, V16, P327, DOI 10.1006/mcpr.2002.0429; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mas-Coma S, 1999, B WORLD HEALTH ORGAN, V77, P340; Mas-Coma S, 2009, ADV PARASIT, V69, P41, DOI 10.1016/S0065-308X(09)69002-3; Morsy Tosson A., 2005, Journal of the Egyptian Society of Parasitology, V35, P825; Periago MV, 2008, INFECT GENET EVOL, V8, P51, DOI 10.1016/j.meegid.2007.10.001; R Core Team, 2021, R LANGUAGE ENV STAT; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Soliman MFM, 2008, J INFECT DEV COUNTR, V2, P182, DOI 10.3855/jidc.260; Sures B., 2011, ENCY BIOL INVASIONS, P500; VANEEDEN JA, 1966, NATURE, V210, P1172, DOI 10.1038/2101172a0; Vazquez AA, 2014, J HELMINTHOL, V88, P434, DOI 10.1017/S0022149X13000382; Walker SM, 2012, INT J PARASITOL, V42, P1193, DOI 10.1016/j.ijpara.2012.10.007; World Health Organization (WHO), 1995, WHO TECHN REP SER, V849, P1	44	18	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88537	10.1371/journal.pone.0088537	http://dx.doi.org/10.1371/journal.pone.0088537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523913	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100062
J	Loo, JMY; Tsai, JS; Raylu, N; Oei, TPS				Loo, Jasmine M. Y.; Tsai, Jung-Shun; Raylu, Namrata; Oei, Tian P. S.			Gratitude, Hope, Mindfulness and Personal-Growth Initiative: Buffers or Risk Factors for Problem Gambling?	PLOS ONE			English	Article							CONFIRMATORY FACTOR VALIDATION; COGNITIONS SCALE GRCS; POSITIVE PSYCHOLOGY; CHINESE VERSION; SCREEN SOGS; GENDER; MODEL; PSYCHOPATHOLOGY; ASSOCIATIONS; RELIABILITY	The majority of prevention and intervention research in problem gambling (PG) has focused on identifying negative risk factors. However, not all at-risk individuals go on to develop anticipated disorders and many thrive in spite of them. In healthcare settings, PG and other disorders are typically conceptualized from the biomedical perspective that frame disorders as something negative residing within the individual and reduction in negativity is seen as success. Indeed, this problem-focused conceptualization may be adequate in many cases as reducing PG behaviour is undoubtedly an important outcome, but the focus on negativity alone is too narrow to capture the complexity of human behaviour. Hence, this study attempts to bridge the gap in literature by providing an evaluation of the predictive ability of the positive dispositions on problem gambling severity, gambling-related cognitions, and gambling urges. The positive psychological dispositions examined were curiosity, gratitude, hope, personal growth initiative, and mindfulness. Participants consisted of 801 Taiwanese Chinese students and community individuals (Mean age = 25.36 years). Higher levels of gratitude and hope have been found to predict lower PG, gambling-related cognitions, or gambling urges. Meanwhile, higher mindfulness predicted lower PG, but only among Chinese males. However, lower personal growth initiative predicted lower PG, gambling-related cognitions, and gambling urges. These analyses have small to medium effect sizes with significant predictions. Findings of this study have essential implications in understanding and treating Chinese problem gamblers. These positive dispositions should be addressed by mental health professionals in preventative and treatment programs among Chinese individuals. Further implications and suggestions for future research are discussed.	[Loo, Jasmine M. Y.] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Sunway, Selangor Darul, Malaysia; [Tsai, Jung-Shun] Yuhing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Raylu, Namrata; Oei, Tian P. S.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	Monash University; Monash University Sunway; University of Queensland	Loo, JMY (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Sunway, Selangor Darul, Malaysia.	jasmine.loo@monash.edu	Oei, Tian Po/K-4870-2012	Oei, Tian Po/0000-0001-9041-8803	Postgraduate Research Allowance	Postgraduate Research Allowance	Funding for this work was provided by Postgraduate Research Allowance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo B., 1998, COLL STUDENT J, V32, P255; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Ariyabuddhiphongs V, 2007, J GAMBL STUD, V23, P201, DOI 10.1007/s10899-006-9035-3; Arthur D, 2008, J GAMBL STUD, V24, P451, DOI 10.1007/s10899-008-9103-y; Blaszczynski A., 1998, J Gambl Stud, V14, P359, DOI 10.1023/A:1023073026236; BOLEN DW, 1968, ARCH GEN PSYCHIAT, V18, P617; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Casey LM, 2004, CLIN PSYCHOL REV, V24, P529, DOI 10.1016/j.cpr.2004.01.005; Casino Victorian, 2000, IMP GAM SPEC CULT GR; [陈灿锐 CHEN Can-rui], 2009, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V17, P24; CHEN CN, 1993, ARCH GEN PSYCHIAT, V50, P125; Chen LH, 2009, J HAPPINESS STUD, V10, P655, DOI 10.1007/s10902-008-9112-7; Choong LL, ASIAN J GAM IN PRESS; Ciarrocchi JW, 1993, J GAMBL STUD, V9, P341, DOI DOI 10.1007/BF01014626; Clarke D, 2006, NEW ZEAL J PSYCHOL, V35, P84; Clarke D, 2006, NEW ZEAL J PSYCHOL, V35, P77; Cyders MA, 2008, PERS INDIV DIFFER, V45, P503, DOI 10.1016/j.paid.2008.06.002; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Ferris J., 2001, CANADIAN PROBLEM GAM; Field A.P., 2020, DISCOVERING STAT USI, V4th; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; GRIFFITHS MD, 1994, BRIT J PSYCHOL, V85, P351, DOI 10.1111/j.2044-8295.1994.tb02529.x; Harris AHS, 2006, J POSIT PSYCHOL, V1, P27, DOI DOI 10.1080/17439760500380930; HOBSON JSP, 1995, TOURISM MANAGE, V16, P237, DOI 10.1016/0261-5177(95)91465-T; Huppert FA., 2004, POSITIVE PSYCHOL PRA, P693; JACCARD J, 1990, MULTIVAR BEHAV RES, V25, P467, DOI 10.1207/s15327906mbr2504_4; Kashdan TB, 2004, J PERS ASSESS, V82, P291, DOI 10.1207/s15327752jpa8203_05; Kashdan TB, 2007, MOTIV EMOTION, V31, P159, DOI [10.1007/s11031-007-9068-7, 10.1007/s11031-007-9074-9]; Kennedy MJ, 2008, DISS ABSTR INT B, V68, P5578; Lai DWL, 2006, J GAMBL STUD, V22, P121, DOI 10.1007/s10899-005-9006-0; Lakey CE, 2007, PERS INDIV DIFFER, V43, P1698, DOI 10.1016/j.paid.2007.05.007; Lampropoulos GK, 2001, AM PSYCHOL, V56, P87, DOI 10.1037/0003-066X.56.1.87; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Li J, 2007, SOCIOL INQ, V77, P626, DOI 10.1111/j.1475-682X.2007.00211.x; Loo J. M., 2011, PSYCHOLOGY, V2, P342, DOI DOI 10.4236/PSYCH.2011.24054; Loo JMY, 2008, CLIN PSYCHOL REV, V28, P1152, DOI 10.1016/j.cpr.2008.04.001; Loo JMY, 2011, J GAMBL STUD, V27, P453, DOI 10.1007/s10899-010-9221-1; Lussier I, 2007, PSYCHOL ADDICT BEHAV, V21, P165, DOI 10.1037/0893-164X.21.2.165; Marlatt G. Alan, 2002, COGN BEHAV PRACT, V9, P44, DOI DOI 10.1016/S1077-7229(02)80039-6; McCown W. G., 2004, HDB ADDICTIVE DISORD, P161; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; McMillen J., 2006, INT GAMBL STUD, V6, P147, DOI DOI 10.1080/14459790600927845; Milne JM, 2001, FAMILY J, V9, P17; Oei T. P. S., 2007, INT GAMBL STUD, V7, P101, DOI DOI 10.1080/14459790601157970; Oei TPS, 2007, J GAMBL STUD, V23, P309, DOI 10.1007/s10899-006-9040-6; Oei TP, 2008, J CROSS CULT PSYCHOL, V39, P147, DOI 10.1177/0022022107312587; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Productivity Commission, 2010, 50 PROD COMM; Queensland Treasury, 2006, QUEENSL HOUS GAMBL S; Raylu N, 2004, PSYCHOL ADDICT BEHAV, V18, P100, DOI 10.1037/0893-164X.18.2.100; Raylu N, 2004, ADDICTION, V99, P757, DOI 10.1111/j.1360-0443.2004.00753.x; Raylu N, 2004, CLIN PSYCHOL REV, V23, P1087, DOI 10.1016/j.cpr.2003.09.005; Raylu N, 2002, CLIN PSYCHOL REV, V22, P1009, DOI 10.1016/S0272-7358(02)00101-0; Robitschek C, 1998, MEAS EVAL COUNS DEV, V30, P183, DOI 10.1080/07481756.1998.12068941; Robitschek C, 1999, J COUNS PSYCHOL, V46, P159, DOI 10.1037/0022-0167.46.2.159; Sachar D, 2000, COMPULSIVE GAMBLERS; Schaler J. A., 1996, ALCOHOLISM TREATMENT, V14, P7, DOI DOI 10.1300/J020V14N03_03; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Sharpe L, 2002, CLIN PSYCHOL REV, V22, P1, DOI 10.1016/S0272-7358(00)00087-8; Sin R, 1997, GAMBLING PROBLEM GAM; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tang CSK, 2007, J GAMBL STUD, V23, P145, DOI 10.1007/s10899-006-9054-0; Tang CSK, 2010, J GAMBL STUD, V26, P145, DOI 10.1007/s10899-009-9147-7; Tien S, 2010, HAPPINESS PSYCHOL WE; Toneatto T, 2007, J GAMBL ISSUES, P91, DOI 10.4309/jgi.2007.19.12; Tseng WS, 1995, CHINESE SOC MENTAL H; Wallace J, 1996, TREATING SUBSTANCE A, P13; Watson D, 2009, CLIN PSYCHOL REV; Weems CF, 2009, CHILD YOUTH CARE FOR, V38, P1, DOI 10.1007/s10566-009-9064-z; Wenzel M., 2004, VALIDATION VICTORIAN; Wood AM, 2010, CLIN PSYCHO IN PRESS; Young M, 2008, J GAMBL STUD, V24, P337, DOI 10.1007/s10899-007-9087-z	76	37	40	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e83889	10.1371/journal.pone.0083889	http://dx.doi.org/10.1371/journal.pone.0083889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523854	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100003
J	Rumpf, SB; Semenchuk, PR; Dullinger, S; Cooper, EJ				Rumpf, Sabine B.; Semenchuk, Philipp R.; Dullinger, Stefan; Cooper, Elisabeth J.			Idiosyncratic Responses of High Arctic Plants to Changing Snow Regimes	PLOS ONE			English	Article							SIMULATED ENVIRONMENTAL-CHANGE; DIFFERENTIAL GROWTH; VACCINIUM MYRTILLUS; CASSIOPE-TETRAGONA; CLIMATE-CHANGE; TUNDRA; WINTER; VEGETATION; PHENOLOGY; DEPTH	The Arctic is one of the ecosystems most affected by climate change; in particular, winter temperatures and precipitation are predicted to increase with consequent changes to snow cover depth and duration. Whether the snow-free period will be shortened or prolonged depends on the extent and temporal patterns of the temperature and precipitation rise; resulting changes will likely affect plant growth with cascading effects throughout the ecosystem. We experimentally manipulated snow regimes using snow fences and shoveling and assessed above ground size of eight common high arctic plant species weekly throughout the summer. We demonstrated that plant growth responded to snow regime, and that air temperature sum during the snow free period was the best predictor for plant size. The majority of our studied species showed periodic growth; increases in plant size stopped after certain cumulative temperatures were obtained. Plants in early snow-free treatments without additional spring warming were smaller than controls. Response to deeper snow with later melt-out varied between species and categorizing responses by growth forms or habitat associations did not reveal generic trends. We therefore stress the importance of examining responses at the species level, since generalized predictions of above ground growth responses to changing snow regimes cannot be made.	[Rumpf, Sabine B.; Dullinger, Stefan] Univ Vienna, Dept Conservat Biol, Vienna, Austria; [Rumpf, Sabine B.; Semenchuk, Philipp R.; Cooper, Elisabeth J.] Univ Tromso, Inst Arctic & Marine Biol, Tromso, Norway; [Rumpf, Sabine B.] Univ Vienna, Inst Interdisciplinary Mt Res, Vienna, Austria; [Semenchuk, Philipp R.] Univ Ctr Svalbard, Dept Arctic Biol, Longyearbyen, Svalbard, Norway; [Semenchuk, Philipp R.] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Capital Region, Denmark; [Dullinger, Stefan] Vienna Inst Nat Conservat & Anal, Vienna, Austria	University of Vienna; UiT The Arctic University of Tromso; University of Vienna; University Centre Svalbard (UNIS); University of Copenhagen	Cooper, EJ (corresponding author), Univ Tromso, Inst Arctic & Marine Biol, Tromso, Norway.	elisabeth.cooper@uit.no	Rumpf, Sabine/AAF-8795-2019	Rumpf, Sabine/0000-0001-5909-9568; Dullinger, Stefan/0000-0003-3919-0887; Semenchuk, Philipp/0000-0002-1949-6427	Osterreichische Gesellschaft fur Polarforschung	Osterreichische Gesellschaft fur Polarforschung	This work was supported by the following: a) 1700(sic) from the 'Osterreichische Gesellschaft fur Polarforschung' and the grant is named "Julius-Payer-Stipendium.'' It was dedicated to Rumpf as support for travel expenses and field equipment (as well as clothing, etc.). b) 3 months long 550(sic)/month from the University of Vienna for Rumpf's living costs. The grant is called "short-term grant abroad'' and is dedicated for the field work of master projects abroad (www.univie.ac.at). c) University of Tromso, uit. no. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, PLANT ECOL, V182, P65, DOI 10.1007/s11258-005-9031-1; Alsos IG, FLORA SVALBARD; Arctic Climate Impact Assessment, 2004, IMPACTS WARMING ARCT; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Bokhorst S, 2011, GLOBAL CHANGE BIOL, V17, P2817, DOI 10.1111/j.1365-2486.2011.02424.x; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; Cooper EJ, 2011, PLANT SCI, V180, P157, DOI 10.1016/j.plantsci.2010.09.005; DeMarco J, 2011, ECOSYSTEMS, V14, P804, DOI 10.1007/s10021-011-9447-5; Dormann CF, 2002, FUNCT ECOL, V16, P4, DOI 10.1046/j.0269-8463.2001.00596.x; Euskirchen ES, 2009, ECOL APPL, V19, P1022, DOI 10.1890/08-0806.1; Fahnestock JT, 2000, ECOGRAPHY, V23, P623, DOI 10.1034/j.1600-0587.2000.230513.x; Forland EJ, 2011, ADV METEOROL, V2011, DOI 10.1155/2011/893790; Forland EJ, 2003, POLAR RES, V22, P113, DOI 10.1111/j.1751-8369.2003.tb00102.x; Gamon JA, 2013, REMOTE SENS ENVIRON, V129, P144, DOI 10.1016/j.rse.2012.10.030; Graae BJ, 2012, OIKOS, V121, P3, DOI 10.1111/j.1600-0706.2011.19694.x; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; HAVSTROM M, 1993, OIKOS, V66, P389, DOI 10.2307/3544933; Hinkler J, 2008, ADV ECOL RES, V40, P175, DOI 10.1016/S0065-2504(07)00008-6; Huelber K, 2006, ARCT ANTARCT ALP RES, V38, P99, DOI 10.1657/1523-0430(2006)038[0099:PROSST]2.0.CO;2; Hulber K, 2010, FUNCT ECOL, V24, P245, DOI 10.1111/j.1365-2435.2009.01645.x; Jonas T, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000680; Korner C., 2003, ALPINE PLANT LIFE, P344, DOI [10.1007/978-3-642-18970-8, DOI 10.1007/978-3-642-18970-8]; Ladinig U, 2013, OECOLOGIA, V171, P743, DOI 10.1007/s00442-012-2581-8; Mallik AU, 2011, ARCT ANTARCT ALP RES, V43, P404, DOI 10.1657/1938-4246-43.3.404; Molau U, 1996, ITEX MANUAL, P23; Morgner E, 2010, POLAR RES-SWEDEN, V29, P58, DOI [10.1111/j.1751-8369.2010.00151.x, 10.1111/J.1751-8369.2010.00151.x]; Ogren E, 1996, FUNCT ECOL, V10, P724, DOI 10.2307/2390507; PARSONS AN, 1994, J ECOL, V82, P307, DOI 10.2307/2261298; Pinheiro J., 2021, NLME LINEAR NONLINEA; Pop EW, 2000, OECOLOGIA, V124, P176, DOI 10.1007/s004420050005; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson CH, 1998, ECOLOGY, V79, P856, DOI 10.1890/0012-9658(1998)079[0856:PCRTSE]2.0.CO;2; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Sarkar D, 2008, USE R, P1; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; SCOTT PA, 1995, CLIM RES, V5, P25, DOI 10.3354/cr005025; Semenchuk PR, 2013, ECOL EVOL, V3, P2586, DOI 10.1002/ece3.648; Semenchuk PR, 2013, INFLUENCE SNOW COVER, P85; Sjogersten S, 2006, BIOGEOCHEMISTRY, V80, P205, DOI 10.1007/s10533-006-9018-6; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Starr G, 2000, GLOBAL CHANGE BIOL, V6, P357, DOI 10.1046/j.1365-2486.2000.00316.x; Starr G, 2008, ARCT ANTARCT ALP RES, V40, P181, DOI 10.1657/1523-0430(06-015)[STARR]2.0.CO;2; Stow DA, 2004, REMOTE SENS ENVIRON, V89, P281, DOI 10.1016/j.rse.2003.10.018; Taulavuori K, 1997, ENVIRON POLLUT, V98, P91, DOI 10.1016/S0269-7491(97)00115-2; Torp M, 2010, ECOSYSTEMS, V13, P741, DOI 10.1007/s10021-010-9351-4; Van Wijk MT, 2003, GLOBAL CHANGE BIOL, V9, P743, DOI 10.1046/j.1365-2486.2003.00625.x; Wahren CHA, 2005, GLOBAL CHANGE BIOL, V11, P537, DOI 10.1111/j.1365-2486.2005.00927.x; Walker MD, 1999, HYDROL PROCESS, V13, P2315, DOI 10.1002/(SICI)1099-1085(199910)13:14/15&lt;2315::AID-HYP888&gt;3.0.CO;2-A; WALKER MD, 1995, ECOLOGY, V76, P1067, DOI 10.2307/1940916; Walsh NE, 1997, GLOBAL CHANGE BIOL, V3, P158, DOI 10.1111/j.1365-2486.1997.gcb142.x; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x; Wipf S, 2010, PLANT ECOL, V207, P53, DOI 10.1007/s11258-009-9653-9; Wipf S, 2009, CLIMATIC CHANGE, V94, P105, DOI [10.1007/s10584-009-9546-x, 10.1007/s10584-009-9546-X]; WOOKEY PA, 1994, OIKOS, V70, P131, DOI 10.2307/3545708; WOOKEY PA, 1995, OECOLOGIA, V102, P478, DOI 10.1007/BF00341360; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x	56	37	37	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e86281	10.1371/journal.pone.0086281	http://dx.doi.org/10.1371/journal.pone.0086281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523859	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100008
J	Seguin, J; Rajeswaran, R; Malpica-Lopez, N; Martin, RR; Kasschau, K; Dolja, VV; Otten, P; Farinelli, L; Pooggin, MM				Seguin, Jonathan; Rajeswaran, Rajendran; Malpica-Lopez, Nachelli; Martin, Robert R.; Kasschau, Kristin; Dolja, Valerian V.; Otten, Patricia; Farinelli, Laurent; Pooggin, Mikhail M.			De Novo Reconstruction of Consensus Master Genomes of Plant RNA and DNA Viruses from siRNAs	PLOS ONE			English	Article							MOSAIC-VIRUS; SEQUENCE; EXPRESSION; DISCOVERY; GEMINIVIRUSES; METHYLATION; DIAGNOSIS; VELVET	Virus-infected plants accumulate abundant, 21-24 nucleotide viral siRNAs which are generated by the evolutionary conserved RNA interference (RNAi) machinery that regulates gene expression and defends against invasive nucleic acids. Here we show that, similar to RNA viruses, the entire genome sequences of DNA viruses are densely covered with siRNAs in both sense and antisense orientations. This implies pervasive transcription of both coding and non-coding viral DNA in the nucleus, which generates double-stranded RNA precursors of viral siRNAs. Consistent with our finding and hypothesis, we demonstrate that the complete genomes of DNA viruses from Caulimoviridae and Geminiviridae families can be reconstructed by deep sequencing and de novo assembly of viral siRNAs using bioinformatics tools. Furthermore, we prove that this 'siRNA omics' approach can be used for reliable identification of the consensus master genome and its microvariants in viral quasispecies. Finally, we utilized this approach to reconstruct an emerging DNA virus and two viroids associated with economically-important red blotch disease of grapevine, and to rapidly generate a biologically-active clone representing the wild type master genome of Oilseed rape mosaic virus. Our findings show that deep siRNA sequencing allows for de novo reconstruction of any DNA or RNA virus genome and its microvariants, making it suitable for universal characterization of evolving viral quasispecies as well as for studying the mechanisms of siRNA biogenesis and RNAi-based antiviral defense.	[Seguin, Jonathan; Rajeswaran, Rajendran; Malpica-Lopez, Nachelli; Pooggin, Mikhail M.] Univ Basel, Inst Bot, Dept Environm Sci, CH-4056 Basel, Switzerland; [Martin, Robert R.] USDA ARS, Hort Crops Res Lab, Corvallis, OR USA; [Martin, Robert R.; Kasschau, Kristin; Dolja, Valerian V.] Oregon State Univ, Dept Bot & Plant Pathol, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Seguin, Jonathan; Otten, Patricia; Farinelli, Laurent] Fasteris SA, Plan Les Ouates, Geneva, Switzerland	University of Basel; United States Department of Agriculture (USDA); Oregon State University	Pooggin, MM (corresponding author), Univ Basel, Inst Bot, Dept Environm Sci, Hebelstr 1, CH-4056 Basel, Switzerland.	Mikhail.Pooggin@unibas.ch		Pooggin, Mikhail/0000-0003-2308-393X; Malpica-Lopez, Nachelli/0000-0001-7800-9118	European Cooperation in Science and Technology [C09.0176]; Swiss National Science Foundation [31003A_143882/1]; Vinoculate, Inc. [2010-744]; USDA-NIFA [2009-04401]; USDA-NIFA-SCRI [2009-51181-06027]; Bard [IS-4314-10C]	European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Vinoculate, Inc.; USDA-NIFA(United States Department of Agriculture (USDA)); USDA-NIFA-SCRI; Bard(US-Israel Binational Science Foundation)	The work was supported by European Cooperation in Science and Technology [grant SERI No. C09.0176 to L.F. and M.M.P.]; Swiss National Science Foundation [grant 31003A_143882/1 to M.M.P.]; Vinoculate, Inc. [contract 2010-744 to V.V.D.], USDA-NIFA [subcontract 2009-04401 to V.V.D.]; USDA-NIFA-SCRI [2009-51181-06027 subaward to R.R.M.]; and Bard [award IS-4314-10C to V.V.D.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Al Rwahnih M, 2013, PHYTOPATHOLOGY, V103, P1069, DOI 10.1094/PHYTO-10-12-0253-R; Aregger M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002941; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Blevins T, 2011, NUCLEIC ACIDS RES, V39, P5003, DOI 10.1093/nar/gkr119; Cuellar WJ, 2011, VIRUS RES, V157, P111, DOI 10.1016/j.virusres.2011.01.010; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; Fuentes S, 2012, ARCH VIROL, V157, P773, DOI 10.1007/s00705-011-1214-6; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Gomez G, 2013, NEW PHYTOL, V198, P10, DOI 10.1111/nph.12196; Hagen C, 2012, ARCH VIROL, V157, P907, DOI 10.1007/s00705-012-1253-7; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Krenz B, 2012, J VIROL, V86, P7715, DOI 10.1128/JVI.00943-12; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kurth EG, 2012, J VIROL, V86, P6002, DOI 10.1128/JVI.00436-12; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Loconsole G, 2012, VIROLOGY, V432, P162, DOI 10.1016/j.virol.2012.06.005; Mansilla C, 2009, MOL PLANT PATHOL, V10, P59, DOI 10.1111/j.1364-3703.2008.00506.x; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Pooggin MM, 2013, INT J MOL SCI, V14, P15233, DOI 10.3390/ijms140815233; Poojari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064194; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seguin J, 2014, J VIROL METHODS, V195, P120, DOI 10.1016/j.jviromet.2013.10.013; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034	35	76	77	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88513	10.1371/journal.pone.0088513	http://dx.doi.org/10.1371/journal.pone.0088513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523907	Green Submitted, gold, Green Published			2022-12-27	WOS:000331258100056
J	van Zelst, C; van Nierop, M; Oorschot, M; Myin-Germeys, I; van Os, J; Delespaul, P				van Zelst, Catherine; van Nierop, Martine; Oorschot, Margreet; Myin-Germeys, Inez; van Os, Jim; Delespaul, Philippe		GROUP	Stereotype Awareness, Self-Esteem and Psychopathology in People with Psychosis	PLOS ONE			English	Article							MENTAL-ILLNESS STIGMA; SCHIZOPHRENIA; DISCRIMINATION; EMPOWERMENT; IMPACT	Introduction: Stigma is an important environmental risk factor for a variety of outcomes schizophrenia. In order to understand and remediate its effects, research is required to assess how stigma experiences are processed at the level of the individual. To this end, stereotype awareness (SA) with respect to people with mental illness and their families was explored in persons with psychotic disorder. Method: Data from the Dutch Genetic Risk and OUtcome of Psychosis project (GROUP) were analyzed. SA was measured using scales that assess a respondent's perception of common opinions about people with a mental illness and their families. Results: People with higher level of self-esteem were less aware of stereotypes about patients and families. People with more severe psychopathology reported more awareness of stereotypes about families, not about patients. Conclusion: Enhancing psychological resources, by increasing self-esteem and the ability to cope with symptoms, can be targeted to diminish stereotype threat and improve stigma resilience. Interventions can be tailored to individual differences to increase their impact. Furthermore, in order to diminish detrimental consequences of negative stereotypes, mental health professionals, health educators and experts by experience can inform the public about mental illness and stigma.	[van Zelst, Catherine; van Nierop, Martine; Oorschot, Margreet; Myin-Germeys, Inez; van Os, Jim; Delespaul, Philippe] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands; [Oorschot, Margreet] Yulius Acad, Org Mental Hlth, Dordrecht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, Kings Hlth Partners, London WC2R 2LS, England; [Delespaul, Philippe] Mondriaan Mental Hlth Trust, Maastricht, Netherlands	Maastricht University; University of London; King's College London	van Zelst, C (corresponding author), Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, EURON, Maastricht, Netherlands.	c.vanzelst@maastrichtuniversity.nl	Myin-Germeys, Inez/L-5106-2014; van Os, Jim/C-2113-2014; Myin Germeys, Inez/HIR-3364-2022; Delespaul, Philippe/L-1396-2019; van Os, Jim/V-8884-2019; Delespaul, Philippe/E-8982-2011; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	Myin Germeys, Inez/0000-0002-3731-4930; Delespaul, Philippe/0000-0001-7420-0898; van Os, Jim/0000-0002-7245-1586; Delespaul, Philippe/0000-0001-7420-0898; van Nierop, Martine/0000-0003-2734-0550; Bruggeman, Richard/0000-0002-3238-8471	Geestkracht program of the Dutch Health Research Council (ZON-MW) [10-000-1002]; European Communitya(sic) [HEALTH-F2-2009-241909]	Geestkracht program of the Dutch Health Research Council (ZON-MW); European Communitya(sic)	This work was supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002) and matching funds from participating universities and mental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk en Duin, Rivierduinen, Erasmus MC, GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical Centre Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGZ De Grote Rivieren and Parnassia psychomedical centre; Site Maastricht: Maastricht University Medical Centre, GGZ Eindhoven, GGZ Midden-Brabant, GGZ Oost-Brabant, GGZ Noord-Midden Limburg, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem). The analyses were supported by unrestricted grants from Jansen-Cilag, Eli Lilly and Company, Astra-Zeneca and Lundbeck. The research leading to these results has received funding from the European Communitya(sic)(TM) s Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajtony Z, 2011, ACTA U SAPIENTIAE PH, V3, P134; Angermeyer MC, 2004, SCHIZOPHRENIA BULL, V30, P1049, DOI 10.1093/oxfordjournals.schbul.a007120; [Anonymous], 2005, SIGMA MENTAL ILLNESS; APA, 2000, DIAGN STAT MAN MENT; Biernat M, 2000, SOCIAL PSYCHOLOGY OF STIGMA, P88; Brohan E, 2010, SCHIZOPHR RES, V122, P232, DOI 10.1016/j.schres.2010.02.1065; Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875; Corrigan PW, 2009, WORLD PSYCHIATRY, V8, P75; Corrigan PW, 2005, ON THE STIGMA OF MENTAL ILLNESS: PRACTICAL STRATEGIES FOR RESEARCH AND SOCIAL CHANGE, P11, DOI 10.1037/10887-001; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Delespaul P.A.E.G., 1995, ASSESSING SCHIZOPHRE; Delespaul PAEG, 2008, HANDLEIDING GGZ MONI; Farina A., 1981, CLIN PSYCHOL REV, V1, P223, DOI DOI 10.1016/0272-7358(81)90005-2; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Harrop Emily, 2006, RESILIENCE COPING SA; Hayward P, 1997, J MENT HEALTH, V6, P345, DOI DOI 10.1080/09638239718671; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613; Mann M, 2004, HEALTH EDUC RES, V19, P357, DOI 10.1093/her/cyg041; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Ostman M, 2002, BRIT J PSYCHIAT, V181, P494, DOI 10.1192/bjp.181.6.494; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Peterson D, 2009, STEPPING OUT SHADOWS; Rogers ES, 1997, PSYCHIATR SERV, V48, P1042; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rusch N, 2009, SCHIZOPHR RES, V110, P59, DOI 10.1016/j.schres.2009.01.006; Schneider DavidJ., 2004, PSYCHOL STEREOTYPING; Sibitz I, 2011, EUR PSYCHIAT, V26, P28, DOI 10.1016/j.eurpsy.2010.08.010; StataCorp, 2021, STATA STAT SOFTWARE; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Struening FL, 2001, PSYCHIATR SERV, V52, P1633; van Zelst C, 2009, SCHIZOPHRENIA BULL, V35, P293, DOI 10.1093/schbul/sbn184; VENTURA J, 1993, INT J METH PSYCH RES, V3, P221; Watson AC, 2005, STIGMA MENTAL ILLNES; Watson AC, 2007, SCHIZOPHRENIA BULL, V33, P1312, DOI 10.1093/schbul/sbl076; Wirth JH, 2009, PSYCHOL SCI, V20, P169, DOI 10.1111/j.1467-9280.2009.02282.x	36	11	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88586	10.1371/journal.pone.0088586	http://dx.doi.org/10.1371/journal.pone.0088586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523918	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100067
J	Yusa, A; Toneri, M; Masuda, T; Ito, S; Yamamoto, S; Okochi, M; Kondo, N; Iwata, H; Yatabe, Y; Ichinosawa, Y; Kinuta, S; Kondo, E; Honda, H; Arai, F; Nakanishi, H				Yusa, Akiko; Toneri, Makoto; Masuda, Taisuke; Ito, Seiji; Yamamoto, Shuhei; Okochi, Mina; Kondo, Naoto; Iwata, Hiroji; Yatabe, Yasushi; Ichinosawa, Yoshiyuki; Kinuta, Seichin; Kondo, Eisaku; Honda, Hiroyuki; Arai, Fumihito; Nakanishi, Hayao			Development of a New Rapid Isolation Device for Circulating Tumor Cells (CTCs) Using 3D Palladium Filter and Its Application for Genetic Analysis	PLOS ONE			English	Article							BREAST-CANCER; MOLECULAR CHARACTERIZATION; SINGLE; MARKER; SIZE; ENUMERATION; PROGRESSION; EXPRESSION; CAPTURE; BLOOD	Circulating tumor cells (CTCs) in the blood of patients with epithelial malignancies provide a promising and minimally invasive source for early detection of metastasis, monitoring of therapeutic effects and basic research addressing the mechanism of metastasis. In this study, we developed a new filtration-based, sensitive CTC isolation device. This device consists of a 3-dimensional (3D) palladium (Pd) filter with an 8 mu m-sized pore in the lower layer and a 30 mu m-sized pocket in the upper layer to trap CTCs on a filter micro-fabricated by precise lithography plus electroforming process. This is a simple pump-less device driven by gravity flow and can enrich CTCs from whole blood within 20 min. After on-device staining of CTCs for 30 min, the filter cassette was removed from the device, fixed in a cassette holder and set up on the upright fluorescence microscope. Enumeration and isolation of CTCs for subsequent genetic analysis from the beginning were completed within 1.5 hr and 2 hr, respectively. Cell spike experiments demonstrated that the recovery rate of tumor cells from blood by this Pd filter device was more than 85%. Single living tumor cells were efficiently isolated from these spiked tumor cells by a micromanipulator, and KRAS mutation, HER2 gene amplification and overexpression, for example, were successfully detected from such isolated single tumor cells. Sequential analysis of blood from mice bearing metastasis revealed that CTC increased with progression of metastasis. Furthermore, a significant increase in the number of CTCs from the blood of patients with metastatic breast cancer was observed compared with patients without metastasis and healthy volunteers. These results suggest that this new 3D Pd filter-based device would be a useful tool for the rapid, cost effective and sensitive detection, enumeration, isolation and genetic analysis of CTCs from peripheral blood in both preclinical and clinical settings.	[Yusa, Akiko] Aichi Sci & Technol Fdn, Knowledge Hub Aichi, Prior Res Projects, Nagoya, Aichi, Japan; [Toneri, Makoto; Ito, Seiji] Aichi Canc Ctr Cent Hosp, Dept Gastrointestinal Surg, Nagoya, Aichi, Japan; [Yusa, Akiko; Masuda, Taisuke; Arai, Fumihito] Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Nagoya, Aichi 4648601, Japan; [Yamamoto, Shuhei; Okochi, Mina; Honda, Hiroyuki] Nagoya Univ, Grad Sch Engn, Dept Biotechnogloy, Nagoya, Aichi 4648601, Japan; [Kondo, Naoto; Iwata, Hiroji] Aichi Canc Ctr Cent Hosp, Dept Breast Oncol, Nagoya, Aichi, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Cent Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan; [Yusa, Akiko; Toneri, Makoto; Kondo, Eisaku; Nakanishi, Hayao] Aichi Canc Ctr Res Inst, Div Oncol Pathol, Nagoya, Aichi, Japan	Aichi Cancer Center; Nagoya University; Nagoya University; Aichi Cancer Center; Aichi Cancer Center; Aichi Cancer Center	Nakanishi, H (corresponding author), Aichi Canc Ctr Res Inst, Div Oncol Pathol, Nagoya, Aichi, Japan.	hnakanis@aichi-cc.jp	YATABE, Yasushi/J-6461-2014	YATABE, Yasushi/0000-0003-1788-559X	Ministry of Education, Culture, Sports, Science and Technology, Japan; Knowledge Hub Aichi, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Hub Aichi, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan(http://www.mext.go.jp/english/), and by a Grant-in-Aid for Priority Research Project from Knowledge Hub Aichi, Japan (http://www.chinokyoten.pref.aichi.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2011, CLIN CANCER RES, V17, P3048, DOI 10.1158/1078-0432.CCR-10-3234; Barbazan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040476; Chen CL, 2013, PROSTATE, V73, P813, DOI 10.1002/pros.22625; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Deneve E, 2013, CLIN CHEM, V59, P1384, DOI 10.1373/clinchem.2013.202846; Desitter I, 2011, ANTICANCER RES, V31, P427; Glinskii AB, 2003, CANCER RES, V63, P4239; Glinsky GV, 2006, CELL CYCLE, V5, P191, DOI 10.4161/cc.5.2.2320; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hosokawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067466; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Ito S, 2002, CANCER LETT, V183, P195, DOI 10.1016/S0304-3835(02)00157-X; Ito Y, 2010, CANCER SCI, V101, P1853, DOI 10.1111/j.1349-7006.2010.01607.x; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kolostova K, 2011, ANTICANCER RES, V31, P1535; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Krishnamurthy S, 2013, CANCER MED-US, V2, P226, DOI 10.1002/cam4.70; Lim LS, 2012, LAB CHIP, V12, P4388, DOI [10.1039/c2lc20750h, 10.1039/c2lc2075011]; Liu MC, 2009, J CLIN ONCOL, V27, P5153, DOI 10.1200/JCO.2008.20.6664; Lu CY, 2013, BRIT J CANCER, V108, P791, DOI 10.1038/bjc.2012.595; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Molloy TJ, 2011, BRIT J CANCER, V104, P1913, DOI 10.1038/bjc.2011.164; Nadal R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3180; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nakanishi H, 2003, CANCER SCI, V94, P112, DOI 10.1111/j.1349-7006.2003.tb01361.x; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Peeters DJE, 2013, BRIT J CANCER, V108, P1358, DOI 10.1038/bjc.2013.92; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Riethdorf S, 2010, CLIN CANCER RES, V16, P2634, DOI 10.1158/1078-0432.CCR-09-2042; Sandri MT, 2010, ANN SURG ONCOL, V17, P1539, DOI 10.1245/s10434-010-0918-2; Takao M, 2011, CYTOM PART A, V79A, P107, DOI 10.1002/cyto.a.21014; Thalgott M, 2013, J CANCER RES CLIN, V139, P755, DOI 10.1007/s00432-013-1377-5; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Welty CJ, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-6; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	42	63	69	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88821	10.1371/journal.pone.0088821	http://dx.doi.org/10.1371/journal.pone.0088821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523941	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100090
J	Sanchez-Covarrubias, L; Slosky, LM; Thompson, BJ; Zhang, YF; Laracuente, ML; DeMarco, KM; Ronaldson, PT; Davis, TP				Sanchez-Covarrubias, Lucy; Slosky, Lauren M.; Thompson, Brandon J.; Zhang, Yifeng; Laracuente, Mei-Li; DeMarco, Kristin M.; Ronaldson, Patrick T.; Davis, Thomas P.			P-glycoprotein Modulates Morphine Uptake into the CNS: A Role for the Non-steroidal Anti-inflammatory Drug Diclofenac	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; NECROSIS-FACTOR-ALPHA; ANTINOCICEPTIVE POTENCY; POSTOPERATIVE PAIN; LAMBDA-CARRAGEENAN; OPIOID ANALGESICS; EFFLUX TRANSPORT; LOADING CONTROL; CANCER PAIN; EXPRESSION	Our laboratory has previously demonstrated that peripheral inflammatory pain (PIP), induced by subcutaneous plantar injection of lambda- carrageenan, results in increased expression and activity of the ATP-dependent efflux transporter Pglycoprotein (P-gp) that is endogenously expressed at the blood-brain barrier (BBB). The result of increased P-gp functional expression was a significant reduction in CNS uptake of morphine and, subsequently, reduced morphine analgesic efficacy. A major concern in the treatment of acute pain/ inflammation is the potential for drug-drug interactions resulting from P-gp induction by therapeutic agents co-administered with opioids. Such effects on P-gp activity can profoundly modulate CNS distribution of opioid analgesics and alter analgesic efficacy. In this study, we examined the ability of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) that is commonly administered in conjunction with the opioids during pain therapy, to alter BBB transport of morphine via P-gp and whether such changes in P-gp morphine transport could alter morphine analgesic efficacy. Administration of diclofenac reduced paw edema and thermal hyperalgesia in rats subjected to PIP, which is consistent with the known mechanism of action of this NSAID. Western blot analysis demonstrated an increase in P-gp expression in rat brain microvessels not only following PIP induction but also after diclofenac treatment alone. Additionally, in situ brain perfusion studies showed that both PIP and diclofenac treatment alone increased P-gp efflux activity resulting in decreased morphine brain uptake. Critically, morphine analgesia was significantly reduced in animals pretreated with diclofenac (3 h), as compared to animals administered diclofenac and morphine concurrently. These novel findings suggest that administration of diclofenac and P-gp substrate opioids during pain pharmacotherapy may result in a clinically significant drug-drug interaction.	[Sanchez-Covarrubias, Lucy; Slosky, Lauren M.; Thompson, Brandon J.; Zhang, Yifeng; Laracuente, Mei-Li; DeMarco, Kristin M.; Ronaldson, Patrick T.; Davis, Thomas P.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA	University of Arizona	Davis, TP (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA.	davistp@email.arizona.edu	davis, thomas p/F-3244-2015	davis, thomas p/0000-0001-8465-4973; Slosky, Lauren/0000-0002-9471-9117	NIH [R01-NS42652, R01-DA11271]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011271] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH Grants R01-NS42652 and R01-DA11271 to TPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Akanuma S, 2010, J PHARMACOL EXP THER, V333, P912, DOI 10.1124/jpet.109.165332; Al-Bataineh MM, 2010, BIOPHARM DRUG DISPOS, V31, P506, DOI 10.1002/bdd.731; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Bauer B, 2004, MOL PHARMACOL, V66, P413; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Bauer B, 2006, MOL PHARMACOL, V70, P1212, DOI 10.1124/mol.106.023796; Bendayan R, 2006, J HISTOCHEM CYTOCHEM, V54, P1159, DOI 10.1369/jhc.5A6870.2006; Brooks TA, 2008, J PHARMACOL EXP THER, V325, P665, DOI 10.1124/jpet.107.135632; BURKE A, 2006, GOODMAN GILMANS PHAR, P671; Chan GNY, 2011, J NEUROCHEM, V118, P163, DOI 10.1111/j.1471-4159.2011.07288.x; Chen CP, 1998, J PHARMACOL EXP THER, V287, P545; Chen CP, 1997, PHARMACEUT RES, V14, P345, DOI 10.1023/A:1012054222845; Dagenais C, 2004, BIOCHEM PHARMACOL, V67, P269, DOI 10.1016/j.bcp.2003.08.027; Daniels S, 2013, CLIN J PAIN, V29, P655, DOI 10.1097/AJP.0b013e318270f957; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Engeler DS, 2005, J UROLOGY, V174, P933, DOI 10.1097/01.ju.0000169483.47777.7e; Fayaz MK, 2004, J CARDIOTHOR VASC AN, V18, P742, DOI 10.1053/j.jvca.2004.08.012; Groenendaal D, 2007, BRIT J PHARMACOL, V151, P701, DOI 10.1038/sj.bjp.0707257; Habgood MD, 1998, CLIN EXP PHARMACOL P, V25, P361, DOI 10.1111/j.1440-1681.1998.tb02364.x; Hamabe W, 2007, J PHARMACOL SCI, V105, P353, DOI 10.1254/jphs.FP0071287; Hamabe W, 2006, PHARMACOL BIOCHEM BE, V85, P629, DOI 10.1016/j.pbb.2006.10.018; Hanks GW, 2001, BRIT J CANCER, V84, P587, DOI 10.1054/bjoc.2001.1680; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hartz AMS, 2010, MOL PHARMACOL, V77, P715, DOI 10.1124/mol.109.061754; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Huber JD, 2002, AM J PHYSIOL-HEART C, V283, pH1531, DOI 10.1152/ajpheart.00027.2002; Ibuki T, 2003, J NEUROCHEM, V86, P318, DOI 10.1046/j.1471-4159.2003.01848.x; Kalvass JC, 2013, CLIN PHARMACOL THER, V94, P80, DOI 10.1038/clpt.2013.34; Labuz D, 2007, BRAIN RES, V1160, P30, DOI 10.1016/j.brainres.2007.05.049; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; McCaffrey G, 2012, J NEUROCHEM, V122, P962, DOI 10.1111/j.1471-4159.2012.07831.x; Mercer SL, 2011, CURR TOP MED CHEM, V11, P1157; Mogadam AY, 2012, ARCH TRAUMA RES, V1, P108, DOI 10.5812/atr.7931; Morgan MM, 2006, J PAIN, V7, P358, DOI 10.1016/j.jpain.2005.12.009; Narala VR, 2010, J BIOL CHEM, V285, P22067, DOI 10.1074/jbc.M109.085118; Narang VS, 2008, AM J PHYSIOL-CELL PH, V295, pC440, DOI 10.1152/ajpcell.00491.2007; Ng A, 2002, BRIT J ANAESTH, V88, P714, DOI 10.1093/bja/88.5.714; Oderda G, 2012, PHARMACOTHERAPY, V32, p6S, DOI 10.1002/j.1875-9114.2012.01177.x; Page TH, 2010, J IMMUNOL, V185, P3694, DOI 10.4049/jimmunol.1000906; PIERETTI S, 1991, GEN PHARMACOL, V22, P929, DOI 10.1016/0306-3623(91)90232-U; Potschka H, 2012, ADV DRUG DELIVER REV, V64, P943, DOI 10.1016/j.addr.2011.12.007; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Ronaldson P.T, 2007, DRUG TRANSPORTERS MO, P411; Ronaldson PT, 2008, GLIA, V56, P1711, DOI 10.1002/glia.20725; Ronaldson PT, 2013, PHARMACOL REV, V65, P291, DOI 10.1124/pr.112.005991; Ronaldson PT, 2011, J PHARMACOL EXP THER, V336, P827, DOI 10.1124/jpet.110.174151; Ronaldson PT, 2009, J CEREBR BLOOD F MET, V29, P1084, DOI 10.1038/jcbfm.2009.32; Ronaldsonl PT, 2013, ARCH TRAUMA RES, V2, P97, DOI 10.5812/atr.11011; Sakat SS, 2013, INFLAMMATION; Sanchez-Covarrubias L, 2013, CURR PHARM DES; Seelbach MJ, 2007, J NEUROCHEM, V102, P1677, DOI 10.1111/j.1471-4159.2007.04644.x; Sharom FJ, 1999, BIOCHEM PHARMACOL, V58, P571, DOI 10.1016/S0006-2952(99)00139-2; Shawahna R, 2011, MOL PHARMACEUT, V8, P1332, DOI 10.1021/mp200129p; Shen KF, 1997, BRAIN RES, V757, P176, DOI 10.1016/S0006-8993(97)00197-2; Slosky LM, 2013, MOL PHARMACOL, V84, P774, DOI 10.1124/mol.113.086298; TAKASATO Y, 1984, AM J PHYSIOL, V247, pH484, DOI 10.1152/ajpheart.1984.247.3.H484; Thompson SJ, 2000, ANESTHESIOLOGY, V92, P1392, DOI 10.1097/00000542-200005000-00030; van Vliet EA, 2010, NEUROPHARMACOLOGY, V58, P404, DOI 10.1016/j.neuropharm.2009.09.012; Vanderah TW, 2008, EUR J PHARMACOL, V583, P62, DOI 10.1016/j.ejphar.2008.01.011; Wetzel L, 2014, EUR J ANAESTH, V31, P35, DOI 10.1097/EJA.0b013e328365ae28; Yousif S, 2012, J NEUROCHEM, V123, P491, DOI 10.1111/j.1471-4159.2012.07890.x; Yukawa Y, 2005, SPINE, V30, P2357, DOI 10.1097/01.brs.0000184377.31427.fa; ZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M; ZLOKOVIC BV, 1986, J NEUROCHEM, V46, P1444, DOI 10.1111/j.1471-4159.1986.tb01760.x	65	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88516	10.1371/journal.pone.0088516	http://dx.doi.org/10.1371/journal.pone.0088516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520393	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600084
J	Sangare, L; van Eijk, AM; ter Kuile, FO; Walson, J; Stergachis, A				Sangare, Laura; van Eijk, Anna Maria; ter Kuile, Feiko O.; Walson, Judd; Stergachis, Andy			The Association between Malaria and Iron Status or Supplementation in Pregnancy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; PLASMODIUM-FALCIPARUM INFECTION; VITAMIN-A-DEFICIENCY; MATERNAL ANEMIA; ERYTHROCYTE PROTOPORPHYRIN; NEONATAL-MORTALITY; PLACENTAL MALARIA; SERUM FERRITIN; GHANAIAN WOMEN; CHILDREN	Introduction: Malaria prevention and iron supplementation are associated with improved maternal and infant outcomes. However, evidence from studies in children suggests iron may adversely modify the risk of malaria. We reviewed the evidence in pregnancy of the association between malaria and markers of iron status, iron supplementation or parenteral treatment. Methods and Findings: We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, the Global Health Library, and the Malaria in Pregnancy library to identify studies that investigated the association between iron status, iron treatment or supplementation during pregnancy and malaria. Thirty one studies contributed to the analysis; 3 experimental and 28 observational studies. Iron supplementation was not associated with an increased risk of P. falciparum malaria during pregnancy or delivery in Africa (summary Relative Risk = 0.89, 95% Confidence Interval (CI) 0.66-1.20, I-2 = 78.8%, 5 studies). One study in Asia reported an increased risk of P. vivax within 30 days of iron supplementation (e. g. adjusted Hazard Ratio = 1.75, 95% CI 1.14-2.70 for 1-15 days), but not after 60 days. Iron deficiency (based on ferritin and C-reactive protein) was associated with lower odds for malaria infection (summary Odds Ratio = 0.35, 0.24-0.51, I-2 = 59.2%, 5 studies). With the exception of the acute phase protein ferritin, biomarkers of iron deficiency were generally not associated with malaria infection. Conclusions: Iron supplementation was associated with a temporal increase in P vivax, but not with an increased risk of P. falciparum; however, data are insufficient to rule out the potential for an increased risk of P. falciparum. Iron deficiency was associated with a decreased malaria risk in pregnancy only when measured with ferritin. Until there is more evidence, it is prudent to provide iron in combination with malaria prevention during pregnancy.	[Sangare, Laura; Walson, Judd; Stergachis, Andy] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Sangare, Laura] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Walson, Judd; Stergachis, Andy] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Walson, Judd] Univ Washington, Dept Med, Seattle, WA USA; [Walson, Judd] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [van Eijk, Anna Maria; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Liverpool School of Tropical Medicine; University of Liverpool	Sangare, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lsangare@u.washington.edu	van Eijk, Anna Maria/AAQ-9894-2021; Walson, Judd/R-7269-2019; Kuile, Feiko ter/ABD-6681-2020; Walson, Judd/HGC-4359-2022	Walson, Judd/0000-0003-4836-720X; Kuile, Feiko ter/0000-0003-3663-5617; van Eijk, Anna Maria/0000-0003-1635-1289	Bill & Melinda Gates Foundation; MiP Consortium	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MiP Consortium	Salary support for LS was covered in part by a pharmacovigilance planning grant and a rapid micronutrient analysis grant both from the Bill & Melinda Gates Foundation. AMvE and FOtK were supported by the MiP Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LS had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abrams ET, 2005, MALARIA J, P4; [Anonymous], PRENATAL IRON SUPPLE; Asaolu M. F., 2009, INT J MED MED SCI, V1, P523, DOI 10.5897/IJMMS.9000216; Ashorn P, 2010, SUPPLEMENTING MATERN; Asobayire FS, 2001, AM J CLIN NUTR, V74, P776; Ayoya MA, 2006, FOOD NUTR BULL, V27, P3, DOI 10.1177/156482650602700101; Banjoko SO, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-26; Bundy DAP, 1998, BRIT MED BULL, V54, P421, DOI 10.1093/oxfordjournals.bmb.a011698; BYLES AB, 1970, BRIT MED J, V3, P625, DOI 10.1136/bmj.3.5723.625; CARRIAGA MT, 1991, AM J CLIN NUTR, V54, P1077, DOI 10.1093/ajcn/54.6.1077; Clark M, 2013, BRIT J HAEMATOL, V161, P262, DOI 10.1111/bjh.12234; Cook James D., 1996, P49; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; Danquah I, 2008, J INFECT DIS, V198, P1573, DOI 10.1086/592449; Das BS, 1997, BRIT J NUTR, V78, P751, DOI 10.1079/BJN19970192; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Engmann C, 2008, INT J GYNECOL OBSTET, V101, P62, DOI 10.1016/j.ijgo.2007.09.032; Eteng MU, 2010, SCI RES ESSAYS, V5, P1009; Fawzi WW, 2010, TRIAL PREPREGNANCY S; Finkelstein JL, 2012, PUBLIC HEALTH NUTR, V15, P928, DOI 10.1017/S1368980011002369; Friedrich JO, 2012, STAT MED, V31, P1857, DOI 10.1002/sim.4501; Georgieff MK, 2002, J PEDIATR-US, V141, P405, DOI 10.1067/mpd.2002.127090; Gies S, 2010, LONG TERM IRON SUPPL; GILLES HM, 1964, Q J MED, V33, P1; GILLESPIE S, 1998, MAJOR ISSUES CONTROL; GORDEUK V, 1992, NEW ENGL J MED, V327, P1473, DOI 10.1056/NEJM199211193272101; GORDEUK VR, 1992, BLOOD, V79, P308; Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010; Hay G, 2004, ACTA PAEDIATR, V93, P592, DOI [10.1080/08035250410027607, 10.1111/j.1651-2227.2004.tb02983.x]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Hinderaker SG, 2002, EUR J CLIN NUTR, V56, P192, DOI 10.1038/sj.ejcn.1601300; Huddle JM, 1999, EUR J CLIN NUTR, V53, P792, DOI 10.1038/sj.ejcn.1600851; Kabyemela ER, 2008, J INFECT DIS, V198, P163, DOI 10.1086/589512; Kapito-Tembo A, 2010, THESIS U N CAROLINA; Kattenberg JH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-321; Klemm R., 2011, ARE WE MAKING PROGR; Kuvibidila S, 1995, J TROP MED HYG, V98, P373; Li H, 2010, ADV HEMATOL, V2010, DOI DOI 10.1155/2010/60543520631898; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; Massawe SN, 2002, GYNECOL OBSTET INVES, V54, P137, DOI 10.1159/000067879; MATTEELLI A, 1994, ANN TROP MED PARASIT, V88, P475, DOI 10.1080/00034983.1994.11812894; MENENDEZ C, 1995, T ROY SOC TROP MED H, V89, P289, DOI 10.1016/0035-9203(95)90546-4; MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Mockenhaupt FP, 2000, T ROY SOC TROP MED H, V94, P477, DOI 10.1016/S0035-9203(00)90057-9; Mwapasa V, 2004, THESIS U MICHIGAN; Nacher M, 2003, T ROY SOC TROP MED H, V97, P273, DOI 10.1016/S0035-9203(03)90140-4; Ndyomugyenyi R, 2000, ANN TROP MED PARASIT, V94, P759, DOI 10.1080/00034980020015189; Ndyomugyenyi R, 2008, T ROY SOC TROP MED H, V102, P130, DOI 10.1016/j.trstmh.2007.09.015; Ojukwu JU, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub2; OPPENHEIMER SJ, 1986, T ROY SOC TROP MED H, V80, P603, DOI 10.1016/0035-9203(86)90154-9; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; OPPENHEIMER SJ, 1986, T ROY SOC TROP MED H, V80, P818, DOI 10.1016/0035-9203(86)90393-7; Ouedraogo S, 2012, AM J TROP MED HYG, V87, P418, DOI 10.4269/ajtmh.2012.11-0706; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Prentice AM, 2007, FOOD NUTR BULL, V28, pS524, DOI 10.1177/15648265070284S406; Raiten D, 2012, CONSIDERATIONS SAFE; Raiten DJ, 2011, AM J CLIN NUTR, V94, p633S, DOI 10.3945/ajcn.110.008227; Rao R, 2001, Semin Neonatol, V6, P425, DOI 10.1053/siny.2001.0063; REINHARDT MC, 1978, HELV PAEDIATR ACTA, P43; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Saad AA, 2012, T ROY SOC TROP MED H, V106, P570, DOI 10.1016/j.trstmh.2012.06.004; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Senga EL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-249; Senga EL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-47; Shulman CE, 1996, T ROY SOC TROP MED H, V90, P535, DOI 10.1016/S0035-9203(96)90312-0; Silverstein SB, 2004, AM J HEMATOL, V76, P74, DOI 10.1002/ajh.20056; Stoltzfus RJ, 1997, J NUTR, V127, P293, DOI 10.1093/jn/127.2.293; Stoltzfus RJ, 1998, GUIDELINES USE IRON; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Titaley CR, 2010, AM J CLIN NUTR, V92, P235, DOI 10.3945/ajcn.2009.29093; van Eijk AM, 2007, TROP MED INT HEALTH, V12, P342, DOI 10.1111/j.1365-3156.2006.01787.x; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; Van Santen S, 2011, AM J TROP MED HYG, V84, P148, DOI 10.4269/ajtmh.2011.10-0250; VanderJagt DJ, 2007, J HEALTH POPUL NUTR, V25, P75; Verhoef H, 2001, AM J CLIN NUTR, V74, P767; Verhoef H, 2011, PRENATAL IRON MALARI; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; Wheeler S, 2008, P NUTR SOC, V67, P437, DOI 10.1017/S0029665108008732; WHO, 2011, SER FERR CONC ASS IR; Williams TN, 1999, AM J TROP MED HYG, V60, P875, DOI 10.4269/ajtmh.1999.60.875; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X	92	37	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87743	10.1371/journal.pone.0087743	http://dx.doi.org/10.1371/journal.pone.0087743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551064	gold, Green Published, Green Accepted			2022-12-27	WOS:000331271500021
J	Lv, C; Li, XG; Li, FT; Li, TJ				Lv, Cheng; Li, Xiaoguang; Li, Fangting; Li, Tiejun			Constructing the Energy Landscape for Genetic Switching System Driven by Intrinsic Noise	PLOS ONE			English	Article							POTENTIAL LANDSCAPE; PATHS; FATE	Genetic switching driven by noise is a fundamental cellular process in genetic regulatory networks. Quantitatively characterizing this switching and its fluctuation properties is a key problem in computational biology. With an autoregulatory dimer model as a specific example, we design a general methodology to quantitatively understand the metastability of gene regulatory system perturbed by intrinsic noise. Based on the large deviation theory, we develop new analytical techniques to describe and calculate the optimal transition paths between the on and off states. We also construct the global quasi-potential energy landscape for the dimer model. From the obtained quasi-potential, we can extract quantitative results such as the stationary distributions of mRNA, protein and dimer, the noise strength of the expression state, and the mean switching time starting from either stable state. In the final stage, we apply this procedure to a transcriptional cascades model. Our results suggest that the quasi-potential energy landscape and the proposed methodology are general to understand the metastability in other biological systems with intrinsic noise.	[Lv, Cheng; Li, Fangting] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Li, Xiaoguang; Li, Tiejun] Peking Univ, LMAM, Beijing 100871, Peoples R China; [Li, Xiaoguang; Li, Tiejun] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Li, Fangting] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Li, Tiejun] Beijing Int Ctr Math Res, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University	Li, FT (corresponding author), Peking Univ, Sch Phys, Beijing 100871, Peoples R China.	li_fangting@pku.edu.cn; tieli@pku.edu.cn		Lyu, Cheng/0000-0003-2921-3061	NSFC [11174011, 11021463, 11171009, 91130005]; National Science Foundation for Excellent Young Scholars [11222114]	NSFC(National Natural Science Foundation of China (NSFC)); National Science Foundation for Excellent Young Scholars	The work is supported by NSFC grants no. 11174011, 11021463 (F.Li), 11171009 and 91130005 and the National Science Foundation for Excellent Young Scholars (Grant No. 11222114) (T.Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao P, 2004, J PHYS A-MATH GEN, V37, pL25, DOI 10.1088/0305-4470/37/3/L01; Assaf M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.248102; Assaf M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021116; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; DYKMAN MI, 1994, J CHEM PHYS, V100, P5735, DOI 10.1063/1.467139; E W, 2004, COMMUN PUR APPL MATH, V57, P637, DOI 10.1002/cpa.20005; Escudero C, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041149; Freidlin M.I., 2012, RANDOM PERTURBATIONS; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Ge H, 2012, INT J MOD PHYS B, V26, DOI 10.1142/S0217979212300125; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Heymann M, 2008, COMMUN PUR APPL MATH, V61, P1052, DOI 10.1002/cpa.20238; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hornos JEM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051907; Intep S, 2010, DISCRETE CONT DYN-B, V14, P495, DOI 10.3934/dcdsb.2010.14.495; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Liptser R, 1996, PROBAB THEORY REL, V106, P71, DOI 10.1007/s004400050058; Liu D, 2008, J COMPUT PHYS, V227, P8672, DOI 10.1016/j.jcp.2008.06.010; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maier RS, 1997, SIAM J APPL MATH, V57, P752, DOI 10.1137/S0036139994271753; Meerson B, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.060103; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; NAEH T, 1990, SIAM J APPL MATH, V50, P595, DOI 10.1137/0150036; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Ptashne M, 1992, GENETIC SWITCH PHAGE; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Shwartz A., 1995, LARGE DEVIATIONS PER; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Touchette H, 2009, PHYS REP, V478, P1, DOI 10.1016/j.physrep.2009.05.002; van Kampen N. G., 1981, STOCHASTIC PROCESSES; Waddington C H, 1957, STRATEGY GENES DISCU; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Weinan E, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.052301; Zhou JX, 2012, J R SOC INTERFACE, V9, P3539, DOI 10.1098/rsif.2012.0434; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	41	40	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88167	10.1371/journal.pone.0088167	http://dx.doi.org/10.1371/journal.pone.0088167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551081	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000024
J	Scheuren, R; Anton, F; Erpelding, N; Michaux, G				Scheuren, Raymonde; Anton, Fernand; Erpelding, Nathalie; Michaux, Gilles			Beep Tones Attenuate Pain following Pavlovian Conditioning of an Endogenous Pain Control Mechanism	PLOS ONE			English	Article							NOXIOUS INHIBITORY CONTROLS; NOCICEPTIVE FLEXOR REFLEX; TEMPORAL SUMMATION; FLEXION REFLEX; MODULATION; STIMULATION; PERCEPTION; EXPRESSION; SYSTEMS	Heterotopic noxious counter-stimulation (HNCS) is commonly used to study endogenous pain control systems. The resulting pain inhibition is primarily based on spinal cord-brainstem loops. Recently, functional imaging studies have shown that limbic structures like the anterior cingulate cortex and amygdala are also implicated. Since these structures are involved in learning processes, it is possible that the HNCS-induced pain inhibition may depend on specific cues from the environment that have been associated with pain reduction through associative learning. We investigated the influence of Pavlovian conditioning on HNCS-induced pain inhibition in 32 healthy subjects by using a differential conditioning paradigm in which two different acoustic stimuli were either repeatedly paired or unpaired with HNCS. Series of noxious electrical pulse trains delivered to the non-dominant foot served as test stimuli. Diffuse noxious inhibitory control (DNIC)like effects were induced by concurrent application of tonic HNCS (immersion of the contralateral hand in ice water). Subjective pain intensity and pain unpleasantness ratings and electromyographic recordings of the facial corrugator muscle and the nocifensive RIII flexion reflex were used to measure changes in pain sensitivity. HNCS induced significant pain and reflex inhibitions. In the post-conditioning phase, only the paired auditory cue was able to significantly reduce pain perceptions and corrugator muscle activity. No conditioned effect could be observed in RIII reflex responses. Our results indicate that the functional state of endogenous pain control systems may depend on associative learning processes that, like in the present study, may lead to an attenuation of pain perception. Similar albeit opposite conditioning of pain control mechanisms may significantly be involved in the exacerbation and chronification of pain states.	[Scheuren, Raymonde; Anton, Fernand] Univ Luxembourg, Integrat Res Unit Social & Individual Dev, Lab Psychobiol & Neurophysiol, Luxembourg, Luxembourg; [Erpelding, Nathalie] Boston Childrens Hosp, PAIN Grp, Waltham, MA USA; [Erpelding, Nathalie] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Michaux, Gilles] St Theresa Clin, Inst Hlth Promot, Luxembourg, Luxembourg	University of Luxembourg; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Anton, F (corresponding author), Univ Luxembourg, Integrat Res Unit Social & Individual Dev, Lab Psychobiol & Neurophysiol, Luxembourg, Luxembourg.	fernand.anton@uni.lu			University of Luxembourg [F3R-INS-PUL09/PAMO]; National research council of Luxembourg (Fonds National de la Recherche) [AFR-PhD2010 1/784732]	University of Luxembourg; National research council of Luxembourg (Fonds National de la Recherche)	This work was supported by the University of Luxembourg grant to Fernand Anton: F3R-INS-PUL09/PAMO (www.uni.lu) and National research council of Luxembourg (Fonds National de la Recherche) grant to Raymonde Scheuren: AFR-PhD2010 1/784732 (www.fnr.lu;www.afr.lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al'Absi M, 2000, PAIN, V88, P61, DOI 10.1016/S0304-3959(00)00306-7; ARENDTNIELSEN L, 1994, EUR J APPL PHYSIOL O, V68, P266, DOI 10.1007/BF00376776; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BINI G, 1981, J NEUROSCI METH, V3, P301, DOI 10.1016/0165-0270(81)90066-2; Bouhassira D, 2003, BRAIN, V126, P1068, DOI 10.1093/brain/awg106; Bruehl S, 2004, NEUROSCI BIOBEHAV R, V28, P395, DOI 10.1016/j.neubiorev.2004.06.004; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Carlsson CPO, 2002, INT CONGR SER, V1238, P31, DOI 10.1016/S0531-5131(02)00407-7; Charlton E, 1995, Pain, V63, P277, DOI 10.1016/0304-3959(95)90040-3; CRAIG KD, 1985, J PERS SOC PSYCHOL, V48, P1080, DOI 10.1037/0022-3514.48.4.1089; Cramp FL, 2000, ARCH PHYS MED REHAB, V81, P324, DOI 10.1016/S0003-9993(00)90079-0; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Flor H, 2002, EUR J PAIN-LONDON, V6, P395, DOI 10.1016/S1090-3801(02)00043-5; Flor H, 2011, CHRONIC PAIN INTEGRA; France CR, 1999, PAIN, V81, P77, DOI 10.1016/S0304-3959(98)00272-3; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Hadjistavropoulos HD, 1996, PAIN, V65, P251, DOI 10.1016/0304-3959(95)00218-9; Hermann C, 2000, EXP BRAIN RES, V132, P203, DOI 10.1007/s002210000343; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Lapate RC, 2012, J COGNITIVE NEUROSCI, V24, P148, DOI 10.1162/jocn_a_00125; Le Bars D, 2002, INT CONGR SER, V1238, P11, DOI 10.1016/S0531-5131(02)00412-0; Le Bars D, 1988, SCI BASES ACUPUNCTUR, P79; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Li J, 2011, NAT NEUROSCI, V14, P1250, DOI 10.1038/nn.2904; Micalos PS, 2009, EUR J APPL PHYSIOL, V105, P55, DOI 10.1007/s00421-008-0872-x; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Piche M, 2010, PAIN, V148, P49, DOI 10.1016/j.pain.2009.10.005; Piche M, 2009, J NEUROSCI, V29, P14236, DOI 10.1523/JNEUROSCI.2341-09.2009; Plaghki L, 1998, J NEUROPHYSIOL, V79, P2557, DOI 10.1152/jn.1998.79.5.2557; Prevost C, 2011, EUR J NEUROSCI, V34, P134, DOI 10.1111/j.1460-9568.2011.07686.x; PRICE DD, 1984, PAIN, V19, P27, DOI 10.1016/0304-3959(84)90062-9; Rainoldi A, 2004, J NEUROSCI METH, V134, P37, DOI 10.1016/j.jneumeth.2003.10.014; Reinert A, 2000, BRAIN RES, V862, P103, DOI 10.1016/S0006-8993(00)02077-1; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Rhudy JL, 2006, PAIN, V126, P221, DOI 10.1016/j.pain.2006.06.027; Ruscheweyh R, 2011, PAIN, V152, P2662, DOI 10.1016/j.pain.2011.08.016; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Sandrini G, 1999, NEUROSCI LETT, V261, P5, DOI 10.1016/S0304-3940(98)01000-3; Schaefer F, 2000, PSYCHOPHYSIOLOGY, V37, P85; Serrao M, 2004, PAIN, V112, P353, DOI 10.1016/j.pain.2004.09.018; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; Staud R, 2003, PAIN, V101, P167, DOI 10.1016/S0304-3959(02)00325-1; Streff A, 2011, EUR J PAIN, V15, P45, DOI 10.1016/j.ejpain.2010.05.011; Streff A, 2010, EUR J PAIN, V14, P266, DOI 10.1016/j.ejpain.2009.05.011; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; van Wijk G, 2010, J PAIN, V11, P408, DOI 10.1016/j.jpain.2009.10.009; Villanueva Luis, 1995, Biological Research, V28, P113; WILLER JC, 1990, EUR J PHARMACOL, V182, P347, DOI 10.1016/0014-2999(90)90293-F; WILLER JC, 1984, BRAIN, V107, P1095, DOI 10.1093/brain/107.4.1095; Wolf S, 1941, J CLIN INVEST, V20, P521, DOI 10.1172/JCI101245; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004	54	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88710	10.1371/journal.pone.0088710	http://dx.doi.org/10.1371/journal.pone.0088710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551138	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000057
J	Tolg, C; Telmer, P; Turley, E				Tolg, Cornelia; Telmer, Patrick; Turley, Eva			Specific Sizes of Hyaluronan Oligosaccharides Stimulate Fibroblast Migration and Excisional Wound Repair	PLOS ONE			English	Article							FETAL SKIN; CD44; RHAMM; ANGIOGENESIS; FRAGMENTS; DIFFERENTIATION; INFLAMMATION; MODULATION; RECEPTOR; INJURY	The extracellular matrix polysaccharide hyaluronan (HA) plays a key role in both fibrotic and regenerative tissue repair. Accumulation of high molecular weight HA is typical of regenerative repair, which is associated with minimal inflammation and fibrosis, while fragmentation of HA is typical of postnatal wounds, which heal in the presence of inflammation and transient fibrosis. It is generally considered that HA oligosaccharides and fragments of a wide size range support these processes of adult, fibrotic wound repair yet the consequences of sized HA fragments/oligosaccharides to each repair stage is not well characterized. Here, we compared the effects of native HA, HA oligosaccharide mixtures and individual sizes (4-10mer oligosaccharides, 5 and, 40 kDa) of HA oligosaccharides and fragments, on fibroblast migration in scratch wound assays and on excisional skin wound repair in vivo. We confirm that 4-10mer mixtures significantly stimulated scratch wound repair and further report that only the 6 and 8mer oligosaccharides in this mixture are responsible for this effect. The HA 6mer promoted wound closure, accumulation of wound M1 and M2 macrophages and the M2 cytokine TGF beta 1, but did not increase myofibroblast differentiation. The effect of 6mer HA on wound closure required both RHAMM and CD44 expression. In contrast, The 40 kDa HA fragment inhibited wound closure, increased the number of wound macrophages but had no effect on TGF beta 1 accumulation or subsequent fibrosis. These results show that specific sizes of HA polymer have unique effects on postnatal wound repair. The ability of 6mer HA to promote wound closure and inflammation resolution without increased myofibroblast differentiation suggests that this HA oligosaccharide could be useful for treatment of delayed or inefficient wound repair where minimal fibrosis is advantageous.	[Tolg, Cornelia; Telmer, Patrick; Turley, Eva] Victoria Hosp, London Hlth Sci Ctr, London Reg Canc Program, London, ON N6A 4G5, Canada; [Turley, Eva] Western Univ London, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada; [Turley, Eva] Western Univ London, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Turley, Eva] Western Univ London, Schulich Sch Med & Dent, Dept Surg, London, ON, Canada	London Health Sciences Centre; University of Victoria; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Turley, E (corresponding author), Victoria Hosp, London Hlth Sci Ctr, London Reg Canc Program, London, ON N6A 4G5, Canada.	eva.turley@lhsc.on.ca			NSERC Discovery grant [56227]; MITACS fellowship	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS fellowship	This work was supported by a NSERC Discovery grant 56227 (www.nserc-crsng.gc.ca) and a MITACS fellowship (http://www.mitacs.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Bourguignon LYW, 2013, J DERMATOL SCI, V72, P32, DOI 10.1016/j.jdermsci.2013.05.003; Brown BC, 2010, J PLAST RECONSTR AES, V63, P1022, DOI 10.1016/j.bjps.2009.03.019; Buchanan EP, 2009, ADV CLIN CHEM, V48, P137, DOI 10.1016/S0065-2423(09)48006-5; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Choi HR, 2012, J COSMET DERMATOL-US, V11, P290, DOI 10.1111/jocd.12009; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; de la Motte CA, 2011, AM J PHYSIOL-GASTR L, V301, pG945, DOI 10.1152/ajpgi.00063.2011; Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467; Gao F, 2010, MATRIX BIOL, V29, P107, DOI 10.1016/j.matbio.2009.11.002; Ghazi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048351; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Harty M, 2003, DEV DYNAM, V226, P268, DOI 10.1002/dvdy.10239; Ibrahim S, 2008, J TISSUE ENG REGEN M, V2, P22, DOI 10.1002/term.61; Islam S, 2010, INJURY, V41, P92, DOI 10.1016/j.injury.2009.07.012; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Leung A, 2012, CURR OPIN PEDIATR, V24, P371, DOI 10.1097/MOP.0b013e3283535790; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; Papakonstantinou E, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.21923; Pardue Erin L, 2008, Organogenesis, V4, P203; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Tolg C, 2003, ONCOGENE, V22, P6873, DOI 10.1038/sj.onc.1206811; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Tolg C, 2012, AM J PATHOL, V181, P1250, DOI 10.1016/j.ajpath.2012.06.036; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Weisser Shelley B, 2013, Methods Mol Biol, V946, P225, DOI 10.1007/978-1-62703-128-8_14; West DC, 1997, INT J BIOCHEM CELL B, V29, P201, DOI 10.1016/S1357-2725(96)00133-1	40	80	83	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88479	10.1371/journal.pone.0088479	http://dx.doi.org/10.1371/journal.pone.0088479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551108	Green Submitted, gold, Green Published			2022-12-27	WOS:000331266000040
J	Wu, YJ; Fang, YH; Chi, HC; Chang, LC; Chung, SY; Huang, WC; Wang, XW; Lee, KW; Chen, SL				Wu, Yi Ju; Fang, Yen Hsin; Chi, Hsiang Cheng; Chang, Li Chiung; Chung, Shih Ying; Huang, Wei Chieh; Wang, Xiao Wen; Lee, Kuan Wei; Chen, Shen Liang			Insulin and LiCl Synergistically Rescue Myogenic Differentiation of FoxO1 Over-Expressed Myoblasts	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; BETA-CATENIN; CELL-CYCLE; ALVEOLAR RHABDOMYOSARCOMA; PROTEASOMAL DEGRADATION; REGULATORY FACTORS; NUCLEAR EXCLUSION; OXIDATIVE STRESS; GENE-EXPRESSION	Most recent studies reported that FoxO1 transcription factor was a negative regulator of myogenesis under serum withdrawal condition, a situation not actually found in vivo. Therefore, the role of FoxO1 in myogenesis should be reexamined under more physiologically relevant conditions. Here we found that FoxO1 was preferentially localized to nucleus in proliferating (PMB) and confluent myoblasts (CMB) and its nuclear exclusion was a prerequisite for formation of multinucleated myotubes (MT). The nuclear shuttling of FoxO1 in PMB could be prevented by leptomycin B and we further found that cytoplasmic accumulation of FoxO1 in myotubes was caused by the blockade of its nuclear import. Although over-expression of wildtype FoxO1 in C2C12 myoblasts significantly blocked their myogenic differentiation under serum withdrawal condition, application of insulin and LiCl, an activator of Wnt signaling pathway, to these cells successfully rescued their myogenic differentiation and generated myotubes with larger diameters. Interestingly, insulin treatment significantly reduced FoxO1 level and also delayed nuclear re-accumulation of FoxO1 triggered by mitogen deprivation. We further found that FoxO1 directly repressed the promoter activity of myogenic genes and this repression can be relieved by insulin and LiCl treatment. These results suggest that FoxO1 inhibits myogenesis in serum withdrawal condition but turns into a hypertrophy potentiator when other myogenic signals, such as Wnt and insulin, are available.	[Wu, Yi Ju; Fang, Yen Hsin; Chi, Hsiang Cheng; Chang, Li Chiung; Chung, Shih Ying; Huang, Wei Chieh; Wang, Xiao Wen; Lee, Kuan Wei; Chen, Shen Liang] Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan	National Central University	Chen, SL (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan.	slchen@cc.ncu.edu.tw			National Science Council of Taiwan, R. O. C. [NSC-93-2311-B-008-008, NSC-94-2311-B-008-002, NSC-95-2311-B-008-002]; Brain Research Center of the University System of Taiwan	National Science Council of Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan); Brain Research Center of the University System of Taiwan	This study is supported by the grants from National Science Council of Taiwan, R. O. C. (NSC-93-2311-B-008-008, NSC-94-2311-B-008-002, and NSC-95-2311-B-008-002) and The Brain Research Center of the University System of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; BACH LA, 1995, ENDOCRINOLOGY, V136, P5061, DOI 10.1210/en.136.11.5061; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Borello U, 1999, DEVELOPMENT, V126, P4247; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chang JH, 2006, ENDOCRINOLOGY, V147, P3093, DOI 10.1210/en.2005-1317; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Chung S. Y., 2013, BIOSCI REP, V33; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Harrell Nicholas B., 2007, Archives of Physiology and Biochemistry, V113, P221, DOI 10.1080/13813450701783158; HAWLEY RG, 1994, GENE THER, V1, P136; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Hsiao SP, 2009, BIOCHEM J, V422, P343, DOI 10.1042/BJ20090072; Hsiao SP, 2010, BIOCHEM J, V428, P223, DOI 10.1042/BJ20100250; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kim CH, 2008, MOL CELL BIOL, V28, P2941, DOI 10.1128/MCB.01682-07; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kortylewski M, 2003, J BIOL CHEM, V278, P5242, DOI 10.1074/jbc.M205403200; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; Martinez-Lopez N, 2013, EMBO REP, V14, P795, DOI 10.1038/embor.2013.111; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Pan WJ, 2005, P NATL ACAD SCI USA, V102, P17378, DOI 10.1073/pnas.0505922102; Pappo A S, 1997, Cancer Treat Res, V92, P309; Pirskanen A, 2000, DEV BIOL, V224, P189, DOI 10.1006/dbio.2000.9784; Puri PL, 2000, GENE DEV, V14, P574; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Tsai WC, 2003, ENDOCRINOLOGY, V144, P5615, DOI 10.1210/en.2003-0481; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Wu AL, 2008, ENDOCRINOLOGY, V149, P1407, DOI 10.1210/en.2007-1470; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	66	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88450	10.1371/journal.pone.0088450	http://dx.doi.org/10.1371/journal.pone.0088450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551104	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000039
J	Bazargani, YT; Ewen, M; de Boer, A; Leufkens, HGM; Mantel-Teeuwisse, AK				Bazargani, Yaser T.; Ewen, Margaret; de Boer, Anthonius; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.			Essential Medicines Are More Available than Other Medicines around the Globe	PLOS ONE			English	Article							ANTIEPILEPTIC DRUGS; AFFORDABILITY; PRICES; CHILDREN; CARE	Background: The World Health Organization (WHO) promotes the development of national Essential Medicines Lists (EMLs) in order to improve the availability and use of medicines considered essential within health care systems. However, despite over 3 decades of international efforts, studies show an inconsistent pattern in the availability of essential medicines. We evaluated and compared the availability of essential medicines, and medicines not included in national EMLs, at global and regional levels. Methods: Medicine availability in the public and private sector were calculated based on data obtained from national and provincial facility-based surveys undertaken in 23 countries using the WHO/HAI methodology. The medicines were grouped according to their inclusion ('essential') or exclusion (termed 'non-essential') in each country's EML current at the time of the survey. Availability was calculated for originator brands, generics and any product type (originator brands or generics) and compared between the two groups. Results were aggregated by WHO regions, World Bank country income groups, a wealth inequality measure, and therapeutic groups. Findings: Across all sectors and any product type, the median availability of essential medicines was suboptimal at 61.5% (IQR 20.6%-86.7%) but significantly higher than non-essential medicines at 27.3% (IQR 3.6%-70.0%). The median availability of essential medicines was 40.0% in the public sector and 78.1% in the private sector; compared to 6.6% and 57.1% for non-essential medicines respectively. A reverse trend between national income level categories and the availability of essential medicines was identified in the public sector. Interpretation: EMLs have influenced the provision of medicines and have resulted in higher availability of essential medicines compared to non-essential medicines particularly in the public sector and in low and lower middle income countries. However, the availability of essential medicines, especially in the public sector does not ensure equitable access.	[Bazargani, Yaser T.; de Boer, Anthonius; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Ewen, Margaret] Hlth Act Int Global, Amsterdam, Netherlands	Utrecht University	Mantel-Teeuwisse, AK (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	A.K.Mantel@uu.nl	Mantel-Teeuwisse, Aukje/I-8902-2016					[Anonymous], WHO MED TERM STRAT P; Balasubramaniam R., 2011, CEYLON MEDICAL JOURNAL, V56, P101, DOI 10.4038/cmj.v56i3.3597; Bertoldi AD, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-6; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2012, VALUE HEALTH, V15, P664, DOI 10.1016/j.jval.2012.04.004; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Carasso BS, 2009, TROP MED INT HEALTH, V14, P1394, DOI 10.1111/j.1365-3156.2009.02383.x; Chakma J, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-9; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Cheraghali AM, 2009, PHARM WORLD SCI, V31, P209, DOI 10.1007/s11096-009-9282-3; Chomba EN, 2010, AM J TROP MED HYG, V83, P571, DOI 10.4269/ajtmh.2010.10-0100; Dixit R, 2011, INDIAN J PHARMACOL, V43, P599, DOI 10.4103/0253-7613.84981; Gitanjali B, 2011, J PHARMACOL PHARMACO, V2, P95, DOI 10.4103/0976-500X.81900; Health Action International, 2008, MEAS MED PRIC AV AFF; Higuchi M, 2010, ASIA-PAC J PUBLIC HE, V22, p96S, DOI 10.1177/1010539510373005; *HLTH ACT INT, 2012, WHO HAI PROJ MED PRI; *HLTH ACT INT, 2003, MED PRIC NEW APPR ME; KANAVOS P, 2011, WORLDS MED SITUATION; Kaplan Warren Allan, 2011, South Med Rev, V4, P51, DOI 10.5655/smr.v4i2.1002; Mackey TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051022; Madden JM, 2010, REV PANAM SALUD PUBL, V27, P291, DOI 10.1590/S1020-49892010000400008; Management Science for Health, 2012, MAN ACC MED HLTH TEC; *NORW I PUBL HLTH, 2012, AN THER CHEM ATC CLA; Odermatt P, 2007, NEUROEPIDEMIOLOGY, V28, P169, DOI 10.1159/000103270; Robertson J, 2007, CLIN PHARMACOL THER, V82, P498, DOI 10.1038/sj.clpt.6100392; Saouadogo Hamado, 2011, World Hosp Health Serv, V47, P8; Senarathna SMDKG, 2011, INDIAN J PHARMACOL, V43, P60, DOI 10.4103/0253-7613.75672; The World Bank, 2011, GINI IND; Twisselmann B, 2005, BRIT MED J, V330, P479, DOI 10.1136/bmj.330.7489.479-a; *UN, MILL DEV GOALS MDG8; *UN, UN DECL HUM RIGHTS A; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; VANDENHAM R, 2011, WORLDS MED SITUATION; Voelker R, 2010, JAMA-J AM MED ASSOC, V304, P259, DOI 10.1001/jama.2010.962; VOLGER S, 2012, FARMECONOMIA HLTH EC, V13, P29; *WHO, 2012, WHO DAT NAT MED LIST; *WHO, 2012, HLTH TOP ESS MED; *WHO, 2012, 20 WAYS WHO HELPS CO; *WHO, 2012, WHO REG LOC REG OFF; WHO, 2011, LOC PROD ACC MED PRO; *WORLD BANK, 2011, COUNTR CLASS; Yang H, 2010, HEALTH POLICY PLANN, V25, P219, DOI 10.1093/heapol/czp056	42	63	64	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87576	10.1371/journal.pone.0087576	http://dx.doi.org/10.1371/journal.pone.0087576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533058	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600016
J	Lin, Y; Yao, JL; Chen, YW; Pang, L; Li, HH; Cao, Z; You, KZ; Dai, HY; Wu, RH				Lin, Yan; Yao, Jianli; Chen, Yaowen; Pang, Li; Li, Haihong; Cao, Zhen; You, Kezeng; Dai, Haiyang; Wu, Renhua			Hippocampal Neurochemical Changes in Senescent Mice Induced with Chronic Injection of D-Galactose and NaNO2: An In Vitro High-Resolution NMR Spectroscopy Study at 9.4T	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MILD COGNITIVE IMPAIRMENT; AGE-RELATED-CHANGES; ALZHEIMERS-DISEASE; H-1 MRS; N-ACETYLASPARTATE; BRAIN-METABOLITES; WHITE-MATTER; MOUSE-BRAIN; PROTON	Proton magnetic resonance spectroscopy (H-1-MRS) has been used to provide useful information about the neurochemical changes reflecting early pathological alterations in Alzheimer's disease (AD) brain. In this study, we have longitudinally measured the hippocampal neurochemical profile in vitro in senescent mice induced with chronic injection of D-Galactose and NaNO2, at different time point from day 30 to day 70 with a 10-day interval. Pathological brain alterations induced by D-Galactose and NaNO2 were monitored through hematoxylin and eosin (HE) staining, Congo red staining and bielschowsky silver staining, and the cognition deficits were assessed via Morris Water Maze (MWM) test. This D-galactose and NaNO2 treated mouse model, characterized by an early-onset memory dysfunction, a robust neuronal loss, amyloid plaques and neurofibrillary tangles in hippocampal subdivision, well mimics a prodromal Alzheimer's phenotype. Consistent with previously published in vivo H-1 MRS findings in human AD patients and AD transgenic mice, our in vitro H-1 MRS on the perchloric acid extractions of hippocampus in senescent mice observed significant decreases of N-acetylaspartate (NAA) and Glutamate (Glu) but an increase in Myo-inositol (mIns). Elevated mIns occurred prior to the reduction of NAA and Glu during the progression of aging. In addition, changes in mIns, NAA and Glu were found to precede pathological abnormalities. Overall, our in vitro findings in senescent mice validated the concept that hippocampal neurochemical alternations preceded the pathological changes of the brain, and could serve as potential markers of AD progression. Reductions of NAA and Glu can be interpreted in terms of neuronal degeneration and dysfunctions in glutamatergic activity that may contribute to the pathophysiological mechanisms underlying AD. Elevated mIns might be related to glial activation. Further experiments are needed to explore the potential value of mIns in the early diagnosis of AD, to verify whether glial cell proliferation occurs earlier than neuronal changes.	[Lin, Yan; Yao, Jianli; Pang, Li; Cao, Zhen; You, Kezeng; Dai, Haiyang; Wu, Renhua] Shantou Univ, Affiliated Hosp 2, Coll Med, Dept Med Imaging, Shantou, Guangdong, Peoples R China; [Chen, Yaowen] Shantou Univ, Cent Lab, Shantou, Guangdong, Peoples R China; [Chen, Yaowen] NMR Unit, Shantou, Guangdong, Peoples R China; [Li, Haihong] Shantou Univ, Mental Hlth Ctr, Coll Med, Shantou, Guangdong, Peoples R China; [Wu, Renhua] Key Lab Mol Imaging Guangdong Prov, Shantou, Peoples R China; [Yao, Jianli] Sichuan Prov Tumor Hosp, Chengdu, Peoples R China	Shantou University; Shantou University; Shantou University	Wu, RH (corresponding author), Shantou Univ, Affiliated Hosp 2, Coll Med, Dept Med Imaging, Shantou, Guangdong, Peoples R China.	rhwu@stu.edu.cn		Lin, Yan/0000-0002-8284-9029	National Natural Science Foundation of China [60971075, 81101102]; key program [30930027]; Natural Science Foundation of Guangdong Province [S2011010004973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key program; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported in part by grants from the National Natural Science Foundation of China (60971075, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#; 81101102, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#) and key program (30930027, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#) and the Natural Science Foundation of Guangdong Province (S2011010004973, http://gdsf.gdstc.gov.cn/User/User.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackl N, 2005, NEUROSCI LETT, V384, P23, DOI 10.1016/j.neulet.2005.04.035; Adalsteinsson E, 2000, LANCET, V355, P1696, DOI 10.1016/S0140-6736(00)02246-7; Barton SJ, 1999, MAGN RESON MATER PHY, V8, P121; Bayer TA, 2008, NEURODEGENER DIS, V5, P140, DOI 10.1159/000113684; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; CARSON FL, 1980, ARCH PATHOL LAB MED, V104, P333; Chen SQ, 2012, BEHAV BRAIN RES, V235, P1, DOI 10.1016/j.bbr.2012.07.016; Chen SQ, 2009, DEMENT GERIATR COGN, V28, P558, DOI 10.1159/000261646; Chu J LL, 2003, CHIN J REHABIL THEOR, V9, P521; Coimbra A, 2006, CURR TOP MED CHEM, V6, P629, DOI 10.2174/156802606776743075; Dedeoglu A, 2004, BRAIN RES, V1012, P60, DOI 10.1016/j.brainres.2004.02.079; den Heijer T, 2006, NEUROLOGY, V66, P540, DOI 10.1212/01.wnl.0000198256.54809.0e; Dixon RM, 2002, BRAIN, V125, P2332, DOI 10.1093/brain/awf226; Fang F, 2007, BASIC CLIN PHARMACOL, V101, P447, DOI 10.1111/j.1742-7843.2007.00138.x; Fayed N, 2011, AM J ALZHEIMERS DIS, V26, P450, DOI 10.1177/1533317511421780; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fischer A. H., 2008, CSH PROTOC; Forster DM, 2012, NMR BIOMED, V25, P52, DOI 10.1002/nbm.1712; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Herminghaus S, 2003, PSYCHIAT RES-NEUROIM, V123, P183, DOI 10.1016/S0925-4927(03)00071-4; Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Huang W, 2001, NEUROLOGY, V57, P626, DOI 10.1212/WNL.57.4.626; HYMAN BT, 1987, ANN NEUROL, V22, P37, DOI 10.1002/ana.410220110; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jessen F, 2005, DEMENT GERIATR COGN, V20, P178, DOI 10.1159/000087095; Jones RS, 2004, NEUROL RES, V26, P488, DOI 10.1179/016164104225017640; Kantarci K, 2007, BRIT J RADIOL, V80, pS146, DOI 10.1259/bjr/60346217; Kantarci K, 2004, NEUROLOGY, V63, P1393; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; Kimura N, 2006, J NEUROSCI RES, V84, P782, DOI 10.1002/jnr.20984; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; Lazeyras F, 1998, PSYCHIAT RES-NEUROIM, V82, P95, DOI 10.1016/S0925-4927(98)00010-9; Lin Y, 2012, J CEREBR BLOOD F MET, V32, P1484, DOI 10.1038/jcbfm.2012.33; Litchfield S, 2001, ACTA NEUROPATHOL, V101, P17; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Metastasio A, 2006, NEUROBIOL AGING, V27, P926, DOI 10.1016/j.neurobiolaging.2005.05.002; Mlynarik V, 2012, J ALZHEIMERS DIS, V31, pS87, DOI 10.3233/JAD-2012-112072; MOATS RA, 1994, MAGNET RESON MED, V32, P110, DOI 10.1002/mrm.1910320115; Newberg AB, 2006, J NUCL MED, V47, P748; Oberg J, 2008, NEUROBIOL AGING, V29, P1423, DOI 10.1016/j.neurobiolaging.2007.03.002; Parnetti L, 1997, MECH AGEING DEV, V97, P9, DOI 10.1016/S0047-6374(97)01877-0; Pfefferbaum A, 1999, MAGNET RESON MED, V41, P276, DOI 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rupsingh R, 2011, NEUROBIOL AGING, V32, P802, DOI 10.1016/j.neurobiolaging.2009.05.002; Schuff N, 2002, NEUROLOGY, V58, P928, DOI 10.1212/WNL.58.6.928; Stephenson MC, 2011, WORLD J RADIOL, V3, P105, DOI 10.4329/wjr.v3.i4.105; Terry AV, 2011, PHARMACOL BIOCHEM BE, V99, P190, DOI 10.1016/j.pbb.2011.02.002; Tkac I, 2005, APPL MAGN RESON, V29, P139, DOI 10.1007/BF03166960; Valenzuela MJ, 2001, NEUROLOGY, V56, P592, DOI 10.1212/WNL.56.5.592; Villemagne VL, 2005, J CLIN NEUROSCI, V12, P221, DOI 10.1016/j.jocn.2004.03.011; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003	57	16	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88562	10.1371/journal.pone.0088562	http://dx.doi.org/10.1371/journal.pone.0088562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533108	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600066
J	Valente, AM; Fonseca, C; Marques, TA; Santos, JP; Rodrigues, R; Torres, RT				Valente, Ana M.; Fonseca, Carlos; Marques, Tiago A.; Santos, Joao P.; Rodrigues, Rogerio; Torres, Rita Tinoco			Living on the Edge: Roe Deer (Capreolus capreolus) Density in the Margins of Its Geographical Range	PLOS ONE			English	Article							PELLET-GROUP; POPULATION; ABUNDANCE; DUNG; MANAGEMENT; PRECISION	Over the last decades roe deer (Capreolus capreolus) populations have increased in number and distribution throughout Europe. Such increases have profound impacts on ecosystems, both positive and negative. Therefore monitoring roe deer populations is essential for the appropriate management of this species, in order to achieve a balance between conservation and mitigation of the negative impacts. Despite being required for an effective management plan, the study of roe deer ecology in Portugal is at an early stage, and hence there is still a complete lack of knowledge of roe deer density within its known range. Distance sampling of pellet groups coupled with production and decay rates for pellet groups provided density estimates for roe deer in northeastern Portugal (Lombada National Hunting Area - LNHA, Serra de Montesinho - SM and Serra da Nogueira - SN; LNHA and SM located in Montesinho Natural Park). The estimated roe deer density using a stratified detection function was 1.23/100 ha for LNHA, 4.87/100 ha for SM and 4.25/100 ha in SN, with 95% confidence intervals (CI) of 0.68 to 2.21, 3.08 to 7.71 and 2.25 to 8.03, respectively. For the entire area, the estimated density was about 3.51/100 ha (95% CI - 2.26-5.45). This method can provide estimates of roe deer density, which will ultimately support management decisions. However, effective monitoring should be based on long-term studies that are able to detect population fluctuations. This study represents the initial phase of roe deer monitoring at the edge of its European range and intends to fill the gap in this species ecology, as the gathering of similar data over a number of years will provide the basis for stronger inferences. Monitoring should be continued, although the study area should be increased to evaluate the accuracy of estimates and assess the impact of management actions.	[Valente, Ana M.; Fonseca, Carlos; Santos, Joao P.; Torres, Rita Tinoco] Univ Aveiro, Dept Biol, CESAM, P-3800 Aveiro, Portugal; [Fonseca, Carlos] Univ Lurio, Nampula, Mozambique; [Marques, Tiago A.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland; [Santos, Joao P.] Inst Invest Recursos Cineget, Ciudad Real, Spain; [Rodrigues, Rogerio] Dept Conservacao Nat & Florestas Norte, Vila Real, Portugal	Universidade de Aveiro; University of St Andrews; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Torres, RT (corresponding author), Univ Aveiro, Dept Biol, CESAM, P-3800 Aveiro, Portugal.	rita.torres@ua.pt	Santos, João P.V./AAC-7646-2019; Marques, Tiago A./M-3253-2019; Torres, Rita Tinoco/G-1638-2011; Marques, Tiago A/A-5530-2010; Fonseca, Carlos MMS/D-9744-2011; Valente, Ana/U-8941-2018	Santos, João P.V./0000-0003-1504-1035; Marques, Tiago A./0000-0002-2581-1972; Torres, Rita Tinoco/0000-0003-4570-459X; Marques, Tiago A/0000-0002-2581-1972; Fonseca, Carlos MMS/0000-0001-6559-7133; Valente, Ana/0000-0002-2985-7687	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/65880/2009]; European Social Fund POPH-QREN program me	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Social Fund POPH-QREN program me	Joao P. Santos was supported by a Ph.D. Grant (SFRH/BD/65880/2009) from Fundacao para a Ciencia e a Tecnologia (FCT http://www.fct.pt) co-financed by the European Social Fund POPH-QREN program me. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2008, J ZOOL, V276, P37, DOI 10.1111/j.1469-7998.2008.00464.x; Acevedo P, 2010, ECOL INDIC, V10, P1226, DOI 10.1016/j.ecolind.2010.04.006; Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alves J, 2013, MAMM BIOL, V78, P134, DOI 10.1016/j.mambio.2012.08.003; [Anonymous], [No title captured]; Apollonio M., 2010, EUROPEAN UNGULATES T; Buckland S.T., 2001, pi; Burnham KP, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P307; BURNHAM KP, 1984, J WILDLIFE MANAGE, V48, P1248, DOI 10.2307/3801785; Campbell D, 2004, J APPL ECOL, V41, P1185, DOI 10.1111/j.0021-8901.2004.00964.x; Carvalho J, 2011, MONITORIZACAO POPULA; Carvalho JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071527; CASTRO J, 2010, MONTESINHO NATURAL P, P119; Cederlund G, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P337; Dick DM, 2011, MAR MAMMAL SCI, V27, P606, DOI 10.1111/j.1748-7692.2010.00435.x; EDGE WD, 1989, J WILDLIFE MANAGE, V53, P621, DOI 10.2307/3809186; Focardi S, 2005, ORYX, V39, P421, DOI 10.1017/S0030605305001109; Focardi S, 2002, J WILDLIFE MANAGE, V66, P48, DOI 10.2307/3802870; Focardi S, 2002, ENVIRONMETRICS, V13, P177, DOI 10.1002/env.491; Focardi S, 2006, ECOGRAPHY, V29, P407, DOI 10.1111/j.2006.0906-7590.04442.x; Forsyth DM, 2007, J WILDLIFE MANAGE, V71, P964, DOI 10.2193/2005-695; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Hemami MR, 2005, FOREST ECOL MANAG, V215, P224, DOI 10.1016/j.foreco.2005.05.013; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; Marques FFC, 2001, J APPL ECOL, V38, P349, DOI 10.1046/j.1365-2664.2001.00584.x; Marques TA, 2004, BIOMETRICS, V60, P757, DOI 10.1111/j.0006-341X.2004.00226.x; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Marques Tiago A., 2011, Endangered Species Research, V13, P163, DOI 10.3354/esr00325; Mayle B.A, 1999, MANY DEER FIELD GUID; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Newey S, 2003, WILDLIFE BIOL, V9, P185, DOI 10.2981/wlb.2003.049; Newson SE, 2008, J APPL ECOL, V45, P1330, DOI 10.1111/j.1365-2664.2008.01480.x; Perez J.M., 2002, Pirineos, V157, P15; Putman R, 2011, MAMMAL REV, V41, P197, DOI 10.1111/j.1365-2907.2010.00172.x; Smart JCR, 2004, MAMMAL REV, V34, P99, DOI 10.1046/j.0305-1838.2003.00026.x; The deer initiative, 2008, REC SURV DUNG COUNT; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Torres RT, 2012, MAMM BIOL, V77, P140, DOI 10.1016/j.mambio.2011.11.002; Torres RT, 2011, MAMM BIOL, V76, P491, DOI 10.1016/j.mambio.2010.10.013; Torres RT, 2013, MAMM BIOL, V9, P7; Vingada J, 2010, UNGULATE MANAGEMENT, P392; Vingada J. V., 1997, CONSERVACAO LOBO CAN; Walander P, 2012, BACHELOR WILDLIFE EC; Ward AI, 2004, MAMMAL REV, V34, P315, DOI 10.1111/j.1365-2907.2004.00046.x; Wronski T, 2013, MAMM BIOL, V78, P226, DOI 10.1016/j.mambio.2012.07.158; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; [No title captured]	48	19	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88459	10.1371/journal.pone.0088459	http://dx.doi.org/10.1371/journal.pone.0088459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533091	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600049
J	Mee, ET; Stebbings, R; Hall, J; Giles, E; Almond, N; Rose, NJ				Mee, Edward T.; Stebbings, Richard; Hall, Joanna; Giles, Elaine; Almond, Neil; Rose, Nicola J.			Allogeneic Lymphocyte Transfer in MHC-Identical Siblings and MHC-Identical Unrelated Mauritian Cynomolgus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; LIVE ATTENUATED SIV; INFECTED MACAQUES; REPLICATION; MONKEYS; VACCINE; SUPERINFECTION; IMMUNIZATION; PREVENTION; PROTECTION	The detailed study of immune effector mechanisms in primate models of infectious disease has been limited by the inability to adoptively transfer lymphocytes from vaccinated animals into naive immunocompetent recipients. Recent advances in our understanding of the Major Histocompatibility Complex diversity of Mauritian cynomolgus macaques enabled the establishment of a breeding program to generate Major Histocompatibility Complex (MHC)-identical animals. The current study utilised this resource to achieve an improved model of adoptive transfer of lymphocytes in macaques. The effect of route of transfusion on persistence kinetics of adoptively transferred lymphocytes was evaluated in an autologous transfer system. Results indicated that peripheral persistence kinetics were comparable following infusion by different routes, and that cells were detectable at equivalent levels in lymphoid tissues six weeks post-infusion. In a pilot-scale experiment, the persistence of adoptively transferred lymphocytes was compared in MHC-identical siblings and MHC-identical unrelated recipients. Lymphocytes transferred intra-peritoneally were detectable in the periphery within one hour of transfer and circulated at detectable levels in the periphery and lymph nodes for 10 days. Donor lymphocytes were detectable at higher levels in MHC-identical siblings compared with unrelated animals, however the total time of persistence did not differ. These results demonstrate a further refinement of the lymphocyte adoptive transfer system in Mauritian cynomolgus macaques and provide a foundation for hitherto impractical experiments to investigate mechanisms of cellular immunity in primate models of infectious disease.	[Mee, Edward T.; Hall, Joanna; Almond, Neil; Rose, Nicola J.] Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Div Virol, S Mimms, Herts, England; [Stebbings, Richard] Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Div Biotherapeut, S Mimms, Herts, England; [Hall, Joanna; Giles, Elaine] Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Div Biol Serv, S Mimms, Herts, England	National Institute for Biological Standards & Control; The Medicines & Healthcare Products Regulatory Agency; National Institute for Biological Standards & Control; The Medicines & Healthcare Products Regulatory Agency; National Institute for Biological Standards & Control; The Medicines & Healthcare Products Regulatory Agency	Mee, ET (corresponding author), Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Div Virol, S Mimms, Herts, England.	edward.mee@nibsc.org; nicola.rose@nibsc.org	Rose, Nicola/E-9366-2013; Stebbings, Richard/E-2117-2013	Stebbings, Richard/0000-0001-9628-2708; Almond, Neil/0000-0001-6105-0616	Health Protection Agency Strategic Research and Development Fund; Centre for Health Protection Research; Medical Research Council [G0601201, G9025730] Funding Source: researchfish; MRC [G9025730, G0601201] Funding Source: UKRI	Health Protection Agency Strategic Research and Development Fund; Centre for Health Protection Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Health Protection Agency Strategic Research and Development Fund, part of the Centre for Health Protection Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond N, 1997, J GEN VIROL, V78, P1919, DOI 10.1099/0022-1317-78-8-1919; Almond N, 1999, IMMUNOL LETT, V66, P167, DOI 10.1016/S0165-2478(98)00153-9; Berry N, 2008, J GEN VIROL, V89, P2240, DOI 10.1099/vir.0.2008/001693-0; Bimber BN, 2008, J IMMUNOL, V181, P6301, DOI 10.4049/jimmunol.181.9.6301; Bolton DL, 2010, J IMMUNOL, V184, P303, DOI 10.4049/jimmunol.0902413; Brandin E, 2006, J VIROL, V80, P9861, DOI 10.1128/JVI.00394-06; CLEMENTS JE, 1995, J VIROL, V69, P2737, DOI 10.1128/JVI.69.5.2737-2744.1995; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Das AT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-44; Das AT, 2007, J VIROL, V81, P11159, DOI 10.1128/JVI.01354-07; Dittmer U, 1996, J GEN VIROL, V77, P2433, DOI 10.1099/0022-1317-77-10-2433; FEICHTINGER H, 1990, AM J PATHOL, V137, P1311; Greene JM, 2013, J VIROL, V87, P7382, DOI 10.1128/JVI.00348-13; Greene JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002384; Habis A, 1999, AIDS RES HUM RETROV, V15, P1389, DOI 10.1089/088922299310098; Jorajuria S, 2000, PATHOL BIOL, V48, P490; LEGRAND R, 1994, AIDS RES HUM RETROV, V10, P1279, DOI 10.1089/aid.1994.10.1279; Maggiorella MT, 1998, BLOOD, V91, P3103, DOI 10.1182/blood.V91.9.3103.3103_3103_3111; Manoussaka MS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-59; Mee ET, 2009, J MED PRIMATOL, V38, P1, DOI 10.1111/j.1600-0684.2008.00299.x; Montgomery MM, 1999, NEUROPATH APPL NEURO, V25, P11; PUTKONEN P, 1991, NATURE, V352, P436, DOI 10.1038/352436a0; Stebbings R, 2004, VIROLOGY, V330, P249, DOI 10.1016/j.virol.2004.09.026; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999	26	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88670	10.1371/journal.pone.0088670	http://dx.doi.org/10.1371/journal.pone.0088670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523927	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100076
J	Rupprecht, A; Sittner, D; Smorodchenko, A; Hilse, KE; Goyn, J; Moldzio, R; Seiler, AEM; Brauer, AU; Pohl, EE				Rupprecht, Anne; Sittner, Dana; Smorodchenko, Alina; Hilse, Karolina E.; Goyn, Justus; Moldzio, Rudolf; Seiler, Andrea E. M.; Braeuer, Anja U.; Pohl, Elena E.			Uncoupling Protein 2 and 4 Expression Pattern during Stem Cell Differentiation Provides New Insight into Their Putative Function	PLOS ONE			English	Article							PREVENTS NEURONAL DEATH; ENERGY-METABOLISM; BRAIN; UCP2; TRANSPORT; PROLIFERATION; NEUROGENESIS; INDUCTION; OXIDATION; INCREASES	Apart from the first family member, uncoupling protein 1 (UCP1), the functions of other UCPs (UCP2-UCP5) are still unknown. In analyzing our own results and those previously published by others, we have assumed that UCP's cellular expression pattern coincides with a specific cell metabolism and changes if the latter is altered. To verify this hypothesis, we analyzed the expression of UCP1-5 in mouse embryonic stem cells before and after their differentiation to neurons. We have shown that only UCP2 is present in undifferentiated stem cells and it disappears simultaneously with the initiation of neuronal differentiation. In contrast, UCP4 is simultaneously up-regulated together with typical neuronal marker proteins TUJ-1 and NeuN during mESC differentiation in vitro as well as during murine brain development in vivo. Notably, several tested cell lines express UCP2, but not UCP4. In line with this finding, neuroblastoma cells that display metabolic features of tumor cells express UCP2, but not UCP4. UCP2's occurrence in cancer, immunological and stem cells indicates that UCP2 is present in cells with highly proliferative potential, which have a glycolytic type of metabolism as a common feature, whereas UCP4 is strongly associated with non-proliferative highly differentiated neuronal cells.	[Rupprecht, Anne; Smorodchenko, Alina; Hilse, Karolina E.; Pohl, Elena E.] Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria; [Rupprecht, Anne; Sittner, Dana; Smorodchenko, Alina; Goyn, Justus; Braeuer, Anja U.; Pohl, Elena E.] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Sittner, Dana; Seiler, Andrea E. M.] German Fed Inst Risk Assessment BfR, Dept Expt Toxicol, Berlin, Germany; [Sittner, Dana; Seiler, Andrea E. M.] German Fed Inst Risk Assessment BfR, ZEBET, Berlin, Germany; [Moldzio, Rudolf] Univ Vet Med, Inst Med Biochem, Vienna, Austria	University of Veterinary Medicine Vienna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Federal Institute for Risk Assessment; Federal Institute for Risk Assessment; University of Veterinary Medicine Vienna	Pohl, EE (corresponding author), Univ Vet Med, Inst Physiol Pathophysiol & Biophys, Vienna, Austria.	elena.pohl@vetmeduni.ac.at	Smorodchenko, Alina/AAU-2854-2020; Pohl, Elena E./A-4025-2009; Bräuer, Anja/N-3692-2019; Smorodchenko, Alina/ABB-2411-2020; Smorodchenko, Alina/D-1880-2010	Pohl, Elena E./0000-0002-0604-5950; Smorodchenko, Alina/0000-0003-1415-1531	Austrian Science Fund [FWF-P25123]; Austrian Science Fund (FWF) [P 25123] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financially supported by The Austrian Science Fund (FWF-P25123 to EEP, http://www.fwf.ac.at/en/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Guerra MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041846; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Beck V, 2006, BBA-BIOENERGETICS, V1757, P474, DOI 10.1016/j.bbabio.2006.03.006; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cardoso S, 2013, J BIOENERG BIOMEMBR, V45, P397, DOI 10.1007/s10863-013-9503-2; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Derdak Z, 2006, CARCINOGENESIS, V27, P956, DOI 10.1093/carcin/bgi335; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Elorza A, 2008, J BIOL CHEM, V283, P30461, DOI 10.1074/jbc.M805400200; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Hoang T, 2012, BIOCHEMISTRY-US, V51, P4004, DOI 10.1021/bi3003378; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Klingenberg M, 2001, BIOCHEM SOC T, V29, P806; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Macintyre AN, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-5; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MUNYON WH, 1959, EXP CELL RES, V17, P490, DOI 10.1016/0014-4827(59)90069-2; Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Rupprecht A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041406; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Shetty PK, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00043; Shimasaki Y, 2013, CIRC RES; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Simon-Areces J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042911; Smorodchenko A, 2011, MOL CELL NEUROSCI, V47, P244, DOI 10.1016/j.mcn.2011.03.002; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Suski JM, 2012, BIOCHEM BIOPH RES CO, V428, P234, DOI 10.1016/j.bbrc.2012.10.025; Visan A, 2012, NEUROTOXICOLOGY, V33, P1135, DOI 10.1016/j.neuro.2012.06.006; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	56	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88474	10.1371/journal.pone.0088474	http://dx.doi.org/10.1371/journal.pone.0088474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523901	gold, Green Published			2022-12-27	WOS:000331258100050
J	Yang, S; Kim, HM				Yang, Seungwon; Kim, Hyun-Man			ROCK Inhibition Activates MCF-7 CellsIntroduction	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-CELL ADHESION; E-CADHERIN; RHO-KINASE; RAC1 ACTIVATION; BREAST-CANCER; BETA-CATENIN; THERAPEUTIC TARGET; ADHERENS JUNCTIONS; INVASION	Dormant carcinoma cancer cells showing epithelial characteristics can be activated to dissipate into the surrounding tissue or organs through epithelial-mesenchymal transition (EMT). However, the molecular details underlying the activation of dormant cancer cells have been less explored. In this study, we examined the molecular pathway to activate dormant breast cancer cells. Rho-associated kinase (ROCK) inhibition disrupted cell junction, promoted cell proliferation and migration / invasion in both two-dimensional and three-dimensional substrates. The disintegration of cell junction upon ROCK inhibition, coupled with the loss of E-cadherin and b-catenin from the cell membrane, was associated with the activation of Rac1 upon ROCK inhibition. Migration / invasion also increased upon ROCK inhibition. However, the activation of MCF-7 cells upon ROCK inhibition was not associated with the up-regulation of typical EMT markers, such as snail and slug. Based on these results, we suggest the potential risk for dormant cancer cells to dissipate through non-typical EMT when ROCK activity is down-regulated.	[Kim, Hyun-Man] Seoul Natl Univ, Lab Study Mol Biointerfaces, Dept Oral Histol & Dev Biol, Program Cell & Dev Biol,Sch Dent, Seoul, South Korea; Seoul Natl Univ, Dent Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, HM (corresponding author), Seoul Natl Univ, Lab Study Mol Biointerfaces, Dept Oral Histol & Dev Biol, Program Cell & Dev Biol,Sch Dent, Seoul, South Korea.	hyunmkim@snu.ac.kr	Yang, Seungwon/AAM-7585-2021		Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT and Future Planning [2011-0015840]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported through funding from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded through the Ministry of Science, ICT and Future Planning (No. 2011-0015840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Akhtar N, 2000, CELL ADHES COMMUN, V7, P465, DOI 10.3109/15419060009040304; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; Fujita H, 2010, HEART VESSELS, V25, P144, DOI 10.1007/s00380-009-1176-8; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Grille SJ, 2003, CANCER RES, V63, P2172; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hage B, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-23; Hu LM, 2009, LAB INVEST, V89, P531, DOI 10.1038/labinvest.2009.17; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Monaghan-Benson E, 2013, ONCOGENE, V32, P4836, DOI 10.1038/onc.2012.492; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Paez D, 2012, CLIN CANCER RES, V18, P645, DOI 10.1158/1078-0432.CCR-11-2186; Peng J, 2012, BIOSCI BIOTECH BIOCH, V76, P42, DOI 10.1271/bbb.110411; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Schuldt A, 2011, NAT REV MOL CELL BIO, V12, P343, DOI 10.1038/nrm3124; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tian YS, 2009, BIOCHEM BIOPH RES CO, V386, P499, DOI 10.1016/j.bbrc.2009.06.087; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Willis L, 2010, CANCER RES, V70, P4310, DOI 10.1158/0008-5472.CAN-09-3144; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Yang S, 2012, BIOMATERIALS, V33, P2902, DOI 10.1016/j.biomaterials.2011.12.051; Yang S, 2011, BIOMATERIALS, V32, P2851, DOI 10.1016/j.biomaterials.2011.01.015; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zheng L, 2013, J BIOMED MATER RES A, V101, P1629, DOI 10.1002/jbm.a.34463	54	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88489	10.1371/journal.pone.0088489	http://dx.doi.org/10.1371/journal.pone.0088489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523903	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100052
J	Zare, Y; Shook, GE; Collins, MT; Kirkpatrick, BW				Zare, Yalda; Shook, George E.; Collins, Michael T.; Kirkpatrick, Brian W.			Genome-Wide Association Analysis and Genomic Prediction of Mycobacterium avium Subspecies paratuberculosis Infection in US Jersey Cattle	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; ANTIBODY-RESPONSE; GENETIC-VARIATION; JOHNES-DISEASE; CROHNS-DISEASE; BOVINE PARATUBERCULOSIS; QUANTITATIVE TRAITS; LOCI; HERITABILITY; MILK	Paratuberculosis (Johne's disease), an enteric disorder in ruminants caused by Mycobacterium avium subspecies paratuberculosis (MAP), causes economic losses in excess of $200 million annually to the US dairy industry. To identify genomic regions underlying susceptibility to MAP infection in Jersey cattle, a case-control genome-wide association study (GWAS) was performed. Blood and fecal samples were collected from,5,000 mature cows in 30 commercial Jersey herds from across the US. Discovery data consisted of 450 cases and 439 controls genotyped with the Illumina BovineSNP50 BeadChip. Cases were animals with positive ELISA and fecal culture (FC) results. Controls were animals negative to both ELISA and FC tests that matched cases on birth date and herd. Validation data consisted of 180 animals including 90 cases (positive to FC) and 90 controls (negative to ELISA and FC), selected from discovery herds and genotyped by Illumina BovineLD BeadChip (similar to 7K SNPs). Two analytical approaches were used: single-marker GWAS using the GRAMMAR-GC method and Bayesian variable selection (Bayes C) using GenSel software. GRAMMAR-GC identified one SNP on BTA7 at 68 megabases (Mb) surpassing a significance threshold of 5 x 10(-5). ARS-BFGL-NGS-11887 on BTA23 (27.7 Mb) accounted for the highest percentage of genetic variance (3.3%) in the Bayes C analysis. SNPs identified in common by GRAMMAR-GC and Bayes C in both discovery and combined data were mapped to BTA23 (27, 29 and 44 Mb), 3 (100, 101, 106 and 107 Mb) and 17 (57 Mb). Correspondence between results of GRAMMAR-GC and Bayes C was high (70-80% of most significant SNPs in common). These SNPs could potentially be associated with causal variants underlying susceptibility to MAP infection in Jersey cattle. Predictive performance of the model developed by Bayes C for prediction of infection status of animals in validation set was low (55% probability of correct ranking of paired case and control samples).	[Zare, Yalda; Kirkpatrick, Brian W.] Univ Wisconsin, Coll Agr & Life Sci, Dept Anim Sci, Madison, WI 53706 USA; [Shook, George E.; Kirkpatrick, Brian W.] Univ Wisconsin, Coll Agr & Life Sci, Dept Dairy Sci, Madison, WI 53706 USA; [Collins, Michael T.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kirkpatrick, BW (corresponding author), Univ Wisconsin, Coll Agr & Life Sci, Dept Anim Sci, Madison, WI 53706 USA.	bwkirkpa@wisc.edu			USDA-NIFA [2010-65205-20442]; American Jersey Cattle Association	USDA-NIFA(United States Department of Agriculture (USDA)); American Jersey Cattle Association	This project was supported by grants from USDA-NIFA (grant # 2010-65205-20442) (http://www.csrees.usda.gov/) and the American Jersey Cattle Association (http://www.usjersey.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; [Anonymous], 2009, GENSEL USER MANUAL P; Attalla SA, 2010, J DAIRY SCI, V93, P1729, DOI 10.3168/jds.2009-2625; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Barkema HW, 2010, PARATUBERCULOSIS: ORGANISM, DISEASE, CONTROL, P10, DOI 10.1079/9781845936136.0010; Berry DP, 2010, LIVEST SCI, V131, P102, DOI 10.1016/j.livsci.2010.03.007; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buchsbaum S, 2012, BIOCHEM BIOPH RES CO, V428, P11, DOI 10.1016/j.bbrc.2012.09.110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; Chen L, 2012, DIS MARKERS, V32, P195, DOI [10.1155/2012/473251, 10.3233/DMA-2011-0877]; Cheung YH, 2011, HUM GENET, V129, P161, DOI 10.1007/s00439-010-0908-2; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Collins MT, 2006, JAVMA-J AM VET MED A, V229, P1912, DOI 10.2460/javma.229.12.1912; COLLINS MT, 1990, J CLIN MICROBIOL, V28, P2514, DOI 10.1128/JCM.28.11.2514-2519.1990; Collins MT, 2002, CLIN DIAGN LAB IMMUN, V9, P1367, DOI 10.1128/CDLI.9.6.1367-1371.2002; Cruickshank J, 2004, ANIM GENET, V35, P206, DOI 10.1111/j.1365-2052.2004.01138.x; Dreyfuss JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-340; Fecteau ME, 2010, PARATUBERCULOSIS: ORGANISM, DISEASE, CONTROL, P144, DOI 10.1079/9781845936136.0144; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Fernando Rohan L, 2013, Methods Mol Biol, V1019, P237, DOI 10.1007/978-1-62703-447-0_10; Fischer A, 2012, AM J RESP CRIT CARE, V186, P877, DOI 10.1164/rccm.201204-0708OC; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Garrick Dorian J, 2013, Methods Mol Biol, V1019, P275, DOI 10.1007/978-1-62703-447-0_11; Gonda MG, 2006, J DAIRY SCI, V89, P1804, DOI 10.3168/jds.S0022-0302(06)72249-4; Haldar T, 2012, ANN HUM GENET, V76, P237, DOI 10.1111/j.1469-1809.2012.00708.x; Haritunians T, 2011, GUT, V60, P1060, DOI 10.1136/gut.2010.227256; Hinger M, 2008, J DAIRY SCI, V91, P3237, DOI 10.3168/jds.2008-1021; Hollis-Moffatt JE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3816; Jakobsen MS, 2000, PREV VET MED, V46, P15, DOI 10.1016/S0167-5877(00)00138-0; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Julia A, 2013, GUT, P1; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Kirkpatrick BW, 2011, ANIM GENET, V42, P149, DOI 10.1111/j.1365-2052.2010.02097.x; Kizilkaya Kadir, 2011, BMC Proc, V5 Suppl 4, pS22, DOI 10.1186/1753-6561-5-S4-S22; Kotlowski R, 2008, INFLAMM BOWEL DIS, V14, P1112, DOI 10.1002/ibd.20425; Kupper J, 2012, J DAIRY SCI, V95, P2734, DOI 10.3168/jds.2011-4994; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Lombard JE, 2013, PREV VET MED, V108, P234, DOI 10.1016/j.prevetmed.2012.08.006; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meuwissen THE, 2001, GENETICS, V157, P1819; Minozzi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032578; Minozzi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011117; Morange PE, 2010, AM J HUM GENET, V86, P592, DOI 10.1016/j.ajhg.2010.02.011; Mortensen H, 2004, J DAIRY SCI, V87, P2108, DOI 10.3168/jds.S0022-0302(04)70029-6; NAHMS, 2007, REF DAIR HLTH MAN 1; Nielsen SS, 2008, J DAIRY SCI, V91, P4610, DOI 10.3168/jds.2008-1272; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Pant SD, 2010, GENOMICS, V95, P176, DOI 10.1016/j.ygeno.2010.01.001; Peters SO, 2012, J ANIM SCI, V90, P3398, DOI [10.2527/jas.2011-4507, 10.2527/jas.2012-4507]; R Core Team, 2021, R LANGUAGE ENV STAT; Ruiz-Larranaga O, 2010, J DAIRY SCI, V93, P1713, DOI 10.3168/jds.2009-2438; Schneider JF, 2012, J ANIM SCI, V90, P3360, DOI 10.2527/jas.2011-4759; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Shin SJ, 2008, CLIN VACCINE IMMUNOL, V15, P1277, DOI 10.1128/CVI.00105-08; Shook GE, 2012, ANIM GENET, V43, P56, DOI 10.1111/j.1365-2052.2012.02349.x; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SOCKETT DC, 1992, CAN J VET RES, V56, P148; Sorge US, 2011, J DAIRY SCI, V94, P754, DOI 10.3168/jds.2010-3404; Stabel JR, 1998, J DAIRY SCI, V81, P283, DOI 10.3168/jds.S0022-0302(98)75577-8; THOMPSON EA, 1990, BIOMETRICS, V46, P399, DOI 10.2307/2531445; Uemoto Y, 2011, ANIM GENET, V42, P141, DOI 10.1111/j.1365-2052.2010.02088.x; van Hulzen KJE, 2012, J DAIRY SCI, V95, P2740, DOI 10.3168/jds.2011-5005; van Hulzen KJE, 2011, J DAIRY SCI, V94, P992, DOI 10.3168/jds.2010-3472; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Zanella R, 2011, ANIM GENET, V42, P28, DOI 10.1111/j.1365-2052.2010.02076.x; Zare Y, 2013, PREV VET ME IN PRESS	72	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88380	10.1371/journal.pone.0088380	http://dx.doi.org/10.1371/journal.pone.0088380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523889	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100038
J	Balhara, V; Deshmukh, SS; Kalman, L; Kornblatt, JA				Balhara, Vinod; Deshmukh, Sasmit S.; Kalman, Laszlo; Kornblatt, Jack A.			The Interaction of Streptococcal Enolase with Canine Plasminogen: The Role of Surfaces in Complex Formation	PLOS ONE			English	Article							DUAL-POLARIZATION INTERFEROMETRY; CRYSTAL-STRUCTURE; PLASMON RESONANCE; ALPHA-ENOLASE; REAL-TIME; BINDING; MEMBRANE; 6-AMINOHEXANOATE; FLUORESCENCE; ACTIVATION	The enolase from Streptococcus pyogenes (Str enolase F137L/E363G) is a homo-octamer shaped like a donut. Plasminogen (Pgn) is a monomeric protein composed of seven discrete separated domains organized into a lock washer. The enolase is known to bind Pgn. In past work we searched for conditions in which the two proteins would bind to one another. The two native proteins in solution would not bind under any of the tried conditions. We found that if the structures were perturbed binding would occur. We stated that only the non-native Str enolase or Pgn would interact such that we could detect binding. We report here the results of a series of dual polarization interferometry (DPI) experiments coupled with atomic force microscopy (AFM), isothermal titration calorimetry (ITC), dynamic light scattering (DLS), and fluorescence. We show that the critical condition for forming stable complexes of the two native proteins involves Str enolase binding to a surface. Surfaces that attract Str enolase are a sufficient condition for binding Pgn. Under certain conditions, Pgn adsorbed to a surface will bind Str enolase.	[Balhara, Vinod] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Deshmukh, Sasmit S.; Kalman, Laszlo] Concordia Univ, Dept Phys, Montreal, PQ H3G 1M8, Canada; [Kornblatt, Jack A.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Kornblatt, Jack A.] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada; Concordia University - Canada; Concordia University - Canada; Concordia University - Canada	Kornblatt, JA (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	jack.kornblatt@concordia.ca		kornblatt, jack/0000-0002-9802-8321; Kalman, Laszlo/0000-0002-6564-0258	Natural Sciences and Engineering Research Council, Canada [9988-2006]	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grant number 9988-2006 to JAK from the Natural Sciences and Engineering Research Council, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; An SSA, 1998, PROTEIN SCI, V7, P1960, DOI 10.1002/pro.5560070911; BACHMANN F, 1994, HAEMOSTASIS THROMBOS, P525; Balhara V, 2013, BBA-BIOMEMBRANES, V1828, P2193, DOI 10.1016/j.bbamem.2013.05.027; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; BURKE LI, 1973, J LIPID RES, V14, P9; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; Coffey PD, 2013, RSC ADV, V3, P3316, DOI 10.1039/c2ra22911k; Conejero-Lara F, 1998, PROTEIN SCI, V7, P2190, DOI 10.1002/pro.5560071017; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Daghestani HN, 2010, SENSORS-BASEL, V10, P9630, DOI 10.3390/s101109630; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Feng XY, 2013, ANAL CHEM, V85, P2370, DOI 10.1021/ac303392a; Fernandez DI, 2013, EUR BIOPHYS J BIOPHY, V42, P47, DOI 10.1007/s00249-012-0796-6; Hirst DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P503, DOI 10.1007/s00249-010-0664-1; Hurmalainen V, 2007, MICROBIOL-SGM, V153, P1112, DOI 10.1099/mic.0.2006/000901-0; Karbassi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008810; Kornblatt JA, 2005, BIOCHEMISTRY-US, V44, P13122, DOI 10.1021/bi050895y; Kornblatt JA, 2001, BIOCHEMISTRY-US, V40, P3639, DOI 10.1021/bi001857b; KORNBLATT JA, 1986, EUR J BIOCHEM, V155, P505, DOI 10.1111/j.1432-1033.1986.tb09517.x; Kornblatt JA, 2000, BBA-PROTEIN STRUCT M, V1481, P1, DOI 10.1016/S0167-4838(00)00119-9; Kornblatt JA, 2007, ANAL CHEM INSIGHTS, V2, P17; Kornblatt MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028481; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee TH, 2010, BBA-BIOMEMBRANES, V1798, P1977, DOI 10.1016/j.bbamem.2010.06.023; Lee TH, 2010, BBA-BIOMEMBRANES, V1798, P544, DOI 10.1016/j.bbamem.2010.01.014; MARKUS G, 1978, J BIOL CHEM, V253, P733; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1989, BIOCHEMISTRY-US, V28, P9337, DOI 10.1021/bi00450a014; OKAMOTO S, 1968, ANN NY ACAD SCI, V146, P414, DOI 10.1111/j.1749-6632.1968.tb20303.x; Osborne MJ, 2013, P NATL ACAD SCI USA, V110, P3877, DOI 10.1073/pnas.1216862110; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; ROGALSKI AA, 1989, J BIOL CHEM, V264, P6438; SHIMOJO T, 1967, J BIOCHEM-TOKYO, V61, P89, DOI 10.1093/oxfordjournals.jbchem.a128524; Sonesson AW, 2007, COLLOID SURFACE B, V54, P236, DOI 10.1016/j.colsurfb.2006.10.028; Swann MJ, 2004, ANAL BIOCHEM, V329, P190, DOI 10.1016/j.ab.2004.02.019; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; VORBECK ML, 1965, BIOCHEMISTRY-US, V4, P296, DOI 10.1021/bi00878a018; Waner MJ, 1998, J PHYS CHEM B, V102, P1649, DOI 10.1021/jp9732219; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x	46	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88395	10.1371/journal.pone.0088395	http://dx.doi.org/10.1371/journal.pone.0088395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520380	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000331254600071
J	Terme, M; Dorvillius, M; Cochonneau, D; Chaumette, T; Xiao, WH; Diccianni, MB; Barbet, J; Yu, AL; Paris, F; Sorkin, LS; Birkle, S				Terme, Mickael; Dorvillius, Mylene; Cochonneau, Denis; Chaumette, Tanguy; Xiao, Wenhua; Diccianni, Mitchell B.; Barbet, Jacques; Yu, Alice L.; Paris, Francois; Sorkin, Linda S.; Birkle, Stephane			Chimeric Antibody c. 8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia	PLOS ONE			English	Article							ANTI-CD20 MONOCLONAL-ANTIBODY; PHASE-I TRIAL; BIOLOGICAL-ACTIVITY; GANGLIOSIDE GD2; CELLS; CYTOTOXICITY; MELANOMA; CANCER; GENE; INTERLEUKIN-2	Background: Anti-GD2 antibody is a proven therapy for GD2-postive neuroblastoma. Monoclonal antibodies against GD2, such as chimeric mAb ch14.18, have become benchmarks for neuroblastoma therapies. Pain, however, can limit immunotherapy with anti-GD2 therapeutic antibodies like ch14.18. This adverse effect is attributed to acute inflammation via complement activation on GD2-expressing nerves. Thus, new strategies are needed for the development of treatment intensification strategies to improve the outcome of these patients. Methodology/ Principal Findings: We established the mouse-human chimeric antibody c.8B6 specific to OAcGD2 in order to reduce potential immunogenicity in patients and to fill the need for a selective agent that can kill neuroblastoma cells without inducing adverse neurological side effects caused by anti-GD2 antibody immunotherapy. We further analyzed some of its functional properties compared with anti-GD2 ch14.18 therapeutic antibody. With the exception of allodynic activity, we found that antibody c.8B6 shares the same anti-neuroblastoma attributes as therapeutic ch14.18 anti-GD2 mAb when tested in cell-based assay and in vivo in an animal model. Conclusion/Significance: The absence of OAcGD2 expression on nerve fibers and the lack of allodynic properties of c.8B6-which are believed to play a major role in mediating anti-GD2 mAb dose-limiting side effects-provide an important rationale for the clinical application of c.8B6 in patients with high-risk neuroblastoma.	[Terme, Mickael; Dorvillius, Mylene] Univ Nantes, ATLAB Pharma, Inst Rech Sante, Nantes, France; [Terme, Mickael; Cochonneau, Denis; Chaumette, Tanguy; Barbet, Jacques; Paris, Francois; Birkle, Stephane] Univ Nantes, Ctr Rech Cancerol Nantes Angers, Inst Rech Sante, INSERM,U892, Nantes, France; [Terme, Mickael; Cochonneau, Denis; Chaumette, Tanguy; Barbet, Jacques; Paris, Francois; Birkle, Stephane] Univ Nantes, Ctr Rech Cancerol Nantes Angers, Inst Rech Sante, CNRS 6299, Nantes, France; [Xiao, Wenhua] McGill Univ, Dept Anesthesia, Montreal, PQ, Canada; [Diccianni, Mitchell B.; Yu, Alice L.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Yu, Alice L.] Chang Gung Mem Hosp, Ctr Stem Cell & Translat Canc Res, Tao Yuan, Taiwan; [Yu, Alice L.] Chang Gung Univ, Tao Yuan, Taiwan; [Sorkin, Linda S.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Chaumette, Tanguy; Birkle, Stephane] Univ Nantes, UFR Sci Pharmaceut & Biol, Nantes, France	Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; McGill University; University of California System; University of California San Diego; Chang Gung Memorial Hospital; Chang Gung University; University of California System; University of California San Diego; Nantes Universite	Birkle, S (corresponding author), Univ Nantes, Ctr Rech Cancerol Nantes Angers, Inst Rech Sante, INSERM,U892, Nantes, France.	Stephane.Birkle@univ-nantes.fr	Paris, francois E/L-4915-2015; , MitchDiccianni/AAF-8486-2019; Barbet, Jacques/AAE-7089-2020; Barbet, Jacques/L-4866-2015; Chaumette, Tanguy/C-4219-2019	Paris, francois E/0000-0002-0176-7348; , MitchDiccianni/0000-0002-5017-9585; Barbet, Jacques/0000-0002-9188-984X; Barbet, Jacques/0000-0002-9188-984X; yu, alice/0000-0003-2444-0505; Chaumette, Tanguy/0000-0002-5830-8767	Agence Nationale pour la Recherche [ANR 13 RPIB 0001 02 - GANGSTEMAB]; Fondation de Projet de l'Universite de Nantes; AAIR LICHENS; Nantes Metropole; Fondation de la Recherche Medicale; Societe Francaise de lutte contre les Cancers et les leucemies de l'Enfant et de l'adolescent, l'Etoile de Martin, les Bagouz' a Manon, la Ligue contre le Cancer; National Institutes of Health (NIH) [CA164132]; NATIONAL CANCER INSTITUTE [R01CA164132] Funding Source: NIH RePORTER	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de Projet de l'Universite de Nantes; AAIR LICHENS; Nantes Metropole(Region Pays de la Loire); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Societe Francaise de lutte contre les Cancers et les leucemies de l'Enfant et de l'adolescent, l'Etoile de Martin, les Bagouz' a Manon, la Ligue contre le Cancer; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Agence Nationale pour la Recherche Grant ANR 13 RPIB 0001 02 - GANGSTEMAB, Fondation de Projet de l'Universite de Nantes, AAIR LICHENS, Nantes Metropole, the Fondation de la Recherche Medicale, the Societe Francaise de lutte contre les Cancers et les leucemies de l'Enfant et de l'adolescent, l'Etoile de Martin, les Bagouz' a Manon, la Ligue contre le Cancer (comite 44 et comite 56) to SB and National Institutes of Health (NIH) Grant CA164132 to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063359; Aixinjueluo W, 2005, J BIOL CHEM, V280, P29828, DOI 10.1074/jbc.M414041200; Alvarez-Rueda N, 2007, CLIN CANCER RES, V13, p5613S, DOI 10.1158/1078-0432.CCR-07-1057; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025220; BARKER E, 1991, CANCER RES, V51, P144; BOUCHON B, 1990, BIOCHIM BIOPHYS ACTA, V1051, P1, DOI 10.1016/0167-4889(90)90166-B; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Cerato E, 1997, HYBRIDOMA, V16, P307, DOI 10.1089/hyb.1997.16.307; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHERESH DA, 1986, CANCER RES, V46, P5112; Cheung NKV, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19864; CHEUNG NKV, 1987, J CLIN ONCOL, V5, P1430, DOI 10.1200/JCO.1987.5.9.1430; Clemenceau B, 2006, J IMMUNOTHER, V29, P53; Cochonneau D, 2013, CANCER LETT, V333, P194, DOI 10.1016/j.canlet.2013.01.032; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Gennari R, 2004, CLIN CANCER RES, V10, P5650, DOI 10.1158/1078-0432.CCR-04-0225; Hagenbeek A, 2008, BLOOD, V111, P5486, DOI 10.1182/blood-2007-10-117671; HANDGRETINGER R, 1992, CANCER IMMUNOL IMMUN, V35, P199, DOI 10.1007/BF01756188; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Imai M, 2005, CANCER RES, V65, P10562, DOI 10.1158/0008-5472.CAN-05-1894; KHAZAELI MB, 1988, JNCI-J NATL CANCER I, V80, P937, DOI 10.1093/jnci/80.12.937; Kushner BH, 2011, J CLIN ONCOL, V29, P1168, DOI 10.1200/JCO.2010.28.3317; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; Louis E, 2004, ALIMENT PHARM THER, V19, P511, DOI 10.1111/j.1365-2036.2004.01871.x; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; MUJOO K, 1989, CANCER RES, V49, P2857; Nakamura K, 2001, CANCER IMMUNOL IMMUN, V50, P275, DOI 10.1007/PL00006689; Popa I, 2002, J LIPID RES, V43, P1335, DOI 10.1194/jlr.D20005-JLR200; Raguin O, 2002, ANAL BIOCHEM, V310, P1, DOI 10.1016/S0003-2697(02)00289-0; SALEH MN, 1992, CANCER RES, V52, P4342; SCHULZ G, 1984, CANCER RES, V44, P5914; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; SJOGREN HO, 1965, EXP CELL RES, V40, P208, DOI 10.1016/0014-4827(65)90319-8; Slart R, 1997, PAIN, V69, P119, DOI 10.1016/S0304-3959(96)03247-2; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; STEPLEWSKI Z, 1988, P NATL ACAD SCI USA, V85, P4852, DOI 10.1073/pnas.85.13.4852; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; Taylor RJ, 2009, CANCER IMMUNOL IMMUN, V58, P997, DOI 10.1007/s00262-008-0613-3; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Vincent M, 2013, INT J CANCER, V133, P757, DOI 10.1002/ijc.28059; Wallace MS, 1997, ANESTH ANALG, V85, P794, DOI 10.1097/00000539-199710000-00014; Wilkinson RW, 2001, J IMMUNOL METHODS, V258, P183, DOI 10.1016/S0022-1759(01)00474-4; Xiao WH, 1997, PAIN, V69, P145, DOI 10.1016/S0304-3959(96)03280-0; YE JN, 1992, INT J CANCER, V50, P197, DOI 10.1002/ijc.2910500207; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Yuki N, 1997, J NEUROL SCI, V149, P127, DOI 10.1016/S0022-510X(97)05390-2; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018	48	31	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87210	10.1371/journal.pone.0087210	http://dx.doi.org/10.1371/journal.pone.0087210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520328	Green Published, gold			2022-12-27	WOS:000331254600019
J	Ali, F; Khan, I; Shafie, S				Ali, Farhad; Khan, Ilyas; Shafie, Sharidan			Closed Form Solutions for Unsteady Free Convection Flow of a Second Grade Fluid over an Oscillating Vertical Plate	PLOS ONE			English	Article							OLDROYD-B FLUID; UNIDIRECTIONAL FLOWS; VISCOELASTIC FLUID; STARTING SOLUTIONS; VARIABLE VISCOSITY; MAXWELL FLUID; HEAT-TRANSFER; POROUS-MEDIUM; MOTION; SURFACE	Closed form solutions for unsteady free convection flows of a second grade fluid near an isothermal vertical plate oscillating in its plane using the Laplace transform technique are established. Expressions for velocity and temperature are obtained and displayed graphically for different values of Prandtl number Pr, thermal Grashof number Gr, viscoelastic parameter alpha, phase angle omega tau and time tau. Numerical values of skin friction tau(0) and Nusselt number Nu are shown in tables. Some well-known solutions in literature are reduced as the limiting cases of the present solutions.	[Ali, Farhad; Khan, Ilyas; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Johor Bahru Johor, Malaysia; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia	Universiti Teknologi Malaysia; Majmaah University	Shafie, S (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Johor Bahru Johor, Malaysia.	ridafie@yahoo.com	Khan, Ilyas/C-8770-2019; Ali, Farhad/Y-5301-2018; SHAFIE, SHARIDAN/A-2210-2013	Khan, Ilyas/0000-0002-2056-9371; SHAFIE, SHARIDAN/0000-0001-7795-2278	Research Management Centre - UTM [4F109, 04H27]	Research Management Centre - UTM	The authors would like to acknowledge the Research Management Centre - UTM for the financial support through vote numbers 4F109 and 04H27 for this research.	Ali F, 2012, INT J NONLIN MECH, V47, P521, DOI 10.1016/j.ijnonlinmec.2011.09.027; Ali F, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.064402; Anwar I, 2008, INT J NONLIN MECH, V43, P814, DOI 10.1016/j.ijnonlinmec.2008.04.008; BANDELLI R, 1995, INT J NONLINEAR MECH, V30, P263, DOI 10.1016/0020-7462(94)00051-B; CAREY VP, 1980, INT J HEAT MASS TRAN, V23, P95, DOI 10.1016/0017-9310(80)90142-8; Chang TB, 2011, COMMUN NONLINEAR SCI, V16, P216, DOI 10.1016/j.cnsns.2010.02.018; Damseh RA, 2008, NONLINEAR ANAL-MODEL, V13, P169, DOI 10.15388/NA.2008.13.2.14577; DUNN JE, 1974, ARCH RATION MECH AN, V56, P191, DOI 10.1007/BF00280970; Erdogan AE, 2005, INT J NONLIN MECH, V40, P545, DOI 10.1016/j.ijnonlinmec.2004.07.014; Erdogan ME, 2007, APPL MATH MODEL, V31, P170, DOI 10.1016/j.apm.2005.08.019; Erdogan ME, 2005, INT J ENG SCI, V43, P721, DOI 10.1016/j.ijengsci.2004.12.011; Erdogan ME, 2000, INT J NONLINEAR MECH, V35, P1, DOI 10.1016/S0020-7462(99)00019-0; Fetecau C, 2006, INT J ENG SCI, V44, P788, DOI 10.1016/j.ijengsci.2006.04.010; Fetecau C, 2005, INT J ENG SCI, V43, P781, DOI 10.1016/j.ijengsci.2004.12.009; Fetecau C, 2008, INT J NONLIN MECH, V43, P451, DOI 10.1016/j.ijnonlinmec.2007.12.022; Fetecau C, 2010, COMPUT MATH APPL, V59, P2836, DOI 10.1016/j.camwa.2010.02.002; Fetecau C, 2009, INT J NONLIN MECH, V44, P1085, DOI 10.1016/j.ijnonlinmec.2009.08.003; FOSDICK RL, 1979, ARCH RATION MECH AN, V70, P145, DOI 10.1007/BF00250351; Ghasemi E., 2011, INT J PHYS SCI, V6, P5022; Hayat T, 2008, J POROUS MEDIA, V11, P389, DOI 10.1615/JPorMedia.v11.i4.50; Hsiao KL, 2011, INT J NONLIN MECH, V46, P1, DOI 10.1016/j.ijnonlinmec.2010.06.005; HSU SH, 1993, POLYMER, V34, P2602, DOI 10.1016/0032-3861(93)90596-3; Hussain M, 2010, NONLINEAR ANAL-REAL, V11, P2403, DOI 10.1016/j.nonrwa.2009.07.016; Jaluria B., 1988, BUOYANCY INDUCED FLO; JANG JY, 1988, WARME STOFFUBERTRAG, V23, P213, DOI 10.1007/BF01807323; KAFOUSSIAS NG, 1992, MECH RES COMMUN, V19, P89, DOI 10.1016/0093-6413(92)90034-8; Kavitha KR., 2011, INT J PHYS MATH SCI, V1, P120; Khan I, 2012, SPEC TOP REV POROUS, V3, P89, DOI 10.1615/SpecialTopicsRevPorousMedia.v3.i1.80; Khan I, 2012, TRANSPORT POROUS MED, V91, P49, DOI 10.1007/s11242-011-9832-8; Khan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061531; LAI FC, 1990, INT J HEAT MASS TRAN, V33, P1028, DOI 10.1016/0017-9310(90)90084-8; MINKOWYCZ WJ, 1966, INT J HEAT MASS TRAN, V9, P1145, DOI 10.1016/0017-9310(66)90036-6; Mishra SR, 2013, INT J HEAT MASS TRAN, V57, P433, DOI 10.1016/j.ijheatmasstransfer.2012.10.053; Nadeem S., 2006, MATH PROBL ENG, V2006, P1; Nandeppanavar MM, 2010, COMMUN NONLINEAR SCI, V15, P1791, DOI 10.1016/j.cnsns.2009.07.009; Nazar M, 2010, NONLINEAR ANAL-REAL, V11, P584, DOI 10.1016/j.nonrwa.2008.10.055; POP I, 1992, INT COMMUN HEAT MASS, V19, P275, DOI 10.1016/0735-1933(92)90038-J; RAJAGOPAL KR, 1982, INT J NONLINEAR MECH, V17, P369, DOI 10.1016/0020-7462(82)90006-3; Rup K, 1988, J THEORETICAL APP ME, V1, P34; Sivaraj R, 2012, APPL APPL MATH, V7, P99; Sparrow EM, 1958, T AM SOC MECH ENG, V80, P869; Tiwari A.K., 2009, ADV THEOR APPL MECH, V2, P33; Vieru D, 2007, MECCANICA, V42, P573, DOI 10.1007/s11012-007-9081-7; Vieru D, 2013, APPL MATH INFORM SCI, V7, P209, DOI 10.12785/amis/070126; Vieru D, 2011, CAN J PHYS, V89, P1061, DOI 10.1139/P11-099	45	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e85099	10.1371/journal.pone.0085099	http://dx.doi.org/10.1371/journal.pone.0085099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551033	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500003
J	Hong, CS; Chung, KM; Huang, PC; Wang, JJ; Yang, CM; Chu, CC; Chio, CC; Chang, FL; Chien, CC				Hong, Chon-Seng; Chung, Kun-Ming; Huang, Po-Chang; Wang, Jhi-Joung; Yang, Chun-Ming; Chu, Chin-Chen; Chio, Chung-Ching; Chang, Fu-Lin; Chien, Chih-Chiang			Epidemiology and Mortality of Liver Abscess in End-Stage Renal Disease Dialysis Patients: Taiwan National Cohort Study	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; RISK-FACTORS; HEMODIALYSIS-PATIENTS; MAINTENANCE DIALYSIS; MORBIDITY; INFECTION; ESRD; PREDICTORS; SURVIVAL; THERAPY	Background and Objectives: To determine the incidence rates and mortality of liver abscess in ESRD patients on dialysis. Design, Setting, Participants, & Measurements: Using Taiwan's National Health Insurance Research Database, we collected data from all ESRD patients who initiated dialysis between 2000 and 2006. Patients were followed until death, end of dialysis, or December 31, 2008. Predictors of liver abscess and mortality were identified using Cox models. Results: Of the 53,249 incident dialysis patients identified, 447 were diagnosed as having liver abscesses during the followup period (224/100,000 person-years). The cumulative incidence rate of liver abscess was 0.3%, 1.1%, and 1.5% at 1 year, 5 years, and 7 years, respectively. Elderly patients and patients on peritoneal dialysis had higher incidence rates. The baseline comorbidities of diabetes mellitus, polycystic kidney disease, malignancy, chronic liver disease, biliary tract disease, or alcoholism predicted development of liver abscess. Overall in-hospital mortality was 10.1%. Conclusions: The incidence of liver abscess is high among ESRD dialysis patients. In addition to the well known risk factors of liver abscess, two other important risk factors, peritoneal dialysis and polycystic kidney disease, were found to predict liver abscess in ESRD dialysis patients.	[Hong, Chon-Seng] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Chung, Kun-Ming] Chi Mei Med Ctr, Dept Gen Med, Tainan, Taiwan; [Huang, Po-Chang] Chi Mei Med Ctr, Dept Orthoped Med, Tainan, Taiwan; [Wang, Jhi-Joung; Chu, Chin-Chen] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Yang, Chun-Ming] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Chio, Chung-Ching] Chi Mei Med Ctr, Dept Neurol Surg, Tainan, Taiwan; [Chang, Fu-Lin] Chung Hwa Univ Med Technol, Dept Pharmaceut Sci & Technol, Tainan, Taiwan; [Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Chien, Chih-Chiang] Chung Hwa Univ Med Technol, Dept Food Nutr, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chung Hua University; Chi Mei Hospital; Chung Hua University	Wang, JJ (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	400002@mail.chimei.org.tw; ccchien58@yahoo.com.tw		Chu, Chin-Chen/0000-0001-8745-239X	Chi Mei Hospital [CMFHR10242]; National Health Research Institutes in Taiwan [NHRI-NHIRD-99182]	Chi Mei Hospital; National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants CMFHR10242 from Chi Mei Hospital and NHRI-NHIRD-99182 from the National Health Research Institutes in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; Chen HA, 2011, J RHEUMATOL, V38, P2390, DOI 10.3899/jrheum.110311; Chen SC, 2006, SWISS MED WKLY, V136, P119; Chien CC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-43; Chien CC, 2012, AM J HYPERTENS, V25, P900, DOI 10.1038/ajh.2012.60; Chonchol M, 2006, SEMIN DIALYSIS, V19, P291, DOI 10.1111/j.1525-139X.2006.00175.x; Chou MT, 2013, INT J CARDIOL, V167, P2719, DOI 10.1016/j.ijcard.2012.06.108; Chuang FR, 2002, RENAL FAILURE, V24, P511, DOI 10.1081/JDI-120006778; Cigarran S, 2008, THER APHER DIAL, V12, P91, DOI 10.1111/j.1744-9987.2007.00548.x; Collins AJ, 2009, CLIN J AM SOC NEPHRO, V4, pS5, DOI 10.2215/CJN.05980809; GABRIEL R, 1984, J ROY SOC MED, V77, P595, DOI 10.1177/014107688407700713; Hansen PS, 1998, APMIS, V106, P396, DOI 10.1111/j.1699-0463.1998.tb01363.x; Kaplan GG, 2004, CLIN GASTROENTEROL H, V2, P1032, DOI 10.1016/S1542-3565(04)00459-8; Lee KT, 2001, DIGEST SURG, V18, P459, DOI 10.1159/000050194; Lee PW, 2013, J NEPHROL, V26, P755, DOI 10.5301/jn.5000224; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; Meddings L, 2010, AM J GASTROENTEROL, V105, P117, DOI 10.1038/ajg.2009.614; Molle I, 2001, GUT, V48, P260, DOI 10.1136/gut.48.2.260; Perrone RD, 2001, AM J KIDNEY DIS, V38, P777, DOI 10.1053/ajkd.2001.27720; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; TELENTI A, 1990, MAYO CLIN PROC, V65, P933, DOI 10.1016/S0025-6196(12)65154-4; Tien KJ, 2013, DIABETES CARE, V36, P3027, DOI 10.2337/dc12-2148; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; United States Renal Data System, 2006, AM J KIDNEY DIS S, pS1; United States Renal Data System, 2010, AM J KIDNEY DIS S, pS1; United States Renal Data System, 2009, EXC USRDS 2009 ANN D; VANHOLDER R, 1993, J AM SOC NEPHROL, V3, P1541; WOLFE RA, 1992, KIDNEY INT, V42, P991, DOI 10.1038/ki.1992.378; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406; Yang YF, 2006, AM J KIDNEY DIS, V47, P856, DOI 10.1053/j.ajkd.2006.01.032; Zeier M, 1996, NEPHROL DIAL TRANSPL, V11, P18	31	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88078	10.1371/journal.pone.0088078	http://dx.doi.org/10.1371/journal.pone.0088078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551077	Green Submitted, gold, Green Published			2022-12-27	WOS:000331271500028
J	Binder, A; Lambert, J; Morbitzer, R; Popp, C; Ott, T; Lahaye, T; Parniske, M				Binder, Andreas; Lambert, Jayne; Morbitzer, Robert; Popp, Claudia; Ott, Thomas; Lahaye, Thomas; Parniske, Martin			A Modular Plasmid Assembly Kit for Multigene Expression, Gene Silencing and Silencing Rescue in Plants	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; RECOMBINANT-DNA; IN-VITRO; RESTRICTION ENZYMES; RAPID CONSTRUCTION; BINARY VECTORS; CLONING METHOD; FUSION SYSTEM; TARGET GENE; P19 PROTEIN	The Golden Gate (GG) modular assembly approach offers a standardized, inexpensive and reliable way to ligate multiple DNA fragments in a pre-defined order in a single-tube reaction. We developed a GG based toolkit for the flexible construction of binary plasmids for transgene expression in plants. Starting from a common set of modules, such as promoters, protein tags and transcribed regions of interest, synthetic genes are assembled, which can be further combined to multigene constructs. As an example, we created T-DNA constructs encoding multiple fluorescent proteins targeted to distinct cellular compartments (nucleus, cytosol, plastids) and demonstrated simultaneous expression of all genes in Nicotiana benthamiana, Lotus japonicus and Arabidopsis thaliana. We assembled an RNA interference (RNAi) module for the construction of intron-spliced hairpin RNA constructs and demonstrated silencing of GFP in N. benthamiana. By combination of the silencing construct together with a codon adapted rescue construct into one vector, our system facilitates genetic complementation and thus confirmation of the causative gene responsible for a given RNAi phenotype. As proof of principle, we silenced a destabilized GFP gene (dGFP) and restored GFP fluorescence by expression of a recoded version of dGFP, which was not targeted by the silencing construct.	[Binder, Andreas; Lambert, Jayne; Morbitzer, Robert; Popp, Claudia; Ott, Thomas; Lahaye, Thomas; Parniske, Martin] Univ Munich LMU, Fac Biol, Martinsried, Germany	University of Munich	Parniske, M (corresponding author), Univ Munich LMU, Fac Biol, Martinsried, Germany.	parniske@lmu.de	Ott, Thomas/G-7056-2011; Ott, Thomas/H-8192-2013; Parniske, Martin/M-3781-2019; Parniske, Martin/F-2202-2011	Ott, Thomas/0000-0002-4494-9811; Parniske, Martin/0000-0001-8561-747X; Parniske, Martin/0000-0001-8561-747X; Popp, Claudia/0000-0003-1482-7909	Emmy Noether grant of the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG) [Sonderforschungsbereich 924 (SFB924)]	Emmy Noether grant of the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG)	The work of all authors was funded as part of the Sonderforschungsbereich 924 (SFB924; http://sfb924.wzw.tum.de/). T.O. and C.P. were additionally funded by the Emmy Noether grant of the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG; http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2012, BIOTECHNOL ADV, V30, P524, DOI 10.1016/j.biotechadv.2011.09.006; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Diaz CL, 2005, LOTUS JAPONICUS HANDBOOK, P261, DOI 10.1007/1-4020-3735-X_26; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2011, METHODS MOL BIOL, V729, P167, DOI 10.1007/978-1-61779-065-2_11; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Gan S, 2009, GENETIC INSULATOR PR; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Haseloff J, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0176.focus; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; JACKSON DA, 1972, P NATL ACAD SCI USA, V69, P2904, DOI 10.1073/pnas.69.10.2904; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; Lampropoulos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083043; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu QH, 2000, METHOD ENZYMOL, V328, P530, DOI 10.1016/S0076-6879(00)28417-6; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Maekawa T, 2008, MOL PLANT MICROBE IN, V21, P375, DOI 10.1094/MPMI-21-4-0375; Marsischky G, 2004, GENOME RES, V14, P2020, DOI 10.1101/gr.2528804; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618, DOI 10.1104/pp.113.217661; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; STOUGAARD J, 1987, MOL GEN GENET, V207, P251, DOI 10.1007/BF00331586; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038186; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	47	64	66	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88218	10.1371/journal.pone.0088218	http://dx.doi.org/10.1371/journal.pone.0088218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551083	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000025
J	Cohen, R; Aviram, I; Elhadad, M; Elhadad, N				Cohen, Raphael; Aviram, Iddo; Elhadad, Michael; Elhadad, Noemie			Redundancy-Aware Topic Modeling for Patient Record Notes	PLOS ONE			English	Article							FDA DRUG LABELS; PASTE; COPY	The clinical notes in a given patient record contain much redundancy, in large part due to clinicians' documentation habit of copying from previous notes in the record and pasting into a new note. Previous work has shown that this redundancy has a negative impact on the quality of text mining and topic modeling in particular. In this paper we describe a novel variant of Latent Dirichlet Allocation (LDA) topic modeling, Red-LDA, which takes into account the inherent redundancy of patient records when modeling content of clinical notes. To assess the value of Red-LDA, we experiment with three baselines and our novel redundancy-aware topic modeling method: given a large collection of patient records, (i) apply vanilla LDA to all documents in all input records; (ii) identify and remove all redundancy by chosing a single representative document for each record as input to LDA; (iii) identify and remove all redundant paragraphs in each record, leaving partial, non-redundant documents as input to LDA; and (iv) apply Red-LDA to all documents in all input records. Both quantitative evaluation carried out through log-likelihood on held-out data and topic coherence of produced topics and qualitative assessement of topics carried out by physicians show that Red-LDA produces superior models to all three baseline strategies. This research contributes to the emerging field of understanding the characteristics of the electronic health record and how to account for them in the framework of data mining. The code for the two redundancy-elimination baselines and Red-LDA is made publicly available to the community.	[Cohen, Raphael; Aviram, Iddo; Elhadad, Michael] Ben Gurion Univ Negev, Dept Comp Sci, Beer Sheva, Israel; [Elhadad, Noemie] Columbia Univ, Dept Biomed Informat, New York, NY USA	Ben Gurion University; Columbia University	Cohen, R (corresponding author), Ben Gurion Univ Negev, Dept Comp Sci, Beer Sheva, Israel.	cohenrap@cs.bgu.ac.il	ELHADAD, MICHAEL/AIB-3614-2022	ELHADAD, MICHAEL/0000-0002-5629-2351	National Library of Medicine [R01 LM010027]; NATIONAL LIBRARY OF MEDICINE [R01LM010027] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by a National Library of Medicine grant R01 LM010027 (NE). Any opinions, findings, or conclusions are those of the authors, and do not necessarily reflect the views of the funding organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, REP; Arnold C, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1031, DOI 10.1145/2348283.2348454; Arnold Corey W, 2010, AMIA Annu Symp Proc, V2010, P26; Barzilay R., 1999, P 37 ANN M ASS COMP, P550, DOI DOI 10.1115/10146781014760; Bisgin H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S6; Bisgin H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S11; Blei D, 2007, ARXIV10030783; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Carterette Ben, CIKM 09; Cohen R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-10; Crain Steven P, 2010, AMIA Annu Symp Proc, V2010, P132; David M., 2011, P 2011 C EMPIRICAL M, VVolume 2011, P262, DOI DOI 10.5555/2145432.2145462; Haghighi A, 2009, P HLT ACL, P326; Halpern Y, 2012, P ICML WORKSH CLIN D; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Lehman Li-wei, 2012, AMIA Annu Symp Proc, V2012, P505; Lippincott T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-212; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Markel A, 2010, AM J MED, V123, pE9, DOI 10.1016/j.amjmed.2009.10.012; Perotte A., 2011, ADV NEURAL INF PROCE, V24; Ramage D., 2009, P 2009 C EMP METH NA, V1, P248, DOI DOI 10.3115/1699510.1699543; Salleb-Aouissi A, 2011, P ICML WORKSH LEARN; Saria S., 2010, P NIPS PRED MOD PERS, DOI 10.1.1.232.390; Siegler EL, 2009, AM J MED, V122, P495, DOI 10.1016/j.amjmed.2009.02.010; Walker Daniel D., 2010, P 2010 C EMP METH NA, P240; Wallach Hanna M., 2009, P 26 INT C MACH LEAR, P1105, DOI DOI 10.1145/1553374.1553515; Wang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017243; Zanzotto F.M., 2011, P C EMP METH NAT LAN, P659	29	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87555	10.1371/journal.pone.0087555	http://dx.doi.org/10.1371/journal.pone.0087555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551060	Green Published, gold			2022-12-27	WOS:000331266000015
J	Barbosa, FHD; Porpino, KD; Fragoso, ABL; Oliveira, EV				de Souza Barbosa, Fernando Henrique; Porpino, Kleberson de Oliveira; Lima Fragoso, Ana Bernadete; Oliveira, Edison Vicente			Arthritis in a Glyptodont (Mammalia, Xenarthra, Cingulata)	PLOS ONE			English	Article							SPONDYLOARTHROPATHY; OSTEOARTHRITIS	Arthritic lesions have been frequently diagnosed in the fossil record, with spondyloarthropathy (a type of erosive and panmammalian arthritis) being one of the most common types described to date for mammals, though not restricted to this group. Here, we identify spondyloarthropathy in fossil bones from the late Pleistocene in Brazil assignable to a large glyptodont individual. Bone erosions in the peripheral joints (viz., the ulna, radius, left femur and tibiae-fibulae) associated with osteosclerosis allow the diagnosis of spondyloarthropathy. The presence of osteophytes in seven bones of the forelimbs (viz., the ulna and radius) and hind limbs (viz., the tibiae-fibulae, left femur and patellae) and a subchondral cyst in one element (viz., the left femur) indicate secondary osteoarthritis. A calcified deposition on the articular surface of the left patella indicates the presence of calcium pyrophosphate deposition disease, which, like the observed osteoarthritic alterations, likely represents a complication of spondyloarthropathy. This is the first report of spondyloarthropathy for xenarthrans.	[de Souza Barbosa, Fernando Henrique; Oliveira, Edison Vicente] Univ Fed Pernambuco, Dept Geol, Recife, PE, Brazil; [Porpino, Kleberson de Oliveira; Lima Fragoso, Ana Bernadete] Univ Estado Rio Grande do Norte, Dept Ciencias Biol, Mossoro, Brazil	Universidade Federal de Pernambuco; Universidade do Estado do Rio Grande do Norte (UERN)	Barbosa, FHD (corresponding author), Univ Fed Pernambuco, Dept Geol, Recife, PE, Brazil.	fhsbarbosa@gmail.com	Oliveira, Edison V/A-8427-2011; Porpino, Kleberson O./B-7328-2014; BARBOSA, FERNANDO H S/A-9593-2019	Porpino, Kleberson O./0000-0003-2081-3722; BARBOSA, FERNANDO H S/0000-0002-9738-2468; Oliveira, Edison/0000-0001-6634-5480	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [149684/2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	With the exception of a Master grant (number 149684/2011) conceded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/http://www.cnpq.br/) to the first author (FHS Barbosa), the authors' research was carried out without any resources provided by funding agencies or institutions. CNPq had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auler AS, 2006, PALAEOGEOGR PALAEOCL, V240, P508, DOI 10.1016/j.palaeo.2006.03.002; Cartelle C., 1999, MAMMALS NEOTROPICALS, V3, P27; Carvalho JNC, 1966, ARQUIVOS I ANTROPOLO, P303; Cisneros JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013425; de Araujo HI, 2013, PALAEOGEOGR PALAEOCL, V378, P52, DOI 10.1016/j.palaeo.2013.04.001; Ferigolo J, 1992, PALEOPATOLOGIA PALEO, P213; Ferigolo J, 1985, C BRAS PAL, P43; HART DJ, 1995, BAILLIERE CLIN RHEUM, V9, P407, DOI 10.1016/S1521-6942(06)80011-2; HENRIQUES DDR, 1998, ACTA GEOL LEOPOL, V21, P149; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Nunn CL, 2007, J EVOLUTION BIOL, V20, P460, DOI 10.1111/j.1420-9101.2006.01276.x; Oliveira EV, 2010, NEUES JAHRB GEOL P-A, V258, P353, DOI 10.1127/0077-7749/2010/0116; Ortner D. J., 2003, IDENTIFICATION PATHO, V2nd, P45, DOI [10.1016/B978-012528628-2/50041-7, DOI 10.1016/B978-012528628-2/50041-7]; Porpino KD, 2010, J VERTEBR PALEONTOL, V30, P911, DOI 10.1080/02724631003765735; Porpino Kleberson de Oliveira, 2002, Revista Brasileira de Paleontologia, V4, P51; Ribeiro RC, 2012, QUAT INT IN PRESS; Rothschild B, 2002, LANCET, V360, P1454, DOI 10.1016/S0140-6736(02)11471-1; Rothschild B, 2006, NEW MEXICO MUSEUM NA, V33, P187; Rothschild B, 2013, J ANC DIS PREV REMED, V1, P1; Rothschild B.M., 2000, J PALEOPATHOL, V11, P103; Rothschild BM, 2001, J ZOO WILDLIFE MED, V32, P58, DOI 10.1638/1042-7260(2001)032[0058:IAICS]2.0.CO;2; ROTHSCHILD BM, 1992, CLIN EXP RHEUMATOL, V10, P557; Rothschild BM, 2001, CLIN EXP RHEUMATOL, P4; Rothschild BM, 2006, CLIN RHEUMATOL, V25, P645, DOI 10.1007/s10067-005-0141-x; Waldron T, 2009, CAMB MAN ARCHAEOL, P1	25	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88646	10.1371/journal.pone.0088646	http://dx.doi.org/10.1371/journal.pone.0088646			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551126	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000048
J	Delker, DA; McGettigan, BM; Kanth, P; Pop, S; Neklason, DW; Bronner, MP; Burt, RW; Hagedorn, CH				Delker, Don A.; McGettigan, Brett M.; Kanth, Priyanka; Pop, Stelian; Neklason, Deborah W.; Bronner, Mary P.; Burt, Randall W.; Hagedorn, Curt H.			RNA Sequencing of Sessile Serrated Colon Polyps Identifies Differentially Expressed Genes and Immunohistochemical Markers	PLOS ONE			English	Article							COLORECTAL HYPERPLASTIC POLYPS; REG-IV; ADENOMAS; MUCIN; RISK; DIAGNOSIS; PATHWAY; BRAF; COLONOSCOPY; METASTASIS	Background: Sessile serrated adenomas/polyps (SSA/Ps) may account for 20-30% of colon cancers. Although large SSA/Ps are generally recognized phenotypically, small (<1 cm) or dysplastic SSA/Ps are difficult to differentiate from hyperplastic or small adenomatous polyps by endoscopy and histopathology. Our aim was to define the comprehensive gene expression phenotype of SSA/Ps to better define this cancer precursor. Results: RNA sequencing was performed on 5' capped RNA from seven SSA/Ps collected from patients with the serrated polyposis syndrome (SPS) versus eight controls. Highly expressed genes were analyzed by qPCR in additional SSA/Ps, adenomas and controls. The cellular localization and level of gene products were examined by immunohistochemistry in syndromic and sporadic SSA/Ps, adenomatous and hyperplastic polyps and controls. We identified 1,294 differentially expressed annotated genes, with 106 increased >= 10-fold, in SSA/Ps compared to controls. Comparing these genes with an array dataset for adenomatous polyps identified 30 protein coding genes uniquely expressed >= 10-fold in SSA/Ps. Biological pathways altered in SSA/Ps included mucosal integrity, cell adhesion, and cell development. Marked increased expression of MUC17, the cell junction protein genes VSIG1 and GJB5, and the antiapoptotic gene REG4 were found in SSA/Ps, relative to controls and adenomas, were verified by qPCR analysis of additional SSA/Ps (n = 21) and adenomas (n = 10). Immunohistochemical staining of syndromic (n >= 11) and sporadic SSA/Ps (n >= 17), adenomatous (n >= 13) and hyperplastic (n >= 10) polyps plus controls (n >= 16) identified unique expression patterns for VSIG1 and MUC17 in SSA/Ps. Conclusion: A subset of genes and pathways are uniquely increased in SSA/Ps, compared to adenomatous polyps, thus supporting the concept that cancer develops by different pathways in these phenotypically distinct polyps with markedly different gene expression profiles. Immunostaining for a subset of these genes differentiates both syndromic and sporadic SSA/Ps from adenomatous and hyperplastic polyps.	[Delker, Don A.; McGettigan, Brett M.; Kanth, Priyanka; Pop, Stelian; Burt, Randall W.; Hagedorn, Curt H.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Bronner, Mary P.; Hagedorn, Curt H.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Neklason, Deborah W.; Bronner, Mary P.; Burt, Randall W.; Hagedorn, Curt H.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Hagedorn, Curt H.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Hagedorn, Curt H.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Hagedorn, CH (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	chhagedorn@uams.edu	McGettigan, Brett/AAT-2828-2021	Kanth, Priyanka/0000-0001-9303-1516	University of Utah Personalized Medicine Program Seed Grant; National Institutes of Health (NIH) [CA148068, CA176130, CA073992, CA146329]; ACG Clinical Research Award; NATIONAL CANCER INSTITUTE [P01CA073992, R21CA148068, R21CA176130, RC1CA146329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	University of Utah Personalized Medicine Program Seed Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACG Clinical Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a University of Utah Personalized Medicine Program Seed Grant (CHH) and National Institutes of Health (NIH) CA148068 (CHH) and CA176130 (CHH), plus CA073992 and CA146329 (RWB). PK was supported by an ACG Clinical Research Award and BMM by the Undergraduate Research Program (currently an MSTP student at University of Colorado). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2008, CANCER IMMUNOL IMMUN, V57, P1017, DOI 10.1007/s00262-007-0433-x; Alexopoulou DK, 2013, CLIN BIOCH; Bartley AN, 2010, MODERN PATHOL, V23, P169, DOI 10.1038/modpathol.2009.155; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Bishnupuri KS, 2010, GASTROENTEROLOGY, V138, P616, DOI 10.1053/j.gastro.2009.10.050; Boparai KS, 2011, AM J PATHOL, V178, P2700, DOI 10.1016/j.ajpath.2011.02.023; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Caruso M, 2009, VIRCHOWS ARCH, V454, P291, DOI 10.1007/s00428-009-0731-0; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chan TL, 2003, CANCER RES, V63, P4878; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Dhar DK, 2003, LAB INVEST, V83, P1343, DOI 10.1097/01.LAB.0000085190.99749.15; Ezumi K, 2008, CLIN CANCER RES, V14, P677, DOI 10.1158/1078-0432.CCR-07-1184; Ferrandez A, 2004, AM J GASTROENTEROL, V99, P2012, DOI 10.1111/j.1572-0241.2004.30021.x; Folkers ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014697; Glatz K, 2007, AM J CLIN PATHOL, V127, P938, DOI 10.1309/NXDB6FMTE9X5CD6Y; Gonzalo DH, 2013, J PATHOL, V230, P420, DOI 10.1002/path.4200; Iino H, 1999, J CLIN PATHOL, V52, P5, DOI 10.1136/jcp.52.1.5; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 2000, GUT, V47, P43, DOI 10.1136/gut.47.1.43; Kalady MF, 2011, DIS COLON RECTUM, V54, P164, DOI 10.1007/DCR.0b013e3181fd4c15; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kim KM, 2011, AM J SURG PATHOL, V35, P1274, DOI 10.1097/PAS.0b013e318224cd2e; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; LONGACRE TA, 1990, AM J SURG PATHOL, V14, P524, DOI 10.1097/00000478-199006000-00003; Makinen MJ, 2007, HISTOPATHOLOGY, V50, P131, DOI 10.1111/j.1365-2559.2006.02548.x; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Moniaux N, 2006, J BIOL CHEM, V281, P23676, DOI 10.1074/jbc.M600302200; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; O'Brien MJ, 2007, GASTROENTEROL CLIN N, V36, P947, DOI 10.1016/j.gtc.2007.08.007; Oidovsambuu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025908; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Oue N, 2005, J PATHOL, V207, P185, DOI 10.1002/path.1827; Papic N, 2012, VIRUSES-BASEL, V4, P581, DOI 10.3390/v4040581; Planell N, 2012, GUT; Pouyet L, 2010, INFLAMM BOWEL DIS, V16, P96, DOI 10.1002/ibd.21031; Resta-Lenert S, 2011, AM J PHYSIOL-GASTR L, V300, pG1144, DOI 10.1152/ajpgi.00138.2010; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rosty C, 2012, AM J SURG PATHOL, V36, P876, DOI 10.1097/PAS.0b013e31824e133f; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Scanlan Matthew J, 2006, Cancer Immun, V6, P2; Schreiner MA, 2010, GASTROENTEROLOGY, V139, P1497, DOI 10.1053/j.gastro.2010.06.074; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Snover DC, 2010, WHO CLASSIFICATION T, P160; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Sternberg LR, 1999, GASTROENTEROLOGY, V116, P363, DOI 10.1016/S0016-5085(99)70133-2; Steward WP, 2013, BRIT J CANCER, V109, P1, DOI 10.1038/bjc.2013.280; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Walker RG, 2010, AM J GASTROENTEROL, V105, P1642, DOI 10.1038/ajg.2009.757; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211; Wang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018434; Weiss AA, 1996, J HISTOCHEM CYTOCHEM, V44, P1161, DOI 10.1177/44.10.8813081; Wong NACS, 2009, HISTOPATHOLOGY, V55, P63, DOI 10.1111/j.1365-2559.2009.03329.x	62	45	46	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88367	10.1371/journal.pone.0088367	http://dx.doi.org/10.1371/journal.pone.0088367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533081	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600039
J	Knowler, SP; McFadyen, AK; Freeman, C; Kent, M; Platt, SR; Kibar, Z; Rusbridge, C				Knowler, Susan P.; McFadyen, Angus K.; Freeman, Courtenay; Kent, Marc; Platt, Simon R.; Kibar, Zoha; Rusbridge, Clare			Quantitative Analysis of Chiari-Like Malformation and Syringomyelia in the Griffon Bruxellois Dog	PLOS ONE			English	Article							KING CHARLES SPANIELS; CAUDAL CRANIAL FOSSA; CAVALIER; SKULL; PREVALENCE; FEATURES; VOLUMES; ANGLE; SHAPE; SIZE	This study aimed to develop a system of quantitative analysis of canine Chiari-like malformation and syringomyelia on variable quality MRI. We made a series of measurements from magnetic resonance DICOM images from Griffon Bruxellois dogs with and without Chiari-like malformation and syringomyelia and identified several significant variables. We found that in the Griffon Bruxellois dog, Chiari-like malformation is characterized by an apparent shortening of the entire cranial base and possibly by increased proximity of the atlas to the occiput. As a compensatory change, there appears to be an increased height of the rostral cranial cavity with lengthening of the dorsal cranial vault and considerable reorganization of the brain parenchyma including ventral deviation of the olfactory bulbs and rostral invagination of the cerebellum under the occipital lobes.	[Knowler, Susan P.; Rusbridge, Clare] Fitzpatrick Referrals, Dept Neurol, Godalming, Surrey, England; [McFadyen, Angus K.] Akm Stats, Glasgow, Lanark, Scotland; [Freeman, Courtenay; Kent, Marc; Platt, Simon R.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA; [Kibar, Zoha] Univ Montreal, Justine Univ Hosp Res Ctr, Dept Neurosci, Quebec City, PQ, Canada; [Rusbridge, Clare] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Medd, Guildford GU2 5XH, Surrey, England	University System of Georgia; University of Georgia; Universite de Montreal; University of Surrey	Knowler, SP (corresponding author), Fitzpatrick Referrals, Dept Neurol, Godalming, Surrey, England.	cmsmindicators@gmail.com	Rusbridge, Clare/A-3794-2019; Knowler, Susan P/AAL-4595-2021; Fiumefreddo, Andrea/T-2977-2019; Rusbridge, Clare/K-6560-2019	Rusbridge, Clare/0000-0002-3366-2110; Knowler, Susan P/0000-0001-8727-8440; Rusbridge, Clare/0000-0002-3366-2110; Platt, Simon/0000-0002-7818-1011	American Kennel Club Canine Health Foundation [1004]; Griffon Bruxellois Club [1897]; For the Love of Ollie Fund; Friends of Lola Fund; Lee and Frank Pieterse	American Kennel Club Canine Health Foundation; Griffon Bruxellois Club; For the Love of Ollie Fund; Friends of Lola Fund; Lee and Frank Pieterse	Contributions towards the cost of magnetic resonance imaging for most of the dogs in this study were made by the following organizations or individuals: Syringomyelia DNA Research (http://www.veterinary-neurologist.co.uk/Syringomyelia/DNA_Research/); American Kennel Club Canine Health Foundation Grant #1004; The Griffon Bruxellois Club 1897; For the Love of Ollie Fund; Friends of Lola Fund and Lee and Frank Pieterse. The Canadian Institutes of Health Research and Cavalier Matters Charity Reg No 1141674 contributed towards the cost of leasing the DICOM viewing software package MIMICS 14.12 Materialise (Technologielaan 15 3001 Leuven Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botelho RV, 2013, NEUROSURG REV, V36, P603, DOI 10.1007/s10143-013-0471-0; BVA, 2013, CHIAR MALF SYR SCHEM; Bynevelt M, 2000, VET RADIOL ULTRASOUN, V41, P521, DOI 10.1111/j.1740-8261.2000.tb01882.x; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; Carruthers H, 2009, J SMALL ANIM PRACT, V50, P394, DOI 10.1111/j.1748-5827.2009.00768.x; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P264, DOI 10.1111/j.1740-8261.2009.01531.x; Cross HR, 2009, J SMALL ANIM PRACT, V50, P399, DOI 10.1111/j.1748-5827.2009.00799.x; D'Addario V, 2001, ULTRASOUND OBST GYN, V18, P146, DOI 10.1046/j.1469-0705.2001.00409.x; Denegar Craig R, 1993, J SPORT REHAB, V2, P35, DOI [10.1123/jsr.2.1.35, DOI 10.1123/JSR.2.1.35]; Driver CJ, 2010, VET REC, V167, P978, DOI 10.1136/vr.c4109; Driver CJ, 2010, J SMALL ANIM PRACT, V51, P382, DOI 10.1111/j.1748-5827.2010.00952.x; Driver CJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-215; DUBRUL EL, 1961, AM J ANAT, V109, P117, DOI 10.1002/aja.1001090203; Fenn J, 2013, VET J, V197, P896, DOI 10.1016/j.tvjl.2013.05.007; Freedman D, 2011, J VET INTERNAL MED, V25; Gasser M, 1976, EARLY FORMATION BASI, P29; Hoyte D.A.N., 1997, FUNDAMENTALS CRANIOF, P258; Hussein AK, 2012, AM J VET RES, V73, P946, DOI 10.2460/ajvr.73.7.946; Kettunen P, 2006, ANAT REC PART A, V288A, P1250, DOI 10.1002/ar.a.20402; Knowler SP, 2011, VET REC, V169, P681, DOI 10.1136/vr.100062; Marino DJ, 2012, AM J VET RES, V73, P105, DOI 10.2460/ajvr.73.1.105; Markunas CA, 2012, J NEUROSURG-PEDIATR, V9, P372, DOI 10.3171/2011.12.PEDS11113; Noden DM, 1985, EMBRYOLOGY DOMESTIC, P181; Pang D, 2011, CHILD NERV SYST, V27, P523, DOI 10.1007/s00381-010-1358-9; Parker JE, 2011, VET REC, V168, DOI 10.1136/vr.d1726; Roberts T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011946; Rusbridge C, 2006, J SMALL ANIM PRACT, V47, P603, DOI 10.1111/j.1748-5827.2006.00048.x; Rusbridge C, 2005, J SMALL ANIM PRACT, V46, P265, DOI 10.1111/j.1748-5827.2005.tb00319.x; Rusbridge C, 2004, J VET INTERN MED, V18, P673, DOI 10.1892/0891-6640(2004)18&lt;673:IOOBHC&gt;2.0.CO;2; Rusbridge C, 2009, J SMALL ANIM PRACT, V50, P386, DOI 10.1111/j.1748-5827.2009.00744.x; Rusbridge C, 2000, J AM ANIM HOSP ASSOC, V36, P34, DOI 10.5326/15473317-36-1-34; Rusbridge C., 2013, EUR J COMPANION, V23, P70, DOI DOI 10.1111/J.1748-5827.2008.00578.X; Schmidt MJ, 2011, VET RADIOL ULTRASOUN, V52, P436, DOI 10.1111/j.1740-8261.2011.01825.x; Schmidt MJ, 2013, VET RADIOL ULTRASOUN, V54, P497, DOI 10.1111/vru.12072; Schmidt MJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-158; Schoenebeck JJ, 2013, GENETICS, V193, P317, DOI 10.1534/genetics.112.145284; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Shaw TA, 2013, VET REC, V172, DOI 10.1136/vr.101082; Shaw TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033660; Stalin CE, 2008, AM J VET RES, V69, P89, DOI 10.2460/ajvr.69.1.89; Stockyard C.R., 1941, ANATOMICAL MEMOIRS, VVolume 19, P40	41	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88120	10.1371/journal.pone.0088120	http://dx.doi.org/10.1371/journal.pone.0088120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533070	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600028
J	Wang, J; Zhao, JY; Wang, F; Peng, QQ; Hou, J; Sun, SN; Gui, YH; Duan, WY; Qiao, B; Wang, HY				Wang, Jue; Zhao, Jian-Yuan; Wang, Feng; Peng, Qian-Qian; Hou, Jia; Sun, Shu-Na; Gui, Yong-Hao; Duan, Wen-Yuan; Qiao, Bin; Wang, Hong-Yan			A Genetic Variant in Vitamin B12 Metabolic Genes That Reduces the Risk of Congenital Heart Disease in Han Chinese Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HOMOCYSTEINE; DEFECTS; FOLATE	Background: Genome-wide association studies on components of the one-carbon metabolic pathway revealed that human vitamin B12 levels could be significantly influenced by variationsinthefucosyltransferase 2 (FUT2), cubilin (CUBN), and transcobalamin-I (TCN1) genes. An altered vitamin B12 level is an important factor that disturbs the homeostasis of the folate metabolism pathway, which in turn can potentially lead to the development of congenital heart disease (CHD). Therefore, we investigated the association between the variants of vitamin B12-related genes and CHD in Han Chinese populations. Methods and Results: Six variants of the vitamin B12-related genes were selected for analysis in two independent casecontrol studies, with a total of 868 CHD patients and 931 controls. The variant rs11254363 of the CUBN gene was associated with a decreased risk of developing CHD in both the separate and combined case-control studies. Combined samples from the two cohorts had a significant decrease in CHD risk for the G allele (OR = 0.48, P = 1.7 x 10(-5)) and AG+GG genotypes (OR = 0.49, P = 4 x 10(-5)), compared with the wild-type A allele and AA genotype, respectively. Conclusions: Considering the G allele of variant rs11254363 of the CUBN gene was associated with an increased level of circulating vitamin B12. This result suggested that the carriers of the G allele would benefit from the protection offered by the high vitamin B12 concentration during critical heart development stages. This finding shed light on the unexpected role of CUBN in CHD development and highlighted the interplay of diet, genetics, and human birth defects.	[Wang, Jue; Zhao, Jian-Yuan; Wang, Hong-Yan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Jue; Zhao, Jian-Yuan; Wang, Hong-Yan] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Feng; Hou, Jia; Sun, Shu-Na; Gui, Yong-Hao; Wang, Hong-Yan] Fudan Univ, Shanghai Childrens Hosp, Shanghai 200433, Peoples R China; [Peng, Qian-Qian] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Duan, Wen-Yuan; Qiao, Bin] Gen Hosp Jinan Mil Reg, Inst Cardiovasc Dis, Jinan, Peoples R China; [Wang, Hong-Yan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Fudan University	Wang, HY (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	wanghy@fudan.edu.cn	Wang, Feng/AAC-9553-2019; Gui, Yonghao/M-4377-2019	Gui, Yonghao/0000-0002-5043-5534; Zhao, Jian-Yuan/0000-0001-9861-0330; Peng, Qianqian/0000-0002-2018-5706	National Science Fund for Distinguished Young Scholars [81025003]; 973 Program [2010CB529601, 2013CB945403, 2012CB910103]; Program for Innovative Research Team in University [IRT1010]; Doctoral Fund of Ministry of Education of China [20110071110026]; Commission for Science and Technology of Shanghai Municipality [13JC1407600, 11XD1400900]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); Program for Innovative Research Team in University; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Commission for Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the grants from the National Science Fund for Distinguished Young Scholars (81025003), the 973 Program (2010CB529601, 2013CB945403), the Program for Innovative Research Team in University (IRT1010), Doctoral Fund of Ministry of Education of China (20110071110026), and the Commission for Science and Technology of Shanghai Municipality (13JC1407600, 11XD1400900) to Dr. Wang; the 973 Program (2012CB910103) to Drs. Qiao and Duan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Botto LD, 2003, AM J MED GENET A, V121A, P95, DOI 10.1002/ajmg.a.20132; Czeizel Endre, 2003, Orv Hetil, V144, P1981; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; Huhta JC, 2005, FETAL PEDIATR PATHOL, V24, P71, DOI 10.1080/15227950591008240; Kapusta L, 1999, J PEDIATR-US, V135, P773, DOI 10.1016/S0022-3476(99)70102-2; Li F, 2009, MOL GENET METAB, V98, P166, DOI 10.1016/j.ymgme.2009.06.004; Lin XL, 2012, HUM MOL GENET, V21, P2610, DOI 10.1093/hmg/dds062; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; SHANE B, 1985, ANNU REV NUTR, V5, P115, DOI 10.1146/annurev.nu.05.070185.000555; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Verkleij-Hagoort AC, 2006, BJOG-INT J OBSTET GY, V113, P1412, DOI 10.1111/j.1471-0528.2006.01109.x; Verkleij-Hagoort AC, 2008, MOL GENET METAB, V94, P112, DOI 10.1016/j.ymgme.2007.12.002; Verkleij-Hagoort AC, 2006, EUR J NUTR, V45, P478, DOI 10.1007/s00394-006-0622-y; Zhao JY, 2014, EUR HEART J, V35, P733, DOI 10.1093/eurheartj/eht221; Zhao JY, 2013, CELL RES, V23, P242, DOI 10.1038/cr.2012.135; Zhao JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031644; Zhao JY, 2012, CIRCULATION, V125, P482, DOI 10.1161/CIRCULATIONAHA.111.050245	19	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88332	10.1371/journal.pone.0088332	http://dx.doi.org/10.1371/journal.pone.0088332			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533076	gold, Green Submitted, Green Published			2022-12-27	WOS:000331262600034
J	Wang, L; Hu, HC; Pan, YJ; Wang, R; Li, Y; Shen, L; Yu, YF; Li, H; Cai, D; Sun, YH; Chen, HQ				Wang, Lei; Hu, Haichuan; Pan, Yunjian; Wang, Rui; Li, Yuan; Shen, Lei; Yu, Yongfu; Li, Hang; Cai, Deng; Sun, Yihua; Chen, Haiquan			PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; COLORECTAL-CANCER; SIGNALING PATHWAY; PTEN EXPRESSION; BREAST-CANCER; COPY NUMBER; GENE; EGFR; ADENOCARCINOMA; CARCINOMAS	Purpose: PIK3CA gene encoding a catalytic subunit of the phosphatidylinositol-3-kinase (PI3K) is mutated and/or amplified in various neoplasia, including lung cancer. Here we investigated PIK3CA gene alterations, the expression of core components of PI3K pathway, and evaluated their clinical importance in non-small cell lung cancer (NSCLC). Materials and methods: Oncogenic mutations/rearrangements in PIK3CA, EGFR, KRAS, HER2, BRAF, AKT1 and ALK genes were detected in tumors from 1117 patients with NSCLC. PIK3CA gene copy number was examined by fluorescent in situ hybridization and the expression of PI3K p110 subunit alpha (PI3K p110 alpha), p-Akt, mTOR, PTEN was determined by immunohistochemistry in PIK3CA mutant cases and 108 patients without PIK3CA mutation. Results: PIK3CA mutation was found in 3.9% of squamous cell carcinoma and 2.7% of adenocarcinoma. Among 34 PIK3CA mutant cases, 17 tumors harbored concurrent EGFR mutations and 4 had KRAS mutations. PIK3CA mutation was significantly associated with high expression of PI3K p110a (p<0.0001), p-Akt (p = 0.024) and mTOR (p = 0.001), but not correlated with PIK3CA amplification (p = 0.463). Patients with single PIK3CA mutation had shorter overall survival than those with PIK3CA-EGFR/KRAS co-mutation or wildtype PIK3CA (p = 0.004). A significantly worse survival was also found in patients with PIK3CA mutations than those without PIK3CA mutations in the EGFR/KRAS wildtype subgroup (p = 0.043) Conclusions: PIK3CA mutations frequently coexist with EGFR/KRAS mutations. The poor prognosis of patients with single PIK3CA mutation in NSCLC and the prognostic value of PIK3CA mutation in EGFR/KRAS wildtype subgroup suggest the distinct mutation status of PIK3CA gene should be determined for individual therapeutic strategies in NSCLC.	[Wang, Lei; Hu, Haichuan; Pan, Yunjian; Wang, Rui; Li, Hang; Cai, Deng; Sun, Yihua; Chen, Haiquan] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Thorac Surg, Shanghai 200433, Peoples R China; [Wang, Lei; Hu, Haichuan; Pan, Yunjian; Wang, Rui; Li, Yuan; Shen, Lei; Li, Hang; Cai, Deng; Sun, Yihua; Chen, Haiquan] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Li, Yuan; Shen, Lei] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Yu, Yongfu] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Sun, YH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Thorac Surg, Shanghai 200433, Peoples R China.	sun_yihua76@hotmail.com; hqchen1@yahoo.com	Yu, Yongfu/GLR-9881-2022; Hu, Haichuan/U-7131-2017; Yu, Yongfu/W-7557-2019; Hu, Haichuan/O-7726-2018	Yu, Yongfu/0000-0003-4208-9480; Li, Yuan/0000-0001-5651-819X; Hu, Haichuan/0000-0003-3436-290X	Key Construction Program of the National "985'' Project [985III-YFX0102]; National Natural Science Foundation of China [81172218, 81101761]; Science and Technology Commission of Shanghai Municipality [12XD1402000]; Foundation of Shanghai Health Administration [20114206]; Shanghai Hospital Development Center [SHDC12012308]	Key Construction Program of the National "985'' Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Foundation of Shanghai Health Administration; Shanghai Hospital Development Center	This study was supported by grants from Key Construction Program of the National "985'' Project (Grant No. 985III-YFX0102), National Natural Science Foundation of China (Grants No. 81172218 and 81101761), the Science and Technology Commission of Shanghai Municipality (Program of Shanghai Subject Chief Scientist; Grant No. 12XD1402000), the Foundation of Shanghai Health Administration (Grant No. 20114206), and a Grant from Shanghai Hospital Development Center (Grant No. SHDC12012308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2013, HUM PATHOL, V44, P199, DOI 10.1016/j.humpath.2012.05.005; Ali G, 2011, EXP THER MED, V2, P787, DOI 10.3892/etm.2011.291; Angelo P, 2007, CLIN CANCER RES, V13, P5988, DOI 10.1158/1078-0432.CCR-07-1106; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Barbareschi M, 2007, CLIN CANCER RES, V13, P6064, DOI 10.1158/1078-0432.CCR-07-0266; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Chaft JE, 2012, MOL CANCER THER, V11, P485, DOI 10.1158/1535-7163.MCT-11-0692; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dunlap J, 2010, BREAST CANCER RES TR, V120, P409, DOI 10.1007/s10549-009-0406-1; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Guan JL, 2013, ANN SURG ONCOL, V20, P1381, DOI 10.1245/s10434-012-2754-z; Janku F, 2012, ONCOTARGET, V3, P1566, DOI 10.18632/oncotarget.716; Jehan Z, 2009, J PATHOL, V219, P337, DOI 10.1002/path.2601; Ji MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-147; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Lee JI, 2001, ARCH OTOLARYNGOL, V127, P1441, DOI 10.1001/archotol.127.12.1441; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Noh WC, 2008, BREAST CANCER RES TR, V110, P477, DOI 10.1007/s10549-007-9746-x; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Spoerke JM, 2012, CLIN CANCER RES, V18, P6771, DOI 10.1158/1078-0432.CCR-12-2347; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Vogt PK, 2006, VIROLOGY, V344, P131, DOI 10.1016/j.virol.2005.09.027; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Wang Y, 2005, AM J CLIN PATHOL, V124, P392, DOI 10.1309/BL7EMW66LQX6GFRP; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Wong DW, 2011, CANCER; Xu JP, 2011, CANCER BIOMARK, V10, P63, DOI 10.3233/CBM-2012-0233; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zhu YF, 2012, WORLD J GASTROENTERO, V18, P3745, DOI 10.3748/wjg.v18.i28.3745	44	112	118	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88291	10.1371/journal.pone.0088291	http://dx.doi.org/10.1371/journal.pone.0088291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533074	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600032
J	Bousquet, N; Chassot, E; Duplisea, DE; Hammill, MO				Bousquet, Nicolas; Chassot, Emmanuel; Duplisea, Daniel E.; Hammill, Mike O.			Forecasting the Major Influences of Predation and Environment on Cod Recovery in the Northern Gulf of St. Lawrence	PLOS ONE			English	Article							GADUS-MORHUA STOCKS; ATLANTIC COD; ENERGY RESERVES; FISH STOCKS; POPULATION-DYNAMICS; SOUTHERN GULF; COLLAPSE; TEMPERATURE; MANAGEMENT; GROWTH	The northern Gulf of St. Lawrence (NGSL) stock of Atlantic cod (Gadus morhua), historically the second largest cod population in the Western Atlantic, has known a severe collapse during the early 1990 s and is currently considered as endangered by the Committee on the Status of Endangered Wildlife in Canada. As for many fish populations over the world which are currently being heavily exploited or overfished, urgent management actions in the form of recovery plans are needed for restoring this stock to sustainable levels. Stochastic projections based on a statistical population model incorporating predation were conducted over a period of 30 years (2010-2040) to assess the expected outcomes of alternative fishing strategies on the stock recovery under different scenarios of harp seal (Pagophilus groenlandicus) abundance and environmental conditions. This sensitivity study shows that water temperature is key in the rebuilding of the NGSL cod stock. Model projections suggest that maintaining the current management practice under cooler water temperatures is likely to maintain the species in an endangered status. Under current or warmer conditions in the Gulf of St. Lawrence, partial recovery might only be achieved by significant reductions in both fishing and predation pressure. In the medium-term, a management strategy that reduces catch could be favoured over a complete moratorium so as to minimize socio-economic impacts on the industry.	[Bousquet, Nicolas] Univ Toulouse 3, UMR CNRS 5219, Inst Math Toulouse, F-31062 Toulouse, France; [Chassot, Emmanuel] Seychelles Fishing Author, Victoria, Seychelles; [Duplisea, Daniel E.; Hammill, Mike O.] Fisheries & Oceans Canada, Mont Joli, PQ, Canada	Universite de Toulouse; Universite Toulouse 1 Capitole; Universite Toulouse III - Paul Sabatier; Universite de Toulouse - Jean Jaures; Institut National des Sciences Appliquees de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Fisheries & Oceans Canada	Bousquet, N (corresponding author), Univ Toulouse 3, UMR CNRS 5219, Inst Math Toulouse, F-31062 Toulouse, France.	nicolas.bousquet@edf.fr		CHASSOT, Emmanuel/0000-0002-6779-4955; Bousquet, Nicolas/0000-0003-0170-0503; Duplisea, Daniel/0000-0002-0844-359X	Department Fisheries and Oceans (DFO) Canada	Department Fisheries and Oceans (DFO) Canada	This work was partly funded by the Department Fisheries and Oceans (DFO) Canada, which collected most of the data used in the present article. All data used are published over DFO's website and can be obtained upon request. The Canada Research Chair in Statistical Sampling and Data Analysis supported the other part of the funding, without having a role in the data collection. Finally, the funders have no role in study design, data analysis, decision to publish or preparation of the manuscript.	Angel JR, 2010, J GREAT LAKES RES, V36, P51, DOI 10.1016/j.jglr.2009.09.006; Avriel M., 2003, NONLINEAR PROGRAMMIN; Bajzak CE, 2011, CAN J ZOOL, V89, P1050, DOI 10.1139/Z11-081; Bayarri MJ, 2007, ANN STAT, V35, P1874, DOI 10.1214/009053607000000163; Bayarri MJ, 2007, TECHNOMETRICS, V49, P138, DOI 10.1198/004017007000000092; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Begg GA, 2002, MAR ECOL PROG SER, V229, P263, DOI 10.3354/meps229263; Beverton RJH, 1957, FISHERIES INVESTIGAT, V2; Bousquet N, 2010, CAN J FISH AQUAT SCI, V67, P1247, DOI 10.1139/F10-051; Bundy A, 2001, CAN J FISH AQUAT SCI, V58, P1153, DOI 10.1139/cjfas-58-6-1153; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Castonguay M, 1999, ICES J MAR SCI, V56, P333, DOI 10.1006/jmsc.1999.0471; Chassot E, 2007, TECHNICAL REPORT; Chassot E, 2009, MAR ECOL PROG SER, V379, P279, DOI 10.3354/meps07897; Chen VCP, 2006, IIE TRANS, V38, P273, DOI 10.1080/07408170500232495; Chouinard GA, 2005, CAN J FISH AQUAT SCI, V62, P1991, DOI 10.1139/f05-107; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; de Rocquigny E., 2008, UNCERTAINTY IND PRAC; DFO, 1999, P NAT MAR MAMM REV C; DFO, 2005, STRAT VIS LONG TERM; DFO, 2003, CAN SCI ADV SECR P S, V2003/021; DFO, 2010, 2010071 DFO CAN SCI; Duplisea D, 2011, TECHNICAL REPORT; Dutil JD, 1999, CAN J FISH AQUAT SCI, V56, P1818, DOI 10.1139/cjfas-56-10-1818; Dutil JD, 2003, FISH OCEANOGR, V12, P502, DOI 10.1046/j.1365-2419.2003.00243.x; Dutil JD, 2003, ICES J MAR SCI, V60, P780, DOI 10.1016/S1054-3139(03)00024-9; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; FAO, 2020, STAT WORLD FISH AQ, DOI 10.4060/ca9229-n; Follestad T, 2003, THESIS NORWEGIAN U S; Frank KT, 2000, CAN J FISH AQUAT SCI, V57, P513, DOI 10.1139/cjfas-57-3-513; Frechet A, 2007, TECHNICAL REPORT; Frechet A, 2009, TECHNICAL REPORT; Fulton T.W., 1902, 20 ANN REPORT FISHER, V3, P326, DOI DOI 10.1371/JOURNAL.PONE.0082836; Galbraith P, 2009, TECHNICAL REPORT; Galbraith PS, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003159; Galbraith PS, 2011, TECHNICAL REPORT; Gerber LR, 2009, SCIENCE, V323, P880, DOI 10.1126/science.1169981; Gilbert D, 2004, 2004061 CAN SCI ADV; Gilbert D, 1997, CAN J FISH AQUAT SCI, V54, P57, DOI 10.1139/cjfas-54-S1-57; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Hammill M, 2011, TECHNICAL REPORT; Hammill M, 2010, 2009114 CAN SCI ADV; Hammill MO, 2007, ICES J MAR SCI, V64, P702, DOI 10.1093/icesjms/fsm037; Hammill M.O., 2000, Journal of Northwest Atlantic Fishery Science, V26, P1, DOI 10.2960/J.v26.a1; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hutchings JA, 2005, CAN J FISH AQUAT SCI, V62, P824, DOI 10.1139/F05-081; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; Hutchings JA, 2001, CAN J FISH AQUAT SCI, V58, P108, DOI 10.1139/cjfas-58-1-108; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; HUTCHINGS JA, 1993, CAN J FISH AQUAT SCI, V50, P2468, DOI 10.1139/f93-271; IPCC, 2007, CONTRIBUTION WORKING; Krohn M, 1997, CAN J FISH AQUAT SCI, V54, P113, DOI 10.1139/cjfas-54-S1-113; Lambert Y, 1997, CAN J FISH AQUAT SCI, V54, P2388, DOI 10.1139/cjfas-54-10-2388; Lambert Y, 2000, CAN J FISH AQUAT SCI, V57, P815, DOI 10.1139/cjfas-57-4-815; Lambert Y, 2011, CAN J FISH AQUAT SCI, V68, P618, DOI [10.1139/F11-007, 10.1139/f2011-007]; Lambert Yvan, 2009, Journal of Northwest Atlantic Fishery Science, V41, P93; Lambert Y, 1997, CAN J FISH AQUAT SCI, V54, P104, DOI 10.1139/cjfas-54-S1-104; LAURENT AG, 1963, J AM STAT ASSOC, V58, P231, DOI 10.2307/2282966; Lavoie D, 2011, P ESSAS S 22 27 MAY; Lawson JW, 1998, MAR ECOL PROG SER, V163, P1, DOI 10.3354/meps163001; Le Fouest V, 2010, J MARINE SYST, V81, P75, DOI 10.1016/j.jmarsys.2009.12.003; Liermann M, 1997, CAN J FISH AQUAT SCI, V54, P1976, DOI 10.1139/cjfas-54-9-1976; Lloret J, 2000, FISH RES, V48, P79, DOI 10.1016/S0165-7836(00)00111-9; MacKenzie BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018998; Marteinsdottir G, 2002, MAR ECOL PROG SER, V235, P235, DOI 10.3354/meps235235; McLaren IA, 2001, TECHNICAL REPORT; Minto C, 2008, NATURE, V452, P344, DOI 10.1038/nature06605; Morissete L, 2006, MAR MAMMAL SCI, V22, P74, DOI 10.1111/j.1748-7692.2006.00007.x; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; MYERS RA, 1995, SCIENCE, V269, P1106, DOI 10.1126/science.269.5227.1106; MYERS RA, 1995, CAN J FISH AQUAT SCI, V52, P1265, DOI 10.1139/f95-123; Ouellet P, 1997, CAN J FISH AQUAT SCI, V54, P198, DOI 10.1139/cjfas-54-1-198; Ouellet P, 2001, ICES J MAR SCI, V58, P672, DOI 10.1006/jmsc.2001.1065; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Ratz HJ, 2003, FISH RES, V60, P369, DOI 10.1016/S0165-7836(02)00132-7; Rice JC, 2003, INT COUNCIL EXPLORAT, V6; Saltelli A., 2000, WILEY SERIES PROBABI; Savenkoff C, 2004, CAN J FISH AQUAT SCI, V61, P2194, DOI 10.1139/F04-154; Shelton PA, 2006, CAN J FISH AQUAT SCI, V63, P235, DOI 10.1139/F05-253; Shelton PA, 1999, CAN J FISH AQUAT SCI, V56, P1521, DOI 10.1139/cjfas-56-9-1521; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Smith ADM, ICES J MARINE SCI; Starr M., 2002, INT COUNC EXPLOR SEA, P16; Swain DP, 2008, CAN J FISH AQUAT SCI, V65, P2315, DOI 10.1139/F08-175; Swain DP, 2003, FISH RES, V59, P327, DOI 10.1016/S0165-7836(02)00027-9; Travers M, 2007, PROG OCEANOGR, V75, P751, DOI 10.1016/j.pocean.2007.08.001; Virtala M, 1998, ICES J MAR SCI, V55, P892, DOI 10.1006/jmsc.1998.0368; Wakeford RC, 2007, TECHNICAL REPORT; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters Carl, 1997, Conservation Ecology, V1, pUnpaginated; Wicker N, 2008, COMPUT STAT DATA AN, V52, P1315, DOI 10.1016/j.csda.2007.07.011; Wilkinson L, 2008, TECHNOMETRICS, V50, P418, DOI 10.1198/004017008000000460; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; YODZIS P, 1994, ECOL APPL, V4, P51, DOI 10.2307/1942114; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	100	5	5	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e82836	10.1371/journal.pone.0082836	http://dx.doi.org/10.1371/journal.pone.0082836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523852	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100001
J	van der Molen, MJW; Stam, CJ; van der Molen, MW				van der Molen, Melle J. W.; Stam, Cornelis J.; van der Molen, Maurits W.			Resting-State EEG Oscillatory Dynamics in Fragile X Syndrome: Abnormal Functional Connectivity and Brain Network Organization	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MENTAL-RETARDATION PROTEIN; GRAPH-THEORETICAL ANALYSIS; PHASE-LAG INDEX; NEURAL SYNCHRONY; CGG REPEAT; MATURATION; ALPHA; TRAJECTORIES; EPILEPSY	Disruptions in functional connectivity and dysfunctional brain networks are considered to be a neurological hallmark of neurodevelopmental disorders. Despite the vast literature on functional brain connectivity in typical brain development, surprisingly few attempts have been made to characterize brain network integrity in neurodevelopmental disorders. Here we used resting-state EEG to characterize functional brain connectivity and brain network organization in eight males with fragile X syndrome (FXS) and 12 healthy male controls. Functional connectivity was calculated based on the phase lag index (PLI), a non-linear synchronization index that is less sensitive to the effects of volume conduction. Brain network organization was assessed with graph theoretical analysis. A decrease in global functional connectivity was observed in FXS males for upper alpha and beta frequency bands. For theta oscillations, we found increased connectivity in long-range (fronto-posterior) and short-range (frontal-frontal and posterior-posterior) clusters. Graph theoretical analysis yielded evidence of increased path length in the theta band, suggesting that information transfer between brain regions is particularly impaired for theta oscillations in FXS. These findings are discussed in terms of aberrant maturation of neuronal oscillatory dynamics, resulting in an imbalance in excitatory and inhibitory neuronal circuit activity.	[van der Molen, Melle J. W.] Leiden Univ, Inst Psychol, Dev Psychol Unit, Leiden, Netherlands; [van der Molen, Melle J. W.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [van der Molen, Maurits W.] Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [van der Molen, Maurits W.] Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	van der Molen, MJW (corresponding author), Leiden Univ, Inst Psychol, Dev Psychol Unit, Leiden, Netherlands.	m.j.w.vandermolen@gmail.com	van der Molen, Maurits W/B-7543-2014; van der Molen, Melle/O-2912-2013	van der Molen, Melle/0000-0003-0431-7630; Stam, Cornelis/0000-0001-9163-7274	Cognition Program of the Netherlands Organization for Scientific Research [051.04.090]	Cognition Program of the Netherlands Organization for Scientific Research	This study was supported by the Cognition Program of the Netherlands Organization for Scientific Research (http://www.nwo.nl; grant number 051.04.090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Barry RJ, 2009, BIOL PSYCHIAT, V66, P398, DOI 10.1016/j.biopsych.2009.04.027; Basar E, 2008, BRAIN RES, V1235, P172, DOI 10.1016/j.brainres.2008.06.103; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Boersma M, 2011, HUM BRAIN MAPP, V32, P413, DOI 10.1002/hbm.21030; Bresnahan SM, 2006, PSYCHIAT RES, V141, P151, DOI 10.1016/j.psychres.2005.09.002; Bresnahan SM, 2002, PSYCHIAT RES, V112, P133, DOI 10.1016/S0165-1781(02)00190-7; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Campbell IG, 2009, P NATL ACAD SCI USA, V106, P5177, DOI 10.1073/pnas.0812947106; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Cornish K, 2012, AJIDD-AM J INTELLECT, V117, P103, DOI 10.1352/1944-7558-117.2.103; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; de Haan W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002582; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Ferri R, 2007, CLIN NEUROPHYSIOL, V118, P449, DOI 10.1016/j.clinph.2006.10.021; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gallinat J, 2006, PSYCHOPHARMACOLOGY, V187, P103, DOI 10.1007/s00213-006-0397-0; Galvez R, 2003, BRAIN RES, V971, P83, DOI 10.1016/S0006-8993(03)02363-1; Goncalves JT, 2013, NAT NEUROSCI, V16, P903, DOI 10.1038/nn.3415; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Hagerman PJ, 2009, EPILEPSY CURR, V9, P108, DOI 10.1111/j.1535-7511.2009.01309.x; Hagerman R.J., 2002, FRAGILE X SYNDROME D; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Laros J. A., 1998, SNIJDERS OOMEN NIET; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Miano S, 2008, CLIN NEUROPHYSIOL, V119, P1242, DOI 10.1016/j.clinph.2008.03.004; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Oostra BA, 2001, CLIN GENET, V60, P399, DOI 10.1034/j.1399-0004.2001.600601.x; Peraza LR, 2012, J NEUROSCI METH, V207, P189, DOI 10.1016/j.jneumeth.2012.04.007; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; RAVEN J, 1998, STANDARD PROGR MATRI; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Scerif G, 2007, NEUROPSYCHOLOGIA, V45, P1889, DOI 10.1016/j.neuropsychologia.2006.12.005; Scerif G, 2012, J CHILD PSYCHOL PSYC, V53, P641, DOI 10.1111/j.1469-7610.2011.02515.x; Schlichting L, 2004, PEABODY PICTURE VOCA; Schneider A, J PSYCHOPHA IN PRESS; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Smit DJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036896; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2012, NEUROIMAGE, V62, P1415, DOI 10.1016/j.neuroimage.2012.05.050; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tagliazucchi E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00339; Tamminga CA, 2007, AM J PSYCHIAT, V164, P556, DOI 10.1176/appi.ajp.164.4.556; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P720, DOI 10.1016/j.clinph.2011.08.023; Van der Molen MJW, 2012, CLIN NEUROPHYSIOL, V123, P1309, DOI 10.1016/j.clinph.2011.11.039; Van der Molen MJW, 2012, BRAIN COGNITION, V78, P206, DOI 10.1016/j.bandc.2011.12.008; Van der Molen MJW, 2010, RES DEV DISABIL, V31, P426, DOI 10.1016/j.ridd.2009.10.013; Van der Molen MJW, 2013, BIOL PSYCHOL, V92, P216, DOI 10.1016/j.biopsycho.2012.11.013; van Steen M, 2010, GRAPH THEORY COMPLEX; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273	77	33	33	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88451	10.1371/journal.pone.0088451	http://dx.doi.org/10.1371/journal.pone.0088451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523898	gold, Green Submitted, Green Published			2022-12-27	WOS:000331258100047
J	Tang, Y; Hua, SC; Qin, GX; Xu, LJ; Jiang, YF				Tang, Ying; Hua, Shu-Cheng; Qin, Gui-Xiang; Xu, Li-Jun; Jiang, Yan-Fang			Different Subsets of Macrophages in Patients with New Onset Tuberculous Pleural Effusion	PLOS ONE			English	Article							LYMPHOCYTE-T; NK-CELLS; ACTIVATION; EXPRESSION	Objective: Macrophages are the infiltrate components of tuberculous pleural effusion (TPE). This study is aimed at examining the role of different subsets of macrophages in pleural fluid (PF) and peripheral blood (PB) from patients with new onset TPE. Methods: The numbers of PB and PF CD163(+), CD206(+) and CD115(+) macrophages in 25 patients with new onset TPE and 17 healthy controls (HC) were determined by flow cytometry. The concentrations of serum and PF cytokines were determined by cytometric bead array (CBA) and enzyme-linked immunosorbentassay (ELISA). The potential association between the numbers of different subsets of macrophages and the values of clinical measures in TPE patients were analyzed. Results: The numbers of PB CD14(+) CD163(-) M1-like and CD14(+) CD163(-) interleukin (IL)-12(+) M1 macrophages were significantly higher than that in the HC, but lower than PF, and the numbers of PF CD14+ CD163+, CD14+ CD163+ CD206+, CD14(+) CD163(+) CDll5(+) M2-like, and CD14(+) CD163(+) IL-10(+) M2 macrophages were less than PB in the TPE patients. The levels of serum IL-1, IL-6, IL-8, IL-12, tumor growth factor (TGF)-beta 1, and tumor necrosis factor (TNF)-alpha in the TPE patients were significantly higher than that in the HC, but lower than that in the PF. The levels of PF IL-10 were significantly higher than that in the PB of patients and HC. In addition, the levels of serum IL-12 and TNF-alpha were correlated positively with the values of erythrocyte sedimentation rate (ESR) and the numbers of ESAT-6- and culture filtrate protein 10 (CFP-10)-specific IFN-csecreting T cells, and the levels of PF TNF-alpha were correlated positively with the levels of PF adenosine deaminase (ADA) and lactate dehydrogenase (LDH) in those patients. Conclusion: Our data indicate that Mycobacterium tuberculosis (M. tb) infection induces M1 predominant pro-inflammatory responses, contributing to the development of TPE in humans.	[Tang, Ying; Hua, Shu-Cheng; Xu, Li-Jun] Jilin Univ, Hosp 1, Dept Resp Med, Changchun 130023, Peoples R China; [Qin, Gui-Xiang] Infect Dis Hosp Changchun, Ctr TB Meningitis Diag & Treatment, Changchun, Peoples R China; [Jiang, Yan-Fang] Jilin Univ, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China; [Jiang, Yan-Fang] Jilin Univ, Dept Cent Lab, Hosp 1, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Xu, LJ (corresponding author), Jilin Univ, Hosp 1, Dept Resp Med, Changchun 130023, Peoples R China.	lijunxu001@sina.com; yanfangjiang@hotmail.com	xu, li/GNH-3667-2022		Science and Technology Department of Jilin Province, China [20110489]; Jilin University [20121121]	Science and Technology Department of Jilin Province, China; Jilin University(Jilin University)	This study was supported by the Science and Technology Department of Jilin Province, China (No. 20110489), Graduate innovation fund of Jilin University (No. 20121121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABO T, 1981, J IMMUNOL, V127, P1024; Adler L, 2008, CELL PHYSL, V394, P1261; Barcelos W, 2006, MICROBIOL IMMUNOL, V50, P597, DOI 10.1111/j.1348-0421.2006.tb03834.x; Basu A, 2012, ANN TROP MED PUBLIC, V5, P168, DOI 10.4103/1755-6783.98606; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; BEDELL SE, 1985, AM J MED, V78, P1001, DOI 10.1016/0002-9343(85)90224-4; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BERGROTH V, 1987, CHEST, V91, P338, DOI 10.1378/chest.91.3.338; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dhiman R, 2012, J IMMUNOL, V189, P897, DOI 10.4049/jimmunol.1102833; DOMAGALA W, 1981, ACTA CYTOL, V25, P108; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Fehlings M, 2013, CANCER RES, V73, P2480; Fehlings M, 2012, INFECT IMMUN, V80, P2724, DOI 10.1128/IAI.00381-12; GHOSH AK, 1985, J CLIN PATHOL, V38, P608, DOI 10.1136/jcp.38.6.608; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Herwig MC, 2013, EXP EYE RES, V107, P52, DOI 10.1016/j.exer.2012.11.012; HOLLINGER NF, 1953, J PEDIATR-US, V42, P304, DOI 10.1016/S0022-3476(53)80186-1; Kaczmarek M, 2011, TUMOR BIOL, V32, P1123, DOI 10.1007/s13277-011-0214-1; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; KOCHMAN S, 1984, EUR J RESPIR DIS, V65, P586; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; LEIBOWITZ S, 1973, BRIT J EXP PATHOL, V54, P152; LUCIVERO G, 1988, EUR RESPIR J, V1, P337; Mahmood DF, 2012, J CELLULAR PHYSL J C, V228, P1577; Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; MOISAN T, 1978, AM REV RESPIR DIS, V117, P507; Nolt D, 2004, INFECT IMMUN, V72, P2976, DOI 10.1128/IAI.72.5.2976-2988.2004; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; PETTERSSON T, 1978, CHEST, V73, P49, DOI 10.1378/chest.73.1.49; Ponticiello A, 2004, RESP MED, V98, P509, DOI 10.1016/j.rmed.2003.12.003; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; Richard L, 1972, ANN INTERN MED, V77, P507; Roy S, 2008, J IMMUNOL, V180, P1729, DOI 10.4049/jimmunol.180.3.1729; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385	40	14	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88343	10.1371/journal.pone.0088343	http://dx.doi.org/10.1371/journal.pone.0088343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520370	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600061
J	van Asseldonk, EHF; Campfens, SF; Verwer, SJF; van Putten, MJAM; Stegeman, DF				van Asseldonk, Edwin H. F.; Campfens, Sanne Floor; Verwer, Stan J. F.; van Putten, Michel J. A. M.; Stegeman, Dick F.			Reliability and Agreement of Intramuscular Coherence in Tibialis Anterior Muscle	PLOS ONE			English	Article							COMMON SYNAPTIC INPUTS; SPINAL-CORD; INTERMUSCULAR COHERENCE; SURFACE EMG; CLINICAL-APPLICATIONS; MOTONEURONAL DRIVE; MOTOR UNITS; WALKING; RECTIFICATION; REPRODUCIBILITY	Background: Neuroplasticity drives recovery of walking after a lesion of the descending tract. Intramuscular coherence analysis provides a way to quantify corticomotor drive during a functional task, like walking and changes in coherence serve as a marker for neuroplasticity. Although intramuscular coherence analysis is already applied and rapidly growing in interest, the reproducibility of variables derived from coherence is largely unknown. The purpose of this study was to determine the test-retest reliability and agreement of intramuscular coherence variables obtained during walking in healthy subjects. Methodology/Principal Findings: Ten healthy participants walked on a treadmill at a slow and normal speed in three sessions. Area of coherence and peak coherence were derived from the intramuscular coherence spectra calculated using rectified and non-rectified M. tibialis anterior Electromyography (EMG). Reliability, defined as the ability of a measurement to differentiate between subjects and established by the intra-class correlation coefficient, was on the limit of good for area of coherence and peak coherence when derived from rectified EMG during slow walking. Yet, the agreement, defined as the degree to which repeated measures are identical, was low as the measurement error was relatively large. The smallest change to exceed the measurement error between two repeated measures was 66% of the average value. For normal walking and/or other EMG-processing settings, not rectifying the EMG and/or high-pass filtering with a high cutoff frequency (100 Hz) the reliability was only moderate to poor and the agreement was considerably lower. Conclusions/significance: Only for specific conditions and EMG-processing settings, the derived coherence variables can be considered to be reliable measures. However, large changes (> 66%) are needed to indicate a real difference. So, although intramuscular coherence is an easy to use and a sufficiently reliable tool to quantify intervention-induced neuroplasticity, the large effects needed to reveal a real change limit its practical use.	[van Asseldonk, Edwin H. F.; Campfens, Sanne Floor; Verwer, Stan J. F.] Univ Twente, Dept Biomechan Engn, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Campfens, Sanne Floor; van Putten, Michel J. A. M.] Univ Twente, Dept Clin Neurophysiol, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Putten, Michel J. A. M.] Med Spectrum Twente, Dept Neurol & Clin Neurophysiol, Enschede, Netherlands; [Stegeman, Dick F.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Stegeman, Dick F.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands	University of Twente; University of Twente; Medical Spectrum Twente; Radboud University Nijmegen; Vrije Universiteit Amsterdam	van Asseldonk, EHF (corresponding author), Univ Twente, Dept Biomechan Engn, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	e.h.f.vanasseldonk@utwente.nl	van Putten, Michel J.A.M./D-6519-2018; Stegeman, Dick/AAN-5134-2021	van Putten, Michel J.A.M./0000-0001-8319-3626; van Asseldonk, Edwin/0000-0003-1534-2348	VENI grant from The Netherlands Organisation for Scientific Research [91610143]	VENI grant from The Netherlands Organisation for Scientific Research	This study was supported by a VENI grant (grant nr: 91610143) from The Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy D, 2010, J NEUROPHYSIOL, V104, P1167, DOI 10.1152/jn.00382.2010; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Boonstra TW, 2012, J NEUROPHYSIOL, V107, P796, DOI 10.1152/jn.00066.2011; Brown P, 1999, BRAIN, V122, P461, DOI 10.1093/brain/122.3.461; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; de Ruiter CJ, 2010, EUR J APPL PHYSIOL, V108, P247, DOI 10.1007/s00421-009-1209-0; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; den Otter AR, 2004, GAIT POSTURE, V19, P270, DOI 10.1016/S0966-6362(03)00071-7; Farina D, 2013, J PHYSIOL-LONDON, V591, P2403, DOI 10.1113/jphysiol.2012.246082; FARMER SF, 1993, J PHYSIOL-LONDON, V470, P127, DOI 10.1113/jphysiol.1993.sp019851; Grosse P, 2003, BRAIN, V126, P326, DOI 10.1093/brain/awg043; Grosse P, 2002, CLIN NEUROPHYSIOL, V113, P1523, DOI 10.1016/S1388-2457(02)00223-7; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; Halliday DM, 2010, J NEUROPHYSIOL, V103, P3547, DOI 10.1152/jn.00222.2010; Halliday DM, 2003, J NEUROPHYSIOL, V89, P960, DOI 10.1152/jn.00844.2002; Hansen NL, 2005, J NEUROPHYSIOL, V94, P934, DOI 10.1152/jn.00082.2005; Hansen NL, 2001, J NEUROPHYSIOL, V86, P1266, DOI 10.1152/jn.2001.86.3.1266; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 2007, HUM MOV SCI; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; McClelland VM, 2012, J NEUROSCI METH, V205, P190, DOI 10.1016/j.jneumeth.2011.11.001; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; Negro F, 2011, J PHYSIOL-LONDON, V589, P629, DOI 10.1113/jphysiol.2010.202473; Nielsen JB, 2008, CLIN NEUROPHYSIOL, V119, P2813, DOI 10.1016/j.clinph.2008.07.283; Nielsen JB, 2002, BRAIN RES REV, V40, P192, DOI 10.1016/S0165-0173(02)00201-1; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Norton JA, 2003, MOVEMENT DISORD, V18, P101, DOI 10.1002/mds.10298; Norton JA, 2006, J NEUROPHYSIOL, V95, P2580, DOI 10.1152/jn.01289.2005; Norton JA, 2004, NEUROLOGY, V62, P632, DOI 10.1212/WNL.62.4.632; Norton JA, 2008, CLIN NEUROPHYSIOL, V119, P2675, DOI 10.1016/j.clinph.2008.08.014; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perez MA, 2006, J PHYSIOL-LONDON, V573, P843, DOI 10.1113/jphysiol.2006.105361; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Petersen TH, 2010, J PHYSIOL-LONDON, V588, P4387, DOI 10.1113/jphysiol.2010.195735; Neto OP, 2010, J NEUROPHYSIOL, V103, P1093, DOI 10.1152/jn.00792.2009; Pohja M, 2005, NEUROIMAGE, V26, P764, DOI 10.1016/j.neuroimage.2005.02.031; Portney L., 2009, FDN CLIN RES, V(3rd ed.); Potvin JR, 2004, J ELECTROMYOGR KINES, V14, P389, DOI 10.1016/j.jelekin.2003.10.005; Power HA, 2006, J PHYSIOL-LONDON, V577, P795, DOI 10.1113/jphysiol.2006.116939; Priestley MB, 1983, SPECTRAL ANAL TIME S; Rogers LM, 2011, RESTOR NEUROL NEUROS, V29, P507, DOI 10.3233/RNN-2011-0625; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; ROY RR, 1995, MUSCLE NERVE, V18, P1187, DOI 10.1002/mus.880181015; Staudenmann D, 2007, J BIOMECH, V40, P900, DOI 10.1016/j.jbiomech.2006.03.021; Stegeman DF, 2010, CLIN NEUROPHYSIOL, V121, P1633, DOI 10.1016/j.clinph.2010.03.052; Wagner JM, 2008, PHYS THER, V88, P652, DOI 10.2522/ptj.20070255; Ward NJ, 2013, J NEUROPHYSIOL, V110, P1744, DOI 10.1152/jn.00296.2013; Yao B, 2007, J NEUROSCI METH, V159, P215, DOI 10.1016/j.jneumeth.2006.07.008	48	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88428	10.1371/journal.pone.0088428	http://dx.doi.org/10.1371/journal.pone.0088428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520387	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600078
J	Fath-Ordoubadi, F; Spaepen, E; El-Omar, M; Fraser, DG; Khan, MA; Neyses, L; Danzi, GB; Roguin, A; Paunovic, D; Mamas, MA				Fath-Ordoubadi, Farzin; Spaepen, Erik; El-Omar, Magdi; Fraser, Douglas G.; Khan, Muhammad A.; Neyses, Ludwig; Danzi, Gian B.; Roguin, Ariel; Paunovic, Dragica; Mamas, Mamas A.			Outcomes in Patients with Acute and Stable Coronary Syndromes; Insights from the Prospective NOBORI-2 Study	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ST-ELEVATION; TASK-FORCE; MORTALITY; REVASCULARIZATION; ASSOCIATION; POPULATION; GUIDELINES; REGISTRY; SOCIETY	Background: Contemporary data remains limited regarding mortality and major adverse cardiac events (MACE) outcomes in patients undergoing PCI for different manifestations of coronary artery disease. Objectives: We evaluated mortality and MACE outcomes in patients treated with PCI for STEMI (ST-elevation myocardial infarction), NSTEMI (non ST-elevation myocardial infarction) and stable angina through analysis of data derived from the Nobori-2 study. Methods: Clinical endpoints were cardiac mortality and MACE (a composite of cardiac death, myocardial infarction and target vessel revascularization). Results: 1909 patients who underwent PCI were studied; 1332 with stable angina, 248 with STEMI and 329 with NSTEMI. Age-adjusted Charlson co-morbidity index was greatest in the NSTEMI cohort (3.78 +/- 1.91) and lowest in the stable angina cohort (3.00 +/- 1.69); P<0.0001. Following Cox multivariate analysis cardiac mortality was independently worse in the NSTEMI vs the stable angina cohort (HR 2.31 (1.10-4.87), p = 0.028) but not significantly different for STEMI vs stable angina cohort (HR 0.72 (0.16-3.19), p = 0.67). Similar observations were recorded for MACE (<180 days) (NSTEMI vs stable angina: HR 2.34 (1.21-4.55), p = 0.012; STEMI vs stable angina: HR 2.19 (0.97-4.98), p = 0.061. Conclusions: The longer-term Cardiac mortality and MACE were significantly worse for patients following PCI for NSTEMI even after adjustment of clinical demographics and Charlson co-morbidity index whilst the longer-term prognosis of patients following PCI STEMI was favorable, with similar outcomes as those patients with stable angina following PCI.	[Fath-Ordoubadi, Farzin; El-Omar, Magdi; Fraser, Douglas G.; Khan, Muhammad A.; Neyses, Ludwig; Mamas, Mamas A.] Manchester Royal Infirm, Manchester Heart Ctr, Manchester M13 9WL, Lancs, England; [Spaepen, Erik] SBD Analyt, Bekkevoort, Belgium; [Danzi, Gian B.] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Div Cardiol, Milan, Italy; [Roguin, Ariel] Rambam Med Ctr, Dept Cardiol, Haifa, Israel; [Paunovic, Dragica] Terumo Europe, European Med & Clin Div, Louvain, Belgium; [Mamas, Mamas A.] Univ Manchester, Cardiovasc Inst, Manchester, Lancs, England	University of Manchester; IRCCS Ca Granda Ospedale Maggiore Policlinico; Rambam Health Care Campus; Technion Israel Institute of Technology; University of Manchester	Mamas, MA (corresponding author), Manchester Royal Infirm, Manchester Heart Ctr, Oxford Rd, Manchester M13 9WL, Lancs, England.	mamasmamas1@yahoo.co.uk	Mamas, Mamas Andreas/A-2549-2019; Danzi, Gian Battista/P-2244-2016; Neyses, Ludwig/AGY-7446-2022	Mamas, Mamas Andreas/0000-0001-9241-8890; Danzi, Gian Battista/0000-0003-0897-8006; 	Terumo Europe N.V. Leuven, Belgium	Terumo Europe N.V. Leuven, Belgium	Terumo Europe N.V. Leuven, Belgium (www.terumo-europe.com/) provided a research grant but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzi D, 2012, INTERN EMERG MED; Chan MY, 2009, CIRCULATION, V119, P3110, DOI 10.1161/CIRCULATIONAHA.108.799981; Danzi GB, 2012, EUROINTERVENTION, V8, P109, DOI 10.4244/EIJV8I1A17; Garcia-Garcia C, 2011, AM J CARDIOL, V108, P1061, DOI 10.1016/j.amjcard.2011.06.003; Hirsch A, 2009, AM J CARDIOL, V104, P333, DOI 10.1016/j.amjcard.2009.03.052; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Montalescot G, 2007, EUR HEART J, V28, P1409, DOI 10.1093/eurheartj/ehm031; Nikus KC, 2007, ANN MED, V39, P63, DOI 10.1080/08037060600997534; Polonski L, 2011, INT J CARDIOL, V152, P70, DOI 10.1016/j.ijcard.2010.07.008; Ramcharitar Steve, 2008, EuroIntervention, V3, P429, DOI 10.4244/A78; Singh M, 2011, CIRC-CARDIOVASC QUAL, V4, P496, DOI 10.1161/CIRCOUTCOMES.111.961375; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Terkelsen CJ, 2005, EUR HEART J, V26, P18, DOI 10.1093/eurheartj/ehi002; Urban P, 2011, J AM COLL CARDIOL, V57, P1445, DOI 10.1016/j.jacc.2010.11.028	17	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88577	10.1371/journal.pone.0088577	http://dx.doi.org/10.1371/journal.pone.0088577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551120	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000331271500048
J	Soliman, H; Khalil, F; Antonia, S				Soliman, Hatem; Khalil, Farah; Antonia, Scott			PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells	PLOS ONE			English	Article							INVASION; B7-H1; METASTASIS; LIGAND-1; PATHWAY	Background: Tumor cells express programmed death ligand 1 (PD-L1) and is a key immune evasion mechanism. PD-L1 expression in multiple breast cancer cell lines was evaluated to identify intrinsic differences that affect their potential for immune evasion. Methods: PD-L1 expression was analyzed in six breast cancer cell lines: AU565&MCF7 (luminal), BT20&HCC1143 (basal A), MDA231&HCC38 (basal B). Surface and intracellular PD-L1 expression +/- interferon gamma for 48 hours was measured by flow cytometry. PD-L1 gene expression data for all breast cancer cell lines in the Comprehensive Cell Line Encyclopedia (CCLE) was analyzed. Correlation between PD-L1 levels and clinicopathologic parameters was analyzed within Oncomine datasets. A tissue microarray containing 61 invasive breast cancer primary tumor cores was stained for PD-L1 expression and analyzed. Results: Basal breast cancer cells constitutively express the highest levels of PD-L1. All cell lines increased PD-L1 expression with interferon gamma, but basal B cells (MDA-231 and HCC38) demonstrated the largest increases. There were no differences in protein localization between cell lines. In the CCLE data, basal cell lines demonstrated higher mean PD-L1 expression compared to luminal cell lines. High PD-L1 expressing basal cell lines over-express genes involved in invasion, proliferation, and chemoresistance compared to low PD-L1 basal cell lines. High PD-L1 basal cell lines had lower expression of IRF2BP2 and higher STAT1 levels compared to low PD-L1 expressing cell lines. Within Oncomine datasets PDL1 mRNA levels were higher in basal type tumors. The TMA analysis demonstrated that lymph node positive cases had higher levels of PD-L1 protein expression compared to lymph node negative cases. Conclusions: Basal type breast cancer (especially basal B) express greater levels of PD-L1 constitutively and with IFN gamma. High PD-L1 basal cells over-express genes involved in invasion, motility, and chemoresistance. Targeting PD-L1 may enhance eradication of aggressive breast cancer cells by the immune system.	[Soliman, Hatem] H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Oncol & Expt Therapeut, Tampa, FL 33612 USA; [Khalil, Farah] H Lee Moffitt Canc Ctr & Res Inst, Dept Anat Pathol, Tampa, FL USA; [Antonia, Scott] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol & Immunol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Soliman, H (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Oncol & Expt Therapeut, Tampa, FL 33612 USA.	Hatem.soliman@moffitt.org			Moffitt Foundation; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Moffitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded through the Moffitt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoudjit Fawzi, 2012, Chemother Res Pract, V2012, P283181, DOI 10.1155/2012/283181; Burbelo P, 2004, BREAST CANCER RES TR, V84, P43, DOI 10.1023/B:BREA.0000018422.02237.f9; Butte MJ P-CV, 2007, MOL IMMUNOL, P3567; Cai Hui, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P91; Carneiro FRG, 2011, MOL CELL BIOL, V31, P2889, DOI 10.1128/MCB.00974-10; Chen YB, 2012, TUMORI, V98, P751, DOI 10.1700/1217.13499; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Droeser RA, 2013, EUR J CANCER, P123; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Ghebeh HBE, 2008, BMC CANCER, P57; Hamanishi JMM, 2008, P NATL ACAD SCI USA, P3360; Hasan A, 2011, EXPERT OPIN THER TAR, V15, P1211, DOI 10.1517/14728222.2011.613826; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Lee SJJB, 2008, FEBS LETT, P755; Mozaffarian N, 2008, RHEUMATOLOGY, V47, P1335, DOI 10.1093/rheumatology/ken256; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Teng ACT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024100; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148	22	171	183	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88557	10.1371/journal.pone.0088557	http://dx.doi.org/10.1371/journal.pone.0088557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551119	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500047
J	Canudas-Romo, V; Liu, L; Zimmerman, L; Ahmed, S; Tsui, A				Canudas-Romo, Vladimir; Liu, Li; Zimmerman, Linnea; Ahmed, Saifuddin; Tsui, Amy			Potential Gains in Reproductive-Aged Life Expectancy by Eliminating Maternal Mortality: A Demographic Bonus of Achieving MDG 5	PLOS ONE			English	Article							SURVIVAL; TRANSITION; COUNTRIES	Objective: We assessed the change over time in the contribution of maternal mortality to a life expectancy calculated between ages 15 and 49, or Reproductive-Aged Life Expectancy (RALE). Our goal was to estimate the increase in RALE in developed countries over the twentieth century and the hypothetical gains in African countries today by eliminating maternal mortality. Methods: Analogous to life expectancy, RALE is calculated from a life table of ages 15 to 49. Specifically, RALE is the average number of years that women at age 15 would be expected to live between 15 and 49 with current mortality rates. Associated single decrement life tables of causes of death other than maternal mortality are explored to assess the possible gains in RALE by reducing or eliminating maternal mortality. We used population-based data from the Human Mortality Database and the Demographic and Health Surveys. Findings: In developed countries, five years in RALE were gained over the twentieth century, of which approximately 10%, or half a year, was attributable to reductions in maternal mortality. In sub-Saharan African countries, the possible achievable gains fluctuate between 0.24 and 1.47 years, or 6% and 44% of potential gains in RALE. Conclusions: Maternal mortality is a rare event, yet it is still a very important component of RALE. Averting the burden of maternal deaths could return a significant increase in the most productive ages of human life.	[Canudas-Romo, Vladimir] Univ Southern Denmark, Max Planck Odense Ctr, Odense, Denmark; [Canudas-Romo, Vladimir; Zimmerman, Linnea; Ahmed, Saifuddin; Tsui, Amy] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of Southern Denmark; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Canudas-Romo, V (corresponding author), Max Planck Odense Ctr Biodemog Aging, J B Winslows Vej 9, DK-5000 Odense C, Denmark.	vcanudas@health.sdu.dk	liu, li/HGC-0900-2022	Canudas Romo, Vladimir/0000-0001-6532-0089	Bill and Melinda Gates Institute for Population and Reproductive Health; European Research Council - ERC [240795]	Bill and Melinda Gates Institute for Population and Reproductive Health; European Research Council - ERC(European Research Council (ERC))	Analyses for this study and development of this paper were funded by The Bill and Melinda Gates Institute for Population and Reproductive Health. The first authors' work was supported by the European Research Council - ERC Starting Grant number 240795. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOB REP UNAIDS REP; Barford A., 2006, BMJ-BRIT MED J, P332; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6; Donnay F, 2000, INT J GYNECOL OBSTET, V70, P89, DOI 10.1016/S0020-7292(00)00236-8; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Hill K, 2007, LANCET, V370; Horton R, 2009, LANCET, V374, P1400, DOI 10.1016/S0140-6736(09)61669-X; Koblinsky M., 2003, REDUCING MATERNAL MO; Lattof SR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001350; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; Loudon I., 1992, DEATH CHILDBIRTH INT; Loudon I, 1965, BMJ CLIN RES ED, V305, P1557; Macro International Inc, 2013, DEM HLTH SURV; Mantel G, 2002, EUROPEAN J OBSTET GY, V100; Merdad L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059834; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Preston S., 2000, DEMOGRAPHY MEASURING; Preston SH, 1976, MORTALITY PATTERNS N; Reed HE., 2000, CONSEQUENCES MATERNA; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; ROSENFIELD A, 1985, LANCET, V2, P83; Rosenfield A, 2006, LANCET, V368, P1133, DOI 10.1016/S0140-6736(06)69386-0; RUTENBERG N, 1991, DIRECT INDIRECT ESTI; Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Vallin J, 2009, POPUL DEV REV, V35, P159, DOI 10.1111/j.1728-4457.2009.00264.x; Wilmoth J, 2009, B WORLD HEALTH ORGAN, V87, P256, DOI 10.2471/BLT.07.048280; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	33	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e86694	10.1371/journal.pone.0086694	http://dx.doi.org/10.1371/journal.pone.0086694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551040	Green Published, gold			2022-12-27	WOS:000331266000005
J	Ssemaganda, A; Kindinger, L; Bergin, P; Nielsen, L; Mpendo, J; Ssetaala, A; Kiwanuka, N; Munder, M; Teoh, TG; Kropf, P; Muller, I				Ssemaganda, Aloysius; Kindinger, Lindsay; Bergin, Philip; Nielsen, Leslie; Mpendo, Juliet; Ssetaala, Ali; Kiwanuka, Noah; Munder, Markus; Teoh, Tiong Ghee; Kropf, Pascale; Mueller, Ingrid			Characterization of Neutrophil Subsets in Healthy Human Pregnancies	PLOS ONE			English	Article							THERAPEUTIC PERSPECTIVES; ARGINASE ACTIVITY; SUPPRESSOR-CELLS; OXIDANT RELEASE; IMMUNE-SYSTEM; L-ARGININE; METABOLISM; GRANULOCYTES; MECHANISMS; EXPRESSION	We have previously shown that in successful pregnancies increased arginase activity is a mechanism that contributes to the suppression of the maternal immune system. We identified the main type of arginase-expressing cells as a population of activated low-density granulocytes (LDGs) in peripheral blood mononuclear cells and in term placentae. In the present study, we analyzed the phenotype of LDGs and compared it to the phenotype of normal density granulocytes (NDGs) in maternal peripheral blood, placental biopsies and cord blood. Our data reveal that only LDGs but no NDGs could be detected in placental biopsies. Phenotypically, NDGs and LDGs from both maternal and cord blood expressed different levels of maturation, activation and degranulation markers. NDGs from the maternal and cord blood were phenotypically similar, while maternal, cord and placental LDGs showed different expression levels of CD66b. LDGs present in cord blood expressed higher levels of arginase compared to maternal and placental LDGs. In summary, our results show that in maternal and cord blood, two phenotypically different populations of neutrophils can be identified, whereas in term placentae, only activated neutrophils are present.	[Ssemaganda, Aloysius; Nielsen, Leslie; Mpendo, Juliet; Ssetaala, Ali; Kiwanuka, Noah] Uganda Virus Res Inst, Int AIDS Vaccine Initiat, Entebbe, Uganda; [Kindinger, Lindsay; Teoh, Tiong Ghee] St Marys Hosp, Dept Obstet & Gynecol, London, England; [Bergin, Philip] Univ London Imperial Coll Sci Technol & Med, Fac Med, Int AIDS Vaccine Initiat, Human Immunol Lab, London, England; [Kropf, Pascale; Mueller, Ingrid] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Immunol Sect, London, England; [Munder, Markus] Univ Med Ctr, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany; [Kiwanuka, Noah] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	International AIDS Vaccine Initiative; Uganda Virus Research Institute; Imperial College London; Imperial College London; International AIDS Vaccine Initiative; Imperial College London; Johannes Gutenberg University of Mainz; Makerere University	Kropf, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Immunol Sect, London, England.	p.kropf@imperial.ac.uk; i.muller@imperial.ac.uk	Ssetaala, Ali/AAB-3832-2020; Munder, Markus/K-6737-2013	Ssetaala, Ali/0000-0003-2156-3024; Bergin, Philip/0000-0001-5522-8350	HIV Trust [HIVVRT13-015]; Imperial College (IM); Wellcome Trust [07664/Z/05/Z]; United States Agency for International Development (USAID)	HIV Trust; Imperial College (IM); Wellcome Trust(Wellcome TrustEuropean Commission); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This work was supported in part by funds received from the HIV Trust (A. Ssemaganda, HIVVRT13-015), Imperial College (IM), The Wellcome Trust (07664/Z/05/Z, PK) and was made possible in part by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibilities of the study authors and do not necessarily reflect the views of USAID, the NIH or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002134; Bhanot U, 2013, ARGINASE MEDIA UNPUB; Branzk N, 2013, SEMIN IMMUNOPATHOL, V35, P513, DOI 10.1007/s00281-013-0384-6; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bryk JA, 2010, J TRAUMA, V68, P843, DOI 10.1097/TA.0b013e3181b026e4; Chen SJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/258391; Cloke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048939; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Grillo MA, 2008, AMINO ACIDS, V34, P517, DOI 10.1007/s00726-007-0006-5; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Hahn S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00362; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Ishikawa T, 2007, PLACENTA, V28, P133, DOI 10.1016/j.placenta.2006.03.015; Kindzelskii AL, 2002, J CLIN INVEST, V110, P1801, DOI 10.1172/JCI200215973; Kindzelskii AL, 2006, EUR J IMMUNOL, V36, P1619, DOI 10.1002/eji.200535391; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; KUIJPERS TW, 1991, BLOOD, V78, P1105; Mellor AL, 2004, TRENDS IMMUNOL, V25, P563, DOI 10.1016/j.it.2004.09.001; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Raber P, 2012, IMMUNOL INVEST, V41, P614, DOI 10.3109/08820139.2012.680634; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Roos S, 2009, BIOCHEM SOC T, V37, P295, DOI 10.1042/BST0370295; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Schmielau J, 2001, CANCER RES, V61, P4756; Taniguchi K, 2004, TRANSFUSION, V44, P581, DOI 10.1111/j.1537-2995.2004.03298.x; Watanabe M, 1997, AM J REPROD IMMUNOL, V37, P368	32	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e85696	10.1371/journal.pone.0085696	http://dx.doi.org/10.1371/journal.pone.0085696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551035	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000004
J	Cheng, C; Wang, Q; You, WJ; Chen, MH; Xia, JH				Cheng, Chao; Wang, Qiang; You, Wenjie; Chen, Manhua; Xia, Jiahong			MiRNAs as Biomarkers of Myocardial Infarction: A MetaAnalysis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CARDIOVASCULAR-DISEASE; PLASMA; CANCER; SERUM; REPERTOIRE; SIGNATURES; ELEVATION; DIAGNOSIS; TROPONIN	Background: Recent studies have demonstrated that acute myocardial infarction induces a distinctive miRNA signature, suggesting that miRNAs may serve as diagnostic markers. Although many studies have investigated the use of miRNAs in the detection of cardiac injury, some had small sample sizes (, 100 patients) or reported different results for the same miRNA. Here, the role of circulating miRNAs for use as biomarkers of myocardial infarction is summarized and analyzed. Methods and Results: Medline, SCI, Embase, and Cochrane databases were searched up to January 2013 for studies that evaluated associations between miRNAs and myocardial infarction. Relevant publications were identified by searching for combinations of "myocardial infarction,'' "miRNAs,'' and their synonyms. Methodological quality was scored using a standardized list of criteria, and diagnostic performance was assessed using estimates of test sensitivity and specificity. These values were summarized using summary receiver-operating characteristic curves. Nineteen studies met the inclusion criteria: 15 studies reported sensitivity, specificity, and AUC, but 4 studies did not. Total miRNAs: sensitivity: 0.78 (95% CI: 0.77-0.80; P = 0.0000); specificity: 0.82 (95% CI: 0.80-0.83; P = 0.0000). miR-499: sensitivity: 0.88 (95% CI: 0.86-0.90; P = 0.0000); specificity: 0.87 (95% CI: 0.84-0.90; P = 0.0000). miR-1: sensitivity: 0.63 (95% CI: 0.59-0.66; P = 0.0000); specificity: 0.76 (95% CI: 0.71-0.80; P = 0.0000). miR-133a: sensitivity: 0.89 (95% CI: 0.83-0.94; P = 0.0047); specificity: 0.87 (95% CI: 0.79-0.92; P = 0.0262). miR-208b: sensitivity: 0.78 (95% CI: 0.76-0.81; P = 0.0581); specificity: 0.88 (95% CI: 0.84-0.91; P = 0.0000). The correlation between miRNAs and other diagnostic biomarkers of myocardial infarction was obvious. Conclusion: MiRNAs, especially miR-499 and miR-133a, may be suitable for use as diagnostic biomarkers of myocardial infarction.	[Cheng, Chao; Xia, Jiahong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan 430074, Hubei, Peoples R China; [Wang, Qiang] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, State Key Lab Med Genom, Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China; [You, Wenjie] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Resp & Crit Care Med, Union Hosp, Wuhan 430074, Hubei, Peoples R China; [Chen, Manhua] Cent Hosp Wuhan, Dept Cardiovasc Med, Wuhan, Peoples R China; [Xia, Jiahong] Cent Hosp Wuhan, Dept Cardiovasc Surg, Wuhan, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai Jiao Tong University; Huazhong University of Science & Technology	Chen, MH (corresponding author), Cent Hosp Wuhan, Dept Cardiovasc Med, Wuhan, Peoples R China.	cmh_centre@163.com; jiahong.xia@mail.hust.edu.cn	Duarte, Graziela Biude Silva/Q-7728-2016					Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Cissell KA, 2008, ANAL BIOANAL CHEM, V391, P2577, DOI 10.1007/s00216-008-2215-5; Cissell KA, 2008, ANAL CHEM, V80, P2319, DOI 10.1021/ac702577a; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Devaux Y, 2012, CLIN CHEM, V58, P559, DOI 10.1373/clinchem.2011.173823; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Iribarren C, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-31; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li CJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-16; Li YQ, 2013, CLINICS, V68, P75, DOI 10.6061/clinics/2013(01)OA12; Lippi G, 2012, INT J CARDIOLOGY; Long GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050926; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Oerlemans MIFJ, 2012, EMBO MOL MED, V4, P1176, DOI 10.1002/emmm.201201749; Olivieri F., 2012, INT J CARDIOLOGY; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Vogel B, 2013, CLIN CHEM, V59, P410, DOI 10.1373/clinchem.2011.181370; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang Hong, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P718; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang RR, 2011, INTERNAL MED, V50, P1789, DOI 10.2169/internalmedicine.50.5129; Wang Y, 2011, NAT NANOTECHNOL, V6, P668, DOI [10.1038/NNANO.2011.147, 10.1038/nnano.2011.147]; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zhao YY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2492	42	79	86	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88566	10.1371/journal.pone.0088566	http://dx.doi.org/10.1371/journal.pone.0088566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533109	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600067
J	Liang, WH; Wu, X; Fang, WF; Zhao, YY; Yang, YP; Hu, ZH; Xue, C; Zhang, J; Zhang, JW; Ma, YX; Zhou, T; Yan, Y; Hou, X; Qin, T; Dinglin, XX; Tian, Y; Huang, PY; Huang, Y; Zhao, HY; Zhang, L				Liang, Wenhua; Wu, Xuan; Fang, Wenfeng; Zhao, Yuanyuan; Yang, Yunpeng; Hu, Zhihuang; Xue, Cong; Zhang, Jing; Zhang, Jianwei; Ma, Yuxiang; Zhou, Ting; Yan, Yue; Hou, Xue; Qin, Tao; Dinglin, Xiaoxiao; Tian, Ying; Huang, Peiyu; Huang, Yan; Zhao, Hongyun; Zhang, Li			Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; PHASE-III; OPEN-LABEL; 1ST-LINE TREATMENT; CHEMOTHERAPY; TRIAL; ADENOCARCINOMA; GEMCITABINE; DOCETAXEL; MULTICENTER	Background: Several EGFR-tyrosine kinase inhibitors (EGFR-TKIs) including erlotinib, gefitinib, afatinib and icotinib are currently available as treatment for patients with advanced non-small-cell lung cancer (NSCLC) who harbor EGFR mutations. However, no head to head trials between these TKIs in mutated populations have been reported, which provides room for indirect and integrated comparisons. Methods: We searched electronic databases for eligible literatures. Pooled data on objective response rate (ORR), progression free survival (PFS), overall survival (OS) were calculated. Appropriate networks for different outcomes were established to incorporate all evidences. Multiple-treatments comparisons (MTCs) based on Bayesian network integrated the efficacy and specific toxicities of all included treatments. Results: Twelve phase III RCTs that investigated EGFR-TKIs involving 1821 participants with EGFR mutation were included. For mutant patients, the weighted pooled ORR and 1-year PFS of EGFR-TKIs were significant superior to that of standard chemotherapy (ORR: 66.6% vs. 30.9%, OR 5.46, 95%CI 3.59 to 8.30, P<0.00001; 1-year PFS: 42.9% vs. 9.7%, OR 7.83, 95%CI 4.50 to 13.61; P<0.00001) through direct meta-analysis. In the network meta-analyses, no statistically significant differences in efficacy were found between these four TKIs with respect to all outcome measures. Trend analyses of rank probabilities revealed that the cumulative probabilities of being the most efficacious treatments were (ORR, 1-year PFS, 1-year OS, 2-year OS): erlotinib (51%, 38%, 14%, 19%), gefitinib (1%, 6%, 5%, 16%), afatinib (29%, 27%, 30%, 27%) and icotinib (19%, 29%, NA, NA), respectively. However, afatinib and erlotinib showed significant severer rash and diarrhea compared with gefitinib and icotinib. Conclusions: The current study indicated that erlotinib, gefitinib, afatinib and icotinib shared equivalent efficacy but presented different efficacy-toxicity pattern for EGFR-mutated patients. Erlotinib and afatinib revealed potentially better efficacy but significant higher toxicities compared with gefitinib and icotinib.	[Liang, Wenhua; Wu, Xuan; Fang, Wenfeng; Zhao, Yuanyuan; Yang, Yunpeng; Hu, Zhihuang; Xue, Cong; Zhang, Jing; Zhang, Jianwei; Ma, Yuxiang; Zhou, Ting; Yan, Yue; Hou, Xue; Qin, Tao; Dinglin, Xiaoxiao; Tian, Ying; Huang, Peiyu; Huang, Yan; Zhao, Hongyun; Zhang, Li] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Zhang, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	zhangli6@mail.sysu.edu.cn	Wu, Xuan/AAE-4778-2020; ZHAO, YUAN/HCI-5831-2022	Wenhua, Liang/0000-0002-1391-8238				Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Chen G, 2012, J CLIN ONCOL S, V30; Cipriani Andrea, 2009, Lancet, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gordon MS, 2013, INVEST NEW DRUG, V31, P409, DOI 10.1007/s10637-012-9904-9; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Grossi F, 2009, ONCOLOGIST, V14, P497, DOI 10.1634/theoncologist.2008-0260; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Hawkins N, 2009, VALUE HEALTH, V12, P996, DOI 10.1111/j.1524-4733.2009.00541.x; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267, DOI 10.1200/JCO.2001.19.13.3267; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Katakami N, 2013, J CLIN ONCOL; Kim ST, 2012, LUNG CANCER, V75, P82, DOI 10.1016/j.lungcan.2011.05.022; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037229; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Mauri D, 2008, JNCI-J NATL CANCER I, V100, P1780, DOI 10.1093/jnci/djn414; Metro G, 2011, EXPERT REV ANTICANC, V11, P673, DOI [10.1586/era.11.34, 10.1586/ERA.11.34]; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; NCCN, 2010, NCCN CLIN PRACT GUID; Paz-Ares L, 2010, J CELL MOL MED, V14, P51, DOI 10.1111/j.1582-4934.2009.00991.x; Ramalingam S, 2008, ONCOLOGIST, V13, P5, DOI 10.1634/theoncologist.13-S1-5; Rodrigues-Pereira J, 2011, J THORAC ONCOL, V6, P1907, DOI 10.1097/JTO.0b013e318226b5fa; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shi YK, 2013, LANCET ONCOL, V14, P953, DOI 10.1016/S1470-2045(13)70355-3; Socinski MA, 2010, J THORAC ONCOL, V5, P1963, DOI 10.1097/JTO.0b013e3181fd42eb; van Valkenhoef G, 2013, DECIS SUPPORT SYST, V55, P459, DOI 10.1016/j.dss.2012.10.005; Wu YL, 2013, ASCO ANN ADV AD LUNG; Yang JCH, 2012, LANCET ONCOL, V13, P539, DOI 10.1016/S1470-2045(12)70086-4; Zhao QO, 2011, LUNG CANCER, V73, P195, DOI 10.1016/j.lungcan.2010.11.007; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	44	98	106	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e85245	10.1371/journal.pone.0085245	http://dx.doi.org/10.1371/journal.pone.0085245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533047	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600005
J	Lu, M; Li, PP; Bandyopadhyay, G; Lagakos, W; DeWolf, WE; Alford, T; Chicarelli, MJ; Williams, L; Anderson, DA; Baer, BR; McVean, M; Conn, M; Veniant, MM; Coward, P				Lu, Min; Li, Pingping; Bandyopadhyay, Gautam; Lagakos, William; DeWolf, Walter E., Jr.; Alford, Taylor; Chicarelli, Mark Joseph; Williams, Lance; Anderson, Deborah A.; Baer, Brian R.; McVean, Maralee; Conn, Marion; Veniant, Murielle M.; Coward, Peter			Characterization of a Novel Glucokinase Activator in Rat and Mouse Models	PLOS ONE			English	Article							DIABETES THERAPY; FATTY LIVER; TYPE-2; DISCOVERY; GLUCOSE; HYPOGLYCEMIA; INFLAMMATION; MUTATIONS; MK-0941; HUMANS	Glucokinase (GK) is a hexokinase isozyme that catalyzes the phosphorylation of glucose to glucose-6-phosphate. Glucokinase activators are being investigated as potential diabetes therapies because of their effects on hepatic glucose output and/or insulin secretion. Here, we have examined the efficacy and mechanisms of action of a novel glucokinase activator, GKA23. In vitro, GKA23 increased the affinity of rat and mouse glucokinase for glucose, and increased glucose uptake in primary rat hepatocytes. In vivo, GKA23 treatment improved glucose homeostasis in rats by enhancing beta cell insulin secretion and suppressing hepatic glucose production. Sub-chronic GKA23 treatment of mice fed a high-fat diet resulted in improved glucose homeostasis and lipid profile.	[Lu, Min; Li, Pingping; Bandyopadhyay, Gautam; Lagakos, William] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [DeWolf, Walter E., Jr.; Alford, Taylor; Chicarelli, Mark Joseph; Williams, Lance; Anderson, Deborah A.; Baer, Brian R.; McVean, Maralee] Array BioPharma Inc, Boulder, CO USA; [Conn, Marion; Coward, Peter] Amgen Inc, San Francisco, CA 94080 USA; [Veniant, Murielle M.] Amgen Inc, Thousand Oaks, CA 91320 USA	University of California System; University of California San Diego; Pfizer; Array BioPharma; Amgen; Amgen	Coward, P (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	pcoward@amgen.com	Li, Pingping/F-1109-2019	Li, Pingping/0000-0003-0679-270X	Amgen Inc.	Amgen Inc.(Amgen)	This study was supported by Amgen Inc., which played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; De Ceuninck F, 2013, BRIT J PHARMACOL, V168, P339, DOI 10.1111/j.1476-5381.2012.02184.x; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Eiki J, 2011, MOL PHARMACOL, V80, P1156, DOI 10.1124/mol.111.074401; Futamura M, 2012, DIABETOLOGIA, V55, P1071, DOI 10.1007/s00125-011-2439-3; Fyfe MCT, 2007, DIABETOLOGIA, V50, P1277, DOI 10.1007/s00125-007-0646-8; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Lu M, 2010, AM J PHYSIOL-ENDOC M, V298, pE1036, DOI 10.1152/ajpendo.00668.2009; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Matschnsky FM, 2011, DIABETES CARE, V34, pS236, DOI 10.2337/dc11-s236; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Miller SP, 1999, DIABETES, V48, P1645, DOI 10.2337/diabetes.48.8.1645; Moller DE, 2012, CELL METAB, V15, P19, DOI 10.1016/j.cmet.2011.10.012; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Riddle MC, 2008, DIABETES CARE, V31, pS125, DOI 10.2337/dc08-s231; Sarabu R, 2012, J MED CHEM, V55, P7021, DOI 10.1021/jm3008689; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; WILDING JP, 2013, DIABETES OBES METAB	26	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88431	10.1371/journal.pone.0088431	http://dx.doi.org/10.1371/journal.pone.0088431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533087	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600045
J	Odagiri, K; Mizuta, I; Yamamoto, M; Miyazaki, Y; Watanabe, H; Uehara, A				Odagiri, Keiichi; Mizuta, Isagi; Yamamoto, Makoto; Miyazaki, Yosuke; Watanabe, Hiroshi; Uehara, Akihiko			Waist to Height Ratio Is an Independent Predictor for the Incidence of Chronic Kidney Disease	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; ABDOMINAL VISCERAL FAT; NECROSIS-FACTOR-ALPHA; METABOLIC SYNDROME; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; PREVALENCE; OBESITY; ASSOCIATION; CIRCUMFERENCE	Objective: Obesity is a risk factor for chronic kidney disease (CKD) and cardiovascular disease. The association between waist to height ratio (WheiR) and CKD is unclear. This study evaluated the association between WheiR and CKD. Design and Methods: In this longitudinal cohort study, 4841 Japanese workers (3686 males, 1155 females) 18 to 67 years of age in 2008 were followed up until 2011. CKD was defined as an estimated glomerular filtration rate of <60 mL/min/1.73 m(2) (by the Modification of Diet in Renal Disease equation for Japanese) or dipstick proteinuria (>= 1+). Cox proportional hazards models were used to examine the relationship between WheiR and development of CKD. Results: A total of 384 (7.9%) participants (300 men and 84 women) were found to have new CKD. The incidence of CKD was 13.7, 24.2, 37.9 and 43.7 per 1000 person-years of follow-up in the lowest, second, third and highest quartiles of WheiR, respectively. After adjustment for potential confounders, the adjusted hazard ratios (95% confidence interval) for CKD were 1.00 (reference), 1.23 (0.85, 1.78), 1.59 (1.11, 2.26) and 1.62 (1.13, 2.32) through the quartiles of WheiR, respectively. WheiR had a significant predictive value for the incidence of both proteinuria and low estimated glomerular filtration rate. After subdivision according to gender, the relationship between WheiR and the incidence of CKD was statistically significant in the unadjusted model. However, after adjusting for potential confounders, WheiR was significantly associated with the incidence of CKD in females, whereas it was not significant in males. Conclusions: WheiR, which is commonly used as an index of central obesity, is associated with CKD. There was a significant gender difference in the relationship between CKD and WheiR.	[Odagiri, Keiichi; Watanabe, Hiroshi] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Mizuta, Isagi; Yamamoto, Makoto; Uehara, Akihiko] Yamaha Hlth Care Ctr, Naka Ku, Hamamatsu, Shizuoka, Japan; [Miyazaki, Yosuke] Univ Occupat & Environm Hlth, Sch Med, Inst Ind Ecol Sci, Dept Mental Hlth,Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan	Hamamatsu University School of Medicine; University of Occupational & Environmental Health - Japan	Odagiri, K (corresponding author), Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan.	kodagiri@hama-med.ac.jp	Odagiri, Keiichi/ABG-2298-2021	Odagiri, Keiichi/0000-0001-6968-0516	Ministry of Health, Labour and Welfare of Japan; Teika Seiyaku; Takeda Pharmaceuticals; Mochida; Pfizer; Astellas Pharmaceuticals; Daiichi Sankyo	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Teika Seiyaku; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Mochida; Pfizer(Pfizer); Astellas Pharmaceuticals(Astellas Pharmaceuticals); Daiichi Sankyo(Daiichi Sankyo Company Limited)	Hiroshi Watanabe received research funding from the Ministry of Health, Labour and Welfare of Japan, Teika Seiyaku, Takeda Pharmaceuticals, Mochida, Pfizer, Astellas Pharmaceuticals, and Daiichi Sankyo. The commercial funding is not specifically related to the study, and there are no other current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Chiba Y, 2007, HYPERTENS RES, V30, P229, DOI 10.1291/hypres.30.229; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Govindarajan G, 2005, AM J MED SCI, V330, P311, DOI 10.1097/00000441-200512000-00009; Grams ME, 2013, AM J KIDNEY DIS, V62, P253, DOI 10.1053/j.ajkd.2013.03.013; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Heerspink HJL, 2013, BRIT J CLIN PHARMACO, V76, P536, DOI 10.1111/bcp.12195; Hooi LS, 2013, KIDNEY INT, V84, P1034, DOI 10.1038/ki.2013.220; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Katzmarzyk PT, 2013, AM J CLIN NUTR, V97, P480, DOI 10.3945/ajcn.112.047787; Kearns B, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-49; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lin CH, 2007, NUTRITION, V23, P788, DOI 10.1016/j.nut.2007.08.007; Liu JK, 2011, ARTERIOSCL THROM VAS, V31, P2715, DOI 10.1161/ATVBAHA.111.234062; Liu Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-35; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Rothney MP, 2013, OBESITY, V21, P1798, DOI 10.1002/oby.20223; Sanches FMR, 2008, AM J KIDNEY DIS, V52, P66, DOI 10.1053/j.ajkd.2008.02.004; Tanaka H, 2006, KIDNEY INT, V69, P369, DOI 10.1038/sj.ki.5000050; Tseng CH, 2005, DIABETES CARE, V28, P2249, DOI 10.2337/diacare.28.9.2249; VERANI RR, 1992, AM J KIDNEY DIS, V20, P629, DOI 10.1016/S0272-6386(12)70230-5; WEISINGE.JR, 1974, ANN INTERN MED, V81, P440, DOI 10.7326/0003-4819-81-4-440; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Zamanzad B., 2009, Eastern Mediterranean Health Journal, V15, P1323; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	35	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88873	10.1371/journal.pone.0088873	http://dx.doi.org/10.1371/journal.pone.0088873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533159	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600117
J	Parra-Cota, FI; Pena-Cabriales, JJ; de los Santos-Villalobos, S; Martinez-Gallardo, NA; Delano-Frier, JP				Parra-Cota, Fannie I.; Pena-Cabriales, Juan J.; de los Santos-Villalobos, Sergio; Martinez-Gallardo, Norma A.; Delano-Frier, John P.			Burkholderia ambifaria and B. caribensis Promote Growth and Increase Yield in Grain Amaranth (Amaranthus cruentus and A-hypochondriacus) by Improving Plant Nitrogen Uptake	PLOS ONE			English	Article							USE EFFICIENCY; ARABIDOPSIS-THALIANA; MYCORRHIZAL FUNGI; GENE-EXPRESSION; L. LEAVES; RHIZOBACTERIA; RHIZOSPHERE; NITRATE; CARBON; ASSIMILATION	Grain amaranth is an emerging crop that produces seeds having high quality protein with balanced amino-acid content. However, production is restricted by agronomic limitations that result in yields that are lower than those normally produced by cereals. In this work, the use of five different rhizobacteria were explored as a strategy to promote growth and yields in Amaranthus hypochondriacus cv. Nutrisol and A. cruentus cv. Candil, two commercially important grain amaranth cultivars. The plants were grown in a rich substrate, high in organic matter, nitrogen (N), and phosphorus (P) and under greenhouse conditions. Burkholderia ambifaria Mex-5 and B. caribensis XV proved to be the most efficient strains and significantly promoted growth in both grain amaranth species tested. Increased grain yield and harvest index occurred in combination with chemical fertilization when tested in A. cruentus. Growth-promotion and improved yields correlated with increased N content in all tissues examined. Positive effects on growth also occurred in A. cruentus plants grown in a poor soil, even after N and P fertilization. No correlation between non-structural carbohydrate levels in roots of inoculated plants and growth promotion was observed. Conversely, gene expression assays performed at 3-, 5- and 7-weeks after seed inoculation in plants inoculated with B. caribensis XV identified a tissue-specific induction of several genes involved in photosynthesis, sugar-and N-metabolism and transport. It is concluded that strains of Burkholderia effectively promote growth and increase seed yields in grain amaranth. Growth promotion was particularly noticeable in plants grown in an infertile soil but also occurred in a well fertilized rich substrate. The positive effects observed may be attributed to a bio-fertilization effect that led to increased N levels in roots and shoots. The latter effect correlated with the differential induction of several genes involved in carbon and N metabolism and transport.	[Parra-Cota, Fannie I.; Pena-Cabriales, Juan J.; Martinez-Gallardo, Norma A.; Delano-Frier, John P.] Ctr Invest & Estudios Avanzados, Unidad Irapuato, Guanajuato, Mexico; [de los Santos-Villalobos, Sergio] Inst Tecnol Sonora, Dept Ciencias Agua & Medio Ambiente, Obregon, Sonora, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Delano-Frier, JP (corresponding author), Ctr Invest & Estudios Avanzados, Unidad Irapuato, Guanajuato, Mexico.	jdelano@ira.cinvestav.mx	Martínez Gallardo, Norma/B-6181-2015; de los Santos Villalobos, Sergio/AAH-2871-2020; Délano-Frier, John/B-5768-2015	Martínez Gallardo, Norma/0000-0001-5726-091X; de los Santos Villalobos, Sergio/0000-0003-2234-7147; PARRA COTA, FANNIE ISELA/0000-0003-2778-9577	European Commission; AMARANTH: FUTURE-FOOD [032263]; Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; National Council for Science and Technology (CONACyT, Mexico); postgraduate scholarships [10506, 10512]	European Commission(European CommissionEuropean Commission Joint Research Centre); AMARANTH: FUTURE-FOOD; Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; National Council for Science and Technology (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); postgraduate scholarships	This work was largely supported financially by the European Commission 6th Framework Programme, AMARANTH: FUTURE-FOOD, Contract No. 032263. Financial support was provided by Mexico Tierra de Amaranto A. C. and The Deborah Presser-Velder Foundation. FIPC and SSV were supported by postgraduate scholarships (codes 10506 and 10512, respectively) granted by The National Council for Science and Technology (CONACyT, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesemoye AO, 2008, CAN J MICROBIOL, V54, P876, DOI [10.1139/W08-081, 10.1139/w08-081]; Akubugwo IE, 2007, AFR J BIOTECHNOL, V6, P2833; Castrillon-Arbelaez PA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-163; Huerta-Ocampo JA, 2011, CURR NUTR FOOD SCI, V7, P1, DOI 10.2174/157340111794941076; Huerta-Ocampo JA, 2009, INT J PLANT SCI, V170, P990, DOI 10.1086/605119; Bashan Y, 1998, SOIL BIOL BIOCHEM, V30, P1225, DOI 10.1016/S0038-0717(97)00187-9; Belimov AA, 2001, CAN J MICROBIOL, V47, P642, DOI 10.1139/cjm-47-7-642; Bevivino A, 1998, FEMS MICROBIOL ECOL, V27, P225, DOI 10.1111/j.1574-6941.1998.tb00539.x; Biemelt S, 2006, J PLANT PHYSIOL, V163, P307, DOI 10.1016/j.jplph.2005.10.011; Brenner D. M., 2000, Plant Breeding Reviews, V19, P227, DOI 10.1002/9780470650172.ch7; CABALLEROMELLADO J, 1992, SYMBIOSIS, V13, P243; Caselato-Sousa VM, 2012, J FOOD SCI, V77, pR93, DOI 10.1111/j.1750-3841.2012.02645.x; CAVALCANTE VA, 1988, PLANT SOIL, V108, P23, DOI 10.1007/BF02370096; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Constantino M, 2008, J AGR RURAL DEV TROP, V109, P169; de los Santos-Villalobos S, 2013, J PLANT GROWTH REGUL, V32, P615, DOI 10.1007/s00344-013-9329-5; de los Santos-Villalobos S, 2012, WORLD J MICROB BIOT, V28, P2615, DOI 10.1007/s11274-012-1071-9; de Silva A, 2000, HORTSCIENCE, V35, P1228, DOI 10.21273/HORTSCI.35.7.1228; DEFREITAS JR, 1990, CAN J MICROBIOL, V36, P265, DOI 10.1139/m90-046; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; DERYLO M, 1993, PLANT SOIL, V154, P211, DOI 10.1007/BF00012526; Dudeja S. S., 2005, Indian Journal of Pulses Research, V18, P107; ELBEHRI A, 1993, AGRON J, V85, P120, DOI 10.2134/agronj1993.00021962008500010023x; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; Gamalero E, 2011, BACTERIA IN AGROBIOLOGY: PLANT NUTRIENT MANAGEMENT, P17, DOI 10.1007/978-3-642-21061-7_2; Glass ADM, 2002, J EXP BOT, V53, P855, DOI 10.1093/jexbot/53.370.855; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Good AG, 2007, CAN J BOT, V85, P252, DOI 10.1139/B07-019; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hayyan Ismaeil Al-Taweil, 2009, American Journal of Agricultural and Biological Sciences, V4, P79; Hernandez-Casillas J.M., 2010, CONSERVACION USO REC; HILL RM, 1982, J AGR FOOD CHEM, V30, P465, DOI 10.1021/jf00111a014; Huerta-Ocampo JA, 2011, PLANT BIOLOGY, V13, P472, DOI 10.1111/j.1438-8677.2010.00391.x; Valenzuela-Soto JH, 2010, PLANTA, V231, P397, DOI 10.1007/s00425-009-1061-9; Humphries EC, 1956, MOD METHOD PLANT, V1, P468, DOI DOI 10.1007/978-3-662-25300-7_17; Jimenez-Delgadillo M, 1999, THESIS CINVESTAV IPN; Johnson BL, 2002, AGRON J, V94, P1437, DOI 10.2134/agronj2002.1437; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Kadereit G, 2003, INT J PLANT SCI, V164, P959, DOI 10.1086/378649; Khurana AL, 1997, MANAGING LEGUME NITR, P217; Khurana AL, 1997, TECHNICAL B INDIAN I, P1; Kiely PD, 2006, MICROB ECOL, V51, P257, DOI 10.1007/s00248-006-9019-y; KLOEPPER JW, 1989, TRENDS BIOTECHNOL, V7, P39, DOI 10.1016/0167-7799(89)90057-7; Kraiser T, 2011, J EXP BOT, V62, P1455, DOI 10.1093/jxb/erq425; Kurai T, 2011, PLANT BIOTECHNOL J, V9, P826, DOI 10.1111/j.1467-7652.2011.00592.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li J., 1989, AGR RES ARID AREAS, V3, P34; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucy M, 2004, ANTON LEEUW INT J G, V86, P1, DOI 10.1023/B:ANTO.0000024903.10757.6e; Lugtenberg BJJ, 2002, ANTON LEEUW INT J G, V81, P373, DOI 10.1023/A:1020596903142; Mantelin S, 2004, J EXP BOT, V55, P27, DOI 10.1093/jxb/erh010; Martinez-Mendoza EK, 2012, AFR J MICROBIOL RES, V6, P1887, DOI 10.5897/AJMR11.554; McCormick AJ, 2008, ANN BOT-LONDON, V101, P89, DOI 10.1093/aob/mcm258; Myers R. L., 1996, Progress in new crops: Proceedings of the Third National Symposium Indianapolis, Indiana, 22-25 October, 1996., P207; Myers RL, 1998, AGRON J, V90, P597, DOI 10.2134/agronj1998.00021962009000050005x; Nair C. B., 2009, Journal of Tropical Agriculture, V47, P43; Nair CB, 2007, WORLD J MICROB BIOT, V23, P1183, DOI 10.1007/s11274-006-9333-z; Narula N, 1989, BIOL NITROGEN FIXATI, P87; Nazoa P, 2003, PLANT MOL BIOL, V52, P689, DOI 10.1023/A:1024899808018; Olaniyi J. O., 2008, World Journal of Agricultural Sciences, V4, P506; Omami EN, 2006, NEW ZEAL J CROP HORT, V34, P11, DOI 10.1080/01140671.2006.9514382; Persello-Cartieaux F, 2003, PLANT CELL ENVIRON, V26, P189, DOI 10.1046/j.1365-3040.2003.00956.x; Persello-Cartieaux F, 2001, PLANTA, V212, P190, DOI 10.1007/s004250000384; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; POSTGATE JR, 1982, PHILOS T ROY SOC B, V296, P375, DOI 10.1098/rstb.1982.0013; Rengel Z, 2005, NEW PHYTOL, V168, P305, DOI 10.1111/j.1469-8137.2005.01558.x; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schofield RA, 2009, PLANT CELL ENVIRON, V32, P271, DOI 10.1111/j.1365-3040.2008.01919.x; Schwachtje J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029382; Sheng XF, 2008, ENVIRON POLLUT, V156, P1164, DOI 10.1016/j.envpol.2008.04.007; Shrawat AK, 2008, PLANT BIOTECHNOL J, V6, P722, DOI 10.1111/j.1467-7652.2008.00351.x; Shukla S, 2006, PLANT FOOD HUM NUTR, V61, P23, DOI 10.1007/s11130-006-0004-x; Steckel LE, 2007, WEED TECHNOL, V21, P567, DOI 10.1614/WT-06-045.1; Suneja Pooja, 2007, Archives of Agronomy and Soil Science, V53, P221, DOI 10.1080/03650340601183723; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thanapornpoonpong S. N., 2004, EFFECT NITROGEN FERT; Tiwari V. N., 1993, Indian Journal of Agricultural Research, V27, P137; Toro M, 1998, NEW PHYTOL, V138, P265, DOI 10.1046/j.1469-8137.1998.00108.x; van de Mortel JE, 2012, PLANT PHYSIOL, V160, P2173, DOI 10.1104/pp.112.207324; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; WEAVER SE, 1980, CAN J PLANT SCI, V60, P1215, DOI 10.4141/cjps80-175; Weaver VB, 2004, J BACTERIOL, V186, P2376, DOI 10.1128/JB.186.8.2376-2384.2004; Weber LE, 1990, AMARANTH GRAIN PRODU; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Zehnder GW, 2001, EUR J PLANT PATHOL, V107, P39, DOI 10.1023/A:1008732400383; Zhang H, 2007, PLANTA, V226, P839, DOI 10.1007/s00425-007-0530-2; [No title captured]	96	35	41	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88094	10.1371/journal.pone.0088094	http://dx.doi.org/10.1371/journal.pone.0088094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533068	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600026
J	Sanchez-Medina, AJ; Romero-Quintero, L; Sosa-Cabrera, S				Sanchez-Medina, Agustin J.; Romero-Quintero, Leonardo; Sosa-Cabrera, Silvia			Environmental Management in Small and Medium-Sized Companies: An Analysis from the Perspective of the Theory of Planned Behavior	PLOS ONE			English	Article							BUSINESS START-UP; STAKEHOLDER MANAGEMENT; FINANCIAL PERFORMANCE; SOCIAL PERFORMANCE; ENTREPRENEURIAL; FIRM; DETERMINANTS; INTENTIONS; MODELS; PERCEPTIONS	In the business context, concern for the environment began to develop when pressure from the public administration and environmental awareness groups raised the specific requirements for companies. The Theory of Planned Behavior considers that people's conduct is determined by the intention of carrying out a certain behavior. Thus, the individual's intent is determined by three factors related to the desired outcome of the behavior. the Personal Attitude toward the Results, the Perceived Social Norms, and the Perceived Behavioral Control over the action. Therefore, the objectives of this paper are to clarify the attitudes of the managers of Canarian small and medium-sized companies about taking environmental measures, and try to demonstrate whether there is a relationship between the proposed factors and the intention to take these measures.	[Sanchez-Medina, Agustin J.; Romero-Quintero, Leonardo; Sosa-Cabrera, Silvia] Univ Las Palmas Gran Canaria, Univ Inst Cybernet Sci & Technol, Las Palmas Gran Canaria, Spain; [Sanchez-Medina, Agustin J.; Romero-Quintero, Leonardo] Univ Las Palmas Gran Canaria, Univ Inst Cybernet Sci & Technol, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Sanchez-Medina, AJ (corresponding author), Univ Las Palmas Gran Canaria, Univ Inst Cybernet Sci & Technol, Las Palmas Gran Canaria, Spain.	asanchez@dede.ulpgc.es	Sánchez-Medina, Agustín/ABE-8733-2020	Sánchez-Medina, Agustín/0000-0002-7569-3556; Sosa-Cabrera, Silvia/0000-0002-4993-0730				AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], REV INT PSICOLOGIA A; [Anonymous], 1993, ENV MANAGEMENT BUSIN; Autio E., 2001, ENTERPRISE INNOVATIO, V2, P145, DOI [10.1080/14632440110094632, DOI 10.1080/14632440110094632]; Barclay D. W., 1995, TECHNOLOGY STUDIES, V2, P285, DOI DOI 10.1017/CBO9781107415324.004; Barney J. B., 1986, Management Science, V32, P1231, DOI 10.1287/mnsc.32.10.1231; BEAUMONT JR, 1992, FUTURES, V24, P187, DOI 10.1016/0016-3287(92)90030-J; BOLDERO J, 1995, J APPL SOC PSYCHOL, V25, P440, DOI 10.1111/j.1559-1816.1995.tb01598.x; BRUDERL J, 1992, AM SOCIOL REV, V57, P227, DOI 10.2307/2096207; Bruderl J, 1998, SMALL BUS ECON, V10, P213, DOI 10.1023/A:1007997102930; BURKE L, 1986, CALIF MANAGE REV, V28, P122, DOI 10.2307/41165206; Buysse K, 2003, STRATEGIC MANAGE J, V24, P453, DOI 10.1002/smj.299; Calvesi M, 2002, STORIA ARTE, P113; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; CHANDLER GN, 1992, J BUS VENTURING, V7, P223, DOI 10.1016/0883-9026(92)90028-P; Chin W, 1998, MANAGEMENT INFORM SY, V22, P7, DOI DOI 10.2307/249674; Common M, 1988, ENV RESOURCES EC INT; COOL K, 1988, STRATEGIC MANAGE J, V9, P207, DOI 10.1002/smj.4250090302; COOPER AC, 1993, J BUS VENTURING, V8, P241, DOI 10.1016/0883-9026(93)90030-9; Cordano M, 2011, ENVIRON BEHAV, V43, P634, DOI 10.1177/0013916510378528; Darnall N, 2010, J MANAGE STUD, V47, P1072, DOI 10.1111/j.1467-6486.2009.00873.x; De Koning A, 1994, INT SMALL BUS J, V13, P25; DelBrio J.A, 2001, MEDIO AMBIENTE EMPRE; Do Valle PO, 2005, ENVIRON BEHAV, V37, P364, DOI 10.1177/0013916504272563; Duran M., 2009, MEDIO AMBIENTE COMPO, V10, P27; Duran M, 2007, REV LAT AM PSICOL, V39, P287; Engle RL, 2010, INT J ENTREP BEHAV R, V16, P35, DOI 10.1108/13552551011020063; Eurostat, 2020, SMALL MEDIUM SIZED E; Fayolle A., 2006, Journal of European Industrial Training, V30, P701, DOI 10.1108/03090590610715022; Fini R, 2012, ENTREP THEORY PRACT, V36, P387, DOI 10.1111/j.1540-6520.2010.00411.x; Fishbein M., 1975, BELIEF ATTITUDE INTE; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Freeman R. E., 1984, STRATEGIC MANAGEMENT; Gallego JA, 1974, EC MEDIO AMBIENTE; Garces C, 1998, THESIS U ZARAGOZA ZA; Gartner W.B., 1988, ENTREP THEORY PRACT, V13, P11, DOI DOI 10.1177/104225878801200401; George D., 1995, SPSS PC STEP STEP SI; GRAVES SB, 1994, ACAD MANAGE J, V37, P1034, DOI 10.2307/256611; HANSEN GS, 1989, STRATEGIC MANAGE J, V10, P399, DOI 10.1002/smj.4250100502; Henriques I, 1999, ACAD MANAGE J, V42, P87, DOI 10.2307/256876; Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014; Hillman AJ, 2001, STRATEGIC MANAGE J, V22, P125, DOI 10.1002/1097-0266(200101)22:2<125::AID-SMJ150>3.0.CO;2-H; Hirshleifer J., 1980, PRICE THEORY APPL; Holt D, 2000, GREENER MANAGEMENT I, V2000, P29, DOI DOI 10.9774/GLEAF.3062.2000.su.00005; Johnson, 1990, ENTREP THEORY PRACT, V14, P39, DOI DOI 10.1177/104225879001400306; Kibler E, 2013, ENTREP REGION DEV, V25, P293, DOI 10.1080/08985626.2012.721008; Kolvereid L, 2006, J BUS VENTURING, V21, P866, DOI 10.1016/j.jbusvent.2005.06.008; Krueger NF, 2000, J BUS VENTURING, V15, P411, DOI 10.1016/S0883-9026(98)00033-0; Lee SH, 2004, J BUS VENTURING, V19, P7, DOI 10.1016/S0883-9026(02)00112-X; Linan F., 2004, PICCOLLA IMPRESA, V3, P11; Linan F, 2009, ENTREP THEORY PRACT, V33, P593, DOI 10.1111/j.1540-6520.2009.00318.x; Loveman G., 1991, SMALL BUSINESS EC, V3, P1, DOI DOI 10.1007/BF00389842; MacGregor R. C., 2007, E COMMERCE REGIONAL; MADDEN TJ, 1992, PERS SOC PSYCHOL B, V18, P3, DOI 10.1177/0146167292181001; McClelland D.C., 1961, ACHIEVING SOC, P23; McGahan AM, 1997, STRATEGIC MANAGE J, V18, P15, DOI 10.1002/(SICI)1097-0266(199707)18:1+<15::AID-SMJ916>3.3.CO;2-T; McWilliams A, 2000, STRATEGIC MANAGE J, V21, P603, DOI 10.1002/(SICI)1097-0266(200005)21:5<603::AID-SMJ101>3.3.CO;2-V; Medina D, 2002, EMPRESA MEDIO AMBIEN, P197; Meredith GG, 1994, SMALL BUSINESS MANAG; Ministerio de Economia y Hacienda, 2007, BOE, V279, P47560; Murillo-Luna JL, 2008, STRATEGIC MANAGE J, V29, P1225, DOI 10.1002/smj.711; Nabi G, 2013, INT J ENTREP BEHAV R, V19, P633, DOI 10.1108/IJEBR-10-2012-0107; NETEMEYER RG, 1991, SOC PSYCHOL QUART, V54, P87, DOI 10.2307/2786928; OCDE, 1993, PET MOYENN ENTR TECH; Oreg S, 2006, ENVIRON BEHAV, V38, P462, DOI 10.1177/0013916505286012; Peterman NE, 2003, ENTREP THEORY PRACT, V28, P129, DOI 10.1046/j.1540-6520.2003.00035.x; Piore M, 1984, 2 RUPTURA IND; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Porter ME., 1981, ACAD MANAGE REV, V6, P609, DOI [DOI 10.2307/257639, 10.5465/AMR.1981.4285706]; Powell TC, 1996, STRATEGIC MANAGE J, V17, P323; REYNOLDS PD, 1987, J BUS VENTURING, V2, P231, DOI 10.1016/0883-9026(87)90011-5; Ringle CM, 2005, SMARTPLS WINDOWS 200; Robinson P.B., 1991, ENTREP THEORY PRACT, V15, P13, DOI DOI 10.1177/104225879101500405; Roldan J, 2005, PLS 05 INT S; Roldan J.L., 2012, RES METHODOLOGIES IN, DOI DOI 10.4018/978-1-4666-0179-6.CH010; Rueda-Manzanares A, 2008, BRIT J MANAGE, V19, P185, DOI 10.1111/j.1467-8551.2007.00538.x; Ruesga SM, 1995, EMPRESA MEDIO AMBIEN; Rumelt R.P., 1984, COMPETITIVE STRATEGI, P556; RUMELT RP, 1991, STRATEGIC MANAGE J, V12, P167, DOI 10.1002/smj.4250120302; Scherer FM, 1970, IND MARKET STRUCTURE; Schlaegel C, 2014, ENTREP THEORY PRACT, V38, P291, DOI 10.1111/etap.12087; SCHWALBACH J, 1994, SMALL BUS ECON, V6, P21, DOI 10.1007/BF01066109; Shapero A., 1982, ENCY ENTREPRENEURSHI, P72, DOI DOI 10.1093/OXFORDHB/9780199546992.003.0019; Sharma S, 2005, STRATEGIC MANAGE J, V26, P159, DOI 10.1002/smj.439; SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170; SHRIVASTAVA P, 1995, STRATEGIC MANAGE J, V16, P183, DOI 10.1002/smj.4250160923; Sierra Bravo R, 1991, TECNICAS INVESTIGACI; Storey, 1994, UNDERSTANDING SMALL; TAYLOR S, 1995, ENVIRON BEHAV, V27, P603, DOI 10.1177/0013916595275001; Taylor S, 1997, J APPL SOC PSYCHOL, V27, P602, DOI 10.1111/j.1559-1816.1997.tb00651.x; TAYLOR SR, 1992, FUTURES, V24, P669, DOI 10.1016/0016-3287(92)90075-Q; ULLMANN AA, 1985, ACAD MANAGE REV, V10, P540, DOI 10.2307/258135; Utomo H., 2001, Journal of Global Information Technology Management (JGITM), V4, P22; VANDEVEN AH, 1984, J MANAGE, V10, P87, DOI 10.1177/014920638401000108; Vargas CM, 2000, SUSTAIN DEV, V8, P11, DOI 10.1002/(SICI)1099-1719(200002)8:1<11::AID-SD119>3.0.CO;2-7; Veciana J.M., 2005, INT ENTREP MANAG J, V1, P165, DOI [10.1007/s11365-005-1127-5, DOI 10.1007/S11365-005-1127-5]; Waddock SA, 1997, STRATEGIC MANAGE J, V18, P303, DOI 10.1002/(SICI)1097-0266(199704)18:4<303::AID-SMJ869>3.3.CO;2-7; Walczuch R., 2000, EUROPEAN MANAGEMENT, V18, P561, DOI 10.1016/S0263-2373(00)00045-1; Wold H., 1979, MODEL CONSTRUCTION E; Zahra SA, 2004, J MANAGE STUD, V41, P885, DOI 10.1111/j.1467-6486.2004.00458.x; Zhao H, 2005, J APPL PSYCHOL, V90, P1265, DOI 10.1037/0021-9010.90.6.1265	102	20	20	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88504	10.1371/journal.pone.0088504	http://dx.doi.org/10.1371/journal.pone.0088504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533094	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600052
J	Zhao, YD; Peng, J; Lu, C; Hsin, M; Mura, M; Wu, LC; Chu, L; Zamel, R; Machuca, T; Waddell, T; Liu, MY; Keshavjee, S; Granton, J; de Perrot, M				Zhao, Yidan; Peng, Jenny; Lu, Catherine; Hsin, Michael; Mura, Marco; Wu, Licun; Chu, Lei; Zamel, Ricardo; Machuca, Tiago; Waddell, Thomas; Liu, Mingyao; Keshavjee, Shaf; Granton, John; de Perrot, Marc			Metabolomic Heterogeneity of Pulmonary Arterial Hypertension	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; BETA-OXIDATION; CANCER-CELLS; FATTY-ACIDS; DICHLOROACETATE; PEROXISOMES; PROGRESSION; RESISTANCE; PREVENTS; HYPOXIA	Although multiple gene and protein expression have been extensively profiled in human pulmonary arterial hypertension (PAH), the mechanism for the development and progression of pulmonary hypertension remains elusive. Analysis of the global metabolomic heterogeneity within the pulmonary vascular system leads to a better understanding of disease progression. Using a combination of high-throughput liquid-and-gas-chromatography-based mass spectrometry, we showed unbiased metabolomic profiles of disrupted glycolysis, increased TCA cycle, and fatty acid metabolites with altered oxidation pathways in the human PAH lung. The results suggest that PAH has specific metabolic pathways contributing to increased ATP synthesis for the vascular remodeling process in severe pulmonary hypertension. These identified metabolites may serve as potential biomarkers for the diagnosis of PAH. By profiling metabolomic alterations of the PAH lung, we reveal new pathogenic mechanisms of PAH, opening an avenue of exploration for therapeutics that target metabolic pathway alterations in the progression of PAH.	[Zhao, Yidan] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON M5G 1L7, Canada; Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Div Thorac Surg, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Zhao, YD (corresponding author), Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON M5G 1L7, Canada.	yidanzhao@gmail.com; marc.deperrot@uhn.ca	Mura, Marco/G-5729-2013; Wu, Licun/AAL-9596-2021	Mura, Marco/0000-0002-2159-7083; Wu, Licun/0000-0003-4803-9361; Keshavjee, Shaf/0000-0003-4547-8094; de Perrot, Marc/0000-0003-2000-9427; Liu, Mingyao/0000-0002-9188-8417; Zhao, Yidan/0000-0002-7304-1802				Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Fessel Joshua P, 2012, Pulm Circ, V2, P201, DOI 10.4103/2045-8932.97606; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hassoun PM, 2013, 5 WORLD S PULM HYP N; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974; Neermann J, 1996, J CELL PHYSIOL, V166, P152; Nordlie RC, 2010, LIFE SCI, V87, P339, DOI 10.1016/j.lfs.2010.06.021; Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6; Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016; Rabinovitch M, 1997, AM J RESP CELL MOL, V16, P364, DOI 10.1165/ajrcmb.16.4.9115745; Sanchez O, 2010, Rev Mal Respir, V27, pe79, DOI 10.1016/j.rmr.2009.12.001; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL202, DOI 10.1152/ajplung.2001.281.1.L202; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sutendra G., 2010, SCI TRANSL MED, V2; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Tuder RM, 2012, AM J RESP CRIT CARE, V185, P260, DOI 10.1164/rccm.201108-1536PP; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zhou KG, 2012, LEUKEMIA LYMPHOMA, V53, P2423, DOI 10.3109/10428194.2012.695359	27	99	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88727	10.1371/journal.pone.0088727	http://dx.doi.org/10.1371/journal.pone.0088727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533144	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600102
J	Liu, YP; Tennant, DA; Zhu, ZX; Heath, JK; Yao, X; He, S				Liu, Yunpeng; Tennant, Daniel A.; Zhu, Zexuan; Heath, John K.; Yao, Xin; He, Shan			DiME: A Scalable Disease Module Identification Algorithm with Application to Glioma Progression	PLOS ONE			English	Article							NETWORK-BASED APPROACH; C-MYC; ANDROGEN RECEPTOR; GENE-EXPRESSION; ETS-1 PROTOONCOGENE; CANCER; CELLS; SURVIVAL; GRADE; ABC	Disease module is a group of molecular components that interact intensively in the disease specific biological network. Since the connectivity and activity of disease modules may shed light on the molecular mechanisms of pathogenesis and disease progression, their identification becomes one of the most important challenges in network medicine, an emerging paradigm to study complex human disease. This paper proposes a novel algorithm, DiME ( Disease Module Extraction), to identify putative disease modules from biological networks. We have developed novel heuristics to optimise Community Extraction, a module criterion originally proposed for social network analysis, to extract topological core modules from biological networks as putative disease modules. In addition, we have incorporated a statistical significance measure, B-score, to evaluate the quality of extracted modules. As an application to complex diseases, we have employed DiME to investigate the molecular mechanisms that underpin the progression of glioma, the most common type of brain tumour. We have built low (grade II) - and high (GBM) - grade glioma co-expression networks from three independent datasets and then applied DiME to extract potential disease modules from both networks for comparison. Examination of the interconnectivity of the identified modules have revealed changes in topology and module activity (expression) between low-and high-grade tumours, which are characteristic of the major shifts in the constitution and physiology of tumour cells during glioma progression. Our results suggest that transcription factors E2F4, AR and ETS1 are potential key regulators in tumour progression. Our DiME compiled software, R/C++ source code, sample data and a tutorial are available at http://www.cs.bham.ac.uk/similar to szh/DiME.	[Liu, Yunpeng; Yao, Xin; He, Shan] Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England; [Tennant, Daniel A.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Heath, John K.; He, Shan] Univ Birmingham, Sch Biol Sci, Ctr Syst Biol, Birmingham B15 2TT, W Midlands, England; [Zhu, Zexuan] Shenzhen Univ, Coll Comp Sci & Software Engn, Shenzhen, Peoples R China	University of Birmingham; University of Birmingham; University of Birmingham; Shenzhen University	He, S (corresponding author), Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England.	s.he@cs.bham.ac.uk	YAO, XIN/W-2158-2018; Tennant, Daniel/ABE-8145-2021	YAO, XIN/0000-0001-8837-4442; Tennant, Daniel/0000-0003-0499-2732; Heath, John/0000-0003-4886-4070	Royal Society International Exchanges 2011 NSFC cost share scheme [IE111069]; NSFC-RS joint project [61211130120]; Shenzhen Scientific Research and Development Funding Program [KQC201108300045A, JCYJ20130329115450637]; EU [247619]	Royal Society International Exchanges 2011 NSFC cost share scheme; NSFC-RS joint project; Shenzhen Scientific Research and Development Funding Program; EU(European Commission)	Royal Society International Exchanges 2011 NSFC cost share scheme (IE111069), the NSFC-RS joint project (61211130120), Shenzhen Scientific Research and Development Funding Program under grants KQC201108300045A and JCYJ20130329115450637, EU FP7-PEOPLE-2009-IRSES project under Nature Inspired Computation and its Applications (NICaiA) (247619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirghofran Z, 2004, PATHOL ONCOL RES, V10, P37, DOI 10.1007/BF02893407; Auvergne RM, 2013, CELL REP, V3, P16; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Batagelj V, 2000, SOC NETWORKS, V22, P173, DOI 10.1016/S0378-8733(00)00023-X; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen TC, 1997, J NEUROIMMUNOL, V73, P155, DOI 10.1016/S0165-5728(96)00190-7; Cheng YC, 2001, MOL BRAIN RES, V92, P193, DOI 10.1016/S0169-328X(01)00147-4; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Claus EB, 2006, CANCER-AM CANCER SOC, V106, P1358, DOI 10.1002/cncr.21733; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Dang CV, 1999, MOL CELL BIOL, V19, P1; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Efron B., 1982, JACKKNIFE BOOTSTRAP, V38; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Glover F., 1989, ORSA Journal on Computing, V1, P190, DOI [10.1287/ijoc.2.1.4, 10.1287/ijoc.1.3.190]; Guardiola X, 2002, CONDMAT020624064 ARX; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Hornik K, 2005, J STAT SOFTWARE, V14; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang JQ, 2010, J LNTEGR BIOINFORM, V7, P149; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Kang KW, 2009, MOL PHARMACEUT, V6, P627, DOI 10.1021/mp800116f; KATO GJ, 1992, FASEB J, V6, P3065, DOI 10.1096/fasebj.6.12.1521738; Kitange G, 1999, MODERN PATHOL, V12, P618; Lamm W, 2005, HEAD NECK-J SCI SPEC, V27, P1068, DOI 10.1002/hed.20285; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046110; Lee SO, 2003, ONCOGENE, V22, P7981, DOI 10.1038/sj.onc.1206735; Liu Y, 2013, 17 ANN INT C RES COM; Loebinger MR, 2008, BRIT J CANCER, V98, P380, DOI 10.1038/sj.bjc.6604185; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Nakayama T, 2001, MODERN PATHOL, V14, P415, DOI 10.1038/modpathol.3880328; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Nguyen X. V., 2009, P 26 ANN INT C MACHI, P1073, DOI [10.1145/1553374.1553511, DOI 10.1145/1553374.1553511]; Ohtsuki S, 2007, BIOL PHARM BULL, V30, P1144, DOI 10.1248/bpb.30.1144; OpenMP Architecture Review Board, 2005, OPENMP APPL PROGR IN; Pei PJ, 2007, IEEE T NANOBIOSCI, V6, P43, DOI 10.1109/TNB.2007.891900; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; RASHEED BKA, 1994, CANCER RES, V54, P1324; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Ruano Y, 2008, CANCER-AM CANCER SOC, V112, P1575, DOI 10.1002/cncr.23338; Silvers AL, 2010, CLIN CANCER RES, V16, P2009, DOI 10.1158/1078-0432.CCR-09-2801; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang PZ, 2011, MOL BIOL REP, V38, P3551, DOI 10.1007/s11033-010-0465-8; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Zeng GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071865; Zhao YP, 2011, P NATL ACAD SCI USA, V108, P7321, DOI 10.1073/pnas.1006642108; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	62	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e86693	10.1371/journal.pone.0086693	http://dx.doi.org/10.1371/journal.pone.0086693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523864	Green Published, gold			2022-12-27	WOS:000331258100013
J	Soares, AP; Perea, M; Comesana, M				Soares, Ana Paula; Perea, Manuel; Comesana, Montserrat			Tracking the Emergence of the Consonant Bias in Visual-Word Recognition: Evidence with Developing Readers	PLOS ONE			English	Article							PHONOLOGICAL SPECIFICITY; PHONETIC SPECIFICITY; VOCALIC INFORMATION; LEXICAL ACCESS; PRINTED WORD; VOWELS; MODEL; ACQUISITION; IDENTIFICATION; CHILDREN	Recent research with skilled adult readers has consistently revealed an advantage of consonants over vowels in visual-word recognition (i.e., the so-called "consonant bias''). Nevertheless, little is known about how early in development the consonant bias emerges. This work aims to address this issue by studying the relative contribution of consonants and vowels at the early stages of visual-word recognition in developing readers (2nd and 4th Grade children) and skilled adult readers (college students) using a masked priming lexical decision task. Target words starting either with a consonant or a vowel were preceded by a briefly presented masked prime (50 ms) that could be the same as the target (e.g., pirata-PIRATA [pirate-PIRATE]), a consonant-preserving prime (e.g., pureto-PIRATA), a vowel-preserving prime (e.g., gicala-PIRATA), or an unrelated prime (e.g., bocelo -PIRATA). Results revealed significant priming effects for the identity and consonant-preserving conditions in adult readers and 4th Grade children, whereas 2nd graders only showed priming for the identity condition. In adult readers, the advantage of consonants was observed both for words starting with a consonant or a vowel, while in 4th graders this advantage was restricted to words with an initial consonant. Thus, the present findings suggest that a Consonant/Vowel skeleton should be included in future (developmental) models of visual-word recognition and reading.	[Soares, Ana Paula; Comesana, Montserrat] Univ Minho, Sch Psychol, Human Cognit Lab, CIPsi, Braga, Portugal; [Perea, Manuel] Univ Valencia, ERI Lectura, Valencia, Spain; [Perea, Manuel] Univ Valencia, Dept Metodol, Valencia, Spain; [Perea, Manuel] Basque Ctr Brain Language & Cognit, Donostia San Sebastian, Spain; [Comesana, Montserrat] Univ Santiago de Compostela, Cognit Proc & Behav Res Grp, Santiago De Compostela, Spain	Universidade do Minho; University of Valencia; University of Valencia; Universidade de Santiago de Compostela	Soares, AP (corresponding author), Univ Minho, Sch Psychol, Human Cognit Lab, CIPsi, Braga, Portugal.	asoares@psi.uminho.pt	Soares, Ana Paula/H-3794-2011; Perea, Manuel/B-3345-2011; COMESAÑA, MONTSERRAT/H-3785-2011	Soares, Ana Paula/0000-0002-4047-3799; Perea, Manuel/0000-0002-3291-1365; COMESAÑA, MONTSERRAT/0000-0003-2547-7684	Portuguese FCT (Fundacao para a Ciencia e Tecnologia) [PTDC/PSI-PCO/104679/2008]; FEDER (Fundo Europeu de Desenvolvimento Regional) through the European programs QREN (Quadro de Referencia Estrategico Nacional); Spanish Government [PSI2011-26924]; COMPETE (Programa Operacional Factores de Competitividade); Fundação para a Ciência e a Tecnologia [PTDC/PSI-PCO/104679/2008] Funding Source: FCT	Portuguese FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); FEDER (Fundo Europeu de Desenvolvimento Regional) through the European programs QREN (Quadro de Referencia Estrategico Nacional); Spanish Government(Spanish GovernmentEuropean Commission); COMPETE (Programa Operacional Factores de Competitividade); Fundação para a Ciência e a Tecnologia	This research has been partially supported by Grant PTDC/PSI-PCO/104679/2008 from Portuguese FCT (Fundacao para a Ciencia e Tecnologia) and FEDER (Fundo Europeu de Desenvolvimento Regional) through the European programs QREN (Quadro de Referencia Estrategico Nacional) and COMPETE (Programa Operacional Factores de Competitividade), and by Grant PSI2011-26924 from the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha J, 2008, BRIT J PSYCHOL, V99, P245, DOI 10.1348/000712607X224478; Adelman JS, 2011, PSYCHOL REV, V118, P570, DOI 10.1037/a0024811; Dunabeitia JA, 2011, J EXP PSYCHOL LEARN, V37, P1143, DOI 10.1037/a0023577; [Anonymous], HDB READING RES; Bailey TM, 2002, COGNITIVE DEV, V17, P1265, DOI 10.1016/S0885-2014(02)00116-8; Ballem KD, 2005, J CHILD LANG, V32, P159, DOI 10.1017/S0305000904006567; BERENT I, 1995, PSYCHOL REV, V102, P146, DOI 10.1037/0033-295X.102.1.146; Berent I, 2005, J EXP PSYCHOL HUMAN, V31, P328, DOI 10.1037/0096-1523.31.2.328; Berent I, 2001, J EXP PSYCHOL LEARN, V27, P1042, DOI 10.1037/0278-7393.27.4.1042; Bonatti LL, 2005, PSYCHOL SCI, V16, P451, DOI 10.1111/j.0956-7976.2005.01556.x; CARAMAZZA A, 1990, COGNITION, V37, P243, DOI 10.1016/0010-0277(90)90047-N; Carreiras M, 2009, CEREB CORTEX, V19, P2659, DOI 10.1093/cercor/bhp019; Carreiras M, 2009, J COGNITIVE NEUROSCI, V21, P275, DOI 10.1162/jocn.2008.21023; Castles A, 1999, LANG COGNITIVE PROC, V14, P201, DOI 10.1080/016909699386347; Castles A, 2007, J EXP CHILD PSYCHOL, V97, P165, DOI 10.1016/j.jecp.2007.01.006; Chetail F, 2012, J MEM LANG, V67, P371, DOI 10.1016/j.jml.2012.07.004; Davis CJ, 2010, PSYCHOL REV, V117, P713, DOI 10.1037/a0019738; Dufau S, 2010, EUR J COGN PSYCHOL, V22, P669, DOI 10.1080/09541440903031230; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Goikoetxea E., 2005, READ WRIT, V18, P51, DOI [10.1007/s11145-004-1955-7, DOI 10.1007/S11145-004-1955-7]; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; Gomez P, 2007, J EXP PSYCHOL GEN, V136, P389, DOI 10.1037/0096-3445.136.3.389; Gough P. B., 1991, LEARNING READ BASIC, P47; Grainger J, 2006, J EXP PSYCHOL HUMAN, V32, P865, DOI 10.1037/0096-1523.32.4.865; Grainger J, 2012, CUR ISS PSYCHOL LANG, P159; Grainger J, 2012, COGNITION, V123, P280, DOI 10.1016/j.cognition.2012.01.003; Havy M, 2011, J EXP CHILD PSYCHOL, V108, P25, DOI 10.1016/j.jecp.2010.08.002; Havy M, 2009, INFANCY, V14, P439, DOI 10.1080/15250000902996532; Lavidor M, 2011, J RES READ, V34, P443, DOI 10.1111/j.1467-9817.2010.01444.x; Lee HW, 2002, PSYCHON B REV, V9, P766, DOI 10.3758/BF03196333; Lee HW, 2001, J MEM LANG, V44, P189, DOI 10.1006/jmla.2000.2725; Lete B, 2013, J EXP CHILD PSYCHOL, V114, P47, DOI 10.1016/j.jecp.2012.09.001; Mani N, 2007, J MEM LANG, V57, P252, DOI 10.1016/j.jml.2007.03.005; Mayall K, 1996, J EXP PSYCHOL LEARN, V22, P278, DOI 10.1037/0278-7393.22.2.278; Mehler J, 2006, CORTEX, V42, P846, DOI 10.1016/S0010-9452(08)70427-1; Moret-Tatay C, 2011, J EXP CHILD PSYCHOL, V110, P125, DOI 10.1016/j.jecp.2011.04.005; Nazzi T, 2005, COGNITION, V98, P13, DOI 10.1016/j.cognition.2004.10.005; Nazzi T, 2007, COGNITIVE DEV, V22, P271, DOI 10.1016/j.cogdev.2006.10.007; Nazzi T, 2009, LANG SPEECH, V52, P463, DOI 10.1177/0023830909336584; Nazzi T, 2009, J EXP CHILD PSYCHOL, V102, P522, DOI 10.1016/j.jecp.2008.05.003; Nespor M., 2003, LINGUE LINGUAGGIO, V2, P221, DOI [10.1418/10879, DOI 10.1418/10879]; New B, 2014, LANG COGN NEUROSCI, V29, P147, DOI 10.1080/01690965.2012.735678; New B, 2008, PSYCHOL SCI, V19, P1223, DOI 10.1111/j.1467-9280.2008.02228.x; Norris D, 2006, PSYCHOL REV, V113, P327, DOI 10.1037/0033-295X.113.2.327; Perea M, 2002, PERCEPT PSYCHOPHYS, V64, P785, DOI 10.3758/BF03194745; Perea M, 2014, EXP PSYCHOL, V61, P23, DOI 10.1027/1618-3169/a000223; Perea M, 2013, J EXP CHILD PSYCHOL, V116, P37, DOI 10.1016/j.jecp.2012.10.014; Perea M, 2012, LEARN INSTR, V22, P420, DOI 10.1016/j.learninstruc.2012.04.001; Perea M, 2012, Q J EXP PSYCHOL, V65, P911, DOI 10.1080/17470218.2011.636151; Perea M, 2009, ACTA PSYCHOL, V130, P127, DOI 10.1016/j.actpsy.2008.11.001; POLLATSEK A, 1995, J EXP PSYCHOL LEARN, V21, P785, DOI 10.1037/0278-7393.21.3.785; Pons F, 2010, COGNITION, V116, P361, DOI 10.1016/j.cognition.2010.05.013; Ratcliff R, 2012, CHILD DEV, V83, P367, DOI 10.1111/j.1467-8624.2011.01683.x; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Schmalz X, 2013, Q J EXP PSYCHOL, V66, P338, DOI 10.1080/17470218.2012.711843; Soares AP, 2014, BEHAV RES METHODS, V46, P240, DOI 10.3758/s13428-013-0350-1; Swingley D, 2000, COGNITION, V76, P147, DOI 10.1016/S0010-0277(00)00081-0; Swingley D, 2009, J MEM LANG, V60, P252, DOI 10.1016/j.jml.2008.11.003; Toro JM, 2008, PSYCHOL SCI, V19, P137, DOI 10.1111/j.1467-9280.2008.02059.x; van Heuven WJB, 2001, PSYCHON B REV, V8, P96, DOI 10.3758/BF03196144; Vergara-Martinez M, 2011, BRAIN LANG, V118, P105, DOI 10.1016/j.bandl.2010.09.006; Vig?rio, 2006, 21 ENC ASS PORT LING, P675; Werker JF, 2002, INFANCY, V3, P1, DOI 10.1207/S15327078IN0301_1; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; Winskel H, 2013, J COGN PSYCHOL, V25, P119, DOI 10.1080/20445911.2012.753077; Yoshida KA, 2009, DEVELOPMENTAL SCI, V12, P412, DOI 10.1111/j.1467-7687.2008.00789.x	67	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88580	10.1371/journal.pone.0088580	http://dx.doi.org/10.1371/journal.pone.0088580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523917	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100066
J	Yuan, YX; Teng, Q; Zhong, RQ; Ye, ZH				Yuan, Youxi; Teng, Quincy; Zhong, Ruiqin; Ye, Zheng-Hua			Identification and Biochemical Characterization of Four Wood-Associated Glucuronoxylan Methyltransferases in Populus	PLOS ONE			English	Article							CELLULOSE SYNTHASE-LIKE; DOWN-REGULATION; XYLAN; DOMAIN; PROTEINS; GENES; BIOSYNTHESIS; ACID; 4-O-METHYLATION; RECALCITRANCE	Wood is one of the promising bioenergy feedstocks for lignocellulosic biofuel production. Understanding how wood components are synthesized will help us design strategies for better utilization of wood for biofuel production. One of the major wood components is xylan, in which about 10% of xylosyl residues are substituted with glucuronic acid ( GlcA) side chains. All the GlcA side chains of xylan in wood of Populus trichocarpa are methylated, which is different from Arabidopsis xylan in which about 60% of GlcA side chains are methylated. Genes responsible for methylation of GlcA side chains in Populus xylan have not been identified. Here, we report genetic and biochemical analyses of four DUF579 domain-containing proteins, PtrGXM1, PtrGXM2, PtrGXM3 and PtrGXM4, from Populus trichocarpa and their roles in GlcA methylation in xylan. The PtrGXM genes were found to be highly expressed in wood-forming cells and their encoded proteins were shown to be localized in the Golgi. When overexpressed in the Arabidopsis gxm1/2/3 triple mutant, PtrGXMs were able to partially complement the mutant phenotypes including defects in glucuronoxylan methyltransferase activity and GlcA methylation in xylan, indicating that PtrGXMs most likely function as glucuronoxylan methyltransferases. Direct evidence was provided by enzymatic analysis of recombinant PtrGXM proteins showing that they possessed a methyltransferase activity capable of transferring the methyl group onto GlcA-substituted xylooligomers. Kinetic analysis showed that PtrGXMs exhibited differential affinities toward the GlcA-substituted xylooligomer acceptor with PtrGXM3 and PtrGXM4 having 10 times higher Km values than PtrGXM1 and PtrGXM2. Together, these findings indicate that PtrGXMs are methyltransferases mediating GlcA methylation in Populus xylan during wood formation.	[Yuan, Youxi; Zhong, Ruiqin; Ye, Zheng-Hua] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Teng, Quincy] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ye, ZH (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	zhye@plantbio.uga.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-03ER15415]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-03ER15415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Brown D, 2011, PLANT J, V66, P401, DOI 10.1111/j.1365-313X.2011.04501.x; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; CURRIE AL, 1959, CAN J CHEM, V37, P922, DOI 10.1139/v59-126; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Jensen JK, 2011, PLANT J, V66, P387, DOI 10.1111/j.1365-313X.2010.04475.x; JOHANSSON MH, 1977, WOOD SCI TECHNOL, V11, P251, DOI 10.1007/BF00356924; Joshi CP, 2011, MOL PLANT, V4, P331, DOI 10.1093/mp/ssq081; Kong YZ, 2009, MOL PLANT, V2, P1040, DOI 10.1093/mp/ssp068; Kuroyama H, 2001, PLANTA, V213, P231, DOI 10.1007/s004250000499; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1934, DOI 10.1093/pcp/pcs138; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1204, DOI 10.1093/pcp/pcs064; Lee C, 2012, PLANT SIGNAL BEHAV, V7, P332, DOI 10.4161/psb.19269; Lee CH, 2011, PLANT CELL PHYSIOL, V52, P1289, DOI 10.1093/pcp/pcr075; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P1075, DOI 10.1093/pcp/pcp060; Li QZ, 2011, TREE PHYSIOL, V31, P226, DOI 10.1093/treephys/tpr008; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teleman A, 2002, CARBOHYD RES, V337, P373, DOI 10.1016/S0008-6215(01)00327-5; Teng Q, 2012, ANALYST, V137, P2226, DOI 10.1039/c2an16251b; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Urbanowicz BR, 2012, P NATL ACAD SCI USA, V109, P14253, DOI 10.1073/pnas.1208097109; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Xiong GY, 2013, MOL PLANT, V6, P1373, DOI 10.1093/mp/sst014; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan YX, 2013, PLANT CELL PHYSIOL, V54, P1186, DOI 10.1093/pcp/pct070; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhong RQ, 2010, PLANT PHYSIOL, V152, P1044, DOI 10.1104/pp.109.148270; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P689, DOI 10.1093/pcp/pcm037; Zhou GK, 2006, PLANT CELL PHYSIOL, V47, P1229, DOI 10.1093/pcp/pcj093	40	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e87370	10.1371/journal.pone.0087370	http://dx.doi.org/10.1371/journal.pone.0087370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523868	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100017
J	Lima, WC; Vinet, A; Pieters, J; Cosson, P				Lima, Wanessa C.; Vinet, Adrien; Pieters, Jean; Cosson, Pierre			Role of PKD2 in Rheotaxis in Dictyostelium	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; POLYCYSTIN-2; MEMBRANE; PROTEIN; EXOCYTOSIS; CALCIUM; CHANNEL; CA2+; DISCOIDEUM; RECEPTOR	The sensing of mechanical forces modulates several cellular responses as adhesion, migration and differentiation. Transient elevations of calcium concentration play a key role in the activation of cells following mechanical stress, but it is still unclear how eukaryotic cells convert a mechanical signal into an ion flux. In this study, we used the model organism Dictyostelium discoideum to assess systematically the role of individual calcium channels in mechanosensing. Our results indicate that PKD2 is the major player in the cell response to rheotaxis (i.e., shear-flow induced mechanical motility), while other putative calcium channels play at most minor roles. Mutant pkd2 KO cells lose the ability to orient relative to a shear flow, whereas their ability to move towards a chemoattractant is unaffected. PKD2 is also important for calcium-induced lysosome exocytosis: WT cells show a transient, 2-fold increase in lysosome secretion upon sudden exposure to high levels of extracellular calcium, but pkd2 KO cells do not. In Dictyostelium, PKD2 is specifically localized at the plasma membrane, where it may generate calcium influxes in response to mechanical stress or extracellular calcium changes.	[Lima, Wanessa C.; Cosson, Pierre] Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, Geneva, Switzerland; [Vinet, Adrien; Pieters, Jean] Univ Basel, Biozentrum, Basel, Switzerland	University of Geneva; University of Basel	Lima, WC (corresponding author), Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, Geneva, Switzerland.	Wanessa.deLima@unige.ch		Pieters, Jean/0000-0002-5284-9757	Swiss National Foundation for Scientific Research [31003A-135789]; Doerenkamp-Zbinden Foundation; Fondation Egon Naef pour la Recherche in Vitro	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Doerenkamp-Zbinden Foundation; Fondation Egon Naef pour la Recherche in Vitro	The PC lab was supported by the Swiss National Foundation for Scientific Research (grant 31003A-135789), the Doerenkamp-Zbinden Foundation and the Fondation Egon Naef pour la Recherche in Vitro. WCL was partially funded during this project with a Telethon Action Suisse grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Benghezal M, 2001, IMMUNOGENETICS, V52, P284; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Charette SJ, 2006, TRAFFIC, V7, P1528, DOI 10.1111/j.1600-0854.2006.00478.x; Charette SJ, 2006, FEBS LETT, V580, P4923, DOI 10.1016/j.febslet.2006.08.009; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Drummond IA, 2011, BBA-MOL BASIS DIS, V1812, P1322, DOI 10.1016/j.bbadis.2011.03.003; Edwards MD, 2004, CURR OPIN MICROBIOL, V7, P163, DOI 10.1016/j.mib.2004.02.006; Fache S, 2005, J CELL SCI, V118, P3445, DOI 10.1242/jcs.02461; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Hadwiger JA, 1999, DIFFERENTIATION, V64, P195, DOI 10.1046/j.1432-0436.1999.6440195.x; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; King JS, 2011, AUTOPHAGY, V7, P1490, DOI 10.4161/auto.7.12.17924; Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kumamoto CA, 2008, NAT REV MICROBIOL, V6, P667, DOI 10.1038/nrmicro1960; Lam D, 2008, MOL BIOL CELL, V19, P691, DOI 10.1091/mbc.E07-08-0823; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Lima Wanessa C, 2013, Methods Mol Biol, V983, P445, DOI 10.1007/978-1-62703-302-2_25; Lima WC, 2012, J CELL SCI, V125, P2315, DOI 10.1242/jcs.100362; Lombardi ML, 2008, EXP CELL RES, V314, P1850, DOI 10.1016/j.yexcr.2008.02.001; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Lusche DF, 2012, J CELL SCI, V125, P1770, DOI 10.1242/jcs.098301; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Mennesson E, 2006, J CONTROL RELEASE, V114, P389, DOI 10.1016/j.jconrel.2006.06.006; Mercanti V, 2006, J CELL SCI, V119, P4079, DOI 10.1242/jcs.03190; Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Patel A, 2010, NAT REV NEPHROL, V6, P530, DOI 10.1038/nrneph.2010.97; Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8; Qian F, 2005, PFLUG ARCH EUR J PHY, V451, P277, DOI 10.1007/s00424-005-1469-4; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Su ZW, 2009, PFLUG ARCH EUR J PHY, V458, P861, DOI 10.1007/s00424-009-0680-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Traynor D, 2000, EMBO J, V19, P4846, DOI 10.1093/emboj/19.17.4846; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wilczynska Z, 2005, EUKARYOT CELL, V4, P1513, DOI 10.1128/EC.4.9.1513-1525.2005; Witzgall R, 2005, N-S ARCH PHARMACOL, V371, P342, DOI 10.1007/s00210-005-1027-9; Xia S, 2010, DEVELOPMENT, V137, P1075, DOI 10.1242/dev.049437; Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus	57	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88682	10.1371/journal.pone.0088682	http://dx.doi.org/10.1371/journal.pone.0088682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520414	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600105
J	Lin, TY; Huang, WJ; Wu, CC; Lu, CW; Wang, SJ				Lin, Tzu-Yu; Huang, Wei-Jan; Wu, Chia-Chan; Lu, Cheng-Wei; Wang, Su-Jane			Acacetin Inhibits Glutamate Release and Prevents Kainic Acid-Induced Neurotoxicity in Rats	PLOS ONE			English	Article							PROTEIN-KINASE-C; CELL-DEATH; PRESYNAPTIC MODULATION; CALCIUM-CHANNELS; OXIDATIVE STRESS; NERVE-TERMINALS; IN-VITRO; NEUROTRANSMITTER; MECHANISMS; EXPRESSION	An excessive release of glutamate is considered to be a molecular mechanism associated with several neurological diseases that causes neuronal damage. Therefore, searching for compounds that reduce glutamate neurotoxicity is necessary. In this study, the possibility that the natural flavone acacetin derived from the traditional Chinese medicine Clerodendrum inerme (L.) Gaertn is a neuroprotective agent was investigated. The effect of acacetin on endogenous glutamate release in rat hippocampal nerve terminals (synaptosomes) was also investigated. The results indicated that acacetin inhibited depolarization-evoked glutamate release and cytosolic free Ca2+ concentration ([Ca2+] C) in the hippocampal nerve terminals. However, acacetin did not alter synaptosomal membrane potential. Furthermore, the inhibitory effect of acacetin on evoked glutamate release was prevented by the Cav2.2 (N-type) and Cav2.1 (P/Q-type) channel blocker known as omega-conotoxin MVIIC. In a kainic acid (KA) rat model, an animal model used for excitotoxic neurodegeneration experiments, acacetin (10 or 50 mg/kg) was administrated intraperitoneally to the rats 30 min before the KA (15 mg/kg) intraperitoneal injection, and subsequently induced the attenuation of KA-induced neuronal cell death and microglia activation in the CA3 region of the hippocampus. The present study demonstrates that the natural compound, acacetin, inhibits glutamate release from hippocampal synaptosomes by attenuating voltage-dependent Ca2+ entry and effectively prevents KA-induced in vivo excitotoxicity. Collectively, these data suggest that acacetin has the therapeutic potential for treating neurological diseases associated with excitotoxicity.	[Lin, Tzu-Yu; Wu, Chia-Chan; Lu, Cheng-Wei] Far Eastern Mem Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Huang, Wei-Jan] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Wang, Su-Jane] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan; [Lin, Tzu-Yu; Lu, Cheng-Wei] Yuan Ze Univ, Dept Mech Engn, New Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Fu Jen Catholic University	Wang, SJ (corresponding author), Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan.	med0003@mail.fju.edu.tw		Lin, Tzu Yu/0000-0002-1374-5189; Wang, Su Jane/0000-0002-4675-0259	National Science Council, Taiwan [NSC 100-2320-B-030-006-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the National Science Council (NSC 100-2320-B-030-006-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN KEO, 1987, J NEUROCHEM, V48, P552, DOI 10.1111/j.1471-4159.1987.tb04128.x; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; BAHN S, 1994, J NEUROSCI, V14, P5525; BARRIE AP, 1991, J NEUROCHEM, V57, P1398, DOI 10.1111/j.1471-4159.1991.tb08306.x; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Chen HL, 2012, EVID-BASED COMPL ALT, V2012, P1; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cui HS, 2007, PHYTOMEDICINE, V14, P696, DOI 10.1016/j.phymed.2007.03.005; Danysz W, 1998, PHARMACOL REV, V50, P597; FERKANY JW, 1983, J PHARMACOL EXP THER, V225, P399; FERKANY JW, 1982, NATURE, V298, P757, DOI 10.1038/298757a0; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Ha SK, 2012, NEUROCHEM RES, V37, P1560, DOI 10.1007/s11064-012-0751-z; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kim DH, 2010, NEUROPHARMACOLOGY, V59, P20, DOI 10.1016/j.neuropharm.2010.03.012; Kim HG, 2012, BIOL PHARM BULL, V35, P1287, DOI 10.1248/bpb.b12-00127; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li GR, 2008, CIRCULATION, V117, P2449, DOI 10.1161/CIRCULATIONAHA.108.769554; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; Lin TY, 2013, J ETHNOPHARMACOL, V147, P488, DOI 10.1016/j.jep.2013.03.045; Lin TY, 2011, PROG NEURO-PSYCHOPH, V35, P1785, DOI 10.1016/j.pnpbp.2011.06.012; Lin TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067215; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MELDRUM BS, 1994, NEUROLOGY, V44, P14; Millan C, 2002, NEUROSCI LETT, V330, P29, DOI 10.1016/S0304-3940(02)00719-X; MINTA A, 1989, J BIOL CHEM, V264, P19449; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Nicholls DG, 1998, PROG BRAIN RES, V116, P15, DOI 10.1016/S0079-6123(08)60427-6; NICHOLLS DG, 1989, J NEUROCHEM, V52, P331, DOI 10.1111/j.1471-4159.1989.tb09126.x; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; Pan MH, 2006, BIOCHEM PHARMACOL, V72, P1293, DOI 10.1016/j.bcp.2006.07.039; Park HJ, 2008, EPILEPSIA, V49, P163, DOI 10.1111/j.1528-1167.2007.01308.x; Paxino G., 1998, RAT BRAIN STEREOTAXI; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; REHM H, 1991, FASEB J, V5, P164, DOI 10.1096/fasebj.5.2.2004663; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shen KH, 2010, MOL CELL BIOCHEM, V333, P279, DOI 10.1007/s11010-009-0229-8; Shim HY, 2007, MOL CELLS, V24, P95; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; Spigolon G, 2010, EUR J NEUROSCI, V31, P1261, DOI 10.1111/j.1460-9568.2010.07158.x; Sy HN, 2008, SYNAPSE, V62, P890, DOI 10.1002/syn.20568; TURNER TJ, 1993, P NATL ACAD SCI USA, V90, P9518, DOI 10.1073/pnas.90.20.9518; Vazquez E, 1997, EUR J NEUROSCI, V9, P2009, DOI 10.1111/j.1460-9568.1997.tb01369.x; Wang L, 2010, BRAIN RES, V1321, P143, DOI 10.1016/j.brainres.2009.12.046; Wu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057864; Wu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059843; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Ye MZ, 2009, J PHARM PHARMACOL, V61, P831, DOI [10.1211/jpp.61.07.0001, 10.1211/jpp/61.07.0001]	60	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88644	10.1371/journal.pone.0088644	http://dx.doi.org/10.1371/journal.pone.0088644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520409	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600100
J	Nugent, MA; Molter, TW				Nugent, Michael Alexander; Molter, Timothy Wesley			AHaH Computing-From Metastable Switches to Attractors to Machine Learning	PLOS ONE			English	Article							NEURAL-NETWORKS; MODEL; SYSTEMS; COMPONENTS; RESISTANCE; DEVICE	Modern computing architecture based on the separation of memory and processing leads to a well known problem called the von Neumann bottleneck, a restrictive limit on the data bandwidth between CPU and RAM. This paper introduces a new approach to computing we call AHaH computing where memory and processing are combined. The idea is based on the attractor dynamics of volatile dissipative electronics inspired by biological systems, presenting an attractive alternative architecture that is able to adapt, self-repair, and learn from interactions with the environment. We envision that both von Neumann and AHaH computing architectures will operate together on the same machine, but that the AHaH computing processor may reduce the power consumption and processing time for certain adaptive learning tasks by orders of magnitude. The paper begins by drawing a connection between the properties of volatility, thermodynamics, and Anti-Hebbian and Hebbian (AHaH) plasticity. We show how AHaH synaptic plasticity leads to attractor states that extract the independent components of applied data streams and how they form a computationally complete set of logic functions. After introducing a general memristive device model based on collections of metastable switches, we show how adaptive synaptic weights can be formed from differential pairs of incremental memristors. We also disclose how arrays of synaptic weights can be used to build a neural node circuit operating AHaH plasticity. By configuring the attractor states of the AHaH node in different ways, high level machine learning functions are demonstrated. This includes unsupervised clustering, supervised and unsupervised classification, complex signal prediction, unsupervised robotic actuation and combinatorial optimization of procedures-all key capabilities of biological nervous systems and modern machine learning algorithms with real world application.	[Nugent, Michael Alexander; Molter, Timothy Wesley] M Alexander Nugent Consulting, Santa Fe, NM USA; [Nugent, Michael Alexander; Molter, Timothy Wesley] KnowmTech LLC, Albuquerque, NM USA; [Nugent, Michael Alexander; Molter, Timothy Wesley] Xeiam LLC, Santa Fe, NM USA		Nugent, MA (corresponding author), M Alexander Nugent Consulting, Santa Fe, NM USA.	i@alexnugent.name			Air Force Research Labs (AFRL); Navy Research Labs (NRL) under the SBIR/STTR programs [AF10-BT31, AF121-049, N12A-T013]	Air Force Research Labs (AFRL)(United States Department of DefenseUS Air Force Research Laboratory); Navy Research Labs (NRL) under the SBIR/STTR programs	This work has been supported in part by the Air Force Research Labs (AFRL) and Navy Research Labs (NRL) under the SBIR/STTR programs AF10-BT31, AF121-049 and N12A-T013 (http://www.sbir.gov/about/about-sttr; http://www.sbir.gov/#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2009, SELF-DEFENSE IN INTERNATIONAL RELATIONS, P1, DOI 10.1057/9780230245747; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; [Anonymous], 1989, ANALOG VLSI IMPLEMEN; [Anonymous], 2010, 2010 INT JOINT C NEU, DOI DOI 10.1109/IJCNN.2010.5596775; APHALO PJ, 1995, FUNCT ECOL, V9, P5, DOI 10.2307/2390084; Arthur J. V., 2012, P INT JOINT C NEUR N, P1, DOI [10.1109/1[CNN.2012.6252637, DOI 10.1109/IJCNN.2012.6252637]; ATHELOGOU M, 1989, HELV PHYS ACTA, V62, P250; Bache Kevin, 2013, UCI MACHINE LEARNING; Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bejan A, 1997, INT J HEAT MASS TRAN, V40, P799, DOI 10.1016/0017-9310(96)00175-5; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bennett KP, 1998, IEEE WORLD CONGRESS ON COMPUTATIONAL INTELLIGENCE, P2396, DOI 10.1109/IJCNN.1998.687237; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Biolek D, 2009, 2009 EUROPEAN CONFERENCE ON CIRCUIT THEORY AND DESIGN, VOLS 1 AND 2, P249, DOI 10.1109/ECCTD.2009.5274934; Bonabeau E, 1999, SWARM INTELLIGENCE N, V4; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1997, ADV NEUR IN, V9, P375; Chaaban I, 2007, HUMAN PERFORMANCE US; Chang T, 2011, ACS NANO, V5, P7669, DOI 10.1021/nn202983n; Chang T, 2011, APPL PHYS A-MATER, V102, P857, DOI 10.1007/s00339-011-6296-1; Chen HL, 2011, EXPERT SYST APPL, V38, P9014, DOI 10.1016/j.eswa.2011.01.120; Choudhary Swadesh, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. Proceedings of the 22nd International Conference on Artificial Neural Networks, P121, DOI 10.1007/978-3-642-33269-2_16; CHUA LO, 1976, P IEEE, V64, P209, DOI 10.1109/PROC.1976.10092; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DESBIEZ MO, 1984, PLANTA, V160, P392, DOI 10.1007/BF00429754; Dong R, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2436720; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; Getling AV, 1998, WORLD SCI; Grime JP, 1985, P 1985 S SOC EXPT BI, V40, P5; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; Hasegawa T, 2011, APPL PHYS A-MATER, V102, P811, DOI 10.1007/s00339-011-6317-0; Hasegawa T, 2010, ADV MATER, V22, P1831, DOI 10.1002/adma.200903680; Hatsopoulos GN., 1981, PRINCIPLES GEN THERM; Hebb Donald O., 1949, ORG BEHAV; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huang F. J., 2007, 2007 IEEE C COMP VIS, P1, DOI [DOI 10.1109/CVPR.2007.383157, 10.1109/CVPR.2007.383157]; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Indiveri G, 2013, ARXIVCSET13027007; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jackson BL, 2013, ACM J EMERG TECH COM, V9, DOI 10.1145/2463585.2463588; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Jo SH, 2009, NANO LETT, V9, P870, DOI 10.1021/nl8037689; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Jorgensen SE., 2004, THERMODYNAMIC THEORY, V1; Kavehei O, 2012, IEEE T NANOTECHNOL, V11, P374, DOI 10.1109/TNANO.2011.2174802; Kim KH, 2012, NANO LETT, V12, P389, DOI 10.1021/nl203687n; Klimo M, 2011, ARXIVCSET11102074; Klimo M, 2012, P 2012 4 INT C FUT C, P84; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Kozicki MN, 2006, IEEE T NANOTECHNOL, V5, P535, DOI 10.1109/TNANO.2006.880407; Kriegel HP, 2011, WIRES DATA MIN KNOWL, V1, P231, DOI 10.1002/widm.30; Kuzum D, 2012, NANO LETT, V12, P2179, DOI 10.1021/nl201040y; Kvatinsky S, 2013, IEEE T CIRCUITS-I, V60, P211, DOI 10.1109/TCSI.2012.2215714; Le QV, 2011, ARXIVCSLG11126209; Li D., 2011, 12 ANN C INT SPEECH, P2285; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01619; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Lotka AJ, 1922, P NATL ACAD SCI USA, V8, P147, DOI 10.1073/pnas.8.6.147; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mead C., 1980, INTRO VLSI SYSTEMS; Menzel S, 2012, J APPL PHYS, V111, DOI 10.1063/1.3673239; Merrikh-Bayat F, 2010, ARXIVCSNE10083450; Merrikh-Bayat F, 2013, IEEE T CYBERNETICS, V43, P269, DOI 10.1109/TSMCB.2012.2205676; Merrikh-Bayat F, 2011, PROCEDIA COMPUT SCI, V3, DOI 10.1016/j.procs.2010.12.022; Minsky M., 1969, PERCEPTRONS; Mladenov VM, 2012, P 2012 IEEE 13 INT W, P1; Morabito FC, 2013, NEURAL NETWORKS, V45, P1, DOI 10.1016/j.neunet.2013.07.001; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Ndong J, 2011, P 2011 3 INT C EV IN, P32; Nugent A, 2004, 2004 NASA/DOD CONFERENCE ON EVOLVABLE HARDWARE, PROCEEDINGS, P146; Nugent A, 2009, US Patent, Patent No. [7,599,895, 7599895]; Nugent A, 2008, US Patent, Patent No. [7,409,375, 7409375]; Nugent A, 2008, US Patent, Patent No. [7,420,396, 7420396]; Nugent MA, 2008, PHYSICA D, V237, P1196, DOI 10.1016/j.physd.2008.03.043; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Pickett MD, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236506; Pino RE, 2010, P 2010 IEEE ACM INT, P1, DOI DOI 10.1109/NANOARCH.2010.5510936; Quinlan JR, 1996, ARXIVCSAI9603103; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rosezin R, 2011, IEEE ELECTR DEVICE L, V32, P191, DOI 10.1109/LED.2010.2090127; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sardar S, 2011, IEEE SYMP DIFF EVOL, P1; Schneider E. D., 2005, COOL ENERGY FLOW THE; Schrodinger E., 1992, WHAT IS LIFE MIND MA; Scialdone A, 2013, ELIFE, V2, DOI 10.7554/eLife.00669; Serrano-Gotarredona R, 2009, IEEE T NEURAL NETWOR, V20, P1417, DOI 10.1109/TNN.2009.2023653; Shang DS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3300637; Sheridan P, 2011, NANOSCALE, V3, P3833, DOI 10.1039/c1nr10557d; Snider G, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015201; Snider GS, 2008, 2008 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURES, P85, DOI 10.1109/NANOARCH.2008.4585796; Stewart DR, 2004, NANO LETT, V4, P133, DOI 10.1021/nl034795u; Strukov DB, 2010, IEEE INT SYMP CIRC S, P1967, DOI 10.1109/ISCAS.2010.5537020; Strukov DB, 2009, APPL PHYS A-MATER, V94, P515, DOI 10.1007/s00339-008-4975-3; Su-il Choi, 2012, 2012 Fourth International Conference on Ubiquitous and Future Networks (ICUFN 2012), P1, DOI 10.1109/ICUFN.2012.6261651; SWENSON R, 1989, SYST RES, V6, P187, DOI 10.1002/sres.3850060302; Szot K, 2006, NAT MATER, V5, P312, DOI 10.1038/nmat1614; Thomas A, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/9/093001; Tsubouchi K, 2007, ADV MATER, V19, P1711, DOI 10.1002/adma.200601957; Turing A.M, 1948, INTELLIGENT MACHINAR; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Valov I, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/7/074005; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Widrow B, 1987, P IEEE INT S CIRC SY, V2, P351; Williams RS, 2013, IEEE INT SYMP CIRC S, P217, DOI 10.1109/ISCAS.2013.6571821; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160; Yang YC, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4719198; Yu HF, 2012, ACM T KNOWL DISCOV D, V5, DOI 10.1145/2086737.2086743; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang JJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804983	121	25	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e85175	10.1371/journal.pone.0085175	http://dx.doi.org/10.1371/journal.pone.0085175			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520315	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600005
J	Ran, Q; Hao, P; Xiao, YN; Xiang, LX; Ye, XD; Deng, XJ; Zhao, J; Li, ZJ				Ran, Qian; Hao, Ping; Xiao, Yanni; Xiang, Lixing; Ye, Xingde; Deng, Xiaojun; Zhao, Jiang; Li, Zhongjun			CRIF1 Interacting with CDK2 Regulates Bone Marrow Microenvironment-Induced G0/G1 Arrest of Leukemia Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CR6-INTERACTING FACTOR-1 INTERACTS; CYCLIN-DEPENDENT KINASES; MINIMAL RESIDUAL DISEASE; STEM-CELLS; IMATINIB MESYLATE; S-PHASE; PHOSPHORYLATION; INHIBITION; ACTIVATION	Background: To assess the level of CR6-interacting factor 1 (CRIF1), a cell cycle negative regulator, in patients with leukemia and investigate the role of CRIF1 in regulating leukemia cell cycle. Methods: We compared the CRIF1 level in bone marrow (BM) samples from healthy and acute myeloid leukemia (AML), iron deficiency anemia (IDA) and AML-complete remission (AML-CR) subjects. We also manipulated CRIF1 level in the Jurkat cells using lentivirus-mediated overexpression or siRNA-mediated depletion. Co-culture with the BM stromal cells (BMSCs) was used to induce leukemia cell cycle arrest and mimic the BM microenvironment. Results: We found significant decreases of CRIF1 mRNA and protein in the AML group. CRIF1 overexpression increased the proportion of Jurkat cells arrested in G0/G1, while depletion of endogenous CRIF1 decreased cell cycle arrest. Depletion of CRIF1 reversed BMSCs induced cell cycle arrest in leukemia cells. Co-immunoprecipitation showed a specific binding of CDK2 to CRIF1 in Jurkat cells during cell cycle arrest. Co-localization of two proteins in both nucleus and cytoplasm was also observed with immunofluorescent staining. Conclusion: CRIF1 may play a regulatory role in the BM microenvironment-induced leukemia cell cycle arrest possibly through interacting with CDK2 and acting as a cyclin-dependent kinase inhibitor.	[Ran, Qian; Xiao, Yanni; Xiang, Lixing; Ye, Xingde; Deng, Xiaojun; Zhao, Jiang; Li, Zhongjun] Third Mil Med Univ, Affiliated Hosp 2, Dept Blood Transfus, Chongqing, Peoples R China; [Hao, Ping] Third Mil Med Univ, Affiliated Hosp 2, Ctr Oncol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, ZJ (corresponding author), Third Mil Med Univ, Affiliated Hosp 2, Dept Blood Transfus, Chongqing, Peoples R China.	johnneyusc@gmail.com			National Natural Science Foundation of China [81102080]; Chongqing Natural Science Key Project Foundation [CSTC2012JJBB10029]; Youth Scientist Foundation of Chongqing [CSTC 2013JCYJJQ10001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Key Project Foundation; Youth Scientist Foundation of Chongqing	This study was supported by the National Natural Science Foundation of China ( No. 81102080), Chongqing Natural Science Key Project Foundation (CSTC2012JJBB10029) and Youth Scientist Foundation of Chongqing (CSTC 2013JCYJJQ10001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 2010, BLOOD, V116, P1083, DOI 10.1182/blood-2009-10-246199; Carroll WL, 2012, J PEDIATR-US, V160, P10, DOI 10.1016/j.jpeds.2011.08.006; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Cornell RF, 2012, DM-DIS MON, V58, P219, DOI 10.1016/j.disamonth.2012.01.011; Correia A. L., 2012, DRUG RESIST UPDAT; DelSal G, 1996, CRIT REV ONCOGENESIS, V7, P127, DOI 10.1615/CritRevOncog.v7.i1-2.80; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Essers MAG, 2010, MOL ONCOL, V4, P443, DOI 10.1016/j.molonc.2010.06.001; Felipe Rico J, 2012, CANC LETT; Fortney JE, 2001, LEUKEMIA RES, V25, P901, DOI 10.1016/S0145-2126(01)00051-0; Furuichi Y, 2007, CANCER RES, V67, P9852, DOI 10.1158/0008-5472.CAN-07-0105; Hoelzer D, 2012, BLOOD REV, V26, P25, DOI 10.1016/j.blre.2011.08.001; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jorgensen HG, 2006, CLIN CANCER RES, V12, P626, DOI 10.1158/1078-0432.CCR-05-0429; Kang HJ, 2010, J BIOL CHEM, V285, P21258, DOI 10.1074/jbc.M109.084590; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kleinberger-Doron N, 1998, EXP CELL RES, V241, P340, DOI 10.1006/excr.1998.4061; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Kwon MC, 2009, J BIOL CHEM, V284, P33634, DOI 10.1074/jbc.M109.059840; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Nair RR, 2010, BIOCHEM PHARMACOL, V80, P602, DOI 10.1016/j.bcp.2010.04.003; Oh NS, 2007, GENE, V386, P147, DOI 10.1016/j.gene.2006.08.023; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Tesfai Y, 2012, LEUKEMIA RES, V36, P299, DOI 10.1016/j.leukres.2011.08.001; Vianello F, 2010, HAEMATOL-HEMATOL J, V95, P1081, DOI 10.3324/haematol.2009.017178; Voorhees PM, 2007, CLIN CANCER RES, V13, P6469, DOI 10.1158/1078-0432.CCR-07-1293; Wierod L, 2008, ONCOGENE, V27, P2763, DOI 10.1038/sj.onc.1210937; YAMADA M, 1990, NEW ENGL J MED, V323, P448, DOI 10.1056/NEJM199008163230705; Zhang B, 2010, CANCER CELL, V17, P427, DOI 10.1016/j.ccr.2010.03.011; Zhang X, 2011, TRANSPL P, V43, P2770, DOI 10.1016/j.transproceed.2011.05.048	37	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e85328	10.1371/journal.pone.0085328	http://dx.doi.org/10.1371/journal.pone.0085328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520316	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600006
J	den Dries, SO; Sutton, ME; Karimian, N; de Boer, MT; Wiersema-Buist, J; Gouw, ASH; Leuvenink, HGD; Lisman, T; Porte, RJ				den Dries, Sanna op; Sutton, Michael E.; Karimian, Negin; de Boer, Marieke T.; Wiersema-Buist, Janneke; Gouw, Annette S. H.; Leuvenink, Henri G. D.; Lisman, Ton; Porte, Robert J.			Hypothermic Oxygenated Machine Perfusion Prevents Arteriolonecrosis of the Peribiliary Plexus in Pig Livers Donated after Circulatory Death	PLOS ONE			English	Article							BILE-DUCT INJURY; BILIARY STRICTURES; CARDIAC DEATH; COLD-STORAGE; DONOR LIVERS; RISK-FACTORS; TRANSPLANTATION; GRAFTS; PRESERVATION; COMPLICATIONS	Background: Livers derived from donation after circulatory death (DCD) are increasingly accepted for transplantation. However, DCD livers suffer additional donor warm ischemia, leading to biliary injury and more biliary complications after transplantation. It is unknown whether oxygenated machine perfusion results in better preservation of biliary epithelium and the peribiliary vasculature. We compared oxygenated hypothermic machine perfusion (HMP) with static cold storage (SCS) in a porcine DCD model. Methods: After 30 min of cardiac arrest, livers were perfused in situ with HTK solution (4 degrees C) and preserved for 4 h by either SCS (n = 9) or oxygenated HMP (10 degrees C; n = 9), using pressure-controlled arterial and portal venous perfusion. To simulate transplantation, livers were reperfused ex vivo at 37 degrees C with oxygenated autologous blood. Bile duct injury and function were determined by biochemical and molecular markers, and a systematic histological scoring system. Results: After reperfusion, arterial flow was higher in the HMP group, compared to SCS (251 +/- 28 vs 166 +/- 28 mL/min, respectively, after 1 hour of reperfusion; p = 0.003). Release of hepatocellular enzymes was significantly higher in the SCS group. Markers of biliary epithelial injury (biliary LDH, gamma-GT) and function (biliary pH and bicarbonate, and biliary transporter expression) were similar in the two groups. However, histology of bile ducts revealed significantly less arteriolonecrosis of the peribiliary vascular plexus in HMP preserved livers (>50% arteriolonecrosis was observed in 7 bile ducts of the SCS preserved livers versus only 1 bile duct of the HMP preserved livers; p = 0.024). Conclusions: Oxygenated HMP prevents arteriolonecrosis of the peribiliary vascular plexus of the bile ducts of DCD pig livers and results in higher arterial flow after reperfusion. Together this may contribute to better perfusion of the bile ducts, providing a potential advantage in the post-ischemic recovery of bile ducts.	[den Dries, Sanna op; Sutton, Michael E.; Karimian, Negin; de Boer, Marieke T.; Lisman, Ton; Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [den Dries, Sanna op; Sutton, Michael E.; Karimian, Negin; Wiersema-Buist, Janneke; Leuvenink, Henri G. D.; Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Surg Res Lab, Groningen, Netherlands; [Gouw, Annette S. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Porte, RJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands.	r.j.porte@umcg.nl		Leuvenink, Henri/0000-0001-5036-2999; Lisman, Ton/0000-0002-3503-7140	Innovatief Actieprogramma Groningen [IAG-3]; Jan Kornelis de Cock Stichting in The Netherlands	Innovatief Actieprogramma Groningen; Jan Kornelis de Cock Stichting in The Netherlands	This research work was financially supported by grants provided by Innovatief Actieprogramma Groningen (IAG-3) and the Jan Kornelis de Cock Stichting in The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae C, 2012, CURR OPIN ORGAN TRAN, V17, P137, DOI 10.1097/MOT.0b013e328351083d; Berendsen TA, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-6; Boehnert MU, 2013, AM J TRANSPLANT, V13, P1441, DOI 10.1111/ajt.12224; Brunner SM, 2013, J HEPATOL, V58, P1133, DOI 10.1016/j.jhep.2012.12.022; Demetris AJ, 2006, WORLD J GASTROENTERO, V12, P3512, DOI 10.3748/wjg.v12.i22.3512; Dubbeld J, 2010, BRIT J SURG, V97, P744, DOI 10.1002/bjs.7043; Dutkowski P, 2008, AM J TRANSPLANT, V8, P917, DOI 10.1111/j.1600-6143.2008.02165.x; Dutkowski P, 2014, J HEPATOL, V60, P765, DOI 10.1016/j.jhep.2013.11.023; Fondevila C, 2012, TRANSPLANTATION, V94, P22, DOI 10.1097/TP.0b013e31825774d7; Gringeri E, 2012, TRANSPL P, V44, P2026, DOI 10.1016/j.transproceed.2012.06.014; Guarrera JV, 2010, AM J TRANSPLANT, V10, P372, DOI 10.1111/j.1600-6143.2009.02932.x; Hansen T, 2012, VIRCHOWS ARCH, V461, P41, DOI 10.1007/s00428-012-1245-8; Heidenhain C, 2010, TRANSPL INT, V23, P14, DOI 10.1111/j.1432-2277.2009.00947.x; Hessheimer AJ, 2012, CURR OPIN ORGAN TRAN, V17, P143, DOI 10.1097/MOT.0b013e328351082a; Imber CJ, 2002, TRANSPLANTATION, V73, P701, DOI 10.1097/00007890-200203150-00008; Karimian N, 2013, J HEPATOL, V58, P1065, DOI 10.1016/j.jhep.2013.02.023; Meurisse N, 2012, TRANSPL P, V44, P2868, DOI 10.1016/j.transproceed.2012.09.077; Nishida S, 2006, J HEPATO-BILIARY-PAN, V13, P511, DOI 10.1007/s00534-005-1081-1; NOACK K, 1993, TRANSPLANTATION, V56, P495, DOI 10.1097/00007890-199309000-00001; op den Dries S, 2013, AM J TRANSPLANT, V13, P1327, DOI 10.1111/ajt.12187; op den Dries S, 2011, TRANSPLANTATION, V92, P373, DOI 10.1097/TP.0b013e318223a384; Pine JK, 2009, LIVER TRANSPLANT, V15, P1072, DOI 10.1002/lt.21853; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; Sharma S, 2008, LIVER TRANSPLANT, V14, P759, DOI 10.1002/lt.21509; Stange BJ, 2003, LIVER TRANSPLANT, V9, P612, DOI 10.1053/jlts.2003.50098; Suarez F, 2008, TRANSPLANTATION, V85, P9, DOI 10.1097/01.tp.0000297945.83430.ce; TURLEY SD, 1978, J LIPID RES, V19, P924; Vajdova K, 2000, CRYOBIOLOGY, V41, P145, DOI 10.1006/cryo.2000.2276; Vekemans K, 2011, TRANSPL P, V43, P3455, DOI 10.1016/j.transproceed.2011.09.029; Verdonk RC, 2007, LIVER TRANSPLANT, V13, P725, DOI 10.1002/lt.21165; Yska MJ, 2008, TRANSPLANTATION, V85, P1625, DOI 10.1097/TP.0b013e318170f5f7	31	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88521	10.1371/journal.pone.0088521	http://dx.doi.org/10.1371/journal.pone.0088521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551114	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500045
J	Krieg, A; Mersch, S; Boeck, I; Dizdar, L; Weihe, E; Hilal, Z; Krausch, M; Mohlendick, B; Topp, SA; Piekorz, RP; Huckenbeck, W; Stoecklein, NH; Anlauf, M; Knoefel, WT				Krieg, Andreas; Mersch, Sabrina; Boeck, Inga; Dizdar, Levent; Weihe, Eberhard; Hilal, Zena; Krausch, Markus; Moehlendick, Birte; Topp, Stefan A.; Piekorz, Roland P.; Huckenbeck, Wolfgang; Stoecklein, Nikolas H.; Anlauf, Martin; Knoefel, Wolfram T.			New Model for Gastroenteropancreatic Large-Cell Neuroendocrine Carcinoma: Establishment of Two Clinically Relevant Cell Lines	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; VESICULAR MONOAMINE TRANSPORTER; ENDOCRINE-CELLS; MOLECULAR-PATHOGENESIS; GENE-EXPRESSION; TUMORS; MIDGUT; CISPLATIN; NEOPLASMS; SYSTEM	Recently, a novel WHO-classification has been introduced that divided gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) according to their proliferation index into G1- or G2-neuroendocrine tumors (NET) and poorly differentiated small-cell or large-cell G3-neuroendocrine carcinomas (NEC). Our knowledge on primary NECs of the GEP-system is limited due to the rarity of these tumors and chemotherapeutic concepts of highly aggressive NEC do not provide convincing results. The aim of this study was to establish a reliable cell line model for NEC that could be helpful in identifying novel druggable molecular targets. Cell lines were established from liver (NEC-DUE1) or lymph node metastases (NEC-DUE2) from large cell NECs of the gastroesophageal junction and the large intestine, respectively. Morphological characteristics and expression of neuroendocrine markers were extensively analyzed. Chromosomal aberrations were mapped by array comparative genomic hybridization and DNA profiling was analyzed by DNA fingerprinting. In vitro and in vivo tumorigenicity was evaluated and the sensitivity against chemotherapeutic agents assessed. Both cell lines exhibited typical morphological and molecular features of large cell NEC. In vitro and in vivo experiments demonstrated that both cell lines retained their malignant properties. Whereas NEC-DUE1 and -DUE2 were resistant to chemotherapeutic drugs such as cisplatin, etoposide and oxaliplatin, a high sensitivity to 5-fluorouracil was observed for the NEC-DUE1 cell line. Taken together, we established and characterized the first GEP large-cell NEC cell lines that might serve as a helpful tool not only to understand the biology of these tumors, but also to establish novel targeted therapies in a preclinical setup.	[Krieg, Andreas; Mersch, Sabrina; Dizdar, Levent; Krausch, Markus; Moehlendick, Birte; Topp, Stefan A.; Stoecklein, Nikolas H.; Knoefel, Wolfram T.] Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany; [Krieg, Andreas; Mersch, Sabrina; Boeck, Inga; Dizdar, Levent; Hilal, Zena; Krausch, Markus; Moehlendick, Birte; Topp, Stefan A.; Huckenbeck, Wolfgang; Stoecklein, Nikolas H.; Anlauf, Martin; Knoefel, Wolfram T.] Univ Hosp Duesseldorf, Dusseldorf, Germany; [Boeck, Inga; Hilal, Zena; Anlauf, Martin] Univ Dusseldorf, Inst Pathol, Dusseldorf, Germany; [Weihe, Eberhard] Univ Marburg, Inst Anat & Cell Biol, Dept Mol Neurosci, Marburg, Germany; [Piekorz, Roland P.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Huckenbeck, Wolfgang] Univ Dusseldorf, Inst Forens Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Philipps University Marburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Krieg, A (corresponding author), Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany.	andreas.krieg@med.uni-duesseldorf.de		Mohlendick, Birte/0000-0001-9093-8585	Forschungskommission of the Medical Faculty, University Duesseldorf [41/09]; Deutsche Forschungsgemeinschaft [KR 3496/2-1]	Forschungskommission of the Medical Faculty, University Duesseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Forschungskommission of the Medical Faculty, University Duesseldorf (41/09 to AK) and by the Deutsche Forschungsgemeinschaft (KR 3496/2-1 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlman H, 2008, NEUROENDOCRINOLOGY, V87, P40, DOI 10.1159/000109976; Bajetta E, 2007, CANCER CHEMOTH PHARM, V59, P637, DOI 10.1007/s00280-006-0306-6; BISHOP AE, 1982, GASTROENTEROLOGY, V83, P902; Bosman F., 2010, WHO CLASSIFICATION T, V4th; BUFFA R, 1987, MOL CELL PROBE, V1, P367, DOI 10.1016/0890-8508(87)90018-1; Eissele R, 1999, DIGESTION, V60, P428, DOI 10.1159/000007688; Ellis LM, 2010, CLIN CANCER RES, V16, P5365, DOI 10.1158/1078-0432.CCR-10-2550; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Fazio N, 2013, CANCER TREAT REV, V39, P270, DOI 10.1016/j.ctrv.2012.06.009; Grozinsky-Glasberg S, 2012, NEUROENDOCRINOLOGY, V96, P173, DOI 10.1159/000338793; JAMES R, 1994, J BIOL CHEM, V269, P15229; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kloppel G, 2009, NEUROENDOCRINOLOGY, V90, P162, DOI 10.1159/000182196; Kolby L, 2001, AM J PATHOL, V158, P745, DOI 10.1016/S0002-9440(10)64017-5; Krausch M, 2013, ENDOCRINE; Lollgen RM, 2001, INT J CANCER, V92, P812, DOI 10.1002/ijc.1276; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; LUNDQVIST M, 1991, EUR J CANCER, V27, P1663, DOI 10.1016/0277-5379(91)90441-F; Mitry E, 1999, BRIT J CANCER, V81, P1351, DOI 10.1038/sj.bjc.6690325; Modlin IM, 2003, CANCER-AM CANCER SOC, V97, P934, DOI 10.1002/cncr.11105; MOERTEL CG, 1991, CANCER, V68, P227, DOI 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I; Niederle MB, 2010, ENDOCR-RELAT CANCER, V17, P909, DOI 10.1677/ERC-10-0152; Nilsson O, 2006, NEUROENDOCRINOLOGY, V84, P212, DOI 10.1159/000098013; Oberg K, 2012, CURR OPIN ONCOL, V24, P433, DOI 10.1097/CCO.0b013e328353d7ba; Pape U, 2006, J CLIN ONCOL S18, P14074, DOI DOI 10.1200/JC0.2006.24.18_; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; Pfragner R, 1996, INT J ONCOL, V8, P513; Pfragner R, 2009, ANTICANCER RES, V29, P1951; Posorski N, 2011, CLIN EXP METASTAS, V28, P637, DOI 10.1007/s10585-011-9397-5; QUINN LA, 1979, CANCER RES, V39, P4914; Rindi G, 2005, BEST PRACT RES CL GA, V19, P519, DOI 10.1016/j.bpg.2005.03.005; RINDI G, 1986, HISTOCHEMISTRY, V85, P19, DOI 10.1007/BF00508649; ROCKWELL S, 1980, BRIT J CANCER, V41, P118; Schott M, 2011, DTSCH ARZTEBL INT, V108, P305, DOI 10.3238/arztebl.2011.0305; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Stilling GA, 2007, ENDOCR PATHOL, V18, P223, DOI 10.1007/s12022-007-9001-3; Takahashi Y, 2000, DIGESTION, V62, P262, DOI 10.1159/000007825; Terris B, 1998, GENE CHROMOSOME CANC, V22, P50, DOI 10.1002/(SICI)1098-2264(199805)22:1<50::AID-GCC7>3.0.CO;2-6; Tonnies H, 2001, GUT, V48, P536, DOI 10.1136/gut.48.4.536; Turner NC, 2010, BRIT J CANCER, V102, P1106, DOI 10.1038/sj.bjc.6605618; Van Buren G, 2007, CLIN CANCER RES, V13, P4704, DOI 10.1158/1078-0432.CCR-06-2723; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730; Wiedenmann B, 1998, J MOL MED, V76, P637, DOI 10.1007/s001090050261; WILLIAMS ED, 1963, LANCET, V1, P238; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zhao CM, 1997, CELL TISSUE RES, V290, P539, DOI 10.1007/s004410050960; Zhao JM, 2000, AM J PATHOL, V157, P1431, DOI 10.1016/S0002-9440(10)64780-3	48	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88713	10.1371/journal.pone.0088713	http://dx.doi.org/10.1371/journal.pone.0088713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551139	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500055
J	Ravi, VK; Goel, M; Kotamarthi, HC; Ainavarapu, SRK; Swaminathan, R				Ravi, Vijay Kumar; Goel, Mohit; Kotamarthi, Hema Chandra; Ainavarapu, Sri Rama Koti; Swaminathan, Rajaram			Preventing Disulfide Bond Formation Weakens Non-Covalent Forces among Lysozyme Aggregates	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; AMYLOID FIBRILS; ALKALINE PH; PROTEIN; SPECTROSCOPY; FLUORESCENCE; BINDING; MICROSCOPY; CONVERSION; MECHANISM	Nonnative disulfide bonds have been observed among protein aggregates in several diseases like amyotrophic lateral sclerosis, cataract and so on. The molecular mechanism by which formation of such bonds promotes protein aggregation is poorly understood. Here in this work we employ previously well characterized aggregation of hen eggwhite lysozyme (HEWL) at alkaline pH to dissect the molecular role of nonnative disulfide bonds on growth of HEWL aggregates. We employed time-resolved fluorescence anisotropy, atomic force microscopy and single-molecule force spectroscopy to quantify the size, morphology and non-covalent interaction forces among the aggregates, respectively. These measurements were performed under conditions when disulfide bond formation was allowed (control) and alternatively when it was prevented by alkylation of free thiols using iodoacetamide. Blocking disulfide bond formation affected growth but not growth kinetics of aggregates which were similar to 50% reduced in volume, flatter in vertical dimension and non-fibrillar in comparison to control. Interestingly, single-molecule force spectroscopy data revealed that preventing disulfide bond formation weakened the non-covalent interaction forces among monomers in the aggregate by at least ten fold, thereby stalling their growth and yielding smaller aggregates in comparison to control. We conclude that while constrained protein chain dynamics in correctly disulfide bonded amyloidogenic proteins may protect them from venturing into partial folded conformations that can trigger entry into aggregation pathways, aberrant disulfide bonds in non-amyloidogenic proteins (like HEWL) on the other hand, may strengthen non-covalent intermolecular forces among monomers and promote their aggregation.	[Ravi, Vijay Kumar; Goel, Mohit; Swaminathan, Rajaram] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Kotamarthi, Hema Chandra; Ainavarapu, Sri Rama Koti] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Tata Institute of Fundamental Research (TIFR)	Swaminathan, R (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	rsw@iitg.ernet.in	Swaminathan, Rajaram/I-2250-2019; Ainavarapu, Sri Rama Koti/D-1231-2011; Swaminathan, Rajaram/B-1230-2008; Goel, Mohit/ABE-3468-2021; Kotamarthi, Hema Chandra/AEB-3344-2022	Swaminathan, Rajaram/0000-0003-1294-8379; Ainavarapu, Sri Rama Koti/0000-0002-1646-2731; Ravi, Vijay/0000-0003-3772-0573	Science and Engineering Research Board, Department of Science and Technology, Government of India [SR/SO/BB-048/2009]; Rajiv Gandhi National Fellowship scheme of University Grants Commission, Government of India, New Delhi [F. 14-2 (SC)/2009 (SA-III)]	Science and Engineering Research Board, Department of Science and Technology, Government of India; Rajiv Gandhi National Fellowship scheme of University Grants Commission, Government of India, New Delhi	This work was financially supported by Science and Engineering Research Board, Department of Science and Technology, Government of India under project SR/SO/BB-048/2009. VKR wishes to acknowledge financial support under Rajiv Gandhi National Fellowship scheme [Ref: F. 14-2 (SC)/2009 (SA-III)] of University Grants Commission, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V, 2011, J BIOL CHEM, V286, P28056, DOI 10.1074/jbc.M111.249045; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P6479, DOI 10.1021/ja800180u; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Grana-Montes R, 2012, ANTIOXID REDOX SIGN, V16, P1, DOI 10.1089/ars.2011.3936; Hane F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059005; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; HERRON JN, 1981, J BIOCHEM BIOPH METH, V5, P1, DOI 10.1016/0165-022X(81)90029-4; Homchaudhuri L, 2006, FEBS LETT, V580, P2097, DOI 10.1016/j.febslet.2006.03.012; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim BH, 2011, BIOCHEMISTRY-US, V50, P5154, DOI 10.1021/bi200147a; Kumar S, 2008, J FLUORESC, V18, P1199, DOI 10.1007/s10895-008-0378-2; Kumar S, 2008, BIOCHEM J, V415, P275, DOI 10.1042/BJ20071499; Kumar S, 2009, BBA-PROTEINS PROTEOM, V1794, P913, DOI 10.1016/j.bbapap.2009.01.009; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Lv ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02880; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Mossuto ME, 2011, ANGEW CHEM INT EDIT, V50, P7048, DOI 10.1002/anie.201100986; Niraula TN, 2004, P NATL ACAD SCI USA, V101, P4089, DOI 10.1073/pnas.0305798101; Scheinost J.C., 2010, PROTEIN MISFOLDING D, P615; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; TURNER DC, 1968, BIOCHEMISTRY-US, V7, P3381, DOI 10.1021/bi00850a011; Wall J, 1999, METHOD ENZYMOL, V309, P204; Xie JB, 2012, PROTEINS, V80, P2501, DOI 10.1002/prot.24132; Xie JB, 2013, ADV HEALTHC MATER, V2, P795, DOI 10.1002/adhm.201200285; Xie JB, 2011, PROTEINS, V79, P2505, DOI 10.1002/prot.23074; Yu JP, 2011, NANOMED-NANOTECHNOL, V7, P146, DOI 10.1016/j.nano.2010.08.001; Yu JP, 2008, J MOL BIOL, V384, P992, DOI 10.1016/j.jmb.2008.10.006	34	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87012	10.1371/journal.pone.0087012	http://dx.doi.org/10.1371/journal.pone.0087012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551048	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500013
J	Williams, MWY; Guiffre, AK; Fletcher, JP				Williams, Michelle W. Y.; Guiffre, Ann K.; Fletcher, John P.			Platelets and Smooth Muscle Cells Affecting the Differentiation of Monocytes	PLOS ONE			English	Article							PROGENITOR CELLS; EXPRESSION; GENE; CD14; CONSTITUENTS; FIBROCYTES; CONTRIBUTE; PROTEIN; CAP	Background: Atherosclerosis is characterised by the formation of plaques. Monocytes play a pivotal role in plaque development as they differentiate into foam cells, a component of the lipid core whilst smooth muscle cells (SMC) are the principal cell identified in the cap. Recently, the ability of monocytes to differentiate into a myriad of other cell types has been reported. In lieu of these findings the ability of monocytes to differentiate into SMCs/smooth muscle (SM)-like cells was investigated. Method and Results: Human monocytes were co-cultured with platelets or human coronary aortic SMCs and then analysed to assess their differentiation into SMCs/SM-like cells. The differentiated cells expressed a number of SMC markers and genes as determined by immunofluorescence staining and quantitative polymerase chain reaction (qPCR). CD array analysis identified marker expression profiles that discriminated them from monocytes, macrophages and foam cells as well as the expression of markers which overlapped with fibroblast and mesenchymal cells. Electron microscopy studies identified microfilaments and increased amounts of rough endoplasmic reticulum indicative of the SM- like cells, fibroblasts. Conclusions: In the appropriate environmental conditions, monocytes can differentiate into SM-like cells potentially contributing to cap formation and plaque stability. Thus, monocytes may play a dual role in the development of plaque formation and ultimately atherosclerosis.	[Williams, Michelle W. Y.; Guiffre, Ann K.; Fletcher, John P.] Univ Sydney, Westmead Hosp, Dept Surg, Westmead, NSW 2145, Australia	University of Sydney	Williams, MWY (corresponding author), Univ Sydney, Westmead Hosp, Dept Surg, Westmead, NSW 2145, Australia.	michellewywilliams@gmail.com						Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; Binai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033508; Brown BE, 2007, FEBS J, V274, P1530, DOI 10.1111/j.1742-4658.2007.05699.x; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Clanchy FIL, 2006, J LEUKOCYTE BIOL, V79, P757, DOI 10.1189/jlb.0905522; Curnow SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009730; Dardik A, 2005, J VASC SURG, V41, P321, DOI 10.1016/j.jvs.2004.11.016; Davies John Q, 2005, Methods Mol Biol, V290, P105; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dotsenko Olena, 2010, Open Cardiovasc Med J, V4, P97, DOI 10.2174/1874192401004020097; Ellmark P, 2006, PROTEOMICS, V6, P1791, DOI 10.1002/pmic.200500468; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Eyden B, 2001, ULTRASTRUCT PATHOL, V25, P39, DOI 10.1080/019131201300004672; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Kodama H, 2006, IMMUNOL CELL BIOL, V84, P209, DOI 10.1111/j.1440-1711.2006.01424.x; Kodama H, 2005, STEM CELLS DEV, V14, P676, DOI 10.1089/scd.2005.14.676; LAUENER RP, 1990, EUR J IMMUNOL, V20, P2375, DOI 10.1002/eji.1830201103; Li ZY, 2006, STROKE, V37, P1195, DOI 10.1161/01.STR.0000217331.61083.3b; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Medbury HJ, 2008, INT ANGIOL, V27, P114; Medina A, 2009, WOUND REPAIR REGEN, V17, P268, DOI 10.1111/j.1524-475X.2009.00457.x; PAULUS JM, 1975, BLOOD, V46, P321; REDDY S, 1990, J BIOL CHEM, V265, P1683; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; RUPPERT J, 1991, IMMUNOBIOLOGY, V182, P449, DOI 10.1016/S0171-2985(11)80209-3; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; SATTERTHWAITE AB, 1990, BLOOD, V75, P2299; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sugiyama S, 2006, ATHEROSCLEROSIS, V187, P351, DOI 10.1016/j.atherosclerosis.2005.09.014; Swirski FK, 2011, ARTERIOSCL THROM VAS, V31, P1517, DOI 10.1161/ATVBAHA.110.221150; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; THYBERG J, 1985, CELL TISSUE RES, V239, P69, DOI 10.1007/BF00214904; Torsney E, 2007, ATHEROSCLEROSIS, V191, P259, DOI 10.1016/j.atherosclerosis.2006.05.033; Yang H, 2006, J CELL MOL MED, V10, P459, DOI 10.1111/j.1582-4934.2006.tb00411.x; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4; Zoll J, 2008, CARDIOVASC RES, V77, P471, DOI 10.1093/cvr/cvm034	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88172	10.1371/journal.pone.0088172	http://dx.doi.org/10.1371/journal.pone.0088172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551082	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500031
J	Azghadi, MR; Iannella, N; Al-Sarawi, S; Abbott, D				Azghadi, Mostafa Rahimi; Iannella, Nicolangelo; Al-Sarawi, Said; Abbott, Derek			Tunable Low Energy, Compact and High Performance Neuromorphic Circuit for Spike-Based Synaptic Plasticity	PLOS ONE			English	Article							TIMING-DEPENDENT-PLASTICITY; STDP; SYNAPSES; NEURONS; MODEL; DESIGN	Cortical circuits in the brain have long been recognised for their information processing capabilities and have been studied both experimentally and theoretically via spiking neural networks. Neuromorphic engineers are primarily concerned with translating the computational capabilities of biological cortical circuits, using the Spiking Neural Network (SNN) paradigm, into in silico applications that can mimic the behaviour and capabilities of real biological circuits/systems. These capabilities include low power consumption, compactness, and relevant dynamics. In this paper, we propose a new accelerated-time circuit that has several advantages over its previous neuromorphic counterparts in terms of compactness, power consumption, and capability to mimic the outcomes of biological experiments. The presented circuit simulation results demonstrate that, in comparing the new circuit to previous published synaptic plasticity circuits, reduced silicon area and lower energy consumption for processing each spike is achieved. In addition, it can be tuned in order to closely mimic the outcomes of various spike timing-and rate-based synaptic plasticity experiments. The proposed circuit is also investigated and compared to other designs in terms of tolerance to mismatch and process variation. Monte Carlo simulation results show that the proposed design is much more stable than its previous counterparts in terms of vulnerability to transistor mismatch, which is a significant challenge in analog neuromorphic design. All these features make the proposed design an ideal circuit for use in large scale SNNs, which aim at implementing neuromorphic systems with an inherent capability that can adapt to a continuously changing environment, thus leading to systems with significant learning and computational abilities.	[Azghadi, Mostafa Rahimi; Iannella, Nicolangelo; Al-Sarawi, Said; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide	Azghadi, MR (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	mostafa@eleceng.adelaide.edu.au	Abbott, Derek/E-8352-2011; Azghadi, Mostafa Rahimi/P-9944-2016; Al-Sarawi, Said/E-9150-2011; Iannella, Nicolangelo/A-1026-2009	Abbott, Derek/0000-0002-0945-2674; Azghadi, Mostafa Rahimi/0000-0001-7975-3985; Al-Sarawi, Said/0000-0002-3242-8197; Iannella, Nicolangelo/0000-0002-1983-9071				[Anonymous], 2006, ADV NEURAL INFORM PR; Azghadi M. R., 2011, Proceedings of the 2011 Seventh International Conference on Intelligent Sensors, Sensor Networks and Information Processing (ISSNIP), P158, DOI 10.1109/ISSNIP.2011.6146525; Azghadi M. R., 2012, P 2012 INT JOINT C N, P1, DOI [10.1109/IJCNN.2012.6252778, DOI 10.1109/IJCNN.2012.6252778]; Azghadi MR, 2013, IEEE INT CONF VLSI, P7, DOI 10.1109/VLSI-SoC.2013.6673236; Azghadi MR, 2013, NEURAL NETWORKS, V45, P70, DOI 10.1016/j.neunet.2013.03.003; Azghadi MR, 2012, 2012 INT JOINT C NEU, DOI [10.1109/IJCNN.2012.6252820, DOI 10.1109/IJCNN.2012.6252820]; Azghani M., 2013, IEEE 11 INTERNAT NEW, P1; Bamford SA, 2012, ELECTRON LETT, V48, P360, DOI 10.1049/el.2012.0257; Bamford SA, 2012, IEEE T BIOMED CIRC S, V6, P385, DOI 10.1109/TBCAS.2012.2184285; Bartolozzi C, 2007, NEURAL COMPUT, V19, P2581, DOI 10.1162/neco.2007.19.10.2581; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bofill-i-Petit A, 2004, IEEE T NEURAL NETWOR, V15, P1296, DOI 10.1109/TNN.2004.832842; Cameron K, 2005, IEEE T NEURAL NETWOR, V16, P1626, DOI 10.1109/TNN.2005.852238; Cassidy A, 2011, IEEE INT SYMP CIRC S, P673; Cooper L., 2004, THEORY CORTICAL PLAS; Cruz-Albrecht JM, 2012, IEEE T BIOMED CIRC S, V6, P246, DOI 10.1109/TBCAS.2011.2174152; DOUGLAS R, 1995, ANNU REV NEUROSCI, V18, P255, DOI 10.1146/annurev.ne.18.030195.001351; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iannella N, 2006, NEUROSCI LETT, V403, P24, DOI 10.1016/j.neulet.2006.03.079; Iannella NL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00021; Indiveri G, 2006, IEEE T NEURAL NETWOR, V17, P211, DOI 10.1109/TNN.2005.860850; Indiveri G., 2011, FRONTIERS NEUROSCIEN, V5; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Koickal TJ, 2007, IEEE T CIRCUITS-I, V54, P60, DOI 10.1109/TCSI.2006.888677; Liu S.-C., 2002, ANALOG VLSI CIRCUITS; Mayr C, 2010, FRONTIERS SYNAPTIC N, V2; Mayr C, 2010, IEEE INT SYMP CIRC S, P105, DOI 10.1109/ISCAS.2010.5537009; Meng YC, 2011, IEEE ENG MED BIO, P7274, DOI 10.1109/IEMBS.2011.6091838; Mitra S, 2009, IEEE T BIOMED CIRC S, V3, P32, DOI 10.1109/TBCAS.2008.2005781; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Poon CS, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00108; Rachmuth G, 2008, HFSP J, V2, P156, DOI 10.2976/1.2905393; Rachmuth G, 2011, P NATL ACAD SCI USA, V108, pE1266, DOI 10.1073/pnas.1106161108; Ramakrishnan S, 2011, IEEE T BIOMED CIRC S, V5, P244, DOI 10.1109/TBCAS.2011.2109000; Schemmel J, 2010, IEEE INT SYMP CIRC S, P1947, DOI 10.1109/ISCAS.2010.5536970; Schemmel J, 2006, IEEE IJCNN, P1; Sheik S, 2012, IEEE IJCNN; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tanaka H, 2009, IEICE T FUND ELECTR, VE92A, P1690, DOI 10.1587/transfun.E92.A.1690; Vitale SA, 2011, IEEE T ELECTRON DEV, V58, P419, DOI 10.1109/TED.2010.2092779; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Wang HY, 1999, J NEUROPHYSIOL, V82, P2024, DOI 10.1152/jn.1999.82.4.2024; Wijekoon JHB, 2012, J NEUROSCI METH, V210, P93, DOI 10.1016/j.jneumeth.2012.01.019; Zamarreno-Ramos C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00026; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	52	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88326	10.1371/journal.pone.0088326	http://dx.doi.org/10.1371/journal.pone.0088326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551089	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000027
J	Pereira, DM; Correia-da-Silva, G; Valenta, P; Teixeira, N; Andrade, PB				Pereira, David M.; Correia-da-Silva, Georgina; Valenta, Patricia; Teixeira, Natercia; Andrade, Paula B.			Anti-Inflammatory Effect of Unsaturated Fatty Acids and Ergosta-7,22-dien-3-ol from Marthasterias glacialis: Prevention of CHOP-Mediated ER-Stress and NF-kappa B Activation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDE-INDUCED APOPTOSIS; INNATE IMMUNITY; INFLAMMATION; CAROTENOIDS; EXPRESSION; PATHWAY; TARGETS; CANCER; CELLS	There has been increasing awareness to the potential interest of drug discovery from marine natural products to treat several pathological conditions, including inflammation. In this work we describe the anti-inflammatory activity of several compounds present in the echinoderm Marthasterias glacialis (spiny sea-star), using the inflammatory model RAW 264.7 cells challenged with LPS. Lipidomic profiling of the organism revealed two major classes of compounds: fatty acids and sterols. Among these, the predominant compounds cis 11-eicosenoic and cis 11,14 eicosadienoic acids and the unsaturated sterol ergosta-7,22-dien-3-ol were evaluated. The mechanism of action of the compounds was distinct as they modulated different levels of the inflammation pathway. Classical inflammatory markers, such as COX-2, iNOS, IL-6 and NF-kappa B, were evaluated. We also studied the contribution of the CHOP pathway-mediated ER-stress to the inflammatory process. Overall, the sterol ergosta-7,22-dien-3-ol was the most active compound, however maximum activity was obtained when all compounds were tested in combination, thus suggesting a potentially synergistic activity of both classes of metabolites. This work establishes the echinoderm M. glacialis as an interesting source of anti-inflammatory molecules.	[Pereira, David M.; Valenta, Patricia; Andrade, Paula B.] Univ Porto, Dept Quim, REQUIMTE Lab Farmacognosia, P-4100 Oporto, Portugal; [Correia-da-Silva, Georgina; Teixeira, Natercia] Univ Porto, Dept Ciencias Biol, Fac Farm, Lab Bioquim, P-4100 Oporto, Portugal; [Correia-da-Silva, Georgina; Teixeira, Natercia] Univ Porto, IBMC, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Andrade, PB (corresponding author), Univ Porto, Dept Quim, REQUIMTE Lab Farmacognosia, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	pandrade@ff.up.pt	Teixeira, Natercia A/K-4663-2013; Correia-da-Silva, Georgina/K-4696-2013; Pereira, David/M-9286-2013; Valentao, Patricia/D-4818-2013; Andrade, Paula/A-5900-2008	Teixeira, Natercia A/0000-0002-3664-1120; Correia-da-Silva, Georgina/0000-0001-5787-9018; Pereira, David/0000-0003-0384-7592; Valentao, Patricia/0000-0002-0740-4396; Andrade, Paula/0000-0002-9764-3920	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-C/EQB/LA0006/2013]; FCT [SFRH/BD/62663/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) for grant no. PEst-C/EQB/LA0006/2013. David M. Pereira is grateful to FCT for the grant (SFRH/BD/62663/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Chae IH, 2004, CLIN CHIM ACTA, V341, P83, DOI 10.1016/j.cccn.2003.11.009; CZECZUGA B, 1977, HYDROBIOLOGIA, V54, P177, DOI 10.1007/BF00034992; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Evans Paul C., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009415; Ferreres F, 2008, J AGR FOOD CHEM, V56, P9967, DOI 10.1021/jf8022723; Ferreres F, 2010, J SEP SCI, V33, P2250, DOI 10.1002/jssc.201000197; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Mariutti LRB, 2012, MAR DRUGS, V10, P1498, DOI 10.3390/md10071498; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pereira D.M., 2013, STUDIES NATURAL PROD; Pereira DM, 2012, TALANTA, V100, P391, DOI 10.1016/j.talanta.2012.08.004; Pereira DM, 2009, J AGR FOOD CHEM, V57, P483, DOI 10.1021/jf8031638; Pereira DM, 2013, GC MS MS LI IN PRESS; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Takada K, 2013, BIOMED REP, V1, P315, DOI 10.3892/br.2013.52; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	23	48	50	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88341	10.1371/journal.pone.0088341	http://dx.doi.org/10.1371/journal.pone.0088341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551093	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000031
J	Ali-Rahmani, F; Huang, MA; Schengrund, CL; Connor, JR; Lee, SY				Ali-Rahmani, Fatima; Huang, Michael A.; Schengrund, C. -L.; Connor, James R.; Lee, Sang Y.			C282Y-HFE Gene Variant Affects Cholesterol Metabolism in Human Neuroblastoma Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PROSTATE-CANCER CELLS; LIPID RAFTS; HEREDITARY HEMOCHROMATOSIS; SURFACE EXPRESSION; SCAVENGER RECEPTOR; HEPATOMA-CELLS; HFE MUTATIONS; IRON OVERLOAD; RISK	Although disruptions in the maintenance of iron and cholesterol metabolism have been implicated in several cancers, the association between variants in the HFE gene that is associated with cellular iron uptake and cholesterol metabolism has not been studied. The C282Y-HFE variant is a risk factor for different cancers, is known to affect sphingolipid metabolism, and to result in increased cellular iron uptake. The effect of this variant on cholesterol metabolism and its possible relevance to cancer phenotype was investigated using wild type (WT) and C282Y-HFE transfected human neuroblastoma SH-SY5Y cells. Expression of C282Y-HFE in SH-SY5Y cells resulted in a significant increase in total cholesterol as well as increased transcription of a number of genes involved in its metabolism compared to cells expressing WT-HFE. The marked increase in expression of NPC1L1 relative to that of most other genes, was accompanied by a significant increase in expression of NPC1, a protein that functions in cholesterol uptake by cells. Because inhibitors of cholesterol metabolism have been proposed to be beneficial for treating certain cancers, their effect on the viability of C282Y-HFE neuroblastoma cells was ascertained. C282Y-HFE cells were significantly more sensitive than WT-HFE cells to U18666A, an inhibitor of desmosterol Delta 24-reductase the enzyme catalyzing the last step in cholesterol biosynthesis. This was not seen for simvastatin, ezetimibe, or a sphingosine kinase inhibitor. These studies indicate that cancers presenting in carriers of the C282Y-HFE allele might be responsive to treatment designed to selectively reduce cholesterol content in their tumor cells.	[Ali-Rahmani, Fatima; Connor, James R.; Lee, Sang Y.] Penn State Univ, Penn State MS Hershey Med Ctr, Penn State Hershey Canc Inst, Dept Neurosurg,Coll Med, Hershey, PA 16801 USA; [Huang, Michael A.] Penn State Univ, Penn State MS Hershey Med Ctr, Penn State Hershey Canc Inst, Div Pediat Hematol Oncol,Coll Med, Hershey, PA USA; [Schengrund, C. -L.] Penn State Univ, Penn State MS Hershey Med Ctr, Penn State Hershey Canc Inst, Dept Biochem & Mol Biol,Coll Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lee, SY (corresponding author), Penn State Univ, Penn State MS Hershey Med Ctr, Penn State Hershey Canc Inst, Dept Neurosurg,Coll Med, Hershey, PA 16801 USA.	SYL3@psu.edu		Schengrund, Cara-Lynne/0000-0001-9894-9684; Lee, Sang/0000-0003-3911-8316	Tara Leah Witmer Endowment	Tara Leah Witmer Endowment	This study was supported in part by the Tara Leah Witmer Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparing of the manuscript. No additional external funding received for this study.	Adams PC, 2009, CIRC-CARDIOVASC GENE, V2, P34, DOI 10.1161/CIRCGENETICS.108.813089; Ali-Rahmani F, 2011, NEUROCHEM RES, V36, P1687, DOI 10.1007/s11064-011-0403-8; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Brown JM, 2007, BIOCHEM J, V406, P273, DOI 10.1042/BJ20070168; Camaschella C, 2002, BEST PRACT RES CL HA, V15, P261, DOI 10.1053/beha.2002.0207; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Fargion S, 2010, HEPATOLOGY, V51, P1119, DOI 10.1002/hep.23541; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fleming RE, 2002, ANNU REV PHYSIOL, V64, P663, DOI 10.1146/annurev.physiol.64.081501.155838; Gannon PO, 2011, INT J CANCER, V128, P2326, DOI 10.1002/ijc.25577; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; HOLMQUIST L, 1989, J BIOCHEM BIOPH METH, V19, P93, DOI 10.1016/0165-022X(89)90054-7; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Lee SY, 2007, FASEB J, V21, P564, DOI 10.1096/fj.06-6397com; Lee SY, 2011, INT J CANCER, V129, P2104, DOI 10.1002/ijc.25888; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Li YH, 2002, J BIOL CHEM, V277, P42366, DOI 10.1074/jbc.M207705200; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Lu Y, 2008, MOL CANCER RES, V6, P546, DOI 10.1158/1541-7786.MCR-07-0277; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; MILLER RG, 1984, CELL BIOL INT REP, V8, P519, DOI 10.1016/0309-1651(84)90050-X; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Osborne NJ, 2010, HEPATOLOGY, V51, P1311, DOI 10.1002/hep.23448; Pan J, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-157; Pankow JS, 2008, TRANSL RES, V152, P3, DOI 10.1016/j.trsl.2008.05.005; Petersen NH, 2008, J LIPID RES, V49, P2023, DOI 10.1194/jlr.M800145-JLR200; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Scheel-Toellner D, 2002, BIOCHEM BIOPH RES CO, V297, P876, DOI 10.1016/S0006-291X(02)02311-2; Shaheen NJ, 2003, JNCI-J NATL CANCER I, V95, P154, DOI 10.1093/jnci/95.2.154; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Syrjakoski K, 2006, INT J CANCER, V118, P518, DOI 10.1002/ijc.21331; Tomioka R, 2009, BIOCHEM BIOPH RES CO, V389, P122, DOI 10.1016/j.bbrc.2009.08.105; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Wuttge DM, 2004, ARTERIOSCL THROM VAS, V24, P750, DOI 10.1161/01.ATV.0000124102.11472.36; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200; Zhuang LY, 2005, J CLIN INVEST, V115, P959	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88724	10.1371/journal.pone.0088724	http://dx.doi.org/10.1371/journal.pone.0088724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533143	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600101
J	Brown, A; Arnott, B				Brown, Amy; Arnott, Bronia			Breastfeeding Duration and Early Parenting Behaviour: The Importance of an Infant-Led, Responsive Style	PLOS ONE			English	Article							6 MONTHS POSTPARTUM; EXPERIENCES; MOTHERS; PERCEPTIONS; DECISIONS; SUPPORT; BIRTH	Background: Popular parenting literature promotes different approaches to caring for infants, based around variations in the use of parent-led routines and promoting infant independence. However, there is little empirical evidence of how these early behaviours affect wider parenting choices such as infant feeding. Breastfeeding often requires an infant-led approach, feeding on demand and allowing the infant to regulate intake whilst conversely formula feeding is open to greater caregiver manipulation. The infant-led style associated with breastfeeding may therefore be at odds with philosophies that encourage strict use of routine and independence. The aim of this study was to explore the association between early parenting behaviours and breastfeeding duration. Methods: Five hundred and eight mothers with an infant aged 0-12 months completed a questionnaire examining breastfeeding duration, attitudes and behaviours surrounding early parenting (e.g. anxiety, use of routine, involvement, nurturance and discipline). Participants were attendees at baby groups or participants of online parenting forums based in the UK. Results: Formula use at birth or short breastfeeding duration were significantly associated with low levels of nurturance, high levels of reported anxiety and increased maternal use of Parent-led routines. Conversely an infant-led approach characterised by responding to and following infant cues was associated with longer breastfeeding duration. Discussion: Maternal desire to follow a structured parenting approach which purports use of Parent-led routines and early demands for infant independence may have a negative impact upon breastfeeding duration. Increased maternal anxiety may further influence this relationship. The findings have important implications for Health Professionals supporting new mothers during pregnancy and the postpartum period.	[Brown, Amy] Swansea Univ, Dept Publ Hlth & Policy Studies, Swansea, W Glam, Wales; [Arnott, Bronia] Univ Durham, Dept Psychol, Durham DH1 3LE, England	Swansea University; Durham University	Brown, A (corresponding author), Swansea Univ, Dept Publ Hlth & Policy Studies, Swansea, W Glam, Wales.	a.e.brown@swansea.ac.uk	Brown, Amy/AAT-2339-2020	Brown, Amy/0000-0002-0438-0157	Economic and Social Research Council	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	AB was supported by a postdoctoral fellowship from the Economic and Social Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocella J, 2003, NEW YORKER      0503, V3, P94; Alcalde MC, 2011, J GENDER STUD, V20, P209, DOI 10.1080/09589236.2011.593321; Anderson G C, 2003, Birth, V30, P206; [Anonymous], 2001, ARCH WOMENS MENTAL H, DOI DOI 10.1007/S007370170010; Arnott B, 2013, INFANT CHILD DEV, V22, P349, DOI 10.1002/icd.1794; Aunola K, 2000, J YOUTH ADOLESCENCE, V29, P289, DOI 10.1023/A:1005143607919; Azar BA., 2000, MONITOR PSYCHOL, V31, P42; BAUMRIND D, 1978, YOUTH SOC, V9, P239, DOI 10.1177/0044118X7800900302; Bolling K, 2007, INFANT FEEDING SURVE; Brown A, 2011, J HUM NUTR DIET, V24, P177, DOI 10.1111/j.1365-277X.2010.01145.x; Brown A, 2014, J ADV NURS, V70, P587, DOI 10.1111/jan.12219; Brown A, 2011, J ADV NURS, V67, P1993, DOI 10.1111/j.1365-2648.2011.05647.x; Brown A, 2011, BREASTFEED MED, V6, P197, DOI 10.1089/bfm.2010.0097; Chan S, 2004, J CLIN NURS, V13, P120, DOI 10.1046/j.1365-2702.2003.00882.x; DECARVALHO M, 1982, EARLY HUM DEV, V7, P155, DOI 10.1016/0378-3782(82)90134-7; Dennis CL, 2009, PEDIATRICS, V123, pE736, DOI 10.1542/peds.2008-1629; DEWEY KG, 1991, J PEDIATR-US, V119, P538, DOI 10.1016/S0022-3476(05)82401-1; Forster DA, 2006, INT BREASTFEED J, V1, P1; Gettlert LT, 2011, AM J PHYS ANTHROPOL, V144, P454, DOI 10.1002/ajpa.21426; Grovslien AH, 2009, J HUM LACT, V25, P206, DOI 10.1177/0890334409333425; Hamilton K, 2012, RES Q EXERCISE SPORT, V83, P340, DOI 10.1080/02701367.2012.10599865; Hardyment C, 2007, DREAM BABIES; Hart CH, 2003, LEA COMMUN SER, P753; Hartmann PE, 1994, INTERCELLULAR SIGNAL, P203; Hisock H, 2008, ARCH DIS CHILD, V92, P952; Horta BL, 2007, EVIDENCE LONG TERM E; Huggins KE, 2000, CLIN LACT, P25; Hughes SO, 2005, APPETITE, V44, P83, DOI 10.1016/j.appet.2004.08.007; ILLINGWORTH RS, 1952, LANCET, V262, P683; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Johnston J, 1986, J CLIN ENDOCRINOLOGY, V62, P301; Kersting A, 2004, J PSYCHOSOM RES, V57, P473, DOI 10.1016/j.jpsychores.2004.03.011; Kurth E, 2010, JOGNN-J OBST GYN NEO, V39, P250, DOI 10.1111/j.1552-6909.2010.01141.x; Li RW, 2008, PEDIATRICS, V122, pS69, DOI 10.1542/peds.2008-1315i; Maccoby E. E., 1983, HDB CHILD PSYCHOL, V4, P643; McFadden A, 2006, MATERN CHILD NUTR, V2, P156, DOI 10.1111/j.1740-8709.2006.00054.x; Office for National Statistics, 2008, SOCIAL TRENDS; Russell Sally, 2006, Community Pract, V79, P44; Sachs M, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-29; Schmied V, 2011, BIRTH-ISS PERINAT C, V38, P49, DOI 10.1111/j.1523-536X.2010.00446.x; Sheehan A, 2010, J ADV NURS, V66, P371, DOI 10.1111/j.1365-2648.2009.05194.x; Sisk PM, 2006, PEDIATRICS, V117, pE67, DOI 10.1542/peds.2005-0267; St James-Roberts I, 2006, PEDIATRICS, V117, pE1146, DOI 10.1542/peds.2005-2387; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; Valentin SR, 2005, PEDIATRICS, V115, P269, DOI 10.1542/peds.2004-0815J; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Wilkins C, 2006, MIDWIFERY, V22, P169, DOI 10.1016/j.midw.2005.07.001; WOOLRIDGE MW, 1990, LANCET, V336, P395, DOI 10.1016/0140-6736(90)91943-5	48	46	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e83893	10.1371/journal.pone.0083893	http://dx.doi.org/10.1371/journal.pone.0083893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533046	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600004
J	Fornaciari, I; Fierabracci, V; Corti, A; Elawadi, HA; Lorenzini, E; Emdin, M; Paolicchi, A; Franzini, M				Fornaciari, Irene; Fierabracci, Vanna; Corti, Alessandro; Elawadi, Hassan Aziz; Lorenzini, Evelina; Emdin, Michele; Paolicchi, Aldo; Franzini, Maria			Gamma-Glutamyltransferase Fractions in Human Plasma and Bile: Characteristic and Biogenesis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HUMAN-LIVER; B-GGT; TRANSPEPTIDASE; EXOSOMES; SERUM; GLUTAMYLTRANSFERASE; ENZYME; HEART; RISK	Total plasma gamma-glutamyltransferase (GGT) activity is a sensitive, non-specific marker of liver dysfunction. Four GGT fractions (b-, m-, s-, f-GGT) were described in plasma and their differential specificity in the diagnosis of liver diseases was suggested. Nevertheless fractional GGT properties have not been investigated yet. The aim of this study was to characterize the molecular nature of fractional GGT in both human plasma and bile. Plasma was obtained from healthy volunteers; whereas bile was collected from patients undergoing liver transplantation. Molecular weight (MW), density, distribution by centrifugal sedimentation and sensitivity to both detergent (deoxycholic acid) and protease (papain) were evaluated. A partial purification of b-GGT was obtained by ultracentrifugation. Plasma b-GGT fraction showed a MW of 2000 kDa and a density between 1.063-1.210 g/ml. Detergent converted b-GGT into s-GGT, whereas papain alone did not produce any effect. Plasma m-GGT and s-GGT showed a MW of 1,000 and 200 kDa, and densities between 1.006-1.063 g/ml and 1.063-1.210 g/ml respectively. Both fractions were unaffected by deoxycholic acid, while GGT activity was recovered into f-GGT peak after papain treatment. Plasma f-GGT showed a MW of 70 kDa and a density higher than 1.21 g/ml. We identified only two chromatographic peaks, in bile, showing similar characteristics as plasma b- and f-GGT fractions. These evidences, together with centrifugal sedimentation properties and immunogold electronic microscopy data, indicate that b-GGT is constituted of membrane microvesicles in both bile and plasma, m-GGT and s-GGT might be constituted of bile-acid micelles, while f-GGT represents the free-soluble form of the enzyme.	[Fornaciari, Irene] Univ Pisa, Dept Biol, Pisa, Italy; [Fierabracci, Vanna; Corti, Alessandro; Elawadi, Hassan Aziz; Lorenzini, Evelina; Paolicchi, Aldo] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Emdin, Michele; Paolicchi, Aldo; Franzini, Maria] CNR, Fdn Toscana G Monasterio, Cardiol & Cardiovasc Med Div, I-56100 Pisa, Italy; [Franzini, Maria] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy	University of Pisa; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Scuola Superiore Sant'Anna	Franzini, M (corresponding author), CNR, Fdn Toscana G Monasterio, Cardiol & Cardiovasc Med Div, I-56100 Pisa, Italy.	franzinimaria@gmail.com	Paolicchi, Aldo/K-3946-2018; Franzini, Maria/L-5650-2013	Paolicchi, Aldo/0000-0002-9940-8481; Franzini, Maria/0000-0001-9496-9370	University of Pisa (Italy); Scuola Superiore Sant'Anna (Italy); Fondazione Toscana G. Monasterio - CNR (Italy)	University of Pisa (Italy); Scuola Superiore Sant'Anna (Italy); Fondazione Toscana G. Monasterio - CNR (Italy)	This work was supported by institutional funding of the authors, i.e. University of Pisa (Italy), Scuola Superiore Sant'Anna (Italy) and Fondazione Toscana G. Monasterio - CNR (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT WA, 1983, J BIOL CHEM, V258, P6193; ACCATINO L, 1995, BBA-GEN SUBJECTS, V1243, P33, DOI 10.1016/0304-4165(94)00116-F; ANDERSON ME, 1982, P NATL ACAD SCI-BIOL, V79, P1088, DOI 10.1073/pnas.79.4.1088; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Corti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034772; Emdin M, 2001, EUR HEART J, V22, P1802, DOI 10.1053/euhj.2001.2807; FINIDORI J, 1984, J BIOL CHEM, V259, P4687; Franzini M, 2008, ANAL BIOCHEM, V374, P1, DOI 10.1016/j.ab.2007.10.025; Franzini M, 2013, CLIN CHIM ACTA, V417, P19, DOI 10.1016/j.cca.2012.12.002; Franzini M, 2013, DRUG ALCOHOL DEPEN, V127, P239, DOI 10.1016/j.drugalcdep.2012.06.004; Franzini M, 2012, LIVER INT, V32, P629, DOI 10.1111/j.1478-3231.2011.02673.x; Franzini M, 2009, BIOMARKERS, V14, P486, DOI 10.3109/13547500903093757; Fraser A, 2007, ARTERIOSCL THROM VAS, V27, P2729, DOI 10.1161/ATVBAHA.107.152298; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Grossi E, 2005, CLIN CHEM, V51, P1232, DOI 10.1373/clinchem.2005.047787; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; HUGHEY RP, 1976, J BIOL CHEM, V251, P7863; HUSEBY NE, 1982, CLIN CHIM ACTA, V124, P113, DOI 10.1016/0009-8981(82)90325-4; HUSEBY NE, 1982, CLIN CHIM ACTA, V124, P103, DOI 10.1016/0009-8981(82)90324-2; Huseby NE, 1982, ADV BIOCHEM PHARM, V3, P47; Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Li JH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-244; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Masyuk AI, 2010, AM J PHYSIOL-GASTR L, V299, pG990, DOI 10.1152/ajpgi.00093.2010; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Nichols TC, 1998, EUR J IMMUNOL, V28, P4123, DOI 10.1002/(SICI)1521-4141(199812)28:12<4123::AID-IMMU4123>3.0.CO;2-G; Pompili M, 2003, J GASTROEN HEPATOL, V18, P288, DOI 10.1046/j.1440-1746.2003.02962.x; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; SHAW LM, 1978, CLIN CHEM, V24, P905; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; WENHAM PR, 1986, CLIN CHIM ACTA, V160, P223, DOI 10.1016/0009-8981(86)90189-0; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	36	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88532	10.1371/journal.pone.0088532	http://dx.doi.org/10.1371/journal.pone.0088532			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533101	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600059
J	Landman, GWD; de Bock, GH; Van Hateren, KJJ; Van Dijk, PR; Groenier, KH; Gans, ROB; Houweling, ST; Bilo, HJG; Kleefstra, N				Landman, Gijs W. D.; de Bock, Geertruide H.; Van Hateren, Kornelis J. J.; Van Dijk, Peter R.; Groenier, Klaas H.; Gans, Rijk O. B.; Houweling, Sebastiaan T.; Bilo, Henk J. G.; Kleefstra, Nanne			Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials	PLOS ONE			English	Review							INSULIN SECRETAGOGUES; INTERNATIONAL COMMITTEE; MYOCARDIAL-INFARCTION; GLYCEMIC CONTROL; DOUBLE-BLIND; METFORMIN; PIOGLITAZONE; COMBINATION; MELLITUS; SELECTIVITY	Objective and Design: Gliclazide has been associated with a low risk of hypoglycemic episodes and beneficial long-term cardiovascular safety in observational cohorts. The aim of this study was to assess in a systematic review and meta-analysis of randomized controlled trials the safety and efficacy of gliclazide compared to other oral glucose-lowering agents (PROSPERO2013:CRD42013004156) Data Sources: Medline, EMBASE, Clinicaltrials.gov, Trialregister.nl, Clinicaltrialsregister.eu and the Cochrane database. Selection: Included were randomized studies of at least 12 weeks duration with the following outcomes: HbA1c change, incidence of severe hypoglycemia, weight change, cardiovascular events and/or mortality when comparing gliclazide with other oral blood glucose lowering drugs. Bias was assessed with the Cochrane risk of bias tool. The inverse variance random effects model was used. Results: Nineteen trials were included; 3,083 patients treated with gliclazide and 3,155 patients treated with other oral blood glucose lowering drugs. There was a considerable amount of heterogeneity between and bias in studies. Compared to other glucose lowering agents except metformin, gliclazide was slightly more effective (-0.13% (95%CI: -0.25, -0.02, I-2 55%)). One out of 2,387 gliclazide users experienced a severe hypoglycemic event, whilst also using insulin. There were 25 confirmed non-severe hypoglycemic events (2.2%) in 1,152 gliclazide users and 22 events (1.8%) in 1,163 patients in the comparator group (risk ratio 1.09 (95% CI: 0.20, 5.78, I-2 77%)). Few studies reported differences in weight and none were designed to evaluate cardiovascular outcomes. Conclusions: The methodological quality of randomized trials comparing gliclazide to other oral glucose lowering agents was poor and effect estimates on weight were limited by publication bias. The number of severe hypoglycemic episodes was extremely low, and gliclazide appears at least equally effective compared to other glucose lowering agents. None of the trials were designed for evaluating cardiovascular outcomes, which warrants attention in future randomized trials.	[Landman, Gijs W. D.; Van Hateren, Kornelis J. J.; Van Dijk, Peter R.; Houweling, Sebastiaan T.; Bilo, Henk J. G.; Kleefstra, Nanne] Diabet Ctr Zwolle, Zwolle, Netherlands; [de Bock, Geertruide H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Gans, Rijk O. B.; Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Bilo, Henk J. G.] Isala Clin, Dept Internal Med, Zwolle, Netherlands	University of Groningen; University of Groningen; University of Groningen; Isala Clinics	Landman, GWD (corresponding author), Diabet Ctr Zwolle, Zwolle, Netherlands.	G.W.D.Landman@isala.nl	de Bock, Geertruida Hendrika/F-6529-2014; Landman, Gijs/AAJ-5540-2021	de Bock, Geertruida Hendrika/0000-0003-3104-4471; Landman, Gijs/0000-0002-6852-6450; Kleefstra, Nanne/0000-0003-1473-8519				Abdelmoneim AS, 2012, DIABETES OBES METAB, V14, P130, DOI 10.1111/j.1463-1326.2011.01496.x; [Anonymous], 2008, TYPE 2 DIABETES NATL; [Anonymous], 2010, COMP REPAGLINIDE GLI; AUCHAMPACH JA, 1992, CIRCULATION, V86, P311, DOI 10.1161/01.CIR.86.1.311; Charbonnel BH, 2005, DIABETIC MED, V22, P399, DOI 10.1111/j.1464-5491.2004.01426.x; COLE WC, 1991, CIRC RES, V69, P571, DOI 10.1161/01.RES.69.3.571; COLLIER A, 1989, DIABETES METAB, V15, P420; DAUT J, 1990, SCIENCE, V247, P1341, DOI 10.1126/science.2107575; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; De Angelis CD, 2005, NEW ENGL J MED, V352, P2436, DOI 10.1056/NEJMe058127; Filozof C, 2010, DIABETIC MED, V27, P318, DOI 10.1111/j.1464-5491.2010.02938.x; Foley JE, 2009, HORM METAB RES, V41, P905, DOI 10.1055/s-0029-1234042; Furlong NJ, 2003, DIABETIC MED, V20, P935, DOI 10.1046/j.1464-5491.2003.01053.x; GRAM J, 1991, American Journal of Medicine, V90, p62S, DOI 10.1016/0002-9343(91)90420-3; Gribble FM, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00272-6; Guvener N, 1999, ACTA DIABETOL, V36, P93, DOI 10.1007/s005920050151; HARROWER ADB, 1985, CURR MED RES OPIN, V9, P676, DOI 10.1185/03007998509109650; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; JERUMS G, 1987, Diabetes Research and Clinical Practice, V3, P71, DOI 10.1016/S0168-8227(87)80010-4; Jorgensen CH, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-54; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369; Kardas P, 2005, DIABETES OBES METAB, V7, P722, DOI 10.1111/j.1463-1326.2004.00462.x; Khalangot M, 2009, DIABETES RES CLIN PR, V86, P247, DOI 10.1016/j.diabres.2009.09.008; Lawrence JM, 2004, DIABETES CARE, V27, P41, DOI 10.2337/diacare.27.1.41; Matthews DR, 2005, DIABETES-METAB RES, V21, P167, DOI 10.1002/dmrr.478; NOURY J, 1991, DIABETES METAB, V17, P209; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perriello G, 2006, DIABETIC MED, V23, P246, DOI 10.1111/j.1464-5491.2006.01801.x; Ristic S, 2006, DIABETIC MED, V23, P757, DOI 10.1111/j.1464-5491.2006.01914.x; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Sadikot SM, 2008, DIABETES RES CLIN PR, V82, P391, DOI 10.1016/j.diabres.2008.09.004; Salman S, 2001, CURR MED RES OPIN, V16, P296, DOI 10.1185/030079901750120231; Schernthaner G, 2004, EUR J CLIN INVEST, V34, P535, DOI 10.1111/j.1365-2362.2004.01381.x; Schramm TK, 2011, EUR HEART J, V32, P1900, DOI 10.1093/eurheartj/ehr077; Swinnen S, 2009, DIABETOLOGIA, V52, P38, DOI 10.1007/s00125-008-1147-0; TESSIER D, 1994, DIABETIC MED, V11, P974, DOI 10.1111/j.1464-5491.1994.tb00256.x; Tessier D, 1999, METABOLISM, V48, P897, DOI 10.1016/S0026-0495(99)90226-3; Vandenbroucke JP, 2008, JAMA-J AM MED ASSOC, V300, P2417, DOI 10.1001/jama.2008.723; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	41	46	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e82880	10.1371/journal.pone.0082880	http://dx.doi.org/10.1371/journal.pone.0082880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533045	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600003
J	Papazova, DA; van Koppen, A; Koeners, MP; Bleys, RL; Verhaar, MC; Joles, JA				Papazova, Diana A.; van Koppen, Arianne; Koeners, Maarten P.; Bleys, Ronald L.; Verhaar, Marianne C.; Joles, Jaap A.			Maintenance of Hypertensive Hemodynamics Does Not Depend on ROS in Established Experimental Chronic Kidney Disease	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; DISMUTASE-MIMETIC DRUG; NITRIC-OXIDE SYNTHESIS; OXIDATIVE STRESS; ANTIOXIDANT THERAPY; ENDOTHELIAL DYSFUNCTION; MYOGENIC CONSTRICTION; MESENTERIC-ARTERIES; VASCULAR-RESISTANCE; NEPHRECTOMIZED RATS	While the presence of oxidative stress in chronic kidney disease (CKD) is well established, its relation to hypertensive renal hemodynamics remains unclear. We hypothesized that once CKD is established blood pressure and renal vascular resistance (RVR) no longer depend on reactive oxygen species. CKD was induced by bilateral ablation of 2/3 of each kidney. Compared to age-matched, sham-operated controls all ablated rats showed proteinuria, decreased glomerular filtration rate (GFR), more renal damage, higher mean arterial pressure (MAP), RVR and excretion of oxidative stress markers and hydrogen peroxide, while excretion of stable nitric oxide (NO) metabolites tended to decrease. We compared MAP, RVR, GFR and fractional excretion of sodium under baseline and during acute Tempol, PEG-catalase or vehicle infusion in rats with established CKD vs. controls. Tempol caused marked reduction in MAP in controls (96 +/- 5 vs. 79 +/- 4 mmHg, P<0.05) but not in CKD (130 +/- 5 vs. 127 +/- 6 mmHg). PEG-catalase reduced MAP in both groups (controls: 102 +/- 2 vs. 94 +/- 4 mmHg, P<0.05; CKD: 118 +/- 4 vs. 110 +/- 4 mmHg, P<0.05), but did not normalize MAP in CKD rats. Tempol and PEG-catalase slightly decreased RVR in both groups. Fractional excretion of sodium was increased by both Tempol and PEG-catalase in both groups. PEG-catalase decreased TBARS excretion in both groups. In sum, although oxidative stress markers were increased, MAP and RVR did not depend more on oxidative stress in CKD than in controls. Therefore reactive oxygen species appear not to be important direct determinants of hypertensive renal hemodynamics in this model of established CKD.	[Papazova, Diana A.; van Koppen, Arianne; Koeners, Maarten P.; Verhaar, Marianne C.; Joles, Jaap A.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Bleys, Ronald L.] Univ Med Ctr Utrecht, Dept Anat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Joles, JA (corresponding author), Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands.	J.A.Joles@umcutrecht.nl	Joles, Jaap/AAX-3249-2020; Verhaar, Marianne/AAM-6788-2020	Verhaar, Marianne/0000-0002-3276-6428; van Koppen, Arianne/0000-0001-9588-8863; Koeners, Maarten/0000-0001-7274-8999	Netherlands organization for Scientific Research (NWO) Vidi [016.096.359]	Netherlands organization for Scientific Research (NWO) Vidi(Netherlands Organization for Scientific Research (NWO))	MCV is supported by the Netherlands organization for Scientific Research (NWO) Vidi grant 016.096.359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia DM, 2002, KIDNEY INT, V61, P1776, DOI 10.1046/j.1523-1755.2002.00313.x; Beswick RA, 2001, HYPERTENSION, V37, P781, DOI 10.1161/01.HYP.37.2.781; Blezer ELA, 1998, STROKE, V29, P167, DOI 10.1161/01.STR.29.1.167; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Bongartz LG, 2010, AM J PHYSIOL-REG I, V298, pR815, DOI 10.1152/ajpregu.00727.2009; Chen J, 2002, AM J KIDNEY DIS, V39, P460, DOI 10.1053/ajkd.2002.31389; Erdei N, 2007, AM J PHYSIOL-HEART C, V292, pH649, DOI 10.1152/ajpheart.00596.2006; Galle J, 2001, NEPHROL DIAL TRANSPL, V16, P2135, DOI 10.1093/ndt/16.11.2135; Gao YJ, 2005, BRIT J PHARMACOL, V146, P1061, DOI 10.1038/sj.bjp.0706423; Garvin JL, 2003, ACTA PHYSIOL SCAND, V179, P225, DOI 10.1046/j.0001-6772.2003.01203.x; Guron GS, 2006, J HYPERTENS, V24, P387, DOI 10.1097/01.hjh.0000200511.02700.99; Hasdan G, 2002, KIDNEY INT, V61, P586, DOI 10.1046/j.1523-1755.2002.00166.x; Hasselwander O, 1998, FREE RADICAL RES, V29, P1, DOI 10.1080/10715769800300011; Himmelfarb J, 2004, SEMIN DIALYSIS, V17, P449, DOI 10.1111/j.0894-0959.2004.17605.x; Hughes JM, 2004, CLIN SCI, V106, P163, DOI 10.1042/CS20030225; Kamgar M, 2009, J NATL MED ASSOC, V101, P336, DOI 10.1016/S0027-9684(15)30881-6; Knight SF, 2010, AM J PHYSIOL-RENAL, V298, pF86, DOI 10.1152/ajprenal.00351.2009; Koeners MP, 2008, AM J PHYSIOL-REG I, V294, pR1847, DOI 10.1152/ajpregu.00073.2008; Koeners MP, 2011, J HYPERTENS, V29, P1160, DOI 10.1097/HJH.0b013e3283468344; Makino A, 2003, HYPERTENSION, V42, P25, DOI 10.1161/01.HYP.0000074903.96928.91; Makino A, 2002, HYPERTENSION, V39, P667, DOI 10.1161/hy0202.103469; Mann JFE, 2004, KIDNEY INT, V65, P1375, DOI 10.1111/j.1523-1755.2004.00513.x; Martin-Mateo MC, 1999, RENAL FAILURE, V21, P155, DOI 10.3109/08860229909066980; Mimic-Oka J, 1999, CLIN NEPHROL, V51, P233; Moreno JM, 2005, AM J PHYSIOL-ENDOC M, V289, pE776, DOI 10.1152/ajpendo.00611.2004; Mulder J, 2013, AM J PHYSIOL-REG I, V304, pR675, DOI 10.1152/ajpregu.00599.2012; Nishiyama A, 2004, J AM SOC NEPHROL, V15, P306, DOI 10.1097/01.ASN.0000108523.02100.E0; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Patel K, 2006, AM J PHYSIOL-REG I, V290, pR37, DOI 10.1152/ajpregu.00469.2005; Quiroz Y, 2001, AM J PHYSIOL-RENAL, V281, pF38, DOI 10.1152/ajprenal.2001.281.1.F38; Quiroz Y, 2009, NEPHRON EXP NEPHROL, V112, pE31, DOI 10.1159/000210577; Racasan S, 2003, AM J PHYSIOL-RENAL, V285, pF105, DOI 10.1152/ajprenal.00348.2002; Rancourt ME, 2010, AM J HYPERTENS, V23, P314, DOI 10.1038/ajh.2009.242; Savage T, 1998, CLIN SCI, V95, P681, DOI 10.1042/cs0950681; Schnackenberg CG, 1998, HYPERTENSION, V32, P59, DOI 10.1161/01.HYP.32.1.59; Schnackenberg CG, 1999, HYPERTENSION, V33, P424, DOI 10.1161/01.HYP.33.1.424; Sindhu RK, 2005, BBA-MOL CELL RES, V1743, P86, DOI 10.1016/j.bbamcr.2004.08.013; Sousa T, 2012, BRIT J PHARMACOL, V166, P2386, DOI 10.1111/j.1476-5381.2012.01957.x; Sousa T, 2008, EUR J PHARMACOL, V588, P267, DOI 10.1016/j.ejphar.2008.04.044; Tanaka T, 2013, NAT REV NEPHROL, V9, P211, DOI 10.1038/nrneph.2013.35; Tepel M, 2003, NEPHROL DIAL TRANSPL, V18, P1439, DOI 10.1093/ndt/gfg201; van Koppen A, 2012, CELL TRANSPLANT, V21, P2299, DOI 10.3727/096368912X636795; Vavrinec P, 2011, J RENIN-ANGIO-ALDO S, V12, P184, DOI 10.1177/1470320310391328; Vaziri ND, 2004, CURR OPIN NEPHROL HY, V13, P93, DOI 10.1097/00041552-200401000-00013; Vaziri ND, 2001, J PHARMACOL EXP THER, V298, P679; Vaziri ND, 2006, NAT CLIN PRACT NEPHR, V2, P582, DOI 10.1038/ncpneph0283; Vettoretti S, 2006, J HYPERTENS, V24, P2215, DOI 10.1097/01.hjh.0000249699.04113.36; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Zou AP, 2001, HYPERTENSION, V37, P547, DOI 10.1161/01.HYP.37.2.547	49	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88596	10.1371/journal.pone.0088596	http://dx.doi.org/10.1371/journal.pone.0088596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533120	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600078
J	Storkey, J; Stratonovitch, P; Chapman, DS; Vidotto, F; Semenov, MA				Storkey, Jonathan; Stratonovitch, Pierre; Chapman, Daniel S.; Vidotto, Francesco; Semenov, Mikhail A.			A Process-Based Approach to Predicting the Effect of Climate Change on the Distribution of an Invasive Allergenic Plant in Europe	PLOS ONE			English	Article							RAGWEED AMBROSIA-ARTEMISIIFOLIA; COMMON RAGWEED; SPECIES DISTRIBUTION; IMPACTS; SPREAD; MODEL; COMPETITION; FRANCE; POLLEN; WHEAT	Ambrosia artemisiifolia is an invasive weed in Europe with highly allergenic pollen. Populations are currently well established and cause significant health problems in the French Rhone valley, Austria, Hungary and Croatia but transient or casual introduced populations are also found in more Northern and Eastern European countries. A process-based model of weed growth, competition and population dynamics was used to predict the future potential for range expansion of A. artemisiifolia under climate change scenarios. The model predicted a northward shift in the available climatic niche for populations to establish and persist, creating a risk of increased health problems in countries including the UK and Denmark. This was accompanied by an increase in relative pollen production at the northern edge of its range. The southern European limit for A. artemisiifolia was not expected to change; populations continued to be limited by drought stress in Spain and Southern Italy. The process-based approach to modelling the impact of climate change on plant populations has the advantage over correlative species distribution models of being able to capture interactions of climate, land use and plant competition at the local scale. However, for this potential to be fully realised, additional empirical data are required on competitive dynamics of A. artemisiifolia in different crops and ruderal plant communities and its capacity to adapt to local conditions.	[Storkey, Jonathan] Rothamsted Res, AgroEcol Dept, Harpenden, Herts, England; [Stratonovitch, Pierre; Semenov, Mikhail A.] Rothamsted Res, Computat & Syst Biol Dept, Harpenden, Herts, England; [Chapman, Daniel S.] Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland; [Vidotto, Francesco] Univ Turin, Grugliasco, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Centre for Ecology & Hydrology (UKCEH); University of Turin	Storkey, J (corresponding author), Rothamsted Res, AgroEcol Dept, Harpenden, Herts, England.	jonathan.storkey@rothamsted.ac.uk	VIDOTTO, Francesco/G-4558-2018; Semenov, Mikhail/HCI-8667-2022; Stratonovitch, Pierre/H-4833-2019; Chapman, Daniel/O-5100-2019; Chapman, Daniel S/C-2900-2008; Semenov, Mikhail/W-8060-2019	VIDOTTO, Francesco/0000-0002-0971-1445; Semenov, Mikhail/0000-0002-1561-7113; Stratonovitch, Pierre/0000-0002-5806-2066; Chapman, Daniel/0000-0003-1836-4112; Chapman, Daniel S/0000-0003-1836-4112; Storkey, Jonathan/0000-0003-1094-8914	European Union [282687 - Atopica]; Natural Environment Research Council [CEH010021] Funding Source: researchfish	European Union(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements no282687 - Atopica. http://cordis.europa.eu/fp7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSETT IJ, 1975, CAN J PLANT SCI, V55, P463, DOI 10.4141/cjps75-072; Berry PM, 2002, GLOBAL ECOL BIOGEOGR, V11, P453, DOI 10.1111/j.1466-8238.2002.00304.x; Bohren C, 2006, J PLANT DIS PROTECT, P497; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Bullock JM, 2012, MAPPING DISTRIBUTION; Chapman DS, 2014, GLOBAL CHANGE BIOL, V20, P192, DOI 10.1111/gcb.12380; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Chauvel B, 2011, ACTA BOT GALLICA, V158, P309, DOI 10.1080/12538078.2011.10516276; Clements DR, 2011, WEED RES, V51, P227, DOI 10.1111/j.1365-3180.2011.00850.x; Dahl A., 1999, AEROBIOLOGIA, V15, P293, DOI [DOI 10.1023/A:1007678107552, 10.1023/A:1007678107552]; Dechamp C, 2009, AMBROISIE 1 INT RAGW; Deen W, 1998, WEED SCI, V46, P555, DOI 10.1017/S0043174500091098; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Dunnett NP, 1999, FUNCT ECOL, V13, P388, DOI 10.1046/j.1365-2435.1999.00331.x; Fumanal B, 2007, ANN AGR ENV MED, V14, P233; Gallinza N, 2010, AGR CONSPECTUS SCI, V75, P75; Genton BJ, 2005, OECOLOGIA, V146, P404, DOI 10.1007/s00442-005-0234-x; Gleeson SK, 1987, BIOMASS ALLOCATION A; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harrison PA, 1996, CLIMATE RES, V7, P225, DOI 10.3354/cr007225; Jamieson PD, 1998, EUR J AGRON, V8, P161, DOI 10.1016/S1161-0301(98)00020-3; Kazinczi G, 2008, HERBOLOGIA, P9; KROPFF MJ, 1992, WEED RES, V32, P437, DOI 10.1111/j.1365-3180.1992.tb01905.x; Lawless C, 2005, EUR J AGRON, V22, P19, DOI 10.1016/j.eja.2003.11.004; Makra L, 2005, GRANA, V44, P57, DOI 10.1080/00173130510010558; Mitich LW, 1996, WEED TECHNOL, V10, P236, DOI 10.1017/S0890037X00045966; Paquin V, 2004, AM J BOT, V91, P430, DOI 10.3732/ajb.91.3.430; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pinke G, 2011, PRESLIA, V83, P219; RICH TCG, 1994, GRANA, V33, P38, DOI 10.1080/00173139409427454; Rodinkova V., 2012, ALERGOLOGIA IMMUNOLO, V9, P181; Semenov MA, 2010, CLIM RES, V44, P3, DOI 10.3354/cr00865; Semenov MA, 2010, CLIM RES, V41, P1, DOI 10.3354/cr00836; Shrestha A, 1999, WEED SCI, V47, P557, DOI 10.1017/S0043174500092262; Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x; Storkey J, 2012, P ROY SOC B-BIOL SCI, V279, P1421, DOI 10.1098/rspb.2011.1686; Storkey J, 2007, AGR ECOSYST ENVIRON, V122, P173, DOI 10.1016/j.agee.2006.12.031; Stratonovitch P, 2012, GLOBAL CHANGE BIOL, V18, P2071, DOI 10.1111/j.1365-2486.2012.02650.x; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Toole E. H., 1946, JOUR AGRIC RES, V72, P201; Vogl G, 2008, EUR PHYS J-SPEC TOP, V161, P167, DOI 10.1140/epjst/e2008-00758-y; WILLEMSEN RW, 1975, AM J BOT, V62, P1, DOI 10.2307/2442073; Ziska LH, 2007, GLOBAL CHANGE BIOL, V13, P266, DOI 10.1111/j.1365-2486.2006.01264.x; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108	44	85	88	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88156	10.1371/journal.pone.0088156	http://dx.doi.org/10.1371/journal.pone.0088156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533071	Green Published, Green Accepted, gold			2022-12-27	WOS:000331262600029
J	Zhou, WG; Hong, MN; Zhang, K; Chen, DR; Han, WQ; Shen, WL; Zhu, DL; Gao, PJ				Zhou, Wugang; Hong, Mona; Zhang, Ke; Chen, Dongrui; Han, Weiqing; Shen, Weili; Zhu, Dingliang; Gao, Pingjin			Mechanisms of Improved Aortic Stiffness by Arotinolol in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ARTERIAL DISTENSIBILITY; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; NEBIVOLOL; DYSFUNCTION; INHIBITION; REACTIVITY; MORTALITY; PRESSURE; S-596	Objectives: This study investigates the effects on aortic stiffness and vasodilation by arotinolol and the underlying mechanisms in spontaneously hypertensive rats (SHR). Methods: The vasodilations of rat aortas, renal and mesenteric arteries were evaluated by isometric force recording. Nitric oxide (NO) was measured in human aortic endothelial cells (HAECs) by fluorescent probes. Sixteen-week old SHRs were treated with metoprolol (200 mg center dot kg-1 center dot d-1), arotinolol (30 mg center dot kg-1 center dot d-1) for 8 weeks. Central arterial pressure (CAP) and pulse wave velocity (PWV) were evaluated via catheter pressure transducers. Collagen was assessed by immunohistochemistry and biochemistry assay, while endothelial nitric oxide synthase (eNOS) and eNOS phosphorylation (p-eNOS) of HAECs or aortas were analyzed by western blotting. Results: Arotinolol relaxed vascular rings and the relaxations were attenuated by N omega-nitro-L-arginine methyl ester (L-NAME, NO synthase inhibitor) and the absence of endothelium. Furthermore, arotinolol-induced relaxations were attenuated by 4-aminopyridine (4-AP, Kv channels blocker). Arotinolol produced more nitric oxide compared to metoprolol and increased the expression of p-eNOS in HAECs. These results indicated that arotinolol-induced vasodilation involves endothelium-derived NO and Kv channels. The treatement with arotinolol in 8 weeks, but not metoprolol, markedly decreased CAP and PWV. Biochemistry assay and immunohistochemistry showed that aortic collagen depositions in the arotinolol groups were reduced compared with SHRs with metoprolol. Moreover, eNOS phosphorylation was significantly increased in aortinolol-treated SHR compared with SHRs with metoprolol. Conclusions: Arotinolol improves arterial stiffness in SHR, which involved in increasing NO and decreasing collagen contents in large arteries.	[Zhou, Wugang; Hong, Mona; Zhang, Ke; Chen, Dongrui; Han, Weiqing; Shen, Weili; Zhu, Dingliang; Gao, Pingjin] Shanghai Jiao Tong Univ, Dept Hypertens, RuiJin Hosp,Sch Med, Shanghai Key Lab Hypertens,Shanghai Inst Hyperten, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Dept Hypertens, RuiJin Hosp,Sch Med, Shanghai Key Lab Hypertens,Shanghai Inst Hyperten, Shanghai 200030, Peoples R China.	gaopingjin@sibs.ac.cn	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Natural Science Foundation of China [81230071, 81070261]; National High-tech RD Program [2012AA02A516]; National Key Project for Basic Research [2011CB503905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD Program(National High Technology Research and Development Program of China); National Key Project for Basic Research(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (81230071, 81070261), National High-tech R&D Program (2012AA02A516) and National Key Project for Basic Research (2011CB503905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MJ, 1999, EXP GERONTOL, V34, P513, DOI 10.1016/S0531-5565(99)00038-8; Chamiot-Clerc P, 2001, HYPERTENSION, V37, P313, DOI 10.1161/01.HYP.37.2.313; Chen QZ, 2013, HYPERTENS RES, V36, P306, DOI 10.1038/hr.2012.170; Dhakam Z, 2008, J HYPERTENS, V26, P351, DOI 10.1097/HJH.0b013e3282f283c9; Dikalov SI, 2013, ANTIOXID REDOX SIGNA; Garcia ML, 2014, J PHARMACOL EXP THER, V348, P153, DOI 10.1124/jpet.113.208603; Guerrero E, 2003, J CARDIOVASC PHARM, V42, P348, DOI 10.1097/00005344-200309000-00005; Han WQ, 2010, J HYPERTENS, V28, P2102, DOI 10.1097/HJH.0b013e32833d0197; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; HARA Y, 1979, FOLIA PHARMACOL JPN, V75, P707, DOI 10.1254/fpj.75.707; Kampus P, 2011, HYPERTENSION, V57, P1122, DOI 10.1161/HYPERTENSIONAHA.110.155507; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; Konduri GG, 2009, PEDIATR RES, V66, P289, DOI 10.1203/PDR.0b013e3181b1bc89; Kosch M, 2008, NEPHROL DIAL TRANSPL, V23, P2280, DOI 10.1093/ndt/gfm936; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; McEniery CM, 2004, HYPERTENSION, V44, P305, DOI 10.1161/01.HYP.0000137983.45556.6e; MIYAGISHI A, 1983, ARCH INT PHARMACOD T, V261, P222; Morecroft I, 2009, BRIT J PHARMACOL, V157, P1241, DOI 10.1111/j.1476-5381.2009.00283.x; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; Paniagua OA, 2000, HYPERTENSION, V36, P941, DOI 10.1161/01.HYP.36.6.941; Protogerou A, 2009, J AM COLL CARDIOL, V53, P445, DOI 10.1016/j.jacc.2008.09.046; Rath G, 2012, CURR HYPERTENS REP, V14, P310, DOI 10.1007/s11906-012-0278-3; Rezzani R, 2010, HYPERTENSION, V55, P1373, DOI 10.1161/HYPERTENSIONAHA.109.148254; Shen WL, 2013, FREE RADICAL BIO MED, V55, P73, DOI 10.1016/j.freeradbiomed.2012.11.011; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Verbeke F, 2011, CLIN J AM SOC NEPHRO, V6, P153, DOI 10.2215/CJN.05120610; Vidal-Petiot E, 2013, P NATL ACAD SCI USA, V110, P14366, DOI 10.1073/pnas.1304230110; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wallace SML, 2007, HYPERTENSION, V50, P228, DOI 10.1161/HYPERTENSIONAHA.107.089391; Weber MA, 2005, AM J HYPERTENS, V18, p169S, DOI 10.1016/j.amjhyper.2005.09.009; Xu CP, 2000, ARTERIOSCL THROM VAS, V20, P2566, DOI 10.1161/01.ATV.20.12.2566	31	6	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88722	10.1371/journal.pone.0088722	http://dx.doi.org/10.1371/journal.pone.0088722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533142	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600100
J	Niesten, JM; van der Schaaf, IC; van Dam, L; Vink, A; Vos, JA; Schonewille, WJ; de Bruin, PC; Mali, WPTM; Velthuis, BK				Niesten, Joris M.; van der Schaaf, Irene C.; van Dam, Lievay; Vink, Aryan; Vos, Jan Albert; Schonewille, Wouter J.; de Bruin, Peter C.; Mali, Willem P. T. M.; Velthuis, Birgitta K.			Histopathologic Composition of Cerebral Thrombi of Acute Stroke Patients Is Correlated with Stroke Subtype and Thrombus Attenuation	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; PERCUTANEOUS CORONARY INTERVENTION; NONCONTRAST CT; RISK-FACTORS; ATHEROSCLEROTIC PLAQUES; INTRAPLAQUE HEMORRHAGE; COMPUTED-TOMOGRAPHY; SINUS DENSITY; DISEASE	Introduction: We related composition of cerebral thrombi to stroke subtype and attenuation on non-contrast CT (NCCT) to gain more insight in etiopathogenesis and to validate thrombus attenuation as a new imaging biomarker for acute stroke. Methods: We histopathologically investigated 22 thrombi retrieved after mechanical thrombectomy in acute stroke patients. First, thrombi were classified as fresh, lytic or organized. Second, percentages of red blood cells (RBCs), platelets and fibrin and number of red, white (respectively RBCs or platelets outnumbering other components with >= 15%) or mixed thrombi were compared between large artery atherosclerosis (LAA), cardioembolism, dissection and unknown subtype. Third, correlation between attenuation and RBCs, platelets and fibrin was calculated using Pearson's correlation coefficients (r). Results: Thrombi were fresh in 73% (n = 16), lytic in 18% (n = 4) and organized in 9% (n = 2). The stroke cause was LAA in eight (36%), cardioembolism in six (27%), dissection in three (14%), and unknown in five (23%) patients. LAA thrombi showed the highest percentage RBCs (median 50 (range 35-90)), followed by dissection (35 (20-40), p = 0.05), cardioembolism (35 (5-45), p = 0.013) and unknown subtype (25 (2-40), p = 0.006). No differences in platelets (p = 0.16) and fibrin (p = 0.52) between subtypes were found. LAA thrombi were classified as red or mixed (both n = 4), cardioembolisms as mixed (n = 5) or white (n = 1) and dissection as mixed (n = 3). There was a moderate positive correlation between attenuation and RBCs (r = 0.401, p = 0.049), and weak negative correlations with platelets (r = -0.368, p = 0.09) and fibrin (r = -0.073, p = 0.75). Conclusions: The majority of cerebral thrombi is fresh. There are no differences in age of thrombi between subtypes. LAA thrombi have highest percentages RBCs, cardioembolism and unknown subtype lowest. No relationship exists between subtype and platelets or fibrin percentages. We found a correlation between the RBC-component and thrombus attenuation, which improves validation of thrombus attenuation on NCCT as an imaging biomarker for stroke management.	[Niesten, Joris M.; van der Schaaf, Irene C.; van Dam, Lievay; Mali, Willem P. T. M.; Velthuis, Birgitta K.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Vink, Aryan] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Vos, Jan Albert] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands; [Schonewille, Wouter J.] St Antonius Hosp, Dept Neurol, Nieuwegein, Netherlands; [de Bruin, Peter C.] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht	Niesten, JM (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	jmniesten@gmail.com	Mali, Willem PThM/I-1123-2014	Mali, Willem PThM/0000-0003-4391-0904	Dutch Heart Foundation [2008T034]; NutsOhra Foundation [0903-012]	Dutch Heart Foundation(Netherlands Heart Foundation); NutsOhra Foundation	Grants were provided by Dutch Heart Foundation (grant 2008T034), NutsOhra Foundation (grant 0903-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Almekhlafi MA, 2008, ANN NEUROL, V64, P344, DOI 10.1002/ana.21404; Bejot Y, 2008, J NEUROL NEUROSUR PS, V79, P1344, DOI 10.1136/jnnp.2008.150318; Besachio DA, 2013, NEURORADIOLOGY, V55, P941, DOI 10.1007/s00234-013-1194-1; Black DF, 2011, AM J NEURORADIOL, V32, P1354, DOI 10.3174/ajnr.A2504; Buyck PJ, 2013, AM J NEURORADIOL, V34, P1568, DOI 10.3174/ajnr.A3469; Chaves CJ, 2000, J NEUROL SCI, V173, P3, DOI 10.1016/S0022-510X(99)00299-3; Chen CJ, 2004, AM J NEURORADIOL, V25, P769; Nam HS, 2012, THROMB HAEMOSTASIS, V107, P786, DOI 10.1160/TH11-08-0585; Jerjes-Sanchez C, 2005, EUR HEART J, V26, P3, DOI 10.1093/eurheartj/ehi041; Kim EY, 2006, NEUROLOGY, V67, P1846, DOI 10.1212/01.wnl.0000244492.99737.a8; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Kim YK, 2009, THROMB RES, V123, P810, DOI 10.1016/j.thromres.2009.01.013; Kimura K, 2010, J NEUROL SCI, V295, P53, DOI 10.1016/j.jns.2010.05.012; Kirchhof K, 2003, RADIOLOGY, V228, P126, DOI 10.1148/radiol.2273020530; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lee SY, 2013, YONSEI MED J, V54, P28, DOI 10.3349/ymj.2013.54.1.28; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Lin HL, 2007, J MOL CELL CARDIOL, V43, P272, DOI 10.1016/j.yjmcc.2007.05.023; Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94; Mathiesen EB, 2001, CIRCULATION, V103, P2171; Moftakhar P, 2013, STROKE, V44, P243, DOI 10.1161/STROKEAHA.112.674127; NEW PFJ, 1976, RADIOLOGY, V121, P635, DOI 10.1148/121.3.635; Niessen F, 2003, STROKE, V34, P2019, DOI 10.1161/01.STR.0000080941.73934.30; Niesten JM, 2013, NEURORADIOLOGY, V55, P1071, DOI 10.1007/s00234-013-1217-y; Okamatsu K, 2004, CIRCULATION, V109, P465, DOI 10.1161/01.CIR.0000109696.92474.92; Puig J, 2012, AM J NEURORADIOL, V33, P90, DOI 10.3174/ajnr.A2878; Quadros AS, 2012, AM HEART J, V164, P553, DOI 10.1016/j.ahj.2012.07.022; Rao DS, 2005, CARDIOVASC PATHOL, V14, P285, DOI 10.1016/j.carpath.2005.07.003; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Schulz UGR, 2003, STROKE, V34, P2050, DOI 10.1161/01.STR.0000079818.08343.8C; SITZER M, 1995, STROKE, V26, P1231, DOI 10.1161/01.STR.26.7.1231; TABATA H, 1995, J AM COLL CARDIOL, V25, P1282, DOI 10.1016/0735-1097(95)00004-N; Takaya N, 2005, CIRCULATION, V111, P2768, DOI 10.1161/CIRCULATIONAHA.104.504167; Uchida Y, 2011, ARTERIOSCL THROM VAS, V31, P1452, DOI 10.1161/ATVBAHA.110.221671; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Wysokinski WE, 2004, J THROMB HAEMOST, V2, P1637, DOI 10.1111/j.1538-7836.2004.00899.x; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754	40	144	154	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88882	10.1371/journal.pone.0088882	http://dx.doi.org/10.1371/journal.pone.0088882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523944	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100093
J	Zhang, J; Zhou, RL				Zhang, Jing; Zhou, Renlai			Individual Differences in Automatic Emotion Regulation Affect the Asymmetry of the LPP Component	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; ELECTROCORTICAL RESPONSE; HEMISPHERIC-ASYMMETRY; ANGER PROVOCATION; STIMULI; AROUSAL; PICTURES; PREDICTS; JUDGMENTS	The main goal of this study was to investigate how automatic emotion regulation altered the hemispheric asymmetry of ERPs elicited by emotion processing. We examined the effect of individual differences in automatic emotion regulation on the late positive potential (LPP) when participants were viewing blocks of positive high arousal, positive low arousal, negative high arousal and negative low arousal pictures from International affect picture system (IAPS). Two participant groups were categorized by the Emotion Regulation-Implicit Association Test which has been used in previous research to identify two groups of participants with automatic emotion control and with automatic emotion express. The main finding was that automatic emotion express group showed a right dominance of the LPP component at posterior electrodes, especially in high arousal conditions. But no right dominance of the LPP component was observed for automatic emotion control group. We also found the group with automatic emotion control showed no differences in the right posterior LPP amplitude between high-and low-arousal emotion conditions, while the participants with automatic emotion express showed larger LPP amplitude in the right posterior in high-arousal conditions compared to low-arousal conditions. This result suggested that AER (Automatic emotion regulation) modulated the hemispheric asymmetry of LPP on posterior electrodes and supported the right hemisphere hypothesis.	[Zhou, Renlai] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China; [Zhou, Renlai] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhou, Renlai] Ctr Collaborat & Innovat Brain & Learning Sci, Beijing, Peoples R China; [Zhang, Jing] Renmin Univ China, Dept Psychol, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Renmin University of China	Zhou, RL (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	rlzhou@bnu.edu.cn	Zhou, Renlai/ABA-1226-2021	Zhou, Renlai/0000-0001-7035-7097	Major Project of the National Social Science Fund [11ZD187]; National Natural Science Foundation of China [31200845]; central government [12XNLF10]	Major Project of the National Social Science Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); central government	This research was supported by the Major Project of the National Social Science Fund (11&ZD187), the evaluation and training to the people with drug addiction in Beijing, the National Natural Science Foundation of China (Grant No. 31200845) and the Basic research funds in Renmin University of China from the central government (code: 12XNLF10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1987, BECK DEPRESSION INVE; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Cacioppo JT, 1996, PERS SOC PSYCHOL B, V22, P1205, DOI 10.1177/01461672962212002; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Dennis TA, 2009, J CHILD PSYCHOL PSYC, V50, P1373, DOI 10.1111/j.1469-7610.2009.02168.x; Dolcos F., 2002, J COGNITIVE NEUROSCI, V2, P252; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Erhan H, 1998, BRAIN COGNITION, V37, P286, DOI 10.1006/brcg.1998.0984; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Heller W., 1993, NEUROPSYCHOLOGY, V7, P476, DOI [10.1037/0894-4105.7.4.476, DOI 10.1037/0894-4105.7.4.476]; Kayser J, 2000, INT J PSYCHOPHYSIOL, V36, P211, DOI 10.1016/S0167-8760(00)00078-7; Kayser J, 1997, PSYCHOPHYSIOLOGY, V34, P414, DOI 10.1111/j.1469-8986.1997.tb02385.x; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Keil A, 2001, CLIN NEUROPHYSIOL, V112, P2057, DOI 10.1016/S1388-2457(01)00654-X; KESTENBAUM R, 1992, J EXP CHILD PSYCHOL, V54, P1, DOI 10.1016/0022-0965(92)90014-W; LAURIAN S, 1991, INT J PSYCHOPHYSIOL, V10, P231, DOI 10.1016/0167-8760(91)90033-T; [刘潇楠 LIU Xiao-nan], 2009, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V17, P687; Mauss IB, 2006, PERS SOC PSYCHOL B, V32, P589, DOI 10.1177/0146167205283841; Mauss IB, 2007, J EXP SOC PSYCHOL, V43, P698, DOI 10.1016/j.jesp.2006.07.003; Mocaiber I, 2010, NEUROSCI LETT, V476, P84, DOI 10.1016/j.neulet.2010.04.008; Munte TF, 1998, NEUROSCI RES, V30, P25, DOI 10.1016/S0168-0102(97)00118-1; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Proverbio AM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-44; Sato W, 2006, BRAIN COGNITION, V62, P261, DOI 10.1016/j.bandc.2006.06.006; Schmidt B, 2009, NEUROSCI LETT, V460, P237, DOI 10.1016/j.neulet.2009.05.068; Spielberger C. D., 1989, STATE TRAIT ANXIETY; TOMARKEN AJ, 1990, J PERS SOC PSYCHOL, V59, P791, DOI 10.1037/0022-3514.59.4.791; VANDERPLOEG RD, 1987, INT J PSYCHOPHYSIOL, V5, P193, DOI 10.1016/0167-8760(87)90006-7; Vogt J, 2011, COGNITION EMOTION, V25, P466, DOI 10.1080/02699931.2010.532613; Williams LE, 2009, EMOTION, V9, P847, DOI 10.1037/a0017745; Zhang J, 2011, J PSYCHOPHYSIOL, V25, P95, DOI 10.1027/0269-8803/a000045	36	21	22	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88261	10.1371/journal.pone.0088261	http://dx.doi.org/10.1371/journal.pone.0088261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523881	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100030
J	Dumont, E; Jokipii-Lukkari, S; Parkash, V; Vuosku, J; Sundstrom, R; Nymalm, Y; Sutela, S; Taskinen, K; Kallio, PT; Salminen, TA; Haggman, H				Dumont, Estelle; Jokipii-Lukkari, Soile; Parkash, Vimal; Vuosku, Jaana; Sundstrom, Robin; Nymalm, Yvonne; Sutela, Suvi; Taskinen, Katariina; Kallio, Pauli T.; Salminen, Tiina A.; Haggman, Hely			Evolution, Three-Dimensional Model and Localization of Truncated Hemoglobin PttTrHb of Hybrid Aspen	PLOS ONE			English	Article							LATERAL ROOT DEVELOPMENT; HEME DISTAL SITE; NITRIC-OXIDE; MYCOBACTERIUM-TUBERCULOSIS; LIGAND-BINDING; VITREOSCILLA HEMOGLOBIN; 2-ON-2 HEMOGLOBIN; EXPRESSION; STRESS; GENES	Thus far, research on plant hemoglobins (Hbs) has mainly concentrated on symbiotic and non-symbiotic Hbs, and information on truncated Hbs (TrHbs) is scarce. The aim of this study was to examine the origin, structure and localization of the truncated Hb (PttTrHb) of hybrid aspen (Populus tremula L. x tremuloides Michx.), the model system of tree biology. Additionally, we studied the PttTrHb expression in relation to non-symbiotic class1 Hb gene (PttHb1) using RNAi-silenced hybrid aspen lines. Both the phylogenetic analysis and the three-dimensional (3D) model of PttTrHb supported the view that plant TrHbs evolved vertically from a bacterial TrHb. The 3D model suggested that PttTrHb adopts a 2-on-2 sandwich of a-helices and has a Bacillus subtilis -like ligand-binding pocket in which E11Gln and B10Tyr form hydrogen bonds to a ligand. However, due to differences in tunnel cavity and gate residue (E7Ala), it might not show similar ligand-binding kinetics as in Bs-HbO (E7Thr). The immunolocalization showed that PttTrHb protein was present in roots, stems as well as leaves of in vitro -grown hybrid aspens. In mature organs, PttTrHb was predominantly found in the vascular bundles and specifically at the site of lateral root formation, overlapping consistently with areas of nitric oxide (NO) production in plants. Furthermore, the NO donor sodium nitroprusside treatment increased the amount of PttTrHb in stems. The observed PttTrHb localization suggests that PttTrHb plays a role in the NO metabolism.	[Dumont, Estelle; Jokipii-Lukkari, Soile; Vuosku, Jaana; Sutela, Suvi; Taskinen, Katariina; Haggman, Hely] Univ Oulu, Dept Biol, Oulu, Finland; [Dumont, Estelle] Aix Marseille Univ, UMR Transporteurs Membranaires Chimioresistance &, Marseille, France; [Parkash, Vimal; Sundstrom, Robin; Nymalm, Yvonne; Salminen, Tiina A.] Abo Akad Univ, Dept Biosci, Struct Bioinformat Lab, Turku, Finland; [Kallio, Pauli T.] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	University of Oulu; UDICE-French Research Universities; Aix-Marseille Universite; Abo Akademi University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Haggman, H (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	hely.haggman@oulu.fi	Salminen, Tiina A/G-7492-2019; Salminen, Tiina A./AAM-5443-2021	Salminen, Tiina A/0000-0002-4135-8020; Salminen, Tiina A./0000-0002-4135-8020; Jokipii-Lukkari, Soile/0000-0002-8935-1469; Sutela, Suvi/0000-0003-0426-0718	Academy of Finland [123826]; Sigrid Juselius Foundation; Tor, Joe, and Pentti Borg Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tor, Joe, and Pentti Borg Foundation	Research funding has been achieved from Academy of Finland (grant no, 123826 to HH), from the Sigrid Juselius Foundation, and Tor, Joe, and Pentti Borg Foundation (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almada R, 2013, TREE GENET GENOMES, V9, P1051, DOI 10.1007/s11295-013-0618-8; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; Bonamore A, 2005, FEBS J, V272, P4189, DOI 10.1111/j.1742-4658.2005.04831.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustos-Sanmamed P, 2011, NEW PHYTOL, V189, P765, DOI 10.1111/j.1469-8137.2010.03527.x; Cantrel C, 2011, NEW PHYTOL, V189, P415, DOI 10.1111/j.1469-8137.2010.03500.x; Christianson JA, 2010, PLANT SIGNAL BEHAV, V5, P1006, DOI [10.4161/psb.5.8.12231, 10.1093/pcp/pcp163]; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Corpas FJ, 2006, PLANTA, V224, P246, DOI 10.1007/s00425-005-0205-9; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; Dordas C, 2003, ANN BOT-LONDON, V91, P173, DOI 10.1093/aob/mcf115; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gabaldon C, 2005, NEW PHYTOL, V165, P121, DOI 10.1111/j.1469-8137.2004.01230.x; Gaupels F, 2008, NEW PHYTOL, V178, P634, DOI 10.1111/j.1469-8137.2008.02388.x; Giangiacomo L, 2005, J BIOL CHEM, V280, P9192, DOI 10.1074/jbc.M407267200; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Guo K, 2008, J EXP BOT, V59, P3443, DOI 10.1093/jxb/ern194; Haggman H, 2003, PLANT BIOTECHNOL J, V1, P287, DOI 10.1046/j.1467-7652.2003.00027.x; Hebelstrup KH, 2013, PHYSIOL PLANTARUM, V148, P457, DOI 10.1111/ppl.12062; Hebelstrup KH, 2012, J EXP BOT, V63, P5581, DOI 10.1093/jxb/ers210; Hemschemeier A, 2013, P NATL ACAD SCI USA, V110, P10854, DOI 10.1073/pnas.1302592110; Hill RD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls004; Hossain KK, 2011, RUSS J PLANT PHYSL+, V58, P629, DOI 10.1134/S1021443711030046; Hossain KK, 2010, RUSS J PLANT PHYSL+, V57, P222, DOI 10.1134/S1021443710020093; Hoy JA, 2008, PLANT PHYSIOL BIOCH, V46, P371, DOI 10.1016/j.plaphy.2007.12.016; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ilari A, 2007, ARCH BIOCHEM BIOPHYS, V457, P85, DOI 10.1016/j.abb.2006.09.033; Johnson MS, 1996, METHOD ENZYMOL, V266, P575; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; Jokipii S, 2008, J EXP BOT, V59, P2449, DOI 10.1093/jxb/ern107; Jokipii-Lukkari S, 2011, THESIS U OULU; Jokipii-Lukkari S, 2009, J EXP BOT, V60, P409, DOI 10.1093/jxb/ern320; Karppinen K, 2010, MOL BIOTECHNOL, V46, P219, DOI 10.1007/s12033-010-9299-9; Kim DY, 2013, BIOL PLANTARUM, V57, P281, DOI 10.1007/s10535-012-0268-y; 이형석, 2004, [Journal of Plant Biology, Journal of Plant Biology(한국식물학회지)], V47, P92; Larsen K, 2003, BBA-GEN SUBJECTS, V1621, P299, DOI 10.1016/S0304-4165(03)00094-1; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Liu C, 2004, BIOCHEM BIOPH RES CO, V316, P1163, DOI 10.1016/j.bbrc.2004.02.170; Milani M, 2005, J INORG BIOCHEM, V99, P97, DOI 10.1016/j.jinorgbio.2004.10.035; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Mur LAJ, 2012, J EXP BOT, V63, P4375, DOI 10.1093/jxb/ers116; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Narsai R, 2011, NEW PHYTOL, V190, P472, DOI 10.1111/j.1469-8137.2010.03589.x; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellet H, 2007, BIOCHEMISTRY-US, V46, P11440, DOI 10.1021/bi7010288; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pesce A, 2011, BBA-PROTEINS PROTEOM, V1814, P810, DOI 10.1016/j.bbapap.2010.11.001; Qiu YL, 1999, TRENDS PLANT SCI, V4, P26, DOI 10.1016/S1360-1385(98)01361-2; Rogstam A, 2007, J BACTERIOL, V189, P3063, DOI 10.1128/JB.01782-06; Ross EJH, 2001, PROTOPLASMA, V218, P125, DOI 10.1007/BF01306602; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smagghe BJ, 2007, PLANT SIGNAL BEHAV, V2, P43, DOI 10.4161/psb.2.1.3812; Soltis DE, 2003, PLANT PHYSIOL, V132, P1790, DOI 10.1104/pp.103.022509; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; Vazquez-Limon C, 2012, PLANT SCI, V191, P71, DOI 10.1016/j.plantsci.2012.04.013; Vieweg MF, 2005, PLANTA, V220, P757, DOI 10.1007/s00425-004-1397-0; Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4; Vuosku J, 2006, PLANT PHYSIOL, V142, P1027, DOI 10.1104/pp.106.083030; Wang YH, 2003, PLANT CELL ENVIRON, V26, P673, DOI 10.1046/j.1365-3040.2003.01002.x; Watts RA, 2001, P NATL ACAD SCI USA, V98, P10119, DOI 10.1073/pnas.191349198; Wingler A, 2004, NEW PHYTOL, V161, P781, DOI 10.1111/j.1469-8137.2004.00996.x; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x	70	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88573	10.1371/journal.pone.0088573	http://dx.doi.org/10.1371/journal.pone.0088573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520401	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600092
J	Han, NN; Zheng, Y; Li, R; Li, XY; Zhou, M; Niu, Y; Zhang, Q				Han, Nana; Zheng, Yong; Li, Ran; Li, Xianyu; Zhou, Mi; Niu, Yun; Zhang, Qi			beta-Catenin Enhances Odontoblastic Differentiation of Dental Pulp Cells through Activation of Runx2	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; STEM-CELLS; EXPRESSION; REGENERATION; MOLECULES; RESPONSES; PATHWAY; STRESS; REPAIR; MOUSE	An intense stimulus can cause death of odontoblasts and initiate odontoblastic differentiation of stem/progenitor cell populations of dental pulp cells (DPCs), which is followed by reparative dentin formation. However, the mechanism of odontoblastic differentiation during reparative dentin formation remains unclear. This study was to determine the role of beta-catenin, a key player in tooth development, in reparative dentin formation, especially in odontoblastic differentiation. We found that beta-catenin was expressed in odontoblast-like cells and DPCs beneath the perforation site during reparative dentin formation after direct pulp capping. The expression of beta-catenin was also significantly upregulated during odontoblastic differentiation of in vitro cultured DPCs. The expression pattern of runt-related transcription factor 2 (Runx2) was similar to that of b-catenin. Immunofluorescence staining indicated that Runx2 was also expressed in beta-catenin-positive odontoblastlike cells and DPCs during reparative dentin formation. Knockdown of b-catenin disrupted odontoblastic differentiation, which was accompanied by a reduction in beta-catenin binding to the Runx2 promoter and diminished expression of Runx2. In contrast, lithium chloride (LiCl) induced accumulation of b-catenin produced the opposite effect to that caused by beta-catenin knockdown. In conclusion, it was reported in this study for the first time that beta-catenin can enhance the odontoblastic differentiation of DPCs through activation of Runx2, which might be the mechanism involved in odontoblastic differentiation during reparative dentin formation.	[Han, Nana; Li, Ran; Li, Xianyu; Zhou, Mi; Niu, Yun; Zhang, Qi] Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Hubei, Peoples R China; [Han, Nana; Li, Ran; Li, Xianyu; Zhou, Mi; Niu, Yun; Zhang, Qi] Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Wuhan 430072, Hubei, Peoples R China; [Zhang, Qi] Tongji Univ, Sch Stomatol, Dept Endodont, Lab Oral Biomed Sci & Translat Med, Shanghai 200092, Peoples R China; [Zheng, Yong] Wuhan Univ, Sch Med, Dept Anat & Embryol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Tongji University; Wuhan University	Zhang, Q (corresponding author), Wuhan Univ, Minist Educ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Hubei, Peoples R China.	qizhang@tongji.edu.cn	li, ran/GPW-6786-2022; NIU, John Yun/B-9922-2017	NIU, John Yun/0000-0002-3471-180X	National Natural Science Foundation of China (NSFC) [81070824, 81371141]; Fundamental Research Funds for the Central Universities [1504-219-032, 201130402020013]; Specialized Research Fund for the Doctoral Program of Higher Education [20130072110020]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the grants from the National Natural Science Foundation of China (NSFC No. 81070824 and 81371141), the Fundamental Research Funds for the Central Universities (Grant No: 1504-219-032 and 201130402020013) and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No: 20130072110020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chau WK, 2013, ONCOGENE, V32, P2767, DOI 10.1038/onc.2012.290; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Chen S, 2002, CONNECT TISSUE RES, V43, P338, DOI 10.1080/03008200290000691; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cooper PR, 2010, J DENT, V38, P687, DOI 10.1016/j.jdent.2010.05.016; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Faraco IM, 2001, DENT TRAUMATOL, V17, P163, DOI 10.1034/j.1600-9657.2001.170405.x; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Heo JS, 2010, MOL CELLS, V30, P449, DOI 10.1007/s10059-010-0139-3; Huang GTJ, 2006, J ENDODONT, V32, P1066, DOI 10.1016/j.joen.2006.05.009; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lee SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061960; Lee SY, 2012, J ENDODONT, V38, P405, DOI 10.1016/j.joen.2011.12.025; Lee SK, 2010, LIFE SCI, V86, P107, DOI 10.1016/j.lfs.2009.11.013; Lee YH, 2013, J ENDODONT, V39, P236, DOI 10.1016/j.joen.2012.11.006; Li J, 2012, MOL CELL BIOCHEM, V362, P233, DOI 10.1007/s11010-011-1148-z; Li ST, 2011, BIOCHEM BIOPH RES CO, V410, P698, DOI 10.1016/j.bbrc.2011.06.065; Li XY, 2012, J ENDODONT, V38, P814, DOI 10.1016/j.joen.2012.03.009; Li Y, 2011, Adv Dent Res, V23, P280, DOI 10.1177/0022034511405387; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lim X, 2013, COLD SPRING IN PRESS, V5; Lin H, 2013, J CELL PHYSIOL, V228, P2076, DOI 10.1002/jcp.24377; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Liu H, 2005, ARCH ORAL BIOL, V50, P923, DOI 10.1016/j.albchoralbio.2005.03.003; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Mitsiadis TA, 2004, J DENT RES, V83, P896, DOI 10.1177/154405910408301202; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; OGUNTEBI BR, 1995, J ENDODONT, V21, P79, DOI 10.1016/S0099-2399(06)81100-3; Ordonez-Moran P, 2013, ONCOGENE IN PRESS; Parirokh M, 2011, J ENDODONT, V37, P786, DOI 10.1016/j.joen.2011.03.010; Piek E, 2010, BONE, V46, P613, DOI 10.1016/j.bone.2009.10.024; Qin W, 2012, J ENDODONT, V38, P66, DOI 10.1016/j.joen.2011.09.025; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Salins P, 2007, NEUROSCI LETT, V412, P211, DOI 10.1016/j.neulet.2006.07.045; Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41; Scheller EL, 2008, J DENT RES, V87, P126, DOI 10.1177/154405910808700206; Silkstone D, 2008, NAT CLIN PRACT RHEUM, V4, P413, DOI 10.1038/ncprheum0838; Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x; Smith AJ, 2002, CARIES RES, V36, P223, DOI 10.1159/000063930; Tecles O, 2005, ARCH ORAL BIOL, V50, P103, DOI 10.1016/j.archoralbio.2004.11.009; Wang J, 2012, CELL PROLIFERAT, V45, P121, DOI 10.1111/j.1365-2184.2012.00806.x; Wei X, 2007, J ENDODONT, V33, P703, DOI 10.1016/j.joen.2007.02.009; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yoshioka S, 2013, J BIOCHEM, V153, P43, DOI 10.1093/jb/mvs117; Yu C, 2007, AUST DENT J, V52, pS4, DOI 10.1111/j.1834-7819.2007.tb00525.x; Zhang Q, 2007, ARCH ORAL BIOL, V52, P720, DOI 10.1016/j.archoralbio.2007.02.005	52	65	77	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88890	10.1371/journal.pone.0088890	http://dx.doi.org/10.1371/journal.pone.0088890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520423	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600114
J	Kawamura, M; Kuriyama, I; Maruo, S; Kuramochi, K; Tsubaki, K; Yoshida, H; Mizushina, Y				Kawamura, Moe; Kuriyama, Isoko; Maruo, Sayako; Kuramochi, Kouji; Tsubaki, Kazunori; Yoshida, Hiromi; Mizushina, Yoshiyuki			Anti-Tumor Effects of Novel 5-O-Acyl Plumbagins Based on the Inhibition of Mammalian DNA Replicative Polymerase Activity	PLOS ONE			English	Article							FATTY-ACIDS; GROWTH; PLANT; MECHANISM; ZEYLANICA; QUINONES; PRIMASE; LAMBDA	We previously found that vitamin K-3 (menadione, 2-methyl-1,4-naphthoquinone) inhibits the activity of human mitochondrial DNA polymerase gamma (pol gamma). In this study, we focused on plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), and chemically synthesized novel plumbagins conjugated with C2:0 to C22:6 fatty acids (5-O-acyl plumbagins). These chemically modified plumbagins enhanced mammalian pol inhibition and their cytotoxic activity. Plumbagin conjugated with chains consisting of more than C18-unsaturated fatty acids strongly inhibited the activities of calf pol a and human pol c. Plumbagin conjugated with oleic acid (C18:1-acyl plumbagin) showed the strongest suppression of human colon carcinoma (HCT116) cell proliferation among the ten synthesized 5-O-acyl plumbagins. The inhibitory activity on pol a, a DNA replicative pol, by these compounds showed high correlation with their cancer cell proliferation suppressive activity. C18:1-Acyl plumbagin selectively inhibited the activities of mammalian pol species, but did not influence the activities of other pols and DNA metabolic enzymes tested. This compound inhibited the proliferation of various human cancer cell lines, and was the cytotoxic inhibitor showing strongest inhibition towards HT-29 colon cancer cells (LD50 = 2.9 mu M) among the nine cell lines tested. In an in vivo anti-tumor assay conducted on nude mice bearing solid tumors of HT-29 cells, C18:1-acyl plumbagin was shown to be a promising tumor suppressor. These data indicate that novel 5-O-acyl plumbagins act as anti-cancer agents based on mammalian DNA replicative pol a inhibition. Moreover, the results suggest that acylation of plumbagin is an effective chemical modification to improve the anti-cancer activity of vitamin K3 derivatives, such as plumbagin.	[Kawamura, Moe; Maruo, Sayako; Kuramochi, Kouji; Tsubaki, Kazunori] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 606, Japan; [Kuriyama, Isoko; Yoshida, Hiromi; Mizushina, Yoshiyuki] Kobe Gakuin Univ, Fac Nutr, Lab Food & Nutr Sci, Kobe, Hyogo 65121, Japan; [Mizushina, Yoshiyuki] Kobe Gakuin Univ, Cooperat Res Ctr Life Sci, Kobe, Hyogo 65121, Japan	Kyoto Prefectural University; Kobe Gakuin University; Kobe Gakuin University	Kuramochi, K (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 606, Japan.	kuramoch@kpu.ac.jp; mizushin@nutr.kobegakuin.ac.jp		Kuramochi, Kouji/0000-0003-0571-9703	MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan); MEXT [24580205, 23710262]; Hyogo Science and Technology Association (Japan); JST (Japan Science and Technology Agency); Grants-in-Aid for Scientific Research [24580205] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association (Japan); JST (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan)-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016. Y.M. acknowledges Grant-in-Aids for Scientific Research (C) (No. 24580205) from MEXT, and the Hyogo Science and Technology Association (Japan). I.K. acknowledges a Grant-in-Aid for Young Scientists (B) (No. 23710262) from MEXT. K.K and Y.M. acknowledge a Grant-in-Aid for A-STEP (Adaptable and Seamless Technology Transfer Program through target-driven R&D) (Exploratory Research) from JST (Japan Science and Technology Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Berdis AJ, 2008, BIOCHEMISTRY-US, V47, P8253, DOI 10.1021/bi801179f; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Cho AK, 2004, AEROSOL SCI TECH, V38, P68, DOI 10.1080/02786820390229471; DATE T, 1988, BIOCHEMISTRY-US, V27, P2983, DOI 10.1021/bi00408a048; Ding YX, 2005, J PHARM PHARMACOL, V57, P111, DOI 10.1211/0022357055119; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Kornberg K., 1992, DNA REPLICATION, P197; Kusumoto R, 2004, GENES CELLS, V9, P1139, DOI 10.1111/j.1365-2443.2004.00797.x; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045023; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; LU BC, 1991, J BIOL CHEM, V266, P21060; Maruo S, 2011, BIOORGAN MED CHEM, V19, P5803, DOI 10.1016/j.bmc.2011.08.023; Mathew R, 2010, CHEM BIOL DRUG DES, V76, P34, DOI 10.1111/j.1747-0285.2010.00987.x; Mizushina Y, 2000, J BIOL CHEM, V275, P33957, DOI 10.1074/jbc.M006096200; Mizushina Y., 2011, Journal of Japanese Society of Nutrition and Food Science, V64, P377; Mizushina Y, 1997, BBA-GEN SUBJECTS, V1336, P509, DOI 10.1016/S0304-4165(97)00067-6; Mizushina Y, 1996, BBA-GENE STRUCT EXPR, V1308, P256, DOI 10.1016/0167-4781(96)00121-2; Mizushina Y, 2002, BIOCHEM PHARMACOL, V63, P421; Mizushina Y., 2007, CURR ENZYME INHIB, V3, P61; Mizushina Y, 2007, BIOCHIMIE, V89, P581, DOI 10.1016/j.biochi.2007.01.009; Mizushina Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1239, DOI 10.1271/bbb.90121; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mossa JS, 2004, PHYTOTHER RES, V18, P934, DOI 10.1002/ptr.1420; NAKAYAMA C, 1985, J BIOCHEM-TOKYO, V97, P1385, DOI 10.1093/oxfordjournals.jbchem.a135192; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Ogawa A, 1998, JPN J CANCER RES, V89, P1154, DOI 10.1111/j.1349-7006.1998.tb00510.x; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Oshige M, 2004, PROTEIN EXPRES PURIF, V35, P248, DOI 10.1016/j.pep.2004.02.001; SAKAGUCHI K, 1980, CELL STRUCT FUNCT, V5, P323, DOI 10.1247/csf.5.323; Sakaguchi K, 2002, SEIKAGAKU, V74, P244; Sasaki R, 2008, CANCER SCI, V99, P1040, DOI 10.1111/j.1349-7006.2008.00771.x; Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x; SOLTIS DA, 1982, J BIOL CHEM, V257, P1332; Srinivas P, 2004, MOL CARCINOGEN, V40, P201, DOI 10.1002/mc.20031; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; TAMAI K, 1988, BIOCHIM BIOPHYS ACTA, V950, P263, DOI 10.1016/0167-4781(88)90122-4; TamiyaKoizumi K, 1997, BIOCHEM MOL BIOL INT, V41, P1179; Tilak JC, 2004, REDOX REP, V9, P219, DOI 10.1179/135100004225005976; Uchiyama Y, 2004, EUR J BIOCHEM, V271, P2799, DOI 10.1111/j.1432-1033.2004.04214.x; Umeda S, 2000, EUR J BIOCHEM, V267, P200, DOI 10.1046/j.1432-1327.2000.00990.x	45	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88736	10.1371/journal.pone.0088736	http://dx.doi.org/10.1371/journal.pone.0088736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520419	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600110
J	Virk, RK; Tambyah, PA; Inoue, M; Lim, EAS; Chan, KW; Chua, C; Tan, BH				Virk, Ramandeep Kaur; Tambyah, Paul Anantharajah; Inoue, Masafumi; Lim, Elizabeth Ai-Sim; Chan, Ka-Wei; Chua, Catherine; Tan, Boon-Huan			Prospective Surveillance and Molecular Characterization of Seasonal Influenza in a University Cohort in Singapore	PLOS ONE			English	Article							VIRUS DETECTION; PCR; ASSAY; EMERGENCE; INFECTION; ILLNESS	Background: Southeast Asia is believed to be a potential locus for the emergence of novel influenza strains, and therefore accurate sentinel surveillance in the region is critical. Limited information exists on sentinel surveillance of influenza-like illness (ILI) in young adults in Singapore in a University campus setting. The objective of the present study was to determine the proportion of ILI caused by influenza A and B viruses in a university cohort in Singapore. Methodology/Principal Findings: We conducted a prospective surveillance study from May through October 2007, at the National University of Singapore (NUS). Basic demographic information and nasopharyngeal swabs were collected from students and staff with ILI. Reverse-transcriptase PCR (RT-PCR) and viral isolation were employed to detect influenza viruses. Sequencing of hemagglutinin (HA) and neuraminidase (NA) genes of some representative isolates was also performed. Overall proportions of influenza A and B virus infections were 47/266 (18%) and 9/266 (3%) respectively. The predominant subtype was A/H3N2 (55%) and the rest were A/H1N1 (45%). The overall sensitivity difference for detection of influenza A viruses using RT-PCR and viral isolation was 53%. Phylogenetic analyses of HA and NA gene sequences of Singapore strains showed identities higher than 98% within both the genes. The strains were more similar to strains included in the WHO vaccine recommendation for the following year (2008). Genetic markers of oseltamivir resistance were not detected in any of the sequenced Singapore isolates. Conclusions/Significance: HA and NA gene sequences of Singapore strains were similar to vaccine strains for the upcoming influenza season. No drug resistance was found. Sentinel surveillance on university campuses should make use of molecular methods to better detect emerging and re-emerging influenza viral threats.	[Virk, Ramandeep Kaur; Tambyah, Paul Anantharajah] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Inoue, Masafumi] Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore; [Lim, Elizabeth Ai-Sim; Chan, Ka-Wei; Tan, Boon-Huan] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore; [Tan, Boon-Huan] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Chua, Catherine] Natl Univ Singapore, Univ Hlth Ctr, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore; National University of Singapore	Virk, RK (corresponding author), Natl Univ Singapore, Dept Med, Singapore 117548, Singapore.	drramandeepvirk@yahoo.com.sg	Tan, Boon Huan/ABB-8381-2021	Tan, Boon Huan/0000-0002-4976-7988	Infectious Diseases Research Fund; NUS-MINDEF JPP grant; Ministry of Defence, Singapore; Biomedical Research Council	Infectious Diseases Research Fund; NUS-MINDEF JPP grant; Ministry of Defence, Singapore(Ministry of Defence, Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	The work at NUS was in part supported and funded by the Infectious Diseases Research Fund and NUS-MINDEF JPP grant. The work at DSO National Laboratories was funded by the Ministry of Defence, Singapore. The work at the Institute of Molecular and Cell Biology (IMCB) was in part supported and funded by the Biomedical Research Council, which is part of Singapore's Agency for Science, Technology, and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell DS, 1997, J OCCUP ENVIRON MED, V39, P408, DOI 10.1097/00043764-199705000-00006; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; Dwyer DE, 2006, MED J AUSTRALIA, V185, pS48; Eggers M, 2012, EUR J CLIN MICROBIOL, V31, P1257, DOI 10.1007/s10096-011-1437-1; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Hindiyeh M, 2005, J CLIN MICROBIOL, V43, P589, DOI 10.1128/JCM.43.2.589-595.2005; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Inoue M, 2010, EMERG INFECT DIS, V16, P1633, DOI 10.3201/eid1610.100688; Kadri Z N, 1970, Singapore Med J, V11, P30; Liao RS, 2009, J CLIN MICROBIOL, V47, P527, DOI 10.1128/JCM.01213-08; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Ministry of Health Singapore, 2010, COMM DIS SURV SING 2, P7; mith AB, 2003, J CLIN VIROL, V28, P51; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mullins J, 2011, J AM COLL HEALTH, V59, P246, DOI 10.1080/07448481.2010.502197; Ng TP, 2002, ANN ACAD MED SINGAP, V31, P182; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Nolte FS, 2008, CLIN INFECT DIS, V47, pS123, DOI 10.1086/591392; Poddar SK, 2002, J VIROL METHODS, V99, P63, DOI 10.1016/S0166-0934(01)00380-9; Reina J, 2010, ENFERM INFEC MICR CL, V28, P95, DOI 10.1016/j.eimc.2008.11.021; Seah SGK, 2010, J CLIN VIROL, V47, P289, DOI 10.1016/j.jcv.2009.12.011; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Sutejo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033732; Tang JLWT, 2010, ANN ACAD MED SINGAP, V39, P291; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Wang RXE, 2010, EXPERT REV ANTI-INFE, V8, P517, DOI 10.1586/ERI.10.24; World Health Organization, 2002, WHO MAN AN INFL DIAG; Zitterkopf NL, 2006, J CLIN MICROBIOL, V44, P3366, DOI 10.1128/JCM.00314-06	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88345	10.1371/journal.pone.0088345	http://dx.doi.org/10.1371/journal.pone.0088345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520371	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600062
J	Wei, LZ; Wang, HL; Liu, X; Lu, YP; Xu, F; Yuan, JQ; Ling, YQ				Wei, Lin-zhen; Wang, Hai-lin; Liu, Xin; Lu, Ya-peng; Xu, Fei; Yuan, Jin-qiu; Ling, Ya-qin			Meta-Analysis on the Relationship between HLA-DRBl Gene Polymorphism and Cervical Cancer in Chinese Population	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CLASS-II ALLELES; ANTIGEN CLASS-II; PUBLICATION BIAS; 2 PARTS; RISK; ASSOCIATION; HLA-DRB1; NEOPLASIA; CARCINOMA	Aim: To determine the association between HLA-DRB1 haplotypes and risk of cervical cancer in unselected and samples from Chinese ethnicities. Methods: A comprehensive search for articles from their inception to April 1st, 2013 was conducted from PubMed, Medline, Elsevier Science, Springer Link, Cochrane Library database, China biology medical literature database (CBM), China National Knowledge Infrastructure (CNKI), VIP, and Chinese literature database(Wang fang). A total of 1596 patients with cervical cancer and 2048 controls from the 12 studies on the relationship between gene polymorphism of HLA-DRB l and cervical cancer were performed and data were analyzed and processed using Review Manager 5.0 and Stata 11.0. Results: Among the 13 family alleles, two (DRB1* 03 and DRB1* 08) were found to be negatively associated with cervical cancer in all studies or in Uighur subgroups, and two (DRB1* 10 and DRB1* 15) were positively associated with in all studies or in Uighur subgroups. Among the 25 specific alleles, six (DRB1* 0301, * 0403,* 0404, * 0803, * 1312 and * 1502) were associated with an increased risk cervical cancer in all studies. No significant association was established for other HLA-DRB1 family alleles and specific alleles. Ethnicity partially explained the race influence of DRB1* 12, DRB1* 14, DRB1* 0301, DRB1* 0403, DRB1* 0404, DRB1* 0803, DRB1* 1312 and DRB1* 1502 phenotypes. Conclusion: Our results support the hypothesis that the HLA-DRB1 family alleles and specific alleles might influence the susceptibility or resistance to cervical cancer, suggesting that immune regulation may play a key role in this disease, although further investigations are still needed.	[Wei, Lin-zhen; Wang, Hai-lin] Gansu Prov Hosp, Dept Obstet & Gynecol, Lanzhou, Gansu, Peoples R China; [Wei, Lin-zhen; Lu, Ya-peng; Xu, Fei] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Gansu, Peoples R China; [Liu, Xin; Ling, Ya-qin] Lanzhou Univ, Sch Basic Med Sci, Inst Pathogen Biol, Lanzhou 730000, Gansu, Peoples R China; [Yuan, Jin-qiu] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China	Lanzhou University; Lanzhou University; Chinese University of Hong Kong	Wang, HL (corresponding author), Gansu Prov Hosp, Dept Obstet & Gynecol, Lanzhou, Gansu, Peoples R China.	xinyuetiantian@foxmail.com	Yuan, Jinqiu/A-4867-2018					Beskow AH, 2001, INT J CANCER, V93, P817, DOI 10.1002/ijc.1412; Castro FA, 2009, INT J CANCER, V125, P1851, DOI 10.1002/ijc.24529; Chan PKS, 2007, J MED VIROL, V79, P970, DOI 10.1002/jmv.20805; Climent Consuelo, 2007, P R Health Sci J, V26, P97; Cuzick J, 2000, BRIT J CANCER, V82, P1348, DOI 10.1054/bjoc.1999.1103; Du Y, 2011, CHINESE FOREIGN WOME, V6, P063; DugganKeen MF, 1996, EUR J IMMUNOGENET, V23, P275, DOI 10.1111/j.1744-313X.1996.tb00123.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Godkin A, 2005, HEPATOLOGY, V41, P1383, DOI 10.1002/hep.20716; [古扎丽努尔·阿不力孜 GUZALNUR.Abliz], 2008, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V35, P629; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Hua L, 2010, FUDAN U J MED SCI, V5, P555; Jager D, 2001, J CLIN PATHOL, V54, P669, DOI 10.1136/jcp.54.9.669; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Lu L, 2008, CANCER, V1, P3; Madeleine MM, 2002, J INFECT DIS, V186, P1565, DOI 10.1086/345285; Mahmud SM, 2007, J INFECT DIS, V196, P82, DOI 10.1086/518612; Miriguli J, 2009, CHINA FOREIGN MECICA, V28, P62; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; SastreGarau X, 1996, INT J CANCER, V69, P159, DOI 10.1002/(SICI)1097-0215(19960621)69:3<159::AID-IJC1>3.0.CO;2-Z; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Schreuder GMT, 2001, HUM IMMUNOL, V62, P826, DOI 10.1016/S0198-8859(01)00271-3; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun Q, 2009, J SHIHEZI U NATURAL, V27, P133; Wang J, 2010, DIGEST DIS SCI, V55, P1818, DOI 10.1007/s10620-009-0978-y; Wu YP, 2007, HUM IMMUNOL, V68, P192, DOI 10.1016/j.humimm.2006.07.005; Yang YC, 2006, HUM IMMUNOL, V67, P331, DOI 10.1016/j.humimm.2006.03.017; Zhao M, 2012, EUROPEAN J GYNAECOLO, V34, P54; 杨桂芳, 2009, [中华妇产科杂志, Chinese Journal of Obstetrics and Gynecology], V44, P383; 黄金双, 2006, [中华妇产科杂志, Chinese Journal of Obstetrics and Gynecology], V41, P715	35	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88439	10.1371/journal.pone.0088439	http://dx.doi.org/10.1371/journal.pone.0088439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551099	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500037
J	Rizos, E; Papathanasiou, MA; Michalopoulou, PG; Laskos, E; Mazioti, A; Kastania, A; Vasilopoulou, K; Nikolaidou, P; Margaritis, D; Papageorgiou, C; Liappas, I				Rizos, Emmanouil; Papathanasiou, Matilda A.; Michalopoulou, Panagiota G.; Laskos, Efstathios; Mazioti, Aggeliki; Kastania, Anastasia; Vasilopoulou, Konstantina; Nikolaidou, Paraskevi; Margaritis, Dimitrios; Papageorgiou, Charalabos; Liappas, Ioannis			A Longitudinal Study of Alterations of Hippocampal Volumes and Serum BDNF Levels in Association to Atypical Antipsychotics in a Sample of First-Episode Patients with Schizophrenia	PLOS ONE			English	Article							LONG-TERM TREATMENT; NEUROTROPHIC FACTOR; RAT-BRAIN; BIPOLAR DISORDER; MESSENGER-RNA; ANIMAL-MODELS; WEIGHT-GAIN; DRUGS; METAANALYSIS; PSYCHOSIS	Background: Schizophrenia is associated with structural and functional abnormalities of the hippocampus, which have been suggested to play an important role in the formation and emergence of schizophrenia syndrome. Patients with schizophrenia exhibit significant bilateral hippocampal volume reduction and progressive hippocampal volume decrease in first-episode patients with schizophrenia has been shown in many neuroimaging studies. Dysfunction of the neurotrophic system has been implicated in the pathophysiology of schizophrenia. The initiation of antipsychotic medication alters the levels of serum Brain Derived Neurotrophic Factor (BDNF) levels. However it is unclear whether treatment with antipsychotics is associated with alterations of hippocampal volume and BDNF levels. Methods: In the present longitudinal study we investigated the association between serum BDNF levels and hippocampal volumes in a sample of fourteen first-episode drug-naive patients with schizophrenia (FEP). MRI scans, BDNF and clinical measurements were performed twice: at baseline before the initiation of antipsychotic treatment and 8 months later, while the patients were receiving monotherapy with second generation antipsychotics (SGAs). Results: We found that left hippocampal volume was decreased (corrected left HV [t = 2.977, df = 13, p = .011] at follow-up; We also found that the higher the BDNF levels change the higher were the differences of corrected left hippocampus after 8 months of treatment with atypical antipsychotics (Pearson r = 0.597, p = 0.024). Conclusions: The association of BDNF with hippocampal volume alterations in schizophrenia merits further investigation and replication in larger longitudinal studies.	[Rizos, Emmanouil; Michalopoulou, Panagiota G.; Vasilopoulou, Konstantina; Nikolaidou, Paraskevi; Margaritis, Dimitrios; Papageorgiou, Charalabos; Liappas, Ioannis] Univ Athens, ATTIKON Gen Hosp, Sch Med, Dept Psychiat 2, Athens 11528, Greece; [Papathanasiou, Matilda A.; Mazioti, Aggeliki] Univ Athens, ATTIKON Gen Hosp, Sch Med, Dept Radiol 2, Athens 11528, Greece; [Michalopoulou, Panagiota G.] Kings Coll London, Inst Psychiat, Sect Schizophrenia Imaging & Therapeut, Dept Psychosis Studies, London, England; [Kastania, Anastasia] Athens Univ Econ & Business, Dept Informat, Athens, Greece; [Laskos, Efstathios] Athens Psychiat Hosp Dromokaition, Dept Biochem & Microbiol, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; University of London; King's College London; Athens University of Economics & Business	Rizos, E (corresponding author), Univ Athens, ATTIKON Gen Hosp, Sch Med, Dept Psychiat 2, Athens 11528, Greece.	erizos@med.uoa.gr	Mazioti, Argyro/ABG-7794-2020; Ilias, Ioannis/AAA-2927-2020	Papageorgiou, Charalabos/0000-0001-7635-1956; Mazioti, Argyro/0000-0003-2705-5696				ACD DVH, 2006, BOOTSTRAP METHODS TH; Adriano F, 2012, NEUROSCIENTIST, V18, P180, DOI 10.1177/1073858410395147; Alessandra B, 2008, STAT SCI, V23, P465; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Angelucci F, 2000, J NEUROSCI RES, V60, P783, DOI 10.1002/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M; Bai O, 2003, J NEUROSCI RES, V71, P127, DOI 10.1002/jnr.10440; Boyer P, 2007, BRAIN RES REV, V54, P92, DOI 10.1016/j.brainresrev.2006.12.008; Buckley PF, 2007, SCHIZOPHR RES, V94, P1, DOI 10.1016/j.schres.2007.01.025; Buckley PF, 2011, CURR OPIN PSYCHIATR, V24, P122, DOI 10.1097/YCO.0b013e3283436eb7; Chakos MH, 2005, BRIT J PSYCHIAT, V186, P26, DOI 10.1192/bjp.186.1.26; CHAKOS MH, 1994, AM J PSYCHIAT, V151, P1430; Chen CC, 2011, PSYCHIAT RES, V189, P327, DOI 10.1016/j.psychres.2011.01.011; Colibazzi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055783; COOK MJ, 1992, BRAIN, V115, P1001, DOI 10.1093/brain/115.4.1001; Davidson CA, 2012, SCHIZOPHR RES, V134, P165, DOI 10.1016/j.schres.2011.11.012; DeLisi LE, 1997, PSYCHIAT RES-NEUROIM, V74, P129, DOI 10.1016/S0925-4927(97)00012-7; Ebdrup BH, 2011, INT J NEUROPSYCHOPH, V14, P69, DOI 10.1017/S1461145710000817; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Gama CS, 2007, NEUROSCI LETT, V420, P45, DOI 10.1016/j.neulet.2007.04.001; Grillo RW, 2007, J PSYCHIAT RES, V41, P31, DOI 10.1016/j.jpsychires.2006.01.005; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Hori H, 2007, INT CLIN PSYCHOPHARM, V22, P21; Huang TL, 2006, J PSYCHIATR RES, V40, P664, DOI 10.1016/j.jpsychires.2005.11.004; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Konradi C, 2011, SCHIZOPHR RES, V131, P165, DOI 10.1016/j.schres.2011.06.007; Koolschijn PCMP, 2010, J CLIN PSYCHIAT, V71, P737, DOI 10.4088/JCP.08m04574yel; Lieberman J, 2001, BIOL PSYCHIAT, V49, P487, DOI 10.1016/S0006-3223(01)01067-8; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; Mamah Daniel, 2012, Front Psychiatry, V3, P96, DOI 10.3389/fpsyt.2012.00096; McClure RK, 2006, PSYCHIAT RES-NEUROIM, V148, P121, DOI 10.1016/j.pscychresns.2006.04.008; Meisenzahl EM, 2008, SCHIZOPHR RES, V104, P44, DOI 10.1016/j.schres.2008.06.023; Nelson MD, 1998, ARCH GEN PSYCHIAT, V55, P433, DOI 10.1001/archpsyc.55.5.433; Nieto R., 2013, FRONT PSYCHIATRY, V4, P45, DOI DOI 10.3389/FPSYT.2013.00045; Palomino A, 2006, SCHIZOPHR RES, V86, P321, DOI 10.1016/j.schres.2006.05.028; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Panenka WJ, 2007, SCHIZOPHR RES, V94, P288, DOI 10.1016/j.schres.2007.05.002; Pedrini M, 2011, NEUROSCI LETT, V491, P207, DOI 10.1016/j.neulet.2011.01.039; Pillai A, 2006, SCHIZOPHR RES, V82, P95, DOI 10.1016/j.schres.2005.11.021; Pirildar S, 2004, PROG NEURO-PSYCHOPH, V28, P709, DOI 10.1016/j.pnpbp.2004.05.008; Reis HJ, 2008, NEUROSCI LETT, V439, P157, DOI 10.1016/j.neulet.2008.05.022; Rizos EN, 2008, PROG NEURO-PSYCHOPH, V32, P1308, DOI 10.1016/j.pnpbp.2008.04.007; Rizos EN, 2011, SCHIZOPHR RES, V129, P201, DOI 10.1016/j.schres.2011.03.011; Rizos EN, 2010, WORLD J BIOL PSYCHIA, V11, P251, DOI 10.3109/15622970802182733; Sartorius A, 2009, PHARMACOPSYCHIATRY, V42, P270, DOI 10.1055/s-0029-1224162; Shenton ME, 2002, PSYCHIAT RES-NEUROIM, V115, P15, DOI 10.1016/S0925-4927(02)00025-2; Shimizu E, 2003, NEUROSCI LETT, V351, P111, DOI 10.1016/j.neulet.2003.08.004; Siekmeier PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058607; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; Tan YL, 2005, NEUROSCI LETT, V382, P27, DOI 10.1016/j.neulet.2005.02.054; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Verma S, 2009, J NEUROPSYCH CLIN N, V21, P24, DOI 10.1176/appi.neuropsych.21.1.24; Vinogradov S, 2009, BIOL PSYCHIAT, V66, P549, DOI 10.1016/j.biopsych.2009.02.017; Vita A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.116; Wakade CG, 2002, J NEUROSCI RES, V69, P72, DOI 10.1002/jnr.10281; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Xiu MH, 2009, PROG NEURO-PSYCHOPH, V33, P1508, DOI 10.1016/j.pnpbp.2009.08.011; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Yoshimura R, 2007, PROG NEURO-PSYCHOPH, V31, P1072, DOI 10.1016/j.pnpbp.2007.03.010; Zhang XY, 2008, NEUROPSYCHOPHARMACOL, V33, P2200, DOI 10.1038/sj.npp.1301619; Zhang XY, 2007, J PSYCHIATR RES, V41, P997, DOI 10.1016/j.jpsychires.2006.08.007	65	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87997	10.1371/journal.pone.0087997	http://dx.doi.org/10.1371/journal.pone.0087997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551075	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000021
J	Cribbs, SK; Guidot, DM; Martin, GS; Lennox, J; Brown, LA				Cribbs, Sushma K.; Guidot, David M.; Martin, Greg S.; Lennox, Jeffrey; Brown, Lou Ann			Anti-Retroviral Therapy Is Associated with Decreased Alveolar Glutathione Levels Even in Healthy HIV-Infected Individuals	PLOS ONE			English	Article							BACTERIAL PNEUMONIA; FLUID GLUTATHIONE; DEFICIENCY; STRESS; ACTIVATION; DISEASE; RISK	Objective: Lung infections are a leading cause of death in HIV-infected individuals. Measuring redox in HIV-infected individuals may identify those with chronic oxidative stress who are at increased risk for lung infection. We sought to estimate the association between HIV infection and oxidative stress in the lung, as reflected by decreased levels of glutathione and cysteine in the epithelial lining fluid. Methods: Bronchoalveolar lavage (BAL) fluid was collected from healthy HIV-infected subjects and controls. Individuals were excluded if they had evidence of major medical co-morbidities, were malnourished or smoked cigarettes. Results: We enrolled 22 otherwise healthy HIV and 21 non-HIV subjects. Among the HIV-infected subjects, 72.7% were on anti-retroviral therapy (ART) with a median CD4 count of 438 (279.8-599) and viral load of 0 (0-1.0) log copies/mL. There were no significant differences in median BAL fluid glutathione and cysteine levels between HIV and HIV-uninfected subjects. However, BAL glutathione was significantly higher in HIV-infected subjects on anti-retroviral therapy (ART) compared to those not on ART [367.4 (102- 965.3) nM vs. 30.8 (1.0-112.1) nM, p = 0.008]. Further, HIV infection with ART was associated with an OR of 2.02 for increased BAL glutathione when adjusted for age and body mass index, whereas HIV infection without ART was associated with an OR of 2.17 for decreased BAL glutathione. Conclusion: HIV infection without ART was associated with increased oxidative stress, as reflected by decreased alveolar glutathione levels, in otherwise healthy HIV-infected individuals. Further study needs to be done identify predictors of lung health in HIV and to address the role of ART in improving lung immunity.	[Cribbs, Sushma K.; Guidot, David M.; Martin, Greg S.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA 30322 USA; [Lennox, Jeffrey] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Brown, Lou Ann] Emory Univ, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Cribbs, SK (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA 30322 USA.	skomaku@emory.edu	Martin, Greg/B-4085-2009	Martin, Greg/0000-0002-9684-7593	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454;]; ACTSI KL2-Mentored Clinical and Translational Research Program; NIH KL2 [KL2TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000455, UL1TR000454] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ACTSI KL2-Mentored Clinical and Translational Research Program; NIH KL2(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported by the following: National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454; and ACTSI KL2-Mentored Clinical and Translational Research Program and NIH KL2 support (KL2TR000454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, HIV SURVEILLANCE S A, V17; Aukrust P, 2003, J INFECT DIS, V188, P232, DOI 10.1086/376459; Awodele O, 2012, J INFECT DEV COUNTR, V6, P79, DOI 10.3855/jidc.1906; BUHL R, 1993, J IMMUNOL, V150, P1019; BUHL R, 1989, LANCET, V2, P1294; CAIAFFA WT, 1993, AM J EPIDEMIOL, V138, P909, DOI 10.1093/oxfordjournals.aje.a116812; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Diaz PT, 2004, CHEST, V126, P1439, DOI 10.1378/chest.126.5.1439; DROGE W, 1986, IMMUNOBIOLOGY, V172, P151; Ghezzi P, 2011, INT J GEN MED, V4, P105, DOI 10.2147/IJGM.S15618; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Hulgan T, 2003, CLIN INFECT DIS, V37, P1711, DOI 10.1086/379776; Jacob BA, 2006, AM J PHYSIOL-LUNG C, V291, pL811, DOI 10.1152/ajplung.00468.2005; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Lassiter Coy, 2009, AIDS Res Ther, V6, P1, DOI 10.1186/1742-6405-6-1; Moss M, 2000, AM J RESP CRIT CARE, V161, P414, DOI 10.1164/ajrccm.161.2.9905002; Naisbitt DJ, 2000, AIDS RES HUM RETROV, V16, P1929, DOI 10.1089/088922200750054657; Pacheco YM, 2009, CURR HIV RES, V7, P612, DOI 10.2174/157016209789973673; Pacht ER, 1997, AM J RESP CRIT CARE, V155, P374, DOI 10.1164/ajrccm.155.1.9001339; Pacht ER, 1997, CHEST, V112, P785, DOI 10.1378/chest.112.3.785; PACHT ER, 1995, AM J MED SCI, V310, P133, DOI 10.1097/00000441-199510000-00001; Wallace JM, 1997, AM J RESP CRIT CARE, V155, P72, DOI 10.1164/ajrccm.155.1.9001292; Yeh MY, 2007, AM J RESP CRIT CARE, V176, P270, DOI 10.1164/rccm.200611-1722OC	27	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88630	10.1371/journal.pone.0088630	http://dx.doi.org/10.1371/journal.pone.0088630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533122	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600080
J	Gawlik, K; Baugh, J; Chatterji, U; Lim, PJ; Bobardt, MD; Gallay, PA				Gawlik, Katarzyna; Baugh, James; Chatterji, Udayan; Lim, Precious J.; Bobardt, Michael D.; Gallay, Philippe A.			HCV Core Residues Critical for Infectivity Are Also Involved in Core-NS5A Complex Formation	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NONSTRUCTURAL PROTEIN 5A; RNA-BINDING; APOLIPOPROTEIN-E; NS5A INHIBITOR; LIPID DROPLET; DOMAIN; REPLICATION; DIMERIZATION; IDENTIFICATION	Hepatitis C virus (HCV) infection is a major cause of liver disease. The molecular machinery of HCV assembly and particle release remains obscure. A better understanding of the assembly events might reveal new potential antiviral strategies. It was suggested that the nonstructural protein 5A (NS5A), an attractive recent drug target, participates in the production of infectious particles as a result of its interaction with the HCV core protein. However, prior to the present study, the NS5Abinding site in the viral core remained unknown. We found that the D1 domain of core contains the NS5A-binding site with the strongest interacting capacity in the basic P38-K74 cluster. We also demonstrated that the N-terminal basic residues of core at positions 50, 51, 59 and 62 were required for NS5A binding. Analysis of all substitution combinations of R50A, K51A, R59A, and R62A, in the context of the HCVcc system, showed that single, double, triple, and quadruple mutants were fully competent for viral RNA replication, but deficient in secretion of viral particles. Furthermore, we found that the extracellular and intracellular infectivity of all the mutants was abolished, suggesting a defect in the formation of infectious particles. Importantly, we showed that the interaction between the single and quadruple core mutants and NS5A was impaired in cells expressing full-length HCV genome. Interestingly, mutations of the four basic residues of core did not alter the association of core or NS5A with lipid droplets. This study showed for the first time that basic residues in the D1 domain of core that are critical for the formation of infectious extracellular and intracellular particles also play a role in core-NS5A interactions.	[Gawlik, Katarzyna; Baugh, James; Chatterji, Udayan; Lim, Precious J.; Bobardt, Michael D.; Gallay, Philippe A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	gallay@scripps.edu			U.S. Public Health Service [AI087746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087746] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. Public Health Service grants no. AI087746 (P.A.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09; Alsaleh K, 2010, J VIROL, V84, P12515, DOI 10.1128/JVI.01393-10; Angus AGN, 2012, J VIROL, V86, P679, DOI 10.1128/JVI.05452-11; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; BUKH J, 1994, P NATL ACAD SCI USA, V91, P8239, DOI 10.1073/pnas.91.17.8239; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Date T, 2007, HEPATOL RES, V37, P433, DOI 10.1111/j.1872-034X.2007.00056.x; Duvignaud JB, 2009, BIOCHEM BIOPH RES CO, V378, P27, DOI 10.1016/j.bbrc.2008.10.141; Foster TL, 2011, J VIROL, V85, P7460, DOI 10.1128/JVI.00393-11; Fromentin R, 2007, ANAL BIOCHEM, V366, P37, DOI 10.1016/j.ab.2007.03.033; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Gane E, 2011, LIVER INT, V31, P62, DOI 10.1111/j.1478-3231.2010.02383.x; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Han Q, 2013, J VIROL; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Hughes M, 2009, J GEN VIROL, V90, P1329, DOI 10.1099/vir.0.009332-0; Hwang J, 2010, J VIROL, V84, P12480, DOI 10.1128/JVI.01319-10; Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051; Ivanyi-Nagy R, 2006, NUCLEIC ACIDS RES, V34, P2618, DOI 10.1093/nar/gkl240; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Joyce MA, 2010, MICROBES INFECT, V12, P263, DOI 10.1016/j.micinf.2009.12.012; Khaliq S, 2011, INFECT GENET EVOL, V11, P543, DOI 10.1016/j.meegid.2011.01.017; Kim S, 2011, J VIROL, V85, P6645, DOI 10.1128/JVI.02156-10; Klein KC, 2005, J VIROL, V79, P6814, DOI 10.1128/JVI.79.11.6814-6826.2005; Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Kushima Y, 2010, J VIROL, V84, P9118, DOI 10.1128/JVI.00402-10; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Lim PJ, 2012, J BIOL CHEM, V287, P30861, DOI 10.1074/jbc.M112.376822; Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mousseau G, 2011, J GEN VIROL, V92, P101, DOI 10.1099/vir.0.023325-0; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Murray CL, 2011, ANNU REV MICROBIOL, V65, P307, DOI 10.1146/annurev-micro-090110-102954; Nakai K, 2006, J VIROL, V80, P11265, DOI 10.1128/JVI.01203-06; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Ploen D., 2013, J HEPATOL; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125; Rice Charles M, 2011, Top Antivir Med, V19, P117; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Sharma KK, 2010, NUCLEIC ACIDS RES, V38, P3632, DOI 10.1093/nar/gkq094; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Stapleford KA, 2011, J VIROL, V85, P1706, DOI 10.1128/JVI.02268-10; Suzuki T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00038; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tung P, 2011, J VIROL, V85, P1193, DOI 10.1128/JVI.01889-10; Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Weldon S, 2008, ANAL BIOCHEM, V375, P156, DOI 10.1016/j.ab.2007.11.035; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	79	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88866	10.1371/journal.pone.0088866	http://dx.doi.org/10.1371/journal.pone.0088866			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533158	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600116
J	Liu, ZM; Ho, SC; Chen, YM; Liu, J; Woo, J				Liu, Zhao-min; Ho, Suzanne C.; Chen, Yu-ming; Liu, Jun; Woo, Jean			Cardiovascular Risks in Relation to Daidzein Metabolizing Phenotypes among Chinese Postmenopausal Women	PLOS ONE			English	Article							EQUOL-PRODUCER PHENOTYPE; PREMENOPAUSAL WOMEN; UNITED-STATES; DIETARY HABITS; SERUM-LIPIDS; URIC-ACID; SOY; ISOFLAVONES; HEALTH; ASSOCIATION	Background: Studies suggested that the inter-individual differences in metabolizing isoflavone daidzein to equol or O-desmethylangolensin (ODMA) might explain the inconsistency of the soy/isoflavones efficacy on cardiovascular health. Objectives: The study aims to evaluate the relationship between equol and ODMA phenotypes and cardiovascular risks with habitual isoflavone consumption in Chinese postmenopausal women. Methods: This is a cross-sectional study among 726 prehypertensive postmenopal women who were screened for a randomized controlled trial. 648 women returned a daidzein-challenged urine samples for determination of equol and ODMA production. 595 attended clinic visits for assessment of cardiovascular risks including body composition, blood pressure (BP), serum lipids, uric acid, high sensitivity C-reactive protein (hs-CRP), fasting glucose and free fatty acid (FFA). Results: The prevalences of equol and O-DMA producers were 53.2% and 60.9% respectively. Equol producers had higher fat free mass (p = 0.001), lower systolic (p = 0.01) and diastolic (p = 0.01) BP, serum triglyceride (p = 0.023), hs-CRP (p = 0.015) and FFA (p = 0.001) than non-producers. O-DMA producers had lower body fat% (p = 0.032), SBP (p = 0.02), total cholesterol (p = 0.002) than non-producers. The significant differences remained after further adjustment for potential confounders. The habitual soy isoflavones intake had little relation to cardiovascular risk factors in either equol/O-DMA producer phenotypes. Conclusion: Equol/O-DMA producers had more favorable cardiovascular risk profiles than non-producers in prehypertensive postmenopausal women.	[Liu, Zhao-min; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Ho, Suzanne C.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Chen, Yu-ming; Liu, Jun] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Sun Yat Sen University	Liu, ZM (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	liuzhaomin@cuhk.edu.hk; jeanwoowong@cuhk.edu.hk	Woo, Jean/K-2625-2014; Liu, Zhaomin/L-8685-2019; Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019; LIU, Zhao-min/ABA-4413-2021	Woo, Jean/0000-0001-7593-3081; 	Chinese University of Hong Kong Research Committee Direct [2041783]	Chinese University of Hong Kong Research Committee Direct	The study was funded by the Chinese University of Hong Kong Research Committee Direct Grant No. 2041783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ H, 1976, J CLIN ENDOCR METAB, V43, P497, DOI 10.1210/jcem-43-3-497; Akaza H, 2004, JPN J CLIN ONCOL, V34, P86, DOI 10.1093/jjco/hyh015; [Anonymous], 2003, P INT C POP DEV, P1; Arai Y, 2000, J Epidemiol, V10, P127; Atkinson C, 2008, AM J CLIN NUTR, V87, P679, DOI 10.1093/ajcn/87.3.679; Atkinson C, 2012, METABOLISM, V61, P1678, DOI 10.1016/j.metabol.2012.05.012; Atkinson C, 2009, BREAST CANCER RES TR, V116, P587, DOI 10.1007/s10549-008-0199-7; Beavers KM, 2009, NUTR REV, V67, P213, DOI 10.1111/j.1753-4887.2009.00191.x; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bolca S, 2007, J NUTR, V137, P2242, DOI 10.1093/jn/137.10.2242; Cano A, 2010, MATURITAS, V67, P219, DOI 10.1016/j.maturitas.2010.07.015; Child MW, 2006, FEMS MICROBIOL ECOL, V55, P299, DOI 10.1111/j.1574-6941.2005.00016.x; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; CORDAIN L, 1986, J SPORT MED PHYS FIT, V26, P101; Decroos K, 2005, ARCH MICROBIOL, V183, P45, DOI 10.1007/s00203-004-0747-4; Frankenfeld CL, 2011, ADV NUTR, V2, P317, DOI 10.3945/an.111.000539; Frankenfeld CL, 2004, EXP BIOL MED, V229, P902, DOI 10.1177/153537020422900906; Gardana C, 2009, J NUTR BIOCHEM, V20, P940, DOI 10.1016/j.jnutbio.2008.08.006; Guo KP, 2010, BRIT J NUTR, V104, P118, DOI 10.1017/S0007114510000279; Hedlund TE, 2005, J NUTR, V135, P1400, DOI 10.1093/jn/135.6.1400; Hwang J, 2003, FREE RADICAL BIO MED, V34, P1271, DOI 10.1016/S0891-5849(03)00104-7; Jackson RL, 2011, NUTR REV, V69, P432, DOI 10.1111/j.1753-4887.2011.00400.x; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; KOFFLER KH, 1992, MED SCI SPORT EXER, V24, P415; Kokubo Y, 2007, CIRCULATION, V116, P2553, DOI 10.1161/CIRCULATIONAHA.106.683755; Lampe JW, 2009, AM J CLIN NUTR, V89, pS1664, DOI 10.3945/ajcn.2009.26736T; Lampe JW, 2001, J NUTR, V131, P740, DOI 10.1093/jn/131.3.740; Liu BH, 2010, J EPIDEMIOL, V20, P377, DOI 10.2188/jea.JE20090185; Liu Z-m, 2013, J OBESITY, V2013, P9; Ma J, 2003, PUBLIC HEALTH NUTR, V6, P139, DOI 10.1079/PHN2002393; Mai V, 2004, NUTR REV, V62, P235, DOI [10.1111/j.1753-4887.2004.tb00045.x, 10.1301/nr2004.jun235-242]; Ozasa K, 2005, J EPIDEMIOL, V15, pS196, DOI 10.2188/jea.15.S196; Protection CfH, 2013, HYPERTENSION; Ricketts ML, 2005, J NUTR BIOCHEM, V16, P321, DOI 10.1016/j.jnutbio.2004.11.008; Ro SC, 2007, MENOPAUSE, V14, P489, DOI 10.1097/gme.0b013e31802v4f4f; SEO A, 1984, J AGR FOOD CHEM, V32, P530, DOI 10.1021/jf00123a028; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Song KB, 2006, J NUTR, V136, P1347, DOI 10.1093/jn/136.5.1347; Vedrine N, 2006, EUR J CLIN NUTR, V60, P1039, DOI 10.1038/sj.ejcn.1602415; Yuexin Y., 2002, CHINA FOOD COMPOSITI; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhang XL, 2005, ARCH INTERN MED, V165, P1890, DOI 10.1001/archinte.165.16.1890	43	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87861	10.1371/journal.pone.0087861	http://dx.doi.org/10.1371/journal.pone.0087861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533060	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600018
J	Mano, H; Fujii, T; Sumikawa, N; Hiwatashi, Y; Hasebe, M				Mano, Hiroaki; Fujii, Tomomi; Sumikawa, Naomi; Hiwatashi, Yuji; Hasebe, Mitsuyasu			Development of an Agrobacterium-Mediated Stable Transformation Method for the Sensitive Plant Mimosa pudica	PLOS ONE			English	Article							ADVENTITIOUS ROOT-FORMATION; COTYLEDONARY-NODE EXPLANTS; T-DNA TRANSFER; ARABIDOPSIS-THALIANA; GENETIC-TRANSFORMATION; SEISMONASTIC MOVEMENT; PARTICLE BOMBARDMENT; SIGNAL MOLECULES; EXCITABLE CELLS; RAPID MOVEMENT	The sensitive plant Mimosa pudica has long attracted the interest of researchers due to its spectacular leaf movements in response to touch or other external stimuli. Although various aspects of this seismonastic movement have been elucidated by histological, physiological, biochemical, and behavioral approaches, the lack of reverse genetic tools has hampered the investigation of molecular mechanisms involved in these processes. To overcome this obstacle, we developed an efficient genetic transformation method for M. pudica mediated by Agrobacterium tumefaciens (Agrobacterium). We found that the cotyledonary node explant is suitable for Agrobacterium-mediated transformation because of its high frequency of shoot formation, which was most efficiently induced on medium containing 0.5 mu g/ml of a synthetic cytokinin, 6-benzylaminopurine (BAP). Transformation efficiency of cotyledonary node cells was improved from almost 0 to 30.8 positive signals arising from the intron-sGFP reporter gene by using Agrobacterium carrying a super-binary vector pSB111 and stabilizing the pH of the co-cultivation medium with 2-(N-morpholino) ethanesulfonic acid (MES) buffer. Furthermore, treatment of the explants with the detergent Silwet L-77 prior to co-cultivation led to a two-fold increase in the number of transformed shoot buds. Rooting of the regenerated shoots was efficiently induced by cultivation on irrigated vermiculite. The entire procedure for generating transgenic plants achieved a transformation frequency of 18.8%, which is comparable to frequencies obtained for other recalcitrant legumes, such as soybean (Glycine max) and pea (Pisum sativum). The transgene was stably integrated into the host genome and was inherited across generations, without affecting the seismonastic or nyctinastic movements of the plants. This transformation method thus provides an effective genetic tool for studying genes involved in M. pudica movements.	[Mano, Hiroaki; Sumikawa, Naomi; Hiwatashi, Yuji; Hasebe, Mitsuyasu] Natl Inst Basic Biol, Div Evolutionary Biol, Okazaki, Aichi 444, Japan; [Fujii, Tomomi; Hiwatashi, Yuji; Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Hasebe, M (corresponding author), Natl Inst Basic Biol, Div Evolutionary Biol, Okazaki, Aichi 444, Japan.	mhasebe@nibb.ac.jp		Hasebe, Mitsuyasu/0000-0001-7425-8758; HIWATASHI, YUJI/0000-0002-3996-0549	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for scientific research from Ministry of Education, Culture, Sports, Science and Technology and Japan Society for the Promotion of Science, Japan. https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMA K, 1992, PLANT CELL REP, V12, P7, DOI 10.1007/BF00232413; ALLEN RD, 1969, PLANT PHYSIOL, V44, P1101, DOI 10.1104/pp.44.8.1101; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BECKER J, 1994, ANN REP BEAN IMPROV, V37, P127; BEVAN MW, 1983, NATURE, V304, P184, DOI 10.1038/304184a0; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; Chandra A, 2003, CURR SCI INDIA, V84, P381; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai SH, 2001, MOL BREEDING, V7, P25, DOI 10.1023/A:1009687511633; De Clercq J, 2002, PLANT CELL REP, V21, P333, DOI 10.1007/s00299-002-0518-0; de Klerk GJ, 2008, PLANT CELL TISS ORG, V95, P285, DOI 10.1007/s11240-008-9442-5; DeKlerk GJ, 1997, PLANT CELL TISS ORG, V49, P39, DOI 10.1023/A:1005850222973; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; Eapen S, 2008, BIOTECHNOL ADV, V26, P162, DOI 10.1016/j.biotechadv.2007.11.001; EISNER T, 1981, P NATL ACAD SCI-BIOL, V78, P402, DOI 10.1073/pnas.78.1.402; FLEURATLESSARD P, 1988, J EXP BOT, V39, P209, DOI 10.1093/jxb/39.2.209; FleuratLessard P, 1997, PLANT PHYSIOL, V114, P827, DOI 10.1104/pp.114.3.827; Fromm J, 1988, TREES-STRUCT FUNCT, V2, P18, DOI 10.1007/BF00196975; Frugoli Julia, 2001, Plant Cell, V13, P458; Geetha N, 1998, CURR SCI INDIA, V75, P1036; Gelvin SB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00052; Grant J, 2006, METH MOL B, V343, P337; GULATI A, 1994, PLANT CELL REP, V13, P523, DOI 10.1007/BF00232949; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Ichikawa T, 2006, PLANT J, V48, P974, DOI 10.1111/j.1365-313X.2006.02924.x; JAYALLEMAND C, 1992, SCI HORTIC-AMSTERDAM, V51, P335, DOI 10.1016/0304-4238(92)90132-V; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jensen EL, 2011, AM NAT, V177, P377, DOI 10.1086/658343; Kameyama K, 2000, NATURE, V407, P37, DOI 10.1038/35024149; Kanzawa N, 2006, PLANT CELL PHYSIOL, V47, P531, DOI 10.1093/pcp/pcj022; Kollarova K, 2005, PLANT GROWTH REGUL, V46, P1, DOI 10.1007/s10725-005-5185-z; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Komari T, 2006, METH MOL B, V343, P15; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; KUMON K, 1984, PLANT CELL PHYSIOL, V25, P975; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Morillon R, 2001, PLANT PHYSIOL, V127, P720, DOI 10.1104/pp.010732; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Ogaki M, 2008, PLANT CELL REP, V27, P699, DOI 10.1007/s00299-007-0481-x; OHTA S, 1990, PLANT CELL PHYSIOL, V31, P805; Olhoft PM, 2003, PLANTA, V216, P723, DOI 10.1007/s00425-002-0922-2; Olhoft PM, 2001, PLANT CELL REP, V20, P706, DOI 10.1007/s002990100379; Olhoft PM, 2001, PLANT CELL REP, V20, P731, DOI 10.1007/s002990100388; RICCA U, 1916, NUOVO GIORN BOT ITAL, V23, P51; ROBLIN G, 1979, BIOL REV, V54, P135, DOI 10.1111/j.1469-185X.1979.tb00870.x; Rout GR, 2006, PLANT GROWTH REGUL, V48, P111, DOI 10.1007/s10725-005-5665-1; SAMEJIMA M, 1980, PLANT CELL PHYSIOL, V21, P467; SAMEJIMA M, 1983, PLANT CELL PHYSIOL, V24, P33, DOI 10.1093/oxfordjournals.pcp.a076511; SATTER RL, 1981, ANNU REV PLANT PHYS, V32, P83, DOI 10.1146/annurev.pp.32.060181.000503; SCHILDKNECHT H, 1983, ANGEW CHEM INT EDIT, V22, P695, DOI 10.1002/anie.198306951; SHIMODA N, 1990, P NATL ACAD SCI USA, V87, P6684, DOI 10.1073/pnas.87.17.6684; SIBAOKA T, 1962, SCIENCE, V137, P226, DOI 10.1126/science.137.3525.226; Somers DA, 2003, PLANT PHYSIOL, V131, P892, DOI 10.1104/pp.102.017681; STACHEL SE, 1986, P NATL ACAD SCI USA, V83, P379, DOI 10.1073/pnas.83.2.379; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; TAMIYA T, 1988, J BIOCHEM-TOKYO, V104, P5, DOI 10.1093/oxfordjournals.jbchem.a122421; Toriyama H, 1955, CYTOLOGIA, V20, P367; Travella S, 2005, PLANT CELL REP, V23, P780, DOI 10.1007/s00299-004-0892-x; Trick HN, 1997, TRANSGENIC RES, V6, P329, DOI 10.1023/A:1018470930944; TURK SCHJ, 1991, PLANT MOL BIOL, V16, P1051, DOI 10.1007/BF00016076; TURNQUIST HM, 1993, PROTOPLASMA, V176, P91, DOI 10.1007/BF01378944; Udvardi MK, 2005, TRENDS PLANT SCI, V10, P222, DOI 10.1016/j.tplants.2005.03.008; Ueda M, 1999, TETRAHEDRON, V55, P10937, DOI 10.1016/S0040-4020(99)00619-5; Venkatachalam P, 1997, APPL BIOCHEM BIOTECH, V67, P237, DOI 10.1007/BF02788801; Visnovitz T, 2007, PLANT SIGNAL BEHAV, V2, P462, DOI 10.4161/psb.2.6.4743; Volkov AG, 2010, PLANT CELL ENVIRON, V33, P163, DOI 10.1111/j.1365-3040.2009.02066.x; WALDEN R, 1994, PLANT MOL BIOL, V26, P1521, DOI 10.1007/BF00016488; WALDRON C, 1985, PLANT MOL BIOL, V5, P103, DOI 10.1007/BF00020092; WANG K, 1987, MOL GEN GENET, V210, P338, DOI 10.1007/BF00325703; Wang K, 2006, METHODS MOL BIOL, V343; Weintraub M, 1952, N PHYTOL, V3, P357, DOI [10.1111/j.1469-8137.1952.tb05196.x, DOI 10.1111/J.1469-8137.1952.TB05196.X]; Wu H, 2003, PLANT CELL REP, V21, P659, DOI 10.1007/s00299-002-0564-7; Yao H, 2008, PLANT SIGNAL BEHAV, V3, P954, DOI 10.4161/psb.6709	76	9	9	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88611	10.1371/journal.pone.0088611	http://dx.doi.org/10.1371/journal.pone.0088611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533121	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600079
J	Perng, CL; Shen, CC; Hu, LY; Yeh, CM; Chen, MH; Tsai, CF; Chiang, HL; Hung, YP; Su, VYF; Hu, YW; Su, TP; Chen, PM; Hung, JH; Liu, CJ; Huang, MW				Perng, Chin-Lin; Shen, Cheng-Che; Hu, Li-Yu; Yeh, Chiu-Mei; Chen, Mu-Hong; Tsai, Chia-Fen; Chiang, Huey-Ling; Hung, Yi-Ping; Su, Vincent Yi-Fong; Hu, Yu-Wen; Su, Tung-Ping; Chen, Pan-Ming; Hung, Jeng-Hsiu; Liu, Chia-Jen; Huang, Min-Wei			Risk of Depressive Disorder following Non-Alcoholic Cirrhosis: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MELATONIN SECRETION; MAJOR DEPRESSION; LIVER; METABOLISM; SEROTONIN; HEPATITIS; SLEEP; INFLAMMATION; ASSOCIATION	Background & Aims: To evaluate the risk of depressive disorders among non-alcoholic patients by using the Taiwan National Health Insurance Research Database (NHIRD). Methods: We conducted a retrospective study of a matched cohort of 52 725 participants (10 545 non-alcoholic cirrhotic patients and 42 180 control patients) who were selected from the NHIRD. Patients were observed for a maximum of 11 years to determine the rates of newly onset depressive disorders, and Cox regression was used to identify the risk factors associated with depressive disorders in cirrhotic patients. Results: During the 11-year follow-up period, 395 (3.75%) non-alcoholic cirrhotic patients and 1 183 (2.80%) control patients were diagnosed with depressive disorders. The incidence risk ratio of depressive disorders between non-alcoholic cirrhotic patients and control patients was 1.76 (95% CI, 1.57-1.98, P<.001). After adjusting for age, sex, and comorbidities, nonalcoholic cirrhotic patients were 1.75 times more likely to develop depressive disorders (95% CI, 1.56-1.96, P<.001) compared with the control patients. The hazard ratios for patients younger than 60 years old (1.31) and female (1.25) indicated that each is an independent risk factor for depressive disorders in non-alcoholic cirrhotic patients. Conclusions: The likelihood of developing depressive disorders is greater among non-alcoholic cirrhotic patients than among patients without cirrhosis. Symptoms of depression should be sought in patients with cirrhosis.	[Perng, Chin-Lin; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Perng, Chin-Lin; Tsai, Chia-Fen; Hung, Yi-Ping; Su, Vincent Yi-Fong; Hu, Yu-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Shen, Cheng-Che; Huang, Min-Wei] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Shen, Cheng-Che] Natl Chung Cheng Univ, Dept Informat Magagement, Chiayi, Taiwan; [Hu, Li-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Yeh, Chiu-Mei] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Mu-Hong; Tsai, Chia-Fen; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chiang, Huey-Ling] Far Eastern Mem Hosp, Dept Psychiat, New Taipei City, Taiwan; [Chiang, Huey-Ling] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chiang, Huey-Ling] Coll Med, Taipei, Taiwan; [Hung, Yi-Ping; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Su, Vincent Yi-Fong] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Hu, Yu-Wen; Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Pan-Ming] Taipei Vet Gen Hosp, Su Ao & Yuanshan Branch, Dept Psychiat, Taipei, Taiwan; [Hung, Jeng-Hsiu] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Obstet & Gynecol, Taipei, Taiwan; [Hung, Jeng-Hsiu] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Cheng University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Tzu Chi University	Huang, MW (corresponding author), Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan.	ymccs@yahoo.com.tw	Chen, MuHong/ACJ-6131-2022	Chen, MuHong/0000-0001-6516-1073; Shen, Cheng-Che/0000-0003-1587-5590; CHIANG, HUEY-LING/0000-0002-2979-6108; Hu, Yu-Wen/0000-0002-7983-415X	Taipei Veterans General Hospital [V101D-001-2]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by a grant from the Taipei Veterans General Hospital (grant number V101D-001-2; http://www.vghtpe.gov.tw/doce/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva AS, 2008, B EXP BIOL MED+, V146, P577, DOI 10.1007/s10517-009-0353-1; Anderson Robert N, 2003, Natl Vital Stat Rep, V52, P1; Becofsky K, 2013, ARTHRITIS, DOI 10.1155/2013/525761; Bednarek PH, 2011, NEW ENGL J MED, V364, P2208, DOI 10.1056/NEJMoa1011600; Bianchi G, 2005, DIGEST LIVER DIS, V37, P593, DOI 10.1016/j.dld.2005.01.020; Chojnacki C, 2013, J GASTROEN HEPATOL, V28, P342, DOI 10.1111/jgh.12055; Chojnacki C, 2012, POL ARCH MED WEWN, V122, P392, DOI 10.20452/pamw.1371; Chuang Cynthia H, 2012, Ment Health Fam Med, V9, P107; Culafic DM, 2007, WORLD J GASTROENTERO, V13, P5750; D'Mello C, 2011, AM J PHYSIOL-GASTR L, V301, pG749, DOI 10.1152/ajpgi.00184.2011; Fritz E, 2009, EUR J GASTROEN HEPAT, V21, P370, DOI 10.1097/MEG.0b013e328318ed19; Gilman SE, 2001, DRUG ALCOHOL DEPEN, V63, P277, DOI 10.1016/S0376-8716(00)00216-7; Hashmi AM, 2013, PAK J MED SCI, V29, P877, DOI 10.12669/pjms.293.3357; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hu LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073057; Huet PM, 2000, AM J GASTROENTEROL, V95, P760; Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69; Ko FY, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-18; Kuria Mary W, 2012, ISRN Psychiatry, V2012, P482802, DOI 10.5402/2012/482802; Lu Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-53; Marchesini G, 2001, GASTROENTEROLOGY, V120, P170, DOI 10.1053/gast.2001.21193; Monroe SM, 2013, J PSYCHIAT RES; Nardelli S, 2013, METAB BRAIN DIS; Neupane SP, 2013, DRUG ALCOHOL REV, V32, P170, DOI 10.1111/j.1465-3362.2012.00487.x; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; Perney P, 2012, ALCOHOL ALCOHOLISM, V47, P133, DOI 10.1093/alcalc/agr160; Psaltopoulou T, 2013, ANN NEUROL; Rahman SA, 2010, SLEEP MED, V11, P131, DOI 10.1016/j.sleep.2009.07.013; Rondanelli M, 2013, AGING CLIN EXP RES, V25, P499, DOI 10.1007/s40520-013-0118-6; Singh N, 1997, DIGEST DIS SCI, V42, P1421, DOI 10.1023/A:1018898106656; Singh N, 1997, CLIN TRANSPLANT, V11, P406; Slomka M, 1991, Ann Univ Mariae Curie Sklodowska Med, V46, P75; Stewart CA, 2011, PRIM CARE COMPANION, V13; Su T.P., 2013, J PSYCHIAT RES; Tenev VT, 2009, AM J GERIAT PSYCHIAT, V17, P276, DOI 10.1097/JGP.0b013e3181953b6e; Toffol E, 2013, MENOPAUSE; VILHJALMSSON R, 1993, SOC SCI MED, V37, P331, DOI 10.1016/0277-9536(93)90264-5; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; Wang JL, 2001, CAN J PSYCHIAT, V46, P632, DOI 10.1177/070674370104600708; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Zhabenko O, 2013, SUBST USE MISUSE, V48, P495, DOI 10.3109/10826084.2013.781182	41	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88721	10.1371/journal.pone.0088721	http://dx.doi.org/10.1371/journal.pone.0088721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533141	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600099
J	Fiorio, M; Marotta, A; Ottaviani, S; Pozzer, L; Tinazzi, M				Fiorio, Mirta; Marotta, Angela; Ottaviani, Sarah; Pozzer, Lara; Tinazzi, Michele			Aristotle's Illusion in Parkinson's Disease: Evidence for Normal Interdigit Tactile Perception	PLOS ONE			English	Article							VIBRATION-INDUCED ILLUSION; IDIOPATHIC FOCAL DYSTONIA; TEMPORAL DISCRIMINATION; SPATIAL DISCRIMINATION; ABNORMAL PERCEPTION; MOVEMENT; DISORDER; STIMULI; ACTIVATION	Sensory alterations, a common feature of such movement disorders as Parkinson's disease (PD) and dystonia, could emerge as epiphenomena of basal ganglia dysfunction. Recently, we found a selective reduction of tactile perception (Aristotle's illusion, the illusory doubling sensation of one object when touched with crossed fingers) in the affected hand of patients with focal hand dystonia. This suggests that reduced tactile illusion might be a specific feature of this type of dystonia and could be due to abnormal somatosensory cortical activation. The aim of the current study was to investigate whether Aristotle's illusion is reduced in the affected hand of patients with PD. We tested 15 PD patients, in whom motor symptoms were mainly localised to one side of the body, and 15 healthy controls. Three pairs of fingers were tested in crossed (evoking the illusion) or parallel position (not evoking the illusion). A sphere was placed in the contact point between the two fingers and the blindfolded participants had to say whether they felt one or two stimuli. Stimuli were applied on the affected and less or unaffected side of the PD patients. We found no difference in illusory perception between the PD patients and the controls, nor between the more affected and less/unaffected side, suggesting that Aristotle's illusion is preserved in PD. The retained tactile illusion in PD and its reduction in focal hand dystonia suggest that the basal ganglia, which are dysfunctional in both PD and dystonia, may not be causally involved in this function. Instead, the level of activation between digits in the somatosensory cortex may be more directly involved. Finally, the similar percentage of illusion in the more affected and less or unaffected body sides indicates that the illusory perception is not influenced by the presence or amount of motor symptoms.	[Fiorio, Mirta; Marotta, Angela; Pozzer, Lara; Tinazzi, Michele] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Ottaviani, Sarah] Borgo Trento Civil Hosp, Neurol Unit, Verona, Italy; [Ottaviani, Sarah] Borgo Trento Civil Hosp, Dept Neurosci, Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Marotta, A (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	angela.marotta@univr.it	Marotta, Angela/K-4562-2016; TINAZZI, Michele/J-7134-2018; Marotta, Angela/AAB-4418-2021	Marotta, Angela/0000-0002-0738-0240; TINAZZI, Michele/0000-0002-2370-7063; Marotta, Angela/0000-0002-2083-3005; Fiorio, Mirta/0000-0002-6356-0211				Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; Aglioti SM, 2003, NEUROLOGY, V60, P782, DOI 10.1212/01.WNL.0000046528.24693.5B; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Bara-Jimenez W, 2000, NEUROLOGY, V55, P1869, DOI 10.1212/WNL.55.12.1869; Bara-Jimenez W, 1998, ANN NEUROL, V44, P828, DOI 10.1002/ana.410440520; BENEDETTI F, 1986, PERCEPTION, V15, P83, DOI 10.1068/p150083; BENEDETTI F, 1986, PERCEPTION, V15, P285, DOI 10.1068/p150285; BENEDETTI F, 1985, J EXP PSYCHOL HUMAN, V11, P517, DOI 10.1037/0096-1523.11.4.517; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Bove M, 2004, BRAIN, V127, P2764, DOI 10.1093/brain/awh291; Bradley D, 2012, J NEUROL, V259, P77, DOI 10.1007/s00415-011-6125-7; Bufalari I, 2014, CEREB CORTEX, V24, P1867, DOI 10.1093/cercor/bht037; Butterworth S, 2003, MOVEMENT DISORD, V18, P673, DOI 10.1002/mds.10416; Cao H, 2011, AM J NEURORADIOL, V32, P1969, DOI 10.3174/ajnr.A2672; Chen LM, 2003, SCIENCE, V302, P881, DOI 10.1126/science.1087846; Conte A, 2010, BRAIN, V133, P2656, DOI 10.1093/brain/awq191; Demirci M, 1997, ANN NEUROL, V41, P781, DOI 10.1002/ana.410410614; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fiorio M, 2003, ANN NEUROL, V53, P630, DOI 10.1002/ana.10525; Fiorio M, 2007, NEUROSCI LETT, V417, P312, DOI 10.1016/j.neulet.2007.02.050; Fiorio M, 2007, BRAIN, V130, P134, DOI 10.1093/brain/awl283; Frima N, 2008, MOVEMENT DISORD, V23, P373, DOI 10.1002/mds.21838; Gierthmuhlen J, 2010, EUR J NEUROL, V17, P513, DOI 10.1111/j.1468-1331.2009.02797.x; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Grunewald RA, 1997, BRAIN, V120, P2179, DOI 10.1093/brain/120.12.2179; Hallett M, 2009, ANN NEUROL, V66, P125, DOI 10.1002/ana.21762; Hayward V, 2008, BRAIN RES BULL, V75, P742, DOI 10.1016/j.brainresbull.2008.01.008; HSIAO SS, 1993, ACTA PSYCHOL, V84, P53, DOI 10.1016/0001-6918(93)90072-Y; Juri C, 2010, J NEUROL SCI, V289, P60, DOI 10.1016/j.jns.2009.08.018; KLOCKGETHER T, 1995, MOVEMENT DISORD, V10, P460, DOI 10.1002/mds.870100410; Marinelli L, 2011, PARKINSONISM RELAT D, V17, P470, DOI 10.1016/j.parkreldis.2011.01.017; Molloy FM, 2003, BRAIN, V126, P2175, DOI 10.1093/brain/awg219; Nallegowda M, 2004, AM J PHYS MED REHAB, V83, P898, DOI 10.1097/01.PHM.0000146505.18244.43; Nelson AJ, 2009, ANN NEUROL, V66, P146, DOI 10.1002/ana.21626; Pastor MA, 2004, J NEUROSCI, V24, P2585, DOI 10.1523/JNEUROSCI.4210-03.2004; Pelosin E, 2009, MOVEMENT DISORD, V24, P1955, DOI 10.1002/mds.22693; Rammsayer T, 1997, INT J NEUROSCI, V91, P45, DOI 10.3109/00207459708986364; Rickards C, 1997, BRAIN, V120, P977, DOI 10.1093/brain/120.6.977; Rome S, 1999, NEUROLOGY, V53, P1794, DOI 10.1212/WNL.53.8.1794; Sailer A, 2003, BRAIN, V126, P1883, DOI 10.1093/brain/awg183; Sanger TD, 2001, MOVEMENT DISORD, V16, P94, DOI 10.1002/1531-8257(200101)16:1<94::AID-MDS1020>3.0.CO;2-O; Sathian K, 1997, NEUROLOGY, V49, P168, DOI 10.1212/WNL.49.1.168; SCHNEIDER JS, 1986, ANN NEUROL, V19, P275, DOI 10.1002/ana.410190309; SCHNEIDER JS, 1987, NEUROLOGY, V37, P951, DOI 10.1212/WNL.37.6.951; Scontrini A, 2009, J NEUROL NEUROSUR PS, V80, P1315, DOI 10.1136/jnnp.2009.178236; Shin HW, 2005, MOVEMENT DISORD, V20, P1640, DOI 10.1002/mds.20642; Tinazzi M, 2002, MOVEMENT DISORD, V17, P333, DOI 10.1002/mds.10019; Tinazzi M, 2004, J NEUROL, V251, P85, DOI 10.1007/s00415-004-0282-x; Tinazzi M, 2013, BRAIN, V136, P782, DOI 10.1093/brain/aws372; Tmazzi M, 2009, MOVEMENT DISORD, V24, P1427; Weder BJ, 1999, HUM BRAIN MAPP, V8, P1; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559; Yoneda Y, 2000, EUR J NEUROL, V7, P529, DOI 10.1046/j.1468-1331.2000.00102.x	54	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88686	10.1371/journal.pone.0088686	http://dx.doi.org/10.1371/journal.pone.0088686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523929	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100078
J	Nagelkerke, SQ; aan de Kerk, DJ; Jansen, MH; van den Berg, TK; Kuijpers, TW				Nagelkerke, Sietse Quirijn; aan de Kerk, Daan Jacob; Jansen, Machiel Hugo; van den Berg, Timo Kars; Kuijpers, Taco Willem			Failure To Detect Functional Neutrophil B Helper Cells in the Human Spleen	PLOS ONE			English	Article							SPLENIC MARGINAL ZONE; TOLL-LIKE RECEPTORS; MEMORY; IDENTIFICATION; EXPRESSION; INDUCTION; MONOCYTES	A novel role for human neutrophilic granulocytes was recently described, showing that these cells, upon entering the spleen, can be reprogrammed into a distinct B cell-helper neutrophil phenotype that is capable of eliciting B cell responses such as immunoglobulin secretion, class switch recombination and somatic hypermutation. Using similar protocols, we detected a homogeneous population of CD15(high) CD16(high) neutrophils in fresh human spleen samples, which did not differ in phenotype and function from blood neutrophils. No phenotypic characteristics of costimulatory nature were detected on splenic or circulating neutrophils, nor could we reproduce the immunoglobulin production of splenic B cells in the presence of splenic neutrophils, although B cell function and neutrophil activity were normal. Independent confirmation of a role for N-BH cells is required.	[Nagelkerke, Sietse Quirijn; van den Berg, Timo Kars; Kuijpers, Taco Willem] Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands; [aan de Kerk, Daan Jacob; Jansen, Machiel Hugo; Kuijpers, Taco Willem] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [aan de Kerk, Daan Jacob; Jansen, Machiel Hugo] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kuijpers, TW (corresponding author), Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands.	t.w.kuijpers@amc.nl	Nagelkerke, Sietse/GZL-6725-2022; van den Berg, Timo K/AAC-2479-2022		Landsteiner Foundation for Bloodtransfusion Research [LSBR-0916]	Landsteiner Foundation for Bloodtransfusion Research	This work was supported by a grant (LSBR-0916) from the Landsteiner Foundation for Bloodtransfusion Research (www.lsbr.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aan de Kerk DJ, 2013, J IMMUNOL, V190, P5012, DOI 10.4049/jimmunol.1201807; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Chen QY, 2013, J IMMUNOL, V190, P1048, DOI 10.4049/jimmunol.1202455; Durandy A, 2013, NAT REV IMMUNOL, V13, P519, DOI 10.1038/nri3466; HUIZINGA TWJ, 1988, NATURE, V333, P667, DOI 10.1038/333667a0; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; KUIJPERS TW, 1991, BLOOD, V78, P1105; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Moir S, 2012, BLOOD, V120, P4850, DOI 10.1182/blood-2012-05-430959; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; Steiniger B, 2006, HISTOCHEM CELL BIOL, V126, P641, DOI 10.1007/s00418-006-0210-5; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; URASHIMA M, 1995, BLOOD, V85, P1903, DOI 10.1182/blood.V85.7.1903.bloodjournal8571903; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; Wang Y, 2013, BBA-MOL CELL RES, V1833, P680, DOI 10.1016/j.bbamcr.2012.11.027; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346	20	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88377	10.1371/journal.pone.0088377	http://dx.doi.org/10.1371/journal.pone.0088377			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523887	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100036
J	Thomas, KC; Zheng, XF; Suarez, FG; Raftery, JM; Quinlan, KGR; Yang, N; North, KN; Houweling, PJ				Thomas, Kristen C.; Zheng, Xi Fiona; Suarez, Francia Garces; Raftery, Joanna M.; Quinlan, Kate G. R.; Yang, Nan; North, Kathryn N.; Houweling, Peter J.			Evidence Based Selection of Commonly Used RT-qPCR Reference Genes for the Analysis of Mouse Skeletal Muscle	PLOS ONE			English	Article							REAL-TIME PCR; MESSENGER-RNA; ACTN3 GENOTYPE; QUANTIFICATION; NORMALIZATION; ASSOCIATION; ALPHA-ACTININ-3; POLYMORPHISM; PERFORMANCE; DEFICIENCY	The ability to obtain accurate and reproducible data using quantitative real-time Polymerase Chain Reaction (RT-qPCR) is limited by the process of data normalization. The use of 'housekeeping' or 'reference' genes is the most common technique used to normalize RT-qPCR data. However, commonly used reference genes are often poorly validated and may change as a result of genetic background, environment and experimental intervention. Here we present an analysis of 10 reference genes in mouse skeletal muscle (Actb, Aldoa, Gapdh, Hprt1, Ppia, Rer1, Rn18s, Rpl27, Rpl41 and Rpl7L1), which were identified as stable either by microarray or in the literature. Using the MIQE guidelines we compared wild-type (WT) mice across three genetic backgrounds (R129, C57BL/6j and C57BL/10) as well as analyzing the alpha-actinin-3 knockout (Actn3 KO) mouse, which is a model of the common null polymorphism (R577X) in human ACTN3. Comparing WT mice across three genetic backgrounds, we found that different genes were more tightly regulated in each strain. We have developed a ranked profile of the top performing reference genes in skeletal muscle across these common mouse strains. Interestingly the commonly used reference genes; Gapdh, Rn18s, Hprt1 and Actb were not the most stable. Analysis of our experimental variant (Actn3 KO) also resulted in an altered ranking of reference gene suitability. Furthermore we demonstrate that a poor reference gene results in increased variability in the normalized expression of a gene of interest, and can result in loss of significance. Our data demonstrate that reference genes need to be validated prior to use. For the most accurate normalization, it is important to test several genes and use the geometric mean of at least three of the most stably expressed genes. In the analysis of mouse skeletal muscle, strain and intervention played an important role in selecting the most stable reference genes.	[Thomas, Kristen C.; Zheng, Xi Fiona; Suarez, Francia Garces; Raftery, Joanna M.; Quinlan, Kate G. R.; Yang, Nan; North, Kathryn N.; Houweling, Peter J.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [Zheng, Xi Fiona; Suarez, Francia Garces; Quinlan, Kate G. R.; Yang, Nan; North, Kathryn N.; Houweling, Peter J.] Univ Sydney, Discipline Paediat & Child Hlth, Fac Med, Sydney, NSW 2006, Australia; [North, Kathryn N.; Houweling, Peter J.] Royal Childrens Hosp, MCRI, Melbourne, Vic, Australia; [North, Kathryn N.] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia	University of Sydney; University of Sydney; Royal Children's Hospital Melbourne; University of Melbourne	North, KN (corresponding author), Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia.	Kathryn.north@mcri.edu.au	North, Kathryn N/K-6476-2012; Houweling, Peter/B-4157-2016	North, Kathryn N/0000-0003-0841-8009; Houweling, Peter/0000-0001-6132-2554; Quinlan, Kate/0000-0002-5722-8183; Cooke, Kristen/0000-0002-3534-1660	National Health and Medical Research Council of Australia [1002033, 1038991]; NHMRC of Australia [0511981]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded in part by a grant from the National Health and Medical Research Council of Australia (1002033). XFZ is supported by a Dora Lush Biomedical Scholarship from the National Health and Medical Research Council of Australia (1038991). KGRQ is supported by an Early Career Fellowship from the NHMRC of Australia (0511981). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Bonnet M, 2013, ANIMAL, V7, P1344, DOI 10.1017/S1751731113000475; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Clarkson PM, 2005, J APPL PHYSIOL, V99, P564, DOI 10.1152/japplphysiol.00130.2005; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Eynon N, 2009, INT J SPORTS MED, V30, P839; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Karge W H 3rd, 1998, Methods Mol Biol, V110, P43; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; Mannhalter C, 2000, CLIN CHEM LAB MED, V38, P171, DOI 10.1515/CCLM.2000.026; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Papadimitriou ID, 2008, INT J SPORTS MED, V29, P352, DOI 10.1055/s-2007-965339; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Roth SM, 2008, EUR J HUM GENET, V16, P391, DOI 10.1038/sj.ejhg.5201964; Santiago C, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.039172; Seto JT, 2013, J CLIN INVEST, V123, P4255, DOI 10.1172/JCI67691; Seto JT, 2011, HUM MOL GENET, V20, P2914, DOI 10.1093/hmg/ddr196; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Simon R, 2008, CURR OPIN BIOTECH, V19, P26, DOI 10.1016/j.copbio.2007.10.008; Stephens AS, 2011, BMC RES NOTES, V4, P2011; Strauss E, 2006, CELL, V127, P657, DOI 10.1016/j.cell.2006.11.005; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Vandesompele, 2009, REAL TIME PCR CURREN; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	37	52	56	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88653	10.1371/journal.pone.0088653	http://dx.doi.org/10.1371/journal.pone.0088653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523926	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100075
J	Grassi, MA; Rao, V; Winkler, KP; Zhang, W; Bogaard, JD; Chen, SQ; LaCroix, B; Lenkala, D; Rehman, J; Malik, AB; Cox, NJ; Huang, RS				Grassi, Michael A.; Rao, Vidhya; Winkler, Kathryn P.; Zhang, Wei; Bogaard, Joseph D.; Chen, Siquan; LaCroix, Bonnie; Lenkala, Divya; Rehman, Jalees; Malik, Asrar B.; Cox, Nancy J.; Huang, R. Stephanie			Genetic Variation Is the Major Determinant of Individual Differences in Leukocyte Endothelial Adhesion	PLOS ONE			English	Article							CELL-ADHESION; EXPRESSION; MOLECULES; HERITABILITY; MONOCYTES; DISCOVERY; MIGRATION; LINES	Objective: To determine the genetic contribution to leukocyte endothelial adhesion. Methods: Leukocyte endothelial adhesion was assessed through a novel cell-based assay using human lymphoblastoid cell lines. A high-throughput screening method was developed to evaluate the inter-individual variability in leukocyte endothelial adhesion using lymphoblastoid cell lines derived from different donors. To assess heritability, ninety-two lymphoblastoid cell lines derived from twenty-three monozygotic twin pairs and twenty-three sibling pairs were compared. These lymphoblastoid cell lines were plated with the endothelial cell line EA. hy926 and labeled with Calcein AM dye. Fluorescence was assessed to determine endothelial cell adhesion to each lymphoblastoid cell line. Intra-pair similarity was determined for monozygotic twins and siblings using Pearson pairwise correlation coefficients. Results: A leukocyte endothelial adhesion assay for lymphoblastoid cell lines was developed and optimized (CV = 8.68, Z'-factor = 0.67, SNR = 18.41). A higher adhesion correlation was found between the twins than that between the siblings. Intrapair similarity for leukocyte endothelial adhesion in monozygotic twins was 0.60 compared to 0.25 in the siblings. The extent to which these differences are attributable to underlying genetic factors was quantified and the heritability of leukocyte endothelial adhesion was calculated to be 69.66% (p-value<0.0001). Conclusions: There is a heritable component to leukocyte endothelial adhesion. Underlying genetic predisposition plays a significant role in inter-individual variability of leukocyte endothelial adhesion.	[Grassi, Michael A.; Rao, Vidhya; Winkler, Kathryn P.; Bogaard, Joseph D.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA; [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL USA; [Chen, Siquan] Univ Chicago, Inst Genom & Syst Biol, Cellular Screening Ctr, Chicago, IL 60637 USA; [Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Cox, Nancy J.] Univ Chicago, Med Genet Sect, Chicago, IL 60637 USA; [LaCroix, Bonnie; Lenkala, Divya; Huang, R. Stephanie] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago	Grassi, MA (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	grassim@uic.edu	Rao, Vidhya R/AAQ-2047-2020; Rehman, Jalees/GVU-1981-2022; Rehman, Jalees/J-8258-2012	Rao, Vidhya R/0000-0002-1465-2646; Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292; LaCroix, Bonnie/0000-0002-6833-5267; Huang, R. Stephanie/0000-0002-9862-0368; Malik, Asrar/0000-0002-8205-7128	NIH [K08 EY019089-02]; National Eye Institute [EY001792]; Research to Prevent Blindness, Inc., New York, NY; NIH/NIGMS [K08GM089941]; NIH/NCI [R21 CA139278]; NIH/NIGMS Pharmacogenomics of Anticancer Agents grant [U01GM61393]; University of Chicago Breast Cancer SPORE Career Development Award; University of Chicago Cancer Center Support Grant [P30 CA14599]; National Center for Advancing Translational Sciences of the NIH [UL1RR024999]; NATIONAL CANCER INSTITUTE [P30CA014599, R21CA139278] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001792, K08EY019089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM089941, U01GM061393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIGMS Pharmacogenomics of Anticancer Agents grant; University of Chicago Breast Cancer SPORE Career Development Award; University of Chicago Cancer Center Support Grant; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge support from the following organizations for this research: NIH K08 EY019089-02, National Eye Institute Core Grant EY001792 for Vision Research and an unrestricted grant from Research to Prevent Blindness, Inc., New York, NY. RSH received support from NIH/NIGMS grant K08GM089941, NIH/NCI Grant R21 CA139278, NIH/NIGMS Pharmacogenomics of Anticancer Agents grant U01GM61393, the University of Chicago Breast Cancer SPORE Career Development Award, the University of Chicago Cancer Center Support Grant (# P30 CA14599) and the National Center for Advancing Translational Sciences of the NIH [UL1RR024999]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj A, 2012, PROGR RETINAL EYE RE; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; BROWN KA, 1993, J IMMUNOL METHODS, V163, P13, DOI 10.1016/0022-1759(93)90234-X; Browning AC, 2012, BRIT J OPHTHALMOL, V96, P128, DOI 10.1136/bjophthalmol-2011-300572; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; CARLOS TM, 1994, BLOOD, V84, P2068; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; ELHABBAL MH, 1993, ARCH DIS CHILD, V69, P463, DOI 10.1136/adc.69.4.463; Falconer D. S., 1996, INTRO QUANTITATIVE G; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Im HK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002525; Lucio PJMDS, 1998, HAEMATOLOGICA, V83, P104; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Lutsey PL, 2006, J THROMB HAEMOST, V4, P2629, DOI 10.1111/j.1538-7836.2006.02237.x; Miller MA, 2003, CLIN SCI, V104, P591, DOI 10.1042/CS20020333; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; MURPHY JF, 1994, BIOCHEM J, V304, P537, DOI 10.1042/bj3040537; Nathan L, 1999, CIRC RES, V85, P377, DOI 10.1161/01.RES.85.4.377; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Olson JA, 1997, DIABETOLOGIA, V40, P1166, DOI 10.1007/s001250050802; Park JY, 2007, J BIOMOL SCREEN, V12, P406, DOI 10.1177/1087057106299162; Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3; Rainwater DL, 2010, ARTERIOSCL THROM VAS, V30, P1628, DOI 10.1161/ATVBAHA.110.205740; RINCON J, 1992, INT J CANCER, V51, P452, DOI 10.1002/ijc.2910510319; Rochford R, 1997, VIRAL IMMUNOL, V10, P183, DOI 10.1089/vim.1997.10.183; Serra AM, 2012, AM J PATHOL, V181, P719, DOI 10.1016/j.ajpath.2012.04.009; Smith JR, 2012, EXP EYE RES, V104, P89, DOI 10.1016/j.exer.2012.08.006; Stark AL, 2010, PHARMACOGENOMICS J, V10, P505, DOI 10.1038/tpj.2010.3; TAYLOR GM, 1988, IMMUNOLOGY, V64, P451; Tenesa A, 2013, NAT REV GENET, V14, P139, DOI 10.1038/nrg3377; THORNHILL MH, 1993, SCAND J IMMUNOL, V38, P279, DOI 10.1111/j.1365-3083.1993.tb01726.x; Ulbrich H, 2003, TRENDS PHARMACOL SCI, V24, P640, DOI 10.1016/j.tips.2003.10.004; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Visscher PM, 2004, TWIN RES, V7, P505, DOI 10.1375/1369052042335250; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Wen YJ, 2011, PHARMACOGENET GENOM, V21, P476, DOI 10.1097/FPC.0b013e3283481967; WILLIAMS CJ, 1992, COMPUT METH PROG BIO, V38, P167, DOI 10.1016/0169-2607(92)90084-K; Zhang DH, 2006, J LEUKOCYTE BIOL, V80, P309, DOI 10.1189/jlb.1005611	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87883	10.1371/journal.pone.0087883	http://dx.doi.org/10.1371/journal.pone.0087883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520339	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600030
J	Schleifman, EB; Desai, R; Spoerke, JM; Xiao, YY; Wong, C; Abbas, I; O'Brien, C; Patel, R; Sumiyoshi, T; Fu, L; Tam, RN; Koeppen, H; Wilson, TR; Raja, R; Hampton, GM; Lackner, MR				Schleifman, Erica B.; Desai, Rupal; Spoerke, Jill M.; Xiao, Yuanyuan; Wong, Cheryl; Abbas, Ilma; O'Brien, Carol; Patel, Rajesh; Sumiyoshi, Teiko; Fu, Ling; Tam, Rachel N.; Koeppen, Hartmut; Wilson, Timothy R.; Raja, Rajiv; Hampton, Garret M.; Lackner, Mark R.			Targeted Biomarker Profiling of Matched Primary and Metastatic Estrogen Receptor Positive Breast Cancers	PLOS ONE			English	Article							PIK3CA MUTATIONS; PHOSPHATIDYLINOSITOL 3-KINASE; GENE; EXPRESSION; TUMORS; PTEN; DISCORDANCE; RESISTANCE; PROGNOSIS; MEDIATOR	Patients with newly diagnosed, early stage estrogen receptor positive (ER+) breast cancer often show disease free survival in excess of five years following surgery and systemic adjuvant therapy. An important question is whether diagnostic tumor tissue from the primary lesion offers an accurate molecular portrait of the cancer post recurrence and thus may be used for predictive diagnostic purposes for patients with relapsed, metastatic disease. As the class I phosphatidylinositol 3' kinase (PI3K) pathway is frequently activated in ER+ breast cancer and has been linked to acquired resistance to hormonal therapy, we hypothesized pathway status could evolve over time and treatment. Biomarker analyses were conducted on matched, asynchronous primary and metastatic tumors from 77 patients with ER+ breast cancer. We examined whether PIK3CA and AKT1 alterations or PTEN and Ki67 levels showed differences between primary and metastatic samples. We also sought to look more broadly at gene expression markers reflective of proliferation, molecular subtype, and key receptors and signaling pathways using an mRNA analysis platform developed on the Fluidigm BioMark TM microfluidics system to measure the relative expression of 90 breast cancer related genes in formalin-fixed paraffin-embedded (FFPE) tissue. Application of this panel of biomarker assays to matched tumor pairs showed a high concordance between primary and metastatic tissue, with generally few changes in mutation status, proliferative markers, or gene expression between matched samples. The collection of assays described here has been optimized for FFPE tissue and may have utility in exploratory analyses to identify patient subsets responsive to targeted therapies.	[Schleifman, Erica B.; Desai, Rupal; Spoerke, Jill M.; Wong, Cheryl; Abbas, Ilma; O'Brien, Carol; Patel, Rajesh; Sumiyoshi, Teiko; Fu, Ling; Tam, Rachel N.; Wilson, Timothy R.; Raja, Rajiv; Hampton, Garret M.; Lackner, Mark R.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Xiao, Yuanyuan] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Koeppen, Hartmut] Genentech Inc, Dept Pathol Res, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Lackner, MR (corresponding author), Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA.	lackner.mark@gene.com	Lackner, Mark/G-4597-2012	Lackner, Mark/0000-0002-6375-2037	Genentech Inc	Genentech Inc(Roche HoldingGenentech)	This study was funded by Genentech Inc. The funders were responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aitken SJ, 2010, ANN ONCOL, V21, P1254, DOI 10.1093/annonc/mdp427; Barbareschi M, 2007, CLIN CANCER RES, V13, P6064, DOI 10.1158/1078-0432.CCR-07-0266; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ellis MJ, 2010, BREAST CANCER RES TR, V119, P379, DOI 10.1007/s10549-009-0575-y; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gonzalez-Angulo AM, 2011, MOL CANCER THER, V10, P1093, DOI 10.1158/1535-7163.MCT-10-1089; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Jensen JD, 2011, CLIN CANCER RES, V17, P667, DOI 10.1158/1078-0432.CCR-10-1133; Kalinsky K, 2011, BREAST CANCER RES TR, V129, P635, DOI 10.1007/s10549-011-1601-4; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Lim E, 2012, ONCOLOGY, V26, P696; Lim E, 2012, ONCOLOGY-NY, V26, P688; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Mangone FR, 2012, CLINICS, V67, P1285, DOI 10.6061/clinics/2012(11)11; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; Patel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051153; Pusztai L, 2010, ONCOLOGIST, V15, P1164, DOI 10.1634/theoncologist.2010-0059; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Shames DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056765; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Team RDC, 2019, R LANG ENV STAT COMP; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	40	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88401	10.1371/journal.pone.0088401	http://dx.doi.org/10.1371/journal.pone.0088401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520381	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600072
J	Wey-Fabrizius, AR; Herlyn, H; Rieger, B; Rosenkranz, D; Witek, A; Welch, DBM; Ebersberger, I; Hankeln, T				Wey-Fabrizius, Alexandra R.; Herlyn, Holger; Rieger, Benjamin; Rosenkranz, David; Witek, Alexander; Welch, David B. Mark; Ebersberger, Ingo; Hankeln, Thomas			Transcriptome Data Reveal Syndermatan Relationships and Suggest the Evolution of Endoparasitism in Acanthocephala via an Epizoic Stage	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; PHYLOGENETIC-RELATIONSHIPS; SEISON-NEBALIAE; ROTIFERA; POSITION; ULTRASTRUCTURE; INFERENCE; SEQUENCE; GENE; GNATHOSTOMULIDA	The taxon Syndermata comprises the biologically interesting wheel animals ("Rotifera'': Bdelloidea + Monogononta + Seisonidea) and thorny-headed worms (Acanthocephala), and is central for testing superordinate phylogenetic hypotheses (Platyzoa, Gnathifera) in the metazoan tree of life. Recent analyses of syndermatan phylogeny suggested paraphyly of Eurotatoria (free-living bdelloids and monogononts) with respect to endoparasitic acanthocephalans. Data of epizoic seisonids, however, were absent, which may have affected the branching order within the syndermatan clade. Moreover, the position of Seisonidea within Syndermata should help in understanding the evolution of acanthocephalan endoparasitism. Here, we report the first phylogenomic analysis that includes all four higher-ranked groups of Syndermata. The analyzed data sets comprise new transcriptome data for Seison spec. (Seisonidea), Brachionus manjavacas (Monogononta), Adineta vaga (Bdelloidea), and Paratenuisentis ambiguus (Acanthocephala). Maximum likelihood and Bayesian trees for a total of 19 metazoan species were reconstructed from up to 410 functionally diverse proteins. The results unanimously place Monogononta basally within Syndermata, and Bdelloidea appear as the sister group to a clade comprising epizoic Seisonidea and endoparasitic Acanthocephala. Our results support monophyly of Syndermata, Hemirotifera (Bdelloidea + Seisonidea + Acanthocephala), and Pararotatoria (Seisonidea + Acanthocephala), rejecting monophyly of traditional Rotifera and Eurotatoria. This serves as an indication that early acanthocephalans lived epizoically or as ectoparasites on arthropods, before their complex lifecycle with arthropod intermediate and vertebrate definite hosts evolved.	[Wey-Fabrizius, Alexandra R.; Rieger, Benjamin; Witek, Alexander; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55122 Mainz, Germany; [Herlyn, Holger; Rosenkranz, David] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany; [Welch, David B. Mark] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Ebersberger, Ingo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60054 Frankfurt, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Marine Biological Laboratory - Woods Hole; Goethe University Frankfurt	Hankeln, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55122 Mainz, Germany.	hankeln@uni-mainz.de	Mallouk, Thomas E/K-7391-2012; Kratochvilova, I./G-5571-2014; Menšík, Miroslav/H-7186-2014	Mallouk, Thomas E/0000-0003-4599-4208; Kratochvilova, I./0000-0002-6633-9432; 	Deutsche Forschungsgemeinschaft (DFG) [Ha2103/4-3, SPP1174]; Center for Computational Sciences (SRFN) of Johannes Gutenberg University Mainz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for Computational Sciences (SRFN) of Johannes Gutenberg University Mainz	The work was funded by the Deutsche Forschungsgemeinschaft (DFG grant Ha2103/4-3, Priority Project "Deep Metazoan Phylogeny", SPP1174; www.dfg.de). Additional financial support came from the Center for Computational Sciences (SRFN) of Johannes Gutenberg University Mainz (http://www.csm.unimainz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ahlrichs WH, 1997, ZOOMORPHOLOGY, V117, P41, DOI 10.1007/s004350050028; Ahlrichs WH, 1998, ZOOMORPHOLOGY, V118, P255, DOI 10.1007/s004350050074; Ahlrichs WH, 1995, ULTRASTRUKTUR PHYLOG; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Bleidorn C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-150; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Claus C, 1876, ORG SYSTEMATISCHE ST; CLEMENT P, 1993, HYDROBIOLOGIA, V255, P527, DOI 10.1007/BF00025882; Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Ferraguti M, 1999, TISSUE CELL, V31, P428, DOI 10.1054/tice.1999.0012; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garey JR, 1998, HYDROBIOLOGIA, V387, P83, DOI 10.1023/A:1017060902909; Gazi M, 2012, PARASITOL INT, V61, P307, DOI 10.1016/j.parint.2011.12.001; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Grube E, 1861, AUSFLUG NACH TRIEST; Hausdorf B, 2010, MOL PHYLOGENET EVOL, V55, P1121, DOI 10.1016/j.ympev.2009.12.022; Hehn N, 2001, PARASITOL RES, V87, P467, DOI 10.1007/s004360100380; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Herlyn H, 1997, ZOOMORPHOLOGY, V117, P135, DOI 10.1007/s004350050038; Herlyn H, 2003, MOL PHYLOGENET EVOL, V26, P155, DOI 10.1016/S1055-7903(02)00309-3; Herlyn H, 2001, ZOOMORPHOLOGY, V121, P13, DOI 10.1007/s004350100039; Herlyn H, 2001, SYST PARASITOL, V50, P105, DOI 10.1023/A:1011925516086; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kristensen RM, 2000, J MORPHOL, V246, P1; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lasek-Nesselquist E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043554; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leasi F, 2012, J MAR BIOL ASSOC UK, V92, P959, DOI 10.1017/S0025315411000129; Littlewood DTJ, 2004, ASSEMBLING THE TREE OF LIFE, P209; Littlewood DTJ, 1998, MOL PHYLOGENET EVOL, V9, P72, DOI 10.1006/mpev.1997.0448; Lorenzen S., 1985, Systematics Association Special Volume Series, P210; MARKEVICH GI, 1993, HYDROBIOLOGIA, V255, P513, DOI 10.1007/BF00025880; Marotta R, 2010, J STRUCT BIOL, V171, P11, DOI 10.1016/j.jsb.2010.04.003; Melone G, 1998, HYDROBIOLOGIA, V387, P101, DOI 10.1023/A:1017057619574; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Meyer A, 1933, KLASSEN ORDNUNGEN TI, P582; Meyer B, 2010, MARE V0 1 RC; MILLER DM, 1978, J PARASITOL, V64, P436, DOI 10.2307/3279776; Min GS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-533; Minelli A, 2009, PERSPECTIVES IN ANIMAL PHYLOGENY AND EVOLUTION, P1; Mollaret I, 1997, MOL BIOCHEM PARASIT, V90, P433, DOI 10.1016/S0166-6851(97)00176-X; Near TJ, 2002, INTEGR COMP BIOL, V42, P668, DOI 10.1093/icb/42.3.668; Near TJ, 1998, MOL PHYLOGENET EVOL, V10, P287, DOI 10.1006/mpev.1998.0569; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; Paps J, 2009, P ROY SOC B-BIOL SCI, V276, P1245, DOI 10.1098/rspb.2008.1574; Park JK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-11; Passamaneck Y, 2006, MOL PHYLOGENET EVOL, V40, P20, DOI 10.1016/j.ympev.2006.02.001; Perkins EM, 2010, INT J PARASITOL, V40, P1237, DOI 10.1016/j.ijpara.2010.02.017; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Podsiadlowski L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-364; Poulin R., 2007, EVOL ECOL, V2; RICCI C, 1993, HYDROBIOLOGIA, V255, P495, DOI 10.1007/BF00025879; Ricci C, 1998, HYDROBIOLOGIA, V387, P93, DOI 10.1023/A:1017091104243; RIEGER RM, 1995, INVERTEBR BIOL, V114, P186, DOI 10.2307/3226891; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt-Rhaesa A, 2007, EVOLUTION ORGAN SYST; Sorensen MV, 2006, MOL PHYLOGENET EVOL, V40, P585, DOI 10.1016/j.ympev.2006.04.001; Sorensen MV, 2005, ZOOL STUD, V44, P34; Sorensen MV, 2002, J ZOOL SYST EVOL RES, V40, P129, DOI 10.1046/j.1439-0469.2002.00188.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2008, MOL BIOL EVOL, V25, P728, DOI 10.1093/molbev/msn019; VANCLEAVE HJ, 1947, J PARASITOL, V33, P118, DOI 10.2307/3273533; Weber M, 2013, MOL PHYLOGENET EVOL, V66, P182, DOI 10.1016/j.ympev.2012.09.017; Welch DBM, 2000, INVERTEBR BIOL, V119, P17; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; WINNEPENNINCKX B, 1995, MOL BIOL EVOL, V12, P1132; Witek A, 2009, MOL PHYLOGENET EVOL, V53, P1037, DOI 10.1016/j.ympev.2009.07.031; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; Zrzavy J, 2003, ZOOL SCR, V32, P61, DOI 10.1046/j.1463-6409.2003.00104.x; Zrzavy J, 2001, FOLIA PARASIT, V48, P81, DOI 10.14411/fp.2001.013	88	30	32	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88618	10.1371/journal.pone.0088618	http://dx.doi.org/10.1371/journal.pone.0088618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520404	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600095
J	Chang, XX; Donnelly, L; Sun, DY; Rao, JP; Reid, MS; Jiang, CZ				Chang, Xiaoxiao; Donnelly, Linda; Sun, Daoyang; Rao, Jingping; Reid, Michael S.; Jiang, Cai-Zhong			A Petunia Homeodomain-Leucine Zipper Protein, PhHD-Zip, Plays an Important Role in Flower Senescence	PLOS ONE			English	Article							ABSCISIC-ACID; ARABIDOPSIS-THALIANA; WATER-DEFICIT; ETHYLENE BIOSYNTHESIS; SENESCING PETALS; ENDOGENOUS ABA; SHOOT GROWTH; DNA-BINDING; GENES; TRANSCRIPTION	Flower senescence is initiated by developmental and environmental signals, and regulated by gene transcription. A homeodomain-leucine zipper transcription factor, PhHD-Zip, is up-regulated during petunia flower senescence. Virus-induced gene silencing of PhHD-Zip extended flower life by 20% both in unpollinated and pollinated flowers. Silencing PhHD-Zip also dramatically reduced ethylene production and the abundance of transcripts of genes involved in ethylene (ACS, ACO), and ABA (NCED) biosynthesis. Abundance of transcripts of senescence-related genes (SAG12, SAG29) was also dramatically reduced in the silenced flowers. Over-expression of PhHD-Zip accelerated petunia flower senescence. Furthermore, PhHD-Zip transcript abundance in petunia flowers was increased by application of hormones (ethylene, ABA) and abiotic stresses (dehydration, NaCl and cold). Our results suggest that PhHD-Zip plays an important role in regulating petunia flower senescence.	[Chang, Xiaoxiao; Sun, Daoyang; Rao, Jingping] Northwest A&F Univ, Dept Hort, Yangling, Shaanxi, Peoples R China; [Chang, Xiaoxiao; Sun, Daoyang; Reid, Michael S.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Donnelly, Linda; Jiang, Cai-Zhong] USDA, Crops Pathol & Genet Res Unit, ARS, Davis, CA USA	Northwest A&F University - China; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Rao, JP (corresponding author), Northwest A&F Univ, Dept Hort, Yangling, Shaanxi, Peoples R China.	dqr0723@163.com; msreid@ucdavis.edu; cjiang@ucdavis.edu	Reid, Michael/ABI-1128-2020	Jiang, Cai-Zhong/0000-0002-5972-7963	United States Department of Agriculture (USDA) CRIS [5306-21000-019-00D]; USDA Floriculture Initiative [5306-13210-001-02S]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAD19B04]	United States Department of Agriculture (USDA) CRIS; USDA Floriculture Initiative; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	This work was partially supported by United States Department of Agriculture (USDA) CRIS project 5306-21000-019-00D, USDA Floriculture Initiative (5306-13210-001-02S) and National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAD19B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; BOROHOV A, 1976, PLANT PHYSIOL, V58, P175, DOI 10.1104/pp.58.2.175; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Chang HS, 2003, PLANT PHYSIOL, V132, P2174, DOI 10.1104/pp.103.023945; Chen JC, 2004, PLANT MOL BIOL, V55, P521, DOI 10.1007/s11103-004-0590-7; Chen MK, 2011, PLANT J, V68, P168, DOI 10.1111/j.1365-313X.2011.04677.x; Cheng WH, 2009, PLANT MOL BIOL, V71, P61, DOI 10.1007/s11103-009-9509-7; El-Sharkawy I, 2009, J EXP BOT, V60, P907, DOI 10.1093/jxb/ern354; Gago GM, 2002, PLANT CELL ENVIRON, V25, P633, DOI 10.1046/j.1365-3040.2002.00853.x; Gazzarrini S, 2001, CURR OPIN PLANT BIOL, V4, P387, DOI 10.1016/S1369-5266(00)00190-4; Gerats T, 2005, TRENDS PLANT SCI, V10, P251, DOI 10.1016/j.tplants.2005.03.005; GOH CJ, 1985, SCI HORTIC-AMSTERDAM, V26, P57, DOI 10.1016/0304-4238(85)90102-5; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; Hay A, 2009, CURR OPIN PLANT BIOL, V12, P593, DOI 10.1016/j.pbi.2009.06.006; Hunter DA, 2004, PHYSIOL PLANTARUM, V121, P313, DOI 10.1111/j.0031-9317.2004.0311.x; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; Jones Michelle L., 2009, P301, DOI 10.1007/978-0-387-84796-2_14; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; LeNoble ME, 2004, J EXP BOT, V55, P237, DOI 10.1093/jxb/erh031; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Liu JX, 2011, J EXP BOT, V62, P825, DOI 10.1093/jxb/erq324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVELL PJ, 1987, ANN BOT-LONDON, V60, P49, DOI 10.1093/oxfordjournals.aob.a087421; Manavella PA, 2008, J EXP BOT, V59, P3143, DOI 10.1093/jxb/ern170; Matilla AJ, 2000, SEED SCI RES, V10, P111, DOI 10.1017/S096025850000012X; MAYAK S, 1970, PLANT PHYSIOL, V46, P497, DOI 10.1104/pp.46.4.497; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Palena CM, 2001, J MOL BIOL, V308, P39, DOI 10.1006/jmbi.2001.4563; Palena CM, 1999, BIOCHEM J, V341, P81, DOI 10.1042/0264-6021:3410081; Panavas T, 1999, PLANT MOL BIOL, V40, P237, DOI 10.1023/A:1006146230602; PECH JC, 1987, PLANT PHYSIOL BIOCH, V25, P431; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; PORAT R, 1993, PHYSIOL PLANTARUM, V89, P291, DOI 10.1111/j.1399-3054.1993.tb00156.x; Re DA, 2011, J EXP BOT, V62, P2229, DOI 10.1093/jxb/err037; REID MS, 1992, PLANT GROWTH REGUL, V11, P37, DOI 10.1007/BF00024431; Rogers HJ, 2006, ANN BOT-LONDON, V97, P309, DOI 10.1093/aob/mcj051; SEREK M, 1995, PHYSIOL PLANTARUM, V94, P229, DOI 10.1111/j.1399-3054.1995.tb05305.x; Sharp RE, 2000, J EXP BOT, V51, P1575, DOI 10.1093/jexbot/51.350.1575; Shibuya K, 2000, J EXP BOT, V51, P2067, DOI 10.1093/jexbot/51.353.2067; Shibuya K, 2013, J EXP BOT, V64, P1111, DOI 10.1093/jxb/ers395; Shin D, 2004, BIOCHEM BIOPH RES CO, V323, P534, DOI 10.1016/j.bbrc.2004.08.127; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Soderman E, 1999, PLANT MOL BIOL, V40, P1073, DOI 10.1023/A:1006267013170; Staden J, 1987, PLANT GROWTH REGUL, V5, P75; TANG XY, 1994, PLANT CELL, V6, P1227, DOI 10.1105/tpc.6.9.1227; Thomas H, 2003, J EXP BOT, V54, P1127, DOI 10.1093/jxb/erg133; Tripathi SK, 2007, PLANT SIGNAL BEHAV, V2, P437, DOI 10.4161/psb.2.6.4991; Trivellini A, 2011, J EXP BOT, V62, P5437, DOI 10.1093/jxb/err218; van Doorn WG, 2001, ANN BOT-LONDON, V87, P447, DOI 10.1006/anbo.2000.1357; Wagstaff C, 2009, PLANT J, V57, P690, DOI 10.1111/j.1365-313X.2008.03722.x; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065800; WU MJ, 1991, SCI HORTIC-AMSTERDAM, V48, P99, DOI 10.1016/0304-4238(91)90156-S; Xu XJ, 2007, J EXP BOT, V58, P2193, DOI 10.1093/jxb/erm058; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081	58	35	37	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88320	10.1371/journal.pone.0088320	http://dx.doi.org/10.1371/journal.pone.0088320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551088	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500035
J	Suk, HI; Fazli, S; Mehnert, J; Muller, KR; Lee, SW				Suk, Heung-Il; Fazli, Siamac; Mehnert, Jan; Mueller, Klaus-Robert; Lee, Seong-Whan			Predicting BCI Subject Performance Using Probabilistic Spatio-Temporal Filters	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; COMMON SPATIAL-PATTERNS; SINGLE-TRIAL EEG; CLASSIFICATION; POTENTIALS	Recently, spatio-temporal filtering to enhance decoding for Brain-Computer-Interfacing (BCI) has become increasingly popular. In this work, we discuss a novel, fully Bayesian-and thereby probabilistic-framework, called Bayesian Spatio-Spectral Filter Optimization (BSSFO) and apply it to a large data set of 80 non-invasive EEG-based BCI experiments. Across the full frequency range, the BSSFO framework allows to analyze which spatio-spectral parameters are common and which ones differ across the subject population. As expected, large variability of brain rhythms is observed between subjects. We have clustered subjects according to similarities in their corresponding spectral characteristics from the BSSFO model, which is found to reflect their BCI performances well. In BCI, a considerable percentage of subjects is unable to use a BCI for communication, due to their missing ability to modulate their brain rhythms-a phenomenon sometimes denoted as BCI-illiteracy or inability. Predicting individual subjects' performance preceding the actual, time-consuming BCI-experiment enhances the usage of BCIs, e.g., by detecting users with BCI inability. This work additionally contributes by using the novel BSSFO method to predict the BCI-performance using only 2 minutes and 3 channels of resting-state EEG data recorded before the actual BCI-experiment. Specifically, by grouping the individual frequency characteristics we have nicely classified them into the subject 'prototypes' (like mu - or beta - rhythm type subjects) or users without ability to communicate with a BCI, and then by further building a linear regression model based on the grouping we could predict subjects' performance with the maximum correlation coefficient of 0.581 with the performance later seen in the actual BCI session.	[Suk, Heung-Il; Fazli, Siamac; Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mehnert, Jan; Mueller, Klaus-Robert] TU Berlin, Machine Learning Grp, Berlin, Germany	Korea University; Technical University of Berlin	Lee, SW (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	klaus-robert.mueller@tu-berlin.de; swlee@image.korea.ac.kr	Fazli, Siamac/GYQ-9627-2022; Mehnert, Jan/AAX-8791-2020; Mueller, Klaus-Robert/Y-3547-2019	Fazli, Siamac/0000-0003-3397-0647; Mehnert, Jan/0000-0001-7088-740X; Mueller, Klaus-Robert/0000-0002-3861-7685; Suk, Heung-Il/0000-0001-7019-8962	National Research Foundation; Ministry of Science, ICT and Future Planning [2012-005741]	National Research Foundation; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation funded by the Ministry of Science, ICT and Future Planning, under grant 2012-005741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison B, 2010, IEEE T NEUR SYS REH, V18, P107, DOI 10.1109/TNSRE.2009.2039495; Allison BZ, 2010, HUM-COMPUT INT-SPRIN, P35, DOI 10.1007/978-1-84996-272-8_3; Ang KK, 2009, IEEE ENG MED BIO, P578, DOI 10.1109/IEMBS.2009.5332817; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2002, ADV NEUR IN, V14, P157; Blankertz B., 2008, ADV NEURAL INFORM PR, V20, P113; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Buttfield A, 2006, IEEE T NEUR SYS REH, V14, P164, DOI 10.1109/TNSRE.2006.875555; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazli S, 2009, ADV NEURAL INFORM PR, V22, P513; Fazli S, 2011, NEUROIMAGE, V56, P2100, DOI 10.1016/j.neuroimage.2011.03.061; Fazli S, 2009, NEURAL NETWORKS, V22, P1305, DOI 10.1016/j.neunet.2009.06.003; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Kai Keng Ang, 2013, Journal of Computing Science and Engineering, V7, P139, DOI 10.5626/JCSE.2013.7.2.139; Koles ZJ, 1998, ELECTROEN CLIN NEURO, V107, P343, DOI 10.1016/S0013-4694(98)00084-4; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Parra LC, 2008, IEEE SIGNAL PROC MAG, V25, P107, DOI 10.1109/MSP.2008.4408447; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; ROCKSTROH B, 1984, BIOFEEDBACK SELF-REG, V9, P139, DOI 10.1007/BF00998830; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Suk HI, 2013, IEEE T PATTERN ANAL, V35, P286, DOI 10.1109/TPAMI.2012.69; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; Wang HX, 2008, IEEE T NEUR SYS REH, V16, P131, DOI 10.1109/TNSRE.2007.914468; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	37	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87056	10.1371/journal.pone.0087056	http://dx.doi.org/10.1371/journal.pone.0087056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551050	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500014
J	Hommel, B; Charuel, JL; Jaureguiberry, S; Arnaud, L; Courtin, R; Kassab, P; Prendki, V; Paris, L; Ghillani-Dalbin, P; Thellier, M; Caumes, E; Amoura, Z; Mazier, D; Musset, L; Buffet, P; Miyara, M				Hommel, Benjamin; Charuel, Jean-Luc; Jaureguiberry, Stephane; Arnaud, Laurent; Courtin, Regis; Kassab, Petra; Prendki, Virginie; Paris, Luc; Ghillani-Dalbin, Pascale; Thellier, Marc; Caumes, Eric; Amoura, Zahir; Mazier, Dominique; Musset, Lucile; Buffet, Pierre; Miyara, Makoto			Chronic Malaria Revealed by a New Fluorescence Pattern on the Antinuclear Autoantibodies Test	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTIBODY; POLYMYOSITIS; SPECIFICITY; EXPRESSION; HEPATITIS; INFECTION; DISEASE; ANTIGEN; SERA	Background: Several clinical forms of malaria such as chronic carriage, gestational malaria or hyper-reactive malarial splenomegaly may follow a cryptic evolution with afebrile chronic fatigue sometimes accompanied by anemia and/or splenomegaly. Conventional parasitological tests are often negative or not performed, and severe complications may occur. Extensive explorations of these conditions often include the search for antinuclear autoantibodies (ANA). Methods: We analysed fluorescence patterns in the ANA test in patients with either chronic cryptic or acute symptomatic malaria, then conducted a one-year prospective study at a single hospital on all available sera drawn for ANA detections. We then identified autoantibodies differentially expressed in malaria patients and in controls using human protein microarray. Results: We uncovered and defined a new, malaria-related, nucleo-cytoplasmic ANA pattern displaying the specific association of a nuclear speckled pattern with diffuse cytoplasmic perinuclearly-enhanced fluorescence. In the one-year prospective analysis, 79% of sera displaying this new nucleo-cytoplasmic fluorescence were from patients with malaria. This specific pattern, not seen in other parasitic diseases, allowed a timely reorientation of the diagnosis toward malaria. To assess if the autoantibody immune response was due to autoreactivity or molecular mimicry we isolated 42 autoantigens, targets of malarial autoantibodies. BLAST analysis indicated that 23 of recognized autoantigens were homologous to plasmodial proteins suggesting autoimmune responses directly driven by the plasmodial infection. Conclusion: In patients with malaria in whom parasitological tests have not been performed recognition of this new, malaria-related fluorescence pattern on the ANA test is highly suggestive of the diagnosis and triggers immediate, easy confirmation and adapted therapy.	[Hommel, Benjamin; Courtin, Regis; Paris, Luc; Thellier, Marc; Mazier, Dominique; Buffet, Pierre] Grp Hosp Pitie Salpetriere, AP HP, Immune Chem & Autoimmun Lab, Dept Immunol, F-75634 Paris, France; [Hommel, Benjamin; Charuel, Jean-Luc; Kassab, Petra; Ghillani-Dalbin, Pascale; Musset, Lucile; Miyara, Makoto] Grp Hosp Pitie Salpetriere, AP HP, Parasitol Mycol Lab, F-75634 Paris, France; [Jaureguiberry, Stephane; Caumes, Eric] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Trop Infect Dis Dept, Paris, France; [Jaureguiberry, Stephane; Arnaud, Laurent; Thellier, Marc; Mazier, Dominique; Buffet, Pierre; Miyara, Makoto] INSERM, Natl Inst Hlth & Med Res, UMR S 945, Paris, France; [Arnaud, Laurent; Amoura, Zahir; Miyara, Makoto] Grp Hosp Pitie Salpetriere, AP HP, French Natl Reference Ctr SLE & Antiphospholipid, Dept Internal Med, F-75634 Paris, France; [Prendki, Virginie] Hop Croix St Simon, Dept Internal Med & Sept Orthopaed, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Miyara, M (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Parasitol Mycol Lab, F-75634 Paris, France.	makoto.miyara@psl.aphp.fr	Thellier, Marc/AAI-3311-2021; Jauréguiberry, Stéphane/GWZ-9904-2022; Miyara, Makoto/P-4491-2017; Prendki, Virginie/ABI-1378-2020; Amoura, Zahir/P-5325-2017; AMOURA, Zahir/P-5324-2017	Thellier, Marc/0000-0003-4867-2423; Jauréguiberry, Stéphane/0000-0003-0057-5464; Miyara, Makoto/0000-0001-8743-8846; AMOURA, Zahir/0000-0003-0292-9043; Hommel, Benjamin/0000-0003-0971-1696; Prendki, Virginie/0000-0003-1315-2938				ADEBAJO AO, 1993, CLIN EXP IMMUNOL, V92, P73, DOI 10.1111/j.1365-2249.1993.tb05950.x; ADU D, 1982, CLIN EXP IMMUNOL, V49, P310; ARGOV S, 1989, CLIN EXP IMMUNOL, V76, P190; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; BATES I, 1991, LANCET, V337, P505, DOI 10.1016/0140-6736(91)91293-4; Bates I, 1997, LANCET, V349, P1178, DOI 10.1016/S0140-6736(05)63061-9; Bidegain F, 2005, CLIN INFECT DIS, V40, pE97, DOI 10.1086/430061; Chien C H, 1996, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V37, P31; CRANE GG, 1972, T ROY SOC TROP MED H, V66, P724, DOI 10.1016/0035-9203(72)90086-7; D'Ortenzio E, 2008, EMERG INFECT DIS, V14, P323, DOI 10.3201/eid1402.061475; Daniel-Ribeiro C, 1991, J Clin Lab Immunol, V35, P109; Farfour E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-285; GREENWOOD BM, 1970, CLIN EXP IMMUNOL, V7, P75; KLOPPEL G, 1977, VIRCHOWS ARCH A, V373, P143, DOI 10.1007/BF00432159; LORTHOLARY O, 1994, ANN MED INTERNE, V145, P155; Lu B, 2010, SCAND J IMMUNOL, V71, P220, DOI 10.1111/j.1365-3083.2009.02364.x; Marangi M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-12; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Obwaller A, 2004, PARASITE IMMUNOL, V26, P327, DOI 10.1111/j.0141-9838.2004.00716.x; Puente S, 2001, J TRAVEL MED, V8, P322, DOI 10.2310/7060.2001.23982; RAHIMA D, 1994, AUTOIMMUNITY, V17, P127, DOI 10.3109/08916939409014668; Ramirez-Olivencia G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-324; Rogerson SJ, 1999, ANN TROP MED PARASIT, V93, pS35, DOI 10.1080/00034989957727; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Schwartz E, 2003, NEW ENGL J MED, V349, P1510, DOI 10.1056/NEJMoa021592; Singh Ranjan K, 2007, Travel Med Infect Dis, V5, P24; TARGOFF IN, 1990, AM J MED, V88, P241, DOI 10.1016/0002-9343(90)90149-8; TARGOFF IN, 1990, ARTHRITIS RHEUM, V33, P1361, DOI 10.1002/art.1780330908; Torres JR, 2003, ANN TROP MED PARASIT, V97, P125, DOI 10.1179/000349803235001372; WATANABE N, 1969, ARTHRITIS RHEUM, V12, P173, DOI 10.1002/art.1780120303; WHO, 2010, GUID TREATM MAL, V2nd; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yahya TM, 1997, CLIN EXP IMMUNOL, V110, P41, DOI 10.1111/j.1365-2249.1997.498-ce1395.x; YOSHIDA S, 1983, ARTHRITIS RHEUM, V26, P604, DOI 10.1002/art.1780260505; Ziegler JL, 2008, AM J TROP MED HYG, V78, P186, DOI 10.4269/ajtmh.2008.78.186	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88548	10.1371/journal.pone.0088548	http://dx.doi.org/10.1371/journal.pone.0088548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551116	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000044
J	Jin, SL; Tan, RJ; Jiang, QH; Xu, L; Peng, JJ; Wang, Y; Wang, YD				Jin, Shuilin; Tan, Renjie; Jiang, Qinghua; Xu, Li; Peng, Jiajie; Wang, Yong; Wang, Yadong			A Generalized Topological Entropy for Analyzing the Complexity of DNA Sequences	PLOS ONE			English	Article								Topological entropy is one of the most difficult entropies to be used to analyze the DNA sequences, due to the finite sample and high-dimensionality problems. In order to overcome these problems, a generalized topological entropy is introduced. The relationship between the topological entropy and the generalized topological entropy is compared, which shows the topological entropy is a special case of the generalized entropy. As an application the generalized topological entropy in introns, exons and promoter regions was computed, respectively. The results indicate that the entropy of introns is higher than that of exons, and the entropy of the exons is higher than that of the promoter regions for each chromosome, which suggest that DNA sequence of the promoter regions is more regular than the exons and introns.	[Jin, Shuilin; Wang, Yong] Harbin Inst Technol, Dept Math, Harbin 150006, Heilongjiang, Peoples R China; [Tan, Renjie; Peng, Jiajie; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Jiang, Qinghua] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Xu, Li] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Harbin Institute of Technology; Harbin Engineering University	Wang, Y (corresponding author), Harbin Inst Technol, Dept Math, Harbin 150006, Heilongjiang, Peoples R China.	mathwy@hit.edu.cn; ydwang@hit.edu.cn	Peng, Jiajie/Y-5601-2019; Peng, Jiajie/C-7776-2016	Peng, Jiajie/0000-0002-3857-7927; 	China Natural Science Foundation [11301110, 61201084, 61102149, 61173085]; China Postdoctoral Science Foundation [2013M541346]; China Scholarship Council (CSC) [201203070290, 201206125024]; Program for Innovation Research of Science in Harbin Institute of Technology; Fundamental Research Funds for the Central Universities [HEUCF100604]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Scholarship Council (CSC)(China Scholarship Council); Program for Innovation Research of Science in Harbin Institute of Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the China Natural Science Foundation (Grant No. 11301110, No. 61201084, No. 61102149 and No. 61173085), China Postdoctoral Science Foundation (Grant No. 2013M541346), the State Scholarship Fund from the China Scholarship Council (CSC) (Grant No. 201203070290 and No. 201206125024), the Program for Innovation Research of Science in Harbin Institute of Technology and the Fundamental Research Funds for the Central Universities (Grant No. HEUCF100604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg D, 2007, GENOME RES, V17, P960, DOI 10.1101/gr.5578007; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bose R, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051918; Colosimo A, 2000, J THEOR BIOL, V204, P29, DOI 10.1006/jtbi.2000.1077; Kirillova OV, 2000, PHYS LETT A, V274, P247, DOI 10.1016/S0375-9601(00)00557-0; Koslicki D, 2011, BIOINFORMATICS, V27, P1061, DOI 10.1093/bioinformatics/btr077; Renyi A, 1961, CONTRIBUTIONS THEORY, V1; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Vinga S, 2004, J THEOR BIOL, V231, P377, DOI 10.1016/j.jtbi.2004.06.030; Zhao FC, 2007, J THEOR BIOL, V247, P645, DOI 10.1016/j.jtbi.2007.03.035	10	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88519	10.1371/journal.pone.0088519	http://dx.doi.org/10.1371/journal.pone.0088519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533097	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600055
J	Li, CX; Siragy, HM				Li, Caixia; Siragy, Helmy M.			High Glucose Induces Podocyte Injury via Enhanced (Pro)renin Receptor-Wnt-beta-Catenin-Snail Signaling Pathway	PLOS ONE			English	Article							PRO RENIN RECEPTOR; TO-MESENCHYMAL TRANSITION; VACUOLAR H+-ATPASE; WNT/BETA-CATENIN; PRORENIN RECEPTOR; KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; UP-REGULATION; RENAL INJURY; EXPRESSION	(Pro)renin receptor (PRR) expression is upregulated in diabetes. We hypothesized that PRR contributes to podocyte injury via activation of Wnt-beta-catenin-snail signaling pathway. Mouse podocytes were cultured in normal (5 mM) or high (25 mM) D-glucose for 3 days. Compared to normal glucose, high glucose significantly decreased mRNA and protein expressions of podocin and nephrin, and increased mRNA and protein expressions of PRR, Wnt3a, beta-catenin, and snail, respectively. Confocal microscopy studies showed significant reduction in expression and reorganization of podocyte cytoskeleton protein, F-actin, in response to high glucose. Transwell functional permeability studies demonstrated significant increase in albumin flux through podocytes monolayer with high glucose. Cells treated with high glucose and PRR siRNA demonstrated significantly attenuated mRNA and protein expressions of PRR, Wnt3a, beta-catenin, and snail; enhanced expressions of podocin mRNA and protein, improved expression and reorganization of F-actin, and reduced transwell albumin flux. We conclude that high glucose induces podocyte injury via PRR-Wnt- beta-catenin- snail signaling pathway.	[Li, Caixia; Siragy, Helmy M.] Univ Virginia Hlth Syst, Div Endocrinol & Metab, Charlottesville, VA 22903 USA	University of Virginia	Siragy, HM (corresponding author), Univ Virginia Hlth Syst, Div Endocrinol & Metab, Charlottesville, VA 22903 USA.	hms7a@virginia.edu	SIRAGY, HELMY/AAP-2651-2021		National Institutes of Health [DK078757, HL091535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK078757 and HL091535 to HM Siragy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Awad AS, 2008, J AM SOC NEPHROL, V19, P59, DOI 10.1681/ASN.2007030276; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Carey RM, 2003, TRENDS ENDOCRIN MET, V14, P274, DOI 10.1016/S1043-2760(03)00111-5; Cheng HF, 2011, J AM SOC NEPHROL, V22, P1240, DOI 10.1681/ASN.2010111149; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; Covington MD, 2012, KIDNEY INT, V81, P391, DOI 10.1038/ki.2011.356; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gaston-Massuet C, 2011, P NATL ACAD SCI USA, V108, P11482, DOI 10.1073/pnas.1101553108; Gonzalez AA, 2013, HYPERTENSION, V61, P443, DOI 10.1161/HYPERTENSIONAHA.112.196303; Hsu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047649; Huang JQ, 2010, ENDOCRINOLOGY, V151, P3317, DOI 10.1210/en.2009-1368; Huang JQ, 2009, ENDOCRINOLOGY, V150, P5557, DOI 10.1210/en.2009-0442; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ichihara A, 2009, J PHARMACOL SCI, V109, P20, DOI 10.1254/jphs.08R07FM; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li CX, 2011, CELL PHYSIOL BIOCHEM, V27, P691, DOI 10.1159/000330078; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Matsui I, 2007, LAB INVEST, V87, P273, DOI 10.1038/labinvest.3700518; Nelson PJ, 2011, EXPERT OPIN THER TAR, V15, P1073, DOI 10.1517/14728222.2011.588210; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2008, CURR OPIN PHARMACOL, V8, P127, DOI 10.1016/j.coph.2007.12.009; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Pulkkinen Kaisa, 2008, Organogenesis, V4, P55; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Schwartz EJ, 2001, J AM SOC NEPHROL, V12, P1677, DOI 10.1681/ASN.V1281677; Sihn G, 2010, KIDNEY INT, V78, P246, DOI 10.1038/ki.2010.151; Siragy HM, 2008, EXP PHYSIOL, V93, P709, DOI 10.1113/expphysiol.2007.040550; Siu Brian, 2006, BMC Nephrol, V7, P6, DOI 10.1186/1471-2369-7-6; Terada Y, 2003, J AM SOC NEPHROL, V14, P1223, DOI 10.1097/01.ASN.0000060577.94532.06; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Ueno K, 2011, INT J CANCER, V129, P2360, DOI 10.1002/ijc.25899; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; Waters A, 2009, J AM SOC NEPHROL, V20, P1864, DOI 10.1681/ASN.2009070762; Wuebken A, 2011, KIDNEY INT, V80, P135, DOI 10.1038/ki.2011.87; Xue C, 2005, HYPERTENSION, V46, P584, DOI 10.1161/01.HYP.0000175814.18550.c0	49	51	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89233	10.1371/journal.pone.0089233	http://dx.doi.org/10.1371/journal.pone.0089233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533170	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600132
J	Chiu, THT; Huang, HY; Chiu, YF; Pan, WH; Kao, HY; Chiu, JPC; Lin, MN; Lin, CL				Chiu, Tina H. T.; Huang, Hui-Ya; Chiu, Yen-Feng; Pan, Wen-Harn; Kao, Hui-Yi; Chiu, Jason P. C.; Lin, Ming-Nan; Lin, Chin-Lon			Taiwanese Vegetarians and Omnivores: Dietary Composition, Prevalence of Diabetes and IFG	PLOS ONE			English	Article							INSULIN SENSITIVITY; VEGETABLE INTAKE; TYPE-2; RISK; ASSOCIATION; HEALTH; FRUIT	Introduction: Vegetarian diets have been shown to improve glucose metabolism and reduce risk for diabetes in Westerners but whether Chinese vegetarian diets have the same benefits is unknown. Methods: We evaluated the association between diet and diabetes/impaired fasting glucose (IFG) among 4384 Taiwanese Buddhist volunteers and identified diabetes/IFG cases from a comprehensive review of medical history and fasting plasma glucose. Results: Vegetarians had higher intakes of carbohydrates, fiber, calcium, magnesium, total and non-heme iron, folate, vitamin A, and lower intakes of saturated fat, cholesterol, and vitamin B12. Besides avoiding meat and fish, vegetarians had higher intakes of soy products, vegetables, whole grains, but similar intakes of dairy and fruits, compared with omnivores. The crude prevalence of diabetes in vegetarians versus omnivores is 0.6% versus 2.3% in pre-menopausal women, 2.8% versus 10% in menopausal women, and 4.3% versus 8.1% in men. Polytomous logistic regression adjusting for age, body mass index, family history of diabetes, education, leisure time physical activity, smoking and alcohol, showed that this vegetarian diet was negatively associated with diabetes and IFG in men (OR for diabetes: 0.49, 95% CI: 0.28-0.89; OR for IFG: 0.66, 95% CI: 0.46-0.95); in pre-menopausal women (OR for diabetes: 0.26, 95% CI: 0.06-1.21; OR for IFG: 0.60, 95% CI: 0.35-1.04); and in menopausal women (OR for diabetes: 0.25, 95% CI: 0.15-0.42; OR for IFG: 0.73, 95% CI: 0.56-0.95). Conclusion: We found a strong protective association between Taiwanese vegetarian diet and diabetes/IFG, after controlling for various potential confounders and risk factors.	[Chiu, Tina H. T.; Lin, Chin-Lon] Tzu Chi Fdn, Hualien, Taiwan; [Chiu, Tina H. T.; Pan, Wen-Harn] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Huang, Hui-Ya; Lin, Ming-Nan] Buddhist Dalin Tzu Chi Hosp, Dept Family Med, Dalin, Chiayi County, Taiwan; [Chiu, Yen-Feng; Kao, Hui-Yi] Natl Hlth Res Inst, Dept Biostat & Bioinformat, Inst Populat Hlth Sci, Zhunan, Miaoli County, Taiwan; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chiu, Jason P. C.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1W5, Canada; [Lin, Ming-Nan] Tzu Chi Univ, Dept Family Med, Coll Med, Hualien, Taiwan; [Lin, Chin-Lon] Buddhist Hualien Tzu Chi Hosp, Dept Internal Med, Hualien, Taiwan; [Lin, Chin-Lon] Tzu Chi Univ, Dept Internal Med, Coll Med, Hualien, Taiwan	National Taiwan University; Buddhist Tzu Chi General Hospital; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; University of British Columbia; Tzu Chi University; Tzu Chi University	Lin, MN (corresponding author), Buddhist Dalin Tzu Chi Hosp, Dept Family Med, Dalin, Chiayi County, Taiwan.	mingnan.lin@gmail.com	Chiu, Yen-Feng/E-3847-2010; Pan, Wen-Harn/F-9972-2010	Pan, Wen-Harn/0000-0001-9136-0658; Chiu, Tina H. T./0000-0002-1773-1104	Buddhist Tzu Chi General Hospital in Taiwan [TCRD-I9605-02]	Buddhist Tzu Chi General Hospital in Taiwan	The study was supported by a grant (TCRD-I9605-02) from the Buddhist Tzu Chi General Hospital in Taiwan. Tzu Chi Hospital's website: or preparation of the manuscript. http://www.tzuchi.com.tw/tzuchi/mainpage/Default.aspx. The funders had no role in study design, data collection and analysis, decision to publish,	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 1988, NUTR COMP DAT BANK F; Assari S, 2013, INT J PREVENTIVE MED, V4, P208; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Barnard ND, 2009, AM J CLIN NUTR, V89, pS1588, DOI 10.3945/ajcn.2009.26736H; Carmody RN, 2011, P NATL ACAD SCI USA, V108, P19199, DOI 10.1073/pnas.1112128108; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chiang JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071799; Chiu TH, 2013, PUBLIC HLTH IN PRESS; Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Hua NW, 2001, BRIT J NUTR, V86, P515, DOI 10.1079/BJN2001421; Hung CJ, 2006, BRIT J NUTR, V95, P129, DOI 10.1079/BJN20051588; Kahleova H, 2011, DIABETIC MED, V28, P549, DOI 10.1111/j.1464-5491.2010.03209.x; Kuo CS, 2004, EUR J CLIN NUTR, V58, P312, DOI 10.1038/sj.ejcn.1601783; Novotny JA, 2012, AM J CLIN NUTR, V96, P296, DOI 10.3945/ajcn.112.035782; Odegaard AO, 2011, DIABETES CARE, V34, P880, DOI 10.2337/dc10-2350; Palli D, 2013, DIABETOLOGIA, V56, P47, DOI 10.1007/s00125-012-2718-7; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; Rizzo NS, 2013, J ACAD NUTR IN PRESS; Seawell AH, 2013, PSYCHOL HLT IN PRESS; Tonstad S, 2013, NUTR METAB CARDIOVAS, V23, P292, DOI 10.1016/j.numecd.2011.07.004; Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886; Villegas Raquel, 2006, Int J Med Sci, V3, P152; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wollstonecroft MM, 2012, P NATL ACAD SCI USA, V109, pE991, DOI 10.1073/pnas.1201050109; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x	34	49	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88547	10.1371/journal.pone.0088547	http://dx.doi.org/10.1371/journal.pone.0088547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523914	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100063
J	de Leon, VP; Merillat, AM; Tesson, L; Anegon, I; Hummler, E				de Leon, Veronica Ponce; Merillat, Anne-Marie; Tesson, Laurent; Anegon, Ignacio; Hummler, Edith			Generation of TALEN-Mediated GR(dim) Knock-In Rats by Homologous Recombination	PLOS ONE			English	Article							DNA-BINDING; GENOME	Transcription Activator-Like Effector Nucleases (TALEN) are potential tools for precise genome engineering of laboratory animals. We report the first targeted genomic integration in the rat using TALENs (Transcription Activator-Like Effector Nucleases) by homology-derived recombination (HDR). We assembled TALENs and designed a linear donor insert targeting a pA476T mutation in the rat Glucocorticoid Receptor (Nr3c1) namely GR(dim), that prevents receptor homodimerization in the mouse. TALEN mRNA and linear double-stranded donor were microinjected into rat one-cell embryos. Overall, we observed targeted genomic modifications in 17% of the offspring, indicating high TALEN cutting efficiency in rat zygotes.	[de Leon, Veronica Ponce; Merillat, Anne-Marie; Hummler, Edith] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Tesson, Laurent; Anegon, Ignacio] Univ Nantes, INSERM, UMR 1064, Nantes, France; [Tesson, Laurent; Anegon, Ignacio] Univ Nantes, Transgen Rat Facil, Nantes, France	University of Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite	de Leon, VP (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	veronica.poncedeleon@unil.ch; edith.hummler@unil.ch	Anegon, Ignacio/I-7760-2018; Anegon, Ignacio/I-7498-2018		NCCR (National Centers of Competence in Research), Kidney.CH, Switzerland	NCCR (National Centers of Competence in Research), Kidney.CH, Switzerland	This work was supported by the NCCR (National Centers of Competence in Research), Kidney.CH, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P657, DOI 10.1534/g3.112.005439; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Davies B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060216; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Huang GY, 2011, CURR OPIN NEPHROL HY, V20, P391, DOI 10.1097/MNH.0b013e328347768a; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; James MR, 1997, TRENDS GENET, V13, P171, DOI 10.1016/S0168-9525(97)01130-X; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Parker CC, 2014, NEUROPHARMACOLOGY, V76, P250, DOI 10.1016/j.neuropharm.2013.05.047; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reyon Deepak, 2012, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1215s100; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	27	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88146	10.1371/journal.pone.0088146	http://dx.doi.org/10.1371/journal.pone.0088146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523878	Green Published, gold			2022-12-27	WOS:000331258100027
J	Shaw, SY; Jolly, AM; Wylie, JL				Shaw, Souradet Y.; Jolly, Ann M.; Wylie, John L.			Outlier Populations: Individual and Social Network Correlates of Solvent-Using Injection Drug Users	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; CORE GROUP-THEORY; INHALANT USE; RISK BEHAVIORS; HCV INFECTION; HIV-INFECTION; B-VIRUS; PREVALENCE; HEROIN	Objective: We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using injection drug users (S-IDU) relative to other injection drug users within the same locality. Here we incorporated social network variables to better characterize some of the behavioural characteristics that may be putting this specific subgroup of IDU at elevated disease risk. Methods: A cross-sectional survey of at-risk populations was carried out in Winnipeg, Canada in 2009. Individuals reporting any history of injection drug and/or solvent use were included in the study. Associations between subgroup membership, infection with HCV and HIV and individual and social network variables were examined. Results: In relation to other IDU, S-IDU were more likely to be infected with HCV, to report ever having shared a syringe, and to associate with other IDU. They were further differentiated in terms of their self-reported sexual orientation, ethnicity and in the injection drugs typically used. Conclusion: Solvent use stands as a proxy measure of numerous other characteristics that put this group of IDU at higher risk of infection. Provision of adequate services to ostracized subpopulations may result in wider population-level benefits.	[Shaw, Souradet Y.; Wylie, John L.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Jolly, Ann M.] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Jolly, Ann M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Wylie, John L.] Cadham Prov Lab, Winnipeg, MB, Canada; [Wylie, John L.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; Public Health Agency of Canada; University of Toronto; University of Manitoba	Shaw, SY (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada.	umshaw@cc.umanitoba.ca		Shaw, Souradet/0000-0002-0982-1302	Canadian Institutes of Health Research; Manitoba Health Research Council; Memorial Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Memorial Scholarship	This study was supported by an operating grant provided by the Canadian Institutes of Health Research. SYS was supported in part by doctoral awards from the Manitoba Health Research Council, David G. Fish Memorial Scholarship and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAY LA, 1994, ANNU REV PUBL HEALTH, V15, P487, DOI 10.1146/annurev.pu.15.050194.002415; ALTENKIRCH H, 1986, ADDICT BEHAV, V11, P93, DOI 10.1016/0306-4603(86)90033-X; [Anonymous], 2008, STUDY CHARACTERIZE E; Aral SO, 2008, SEX TRANSM INFECT, V84, pII1, DOI 10.1136/sti.2008.033613; Aral SO, 2007, SEX TRANSM INFECT, V83, pI1, DOI 10.1136/sti.2007.027169; Aral SO, 2000, SEX TRANSM DIS, V27, P327, DOI 10.1097/00007435-200007000-00005; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; Bruneau J, 1997, AM J EPIDEMIOL, V146, P994, DOI 10.1093/oxfordjournals.aje.a009240; Brunham RC, 1997, VENEREOLOGY, V10, P34; Burt RD, 2007, J URBAN HEALTH, V84, P436, DOI 10.1007/s11524-007-9178-2; BYRNE A, 1991, CAN J PSYCHIAT, V36, P735, DOI 10.1177/070674379103601008; Cates Jr W, 1999, LANCET S, V354; Centers for Disease Control and Prevention, 2010, HIV SURV REP 2008; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; DAMANDA C, 1977, INT J ADDICT, V12, P255, DOI 10.3109/10826087709027223; De P, 2006, CAN J PUBLIC HEALTH, V97, P207, DOI 10.1007/BF03405586; Dean HD, 2005, J NATL MED ASSOC, V97, p5S; Dell CA, 2005, INT J INDIG HEALTH, V2, P4; Des Jarlais DC, 2003, AM J EPIDEMIOL, V157, P467, DOI 10.1093/aje/kwf222; Des Jarlais DC, 2007, ADDICTION, V102, P778, DOI 10.1111/j.1360-0443.2007.01764.x; Des Jarlais DC, 2007, AIDS, V21, P231, DOI 10.1097/QAD.0b013e3280114a15; Medina-Mora ME, 2008, CURR OPIN PSYCHIATR, V21, P247, DOI 10.1097/YCO.0b013e3282fc9875; Fendrich M, 1997, AM J PUBLIC HEALTH, V87, P765, DOI 10.2105/AJPH.87.5.765; Garland EL, 2011, SUBST USE MISUSE, V46, P8, DOI 10.3109/10826084.2011.580172; Garland EL, 2010, EXP CLIN PSYCHOPHARM, V18, P498, DOI 10.1037/a0021737; GARNETT GP, 1993, SEX TRANSM DIS, V20, P181, DOI 10.1097/00007435-199307000-00001; Hagan H, 2000, MT SINAI J MED, V67, P423; Hagan H, 1998, SUBST USE MISUSE, V33, P1197, DOI 10.3109/10826089809062214; Han B, 2010, ANN EPIDEMIOL, V20, P289, DOI 10.1016/j.annepidem.2010.01.003; Hernando V, 2012, J HEPATOL, V57, P743, DOI 10.1016/j.jhep.2012.06.010; Howard MO, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-8; Howard MO, 1999, ADDICTION, V94, P83, DOI 10.1046/j.1360-0443.1999.941835.x; Howard MO, 1999, ADDICT BEHAV, V24, P59, DOI 10.1016/S0306-4603(98)00039-2; Johnson EO, 1995, DRUG ALCOHOL DEPEN, V40, P159, DOI 10.1016/0376-8716(95)01201-X; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Latkin C, 1996, J ACQ IMMUN DEF SYND, V13, P273, DOI 10.1097/00042560-199611010-00010; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Lelutiu-Weinberger C, 2009, SOC SCI MED, V68, P579, DOI 10.1016/j.socscimed.2008.10.011; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Lovell AM, 2002, SOC SCI MED, V55, P803, DOI 10.1016/S0277-9536(01)00204-0; Mackesy-Amiti ME, 2000, AM J DRUG ALCOHOL AB, V26, P569, DOI 10.1081/ADA-100101896; Maher L, 2006, ADDICTION, V101, P1499, DOI 10.1111/j.1360-0443.2006.01543.x; Marshall BDL, 2011, AIDS BEHAV, V15, P1546, DOI 10.1007/s10461-010-9876-8; Marshall BDL, 2011, PREV SCI, V12, P173, DOI 10.1007/s11121-010-0197-y; Millson P, 2003, CAN J PUBLIC HEALTH, V94, P431, DOI 10.1007/BF03405080; Morissette C, 2007, INT J DRUG POLICY, V18, P204, DOI 10.1016/j.drugpo.2006.08.004; Moses SA, 2006, AIDS S ASIA UNDERSTA; Neaigus A, 1996, J ACQ IMMUN DEF SYND, V11, P499, DOI 10.1097/00042560-199604150-00011; Needle RH, 1998, SUBST USE MISUSE, V33, P2403, DOI 10.3109/10826089809059332; Orland JR, 2001, HEPATOLOGY, V33, P321, DOI 10.1053/jhep.2001.22112; Ouellet L, 2004, JAIDS-J ACQ IMM DEF, V37, P1187, DOI 10.1097/01.qai.0000120802.43677.ea; Patrick DM, 1997, INT J STD AIDS, V8, P437, DOI 10.1258/0956462971920497; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; SCHUTZ CG, 1994, COMPR PSYCHIAT, V35, P99, DOI 10.1016/0010-440X(94)90053-K; Shaw SY, 2008, AM J PUBLIC HEALTH, V98, P1430, DOI 10.2105/AJPH.2007.120741; Shaw SY, 2007, ADDICTION, V102, P1626, DOI 10.1111/j.1360-0443.2007.01940.x; Shaw SY, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-16; Sherman SG, 2001, SUBST USE MISUSE, V36, P2113, DOI 10.1081/JA-100108439; SMART RG, 1986, J PSYCHOACTIVE DRUGS, V18, P87; Smyth BP, 2007, ADDICT BEHAV, V32, P1943, DOI 10.1016/j.addbeh.2006.12.021; Smyth BP, 2001, ADDICTION, V96, P717, DOI 10.1046/j.1360-0443.2001.9657177.x; Strathdee SA, 1997, ADDICTION, V92, P1339, DOI 10.1046/j.1360-0443.1997.9210133910.x; Substance Abuse and Mental Health Services Administration, 2010, RES 2009 NAT SURV DR, VI; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Treloar C, 2009, QUAL HEALTH RES, V19, P1321, DOI 10.1177/1049732309341656; Treloar CJ, 2009, DRUG ALCOHOL REV, V28, P436, DOI 10.1111/j.1465-3362.2009.00031.x; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; Valente TW, 2001, AM J PUBLIC HEALTH, V91, P406, DOI 10.2105/AJPH.91.3.406; van Beek I, 1998, BMJ-BRIT MED J, V317, P433, DOI 10.1136/bmj.317.7156.433; Vlahov D, 1998, Public Health Rep, V113 Suppl 1, P75; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Wada K, 1999, ADDICTION, V94, P1063, DOI 10.1046/j.1360-0443.1999.947106311.x; Watts C, 2010, SEX TRANSM INFECT, V86, P85, DOI 10.1136/sti.2010.044602; Weir E, 2001, CAN MED ASSOC J, V164, P397; Wu LT, 2008, ADDICT BEHAV, V33, P968, DOI 10.1016/j.addbeh.2008.02.019; Wylie JL, 2007, HEALTH PLACE, V13, P617, DOI 10.1016/j.healthplace.2006.09.002	76	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88623	10.1371/journal.pone.0088623	http://dx.doi.org/10.1371/journal.pone.0088623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523923	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100072
J	Tremblay, Y; Thiebault, A; Mullers, R; Pistorius, P				Tremblay, Yann; Thiebault, Andrea; Mullers, Ralf; Pistorius, Pierre			Bird-Borne Video-Cameras Show That Seabird Movement Patterns Relate to Previously Unrevealed Proximate Environment, Not Prey	PLOS ONE			English	Article							PREDATOR	The study of ecological and behavioral processes has been revolutionized in the last two decades with the rapid development of biologging-science. Recently, using image-capturing devices, some pilot studies demonstrated the potential of understanding marine vertebrate movement patterns in relation to their proximate, as opposed to remote sensed environmental contexts. Here, using miniaturized video cameras and GPS tracking recorders simultaneously, we show for the first time that information on the immediate visual surroundings of a foraging seabird, the Cape gannet, is fundamental in understanding the origins of its movement patterns. We found that movement patterns were related to specific stimuli which were mostly other predators such as gannets, dolphins or fishing boats. Contrary to a widely accepted idea, our data suggest that foraging seabirds are not directly looking for prey. Instead, they search for indicators of the presence of prey, the latter being targeted at the very last moment and at a very small scale. We demonstrate that movement patterns of foraging seabirds can be heavily driven by processes unobservable with conventional methodology. Except perhaps for large scale processes, local-enhancement seems to be the only ruling mechanism; this has profounds implications for ecosystem-based management of marine areas.	[Tremblay, Yann; Thiebault, Andrea] Ctr Rech Halieut Mediterranneenne & Trop, Inst Rech & Dev, UMR IRD IFREMER Expoited Marine Ecosyst 212 UM2, Sete, France; [Mullers, Ralf] Univ Cape Town, Percy FitzPatrick Inst, ZA-7925 Cape Town, South Africa; [Mullers, Ralf] Univ Cape Town, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Pistorius, Pierre] Nelson Mandela Metropolitan Univ, Dept Zool, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, Port Elizabeth, South Africa	Ifremer; Institut de Recherche pour le Developpement (IRD); University of Cape Town; National Research Foundation - South Africa; University of Cape Town; National Research Foundation - South Africa; Nelson Mandela University	Tremblay, Y (corresponding author), Inst Mar Peru, Chucuito Callao, Peru.	yann.tremblay@ird.fr		Tremblay, Yann/0000-0002-4653-9269; Pistorius, Pierre/0000-0001-6561-7069; Thiebault, Andrea/0000-0001-9585-1083	Institute for Research and Development	Institute for Research and Development	The study was funded by the Institute for Research and Development, from recurrent funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Capuska GEM, 2011, IBIS, V153, P631, DOI 10.1111/j.1474-919X.2011.01129.x; Crawford RJM, 2008, AFR J MAR SCI, V30, P189, DOI 10.2989/AJMS.2008.30.1.20.470; Davoren GK, 2010, MAR ECOL PROG SER, V404, P275, DOI 10.3354/meps08370; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Fronhofer EA, 2013, OIKOS, V122, P857, DOI 10.1111/j.1600-0706.2012.21021.x; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; HANEY JC, 1992, ORNIS SCAND, V23, P49, DOI 10.2307/3676427; HANEY JC, 1988, MAR ECOL PROG SER, V49, P1, DOI 10.3354/meps049001; Holyoak M, 2008, P NATL ACAD SCI USA, V105, P19060, DOI 10.1073/pnas.0800483105; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Mullers RHE, 2009, ICES J MAR SCI, V66, P2244, DOI 10.1093/icesjms/fsp210; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P361, DOI 10.2989/1814232X.2010.502640; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007322; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Thiebault A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1013, DOI 10.1007/s00265-013-1546-1; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Votier SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057376; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Yoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019602	24	60	61	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88424	10.1371/journal.pone.0088424	http://dx.doi.org/10.1371/journal.pone.0088424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523892	Green Submitted, gold, Green Published			2022-12-27	WOS:000331258100041
J	Dharma, S; Siswanto, BB; Firdaus, I; Dakota, I; Andriantoro, H; Wardeh, AJ; van der Laarse, A; Jukema, JW				Dharma, Surya; Siswanto, Bambang Budi; Firdaus, Isman; Dakota, Iwan; Andriantoro, Hananto; Wardeh, Alexander J.; van der Laarse, Arnoud; Jukema, J. Wouter			Temporal Trends of System of Care for STEMI: Insights from the Jakarta Cardiovascular Care Unit Network System	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREHOSPITAL ELECTROCARDIOGRAMS; NATIONAL-REGISTRY; GUIDELINES; MORTALITY; IMPACT; ANGIOPLASTY; MANAGEMENT; OUTCOMES	Aim: Guideline implementation programs are of paramount importance in optimizing acute ST- elevation myocardial infarction (STEMI) care. Assessment of performance indicators from a local STEMI network will provide knowledge of how to improve the system of care. Methods and Results: Between 2008-2011, 1505 STEMI patients were enrolled. We compared the performance indicators before (n = 869) and after implementation (n = 636) of a local STEMI network. In 2011 (after introduction of STEMI networking) compared to 2008-2010, there were more inter-hospital referrals for STEMI patients (61% vs 56%, p<0.001), more primary percutaneous coronary intervention (PCI) procedures (83% vs 73%, p = 0.005), and more patients reaching door-to-needle time <= 30 minutes (84.5% vs 80.2%, p<0.001). However, numbers of patients who presented very late (>12 hours after symptom onset) were similar (53% vs 51%, NS). Moreover, the numbers of patients with door-to-balloon time <= 90 minutes were similar (49.1% vs 51.3%, NS), and in-hospital mortality rates were similar (8.3% vs 6.9%, NS) in 2011 compared to 2008-2010. Conclusion: After a local network implementation for patients with STEMI, there were significantly more inter-hospital referral cases, primary PCI procedures, and patients with a door-to-needle time <= 30 minutes, compared to the period before implementation of this network. However, numbers of patients who presented very late, the targeted door-to-balloon time and in-hospital mortality rate were similar in both periods. To improve STEMI networking based on recent guidelines, existing pre-hospital and in-hospital protocols should be improved and managed more carefully, and should be accommodated whenever possible.	[Dharma, Surya; Siswanto, Bambang Budi; Firdaus, Isman; Dakota, Iwan; Andriantoro, Hananto] Univ Indonesia, Fac Med, Dept Cardiol & Vasc Med, Natl Cardiovasc Ctr Harapan Kita, Jakarta, Indonesia; [Wardeh, Alexander J.] MC Haaglanden, Dept Cardiol, The Hague, Netherlands; [van der Laarse, Arnoud; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	Harapan Kita National Heart Center; University of Indonesia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Dharma, S (corresponding author), Univ Indonesia, Fac Med, Dept Cardiol & Vasc Med, Natl Cardiovasc Ctr Harapan Kita, Jakarta, Indonesia.	drsuryadharma@yahoo.com		Dharma, Surya/0000-0002-6687-4371; Siswanto, Bambang Budi/0000-0003-3998-1590				Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Burwen DR, 2003, ARCH INTERN MED, V163, P1430, DOI 10.1001/archinte.163.12.1430; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Danchin N, 2009, JACC-CARDIOVASC INTE, V2, P901, DOI 10.1016/j.jcin.2009.05.025; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Dharma S, 2012, NETH HEART J, V20, P254, DOI 10.1007/s12471-012-0259-9; Diercks DB, 2009, J AM COLL CARDIOL, V53, P161, DOI 10.1016/j.jacc.2008.09.030; Eagle KA, 2005, J AM COLL CARDIOL, V46, P1242, DOI 10.1016/j.jacc.2004.12.083; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; Kudenchuk PJ, 1998, J AM COLL CARDIOL, V32, P17, DOI 10.1016/S0735-1097(98)00175-2; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; Liem SS, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.002; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2003, AM J CARDIOL, V92, P824, DOI 10.1016/S0002-9149(03)00891-9; Rokos IC, 2009, JACC-CARDIOVASC INTE, V2, P339, DOI 10.1016/j.jcin.2008.11.013; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215	18	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e86665	10.1371/journal.pone.0086665	http://dx.doi.org/10.1371/journal.pone.0086665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520322	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600013
J	Guo, ZH; Zhang, ZC; Li, X; Li, Q; You, J				Guo, Zhenhua; Zhang, Zhongcheng; Li, Xiu; Li, Qin; You, Jane			Texture Classification by Texton: Statistical versus Binary	PLOS ONE			English	Article							GRAY-SCALE; ROTATION; FEATURES; REPRESENTATION; VIEWPOINT	Using statistical textons for texture classification has shown great success recently. The maximal response 8 (Statistical_MR8), image patch (Statistical_Joint) and locally invariant fractal (Statistical_Fractal) are typical statistical texton algorithms and state-of-the-art texture classification methods. However, there are two limitations when using these methods. First, it needs a training stage to build a texton library, thus the recognition accuracy will be highly depended on the training samples; second, during feature extraction, local feature is assigned to a texton by searching for the nearest texton in the whole library, which is time consuming when the library size is big and the dimension of feature is high. To address the above two issues, in this paper, three binary texton counterpart methods were proposed, Binary_MR8, Binary_Joint, and Binary_Fractal. These methods do not require any training step but encode local feature into binary representation directly. The experimental results on the CUReT, UIUC and KTH-TIPS databases show that binary texton could get sound results with fast feature extraction, especially when the image size is not big and the quality of image is not poor.	[Guo, Zhenhua; Zhang, Zhongcheng] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Broadband Network & Multimedia, Shenzhen 518057, Peoples R China; [Li, Xiu] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Li, Qin] Shenzhen Inst Informat Technol, Coll Software, Shenzhen, Peoples R China; [You, Jane] Hong Kong Polytech Univ, Dept Comp, Hong Kong, Hong Kong, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Shenzhen Institute of Information Technology; Hong Kong Polytechnic University	Li, Q (corresponding author), Shenzhen Inst Informat Technol, Coll Software, Shenzhen, Peoples R China.	kenneth_lee_qin@qq.com	/AAD-1578-2020	You, Jane/0000-0002-8181-4836	Natural Science Foundation of China (NSFC) [61101150]; Shenzhen special fund for the strategic development of emerging industries [JCYJ20120831165730901]; National High-Tech Research and Development Plan of China (863) [2012AA09A408]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shenzhen special fund for the strategic development of emerging industries; National High-Tech Research and Development Plan of China (863)(National High Technology Research and Development Program of China)	The authors sincerely thank MVG and VGG for sharing the source codes of LBP and Statistical_ MR8. The work is partially supported by the Natural Science Foundation of China (NSFC) (number 61101150), Shenzhen special fund for the strategic development of emerging industries (grant number JCYJ20120831165730901) and the National High-Tech Research and Development Plan of China (863) (number 2012AA09A408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANYS H, 1995, IEEE T GEOSCI REMOTE, V33, P1170, DOI 10.1109/36.469481; COHEN FS, 1991, IEEE T PATTERN ANAL, V13, P803, DOI 10.1109/34.85670; Cula OG, 2001, PROC CVPR IEEE, P1041; Dana KJ, 1999, ACM T GRAPHIC, V18, P1, DOI 10.1145/300776.300778; Deng HW, 2004, IEEE T PATTERN ANAL, V26, P951, DOI 10.1109/TPAMI.2004.30; DUDA RO, 2001, PATTERN CLASSIFICATI; Guo ZH, 2009, LECT NOTES COMPUT SC, V5702, P1130; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hayman E, 2004, LECT NOTES COMPUT SC, V2034, P253; Ji Q, 2000, IEEE T MED IMAGING, V19, P1144, DOI 10.1109/42.896790; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; KASHYAP RL, 1986, IEEE T PATTERN ANAL, V8, P472, DOI 10.1109/TPAMI.1986.4767811; Lazebnik S, 2005, IEEE T PATTERN ANAL, V27, P1265, DOI 10.1109/TPAMI.2005.151; Leung T, 2001, INT J COMPUT VISION, V43, P29, DOI 10.1023/A:1011126920638; MAO JC, 1992, PATTERN RECOGN, V25, P173, DOI 10.1016/0031-3203(92)90099-5; Mellor M, 2008, IEEE T PATTERN ANAL, V30, P52, DOI 10.1109/TPAMI.2007.1161; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Randen T, 1999, IEEE T PATTERN ANAL, V21, P291, DOI 10.1109/34.761261; Rubner Y, 2001, COMPUT VIS IMAGE UND, V84, P25, DOI 10.1006/cviu.2001.0934; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Tuceryan M., 1993, HDB PATTERN RECOGNIT, P235, DOI DOI 10.1142/9789814343138_0010; Varma M, 2004, IMAGE VISION COMPUT, V22, P1175, DOI 10.1016/j.imavis.2004.03.012; Varma M, 2005, INT J COMPUT VISION, V62, P61, DOI 10.1007/s11263-005-4635-4; Varma M, 2002, LECT NOTES COMPUT SC, V2352, P255; Varma M., 2007, PROC INT C COMPUTING, P1, DOI DOI 10.1109/ICCV.2007.4408875; VARMA M, 2003, PROC CVPR IEEE, P691, DOI DOI 10.1109/CVPR.2003.1211534; Varma M, 2009, IEEE T PATTERN ANAL, V31, P2032, DOI 10.1109/TPAMI.2008.182; Wu WR, 1996, IEEE T IMAGE PROCESS, V5, P1423, DOI 10.1109/83.536891; Xu Y, 2009, INT J COMPUT VISION, V83, P85, DOI 10.1007/s11263-009-0220-6; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88073	10.1371/journal.pone.0088073	http://dx.doi.org/10.1371/journal.pone.0088073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520346	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600037
J	Ren, XP; Jiang, HF; Yan, ZY; Chen, YN; Zhou, XJ; Huang, L; Lei, Y; Huang, JQ; Yan, LY; Qi, Y; Wei, WH; Liao, BS				Ren, Xiaoping; Jiang, Huifang; Yan, Zhongyuan; Chen, Yuning; Zhou, Xiaojing; Huang, Li; Lei, Yong; Huang, Jiaquan; Yan, Liying; Qi, Yue; Wei, Wenhui; Liao, Boshou			Genetic Diversity and Population Structure of the Major Peanut (Arachis hypogaea L.) Cultivars Grown in China by SSR Markers	PLOS ONE			English	Article							MINI CORE COLLECTION; SIMPLE SEQUENCE REPEAT; LINKAGE MAP; MICROSATELLITE MARKERS; DNA MARKERS; B-GENOME; IDENTIFICATION; RESISTANCE; DISCOVERY; GERMPLASM	One hundred and forty-six highly polymorphic simple sequence repeat (SSR) markers were used to assess the genetic diversity and population structure of 196 peanut (Arachis Hypogaea L.) cultivars which had been extensively planted in different regions in China. These SSR markers amplified 440 polymorphic bands with an average of 2.99, and the average gene diversity index was 0.11. Eighty-six rare alleles with a frequency of less than 1% were identified in these cultivars. The largest Fst or genetic distance was found between the cultivars that adapted to the south regions and those to the north regions in China. A neighbor-joining tree of cultivars adapted to different ecological regions was constructed based on pairwise Nei's genetic distances, which showed a significant difference between cultivars from the south and the north regions. A model-based population structure analysis divided these peanut cultivars into five subpopulations (P1a, P1b, P2, P3a and P3b). P1a and P1b included most the cultivars from the southern provinces including Guangdong, Guangxi and Fujian. P2 population consisted of the cultivars from Hubei province and parts from Shandong and Henan. P3a and P3b had cultivars from the northern provinces including Shandong, Anhui, Henan, Hebei, Jiangsu and the Yangtze River region including Sichuan province. The cluster analysis, PCoA and PCA based on the marker genotypes, revealed five distinct clusters for the entire population that were related to their germplasm regions. The results indicated that there were obvious genetic variations between cultivars from the south and the north, and there were distinct genetic differentiation among individual cultivars from the south and the north. Taken together, these results provided a molecular basis for understanding genetic diversity of Chinese peanut cultivars.	[Ren, Xiaoping; Jiang, Huifang; Yan, Zhongyuan; Chen, Yuning; Zhou, Xiaojing; Huang, Li; Lei, Yong; Huang, Jiaquan; Yan, Liying; Wei, Wenhui; Liao, Boshou] Chinese Acad Agr Sci, Oil Crop Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China; [Qi, Yue] Wuhan Univ, Coll Life Sci, Natl Facil Training Personnel Life Sci & Biotechn, Wuhan 430072, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Wuhan University	Jiang, HF (corresponding author), Chinese Acad Agr Sci, Oil Crop Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	peanutlab@oilcrops.cn; lboshou@hotmail.com			Major State Basic Research Development Program of China (973 Program) [2011CB109304]; National Natural Science Foundation of China [31271764, 31000724]; National Program for Crop Germplasm Protection of China [NB20122130135]; National Key Technology Support Program [2013BAD01B03]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Crop Germplasm Protection of China; National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the Major State Basic Research Development Program of China (973 Program) (grant no. 2011CB109304), the National Natural Science Foundation of China (Grants No. 31271764 and 31000724), the National Program for Crop Germplasm Protection of China (Grant No. NB20122130135), the National Key Technology Support Program (Grants No. 2013BAD01B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson W. F., 1996, Peanut Science, V23, P57, DOI 10.3146/i0095-3679-23-1-11; Belamkar V, 2011, GENETICA, V139, P411, DOI 10.1007/s10709-011-9556-2; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferguson ME, 2004, THEOR APPL GENET, V108, P1064, DOI 10.1007/s00122-003-1535-2; Gimenes MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-9; Guo YF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-608; He GH, 2005, EUPHYTICA, V142, P131, DOI 10.1007/s10681-005-1043-3; He GH, 1997, EUPHYTICA, V97, P143, DOI 10.1023/A:1002949813052; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Herselman L, 2003, EUPHYTICA, V133, P319, DOI 10.1023/A:1025769212187; HOLBROOK CC, 1993, CROP SCI, V33, P859, DOI 10.2135/cropsci1993.0011183X003300040044x; HOLBROOK CC, 1995, CROP SCI, V35, P1700, DOI 10.2135/cropsci1995.0011183X003500060032x; Holbrook CC, 2005, CROP SCI, V45, P1540, DOI 10.2135/cropsci2004.0368; Hong YB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-17; Hopkins MS, 1999, CROP SCI, V39, P1243, DOI 10.2135/cropsci1999.0011183X003900040047x; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050002; Jiang HuiFang, 2010, Chinese Journal of Oil Crop Sciences, V32, P472; [姜慧芳 JIANG Huifang], 2008, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V30, P294; Jiang HuiFang, 2008, Acta Agronomica Sinica, V34, P25; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; KOCHERT G, 1991, THEOR APPL GENET, V81, P565, DOI 10.1007/BF00226719; Kottapalli KR, 2007, CROP SCI, V47, P1718, DOI 10.2135/cropsci2006.06.0407; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu K, 2004, POWERMARKER NEW GENE; Luo M, 2005, CROP SCI, V45, P346, DOI 10.2135/cropsci2005.0346; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; Moretzsohn Marcio de Carvalho, 2004, BMC Plant Biology, V4, P11, DOI 10.1186/1471-2229-4-11; Moretzsohn MC, 2005, THEOR APPL GENET, V111, P1060, DOI 10.1007/s00122-005-0028-x; Patzak J, 2012, GENOME, V55, P647, DOI [10.1139/g2012-054, 10.1139/G2012-054]; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; [任小平 REN Xiaoping], 2011, [植物遗传资源学报, Journal of Plant Genetic Resources], V12, P513; Ren XiaoPing, 2010, Scientia Agricultura Sinica, V43, P2848; Ren XP, 2010, GENET RESOUR CROP EV, V57, P903, DOI 10.1007/s10722-010-9532-1; Rohlf F, 2006, NTSYSPC NUMERICAL TA; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Tang Mei, 2012, Acta Agronomica Sinica, V38, P1221, DOI 10.3724/SP.J.1006.2012.01221; Tang Ronghua, 2007, Journal of Genetics and Genomics, V34, P449, DOI 10.1016/S1673-8527(07)60049-6; Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020; Upadhyaya H. D., 2001, INDIAN J PLANT GENET, V14, P165; Upadhyaya HD, 2006, FIELD CROP RES, V97, P261, DOI 10.1016/j.fcr.2005.10.010; Upadhyaya HD, 2005, CROP SCI, V45, P1432, DOI 10.2135/cropsci2004.0389; Upadhyaya HD, 2003, GENET RESOUR CROP EV, V50, P139, DOI 10.1023/A:1022945715628; Upadhyaya HD, 2002, CROP SCI, V42, P2150, DOI 10.2135/cropsci2002.2150; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Yu S. L., 2011, PEANUT GENETICS BREE; Yu SL, 2010, PEANUT VARIETIES THE; Zhang Jun, 2008, Acta Agronomica Sinica, V34, P2059, DOI 10.3724/SP.J.1006.2008.02059; Zhang Jun, 2008, Acta Agronomica Sinica, V34, P1529, DOI 10.3724/SP.J.1006.2008.01529; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhao WG, 2009, GENES GENOM, V31, P283, DOI 10.1007/BF03191201	60	43	58	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88091	10.1371/journal.pone.0088091	http://dx.doi.org/10.1371/journal.pone.0088091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520347	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600038
J	Zhang, MY; Zhang, HF; Shi, CX; McGoogan, JM; Zhang, BH; Zhao, LL; Zhang, MZ; Rou, KM; Wu, ZY				Zhang, Minying; Zhang, Huifang; Shi, Cynthia X.; McGoogan, Jennifer M.; Zhang, Baohua; Zhao, Linglong; Zhang, Mianzhi; Rou, Keming; Wu, Zunyou			Sexual Dysfunction Improved in Heroin-Dependent Men after Methadone Maintenance Treatment in Tianjin, China	PLOS ONE			English	Article							BUPRENORPHINE MAINTENANCE; RECEIVING METHADONE; ERECTILE DYSFUNCTION; INTERNATIONAL INDEX; PLASMA TESTOSTERONE; USERS; BEHAVIOR; ADDICTION; SCALE; CARE	Objective: To investigate whether methadone maintenance treatment (MMT) is correlated with sexual dysfunction in heroin-dependent men and to determine the prevalence and risk factors of sexual dysfunction among men on MMT. Methods: The study included a retrospective survey and a cross-sectional survey which contained interviews of 293 men who are currently engaged in MMT. The results of the two surveys were compared. For a subset of 43 participants, radioimmunoassay was additionally conducted using retrospective and prospective blood samples to test the levels of plasma testosterone and luteinizing hormone. Other study evaluations were the International Index of Erectile Function (IIEF-15), and Self-rating Depression Scale. Results: Sexual dysfunction in all five IIEF-15 domains (erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction) was strongly associated with long-term use of heroin. A decrease in the severity of sexual dysfunction was associated with MMT initiation. Erectile dysfunction, lack of sexual desire, inability to orgasm, and lack of intercourse satisfaction were significantly correlated with increasing age of the participants. Methadone dose and duration of methadone treatment were not found to be associated with sexual dysfunction. The level of plasma testosterone significantly declined during methadone treatment, but results from multivariate analysis indicated low levels of testosterone were not the main cause of sexual dysfunction. No correlation between reported depression status and sexual function was found. Conclusions: While high levels of sexual dysfunction were reported by heroin-dependent men in our study before and after MMT initiation, MMT appears to be correlated with improved sexual function in the population of the study.	[Zhang, Minying; Zhang, Huifang] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Shi, Cynthia X.; McGoogan, Jennifer M.; Rou, Keming; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhang, Baohua] Ankang Hosp, Tianjin, Peoples R China; [Zhao, Linglong; Zhang, Mianzhi] Publ Secur Hosp, Tianjin, Peoples R China	Nankai University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, MY (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	zhangminying@nankai.edu.cn; wuzy@263.net	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		China-Bill Melinda Gates Foundation program on HIV/AIDS	China-Bill Melinda Gates Foundation program on HIV/AIDS	This work was supported by China-Bill Melinda Gates Foundation program on HIV/AIDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1984, J PSYCHOACTIVE DRUGS, V16, P205, DOI 10.1080/02791072.1984.10524313; AZIZI F, 1973, STEROIDS, V22, P467, DOI 10.1016/0039-128X(73)90002-0; BELL J, 1992, BRIT J ADDICT, V87, P251; Bliesener N, 2005, J CLIN ENDOCR METAB, V90, P203, DOI 10.1210/jc.2004-0929; Brown R, 2005, J ADDICT DIS, V24, P91, DOI 10.1300/J069v24n02_08; Brown R, 2004, POSTGRAD MED J, V80, P654, DOI 10.1136/pgmj.2004.022988; Chekuri V, 2012, ADDICT BEHAV, V37, P124, DOI 10.1016/j.addbeh.2011.08.005; CICERO TJ, 1975, NEW ENGL J MED, V292, P882, DOI 10.1056/NEJM197504242921703; CROWLEY TJ, 1978, INT J ADDICT, V13, P285, DOI 10.3109/10826087809039281; CUSHMAN P, 1972, NEW YORK STATE J MED, V72, P1261; Hallinan R, 2009, INT J ANDROL, V32, P131, DOI 10.1111/j.1365-2605.2007.00824.x; Hallinan R, 2008, J SEX MED, V5, P684, DOI 10.1111/j.1743-6109.2007.00702.x; HANBURY R, 1977, AM J DRUG ALCOHOL AB, V4, P13, DOI 10.3109/00952997709002743; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Jamieson BLA Inc, 2002, LIT REV METH MAINT T; Langendam MW, 2001, AM J PUBLIC HEALTH, V91, P774, DOI 10.2105/AJPH.91.5.774; Li T, 2010, GUIDE CHINA MED, V8, P29; MENDELSON JH, 1975, J PHARMACOL EXP THER, V192, P211; MENDELSON JH, 1975, J PHARMACOL EXP THER, V195, P296; Ng M L, 2004, Sex Health, V1, P35, DOI 10.1071/SH03020; OCONNOR PG, 1994, NEW ENGL J MED, V331, P450, DOI 10.1056/NEJM199408183310707; Palha A, 2002, J SEX MARITAL THER, V28, P427; PFAUS JG, 1987, NEUROSCI BIOBEHAV R, V11, P1, DOI 10.1016/S0149-7634(87)80002-7; Quaglio G, 2008, DRUG ALCOHOL DEPEN, V94, P12, DOI 10.1016/j.drugalcdep.2007.09.025; Gomes ALQ, 2012, J SEX MED, V9, P180, DOI 10.1111/j.1743-6109.2011.02467.x; RAGNI G, 1988, INT J ANDROL, V11, P93, DOI 10.1111/j.1365-2605.1988.tb00984.x; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Shen LL, 2012, INT J PSYCHIAT MED, V44, P257, DOI 10.2190/PM.44.3.f; SMITH DE, 1982, J PSYCHOACTIVE DRUGS, V14, P91, DOI 10.1080/02791072.1982.10471916; SPRING WD, 1992, INT J ADDICT, V27, P1325, DOI 10.3109/10826089209047354; Vemter A, 2003, INFORM POLICYMAKERS; Ward J, 1994, Drug Alcohol Rev, V13, P327, DOI 10.1080/09595239400185431; YANCOVITZ SR, 1991, AM J PUBLIC HEALTH, V81, P1185, DOI 10.2105/AJPH.81.9.1185; [尹潞 YIN Lu], 2006, [中国药物依赖性杂志, Chinese Journal of Drug Dependence], V15, P385; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	35	25	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88289	10.1371/journal.pone.0088289	http://dx.doi.org/10.1371/journal.pone.0088289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520361	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600052
J	Zhang, XLL; Sun, JP; Luo, ZG				Zhang, Xianglilan; Sun, Jiping; Luo, Zhigang			One-against-All Weighted Dynamic Time Warping for Language-Independent and Speaker-Dependent Speech Recognition in Adverse Conditions	PLOS ONE			English	Article							ALGORITHM	Considering personal privacy and difficulty of obtaining training material for many seldom used English words and (often non-English) names, language-independent (LI) with lightweight speaker-dependent (SD) automatic speech recognition (ASR) is a promising option to solve the problem. The dynamic time warping (DTW) algorithm is the state-of-the-art algorithm for small foot-print SD ASR applications with limited storage space and small vocabulary, such as voice dialing on mobile devices, menu-driven recognition, and voice control on vehicles and robotics. Even though we have successfully developed two fast and accurate DTW variations for clean speech data, speech recognition for adverse conditions is still a big challenge. In order to improve recognition accuracy in noisy environment and bad recording conditions such as too high or low volume, we introduce a novel one-against-all weighted DTW (OAWDTW). This method defines a one-against-all index (OAI) for each time frame of training data and applies the OAIs to the core DTW process. Given two speech signals, OAWDTW tunes their final alignment score by using OAI in the DTW process. Our method achieves better accuracies than DTW and merge-weighted DTW (MWDTW), as 6.97% relative reduction of error rate (RRER) compared with DTW and 15.91% RRER compared with MWDTW are observed in our extensive experiments on one representative SD dataset of four speakers' recordings. To the best of our knowledge, OAWDTW approach is the first weighted DTW specially designed for speech data in adverse conditions.	[Zhang, Xianglilan; Luo, Zhigang] Natl Univ Def Technol, Sch Comp Sci, Sci & Technol Parallel & Distributed Proc Lab, Changsha, Hunan, Peoples R China; [Zhang, Xianglilan] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Xianglilan] Univ Waterloo, David R Cheriton Sch Comp Sci, Waterloo, ON N2L 3G1, Canada; [Sun, Jiping] Voice Enabling Syst Technol, Waterloo, ON, Canada	National University of Defense Technology - China; Beijing Institute of Microbiology & Epidemiology; University of Waterloo	Luo, ZG (corresponding author), Natl Univ Def Technol, Sch Comp Sci, Sci & Technol Parallel & Distributed Proc Lab, Changsha, Hunan, Peoples R China.	zgluo@nudt.edu.cn			Research Plan Project of National University of Defense Technology [JC13-06-01]; National University of Defense Technology; OCRit Project	Research Plan Project of National University of Defense Technology; National University of Defense Technology; OCRit Project	This work has been supported by Research Plan Project of National University of Defense Technology under Grant JC13-06-01, by Plan for Innovative Graduate Student at National University of Defense Technology, and by the OCRit Project, which is made possible by the Global Leadership Round in Genomics & Life Sciences grant (GL2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla WH, 2003, TENCON IEEE REGION, P1576; Adami AG, 2003, INT CONF ACOUST SPEE, P788; Baker JM, 2009, IEEE SIGNAL PROC MAG, V26, P75, DOI 10.1109/MSP.2009.932166; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chapaneri S. V., 2012, INT J COMPUT APPL, V40, P6, DOI [10.5120/5022-7167, DOI 10.5120/5022-7167]; Cox RV, 2000, P IEEE, V88, P1314, DOI 10.1109/5.880086; Deller Jr J. R., 1993, DISCRETE TIME PROCES; Furui S, 2010, SPEECH TECHNOLOGY, DOI [10.1007/978-0-387-73819-2-1, DOI 10.1007/978-0-387-73819-2-1]; Jeong YS, 2011, PATTERN RECOGN, V44, P2231, DOI 10.1016/j.patcog.2010.09.022; Jiping Sun, 2012, Autonomous and Intelligent Systems. Proceedings Third International Conference, AIS 2012, P192, DOI 10.1007/978-3-642-31368-4_23; Kim C, 2005, IEEE T CONSUM ELECTR, V51, P699, DOI 10.1109/TCE.2005.1468022; Kim SW, 2001, PROC INT CONF DATA, P607, DOI 10.1109/ICDE.2001.914875; Lawton G, 2012, IEEE INTELL SYST, V27, P2, DOI 10.1109/MIS.2012.39; Levy C, 2003, WORKSH DSP MOB VEH S; Muda L., 2010, ARXIV10034083, V2, P138; Muller M., 2007, INFORM RETRIEVAL MUS, DOI [10.1007/978-3-540- 74048-3_4, DOI 10.1007/978-3-540-74048-3]; Muller M, 2006, P INT C MUS INF RETR, P192; MYERS C, 1980, IEEE T ACOUST SPEECH, V28, P623, DOI 10.1109/TASSP.1980.1163491; Nair N. U., 2008, TENCON 2008 2008 IEE, P1, DOI DOI 10.1371/JOURNAL.PCBI.1008049; Papapetrou P, 2011, ACM T DATABASE SYST, V36, DOI 10.1145/2000824.2000827; Rabiner L., 1993, FUNDAMENTALS SPEECH; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Shanker AP, 2007, PATTERN RECOGN LETT, V28, P1407, DOI 10.1016/j.patrec.2007.02.016; Sheikhan M, 2012, NEURAL COMPUT APPL, V21, P1765, DOI 10.1007/s00521-011-0620-8; Vintsyuk T.K., 1968, CYBERNETICS+, V4, P52, DOI DOI 10.1007/BF01074755; Wang JF, 2008, IEEE T CONSUM ELECTR, V54, P870, DOI 10.1109/TCE.2008.4560173; Wen J.Y.C., 2006, P INT WORKSH AC ECH, P12; Yasushi S, 2005, P 24 ACM SIGMOD SIGA, P326, DOI 10.1145/1065167.1065210; Young S., 2006, HTK BOOK HTK VERSION; Zhang X, 2013, ICASSP 2013 IN PRESS; Zhang X, 2013, J COMPUTER SCI UNPUB; Zhu Y, 2003, P 2003 ACM SIGMOD IN, P181, DOI DOI 10.1145/872757.872780	33	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e85458	10.1371/journal.pone.0085458	http://dx.doi.org/10.1371/journal.pone.0085458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520317	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600007
J	Zheng, YW; Schwabe, L				Zheng, Youwei; Schwabe, Lars			Shaping Synaptic Learning by the Duration of Postsynaptic Action Potential in a New STDP Model	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; PYRAMIDAL NEURONS; SPIKE; TRANSMISSION; CELLS	Single spikes and their timing matter in changing synaptic efficacy, which is known as spike-timing-dependent plasticity (STDP). Most previous studies treated spikes as all-or-none events, and considered their duration and magnitude as negligible. Here we explore the effects of action potential (AP) duration on synaptic plasticity in a simplified model neuron using computer simulations. We propose a novel STDP model that depresses synapses using an AP duration dependent LTD window and induces potentiation of synaptic strength when presynaptic spikes arrive before and during a postsynaptic AP (dSTDP). We demonstrate that AP duration is another key factor for insensitizing the postsynaptic neural firing and for controlling the shape of synaptic weight distribution. Extended AP durations produce a wide unimodal weight distribution that resembles the ones reported experimentally and make the postsynaptic neuron tranquil when disturbed by poisson noise spike trains, while equivalently sensitive to the synchronized. Our results suggest that the impact of AP duration, modeled here as an AP-dependent STDP window, on synaptic plasticity can be dramatic and should motivate future STDP studies.	[Zheng, Youwei; Schwabe, Lars] Univ Rostock, Fac Comp Sci & Elect Engn, D-18055 Rostock, Germany	University of Rostock	Zheng, YW (corresponding author), Univ Rostock, Fac Comp Sci & Elect Engn, D-18055 Rostock, Germany.	youwei.zheng@uni-rostock.de			DFG German Research Foundation (GRK dIEM oSiRiS)	DFG German Research Foundation (GRK dIEM oSiRiS)	This work was supported by the DFG German Research Foundation (GRK dIEM oSiRiS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Babadi B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000961; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Billings G, 2009, J NEUROPHYSIOL, V101, P2775, DOI 10.1152/jn.91007.2008; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Delgado JY, 2010, J NEUROSCI, V30, P15713, DOI 10.1523/JNEUROSCI.3068-10.2010; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; Karmarkar UR, 2002, BIOL CYBERN, V87, P373, DOI 10.1007/s00422-002-0351-0; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; Kempter R, 2001, NEURAL COMPUT, V13, P2709, DOI 10.1162/089976601317098501; Kepecs A, 2002, BIOL CYBERN, V87, P446, DOI 10.1007/s00422-002-0358-6; Knoblauch A, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00055; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Lisman John, 2010, Front Synaptic Neurosci, V2, P140, DOI 10.3389/fnsyn.2010.00140; Manninen T, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00152; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sejnowski TJ, 2003, CAN PSYCHOL, V44, P17, DOI 10.1037/h0085814; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Spruston N, 2010, NAT NEUROSCI, V13, P277, DOI 10.1038/nn0310-277; Stanley GB, 2012, J NEUROSCI, V32, P9073, DOI 10.1523/JNEUROSCI.4968-11.2012; Urakubo H, 2008, J NEUROSCI, V28, P3310, DOI 10.1523/JNEUROSCI.0303-08.2008; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Wheeler DB, 1996, J NEUROSCI, V16, P2226	38	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88592	10.1371/journal.pone.0088592	http://dx.doi.org/10.1371/journal.pone.0088592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551122	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500050
J	Chen, Q; Xu, R; Zeng, CY; Lu, QQ; Huang, DL; Shi, C; Zhang, WL; Deng, LB; Yan, RW; Rao, H; Gao, GL; Luo, SW				Chen, Qi; Xu, Rong; Zeng, Chunyan; Lu, Quqin; Huang, Dengliang; Shi, Chao; Zhang, Weilong; Deng, Libin; Yan, Runwei; Rao, Hai; Gao, Guolan; Luo, Shiwen			Down-Regulation of Gli Transcription Factor Leads to the Inhibition of Migration and Invasion of Ovarian Cancer Cells via Integrin beta 4-Mediated FAK Signaling	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PANCREATIC-CANCER; SONIC-HEDGEHOG; EXTRACELLULAR-MATRIX; MEDIATED ACTIVATION; POTENTIAL TARGET; MOUSE MODEL; IN-VITRO; PATHWAY; GROWTH	Background: Recent evidence suggests that aberrant activation of Hedgehog (Hh) signaling by Gli transcription factors is characteristic of a variety of aggressive human carcinomas including ovarian cancer. Therefore, chemotherapeutic agents that inhibit activation of Gli transcription factors have emerged as promising novel therapeutic drugs for ovarian cancer. Results: In this study, we show that activation of Hh signaling promoted cellular migration and invasion, whereas blockade of Hh signaling with GANT61 suppressed cellular migration and invasion in ovarian cancer cells. After treatment with GANT61, cDNA microarray analyses revealed changes in many genes such as Integrin beta 4 subunit (ITGB4), focal adhesion kinase (FAK), etc. Furthermore, ITGB4 expression was up-regulated by Sonic Hedgehog (Shh) ligand and down-regulated by Hh signaling inhibitor. The Shh-mediated ovarian cell migration and invasion was blocked by neutralizing antibodies to ITGB4. In addition, phosphorylations of FAK were increased by Shh and decreased by Hh signaling inhibitor. Inhibition of Gli1 expression using siRNA mimicked the effects of GANT61 treatment, supporting the specificity of GANT61. Further investigations showed that activation of FAK was required for Shh-mediated cell migration and invasion. Finally, we found that down-regulation of Gli reduced the expression of ITGB4 and the phosphorylated FAK, resulting in the inhibition of tumor growth in vivo. Conclusions: The Hh signaling pathway induces cell migration and invasion through ITGB4-mediated activation of FAK in ovarian cancer. Our findings suggest that the diminishment of crosstalk between phosphorylated FAK and ITGB4 due to the down-regulation of Gli family transcription factors might play a pivotal role for inhibiting ovarian cancer progression.	[Chen, Qi; Xu, Rong; Zeng, Chunyan] Nanchang Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China; [Lu, Quqin] Nanchang Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Nanchang, Jiangxi, Peoples R China; [Huang, Dengliang; Shi, Chao; Yan, Runwei; Luo, Shiwen] Nanchang Univ, Affiliated Hosp 1, Ctr Med Expt, Nanchang, Jiangxi, Peoples R China; [Zhang, Weilong; Deng, Libin] Nanchang Univ, Inst Translat Med, Nanchang, Jiangxi, Peoples R China; [Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Gao, Guolan] Gen Hosp Beijing Aeronaut, Dept Obstet & Gynecol, Beijing, Peoples R China	Nanchang University; Nanchang University; Nanchang University; Nanchang University; University of Texas System; University of Texas Health San Antonio	Gao, GL (corresponding author), Gen Hosp Beijing Aeronaut, Dept Obstet & Gynecol, Beijing, Peoples R China.	guolan_gao@yahoo.com.cn; shiwenluo@ncu.edu.cn		RAO, HAI/0000-0002-4235-2210; Xu, Rong/0000-0001-5465-3566	China National Basic Research Program [2010CB535001]; National Natural Science Foundation of China [81060095, 31171359]; Specialized Research Fund for the Doctoral Program of Higher Education [2010360111007]; NIH [P30 CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	China National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the China National Basic Research Program (2010CB535001), the National Natural Science Foundation of China (81060095, 31171359), the Specialized Research Fund for the Doctoral Program of Higher Education (2010360111007) and the NIH (P30 CA054174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Ayaki M, 2001, CLIN CANCER RES, V7, P3106; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Cary LA, 1996, J CELL SCI, V109, P1787; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chen JS, 2013, CARCINOGENESIS, V34, P10, DOI 10.1093/carcin/bgs274; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Costello E, 2012, NAT REV GASTRO HEPAT, V9, P435, DOI 10.1038/nrgastro.2012.119; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Das S, 2013, J BIOL CHEM, V288, P11824, DOI 10.1074/jbc.M112.432302; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Fu JS, 2013, CANCER LETT, V330, P22, DOI 10.1016/j.canlet.2012.11.018; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Han EKH, 2007, ANTI-CANCER AGENT ME, V7, P681, DOI 10.2174/187152007784111296; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Li ZJ, 2012, DEVELOPMENT, V139, P4152, DOI 10.1242/dev.081190; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; Luo SW, 2008, NEURON, V60, P97, DOI 10.1016/j.neuron.2008.08.013; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; McLean GW, 2003, EXPERT OPIN PHARMACO, V4, P227, DOI 10.1517/eoph.4.2.227.21093; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mori Y, 2006, ONCOLOGY-BASEL, V70, P378, DOI 10.1159/000098111; Moser C, 2007, MOL CANCER THER, V6, P2868, DOI 10.1158/1535-7163.MCT-07-0410; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; OWENS LV, 1995, CANCER RES, V55, P2752; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Rauh-Hain Jose A, 2011, Rev Obstet Gynecol, V4, P15; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; SCHLAEPFER DD, 1994, NATURE, V372, P786; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Skubitz APN, 1996, AM J PATHOL, V148, P1445; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Soung YH, 2011, CURR PROTEIN PEPT SC, V12, P23; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; TURNER CE, 1994, J CELL SCI, V107, P1583; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vokes SA, 2004, DEVELOPMENT, V131, P4371, DOI 10.1242/dev.01304; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Xie JW, 2008, CURR ONCOL REP, V10, P107, DOI 10.1007/s11912-008-0018-7; Yan RW, 2013, CELL ONCOL, V36, P421, DOI 10.1007/s13402-013-0149-1; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	75	66	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88386	10.1371/journal.pone.0088386	http://dx.doi.org/10.1371/journal.pone.0088386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533083	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600041
J	Fukuda, T; Kuroda, T; Kono, M; Miyamoto, T; Tanaka, M; Matsui, T				Fukuda, Toshihiko; Kuroda, Takahiro; Kono, Miki; Miyamoto, Takahisa; Tanaka, Mitsuru; Matsui, Toshiro			Attenuation of L-Type Ca2+ Channel Expression and Vasomotor Response in the Aorta with Age in Both Wistar-Kyoto and Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ANGIOTENSIN-II RECEPTORS; DIPEPTIDE TRP-HIS; ENDOTHELIAL DYSFUNCTION; MEDIATED RELAXATION; DI-PEPTIDE; CONTRACTION; ATHEROSCLEROSIS; PHOSPHORYLATION; NIFEDIPINE	Age-related vascular diseases are induced by vascular dysfunction, which involves changes in the vasomotor response. The voltage-dependent L-type calcium channel (VDCC) protein is involved in the regulation of vessel function (contraction/relaxation action). In the present study, we evaluated age-related vasomotor function and expression of the signal-related target proteins, including VDCC, using thoracic aorta from both 8- and 40-week old Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR). In contraction experiments using aortic rings, vasomotor responses of both phenylephrine-induced contraction and acetylcholine-induced relaxation were significantly attenuated with age in SHR, whereas WKY did not lose activity with age. Contraction induced by angiotensin II was impaired only for the 40-week old SHR among all the rat groups tested, although enhanced AT1R/reduced AT2R expression with age was observed for both WKY and SHR. In contrast, a vasomotor responsiveness to Bay K 8644 (a VDCC agonist) at the initial contraction phase was significantly attenuated in both 40-week WKY and SHR with significant reduction of VDCC protein expression. The reduced VDCC expression in 40-week old rats significantly lowered the relaxation activity of VDCC blockers, such as verapamil and Trp-His, but did not affect that of nifedipine. Taken together, we provided the first evidence that aging caused a reduction of VDCC expression in rat aorta, irrespective of the rat strain, along with diminishment of the therapeutic potential of VDCC blockers.	[Fukuda, Toshihiko; Kuroda, Takahiro; Kono, Miki; Miyamoto, Takahisa; Tanaka, Mitsuru; Matsui, Toshiro] Kyushu Univ, Fac Agr, Grad Sch, Dept Biosci & Biotechnol,Higashi Ku, Fukuoka 812, Japan	Kyushu University	Matsui, T (corresponding author), Kyushu Univ, Fac Agr, Grad Sch, Dept Biosci & Biotechnol,Higashi Ku, Fukuoka 812, Japan.	tmatsui@agr.kyushu-u.ac.jp	Tanaka, Mitsuru/AAF-9521-2021	Tanaka, Mitsuru/0000-0002-8242-5058	Ministry of Education, Science, Sports and Culture of Japan [22248014]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a grand-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (No. 22248014) to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun KHS, 2005, CARDIOVASC RES, V65, P374, DOI 10.1016/j.cardiores.2004.10.010; Bussemaker E, 2003, HYPERTENSION, V42, P562, DOI 10.1161/01.HYP.0000088852.28814.E2; CAI GP, 1994, MECH AGEING DEV, V76, P125, DOI 10.1016/0047-6374(94)91587-3; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Ding YX, 2000, J PHARMACOL EXP THER, V292, P606; Herrera MD, 2010, AGEING RES REV, V9, P142, DOI 10.1016/j.arr.2009.07.002; Endemann D, 1999, AM J HYPERTENS, V12, P716, DOI 10.1016/S0895-7061(99)00036-9; Georgeon-Chartier C, 2013, PFLUG ARCH EUR J PHY, V465, P829, DOI 10.1007/s00424-012-1195-7; GODFRAIND T, 1994, PHARMACOL THERAPEUT, V64, P37, DOI 10.1016/0163-7258(94)90033-7; Hayashi K, 2007, CIRC RES, V100, P342, DOI 10.1161/01.RES.0000256155.31133.49; HERNANDEZ MC, 1995, J AUTON PHARMACOL, V15, P257, DOI 10.1111/j.1474-8673.1995.tb00309.x; Idris-Khodja N, 2012, N-S ARCH PHARMACOL, V385, P749, DOI 10.1007/s00210-012-0749-8; Ishii N, 2010, ARTERIOSCL THROM VAS, V30, P1598, DOI 10.1161/ATVBAHA.109.202309; Jones SA, 2007, CIRCULATION, V115, P1183, DOI 10.1161/CIRCULATIONAHA.106.663070; Kobayashi Y, 2012, FEBS OPEN BIO, V2, P83, DOI 10.1016/j.fob.2012.04.005; Matsui T, 2010, BRIT J NUTR, V103, P309, DOI 10.1017/S0007114509991814; Moore A, 2003, BRIT J CLIN PHARMACO, V56, P254, DOI 10.1046/j.0306-5251.2003.01876.x; Mudnic I, 2010, FOOD CHEM, V119, P1205, DOI 10.1016/j.foodchem.2009.08.038; Schulman IH, 2010, AM J NEPHROL, V32, P249, DOI 10.1159/000318607; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Sung JY, 2011, VASCUL PHARM, V56, P1; Taddei S, 1998, CIRCULATION, V97, P2222, DOI 10.1161/01.CIR.97.22.2222; Tanaka M, 2012, J AGR FOOD CHEM, V60, P9048, DOI 10.1021/jf3010228; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Touyz RM, 1999, HYPERTENSION, V33, P366, DOI 10.1161/01.HYP.33.1.366; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Wang ZQ, 2010, PEPTIDES, V31, P2060, DOI 10.1016/j.peptides.2010.07.013; Widdop RE, 2002, HYPERTENSION, V40, P516, DOI 10.1161/01.HYP.0000033224.99806.8A; Wind S, 2010, HYPERTENSION, V56, P490, DOI 10.1161/HYPERTENSIONAHA.109.149187; Yildiz G, 2007, ANN NY ACAD SCI, V1100, P353, DOI 10.1196/annals.1395.038	30	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88975	10.1371/journal.pone.0088975	http://dx.doi.org/10.1371/journal.pone.0088975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533163	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600122
J	Money, TGA; Sproule, MKJ; Hamour, AF; Robertson, RM				Money, Tomas G. A.; Sproule, Michael K. J.; Hamour, Amr F.; Robertson, R. Meldrum			Reduction in Neural Performance following Recovery from Anoxic Stress Is Mimicked by AMPK Pathway Activation	PLOS ONE			English	Article							LOCUST VISUAL INTERNEURON; NA+-K+-ATPASE; PROTEIN-KINASE; I-H; SPREADING DEPRESSION; ENERGY SENSOR; PACEMAKER CHANNELS; MOVEMENT DETECTOR; METABOLIC SENSOR; SENSITIVE NEURON	Nervous systems are energetically expensive to operate and maintain. Both synaptic and action potential signalling require a significant investment to maintain ion homeostasis. We have investigated the tuning of neural performance following a brief period of anoxia in a well-characterized visual pathway in the locust, the LGMD/DCMD looming motion-sensitive circuit. We hypothesised that the energetic cost of signalling can be dynamically modified by cellular mechanisms in response to metabolic stress. We examined whether recovery from anoxia resulted in a decrease in excitability of the electrophysiological properties in the DCMD neuron. We further examined the effect of these modifications on behavioural output. We show that recovery from anoxia affects metabolic rate, flight steering behaviour, and action potential properties. The effects of anoxia on action potentials can be mimicked by activation of the AMPK metabolic pathway. We suggest this is evidence of a coordinated cellular mechanism to reduce neural energetic demand following an anoxic stress. Together, this represents a dynamically-regulated means to link the energetic demands of neural signaling with the environmental constraints faced by the whole animal.	[Money, Tomas G. A.; Sproule, Michael K. J.; Hamour, Amr F.; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Money, TGA (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	moneyt@queensu.ca	Robertson, Robert M/B-2482-2009	Robertson, Robert M/0000-0002-2666-7861	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to RMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; AMES A, 1995, J CEREBR BLOOD F MET, V15, P433, DOI 10.1038/jcbfm.1995.54; Armstrong GAB, 2006, J NEUROSCI, V26, P12118, DOI 10.1523/JNEUROSCI.3347-06.2006; Armstrong GAB, 2009, J NEUROSCI, V29, P8225, DOI 10.1523/JNEUROSCI.1652-09.2009; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baginskas A, 2009, EUR J NEUROSCI, V29, P87, DOI 10.1111/j.1460-9568.2008.06566.x; Ballo AW, 2012, J NEUROSCI, V32, P5106, DOI 10.1523/JNEUROSCI.6320-11.2012; Beaumont V, 2002, NEURON, V33, P601, DOI 10.1016/S0896-6273(02)00581-0; Borger DR, 2008, BIOCHEM BIOPH RES CO, V370, P230, DOI 10.1016/j.bbrc.2008.03.056; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Budd JML, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000711; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Crotty P, 2006, J NEUROPHYSIOL, V96, P1237, DOI 10.1152/jn.01204.2005; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Dawson JW, 1997, J EXP BIOL, V200, P2323; Deng P, 2008, J CEREBR BLOOD F MET, V28, P939, DOI 10.1038/sj.jcbfm.9600583; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Fotowat H, 2011, NEURON, V69, P147, DOI 10.1016/j.neuron.2010.12.007; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Gao LL, 2006, BRAIN RES, V1078, P49, DOI 10.1016/j.brainres.2006.01.037; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Kang YN, 2004, J NEUROSCI, V24, P3694, DOI 10.1523/JNEUROSCI.5641-03.2004; Kim JH, 2012, J NEUROPHYSIOL, V108, P1924, DOI 10.1152/jn.00103.2012; Koch U, 2003, J NEUROPHYSIOL, V90, P3679, DOI 10.1152/jn.00375.2003; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Matheson T, 2004, J NEUROPHYSIOL, V91, P1, DOI 10.1152/jn.00795.2003; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Menze MA, 2010, CRYOBIOLOGY, V61, P79, DOI 10.1016/j.cryobiol.2010.05.004; Money TGA, 2005, J NEUROPHYSIOL, V93, P1908, DOI 10.1152/jn.00908.2004; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; OSHEA M, 1974, J COMP PHYSIOL, V91, P257, DOI 10.1007/BF00698057; OSHEA M, 1974, J EXP BIOL, V60, P1; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; Ramnanan CJ, 2010, MOL CELL BIOCHEM, V335, P91, DOI 10.1007/s11010-009-0246-7; Rind FC, 2008, J NEUROPHYSIOL, V100, P670, DOI 10.1152/jn.01055.2007; Rind FC, 1996, J NEUROPHYSIOL, V75, P986, DOI 10.1152/jn.1996.75.3.986; ROBERTSON RM, 1982, J COMP PHYSIOL, V146, P311, DOI 10.1007/BF00612702; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rodgers CI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001366; Rodgers-Garlick CI, 2011, J NEUROSCI, V31, P3207, DOI 10.1523/JNEUROSCI.5215-10.2011; ROWELL CHF, 1971, J EXP BIOL, V55, P727; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Santer RD, 2006, J NEUROPHYSIOL, V95, P3391, DOI 10.1152/jn.00024.2006; Seely J, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021906; Sengupta B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000840; Soleng AF, 2003, J PHYSIOL-LONDON, V552, P459, DOI 10.1113/jphysiol.2003.048058; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Spasic MR, 2009, NEUROSCIENTIST, V15, P309, DOI 10.1177/1073858408327805; VANWHY SK, 1994, AM J PHYSIOL, V267, pF75, DOI 10.1152/ajprenal.1994.267.1.F75; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; WEGENER G, 1995, THERMOCHIM ACTA, V251, P209, DOI 10.1016/0040-6031(94)02009-D; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wu BS, 2002, J EXP BIOL, V205, P815; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang HY, 2012, CURR BIOL, V22, P526, DOI 10.1016/j.cub.2012.01.058	71	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88570	10.1371/journal.pone.0088570	http://dx.doi.org/10.1371/journal.pone.0088570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533112	gold, Green Submitted, Green Published			2022-12-27	WOS:000331262600070
J	Uno, M; Saitoh, Y; Mochida, K; Tsuruyama, E; Kiyono, T; Imoto, I; Inazawa, J; Yuasa, Y; Kubota, T; Yamaoka, S				Uno, Masaya; Saitoh, Yasunori; Mochida, Kanako; Tsuruyama, Eri; Kiyono, Tohru; Imoto, Issei; Inazawa, Johji; Yuasa, Yasuhito; Kubota, Toshiro; Yamaoka, Shoji			NF-kappa B Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-kappa B, Contributes to Ovarian Cancer Progression	PLOS ONE			English	Article							T-CELL LEUKEMIA; TUMOR-SUPPRESSOR GENE; TRANSCRIPTION FACTORS; ALTERNATIVE PATHWAY; MULTIPLE-MYELOMA; EPITHELIAL-CELLS; DRUG-RESISTANCE; GROWTH-FACTOR; NIK; ACTIVATION	Ovarian cancer is one of the leading causes of female death and the development of novel therapeutic approaches is urgently required. Nuclear factor-kappa B (NF-kappa B) is constitutively activated in several types of cancer including ovarian cancer and is known to support the survival of cancer cells. However, molecular mechanisms of persistent activation of NF-kappa B in ovarian cancer remain largely unknown. We report here that, in addition to the previously reported canonical activation, NF-kappa B is activated through the noncanonical pathway in ovarian cancer cells. RNA interference-mediated silencing of NF-kappa B inducing kinase (NIK), a central regulator of the noncanonical pathway, reduced the NF-kappa B2/p52 DNA binding activity and NF-kappa B-dependent reporter gene expression as well as NF-kappa B target gene expression. Notably, anchorage-dependent and independent cell growth was impaired in NIK-depleted cells. Depletion of NIK also suppressed tumor formation in the nude mouse xenograft assay. These results indicate that NIK plays a key role in constitutive NF-kB activation and the progression of ovarian cancer cells and suggest that NIK represents an attractive therapeutic target for ovarian cancer.	[Uno, Masaya; Kubota, Toshiro] Tokyo Med & Dent Univ, Dept Comprehens Reprod Med, Tokyo, Japan; [Uno, Masaya; Saitoh, Yasunori; Mochida, Kanako; Tsuruyama, Eri; Yamaoka, Shoji] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan; [Yuasa, Yasuhito] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Oncol, Tokyo, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Virol, Tokyo 104, Japan; [Imoto, Issei] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Genet, Tokushima 770, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Cancer Center - Japan; Tokushima University	Saitoh, Y (corresponding author), Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan.	yasumolv@tmd.ac.jp; shojmmb@tmd.ac.jp	Imoto, Issei/AAD-5799-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [22117004]; Grants-in-Aid for Scientific Research [22134002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan to S. Yamaoka (22117004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2009, GYNECOL ONCOL, V115, P215, DOI 10.1016/j.ygyno.2009.07.023; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Asangani IA, 2012, ONCOTARGET, V3, P1011, DOI 10.18632/oncotarget.622; Barbieri F, 2004, ONCOLOGY-BASEL, V66, P310, DOI 10.1159/000078332; Connelly L, 2007, J BIOL CHEM, V282, P10028, DOI 10.1074/jbc.M611300200; Frankel A, 2000, CLIN CANCER RES, V6, P3719; Fritz RD, 2010, MOL CANCER RES, V8, P395, DOI 10.1158/1541-7786.MCR-09-0296; Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912; Huang S, 2000, CANCER RES, V60, P5334; Huang Y, 2002, MOL PHARMACOL, V61, P105, DOI 10.1124/mol.61.1.105; ISRAEL A, 1989, NUCLEIC ACIDS RES, V17, P5245, DOI 10.1093/nar/17.13.5245; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kikuchi R, 2007, CANCER RES, V67, P7095, DOI 10.1158/0008-5472.CAN-06-4567; Kleinberg L, 2009, HUM PATHOL, V40, P795, DOI 10.1016/j.humpath.2008.10.019; Lengyel E, 2001, GYNECOL ONCOL, V82, P291, DOI 10.1006/gyno.2001.6243; Mori N, 2000, BLOOD, V95, P3915; Okamoto T, 2007, CURR PHARM DESIGN, V13, P447, DOI 10.2174/138161207780162944; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Ranuncolo SM, 2012, BLOOD, V120, P3756, DOI 10.1182/blood-2012-01-405951; Rattan R, 2010, ONCOGENE, V29, P1362, DOI 10.1038/onc.2009.431; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Saitoh Y, 2010, LUNG CANCER, V70, P263, DOI 10.1016/j.lungcan.2010.03.001; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Suzuki N, 2004, GYNECOL ONCOL, V95, P290, DOI 10.1016/j.ygyno.2004.06.024; Uota S, 2012, CANCER SCI, V103, P100, DOI 10.1111/j.1349-7006.2011.02110.x; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wakana K, 2006, CANCER LETT, V241, P281, DOI 10.1016/j.canlet.2005.10.039; Watanabe T, 2001, GYNECOL ONCOL, V81, P172, DOI 10.1006/gyno.2001.6132; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yamamoto M, 2010, CANCER SCI, V101, P2391, DOI 10.1111/j.1349-7006.2010.01685.x; Yang G, 2011, CLIN CANCER RES, V17, P2181, DOI 10.1158/1078-0432.CCR-10-3265; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang JP, 2007, ENDOCRINOLOGY, V148, P268, DOI 10.1210/en.2006-0500	41	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88347	10.1371/journal.pone.0088347	http://dx.doi.org/10.1371/journal.pone.0088347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533079	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600037
J	Gersch, TM; Foley, NC; Eisenberg, I; Gottlieb, J				Gersch, Timothy M.; Foley, Nicholas C.; Eisenberg, Ian; Gottlieb, Jacqueline			Neural Correlates of Temporal Credit Assignment in the Parietal Lobe	PLOS ONE			English	Article							MEMORY TRACES; DECISION; REPRESENTATION; CHOICE; AMYGDALA; NEURONS	Empirical studies of decision making have typically assumed that value learning is governed by time, such that a reward prediction error arising at a specific time triggers temporally-discounted learning for all preceding actions. However, in natural behavior, goals must be acquired through multiple actions, and each action can have different significance for the final outcome. As is recognized in computational research, carrying out multi-step actions requires the use of credit assignment mechanisms that focus learning on specific steps, but little is known about the neural correlates of these mechanisms. To investigate this question we recorded neurons in the monkey lateral intraparietal area (LIP) during a serial decision task where two consecutive eye movement decisions led to a final reward. The underlying decision trees were structured such that the two decisions had different relationships with the final reward, and the optimal strategy was to learn based on the final reward at one of the steps (the "F" step) but ignore changes in this reward at the remaining step (the "I" step). In two distinct contexts, the F step was either the first or the second in the sequence, controlling for effects of temporal discounting. We show that LIP neurons had the strongest value learning and strongest post-decision responses during the transition after the F step regardless of the serial position of this step. Thus, the neurons encode correlates of temporal credit assignment mechanisms that allocate learning to specific steps independently of temporal discounting.	[Gersch, Timothy M.; Foley, Nicholas C.; Eisenberg, Ian; Gottlieb, Jacqueline] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Gottlieb, Jacqueline] Columbia Univ, Kavli Inst Brain Sci, New York, NY USA	Columbia University; Columbia University	Gottlieb, J (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	jg2141@columbia.edu		Foley, Nicholas C/0000-0003-0691-1748	National Institute of Mental Health [5R03MH91590-2]; National Alliance for Research on Schizophrenia and Depression (NARSAD YI); NIH [EY013933-10];  [T32 MH015174-35]; NATIONAL EYE INSTITUTE [T32EY013933, P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH091590, T32MH015174] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD YI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by: The National Institute of Mental Health (5R03MH91590-2 to JG; http://www.nimh.nih.gov/index.shtml); The National Alliance for Research on Schizophrenia and Depression (NARSAD YI 2009, http://bbrfoundation.org/yi); training grant NIH EY013933-10 (http://www.nei.nih.gov/) to TG and NF; and training grant T32 MH015174-35 (http://www.nimh.nih.gov/index.shtml) to NF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Averbeck BB, 2007, J NEUROSCI, V27, P2204, DOI 10.1523/JNEUROSCI.4483-06.2007; Berdyyeva TK, 2009, J NEUROSCI, V29, P551, DOI 10.1523/JNEUROSCI.4803-08.2009; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bogacz R, 2007, BRAIN RES, V1153, P111, DOI 10.1016/j.brainres.2007.03.057; Daw N. D., 2012, CURR OPIN NEUROBIOL; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Fu WT, 2006, J EXP PSYCHOL GEN, V135, P184, DOI 10.1037/0096-3445.135.2.184; Gershman SJ, 2010, CURR OPIN NEUROBIOL, V20, P251, DOI 10.1016/j.conb.2010.02.008; Gottlieb J, 2010, TRENDS COGNITIVE SCI, V14, P240; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kim H, 2013, J NEUROSCI, V33, P52, DOI 10.1523/JNEUROSCI.2422-12.2013; Le Pelley ME, 2010, ATTENTION HUMAN ASS; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Maddux J.-M., 2010, ATTENTION ASS LEARNI; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nassar MR, 2012, NAT NEUROSCI; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Payzan-LeNestour E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001048; Pearce J.M., 2010, 2 THEORIES ATTENTION; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rothkopf CA, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00173; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takahashi YK, 2011, NAT NEUROSCI, V14, P1590, DOI 10.1038/nn.2957	33	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88725	10.1371/journal.pone.0088725	http://dx.doi.org/10.1371/journal.pone.0088725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523935	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100084
J	Lau, KK; Wong, YK; Teo, KC; Chang, RSK; Hon, SFK; Chan, KH; Cheung, RTF; Li, LSW; Tse, HF; Ho, SL; Siu, CW				Lau, Kui-Kai; Wong, Yuen-Kwun; Teo, Kay-Cheong; Chang, Richard Shek-Kwan; Hon, Sonny Fong-Kwong; Chan, Koon-Ho; Cheung, Raymond Tak-Fai; Li, Leonard Sheung-Wai; Tse, Hung-Fat; Ho, Shu-Leong; Siu, Chung-Wah			Stroke Patients with a Past History of Cancer Are at Increased Risk of Recurrent Stroke and Cardiovascular Mortality	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CEREBROVASCULAR COMPLICATIONS; STATIN USE; MANIFESTATION; FREQUENCY; EVENTS	Background and Purpose: Cancer patients are at increased risk of cardiovascular and cerebrovascular events. It is unclear whether cancer confers any additional risk for recurrent stroke or cardiovascular mortality after stroke. Methods: This was a single center, observational study of 1,105 consecutive Chinese ischemic stroke patients recruited from a large stroke rehabilitation unit based in Hong Kong. We sought to determine whether patients with cancer are at higher risk of recurrent stroke and cardiovascular mortality. Results: Amongst 1,105 patients, 58 patients (5.2%) had cancer, of whom 74% were in remission. After a mean follow-up of 76618 months, 241 patients developed a recurrent stroke: 22 in patients with cancer (38%, annual incidence 13.94%/year), substantially more than those without cancer (21%, 4.65%/year) (p<0.01). In a Cox regression model, cancer, age and atrial fibrillation were the 3 independent predictors of recurrent stroke with a hazard ratio (HR) of 2.42 (95% confidence interval (CI): 1.54-3.80), 1.01 (1.00-1.03) and 1.35 (1.01-1.82) respectively. Likewise, patients with cancer had a higher cardiovascular mortality compared with those without cancer (4.30%/year vs. 2.35%/year, p = 0.08). In Cox regression analysis, cancer (HR: 2.08, 95% CI: 1.08-4.02), age (HR: 1.04, 95% CI 1.02-1.06), heart failure (HR: 3.06, 95% CI 1.72-5.47) and significant carotid atherosclerosis (HR: 1.55, 95% CI 1.02-2.36) were independent predictors for cardiovascular mortality. Conclusions: Stroke patients with a past history of cancer are at increased risk of recurrent stroke and cardiovascular mortality.	[Lau, Kui-Kai; Wong, Yuen-Kwun; Teo, Kay-Cheong; Chang, Richard Shek-Kwan; Hon, Sonny Fong-Kwong; Chan, Koon-Ho; Cheung, Raymond Tak-Fai; Ho, Shu-Leong] Univ Hong Kong, Dept Med, Div Neurol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Lau, Kui-Kai; Chan, Koon-Ho; Cheung, Raymond Tak-Fai; Tse, Hung-Fat; Ho, Shu-Leong; Siu, Chung-Wah] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Li, Leonard Sheung-Wai] Univ Hong Kong, Dept Med, Div Rehabil Med, Tung Wah Hosp, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat; Siu, Chung-Wah] Univ Hong Kong, Dept Med, Div Cardiol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Ho, SL (corresponding author), Univ Hong Kong, Dept Med, Div Neurol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	slho@hku.hk; cwdsiu@hku.hk	Siu, Chung Wah/C-6947-2011; Tse, Hung-Fat/C-4426-2009; Ho, Shu-Leong/AFK-8146-2022; Lau, Gary Kui Kai/D-7944-2011	Tse, Hung-Fat/0000-0002-9578-7808; Tse, Hung Fat/0000-0003-4665-7887; Lau, Gary Kui Kai/0000-0002-8657-2418; Teo, Kay-Cheong/0000-0002-3291-2958				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alvarez-Perez FJ, 2012, EUR NEUROL, V68, P209, DOI 10.1159/000341343; Cestari DM, 2004, NEUROLOGY, V62, P2025, DOI 10.1212/01.WNL.0000129912.56486.2B; CHATURVEDI S, 1994, STROKE, V25, P1215, DOI 10.1161/01.STR.25.6.1215; Elkind MSV, 2005, NEUROLOGY, V65, P253, DOI 10.1212/01.WNL.0000171746.63844.6a; Flint AC, 2012, STROKE, V43, P147, DOI 10.1161/STROKEAHA.111.627729; GRAUS F, 1985, MEDICINE, V64, P16, DOI 10.1097/00005792-198501000-00002; Grisold W, 2009, ACTA NEUROL SCAND, V119, P1, DOI 10.1111/j.1600-0404.2008.01059.x; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Kieslich M, 2003, J PEDIAT HEMATOL ONC, V25, P484, DOI 10.1097/00043426-200306000-00011; Kim JM, 2013, J NEURO-ONCOL, V111, P295, DOI 10.1007/s11060-012-1011-4; Kim SG, 2010, STROKE, V41, P798, DOI 10.1161/STROKEAHA.109.571356; LAI SM, 1994, STROKE, V25, P958, DOI 10.1161/01.STR.25.5.958; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Numico G, 2005, CANCER, V103, P994, DOI 10.1002/cncr.20893; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Plummer C, 2011, STROKE, V42, P2410, DOI 10.1161/STROKEAHA.111.615203; Prandoni P, 2005, LANCET ONCOL, V6, P401, DOI 10.1016/S1470-2045(05)70207-2; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Sacco RL, 2013, STROKE J CEREBRAL CI; Schwarzbach CJ, 2012, STROKE, V43, P3029, DOI 10.1161/STROKEAHA.112.658625; Sumer M, 2003, J CLIN NEUROSCI, V10, P177, DOI 10.1016/S0967-5868(02)00325-9; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Verso M, 2012, THROMB RES, V130, P369, DOI 10.1016/j.thromres.2012.04.003; Wiviott SD, 2006, CURR OPIN LIPIDOL, V17, P626, DOI 10.1097/MOL.0b013e328010872d	25	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88283	10.1371/journal.pone.0088283	http://dx.doi.org/10.1371/journal.pone.0088283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523883	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100032
J	Joy, ME; Vollmer, LL; Hulkower, K; Stern, AM; Peterson, CK; Boltz, RC; Roy, P; Vogt, A				Joy, Marion E.; Vollmer, Laura L.; Hulkower, Keren; Stern, Andrew M.; Peterson, Cameron K.; Boltz, R. C.; Roy, Partha; Vogt, Andreas			A High-Content, Multiplexed Screen in Human Breast Cancer Cells Identifies Profilin-1 Inducers with Anti-Migratory Activities	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASES; SMOOTH-MUSCLE-CELLS; VERTEBRATE GASTRULATION; IN-VITRO; ASSAY; MOTILITY; INVASION; ACTIN; METASTASIS; INHIBITORS	Profilin-1 (Pfn-1) is a ubiquitously expressed actin-binding protein that is essential for normal cell proliferation and migration. In breast cancer and several other adenocarcinomas, Pfn-1 expression is downregulated when compared to normal tissues. Previous studies from our laboratory have shown that genetically modulating Pfn-1 expression significantly impacts proliferation, migration, and invasion of breast cancer cells in vitro, and mammary tumor growth, dissemination, and metastatic colonization in vivo. Therefore, small molecules that can modulate Pfn-1 expression could have therapeutic potential in the treatment of metastatic breast cancer. The overall goal of this study was to perform a multiplexed phenotypic screen to identify compounds that inhibit cell motility through upregulation of Pfn-1. Screening of a test cassette of 1280 compounds with known biological activities on an Oris (TM) Pro 384 cell migration platform identified several agents that increased Pfn-1 expression greater than two-fold over vehicle controls and exerted anti-migratory effects in the absence of overt cytotoxicity in MDA-MB-231 human breast cancer cells. Concentration-response confirmation and orthogonal follow-up assays identified two bona fide inducers of Pfn-1, purvalanol and tyrphostin A9, that confirmed in single-cell motility assays and Western blot analyses. SiRNA-mediated knockdown of Pfn-1 abrogated the inhibitory effect of tyrphostin A9 on cell migration, suggesting Pfn-1 is mechanistically linked to tyrphostin A99s anti-migratory activity. The data illustrate the utility of the high-content cell motility assay to discover novel targeted anti-migratory agents by integrating functional phenotypic analyses with target-specific readouts in a single assay platform.	[Joy, Marion E.; Roy, Partha] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Stern, Andrew M.; Boltz, R. C.; Vogt, Andreas] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Roy, Partha] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Vollmer, Laura L.; Stern, Andrew M.; Peterson, Cameron K.; Boltz, R. C.; Vogt, Andreas] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Roy, Partha] Magee Womens Res Inst, Pittsburgh, PA USA; [Hulkower, Keren] Platypus Technol LLC, Madison, WI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Roy, P (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.	par19@pitt.edu; avogt@pitt.edu		Roy, Partha/0000-0002-4946-8531; Stern, Andrew/0000-0002-8437-2957	National Institutes of Health [R21CA147985, R01CA108607, R44GM090368]; NIH [P30CA047904]; NATIONAL CANCER INSTITUTE [R21CA147985, P30CA047904, R01CA108607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R21CA147985, R01CA108607, R44GM090368 from the National Institutes of Health and used the UPCI Chemical Biology Facility supported in part by award NIH P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghoul M, 2008, THER DRUG MONIT, V30, P234, DOI 10.1097/FTD.0b013e31816b90ff; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; BILDER GE, 1991, AM J PHYSIOL, V260, pC721, DOI 10.1152/ajpcell.1991.260.4.C721; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Ding Z, 2013, ONCOGENE, DOI [10.1038/onc.2013.166, DOI 10.1038/0NC.2013.166.[]; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3433; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Entschladen F, 2002, CANCER IMMUNOL IMMUN, V51, P467, DOI 10.1007/s00262-002-0300-8; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Iversen PW, 2004, ASSAY GUIDANCE MANUA; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Khadka DK, 2009, DEV BIOL, V332, P396, DOI 10.1016/j.ydbio.2009.06.008; Kullmann JA, 2012, EMBO REP, V13, P75, DOI 10.1038/embor.2011.211; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Quintavalle M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002032; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Stringa E, 2000, J CELL SCI, V113, P2055; Tarcic G, 2010, METHODS MOL BIOL, V661, P125, DOI 10.1007/978-1-60761-795-2_7; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Vogt A, 2010, EUROPEAN PHARM REV, V15, P26; Vogt A, 2008, MOL CANCER THER, V7, P330, DOI 10.1158/1535-7163.MCT-07-2165; Vogt A, 2007, METHODS, V42, P268, DOI 10.1016/j.ymeth.2007.02.006; Vollmer LL, 2011, MOL CANCER THER, V10, P994, DOI 10.1158/1535-7163.MCT-10-1048; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	35	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88350	10.1371/journal.pone.0088350	http://dx.doi.org/10.1371/journal.pone.0088350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520372	Green Accepted, Green Published, gold			2022-12-27	WOS:000331254600063
J	Poonia, B; Pauza, CD				Poonia, Bhawna; Pauza, C. David			Levels of CD56+TIM-3-Effector CD8 T Cells Distinguish HIV Natural Virus Suppressors from Patients Receiving Antiretroviral Therapy	PLOS ONE			English	Article							KILLER NK CELLS; INFECTION; LYMPHOCYTES; EXPRESSION; RECEPTORS; CYTOTOXICITY; CD56; RECONSTITUTION; REPLICATION; CYTOKINES	Prolonged antiretroviral therapy (ART) with effective HIV suppression and reconstitution of CD4 T cells, fails to restore CD8 T cell lytic effector function that is needed to eradicate the viral reservoir. Better understanding of the phenotype and function of circulating CD8 cells in HIV patients will contribute to new targeted therapies directed at increasing CD8 T cell lytic effector function and destruction of the viral reservoir. We show that CD8 T cells from ART treated patients had sharply reduced expression of CD56 (neural cell adhesion molecule-1), a marker associated with cytolytic function whereas elite patients who control HIV in the absence of ART had CD56+ CD8 T cell levels similar to uninfected controls. The CD56+ CD8 T cells had higher perforin upregulation as well as degranulation following stimulation with HIV gag peptides compared with CD56 negative CD8 T cells. Elite patients had the highest frequencies of perforin producing CD56+ CD8 T cells among all HIV+ groups. In patients receiving ART we noted high levels of the exhaustion marker TIM-3 on CD56+ CD8 T cells, implying that defective effector function was related to immune exhaustion. CD56+ CD8 T cells from elite or treated HIV patients responded to PMA plus ionomycin stimulation, and expressed transcription factors T-bet and EOMES at levels similar to uninfected controls. Consequently, the lytic effector defect in chronic HIV disease is due to immune exhaustion and quantitative loss of CD56+ CD8 T cells and this defect is not repaired in patients where viremia is suppressed and CD4 T cells are recovered after ART. Reconstituting the cytotoxic CD56+ subset of CD8+ T cells through new interventions might improve the lytic effector capacity and contribute to reducing the viral reservoir. Our initial studies indicate that IL-15 treatment partly reverses the CD56 defect, implying that myeloid cell defects could be targeted for immune therapy during chronic HIV disease.	[Poonia, Bhawna; Pauza, C. David] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Poonia, B (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	bpoonia@ihv.umaryland.edu		Poonia, Bhawna/0000-0001-9640-0524	Institute of Human Virology Institutional Grant [2010-01]; Public Health Services grant [AI42458]	Institute of Human Virology Institutional Grant; Public Health Services grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by Institute of Human Virology Institutional Grant 2010-01 (BP) and Public Health Services grant AI42458 (CDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; BARTSCH U, 1990, J NEUROCYTOL, V19, P550, DOI 10.1007/BF01257243; Boudova S, 2012, J INFECT DIS, V205, P1448, DOI 10.1093/infdis/jis217; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Chaudhry S, 2013, AIDS; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Crawford TQ, 2011, J VIROL, V85, P12343, DOI 10.1128/JVI.05682-11; Cummings JS, 2008, J LEUKOCYTE BIOL, V84, P371, DOI 10.1189/jlb.1207847; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; De Smedt M, 2007, BLOOD, V110, P2696, DOI 10.1182/blood-2007-03-082206; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Finney CA, 2013, J ACQUIR IMMUNE DEFI; Hardy G, 2004, HIV MED, V5, P67, DOI 10.1111/j.1468-1293.2004.00187.x; Hay CM, 1999, J VIROL, V73, P5509, DOI 10.1128/JVI.73.7.5509-5519.1999; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060186; Hou W, 2012, J LEUKOCYTE BIOL, V92, P343, DOI 10.1189/jlb.0312146; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Killian MS, 2011, J VIROL, V85, P1696, DOI 10.1128/JVI.01120-10; Lopez M, 2008, AIDS RES; Lopez M, 2008, EUR J IMMUNOL, V38, P1548, DOI 10.1002/eji.200738054; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Mueller YM, 2003, BLOOD, V101, P1024, DOI 10.1182/blood-2002-07-1957; O'Connell KA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-63; Pittet MJ, 2000, J IMMUNOL, V164, P1148, DOI 10.4049/jimmunol.164.3.1148; Quiros-Roldan E, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-94; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Ribeiro-dos-Santos P, 2012, BLOOD, V119, P4928, DOI 10.1182/blood-2011-12-395186; Riedel DJ, 2009, AIDS, V23, P1955, DOI 10.1097/QAD.0b013e32832ff1ff; Rosenberg ES, 1999, IMMUNOL LETT, V66, P89, DOI 10.1016/S0165-2478(98)00165-5; Santin AD, 2001, CLIN CANCER RES, V7, p804S; Scott-Algara D, 2005, J CLIN IMMUNOL, V25, P57, DOI 10.1007/s10875-005-0358-3; Sondergaard SR, 1999, CELL IMMUNOL, V197, P91, DOI 10.1006/cimm.1999.1565; SPITS H, 1995, BLOOD, V85, P2654, DOI 10.1182/blood.V85.10.2654.bloodjournal85102654; Takasaki S, 2000, CELL BIOL INT, V24, P101, DOI 10.1006/cbir.1999.0457; Tarazona R, 2002, J CLIN IMMUNOL, V22, P176, DOI 10.1023/A:1015476114409; Tarazona R, 2002, AIDS, V16, P197, DOI 10.1097/00002030-200201250-00008; Trabattoni D, 2004, AIDS, V18, P859, DOI 10.1097/00002030-200404090-00003; Trabattoni D, 2002, J BIOL REG HOMEOS AG, V16, P25; Trimble LA, 2000, J VIROL, V74, P7320, DOI 10.1128/JVI.74.16.7320-7330.2000; Xu HB, 2012, FASEB J, V26, P2294, DOI 10.1096/fj.11-195180; Yan JY, 2013, J VIROL, V87, P5170, DOI 10.1128/JVI.02379-12	50	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88884	10.1371/journal.pone.0088884	http://dx.doi.org/10.1371/journal.pone.0088884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520422	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600113
J	Xu, YS; Li, YJ; Ding, WD; Lu, F				Xu, Yaoshan; Li, Yongjuan; Ding, Weidong; Lu, Fan			Controlled versus Automatic Processes: Which Is Dominant to Safety? The Moderating Effect of Inhibitory Control	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; WORKING-MEMORY CAPACITY; INDIVIDUAL-DIFFERENCES; MULTIPLE PROCESSES; BEHAVIOR; EXPLICIT; CLIMATE; INTENTION; ATTITUDES; COGNITION	This study explores the precursors of employees' safety behaviors based on a dual-process model, which suggests that human behaviors are determined by both controlled and automatic cognitive processes. Employees' responses to a self-reported survey on safety attitudes capture their controlled cognitive process, while the automatic association concerning safety measured by an Implicit Association Test (IAT) reflects employees' automatic cognitive processes about safety. In addition, this study investigates the moderating effects of inhibition on the relationship between self-reported safety attitude and safety behavior, and that between automatic associations towards safety and safety behavior. The results suggest significant main effects of self-reported safety attitude and automatic association on safety behaviors. Further, the interaction between self-reported safety attitude and inhibition and that between automatic association and inhibition each predict unique variances in safety behavior. Specifically, the safety behaviors of employees with lower level of inhibitory control are influenced more by automatic association, whereas those of employees with higher level of inhibitory control are guided more by self-reported safety attitudes. These results suggest that safety behavior is the joint outcome of both controlled and automatic cognitive processes, and the relative importance of these cognitive processes depends on employees' individual differences in inhibitory control. The implications of these findings for theoretical and practical issues are discussed at the end.	[Xu, Yaoshan; Li, Yongjuan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Xu, Yaoshan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ding, Weidong; Lu, Fan] Res Inst Nucl Power Operat China, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, YJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liyj@psych.ac.cn			National Natural Science Foundation of China [71071149, 71371179]; Chinese Academy of Sciences [KJZD-EW-L04]; National Basic Research Program of China (973 Program) [2011CB711000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (grant numbers 71071149 and 71371179), Chinese Academy of Sciences (grant number KJZD-EW-L04), and National Basic Research Program of China (973 Program, grant number 2011CB711000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Asendorpf JB, 2002, J PERS SOC PSYCHOL, V83, P380, DOI 10.1037//0022-3514.83.2.380; Barling J, 2003, J APPL PSYCHOL, V88, P276, DOI 10.1037/0021-9010.88.2.276; Burke MJ, 2006, AM J PUBLIC HEALTH, V96, P315, DOI 10.2105/AJPH.2004.059840; Burns C, 2006, RISK ANAL, V26, P1139, DOI 10.1111/j.1539-6924.2006.00821.x; Cai HJ, 2004, SOC COGNITION, V22, P673, DOI 10.1521/soco.22.6.673.54821; Christian MS, 2009, J APPL PSYCHOL, V94, P1103, DOI 10.1037/a0016172; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Dijksterhuis A., 2010, HDB SOCIAL PSYCHOL, V5th ed, P228; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Fazio RH, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P97; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FAZIO RH, 1990, ADV EXP SOC PSYCHOL, V23, P75, DOI 10.1016/S0065-2601(08)60318-4; Ferreira MB, 2006, J PERS SOC PSYCHOL, V91, P797, DOI 10.1037/0022-3514.91.5.797; Finkel EJ, 2009, J PERS SOC PSYCHOL, V97, P483, DOI 10.1037/a0015433; Fogarty GJ, 2010, ACCIDENT ANAL PREV, V42, P1455, DOI 10.1016/j.aap.2009.08.008; Friese M, 2007, EXP PSYCHOL, V54, P247, DOI 10.1027/1618-3169.54.4.247; Friese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044130; Fugas CS, 2012, ACCIDENT ANAL PREV, V45, P468, DOI 10.1016/j.aap.2011.08.013; Gawronski B, 2008, J EXP SOC PSYCHOL, V44, P1355, DOI 10.1016/j.jesp.2008.04.005; Greenwald A. G., 2003, ATTITUDES SOCIAL COG, V2, P197, DOI [DOI 10.1037/0022-3514.85.2.197, 10.1037/0022-3514.85.2.197]; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hall PA, 2008, PSYCHOL HEALTH, V23, P309, DOI 10.1080/14768320701212099; Henning JB, 2009, SAFETY SCI, V47, P337, DOI 10.1016/j.ssci.2008.05.003; Hinsz VB, 2007, J EXP PSYCHOL-APPL, V13, P105, DOI 10.1037/1076-898X.13.2.105; Hofmann W, 2008, J PERS SOC PSYCHOL, V95, P962, DOI 10.1037/a0012705; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hofmann W, 2009, PERSPECT PSYCHOL SCI, V4, P162, DOI 10.1111/j.1745-6924.2009.01116.x; Hofmann W, 2009, J EXP SOC PSYCHOL, V45, P431, DOI 10.1016/j.jesp.2008.09.013; Houben K, 2009, ALCOHOL CLIN EXP RES, V33, P626, DOI 10.1111/j.1530-0277.2008.00877.x; Jiang L, 2010, ACCIDENT ANAL PREV, V42, P1468, DOI 10.1016/j.aap.2009.08.017; Johnson SE, 2005, J SAFETY RES, V36, P63, DOI 10.1016/j.jsr.2004.12.004; Leavitt K, 2011, J ORGAN BEHAV, V32, P672, DOI 10.1002/job.746; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Marquardt N, 2010, HUMAN FACTORS ERGONO, V22, P213; McFarland SG, 2002, SOC COGNITION, V20, P483, DOI 10.1521/soco.20.6.483.22977; McGovern PM, 2000, J BUS PSYCHOL, V15, P149, DOI 10.1023/A:1007727104284; Mierke J, 2003, J PERS SOC PSYCHOL, V85, P1180, DOI 10.1037/0022-3514.85.6.1180; Molesworth BRC, 2009, HUM FACTORS, V51, P845, DOI 10.1177/0018720809357756; Neal A, 2000, SAFETY SCI, V34, P99, DOI 10.1016/S0925-7535(00)00008-4; Neal A., 2004, PSYCHOL WORKPLACE SA, P15; Neal A, 2006, J APPL PSYCHOL, V91, P946, DOI 10.1037/0021-9010.91.4.946; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Probst T M, 2001, J Occup Health Psychol, V6, P139, DOI 10.1037/1076-8998.6.2.139; REASON J, 1995, ERGONOMICS, V38, P1708, DOI 10.1080/00140139508925221; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Ronay R, 2006, BRIT J SOC PSYCHOL, V45, P397, DOI 10.1348/014466605X66420; Rundmo T, 1996, SAFETY SCI, V24, P197, DOI 10.1016/S0925-7535(97)00038-6; SCHEIN EH, 1990, AM PSYCHOL, V45, P109, DOI 10.1037/0003-066X.45.2.109; Schumacher S, 2011, SAFETY SCI, V49, P394, DOI 10.1016/j.ssci.2010.10.002; Sherman JW, 2008, PSYCHOL REV, V115, P314, DOI 10.1037/0033-295X.115.2.314; Smith ER, 2000, PERS SOC PSYCHOL REV, V4, P108, DOI 10.1207/S15327957PSPR0402_01; State Administration of Work Safety, 2011, WORKPL SAF REP 2010; Stroop J. R., 1935, J EXP PSYCHOL, V12, P242; Thush C, 2008, DRUG ALCOHOL DEPEN, V94, P116, DOI 10.1016/j.drugalcdep.2007.10.019; Tsui AS, 1995, ACAD MANAGE J, V38, P1515, DOI 10.2307/256842; von Hippel W, 2005, PSYCHOL SCI, V16, P497, DOI 10.1111/j.0956-7976.2005.01563.x; Wallace JC, 2006, J APPL PSYCHOL, V91, P681, DOI 10.1037/0021-9010.91.3.681; World Health Organization, 2008, GLOB STRAT OCC HLTH; Xu YS, 2013, ACCIDENT ANAL PREV, V50, P811, DOI 10.1016/j.aap.2012.07.007; Zohar D, 2004, J APPL PSYCHOL, V89, P322, DOI 10.1037/0021-9010.89.2.322; Zohar D, 2000, J APPL PSYCHOL, V85, P587, DOI 10.1037//0021-9010.85.4.587; Zohar D., 2003, HDB OCCUPATIONAL HLT, P123, DOI [DOI 10.1037/10474-006, 10.1037/10474-006]	66	13	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87881	10.1371/journal.pone.0087881	http://dx.doi.org/10.1371/journal.pone.0087881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520338	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600029
J	Martines, MS; Mendes, MM; Shimizu, MHM; Rodrigues, VM; de Castro, I; Ferreira, SR; Malheiros, DMAC; Yu, L; Burdmann, EA				Martines, Monique Silva; Mendes, Mirian M.; Shimizu, Maria H. M.; Rodrigues, Veridiana Melo; de Castro, Isac; Ferreira Filho, Sebastiao R.; Malheiros, Denise M. A. C.; Yu, Luis; Burdmann, Emmanuel A.			Effects of Schizolobium parahyba Extract on Experimental Bothrops Venom-Induced Acute Kidney Injury	PLOS ONE			English	Article							ALTERNATUS SNAKE-VENOM; ACUTE-RENAL-FAILURE; AQUEOUS EXTRACT; NEPHROTOXICITY; BITE; ANTIVENOMS; BIOMARKERS; BURDEN; INDIA	Background: Venom-induced acute kidney injury (AKI) is a frequent complication of Bothrops snakebite with relevant morbidity and mortality. The aim of this study was to assess the effects of Schizolobium parahyba (SP) extract, a natural medicine with presumed anti-Bothrops venom effects, in an experimental model of Bothrops jararaca venom (BV)-induced AKI. Methodology: Groups of 8 to 10 rats received infusions of 0.9% saline (control, C), SP 2 mg/kg, BV 0.25 mg/kg and BV immediately followed by SP (treatment, T) in the doses already described. After the respective infusions, animals were assessed for their glomerular filtration rate (GFR, inulin clearance), renal blood flow (RBF, Doppler), blood pressure (BP, intra-arterial transducer), renal vascular resistance (RVR), urinary osmolality (UO, freezing point), urinary neutrophil gelatinase-associated lipocalin (NGAL, enzyme-linked immunosorbent assay [ ELISA]), lactate dehydrogenase (LDH, kinetic method), hematocrit (Hct, microhematocrit), fibrinogen (Fi, Klauss modified) and blinded renal histology (acute tubular necrosis score). Principal Findings: BV caused significant decreases in GFR, RBF, UO, HcT and Fi; significant increases in RVR, NGAL and LDH; and acute tubular necrosis. SP did not prevent these changes; instead, it caused a significant decrease in GFR when used alone. Conclusion: SP administered simultaneously with BV, in an approximate 10: 1 concentration, did not prevent BV-induced AKI, hemolysis and fibrinogen consumption. SP used alone caused a decrease in GFR.	[Martines, Monique Silva; Shimizu, Maria H. M.; Malheiros, Denise M. A. C.; Yu, Luis; Burdmann, Emmanuel A.] Univ Sao Paulo, Sch Med, Div Nephrol, LIM 12, BR-05508 Sao Paulo, Brazil; [Mendes, Mirian M.] Goias Fed Univ, Inst Biol Sci, Jatai, Goias, Brazil; [Rodrigues, Veridiana Melo] Univ Fed Uberlandia, Inst Genet & Biochem, BR-38400 Uberlandia, MG, Brazil; [de Castro, Isac] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [Ferreira Filho, Sebastiao R.] Univ Fed Uberlandia, Div Nephrol, BR-38400 Uberlandia, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Goias; Universidade Federal de Uberlandia; Universidade de Sao Paulo; Universidade Federal de Uberlandia	Burdmann, EA (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, LIM 12, BR-05508 Sao Paulo, Brazil.	burdmann@usp.br	Mendes, Mirian Machado/G-9781-2012; Burdmann, Emmanuel/B-7023-2009; Burdmann, Emmanuel/AAY-1966-2020; rodrigues, veridiana/A-3662-2013; de Castro, Isac/AAA-8990-2021; Castro, Isac de/J-1984-2015; Mendes, Mirian Machado/AAI-6249-2021; Yu, Luis/E-8735-2012; Shimizu, Maria/B-7887-2013; Ferreira-Filho, S R/G-2354-2012; MALHEIROS, DENISE MAC/L-7382-2017	Burdmann, Emmanuel/0000-0002-7644-8579; rodrigues, veridiana/0000-0002-3386-9197; Castro, Isac de/0000-0002-1160-3064; Mendes, Mirian Machado/0000-0003-2878-1999; Ferreira-Filho, S R/0000-0003-4176-9572; MALHEIROS, DENISE MAC/0000-0002-0409-816X; Yu, Luis/0000-0001-9102-0063	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [134872/2010-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	EAB is partially supported by a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. MSM was supported by a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (process number 134872/2010-0), Brazil. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes TC, 2010, TOXICON, V56, P1443, DOI 10.1016/j.toxicon.2010.08.011; Athappan Ganesh, 2008, Saudi J Kidney Dis Transpl, V19, P404; Boer-Lima PA, 1999, AM J TROP MED HYG, V61, P698, DOI 10.4269/ajtmh.1999.61.698; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Brown NI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001670; BURDMANN EA, 1993, AM J TROP MED HYG, V48, P82, DOI 10.4269/ajtmh.1993.48.82; Chippaux JP, 2011, TOXICON, V57, P586, DOI 10.1016/j.toxicon.2010.12.022; Cruz LS, 2009, ETHN DIS S1, V19; de Castroa I, 2004, TOXICON, V43, P833, DOI 10.1016/j.toxicon.2004.03.015; Downey P, 2001, AM J PHYSIOL-RENAL, V280, pF607, DOI 10.1152/ajprenal.2001.280.4.F607; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Gutierrez Jose Maria, 2011, Inflammation & Allergy Drug Targets, V10, P369; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; Harshavardhan L, 2013, J CLIN DIAGN RES, V7, P853, DOI 10.7860/JCDR/2013/5495.2957; Hasan SMK, 2012, TROP DOCT, V42, P41, DOI 10.1258/td.2011.110137; Kanjanabuch T, 2008, SEMIN NEPHROL, V28, P363, DOI 10.1016/j.semnephrol.2008.04.005; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Krawczeski CD, 2011, J AM COLL CARDIOL, V58, P2301, DOI 10.1016/j.jacc.2011.08.017; Linardi A, 2011, BBA-GEN SUBJECTS, V1810, P895, DOI 10.1016/j.bbagen.2011.06.006; Mello SM, 2010, TOXICON, V55, P470, DOI 10.1016/j.toxicon.2009.09.018; Mendes MM, 2008, PHYTOTHER RES, V22, P859, DOI 10.1002/ptr.2371; Mendes MM, 2010, PHYTOTHER RES, V24, P459, DOI 10.1002/ptr.2956; Mohapatra B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001018; Molander M, 2012, J ETHNOPHARMACOL, V139, P863, DOI 10.1016/j.jep.2011.12.032; Naicker S, 2008, SEMIN NEPHROL, V28, P348, DOI 10.1016/j.semnephrol.2008.04.003; Nascimento JM, 2007, BIOCHEM CELL BIOL, V85, P591, DOI 10.1139/O07-067; de Morais ICO, 2013, TOXICON, V61, P38, DOI 10.1016/j.toxicon.2012.10.005; Pinho FMO, 2008, SEMIN NEPHROL, V28, P354, DOI 10.1016/j.semnephrol.2008.04.004; Otero-Patino R, 2009, TOXICON, V54, P998, DOI 10.1016/j.toxicon.2009.07.001; Pinho FMO, 2005, KIDNEY INT, V67, P659, DOI 10.1111/j.1523-1755.2005.67122.x; Rahman R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000860; Ribeiro L A, 1998, Rev Assoc Med Bras (1992), V44, P312, DOI 10.1590/S0104-42301998000400010; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Sgrignolli LR, 2011, NEPHRON CLIN PRACT, V119, pC131, DOI 10.1159/000324228; Sgrignolli LR, 1995, JASN, V16, p540A; Suchithra N, 2008, EMERG MED J, V25, P200, DOI 10.1136/emj.2007.051136; Vale LHF, 2008, BASIC CLIN PHARMACOL, V103, P104, DOI 10.1111/j.1742-7843.2008.00248.x; Vale LHF, 2011, CURR TOP MED CHEM, V11, P2566; Waring WS, 2011, CLIN TOXICOL, V49, P720, DOI 10.3109/15563650.2011.615319; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Williams DJ, 2011, J PROTEOMICS, V74, P1735, DOI 10.1016/j.jprot.2011.05.027; Williamson GB, 2012, AM J BOT, V99, P1010, DOI 10.3732/ajb.1100516; World Health Organization, 2016, WHO GUID PROD CONTR; Zornetta I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001526	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e86828	10.1371/journal.pone.0086828	http://dx.doi.org/10.1371/journal.pone.0086828			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551041	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500009
J	Galli, V; Guzman, F; de Oliveira, LFV; Loss-Morais, G; Korbes, AP; Silva, SDA; Margis-Pinheiro, MMAN; Margis, R				Galli, Vanessa; Guzman, Frank; de Oliveira, Luiz F. V.; Loss-Morais, Guilherme; Koerbes, Ana P.; Silva, Sergio D. A.; Margis-Pinheiro, Marcia M. A. N.; Margis, Rogerio			Identifying MicroRNAs and Transcript Targets in Jatropha Seeds	PLOS ONE			English	Article							CURCAS L.; GENE; EXPRESSION; IDENTIFICATION; MIRNAS; ARABIDOPSIS; OIL; MECHANISMS; PROTEINS; PATHWAY	MicroRNAs, or miRNAs, are endogenously encoded small RNAs that play a key role in diverse plant biological processes. Jatropha curcas L. has received significant attention as a potential oilseed crop for the production of renewable oil. Here, a sRNA library of mature seeds and three mRNA libraries from three different seed development stages were generated by deep sequencing to identify and characterize the miRNAs and pre-miRNAs of J. curcas. Computational analysis was used for the identification of 180 conserved miRNAs and 41 precursors (pre-miRNAs) as well as 16 novel pre-miRNAs. The predicted miRNA target genes are involved in a broad range of physiological functions, including cellular structure, nuclear function, translation, transport, hormone synthesis, defense, and lipid metabolism. Some pre-miRNA and miRNA targets vary in abundance between the three stages of seed development. A search for sequences that produce siRNA was performed, and the results indicated that J. curcas siRNAs play a role in nuclear functions, transport, catalytic processes and disease resistance. This study presents the first large scale identification of J. curcas miRNAs and their targets in mature seeds based on deep sequencing, and it contributes to a functional understanding of these miRNAs.	[Galli, Vanessa; de Oliveira, Luiz F. V.; Loss-Morais, Guilherme; Margis, Rogerio] Fed Univ Rio Grande do Sul UFRGS, Ctr Biotechnol, Porto Alegre, RS, Brazil; [Galli, Vanessa; de Oliveira, Luiz F. V.; Loss-Morais, Guilherme; Margis, Rogerio] Fed Univ Rio Grande do Sul UFRGS, Lab Genomes & Plant Populat, PPGBCM, Porto Alegre, RS, Brazil; [Galli, Vanessa; Silva, Sergio D. A.] Brazilian Agr Res EMBRAPA, Pelotas, RS, Brazil; [Guzman, Frank; Koerbes, Ana P.; Margis-Pinheiro, Marcia M. A. N.; Margis, Rogerio] Fed Univ Rio Grande do Sul UFRGS, PPGGBM, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Rio Grande do Sul	Margis, R (corresponding author), Fed Univ Rio Grande do Sul UFRGS, Ctr Biotechnol, Porto Alegre, RS, Brazil.	rogerio.margis@ufrgs.br	Margis-Pinheiro, Marcia/K-3064-2013; Morais, Guilherme/M-9853-2013; Guzman, Fanny fg/K-5592-2013; Guzman, Frank L/H-1271-2014; Margis, Rogerio/A-7230-2008; de Oliveira, Luiz Felipe Valter/C-6850-2008; galli, vanessa/P-3137-2014	Margis-Pinheiro, Marcia/0000-0001-5356-3497; Guzman, Fanny fg/0000-0003-1537-0904; Guzman, Frank L/0000-0002-5048-4213; Margis, Rogerio/0000-0002-2871-4473; de Oliveira, Luiz Felipe Valter/0000-0003-4535-0621; galli, vanessa/0000-0002-5735-9749	Conselho Nacional de Desenvolvimento Cientifico e Tencologico - CNPq [559636/2009-1, 307868/2011-7]; Ministerio de Ciencia e Tecnologia - MCT and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tencologico - CNPq; Ministerio de Ciencia e Tecnologia - MCT and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tencologico - CNPq grants numbers (559636/2009-1 and 307868/2011-7), Ministerio de Ciencia e Tecnologia - MCT and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Becker K., 2008, LIPID TECHNOL, V20, P104, DOI [DOI 10.1002/LITE.200800023, 10.1002/lite.200800023]; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Berchmans HJ, 2008, BIORESOURCE TECHNOL, V99, P1716, DOI 10.1016/j.biortech.2007.03.051; Carels N, 2009, ADV BOT RES, V50, P39, DOI 10.1016/S0065-2296(08)00802-1; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen H, 2012, FEBS LETT, V586, P1742, DOI 10.1016/j.febslet.2012.05.013; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dai X, 2011, NUCLEIC ACIDS RES, V39, P9; Divakara BN, 2010, APPL ENERG, V87, P732, DOI 10.1016/j.apenergy.2009.07.013; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Gu KY, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-47; Guzman F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049811; He GM, 2011, ANNU REV PLANT BIOL, V62, P411, DOI 10.1146/annurev-arplant-042110-103806; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Hills MJ, 2004, CURR OPIN PLANT BIOL, V7, P302, DOI 10.1016/j.pbi.2004.03.003; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; King AJ, 2009, J EXP BOT, V60, P2897, DOI 10.1093/jxb/erp025; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Molina LG, 2012, GENET MOL BIOL, V35, P292, DOI 10.1590/S1415-47572012000200010; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson MD, 2010, GENOME BIOL, V11, P25, DOI DOI 10.1186/GB-2010-11-3-R25.ACCESSED; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schommer C., 2012, SIGNAL COMMUN PLANTS, V15, P29, DOI [DOI 10.1007/978-3-642-27384-1_2, 10.1007/978-3-642-27384-1_2]; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Tang MJ, 2011, PLANT SCI, V181, P623, DOI 10.1016/j.plantsci.2011.06.014; Vishwakarma NP, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23152; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang CM, 2012, INT J BIOL SCI, V8, P418, DOI 10.7150/ijbs.3676; Wang WG, 2011, ACTA PHYSIOL PLANT, V33, P1591, DOI 10.1007/s11738-010-0692-6; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xu RH, 2011, BIOMASS BIOENERG, V35, P1683, DOI 10.1016/j.biombioe.2011.01.001; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yi CX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-259; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X	62	25	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e83727	10.1371/journal.pone.0083727	http://dx.doi.org/10.1371/journal.pone.0083727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551031	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000002
J	Li, XQ; Du, DL				Li, Xiu-Qing; Du, Donglei			Variation, Evolution, and Correlation Analysis of C plus G Content and Genome or Chromosome Size in Different Kingdoms and Phyla	PLOS ONE			English	Article							BASE COMPOSITION; DNA-SEQUENCES; TEMPERATURE; CONSEQUENCES; BACTERIA; MUTATION; ELEMENTS; GENES; RATES	C+G content (GC content or G+C content) is known to be correlated with genome/chromosome size in bacteria but the relationship for other kingdoms remains unclear. This study analyzed genome size, chromosome size, and base composition in most of the available sequenced genomes in various kingdoms. Genome size tends to increase during evolution in plants and animals, and the same is likely true for bacteria. The genomic C+G contents were found to vary greatly in microorganisms but were quite similar within each animal or plant subkingdom. In animals and plants, the C+G contents are ranked as follows: monocot plants>mammals>non-mammalian animals>dicot plants. The variation in C+G content between chromosomes within species is greater in animals than in plants. The correlation between average chromosome C+G content and chromosome length was found to be positive in Proteobacteria, Actinobacteria (but not in other analyzed bacterial phyla), Ascomycota fungi, and likely also in some plants; negative in some animals, insignificant in two protist phyla, and likely very weak in Archaea. Clearly, correlations between C+G content and chromosome size can be positive, negative, or not significant depending on the kingdoms/groups or species. Different phyla or species exhibit different patterns of correlation between chromosome-size and C+G content. Most chromosomes within a species have a similar pattern of variation in C+G content but outliers are common. The data presented in this study suggest that the C+G content is under genetic control by both trans-and cis-factors and that the correlation between C+G content and chromosome length can be positive, negative, or not significant in different phyla.	[Li, Xiu-Qing] Agr & Agri Food Canada, Potato Res Ctr, Mol Genet Lab, Fredericton, NB, Canada; [Du, Donglei] Univ New Brunswick, Fac Business Adm, Quantitat Methods Res Grp, Fredericton, NB, Canada	Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP); University of New Brunswick	Li, XQ (corresponding author), Agr & Agri Food Canada, Potato Res Ctr, Mol Genet Lab, Fredericton, NB, Canada.	Xiu-Qing.Li@agr.gc.ca		Du, Donglei/0000-0003-0111-8572; Li, Xiu-Qing/0000-0002-7308-0596	Agriculture and Agri-Food Canada; Agriculture and Agri-Food Canada potato genomics project; Canadian Food Inspection Agency [CHA-P-1101]; New Brunswick EARI Growing Forward Program	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Agriculture and Agri-Food Canada potato genomics project(Agriculture & Agri Food Canada); Canadian Food Inspection Agency; New Brunswick EARI Growing Forward Program	The research was supported by LXQ's research funding from Agriculture and Agri-Food Canada potato genomics project, Canadian Food Inspection Agency CHA-P-1101 project, and New Brunswick EARI Growing Forward Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; APPELS R, 1981, CHROMOSOMA, V84, P265, DOI 10.1007/BF00399137; Best DJ, 1975, APPL STAT, V4, P377, DOI DOI 10.2307/2347111; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; CHARGAFF E, 1952, J BIOL CHEM, V195, P155; CIONINI PG, 1985, PROTOPLASMA, V124, P106, DOI 10.1007/BF01279729; Cullis CA, 2005, ANN BOT-LONDON, V95, P201, DOI 10.1093/aob/mci013; CULLIS CA, 1986, TRENDS GENET, V2, P307, DOI 10.1016/0168-9525(86)90285-4; Darwin Charles, 1876, ORIGIN SPECIES MEANS, V6th; Davidson MB, 2012, EMBO J, V31, P895, DOI 10.1038/emboj.2011.485; Gardiner K, 1996, TRENDS GENET, V12, P519, DOI 10.1016/S0168-9525(97)81400-X; Halaimia-Toumi N, 2004, J MOL EVOL, V59, P747, DOI 10.1007/s00239-004-2665-0; Hollander M., 1973, NONPARAMETRIC STAT M; Jiang CZ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-316; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062510; Li WL, 2004, PLANT J, V40, P500, DOI 10.1111/j.1365-313X.2004.02228.x; LI X, 2014, PLOS ONE; Li XQ, 2009, HEREDITY, V102, P323, DOI 10.1038/hdy.2008.132; Li XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079511; Li XQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00982; LI XQ, 1988, CURR GENET, V13, P261, DOI 10.1007/BF00387773; Li XQ, 2008, CAB REV PERSPECT AGR, V3; Li XQ, 1983, THESIS U PARIS SUD; Mitchell D, 2007, BIOCHEM BIOPH RES CO, V353, P207, DOI 10.1016/j.bbrc.2006.12.008; Mooers AO, 2000, TRENDS ECOL EVOL, V15, P365, DOI 10.1016/S0169-5347(00)01934-0; Musto H, 2006, BIOCHEM BIOPH RES CO, V347, P1, DOI 10.1016/j.bbrc.2006.06.054; Nellaker C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-532; Nishida H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00420; Okada N, 2010, GENES CELLS, V15, P801, DOI 10.1111/j.1365-2443.2010.01429.x; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Pozzoli U, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-99; PRESBER W, 1976, J THEOR BIOL, V59, P353, DOI 10.1016/0022-5193(76)90175-2; Pritham EJ, 2009, J HERED, V100, P648, DOI 10.1093/jhered/esp065; Sanmiguel P, 1998, ANN BOT-LONDON, V82, P37, DOI 10.1006/anbo.1998.0746; Schmitz J, 2012, GENOME DYNAM, V7, P92, DOI 10.1159/000337117; Skoneczna A, 2007, J MOL BIOL, V366, P1074, DOI 10.1016/j.jmb.2006.11.093; Smarda P, 2012, PLANT GENOME DIVERSI, V1, P209, DOI [10.1007/978-3-7091-1130-7_14, DOI 10.1007/978-3-7091-1130-7_14]; Smarda P, 2012, NEW PHYTOL, V193, P513, DOI 10.1111/j.1469-8137.2011.03942.x; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Smith JJ, 2012, CURR BIOL, V22, P1524, DOI 10.1016/j.cub.2012.06.028; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yao YL, 2011, MUTAT RES-FUND MOL M, V709-10, P7, DOI 10.1016/j.mrfmmm.2011.02.014; Zheng H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S7	48	42	46	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88339	10.1371/journal.pone.0088339	http://dx.doi.org/10.1371/journal.pone.0088339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551092	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000030
J	Alvarez-Simon, D; Cruz, MJ; Untoria, MD; Munoz, X; Villalbi, JR; Morell, F; Gomez-Olles, S				Alvarez-Simon, Daniel; Cruz, Maria-Jesus; Untoria, Maria-Dolores; Munoz, Xavier; Villalbi, Joan R.; Morell, Ferran; Gomez-Olles, Susana			A Rapid Test for Soy Aeroallergens Exposure Assessment	PLOS ONE			English	Article							EPIDEMIC ASTHMA; SOYBEAN DUST; BARCELONA; OUTBREAKS; ALLERGENS; SPAIN	Background: Determining soy aeroallergens levels is extremely important in the assessment of health risks due to these airborne substances. Currently, soy aeroallergens exposure in the environment is monitored using enzyme immunoassays (EIA) which must be evaluated in a specialized laboratory by skilled personnel. Objective: To describe the development and performance of a rapid immunochromatography assay for the detection of soy aeroallergens in environmental samples. Methods: A test strip using gold labeled anti-soy hull low molecular weight extract (SHLMWE) antibody for the rapid detection of soy aeroallergens in environmental samples was developed. One hundred nineteen airborne samples were analysed in parallel by the strip assay and the anti-SHLMWE sandwich EIA. The assay results were visually analysed by three independent observers who ranked samples as: -, + or ++. Strips were also scanned and analysed by densitometry. Results: The rapid test detected a range of concentrations from 6.25 to 25 ng/mL. Agreement in strip assay interpretations between evaluators was substantial (Kappa = 0.63; CI 0.544-0.715). Visual interpretation also gave a good concordance with EIA results, with sensitivity ranging from 77.3 to 100 and specificity from 65 to 83.5 depending on the observer. Furthermore, a strong correlation was observed between densitometry results of strip assay and EIA determinations. Conclusions: The strip assay developed is rapid, simple, and sensitive and does not require expensive equipment or specific skills. It has considerable potential in the environmental monitoring field for screening soy aeroallergens levels in port cities where allergen measurements are not currently performed. Due to its simplicity, the test will improve the management of soy allergic patients by controlling environmental allergen exposure without the need for apparatus or skilled personnel.	[Alvarez-Simon, Daniel; Cruz, Maria-Jesus; Untoria, Maria-Dolores; Munoz, Xavier; Morell, Ferran; Gomez-Olles, Susana] Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Spain; [Alvarez-Simon, Daniel; Cruz, Maria-Jesus; Munoz, Xavier; Morell, Ferran; Gomez-Olles, Susana] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Cruz, Maria-Jesus; Untoria, Maria-Dolores; Munoz, Xavier; Morell, Ferran; Gomez-Olles, Susana] CIBER Enfermedades Resp CIBERES, Barcelona, Spain; [Munoz, Xavier] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, E-08193 Barcelona, Spain; [Villalbi, Joan R.] Agencia Salut Publ Barcelona, Barcelona, Spain; [Villalbi, Joan R.] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Villalbi, Joan R.] Inst Invest Biomed St Pau, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Cruz, MJ (corresponding author), Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Spain.	mj.cruz@vhir.org	Muñoz, Xavier/I-9009-2014; Alvarez-Simón, Daniel/AAD-3351-2021; Alvarez-Simon, Daniel/C-4901-2014; Cruz, Maria Jesus/I-9073-2014	Alvarez-Simón, Daniel/0000-0002-3464-0909; Alvarez-Simon, Daniel/0000-0002-3464-0909; Cruz, Maria Jesus/0000-0001-9759-5466; Morell Brotad, Ferran/0000-0002-7206-4543; Villalbi, Joan/0000-0001-6915-2545; Munoz, Xavier/0000-0002-8693-022X	Beatriu de Pinos programme from El Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya; Miguel Servet programme from Instituto de Salud Carlos III [CP12/03101]	Beatriu de Pinos programme from El Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya; Miguel Servet programme from Instituto de Salud Carlos III(Instituto de Salud Carlos III)	SGO is a postdoctoral fellow supported by the Beatriu de Pinos programme from El Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya. MJC is a researcher supported by the Miguel Servet programme from Instituto de Salud Carlos III (CP12/03101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTO JM, 1993, NEW ENGL J MED, V329, P1760, DOI 10.1056/NEJM199312093292402; ANTO JM, 1989, NEW ENGL J MED, V320, P1097, DOI 10.1056/NEJM198904273201701; Ballester F, 1999, AM J EPIDEMIOL, V149, P315, DOI 10.1093/oxfordjournals.aje.a009815; Bogdanovic J, 2006, J ALLERGY CLIN IMMUN, V118, P1157, DOI 10.1016/j.jaci.2006.07.004; Cruz MJ, 2000, INT ARCH ALLERGY IMM, V122, P42, DOI 10.1159/000024357; Cummings KJ, 2010, EUR RESPIR J, V36, P1007, DOI 10.1183/09031936.00151109; FLEISS JL, 1979, PSYCHOL BULL, V86, P974, DOI 10.1037/0033-2909.86.5.974; GarciaOrtega P, 1997, MED CLIN-BARCELONA, V108, P677; Gillet P., 2009, MALAR J, V8; Gomez-Olles S, 2006, CLIN EXP ALLERGY, V36, P1176, DOI 10.1111/j.1365-2222.2006.02542.x; Harris-Roberts J, 2012, AM J IND MED, V55, P458, DOI 10.1002/ajim.22009; Koets M, 2011, J ENVIRON MONITOR, V13, P3475, DOI 10.1039/c1em10658a; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; NAVARRO C, 1993, EPIDEMIOLOGY, V4, P76, DOI 10.1097/00001648-199301000-00014; Rodrigo MJ, 2004, INT ARCH ALLERGY IMM, V134, P158, DOI 10.1159/000078649; Tsay A., 2002, Clinical and Experimental Allergy, V32, P1596, DOI 10.1046/j.1365-2222.2002.01533.x; Villalbi JR, 2011, GAC SANIT, V25, P542, DOI 10.1016/j.gaceta.2011.05.011; Villalbi JR, 2004, J EPIDEMIOL COMMUN H, V58, P461, DOI 10.1136/jech.2003.009001; White MC, 1997, AM J EPIDEMIOL, V145, P432, DOI 10.1093/oxfordjournals.aje.a009125; ZUBELDIA JM, 1995, J ALLERGY CLIN IMMUN, V95, P622, DOI 10.1016/S0091-6749(95)70325-X; ZUSKIN E, 1991, Arhiv za Higijenu Rada i Toksikologiju, V42, P267	21	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88676	10.1371/journal.pone.0088676	http://dx.doi.org/10.1371/journal.pone.0088676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533134	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600092
J	Feng, WP; Zhang, B; Li, W; Liu, J				Feng, Wen-Ping; Zhang, Bo; Li, Wen; Liu, Juan			Lack of Association of P2RX7 Gene rs2230912 Polymorphism with Mood Disorders: A Meta-Analysis	PLOS ONE			English	Article							PURINERGIC RECEPTOR; DEPRESSIVE DISORDER; MAJOR DEPRESSION; P2X(7); BIPOLAR; SUSCEPTIBILITY; LINKAGE; LOCUS; GLN460ARG; PROTEIN	Background: To assess the association of P2RX7 gene rs2230912 polymorphism with mood disorders using a meta-analysis. Methods: Data were collected from the following electronic databases: PubMed, Excerpta Medica Database, Elsevier Science Direct, Cochrane Library, and Chinese Biomedical Literature Database, with the last report up to April 1, 2013. Odds ratio (OR) with 95% confidence interval (CI) was used to assess the strength of the association. Dependent on the results of heterogeneity test among individual studies, the fixed effect model (Mantel-Haenszel) or random effect model (DerSimonian-Laird) was selected to summarize the pooled OR. Results: We identified 13 separate studies using search (6,962 cases and 9,262 controls). We detected significant between-study heterogeneity. No significant association of this polymorphism with mood disorders was found (P>0.05). We also performed disease-specific meta-analysis in unipolar depression and bipolar disorder. No significant association of this polymorphism with unipolar depression or bipolar disorder was found (P>0.05). Additionally, we performed subgroup analysis by different types of cases. No significant association of this polymorphism with mood disorders in clinical cohorts or population-based cohorts (P>0.05). A significant association of this polymorphism with mood disorders was found for the allele contrast in family-based cohorts (OR = 1.26, 95% CI = 1.05-1.50, P = 0.01). Conclusions: Overall, our meta-analysis suggests that P2RX7 gene rs2230912 polymorphism may not contribute to the risk of developing mood disorders using a case-control design. Given the discordance in the subgroup analysis by different types of cases, further studies based on larger sample size are still needed.	[Feng, Wen-Ping] Shangluo Vocat & Tech Coll, Affiliated Hosp, Dept Neurol, Shangluo, Peoples R China; [Zhang, Bo; Liu, Juan] Cent Hosp Shangluo, Dept Neurol, Shangluo, Peoples R China; [Li, Wen] Nanjing Med Univ, Affiliated Hosp, Suzhou BenQ Hosp, Dept Neurol, Suzhou, Peoples R China	Nanjing Medical University	Liu, J (corresponding author), Cent Hosp Shangluo, Dept Neurol, Shangluo, Peoples R China.	slfengwen@sina.com			Youth Scientific Research Foundation of Shanxi Provincial Health Department [2012E9]	Youth Scientific Research Foundation of Shanxi Provincial Health Department	This work was supported by grant from the Youth Scientific Research Foundation of Shanxi Provincial Health Department (2012E9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2003, AM J HUM GENET, V73, P1271, DOI 10.1086/379978; Backlund L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043057; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Craddock N, 2006, EUR J HUM GENET, V14, P660, DOI 10.1038/sj.ejhg.5201549; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Denlinger LC, 2006, CLIN CHEM, V52, P995, DOI 10.1373/clinchem.2005.065425; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Green EK, 2009, AM J MED GENET B, V150B, P1063, DOI 10.1002/ajmg.b.30931; Grigoroiu-Serbanescu M, 2009, AM J MED GENET B, V150B, P1017, DOI 10.1002/ajmg.b.30952; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Lavebratt C, 2010, J AFFECT DISORDERS, V125, P249, DOI 10.1016/j.jad.2010.02.113; Lee S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-8; Leonard BE, 2001, PROG NEURO-PSYCHOPH, V25, P767, DOI 10.1016/S0278-5846(01)00155-5; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; MANTEL N, 1959, J NATL CANCER I, V22, P719; McGuffin P, 2005, HUM MOL GENET, V14, P3337, DOI 10.1093/hmg/ddi363; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morissette J, 1999, AM J MED GENET, V88, P567, DOI 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Rahman OA, 2010, ELECTROPHORESIS, V31, P1790, DOI 10.1002/elps.200900664; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Soronen P, 2011, AM J MED GENET B, V156B, P435, DOI 10.1002/ajmg.b.31179; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Viikki M, 2011, NEUROSCI LETT, V493, P127, DOI 10.1016/j.neulet.2011.02.023; Yosifova A, 2009, J AFFECT DISORDERS, V117, P87, DOI 10.1016/j.jad.2008.12.021	39	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88575	10.1371/journal.pone.0088575	http://dx.doi.org/10.1371/journal.pone.0088575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533115	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600073
J	Motani, R; Jiang, DY; Tintori, A; Rieppel, O; Chen, GB				Motani, Ryosuke; Jiang, Da-yong; Tintori, Andrea; Rieppel, Olivier; Chen, Guan-bao			Terrestrial Origin of Viviparity in Mesozoic Marine Reptiles Indicated by Early Triassic Embryonic Fossils	PLOS ONE			English	Article							LIVE BIRTH; LIFE-HISTORY; EVOLUTION; REPRODUCTION; ICHTHYOSAURIA; PHYLOGENY	Viviparity in Mesozoic marine reptiles has traditionally been considered an aquatic adaptation. We report a new fossil specimen that strongly contradicts this traditional interpretation. The new specimen contains the oldest fossil embryos of Mesozoic marine reptile that are about 10 million years older than previous such records. The fossil belongs to Chaohusaurus (Reptilia, Ichthyopterygia), which is the oldest of Mesozoic marine reptiles (ca. 248 million years ago, Early Triassic). This exceptional specimen captures an articulated embryo in birth position, with its skull just emerged from the maternal pelvis. Its headfirst birth posture, which is unlikely to be a breech condition, strongly indicates a terrestrial origin of viviparity, in contrast to the traditional view. The tail-first birth posture in derived ichthyopterygians, convergent with the conditions in whales and sea cows, therefore is a secondary feature. The unequivocally marine origin of viviparity is so far not known among amniotes, a subset of vertebrate animals comprising mammals and reptiles, including birds. Therefore, obligate marine amniotes appear to have evolved almost exclusively from viviparous land ancestors. Viviparous land reptiles most likely appeared much earlier than currently thought, at least as early as the recovery phase from the end-Permian mass extinction.	[Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Lab Orogen Belt & Crustal Evolut, Minist Educ, Dept Geol, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Jiang, Da-yong] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Tintori, Andrea] Univ Milan, Dipartimento Sci Terra, I-20133 Milan, Italy; [Rieppel, Olivier] Field Museum Nat Hist, Ctr Integrat Res, Chicago, IL 60605 USA; [Chen, Guan-bao] Anhui Geol Museum, Dept Res, Hefei, Anhui, Peoples R China	University of California System; University of California Davis; Peking University; Peking University; Chinese Academy of Sciences; University of Milan; Field Museum of Natural History (Chicago)	Jiang, DY (corresponding author), Peking Univ, Lab Orogen Belt & Crustal Evolut, Minist Educ, Dept Geol, Beijing 100871, Peoples R China.	djiang@pku.edu.cn	Tintori, Andrea/D-7878-2014; Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	National Geographic Society Committee for Research and Exploration [8669-09]; National Natural Science Foundation of China [40920124002]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123102]; Research Fund for the Doctoral Program of Higher Education [20120001110072]	National Geographic Society Committee for Research and Exploration(National Geographic Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	National Geographic Society Committee for Research and Exploration (#8669-09, http://www.nationalgeographic.com/) to RM, Project 40920124002 from the National Natural Science Foundation of China to DJ (http://www.nsfc.gov.cn/), Project 123102 from State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) to DJ (http://www.nigpas.cas.cn/), Project 20120001110072 from the Research Fund for the Doctoral Program of Higher Education to DJ (http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; BLACKBURN D G, 1985, Amphibia-Reptilia, V6, P259, DOI 10.1163/156853885X00290; Blackburn DG, 2006, HERPETOL MONOGR, V20, P131, DOI 10.1655/0733-1347(2007)20[131:SRAMOF]2.0.CO;2; Blackburn DG, 1999, HERPETOLOGICA, V55, P556; BLACKBURN DG, 1995, J THEOR BIOL, V174, P199, DOI 10.1006/jtbi.1995.0092; Bleu J, 2012, J EVOLUTION BIOL, V25, P1264, DOI 10.1111/j.1420-9101.2012.02518.x; Boettcher R, 1990, STUTTGARTER BEITRA B, V1-51; Brinkmann W, 1996, ECLOGAE GEOL HELV, V89, P1321; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; Cheng YN, 2004, NATURE, V432, P383, DOI 10.1038/nature03050; Dal Sasso C., 1996, PALEONTOLOGIA LOMBAR, V4, P3; Deeming D. Charles, 1993, Modern Geology, V18, P423; Edmund A.G., 1969, BIOLOGY REPTILIA, V1, P117; Gingerich PD, 2009, PLOS ONE, V4; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hou LH, 2010, P ROY SOC B-BIOL SCI, V277, P1235, DOI 10.1098/rspb.2009.2035; HUNSAKER DON, 1959, COPEIA, V1959, P260, DOI 10.2307/1440408; Ji Q, 2010, NATURWISSENSCHAFTEN, V97, P423, DOI 10.1007/s00114-010-0654-2; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; MARSH H, 1984, AUST J ZOOL, V32, P767, DOI 10.1071/ZO9840767; Maxwell EE, 2003, P ROY SOC B-BIOL SCI, V270, pS104, DOI 10.1098/rsbl.2003.0029; MCBRIDE AF, 1951, J MAMMAL, V32, P251, DOI 10.2307/1375657; McGowan C., 2003, ICHTHYOPTERYGIA; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; Motani R, 1998, J VERTEBR PALEONTOL, V18, P533, DOI 10.1080/02724634.1998.10011080; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; O'Keefe FR, 2011, SCIENCE, V333, P870, DOI 10.1126/science.1205689; Pineiro G, 2012, HIST BIOL, V24, P620, DOI 10.1080/08912963.2012.662230; Rafferty AR, 2013, AM NAT, V181, P245, DOI 10.1086/668827; Renesto S, 2003, J VERTEBR PALEONTOL, V23, P957, DOI 10.1671/1840-21; Renfree MB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0151; Robeck TR, 2005, ZOO BIOL, V24, P29, DOI 10.1002/zoo.20037; Rodriguez-Diaz T, 2012, J EVOLUTION BIOL, V25, P1877, DOI 10.1111/j.1420-9101.2012.02575.x; SANDER PM, 1988, SCIENCE, V239, P780, DOI 10.1126/science.3340859; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R., 1985, Biology of Reptilia, V15, P605; Smith SA, 1997, AUST J ZOOL, V45, P435, DOI 10.1071/ZO97023; Stone R, 2010, SCIENCE, V330, P1164, DOI 10.1126/science.330.6008.1164-b; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Vallarino O, 1996, ZOO BIOL, V15, P309; Wang Y, 2011, NATURWISSENSCHAFTEN, V98, P739, DOI 10.1007/s00114-011-0820-1	45	49	56	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88640	10.1371/journal.pone.0088640	http://dx.doi.org/10.1371/journal.pone.0088640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533127	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600085
J	Ortman, SG; Cabaniss, AHF; Sturm, JO; Bettencourt, LMA				Ortman, Scott G.; Cabaniss, Andrew H. F.; Sturm, Jennie O.; Bettencourt, Luis M. A.			The Pre-History of Urban Scaling	PLOS ONE			English	Article							SIZE; CITY; STATE	Cities are increasingly the fundamental socio-economic units of human societies worldwide, but we still lack a unified characterization of urbanization that captures the social processes realized by cities across time and space. This is especially important for understanding the role of cities in the history of human civilization and for determining whether studies of ancient cities are relevant for contemporary science and policy. As a step in this direction, we develop a theory of settlement scaling in archaeology, deriving the relationship between population and settled area from a consideration of the interplay between social and infrastructural networks. We then test these models on settlement data from the Pre-Hispanic Basin of Mexico to show that this ancient settlement system displays spatial scaling properties analogous to those observed in modern cities. Our data derive from over 1,500 settlements occupied over two millennia and spanning four major cultural periods characterized by different levels of agricultural productivity, political centralization and market development. We show that, in agreement with theory, total settlement area increases with population size, on average, according to a scale invariant relation with an exponent in the range 2/3 <= alpha <= 5/6. As a consequence, we are able to infer aggregate socioeconomic properties of ancient societies from archaeological measures of settlement organization. Our findings, from an urban settlement system that evolved independently from its old-world counterparts, suggest that principles of settlement organization are very general and may apply to the entire range of human history.	[Ortman, Scott G.] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [Ortman, Scott G.; Cabaniss, Andrew H. F.; Bettencourt, Luis M. A.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Cabaniss, Andrew H. F.] Univ N Carolina, Class Dept, Chapel Hill, NC USA; [Sturm, Jennie O.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of Colorado System; University of Colorado Boulder; The Santa Fe Institute; University of North Carolina; University of North Carolina Chapel Hill; University of New Mexico	Ortman, SG (corresponding author), Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.	scott.ortman@colorado.edu	Bettencourt, Luis/R-9861-2019	Cabaniss, Andrew/0000-0003-0884-9503	National Science Foundation [1005075, 103522]; James S. McDonnell Foundation [220020195]; John Templeton Foundation [15705]; Rockefeller Foundation; Bryan J. and June B. Zwan Foundation	National Science Foundation(National Science Foundation (NSF)); James S. McDonnell Foundation; John Templeton Foundation; Rockefeller Foundation; Bryan J. and June B. Zwan Foundation	Funded by National Science Foundation (1005075 and 103522); James S. McDonnell Foundation (220020195); John Templeton Foundation (15705); Rockefeller Foundation; Bryan J. and June B. Zwan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RM, 1966, EVOLUTION URBAN SOC; Angel S, 2011, PROGR PLANNING, V75, P53107; [Anonymous], 2012, WORLD BAS; Arnauld M., 2012, NEIGHBORHOOD SOCIAL; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bettencourt LMA, 2013, PROFESSIONAL DIVERSI; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Blanton R. E., 1972, PREHISPANIC SETTLEME; Chernick M.R., 1999, BOOTSTRAP METHODS PR; Childe V.G., 1950, TOWN PLAN REV, V21, P3; Christaller W., 1933, ZENTRALEN ORTE SUDDE; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cowgill GL, 1997, ANNU REV ANTHROPOL, V26, P129, DOI 10.1146/annurev.anthro.26.1.129; Cristelli M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00812; DRENNAN RD, 1984, AM ANTHROPOL, V86, P105, DOI 10.1525/aa.1984.86.1.02a00100; Evans ST, 2000, TEOTIHUACAN VALLEY 1, V5; Feinman G.M., 1998, ARCHAIC STATES; Fujita M., 1999, SPATIAL EC CITIES RE; Glaeser EL, 1999, J POLIT ECON, V107, pS225, DOI 10.1086/250109; Gorenflo LJ, 2007, ARCHAEOLOGICAL SETTL; Henderson J. V., 1977, EC THEORY CITIES; Johnson C. A., 1987, ARCHAEOLOGY W IRAN, P107; JOHNSON GA, 1980, ECON GEOGR, V56, P234, DOI 10.2307/142715; JOHNSON GA, 1977, ANNU REV ANTHROPOL, V6, P479, DOI 10.1146/annurev.an.06.100177.002403; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Marcus Joyce, 2008, ANCIENT CITY NEW PER; Marshall A., 2009, PRINCIPLES EC UNABRI; Millon R, 1973, TEOTIHUACAN MAP 2; Millon R, 1973, TEOTIHUACAN MAP 1; Mori T, 2008, J REGIONAL SCI, V48, P165, DOI 10.1111/j.1467-9787.2008.00550.x; Mumford L., 1961, CITY HIST ITS ORIGIN, DOI DOI 10.1016/j.jaa.2011.06.005; NORDBECK S, 1971, GEOGR ANAL, VB 53, P54, DOI 10.2307/490887; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Parsons J.R., 2008, PREHISPANIC SETTLEME; PARSONS J. R., 1971, PREHISTORIC SETTLEME; Parsons J.R., 1982, PREHISPANIC SETTLEME; Parsons JR, 1983, ARCHAEOLOGICAL SETTL; Samaniego H, 2009, J TRANSP LAND USE, V1, P2139; Sanders W. T., 1965, CULTURAL ECOLOGY TEO; Sanders W.T., 2007, PREHISPANIC SETTLEME; Sanders William T., 1976, VALLEY MEXICO STUDIE, P101; Sanders William T., 1979, BASIN MEXICO ECOLOGI; Sanders WT, 1996, TEOTIHUACAN VALLEY 3, V3; Sanders WT, 1987, TEOTIHUACAN VALLEY 2, V4; Sanders WT, 1975, TEOTIHUACAN VALLEY 1, V2; SIMON HA, 1955, BIOMETRIKA, V42, P425; Smith ME, 2005, J URBAN HIST, V31, P403, DOI 10.1177/0096144204274396; Smith ME, 1992, ARCHAEOLOGICAL RES A; Smith ME, 2007, J PLAN HIST, V6, P3, DOI 10.1177/1538513206293713; Smith ME, 2012, P NATL ACAD SCI USA, V109, P7617, DOI 10.1073/pnas.1201714109; Smith Michael E, 2008, AZTEC CITY STATE CAP; SVEIKAUSKAS L, 1975, Q J ECON, V89, P393, DOI 10.2307/1885259; Trigger B., 2003, UNDERSTANDING EARLY; USGS, 2005, ASTER IM; WRIGHT H. T., 2001, URUK MESOPOTAMIA ITS, P123; WRIGHT HT, 1975, AM ANTHROPOL, V77, P267, DOI 10.1525/aa.1975.77.2.02a00020; Yoffee Norman, 2005, MYTHS ARCHAIC STATE; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	61	93	97	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87902	10.1371/journal.pone.0087902	http://dx.doi.org/10.1371/journal.pone.0087902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533062	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600020
J	Wang, J; Qian, WY; Liu, JL; Zhao, JJ; Yu, P; Jiang, L; Zhou, J; Gao, R; Xiao, H				Wang, Jun; Qian, Wenyi; Liu, Jingli; Zhao, Jingjing; Yu, Pan; Jiang, Lei; Zhou, Jing; Gao, Rong; Xiao, Hang			Effect of Methamphetamine on the Microglial Damage: Role of Potassium Channel Kv1.3	PLOS ONE			English	Article							K+ CHANNELS; BRAIN; ACTIVATION; CELLS; NEURODEGENERATION; NEUROTOXICITY; EXPRESSION; APOPTOSIS; CYTOKINES; DOPAMINE	Methamphetamine (Meth) abusing represents a major public health problem worldwide. Meth has long been known to induce neurotoxicity. However, the mechanism is still remained poorly understood. Growing evidences indicated that the voltage-gated potassium channels (Kv) were participated in neuronal damage and microglia function. With the whole cell patch clamp, we found that Meth significantly increased the outward K+ currents, therefore, we explored whether Kv1.3, one of the major K+ channels expressed in microglia, was involved in Meth-induced microglia damage. Our study showed that Meth significantly increased the cell viability in a dose dependent manner, while the Kv blocker, tetraethylamine (TEA), 4-Aminopyridine (4-AP) and Kv1.3 specific antagonist margatoxin (MgTx), prevented against the damage mediated by Meth. Interestingly, treatment of cells with Meth resulted in increasing expression of Kv1.3 rather than Kv1.5, at both mRNA and protein level, which is partially blocked by MgTx. Furthermore, Meth also stimulated a significant increased expression of IL-6 and TNF-alpha at protein level, which was significantly inhibited by MgTx. Taken together, these results demonstrated that Kv1.3 was involved in Meth-mediated microglial damage, providing the potential target for the development of therapeutic strategies for Meth abuse.	[Wang, Jun; Qian, Wenyi; Liu, Jingli; Zhao, Jingjing; Yu, Pan; Zhou, Jing; Gao, Rong; Xiao, Hang] Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Jiang, Lei] Nanjing Med Univ, Dept Emergency Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Liu, Jingli] Nanjing Med Univ, Nanjing Drum Tower Hosp, Dept Expt Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University	Xiao, H (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China.	hxiao@njmu.edu.cn	Liu, Jingli/GQH-2490-2022; Liu, Jingli/ABU-8123-2022		National Science Foundation of China [81202230]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Foundation of Nanjing Medical University [2011NJMU275]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Foundation of Nanjing Medical University	This work was supported by the National Science Foundation of China (81202230) the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Foundation of Nanjing Medical University (2011NJMU275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson TE, 1999, WESTERN J MED, V170, P214; Armstrong BD, 2004, NEUROTOXICOLOGY, V25, P905, DOI 10.1016/j.neuro.2004.06.003; BAKHIT C, 1981, NEUROPHARMACOLOGY, V20, P1135, DOI 10.1016/0028-3908(81)90053-8; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Byun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037917; Chung S, 2001, NEUROSCI LETT, V300, P67, DOI 10.1016/S0304-3940(01)01516-6; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Doursout MF, 2013, J INTERF CYTOK RES, V33, P376, DOI 10.1089/jir.2012.0088; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Guilarte TR, 2003, NEUROSCIENCE, V122, P499, DOI 10.1016/S0306-4522(03)00476-7; Hao F, 2013, NEUROCHEM RES, V38, P1002, DOI 10.1007/s11064-013-1010-7; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Kitamura O, 2010, LEGAL MED-TOKYO, V12, P57, DOI 10.1016/j.legalmed.2009.11.001; Liu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.140; Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013; Nam KN, 2013, CELL BIOCHEM FUNCT, V31, P707, DOI 10.1002/cbf.2959; Pannasch U, 2006, MOL CELL NEUROSCI, V33, P401, DOI 10.1016/j.mcn.2006.08.009; Perez JA, 1999, J EMERG MED, V17, P469, DOI 10.1016/S0736-4679(99)00009-8; Reynolds JL, 2007, BBA-PROTEINS PROTEOM, V1774, P433, DOI 10.1016/j.bbapap.2007.02.001; Robson MJ, 2013, EXP NEUROL, V247, P134, DOI 10.1016/j.expneurol.2013.04.009; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Segal DS, 2005, PSYCHOPHARMACOLOGY, V180, P501, DOI 10.1007/s00213-005-2188-4; Sekine Y, 2001, AM J PSYCHIAT, V158, P1206, DOI 10.1176/appi.ajp.158.8.1206; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Tocharus J, 2010, J PINEAL RES, V48, P347, DOI 10.1111/j.1600-079X.2010.00761.x; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Zhao YM, 2006, NEUROSCI LETT, V398, P22, DOI 10.1016/j.neulet.2005.12.073	30	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88642	10.1371/journal.pone.0088642	http://dx.doi.org/10.1371/journal.pone.0088642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533129	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600087
J	Cheng, HH; Wang, KH; Chu, LY; Chang, TC; Kuo, CC; Wu, KK				Cheng, Huei-Hsuan; Wang, Kai-Hsuan; Chu, Ling-yun; Chang, Tzu-Ching; Kuo, Cheng-Chin; Wu, Kenneth K.			Quiescent and Proliferative Fibroblasts Exhibit Differential p300 HAT Activation through Control of 5-Methoxytryptophan Production	PLOS ONE			English	Article							CYCLOOXYGENASE-2 PROMOTER ACTIVATION; HISTONE ACETYLTRANSFERASE ACTIVITY; STREPTAVIDIN-AGAROSE PULLDOWN; INFLAMMATORY MEDIATORS; ACETYLATION; BINDING; EXPRESSION; TRANSCRIPTION	Quiescent fibroblasts possess unique genetic program and exhibit high metabolic activity distinct from proliferative fibroblasts. In response to inflammatory stimulation, quiescent fibroblasts are more active in expressing cyclooxygenase-2 and other proinflammatory genes than proliferative fibroblasts. The underlying transcriptional mechanism is unclear. Here we show that phorbol 12-myristate 13-acetate (PMA) and cytokines increased p300 histone acetyltransferase activity to a higher magnitude (> 2 fold) in quiescent fibroblasts than in proliferative fibroblasts. Binding of p300 to cyclooxygenase-2 promoter was reduced in proliferative fibroblasts. By ultrahigh-performance liquid chromatography coupled with a quadrupole time of flight mass spectrometer and enzyme-immunoassay, we found that production of 5-methoxytryptophan was 2-3 folds higher in proliferative fibroblasts than that in quiescent fibroblasts. Addition of 5-methoxytryptophan and its metabolic precursor, 5-hydroxytryptophan, to quiescent fibroblasts suppressed PMA-induced p300 histone acetyltransferase activity and cyclooxygenase-2 expression to the level of proliferative fibroblasts. Silencing of tryptophan hydroxylase-1 or hydroxyindole O-methyltransferase in proliferative fibroblasts with siRNA resulted in elevation of PMA-induced p300 histone acetyltransferase activity to the level of that in quiescent fibroblasts, which was rescued by addition of 5-hydroxytryptophan or 5-methoxytryptophan. Our findings indicate that robust inflammatory gene expression in quiescent fibroblasts vs. proliferative fibroblasts is attributed to uncontrolled p300 histone acetyltransferase activation due to deficiency of 5-methoxytryptophan production. 5-methoxytryptophan thus is a potential valuable lead compound for new anti-inflammatory drug development.	[Cheng, Huei-Hsuan; Chang, Tzu-Ching; Wu, Kenneth K.] China Med Univ, Metabol Med Res Ctr, Taichung, Taiwan; [Cheng, Huei-Hsuan; Chang, Tzu-Ching] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Kai-Hsuan; Chu, Ling-yun; Kuo, Cheng-Chin; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli, Taiwan; [Wang, Kai-Hsuan; Wu, Kenneth K.] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan	China Medical University Taiwan; China Medical University Taiwan; National Health Research Institutes - Taiwan; National Tsing Hua University	Wu, KK (corresponding author), China Med Univ, Metabol Med Res Ctr, Taichung, Taiwan.	kkgo@nhri.org.tw	Kuo, Cheng-Chin/B-1064-2010		NHRI	NHRI(National Health Research Institutes - Taiwan)	Financial support from NHRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Chen BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049232; Cheng HH, 2012, P NATL ACAD SCI USA, V109, P13231, DOI 10.1073/pnas.1209919109; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2002, FASEB J, V16, P1286, DOI 10.1096/fj.01-0844fje; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Gilroy DW, 2001, FASEB J, V15, P288; Goodman RH, 2000, GENE DEV, V14, P1553; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Mai A, 2006, J MED CHEM, V49, P6897, DOI 10.1021/jm060601m; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McKinsey TA, 2004, TRENDS GENET, V20, P206, DOI 10.1016/j.tig.2004.02.002; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Saunders MA, 2001, J BIOL CHEM, V276, P18897, DOI 10.1074/jbc.M011147200; Schroer K, 2002, CIRCULATION, V105, P2760, DOI 10.1161/01.CIR.0000018127.10968.34; Smith JL, 2004, P NATL ACAD SCI USA, V101, P11554, DOI 10.1073/pnas.0402156101; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wu Kenneth K., 2006, V338, P281	27	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88507	10.1371/journal.pone.0088507	http://dx.doi.org/10.1371/journal.pone.0088507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523905	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100054
J	Arvanitis, DN; Behar, A; Drougard, A; Roullet, P; Davy, A				Arvanitis, Dina N.; Behar, Annie; Drougard, Anne; Roullet, Pascal; Davy, Alice			Cortical Abnormalities and Non-Spatial Learning Deficits in a Mouse Model of CranioFrontoNasal Syndrome	PLOS ONE			English	Article							PERIRHINAL CORTEX; DIFFERENTIAL INVOLVEMENT; HIPPOCAMPAL CA3-REGION; MEMORY CONSOLIDATION; OBJECT RECOGNITION; NEURAL PROGENITORS; SIGNALING CONTROLS; SYNAPTIC FUNCTIONS; DENDRITIC SPINES; SPATIAL MEMORY	Eph receptors and their ephrin ligands play critical roles in the development of the nervous system, however, less is known about their functions in the adult brain. Here, we investigated the function of ephrinB1, an ephrinB family member that is mutated in CranioFrontoNasal Syndrome. We show that ephrinB1 deficient mice (EfnB1(Y/-)) demonstrate spared spatial learning and memory but exhibit exclusive impairment in non-spatial learning and memory tasks. We established that ephrinB1 does not control learning and memory through direct modulation of synaptic plasticity in adults, since it is not expressed in the adult brain. Rather we show that the cortex of EfnB1(Y/-) mice displayed supernumerary neurons, with a particular increase in calretinin-positive interneurons. Further, the increased neuron number in EfnB1(Y/-) mutants correlated with shorter dendritic arborization and decreased spine densities of cortical pyramidal neurons. Our findings indicate that ephrinB1 plays an important role in cortical maturation and that its loss has deleterious consequences on selective cognitive functions in the adult.	[Arvanitis, Dina N.; Behar, Annie; Davy, Alice] CNRS, UMR5547, Ctr Dev Biol, Toulouse, France; [Arvanitis, Dina N.; Behar, Annie; Drougard, Anne; Roullet, Pascal; Davy, Alice] Univ Toulouse UPS, Toulouse, France; [Roullet, Pascal] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Drougard, Anne] Fac Med Toulouse, INSERM, I2MC, F-31073 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Davy, A (corresponding author), CNRS, UMR5547, Ctr Dev Biol, Toulouse, France.	alice.davy@univ-tlse3.fr		Arvanitis, D.N./0000-0003-4676-4455	Human Frontier Science Program Organization; CNRS; Fondation pour la Recherche Medicale	Human Frontier Science Program Organization(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by a Career Development Award from the Human Frontier Science Program Organization (http://www.hfsp.org/) and an ATIP from the CNRS (http://www.cnrs.fr/) both awarded to AD. DA was supported by the Fondation pour la Recherche Medicale (http://www.frm.org/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arikkath J, 2009, MOL NEUROBIOL, V40, P46, DOI 10.1007/s12035-009-8068-x; Artinian J, 2007, HIPPOCAMPUS, V17, P181, DOI 10.1002/hipo.20256; Arvanitis DN, 2013, DEVELOPMENT, V140, P2082, DOI 10.1242/dev.088203; Arvanitis DN, 2010, MOL CELL BIOL, V30, P2508, DOI 10.1128/MCB.01620-09; Barinka F, 2010, PHYSIOL RES, V59, P665, DOI 10.33549/physiolres.931930; Bouzioukh F, 2007, J NEUROSCI, V27, P11279, DOI 10.1523/JNEUROSCI.3393-07.2007; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Bucci DJ, 2000, BEHAV NEUROSCI, V114, P882, DOI 10.1037//0735-7044.114.5.882; Bush JO, 2009, GENE DEV, V23, P1586, DOI 10.1101/gad.1807209; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Florian C, 2004, BEHAV BRAIN RES, V154, P365, DOI 10.1016/j.bbr.2004.03.003; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 1998, TRENDS COGN SCI, V2, P39, DOI 10.1016/S1364-6613(98)01123-1; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Martinez A, 2005, NEUROSCIENCE, V135, P451, DOI 10.1016/j.neuroscience.2005.06.052; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Mizumori SJY, 1999, HIPPOCAMPUS, V9, P444, DOI 10.1002/(SICI)1098-1063(1999)9:4<444::AID-HIPO10>3.0.CO;2-Z; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Paluszkiewicz SM, 2011, DEV NEUROSCI-BASEL, V33, P349, DOI 10.1159/000329420; Park Soochul, 2013, Exp Neurobiol, V22, P143, DOI 10.5607/en.2013.22.3.143; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Paul B, 2008, HEART LUNG CIRC, V17, P497, DOI 10.1016/j.hlc.2008.06.001; RIOLOBOS AS, 1987, PHYSIOL BEHAV, V39, P715, DOI 10.1016/0031-9384(87)90255-1; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Sargolini F, 2003, LEARN MEMORY, V10, P285, DOI 10.1101/lm.54003; SHOLL DA, 1953, J ANAT, V87, P387; Song XJ, 2008, PAIN, V139, P168, DOI 10.1016/j.pain.2008.03.019; Stuckmann I, 2001, J NEUROSCI, V21, P2726, DOI 10.1523/JNEUROSCI.21-08-02726.2001; Stupien G, 2003, NEUROBIOL LEARN MEM, V80, P32, DOI 10.1016/S1074-7427(03)00022-4; Tassoni G, 1999, BEHAV NEUROSCI, V113, P1161, DOI 10.1037/0735-7044.113.6.1161; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Van Kleunen M, 2008, AM NAT, V171, P195, DOI 10.1086/525057; Wang Y, 2005, EUR J NEUROSCI, V21, P2336, DOI 10.1111/j.1460-9568.2005.04093.x; White NM, 2003, BEHAV BRAIN RES, V142, P99, DOI 10.1016/S0166-4328(02)00402-3; Wieland I, 2007, CLIN GENET, V72, P506, DOI 10.1111/j.1399-0004.2007.00905.x; Wieland I, 2004, AM J HUM GENET, V74, P1209, DOI 10.1086/421532; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88325	10.1371/journal.pone.0088325	http://dx.doi.org/10.1371/journal.pone.0088325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520368	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600059
J	Black, KJ; Snyder, AZ; Mink, JW; Tolia, VN; Revilla, FJ; Moerlein, SM; Perlmutter, JS				Black, Kevin J.; Snyder, Abraham Z.; Mink, Jonathan W.; Tolia, Veeral N.; Revilla, Fredy J.; Moerlein, Stephen M.; Perlmutter, Joel S.			Spatial Reorganization of Putaminal Dopamine D-2-Like Receptors in Cranial and Hand Dystonia	PLOS ONE			English	Article							POSITRON EMISSION TOMOGRAPHY; STEADY-STATE MEASUREMENT; BASAL GANGLIA; SOMATOTOPIC ORGANIZATION; RESPONSIVE DYSTONIA; TEMPLATE IMAGES; FOCAL DYSTONIA; DYT1 DYSTONIA; BINDING; D2	The putamen has a somatotopic organization of neurons identified by correspondence of firing rates with selected body part movements, as well as by complex, but organized, differential cortical projections onto putamen. In isolated focal dystonia, whole putaminal binding of dopamine D-2-like receptor radioligands is quantitatively decreased, but it has not been known whether selected parts of the putamen are differentially affected depending upon the body part affected by dystonia. The radioligand [F-18] spiperone binds predominantly to D-2-like receptors in striatum. We hypothesized that the spatial location of [F-18] spiperone binding within the putamen would differ in patients with dystonia limited to the hand versus the face, and we tested that hypothesis using positron emission tomography and magnetic resonance imaging. To address statistical and methodological concerns, we chose a straightforward but robust image analysis method. An automated algorithm located the peak location of [F-18] spiperone binding within the striatum, relative to a brain atlas, in each of 14 patients with cranial dystonia and 8 patients with hand dystonia. The mean (left and right) |x|, y, and z coordinates of peak striatal binding for each patient were compared between groups by t test. The location of peak [F-18] spiperone binding within the putamen differed significantly between groups (cranial dystonia z<hand dystonia z, p = 0.016). We conclude that in isolated focal dystonia, dopamine D-2-like receptors are distributed differently in the putamen depending on the body part manifesting dystonia.	[Black, Kevin J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Black, Kevin J.; Snyder, Abraham Z.; Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Black, Kevin J.; Snyder, Abraham Z.; Moerlein, Stephen M.; Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Black, Kevin J.; Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Moerlein, Stephen M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO USA; [Mink, Jonathan W.] Univ Rochester, Dept Neurol, Rochester, NY USA; [Mink, Jonathan W.] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Mink, Jonathan W.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA; [Mink, Jonathan W.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Tolia, Veeral N.] Pediatrix Med Grp, Sunrise, FL USA; [Revilla, Fredy J.] Univ Cincinnati, Coll Med, Gardner Family Ctr Parkinsons Dis & Movement Diso, Cincinnati, OH USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Rochester; University of Rochester; University of Rochester; University of Rochester; University System of Ohio; University of Cincinnati	Perlmutter, JS (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	joel@npg.wustl.edu	Black, Kevin John/B-8272-2008	Black, Kevin John/0000-0002-6921-9567; Moerlein, Stephen/0000-0002-8897-092X	National Institutes of Health [NS001898, NS031001]; Dana Foundation; American Parkinson Disease Association; National Alliance for Research on Schizophrenia and Depression (NARSAD); Tourette Syndrome Association; McDonnell Center for Higher Brain Function; NIH [MH087913, NS048056]; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031001, R55NS031001, K08NS001898, P30NS048056, R01NS041509, R01NS075321, R01NS058714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; American Parkinson Disease Association; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Tourette Syndrome Association; McDonnell Center for Higher Brain Function; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institutes of Health grants NS001898 and NS031001, the Dana Foundation, the American Parkinson Disease Association, the National Alliance for Research on Schizophrenia and Depression (NARSAD), the Tourette Syndrome Association, and the McDonnell Center for Higher Brain Function. Manuscript preparation supported in part by NIH grants MH087913 and NS048056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; ANDERSSON JLR, 1995, J NUCL MED, V36, P1307; Asanuma K, 2005, NEUROLOGY, V64, P347, DOI 10.1212/01.WNL.0000149764.34953.BF; Augood SJ, 2002, NEUROLOGY, V59, P445, DOI 10.1212/WNL.59.3.445; Black KJ, 2001, NEUROIMAGE, V14, P736, DOI 10.1006/nimg.2001.0752; Black KJ, 2001, NEUROIMAGE, V14, P744, DOI 10.1006/nimg.2001.0871; Black KJ, 1998, NEUROLOGY, V51, P819, DOI 10.1212/WNL.51.3.819; Byl NN, 1996, NEUROLOGY, V47, P508, DOI 10.1212/WNL.47.2.508; Carbon M, 2009, NEUROLOGY, V72, P2097, DOI 10.1212/WNL.0b013e3181aa538f; Defazio G, 2007, BRAIN, V130, P1183, DOI 10.1093/brain/awl355; Delmaire C, 2005, NEUROLOGY, V64, P1391, DOI 10.1212/01.WNL.0000158424.01299.76; Deuschl G, 1995, ANN NEUROL, V38, P862, DOI 10.1002/ana.410380606; Eisenstein SA, 2012, SYNAPSE, V66, P770, DOI 10.1002/syn.21566; FLAHERTY AW, 1991, J NEUROPHYSIOL, V66, P1249; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hallett M, 2006, HUM MOVEMENT SCI, V25, P454, DOI 10.1016/j.humov.2006.05.004; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Horstink CA, 1997, J NEUROL NEUROSUR PS, V62, P672, DOI 10.1136/jnnp.62.6.672-a; HWANG D-R, 1989, Journal of Labelled Compounds and Radiopharmaceuticals, V26, P391; JANKOVIC J, 1993, PARKINSONS DIS MOVEM, P337; Karimi M, 2011, MOVEMENT DISORD, V26, P100, DOI 10.1002/mds.23401; Kishore A, 1998, NEUROLOGY, V50, P1028, DOI 10.1212/WNL.50.4.1028; Kunig G, 1998, ANN NEUROL, V44, P758, DOI 10.1002/ana.410440509; KUNZLE H, 1975, BRAIN RES, V88, P195, DOI 10.1016/0006-8993(75)90384-4; Lehericy S, 2004, NEUROREPORT, V15, P1887; MAZOYER B, 1991, IEEE T MED IMAGING, V10, P499, DOI 10.1109/42.108583; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; Moerlein SM, 1997, J CEREBR BLOOD F MET, V17, P833, DOI 10.1097/00004647-199708000-00002; Mugler III JP, 1990, MAGN RESON MED, V14, P68, DOI [10.1002/mrm.1910140108, DOI 10.1002/MRM.1910140108]; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; Naumann M, 1998, MOVEMENT DISORD, V13, P319, DOI 10.1002/mds.870130219; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palfi S, 1998, EXP NEUROL, V150, P272, DOI 10.1006/exnr.1997.6754; PARENT A, 1990, TRENDS NEUROSCI, V13, P254, DOI 10.1016/0166-2236(90)90105-J; PERCHERON G, 1984, J COMP NEUROL, V227, P214, DOI 10.1002/cne.902270207; Perlmutter Joel S, 2004, Adv Neurol, V94, P163; Perlmutter JS, 1997, NEUROLOGY, V49, P1432, DOI 10.1212/WNL.49.5.1432; PERLMUTTER JS, 1986, J CEREBR BLOOD F MET, V6, P154, DOI 10.1038/jcbfm.1986.29; PERLMUTTER JS, 1989, J NEUROSCI, V9, P2344; PERLMUTTER JS, 1991, J NEUROSCI, V11, P1381; Perlmutter JS, 1997, J NEUROSCI, V17, P843; Perlmutter JS, 1998, ABSTR SOC NEUROSCI 2, V24, P1475; Peterson DA, 2010, NEUROBIOL DIS, V37, P558, DOI 10.1016/j.nbd.2009.12.003; Rinne JO, 2004, J NEURAL TRANSM, V111, P59, DOI 10.1007/s00702-003-0053-3; Schicatano EJ, 1997, J NEUROPHYSIOL, V77, P2842, DOI 10.1152/jn.1997.77.5.2842; Sciamanna G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024261; Snyder A.Z., 1996, QUANTIFICATION BRAIN; SPINKS TJ, 1992, PHYS MED BIOL, V37, P1637, DOI 10.1088/0031-9155/37/8/002; Tabbal SD, 2006, NEUROSCIENCE, V141, P1281, DOI 10.1016/j.neuroscience.2006.04.072; Talairach J., 1988, COPLANAR STEREOTAXIC; TEMPEL LW, 1993, NEUROLOGY, V43, P2252, DOI 10.1212/WNL.43.11.2252; TEMPEL LW, 1990, BRAIN, V113, P691, DOI 10.1093/brain/113.3.691; Todd RD, 1998, MOL NEUROBIOL, V16, P135, DOI 10.1007/BF02740641; Torres-Russotto D, 2008, ANN NY ACAD SCI, V1142, P179, DOI 10.1196/annals.1444.012; Wichmann T, 2008, EXP NEUROL, V212, P242, DOI 10.1016/j.expneurol.2008.04.020	58	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88121	10.1371/journal.pone.0088121	http://dx.doi.org/10.1371/journal.pone.0088121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520350	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600041
J	Chen, LH; Wang, X; Bao, J; Geng, CJ; Xia, YB; Wang, J				Chen, Lihua; Wang, Xiao; Bao, Jing; Geng, Chengjun; Xia, Yunbao; Wang, Jian			Direct Comparison of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography for Detection of Coronary Artery Disease: A Meta-Analysis	PLOS ONE			English	Article							DIAGNOSTIC PERFORMANCE; SYSTEMATIC-REVIEWS; HEART-DISEASE; FLOW RESERVE; TASK-FORCE; MR-IMPACT; PERFUSION; INTERVENTION; ASSOCIATION; MULTICENTER	Objective: To use direct comparative studies or randomised controlled trials to compare the accuracy of cardiac magnetic resonance (CMR) and single-photon emission computed tomography (SPECT) for the detection of obstructive coronary artery disease (CAD). Materials and Methods: Various databases were searched for original articles published prior to June 2013. Studies were selected that performed both CMR and SPECT in the same or randomised patients to detect CAD and that presented sufficient data to allow construction of contingency tables. For each study, the true-positive, false-positive, true-negative, and false-negative values were extracted or derived, and 262 contingency tables were constructed. To reduce heterogeneity, the meta-analysis was carried out in two parts: (1) coronary territory-based analysis and (2) patient-based analysis. Results: 10 studies (5 studies based on patient, 4 studies based on coronary territory, and 1 study based on both) were included in the meta-analysis with a total of 1727 patients. The methodological quality was moderate. For part (1), the summary estimates were as follows: for CMR based on patient-a sensitivity of 0.79 (95% confidence interval: 0.72-0.84) and a specificity of 0.75 (0.65-0.83); for SPECT based on patient-a sensitivity of 0.70 (0.59-0.79) and a specificity of 0.76 (0.660.83). For part (2), the summary estimates for CMR based on coronary territory were a sensitivity of 0.80 (0.73-0.85) and a specificity of 0.87 (0.81-0.91), and the summary estimates for SPECT based on coronary territory were a sensitivity of 0.67 (0.60-0.72) and a specificity of 0.80 (0.75-0.84). Conclusions: Compared with SPECT, CMR is more sensitive to detect CAD on a per-patient basis. Nonetheless, large scale, well-designed trials are necessary to assess its clinical value on a per-coronary territory basis.	[Chen, Lihua; Geng, Chengjun; Xia, Yunbao] Taihu Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China; [Wang, Xiao] Taihu Hosp, Dept Cardiol, Wuxi, Jiangsu, Peoples R China; [Bao, Jing] Wuxi Ctr Dis Control & Prevent, Mol Biol Lab, Wuxi, Jiangsu, Peoples R China; [Wang, Jian] Third Mil Med Univ, Dept Radiol, Southwest Hosp, Chongqing, Peoples R China	Army Medical University	Xia, YB (corresponding author), Taihu Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China.	xiayb@aliyun.com; wangjian811@gmail.com		Chen, Lihua/0000-0001-7249-2014; Chen, Lihua/0000-0001-5037-050X				Brazzelli M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007424.pub2; Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160; de Jong MC, 2012, EUR RADIOL, V22, P1881, DOI 10.1007/s00330-012-2434-1; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Doyle M, 2003, J CARDIOV MAGN RESON, V5, P475, DOI 10.1081/JCMR-120022263; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishida N, 2003, RADIOLOGY, V229, P209, DOI 10.1148/radiol.2291021118; Iwata Kunihiro, 2008, Nihon Hoshasen Gijutsu Gakkai Zasshi, V64, P251; Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040; Jogiya R, 2012, J AM COLL CARDIOL, V60, P756, DOI 10.1016/j.jacc.2012.02.075; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lerakis S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-37; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Menke J, 2010, METHOD INFORM MED, V49, P54, DOI 10.3414/ME09-01-0001; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mowatt G, 2004, HEALTH TECHNOL ASSES, V8, P1; Okuda Shigeo, 2005, Radiat Med, V23, P230; Panting JR, 2001, J MAGN RESON IMAGING, V13, P192; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Sakuma H, 2005, AM J ROENTGENOL, V185, P95, DOI 10.2214/ajr.185.1.01850095; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Schwitter J, 2013, EUR HEART J, V34, P775, DOI 10.1093/eurheartj/ehs022; Sharples L, 2007, HEALTH TECHNOL ASSES, V11, p[iii, ix]; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; StataCorp, 2021, STATA STAT SOFTWARE; Thiele H, 2004, INT J CARDIOVAS IMAG, V20, P371, DOI 10.1023/B:CAIM.0000041938.45383.a4; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WIJNS W, 2010, EUR HEART J, V31, P2501, DOI DOI 10.1093/EURHEARTJ/EHQ277	33	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88402	10.1371/journal.pone.0088402	http://dx.doi.org/10.1371/journal.pone.0088402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520382	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600073
J	Choi, EJ; Chen, WQ; Jun, K; Arthur, HM; Young, WL; Su, H				Choi, Eun-Jung; Chen, Wanqiu; Jun, Kristine; Arthur, Helen M.; Young, William L.; Su, Hua			Novel Brain Arteriovenous Malformation Mouse Models for Type 1 Hereditary Hemorrhagic Telangiectasia	PLOS ONE			English	Article							CAUSE CEREBROVASCULAR DYSPLASIA; ENDOTHELIAL-CELLS; BONE-MARROW; ENDOGLIN; GENE; STIMULATION; SUFFICIENT; EXPRESSION; RESPONSES	Endoglin (ENG) is a causative gene of type 1 hereditary hemorrhagic telangiectasia (HHT1). HHT1 patients have a higher prevalence of brain arteriovenous malformation (AVM) than the general population and patients with other HHT subtypes. The pathogenesis of brain AVM in HHT1 patients is currently unknown and no specific medical therapy is available to treat patients. Proper animal models are crucial for identifying the underlying mechanisms for brain AVM development and for testing new therapies. However, creating HHT1 brain AVM models has been quite challenging because of difficulties related to deleting Eng-floxed sequence in Eng(2fl/2fl) mice. To create an HHT1 brain AVM mouse model, we used several Cre transgenic mouse lines to delete Eng in different cell-types in Eng(2fl/2fl) mice: R26CreER (all cell types after tamoxifen treatment), SM22a-Cre (smooth muscle and endothelial cell) and LysM-Cre (lysozyme M-positive macrophage). An adenoassociated viral vector expressing vascular endothelial growth factor (AAV-VEGF) was injected into the brain to induce focal angiogenesis. We found that SM22 proportional to-Cre-mediated Eng deletion in the embryo caused AVMs in the postnatal brain, spinal cord, and intestines. Induction of Eng deletion in adult mice using R26CreER plus local VEGF stimulation induced the brain AVM phenotype. In both models, Eng-null endothelial cells were detected in the brain AVM lesions, and formed mosaicism with wildtype endothelial cells. However, LysM-Cre-mediated Eng deletion in the embryo did not cause AVM in the postnatal brain even after VEGF stimulation. In this study, we report two novel HHT1 brain AVM models that mimic many phenotypes of human brain AVM and can thus be used for studying brain AVM pathogenesis and testing new therapies. Further, our data indicate that macrophage Eng deletion is insufficient and that endothelial Eng homozygous deletion is required for HHT1 brain AVM development.	[Choi, Eun-Jung; Chen, Wanqiu; Jun, Kristine; Young, William L.; Su, Hua] Univ Calif San Francisco, Ctr Cerebrovasc Res, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Arthur, Helen M.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Young, William L.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Young, William L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; Newcastle University - UK; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Su, H (corresponding author), Univ Calif San Francisco, Ctr Cerebrovasc Res, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	hua.su@ucsf.edu	Arthur, Helen/C-7808-2009	Arthur, Helen/0000-0001-6522-1363	National Institutes of Health [R01NS027713, P01NS044155]; Leslie Munzer Foundation; Michael Ryan Zodda Foundation; British Heart Foundation [RG/12/2/29416] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027713, R21NS083788, P01NS044155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leslie Munzer Foundation; Michael Ryan Zodda Foundation; British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants to HS from the National Institutes of Health (R01NS027713 and P01NS044155), and from the Leslie Munzer Foundation; additional support was provided by a grant to WLY from the Michael Ryan Zodda Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson KR, 2007, GENESIS, V45, P391, DOI 10.1002/dvg.20284; Bambakidis NC, 2013, NEUROSURGERY, V73, pE379, DOI 10.1227/NEU.0000000000000067; Bourdeau A, 2000, AM J PATHOL, V156, P911, DOI 10.1016/S0002-9440(10)64960-7; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; Chen WQ, 2013, ARTERIOSCL THROM VAS, V33, P305, DOI 10.1161/ATVBAHA.112.300485; Chen YM, 2008, NEUROSURGERY, V62, P1340, DOI 10.1227/01.neu.0000333306.64683.b5; Chen Y, 2009, ANN NEUROL, V66, P19, DOI 10.1002/ana.21710; Choi EJ, 2013, STROKE, V44, P795, DOI 10.1161/STROKEAHA.112.671974; Choi EJ, 2012, CEREBROVASC DIS, V33, P540, DOI 10.1159/000337762; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Easey AJ, 2003, J NEUROL NEUROSUR PS, V74, P743, DOI 10.1136/jnnp.74.6.743; Guo Y, 2012, STROKE, V43, P1240, DOI 10.1161/STROKEAHA.111.647263; Han PP, 2003, J NEUROSURG, V98, P3, DOI 10.3171/jns.2003.98.1.0003; Hao Q, 2008, ARTERIOSCL THROM VAS, V28, P2151, DOI 10.1161/ATVBAHA.108.176297; Hao Q, 2010, TRANSL STROKE RES, V1, P197, DOI 10.1007/s12975-010-0020-x; Hao Q, 2011, STROKE, V42, P453, DOI 10.1161/STROKEAHA.110.596452; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kim H, 2008, ACTA NEUROCHIR SUPPL, V105, P199; Kim H, 2011, ACTA NEUROCHIR SUPPL, V111, P83, DOI 10.1007/978-3-7091-0693-8_14; Li CG, 2003, ANTICANCER RES, V23, P1189; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Milton I, 2012, STROKE, V43, P1432, DOI 10.1161/STROKEAHA.111.647024; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Post S, 2010, CARDIOVASC RES, V85, P494, DOI 10.1093/cvr/cvp313; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Shen F, 2013, STROKE, V44; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Su H, 2000, P NATL ACAD SCI USA, V97, P13801, DOI 10.1073/pnas.250488097; van Laake LW, 2006, CIRCULATION, V114, P2288, DOI 10.1161/CIRCULATIONAHA.106.639161; Walker EJ, 2011, ANN NEUROL, V69, P954, DOI 10.1002/ana.22348; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002	33	66	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88511	10.1371/journal.pone.0088511	http://dx.doi.org/10.1371/journal.pone.0088511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520391	gold, Green Published			2022-12-27	WOS:000331254600082
J	He, P; Philbrick, MJ; An, XJ; Wu, JP; Messmer-Blust, AF; Li, J				He, Ping; Philbrick, Melissa J.; An, Xiaojin; Wu, Jiaping; Messmer-Blust, Angela F.; Li, Jian			Endothelial Differentiation Gene-1, a New Downstream Gene Is Involved in RTEF-1 Induced Angiogenesis in Endothelial Cells	PLOS ONE			English	Article							M-CAT ELEMENTS; TRANSGENIC MICE; TRANSCRIPTION; EDG-1; RECEPTORS; SPHINGOSINE-1-PHOSPHATE; PROLIFERATION; EXPRESSION; PROTEINS; LINEAGE	Related Transcriptional Enhancer Factor-1 (RTEF-1) has been suggested to induce angiogenesis through regulating target genes. Whether RTEF-1 has a direct role in angiogenesis and what specific genes are involved in RTEF-1 driven angiogenisis have not been elucidated. We found that over-expressing RTEF-1 in Human dermal microvascular endothelial cells-1 (HMEC-1) significantly increased endothelial cell aggregation, growth and migration while the processes were inhibited by siRNA of RTEF-1. In addition, we observed that Endothelial differentiation gene-1 (Edg-1) expression was up-regulated by RTEF-1 at the transcriptional level. RTEF-1 could bind to Edg-1 promoter and subsequently induce its activity. Edg-1 siRNA significantly blocked RTEF-1-driven increases in endothelial cell aggregation in a Matrigel assay and retarded RTEF-1-induced endothelial cell growth and migration. Pertussis Toxin (PTX), a Gi/Go protein sensitive inhibitor, was found to inhibit RTEF-1 driven endothelial cell aggregation and migration. Our data demonstrates that Edg-1 is a potential target gene of RTEF-1 and is involved in RTEF-1-induced angiogenesis in endothelial cells. Gi/Go protein coupled receptor pathway plays a role in RTEF-1 driven angiogenesis in endothelial cells.	[He, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gerontol, Wuhan 430074, Peoples R China; [He, Ping; Philbrick, Melissa J.; An, Xiaojin; Wu, Jiaping; Messmer-Blust, Angela F.; Li, Jian] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA	Huazhong University of Science & Technology; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Li, J (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA.	jli@bidmc.harvard.edu		Messmer-Blust, Angela/0000-0001-9582-5301	NIH [HLR01082837]; National Institute of Health (Li); China Scholarship Council	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health (Li); China Scholarship Council(China Scholarship Council)	This work was supported in part by NIH grant HLR01082837 from the National Institute of Health (Li) and China Scholarship Council (He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XJ, 2012, ARTERIOSCL THROM VAS, V32, P1951, DOI 10.1161/ATVBAHA.112.250159; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Gory S, 1999, BLOOD, V93, P184, DOI 10.1182/blood.V93.1.184.401a20_184_192; Hla T, 2000, ANN NY ACAD SCI, V905, P16; Jin Y, 2011, J BIOL CHEM, V286, P22699, DOI 10.1074/jbc.M111.237024; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Messmer-Blust AF, 2012, J VASC RES, V49, P249, DOI 10.1159/000335180; Ozaki Harunobu, 2003, J Atheroscler Thromb, V10, P125; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Xu M, 2011, CARDIOVASC RES, V90, P325, DOI 10.1093/cvr/cvq400; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223	18	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88143	10.1371/journal.pone.0088143	http://dx.doi.org/10.1371/journal.pone.0088143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520353	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600044
J	Kawai, T; Takemoto, M; Fujibayashi, S; Akiyama, H; Tanaka, M; Yamaguchi, S; Pattanayak, DK; Doi, K; Matsushita, T; Nakamura, T; Kokubo, T; Matsuda, S				Kawai, Toshiyuki; Takemoto, Mitsuru; Fujibayashi, Shunsuke; Akiyama, Haruhiko; Tanaka, Masashi; Yamaguchi, Seiji; Pattanayak, Deepak K.; Doi, Kenji; Matsushita, Tomiharu; Nakamura, Takashi; Kokubo, Tadashi; Matsuda, Shuichi			Osteoinduction on Acid and Heat Treated Porous Ti Metal Samples in Canine Muscle	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CERAMICS; TITANIUM IMPLANTS; SURFACE-STRUCTURE; BONE; DIFFERENTIATION; HYDROXYAPATITE; DOGS; TISSUE; LAYER; KINDS	Samples of porous Ti metal were subjected to different acid and heat treatments. Ectopic bone formation on specimens embedded in dog muscle was compared with the surface characteristics of the specimen. Treatment of the specimens by H2SO4/HCl and heating at 600 degrees C produced micrometer-scale roughness with surface layers composed of rutile phase of titanium dioxide. The acid-and heat-treated specimens induced ectopic bone formation within 6 months of implantation. A specimen treated using NaOH followed by HCl acid and then heat treatment produced nanometer-scale surface roughness with a surface layer composed of both rutile and anatase phases of titanium dioxide. These specimens also induced bone formation after 6 months of implantation. Both these specimens featured positive surface charge and good apatite-forming abilities in a simulated body fluid. The amount of the bone induced in the porous structure increased with apatite-forming ability and higher positive surface charge. Untreated porous Ti metal samples showed no bone formation even after 12 months. Specimens that were only heat treated featured a smooth surface composed of rutile. A mixed acid treatment produced specimens with micrometer-scale rough surfaces composed of titanium hydride. Both of them also showed no bone formation after 12 months. The specimens that showed no bone formation also featured almost zero surface charge and no apatite-forming ability. These results indicate that osteoinduction of these porous Ti metal samples is directly related to positive surface charge that facilitates formation of apatite on the metal surfaces in vitro.	[Kawai, Toshiyuki; Takemoto, Mitsuru; Fujibayashi, Shunsuke; Akiyama, Haruhiko; Tanaka, Masashi; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Yamaguchi, Seiji; Pattanayak, Deepak K.; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Doi, Kenji] Osaka Yakin Kogyo Co Ltd, Osaka, Japan; [Nakamura, Takashi] Natl Hosp Org Kyoto Med Ctr, Kyoto, Japan	Kyoto University; Chubu University	Kawai, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan.	kawait@kuhp.kyoto-u.ac.jp	Matsushita, Tomiharu/AAG-2432-2021	Matsuda, Shuichi/0000-0003-0802-1255; Nakamura, Takashi/0000-0003-0326-1903				Bruijn JD, 2008, OSTEOINDUCTION ITS E, P210; Cai KY, 2006, COLLOID SURFACE B, V50, P1, DOI 10.1016/j.colsurfb.2006.03.016; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028; Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)00551-9; Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056; Kawai T, 2012, J MAT SCI MAT MED; Kawai T, 2013, J MATER SCI-MATER M, V24, P1707, DOI 10.1007/s10856-013-4919-0; Kim HM, 1999, J BIOMED MATER RES, V45, P100, DOI 10.1002/(SICI)1097-4636(199905)45:2<100::AID-JBM4>3.3.CO;2-S; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Kokubo T, 2010, J R SOC INTERFACE, V7, pS503, DOI 10.1098/rsif.2010.0129.focus; Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004; Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.0.CO;2-W; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013; Parekh SH, 2011, BIOMATERIALS, V32, P2256, DOI 10.1016/j.biomaterials.2010.11.065; RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007; Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014; Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23; VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010; Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0; WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0; Yamaguchi S, 2009, J CERAM SOC JPN, V117, P1126, DOI 10.2109/jcersj2.117.1126; YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R; Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082; Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0; Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665; Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6; Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7	31	31	32	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88366	10.1371/journal.pone.0088366	http://dx.doi.org/10.1371/journal.pone.0088366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520375	Green Submitted, gold, Green Published			2022-12-27	WOS:000331254600066
J	Sgarra, L; Leo, V; Addabbo, F; Iacobazzi, D; Carratu, MR; Montagnani, M; Potenza, MA				Sgarra, Luca; Leo, Valentina; Addabbo, Francesco; Iacobazzi, Dominga; Carratu, Maria Rosaria; Montagnani, Monica; Potenza, Maria Assunta			Intermittent Losartan Administration Triggers Cardiac Post-Conditioning in Isolated Rat Hearts: Role of BK2 Receptors	PLOS ONE			English	Article							KALLIDIN-LIKE PEPTIDE; MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIC REPERFUSION INJURY; MYOCARDIAL INFARCT SIZE; ANGIOTENSIN-II; MEDIATED VASODILATION; SIGNALING PATHWAYS; SALVAGE KINASE; RABBIT HEARTS; CARDIOPROTECTION	Introduction: The angiotensin (Ang) and bradykinin (BK) tissue-system plays a pivotal role in post-conditioning, but the efficacy of angiotensin type 1 receptor (AT1R) blockers (ARBs) in post-ischemic strategies is still under investigation. We evaluated functional and morphological outcomes, together with activation of cytosolic RISK pathway kinases, in rat hearts subjected to losartan (LOS) or irbesartan (IRB) post-ischemic administration. Methods: Isolated rat hearts underwent 30 min ischemia and 120 min reperfusion. Post-conditioning was obtained by intermittent (10 s/each) or continuous drug infusion during the first 3 min of reperfusion. Left ventricular end-diastolic pressure (LVEDP), left ventricular developed pressure (dLVP), coronary flow (CF), and left ventricular infarct mass (IM) were measured together with the activation status of RISK kinases Akt, p42/44 MAPK and GSK3b. Results: When compared to hearts subjected to ischemia/reperfusion (iI/R) alone, continuous IRB or LOS administration did not significantly reduce total infarct mass (cIRB or cLOS vs. iI/R, p = 0.2). Similarly, intermittent IRB (iIRB) was not able to enhance cardioprotection. Conversely, intermittent LOS administration (iLOS) significantly ameliorated cardiac recovery (iLOS vs iI/R, p<0.01). Differences between iLOS and iIRB persisted under continuous blockade of AT2R (iLOS+ cPD vs. iIRB+ cPD, p<0.05). Interestingly, iLOS cardioprotection was lost when BK2R was simultaneously blocked (iLOS+ cHOE vs. iI/R, p = 0.6), whereas concurrent administration of iBK and iIRB replicated iLOS effects (iIRB+ iBK vs. iLOS, p = 0.7). At the molecular level, iIRB treatment did not significantly activate RISK kinases, whereas both iLOS and iBK treatments were associated with activation of the Akt/GSK3b branch of the RISK pathways (p, 0.05 vs. iI/R, for both). Conclusions: Our results suggest that intermittent losartan is effective in mediating post-conditioning cardioprotection, whereas irbesartan is not. The infarct mass reduction by intermittent losartan seem mainly related on its specific ability to modulate BK2R, and only modestly associated on AT1R blocking properties.	[Sgarra, Luca; Leo, Valentina; Addabbo, Francesco; Iacobazzi, Dominga; Carratu, Maria Rosaria; Montagnani, Monica; Potenza, Maria Assunta] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Montagnani, M (corresponding author), Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy.	monica.montagnani@uniba.it	Sgarra, Luca/AAC-4773-2022; Montagnani, Monica/AAV-2057-2020	Montagnani, Monica/0000-0002-5697-8185; Potenza, Maria Assunta/0000-0002-9995-1468; Carratu, Maria/0000-0002-9709-6533; IACOBAZZI, DOMINGA/0000-0001-5977-0518; Leo, Valentina/0000-0003-3368-5133; Sgarra, Luca/0000-0001-8475-8270	Italian Ministry for Instruction, University and Research (MIUR) [PRIN 2010YK7Z5K_008]; University of Bari [ORBA10DLZD]	Italian Ministry for Instruction, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Bari	This work was supported by a research grant award from the Italian Ministry for Instruction, University and Research (MIUR) PRIN 2010YK7Z5K_008 (to MM), and by a research grant from the University of Bari (ORBA10DLZD to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batenburg WW, 2004, CIRCULATION, V109, P2296, DOI 10.1161/01.CIR.0000128696.12245.57; Bhuiyan MA, 2009, LIFE SCI, V85, P136, DOI 10.1016/j.lfs.2009.05.001; Bonde MM, 2011, REGUL PEPTIDES, V167, P21, DOI 10.1016/j.regpep.2010.11.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunner HR, 1997, AM J HYPERTENS, V10, p311S, DOI 10.1016/S0895-7061(97)00391-9; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Campbell DJ, 2005, CIRCULATION, V111, P315, DOI 10.1161/01.CIR.0000153269.07762.3B; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Darling CE, 2005, AM J PHYSIOL-HEART C, V289, pH1618, DOI 10.1152/ajpheart.00055.2005; Das DK, 1995, J MOL CELL CARDIOL, V27, P181; Das S, 2006, CELL BIOCHEM BIOPHYS, V44, P103, DOI 10.1385/CBB:44:1:103; Driamov S, 2004, BASIC RES CARDIOL, V99, P299, DOI 10.1007/s00395-004-0468-5; FEOLDE E, 1993, J MOL CELL CARDIOL, V25, P1359, DOI 10.1006/jmcc.1993.1148; Flynn JD, 2003, PHARMACOTHERAPY, V23, P1401, DOI 10.1592/phco.23.14.1401.31947; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; Gelpi RJ, 2002, BASIC RES CARDIOL, V97, P40, DOI 10.1007/s395-002-8386-0; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Gross ER, 2004, CIRC RES, V94, P960, DOI 10.1161/01.RES.0000122392.33172.09; Halkos ME, 2004, ANN THORAC SURG, V78, P961, DOI 10.1016/j.athoracsur.2004.03.033; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hilgenfeldt U, 2005, BRIT J PHARMACOL, V146, P958, DOI 10.1038/sj.bjp.0706409; Hostrup A, 2012, CELL PHYSIOL BIOCHEM, V30, P642, DOI 10.1159/000341445; Kimura S, 2005, HYPERTENSION, V45, P860, DOI 10.1161/01.HYP.0000163462.98381.7f; Liu X, 2006, BRIT J PHARMACOL, V148, P825, DOI 10.1038/sj.bjp.0706799; Liu XX, 2005, BRIT J PHARMACOL, V146, P952, DOI 10.1038/sj.bjp.0706402; Lo MW, 1995, CLIN PHARMACOL THER, V58, P641, DOI 10.1016/0009-9236(95)90020-9; Marktanner R, 2006, CLIN EXP PHARMACOL P, V33, P787, DOI 10.1111/j.1440-1681.2006.04439.x; Messadi-Laribi E, 2008, CLIN EXP PHARMACOL P, V35, P489, DOI 10.1111/j.1440-1681.2008.04902.x; Michel MC, 2013, PHARMACOL REV, V65, P809, DOI 10.1124/pr.112.007278; Miki T, 1996, J AM COLL CARDIOL, V28, P1616, DOI 10.1016/S0735-1097(96)00371-3; Nishino Y, 2008, CIRC RES, V103, P307, DOI 10.1161/CIRCRESAHA.107.169953; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Penna C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0371-z; Penna C, 2007, CARDIOVASC RES, V75, P168, DOI 10.1016/j.cardiores.2007.03.001; Penna C, 2009, BASIC RES CARDIOL, V104, P390, DOI 10.1007/s00395-008-0762-8; Perrelli MG, 2011, WORLD J CARDIOL, V3, P186, DOI 10.4330/wjc.v3.i6.186; Potenza MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE685, DOI 10.1152/ajpendo.00291.2009; Przyklenk K, 2008, J AM COLL CARDIOL, V51, P1393, DOI 10.1016/j.jacc.2007.11.070; Quinlan CL, 2008, AM J PHYSIOL-HEART C, V295, pH953, DOI 10.1152/ajpheart.00520.2008; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Sato M, 2000, CIRCULATION, V102; Schmidt B, 2003, J MED CHEM, V46, P2261, DOI 10.1021/jm0204237; Schwarz ER, 1997, CARDIOVASC DRUG THER, V11, P687, DOI 10.1023/A:1007743125918; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; van Esch JHM, 2006, BRIT J PHARMACOL, V148, P452, DOI 10.1038/sj.bjp.0706762; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yang XM, 2004, J AM COLL CARDIOL, V44, P1103, DOI 10.1016/j.jacc.2004.05.060; Zhao ZQ, 2006, CARDIOVASC RES, V70, P200, DOI 10.1016/j.cardiores.2006.01.024; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	52	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88542	10.1371/journal.pone.0088542	http://dx.doi.org/10.1371/journal.pone.0088542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520397	Green Submitted, gold, Green Published			2022-12-27	WOS:000331254600088
J	Abolhasani, MM; Naebe, M; Jalali-Arani, A; Guo, QP				Abolhasani, Mohammad Mahdi; Naebe, Minoo; Jalali-Arani, Azam; Guo, Qipeng			Influence of Miscibility Phenomenon on Crystalline Polymorph Transition in Poly(Vinylidene Fluoride)/Acrylic Rubber/Clay Nanocomposite Hybrid	PLOS ONE			English	Article							FLUORIDE)/CLAY NANOCOMPOSITES; INTERCALATION; RHEOLOGY; BEHAVIOR	In this paper, intercalation of nanoclay in the miscible polymer blend of poly(vinylidene fluoride) (PVDF) and acrylic rubber(ACM) was studied. X-ray diffraction was used to investigate the formation of nanoscale polymer blend/clay hybrid. Infrared spectroscopy and X-ray analysis revealed the coexistence of beta and gamma crystalline forms in PVDF/Clay nanocomposite while alpha crystalline form was found to be dominant in PVDF/ACM/Clay miscible hybrids. Flory-Huggins interaction parameter (B) was used to further explain the miscibility phenomenon observed. The B parameter was determined by combining the melting point depression and the binary interaction model. The estimated B values for the ternary PVDF/ACM/Clay and PVDF/ACM pairs were all negative, showing both proper intercalation of the polymer melt into the nanoclay galleries and the good miscibility of PVDF and ACM blend. The B value for the PVDF/ACM blend was almost the same as that measured for the PVDF/ACM/Clay hybrid, suggesting that PVDF chains in nanocomposite hybrids interact with ACM chains and that nanoclay in hybrid systems is wrapped by ACM molecules.	[Abolhasani, Mohammad Mahdi] Kashan Univ, Dept Chem Engn, Kashan, Iran; [Naebe, Minoo; Guo, Qipeng] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia; [Jalali-Arani, Azam] Amirkabir Univ Technol, Dept Polymer Engn & Color Technol, Tehran, Iran	University Kashan; Deakin University; Amirkabir University of Technology	Abolhasani, MM (corresponding author), Kashan Univ, Dept Chem Engn, Kashan, Iran.	abolhasani@kashanu.ac.ir	Guo, Qipeng/A-8140-2013; Abolhasani, Mohammadmahdi/GPK-0655-2022; Jalali-Arani, Azam/I-3816-2018	Jalali-Arani, Azam/0000-0002-3805-8916; Naebe, Minoo/0000-0002-0607-6327; Guo, Qipeng/0000-0001-7113-651X; Abolhasani, Mohammad Mahdi/0000-0002-4605-3648				Abolhasani MM, 2013, POLYMER, V54, P4686, DOI 10.1016/j.polymer.2013.06.044; Abolhasani MM, NEW APPROACH M UNPUB; Abolhasani MM, FOLD SURFACE F UNPUB; Abolhasani MM, 2013, J APPL POLYM SCI, V130, P1247, DOI 10.1002/app.39213; AKELAH A, 1994, NANOSTRUCT MATER, V4, P965; Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7; Asai K, 2008, POLYMER, V49, P5186, DOI 10.1016/j.polymer.2008.09.061; Asai K, 2008, POLYMER, V49, P4298, DOI 10.1016/j.polymer.2008.07.037; Buckley J, 2006, POLYMER, V47, P2411, DOI 10.1016/j.polymer.2006.02.012; Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104; Hoffmann B, 2000, MACROMOL RAPID COMM, V21, P57, DOI 10.1002/(SICI)1521-3927(20000101)21:1<57::AID-MARC57>3.3.CO;2-5; Hyun YH, 2001, MACROMOLECULES, V34, P8084, DOI 10.1021/ma002191w; Krishnamoorti R, 1996, CHEM MATER, V8, P1728, DOI 10.1021/cm960127g; LeBaron PC, 1999, APPL CLAY SCI, V15, P11, DOI 10.1016/S0169-1317(99)00017-4; Li Y, 2008, MACROMOLECULES, V41, P3396, DOI 10.1021/ma800148x; Li YJ, 2008, MACROMOLECULES, V41, P3120, DOI 10.1021/ma7027402; Li YJ, 2006, POLYMER, V47, P3946, DOI 10.1016/j.polymer.2006.03.075; Li YJ, 2006, MACROMOLECULES, V39, P4195, DOI 10.1021/ma060181a; Lim SK, 2002, CHEM MATER, V14, P1989, DOI 10.1021/cm010498j; NISHI T, 1975, MACROMOLECULES, V8, P909, DOI 10.1021/ma60048a040; Priya L, 2003, J APPL POLYM SCI, V89, P2036, DOI 10.1002/app.12346; Priya L, 2003, J POLYM SCI POL PHYS, V41, P31, DOI 10.1002/polb.10355; Priya L, 2002, J POLYM SCI POL PHYS, V40, P1682, DOI 10.1002/polb.10223; Ramasundaram S, 2008, J POLYM SCI POL PHYS, V46, P2173, DOI 10.1002/polb.21550; RIEDL B, 1984, POLYM ENG SCI, V24, P1291, DOI 10.1002/pen.760241705; Shah D, 2004, ADV MATER, V16, P1173, DOI 10.1002/adma.200306355; VAIA RA, 1993, CHEM MATER, V5, P1694, DOI 10.1021/cm00036a004; Vaia RA, 1996, CHEM MATER, V8, P2628, DOI 10.1021/cm960102h; VAIA RA, 1995, MACROMOLECULES, V28, P8080, DOI 10.1021/ma00128a016; Zare Y, 2012, J APPL POLYM SCI, V124, P1225, DOI 10.1002/app.35134	30	23	23	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88715	10.1371/journal.pone.0088715	http://dx.doi.org/10.1371/journal.pone.0088715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551141	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500057
J	Hrdlickova, R; Nehyba, J; Bargmann, W; Bose, HR				Hrdlickova, Radmila; Nehyba, Jiri; Bargmann, William; Bose, Henry R., Jr.			Multiple Tumor Suppressor microRNAs Regulate Telomerase and TCF7, an Important Transcriptional Regulator of the Wnt Pathway	PLOS ONE			English	Article							CANCER CELL-PROLIFERATION; DOWN-REGULATION; SIGNALING PATHWAY; HTERT EXPRESSION; NONCODING RNAS; MESSENGER-RNAS; TARGET; INVASION; GENE; IDENTIFICATION	The human TERT (hTERT) gene encodes the telomerase catalytic subunit which plays a role in telomerase regulation. Telomerase is activated in more than 90% of all human malignancies and understanding how telomerase is regulated is necessary for implementation of successful anti-cancer therapies. microRNAs (miRNAs) are important regulators of gene expression in eukaryotic cells but evidence of their role in telomerase regulation has not been documented. To determine whether hTERT activity is regulated by multiple miRNAs, eight miRNAs which have putative binding sites in the hTERT 3'UTR together with miR-138-5p were evaluated in luciferase assays with a reporter containing the hTERT 3'UTR. Six miRNAs (let-7g*, miR-133a, miR-138-5p, miR-342-5p, miR-491-5p, and miR-541-3p) specifically inhibited the expression of the reporter luciferase-driven constructs and let-7g*, miR-133a, miR-138-5p, and miR-491-5p also downregulated endogenous telomerase activity in cells. Moreover, all six miRNAs significantly inhibited cell proliferation. miRNAs (miR-133a, miR-138-5p, 342-5p, 491-5p, 541-3p) also have predicted binding sites within the 3'UTR of three genes involved in Wnt signaling (TCF7, MSI1, and PAX5). These miRNAs inhibited the expression of the luciferase reporter constructs containing 3'UTRs of these genes and downregulated protein expression of the TCF7 transcription factor, which mediates the canonical Wnt pathway. Together, these results suggest the existence of a miRNA regulatory network involving the hTERT and Wnt pathway.	[Bose, Henry R., Jr.] Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Bose, HR (corresponding author), Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA.	bose@mail.utexas.edu			Public Health Service from the National Cancer Institute [CA33192, CA098151]; NATIONAL CANCER INSTITUTE [R01CA033192, R01CA098151] Funding Source: NIH RePORTER	Public Health Service from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Public Health Service grants CA33192 and CA098151 from the National Cancer Institute (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AceView, 2010, ACEVIEW HOM SAP COMP; Akasaka Y, 2005, HISTOPATHOLOGY, V47, P348, DOI 10.1111/j.1365-2559.2005.02223.x; Ballabio E, 2010, BLOOD, V116, P1105, DOI 10.1182/blood-2009-12-256719; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Blackburn EH, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003558; Boelz S, 2006, BIOCHEM BIOPH RES CO, V349, P186, DOI 10.1016/j.bbrc.2006.08.017; Bollmann FM, 2008, BIOESSAYS, V30, P728, DOI 10.1002/bies.20793; Bougel S, 2010, J PATHOL, V220, P87, DOI 10.1002/path.2620; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bueno MJ, 2011, BLOOD, V117, P6255, DOI 10.1182/blood-2010-10-315432; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dacic S, 2010, MODERN PATHOL, V23, P1577, DOI 10.1038/modpathol.2010.152; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Devor EJ, 2011, P OBSTET GYNECOL, P2; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YJ, 2011, INT J CANCER, V129, P1541, DOI 10.1002/ijc.26102; Grossmann TN, 2012, P NATL ACAD SCI USA, V109, P17942, DOI 10.1073/pnas.1208396109; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jain K.K, 2010, HDB BIOMARKERS; Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320; Jin ZX, 2002, J IMMUNOL, V169, P3783, DOI 10.4049/jimmunol.169.7.3783; Katzenellenbogen RA, 2009, J VIROL, V83, P6446, DOI 10.1128/JVI.02556-08; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P94, DOI 10.1016/j.mrgentox.2010.05.006; Koziel JE, 2011, J CELL MOL MED, V15, P457, DOI 10.1111/j.1582-4934.2011.01276.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Luu HH, 2004, CURR CANCER DRUG TAR, V4, P653, DOI 10.2174/1568009043332709; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mao CD, 2011, CRIT REV EUKAR GENE, V21, P207, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.10; McClure LV, 2011, METHODS MOL BIOL, V725, P173, DOI 10.1007/978-1-61779-046-1_12; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Seto AG, 2010, INT J BIOCHEM CELL B, V42, P1298, DOI 10.1016/j.biocel.2010.03.003; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Singh MK, 2010, EPIGENETIC MECH LUNG; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; TIBBETTS LM, 1977, CANCER, V40, P2651, DOI 10.1002/1097-0142(197711)40:5+<2651::AID-CNCR2820400939>3.0.CO;2-V; Tombol Z, 2010, MODERN PATHOL, V23, P1583, DOI 10.1038/modpathol.2010.164; Ulaner GA, 1998, CANCER RES, V58, P4168; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vo DT, 2011, RNA BIOL, V8, P817, DOI 10.4161/rna.8.5.16041; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wang S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.79; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wang YM, 2011, MOL CANCER RES, V9, P1100, DOI 10.1158/1541-7786.MCR-11-0007; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; Wojtyla A, 2011, MOL BIOL REP, V38, P3339, DOI 10.1007/s11033-010-0439-x; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xu D, 1999, BRIT J CANCER, V80, P1156, DOI 10.1038/sj.bjc.6690480; Xu WY, 2013, INT J ONCOL, V42, P757, DOI 10.3892/ijo.2012.1742; Yan W, 2011, BRAIN RES, V1411, P108, DOI 10.1016/j.brainres.2011.07.002; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu JY, 2010, PROTEIN CELL, V1, P22, DOI 10.1007/s13238-010-0014-1	90	45	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e86990	10.1371/journal.pone.0086990	http://dx.doi.org/10.1371/journal.pone.0086990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551047	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500012
J	Song, YL				Song, Yinglei			A New Parameterized Algorithm for Rapid Peptide Sequencing	PLOS ONE			English	Article							DATABASE SEARCH; IDENTIFICATION	De novo sequencing is an important computational approach to determining the amino acid sequence of a peptide with tandem mass spectrometry (MS/MS). Most of the existing approaches use a graph model to describe a spectrum and the sequencing is performed by computing the longest antisymmetric path in the graph. The task is often computationally intensive since a given MS/MS spectrum often contains noisy data, missing mass peaks, or post translational modifications/mutations. This paper develops a new parameterized algorithm that can efficiently compute the longest antisymmetric partial path in an extended spectrum graph that is of bounded path width. Our testing results show that this algorithm can efficiently process experimental spectra and provide sequencing results of high accuracy.	Jiangsu Univ Sci & Technol, Sch Comp Sci & Engn, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology	Song, YL (corresponding author), Jiangsu Univ Sci & Technol, Sch Comp Sci & Engn, Zhenjiang, Jiangsu, Peoples R China.	yingleisong@gmail.com			new faculty start-up funding at Jiangsu University of Science and Technology, China;  [635301202]	new faculty start-up funding at Jiangsu University of Science and Technology, China; 	This work is fully supported by the new faculty start-up funding at Jiangsu University of Science and Technology, China. The funding number is 635301202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNBORG S, 1989, DISCRETE APPL MATH, V23, P11, DOI 10.1016/0166-218X(89)90031-0; BARTELS C, 1990, BIOMED ENVIRON MASS, V19, P363, DOI 10.1002/bms.1200190607; BIEMANN K, 1987, SCIENCE, V237, P992, DOI 10.1126/science.3303336; Bodlaender HL, 2004, P 6 WORKSH ALG ENG E, P70; Chen T, 2001, J COMPUT BIOL, V8, P325, DOI 10.1089/10665270152530872; Cormen Thomas H., 2009, INTRO ALGORITHMS; Dancik V, 1999, J COMPUT BIOL, V6, P327, DOI 10.1089/106652799318300; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FERNANDEZDECOSSIO J, 1995, COMPUT APPL BIOSCI, V11, P427; Fischer B, 2005, ANAL CHEM, V77, P7265, DOI 10.1021/ac0508853; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Frank A, 2005, J PROTEOME RES, V4, P1287, DOI 10.1021/pr050011x; HINES WM, 1992, J AM SOC MASS SPECTR, V3, P326, DOI 10.1016/1044-0305(92)87060-C; Jones P, 2006, NUCLEIC ACIDS RES, V34, pD659, DOI 10.1093/nar/gkj138; Liu Chunmei, 2006, Pac Symp Biocomput, P255, DOI 10.1142/9789812701626_0024; Liu C, 2006, BIOINFORMATICS, V22, pE307, DOI 10.1093/bioinformatics/btl226; Liu CM, 2011, J COMB OPTIM, V22, P684, DOI 10.1007/s10878-010-9317-7; Liu CM, 2009, J COMB OPTIM, V18, P87, DOI 10.1007/s10878-008-9141-5; Pevzner P. A., 2000, RECOMB 2000. Proceedings of the Fourth Annual International Conference on Computational Molecular Biology, P231, DOI 10.1145/332306.332560; Pevzner PA, 2001, GENOME RES, V11, P290, DOI 10.1101/gr.154101; ROBERTSON N, 1986, J ALGORITHM, V7, P309, DOI 10.1016/0196-6774(86)90023-4; SAKURAI T, 1984, BIOMED MASS SPECTROM, V11, P396, DOI 10.1002/bms.1200110806; SIEGEL MM, 1988, BIOMED ENVIRON MASS, V15, P333, DOI 10.1002/bms.1200150606; Song YL, 2006, LECT NOTES COMPUT SC, V4175, P68; Song YL, 2006, IEEE ACM T COMPUT BI, V3, P423, DOI 10.1109/TCBB.2006.52; Song YL, 2005, 2005 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P223; Taylor JA, 1997, RAPID COMMUN MASS SP, V11, P1067, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1067::AID-RCM953>3.0.CO;2-L; Yan B, 2005, BIOINFORMATICS, V21, P563, DOI 10.1093/bioinformatics/bti044; Yates J.R., 1991, TECHN PROT CHEM 2, VII, P477; ZIDAROV D, 1990, BIOMED ENVIRON MASS, V19, P13, DOI 10.1002/bms.1200190103	30	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87476	10.1371/journal.pone.0087476	http://dx.doi.org/10.1371/journal.pone.0087476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551059	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500018
J	Yamahara, K; Harada, K; Ohshima, M; Ishikane, S; Ohnishi, S; Tsuda, H; Otani, K; Taguchi, A; Soma, T; Ogawa, H; Katsuragi, S; Yoshimatsu, J; Harada-Shiba, M; Kangawa, K; Ikeda, T				Yamahara, Kenichi; Harada, Kazuhiko; Ohshima, Makiko; Ishikane, Shin; Ohnishi, Shunsuke; Tsuda, Hidetoshi; Otani, Kentaro; Taguchi, Akihiko; Soma, Toshihiro; Ogawa, Hiroyasu; Katsuragi, Shinji; Yoshimatsu, Jun; Harada-Shiba, Mariko; Kangawa, Kenji; Ikeda, Tomoaki			Comparison of Angiogenic, Cytoprotective, and Immunosuppressive Properties of Human Amnion- and Chorion-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							STROMAL CELLS; TRANSPLANTATION; RESPONSES; ISCHEMIA; PLACENTA; MARROW; REPAIR	Although mesenchymal stem cells (MSCs) can be obtained from the fetal membrane (FM), little information is available regarding biological differences in MSCs derived from different layers of the FM or their therapeutic potential. Isolated MSCs from both amnion and chorion layers of FM showed similar morphological appearance, multipotency, and cell-surface antigen expression. Conditioned media obtained from amnion-and chorion-derived MSCs inhibited cell death caused by serum starvation or hypoxia in endothelial cells and cardiomyocytes. Amnion and chorion MSCs secreted significant amounts of angiogenic factors including HGF, IGF-1, VEGF, and bFGF, although differences in the cellular expression profile of these soluble factors were observed. Transplantation of human amnion or chorion MSCs significantly increased blood flow and capillary density in a murine hindlimb ischemia model. In addition, compared to human chorion MSCs, human amnion MSCs markedly reduced T-lymphocyte proliferation with the enhanced secretion of PGE2, and improved the pathological situation of a mouse model of acute graft-versus-host disease. Our results highlight that human amnion-and chorion-derived MSCs, which showed differences in their soluble factor secretion and angiogenic/immuno-suppressive function, could be ideal cell sources for regenerative medicine.	[Yamahara, Kenichi; Ohshima, Makiko; Tsuda, Hidetoshi; Otani, Kentaro; Harada-Shiba, Mariko; Ikeda, Tomoaki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan; [Harada, Kazuhiko; Ishikane, Shin; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, Suita, Osaka, Japan; [Ohnishi, Shunsuke] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Taguchi, Akihiko] Inst Biomed Res & Innovat, Dept Regenerat Med Res, Kobe, Hyogo, Japan; [Soma, Toshihiro; Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan; [Katsuragi, Shinji; Yoshimatsu, Jun; Ikeda, Tomoaki] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol, Suita, Osaka, Japan; [Harada-Shiba, Mariko] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Innovat Lipidol, Suita, Osaka, Japan; [Ikeda, Tomoaki] Mie Univ, Sch Med, Dept Obstet & Gynecol, Tsu, Mie 514, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Hokkaido University; Institute for Biomedical Research & Innovation (IBRI); Hyogo College of Medicine; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Mie University	Yamahara, K (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan.	yamahara@ncvc.go.jp	Yoshimatsu, Jun/AAE-9474-2022; Yoshimatsu, Jun/AFD-9150-2022; Ohnishi, Shunsuke/A-5982-2012	Ohnishi, Shunsuke/0000-0003-1194-4149; Otani, Kentaro/0000-0001-7607-8056	Japan Society for the Promotion of Science; Health Labour Sciences Research Grant/Research grants for Cardiovascular Disease, The Ministry of Health Labour and Welfare	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labour Sciences Research Grant/Research grants for Cardiovascular Disease, The Ministry of Health Labour and Welfare	This study was supported by a Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, and Health Labour Sciences Research Grant/Research grants for Cardiovascular Disease, The Ministry of Health Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Ishikane S, 2013, TRANSPLANTATION; Ishikane S, 2008, STEM CELLS, V26, P2625, DOI 10.1634/stemcells.2008-0236; Ishikane S, 2010, J MOL CELL CARDIOL, V49, P753, DOI 10.1016/j.yjmcc.2010.07.019; Kikuchi-Taura A, 2012, CYTOTHERAPY, V14, P441, DOI 10.3109/14653249.2012.658911; Kim SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041105; Lee JM, 2012, INT IMMUNOPHARMACOL, V13, P219, DOI 10.1016/j.intimp.2012.03.024; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; NAKAGAWA O, 1995, J CLIN INVEST, V96, P1280, DOI 10.1172/JCI118162; Ohshima M, 2012, J MOL CELL CARDIOL, V53, P420, DOI 10.1016/j.yjmcc.2012.06.020; Pan HC, 2006, J CLIN NEUROSCI, V13, P570, DOI 10.1016/j.jocn.2005.06.007; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rossi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046956; Tsuda H, 2013, CELL TRANSPLANT; Tsuda H, 2010, AM J PHYSIOL-RENAL, V299, pF1004, DOI 10.1152/ajprenal.00587.2009; Wei JP, 2003, CELL TRANSPLANT, V12, P545, DOI 10.3727/000000003108747000; Yamahara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001666; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	22	71	72	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88319	10.1371/journal.pone.0088319	http://dx.doi.org/10.1371/journal.pone.0088319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551087	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500034
J	Yang, X; Yang, J; Chu, YW; Xue, Y; Xuan, DD; Zheng, SC; Zou, HJ				Yang, Xue; Yang, Ji; Chu, Yiwei; Xue, Yu; Xuan, Dandan; Zheng, Shucong; Zou, Hejian			T Follicular Helper Cells and Regulatory B Cells Dynamics in Systemic Lupus Erythematosus	PLOS ONE			English	Article							B10 CELLS; IMMUNE-RESPONSES; MURINE LUPUS; IL-10; INTERLEUKIN-21; AUTOIMMUNITY; RECEPTOR; SUBSET; IL-21; DIFFERENTIATION	T follicular helper (Tfh) cells aid effector B cells, and augment autoimmunity, whereas the role of Tfh cells on regulatory B (Breg) cells in systemic lupus erythematosus (SLE) is not known. The aim of this study is to investigate the percentage of Breg cells in SLE, and the role of Tfh cells on Breg cells. First, we demonstrated the presence of Breg cells in SLE peripheral blood mononuclear cells and in involved skins. Both the percentage of circulating Breg cells and the ability to produce interleukin-10 (IL-10) were elevated in SLE patients. The percentage of Breg cells increased during SLE flares and decreased following disease remission. Second, Tfh cell expansion was not only related to autoantibody production but also correlated with the increased percentage of Breg cells. Third, in vitro studies revealed that Tfh cell-derived IL-21 could promote IL-10 production and Breg cell differentiation. In conclusions, these data imply that SLE flares may be linked to the expansion of Tfh cells and that Breg cells are increased in a regulatory feedback manner. Thus, SLE development may be associated with the complex regulation of Tfh cells and diverse B cell subsets.	[Yang, Xue; Xue, Yu; Xuan, Dandan; Zheng, Shucong; Zou, Hejian] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China; [Yang, Xue; Xue, Yu; Xuan, Dandan; Zheng, Shucong; Zou, Hejian] Fudan Univ, Inst Rheumatol Immunol & Allergy, Shanghai 200433, Peoples R China; [Yang, Xue; Xue, Yu; Xuan, Dandan; Zheng, Shucong; Zou, Hejian] Fudan Univ, Huashan Hosp, Inst Mol & Translat Med, Shanghai 200433, Peoples R China; [Yang, Ji] Fudan Univ, Zhongshan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Chu, Yiwei] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Zou, HJ (corresponding author), Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China.	hejianzou@gmail.com			National Natural Science Foundation of China [81373213, 81072463, 81000693]; Program of Shanghai Subject Chief Scientist [11XD1401100]; Medical Guide Project from Shanghai Science and Technology Committee [134119a8400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Medical Guide Project from Shanghai Science and Technology Committee	This work was supported by grants from National Natural Science Foundation of China (No. 81373213, 81072463, 81000693), Program of Shanghai Subject Chief Scientist (No. 11XD1401100), and Medical Guide Project from Shanghai Science and Technology Committee (No. 134119a8400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Dong WJ, 2011, AUTOIMMUN REV, V10, P299, DOI 10.1016/j.autrev.2010.11.004; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kashipaz MRA, 2003, LUPUS, V12, P356, DOI 10.1191/0961203303lu338oa; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Lee JH, 2011, YONSEI MED J, V52, P851, DOI 10.3349/ymj.2011.52.5.851; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Sun F, 2013, MUSCLE NERVE; van der Vlugt LEPM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030883; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Wong CK, 2010, J CLIN IMMUNOL, V30, P45, DOI 10.1007/s10875-009-9325-5; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang J, 2011, RHEUMATOLOGY, V50, P1366, DOI 10.1093/rheumatology/ker116; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Yang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062855; Yin ZN, 2002, J IMMUNOL, V169, P2148, DOI 10.4049/jimmunol.169.4.2148; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Yu B, 2011, ARTHRITIS RHEUM-US, V63, P3487, DOI 10.1002/art.30595; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	38	71	82	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88441	10.1371/journal.pone.0088441	http://dx.doi.org/10.1371/journal.pone.0088441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551101	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500038
J	Janssen, PML; Murray, JD; Schill, KE; Rastogi, N; Schultz, EJ; Tran, T; Raman, SV; Rafael-Fortney, JA				Janssen, Paul M. L.; Murray, Jason D.; Schill, Kevin E.; Rastogi, Neha; Schultz, Eric J.; Tran, Tam; Raman, Subha V.; Rafael-Fortney, Jill A.			Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							6-MINUTE WALK TEST; MUSCLE; FIBROSIS; GENE	Duchenne muscular dystrophy (DMD) is an inherited disease that causes striated muscle weakness. Recently, we showed therapeutic effects of the combination of lisinopril (L), an angiotensin converting enzyme (ACE) inhibitor, and spironolactone (S), an aldosterone antagonist, in mice lacking dystrophin and haploinsufficient for utrophin (utrn(+/-); mdx, het mice); both cardiac and skeletal muscle function and histology were improved when these mice were treated early with LS. It was unknown to what extent LS treatment is effective in the most commonly used DMD murine model, the mdx mouse. In addition, current standard-of-care treatment for DMD is limited to corticosteroids. Therefore, potentially useful alternative or additive drugs need to be both compared directly to corticosteroids and tested in presence of corticosteroids. We evaluated the effectiveness of this LS combination in the mdx mouse model both compared with corticosteroid treatment (prednisolone, P) or in combination (LSP). We tested the additional combinatorial treatment containing the angiotensin II receptor blocker losartan (T), which is widely used to halt and treat the developing cardiac dysfunction in DMD patients as an alternative to an ACE inhibitor. Peak myocardial strain rate, assessed by magnetic resonance imaging, showed a negative impact of P, whereas in both diaphragm and extensor digitorum longus (EDL) muscle contractile function was not significantly impaired by P. Histologically, P generally increased cardiac damage, estimated by percentage area infiltrated by IgG as well as by collagen staining. In general, groups that only differed in the presence or absence of P (i. e. mdx vs. P, LS vs. LSP, and TS vs. TSP) demonstrated a significant detrimental impact of P on many assessed parameters, with the most profound impact on cardiac pathology.	[Janssen, Paul M. L.; Murray, Jason D.; Rastogi, Neha] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Schill, Kevin E.; Schultz, Eric J.; Rafael-Fortney, Jill A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Tran, Tam; Raman, Subha V.] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA; [Janssen, Paul M. L.; Raman, Subha V.; Rafael-Fortney, Jill A.] Ohio State Univ, Dorothy M Davis Heart & Lung Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Janssen, PML (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	janssen.10@osu.edu; rafael-fortney.1@osu.edu		Janssen, Paul/0000-0002-9682-3014	CureDuchenne; NIH/NINDS [P30 NS045758]; NIH [R01 NS082868]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758, R01NS082868] Funding Source: NIH RePORTER	CureDuchenne; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank CureDuchenne, and the NIH/NINDS P30 NS045758 Core (PI: Dr. Christine Beattie) grant for the majority of funding for this study, and NIH R01 NS082868 for partial funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Beastrom N, 2011, AM J PATHOL; Bish LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020856; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; De Luca Annamaria, 2012, Acta Myol, V31, P40; FENICHEL GM, 1991, NEUROLOGY, V41, P1874, DOI 10.1212/WNL.41.12.1874; Goyenvalle A, 2011, HUM MOL GENET, V20, pR69, DOI 10.1093/hmg/ddr105; Guerron AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011220; Hagenbuch SC, 2010, AM J CARDIOL, V105, P1451, DOI 10.1016/j.amjcard.2009.12.070; Henricson E, 2013, PLOS CURR, V5; Janssen PML, 2005, AM J PHYSIOL-HEART C, V289, pH2373, DOI 10.1152/ajpheart.00448.2005; Machado Darlene L, 2012, BMC Res Notes, V5, P435, DOI 10.1186/1756-0500-5-435; Martin PT, 2009, AM J PHYSIOL-CELL PH, V296, pC476, DOI 10.1152/ajpcell.00456.2008; Mazzone E, 2010, NEUROMUSCULAR DISORD, V20, P712, DOI 10.1016/j.nmd.2010.06.014; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; McMurray JJV, 2004, CIRCULATION, V110, P3281, DOI 10.1161/01.CIR.0000147274.83071.68; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Merlini L, 2012, MUSCLE NERVE, V45, P796, DOI 10.1002/mus.23272; Muntoni F, 2003, CURR OPIN NEUROL, V16, P577, DOI 10.1097/00019052-200310000-00003; Murray JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00422; Payne JR, 2004, HEART, V90, P473, DOI 10.1136/hrt.2003.025783; Peterson JM, 2011, MOL MED, V17, P508, DOI 10.2119/molmed.2010.00263; Rafael-Fortney JA, 2011, CIRCULATION, V124, P582, DOI 10.1161/CIRCULATIONAHA.111.031716; Rodino-Klapac LR, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-45; Sali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034204; SANYAL SK, 1978, CIRCULATION, V57, P1122, DOI 10.1161/01.CIR.57.6.1122; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; van der Hooft CS, 2006, ARCH INTERN MED, V166, P1016, DOI 10.1001/archinte.166.9.1016; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	33	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88360	10.1371/journal.pone.0088360	http://dx.doi.org/10.1371/journal.pone.0088360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551095	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000033
J	Liu, Y; Ding, Y; Huang, J; Wang, S; Ni, W; Guan, J; Li, QS; Zhang, YQ; Ding, YQ; Chen, B; Chen, LH				Liu, Ying; Ding, Yi; Huang, Jing; Wang, Shuang; Ni, Wen; Guan, Jian; Li, Qisheng; Zhang, Yuqin; Ding, Yanqing; Chen, Bin; Chen, Longhua			MiR-141 Suppresses the Migration and Invasion of HCC Cells by Targeting Tiam1	PLOS ONE			English	Article							T-LYMPHOMA INVASION; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; DOWN-REGULATION; CANCER; OVEREXPRESSION; SURVIVAL; MICRORNA-141; METASTASIS; PROGNOSIS	Background: We have demonstrated that T lymphoma invasion and metastasis 1 (Tiam1) gene is associated with the poor prognosis of patients with hepatocellular carcinoma (HCC), and we used a computational approach to identify miR-141 as a Tiam1-targeting microRNA (miRNA). Here, we explored the function of miR-141 and the relationship between miR-141 and Tiam1 gene in HCC. Methods: The miR-141 expression in HCC tissues and cell lines was detected and its roles in regulation of HCC cell proliferation, migration and invasion and target gene expression was investigated. Tiam1 was identified as a novel target of miR-141. Ethics statement: our study was approved by the Nanfang Hospital Medical Ethics Committee Ethics statement. Written informed consent was obtained before collection. Results: Based on in situ hybridization (ISH) analysis, miR-141 was down-regulated in the same HCC samples. Kaplan-Meier analysis demonstrated that patients with low miR-141 expression had poorer overall survival rate than that of the patients with high miR-141 expression. Furthermore, multivariate Cox regression analysis indicated that miR-141 could serve as an independent prognostic factor in HCC. MiR-141 significantly inhibited in vitro cell proliferation, migration and invasion as proved by gain-and loss-of function studies, while the mRNA and protein levels of Tiam1 were reduced in cells overe-xpressing miR-141. Moreover, Tiam1 treatment antagonized this effect, while knockdown of Tiam1 by Tiam1 short hairpin RNA (shTiam1) induced inhibitory effects. Conclusions: These findings indicated that miR-141 functions as a tumor suppressor and inhibits the migration and invasion of HCC cells by targeting Tiam1, which may provide novel prognostic and treatment strategies for HCC patients.	[Liu, Ying; Ding, Yi; Ni, Wen; Guan, Jian; Li, Qisheng; Zhang, Yuqin; Chen, Longhua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Chen, Bin] Southern Med Univ, Gen Hosp Guangzhou Mil Command PLA, Guangzhou, Guangdong, Peoples R China; [Wang, Shuang; Ding, Yanqing] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Huang, Jing] Affiliated Hosp, Guangdong Med Coll, Dept Canc Ctr, Zhanjiang, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Theater Command General Hospital; Southern Medical University - China; Guangdong Medical University	Chen, B (corresponding author), Southern Med Univ, Gen Hosp Guangzhou Mil Command PLA, Guangzhou, Guangdong, Peoples R China.	binchengzzyy@126.com; chenlhsmu@126.com	Ding, Yi/CAG-6304-2022	Ding, Yi/0000-0001-5035-9255	National Natural Science Foundation of China (NSFC) [81101822, 81272507]; Guangzhou Science and Technology Key Project [11C26090521]; Natural Science Foundation of Guangdong Province, China [S2013010014185]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Key Project; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (NSFC) (Grant Nos. 81101822 and 81272507) and Guangzhou Science and Technology Key Project (No. 11C26090521) and Natural Science Foundation of Guangdong Province, China (Grant No. S2013010014185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Barshack I, 2010, INT J BIOCHEM CELL B, V42, P1355, DOI 10.1016/j.biocel.2009.02.021; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Ding Y, 2009, INT J CANCER, V124, P653, DOI 10.1002/ijc.23954; Du Y, 2009, J GASTROENTEROL, V44, P556, DOI 10.1007/s00535-009-0037-7; Engers R, 2006, BRIT J CANCER, V95, P1081, DOI 10.1038/sj.bjc.6603385; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hou M, 2004, ACTA BIOCH BIOPH SIN, V36, P537, DOI 10.1093/abbs/36.8.537; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034165; Huang J, 2013, INT J CANCER, V132, P90, DOI 10.1002/ijc.27627; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jin H, 2011, HUM PATHOL, V42, P541, DOI 10.1016/j.humpath.2010.08.013; JING YK, 1994, JPN J CANCER RES, V85, P645, DOI 10.1111/j.1349-7006.1994.tb02408.x; Kim DY, 2007, ONCOLOGY-BASEL, V72, P52, DOI 10.1159/000111707; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Liu L, 2005, WORLD J GASTROENTERO, V11, P705, DOI 10.3748/wjg.v11.i5.705; Liu YF, 2013, STAT INTERFACE, V6, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mazzanti R, 2008, MOL ASPECTS MED, V29, P130, DOI 10.1016/j.mam.2007.09.008; Milazzo M, 2011, Minerva Gastroenterol Dietol, V57, P257; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Ng KK, 2008, ARCH SURG-CHICAGO, V143, P68, DOI 10.1001/archsurg.2007.15; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Olsen Sonja K, 2010, Therap Adv Gastroenterol, V3, P55, DOI 10.1177/1756283X09346669; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Stebel A, 2009, ONCOL REP, V21, P217, DOI 10.3892/or_00000211; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Yu XY, 2013, ONCOTARGETS THER, V6, P349, DOI 10.2147/OTT.S41343; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhao LA, 2011, J CANCER RES CLIN, V137, P393, DOI 10.1007/s00432-010-0895-7	39	46	50	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88393	10.1371/journal.pone.0088393	http://dx.doi.org/10.1371/journal.pone.0088393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551096	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000034
J	Mishra, SR; Joshi, MP; Khanal, V				Mishra, Shiva Raj; Joshi, Mahesh Prasad; Khanal, Vishnu			Family Planning Knowledge and Practice among People Living with HIV in Nepal	PLOS ONE			English	Article							HARD-TO-REACH; CONTRACEPTIVE USE; POSITIVE MEN; UNSAFE SEX; INTENTIONS; FERTILITY; PREGNANCY; SUPERINFECTION; PREVALENCE; PREVENTION	Unsafe sexual behavior is common among the HIV infected. This exposes them to the risks of unintended pregnancy, HIV transmission to uninfected partners and super-infection. Studies on the use of family planning measures among People Living with HIV (PLHIV) are scarce in Nepal. The aim of this study was to explore the knowledge and practice of family planning (FP) in PLHIV. A cross sectional survey was conducted during July-December 2012 in Kaski district of Nepal. A total of 120 PLHIVs were recruited using snowball sampling from three HIV clinics within the Pokhara sub-metropolitan city area. This study found that nine in ten PLHIV had heard about family planning. Two thirds of respondents were using at least one FP method. The majority (65.8%) used condoms and had received FP counseling (67.5%). Less than one percent used condoms in addition to another contraceptive. Being single, being female and having received the counselling sessions were associated with the use of FP. The individuals who received FP counseling were more likely [OR 4.522; 95% CI (1.410-14.504)] to use FP. Females were more likely [OR 4.808; 95% CI (1.396-16.556)] to use FP than males. The individuals who were single/de-facto widowed were more likely [OR 7.330; 95% CI (2.064-26.028)] to use FP than the married individuals. Our findings suggest that there is a need to focus on FP counseling if the HIV prevention program is to increase FP use among the PLHIV population. Use of dual contraceptives need to be promoted through counseling sessions and other health promotion programs focusing in HIV prevention.	[Mishra, Shiva Raj] Inst Med, Kathmandu, Nepal; [Joshi, Mahesh Prasad] Naulo Ghumti Nepal, Kaski, Nepal; [Khanal, Vishnu] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia	Curtin University	Mishra, SR (corresponding author), Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal.	shivarajmishra@gmail.com	Khanal, Vishnu/AAE-5948-2020; Mishra, Shiva Raj/C-4172-2014	Mishra, Shiva Raj/0000-0002-2993-3504; Khanal, Vishnu/0000-0002-3863-9913				[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Boler T, 2006, SOUND SILENCE DIFFIC; Botnick MR, 2000, J HOMOSEXUAL, V38, P77, DOI 10.1300/J082v38n04_04; Bouhnik AD, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000255086.54599.23; Cates W, 2002, SEX TRANSM DIS, V29, P168, DOI 10.1097/00007435-200203000-00007; Central Bureau of Statistics (CBS), 2011, AR POP; Ceylan A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-20; Chakrapani V, 2011, INFECT DIS OBSTET GY, V2011; Chakrapani V, 2010, AIDS PATIENT CARE ST, V24, P49, DOI 10.1089/apc.2009.0214; Day J., 2012, SAIL WORLD AUSTR FIS; Dia A, 2010, SEX TRANSM INFECT, V86, P148, DOI 10.1136/sti.2008.035147; District AIDS Coordination Committee (DACC), 2011, GLIMPS KASK DISTR DA; DoHS, 2010, ANN REPORT; Elul B, 2009, AIDS, V23, pS19, DOI 10.1097/01.aids.0000363774.91376.dc; Family Health International (FHI), 2010, 5 COUNTR STUD FAM PL; Family Health International (FHI), 2010, PREV MOTH TO CHILD H; Family Planning Association of Nepal (FPAN), 2011, PEOPL LIV HIV STIGM; Hailemariam TG, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-900; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Jha SM, 2009, KNOWLEDGE CONDOMS AD; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, REP GLOB AIDS EP; Josheph EJ, 2010, UTILIZATION FAMILY P; Kalichman SC, 2007, SEX TRANSM INFECT, V83, P371, DOI 10.1136/sti.2006.023630; Khanal V, 2013, J COMMUNITY HLTH; Khanal V, 2013, BREASTFEED MED; Loubiere S, 2009, SOC SCI MED, V69, P885, DOI 10.1016/j.socscimed.2009.05.044; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; MARSTON C, 2004, EFFECTS CONTRACEPTIO; Ministry of Health & Population NE ICF Macro USAID, 2006, NEP DEM HLTH SURV 20; Ministry of Health & Population NE ICF Macro USAID, 2012, NEP DEM HLTH SURV 20; Mishra SR, 2013, OPPORTUNITIES INTEGR; National Centre for AIDS and STD Control (NCASC), 2003, NAT GUID VOL HIV AID; Nattabi Barbara, 2011, Confl Health, V5, P18, DOI 10.1186/1752-1505-5-18; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Neupane D, 2012, J Nepal Health Res Counc, V10, P136; Peipert JF, 2011, CONTRACEPTION, V84, P252, DOI 10.1016/j.contraception.2011.01.023; Pokharel S, 2006, REPROD HEALTH MATTER, V14, P156, DOI 10.1016/S0968-8080(06)28255-7; Poudel KC, 2011, J HEALTH POPUL NUTR, V29, P191, DOI 10.3329/jhpn.v29i3.7866; Poudel KC, 2009, AIDS BEHAV, V13, P1143, DOI 10.1007/s10461-008-9454-5; Sadler GR, 2010, NURS HEALTH SCI, V12, P369, DOI 10.1111/j.1442-2018.2010.00541.x; Shrestha D R, 2012, J Nepal Health Res Counc, V10, P108; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Soto Mas F, 1997, Rev Esp Salud Publica, V71, P335; US Food and Administration (FDA), COND COULD SAV YOUR; USAID Acquire Project, 2008, COUNS EFF US FAM PLA; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; WHO Medica Center, 2009, COND HIV PREV; WHO UNFPA, 2006, GLION CONS STRENGTH; Zodpey S P, 2004, Indian J Dermatol Venereol Leprol, V70, P123	50	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88663	10.1371/journal.pone.0088663	http://dx.doi.org/10.1371/journal.pone.0088663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551132	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000052
J	Su, HM; Lin, TH; Hsu, PC; Lee, WH; Chu, CY; Chen, SC; Lee, CS; Voon, WC; Lai, WT; Sheu, SH				Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Lee, Wen-Hsien; Chu, Chun-Yuan; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Association of Bilateral Brachial-Ankle Pulse Wave Velocity Difference with Peripheral Vascular Disease and Left Ventricular Mass Index	PLOS ONE			English	Article							BLOOD-PRESSURE DIFFERENCE; REGIONAL ARTERIAL STIFFNESS; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; CARDIOVASCULAR MORTALITY; HYPERTENSIVE PATIENTS; HEMODIALYSIS-PATIENTS; DIABETES-MELLITUS; AORTIC STIFFNESS; HYPERTROPHY	Unequal arterial stiffness had been associated with cardiovascular risks. We investigated whether an association existed between unequal arterial stiffness indicated by bilateral brachial-ankle pulse wave velocity (baPWV) difference and anklebrachial index (ABI), baPWV, echocardiographic parameters and interarm and interankle systolic blood pressure (BP) differences. A total of 1111 patients referred for echocardiographic examination were included in this study. The BPs, ABI and baPWV were measured simultaneously by an ABI-form device. The Delta baPWV was defined as absolute value of difference between bilateral baPWV. We performed three multivariate analyses for determining the factors associated with a Delta baPWV >= 185 cm/s (90 percentile of Delta baPWV) (model 1: significant variables in univariate analysis and ABI <0.9 and baPWV; model 2: significant variables in univariate analysis and left ventricular mass index [LVMI]; model 3: significant variables in univariate analysis and interankle systolic BP difference >= 15 mmHg). The ABI <0.9 and high baPWV (both P<0.001) in model 1, high LVMI (P = 0.021) in model 2 and an interankle systolic BP difference >= 15 mmHg (P = 0.026) in model 3 were associated with a Delta baPWV >= 185 cm/s, but the interarm systolic BP difference >= 10 mmHg was not (P = NS). Our study demonstrated ABI, 0.9, high baPWV, high LVMI and an interankle systolic BP difference >= 15 mmHg were associated with unequal arterial stiffness.	[Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Lee, Wen-Hsien; Chu, Chun-Yuan; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming; Lee, Wen-Hsien; Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, SC (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	蘇, 河名/AAE-9843-2019	Lin, Tsung-Hsien/0000-0002-7226-8730; Chu, Chun-Yuan/0000-0001-5550-102X; Su, Ho-Ming/0000-0003-0247-3250	Kaohsiung Municipal Hsiao-Kang Hospital [kmhk-101-019]; Kaohsiung Medical University, Kaohsiung	Kaohsiung Municipal Hsiao-Kang Hospital; Kaohsiung Medical University, Kaohsiung	The research presented in this article is supported by the grant from Kaohsiung Municipal Hsiao-Kang Hospital (kmhk-101-019), Kaohsiung Medical University, Kaohsiung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2007, J AM COLL CARDIOL, V49, P1540, DOI 10.1016/j.jacc.2006.09.055; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; Bosevski M, 2013, ANGIOLOGY, V64, P64, DOI 10.1177/0003319711435936; Bossuyt J, 2013, J HYPERTENS, V31, P946, DOI 10.1097/HJH.0b013e328360275d; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Chen SC, 2012, CLIN J AM SOC NEPHRO, V7, P1646, DOI 10.2215/CJN.04570512; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Chung CM, 2012, AM J MED SCI, V344, P190, DOI 10.1097/MAJ.0b013e318242a354; Clark CE, 2007, J HUM HYPERTENS, V21, P633, DOI 10.1038/sj.jhh.1002209; Clark CE, 2006, J HUM HYPERTENS, V20, P923, DOI 10.1038/sj.jhh.1002093; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; Clark CE, 2009, BRIT J GEN PRACT, V59, P428, DOI 10.3399/bjgp09X420752; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Dellegrottaglie S, 2011, NEPHROL DIAL TRANSPL, V26, P2891, DOI 10.1093/ndt/gfr186; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; FISHBANE S, 1995, AM J KIDNEY DIS, V25, P34, DOI 10.1016/0272-6386(95)90622-3; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Hatsuda S, 2006, J ATHEROSCLER THROMB, V13, P114, DOI 10.5551/jat.13.114; KELLY R, 1989, CIRCULATION, V80, P1652, DOI 10.1161/01.CIR.80.6.1652; Kim WJ, 2012, ATHEROSCLEROSIS, V225, P237, DOI 10.1016/j.atherosclerosis.2012.08.034; Kingwell BA, 2002, J AM COLL CARDIOL, V40, P773, DOI 10.1016/S0735-1097(02)02009-0; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lehmann ED, 1999, LANCET, V354, P528, DOI 10.1016/S0140-6736(99)00179-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Masugata H, 2010, TOHOKU J EXP MED, V220, P177, DOI 10.1620/tjem.220.177; Matsui Y, 2011, ATHEROSCLEROSIS, V219, P637, DOI 10.1016/j.atherosclerosis.2011.09.027; Motobe K, 2005, CIRC J, V69, P55, DOI 10.1253/circj.69.55; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3; Pasqualini L, 2012, EUR J INTERN MED, V23, P240, DOI 10.1016/j.ejim.2011.09.004; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; ROMAN MJ, 1995, J AM COLL CARDIOL, V25, P83, DOI 10.1016/0735-1097(94)00316-I; Sheng CS, 2013, HYPERTENSION, V61, P1155, DOI 10.1161/HYPERTENSIONAHA.111.00969; Shoji T, 2001, J AM SOC NEPHROL, V12, P2117, DOI 10.1681/ASN.V12102117; Su HM, 2013, AM J MED SCI; Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041173; Su HM, 2012, ATHEROSCLEROSIS, V223, P171, DOI 10.1016/j.atherosclerosis.2012.04.022; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070777	44	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88331	10.1371/journal.pone.0088331	http://dx.doi.org/10.1371/journal.pone.0088331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551090	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000028
J	Xuan, N; Bu, X; Liu, YY; Yang, X; Liu, GX; Fan, ZX; Bi, YP; Yang, LQ; Lou, QN; Rajashekar, B; Leppik, G; Kasvandik, S; Picimbon, JF				Xuan, Ning; Bu, Xun; Liu, Yan Yan; Yang, Xue; Liu, Guo Xia; Fan, Zhong Xue; Bi, Yu Ping; Yang, Lian Qun; Lou, Qi Nian; Rajashekar, Balaji; Leppik, Getter; Kasvandik, Sergo; Picimbon, Jean-Francois			Molecular Evidence of RNA Editing in Bombyx Chemosensory Protein Family	PLOS ONE			English	Article							ODORANT-BINDING-PROTEINS; MULTIPLE SEQUENCE ALIGNMENT; EXPRESSION PATTERN; IMMUNOCYTOCHEMICAL LOCALIZATION; REGENERATING LEGS; SOLUBLE-PROTEINS; PHEROMONE GLAND; WIDESPREAD RNA; PARALLEL DNA; GENE FAMILY	Chemosensory proteins (CSPs) are small scavenger proteins that are mainly known as transporters of pheromone/odor molecules at the periphery of sensory neurons in the insect antennae and in the producing cells from the moth female pheromone gland. Sequencing cDNAs of RNA encoding CSPs in the antennae, legs, head, pheromone gland and wings from five single individual adult females of the silkworm moth Bombyx mori showed that they differed from genomic sequences by subtle nucleotide replacement (RDD). Both intronless and intronic CSP genes expressed RDDs, although in different rates. Most interestingly, in our study the degree of RDDs in CSP genes were found to be tissue-specific. The proportion of CSP-RDDs was found to be significantly much higher in the pheromone gland. In addition, Western blot analysis of proteins in different tissues showed existence of multiple CSP protein variant chains particularly found in the pheromone gland. Peptide sequencing demonstrated the occurrence of a pleiad of protein variants for most of all BmorCSPs from the pheromone gland. Our findings show that RNA editing is an important feature in the expression of CSPs and that a high variety of RDDs is found to expand drastically thus altering the repertoire of CSP proteins in a tissue-specific manner.	[Xuan, Ning; Bu, Xun; Liu, Yan Yan; Yang, Xue; Liu, Guo Xia; Fan, Zhong Xue; Bi, Yu Ping; Yang, Lian Qun; Picimbon, Jean-Francois] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Shandong, Peoples R China; [Lou, Qi Nian] Shandong Acad Agr Sci, Shandong Silkworm Inst, Yantai, Shandong, Peoples R China; [Rajashekar, Balaji] Univ Tartu, Inst Comp Sci, EE-50090 Tartu, Tartumaa Provin, Estonia; [Leppik, Getter; Kasvandik, Sergo] Univ Tartu, Inst Technol, Prote Core Facil, EE-50090 Tartu, Tartumaa Provin, Estonia	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences; University of Tartu; University of Tartu	Picimbon, JF (corresponding author), Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Shandong, Peoples R China.	jfpicimbon@gmail.com	liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; Rajashekar, Balaji/W-8012-2018; Picimbon, Jean-François/AAE-7720-2020	Rajashekar, Balaji/0000-0002-1665-5584; Kasvandik, Sergo/0000-0003-0218-2410	Natural Sciences Foundation of Shandong Province; Overseas Talent and Taishan Scholar; Estonian Center of Excellence in Computer Science; Estonian Research Mobility Scheme; European Regional Development Fund through Center of Excellence in Chemical Biology	Natural Sciences Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Overseas Talent and Taishan Scholar; Estonian Center of Excellence in Computer Science; Estonian Research Mobility Scheme; European Regional Development Fund through Center of Excellence in Chemical Biology	This work was funded by Natural Sciences Foundation of Shandong Province, Overseas Talent and Taishan Scholar, Estonian Center of Excellence in Computer Science, Estonian Research Mobility Scheme and European Regional Development Fund through Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Campanacci V, 2003, P NATL ACAD SCI USA, V100, P5069, DOI 10.1073/pnas.0836654100; CHUMAKOV KM, 1992, J VIROL, V66, P966, DOI 10.1128/JVI.66.2.966-970.1992; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Hayden EC, 2012, NATURE NEWS COMMENTS, DOI [10.1038/nature.2012.10217, DOI 10.1038/NATURE.2012.10217]; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Idler RK, 2012, J ANDROL, V33, P309, DOI 10.2164/jandrol.111.014167; Ishida Y, 2002, NATURWISSENSCHAFTEN, V89, P505, DOI 10.1007/s00114-002-0368-1; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; Jansen S, 2006, J BIOMOL NMR, V36, P47, DOI 10.1007/s10858-006-9019-8; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; KASANG G, 1978, ANGEW CHEM INT EDIT, V17, P60, DOI 10.1002/anie.197800601; Keegan LP, 2011, NUCLEIC ACIDS RES, V39, P7249, DOI 10.1093/nar/gkr423; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Matsumoto S, 2001, RIKEN REV, V41, P79; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Monteforti G, 2002, ARTHROPOD STRUCT DEV, V30, P195, DOI 10.1016/S1467-8039(01)00036-6; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mosbah A, 2003, BIOCHEM J, V369, P39, DOI 10.1042/BJ20021217; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Ozaki K, 2008, INSECT BIOCHEM MOLEC, V38, P969, DOI 10.1016/j.ibmb.2008.07.010; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Park Y, 2008, INSECT BIOCHEM MOLEC, V38, P380, DOI 10.1016/j.ibmb.2007.09.008; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Picimbon Jean-Francois, 2003, P539, DOI 10.1016/B978-012107151-6/50020-7; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 1999, INSECT BIOCHEM MOLEC, V29, P973, DOI 10.1016/S0965-1748(99)00073-9; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; SCHLYTER F, 1989, HOLARCTIC ECOL, V12, P457; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Simpson L, 1998, ORIGIN EVOLUTION LIF, VI, P483; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Strandh M, 2008, INSECT MOL BIOL, V17, P73, DOI 10.1111/j.1365-2583.2008.00782.x; Tan BZ, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-13; Tomaselli S, 2006, BIOCHEMISTRY-US, V45, P10606, DOI 10.1021/bi060998w; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wanner KW, 2005, INSECT MOL BIOL, V14, P289, DOI 10.1111/j.1365-2583.2005.00559.x; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Zhang S, 2007, CHEM SENSES, V34, P503; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050	72	12	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e86932	10.1371/journal.pone.0086932	http://dx.doi.org/10.1371/journal.pone.0086932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551045	Green Published, Green Submitted, gold			2022-12-27	WOS:000331266000007
J	Yin, HG; Kosa, P; Liu, XB; Swaim, WD; Lai, ZN; Cabrera-Perez, J; Di Pasquale, G; Ambudkar, IS; Bugge, TH; Chiorini, JA				Yin, Hongen; Kosa, Peter; Liu, Xibao; Swaim, William D.; Lai, Zhennan; Cabrera-Perez, Javier; Di Pasquale, Giovanni; Ambudkar, Indu S.; Bugge, Thomas H.; Chiorini, John A.			Matriptase Deletion Initiates a Sjogren's Syndrome-Like Disease in Mice	PLOS ONE			English	Article							SALIVARY-GLAND; TIGHT JUNCTION; EPITHELIAL-CELLS; EXPRESSION; GENE; MUTATIONS; ICHTHYOSIS; FILAGGRIN; MODEL; ACTIVATION	Objective: The objective of this study was to determine the effect of epithelial barrier disruption, caused by deficiency of the membrane-anchored serine protease, matriptase, on salivary gland function and the induction of autoimmunity in an animal model. Methods: Embryonic and acute ablation of matriptase expression in the salivary glands of mice was induced, leading to decreased epithelial barrier function. Mice were characterized for secretory epithelial function and the induction of autoimmunity including salivary and lacrimal gland dysfunction, lymphocytic infiltration, serum anti-Ro/SSA, anti-La/SSB and antinuclear antibodies. Salivary glands immune activation/regulation, barrier function as well as tight junction proteins expression also were determined. Expression of matriptase in minor salivary gland biopsies was compared among pSS patients and healthy volunteers. Results: Embryonic ablation of matriptase expression in mice resulted in the loss of secretory epithelial cell function and the induction of autoimmunity similar to that observed in primary Sjogren's syndrome. Phenotypic changes included exocrine gland dysfunction, lymphocytic infiltrates, production of Sjogren's syndrome-specific autoantibodies, and overall activation of the immune system. Acute ablation of matriptase expression resulted in significant salivary gland dysfunction in the absence of overt immune activation. Analysis of the salivary glands indicates a loss of electrical potential across the epithelial layer as well as altered distribution of a tight junction protein. Moreover, a significant decrease in matriptase gene expression was detected in the minor salivary glands of pSS patients compared with healthy volunteers. Conclusions: Our findings demonstrate that local impairment of epithelial barrier function can lead to loss of exocrine gland dysfunction in the absence of inflammation while systemic deletion can induce a primary Sjogren's syndrome like phenotype with autoimmunity and loss of gland function.	[Yin, Hongen; Liu, Xibao; Swaim, William D.; Lai, Zhennan; Cabrera-Perez, Javier; Di Pasquale, Giovanni; Ambudkar, Indu S.; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Kosa, Peter; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Yin, HG (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA.	yinho@mail.nih.gov; jchiorini@dir.nidcr.nih.gov			National Institutes of Health (NIH); National Institute of Dental and Craniofacial Research (NIDCR) intramural grants; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699, ZIADE000438, ZIADE000695] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research (NIDCR) intramural grants; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) intramural grants to JAC and THB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker OJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/278948; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Gerberick GF, 1997, TOXICOL APPL PHARM, V146, P1, DOI 10.1006/taap.1997.8218; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Hashizume A, 2004, DEV DYNAM, V231, P425, DOI 10.1002/dvdy.20142; Katano H, 2006, GENE THER, V13, P594, DOI 10.1038/sj.gt.3302691; Kok MR, 2003, HUM GENE THER, V14, P1605, DOI 10.1089/104303403322542257; Kosa P, 2011, ONCOGENE; LAN HY, 1993, CLIN EXP IMMUNOL, V92, P336; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Nguyen CQ, 2008, ARTHRITIS RHEUM-US, V58, P734, DOI 10.1002/art.23214; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Peppi M, 2004, J ANAT, V205, P257, DOI 10.1111/j.0021-8782.2004.00332.x; Rice NE, 2008, J ALLERGY CLIN IMMUN, V122, P834, DOI 10.1016/j.jaci.2008.07.027; SAITO T, 1991, ORAL SURG ORAL MED O, V71, P179, DOI 10.1016/0030-4220(91)90462-L; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shaykhiev R, 2007, J LEUKOCYTE BIOL, V82, P1, DOI 10.1189/jlb.0207096; Shen GQ, 1996, CLIN DIAGN LAB IMMUN, V3, P162, DOI 10.1128/CDLI.3.2.162-166.1996; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; SMITH DL, 1995, BRIT J DERMATOL, V133, P153; SMITH DL, 1995, J ALLERGY CLIN IMMUN, V95, P116, DOI 10.1016/S0091-6749(95)70159-1; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Umesaki Y, 1997, SCIENCE, V276, P964, DOI 10.1126/science.276.5314.964; van Woerkom JM, 2005, ANN RHEUM DIS, V64, P1474, DOI 10.1136/ard.2004.031781; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Venables PJW, 2004, BEST PRACT RES CL RH, V18, P313, DOI 10.1016/j.berh.2004.02.010; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vosters JL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2888; Vosters JL, 2009, ARTHRITIS RHEUM-US, V60, P3633, DOI 10.1002/art.24980; Voulgarelis M, 2010, NAT REV RHEUMATOL, V6, P529, DOI 10.1038/nrrheum.2010.118; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wu AJ, 1996, J CELL PHYSIOL, V167, P297, DOI 10.1002/(SICI)1097-4652(199605)167:2<297::AID-JCP14>3.0.CO;2-5; Yin HE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3753; Yin HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018003; Yin H, 2009, J NEUROIMMUNOL, V215, P43, DOI 10.1016/j.jneuroim.2009.08.002	48	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e82852	10.1371/journal.pone.0082852	http://dx.doi.org/10.1371/journal.pone.0082852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551030	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000001
J	Calderaro, A; Gorrini, C; Piccolo, G; Montecchini, S; Buttrini, M; Rossi, S; Piergianni, M; Arcangeletti, MC; De Conto, F; Chezzi, C; Medici, MC				Calderaro, Adriana; Gorrini, Chiara; Piccolo, Giovanna; Montecchini, Sara; Buttrini, Mirko; Rossi, Sabina; Piergianni, Maddalena; Arcangeletti, Maria Cristina; De Conto, Flora; Chezzi, Carlo; Medici, Maria Cristina			Identification of Borrelia Species after Creation of an In-House MALDI-TOF MS Database	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; DESORPTION IONIZATION-TIME; JAPONICA SP-NOV; LYME-DISEASE; RIBOSOMAL-RNA; PCR; INFECTIONS; DIAGNOSIS; ASSAY	Lyme borreliosis (LB) is a multisystemic disease caused by Borrelia burgdorferi sensu lato (sl) complex transmitted to humans by Ixodes ticks. B. burgdorferi sl complex, currently comprising at least 19 genospecies, includes the main pathogenic species responsible for human disease in Europe: B. burgdorferi sensu stricto (ss), B. afzelii, and B. garinii. In this study, for the first time, MALDI-TOF MS was applied to Borrelia spp., supplementing the existing database, limited to the species B. burgdorferi ss, B. spielmanii and B. garinii, with the species B. afzelii, in order to enable the identification of all the species potentially implicated in LB in Europe. Moreover, we supplemented the database also with B. hermsii, which is the primary cause of tick-borne relapsing fever in western North America, B. japonica, circulating in Asia, and another reference strain of B. burgdorferi ss (B31 strain). The dendrogram obtained by analyzing the protein profiles of the different Borrelia species reflected Borrelia taxonomy, showing that all the species included in the Borrelia sl complex clustered in a unique branch, while Borrelia hermsii clustered separately. In conclusion, in this study MALDI-TOF MS proved a useful tool suitable for identification of Borrelia spp. both for diagnostic purpose and epidemiological surveillance.	[Calderaro, Adriana; Gorrini, Chiara; Piccolo, Giovanna; Montecchini, Sara; Buttrini, Mirko; Rossi, Sabina; Piergianni, Maddalena; Arcangeletti, Maria Cristina; De Conto, Flora; Chezzi, Carlo; Medici, Maria Cristina] Univ Parma, Fac Med & Surg, Dept Clin & Expt Med, Unit Microbiol & Virol, I-43100 Parma, Italy	University of Parma; University Hospital of Parma	Calderaro, A (corresponding author), Univ Parma, Fac Med & Surg, Dept Clin & Expt Med, Unit Microbiol & Virol, I-43100 Parma, Italy.	adriana.calderaro@unipr.it	ROSSI, Sabina/ABD-2601-2020; piccolo, giovanna/HHZ-8454-2022; De Conto, Flora/H-9760-2019	De Conto, Flora/0000-0002-0493-2353	Ministry of University and Scientific Research Grant FIL, Parma, Italy	Ministry of University and Scientific Research Grant FIL, Parma, Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Ministry of University and Scientific Research Grant FIL, Parma, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Ates L, 2010, TICKS TICK-BORNE DIS, V1, P30, DOI 10.1016/j.ttbdis.2009.11.004; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BURIONI R, 1988, EUR J EPIDEMIOL, V4, P506, DOI 10.1007/BF00146408; Calderaro A, 2010, DIAGN MICROBIOL INFE, V70, P455; Calderaro A, 2013, 23 C CLIN MICR INF D; Calderaro A, 2013, J PROTEOMICS, V78, P273, DOI 10.1016/j.jprot.2012.09.027; COENE M, 1989, INFECT IMMUN, V57, P138, DOI 10.1128/IAI.57.1.138-145.1989; DETTORI G, 1995, MICROBIOLOGICA, V18, P13; Dieterich R, 2010, INFECT IMMUN, V78, P4467, DOI 10.1128/IAI.00138-10; Franz JK, 2003, BEST PRACT RES CL RH, V17, P241, DOI 10.1016/S1521-6942(02)00129-8; Fukunaga M, 1996, MICROBIOL IMMUNOL, V40, P877, DOI 10.1111/j.1348-0421.1996.tb01154.x; Ivacic L, 2007, DIAGN MICR INFEC DIS, V57, P137, DOI 10.1016/j.diagmicrobio.2006.08.005; Joss AWL, 2008, J CLIN PATHOL, V61, P221, DOI 10.1136/jcp.2007.048801; KAWABATA H, 1993, MICROBIOL IMMUNOL, V37, P843, DOI 10.1111/j.1348-0421.1993.tb01714.x; Kraiczy P, 2008, CLIN VACCINE IMMUNOL, V15, P484, DOI 10.1128/CVI.00415-07; Lau AF, 2013, J CLIN MICROBIOL, V51, P828, DOI 10.1128/JCM.02852-12; MARCONI RT, 1995, J CLIN MICROBIOL, V33, P2427, DOI 10.1128/JCM.33.9.2427-2434.1995; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Nilsson CL, 2002, J AM SOC MASS SPECTR, V13, P295, DOI 10.1016/S1044-0305(01)00365-8; Portnoi D, 2006, FEMS MICROBIOL LETT, V259, P35, DOI 10.1111/j.1574-6968.2006.00249.x; Postic D, 2000, BIOL DIAGNOSIS LEPTO, P215; Rizzoli A, 2011, EUROSURVEIL, V16; ROSA PA, 1989, J INFECT DIS, V160, P1018, DOI 10.1093/infdis/160.6.1018; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Schwan TG, 2009, EMERG INFECT DIS, V15, P1026, DOI 10.3201/eid1507.090223; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Tijsse-Klasen E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-23; Vorou RM, 2007, EPIDEMIOL INFECT, V135, P1231, DOI 10.1017/S0950268807008527	33	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88895	10.1371/journal.pone.0088895	http://dx.doi.org/10.1371/journal.pone.0088895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533160	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600118
J	Li, MH; Zheng, YY; Zhao, GY; Fu, SH; Wang, D; Wang, ZY; Liang, GD				Li, Minghua; Zheng, Yayun; Zhao, Guoyan; Fu, Shihong; Wang, David; Wang, Zhiyu; Liang, Guodong			Tibet Orbivirus, a Novel Orbivirus Species Isolated from Anopheles maculatus Mosquitoes in Tibet, China	PLOS ONE			English	Article							COMPLETE SEQUENCE; JAPANESE ENCEPHALITIS; FAMILY REOVIRIDAE; VIRUS; PROTEINS; GENOME; BORNE; CORE	Background: The genus Orbivirus includes a number of important pathogenic viruses, including Bluetongue virus (BTV), African horse sickness virus (AHSV), and Epizootic hemorrhagic disease virus (EHDV). In this study we describe the isolation and characterization of an Orbivirus strain isolated from Anopheles maculatus mosquitoes collected in Tibet, China. Methods and Results: Initial viral screening identified a viral strain (XZ0906) that caused significant cytopathic effect (CPE) in BHK-21 cells, including rounding, cell rupture, and floating. Although CPE was not observed in insect cells (C6/36), these cells supported viral replication. Polyacrylamide gel analysis revealed a genome consisting of 10 segments of double-stranded RNA (dsRNA), with a distribution pattern of 3-3-3-1. 454 high throughput sequencing of culture supernatant was used for viral identification. Complete genome sequencing was performed by Sanger sequencing in combination with 5'RACE and 3'-RACE. Sequence analysis demonstrated that all 5'-and 3'-untranslated regions (UTRs) for each of the 10 genome segments contained a series of six highly conserved nucleotides. In addition, homology analysis and phylogenetic analysis based on amino acid sequence was completed, and all results show that virus XZ0906 was not a member of any known species or serotype of Orbivirus, indicating it to be a new species within the genus Orbivirus. Conclusions: The isolated Orbivirus strain was designated Tibet Orbivirus, TIBOV to denote the location from which it was isolated. TIBOV is a novel orbivirus species which is isolated from Anopheles maculatus mosquitoes collected in Tibet, China.	[Li, Minghua; Zheng, Yayun; Fu, Shihong; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zheng, Yayun; Wang, Zhiyu; Liang, Guodong] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Zhao, Guoyan; Wang, David] Washington Univ, St Louis, MO USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Shandong University; Washington University (WUSTL)	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	Li, Minghua/M-8776-2016	Li, Minghua/0000-0003-0409-5214; Zhao, Guoyan/0000-0001-5615-6774	National Natural Science Foundation of China [81290342]; Ministry of Science and Technology, China [2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	This work is supported by grants from National Natural Science Foundation of China (81290342), The Ministry of Science and Technology, China (2011CB504702) and Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H, 2011, FAMILY REOVIRIDAE, P541; Belaganahalli MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031911; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Cowled C, 2007, J GEN VIROL, V88, P3413, DOI 10.1099/vir.0.83231-0; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231; Li YX, 2011, EMERG INFECT DIS, V17, P934, DOI 10.3201/eid1705.101417; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Mertens P P C, 2004, Vet Ital, V40, P426; Mertens P.P.C., 1999, ORBIVIRUSES COLTIVIR, V2, P1043; MOSS SR, 1992, J GEN VIROL, V73, P2585, DOI 10.1099/0022-1317-73-10-2585; Roy P, 2007, ORBIVIRUSES VIRION S, P1976; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078470	21	53	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88738	10.1371/journal.pone.0088738	http://dx.doi.org/10.1371/journal.pone.0088738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533145	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600103
J	Rawal, A; Harmer, CJ; Park, RJ; O'Sullivan, UD; Williams, JMG				Rawal, Adhip; Harmer, Catherine J.; Park, Rebecca J.; O'Sullivan, Ursula D.; Williams, J. Mark G.			A Sense of Embodiment Is Reflected in People's Signature Size	PLOS ONE			English	Article							ANOREXIA-NERVOSA; SELF-ESTEEM; VALIDATION; COGNITION; EMOTION; FOCUS; MIND	Background: The size of a person's signature may reveal implicit information about how the self is perceived although this has not been closely examined. Methods/Results: We conducted three experiments to test whether increases in signature size can be induced. Specifically, the aim of these experiments was to test whether changes in signature size reflect a person's current implicit sense of embodiment. Experiment 1 showed that an implicit affect task (positive subliminal evaluative conditioning) led to increases in signature size relative to an affectively neutral task, showing that implicit affective cues alter signature size. Experiments 2 and 3 demonstrated increases in signature size following experiential self-focus on sensory and affective stimuli relative to both conceptual self-focus and external (non-self-focus) in both healthy participants and patients with anorexia nervosa, a disorder associated with self-evaluation and a sense of disembodiment. In all three experiments, increases in signature size were unrelated to changes in self-reported mood and larger than manipulation unrelated variations. Conclusions: Together, these findings suggest that a person's sense of embodiment is reflected in their signature size.	[Rawal, Adhip] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Harmer, Catherine J.; Park, Rebecca J.; Williams, J. Mark G.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [O'Sullivan, Ursula D.] Southern Dist Hlth Board, Dunedin, New Zealand	University of Sussex; University of Oxford; Dunedin Public Hospital	Rawal, A (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	adhip.rawal@sussex.ac.uk		Harmer, Catherine/0000-0002-1609-8335	Wellcome Trust [GR067797]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust GR067797 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JM, 2010, SCIENCE, V328, P1712, DOI 10.1126/science.1189993; AIKEN LR, 1978, J SOC PSYCHOL, V106, P273, DOI 10.1080/00224545.1978.9924179; Allport GW, 1933, STUDIES EXPRESSIVE M; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; BEUMONT P, 1971, BRIT J PSYCHIAT, V119, P349, DOI 10.1192/bjp.119.550.349-a; Cowdrey FA, 2012, EAT BEHAV, V13, P100, DOI 10.1016/j.eatbeh.2012.01.001; Dijksterhuis A, 2004, J PERS SOC PSYCHOL, V86, P345, DOI 10.1037/0022-3514.86.2.345; DUCLOS SE, 1989, J PERS SOC PSYCHOL, V57, P100, DOI 10.1037/0022-3514.57.1.100; Duguid MM, 2012, PSYCHOL SCI, V23, P36, DOI 10.1177/0956797611422915; Friedman RS, 2010, PSYCHOL BULL, V136, P875, DOI 10.1037/a0020495; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hafner M, 2013, EXP PSYCHOL, V60, P255, DOI 10.1027/1618-3169/a000194; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Park RJ, 2011, INT J COGN THER, V4, P415, DOI 10.1521/ijct.2011.4.4.415; Rawal A., 2009, HEALTHCARE COUNSELLI, V9, P16; Rawal A, 2011, BEHAV RES THER, V49, P635, DOI 10.1016/j.brat.2011.06.011; Rawal A, 2010, BEHAV RES THER, V48, P851, DOI 10.1016/j.brat.2010.05.009; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; ROSEN JC, 1990, BODY IMAGES DEV DEVI, P190; Sekar MK, 2010, INT J EAT DISORDER, V43, P762, DOI 10.1002/eat.20768; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; SWANSON BR, 1972, J SOC PSYCHOL, V87, P319, DOI 10.1080/00224545.1972.9922531; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; Watkins E, 2004, J AFFECT DISORDERS, V82, P1, DOI 10.1016/j.jad.2003.10.006; Wells GL, 1980, BASIC APPL SOC PSYCH, V1, P219, DOI 10.1207/s15324834basp0103_2; Yap AJ, 2013, PSYCHOL SCI, V24, P2281, DOI 10.1177/0956797613492425; ZWEIGENHAFT RL, 1977, SOC BEHAV PERSONAL, V5, P177, DOI 10.2224/sbp.1977.5.1.177; ZWEIGENHAFT RL, 1973, J CONSULT CLIN PSYCH, V40, P469, DOI 10.1037/h0034503; ZWEIGENHAFT RL, 1970, J SOC PSYCHOL, V81, P49, DOI 10.1080/00224545.1970.9919908	31	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88438	10.1371/journal.pone.0088438	http://dx.doi.org/10.1371/journal.pone.0088438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533088	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600046
J	Shin, A; Joo, J; Yang, HR; Bak, J; Park, Y; Kim, J; Oh, JH; Nam, BH				Shin, Aesun; Joo, Jungnam; Yang, Hye-Ryung; Bak, Jeongin; Park, Yunjin; Kim, Jeongseon; Oh, Jae Hwan; Nam, Byung-Ho			Risk Prediction Model for Colorectal Cancer: National Health Insurance Corporation Study, Korea	PLOS ONE			English	Article							COLON-CANCER; WHITE MEN; MORTALITY; VALIDATION; WOMEN; TOOL	Purpose: Incidence and mortality rates of colorectal cancer have been rapidly increasing in Korea during last few decades. Development of risk prediction models for colorectal cancer in Korean men and women is urgently needed to enhance its prevention and early detection. Methods: Gender specific five-year risk prediction models were developed for overall colorectal cancer, proximal colon cancer, distal colon cancer, colon cancer and rectal cancer. The model was developed using data from a population of 846,559 men and 479,449 women who participated in health examinations by the National Health Insurance Corporation. Examinees were 30-80 years old and free of cancer in the baseline years of 1996 and 1997. An independent population of 547,874 men and 415,875 women who participated in 1998 and 1999 examinations was used to validate the model. Model validation was done by evaluating its performance in terms of discrimination and calibration ability using the C-statistic and Hosmer-Lemeshow-type chi-square statistics. Results: Age, body mass index, serum cholesterol, family history of cancer, and alcohol consumption were included in all models for men, whereas age, height, and meat intake frequency were included in all models for women. Models showed moderately good discrimination ability with C-statistics between 0.69 and 0.78. The C-statistics were generally higher in the models for men, whereas the calibration abilities were generally better in the models for women. Conclusions: Colorectal cancer risk prediction models were developed from large-scale, population-based data. Those models can be used for identifying high risk groups and developing preventive intervention strategies for colorectal cancer.	[Shin, Aesun; Kim, Jeongseon] Natl Canc Ctr, Mol Epidemiol Branch, Goyang Si, South Korea; [Joo, Jungnam; Yang, Hye-Ryung; Bak, Jeongin; Park, Yunjin; Nam, Byung-Ho] Natl Canc Ctr, Biometr Res Branch, Goyang Si, South Korea; [Oh, Jae Hwan] Natl Canc Ctr Hosp, Natl Canc Ctr, Ctr Colorectal Canc, Goyang Si, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Nam, BH (corresponding author), Natl Canc Ctr, Biometr Res Branch, Goyang Si, South Korea.	byunghonam@ncc.re.kr	Shin, Aesun/E-9145-2014; KIM, JEONGSEON/AAA-4643-2022	Shin, Aesun/0000-0002-6426-1969; 				Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; D'Agostino RB, 2004, HANDB STAT, V23, P1; de la Torre I, 2012, J MED SYST, V36, P2557, DOI 10.1007/s10916-011-9728-8; Evans DGR, 1997, BRIT J SURG, V84, P1281; Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hong TS, 2012, CANCER DISCOV, V2, P117, DOI 10.1158/2159-8290.CD-11-0315; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Jung KW, 2012, CANCER RES TREAT, V44, P25, DOI 10.4143/crt.2012.44.1.25; Ma EB, 2010, CANCER EPIDEMIOL, V34, P534, DOI 10.1016/j.canep.2010.04.021; MCMICHAEL AJ, 1985, JNCI-J NATL CANCER I, V75, P185; Park Y, 2009, J CLIN ONCOL, V27, P694, DOI 10.1200/JCO.2008.17.4813; Selvachandran SN, 2002, LANCET, V360, P278, DOI 10.1016/S0140-6736(02)09549-1; Shin A, 2013, WORLD J GASTROENTERO, V19, P979, DOI 10.3748/wjg.v19.i7.979; Shin A, 2012, CANCER RES TREAT, V44, P219, DOI 10.4143/crt.2012.44.4.219; Shin A, 2011, INT J EPIDEMIOL, V40, P1261, DOI 10.1093/ije/dyr121; Shin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023196; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Vargas AJ, 2012, NUTR CLIN PRACT, V27, P613, DOI 10.1177/0884533612454885; Wei EK, 2009, AM J EPIDEMIOL, V170, P863, DOI 10.1093/aje/kwp210; Win AK, 2012, CANCER EPIDEM BIOMAR, V21, P398, DOI 10.1158/1055-9965.EPI-11-0771	26	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88079	10.1371/journal.pone.0088079	http://dx.doi.org/10.1371/journal.pone.0088079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533067	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600025
J	Song, K; Du, HM; Zhang, Q; Wang, CJ; Guo, YT; Wu, HM; Liu, L; Jia, QY; Wang, X; Shi, HB; Sun, SM; Niu, KJ				Song, Kun; Du, Huanmin; Zhang, Qing; Wang, Chongjin; Guo, Yinting; Wu, Hongmei; Liu, Li; Jia, Qiyu; Wang, Xing; Shi, Hongbin; Sun, Shaomei; Niu, Kaijun			Serum Immunoglobulin M Concentration Is Positively Related to Metabolic Syndrome in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) Cohort Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; OBESITY; IGM; ANTIBODIES; MECHANISMS; GENDER	Persistent low-grade systemic inflammation has been increasingly recognized as a common pathological process, and an important contributing factor to cardiovascular diseases and its risk factor, metabolic syndrome. Immunoglobulin M is reactive to multiple autoantigens and is inferred to be important for autoimmunity, implying that immunoglobulin M may be a potential risk factor for metabolic syndrome. However, few epidemiological studies are available which are related to this potential link. Therefore, we designed a cross-sectional study of 9,379 subjects to evaluate the relationship between immunoglobulin M and metabolic syndrome in an adult population. Subjects who received health examinations were recruited from the Tianjin Medical University General Hospital-Health Management Center in Tianjin, China. Immunoglobulin M was determined with an immunonephelometric technique. Metabolic syndrome was defined according to the criteria of the American Heart Association scientific statements of 2009. Multiple logistic regression analysis was used to examine the relationships between the quartiles of immunoglobulin M and the prevalence of metabolic syndrome. After adjustment for covariates, the odds ratio of having metabolic syndrome in the fourth quartile compared with the first quartile of immunoglobulin M was 1.19 times for males (95% confidence interval, 1.002-1.41) and 1.39 times for females (95% confidence interval, 1.07-1.80). Immunoglobulin M levels also showed positive relationships with the ratio of elevated triglycerides and reduced high-density lipoprotein cholesterol in males. The study is the first to show that immunoglobulin M is independently related to metabolic syndrome and its individual components (elevated triglycerides and reduced high-density lipoprotein cholesterol) in males, whereas immunoglobulin M is independently related to metabolic syndrome in females but not to its individual components. Further studies are needed to explore the causality and the exact role of immunoglobulin M in metabolic syndrome.	[Song, Kun; Zhang, Qing; Wang, Chongjin; Liu, Li; Jia, Qiyu; Wang, Xing; Shi, Hongbin; Sun, Shaomei] Tianjin Med Univ Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China; [Du, Huanmin; Guo, Yinting; Wu, Hongmei; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Du, Huanmin; Guo, Yinting; Wu, Hongmei; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Niu, KJ (corresponding author), Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China.	nkj0809@gmail.com		Niu, Kaijun/0000-0002-8772-2481	key technologies R&D program of Tianjin [11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200]; Science Foundation of Tianjin Medical University, China [2010KY28]	key technologies R&D program of Tianjin; Science Foundation of Tianjin Medical University, China	This study was supported by grants from the key technologies R&D program of Tianjin (Key Project: No. 11ZCGYSY05700, 12ZCZDSY20400, and 13ZCZDSY20200), and the Science Foundation of Tianjin Medical University, China (No. 2010KY28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arai S, 2013, CELL REP, V3, P1187, DOI 10.1016/j.celrep.2013.03.006; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Calabro P, 2009, INTERN EMERG MED, V4, P25, DOI 10.1007/s11739-008-0207-2; Duarte-Rey C, 2012, AUTOIMMUN REV, V11, pA404, DOI 10.1016/j.autrev.2011.12.001; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Elks CM, 2010, CURR HYPERTENS REP, V12, P99, DOI 10.1007/s11906-010-0096-4; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Jenny NS, 2012, DISCOV MED, V13, P451; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Knudsen GP, 2009, J NEUROL SCI, V286, P43, DOI 10.1016/j.jns.2009.04.022; Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1; Kovanen PT, 1998, ARCH INTERN MED, V158, P1434, DOI 10.1001/archinte.158.13.1434; Licata G, 2006, PANMINERVA MED, V48, P77; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MARCHALONIS JJ, 1993, GERONTOLOGY, V39, P65; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Marzullo P, 2013, ENDOCRINE; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Nathan C, 2008, MOL MED, V14, P485, DOI 10.2119/2008-00038.Nathan; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Ortona E, 2008, AUTOIMMUN REV, V7, P579, DOI 10.1016/j.autrev.2008.06.001; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Sell H, 2010, CURR OPIN CLIN NUTR, V13, P366, DOI 10.1097/MCO.0b013e32833aab7f; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shirai K, 2004, CURR MED RES OPIN, V20, P295, DOI 10.1185/030079903125003008; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Vollmers HP, 2006, ADV DRUG DELIVER REV, V58, P755, DOI 10.1016/j.addr.2005.08.007; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	34	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88701	10.1371/journal.pone.0088701	http://dx.doi.org/10.1371/journal.pone.0088701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533139	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600097
J	Norbaeck, D; Markowicz, P; Cai, GH; Hashim, Z; Ali, F; Zheng, YW; Lai, XX; Spangfort, MD; Larsson, L; Hashim, JH				Norbaeck, Dan; Markowicz, Pawel; Cai, Gui-Hong; Hashim, Zailina; Ali, Faridah; Zheng, Yi-Wu; Lai, Xu-Xin; Spangfort, Michael Dho; Larsson, Lennart; Hashim, Jamal Hisham			Endotoxin, Ergosterol, Fungal DNA and Allergens in Dust from Schools in Johor Bahru, Malaysia-Associations with Asthma and Respiratory Infections in Pupils	PLOS ONE			English	Article							HOUSE-DUST; MICROBIAL COMMUNITY; INDOOR ENVIRONMENTS; SYMPTOMS; CHILDREN; HEALTH; EXPOSURE; HOMES; QUANTIFICATION; ASPERGILLUS	There are few studies on associations between respiratory health and allergens, fungal and bacterial compounds in schools in tropical countries. The aim was to study associations between respiratory symptoms in pupils and ethnicity, chemical microbial markers, allergens and fungal DNA in settled dust in schools in Malaysia. Totally 462 pupils (96%) from 8 randomly selected secondary schools in Johor Bahru, Malaysia, participated. Dust was vacuumed from 32 classrooms and analysed for levels of different types of endotoxin as 3-hydroxy fatty acids (3-OH), muramic acid, ergosterol, allergens and five fungal DNA sequences. Multiple logistic regression was applied. Totally 13.1% pupils reported doctor's diagnosed asthma, 10.3% wheeze and 21.1% pollen or pet allergy. Indian and Chinese children had less atopy and asthma than Malay. Carbon dioxide levels were low (380-690 ppm). No cat (Fel d1), dog (Can f 1) or horse allergens (Ecu cx) were detected. The levels of Bloomia tropicalis (Blo t), house dust mite allergens (Der p 1, Der f 1, Der m 1) and cockroach allergens (Per a 1 and Bla g 1) were low. There were positive associations between levels of Aspergillus versicolor DNA and daytime breathlessness, between C14 3-OH and respiratory infections and between ergosterol and doctors diagnosed asthma. There were negative (protective) associations between levels of C10 3-OH and wheeze, between C16 3-OH and day time and night time breathlessness, between cockroach allergens and doctors diagnosed asthma. Moreover there were negative associations between amount of fine dust, total endotoxin (LPS) and respiratory infections. In conclusion, endotoxin at school seems to be mainly protective for respiratory illness but different types of endotoxin could have different effects. Fungal contamination measured as ergosterol and Aspergillus versicolor DNA can be risk factors for respiratory illness. The ethnical differences for atopy and asthma deserve further attention.	[Norbaeck, Dan; Cai, Gui-Hong] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Univ Hosp, Uppsala, Sweden; [Markowicz, Pawel; Larsson, Lennart] Lund Univ, Div Med Microbiol, Dept Lab Med, Lund, Sweden; [Hashim, Zailina] Univ Putra Malaysia, Dept Environm & Occupat Hlth, Fac Med & Hlth Sci, Serdang 43400, Selangor, Malaysia; [Ali, Faridah] Johor State Hlth Dept, Primary Care Unit, Johor Baharu, Malaysia; [Zheng, Yi-Wu; Lai, Xu-Xin; Spangfort, Michael Dho] ALK Abello AS, Asia Pacific Res, Guangzhou, Peoples R China; [Hashim, Jamal Hisham] United Nations Univ, Int Inst Global Hlth, Kuala Lumpur, Malaysia; [Hashim, Jamal Hisham] Natl Univ Malaysia, Dept Community Hlth, Kuala Lumpur, Malaysia	Uppsala University; Uppsala University Hospital; Lund University; Universiti Putra Malaysia; ALK-Abello AS; Universiti Kebangsaan Malaysia	Norbaeck, D (corresponding author), Uppsala Univ, Dept Med Sci Occupat & Environm Med, Univ Hosp, Uppsala, Sweden.	dan.norback@medsci.uu.se	Lai, Xuxin/L-3743-2019	Norback, Dan/0000-0002-5174-6668; Cai, Guihong/0000-0002-7797-807X	Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS); CFUG Gavleborg County; Swedish Asthma and Allergy Association's Research Foundation; Swedish Foundation for Health Care Sciences and Allergy Research; Swedish International Development Agency (SIDA)	Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS); CFUG Gavleborg County; Swedish Asthma and Allergy Association's Research Foundation; Swedish Foundation for Health Care Sciences and Allergy Research; Swedish International Development Agency (SIDA)	This study was supported by grants from the Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS), CFUG Gavleborg County, the Swedish Asthma and Allergy Association's Research Foundation, the Swedish Foundation for Health Care Sciences and Allergy Research and Swedish International Development Agency (SIDA). The funders supported the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHRAE, 1999, VENT ACC IND AIR QUA; Bloom E, 2007, APPL ENVIRON MICROB, V73, P4211, DOI 10.1128/AEM.00343-07; Cai GH, 2009, INDOOR AIR, V19, P392, DOI 10.1111/j.1600-0668.2009.00600.x; Cai GH, 2011, PEDIAT ALLERG IMM-UK, V22, P290, DOI 10.1111/j.1399-3038.2010.01127.x; Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x; Dharmage S, 2001, AM J RESP CRIT CARE, V164, P65, DOI 10.1164/ajrccm.164.1.9911066; Douwes J., 1996, APPL ENVIRON MICROB, V62, P1272; Haugland RA, 2004, SYST APPL MICROBIOL, V27, P198, DOI 10.1078/072320204322881826; Hussin NHM, 2011, INDOOR BUILT ENVIRON, V20, P607, DOI 10.1177/1420326X11414318; Jacobs JH, 2013, EUR RESPIR J, V42, P314, DOI 10.1183/09031936.00084612; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jarvis Bruce B., 1995, Natural Toxins, V3, P10, DOI 10.1002/nt.2620030104; Kim JL, 2007, INDOOR AIR, V17, P153, DOI 10.1111/j.1600-0668.2006.00466.x; Kim JL, 2007, INDOOR AIR, V17, P122, DOI 10.1111/j.1600-0668.2006.00460.x; LEUNG R, 1994, THORAX, V49, P1205, DOI 10.1136/thx.49.12.1205; Loh LC, 2006, ASIA-PAC J PUBLIC HE, V18, P49, DOI 10.1177/10105395060180010801; Mendell MJ, 2005, INDOOR AIR, V15, P27, DOI 10.1111/j.1600-0668.2004.00320.x; Mi YH, 2006, INDOOR AIR, V16, P454, DOI 10.1111/j.1600-0668.2006.00439.x; NG TP, 1994, THORAX, V49, P347, DOI 10.1136/thx.49.4.347; Ng TP, 2003, ANN ALLERG ASTHMA IM, V90, P51, DOI 10.1016/S1081-1206(10)63614-9; Norback D, 2011, J ENVIRON MONITOR, V13, P2895, DOI 10.1039/c1em10439j; OMAR A H, 1990, Acta Paediatrica Japonica, V32, P183; Quah BS, 2005, RESPIROLOGY, V10, P244, DOI 10.1111/j.1440-1843.2005.00645.x; Rullo VEV, 2002, J ALLERGY CLIN IMMUN, V110, P582, DOI 10.1067/mai.2002.127511; Salo PM, 2009, J ALLERGY CLIN IMMUN, V124, P185, DOI 10.1016/j.jaci.2009.05.012; Saraf A, 1997, APPL ENVIRON MICROB, V63, P2554, DOI 10.1128/AEM.63.7.2554-2559.1997; Schram-Bijkerk D, 2005, CLIN EXP ALLERGY, V35, P1272, DOI 10.1111/j.1365-2222.2005.02339.x; Sebastian A, 2005, INDOOR AIR, V15, P20, DOI 10.1111/j.1600-0668.2005.00341.x; Sebastian A, 2004, J ENVIRON MONITOR, V6, P300, DOI 10.1039/b314554a; Sebastian A, 2003, APPL ENVIRON MICROB, V69, P3103, DOI 10.1128/AEM.69.6.3103-3109.2003; Simoni M, 2011, PEDIAT ALLERG IMM-UK, V22, P843, DOI 10.1111/j.1399-3038.2011.01208.x; Smedje G, 1997, CLIN EXP ALLERGY, V27, P1270, DOI 10.1111/j.1365-2222.1997.tb01171.x; Su HJJ, 2001, ARCH ENVIRON HEALTH, V56, P144, DOI 10.1080/00039890109604066; Tischer C, 2011, EUR RESPIR J, V38, P812, DOI 10.1183/09031936.00184010; Vesper SJ, 2005, LETT APPL MICROBIOL, V41, P367, DOI 10.1111/j.1472-765X.2005.01764.x; Website for WHO Regional office for Europe, WHO GUID IND AIR QUA; Zhang L, 1997, CLIN EXP ALLERGY, V27, P876, DOI 10.1111/j.1365-2222.1997.tb01227.x; Zhang WD, 2007, RESP MED, V101, P186, DOI 10.1016/j.rmed.2006.04.004; Zhao ZH, 2008, PEDIAT ALLERG IMM-UK, V19, P455, DOI 10.1111/j.1399-3038.2007.00664.x	40	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88303	10.1371/journal.pone.0088303	http://dx.doi.org/10.1371/journal.pone.0088303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523884	Green Published, Green Accepted, gold			2022-12-27	WOS:000331258100033
J	Rapaport, T; Hochberg, U; Rachmilevitch, S; Karnieli, A				Rapaport, Tal; Hochberg, Uri; Rachmilevitch, Shimon; Karnieli, Arnon			The Effect of Differential Growth Rates across Plants on Spectral Predictions of Physiological Parameters	PLOS ONE			English	Article							VITIS-VINIFERA L.; LEAF OPTICAL-PROPERTIES; WATER-USE EFFICIENCY; GAS-EXCHANGE; CHLOROPHYLL CONTENT; REFLECTANCE INDEXES; NONSTOMATAL LIMITATIONS; NONIRRIGATED CONDITIONS; HYPERSPECTRAL INDEXES; STOMATAL CONDUCTANCE	Leaves of various ages and positions in a plant's canopy can present distinct physiological, morphological and anatomical characteristics, leading to complexities in selecting a single leaf for spectral representation of an entire plant. A fortiori, as growth rates between canopies differ, spectral-based comparisons across multiple plants - often based on leaves' position but not age - becomes an even more challenging mission. This study explores the effect of differential growth rates on the reflectance variability between leaves of different canopies, and its implication on physiological predictions made by widely-used spectral indices. Two distinct irrigation treatments were applied for one month, in order to trigger the formation of different growth rates between two groups of grapevines. Throughout the experiment, the plants were physiologically and morphologically monitored, while leaves from every part of their canopies were spectrally and histologically sampled. As the control vines were constantly developing new leaves, the water deficit plants were experiencing growth inhibition, resulting in leaves of different age at similar nodal position across the treatments. This modification of the age-position correlation was characterized by a near infrared reflectance difference between younger and older leaves, which was found to be exponentially correlated (R-2 = 0.98) to the age-dependent area of intercellular air spaces within the spongy parenchyma. Overall, the foliage of the control plant became more spectrally variable, creating complications for intra-and intertreatment leaf-based comparisons. Of the derived indices, the Structure-Insensitive Pigment Index (SIPI) was found indifferent to the age-position effect, allowing the treatments to be compared at any nodal position, while a Normalized Difference Vegetation Index (NDVI)-based stomatal conductance prediction was substantially affected by differential growth rates. As various biotic and abiotic factors may form distinctions in growth, future precision agriculture studies should consider its spectral effect on physiological predictions.	[Rapaport, Tal; Karnieli, Arnon] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Remote Sensing Lab, IL-84105 Beer Sheva, Israel; [Hochberg, Uri; Rachmilevitch, Shimon] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Karnieli, A (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Remote Sensing Lab, IL-84105 Beer Sheva, Israel.	karnieli@bgu.ac.il	Karnieli, Arnon/F-1782-2012; Rachmilevitch, Shimon/F-1329-2012	Karnieli, Arnon/0000-0001-8065-9793; Rachmilevitch, Shimon/0000-0003-3600-5949	Israeli Ministry of Agriculture [857-0614-11]	Israeli Ministry of Agriculture	The reported project was funded by the Israeli Ministry of Agriculture (grant 857-0614-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERLY DD, 1995, OECOLOGIA, V101, P289, DOI 10.1007/BF00328814; Aldakheel YY, 1997, INT J REMOTE SENS, V18, P3683, DOI 10.1080/014311697216883; ALLEN WA, 1969, J OPT SOC AM, V59, P1376, DOI 10.1364/JOSA.59.001376; Baluja J, 2012, IRRIGATION SCI, V30, P511, DOI 10.1007/s00271-012-0382-9; BARNA B, 1992, PHYSIOL MOL PLANT P, V40, P247, DOI 10.1016/0885-5765(92)90075-7; Barry K., 2009, INNOVATIONS REMOTE S, P193; CARTER GA, 1989, PLANT CELL ENVIRON, V12, P309, DOI 10.1111/j.1365-3040.1989.tb01945.x; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Carvalho L, 2002, VITIS, V41, P1; Castro KL, 2008, SENSORS-BASEL, V8, P51, DOI 10.3390/s8010051; Choinski JS, 2003, AUST J BOT, V51, P111, DOI 10.1071/BT02008; Cifre J, 2005, AGR ECOSYST ENVIRON, V106, P159, DOI 10.1016/j.agee.2004.10.005; Colombo R, 2008, REMOTE SENS ENVIRON, V112, P1820, DOI 10.1016/j.rse.2007.09.005; CONNOR DJ, 1995, OECOLOGIA, V101, P274, DOI 10.1007/BF00328812; Datt B, 1999, J PLANT PHYSIOL, V154, P30, DOI 10.1016/S0176-1617(99)80314-9; Dawson TP, 1998, REMOTE SENS ENVIRON, V65, P50, DOI 10.1016/S0034-4257(98)00007-8; DURING H, 1982, VITIS, V21, P223; DWYER LM, 1986, AGR FOREST METEOROL, V37, P29, DOI 10.1016/0168-1923(86)90026-2; Eitel JUH, 2011, AGR FOREST METEOROL, V151, P1338, DOI 10.1016/j.agrformet.2011.05.015; El-Shikha DM, 2007, AGR WATER MANAGE, V92, P183, DOI 10.1016/j.agwat.2007.05.020; Escalona JM, 2003, VITIS, V42, P57; Escalona JM, 1999, AUST J PLANT PHYSIOL, V26, P421, DOI 10.1071/PP99019; FIELD C, 1983, OECOLOGIA, V56, P348, DOI 10.1007/BF00379711; Flexas J, 2002, PHYSIOL PLANTARUM, V114, P231, DOI 10.1034/j.1399-3054.2002.1140209.x; Flexas J, 2002, FUNCT PLANT BIOL, V29, P461, DOI 10.1071/PP01119; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Flexas J, 2009, J EXP BOT, V60, P2361, DOI 10.1093/jxb/erp069; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; GAUSMAN HW, 1971, AGRON J, V63, P87, DOI 10.2134/agronj1971.00021962006300010027x; GAUSMAN HW, 1973, AGRON J, V65, P194, DOI 10.2134/agronj1973.00021962006500020003x; GAUSMAN HW, 1970, APPL OPTICS, V9, P545, DOI 10.1364/AO.9.000545; GAUSMAN HW, 1973, PLANT PHYSIOL, V52, P57, DOI 10.1104/pp.52.1.57; GAUSMAN HW, 1974, APPL OPTICS, V13, P109, DOI 10.1364/AO.13.000109; Gausman HW, 1973, LEAF MESOPHYLL 20 CR; Gausman HW, 1969, REMOTE SENS ENVIRON, V1, P19, DOI 10.1016/S0034-4257(69)90055-8; GRANT L, 1987, REMOTE SENS ENVIRON, V22, P309, DOI 10.1016/0034-4257(87)90064-2; Hall A, 2002, AUST J GRAPE WINE R, V8, P36, DOI 10.1111/j.1755-0238.2002.tb00209.x; Hochberg U, 2013, PHYSIOL PLANTARUM, V147, P443, DOI 10.1111/j.1399-3054.2012.01671.x; HSIAO TC, 1976, PHILOS T R SOC B, V273, P479, DOI 10.1098/rstb.1976.0026; HUNT ER, 1989, REMOTE SENS ENVIRON, V30, P43, DOI 10.1016/0034-4257(89)90046-1; HUNTER J J, 1990, South African Journal for Enology and Viticulture, V11, P26; HUNTER J J, 1988, South African Journal for Enology and Viticulture, V9, P9; Isaacson BN, 2012, LANDSCAPE ECOL, V27, P529, DOI 10.1007/s10980-012-9703-x; JACQUEMOUD S, 1990, REMOTE SENS ENVIRON, V34, P75, DOI 10.1016/0034-4257(90)90100-Z; KENNEDY R A, 1981, Photosynthesis Research, V2, P213, DOI 10.1007/BF00032360; Kitajima K, 2002, AM J BOT, V89, P1925, DOI 10.3732/ajb.89.12.1925; Knapp AK, 1998, AM J BOT, V85, P940, DOI 10.2307/2446360; KNIPLING E B, 1970, Remote Sensing of Environment, V1, P155; KRIEDEMANN P E, 1968, Vitis, V7, P213; KRIEDEMANN P E, 1970, Vitis, V9, P97; Lenz MS, 2009, AM J ENOL VITICULT, V60, P130; LEROUX HAJP, 1994, ANN BOT-LONDON, V73, P507, DOI 10.1006/anbo.1994.1063; LIN ZF, 1982, PHOTOSYNTHETICA, V16, P520; LIN ZF, 1982, PHOTOSYNTHETICA, V16, P514; Liu N, 2009, PLANT GROWTH REGUL, V58, P73, DOI 10.1007/s10725-008-9353-9; MCCAIG TN, 1991, CROP SCI, V31, P1583, DOI 10.2135/cropsci1991.0011183X003100060041x; Medrano H, 2002, ANN BOT-LONDON, V89, P895, DOI 10.1093/aob/mcf079; Medrano H, 2012, AGR WATER MANAGE, V114, P4, DOI 10.1016/j.agwat.2012.06.025; Meggio F, 2008, CAN J REMOTE SENS, V34, P220; Moran MS, 1997, REMOTE SENS ENVIRON, V61, P319, DOI 10.1016/S0034-4257(97)00045-X; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Nobel PS, 1975, PLANT PHYSIOL, V55; Ollinger SV, 2011, NEW PHYTOL, V189, P375, DOI 10.1111/j.1469-8137.2010.03536.x; Ourcival JM, 1999, NEW PHYTOL, V143, P351, DOI 10.1046/j.1469-8137.1999.00456.x; Padgett-Johnson M, 2003, J AM SOC HORTIC SCI, V128, P269, DOI 10.21273/JASHS.128.2.0269; PENUELAS J, 1993, INT J REMOTE SENS, V14, P1887, DOI 10.1080/01431169308954010; Penuelas J, 1999, PHOTOSYNTHETICA, V36, P355, DOI 10.1023/A:1007033503276; Penuelas J, 1998, J EXP BOT, V49, P229, DOI 10.1093/jexbot/49.319.229; Poni S, 2008, VITIS, V47, P1; Poni S., 2000, Australian Journal of Grape and Wine Research, V6, P216, DOI 10.1111/j.1755-0238.2000.tb00182.x; PONI S, 1994, AM J ENOL VITICULT, V45, P71; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; Pou A, 2012, PLANT SOIL, V359, P335, DOI 10.1007/s11104-012-1206-7; Prieto JA, 2012, PLANT CELL ENVIRON, V35, P1313, DOI 10.1111/j.1365-3040.2012.02491.x; Qin J.L., 2010, ACTA ECOLOGICA SINIC, V30, P297; Rabas AR, 2003, ANN BOT-LONDON, V92, P529, DOI 10.1093/aob/mcg171; Rahimzadeh-Bajgiran P, 2012, PHOTOSYNTH RES, V113, P261, DOI 10.1007/s11120-012-9747-4; Rewald B, 2012, J EXP BOT, V63, P2717, DOI 10.1093/jxb/err457; Rodriguez-Perez JR, 2007, AM J ENOL VITICULT, V58, P302; Sabat S. C., 1989, Photosynthesis: molecular biology and bioenergetics., P343; Santesteban LG, 2009, SCI HORTIC-AMSTERDAM, V121, P434, DOI 10.1016/j.scienta.2009.03.008; Schurr U, 2000, J EXP BOT, V51, P1515, DOI 10.1093/jexbot/51.350.1515; Seelan SK, 2003, REMOTE SENS ENVIRON, V88, P157, DOI 10.1016/j.rse.2003.04.007; Seelig HD, 2008, REMOTE SENS ENVIRON, V112, P445, DOI 10.1016/j.rse.2007.05.002; Serrano L, 2008, INT J REMOTE SENS, V29, P5265, DOI 10.1080/01431160802036359; SHIBATA K, 1957, J BIOCHEM-TOKYO, V44, P147, DOI 10.1093/oxfordjournals.jbchem.a126741; Sims DA, 2003, REMOTE SENS ENVIRON, V84, P526, DOI 10.1016/S0034-4257(02)00151-7; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; SINCLAIR TR, 1971, AGRON J, V63, P864, DOI 10.2134/agronj1971.00021962006300060012x; Slaton MR, 2001, AM J BOT, V88, P278, DOI 10.2307/2657019; Snider JL, 2009, J PLANT PHYSIOL, V166, P686, DOI 10.1016/j.jplph.2008.09.007; Stone C, 2005, AUST J BOT, V53, P45, DOI 10.1071/BT04062; THOMAS JR, 1971, AGRON J, V63, P845, DOI 10.2134/agronj1971.00021962006300060007x; WILSON D, 1969, NEW PHYTOL, V68, P645, DOI 10.1111/j.1469-8137.1969.tb06468.x; Wilson KB, 2000, TREE PHYSIOL, V20, P565; Zarco-Tejada PJ, 2013, REMOTE SENS ENVIRON, V138, P38, DOI 10.1016/j.rse.2013.07.024; Zarco-Tejada PJ, 2005, REMOTE SENS ENVIRON, V99, P271, DOI 10.1016/j.rse.2005.09.002; Zhu Y, 2013, PLANT PHYSIOL, V161, P2005, DOI 10.1104/pp.112.213363	99	22	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88930	10.1371/journal.pone.0088930	http://dx.doi.org/10.1371/journal.pone.0088930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523946	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100095
J	Schwieterman, ML; Colquhoun, TA; Jaworski, EA; Bartoshuk, LM; Gilbert, JL; Tieman, DM; Odabasi, AZ; Moskowitz, HR; Folta, KM; Klee, HJ; Sims, CA; Whitaker, VM; Clark, DG				Schwieterman, Michael L.; Colquhoun, Thomas A.; Jaworski, Elizabeth A.; Bartoshuk, Linda M.; Gilbert, Jessica L.; Tieman, Denise M.; Odabasi, Asli Z.; Moskowitz, Howard R.; Folta, Kevin M.; Klee, Harry J.; Sims, Charles A.; Whitaker, Vance M.; Clark, David G.			Strawberry Flavor: Diverse Chemical Compositions, a Seasonal Influence, and Effects on Sensory Perception	PLOS ONE			English	Article							ACROSS-GROUP COMPARISONS; LABELED SCALES; QUALITY; TOMATO	Fresh strawberries (Fragaria x ananassa) are valued for their characteristic red color, juicy texture, distinct aroma, and sweet fruity flavor. In this study, genetic and environmentally induced variation is exploited to capture biochemically diverse strawberry fruit for metabolite profiling and consumer rating. Analyses identify fruit attributes influencing hedonics and sensory perception of strawberry fruit using a psychophysics approach. Sweetness intensity, flavor intensity, and texture liking are dependent on sugar concentrations, specific volatile compounds, and fruit firmness, respectively. Overall liking is most greatly influenced by sweetness and strawberry flavor intensity, which are undermined by environmental pressures that reduce sucrose and total volatile content. The volatile profiles among commercial strawberry varieties are complex and distinct, but a list of perceptually impactful compounds from the larger mixture is better defined. Particular esters, terpenes, and furans have the most significant fits to strawberry flavor intensity. In total, thirty-one volatile compounds are found to be significantly correlated to strawberry flavor intensity, only one of them negatively. Further analysis identifies individual volatile compounds that have an enhancing effect on perceived sweetness intensity of fruit independent of sugar content. These findings allow for consumer influence in the breeding of more desirable fruits and vegetables. Also, this approach garners insights into fruit metabolomics, flavor chemistry, and a paradigm for enhancing liking of natural or processed products.	[Schwieterman, Michael L.; Colquhoun, Thomas A.; Folta, Kevin M.; Klee, Harry J.; Clark, David G.] Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA; [Colquhoun, Thomas A.; Jaworski, Elizabeth A.; Clark, David G.] Univ Florida, Dept Environm Hort, Gainesville, FL 32611 USA; [Bartoshuk, Linda M.] Univ Florida, Coll Dent, Gainesville, FL USA; [Gilbert, Jessica L.; Tieman, Denise M.; Folta, Kevin M.; Klee, Harry J.] Univ Florida, Dept Hort Sci, Gainesville, FL USA; [Odabasi, Asli Z.; Sims, Charles A.; Whitaker, Vance M.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Moskowitz, Howard R.] Moskowitz Jacobs Inc, White Plains, NY USA; [Whitaker, Vance M.] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL USA; [Schwieterman, Michael L.; Colquhoun, Thomas A.; Jaworski, Elizabeth A.; Bartoshuk, Linda M.; Gilbert, Jessica L.; Tieman, Denise M.; Odabasi, Asli Z.; Folta, Kevin M.; Klee, Harry J.; Sims, Charles A.; Whitaker, Vance M.; Clark, David G.] Univ Florida, Plant Innovat Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Clark, DG (corresponding author), Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA.	geranium@ufl.edu	Klee, Harry/A-7912-2008; Odabasi, Asli Z./ABH-2441-2020	Jaworski, Elizabeth/0000-0002-4886-0451	USDA Specialty Crop Block Grant; USDA National Needs Fellowship	USDA Specialty Crop Block Grant; USDA National Needs Fellowship(United States Department of Agriculture (USDA))	This work is supported by grants from USDA Specialty Crop Block Grant. Graduate funding is provided by USDA National Needs Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2000, PLANT CELL, P12; Aharoni A, 2004, PLANT CELL, V16; Baldwin EA, 2008, J FOOD SCI, V73, pS294, DOI 10.1111/j.1750-3841.2008.00825.x; Bartoshuk LM, 2013, CURR BIOL, V23, pR374, DOI 10.1016/j.cub.2013.03.038; Bartoshuk LM, 2003, FOOD QUAL PREFER, V14, P125, DOI 10.1016/S0950-3293(02)00077-0; Bartoshuk LM, 2005, CURR DIR PSYCHOL SCI, V14, P122, DOI 10.1111/j.0963-7214.2005.00346.x; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Basson CE, 2010, FOOD CHEM, V121; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Burdach KJ, 1984, PERCEPTION PSYCHOPHY, V36; Causse M, 2001, THEOR APPL GENET, V102, P273, DOI 10.1007/s001220051644; CHRISTENSEN CM, 1983, J FOOD SCI, V48, P787, DOI 10.1111/j.1365-2621.1983.tb14899.x; CLIFF M, 1990, J FOOD SCI, V55, P450, DOI 10.1111/j.1365-2621.1990.tb06784.x; Colquhoun TA, 2012, J BERRY RES, V2, P45, DOI 10.3233/JBR-2011-027; Cumplido-Laso G, 2012, J EXPT BOT, V63; Fait A, 2008, PLANT PHYSIOL, P148; Frank RA, 1988, CHEM SENSES; Fujimaru T, 2013, CHEMOSENS PERCEPT, V6, P1, DOI 10.1007/s12078-013-9140-5; Hakala MA, 2002, J AGR FOOD CHEM, P50; HALL RL, 1968, FOOD TECHNOL-CHICAGO, V22, P1496; Hancock J.F., 1999, STRAWBERRIES, P25; Hoffmann T, 2006, PLANT J, P48; Hong V, 1990, J AGR FOOD CHEM, P38; Jetti RR, 2007, J FOOD SCI, P72; Jouquand C, 2008, J AM SOC HORTIC SCI, V133, P859, DOI 10.21273/JASHS.133.6.859; Lavin JG, 1998, FOOD QUALITY PREFERE, V9; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Loren B, 1955, ROLE SWEETENERS FOOD, P108; Maarse H., 1991, VOLATILE COMPOUNDS F; MacKenzie SJ, 2011, HORTSCIENCE, P46; MacKenzie SJ, 2009, ACTA HORTICULTURAE; Masaoka Y, 2010, NEUROSCI LETT, V473, P92, DOI 10.1016/j.neulet.2010.02.024; Menager I, 2004, J AGR FOOD CHEM, P52; Mikulic-Petkovsek M, 2012, J FOOD SCI, V77, pC1064, DOI 10.1111/j.1750-3841.2012.02896.x; Murphy C, 1980, PHYSL BEHAV, V24; Olbricht K, 2008, PLANT BREEDING, P127; Pelayo-Zaldivar C, 2005, J FOOD QUALITY, V28, P78, DOI 10.1111/j.1745-4557.2005.00005.x; Perez AG, 2002, J AGR FOOD CHEM, P50; Pierce J, 1996, CHEM SENSES, V21, P529, DOI 10.1093/chemse/21.5.529; Prescott J., 2004, FLAVOR PERCEPTION; Prescott J, 1999, FOOD QUALITY PREFERE, V10; Quesada MA, 2009, PLANT PHYSIOL, P150; Santos BM, 2012, VEGETABLE PRODUCTION; Schieberle P, 1997, J AGR FOOD CHEM, P45; Schmelz EA, 2003, PLANTA, V216, P665, DOI 10.1007/s00425-002-0898-y; Schmelz EA, 2001, PLANTA, V214, P171, DOI 10.1007/s004250100603; Small DM, 2004, J NEUROPHYSIOLOGY, V92; Small DM, 2001, CHEM SENSES, P1034; Stevenson RJ, 1999, CHEM SENSES, V24, P627, DOI 10.1093/chemse/24.6.627; Stommel J, 2005, J AM SOC HORTIC SCI, V130, P244, DOI 10.21273/JASHS.130.2.244; Strand LL., 2008, INTEGRATED PEST MANA; Tieman D, 2012, CURR BIOL, V22, P1035, DOI 10.1016/j.cub.2012.04.016; Trainotti L, 1999, J PLANT PHYSL, P154; Ulrich D, 1997, Z LEBENSMITTEL UNTER, P205; Underwood BA, 2005, PLANT PHYSIOL, V138, P255, DOI 10.1104/pp.104.051144; Veldhuizen MG, 2010, CHEM SENSES, V35, P121, DOI 10.1093/chemse/bjp089; Watson R, 2002, J EXPT BOT, V53; Whitaker VM, 2011, HORTSCIENCE, V46, P553, DOI 10.21273/HORTSCI.46.4.553; Zhang J, 2011, J EXPT BOT, V62	59	160	164	6	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88446	10.1371/journal.pone.0088446	http://dx.doi.org/10.1371/journal.pone.0088446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523895	gold, Green Submitted, Green Published			2022-12-27	WOS:000331258100044
J	Zhang, JZ; Mei, L; Liu, R; Khan, MRG; Hu, CG				Zhang, Jin-Zhi; Mei, Li; Liu, Rong; Khan, Muhammad Rehman Gul; Hu, Chun-Gen			Possible Involvement of Locus-Specific Methylation on Expression Regulation of LEAFY Homologous Gene (CiLFY) during Precocious Trifoliate Orange Phase Change Process	PLOS ONE			English	Article							LATE-FLOWERING PHENOTYPE; DNA METHYLATION; PERILLA-FRUTESCENS; ARABIDOPSIS; 5-AZACYTIDINE; PLANT; INITIATION; DEMETHYLATION; INDUCTION; MUTATION	DNA methylation plays an essential role in regulating plant development. Here, we described an early flowering trifoliate orange (precocious trifoliate orange, Poncirus trifoliata L. Raf) was treated with 5-azacytidine and displayed a number of phenotypic and developmental abnormalities. These observations suggested that DNA methylation might play an important role in regulating many developmental pathways including early flowering trait, and then the expression level of five key or integrated citrus flowering genes were analyzed. Our results showed that FLOWERING LOCUS T (CiFT) relative expression level was increased with the increasing concentrations of 5-AzaC. However, LEAFY (CiLFY), APETELA1 (CiAP1), TERMINAL FLOWER1 (CiTFL1), and FLOWERING LOCUS C (CiFLC) showed highest relative expression levels at 250 mu M treatment, while decreased sharply at higher concentrations. In order to further confirm DNA methylation affects the expression of these genes, their full-length sequences were isolated by genome-walker method, and then was analyzed by using bioinformatics tools. However, only one locus-specific methylation site was observed in CiLFY sequence. Therefore, DNA methylation level of the CiLFY was investigated both at juvenile and adult stages of precocious trifoliate orange by bisulfate sequencing PCR; it has been shown that the level of DNA methylation was altered during phase change. In addition, spatial and temporal expression patterns of CiLFY promoter and a series of 59 deletions were investigated by driving the expression of a beta-glucuronidase reporter gene in Arabidopsis. Exogenous GA(3) treatment on transgenic Arabidopsis revealed that GA(3) might be involved in the developmental regulation of CiLFY during flowering process of precocious trifoliate orange. These results provided insights into the molecular regulation of CiLFY gene expression, which would be helpful for studying citrus flowering.	[Zhang, Jin-Zhi; Mei, Li; Liu, Rong; Khan, Muhammad Rehman Gul; Hu, Chun-Gen] Huazhong Agr Univ, Key Lab Hort Plant Biol, Coll Hort & Forestry Sci, Minist Educ, Wuhan, Hubei Province, Peoples R China	Huazhong Agricultural University	Hu, CG (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Coll Hort & Forestry Sci, Minist Educ, Wuhan, Hubei Province, Peoples R China.	chungen@mail.hzau.edu.cn		Zhang, Jin-Zhi/0000-0002-3820-889X	Fundamental Research Funds for the National Natural Science Foundation of China [31130046, 3107177, 31101528]	Fundamental Research Funds for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by the Fundamental Research Funds for the National Natural Science Foundation of China (grant numbers 31130046, 31071777, and 31101528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Blazquez MA, 2000, J CELL SCI, V113, P3547; Brown JCL, 2008, PLANT SCI, V175, P217, DOI 10.1016/j.plantsci.2008.03.023; BURN JE, 1993, P NATL ACAD SCI USA, V90, P287, DOI 10.1073/pnas.90.1.287; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Carmona MJ, 2002, PLANT PHYSIOL, V130, P68, DOI 10.1104/pp.002428; Castilho A, 1999, J CELL SCI, V112, P4397; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; El-Otmani M, 2000, CRIT REV PLANT SCI, V19, P395, DOI 10.1016/S0735-2689(00)80025-8; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; Gallagher S.R., 1992, GUS PROTOCOLS USING, P47; Garcia-Manero G, 2002, CLIN CANCER RES, V8, P2217; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Genger RK, 2003, PLANTA, V216, P461, DOI 10.1007/s00425-002-0855-9; Giannino D, 2003, J EXP BOT, V54, P2623, DOI 10.1093/jxb/erg292; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hsu CY, 2006, PLANT CELL, V18, P1846, DOI 10.1105/tpc.106.041038; Iwase Y, 2010, PHYSIOL PLANTARUM, V139, P118, DOI [10.1111/j.1399-3054.2010.01345.x, 10.1111/j.1399-3054.2009.01345.x]; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1999, GENETICS, V151, P831; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kondo H, 2006, PHYSIOL PLANTARUM, V127, P130, DOI 10.1111/j.1399-3054.2005.00635.x; Kondo H, 2007, PHYSIOL PLANTARUM, V131, P462, DOI 10.1111/j.1399-3054.2007.00965.x; Kondo H, 2010, PLANT SCI, V178, P321, DOI 10.1016/j.plantsci.2010.01.012; Krawczyk J, 2013, EXPERT OPIN PHARMACO, V14, P1255, DOI 10.1517/14656566.2013.794222; Li CJ, 2013, GENET EPIGENETICS, V5, P43, DOI 10.4137/GEG.S12143; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li WX, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003937; Liang S., 1999, ZHE JIANG CITRUS, V16, P2; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Marfil CF, 2012, PLANT CELL REP, V31, P1449, DOI 10.1007/s00299-012-1260-x; Matzke M, 2006, COLD SPRING HARB SYM, V71, P449, DOI 10.1101/sqb.2006.71.028; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michaels SD, 2000, PLANT CELL ENVIRON, V23, P1145, DOI 10.1046/j.1365-3040.2000.00643.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nishikawa F, 2007, J EXP BOT, V58, P3915, DOI 10.1093/jxb/erm246; Nishikawa F, 2009, TREE PHYSIOL, V29, P921, DOI 10.1093/treephys/tpp021; Pena L, 2001, NAT BIOTECHNOL, V19, P263, DOI 10.1038/85719; Pillitteri LJ, 2004, J AM SOC HORTIC SCI, V129, P846, DOI 10.21273/JASHS.129.6.0846; Pillitteri LJ, 2004, PLANT PHYSIOL, V135, P1540, DOI 10.1104/pp.103.036178; Preuss D, 1999, PLANT CELL, V11, P765, DOI 10.1105/tpc.11.5.765; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Shibukawa T, 2009, GENE, V437, P22, DOI 10.1016/j.gene.2009.02.011; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Tan FC, 2006, PHYSIOL PLANTARUM, V128, P8, DOI 10.1111/j.1399-3054.2006.00724.x; Vanyushin BF, 2004, INT REV CYTOL, V233, P135, DOI 10.1016/S0074-7696(04)33004-4; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; Zhang JZ, 2008, TREE PHYSIOL, V28, P1449, DOI 10.1093/treephys/28.10.1449; Zhang JZ, 2009, PLANTA, V229, P847, DOI 10.1007/s00425-008-0885-z; Zhang JZ, 2009, GENE, V430, P95, DOI 10.1016/j.gene.2008.09.023	66	14	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88558	10.1371/journal.pone.0088558	http://dx.doi.org/10.1371/journal.pone.0088558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523915	Green Submitted, gold, Green Published			2022-12-27	WOS:000331258100064
J	Char, JE; Wolfe, MH; Cho, HJ; Park, IH; Jeong, JH; Frisbee, E; Dunn, C; Davies, Z; Milla, C; Moss, RB; Thomas, EAC; Wine, JJ				Char, Jessica E.; Wolfe, Marlene H.; Cho, Hyung-ju; Park, Il-Ho; Jeong, Jin Hyeok; Frisbee, Eric; Dunn, Colleen; Davies, Zoe; Milla, Carlos; Moss, Richard B.; Thomas, Ewart A. C.; Wine, Jeffrey J.			A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor	PLOS ONE			English	Article							DISEASE; MUTATIONS; VX-770; HYPOSECRETION; ASSOCIATION; POTENTIATOR; TRANSPORT; BIOPSIES; MODEL; FORM	To determine if oral dosing with the CFTR-potentiator ivacaftor (VX-770, Kalydeco) improves CFTR-dependent sweating in CF subjects carrying G551D or R117H-5T mutations, we optically measured sweat secretion from 32-143 individually identified glands in each of 8 CF subjects; 6 F508del/G551D, one G551D/R117H-5T, and one I507del/R117H-5T. Two subjects were tested only (-) ivacaftor, 3 only (+) ivacaftor and 3 (+/-) ivacaftor (1-5 tests per condition). The total number of gland measurements was 852 (2) ivacaftor and 906 (+) ivacaftor. A healthy control was tested 4 times (51 glands). For each gland we measured both CFTR-independent (M-sweat) and CFTR-dependent (C-sweat); C-sweat was stimulated with a badrenergic cocktail that elevated [cAMP](i) while blocking muscarinic receptors. Absent ivacaftor, almost all CF glands produced M-sweat on all tests, but only 1/593 glands produced C-sweat (10 tests, 5 subjects). By contrast, 6/6 subjects (113/ 342 glands) produced C-sweat in the (+) ivacaftor condition, but with large inter-subject differences; 3-74% of glands responded with C/M sweat ratios 0.04%-2.57% of the average WT ratio of 0.265. Sweat volume losses cause proportionally larger underestimates of CFTR function at lower sweat rates. The losses were reduced by measuring C/M ratios in 12 glands from each subject that had the highest M-sweat rates. Remaining losses were estimated from single channel data and used to correct the C/M ratios, giving estimates of CFTR function (+) ivacaftor = 1.6%-7.7% of the WT average. These estimates are in accord with single channel data and transcript analysis, and suggest that significant clinical benefit can be produced by low levels of CFTR function.	[Char, Jessica E.; Wolfe, Marlene H.; Cho, Hyung-ju; Park, Il-Ho; Jeong, Jin Hyeok; Frisbee, Eric; Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA; [Dunn, Colleen; Davies, Zoe; Milla, Carlos; Moss, Richard B.; Wine, Jeffrey J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Thomas, Ewart A. C.; Wine, Jeffrey J.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wine, JJ (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA.	wine@stanford.edu	Park, Il-Ho/AAI-1394-2019; Moss, Richard B./S-9218-2019; Jeong, Jin Hyeok/L-1362-2016	Park, Il-Ho/0000-0002-7011-6071; Moss, Richard B./0000-0003-3611-4221; Milla, Carlos/0000-0001-5515-3053; Jeong, Jin Hyeok/0000-0001-8424-3998	Cystic Fibrosis Foundation Therapeutics [WINE08A0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Cystic Fibrosis Foundation Therapeutics, Grant WINE08A0 to JJW. http://www.cff.org/research/cfft/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Barlow D., 1984, SINGLE CASE EXPT DES; BEHM JK, 1987, PEDIATR RES, V22, P271, DOI 10.1203/00006450-198709000-00007; BERSCHNEIDER HM, 1988, FASEB J, V2, P2625, DOI 10.1096/fasebj.2.10.2838365; BIJMAN J, 1984, AM J PHYSIOL, V247, pC3, DOI 10.1152/ajpcell.1984.247.1.C3; BIJMAN J, 1991, ADV EXP MED BIOL, V290, P287; Bijman J., 1991, ADV EXP MED BIOL, V290, P294; Billet A, 2013, J BIOL CHEM; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; CHAMPIGNY G, 1995, EMBO J, V14, P2417, DOI 10.1002/j.1460-2075.1995.tb07239.x; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cho HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024424; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; de Nooijer RA, 2011, J CYST FIBROS, V10, P326, DOI 10.1016/j.jcf.2011.03.009; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; FARBER S, 1945, J MICH MED SOC, V44, P587; Friedman KJ, 1997, HUM MUTAT, V10, P108, DOI 10.1002/(SICI)1098-1004(1997)10:2<108::AID-HUMU3>3.3.CO;2-3; GOCHBERG SH, 1956, PEDIATRICS, V18, P701; Gonska T, 2012, CHEST, V142, P996, DOI 10.1378/chest.11-2543; Guo XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025452; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Kazdin A., 2021, SINGLE CASE RES DESI, V3rd; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; ROCHON J, 1990, J CLIN EPIDEMIOL, V43, P499, DOI 10.1016/0895-4356(90)90139-G; Salinas D, 2004, FASEB J, V18, P431, DOI 10.1096/fj.04-2879fje; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Sosnay PR, 2013, NAT GENET; SPIEGELHALTER DJ, 1988, SCAND J GASTROENTERO, V23, P40, DOI 10.3109/00365528809099158; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; TAYLOR CJ, 1988, GUT, V29, P957, DOI 10.1136/gut.29.7.957; Van Goor F, 2012, PEDIATR PULM, V47, P233; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; VEEZE HJ, 1994, J CLIN INVEST, V93, P461, DOI 10.1172/JCI116993; WILSCHANSKI M, 1995, J PEDIATR-US, V127, P705, DOI 10.1016/S0022-3476(95)70157-5; Wine JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077114; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	39	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88564	10.1371/journal.pone.0088564	http://dx.doi.org/10.1371/journal.pone.0088564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520399	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600090
J	Franceschelli, S; Pesce, M; Ferrone, A; De Lutiis, MA; Patruno, A; Grilli, A; Felaco, M; Speranza, L				Franceschelli, Sara; Pesce, Mirko; Ferrone, Alessio; De Lutiis, Maria Anna; Patruno, Antonia; Grilli, Alfredo; Felaco, Mario; Speranza, Lorenza			Astaxanthin Treatment Confers Protection against Oxidative Stress in U937 Cells Stimulated with Lipopolysaccharide Reducing O-2(-) Production	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HEME OXYGENASE-1/CARBON MONOXIDE; INDUCED INFLAMMATORY RESPONSE; TRANSCRIPTION FACTOR; CAROTENOIDS; NRF2; MACROPHAGES; ACTIVATION; MODULATE	Recently, astaxanthin (ASTA) studies have focused on several biological functions such as radical scavenging, singlet oxygen quenching, anti-carcinogenesis, anti-diabetic, anti-obesity, anti-inflammatory, anti-melanogenesis, and immune enhancement activities. In this study, we investigated the potential role protective of ASTA, an antioxidant marine carotenoid, in restoring physiological conditions in U937 cells stimulated with LPS (10 mu g/ml). Our results show that pre-treatment with ASTA (10 mu M) for 1 h attenuates the LPS-induced toxicity and ROS production. The beneficial effect of ASTA is associated with a reduction intracellular O-2(-) production by restoring the antioxidant network activity of superoxide dismutase (SOD) and catalase (CAT), which influence HO-1 expression and activity by inhibiting nuclear translocation of Nrf2. We accordingly hypothesize that ASTA has therapeutic properties protecting U937 cells from LPS-induced inflammatory and oxidative stress.	[Franceschelli, Sara; Pesce, Mirko; Ferrone, Alessio; De Lutiis, Maria Anna; Patruno, Antonia; Felaco, Mario; Speranza, Lorenza] Univ G DAnnunzio, Dept Med & Sci Aging, Chieti, Italy; [Grilli, Alfredo] Univ G DAnnunzio, Dept Psychol Humanist & Terr Sci, Dept Psychol, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Speranza, L (corresponding author), Univ G DAnnunzio, Dept Med & Sci Aging, Chieti, Italy.	l.speranza@unich.it	Franceschelli, Sara/ABA-6335-2020; Franceschelli, Sara/G-1738-2015; Patruno, Alessandro/T-6621-2019	grilli, alfredo/0000-0002-5746-5007; Franceschelli, Sara/0000-0002-1580-6520; Patruno, Alessandro/0000-0002-6459-0674; Pesce, Mirko/0000-0001-8836-2564	Italian Ministry for University and Research	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))	The Italian Ministry for University and Research is acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Barbagallo I, 2013, ANTIOXID REDOX SIGN, V18, P507, DOI 10.1089/ars.2011.4360; Cheng HW, 2013, J SCI FOOD AGR, V93, P491, DOI 10.1002/jsfa.5795; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; ELFERINK JGR, 1984, RES COMMUN CHEM PATH, V43, P339; Franceschelli S, 2011, MOLECULES, V16, P5720, DOI 10.3390/molecules16075720; Grilli A, 2003, ANN CLIN LAB SCI, V33, P208; He XQ, 2009, MOL PHARMACOL, V76, P1265, DOI 10.1124/mol.109.058453; Iarlori C, 2008, MULT SCLER, V14, P739, DOI 10.1177/1352458508088918; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Kurata SI, 1996, EUR J BIOCHEM, V239, P566, DOI 10.1111/j.1432-1033.1996.0566u.x; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Miyashita K, 2009, FORUM NUTR, V61, P136, DOI 10.1159/000212746; Paiva SAR, 1999, J AM COLL NUTR, V18, P426, DOI 10.1080/07315724.1999.10718880; Patruno A, 2010, BRIT J DERMATOL, V162, P258, DOI 10.1111/j.1365-2133.2009.09527.x; Patruno A, 2012, BBA-GEN SUBJECTS, V1820, P2095, DOI 10.1016/j.bbagen.2012.08.014; Riccioni G, 2012, INT J VITAM NUTR RES, V82, P15, DOI 10.1024/0300-9831/a000090; Riccioni G, 2012, NUTRITION, V28, P605, DOI 10.1016/j.nut.2011.11.028; Riccioni G, 2011, MAR DRUGS, V9, P1166, DOI 10.3390/md9071166; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Scapagnini G, 2002, MOL PHARMACOL, V61, P1264; Scapagnini G, 2002, MOL PHARMACOL, V61, P554, DOI 10.1124/mol.61.3.554; Speranza L, 2008, INT J IMMUNOPATH PH, V21, P879, DOI 10.1177/039463200802100412; Speranza Lorenza, 2013, Front Biosci (Elite Ed), V5, P551; Speranza L, 2012, MAR DRUGS, V10, P890, DOI 10.3390/md10040890; Speranza L, 2012, CELL BIOCHEM FUNCT, V30, P217, DOI 10.1002/cbf.1838; Speranza Lorenza, 2012, Front Biosci (Elite Ed), V4, P1255; Speranza L, 2010, PHYTOTHER RES, V24, P1398, DOI 10.1002/ptr.3173; Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005	33	61	64	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88359	10.1371/journal.pone.0088359	http://dx.doi.org/10.1371/journal.pone.0088359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520374	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600065
J	Perreault, M; Zulyniak, MA; Badoud, F; Stephenson, S; Badawi, A; Buchholz, A; Mutch, DM				Perreault, Maude; Zulyniak, Michael A.; Badoud, Flavia; Stephenson, Susan; Badawi, Alaa; Buchholz, Andrea; Mutch, David M.			A Distinct Fatty Acid Profile Underlies the Reduced Inflammatory State of Metabolically Healthy Obese Individuals	PLOS ONE			English	Article							LOW-GRADE INFLAMMATION; INSULIN-RESISTANCE; DIETARY FACTORS; WEIGHT; LIPIDS; OVERWEIGHT; GLUCOSE; TRIGLYCERIDES; ASSOCIATION; CHILDREN	Background: Obesity is associated with numerous health complications; however, a subgroup of obese individuals (termed the metabolically healthy obese or MHO) appear to have lower risk for complications such as type 2 diabetes and cardiovascular disease. Emerging evidence suggests that MHO individuals have reduced inflammation compared to their metabolically unhealthy obese (MUO) counterparts. As it is recognized that fatty acids (FAs) have a strong relationship with inflammation, the current study aimed to uncover if the reduced inflammation observed in MHO individuals is mirrored by a more favourable FA profile. Methods: Fasted serum samples were collected from lean healthy (LH), MHO, and MUO participants (n = 10/group) recruited from the Diabetes Risk Assessment study. A panel of pro-and anti-inflammatory markers were measured by immunoassay. Total serum FA profiling, as well as the FA composition of circulating phospholipids (PL) and triglycerides (TG), was measured by gas chromatography. ANOVA and Mann-Whitney-Wilcoxon tests were used to assess statistical significance between the groups (P<0 .05). Results: MHO and MUO individuals had similar BMI and body fat %; however, lipid parameters in MHO individuals more closely resembled that of LH individuals. MHO individuals had circulating levels of high sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) similar to LH individuals, while levels of platelet derived growth factor-beta beta (PDGF-beta beta) were intermediate to that of LH and MUO individuals. FA profiling analysis combined with discriminant analysis modelling highlighted a panel of nine FAs (consisting of three saturated, three monounsaturated, and three polyunsaturated FAs) in PL and TG fractions that distinguished the three groups. Specifically, saturated FA (myristic and stearic acids) levels in MHO individuals resembled that of LH individuals. Conclusion: Our results suggest that the reduced inflammatory state of MHO individuals compared to MUO individuals may stem, in part, from a more favourable underlying FA profile.	[Perreault, Maude; Zulyniak, Michael A.; Badoud, Flavia; Mutch, David M.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Stephenson, Susan] Yarmouth Med Grp, Guelph Family Hlth Team, Guelph, ON, Canada; [Badawi, Alaa] Publ Hlth Agcy Canada, Off Biotechnol Genom & Populat Hlth, Toronto, ON, Canada; [Buchholz, Andrea] Univ Guelph, Dept Family Relat & Appl Nutr, Guelph, ON N1G 2W1, Canada	University of Guelph; Public Health Agency of Canada; University of Guelph	Mutch, DM (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	dmutch@uoguelph.ca	Badawi, Alaa/ABC-1300-2021	Zulyniak, Michael/0000-0003-4944-5521; Mutch, David/0000-0002-0908-7259	Public Health Agency of Canada; Ontario Graduate Scholarships; Swiss National Science Foundation	Public Health Agency of Canada; Ontario Graduate Scholarships(Ontario Graduate Scholarship); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by a grant from the Public Health Agency of Canada. MP and MAZ were supported by Ontario Graduate Scholarships. FB is a recipient of a postdoctoral fellowship from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Basu A, 2006, ARTERIOSCL THROM VAS, V26, P995, DOI 10.1161/01.ATV.0000214295.86079.d1; Bluher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Donovan EL, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-24; Doumatey AP, 2012, J ENDOCRINOL METAB, V2, P51, DOI 10.4021/jem95w; Elisha B, 2010, DIABETES METAB, V36, P319, DOI 10.1016/j.diabet.2010.03.004; Fernandez-Real JM, 2003, DIABETES CARE, V26, P1362, DOI 10.2337/diacare.26.5.1362; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Gil-Campos M, 2008, LIPIDS, V43, P723, DOI 10.1007/s11745-008-3203-4; Hatsugai M, 2010, J GASTROENTEROL, V45, P488, DOI 10.1007/s00535-009-0183-y; Imamura F, 2013, CIRCULATION, V127, P1512, DOI 10.1161/CIRCULATIONAHA.112.001197; Jiang ZG, 2013, J BIOMED RES, V27, P1, DOI 10.7555/JBR.27.20120077; Kalogeropoulos N, 2010, CLIN CHIM ACTA, V411, P584, DOI 10.1016/j.cca.2010.01.023; Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kim OY, 2013, NUTR METAB CARDIOVAS, V23, P366, DOI 10.1016/j.numecd.2011.06.006; Klein-Platat C, 2005, AM J CLIN NUTR, V82, P1178, DOI 10.1093/ajcn/82.6.1178; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; LARYEA MD, 1992, ANN NUTR METAB, V36, P273, DOI 10.1159/000177729; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Lottenberg AM, 2012, J NUTR BIOCHEM, V23, P1027, DOI 10.1016/j.jnutbio.2012.03.004; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052; Micha R, 2010, LIPIDS, V45, P893, DOI 10.1007/s11745-010-3393-4; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Naukkarinen J, 2014, DIABETOLOGIA, V57, P167, DOI 10.1007/s00125-013-3066-y; Ogorodnikova AD, 2012, OBESITY; Petersson H, 2008, BRIT J NUTR, V99, P1186, DOI 10.1017/S0007114507871674; Petersson H, 2009, ATHEROSCLEROSIS, V203, P298, DOI 10.1016/j.atherosclerosis.2008.06.020; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Savary S, 2012, CURR DRUG METAB, V13, P1358, DOI 10.2174/138920012803762729; Savva SC, 2004, BRIT J NUTR, V91, P643, DOI 10.1079/BJN20031084; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Shaw B, 2013, J NUTRIGENET NUTRIGE, V6, P1, DOI 10.1159/000345913; Stryjecki C, 2012, MOL GENET METAB, V105, P421, DOI 10.1016/j.ymgme.2011.12.003; Succurro E, 2008, OBESITY, V16, P1881, DOI 10.1038/oby.2008.308; Telle-Hansen VH, 2013, GENES NUTR, V8, P425, DOI 10.1007/s12263-012-0329-z; Wang XP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-25; Welty FK, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0400-4; Zulyniak MA, 2012, APPL PHYSIOL NUTR ME, V37, P1003, DOI [10.1139/h2012-081, 10.1139/H2012-081]	50	52	52	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88539	10.1371/journal.pone.0088539	http://dx.doi.org/10.1371/journal.pone.0088539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520395	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600086
J	Zagato, E; Mileti, E; Massimiliano, L; Fasano, F; Budelli, A; Penna, G; Rescigno, M				Zagato, Elena; Mileti, Erika; Massimiliano, Lucia; Fasano, Francesca; Budelli, Andrea; Penna, Giuseppe; Rescigno, Maria			Lactobacillus paracasei CBA L74 Metabolic Products and Fermented Milk for Infant Formula Have Anti-Inflammatory Activity on Dendritic cells In Vitro and Protective effects against Colitis and an Enteric Pathogen In Vivo	PLOS ONE			English	Article							IMMUNE-SYSTEM; IMMUNOMODULATORY PROPERTIES; INTESTINAL MICROBIOTA; COLONIC INJURY; THYMUS SIZE; MICE; CYCLOOXYGENASE-2; INFLAMMATION; INFECTION; PROMOTION	The rapid expansion of commercially available fermented food products raises important safety issues particularly when infant food is concerned. In many cases, the activity of the microorganisms used for fermentation as well as what will be the immunological outcome of fermented food intake is not known. In this manuscript we used complex in vitro, ex-vivo and in vivo systems to study the immunomodulatory properties of probiotic-fermented products (culture supernatant and fermented milk without live bacteria to be used in infant formula). We found in vitro and ex-vivo that fermented products of Lactobacillus paracasei CBA L74 act via the inhibition of proinflammatory cytokine release leaving anti-inflammatory cytokines either unaffected or even increased in response to Salmonella typhimurium. These activities are not dependent on the inactivated bacteria but to metabolic products released during the fermentation process. We also show that our in vitro systems are predictive of an in vivo efficacy by the fermented products. Indeed CBA L74 fermented products (both culture medium and fermented milk) could protect against colitis and against an enteric pathogen infection (Salmonella typhimurium). Hence we found that fermented products can act via the inhibition of immune cell inflammation and can protect the host from pathobionts and enteric pathogens. These results open new perspectives in infant nutrition and suggest that L. paracasei CBA L74 fermented formula can provide immune benefits to formula-fed infants, without carrying live bacteria that may be potentially dangerous to an immature infant immune system.	[Zagato, Elena; Mileti, Erika; Massimiliano, Lucia; Penna, Giuseppe; Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Fasano, Francesca; Budelli, Andrea] Heinz Italia SpA, R&D, Latina, Italy	IRCCS European Institute of Oncology (IEO)	Penna, G (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.	giuseppe.penna@ieo.eu; maria.rescigno@ieo.eu	Penna, Giuseppe/B-3359-2015; Penna, Giuseppe/AAB-8784-2019; Massimiliano, Lucia/AAP-5179-2020; Mileti, Erika/AAR-7801-2020; Zagato, Elena/AAN-1997-2021; Zagato, Elena/N-1285-2017; Rescigno, Maria/J-9704-2012	Penna, Giuseppe/0000-0003-3534-7090; Mileti, Erika/0000-0003-0425-5169; Zagato, Elena/0000-0001-6756-3674; Zagato, Elena/0000-0001-6756-3674; Rescigno, Maria/0000-0002-6464-509X; Massimiliano, Lucia/0000-0001-9128-4317; Budelli, Andrea/0000-0003-1866-1301				Agostoni C, 2007, J PEDIATR GASTR NUTR, V44, P392, DOI 10.1097/01.mpg.0000258887.93866.69; Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; CAMPEOTTO F, 2011, BR J NUTR, P1; Cattaneo A, 2010, PUBLIC HEALTH NUTR, V13, P751, DOI 10.1017/S1368980009991844; Cleary TG, 2004, ADV EXP MED BIOL, V554, P145; De Greef E, 2013, ACTA GASTRO-ENT BELG, V76, P15; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Garai P, 2012, VIRULENCE, V3, P377, DOI 10.4161/viru.21087; Grangette C, 2005, PNAS IN PRESS; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hasselbalch H, 1996, ACTA PAEDIATR, V85, P1029, DOI 10.1111/j.1651-2227.1996.tb14211.x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HOWIE PW, 1990, BRIT MED J, V300, P11, DOI 10.1136/bmj.300.6716.11; Indrio F, 2007, PEDIATR RES, V62, P98, DOI 10.1203/pdr.0b013e31806772d3; Kato-Mori Y, 2010, J MED FOOD, V13, P1460, DOI 10.1089/jmf.2010.1137; Klaenhammer TR, 2012, NAT REV IMMUNOL, V12, P728, DOI 10.1038/nri3312; Koletzko B, 2005, J PEDIATR GASTR NUTR, V41, P584, DOI 10.1097/01.mpg.0000187817.38836.42; Madan JC, 2012, CURR OPIN PEDIATR, V24, P753, DOI 10.1097/MOP.0b013e32835a1ac8; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Menard S, 2006, J PEDIATR GASTR NUTR, V43, P451, DOI 10.1097/01.mpg.0000239738.71864.19; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; Mullie C, 2004, PEDIATR RES, V56, P791, DOI 10.1203/01.PDR.0000141955.47550.A0; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pastorelli L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/608187; Pushparaj PN, 2013, IMMUNOLOGY, V140, P70, DOI 10.1111/imm.12111; Reuter BK, 1996, J CLIN INVEST, V98, P2076, DOI 10.1172/JCI119013; Riva E, 2005, J INT MED RES, V33, P595, DOI 10.1177/147323000503300601; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sedhom MA, 2012, GUT; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Sim K, 2013, ARCH DIS CHILD-FETAL, V98, pF362, DOI 10.1136/archdischild-2012-302872; Thibault H, 2004, J PEDIATR GASTR NUTR, V39, P147, DOI 10.1097/00005176-200408000-00004; Tsilingiri K, 2013, BENEF MICROBES, V4, P101, DOI 10.3920/BM2012.0046; Tsilingiri K., 2012, GUT; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Ward TL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-116; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	40	62	64	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87615	10.1371/journal.pone.0087615	http://dx.doi.org/10.1371/journal.pone.0087615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520333	Green Submitted, gold, Green Published			2022-12-27	WOS:000331254600024
J	Tafuma, TA; Burnett, RJ; in 't Veld, DH				Tafuma, Taurayi A.; Burnett, Rosemary J.; in 't Veld, Diana Huis			National Guidelines Not Always Followed When Diagnosing Smear-Negative Pulmonary Tuberculosis in Patients with HIV in Botswana	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; MICROSCOPY; INFECTION; SETTINGS	Background: Diagnosis of smear negative pulmonary tuberculosis (SNPTB) is challenging, especially in patients with HIV. The Botswana National Tuberculosis Program (BNTP) guidelines give guidance in diagnosing and treating SNPTB. Patients with chronic cough should be screened for TB by 3 sputum smear investigations. If negative, a chest x-ray (CXR) should be performed. If negative for TB, antimicrobial treatment for other infections should be started. We investigated the clinicians' use of the guidelines in clinical practice. Methods: Data regarding the medical history (coughing period), requested and conducted investigations concerning tuberculosis diagnosis (sputum smear or culture or CXR) or alternative diagnoses (sputum microscopy or blood or sputum culture for diagnosis of other organisms), in SNPTB HIV-positive patients (outpatients and admitted patients) from 2006-2009 in a district hospital in Botswana were extracted from all available hospital medical records. Additionally, a survey was done in all doctors diagnosing SNPTB in this hospital using a self-administered questionnaire with questions regarding the application of the BNTP guidelines in practice. Descriptive analyses of collected data were performed to test the compliance to the guidelines. Results: Data from medical records showed that in 47.0% (132/281) of patients, TB treatment was started without microbiological results from sputum smears. Other methods to rule out or confirm PTB were used in 2.1% (6/281); and 99.6% (280/281) of SNPTB patients had received a CXR. The survey in 7 clinicians found that all always used CXR, and all clinicians requested three sputum results only sometimes. Six out of 7 clinicians started antibiotics before starting TB treatment. Reasons clinicians gave for difficulties in following the guidelines included inability of patients to produce sputum; and laboratory delays in releasing sputum results. Conclusion: Between 2006 and 2009 a high proportion of SNPTB diagnoses in a district hospital in Botswana were not supported by laboratory investigation.	[Tafuma, Taurayi A.] Minist Hlth, Dept HIV AIDS Prevent & Care, Gaborone, Botswana; [Burnett, Rosemary J.] Univ Limpopo, Dept Publ Hlth, Pretoria, South Africa; [in 't Veld, Diana Huis] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [in 't Veld, Diana Huis] FWO Res Fdn Flanders, Brussels, Belgium	University of Limpopo; University of Antwerp	Tafuma, TA (corresponding author), Minist Hlth, Dept HIV AIDS Prevent & Care, Gaborone, Botswana.	tauadd@gmail.com		Burnett, Rosemary/0000-0003-1346-1570				Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; Central Statistics Office, 2008, BOTSW AIDS IMP SURV; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Gearing RE, 2006, J CAN ACAD CHILD ADO, V15, P126; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Huebner RE, 1997, INT J TUBERC LUNG D, V1, P333; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Matee M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-68; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; MESFIN MM, 2003, ETHIOP J HEALTH DEV, V19, P13; Morse M, 2008, INT J TUBERC LUNG D, V12, P1279; Talbot EA, 2004, CLIN INFECT DIS, V39, pE1, DOI 10.1086/421388; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; 2007, BOTSWANA NATL TB PRO	17	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88654	10.1371/journal.pone.0088654	http://dx.doi.org/10.1371/journal.pone.0088654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551128	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500053
J	Toth, G; Gardai, SJ; Zago, W; Bertoncini, CW; Cremades, N; Roy, SL; Tambe, MA; Rochet, JC; Galvagnion, C; Skibinski, G; Finkbeiner, S; Bova, M; Regnstrom, K; Chiou, SS; Johnston, J; Callaway, K; Anderson, JP; Jobling, MF; Buell, AK; Yednock, TA; Knowles, TPJ; Vendruscolo, M; Christodoulou, J; Dobson, CM; Schenk, D; McConlogue, L				Toth, Gergely; Gardai, Shyra J.; Zago, Wagner; Bertoncini, Carlos W.; Cremades, Nunilo; Roy, Susan L.; Tambe, Mitali A.; Rochet, Jean-Christophe; Galvagnion, Celine; Skibinski, Gaia; Finkbeiner, Steven; Bova, Michael; Regnstrom, Karin; Chiou, San-San; Johnston, Jennifer; Callaway, Kari; Anderson, John P.; Jobling, Michael F.; Buell, Alexander K.; Yednock, Ted A.; Knowles, Tuomas P. J.; Vendruscolo, Michele; Christodoulou, John; Dobson, Christopher M.; Schenk, Dale; McConlogue, Lisa			Targeting the Intrinsically Disordered Structural Ensemble of alpha-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson's Disease	PLOS ONE			English	Article							MICE LACKING; MEMBRANE; RELEASE; BINDING; NMR; PATHOGENESIS; AGGREGATION; ASSOCIATION; INHIBITORS; MUTATIONS	The misfolding of intrinsically disordered proteins such as alpha-synuclein, tau and the A beta peptide has been associated with many highly debilitating neurodegenerative syndromes including Parkinson's and Alzheimer's diseases. Therapeutic targeting of the monomeric state of such intrinsically disordered proteins by small molecules has, however, been a major challenge because of their heterogeneous conformational properties. We show here that a combination of computational and experimental techniques has led to the identification of a drug-like phenyl-sulfonamide compound (ELN484228), that targets alpha-synuclein, a key protein in Parkinson's disease. We found that this compound has substantial biological activity in cellular models of alpha-synuclein-mediated dysfunction, including rescue of alpha-synuclein-induced disruption of vesicle trafficking and dopaminergic neuronal loss and neurite retraction most likely by reducing the amount of alpha-synuclein targeted to sites of vesicle mobilization such as the synapse in neurons or the site of bead engulfment in microglial cells. These results indicate that targeting alpha-synuclein by small molecules represents a promising approach to the development of therapeutic treatments of Parkinson's disease and related conditions.	[Toth, Gergely; Bertoncini, Carlos W.; Cremades, Nunilo; Galvagnion, Celine; Buell, Alexander K.; Knowles, Tuomas P. J.; Vendruscolo, Michele; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Bertoncini, Carlos W.] Univ Nacl Rosario, SEDIPFAR Serv Descubrimiento Diseno & Desarrollo, RA-2000 Rosario, Argentina; [Roy, Susan L.; Tambe, Mitali A.; Rochet, Jean-Christophe] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Toth, Gergely; Gardai, Shyra J.; Zago, Wagner; Bova, Michael; Regnstrom, Karin; Chiou, San-San; Johnston, Jennifer; Callaway, Kari; Anderson, John P.; Jobling, Michael F.; Yednock, Ted A.; Christodoulou, John; Dobson, Christopher M.] Elan Pharmaceut, San Francisco, CA USA; [Christodoulou, John] UCL, Dept Struct & Mol Biol, London, England; [Skibinski, Gaia; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Skibinski, Gaia; Finkbeiner, Steven] Consortium Frontotemporal Dementia Res, Taube Koret Ctr Neurodegenerat Dis Res, San Francisco, CA USA; [Skibinski, Gaia; Finkbeiner, Steven] Hellman Family Fdn, Program Alzheimers Dis Res, San Francisco, CA USA; [Finkbeiner, Steven] UCSF, Dept Neurol, San Francisco, CA USA; [Finkbeiner, Steven] UCSF, Dept Physiol, San Francisco, CA USA	University of Cambridge; National University of Rosario; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of London; University College London; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Toth, G (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	gt293@cam.ac.uk; mv245@cam.ac.uk; cmd44@cam.ac.uk; dale.schenk@prothena.com; lisam@msg.ucsf.edu	Buell, Alexander/B-4155-2013; Vendruscolo, Michele/F-5901-2012; Knowles, Tuomas/C-6663-2009; Tambe, Mitali/AGX-3558-2022; Galvagnion, Celine/K-7940-2018; Cremades, Nunilo/F-9634-2015	Buell, Alexander/0000-0003-1161-3622; Vendruscolo, Michele/0000-0002-3616-1610; Knowles, Tuomas/0000-0002-7879-0140; Tambe, Mitali/0000-0001-9389-2308; Galvagnion, Celine/0000-0001-9753-3310; Cremades, Nunilo/0000-0002-9138-6687; Johnston, Jennifer/0000-0002-4867-9230; Christodoulou, John/0000-0002-6710-3843; Rochet, Jean-Christophe/0000-0002-6484-1541	Elan Pharmaceuticals; Wellcome Trust; EU-FP7 Marie Curie Fellowship; Ramon y Cajal research contract from MICINN-Spain; Human Frontier Science Program Long-term Fellowship; NIH/NINDS; Biotechnology and Biological Sciences Research Council [BB/H003843/1] Funding Source: researchfish; Medical Research Council [MC_G1000734] Funding Source: researchfish; BBSRC [BB/H003843/1] Funding Source: UKRI; MRC [MC_G1000734] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039074, R01NS083390] Funding Source: NIH RePORTER	Elan Pharmaceuticals; Wellcome Trust(Wellcome TrustEuropean Commission); EU-FP7 Marie Curie Fellowship; Ramon y Cajal research contract from MICINN-Spain; Human Frontier Science Program Long-term Fellowship(Human Frontier Science Program); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work at Elan and some of the work at the University of Cambridge was funded by Elan Pharmaceuticals. Additional funding came from the Wellcome Trust, EU-FP7 Marie Curie Fellowship, a Ramon y Cajal research contract from MICINN-Spain, a Human Frontier Science Program Long-term Fellowship and the NIH/NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JR, 2009, J AM CHEM SOC, V131, P18314, DOI 10.1021/ja904716h; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen J, 2010, J AM CHEM SOC, V132, P17015, DOI 10.1021/ja107552s; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Jensen MR, 2009, STRUCTURE, V17, P1169, DOI 10.1016/j.str.2009.08.001; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kortvelyesi T, 2003, PROTEINS, V51, P340, DOI 10.1002/prot.10287; Landon MR, 2007, J MED CHEM, V50, P1231, DOI 10.1021/jm061134b; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Liu F, 2008, J NEUROCHEM, V105, P2435, DOI 10.1111/j.1471-4159.2008.05333.x; Liu J, 2003, GENE, V308, P1, DOI 10.1016/S0378-1119(03)00453-0; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Orwig SD, 2011, BIOCHEMISTRY-US, V50, P10647, DOI 10.1021/bi201619z; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Palokangas H, 1997, J CELL SCI, V110, P1767; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Saiki S, 2012, J NEUROL NEUROSUR PS, V83, P430, DOI 10.1136/jnnp-2011-301205; Salmon L, 2010, J AM CHEM SOC, V132, P8407, DOI 10.1021/ja101645g; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Sharma P, 2012, METHOD ENZYMOL, V506, P331, DOI 10.1016/B978-0-12-391856-7.00041-X; Shyra J., 2013, PLOS ONE; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vendruscolo M, 2007, CURR OPIN STRUC BIOL, V17, P15, DOI 10.1016/j.sbi.2007.01.002; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811831	68	92	99	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87133	10.1371/journal.pone.0087133	http://dx.doi.org/10.1371/journal.pone.0087133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551051	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500015
J	Yanchukov, A; Proulx, SR				Yanchukov, Alexey; Proulx, Stephen R.			Migration-Selection Balance at Multiple Loci and Selection on Dominance and Recombination	PLOS ONE			English	Article							GENE-FLOW; HETEROGENEOUS ENVIRONMENT; MULTILOCUS CLINES; GENOMIC ISLANDS; HYBRID ZONES; MATE CHOICE; EVOLUTION; SPECIATION; POPULATIONS; ADAPTATION	A steady influx of a single deleterious multilocus genotype will impose genetic load on the resident population and leave multiple descendants carrying various numbers of the foreign alleles. Provided that the foreign types are rare at equilibrium, and all immigrant genes are eventually eliminated by selection, the population structure can be inferred explicitly from the branching process taking place within a single immigrant lineage. Unless the migration and recombination rates were high, this novel method gives a close approximation to the simulation with all possible multilocus genotypes considered. Once the load and the foreign genotypes frequencies are known, it becomes possible to estimate selection acting on the invading modifiers of (i) dominance and (ii) recombination rate on the foreign gene block. We found that the modifiers of the (i) type are able to invade faster than the type (ii) modifier, however, this result only applies in the strong selection/low migration/low recombination scenario. Varying the number of genes in the immigrant genotype can have a non-monotonic effect on the migration load and the modifier's invasion rate: although blocks carrying more genes can give rise to longer lineages, they also experience stronger selection pressure. The heaviest load is therefore imposed by the genotypes carrying moderate numbers of genes.	[Yanchukov, Alexey; Proulx, Stephen R.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Yanchukov, A (corresponding author), Acad Sci Czech Republic, Inst Vertebrate Biol, Studenec, Czech Republic.	yawa33@gmail.com	Proulx, Stephen/C-9213-2009; Yanchukov, Alexey/A-2501-2014	Proulx, Stephen/0000-0003-0307-1907; Yanchukov, Alexey/0000-0002-9613-8770	NSF [EF-0742582]	NSF(National Science Foundation (NSF))	This work has been supported by the NSF grant EF-0742582 to SRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Agrawal AF, 2012, ANNU REV ECOL EVOL S, V43, P115, DOI 10.1146/annurev-ecolsys-110411-160257; Baird SJE, 2003, THEOR POPUL BIOL, V64, P451, DOI 10.1016/S0040-5809(03)00098-4; Baird SJE, 1995, EVOLUTION, V49, P1038, DOI [10.2307/2410429, 10.1111/j.1558-5646.1995.tb04431.x]; Bank C, 2012, GENETICS, V191, P845, DOI 10.1534/genetics.111.137513; BARTON N, 1986, HEREDITY, V57, P357, DOI 10.1038/hdy.1986.135; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; BARTON NH, 1983, EVOLUTION, V37, P454, DOI 10.1111/j.1558-5646.1983.tb05563.x; Barton NH, 2002, MULTILOCUS PACKAGE; Billiard S, 2005, EVOLUTION, V59, P13; Blanquart F, 2012, J EVOLUTION BIOL, V25, P1351, DOI 10.1111/j.1420-9101.2012.02524.x; Bolnick DI, 2007, EVOLUTION, V61, P2229, DOI 10.1111/j.1558-5646.2007.00179.x; Durinx M, 2009, EVOLUTION, V63, P334, DOI 10.1111/j.1558-5646.2008.00578.x; Gray JC, 2012, ECOL LETT, V15, P955, DOI 10.1111/j.1461-0248.2012.01814.x; HALDANE J. B. S., 1957, JOUR GENETICS, V55, P511, DOI 10.1007/BF02984069; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Harrison RG, 1993, HYBRID ZONES EVOLUTI; HEATHCOTE CR, 1965, J ROY STAT SOC B, V27, P138; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; KARLIN S, 1974, THEOR POPUL BIOL, V5, P59, DOI 10.1016/0040-5809(74)90052-5; Lenormand T, 2000, GENETICS, V156, P423; Macholan M, 2011, EVOLUTION, V65, P1428, DOI 10.1111/j.1558-5646.2011.01228.x; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Nagylaki T., 1992, INTRO THEORETICAL PO; Noor MAF, 2009, HEREDITY, V103, P439, DOI 10.1038/hdy.2009.151; Otto S.P., 2011, BIOLOGISTS GUIDE MAT; Otto SP, 1999, AM NAT, V153, P561, DOI 10.1086/303204; Papa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057033; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; Proulx SR, 2001, EVOLUTION, V55, P2401; Proulx SR, 2009, EVOLUTION, V63, P2031, DOI 10.1111/j.1558-5646.2009.00710.x; Rieseberg LH, 1999, GENETICS, V152, P713; Ronce O, 2001, EVOLUTION, V55, P1520, DOI 10.1111/j.0014-3820.2001.tb00672.x; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Servedio MR, 2007, EVOLUTION, V61, P2772, DOI 10.1111/j.1558-5646.2007.00247.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Servedio MR, 1997, EVOLUTION, V51, P1764, DOI 10.1111/j.1558-5646.1997.tb05100.x; Star B, 2007, GENETICS, V176, P1625, DOI 10.1534/genetics.107.071639; Storfer A, 1999, EVOLUTION, V53, P889, DOI 10.1111/j.1558-5646.1999.tb05383.x; SZYMURA JM, 1991, EVOLUTION, V45, P237, DOI 10.1111/j.1558-5646.1991.tb04400.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; van Doorn GS, 2006, AM NAT, V168, P742, DOI 10.1086/508634; Yanchukov A, 2012, EVOLUTION, V66, P1543, DOI 10.1111/j.1558-5646.2011.01551.x; Yeaman S, 2011, EVOLUTION, V65, P2123, DOI 10.1111/j.1558-5646.2011.01277.x; Yeaman S, 2011, EVOLUTION, V65, P1897, DOI 10.1111/j.1558-5646.2011.01269.x	46	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88651	10.1371/journal.pone.0088651	http://dx.doi.org/10.1371/journal.pone.0088651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551127	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500052
J	Allard, B; Bara, I; Gilbert, G; Carvalho, G; Trian, T; Ozier, A; Gillibert-Duplantier, J; Ousova, O; Maurat, E; Thumerel, M; Quignard, JF; Girodet, PO; Marthan, R; Berger, P				Allard, Benoit; Bara, Imane; Gilbert, Guillaume; Carvalho, Gabrielle; Trian, Thomas; Ozier, Annaig; Gillibert-Duplantier, Jennifer; Ousova, Olga; Maurat, Elise; Thumerel, Matthieu; Quignard, Jean-Francois; Girodet, Pierre-Olivier; Marthan, Roger; Berger, Patrick			Protease Activated Receptor-2 Expression and Function in Asthmatic Bronchial Smooth Muscle	PLOS ONE			English	Article							MAST-CELLS; TRYPTASE; PAR-2; CONTRIBUTES; THROMBIN; INDUCE	Asthmatic bronchial smooth muscle (BSM) is characterized by structural remodeling associated with mast cell infiltration displaying features of chronic degranulation. Mast cell-derived tryptase can activate protease activated receptor type-2 (PAR-2) of BSM cells. The aims of the present study were (i) to evaluate the expression of PAR-2 in both asthmatic and non asthmatic BSM cells and, (ii) to analyze the effect of prolonged stimulation of PAR-2 in asthmatic BSM cells on cell signaling and proliferation. BSM cells were obtained from both 33 control subjects and 22 asthmatic patients. PAR-2 expression was assessed by flow cytometry, western blot and quantitative RT-PCR. Calcium response, transduction pathways and proliferation were evaluated before and following PAR-2 stimulation by SLIGKV-NH2 or trypsin for 1 to 3 days. Asthmatic BSM cells expressed higher basal levels of functional PAR-2 compared to controls in terms of mRNA, protein expression and calcium response. When PAR-2 expression was increased by means of lentivirus in control BSM cells to a level similar to that of asthmatic cells, PAR-2-induced calcium response was then similar in both types of cell. However, repeated PAR-2 stimulations increased the proliferation of asthmatic BSM cells but not that of control BSM cells even following lentiviral over-expression of PAR-2. Such an increased proliferation was related to an increased phosphorylation of ERK in asthmatic BSM cells. In conclusion, we have demonstrated that asthmatic BSM cells express increased baseline levels of functional PAR-2. This higher basal level of PAR-2 accounts for the increased calcium response to PAR-2 stimulation, whereas the increased proliferation to repeated PAR-2 stimulation is related to increased ERK phosphorylation.	[Allard, Benoit; Bara, Imane; Gilbert, Guillaume; Carvalho, Gabrielle; Trian, Thomas; Ozier, Annaig; Gillibert-Duplantier, Jennifer; Ousova, Olga; Maurat, Elise; Thumerel, Matthieu; Quignard, Jean-Francois; Girodet, Pierre-Olivier; Marthan, Roger; Berger, Patrick] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, Dept Pharmacol, U1045, Bordeaux, France; [Allard, Benoit; Bara, Imane; Gilbert, Guillaume; Carvalho, Gabrielle; Trian, Thomas; Ozier, Annaig; Gillibert-Duplantier, Jennifer; Ousova, Olga; Maurat, Elise; Thumerel, Matthieu; Quignard, Jean-Francois; Girodet, Pierre-Olivier; Marthan, Roger; Berger, Patrick] INSERM, Ctr Rech Cardiothorac Bordeaux, U1045, Bordeaux, France; [Ozier, Annaig; Thumerel, Matthieu; Girodet, Pierre-Olivier; Marthan, Roger; Berger, Patrick] CHU Bordeaux, Serv Explorat Fonctionnelle Resp, Pessac, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Berger, P (corresponding author), Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, Dept Pharmacol, U1045, Bordeaux, France.	patrick.berger@u-bordeaux2.fr	Berger, Patrick/D-8779-2012; QUIGNARD, Jean-Francois/M-2837-2014	Berger, Patrick/0000-0003-4702-0343; Allard, Benoit/0000-0002-7093-5851; thumerel, matthieu/0000-0003-4673-8433; trian, thomas/0000-0002-2567-4867; Girodet, Pierre-Olivier/0000-0002-9298-9711; Marthan, Roger/0000-0001-5412-5712	Agence Nationale de la Recherche [ANR Ndegrees2010 CESA 001 01 (2010-0145)]; France and the "Fondation pour la Recherche Medicale (FRM)'', France; "Societe de Pneumologie de Langue Francaise'', France; Fondation pour la Recherche Medicale (FRM)	Agence Nationale de la Recherche(French National Research Agency (ANR)); France and the "Fondation pour la Recherche Medicale (FRM)'', France; "Societe de Pneumologie de Langue Francaise'', France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This study was supported by a grant from the "Agence Nationale de la Recherche (ANR N degrees 2010 CESA 001 01 (2010-0145))'', France and the "Fondation pour la Recherche Medicale (FRM)'', France; Mrs. Bara was funded by the "Societe de Pneumologie de Langue Francaise'', France. Mrs Jennifer Gillibert-Duplantier was funded by the "Fondation pour la Recherche Medicale (FRM)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bara I, 2010, EUR RESPIR J, V36, P1174, DOI 10.1183/09031936.00019810; Bara I, 2012, AM J RESP CRIT CARE, V185, P715, DOI 10.1164/rccm.201105-0915OC; Begueret H, 2007, THORAX, V62, P8, DOI 10.1136/thx.2006.062141; Berger P, 2003, FASEB J, V17, P2139, DOI 10.1096/fj.03-0041fje; Berger P, 2001, J APPL PHYSIOL, V91, P1372, DOI 10.1152/jappl.2001.91.3.1372; Berger P, 2001, J APPL PHYSIOL, V91, P995, DOI 10.1152/jappl.2001.91.2.995; Berger P, 1999, CLIN EXP ALLERGY, V29, P804; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Carvalho G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018159; Chambers LS, 2001, AM J PHYSIOL-LUNG C, V281, pL1369, DOI 10.1152/ajplung.2001.281.6.L1369; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; *GINA GLOB STR AST, 2012, GINA GLOB STRAT ASTH; Girodet PO, 2010, ALLERGY, V65, P1004, DOI 10.1111/j.1398-9995.2009.02308.x; Hamilton JR, 1999, BRIT J PHARMACOL, V127, P617, DOI 10.1038/sj.bjp.0702583; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; Ramos-Barbon D, 2010, AM J RESP CRIT CARE, V182, P317, DOI 10.1164/rccm.200905-0745OC; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Tran T, 2003, BRIT J PHARMACOL, V138, P865, DOI 10.1038/sj.bjp.0705106; Trian T, 2006, AM J RESP CELL MOL, V34, P49, DOI 10.1165/rcmb.2005-0187OC; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; WALLS AF, 1990, J PATHOL, V162, P119, DOI 10.1002/path.1711620204; Yang WD, 2006, J IMMUNOL, V176, P1238, DOI 10.4049/jimmunol.176.2.1238	27	14	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e86945	10.1371/journal.pone.0086945	http://dx.doi.org/10.1371/journal.pone.0086945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551046	gold, Green Submitted, Green Published			2022-12-27	WOS:000331266000008
J	Chen, HJ; Chen, CY				Chen, Hwajiun; Chen, Chun-Yao			Starvation Induces Phenotypic Diversification and Convergent Evolution in Vibrio vulnificus	PLOS ONE			English	Article							LONG-TERM SURVIVAL; STATIONARY-PHASE; GROWTH ADVANTAGE; ESCHERICHIA-COLI; NONCULTURABLE STATE; REGULATORY MUTATIONS; RESUSCITATION; TEMPERATURE; CULTURES; PATHOGEN	Starvation is a common stress experienced by bacteria living in natural environments and the ability to adapt to and survive intense stress is of paramount importance for any bacterial population. A series of starvation experiments were conducted using V. vulnificus 93U204 in phosphate-buffered saline and seawater. The starved population entered the death phase during the first week and approximately 1% of cells survived. After that the population entered a long-term stationary phase, and could survive for years. Starvation-induced diversification (SID) of phenotypes was observed in starved populations and phenotypic variants (PVs) appeared in less than 8 days. The cell density, rather than the population size, had a major effect on the extent of SID. SID was also observed in strain YJ016, where it evolved at a faster pace. PVs appeared to emerge in a fixed order: PV with reduced motility, PV with reduced proteolytic activity, and PV with reduced hemolytic activity. All of the tested PVs had growth advantages in the stationary phase phenotypes and increased fitness compared with 93U204 cells in co-culture competition experiments, which indicates that they had adapted to starvation. We also found that SID occurred in natural seawater with a salinity of 1%-3%, so this mechanism may facilitate bacterial adaptation in natural environments.	[Chen, Hwajiun; Chen, Chun-Yao] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Chen, Hwajiun; Chen, Chun-Yao] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan	Tzu Chi University; Tzu Chi University	Chen, CY (corresponding author), Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan.	cychen@mail.tcu.edu.tw		Chen, Chun-Yao/0000-0002-5028-8319	National Science Council [NSC96-2311-B-320-004]; Tzu Chi University [TCIRP96003-01]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu Chi University	National Science Council grant NSC96-2311-B-320-004, (http://web1.nsc.gov.tw/). Tzu Chi University grant TCIRP96003-01, (http://www.tcu.edu.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel BKN, 2008, MICROBIOL RES, V163, P323, DOI 10.1016/j.micres.2006.06.006; AMY PS, 1983, APPL ENVIRON MICROB, V45, P1109, DOI 10.1128/AEM.45.3.1109-1115.1983; Arias CR, 1998, APPL ENVIRON MICROB, V64, P3403; Bacun-Druzina V, 2007, FEMS MICROBIOL LETT, V266, P119, DOI 10.1111/j.1574-6968.2006.00515.x; Biosca EG, 1996, APPL ENVIRON MICROB, V62, P450, DOI 10.1128/AEM.62.2.450-455.1996; Chen C, 2005, THESIS CHUNG SHAN ME; Chen CY, 2006, J WORLD AQUACULT SOC, V37, P82, DOI 10.1111/j.1749-7345.2006.00010.x; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Chen SY, 2009, INT J FOOD MICROBIOL, V129, P157, DOI 10.1016/j.ijfoodmicro.2008.11.009; Dalsgaard I, 1999, DIS AQUAT ORGAN, V35, P187, DOI 10.3354/dao035187; Daniels NA, 2011, CLIN INFECT DIS, V52, P788, DOI 10.1093/cid/ciq251; DEATH A, 1993, J BACTERIOL, V175, P1475, DOI 10.1128/JB.175.5.1475-1483.1993; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Ferenci T, 2003, TRENDS MICROBIOL, V11, P457, DOI 10.1016/j.tim.2003.08.003; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Fouz B, 2006, J FISH DIS, V29, P285, DOI 10.1111/j.1365-2761.2006.00719.x; Gonzalez C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000208; Gonzalez-Escalona N, 2006, ENVIRON MICROBIOL, V8, P658, DOI 10.1111/j.1462-2920.2005.00943.x; Gopal S, 2005, INT J FOOD MICROBIOL, V102, P151, DOI 10.1016/j.ijfoodmicro.2004.12.011; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Helmus RA, 2012, FEMS MICROBIOL ECOL, V79, P218, DOI 10.1111/j.1574-6941.2011.01211.x; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; HILL WE, 1991, APPL ENVIRON MICROB, V57, P707, DOI 10.1128/AEM.57.3.707-711.1991; Hulsmann A, 2003, APPL ENVIRON MICROB, V69, P6114, DOI 10.1128/AEM.69.10.6114-6120.2003; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kim SM, 2012, MICROBIOL-SGM, V158, P2017, DOI 10.1099/mic.0.059071-0; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Mahmud ZH, 2010, APPL ENVIRON MICROB, V76, P4890, DOI 10.1128/AEM.00636-10; Marco-Noales E, 1999, APPL ENVIRON MICROB, V65, P1117; Martinez-Rodriguez A, 2004, INT J FOOD MICROBIOL, V90, P321, DOI 10.1016/S0168-1605(03)00325-8; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Notley-McRobb L, 2000, GENETICS, V156, P1493; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P33, DOI 10.1046/j.1462-2920.1999.00002.x; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; Notley-McRobb L, 2003, P ROY SOC B-BIOL SCI, V270, P843, DOI 10.1098/rspb.2002.2295; OLIVER JD, 1995, APPL ENVIRON MICROB, V61, P2620, DOI 10.1128/AEM.61.7.2620-2623.1995; OLIVER JD, 1995, APPL ENVIRON MICROB, V61, P2624, DOI 10.1128/AEM.61.7.2624-2630.1995; OSTLING J, 1995, J BACTERIOL, V177, P6978, DOI 10.1128/jb.177.23.6978-6982.1995; Park KJ, 2004, J BACTERIOL, V186, P3304, DOI 10.1128/JB.186.11.3304-3312.2004; Paul K, 2004, INFECT IMMUN, V72, P5478, DOI 10.1128/IAI.72.9.5478-5482.2004; Petrun B, 2013, CAN J MICROBIOL, V59, P130, DOI 10.1139/cjm-2012-0439; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Silby MW, 2005, APPL ENVIRON MICROB, V71, P569, DOI 10.1128/AEM.71.1.569-573.2005; Smith B, 2006, APPL ENVIRON MICROB, V72, P1445, DOI 10.1128/AEM.72.2.1445-1451.2006; Stretton S, 1997, FEMS MICROBIOL LETT, V146, P23, DOI 10.1016/S0378-1097(96)00387-4; Tark M, 2005, J BACTERIOL, V187, P5203, DOI 10.1128/JB.187.15.5203-5213.2005; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Vattakaven T, 2006, APPL ENVIRON MICROB, V72, P6508, DOI 10.1128/AEM.00798-06; Wei XM, 1998, APPL ENVIRON MICROB, V64, P1708; Wong HC, 2005, J FOOD PROTECT, V68, P154, DOI 10.4315/0362-028X-68.1.154; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x	57	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88658	10.1371/journal.pone.0088658	http://dx.doi.org/10.1371/journal.pone.0088658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551129	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000049
J	Karako-Lampert, S; Zoccola, D; Salmon-Divon, M; Katzenellenbogen, M; Tambutte, S; Bertucci, A; Hoegh-Guldberg, O; Deleury, E; Allemand, D; Levy, O				Karako-Lampert, Sarit; Zoccola, Didier; Salmon-Divon, Mali; Katzenellenbogen, Mark; Tambutte, Sylvie; Bertucci, Anthony; Hoegh-Guldberg, Ove; Deleury, Emeline; Allemand, Denis; Levy, Oren			Transcriptome Analysis of the Scleractinian Coral Stylophora pistillata	PLOS ONE			English	Article							MOLECULAR-CLONING; ORGANIC MATRIX; STONY CORALS; GENE; EXPRESSION; PROTEIN; EVOLUTION; CALCIFICATION; DATABASE; FAMILY	The principal architects of coral reefs are the scleractinian corals; these species are divided in two major clades referred to as "robust'' and "complex'' corals. Although the molecular diversity of the "complex'' clade has received considerable attention, with several expressed sequence tag (EST) libraries and a complete genome sequence having been constructed, the "robust'' corals have received far less attention, despite the fact that robust corals have been prominent focal points for ecological and physiological studies. Filling this gap affords important opportunities to extend these studies and to improve our understanding of the differences between the two major clades. Here, we present an EST library from Stylophora pistillata (Esper 1797) and systematically analyze the assembled transcripts compared to putative homologs from the complete proteomes of six well-characterized metazoans: Nematostella vectensis, Hydra magnipapillata, Caenorhabditis elegans, Drosophila melanogaster, Strongylocentrotus purpuratus, Ciona intestinalis and Homo sapiens. Furthermore, comparative analyses of the Stylophora pistillata ESTs were performed against several Cnidaria from the Scleractinia, Actiniaria and Hydrozoa, as well as against other stony corals separately. Functional characterization of S. pistillata transcripts into KOG/COG categories and further description of Wnt and bone morphogenetic protein (BMP) signaling pathways showed that the assembled EST library provides sufficient data and coverage. These features of this new library suggest considerable opportunities for extending our understanding of the molecular and physiological behavior of "robust'' corals.	[Karako-Lampert, Sarit; Katzenellenbogen, Mark; Levy, Oren] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Zoccola, Didier; Tambutte, Sylvie; Bertucci, Anthony; Allemand, Denis] Ctr Sci Monaco, Monaco, Monaco; [Salmon-Divon, Mali] Ariel Univ, Dept Mol Biol, Ariel, Israel; [Bertucci, Anthony; Deleury, Emeline] Univ Nice Sophia Antipolis, UFR Sci, F-06189 Nice, France; [Bertucci, Anthony] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld 4811, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Deleury, Emeline] Inst Sophia Agrobiotech INRA 1355, CNRS 7254, Sophia Antipolis, France	Bar Ilan University; Ariel University; UDICE-French Research Universities; Universite Cote d'Azur; James Cook University; University of Queensland; INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Zoccola, D (corresponding author), Ctr Sci Monaco, Monaco, Monaco.	zoccola@centrescientifique.mc; oren.levy@biu.ac.il	Zoccola, Didier/A-5997-2009; Salmon-Divon, Mali/AAG-4479-2019; Bertucci, Anthony/O-6974-2014; Hoegh-Guldberg, Ove/ABA-5420-2020	Zoccola, Didier/0000-0002-1524-8098; Salmon-Divon, Mali/0000-0002-7272-0846; Bertucci, Anthony/0000-0001-5727-7228; Hoegh-Guldberg, Ove/0000-0001-7510-6713	Government of the Principality of Monaco; Israeli Science Foundation [243/10]	Government of the Principality of Monaco; Israeli Science Foundation(Israel Science Foundation)	This study was conducted as part of the Centre Scientifique de Monaco Research Program, supported by the Government of the Principality of Monaco. It was partially funded by an Israeli Science Foundation (No. 243/10) grant to OL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand D, 1998, J EXP BIOL, V201, P2001; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; Ball EE, 2002, P 9 INT COR REEF S B, V1, P395; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; Bode HR, 1996, J CELL SCI, V109, P1155; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Gattuso JP, 1999, AM ZOOL, V36; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang SPL, 1999, BIOCHEM BIOPH RES CO, V258, P457, DOI 10.1006/bbrc.1999.0663; Hwang SPL, 2003, ZOOL STUD, V42, P227; Iguchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020140; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Lelong C, 2001, BIOCHIMIE, V83, P423, DOI 10.1016/S0300-9084(01)01260-3; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Loya Y, 2000, PLEN LECT 9 INT COR; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; Nederbragt AJ, 2002, DEV BIOL, V246, P341, DOI 10.1006/dbio.2002.0653; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Rentzsch F, 2006, DEV BIOL, V296, P375, DOI 10.1016/j.ydbio.2006.06.003; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; RINKEVICH B, 1984, MAR BIOL, V80, P1, DOI 10.1007/BF00393120; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Shinzato C, 2011, NATURE; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Steele RE, 1999, GENE, V239, P91, DOI 10.1016/S0378-1119(99)00373-X; Suga H, 1999, FEBS LETT, V453, P346, DOI 10.1016/S0014-5793(99)00749-8; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Tambutte E, 1996, J EXP BIOL, V199, P1029; TAMBUTTE E, 1995, MAR BIOL, V122, P453, DOI 10.1007/BF00350879; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Voolstra CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020392; Weis VM, 2009, SCIENCE, V324, P1153, DOI 10.1126/science.1172540; WHARTON KA, 1991, P NATL ACAD SCI USA, V88, P9214, DOI 10.1073/pnas.88.20.9214; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/00007632-200208151-00002; YAMASHIRO H, 1995, J EXP MAR BIOL ECOL, V191, P57, DOI 10.1016/0022-0981(95)00045-S; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010; Zoccola D, 1999, GENE, V227, P157, DOI 10.1016/S0378-1119(98)00602-7; Zoccola D, 2009, MAR BIOTECHNOL, V11, P260, DOI 10.1007/s10126-008-9141-6	63	42	42	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88615	10.1371/journal.pone.0088615	http://dx.doi.org/10.1371/journal.pone.0088615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551124	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000331266000046
J	Nicolas, D; Rochette, S; Llope, M; Licandro, P				Nicolas, Delphine; Rochette, Sebastien; Llope, Marcos; Licandro, Priscilla			Spatio-Temporal Variability of the North Sea Cod Recruitment in Relation to Temperature and Zooplankton	PLOS ONE			English	Article							GADUS-MORHUA; ATLANTIC COD; CALANUS-FINMARCHICUS; SPAWNING STOCK; PREY AVAILABILITY; CONTINENTAL-SHELF; CLIMATE-CHANGE; MARINE FISH; GROWTH; PLANKTON	The North Sea cod (Gadus morhua, L.) stock has continuously declined over the past four decades linked with overfishing and climate change. Changes in stock structure due to overfishing have made the stock largely dependent on its recruitment success, which greatly relies on environmental conditions. Here we focus on the spatio-temporal variability of cod recruitment in an effort to detect changes during the critical early life stages. Using International Bottom Trawl Survey (IBTS) data from 1974 to 2011, a major spatio-temporal change in the distribution of cod recruits was identified in the late 1990s, characterized by a pronounced decrease in the central and southeastern North Sea stock. Other minor spatial changes were also recorded in the mid-1980s and early 1990s. We tested whether the observed changes in recruits distribution could be related with direct (i. e. temperature) and/or indirect (i. e. changes in the quantity and quality of zooplankton prey) effects of climate variability. The analyses were based on spatially-resolved time series, i. e. sea surface temperature (SST) from the Hadley Center and zooplankton records from the Continuous Plankton Recorder Survey. We showed that spring SST increase was the main driver for the most recent decrease in cod recruitment. The late 1990s were also characterized by relatively low total zooplankton biomass, particularly of energy-rich zooplankton such as the copepod Calanus finmarchicus, which have further contributed to the decline of North Sea cod recruitment. Long-term spatially-resolved observations were used to produce regional distribution models that could further be used to predict the abundance of North Sea cod recruits based on temperature and zooplankton food availability.	[Nicolas, Delphine; Licandro, Priscilla] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Rochette, Sebastien] IFREMER, Dept Coastal Environm Dynam, Plouzane, France; [Llope, Marcos] Ctr Oceanog Cadiz, Inst Espanol Oceanog, Cadiz, Andalucia, Spain	Ifremer; Spanish Institute of Oceanography	Nicolas, D (corresponding author), Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England.	delphine.nicolas@irstea.fr	Llope, Marcos/T-6885-2017	Llope, Marcos/0000-0003-1408-6848; Rochette, Sebastien/0000-0002-1565-9313; LICANDRO, Priscilla/0000-0001-6963-0068; Nicolas, Delphine/0000-0002-9101-2271	European Community within the Ocean of Tomorrow call [266445]; Marie Curie European Reintegration; Directorate For Geosciences [1154661] Funding Source: National Science Foundation	European Community within the Ocean of Tomorrow call; Marie Curie European Reintegration(European Commission); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) within the Ocean of Tomorrow call under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS). M. Ll. acknowledges support from a Marie Curie European Reintegration Grant (FP7). The funders had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2012, MAR ECOL PROG SER, V445, P293, DOI 10.3354/meps09493; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Brander K, 2004, CAN J FISH AQUAT SCI, V61, P1558, DOI 10.1139/F04-087; BRANDER KM, 1994, ICES J MAR SCI, V51, P71, DOI 10.1006/jmsc.1994.1007; Brander KM, 2005, ICES J MAR SCI, V62, P339, DOI 10.1016/j.icesjms.2004.07.029; Brown J. H., 1995, MACROECOLOGY; Cabral RB, 2013, ECOL MODEL, V253, P1, DOI 10.1016/j.ecolmodel.2012.12.031; Ciannelli L, 2004, ECOLOGY, V85, P3418, DOI 10.1890/03-0755; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; CUSHING DH, 1984, J CONSEIL, V41, P159; CUSHING DH, 1990, MAR ECOL PROG SER, V58, P287; Daewel U, 2011, CAN J FISH AQUAT SCI, V68, P426, DOI 10.1139/F10-164; Dickson R., 1974, EARLY LIFE HIST FISH, P69; Durant JM, 2013, MAR ECOL PROG SER, V480, P277, DOI 10.3354/meps10308; ECONOMOU AN, 1991, J CONSEIL, V47, P339; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Engelhard GH, 2010, COD FUTURE CLIMATE C; Gascuel D, 2016, FISH FISH, V17, P31, DOI 10.1111/faf.12090; Geffen AJ, 2006, J FISH BIOL, V69, P1060, DOI 10.1111/j.1095-8649.2006.01181.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Heath MR, 2007, FISH OCEANOGR, V16, P169, DOI 10.1111/j.1365-2419.2006.00423.x; Heath MR, 2008, FISH RES, V93, P92, DOI 10.1016/j.fishres.2008.02.014; Hjermann DO, 2013, MAR ECOL PROG SER, V480, P263, DOI 10.3354/meps10315; Hjollo SS, 2009, J MARINE SYST, V78, P180, DOI 10.1016/j.jmarsys.2009.06.001; Holmes S, 2006, J FISH BIOL, V69, P244; Holt J, 2012, PROG OCEANOGR, V106, P96, DOI 10.1016/j.pocean.2012.08.001; Houde Edward D., 2002, P64; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hutchinson WF, 2001, MAR ECOL PROG SER, V223, P251, DOI 10.3354/meps223251; ICES, 2012, N SEA COD SUB 4 N SE; Isaaks EH, 1989, APPL GEOSTATISTICS; Jennings S, 2004, J ANIM ECOL, V73, P632, DOI 10.1111/j.0021-8790.2004.00839.x; Jennings S, 1999, FISH RES, V40, P125, DOI 10.1016/S0165-7836(98)00208-2; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kempf A, 2013, FISH OCEANOGR, V22, P174, DOI 10.1111/fog.12013; Kempf A, 2009, CAN J FISH AQUAT SCI, V66, P633, DOI 10.1139/F09-022; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Llope M, 2012, GLOBAL CHANGE BIOL, V18, P106, DOI 10.1111/j.1365-2486.2011.02492.x; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Loots C, 2010, ICES J MAR SCI, V67, P244, DOI 10.1093/icesjms/fsp238; Moller EF, 2012, LIMNOL OCEANOGR, V57, P211, DOI 10.4319/lo.2012.57.1.0211; Munk P, 1997, J FISH BIOL, V51, P340, DOI 10.1111/j.1095-8649.1997.tb06107.x; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Olsen EM, 2011, P ROY SOC B-BIOL SCI, V278, P504, DOI 10.1098/rspb.2010.1465; Olsen EM, 2009, ECOL LETT, V12, P622, DOI 10.1111/j.1461-0248.2009.01311.x; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; Ottersen G, 2006, FISH OCEANOGR, V15, P230, DOI 10.1111/j.1365-2419.2006.00404.x; Ottersen G, 2010, J MARINE SYST, V79, P343, DOI 10.1016/j.jmarsys.2008.12.013; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Philippart CJM, 2011, J EXP MAR BIOL ECOL, V400, P52, DOI 10.1016/j.jembe.2011.02.023; Pitois SG, 2008, ICES J MAR SCI, V65, P1559, DOI 10.1093/icesjms/fsn150; Planque B, 1996, MAR ECOL PROG SER, V134, P101, DOI 10.3354/meps134101; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Planque B, 2000, ICES J MAR SCI, V57, P1528, DOI 10.1006/jmsc.2000.0970; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; *R DEV COR TEAM, 2005, R LANG ENV STAT 609; Rey-Rassat C, 2002, MAR ECOL PROG SER, V238, P301, DOI 10.3354/meps238301; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Rindorf A, 2006, J APPL ECOL, V43, P445, DOI 10.1111/j.1365-2664.2006.01161.x; Rochette S, 2012, FISH OCEANOGR, V21, P229, DOI 10.1111/j.1365-2419.2012.00621.x; Rouyer T, 2011, GLOBAL CHANGE BIOL, V17, P3046, DOI 10.1111/j.1365-2486.2011.02443.x; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Svendsen E., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P641; THORISSON K, 1989, RAP PROCES, V191, P264; van der Meeren T, 2006, AQUAC RES, V37, P898, DOI 10.1111/j.1365-2109.2006.01510.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wright PJ, 2006, J FISH BIOL, V69, P181, DOI 10.1111/j.1095-8649.2006.01262.x; Yoneda M, 2005, J FISH BIOL, V67, P1225, DOI 10.1111/j.1095-8649.2005.00819.x	76	24	24	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88447	10.1371/journal.pone.0088447	http://dx.doi.org/10.1371/journal.pone.0088447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551103	gold, Green Published			2022-12-27	WOS:000331266000038
J	Ferraro, AJ; Charlton-Perez, AJ; Highwood, EJ				Ferraro, Angus J.; Charlton-Perez, Andrew J.; Highwood, Eleanor J.			A Risk-Based Framework for Assessing the Effectiveness of Stratospheric Aerosol Geoengineering	PLOS ONE			English	Article							CLIMATE	Geoengineering by stratospheric aerosol injection has been proposed as a policy response to warming from human emissions of greenhouse gases, but it may produce unequal regional impacts. We present a simple, intuitive risk-based framework for classifying these impacts according to whether geoengineering increases or decreases the risk of substantial climate change, with further classification by the level of existing risk from climate change from increasing carbon dioxide concentrations. This framework is applied to two climate model simulations of geoengineering counterbalancing the surface warming produced by a quadrupling of carbon dioxide concentrations, with one using a layer of sulphate aerosol in the lower stratosphere, and the other a reduction in total solar irradiance. The solar dimming model simulation shows less regional inequality of impacts compared with the aerosol geoengineering simulation. In the solar dimming simulation, 10% of the Earth's surface area, containing 10% of its population and 11% of its gross domestic product, experiences greater risk of substantial precipitation changes under geoengineering than under enhanced carbon dioxide concentrations. In the aerosol geoengineering simulation the increased risk of substantial precipitation change is experienced by 42% of Earth's surface area, containing 36% of its population and 60% of its gross domestic product.	[Ferraro, Angus J.; Charlton-Perez, Andrew J.; Highwood, Eleanor J.] Univ Reading, Dept Meteorol, Reading, Berks, England	University of Reading	Ferraro, AJ (corresponding author), Univ Reading, Dept Meteorol, Reading, Berks, England.	a.j.ferraro@exeter.ac.uk	Charlton-Perez, Andrew/F-4079-2010; Ferraro, Angus/F-8968-2012	Charlton-Perez, Andrew/0000-0001-8179-6220; Ferraro, Angus/0000-0002-3977-7306	UK Natural Environment Research Council [NE/I528569/1]; NERC [NE/J017221/1] Funding Source: UKRI; Natural Environment Research Council [NE/J017221/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is funded by the UK Natural Environment Research Council grant number NE/I528569/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Center for International Earth Science Information Network (CIESIN)/Columbia University United Nations Food and Agriculture Programme (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Crutzen PJ, 2006, CLIM CHANGE; Ferraro AJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049761; Forster PM, 2000, CLIM DYNAM, V16, P833, DOI 10.1007/s003820000083; Fujii Y, 2011, J ATMOS SOL-TERR PHY, V73, P643, DOI 10.1016/j.jastp.2011.01.005; Hommel R, 2011, ATMOS SCI LETT, V12, P168, DOI 10.1002/asl.285; Irvine PJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044447; Keith DW, 2000, ANNU REV ENERG ENV, V25, P245, DOI 10.1146/annurev.energy.25.1.245; Kravitz B, 2013, J GEOPHYS RES-ATMOS, V118, P8320, DOI 10.1002/jgrd.50646; Kravitz B, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017341; Kravitz B, 2011, ATMOS SCI LETT, V12, P162, DOI 10.1002/asl.316; Marsh T., 2007, Weather, V62, P87, DOI 10.1002/wea.67; Moreno-Cruz JB, 2012, CLIMATIC CHANGE, V110, P649, DOI 10.1007/s10584-011-0103-z; Niemeier U, 2013, J GEOPHYS RES-ATMOS, V118, P11905, DOI 10.1002/2013JD020445; Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103; Pope FD, 2012, NAT CLIM CHANGE, V2, P713, DOI 10.1038/NCLIMATE1528; Rasch PJ, 2008, PHILOS T R SOC A, V366, P4007, DOI 10.1098/rsta.2008.0131; Ricke KL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014021; Ricke KL, 2010, NAT GEOSCI, V3, P537, DOI [10.1038/NGEO915, 10.1038/ngeo915]; Robock A, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1175/2779.1; Tilmes S, 2013, J GEOPHYS R IN PRESS, DOI [10.1002/jgra.50868, DOI 10.1002/JGRA.50868]; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4	23	13	13	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88849	10.1371/journal.pone.0088849	http://dx.doi.org/10.1371/journal.pone.0088849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533155	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000331262600113
J	Janssens, L; Brumagne, S; McConnell, AK; Claeys, K; Pijnenburg, M; Goossens, N; Burtin, C; Janssens, W; Decramer, M; Troosters, T				Janssens, Lotte; Brumagne, Simon; McConnell, Alison K.; Claeys, Kurt; Pijnenburg, Madelon; Goossens, Nina; Burtin, Chris; Janssens, Wim; Decramer, Marc; Troosters, Thierry			Impaired Postural Control Reduces Sit-to-Stand-to-Sit Performance in Individuals with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							MUSCLE STRENGTH; FUNCTIONAL PERFORMANCE; NORMATIVE DATA; BALANCE; PEOPLE; COPD; EXERCISE; FALLS; TASK	Background: Functional activities, such as the sit-to-stand-to-sit (STSTS) task, are often impaired in individuals with chronic obstructive pulmonary disease (COPD). The STSTS task places a high demand on the postural control system, which has been shown to be impaired in individuals with COPD. It remains unknown whether postural control deficits contribute to the decreased STSTS performance in individuals with COPD. Methods: Center of pressure displacement was determined in 18 individuals with COPD and 18 age/gender-matched controls during five consecutive STSTS movements with vision occluded. The total duration, as well as the duration of each sit, sit-to-stand, stand and stand-to-sit phase was recorded. Results: Individuals with COPD needed significantly more time to perform five consecutive STSTS movements compared to healthy controls (1966 vs. 1364 seconds, respectively; p = 0.001). The COPD group exhibited a significantly longer stand phase (p = 0.028) and stand-to-sit phase (p = 0.001) compared to the control group. In contrast, the duration of the sit phase (p = 0.766) and sit-to-stand phase (p = 0.999) was not different between groups. Conclusions: Compared to healthy individuals, individuals with COPD needed significantly more time to complete those phases of the STSTS task that require the greatest postural control. These findings support the proposition that suboptimal postural control is an important contributor to the decreased STSTS performance in individuals with COPD.	[Janssens, Lotte; Brumagne, Simon; Claeys, Kurt; Pijnenburg, Madelon; Goossens, Nina; Burtin, Chris; Decramer, Marc; Troosters, Thierry] Univ Louvain, Dept Rehabil Sci, KU Leuven, Louvain, Belgium; [McConnell, Alison K.] Brunel Univ, Ctr Sports Med & Human Performance, Uxbridge UB8 3PH, Middx, England; [Claeys, Kurt] Univ Leuven KULAB, Dept Rehabil Sci, KU Leuven, Brugge, Belgium; [Burtin, Chris; Janssens, Wim; Decramer, Marc; Troosters, Thierry] Univ Hosp Leuven, Resp Rehabil & Resp Div, Louvain, Belgium; [Burtin, Chris] Fontys Univ Appl Sci, Dept Allied Hlth Profess, Eindhoven, Netherlands	KU Leuven; Brunel University; KU Leuven; KU Leuven; University Hospital Leuven	Janssens, L (corresponding author), Univ Louvain, Dept Rehabil Sci, KU Leuven, Louvain, Belgium.	Lotte.Janssens@faber.kuleuven.be	burtin, chris/B-3343-2015; McConnell, Alison/ABB-1170-2020; McConnell, Alison K/G-5810-2014; Janssens, Lotte/T-1845-2017; Goossens, Nina/AAH-9865-2021; Claeys, Kurt/AAW-3505-2020	McConnell, Alison K/0000-0002-3160-673X; Janssens, Lotte/0000-0002-6133-4915; Goossens, Nina/0000-0002-9458-3125; Brumagne, Simon/0000-0002-0251-9338; Claeys, Kurt/0000-0002-2794-3071; Janssens, Wim/0000-0003-1830-2982	Research Foundation - Flanders (FWO) [1.5.104.03, G.0674.09, G.0871.13]	Research Foundation - Flanders (FWO)(FWO)	This work was supported by The Research Foundation - Flanders (FWO) grants 1.5.104.03, G.0674.09 and G.0871.13. Madelon Pijnenburg is PhD fellow of Agency for Innovation by Science and Technology - Flanders (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcelus A, 2009, IEEE T BIO-MED ENG, V56, P2485, DOI 10.1109/TBME.2009.2026733; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Beauchamp MK, 2012, CHEST, V141, P1496, DOI 10.1378/chest.11-1708; Buatois S, 2008, J AM GERIATR SOC, V56, P1575, DOI 10.1111/j.1532-5415.2008.01777.x; Butcher Scott J, 2004, J Cardiopulm Rehabil, V24, P274, DOI 10.1097/00008483-200407000-00013; Butcher SJ, 2012, INT J CHRONIC OBSTR, V7, P537, DOI 10.2147/COPD.S34170; Chang AT, 2008, J CARDIOPULM REHABIL, V28, P142, DOI 10.1097/01.HCR.0000314209.17300.cc; Claeys K, 2012, J ELECTROMYOGR KINES, V22, P821, DOI 10.1016/j.jelekin.2012.04.007; Dall PM, 2010, APPL ERGON, V41, P58, DOI 10.1016/j.apergo.2009.04.005; Rocco CCD, 2011, CLINICS, V66, P125, DOI 10.1590/S1807-59322011000100022; DECRAMER M, 1994, AM J RESP CRIT CARE, V150, P11, DOI 10.1164/ajrccm.150.1.8025735; Dubost V, 2005, PHYS THER, V85, P404, DOI 10.1093/ptj/85.5.404; Duchateau J, 2013, J APPL PHYSL; Eisner MD, 2011, THORAX, V66, P108, DOI 10.1136/thx.2010.137661; Engel R, 2011, J ALTERN COMPLEM MED, V17, P797, DOI 10.1089/acm.2010.0517; Gosselink R, 2011, EUR RESPIR J, V37, P416, DOI 10.1183/09031936.00031810; Hellstrom K, 2009, CLIN REHABIL, V23, P1136, DOI 10.1177/0269215509342329; Hodges PW, 2000, J PHYSIOL-LONDON, V522, P165, DOI 10.1111/j.1469-7793.2000.t01-1-00165.xm; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/0021-9290(96)00083-8; Janaudis-Ferreira T, 2006, RESP MED, V100, P1451, DOI 10.1016/j.rmed.2005.11.001; Janssens L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057949; KRALJ A, 1990, J BIOMECH, V23, P1123, DOI 10.1016/0021-9290(90)90005-N; Kuznetsov NA, 2012, J MOTOR BEHAV, V44, P241, DOI 10.1080/00222895.2012.688894; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Lawlor DA, 2003, BRIT MED J, V327, P712, DOI 10.1136/bmj.327.7417.712; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; Leidy N K, 1995, Image J Nurs Sch, V27, P23; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Mourey F, 1998, AGE AGEING, V27, P137, DOI 10.1093/ageing/27.2.137; Najafi B, 2002, IEEE T BIO-MED ENG, V49, P843, DOI 10.1109/TBME.2002.800763; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; O'Shea SD, 2009, CHEST, V136, P1269, DOI 10.1378/chest.09-0029; Ozalevli S, 2007, RESP MED, V101, P286, DOI 10.1016/j.rmed.2006.05.007; Puhan MA, 2013, EUR RESPIR J, V42, P956, DOI 10.1183/09031936.00131612; Reisman DS, 2002, GAIT POSTURE, V15, P45, DOI 10.1016/S0966-6362(01)00158-8; ROCHESTER DF, 1983, MED CLIN N AM, V67, P573, DOI 10.1016/S0025-7125(16)31190-7; Roig M, 2011, RESP MED, V105, P461, DOI 10.1016/j.rmed.2010.08.015; Smith MD, 2010, GAIT POSTURE, V31, P456, DOI 10.1016/j.gaitpost.2010.01.022; Troosters T, 2010, RESP MED, V104, P1005, DOI 10.1016/j.rmed.2010.01.012; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034	41	54	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88247	10.1371/journal.pone.0088247	http://dx.doi.org/10.1371/journal.pone.0088247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533072	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000331262600030
J	Libraty, DH; Zhang, L; Woda, M; Giaya, K; Kathivu, CL; Acosta, LP; Tallo, V; Segubre-Mercado, E; Bautista, A; Obcena, A; Brion, JD; Capeding, RZ				Libraty, Daniel H.; Zhang, Lei; Woda, Marcia; Giaya, Kris; Kathivu, Chido Loveness; Acosta, Luz P.; Tallo, Veronica; Segubre-Mercado, Edelwisa; Bautista, Analisa; Obcena, AnaMae; Brion, Job D.; Capeding, Rosario Z.			Low Adiposity during Early Infancy Is Associated with a Low Risk for Developing Dengue Hemorrhagic Fever: A Preliminary Model	PLOS ONE			English	Article							LEPTIN RECEPTOR; BODY-WEIGHT; SYSTEM; EXPRESSION; NUTRITION; TISSUE; OBESE; CELLS	Dengue virus (DENV) infections range from asymptomatic or mild illness to a severe and potentially life threatening disease, dengue hemorrhagic fever (DHF). DHF occurs in primary DENV infections during early infancy. A prospective clinical study of DENV infections during infancy was conducted in San Pablo, Philippines. We found that infants who developed DHF with a primary DENV infection had higher WHO weight-for-age z scores before and at the time of infection compared to infants with primary DENV infections who did not develop DHF. In addition, TLR 7/8-stimulated tumor necrosis factor-alpha (TNF-alpha) production from myeloid-derived cells was higher among well-nourished infants. Leptin augmented TLR 7/8-mediated TNF-alpha production in monocytes and decreased intracellular cAMP levels. Circulating leptin levels were elevated during early infancy and correlated with WHO weight-for-age z scores. Our data support a plausible hypothesis as to why well-nourished infants are at risk for developing DHF with their first DENV infection.	[Libraty, Daniel H.; Zhang, Lei; Woda, Marcia; Giaya, Kris; Kathivu, Chido Loveness] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Acosta, Luz P.] Res Inst Trop Med, Dept Immunol, Manila, Philippines; [Tallo, Veronica] Res Inst Trop Med, Dept Epidemiol, Manila, Philippines; [Segubre-Mercado, Edelwisa] Res Inst Trop Med, Dept Mol Biol, Manila, Philippines; [Bautista, Analisa] Res Inst Trop Med, Dept Virol, Manila, Philippines; [Obcena, AnaMae; Capeding, Rosario Z.] Res Inst Trop Med, Dept Med, Manila, Philippines; [Brion, Job D.] San Pablo City Hlth Off, San Pablo, Philippines; [Capeding, Rosario Z.] Res Inst Trop Med, Dept Microbiol, Manila, Philippines	University of Massachusetts System; University of Massachusetts Worcester; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines	Libraty, DH (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA.	daniel.libraty@umassmed.edu			National Institutes of Health [NIH/NIAID R01 AI091820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065654, R01AI091820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant NIH/NIAID R01 AI091820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; [Anonymous], 2012, DIS BURD; Bornstein SR, 2000, DIABETES, V49, P532, DOI 10.2337/diabetes.49.4.532; Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hung NT, 2005, AM J TROP MED HYG, V72, P370; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Jones KDJ, 2010, PEDIAT ALLERG IMM-UK, V21, P564, DOI 10.1111/j.1399-3038.2010.01002.x; Kuzawa CW, 1998, YEARB PHYS ANTHROPOL, V41, P177; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Mattioli B, 2008, FASEB J, V22, P2012, DOI 10.1096/fj.07-098095; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Patkar C, 2013, AM J TROP MED HYG, V88, P89, DOI 10.4269/ajtmh.2012.12-0474; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Schroeter MR, 2007, HISTOCHEM CELL BIOL, V128, P323, DOI 10.1007/s00418-007-0319-1; THISYAKORN U, 1993, CLIN INFECT DIS, V16, P295, DOI 10.1093/clind/16.2.295; World Health Organization, 2011, WHO ANTHR PERS COMP; Zarkesh-Esfahani H, 2001, J IMMUNOL, V167, P4593, DOI 10.4049/jimmunol.167.8.4593	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88944	10.1371/journal.pone.0088944	http://dx.doi.org/10.1371/journal.pone.0088944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533162	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600120
J	Periasamy, K; Pichler, R; Poli, M; Cristel, S; Cetra, B; Medus, D; Basar, M; Thiruvenkadan, AK; Ramasamy, S; Ellahi, MB; Mohammed, F; Teneva, A; Shamsuddin, M; Podesta, MG; Diallo, A				Periasamy, Kathiravan; Pichler, Rudolf; Poli, Mario; Cristel, Silvina; Cetra, Bibiana; Medus, Daniel; Basar, Muladno; Thiruvenkadan, A. K.; Ramasamy, Saravanan; Ellahi, Masroor Babbar; Mohammed, Faruque; Teneva, Atanaska; Shamsuddin, Mohammed; Podesta, Mario Garcia; Diallo, Adama			Candidate Gene Approach for Parasite Resistance in Sheep - Variation in Immune Pathway Genes and Association with Fecal Egg Count	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; POPULATION-STRUCTURE; GASTROINTESTINAL NEMATODES; BALANCING SELECTION; REVEALS; INFECTION; POLYMORPHISM; DIVERSITY; SEQUENCE; SUBDIVISION	Sheep chromosome 3 (Oar3) has the largest number of QTLs reported to be significantly associated with resistance to gastro-intestinal nematodes. This study aimed to identify single nucleotide polymorphisms (SNPs) within candidate genes located in sheep chromosome 3 as well as genes involved in major immune pathways. A total of 41 SNPs were identified across 38 candidate genes in a panel of unrelated sheep and genotyped in 713 animals belonging to 22 breeds across Asia, Europe and South America. The variations and evolution of immune pathway genes were assessed in sheep populations across these macro-environmental regions that significantly differ in the diversity and load of pathogens. The mean minor allele frequency (MAF) did not vary between Asian and European sheep reflecting the absence of ascertainment bias. Phylogenetic analysis revealed two major clusters with most of South Asian, South East Asian and South West Asian breeds clustering together while European and South American sheep breeds clustered together distinctly. Analysis of molecular variance revealed strong phylogeographic structure at loci located in immune pathway genes, unlike microsatellite and genome wide SNP markers. To understand the influence of natural selection processes, SNP loci located in chromosome 3 were utilized to reconstruct haplotypes, the diversity of which showed significant deviations from selective neutrality. Reduced Median network of reconstructed haplotypes showed balancing selection in force at these loci. Preliminary association of SNP genotypes with phenotypes recorded 42 days post challenge revealed significant differences (P<0.05) in fecal egg count, body weight change and packed cell volume at two, four and six SNP loci respectively. In conclusion, the present study reports strong phylogeographic structure and balancing selection operating at SNP loci located within immune pathway genes. Further, SNP loci identified in the study were found to have potential for future large scale association studies in naturally exposed sheep populations.	[Periasamy, Kathiravan; Pichler, Rudolf; Shamsuddin, Mohammed; Podesta, Mario Garcia; Diallo, Adama] IAEA, Joint FAO IAEA Div Nucl Tech Food & Agr, Anim Prod & Hlth Lab, A-1400 Vienna, Austria; [Poli, Mario] Inst Nacl Tecnol Agr, Inst Genet Ewald A Favret, Buenos Aires, DF, Argentina; [Cristel, Silvina] Inst Nacl Tecnol Agr Santa Rosa, Anguil Expt Stn, La Pampa, Argentina; [Cetra, Bibiana] Inst Nacl Tecnol Agr Mercedes, Mercedes Expt Stn, Corrientes, Argentina; [Medus, Daniel] Inst Nacl Tecnol Agr Concepc Uruguay, Concepc Uruguay Expt Stn, Entre Rios, Argentina; [Basar, Muladno] Bogor Agr Univ, Dept Anim Sci, Bogor, Indonesia; [Thiruvenkadan, A. K.; Ramasamy, Saravanan] Tamil Nadu Vet & Anim Sci Univ, Vet Coll & Res Inst Namakkal, Chennai, Tamil Nadu, India; [Ellahi, Masroor Babbar] Univ Vet & Anim Sci, Dept Anim Genet & Breeding, Lahore, Pakistan; [Mohammed, Faruque] Bangladesh Agr Univ, Dept Anim Breeding & Genet, Mymensingh, Bangladesh; [Teneva, Atanaska] Univ Forestry, Sofia, Bulgaria	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); Bogor Agricultural University; Tamil Nadu Veterinary & Animal Sciences University; University of Veterinary & Animal Science - Pakistan; Bangladesh Agricultural University (BAU); University of Forestry - Bulgaria	Periasamy, K (corresponding author), IAEA, Joint FAO IAEA Div Nucl Tech Food & Agr, Anim Prod & Hlth Lab, A-1400 Vienna, Austria.	K.Periasamy@iaea.org	Ramasamy, Saravanan/ADW-8513-2022; Aranganoor Kannan, thiruvenkadan/I-1180-2014	Ramasamy, Saravanan/0000-0003-2409-0357; Aranganoor Kannan, thiruvenkadan/0000-0001-5849-2800	International Atomic Energy Agency [D3.10.26]	International Atomic Energy Agency(International Atomic Energy Agency)	The study is funded by International Atomic Energy Agency through grant of Research Contracts to member state counterparts under the Coordinated Research Project D3.10.26 "Genetic Variation on the control of resistance to infectious diseases to improve productivity in small ruminants". The Research Contracts Administration Section of IAEA (funder) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, FSTAT VERSION 2 9 3; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Arora R, 2011, ANIM GENET, V42, P242, DOI 10.1111/j.1365-2052.2010.02147.x; Baker RL, 2002, P 7 WORLD C GEN APPL, P13; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cagliani R, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-171; Davies G, 2006, HEREDITY, V96, P252, DOI 10.1038/sj.hdy.6800788; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Gauly M, 2001, VET PARASITOL, V102, P253, DOI 10.1016/S0304-4017(01)00530-1; Gruner L, 2003, VET PARASITOL, V116, P239, DOI 10.1016/j.vetpar.2003.07.005; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hadfield TS, 2007, PLANT AN GEN C 15 P; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Harvey WR, 1987, LEAST SQUARES ANAL D; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kenyon F, 2009, VET PARASITOL, V164, P3, DOI 10.1016/j.vetpar.2009.04.015; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Lam Alex C, 2007, BMC Proc, V1 Suppl 1, pS144; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Marshall K, 2009, ANIM GENET, V40, P262, DOI 10.1111/j.1365-2052.2008.01836.x; Mckay SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-37; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Miller JE, 2006, VET PARASITOL, V140, P83, DOI 10.1016/j.vetpar.2006.02.043; Molento MB, 2011, VET PARASITOL, V180, P126, DOI 10.1016/j.vetpar.2011.05.033; Morris CA, 2000, ANIM SCI, V70, P17, DOI 10.1017/S1357729800051560; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; Nimbkar C, 2003, ANIM SCI, V76, P503, DOI 10.1017/S1357729800058720; Perry B. D, 2002, INVESTING ANIMAL HLT; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Peter J Waller, 2005, Trop Biomed, V22, P131; Prince LLL, 2010, TROP ANIM HEALTH PRO, V42, P785, DOI 10.1007/s11250-009-9487-4; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sayre BL, 2012, ANIM GENET, V43, P190, DOI 10.1111/j.1365-2052.2011.02231.x; Seabury CM, 2010, P NATL ACAD SCI USA, V107, P151, DOI 10.1073/pnas.0913006107; Smith JA, 1999, P ROY SOC B-BIOL SCI, V266, P1283, DOI 10.1098/rspb.1999.0776; Sodiq A, 2004, J AGR RURAL DEV TROP, V105, P71; Stear MJ, 1997, NATURE, V389, P27, DOI 10.1038/37895; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suarez VH, 2000, SMALL RUMINANT RES, V36, P85, DOI 10.1016/S0921-4488(99)00111-X; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; TAKAHATA N, 1992, GENETICS, V130, P925; TAKAHATA N, 1990, GENETICS, V124, P967; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Woolaston RR, 2001, ANIM SCI, V73, P41, DOI 10.1017/S1357729800058033; Woolaston RR, 1991, BREEDING DIS RESISTA, P1; Xu SH, 2010, MOL ECOL RESOUR, V10, P1085, DOI 10.1111/j.1755-0998.2010.02862.x; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x	58	35	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88337	10.1371/journal.pone.0088337	http://dx.doi.org/10.1371/journal.pone.0088337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533078	Green Published, gold			2022-12-27	WOS:000331262600036
J	Bellasio, C; Fini, A; Ferrini, F				Bellasio, Chandra; Fini, Alessio; Ferrini, Francesco			Evaluation of a High Throughput Starch Analysis Optimised for Wood	PLOS ONE			English	Article							CARBOHYDRATE RESERVES; PERCHLORIC-ACID; SOLUBLE SUGARS; PLANT-MATERIAL; AMYLOGLUCOSIDASE; EXTRACTION; ALLOCATION; SORBITOL; STORAGE; TISSUE	Starch is the most important long-term reserve in trees, and the analysis of starch is therefore useful source of physiological information. Currently published protocols for wood starch analysis impose several limitations, such as long procedures and a neutralization step. The high-throughput standard protocols for starch analysis in food and feed represent a valuable alternative. However, they have not been optimised or tested with woody samples. These have particular chemical and structural characteristics, including the presence of interfering secondary metabolites, low reactivity of starch, and low starch content. In this study, a standard method for starch analysis used for food and feed (AOAC standard method 996.11) was optimised to improve precision and accuracy for the analysis of starch in wood. Key modifications were introduced in the digestion conditions and in the glucose assay. The optimised protocol was then evaluated through 430 starch analyses of standards at known starch content, matrix polysaccharides, and wood collected from three organs (roots, twigs, mature wood) of four species (coniferous and flowering plants). The optimised protocol proved to be remarkably precise and accurate (3%), suitable for a high throughput routine analysis (35 samples a day) of specimens with a starch content between 40 mg and 21 mu g. Samples may include lignified organs of coniferous and flowering plants and non-lignified organs, such as leaves, fruits and rhizomes.	[Bellasio, Chandra] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Bellasio, Chandra] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Fini, Alessio; Ferrini, Francesco] Univ Florence, Sect Woody Plants, Dept Agrifood Prod & Environm Sci, Florence, Italy	University of Sheffield; University of Cambridge; University of Florence	Bellasio, C (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	C.Bellasio@sheffield.ac.uk	Bellasio, Chandra/H-4559-2019	Bellasio, Chandra/0000-0002-3865-7521; FINI, ALESSIO/0000-0002-9713-689X; ferrini, Francesco/0000-0003-2222-0437	EU [238017]; Ente Cassa di Risparmio di Firenze; Regione Lombardia Project "Miglioramento delle tecniche produttive e della qualita del prodotto nel vivaismo ornamentale (TECPRO); Uniser Consortium Pistoia; LABVIVA (Laboratorio per la Ricerca nel Settore Vivaistico-Ornamentale)	EU(European Commission); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Regione Lombardia Project "Miglioramento delle tecniche produttive e della qualita del prodotto nel vivaismo ornamentale (TECPRO); Uniser Consortium Pistoia; LABVIVA (Laboratorio per la Ricerca nel Settore Vivaistico-Ornamentale)	Funded by EU FP7 Marie Curie ITN Harvest grant no 238017; Ente Cassa di Risparmio di Firenze; Regione Lombardia Project "Miglioramento delle tecniche produttive e della qualita del prodotto nel vivaismo ornamentale (TECPRO); Uniser Consortium Pistoia; LABVIVA (Laboratorio per la Ricerca nel Settore Vivaistico-Ornamentale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL PK, 1980, PHYTOCHEMISTRY, V19, P1260, DOI 10.1016/0031-9422(80)83107-4; AGRAWAL PK, 1980, PHYTOCHEMISTRY, V19, P893, DOI 10.1016/0031-9422(80)85133-8; ASHWORTH EN, 1993, TREE PHYSIOL, V13, P379, DOI 10.1093/treephys/13.4.379; BAILEY RW, 1958, BIOCHEM J, V68, P669, DOI 10.1042/bj0680669; Barbaroux C, 2002, TREE PHYSIOL, V22, P1201, DOI 10.1093/treephys/22.17.1201; BATEY IL, 1982, STARKE, V34, P125, DOI 10.1002/star.19820340407; BECK E, 1989, ANNU REV PLANT PHYS, V40, P95, DOI 10.1146/annurev.pp.40.060189.000523; Bell TL, 1999, NEW PHYTOL, V144, P143, DOI 10.1046/j.1469-8137.1999.00489.x; BENNETT E, 1955, PLANT PHYSIOL, V30, P562, DOI 10.1104/pp.30.6.562; BIPM IFCC IUPAC ISO, 2008, JSGM, V200, P2008; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; CANDOLFIVASCONCELOS MC, 1990, VITIS, V29, P199; Canham CD, 1999, OECOLOGIA, V121, P1, DOI 10.1007/s004420050900; Chantuma P, 2009, TREE PHYSIOL, V29, P1021, DOI 10.1093/treephys/tpp043; Chow PS, 2004, TREE PHYSIOL, V24, P1129, DOI 10.1093/treephys/24.10.1129; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUNN JP, 1990, OECOLOGIA, V83, P458, DOI 10.1007/BF00317195; EBELL LF, 1969, PHYTOCHEMISTRY, V8, P25, DOI 10.1016/S0031-9422(00)85790-8; Fini A, 2013, URBAN FORES IN PRESS; Giovannelli A, 2011, DENDROCHRONOLOGIA, V29, P177, DOI 10.1016/j.dendro.2011.01.001; GREUB LJ, 1969, CROP SCI, V9, P595, DOI 10.2135/cropsci1969.0011183X000900050024x; Gupta AK, 2000, CARBOHYDRATE RESERVE; HAISSIG BE, 1979, PHYSIOL PLANTARUM, V47, P151, DOI 10.1111/j.1399-3054.1979.tb03207.x; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; JERMYN MA, 1956, NATURE, V177, P38, DOI 10.1038/177038a0; Jones A, 1999, BIOL PLANTARUM, V42, P303, DOI 10.1023/A:1002129206405; Knox KJE, 2005, FUNCT ECOL, V19, P690, DOI 10.1111/j.1365-2435.2005.01006.x; Kozloski GV, 1999, J SCI FOOD AGR, V79, P1112, DOI 10.1002/(SICI)1097-0010(199906)79:8&lt;1112::AID-JSFA318&gt;3.0.CO;2-D; MACRAE JC, 1974, J SCI FOOD AGR, V25, P1465, DOI 10.1002/jsfa.2740251206; MCCLEARY BV, 1994, CEREAL CHEM, V71, P501; Megazyme L, 2012, SUCROSE D FRUCTOSE D; Megazyme L, 2009, TOTAL STARCH ASSAY P; Mumm R, 2004, PHYTOCHEMISTRY, V65, P3221, DOI 10.1016/j.phytochem.2004.10.010; Ogren E, 2000, PHYSIOL PLANTARUM, V108, P295, DOI 10.1034/j.1399-3054.2000.108003295.x; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P1; PETTERSEN RC, 1984, ADV CHEM SER, P57; RASMUSSEN TS, 1990, J SCI FOOD AGR, V52, P159, DOI 10.1002/jsfa.2740520203; Richter A, 2009, RAPID COMMUN MASS SP, V23, P2476, DOI 10.1002/rcm.4088; Robyt JF, 2009, FOOD SCI TECH-INT SE, P237, DOI 10.1016/B978-0-12-746275-2.00007-0; ROSE R, 1991, J AGR FOOD CHEM, V39, P2, DOI 10.1021/jf00001a001; SAKAI A, 1966, PLANT PHYSIOL, V41, P353, DOI 10.1104/pp.41.2.353; Sigma-Aldrich, 2010, STA20 TECHN B; Vasanthan T, 2005, HDB FOOD ANAL CHEM, P671; Amaral Lourdes Isabel Velho do, 2007, Hoehnea, V34, P425; Wang Z, 1997, AUST J PLANT PHYSIOL, V24, P587, DOI 10.1071/PP96134; Wang ZC, 1997, PLANT PHYSIOL, V114, P294; Wong BL, 2003, CAN J BOT, V81, P780, DOI [10.1139/B03-079, 10.1139/b03-079]	47	19	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e86645	10.1371/journal.pone.0086645	http://dx.doi.org/10.1371/journal.pone.0086645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523863	Green Published, Green Accepted, gold			2022-12-27	WOS:000331258100012
J	Borel, L; Redon-Zouiteni, C; Cauvin, P; Dumitrescu, M; Deveze, A; Magnan, J; Peruch, P				Borel, Liliane; Redon-Zouiteni, Christine; Cauvin, Pierre; Dumitrescu, Michel; Deveze, Arnaud; Magnan, Jacques; Peruch, Patrick			Unilateral Vestibular Loss Impairs External Space Representation	PLOS ONE			English	Article							VISUAL-FIELD; DEFECTIVE PATIENTS; POSTURAL CONTROL; SPATIAL NEGLECT; ORIENTATION; PERFORMANCE; LOCALIZATION; WALKING; HUMANS; HEAD	The vestibular system is responsible for a wide range of postural and oculomotor functions and maintains an internal, updated representation of the position and movement of the head in space. In this study, we assessed whether unilateral vestibular loss affects external space representation. Patients with Meniere's disease and healthy participants were instructed to point to memorized targets in near (peripersonal) and far (extrapersonal) spaces in the absence or presence of a visual background. These individuals were also required to estimate their body pointing direction. Meniere's disease patients were tested before unilateral vestibular neurotomy and during the recovery period (one week and one month after the operation), and healthy participants were tested at similar times. Unilateral vestibular loss impaired the representation of both the external space and the body pointing direction: in the dark, the configuration of perceived targets was shifted toward the lesioned side and compressed toward the contralesioned hemifield, with higher pointing error in the near space. Performance varied according to the time elapsed after neurotomy: deficits were stronger during the early stages, while gradual compensation occurred subsequently. These findings provide the first demonstration of the critical role of vestibular signals in the representation of external space and of body pointing direction in the early stages after unilateral vestibular loss.	[Borel, Liliane; Redon-Zouiteni, Christine; Cauvin, Pierre; Dumitrescu, Michel; Deveze, Arnaud; Magnan, Jacques; Peruch, Patrick] Aix Marseille Univ, Marseille, France; [Borel, Liliane; Dumitrescu, Michel; Magnan, Jacques] CNRS, UMR Lab Neurosci Integrat & Adaptat 7260, Marseille, France; [Deveze, Arnaud] Hop Nord Marseille, Serv Otorhinolaryngol & Chirurg Cervicofacial, Marseille, France; [Peruch, Patrick] INSERM, UMR S Inst Neurosci Syst 1106, F-13258 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Borel, L (corresponding author), Aix Marseille Univ, Marseille, France.	liliane.borel@univ-amu.fr			Ministere de l'Enseignement Superieur et de la Recherche [CNRS UMR 7260, INSERM UMR S1106]	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council)	This study was supported by grants from Ministere de l'Enseignement Superieur et de la Recherche to CNRS UMR 7260 and to INSERM UMR S1106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Angelaki DE, 2009, NEURON, V64, P448, DOI 10.1016/j.neuron.2009.11.010; Berthoz A., 1996, DISORDERS VESTIBULAR; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; BLOUIN J, 1993, EXP BRAIN RES, V93, P324; Borel L, 2004, BEHAV BRAIN RES, V150, P191, DOI 10.1016/S0166-4328(03)00257-2; Borel L, 2002, BRAIN, V125, P880, DOI 10.1093/brain/awf085; Borel L, 2008, NEUROPHYSIOL CLIN, V38, P375, DOI 10.1016/j.neucli.2008.09.002; Borel L, 2001, NEUROREPORT, V12, P3137, DOI 10.1097/00001756-200110080-00031; Bottini G, 2001, BRAIN, V124, P1182, DOI 10.1093/brain/124.6.1182; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; Brandt T, 2001, ADV NEUROL, V87, P165; BRIDGEMAN B, 1991, VISION RES, V31, P1903, DOI 10.1016/0042-6989(91)90185-8; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Campos JL, 2012, EXP BRAIN RES, V218, P551, DOI 10.1007/s00221-012-3048-1; Carrozzo M, 2002, EXP BRAIN RES, V147, P426, DOI 10.1007/s00221-002-1232-4; Coello Y, 1997, PERCEPTION, V26, P287, DOI 10.1068/p260287; Curthoys IS, 2000, CURR OPIN NEUROL, V13, P27, DOI 10.1097/00019052-200002000-00006; Demer JL, 2001, ANN NY ACAD SCI, V942, P428; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Dokka K, 2011, J VISION, V11, DOI 10.1167/11.13.2; Fetter Michael, 2007, Dev Ophthalmol, V40, P35; Figliozzi F, 2005, J COGNITIVE NEUROSCI, V17, P1638, DOI 10.1162/089892905774597272; Galati G, 2000, EXP BRAIN RES, V133, P156, DOI 10.1007/s002210000375; Glasauer S, 2002, EXP BRAIN RES, V145, P489, DOI 10.1007/s00221-002-1146-1; Grabherr L, 2011, EXP BRAIN RES, V209, P205, DOI 10.1007/s00221-011-2535-0; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; Halmagyi GM, 2010, RESTOR NEUROL NEUROS, V28, P37, DOI 10.3233/RNN-2010-0533; Hamann KF, 2009, ANN NY ACAD SCI, V1164, P305, DOI 10.1111/j.1749-6632.2009.03867.x; Hanes DA, 2006, J VESTIBUL RES-EQUIL, V16, P75; Hay L, 2006, NEUROSCI LETT, V408, P194, DOI 10.1016/j.neulet.2006.08.080; Herdman SJ, 2000, CURR OPIN NEUROL, V13, P39, DOI 10.1097/00019052-200002000-00008; HORNSTEN G, 1979, BRAIN, V102, P685, DOI 10.1093/brain/102.4.685; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; Lacour M, 2009, ANN NY ACAD SCI, V1164, P268, DOI 10.1111/j.1749-6632.2008.03731.x; Lopez C, 2005, BRAIN, V128, P1511, DOI 10.1093/brain/awh504; Lopez C, 2006, NEUROREPORT, V17, P797, DOI 10.1097/01.wnr.0000221843.58373.c8; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Magnan J, 2000, MENIERES DIS UPDATE, P793; MATIN L, 1982, SCIENCE, V216, P198, DOI 10.1126/science.7063881; Maurer C, 1997, J VESTIBUL RES-EQUIL, V7, P119, DOI 10.1016/S0957-4271(96)00173-5; Paillard J., 1991, BRAIN SPACE, P163; Peruch P, 1999, J VESTIBUL RES-EQUIL, V9, P37; Peruch P, 2005, COGNITIVE BRAIN RES, V25, P862, DOI 10.1016/j.cogbrainres.2005.09.012; Peruch P, 2011, NEUROPSYCHOLOGIA, V49, P3136, DOI 10.1016/j.neuropsychologia.2011.07.026; Prieur JM, 2005, EXP BRAIN RES, V161, P432, DOI 10.1007/s00221-004-2087-7; Redfern MS, 2004, GAIT POSTURE, V19, P105, DOI 10.1016/S0966-6362(03)00032-8; Rode G, 2006, NEUROLOGY, V67, P1801, DOI 10.1212/01.wnl.0000244432.91915.d0; Rode G, 2012, NEUROPSYCHOLOGIA, V50, P245, DOI 10.1016/j.neuropsychologia.2011.11.018; Saj A, 2007, CURR BIOL, V17, pR1060, DOI 10.1016/j.cub.2007.10.016; Saj A, 2013, CORTEX, V49, P1219, DOI 10.1016/j.cortex.2012.05.019; Saj A, 2011, J NEUROL SCI, V308, P142, DOI 10.1016/j.jns.2011.06.040; Seemungal BM, 2008, PROG BRAIN RES, V171, P339, DOI 10.1016/S0079-6123(08)00650-X; Smith PF, 2005, J VESTIBUL RES-EQUIL, V15, P1; Talkowski ME, 2005, J COGNITIVE NEUROSCI, V17, P1432, DOI 10.1162/0898929054985419; Vallar G, 2009, EPILEPSY BEHAV, V16, P397, DOI 10.1016/j.yebeh.2009.09.001; VELAY JL, 1994, VISION RES, V34, P2169, DOI 10.1016/0042-6989(94)90325-5; Vibert D, 2000, ACTA OTO-LARYNGOL, V120, P620, DOI 10.1080/000164800750000432; Yardley L, 2001, J NEUROL NEUROSUR PS, V71, P48, DOI 10.1136/jnnp.71.1.48	62	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88576	10.1371/journal.pone.0088576	http://dx.doi.org/10.1371/journal.pone.0088576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523916	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100065
J	Chen, NTM; Clarke, PJF; Watson, TL; MacLeod, C; Guastella, AJ				Chen, Nigel T. M.; Clarke, Patrick J. F.; Watson, Tamara L.; MacLeod, Colin; Guastella, Adam J.			Biased Saccadic Responses to Emotional Stimuli in Anxiety: An Antisaccade Study	PLOS ONE			English	Article							ATTENTIONAL CONTROL-THEORY; GENERALIZED SOCIAL PHOBIA; SELECTIVE ATTENTION; INHIBITORY CONTROL; TRAIT ANXIETY; EYE-MOVEMENT; ANGRY FACES; TASK; INDIVIDUALS; VULNERABILITY	Research suggests that anxiety is maintained by an attentional bias to threat, and a growing base of evidence suggests that anxiety may additionally be associated with the deficient attentional processing of positive stimuli. The present study sought to examine whether such anxiety-linked attentional biases were associated with either stimulus driven or attentional control mechanisms of attentional selectivity. High and low trait anxious participants completed an emotional variant of an antisaccade task, in which they were required to prosaccade towards, or antisaccade away from a positive, neutral or threat stimulus, while eye movements were recorded. While low anxious participants were found to be slower to saccade in response to positive stimuli, irrespectively of whether a pro- or antisaccade was required, such a bias was absent in high anxious individuals. Analysis of erroneous antisaccades further revealed at trend level, that anxiety was associated with reduced peak velocity in response to threat. The findings suggest that anxiety is associated with the aberrant processing of positive stimuli, and greater compensatory efforts in the inhibition of threat. The findings further highlight the relevance of considering saccade peak velocity in the assessment of anxiety-linked attentional processing.	[Chen, Nigel T. M.; Guastella, Adam J.] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Clarke, Patrick J. F.; MacLeod, Colin] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Watson, Tamara L.] Univ Western Sydney, Sch Social Sci & Psychol, Penrith, NSW 1797, Australia	University of Sydney; University of Western Australia; Western Sydney University	Chen, NTM (corresponding author), Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW, Australia.	nigel.chen@sydney.edu.au	Watson, Tamara/AAD-2575-2020; Clarke, Patrick/H-8998-2014; Watson, Tamara/F-9920-2010	Clarke, Patrick/0000-0003-0303-4479; Watson, Tamara/0000-0001-7899-0858; MacLeod, Colin/0000-0003-2407-7339	Australian Research Council (ARC) [LP110200562, DP140104448]; Romanian National Authority for Scientific Research; CNCS - UEFISCDI [PNII-ID-PCCE-2011-2-0045]; ARC postdoctoral fellowship [DP110102173]	Australian Research Council (ARC)(Australian Research Council); Romanian National Authority for Scientific Research; CNCS - UEFISCDI; ARC postdoctoral fellowship(Australian Research Council)	This project was partially supported by an Australian Research Council (ARC) linkage grant (LP110200562) to Guastella and MacLeod. MacLeod is supported by an ARC Grant - DP140104448 and by a grant from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, project number PNII-ID-PCCE-2011-2-0045. Watson is supported by an ARC postdoctoral fellowship (DP110102173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden LE, 2008, J ANXIETY DISORD, V22, P577, DOI 10.1016/j.janxdis.2007.05.007; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Ansari TL, 2011, BIOL PSYCHOL, V86, P337, DOI 10.1016/j.biopsycho.2010.12.013; Aupperle Robin L, 2010, Dialogues Clin Neurosci, V12, P517; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; Berggren N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00188; Berggren N, 2013, BIOL PSYCHOL, V92, P440, DOI 10.1016/j.biopsycho.2012.03.007; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Campbell DW, 2009, DEPRESS ANXIETY, V26, P419, DOI 10.1002/da.20474; Chen Nigel T. M., 2012, Cognitive Behaviour Therapy, V41, P96, DOI 10.1080/16506073.2012.666562; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Derakshan N, 2009, EXP PSYCHOL, V56, P48, DOI 10.1027/1618-3169.56.1.48; Di Stasi LL, 2013, NEUROSCI BIOBEHAV R, V37, P968, DOI 10.1016/j.neubiorev.2013.03.011; Di Stasi LL, 2010, AVIAT SPACE ENVIR MD, V81, P413, DOI 10.3357/ASEM.2579.2010; Edelman JA, 2006, VISION RES, V46, P1411, DOI 10.1016/j.visres.2005.09.013; Ettinger U, 2008, CEREB CORTEX, V18, P1148, DOI 10.1093/cercor/bhm147; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Eysenck MW, 2011, PERS INDIV DIFFER, V50, P955, DOI 10.1016/j.paid.2010.08.019; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Isaacowitz DM, 2005, PERS SOC PSYCHOL B, V31, P407, DOI 10.1177/0146167204271599; Jazbec S, 2005, BIOL PSYCHIAT, V58, P632, DOI 10.1016/j.biopsych.2005.04.010; Kashdan TB, 2011, CLIN PSYCHOL REV, V31, P786, DOI 10.1016/j.cpr.2011.03.012; Lowe R, 2012, J FLUENCY DISORD, V37, P263, DOI 10.1016/j.jfludis.2012.04.004; Di Stasi LL, 2011, APPL ERGON, V42, P807, DOI 10.1016/j.apergo.2011.01.003; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Mueller SC, 2012, J CHILD PSYCHOL PSYC, V53, P856, DOI 10.1111/j.1469-7610.2012.02541.x; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Pishyar R, 2004, ANXIETY STRESS COPIN, V17, P23, DOI 10.1080/10615800310001601458; Pishyar R, 2008, COGNITION EMOTION, V22, P1209, DOI 10.1080/02699930701686008; Reinholdt-Dunne ML, 2012, J COGN PSYCHOL, V24, P54, DOI 10.1080/20445911.2011.560111; Roelofs K, 2010, BEHAV RES THER, V48, P290, DOI 10.1016/j.brat.2009.11.008; See J, 2009, J ABNORM PSYCHOL, V118, P65, DOI 10.1037/a0014377; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tamir M, 2007, PERS SOC PSYCHOL B, V33, P1124, DOI 10.1177/0146167207301030; Taylor CT, 2011, EMOTION, V11, P127, DOI 10.1037/a0021301; Taylor CT, 2010, J ANXIETY DISORD, V24, P403, DOI 10.1016/j.janxdis.2010.02.004; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Unsworth N, 2004, J EXP PSYCHOL LEARN, V30, P1302, DOI 10.1037/0278-7393.30.6.1302; Veljaca KA, 1998, BEHAV RES THER, V36, P311, DOI 10.1016/S0005-7967(98)00016-3; Wadlinger HA, 2011, PERS SOC PSYCHOL REV, V15, P75, DOI 10.1177/1088868310365565; Weeks JW, 2008, J ANXIETY DISORD, V22, P386, DOI 10.1016/j.janxdis.2007.04.009; Weeks Justin W., 2012, Cognitive Behaviour Therapy, V41, P79, DOI 10.1080/16506073.2012.680782; Wieser MJ, 2009, COGN AFFECT BEHAV NE, V9, P314, DOI 10.3758/CABN.9.3.314; Willenbockel V., 2010, J VISION, V10, P653, DOI [10.1167/10.7.653, DOI 10.1167/10.7.653]; Williams M., 1997, COGNITIVE PSYCHOL EM	49	48	49	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e86474	10.1371/journal.pone.0086474	http://dx.doi.org/10.1371/journal.pone.0086474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523861	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100010
J	Kol-Maimon, H; Ghanim, M; Franco, JC; Mendel, Z				Kol-Maimon, Hofit; Ghanim, Murad; Franco, Jose Carlos; Mendel, Zvi			Evidence for Gene Flow between Two Sympatric Mealybug Species (Insecta; Coccoidea; Pseudococcidae)	PLOS ONE			English	Article							SEX-PHEROMONE RESPONSES; EUROPEAN CORN-BORER; VINE MEALYBUG; PLANOCOCCUS-FICUS; MOLECULAR-IDENTIFICATION; REPRODUCTIVE ISOLATION; CROSS-ATTRACTION; CITRUS MEALYBUG; HOST RACES; HYBRIDIZATION	Occurrence of inter-species hybrids in natural populations might be evidence of gene flow between species. In the present study we found evidence of gene flow between two sympatric, genetically related scale insect species - the citrus mealybug Planococcus citri (Risso) and the vine mealybug Planococcus ficus (Signoret). These species can be distinguished by morphological, behavioral, and molecular traits. We employed the sex pheromones of the two respective species to study their different patterns of male attraction. We also used nuclear ITS2 (internal transcribed spacer 2) and mitochondrial COI (Cytochrome c oxidase sub unit 1) DNA sequences to characterize populations of the two species, in order to demonstrate the outcome of a possible gene flow between feral populations of the two species. Our results showed attraction to P. ficus pheromones of all tested populations of P. citri males but not vice versa. Furthermore, ITS2 sequences revealed the presence of 'hybrid females' among P. citri populations but not among those of P. ficus. ` hybrid females' from P. citri populations identified as P. citri females according to COI sequences. We offer two hypotheses for these results. 1) The occurrence of phenotypic and genotypic traits of P. ficus in P. citri populations may be attributed to both ancient and contemporary gene flow between their populations; and 2) we cannot rule out that an ancient sympatric speciation by which P. ficus emerged from P. citri might have led to the present situation of shared traits between these species. In light of these findings we also discuss the origin of the studied species and the importance of the pherotype phenomenon as a tool with which to study genetic relationships between congener scale insects.	[Kol-Maimon, Hofit; Ghanim, Murad; Mendel, Zvi] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel; [Franco, Jose Carlos] Univ Lisbon, Dept Ciencias & Engn Biossistemas, Ctr Estudos Florestais, Inst Super Agron, P-1699 Lisbon, Portugal	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Universidade de Lisboa	Ghanim, M (corresponding author), Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel.	ghanim@volcani.agri.gov.il	Franco, José Carlos/B-8534-2009	Franco, José Carlos/0000-0002-0898-3510				Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Abe TA, 2005, CAN J ZOOL, V83, P432, DOI 10.1139/Z05-030; Agatsuma T, 2000, PARASITOL INT, V49, P231, DOI 10.1016/S1383-5769(00)00051-9; Ahmed F, 2008, AQUAC RES, V39, P532, DOI 10.1111/j.1365-2109.2008.01911.x; Anga Jean-Marc, 1999, Bulletin of the Natural History Museum Entomology Series, V68, P93; Baker AM, 2004, HEREDITY, V93, P196, DOI 10.1038/sj.hdy.6800493; Barkman TJ, 2002, SYST BOT, V27, P209; Baumann L, 2005, CURR MICROBIOL, V50, P84, DOI 10.1007/s00284-004-4437-x; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y., 1994, SYSTEMATIC CATALOGUE; BIERLLEONHARDT BA, 1981, TETRAHEDRON LETT, V22, P389, DOI 10.1016/0040-4039(81)80107-4; Bodenheimer FS, 1951, CITRUS ENTOMOLOGY MI; Cabaleiro C, 1997, EUR J PLANT PATHOL, V103, P373, DOI 10.1023/A:1008619523666; Caceres C, 2009, BIOL J LINN SOC, V97, P152, DOI 10.1111/j.1095-8312.2008.01193.x; Casteleyn G, 2009, PROTIST, V160, P343, DOI 10.1016/j.protis.2008.11.002; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles JG, 2000, SYST ENTOMOL, V25, P285, DOI 10.1046/j.1365-3113.2000.00104.x; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Compere H., 1939, Unif Calif Publ Ent Berkeley, V7, P57; Cox J.M., 1989, Bulletin of the British Museum (Natural History) Entomology, V58, P1; COX JM, 1983, SYST ENTOMOL, V8, P361, DOI 10.1111/j.1365-3113.1983.tb00489.x; COX JM, 1981, SYST ENTOMOL, V6, P47, DOI 10.1111/j.1365-3113.1981.tb00012.x; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Coyne JA, 2004, SPECIATION, P24; De Lotto G., 1975, Journal of the Entomological Society of Southern Africa, V38, P125; de Silva DPP, 2002, PLANT PATHOL, V51, P537, DOI 10.1046/j.0032-0862.2002.00757.x; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; EIVNAY E., 1960, Ktavim, V10, P223; FEDER JL, 1993, ENTOMOL EXP APPL, V69, P117, DOI 10.1007/BF02380639; FEDER JL, 1989, ENTOMOL EXP APPL, V51, P113, DOI 10.1007/BF00186728; FLANDERS S. E., 1951, CALIFORNIA AGRIC, V5, P11; Franco CJ, 2004, 10 INT S SCAL INS ST; Franco JC, 2011, BIOL CONTROL, V58, P230, DOI 10.1016/j.biocontrol.2011.06.008; Franco JC, 2009, BIORATIONAL CONTROL OF ARTHROPOD PESTS: APPLICATION AND RESISTANCE MANAGEMENT, P233, DOI 10.1007/978-90-481-2316-2_10; Girault A. A., 1915, Memoirs of the Queensland Museum, V4; GLOVER TJ, 1991, ENVIRON ENTOMOL, V20, P1356, DOI 10.1093/ee/20.5.1356; GRAY HE, 1954, J ECON ENTOMOL, V47, P174, DOI 10.1093/jee/47.1.174; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Harper FM, 2007, EVOLUTION, V61, P2410, DOI 10.1111/j.1558-5646.2007.00200.x; HENDRIKSE A, 1988, ENTOMOL EXP APPL, V48, P213, DOI 10.1007/BF00376400; Hinkens DM, 2001, TETRAHEDRON LETT, V42, P1619, DOI 10.1016/S0040-4039(00)02347-9; Ho HY, 2007, J CHEM ECOL, V33, P1986, DOI 10.1007/s10886-007-9361-7; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; KARL SA, 1992, GENETICS, V131, P163; Kochansky J, 1975, J CHEM ECOL, V1, P225, DOI 10.1007/BF00987871; Kol-Maimon H, 2010, NATURWISSENSCHAFTEN, V97, P1047, DOI 10.1007/s00114-010-0726-3; Kronforst MR, 2006, EVOLUTION, V60, P1254, DOI 10.1554/06-005.1; La Rosa G, 2003, INT J PARASITOL, V33, P209, DOI 10.1016/S0020-7519(02)00258-8; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Linn C, 1999, J COMP PHYSIOL A, V184, P273, DOI 10.1007/s003590050325; Lofstedt C., 1991, Chemoecology, V2, P20, DOI 10.1007/BF01240662; Lovette IJ, 1999, MOL ECOL, V8, P1431, DOI 10.1046/j.1365-294x.1999.00706.x; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mcmillan OW, 1997, EVOLUTION, V94, P8628; Mendel Z, 2012, J INSECT BEHAV, V25, P504, DOI 10.1007/s10905-012-9317-9; Meyer JB, 2008, PLANT DIS, V92, P1158, DOI 10.1094/PDIS-92-8-1158; Millar JG, 2002, J ECON ENTOMOL, V95, P706, DOI 10.1603/0022-0493-95.4.706; Miller DR, 2005, P ENTOMOL SOC WASH, V107, P123; Moody ML, 2002, P NATL ACAD SCI USA, V99, P14867, DOI 10.1073/pnas.172391499; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; NUR U, 1963, AM NAT, V97, P197, DOI 10.1086/282270; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; PHELAN PL, 1986, ENVIRON ENTOMOL, V15, P369, DOI 10.1093/ee/15.2.369; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Rees DJ, 2003, MOL PHYLOGENET EVOL, V27, P131, DOI 10.1016/S1055-7903(02)00374-3; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; ROTUNDO G, 1982, SYST ENTOMOL, V7, P475, DOI 10.1111/j.1365-3113.1982.tb00459.x; Rung A, 2008, ANN ENTOMOL SOC AM, V101, P525, DOI 10.1603/0013-8746(2008)101[525:MIOTCR]2.0.CO;2; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Sota T, 2002, POPUL ECOL, V44, P145, DOI 10.1007/s101440200018; Stevens JR, 2002, INSECT MOL BIOL, V11, P141, DOI 10.1046/j.1365-2583.2002.00318.x; Thieme T, 1996, ENTOMOL EXP APPL, V79, P85, DOI 10.1007/BF00333825; TRANFAGLIA A, 1982, Entomotaxonomia, V4, P1; Triapitsyn SV, 2007, BIOL CONTROL, V41, P14, DOI 10.1016/j.biocontrol.2006.12.013; Tsai CW, 2008, PHYTOPATHOLOGY, V98, P1093, DOI 10.1094/PHYTO-98-10-1093; TUMLINSON JH, 1974, SCIENCE, V185, P614, DOI 10.1126/science.185.4151.614; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; VIERECK H. L., 1915, Monthly Bulletin. California Commission of Horticulture, V4, P208; Wakabayashi K, 2008, BIOL BULL-US, V215, P89, DOI 10.2307/25470686; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Watson GW, 2005, AFR ENTOMOL, V13, P35; WIERNASZ DC, 1992, ANIM BEHAV, V43, P89, DOI 10.1016/S0003-3472(05)80074-0; Williams D.J., 1985, AUSTR MEALYBUGS; WU CI, 1994, ANNU REV GENET, V28, P283, DOI 10.1146/annurev.ge.28.120194.001435; Zada A, 2003, J CHEM ECOL, V29, P977, DOI 10.1023/A:1022944119077; Zilkowski BW, 1999, J CHEM ECOL, V25, P1759, DOI 10.1023/A:1020921530406	92	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88433	10.1371/journal.pone.0088433	http://dx.doi.org/10.1371/journal.pone.0088433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523894	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100043
J	Young, KD; Zotev, V; Phillips, R; Misaki, M; Yuan, H; Drevets, WC; Bodurka, J				Young, Kymberly D.; Zotev, Vadim; Phillips, Raquel; Misaki, Masaya; Yuan, Han; Drevets, Wayne C.; Bodurka, Jerzy			Real-Time fMRI Neurofeedback Training of Amygdala Activity in Patients with Major Depressive Disorder	PLOS ONE			English	Article							TORONTO-ALEXITHYMIA-SCALE; AUTOBIOGRAPHICAL MEMORY; BRAIN ACTIVATION; CORTEX ACTIVITY; MOOD; EMOTION; NUMBER; ABNORMALITIES; BEHAVIOR; THERAPY	Background: Amygdala hemodynamic responses to positive stimuli are attenuated in major depressive disorder (MDD), and normalize with remission. Real-time functional MRI neurofeedback (rtfMRI-nf) offers a non-invasive method to modulate this regional activity. We examined whether depressed participants can use rtfMRI-nf to enhance amygdala responses to positive autobiographical memories, and whether this ability alters symptom severity. Methods: Unmedicated MDD subjects were assigned to receive rtfMRI-nf from either left amygdala (LA; experimental group, n = 14) or the horizontal segment of the intraparietal sulcus (HIPS; control group, n = 7) and instructed to contemplate happy autobiographical memories (AMs) to raise the level of a bar representing the hemodynamic signal from the target region to a target level. This 40s Happy condition alternated with 40s blocks of rest and counting backwards. A final Transfer run without neurofeedback information was included. Results: Participants in the experimental group upregulated their amygdala responses during positive AM recall. Significant pre-post scan decreases in anxiety ratings and increases in happiness ratings were evident in the experimental versus control group. A whole brain analysis showed that during the transfer run, participants in the experimental group had increased activity compared to the control group in left superior temporal gyrus and temporal polar cortex, and right thalamus. Conclusions: Using rtfMRI-nf from the left amygdala during recall of positive AMs, depressed subjects were able to self-regulate their amygdala response, resulting in improved mood. Results from this proof-of-concept study suggest that rtfMRI-nf training with positive AM recall holds potential as a novel therapeutic approach in the treatment of depression.	[Young, Kymberly D.; Zotev, Vadim; Phillips, Raquel; Misaki, Masaya; Yuan, Han; Drevets, Wayne C.; Bodurka, Jerzy] Laureate Inst Brain Res, Tulsa, OK USA; [Drevets, Wayne C.] Johnson & Johnson Inc, Janssen Pharmaceut LCC, Titusville, NJ USA; [Bodurka, Jerzy] Univ Oklahoma, Ctr Biomed Engn, Norman, OK 73019 USA; [Bodurka, Jerzy] Univ Oklahoma, Coll Engn, Norman, OK 73019 USA	Laureate Institute for Brain Research, Inc.; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Bodurka, J (corresponding author), Laureate Inst Brain Res, Tulsa, OK USA.	jbodurka@laureateinstitute.org	Misaki, Masaya/H-3042-2013; Young, Kymberly/AAV-5407-2021; Yuan, Han/AAH-2894-2019	Misaki, Masaya/0000-0002-6829-4311; Yuan, Han/0000-0003-0055-9691; Young, Kymberly/0000-0001-5133-2142; Zotev, Vadim/0000-0002-5784-2562	Laureate Institute for Brain Research; William K. Warren Foundation	Laureate Institute for Brain Research; William K. Warren Foundation	This research was supported by the Laureate Institute for Brain Research and the William K. Warren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1985, EXP BRAIN RES, V57, P390; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; APA, 2000, DIAGN STAT MAN MENT; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BEUTLER LE, 1991, J CONSULT CLIN PSYCH, V59, P333, DOI 10.1037/0022-006X.59.2.333; Bodurka J., 2008, NEUROIMAGE S1, V41, pS85; BRADLEY B, 1983, BRIT J CLIN PSYCHOL, V22, P173, DOI 10.1111/j.2044-8260.1983.tb00598.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cain RA, 2007, PRIMARY CARE, V34, P505, DOI 10.1016/j.pop.2007.05.006; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; Cannon R, 2007, INT J NEUROSCI, V117, P337, DOI 10.1080/00207450500514003; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; COX RW, 1995, MAGNET RESON MED, V33, P230, DOI 10.1002/mrm.1910330213; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dichter G.S., 2010, OPEN PSYCHIAT J, V4, P1, DOI [10.2174/1874354401004010001, DOI 10.2174/1874354401004010001]; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Droppelman L.F., 1971, EDITS MANUAL PROFILE; ELKIN I, 1995, J CONSULT CLIN PSYCH, V63, P841, DOI 10.1037/0022-006X.63.5.841; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Fias W, 2007, J NEUROSCI, V27, P8952, DOI 10.1523/JNEUROSCI.2076-07.2007; First MB, 2002, STRUCTURED CLIN INTE; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greenberg DL, 2005, NEUROPSYCHOLOGIA, V43, P659, DOI 10.1016/j.neuropsychologia.2004.09.002; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harmer CJ, 2009, AM J PSYCHIAT, V166, P1178, DOI 10.1176/appi.ajp.2009.09020149; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Johnston S, 2011, COGN AFFECT BEHAV NE, V11, P44, DOI 10.3758/s13415-010-0010-1; Kelsey J. E., 2004, J AM OSTEOPATH ASSOC, V104, pS6; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Loas G, 1996, PSYCHOPATHOLOGY, V29, P139, DOI 10.1159/000284983; McMakin DL, 2009, J POSIT PSYCHOL, V4, P182, DOI 10.1080/17439760802650600; Merkl A, 2009, EXP NEUROL, V219, P20, DOI 10.1016/j.expneurol.2009.04.027; Merrill KA, 2003, J CONSULT CLIN PSYCH, V71, P404, DOI 10.1037/0022-006X.71.2.404; Mohr P, 2011, NEUROPSYCHOBIOLOGY, V64, P170, DOI 10.1159/000325225; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Newman SD, 2011, BRAIN RES, V1410, P77, DOI 10.1016/j.brainres.2011.06.053; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Phillips R, 2012, SELF REGULATION AMYG; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sakai K, 2002, J NEUROPHYSIOL, V88, P2035, DOI 10.1152/jn.2002.88.4.2035; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2007, COGNITIVE THER RES, V31, P235, DOI 10.1007/s10608-006-9118-6; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Suslow T, 2010, BIOL PSYCHIAT, V67, P155, DOI 10.1016/j.biopsych.2009.07.023; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Talairach J., 1988, COPLANAR STEREOTAXIC; van Vreeswijk MF, 2004, BEHAV RES THER, V42, P731, DOI 10.1016/S0005-7967(03)00194-3; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007; World Health Organization, 2004, WORLD HLTH REP 2004; Young K, 2012, SELF REGULATION AMYG; Young KD, 2012, PSYCHOL MED, V42, P345, DOI 10.1017/S0033291711001371; Zotev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079184; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	84	164	167	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88785	10.1371/journal.pone.0088785	http://dx.doi.org/10.1371/journal.pone.0088785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523939	gold, Green Published			2022-12-27	WOS:000331258100088
J	Asadi, H; Dowling, R; Yan, B; Mitchell, P				Asadi, Hamed; Dowling, Richard; Yan, Bernard; Mitchell, Peter			Machine Learning for Outcome Prediction of Acute Ischemic Stroke Post Intra-Arterial Therapy	PLOS ONE			English	Article							BASILAR ARTERY-OCCLUSION; SINGLE-CENTER EXPERIENCE; MECHANICAL THROMBECTOMY; ENDOVASCULAR TREATMENT; MERCI RETRIEVER; INTERVENTIONAL MANAGEMENT; INTRAVENOUS THROMBOLYSIS; FLOW RESTORATION; RECANALIZATION; TRIAL	Introduction: Stroke is a major cause of death and disability. Accurately predicting stroke outcome from a set of predictive variables may identify high-risk patients and guide treatment approaches, leading to decreased morbidity. Logistic regression models allow for the identification and validation of predictive variables. However, advanced machine learning algorithms offer an alternative, in particular, for large-scale multi-institutional data, with the advantage of easily incorporating newly available data to improve prediction performance. Our aim was to design and compare different machine learning methods, capable of predicting the outcome of endovascular intervention in acute anterior circulation ischaemic stroke. Method: We conducted a retrospective study of a prospectively collected database of acute ischaemic stroke treated by endovascular intervention. Using SPSSH, MATLABH, and RapidminerH, classical statistics as well as artificial neural network and support vector algorithms were applied to design a supervised machine capable of classifying these predictors into potential good and poor outcomes. These algorithms were trained, validated and tested using randomly divided data. Results: We included 107 consecutive acute anterior circulation ischaemic stroke patients treated by endovascular technique. Sixty-six were male and the mean age of 65.3. All the available demographic, procedural and clinical factors were included into the models. The final confusion matrix of the neural network, demonstrated an overall congruency of similar to 80% between the target and output classes, with favourable receiving operative characteristics. However, after optimisation, the support vector machine had a relatively better performance, with a root mean squared error of 2.064 (SD: +/- 0.408). Discussion: We showed promising accuracy of outcome prediction, using supervised machine learning algorithms, with potential for incorporation of larger multicenter datasets, likely further improving prediction. Finally, we propose that a robust machine learning system can potentially optimise the selection process for endovascular versus medical treatment in the management of acute stroke.	[Asadi, Hamed; Dowling, Richard; Yan, Bernard; Mitchell, Peter] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; University of Melbourne	Mitchell, P (corresponding author), Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia.	peter.mitchell@mh.org.au		Yan, Bernard/0000-0001-8802-9606; Dowling, Richard/0000-0002-4082-8676				Adelman S M, 1981, Stroke, V12, pI69; Agrawal Abhishek, 2012, Asian J Neurosurg, V7, P166, DOI 10.4103/1793-5482.106647; Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; Alpaydin E., 2010, INTRO MACHINE LEARNI; Alshekhlee A, 2012, NEUROLOGY, V79, pS126, DOI 10.1212/WNL.0b013e3182697e89; [Anonymous], 2004, Clin Privil White Pap, P1; [Anonymous], 2012, Clin Privil White Pap, P1; Barreto AD, 2012, STROKE, V43, P591, DOI 10.1161/STROKEAHA.111.617902; Becker KJ, 2005, STROKE, V36, P400, DOI 10.1161/01.STR.0000153056.25397.ff; Blackham KA, 2012, J NEUROINTERV SURG, V4, P87, DOI 10.1136/neurintsurg-2011-010243; Bosel Julian, 2012, Curr Treat Options Cardiovasc Med, V14, P260, DOI 10.1007/s11936-012-0172-y; Bouts MJRJ, 2013, J CEREBR BLOOD F MET, V33, P1075, DOI 10.1038/jcbfm.2013.51; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Campbell BC, 2013, NEW ENGL J MED, V368, P2431, DOI [10.1056/NEJMc1304759, 10.1056/NEJMoa1213701]; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Ciccone A, 2011, INT J STROKE, V6, P259, DOI 10.1111/j.1747-4949.2011.00587.x; Cloft HJ, 2009, AM J NEURORADIOL, V30, P453, DOI 10.3174/ajnr.A1462; Cohen JE, 2012, J CLIN NEUROSCI, V19, P39, DOI 10.1016/j.jocn.2011.06.015; Cuingnet R, 2010, LECT NOTES COMPUT SC, V6361, P316; Day JS, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS10267; Dorn F, 2012, CEREBROVASC DIS, V34, P70, DOI 10.1159/000338903; Ferrell Andrew S, 2013, Surg Neurol Int, V4, pS31, DOI 10.4103/2152-7806.109194; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Gonzalez RG, 2013, J NEUROINTERV SURG, V5, P7, DOI 10.1136/neurintsurg-2013-010715; Grotta JC, 2001, STROKE, V32, P661, DOI 10.1161/01.STR.32.3.661; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; Hirsch JA, 2009, J NEUROINTERV SURG, V1, P27, DOI 10.1136/jnis.2009.000166; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jeromel M, 2013, CARDIOVASC INTER RAD, V36, P338, DOI 10.1007/s00270-012-0441-x; Khatri P, 2008, INT J STROKE, V3, P130, DOI 10.1111/j.1747-4949.2008.00151.x; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kulcsar Z, 2010, AM J NEURORADIOL, V31, P628, DOI 10.3174/ajnr.A1924; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Levy EI, 1999, NEUROSURGERY, V45, P539, DOI 10.1097/00006123-199909000-00025; Lindsberg PJ, 2006, STROKE, V37, P922, DOI 10.1161/01.STR.0000202582.29510.6b; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Nogueira RG, 2009, AM J NEURORADIOL, V30, P859, DOI 10.3174/ajnr.A1604; Rai AT, 2013, J NEUROINTERV SURG, V5, P25, DOI 10.1136/neurintsurg-2012-010293; Riedel CH, 2011, STROKE, V42, P1775, DOI 10.1161/STROKEAHA.110.609693; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Roth C, 2010, STROKE, V41, P2559, DOI 10.1161/STROKEAHA.110.592071; Russell SP, 2010, ARTIFICIAL INTELLIGE; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Saver JL, 2006, STROKE, V37, P1340, DOI 10.1161/01.STR.0000217436.17531.fa; Schonewille WJ, 2009, LANCET NEUROL, V8, P724, DOI 10.1016/S1474-4422(09)70173-5; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2007, STROKE, V38, P701, DOI 10.1161/01.STR.0000247897.33267.42; Smith WS, 2006, AM J NEURORADIOL, V27, P1177; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Stampfl S, 2011, AM J NEURORADIOL, V32, P1245, DOI 10.3174/ajnr.A2505; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; Tenser MS, 2011, WORLD NEUROSURG, V76, pS16, DOI 10.1016/j.wneu.2011.07.003; Warwick K., 2012, ARTIFICIAL INTELLIGE; Warwick K., 2004, MARCH MACHINES BREAK; Wechsler LR, 2006, STROKE, V37, P1341, DOI 10.1161/01.STR.0000217361.50952.5c; Zaidat OO, 2012, J NEUROINTERV SURG, V4, P235, DOI 10.1136/neurintsurg-2012-010409	58	105	108	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88225	10.1371/journal.pone.0088225	http://dx.doi.org/10.1371/journal.pone.0088225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520356	Green Published, gold			2022-12-27	WOS:000331254600047
J	Chen, JM; Chang, CW; Chang, TH; Hsu, CC; Horng, JT; Sheu, WHH				Chen, Jui-Ming; Chang, Cheng-Wei; Chang, Tzu-Hao; Hsu, Chi-Chang; Horng, Jorng-Tzong; Sheu, Wayne H-H			Effects of Statins on Incident Dementia in Patients with Type 2 DM: A Population-Based Retrospective Cohort Study in Taiwan	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MODERATE ALZHEIMER-DISEASE; DIABETES-MELLITUS; COGNITIVE FUNCTION; VASCULAR DEMENTIA; RISK; DECLINE; ATORVASTATIN; INDIVIDUALS; SIMVASTATIN	Background: Patients with Type 2 diabetes (T2DM) are prone to develop dementia. Results from a recent study indicated that statin users had lower chance of developing incident dementia. However there is little information on the potential benefits of statin use on dementia in patients with T2DM cohort. Method: A population-based retrospective study using a nationwide cohort of National Health Insurance Research Database in Taiwan was performed. T2DM cohort with regular use of statins was followed up to 8 years. Multivariate cox-proportional hazards regression model was used to estimate the association between statin use and incidence of dementia including Alzheimer's disease and non-Alzheimer dementia after adjusting for several potential confounders. Results: Among 28,321 patients diagnosed with T2DM age above 50 and without history of dementia before 2000/1/1, 15,770 patients who had never used statin and 2,400 patients who regularly used statin drugs were enrolled. After adjusting for age group, gender, CCI (Charlson-Deyo comorbidity index) group, stroke types and anti-diabetic drugs, regular statin use was associated with a decreased risk of developing incident Alzheimer's disease dementia (adjusted HR: 0.48, 95% CI 0.30 - 0.76, p < 0.001), but not in non-Alzheimer dementia (adjusted HR: 1.07, 95% CI 0.54-2.12 p = 0.844) in patients with T2DM. Further analysis showed significant protective effects of the use of atorvastatin and simvastatin. Conclusion: Regular use of statins might decrease the risk of developing Alzheimer's disease in patients with T2DM while no benefit was observed in non-Alzheimer dementia. Among statins, both atorvastatin and simvastatin showed significant benefits.	[Chen, Jui-Ming] Tungs Taichung MetroHarbor Hosp, Dept Endocrinol & Metab, Taichung, Taiwan; [Chang, Cheng-Wei] Hsing Wu Univ, Dept Informat Management, New Taipei City, Taiwan; [Chen, Jui-Ming] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chen, Jui-Ming; Horng, Jorng-Tzong] Nan Kai Univ Technol, Dept Gerontechnol, Nantou, Taiwan; [Chen, Jui-Ming; Horng, Jorng-Tzong] Nan Kai Univ Technol, Serv Management, Nantou, Taiwan; [Chang, Tzu-Hao] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Hsu, Chi-Chang; Horng, Jorng-Tzong] Natl Cent Univ, Dept Comp Sci & Informat Engn, Chungli 32054, Taiwan; [Sheu, Wayne H-H] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan; [Sheu, Wayne H-H] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Sheu, Wayne H-H] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Sheu, Wayne H-H] Natl Chung Hsing Univ, Inst Med Technol, Taichung 40227, Taiwan	Tungs' Taichung MetroHarbor Hospital; Asia University Taiwan; Nan Kai University Technology; Nan Kai University Technology; Taipei Medical University; National Central University; Taichung Veterans General Hospital; National Defense Medical Center; National Yang Ming Chiao Tung University; National Chung Hsing University	Horng, JT (corresponding author), Nan Kai Univ Technol, Dept Gerontechnol, Nantou, Taiwan.	horng@db.csie.ncu.edu.tw; whhsheu@vghtc.gov.tw						Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Ancelin ML, 2012, J ALZHEIMERS DIS, V30, P629, DOI 10.3233/JAD-2012-120064; [Anonymous], INTR NAT HLTH INS RE; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Benito-Leon J, 2010, J ALZHEIMERS DIS, V21, P95, DOI 10.3233/JAD-2010-100180; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050729; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fei M, 2013, AGE AGEING, V42, P398, DOI 10.1093/ageing/afs188; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; International AsD, 2009, WORLD ALZHEIMER REPO; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Johnson ML, 2012, ALZHEIMERS DEMENT, V8, P437, DOI 10.1016/j.jalz.2011.05.2414; Joshi Hemant N., 1999, Pharmacy and Pharmacology Communications, V5, P269; Li G, 2007, NEUROLOGY, V69, P878, DOI 10.1212/01.wnl.0000277657.95487.1c; Lin CH, 2013, J INTERN MED, V273, P102, DOI 10.1111/joim.12000; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Rea TD, 2005, ARCH NEUROL-CHICAGO, V62, P1047, DOI 10.1001/archneur.62.7.1047; Reitz C, 2004, ARCH NEUROL-CHICAGO, V61, P705, DOI 10.1001/archneur.61.5.705; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; Wang KC, 2012, NEUROEPIDEMIOLOGY, V38, P237, DOI 10.1159/000337428; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Wong WB, 2013, PHARMACOEPIDEM DR S, V22, P345, DOI 10.1002/pds.3381; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378	34	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88434	10.1371/journal.pone.0088434	http://dx.doi.org/10.1371/journal.pone.0088434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520388	Green Submitted, gold, Green Published			2022-12-27	WOS:000331254600079
J	Li, YF; Reynolds, P; O'Neill, P; Cucinotta, FA				Li, Yongfeng; Reynolds, Pamela; O'Neill, Peter; Cucinotta, Francis A.			Modeling Damage Complexity-Dependent Non-Homologous End-Joining Repair Pathway	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; KINASE CATALYTIC SUBUNIT; ULTRASOFT X-RAYS; DNA ENDS; PROTEIN-KINASE; IONIZING-RADIATION; GAMMA-H2AX FOCI; HUMAN-CELLS; MATHEMATICAL-MODEL; ATM	Non-homologous end joining (NHEJ) is the dominant DNA double strand break (DSB) repair pathway and involves several repair proteins such as Ku, DNA-PKcs, and XRCC4. It has been experimentally shown that the choice of NHEJ proteins is determined by the complexity of DSB. In this paper, we built a mathematical model, based on published data, to study how NHEJ depends on the damage complexity. Under an appropriate set of parameters obtained by minimization technique, we can simulate the kinetics of foci track formation in fluorescently tagged mammalian cells, Ku80-EGFP and DNA-PKcs-YFP for simple and complex DSB repair, respectively, in good agreement with the published experimental data, supporting the notion that simple DSB undergo fast repair in a Ku-dependent, DNA-PKcs-independent manner, while complex DSB repair requires additional DNA-PKcs for end processing, resulting in its slow repair, additionally resulting in slower release rate of Ku and the joining rate of complex DNA ends. Based on the numerous experimental descriptions, we investigated several models to describe the kinetics for complex DSB repair. An important prediction of our model is that the rejoining of complex DSBs is through a process of synapsis formation, similar to a second order reaction between ends, rather than first order break filling/joining. The synapsis formation (SF) model allows for diffusion of ends before the synapsis formation, which is precluded in the first order model by the rapid coupling of ends. Therefore, the SF model also predicts the higher number of chromosomal aberrations observed with high linear energy transfer (LET) radiation due to the higher proportion of complex DSBs compared to low LET radiation, and an increased probability of misrejoin following diffusion before the synapsis is formed, while the first order model does not provide a mechanism for the increased effectiveness in chromosomal aberrations observed.	[Li, Yongfeng] Univ Space Res Assoc, Div Space Life Sci, Houston, TX USA; [Reynolds, Pamela; O'Neill, Peter] Univ Oxford, Gray Inst Radiat Oncol & Biol, Dept Oncol, Oxford, England; [Cucinotta, Francis A.] Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA; [Cucinotta, Francis A.] NASA, Lyndon B Johnson Space Ctr, Space Radiat Program, Houston, TX 77058 USA	Universities Space Research Association (USRA); University of Oxford; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Cucinotta, FA (corresponding author), Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA.	Francis.Cucinotta@unlv.edu	Cucinotta, Francis/AAZ-5941-2020		DoE Low Dose Program; NASA Space Radiation Program; Medical Research Council [MC_PC_12001] Funding Source: researchfish; MRC [MC_PC_12001] Funding Source: UKRI	DoE Low Dose Program; NASA Space Radiation Program(National Aeronautics & Space Administration (NASA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by DoE Low Dose Program and NASA Space Radiation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Botchway SW, 2012, METHOD ENZYMOL, V504, P3, DOI 10.1016/B978-0-12-391857-4.00001-X; Botchway SW, 1997, RADIAT RES, V148, P317, DOI 10.2307/3579516; Bryans M, 1999, MUTAT RES-DNA REPAIR, V433, P53, DOI 10.1016/S0921-8777(98)00063-9; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Cucinotta FA, 2002, RADIAT PROT DOSIM, V99, P85, DOI 10.1093/oxfordjournals.rpd.a006846; Cucinotta FA, 2000, ADV SPACE RES, V25, P2131, DOI 10.1016/S0273-1177(99)01065-0; Cucinotta FA, 2000, INT J RADIAT BIOL, V76, P1463, DOI 10.1080/09553000050176225; Cucinotta FA, 2008, RADIAT RES, V169, P214, DOI 10.1667/RR1035.1; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Datta K, 2005, P NATL ACAD SCI USA, V102, P10569, DOI 10.1073/pnas.0503975102; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Dobbs TA, 2008, DNA REPAIR, V7, P1372, DOI 10.1016/j.dnarep.2008.05.001; Drouet J, 2006, J BIOL CHEM, V281, P27784, DOI 10.1074/jbc.M603047200; Friedland W, 2011, RADIAT PROT DOSIM, V143, P542, DOI 10.1093/rpd/ncq383; Friedland W, 2010, RADIAT RES, V173, P677, DOI 10.1667/RR1965.1; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Gulston M, 2004, NUCLEIC ACIDS RES, V32, P1602, DOI 10.1093/nar/gkh306; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Harper JV, 2008, PHOTOCHEM PHOTOBIOL, V84, P1506, DOI 10.1111/j.1751-1097.2008.00378.x; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Jeggo PA, 2005, CELL CYCLE, V4, P359, DOI 10.4161/cc.4.3.1527; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Li YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044293; Li YF, 2011, J THEOR BIOL, V283, P122, DOI 10.1016/j.jtbi.2011.05.015; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Lorat Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038165; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; METZGER L, 1991, INT J RADIAT BIOL, V59, P1325, DOI 10.1080/09553009114551201; MIMORI T, 1986, J BIOL CHEM, V261, P2274; Okayasu R, 2006, RADIAT RES, V165, P59, DOI 10.1667/RR3489.1; Postow L, 2008, J CELL BIOL, V182, P467, DOI 10.1083/jcb.200802146; Reynolds P, 2013, MUTAT RES-GEN TOX EN, V756, P14, DOI 10.1016/j.mrgentox.2013.05.006; Reynolds P, 2012, NUCLEIC ACIDS RES, V40, P10821, DOI 10.1093/nar/gks879; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rief N, 2002, J BIOL CHEM, V277, P20572, DOI 10.1074/jbc.M200265200; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Splinter J, 2010, MUTAGENESIS, V25, P289, DOI 10.1093/mutage/geq005; Taleei R, 2013, RADIAT RES, V179, P540, DOI 10.1667/RR3124.1; Taleei R, 2013, RADIAT RES, V179, P530, DOI 10.1667/RR3123.1; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137	57	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e85816	10.1371/journal.pone.0085816	http://dx.doi.org/10.1371/journal.pone.0085816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520318	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600008
J	Mukherjee, AK				Mukherjee, Ashis K.			The Pro-Coagulant Fibrinogenolytic Serine Protease Isoenzymes Purified from Daboia russelii russelii Venom Coagulate the Blood through Factor V Activation: Role of Glycosylation on Enzymatic Activity	PLOS ONE			English	Article							HEMORRHAGIC ACTIVITY; BASIC PROTEINASES; VIPER; SPECIFICITY; SEQUENCE; ALPHA; PURIFICATION	Proteases from Russell's viper venom (RVV) induce a variety of toxic effects in victim. Therefore, four new RVV protease isoenzymes of molecular mass 32901.044 Da, 333631.179 Da, 333571.472 Da, and 34594.776 Da, were characterized in this study. The first 10 N-terminal residues of these serine protease isoenzymes showed significant sequence homology with N-terminal sequences of snake venom thrombin-like and factor V-activating serine proteases, which was reconfirmed by peptide mass fingerprinting analysis. These proteases were found to be different from previously reported factor V activators isolated from snake venoms. These proteases showed significantly different fibrinogenolytic, BAEE-esterase and plasma clotting activities but no fibrinolytic, TAME-esterase or amidolytic activity against the chromogenic substrate for trypsin, thrombin, plasmin and factor Xa. Their Km and Vmax values towards fibrinogen were determined in the range of 6.6 to 10.5 mu M and 111.0 to 125.5 units/mg protein, respectively. On the basis of fibrinogen degradation pattern, they may be classified as A/B serine proteases isolated from snake venom. These proteases contain similar to 42% to 44% of N-linked carbohydrates by mass whereas partially deglycosylated enzymes showed significantly less catalytic activity as compared to native enzymes. In vitro these protease isoenzymes induce blood coagulation through factor V activation, whereas in vivo they provoke dose-dependent defibrinogenation and anticoagulant activity in the mouse model. At a dose of 5 mg/kg, none of these protease isoenzymes were found to be lethal in mice or house geckos, suggesting therapeutic application of these anticoagulant peptides for the prevention of thrombosis.	[Mukherjee, Ashis K.] Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur, Assam, India; [Mukherjee, Ashis K.] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA	Tezpur University; University of Northern Colorado	Mukherjee, AK (corresponding author), Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur, Assam, India.	akm@tezu.ernet.in			Ministry of Science and Technology, Govt. of India; DBT-twinning project	Ministry of Science and Technology, Govt. of India; DBT-twinning project	The author received DBT-Crest award from Ministry of Science and Technology, Govt. of India enabling his participation in this study. A part of this study received support from DBT-twinning project granted to the author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiconi G, 2000, BIOCHEMISTRY-US, V39, P10294, DOI 10.1021/bi000145i; BURMESTER HB, 1970, J CLIN PATHOL, V23, P43, DOI 10.1136/jcp.23.1.43; Patino AC, 2013, TOXICON, V63, P32, DOI 10.1016/j.toxicon.2012.11.010; Deshimaru M, 1996, FEBS LETT, V397, P83, DOI 10.1016/S0014-5793(96)01144-1; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; GERADS I, 1992, TOXICON, V30, P1065, DOI 10.1016/0041-0101(92)90052-7; KISIEL W, 1979, J BIOL CHEM, V254, P2230; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Markland FS, 1996, ADV EXP MED BIOL, V391, P427; Menaldo DL, 2012, BIOCHIMIE, V94, P2545, DOI 10.1016/j.biochi.2012.07.007; MONKOVIC DD, 1990, J BIOL CHEM, V265, P17132; Mukheriee AK, 2008, TOXICON, V51, P923, DOI 10.1016/j.toxicon.2007.12.008; Mukherjee A.K., 2013, PROTEASES HLTH DIS A, V7, P163; Mukherjee AK, 2000, TOXICON, V38, P163, DOI 10.1016/S0041-0101(99)00125-7; Mukherjee AK, 2013, BBA-GEN SUBJECTS, V1830, P3476, DOI 10.1016/j.bbagen.2013.02.007; Mukherjee AK, 2012, BIOCHIMIE, V94, P1300, DOI 10.1016/j.biochi.2012.02.027; Mukherjee Ashis K, 2010, J Venom Res, V1, P37; Oyama E, 2003, TOXICON, V41, P559, DOI 10.1016/S0041-0101(02)00363-X; REICHL AP, 1993, TOXICON, V31, P1479, DOI 10.1016/0041-0101(93)90213-3; SERRANO SMT, 1993, TOXICON, V31, P471, DOI 10.1016/0041-0101(93)90182-I; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Serrano SMT, 1998, EUR J BIOCHEM, V251, P845, DOI 10.1046/j.1432-1327.1998.2510845.x; Siigur E, 1998, BBA-PROTEIN STRUCT M, V1429, P239, DOI 10.1016/S0167-4838(98)00232-5; Swenson S, 2005, TOXICON, V45, P1021, DOI 10.1016/j.toxicon.2005.02.027; TOKUNAGA F, 1988, J BIOL CHEM, V263, P17471; TRACY PB, 1979, J BIOL CHEM, V254, P354; WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8; Weldon CL, 2012, BIOCHIMIE, V94, P1189, DOI 10.1016/j.biochi.2012.02.006; WUSTER W, 1992, BIOL J LINN SOC, V47, P97, DOI 10.1111/j.1095-8312.1992.tb00658.x	30	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e86823	10.1371/journal.pone.0086823	http://dx.doi.org/10.1371/journal.pone.0086823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520323	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600014
J	Sesti, G; Fiorentino, TV; Arturi, F; Perticone, M; Sciacqua, A; Perticone, F				Sesti, Giorgio; Fiorentino, Teresa Vanessa; Arturi, Franco; Perticone, Maria; Sciacqua, Angela; Perticone, Francesco			Association between Noninvasive Fibrosis Markers and Chronic Kidney Disease among Adults with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							GROWTH-FACTOR-I; GLOMERULAR-FILTRATION-RATE; TERM-FOLLOW-UP; CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; NATURAL-HISTORY; PLASMA-GLUCOSE; RENAL-FUNCTION; NAFLD; RISK	Evidence suggests that nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are associated with an increased risk of chronic kidney disease (CKD). In this study we aimed to evaluate whether the severity of liver fibrosis estimated by NAFLD fibrosis score is associated with higher prevalence of CKD in individuals with NAFLD. To this end NAFLD fibrosis score and estimated glomerular filtration rate (eGFR) were assessed in 570 White individuals with ultrasonography-diagnosed NAFLD. As compared with subjects at low probability of liver fibrosis, individuals at high and intermediate probability showed an unfavorable cardio-metabolic risk profile having significantly higher values of waist circumference, insulin resistance, high sensitivity C-reactive protein, fibrinogen, uric acid and lower insulin-like growth factor-1 levels. Individuals at high and intermediate probability of liver fibrosis have lower eGFR after adjustment for gender, smoking, glucose tolerance status, homeostasis model assessment index of insulin resistance (HOMA-IR index), diagnosis of metabolic syndrome, statin therapy, anti-diabetes and anti-hypertensive treatments (P = 0.001). Individuals at high probability of liver fibrosis had a 5.1-fold increased risk of having CKD (OR 5.13, 95% CI 1.13-23.28; P = 0.03) as compared with individuals at low probability after adjustment for age, gender, and BMI. After adjustment for glucose tolerance status, statin therapy, and anti-hypertensive treatment in addition to gender, individuals at high probability of liver fibrosis had a 3.9-fold increased risk of CKD (OR 3.94, 95% CI 1.11-14.05; P = 0.03) as compared with individuals at low probability. In conclusion, advanced liver fibrosis, determined by noninvasive fibrosis markers, is associated with CKD independently from other known factors.	[Sesti, Giorgio; Fiorentino, Teresa Vanessa; Arturi, Franco; Perticone, Maria; Sciacqua, Angela; Perticone, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	Fiorentino, Teresa Vanessa/AAP-1855-2020; Sesti, Giorgio/B-1509-2012; Perticone, Francesco/I-4260-2017; Perticone, Maria/J-9965-2016	Perticone, Maria/0000-0002-2456-1123; ARTURI, Franco/0000-0002-1660-1228; Sesti, Giorgio/0000-0002-1618-7688	Italian Ministry of University [FIRB/MERIT RBNE08NKH7_002]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This work was supported by Italian Ministry of University grant FIRB/MERIT RBNE08NKH7_002 to Giorgio Sesti. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Chang Y, 2008, METABOLISM, V57, P569, DOI 10.1016/j.metabol.2007.11.022; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Demir M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058360; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; GIORDANO M, 1995, NEPHRON, V71, P10, DOI 10.1159/000188667; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; HAYLOR J, 1991, KIDNEY INT, V39, P333, DOI 10.1038/ki.1991.42; Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Myers RP, 2008, LIVER INT, V28, P705, DOI 10.1111/j.1478-3231.2008.01691.x; Perticone F, 2010, CIRCULATION, V122, P379, DOI 10.1161/CIRCULATIONAHA.110.940932; Perticone F, 2009, EUR J CARDIOV PREV R, V16, P481, DOI 10.1097/HJR.0b013e32832b8d87; Perticone F, 2009, J HYPERTENS, V27, P613, DOI 10.1097/HJH.0b013e32831fda24; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Sciacqua A, 2011, NUTR METAB CARDIOVAS, V21, P485, DOI 10.1016/j.numecd.2009.11.015; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Stepanova M, 2012, CLIN GASTROENTEROL H, V10, P646, DOI 10.1016/j.cgh.2011.12.039; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Succurro E, 2011, NUTR METAB CARDIOVAS, V21, P713, DOI 10.1016/j.numecd.2011.02.002; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2008, J AM SOC NEPHROL, V19, P1564, DOI 10.1681/ASN.2007101155; Targher G, 2010, CLIN J AM SOC NEPHRO, V5, P2166, DOI 10.2215/CJN.05050610; Targher G, 2011, J HEPATOL, V54, P1020, DOI 10.1016/j.jhep.2010.11.007; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Targher G, 2009, SEMIN THROMB HEMOST, V35, P277, DOI 10.1055/s-0029-1222606; The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2013, DIABETES CARE, V26, P3160; Treeprasertsuk S, 2013, WORLD J GASTROENTERO, V19, P1219, DOI 10.3748/wjg.v19.i8.1219; TSUKAHARA H, 1994, KIDNEY INT, V45, P598, DOI 10.1038/ki.1994.78; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Weiner DE, 2008, AM J KIDNEY DIS, V51, P212, DOI 10.1053/j.ajkd.2007.10.035; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Yasui K, 2011, METABOLISM, V60, P735, DOI 10.1016/j.metabol.2010.07.022	46	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88569	10.1371/journal.pone.0088569	http://dx.doi.org/10.1371/journal.pone.0088569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520400	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600091
J	Shav, D; Gotlieb, R; Zaretsky, U; Elad, D; Einav, S				Shav, Dalit; Gotlieb, Ruth; Zaretsky, Uri; Elad, David; Einav, Shmuel			Wall Shear Stress Effects on Endothelial-Endothelial and Endothelial- Smooth Muscle Cell Interactions in Tissue Engineered Models of the Vascular Wall	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MYOENDOTHELIAL GAP-JUNCTIONS; DISTURBED FLOW; VE-CADHERIN; COCULTURE; EXPRESSION; MECHANOTRANSDUCTION; COMMUNICATION; ACTIVATION; CONNEXIN43	Vascular functions are affected by wall shear stresses (WSS) applied on the endothelial cells (EC), as well as by the interactions of the EC with the adjacent smooth muscle cells (SMC). The present study was designed to investigate the effects of WSS on the endothelial interactions with its surroundings. For this purpose we developed and constructed two co-culture models of EC and SMC, and compared their response to that of a single monolayer of cultured EC. In one co-culture model the EC were cultured on the SMC, whereas in the other model the EC and SMC were cultured on the opposite sides of a membrane. We studied EC-matrix interactions through focal adhesion kinase morphology, EC-EC interactions through VE-Cadherin expression and morphology, and EC-SMC interactions through the expression of Cx43 and Cx37. In the absence of WSS the SMC presence reduced EC-EC connectivity but produced EC-SMC connections using both connexins. The exposure to WSS produced discontinuity in the EC-EC connections, with a weaker effect in the co-culture models. In the EC monolayer, WSS exposure (12 and 4 dyne/ cm 2 for 30 min) increased the EC-EC interaction using both connexins. WSS exposure of 12 dyne/ cm 2 did not affect the EC-SMC interactions, whereas WSS of 4 dyne/cm(2) elevated the amount of Cx43 and reduced the amount of Cx37, with a different magnitude between the models. The reduced endothelium connectivity suggests that the presence of SMC reduces the sealing properties of the endothelium, showing a more inflammatory phenotype while the distance between the two cell types reduced their interactions. These results demonstrate that EC-SMC interactions affect EC phenotype and change the EC response to WSS. Furthermore, the interactions formed between the EC and SMC demonstrate that the 1-side model can simulate better the arterioles, while the 2-side model provides better simulation of larger arteries.	[Shav, Dalit; Gotlieb, Ruth; Zaretsky, Uri; Elad, David; Einav, Shmuel] Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel	Tel Aviv University	Shav, D (corresponding author), Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.	dalitsh1@post.tau.ac.il			Herbert Berman Fund; Joseph Drown Foundation	Herbert Berman Fund; Joseph Drown Foundation	This work was supported by the Herbert Berman Fund and The Joseph Drown Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Brown DJ, 2005, J VASC SURG, V41, P509, DOI 10.1016/j.jvs.2004.12.024; Cao L, 2011, J BIOMECH, V44, P2150, DOI 10.1016/j.jbiomech.2011.05.024; Cao Xiang-feng, 2010, Yingyong Shengtai Xuebao, V21, P3063; Chen CN, 2006, BLOOD, V107, P1933, DOI 10.1182/blood-2005-08-3137; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Chiu JJ, 2004, J BIOMECH, V37, P531, DOI 10.1016/j.jbiomech.2003.08.012; Chiu JJ, 2003, BLOOD, V101, P2667, DOI 10.1182/blood-2002-08-2560; DAVIES PF, 1994, J CLIN INVEST, V93, P2031, DOI 10.1172/JCI117197; de Wit C, 2008, CELL COMMUN ADHES, V15, P231, DOI 10.1080/15419060802440260; DePaola N, 1999, P NATL ACAD SCI USA, V96, P3154, DOI 10.1073/pnas.96.6.3154; Ding ZF, 2009, SCI CHINA SER C, V52, P1023, DOI 10.1007/s11427-009-0135-z; Ebong EE, 2006, AM J PHYSIOL-HEART C, V290, pH2015, DOI 10.1152/ajpheart.00204.2005; Even-Tzur N, 2006, ANN BIOMED ENG, V34, P1890, DOI 10.1007/s10439-006-9211-8; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Fillinger MF, 1997, J SURG RES, V67, P169, DOI 10.1006/jsre.1996.4978; Fujiwara K, 2006, J INTERN MED, V259, P373, DOI 10.1111/j.1365-2796.2006.01623.x; Gabriels JE, 1998, CIRC RES, V83, P636, DOI 10.1161/01.RES.83.6.636; Gairhe S, 2011, AM J PHYSIOL-LUNG C, V301, pL527, DOI 10.1152/ajplung.00091.2011; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Heberlein KR, 2010, CIRC RES, V106, P1092, DOI 10.1161/CIRCRESAHA.109.215723; Heberlein KR, 2009, MICROCIRCULATION, V16, P307, DOI 10.1080/10739680902744404; Helenius G, 2008, EUR SURG RES, V40, P325, DOI 10.1159/000118028; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Heydarkhan-Hagvall S, 2006, MOL CELL BIOCHEM, V281, P1, DOI 10.1007/s11010-006-0168-6; Isakson BE, 2005, CIRC RES, V97, P44, DOI 10.1161/01.RES.0000173461.36221.2e; Johnson TL, 2007, ENDOTHELIUM-J ENDOTH, V14, P215, DOI 10.1080/10623320701617233; Kladakis SM, 2004, ENDOTHELIUM-J ENDOTH, V11, P29, DOI 10.1080/10623320490432461; Kuckleburg CJ, 2011, CARDIOVASC RES, V91, P134, DOI 10.1093/cvr/cvr040; Kwak BR, 2005, CELL COMMUN ADHES, V12, P261, DOI 10.1080/15419060500514119; Lavender MD, 2005, BIOMATERIALS, V26, P4642, DOI 10.1016/j.biomaterials.2004.11.045; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Liu YX, 2012, ACS APPL MATER INTER, V4, P1378, DOI 10.1021/am201648f; Miao H, 2005, J VASC RES, V42, P77, DOI 10.1159/000083094; Niwa K, 2004, ANN BIOMED ENG, V32, P537, DOI 10.1023/B:ABME.0000019173.79939.54; Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504; Rose SL, 2007, ANN BIOMED ENG, V35, P1382, DOI 10.1007/s10439-007-9311-0; Sakai J, 2008, CLIN HEMORHEOL MICRO, V38, P245; Sandow SL, 2002, CIRC RES, V90, P1108, DOI 10.1161/01.RES.0000019756.88731.83; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Scott D, 2013, AM J PHYSIOL-LUNG C, V304, pL70, DOI 10.1152/ajplung.00342.2012; Scott-Drechsel D, 2012, CYTOTECHNOLOGY, V64, P649, DOI 10.1007/s10616-012-9445-2; Seebach J, 2007, CARDIOVASC RES, V75, P596, DOI 10.1016/j.cardiores.2007.04.017; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Straub AC, 2010, J VASC RES, V47, P277, DOI 10.1159/000265562; Tarbell JM, 2003, ANNU REV BIOMED ENG, V5, P79, DOI 10.1146/annurev.bioeng.5.040202.121529; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; Tolsa JF, 2006, J CARDIOVASC PHARM, V47, P501, DOI 10.1097/01.fjc.0000211742.86078.8b; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Truskey George A, 2010, Int J High Throughput Screen, V2010, P171; Tsai MC, 2009, CIRC RES, V105, P471, DOI 10.1161/CIRCRESAHA.109.193656; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Ukropec JA, 2002, EXP CELL RES, V273, P240, DOI 10.1006/excr.2001.5453; Wallace CS, 2007, AM J PHYSIOL-HEART C, V293, pH1978, DOI 10.1152/ajpheart.00618.2007; Wallace CS, 2010, AM J PHYSIOL-HEART C, V299, pH338, DOI 10.1152/ajpheart.01029.2009; Wallace CS, 2007, ANN BIOMED ENG, V35, P375, DOI 10.1007/s10439-006-9230-5; Wang HQ, 2006, ENDOTHELIUM-J ENDOTH, V13, P171, DOI 10.1080/10623320600760282; Wang HQ, 2007, EUR J CELL BIOL, V86, P51, DOI 10.1016/j.ejcb.2006.09.001; Wang YH, 2010, ANN BIOMED ENG, V38, P729, DOI 10.1007/s10439-009-9896-6; Wang YH, 2009, EUR J CELL BIOL, V88, P701, DOI 10.1016/j.ejcb.2009.06.001; Warboys CM, 2010, AM J PHYSIOL-HEART C, V298, pH1850, DOI 10.1152/ajpheart.00114.2010; Xia Y, 2012, BIOMATERIALS, V33, P2462, DOI 10.1016/j.biomaterials.2011.12.001; Zebda N, 2012, MICROVASC RES, V83, P71, DOI 10.1016/j.mvr.2011.06.007; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883	70	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88304	10.1371/journal.pone.0088304	http://dx.doi.org/10.1371/journal.pone.0088304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520363	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600054
J	Yang, BW; Shi, JP; Chen, X; Ma, B; Sun, H				Yang, Bowen; Shi, Jingpu; Chen, Xin; Ma, Bing; Sun, Hao			Efficacy and Safety of Therapies for Acute Ischemic Stroke in China: A Network Meta-Analysis of 13289 Patients from 145 Randomized Controlled Trials	PLOS ONE			English	Article							MIXED TREATMENT COMPARISONS; FREE-RADICAL SCAVENGER; MCI-186; QUALITY; COMBINATION; INFARCTION; DISEASE	Background: Many of these therapies have been compared against placebos, but have not been directly compared against each other. To evaluate the efficacy and safety of several commonly used drugs for AIS directly or indirectly. Methods: A systematic literature review was performed to identify randomized controlled trials (RCTs) published prior to April 2013 for AIS therapies. The primary outcome measures were the National Institutes of Health Stroke Scale (NIHSS) scores and the clinical effective rate. A fixed-effects meta-analysis and meta-regression are performed; lastly, performed a mixed treatment comparison was performed through the Bayesian methods. Results: Outcome of Efficacy of therapies for acute ischemic stroke are as followed: All of the therapies mentioned above yielded results a more effective result than placebo, Sodium ozagrel (RR 3.86, 95% CI 3.18-4.61); Sodium ozagrel + edaravone (RR 9.60, 95% CI 7.04-13.06); Edaravone (RR 4.07, 95% CI 3.30-5.01); Edaravone + Kininogenase (RR 15.33, 95% CI 10.03-23.05). The significant difference in efficacy between edaravone monotherapy and Sodium ozagrel + edaravone was evident (RR 0.43, 95% CI 0.08-0.61) and was also significant between efficacy of edaravone + Kininogenase and Sodium ozagrel (RR 4.00, 95% CI 2.47-6.24). The differences between the risk and benefit were not significant when comparing Sodium ozagrel and edaravone or edaravone + Kininogenase and Sodium ozagrel + Edaravone for AIS. Outcome of the defect of neurological function: Placebo served a significant difference in treating the defects of neurological function compared with Sodium ozagrel (WMD = -3.11, 95% CI -4.43 to -1.79), Sodium ozagrel + edaravone (WMD = -6.25, 95% CI -7.96 to -4.54) and Edaravone + Kininogenase (WMD = -3.47, 95% CI -5.73 to -1.21). Conclusions: It provides that the efficacy of edaravone monotherapy in treatment was not more effective than Sodium ozagrel + edaravone. The efficacy of edaravone + Kininogenase monotherapy in treatment was more effective than Sodium ozagrel. Edaravone + Kininogenase and Sodium ozagrel + Edaravone appeared the most effective treatments. And Sodium ozagrel, Sodium ozagrel + edaravone, Edaravone + Kininogenase can improve the nerve dysfunction.	[Shi, Jingpu] China Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Dept Clin Epidemiol, Shenyang, Peoples R China; China Med Univ, Affiliated Hosp 1, Ctr Evidence Based Med, Shenyang, Peoples R China	China Medical University; China Medical University	Shi, JP (corresponding author), China Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Dept Clin Epidemiol, Shenyang, Peoples R China.	jingpushi56@yahoo.com	Sun, Hao/M-6027-2014					Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Campbell DJ, 2001, CLIN EXP PHARMACOL P, V28, P1060, DOI 10.1046/j.1440-1681.2001.03564.x; Chen QT, 1996, J NEUROL, V29, P376; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Feng S, 2011, COCHRANE DB SYST REV, V12; Glenny AM, 2005, INDIRECT COMP COMPET; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Jansen JP, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-61; Jia Q, 2010, CLIN EXP PHARMACOL P, V37, P259, DOI 10.1111/j.1440-1681.2009.05290.x; Kamienski M, 2012, INT J EVID-BASED HEA, V10, P417, DOI 10.1111/j.1744-1609.2012.00300.x; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; Lapchak PA, 2007, ADV ISCHEMIC STROKE; Lapchak PA, 2011, TRANSL STROKE RES, V2, P129, DOI 10.1007/s12975-011-0074-4; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2006, J AM STAT ASS, V101; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mishina M, 2005, NEUROL MED-CHIR, V45, P344, DOI 10.2176/nmc.45.344; NAGANO H, 1993, YAKUGAKU ZASSHI, V113, P803, DOI 10.1248/yakushi1947.113.11_803; Nagano Hiroshi, 1992, In Vivo (Attiki), V6, P497; Ntzoufras I., 2011, BAYESIAN MODELING US, V698; Ohtomo E, 1991, J CLIN THERAPEUT MED, V7, P353; Ouwens MJNM, 2010, RES SYNTH METHODS, V1, P258, DOI 10.1002/jrsm.25; Sacchetti ML, 1997, NEUROLOGY, V49, pS70, DOI 10.1212/WNL.49.5_Suppl_4.S70; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Takabatake Yasushi, 2003, Brain and Nerve (Tokyo), V55, P589; Taqi MA, 2012, NEUROLOGY, V79, pS213, DOI 10.1212/WNL.0b013e31826959e5; Toni D, 1997, STROKE, V28, P10, DOI 10.1161/01.STR.28.1.10; WATANABE T, 1988, PROSTAG LEUKOTR ESS, V33, P81, DOI 10.1016/0952-3278(88)90127-5; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Zhang J, 2012, NEUROL RES, V34, P346, DOI 10.1179/1743132812Y.0000000022	37	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88440	10.1371/journal.pone.0088440	http://dx.doi.org/10.1371/journal.pone.0088440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551100	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000036
J	Bocalini, DS; Beutel, A; Bergamaschi, CT; Tucci, PJ; Campos, RR				Bocalini, Danilo S.; Beutel, Abram; Bergamaschi, Cassia T.; Tucci, Paulo J.; Campos, Ruy R.			Treadmill Exercise Training Prevents Myocardial Mechanical Dysfunction Induced by Androgenic-Anabolic Steroid Treatment in Rats	PLOS ONE			English	Article							HEART-FAILURE; SEX-HORMONES; TESTOSTERONE; HYPERTENSION; HYPERTROPHY; CYTOKINES; RECEPTOR; DISEASE; LIVER	Elevated concentrations of testosterone and its synthetic analogs may induce changes in cardiovascular function. However, the effects of the combination of anabolic/androgenic steroid (AAS) treatment and exercise training on systolic and diastolic cardiac function are poorly understood. In the present study, we aimed to investigate the effects of low-dose steroid treatment (stanozolol) on cardiac contractile parameters when this steroid treatment was combined with exercise training in rats and the effects of chronic steroid treatment on the Frank-Starling (length-tension curves) relationship. Male Wistar rats were randomly assigned to one of four groups: U (untrained), US (untrained and treated with stanozolol 5 mg/kg/week), T (trained, 16 m/min/1 h) and TS (trained and treated with stanozolol 5 mg/kg/week). Continuous exercise training was conducted 5 days/week for 8 consecutive weeks. The speed of the treadmill was gradually increased to a final setting of 16 m/min/1 h. Experiments were divided into two independent series: 1) central hemodynamic analysis for mean arterial blood pressure (MAP) and cardiac output (CO) measurements and 2) isolated papillary muscle preparation in Krebs solution. Stanozolol treatment significantly increased the MAP and the heart size in untrained and trained rats (U 113 +/- 2; T 106 +/- 2; US 138 +/- 8 and TS 130 +/- 7 mmHg). Furthermore, stanozolol significantly decreased developed tension and dT/dt (maximal and minimal) in U rats. However, the developed tension was completely restored by training. The Frank/Starling relationship was impaired in rats treated with stanozolol; however, again, training completely restored diastolic function. Taken together, the present data suggest that AAS treatment is able to decrease cardiac performance (systolic and diastolic functions). The combination of stanozolol and physical training improved cardiac performance, including diastolic and systolic functions, independent of changes in central hemodynamic parameters. Therefore, changes in ventricular myocyte calcium transients may play a cardioprotective role.	[Bocalini, Danilo S.] Univ Sao Judas Tadeu, Dept Post Grad Phys Educ, Sao Paulo, Brazil; [Beutel, Abram; Bergamaschi, Cassia T.; Campos, Ruy R.] Univ Fed Sao Paulo, Dept Physiol, Div Cardiovasc, Sao Paulo, Brazil; [Tucci, Paulo J.] Univ Fed Sao Paulo, Dept Med, Div Cardiol, Sao Paulo, Brazil	Universidade Sao Judas Tadeu; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Campos, RR (corresponding author), Univ Fed Sao Paulo, Dept Physiol, Div Cardiovasc, Sao Paulo, Brazil.	ruy.camposjr@unifesp.br	Bergamaschi, Cassia/AAZ-9441-2020; Bocalini, Danilo/J-1997-2014; Campos, Ruy R/H-8339-2017; Campos, Ruy R R/I-3691-2015; Tucci, Paulo/D-1441-2015	Campos, Ruy R/0000-0002-9404-0817; Campos, Ruy R R/0000-0002-9404-0817; Tucci, Paulo/0000-0001-9793-670X; Bergamaschi, Cassia/0000-0002-5741-6993	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CNPq Fellowships	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq Fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). CTB, PJT and RRC are recipients of CNPq Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman DH, 1988, AM J SPORTS MED, V6, P397; Beutel A, 2005, J STEROID BIOCHEM, V93, P43, DOI 10.1016/j.jsbmb.2004.11.003; Biancardi VC, 2007, BRAZ J MED BIOL RES, V40, P401, DOI 10.1590/S0100-879X2006005000077; Bocalini DS, 2010, EUR J APPL PHYSIOL, V109, P909, DOI 10.1007/s00421-010-1406-x; Bocalini DS, 2009, INT HEART J, V50, P643, DOI 10.1536/ihj.50.643; CABRAL AM, 1988, HYPERTENSION, V11, P93; Celec P, 2003, LIFE SCI, V74, P419, DOI 10.1016/j.lfs.2003.05.008; Do Carmo EC, 2011, MED SCI SPORT EXER, V43, P1836, DOI 10.1249/MSS.0b013e318217e8b6; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; GARDNER FH, 1985, ACTA ENDOCRINOL-COP, V110, P87; HARKONEN M, 1990, J STEROID BIOCHEM, V35, P127, DOI 10.1016/0022-4731(90)90156-M; Hartgens F, 1996, INT J SPORTS MED, V17, P429, DOI 10.1055/s-2007-972873; Houser SR, 2003, CIRC RES, V92, P350, DOI 10.1161/01.RES.0000060027.40275.A6; Hu Y, 2004, INT J SPORTS MED, V25, P99; Ketelhut RG, 2004, MED SCI SPORT EXER, V36, P4, DOI 10.1249/01.MSS.0000106173.81966.90; KINSON GA, 1991, CAN J PHYSIOL PHARM, V69, P1698, DOI 10.1139/y91-252; KOCHAKIAN CD, 1950, AM J PHYSIOL, V163, P332, DOI 10.1152/ajplegacy.1950.163.2.332; LeGros T, 2000, MED SCI SPORT EXER, V32, P897; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lu SS, 1997, MED SCI SPORT EXER, V29, P1048, DOI 10.1097/00005768-199708000-00010; MALHOTRA A, 1990, AM J PHYSIOL, V259, pH866, DOI 10.1152/ajpheart.1990.259.3.H866; Masonis TAE, 1995, NEUROSCI LETT, V189, P35; Matsakas A, 2004, INT J SPORTS MED, V25, P502, DOI 10.1055/s-2004-820945; MCGILL HC, 1981, CIRC RES, V48, P238, DOI 10.1161/01.RES.48.2.238; MOLTENI A, 1969, LAB INVEST, V21, P129; Muller M, 2003, J CLIN ENDOCR METAB, V88, P5076, DOI 10.1210/jc.2003-030611; Pey A, 2003, J STEROID BIOCHEM, V87, P269, DOI 10.1016/j.jsbmb.2003.09.001; Portes Leslie Andrews, 2006, Arq. Bras. Cardiol., V87, P54, DOI 10.1590/S0066-782X2006001400008; Portes LA, 2009, CLIN EXP PHARMACOL P, V36, P394, DOI 10.1111/j.1440-1681.2008.05070.x; Riezzo I, 2011, CURR PHARM BIOTECHNO, V12, P275, DOI 10.2174/138920111794295792; Serra AJ, 2010, J PHYSIOL-LONDON, V588, P2431, DOI 10.1113/jphysiol.2010.187310; Tagarakis CVM, 2000, MED SCI SPORT EXER, V32, P946; VANZYL CG, 1995, MED SCI SPORT EXER, V27, P1385; Veras-Silva AS, 1997, AM J PHYSIOL-HEART C, V273, pH2627, DOI 10.1152/ajpheart.1997.273.6.H2627; Wright J E, 1980, Exerc Sport Sci Rev, V8, P149, DOI 10.1249/00003677-198000080-00007	35	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87106	10.1371/journal.pone.0087106	http://dx.doi.org/10.1371/journal.pone.0087106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533053	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600011
J	Jalan, S; Sarkar, C; Madhusudanan, A; Dwivedi, SK				Jalan, Sarika; Sarkar, Camellia; Madhusudanan, Anagha; Dwivedi, Sanjiv Kumar			Uncovering Randomness and Success in Society	PLOS ONE			English	Article							NETWORK ANALYSIS; MODEL	An understanding of how individuals shape and impact the evolution of society is vastly limited due to the unavailability of large-scale reliable datasets that can simultaneously capture information regarding individual movements and social interactions. We believe that the popular Indian film industry, "Bollywood'', can provide a social network apt for such a study. Bollywood provides massive amounts of real, unbiased data that spans more than 100 years, and hence this network has been used as a model for the present paper. The nodes which maintain a moderate degree or widely cooperate with the other nodes of the network tend to be more fit (measured as the success of the node in the industry) in comparison to the other nodes. The analysis carried forth in the current work, using a conjoined framework of complex network theory and random matrix theory, aims to quantify the elements that determine the fitness of an individual node and the factors that contribute to the robustness of a network. The authors of this paper believe that the method of study used in the current paper can be extended to study various other industries and organizations.	[Jalan, Sarika; Sarkar, Camellia; Dwivedi, Sanjiv Kumar] Indian Inst Technol, Complex Syst Lab, Indore, Madhya Pradesh, India; [Madhusudanan, Anagha] Univ Enclave Delhi, Univ Delhi, Hindu Coll, Dept Phys, Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Indore; University of Delhi	Jalan, S (corresponding author), Indian Inst Technol, Complex Syst Lab, Indore, Madhya Pradesh, India.	sarika@iiti.ac.in	Dwivedi, Sanjiv/GXG-1080-2022; Madhusudanan, Anagha/HIR-1702-2022; Jalan, Sarika/L-1732-2017; Jalan, Sarika/AAJ-4908-2021	Jalan, Sarika/0000-0002-9984-6107; Sarkar, Camellia/0000-0002-7988-8844	Department of Science and Technology (DST), Govt. of India [SR/FTP/PS-067/2011]; Council of Scientific and Industrial Research (CSIR), Govt. of India [25(02205)/12/EMR-II]	Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	SJ thanks Department of Science and Technology (DST), Govt. of India grant SR/FTP/PS-067/2011 and Council of Scientific and Industrial Research (CSIR), Govt. of India grant 25(02205)/12/EMR-II for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Boldi P, 2011, LECT NOTES COMPUT SC, V6984, P8, DOI 10.1007/978-3-642-24704-0_7; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; BOSE M., 2007, BOLLYWOOD HIST, P37; BRODY TA, 1973, LETT NUOVO CIMENTO, V7, P482, DOI 10.1007/BF02727859; Carrington J.P., 2005, CAN J SOCIOL, P1; Cattani G., 2006, ORGAN SCI, V4, P53; Chauhan S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056114; Das D., 2012, ASIAN J SOCIAL SCI H, V1, P257; de Aguiar MAM, 2005, PHYS REV E, V71; Dorogovtsev SN, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046109; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Guhr T, 1998, PHYS REP, V299, P190; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Jackson MO, 1996, J ECON THEORY, V71, P44, DOI 10.1006/jeth.1996.0108; Jalan S, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/48004; Jalan S, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48010; Jalan S, 2007, PHYS REV E, V76; KPMG India Confederation of Indian Industry, 2005, CII KPMG REP IND ENT; KPMG India Federation of Indian Chambers of Commerce and Industry, 2012, FICCI KPMG IND MED E; KPMG India Federation of Indian Chambers of Commerce and Industry, 2011, FICCI KPMG IND MED E; Kristof ND, 2009, HALF SKY TURNING OPP, P1; Martino F, 2006, PSYCHNOLOGY J, V4, P53; Mehta M. L., 1991, RANDOM MATRICES; Mieghem PV, 2011, GRAPH SPECTRA COMPLE, P11; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Ray R, 2012, 17 INT BUS RES C TOR; Research Unit (LARRDIS) Rajya Sabha Secretariat New Delhi, 2009, GLOB EC CRIS ITS IMP; Suarez YR, 2004, FISHERIES MANAG ECOL, V11, P45, DOI 10.1111/j.1365-2400.2004.00347.x; Tichy N. M., 1979, ACAD MANAGE REV, V4, P507, DOI [10.5465/AMR.1979.4498309, DOI 10.5465/AMR.1979.4498309]; University of Chicago, 2006, TASK FORC REP EC REF; Watts A, 2001, GAME ECON BEHAV, V34, P331, DOI 10.1006/game.2000.0803	35	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88249	10.1371/journal.pone.0088249	http://dx.doi.org/10.1371/journal.pone.0088249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533073	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600031
J	Mohammed, M; Ch, S; Ch, RV				Mohammed, Mujahid; Ch, Sasikala; Ch, Ramana V.			Aniline Is an Inducer, and Not a Precursor, for Indole Derivatives in Rubrivivax benzoatilyticus JA2	PLOS ONE			English	Article							AMINO-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; MICROBIAL TRANSFORMATION; OXIDATIVE STRESS; TRYPTOPHAN; PATHWAY; IDENTIFICATION; GENES; BIODEGRADATION; METABOLITES	Rubrivivax benzoatilyticus JA2 and other anoxygenic photosynthetic bacteria produce indole derivatives when exposed to aniline, a xenobiotic compound. Though this phenomenon has been reported previously, the role of aniline in the production of indoles is still a biochemical riddle. The present study aims at understanding the specific role of aniline (as precursor or stimulator) in the production of indoles and elucidating the biochemical pathway of indoles in aniline-exposed cells by using stable isotope approaches. Metabolic profiling revealed tryptophan accumulation only in aniline exposed cells along with indole 3-acetic acid (IAA) and indole 3-aldehyde (IAld), the two major catabolites of tryptophan. Deuterium labelled aniline feeding studies revealed that aniline is not a precursor of indoles in strain JA2. Further, production of indoles only in aniline-exposed cells suggests that aniline is an indoles stimulator. In addition, production of indoles depended on the presence of a carbon source, and production enhanced when carbon sources were added to the culture. Isotope labelled fumarate feeding identified, fumarate as the precursor of indole, indicating de novo synthesis of indoles. Glyphosate (shikimate pathway inhibitor) inhibited the indoles production, accumulation of tryptophan, IAA and IAld indicating that indoles synthesis in strain JA2 occurs via the de novo shikimate pathway. The up-regulation of anthranilate synthase gene and induction of anthranilate synthase activity correlated well with tryptophan production in strain JA2. Induction of tryptophan aminotransferase and tryptophan 2-monooxygenase activities corroborated well with IAA levels, suggesting that tryptophan catabolism occurs simultaneously in aniline exposed cells. Our study demonstrates that aniline (stress) stimulates tryptophan/indoles synthesis via the shikimate pathway by possibly modulating the metabolic pathway.	[Mohammed, Mujahid; Ch, Ramana V.] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India; [Ch, Sasikala] Univ Hyderabad, J NT, IST, Bacterial Discovery Lab,Ctr Environm, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Ch, RV (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	r449@sify.com	sasikala, Ch/AAP-8460-2020; sasikala, Ch/AAS-4530-2021	sasikala, Ch/0000-0003-1952-5045; 				Balderas-Hernandez VE, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-19; Boon N, 2001, APPL ENVIRON MICROB, V67, P1107, DOI 10.1128/AEM.67.3.1107-1115.2001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; CERNIGLIA CE, 1981, ARCH MICROBIOL, V130, P272, DOI 10.1007/BF00425939; Chakravarthy SK, 2007, INT J SYST EVOL MICR, V57, P2453, DOI 10.1099/ijs.0.65105-0; Consonni C, 2010, PLANT PHYSIOL, V152, P1544, DOI 10.1104/pp.109.147660; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; Drzyzga O, 1996, APPL ENVIRON MICROB, V62, P1710, DOI 10.1128/AEM.62.5.1710-1716.1996; Gazarian IG, 1998, BIOCHEM J, V333, P223, DOI 10.1042/bj3330223; Gordon SAPL, 1975, PLANT PHYSIOL, V10, P37; GORONTZY T, 1993, J GEN MICROBIOL, V139, P1331, DOI 10.1099/00221287-139-6-1331; Gosset G, 2009, CURR OPIN BIOTECH, V20, P651, DOI 10.1016/j.copbio.2009.09.012; Hamilton S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-599; Hirasawa T, 2007, J BIOTECHNOL, V131, P34, DOI 10.1016/j.jbiotec.2007.05.010; Ikeda M, 2006, APPL MICROBIOL BIOT, V69, P615, DOI 10.1007/s00253-005-0252-y; Imaoka A, 2008, J GEN PLANT PATHOL, V74, P109, DOI 10.1007/s10327-007-0066-0; Johnson CH, 2012, ANNU REV PHARMACOL, V52, P37, DOI 10.1146/annurev-pharmtox-010611-134748; Kang K, 2011, PLANT J, V66, P247, DOI 10.1111/j.1365-313X.2011.04486.x; Kang K, 2009, PLANT PHYSIOL, V150, P1380, DOI 10.1104/pp.109.138552; KONOPKA A, 1989, APPL ENVIRON MICROB, V55, P385, DOI 10.1128/AEM.55.2.385-389.1989; Kuczynska-Wisnik D, 2010, RES MICROBIOL, V161, P847, DOI 10.1016/j.resmic.2010.09.012; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Liang O, 2005, MICROBIOL-SGM, V151, P3435, DOI 10.1099/mic.0.28137-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Malhotra M, 2009, EUR J SOIL BIOL, V45, P73, DOI 10.1016/j.ejsobi.2008.05.006; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Merino E, 2008, CURR OPIN MICROBIOL, V11, P78, DOI 10.1016/j.mib.2008.02.005; Mittal M, 2008, J ENVIRON SCI HEAL A, V43, P1027, DOI 10.1080/10934520802059896; Mujahid M, 2011, APPL MICROBIOL BIOT, V89, P1001, DOI 10.1007/s00253-010-2951-2; Mujahid M, 2010, CURR MICROBIOL, V61, P285, DOI 10.1007/s00284-010-9609-2; Panina EM, 2001, J MOL MICROB BIOTECH, V3, P529; Park S, 2009, PLANTA, V230, P1197, DOI 10.1007/s00425-009-1015-2; Pedras MSC, 2009, PHYTOCHEMISTRY, V70, P1129, DOI 10.1016/j.phytochem.2009.05.015; Pluvinage B, 2007, BIOCHEMISTRY-US, V46, P7069, DOI 10.1021/bi700351w; POWELL LE, 1964, PLANT PHYSIOL, V39, P836, DOI 10.1104/pp.39.5.836; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; SCRIBNER JD, 1979, CHEM-BIOL INTERACT, V26, P11, DOI 10.1016/0009-2797(79)90090-5; SHANKAR S, 1995, MOL MICROBIOL, V17, P935, DOI 10.1111/j.1365-2958.1995.mmi_17050935.x; Shanker V, 2006, CURR MICROBIOL, V52, P413, DOI 10.1007/s00284-005-0057-3; Shen T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/605219; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Suzuki H, 2007, J BACTERIOL, V189, P2155, DOI 10.1128/JB.01708-06; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Han TH, 2011, RES MICROBIOL, V162, P108, DOI 10.1016/j.resmic.2010.11.005; Vangnai AS, 2007, FEMS MICROBIOL LETT, V268, P209, DOI 10.1111/j.1574-6968.2006.00579.x; Villa F, 2012, ENVIRON MICROBIOL, V14, P1753, DOI 10.1111/j.1462-2920.2011.02678.x; Xie G, 2003, MICROBIOL MOL BIOL R, V67, P303, DOI 10.1128/MMBR.67.3.303-342.2003; Xu P, 2007, TRENDS BIOTECHNOL, V25, P571, DOI 10.1016/j.tibtech.2007.08.011; Zhao JM, 1998, PLANT CELL, V10, P359, DOI 10.1105/tpc.10.3.359	52	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87503	10.1371/journal.pone.0087503	http://dx.doi.org/10.1371/journal.pone.0087503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533057	gold, Green Published			2022-12-27	WOS:000331262600015
J	Montaner, JSG; Lima, VD; Harrigan, PR; Lourenco, L; Yip, B; Nosyk, B; Wood, E; Kerr, T; Shannon, K; Moore, D; Hogg, RS; Barrios, R; Gilbert, M; Krajden, M; Gustafson, R; Daly, P; Kendall, P				Montaner, Julio S. G.; Lima, Viviane D.; Harrigan, P. Richard; Lourenco, Lillian; Yip, Benita; Nosyk, Bohdan; Wood, Evan; Kerr, Thomas; Shannon, Kate; Moore, David; Hogg, Robert S.; Barrios, Rolando; Gilbert, Mark; Krajden, Mel; Gustafson, Reka; Daly, Patricia; Kendall, Perry			Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The "HIV Treatment as Prevention'' Experience in a Canadian Setting	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INJECTING DRUG-USERS; HOMOSEXUAL-MEN; EXPANDING ACCESS; INFECTION; RISK; SEX; RNA; RECOMMENDATIONS; STRATEGIES	Background: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, population-level sustainability of this strategy has not been characterized. Methods: We used population-level longitudinal data from province-wide registries including plasma viral load, CD4 count, drug resistance, HAART use, HIV diagnoses, AIDS incidence, and HIV-related mortality. We fitted two Poisson regression models over the study period, to relate estimated HIV incidence and the number of individuals on HAART and the percentage of virologically suppressed individuals. Results: HAART coverage, median pre-HAART CD4 count, and HAART adherence increased over time and were associated with increasing virological suppression and decreasing drug resistance. AIDS incidence decreased from 6.9 to 1.4 per 100,000 population (80% decrease, p = 0.0330) and HIV-related mortality decreased from 6.5 to 1.3 per 100,000 population (80% decrease, p = 0.0115). New HIV diagnoses declined from 702 to 238 cases (66% decrease; p = 0.0004) with a consequent estimated decline in HIV incident cases from 632 to 368 cases per year (42% decrease; p = 0.0003). Finally, our models suggested that for each increase of 100 individuals on HAART, the estimated HIV incidence decreased 1.2% and for every 1% increase in the number of individuals suppressed on HAART, the estimated HIV incidence also decreased by 1%. Conclusions: Our results show that HAART expansion between 1996 and 2012 in BC was associated with a sustained and profound population-level decrease in morbidity, mortality and HIV transmission. Our findings support the long-term effectiveness and sustainability of HIV treatment as prevention within an adequately resourced environment with no financial barriers to diagnosis, medical care or antiretroviral drugs. The 2013 Consolidated World Health Organization Antiretroviral Therapy Guidelines offer a unique opportunity to further evaluate TasP in other settings, particularly within generalized epidemics, and resource-limited setting, as advocated by UNAIDS.	[Montaner, Julio S. G.; Lima, Viviane D.; Harrigan, P. Richard; Lourenco, Lillian; Yip, Benita; Nosyk, Bohdan; Wood, Evan; Kerr, Thomas; Shannon, Kate; Moore, David; Hogg, Robert S.; Barrios, Rolando] Providence Hlth Care, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Montaner, Julio S. G.; Lima, Viviane D.; Harrigan, P. Richard; Wood, Evan; Kerr, Thomas; Shannon, Kate; Moore, David] Univ British Columbia, Dept Med, Div Aids, Vancouver, BC, Canada; [Nosyk, Bohdan; Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Gilbert, Mark; Krajden, Mel] BC Ctr Dis Control, Vancouver, BC, Canada; [Barrios, Rolando; Gustafson, Reka; Daly, Patricia] Vancouver Coastal Hlth Author, Vancouver, BC, Canada; [Kendall, Perry] Minist Hlth British Columbia, Victoria, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Simon Fraser University; Vancouver Coastal Health Research Institute	Montaner, JSG (corresponding author), Providence Hlth Care, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	jmontaner@cfenet.ubc.ca	Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488	British Columbia Ministry of Health; Avant-Garde Award [1DP1DA026182]; National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH) [1R01DA036307-01]; Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); Scholar Award from the Michael Smith Foundation for Health Research; New Investigator Award from CIHR; NIDA award [R03DA033851, R01DA028532]; CIHR award [MOP-125948, MOP-102742]; Tier 1 Canada Research Chair in Inner City Medicine; Abbvie, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182, R01DA036307, R01DA028532, R03DA033851] Funding Source: NIH RePORTER	British Columbia Ministry of Health; Avant-Garde Award; National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH); Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); Scholar Award from the Michael Smith Foundation for Health Research; New Investigator Award from CIHR(Canadian Institutes of Health Research (CIHR)); NIDA award; CIHR award(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair in Inner City Medicine; Abbvie, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work here described [Treatment as Prevention in BC initiative (PI: JM)] has been financially supported by the British Columbia Ministry of Health, as well as an Avant-Garde Award (No. 1DP1DA026182) and grant 1R01DA036307-01 from the National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH). In addition, JM was funded through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR). VDL is supported by a Scholar Award from the Michael Smith Foundation for Health Research and a New Investigator Award from CIHR, and by a NIDA award (R03DA033851) and CIHR award (MOP-125948). TK was supported in part by a NIDA award (R01DA028532) and a CIHR award (MOP-102742). EW is supported by a Tier 1 Canada Research Chair in Inner City Medicine. Additional limited unrestricted funding was provided by Abbvie, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. None of the funders played any role in study design, data collection and analysis, decision to publish, preparation or review of the manuscript.	[Anonymous], 2013, 7 IAS C HIV PATH TRE; [Anonymous], HIV AIDS ANN REP; [Anonymous], 2012, SUBPR POP PROJ PEOPL; [Anonymous], BRIT COL CTR EXC HIV; Archibald C, 2013, COMMUNICATION; Avettand-Fenoel V, 2008, AIDS, V22, P1880, DOI 10.1097/QAD.0b013e32830fbdbc; Baggaley RF, 2010, AIDS, V24, P2418, DOI 10.1097/QAD.0b013e32833dbdfd; British Columbia Vital Statistics Agency, ANN REP; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Celum C, 2012, ANTIVIR THER, V17, P1483, DOI 10.3851/IMP2492; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Doherty M, 2013, 2013 INT TREATM PREV; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Ford N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001535; Garnett GP, 2012, CURR OPIN HIV AIDS, V7, P157, DOI 10.1097/COH.0b013e3283504ab7; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hogg RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047260; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kato M, 2013, J ACQUIR IMMUNE DEFI; Kerr T, 2012, JOINT UN PROGRAMME H; Kirk GD, 2011, 8 C RETR OPP INF BOS; Lafeuillade A, 2009, HIV CLIN TRIALS, V10, P324, DOI 10.1310/hct1005-324; Lagakos SW, 2008, NEW ENGL J MED, V358, P1543, DOI 10.1056/NEJMp0802028; Lester RT, 2013, BCMJ, V55, P204; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2011, LANCET, V378, P208, DOI 10.1016/S0140-6736(11)60821-0; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Peter M. C., 1989, GEN LINEAR MODELS; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Stolte IG, 2001, SEX TRANSM INFECT, V77, P184, DOI 10.1136/sti.77.3.184; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS12, DOI 10.1097/QAI.0b013e31829202a2; Vermund SH, 2009, CURR OPIN HIV AIDS, V4, P266, DOI 10.1097/COH.0b013e32832c91dd; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Wand H, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-19; Werb D, 2010, LANCET INFECT DIS, V10, P464, DOI 10.1016/S1473-3099(10)70097-9; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organization, INT STAT CLASS DIS R, V10th; Wu Z, 2013, 2013 INT TREATM PREV; Yan P, 2011, STAT COMMUNICATIONS, DOI [10.2202/1948-4690.1011, DOI 10.2202/1948-4690.1011]; Yang QY, 2010, CAN J PUBLIC HEALTH, V101, P486, DOI 10.1007/BF03403969; Zuckerman RA, 2004, J INFECT DIS, V190, P156, DOI 10.1086/421246	61	224	234	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87872	10.1371/journal.pone.0087872	http://dx.doi.org/10.1371/journal.pone.0087872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533061	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600019
J	van Griensven, J; Phirum, L; Choun, K; Thai, S; De Weggheleire, A; Lynen, L				van Griensven, Johan; Phirum, Lay; Choun, Kimcheng; Sopheak Thai; De Weggheleire, Anja; Lynen, Lutgarde			Hepatitis B and C Co-Infection among HIV-Infected Adults while on Antiretroviral Treatment: Long-Term Survival, CD4 Cell Count Recovery and Antiretroviral Toxicity in Cambodia	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE RECOVERY; DISEASE PROGRESSION; HCV COINFECTION; NAT COHORT; THERAPY; MORTALITY; IMPACT; METAANALYSIS	Background: Despite the high burden, there is a dearth of (long-term) outcome data of hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infected patients receiving antiretroviral treatment (ART) in a clinical setting in resource-constrained settings, particularly from Asia. Methods: We conducted a retrospective cohort study including all adults initiating standard ART (non-tenofovir-based) between 03/2003 and 09/2012. HBV infection was diagnosed by HBV surface antigen detection. HCV diagnosis relied on antibody detection. The independent effect of HBV and HCV on long-term (>= 5 years) ART response in terms of mortality (using Cox regression), severe livertoxicity (using logistic regression) and CD4 count increase (using mixed-effects modelling) was determined. Results: A total of 3089 adults were included (median age: 35 years (interquartile range 30-41); 46% male), of whom 341 (11.0%) were co-infected with HBV and 163 (5.3%) with HCV. Over a median ART follow-up time of 4.3 years, 240 individuals died. Mortality was 1.6 higher for HBV co-infection in adjusted analysis (P = 0.010). After the first year of ART, the independent mortality risk was 3-fold increased in HCV co-infection (P = 0.002). A total of 180 (5.8%) individuals discontinued efavirenz or nevirapine due to severe livertoxicity, with an independently increased risk for HBV (hazard ratio (HR) 2.3; P<0.001) and HCV (HR 2.8; P<0.001). CD4 recovery was lower in both HBV and HCV co-infection but only statistically significant for HBV (P<0.001). Discussion: HBV and HCV co-infection was associated with worse ART outcomes. The effect of early ART initiation and providing effective treatment for hepatitis co-infection should be explored.	[van Griensven, Johan; Phirum, Lay; Choun, Kimcheng; Sopheak Thai] HOPE, Sihanouk Hosp Ctr, Phnom Penh, Cambodia; [van Griensven, Johan; De Weggheleire, Anja; Lynen, Lutgarde] Inst Trop Med, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	van Griensven, J (corresponding author), HOPE, Sihanouk Hosp Ctr, Phnom Penh, Cambodia.	jvangriensven@itg.be	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014; De Weggheleire, Anja/C-7345-2018	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; De Weggheleire, Anja/0000-0001-9377-4766	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund; Hope World Wide; InBev-Baillet Latour Fund	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp; Global Fund; Hope World Wide; InBev-Baillet Latour Fund	The HIV program was supported by the Belgian Directorate General of Development Cooperation through the framework agreement with the Institute of Tropical Medicine, Antwerp, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide. JvG is supported by the InBev-Baillet Latour Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Farias AA, 2013, T ROY SOC TROP MED H, V107, P432, DOI 10.1093/trstmh/trt043; Andrade BB, 2013, J INFECT DIS, V207, P1379, DOI 10.1093/infdis/jit033; [Anonymous], 2013, BRIT HIV ASS GUID MA; [Anonymous], 2013, 7 IAS C HIV PATH TRE; Antonello VS, 2013, BRAZ J INFECT DIS; Braitstein P, 2006, J INFECT DIS, V193, P259, DOI 10.1086/498908; Cachay ER, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-9; Chang CC, 2013, IMMUNOL REV, V254, P114, DOI 10.1111/imr.12063; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; DHHS, 2012, GUID US ANT AG HIV 1; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; EACS, 2012, EUR AIDS CLIN SOC GU; Easterbrook P, 2012, SEMIN LIVER DIS, V32, P147, DOI 10.1055/s-0032-1316476; Ford N, 2012, B WORLD HEALTH ORGAN, V90, P540, DOI 10.2471/BLT.11.097147; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; French AL, 2013, J INFECT DIS; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Hoffmann CJ, 2009, AIDS, V23, P1881, DOI 10.1097/QAD.0b013e32832e463a; Jain MK, 2009, CLIN INFECT DIS, V48, P1772, DOI 10.1086/599111; Jones M, 2011, CURR OPIN HIV AIDS, V6, P546, DOI 10.1097/COH.0b013e32834bcbd9; Kolev G., 2022, GLOBAL VALUE CHAINS; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Ladep NG, 2013, WORLD J GASTROENTERO, V19, P1602, DOI 10.3748/wjg.v19.i10.1602; Law WP, 2004, AIDS, V18, P1169, DOI 10.1097/00002030-200405210-00010; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Lerolle N, 2012, J AIDS CLIN RES, V3, P1; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; Maek A. N. W., 2012, AIDS RES TREAT, V2012; Matthews GV, 2008, HEPATOLOGY, V48, P1062, DOI 10.1002/hep.22462; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Mbougua JBT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-105; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Moore E, 2010, J INFECTION, V61, P155, DOI 10.1016/j.jinf.2010.04.009; Nguyen LH, 2013, ALIMENT PHARM THER, V37, P921, DOI 10.1111/apt.12300; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Ocama P, 2011, CURR OPIN HIV AIDS, V6, P539, DOI 10.1097/COH.0b013e32834bd23f; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Page EE, 2011, CURR OPIN HIV AIDS, V6, P472, DOI 10.1097/COH.0b013e32834bbc71; Peters L, 2009, JAIDS-J ACQ IMM DEF, V50, P457, DOI 10.1097/QAI.0b013e318198a0e1; Phan V, 2013, JAIDS-J ACQ IMM DEF, V62, P509, DOI 10.1097/QAI.0b013e318285d28c; Pinzone MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/515962; Potter M, 2010, AIDS, V24, P1857, DOI 10.1097/QAD.0b013e32833adbb5; Price H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068152; Taye S, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-23; Than NN, 2012, SE ASIAN J TROP MED, V43, P646; Tsuchiya N, 2013, EPIDEMIOL INFECT, V141, P1840, DOI 10.1017/S0950268812002397; Tuma P, 2010, ANTIVIR THER, V15, P881, DOI 10.3851/IMP1630; UNAIDS, 2012, GLOBAL REPORT UNAIDS; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; Wandeler G, 2013, J INFECT DIS, V208, P1454, DOI 10.1093/infdis/jit351; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yacisin K, 2008, AIDS RES HUM RETROV, V24, P935, DOI 10.1089/aid.2008.0069; Zhou J, 2007, J GASTROEN HEPATOL, V22, P1510, DOI 10.1111/j.1440-1746.2007.05062.x	61	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88552	10.1371/journal.pone.0088552	http://dx.doi.org/10.1371/journal.pone.0088552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533106	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600064
J	Deiner, K; Altermatt, F				Deiner, Kristy; Altermatt, Florian			Transport Distance of Invertebrate Environmental DNA in a Natural River	PLOS ONE			English	Article							CLADOCERA; CRUSTACEA; DIVERSITY; ECOLOGY	Environmental DNA (eDNA) monitoring is a novel molecular technique to detect species in natural habitats. Many eDNA studies in aquatic systems have focused on lake or ponds, and/or on large vertebrate species, but applications to invertebrates in river systems are emerging. A challenge in applying eDNA monitoring in flowing waters is that a species' DNA can be transported downstream. Whether and how far eDNA can be detected due to downstream transport remains largely unknown. In this study we tested for downstream detection of eDNA for two invertebrate species, Daphnia longispina and Unio tumidus, which are lake dwelling species in our study area. The goal was to determine how far away from the source population in a lake their eDNA could be detected in an outflowing river. We sampled water from eleven river sites in regular intervals up to 12.3 km downstream of the lake, developed new eDNA probes for both species, and used a standard PCR and Sanger sequencing detection method to confirm presence of each species' eDNA in the river. We detected D. longispina at all locations and across two time points (July and October); whereas with U. tumidus, we observed a decreased detection rate and did not detect its eDNA after 9.1 km. We also observed a difference in detection for this species at different times of year. The observed movement of eDNA from the source amounting to nearly 10 km for these species indicates that the resolution of an eDNA sample can be large in river systems. Our results indicate that there may be species' specific transport distances for eDNA and demonstrate for the first time that invertebrate eDNA can persist over relatively large distances in a natural river system.	[Deiner, Kristy; Altermatt, Florian] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Deiner, K (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.	alpinedna@gmail.com		Altermatt, Florian/0000-0002-4831-6958; Deiner, Kristy/0000-0001-9755-3223	Eawag: Swiss Federal Institute of Aquatic Science and Technology; Swiss National Science Foundation [31003A_135622]	Eawag: Swiss Federal Institute of Aquatic Science and Technology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding for this work was provided by Eawag: Swiss Federal Institute of Aquatic Science and Technology (to KD) and by the Swiss National Science Foundation Grant no. 31003A_135622 (to FA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2007, EVOL ECOL, V21, P561, DOI 10.1007/s10682-006-9136-6; Altermatt F, 2013, J BIOGEOGR, V40, P2249, DOI 10.1111/jbi.12178; Altermatt F, 2013, AQUAT ECOL, V47, P365, DOI 10.1007/s10452-013-9450-3; AWEL, 2012, ZURCH GEW 2012 ENTW; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Butcher GS, 2007, COMBINING DATA CHRIS; Carrara F, 2012, P NATL ACAD SCI USA, V109, P5761, DOI 10.1073/pnas.1119651109; CARVALHO GR, 1987, J ANIM ECOL, V56, P453, DOI 10.2307/5060; Crawley M.J., 2007, R BOOK; Darling JA, 2011, ENV RES; Deiner K, 2007, CONSERV GENET, V8, P437, DOI 10.1007/s10592-006-9183-0; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Elbroch LM, 2012, FIELD GUIDE ANIMAL T; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fulton TL, 2012, METHODS MOL BIOL, V840, P1, DOI 10.1007/978-1-61779-516-9_1; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gotelli NJ, 2008, PRIMER ECOLOGY, P203; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Merritt R. W., 2008, INTRO AQUATIC INSECT; Minamoto T, 2011, LIMNOLOGY, P1; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Petrusek A, 2008, ZOOL SCR, V37, P507, DOI 10.1111/j.1463-6409.2008.00336.x; Pfrender ME, 2010, Q REV BIOL, V85, P319, DOI 10.1086/655118; Pilliod DS, 2013, CANADIAN J FISHERIES, P1; R Core Team, 2021, R LANGUAGE ENV STAT; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; Remane A, 1986, SYSTEMATISCHE ZOOLOG; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	38	312	345	16	239	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88786	10.1371/journal.pone.0088786	http://dx.doi.org/10.1371/journal.pone.0088786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523940	Green Published, gold			2022-12-27	WOS:000331258100089
J	Jacobi, A; Schmalz, A; Bareyre, FM				Jacobi, Anne; Schmalz, Anja; Bareyre, Florence M.			Abundant Expression of Guidance and Synaptogenic Molecules in the Injured Spinal Cord	PLOS ONE			English	Article							GROWTH CONE GUIDANCE; NEURAL DEVELOPMENT; ADHESION MOLECULE; SEMAPHORIN-III; EPHB RECEPTORS; AXON OUTGROWTH; SLIT; NEUREXINS; RECOVERY; MIDLINE	Background: Spinal interneurons have emerged as crucial targets of supraspinal input during post-injury axonal remodelling. For example, lesioned corticospinal projections use propriospinal neurons as relay stations to form intraspinal detour circuits that ccircumvent the lesion site and contribute to functional recovery. While a number of the molecules that determine the formation of neuronal circuits in the developing nervous system have been identified, it is much less understood which of these cues are also expressed in the injured spinal cord and can thus guide growing collaterals and initiate synaptogenesis during circuit remodelling. Methodology/Principal Findings: To address this question we characterized the expression profile of a number of guidance and synaptogenic molecules in the cervical spinal cord of healthy and spinal cord-injured mice by in situ hybridization. To assign the expression of these molecules to distinct populations of interneurons we labeled short and long propriospinal neurons by retrograde tracing and glycinergic neurons using a transgenically expressed fluorescent protein. Interestingly, we found that most of the molecules studied including members of slit-, semaphorin-, synCAM-, neuroligin-and ephrinfamilies as well as their receptors are also present in the adult CNS. While many of these molecules were abundantly expressed in all interneurons examined, some molecules including slits, semaphorin 7a, synCAM4 and neuroligin 1 showed preferential expression in propriospinal interneurons. Overall the expression pattern of guidance and synaptogenic molecules in the cervical spinal cord appeared to be stable over time and was not substantially altered following a midthoracic spinal cord injury. Conclusions: Taken together, our study indicates that many of the guidance and synaptogenic cues that regulate neuronal circuit formation in development are also present in the adult CNS and therefore likely contribute to the remodelling of axonal connections in the injured spinal cord.	[Jacobi, Anne; Schmalz, Anja; Bareyre, Florence M.] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany; [Bareyre, Florence M.] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; University of Munich	Bareyre, FM (corresponding author), Univ Munich, Inst Clin Neuroimmunol, Munich, Germany.	Florence.Bareyre@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 870]; German Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Work in F.M.B.'s lab is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB 870) and the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; ALSTERMARK B, 1987, BRAIN RES, V404, P395, DOI 10.1016/0006-8993(87)91402-8; ALSTERMARK B, 1990, EXP BRAIN RES, V80, P1; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2006, NAT NEUROSCI, V9, P1203, DOI 10.1038/nn1006-1203; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Chamankhah M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-583; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; Eberhart J, 2000, DEV NEUROSCI-BASEL, V22, P237, DOI 10.1159/000017446; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jevince AR, 2006, J COMP NEUROL, V497, P734, DOI 10.1002/cne.21001; Kadison SR, 2006, DEV BIOL, V296, P499, DOI 10.1016/j.ydbio.2006.06.022; Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kolodkin AL, 2011, COLD SPRING HARB PER, V3; Kopp MA, 2010, GLIA, V58, P1748, DOI 10.1002/glia.21045; Lang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030461; Lopez-Bendito G, 2007, J NEUROSCI, V27, P3395, DOI 10.1523/JNEUROSCI.4605-06.2007; Lu YJ, 2008, CHIN J TRAUMATOL, V11, P98, DOI 10.1016/S1008-1275(08)60021-8; Mann F, 2007, PROG NEUROBIOL, V82, P57, DOI 10.1016/j.pneurobio.2007.02.011; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Mauti O, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-28; Moreno-Flores MT, 1999, NEUROSCIENCE, V91, P193, DOI 10.1016/S0306-4522(98)00568-5; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Muller BK, 1996, CURR OPIN GENET DEV, V6, P469, DOI 10.1016/S0959-437X(96)80069-4; Muramatsu R, 2012, NAT MED, V18, P1658, DOI 10.1038/nm.2943; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Pasterkamp RJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-98; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Philipp M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-36; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Sang Q, 2002, MOL CELL NEUROSCI, V21, P250, DOI 10.1006/mcne.2002.1156; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shim SO, 2012, MOL CELL NEUROSCI, V50, P193, DOI 10.1016/j.mcn.2012.04.007; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thomas LA, 2008, J COMP NEUROL, V510, P47, DOI 10.1002/cne.21773; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wang Y, 2005, EUR J NEUROSCI, V21, P2336, DOI 10.1111/j.1460-9568.2005.04093.x; Wehrle R, 2005, EUR J NEUROSCI, V22, P2134, DOI 10.1111/j.1460-9568.2005.04419.x; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zelano J, 2007, J COMP NEUROL, V503, P308, DOI 10.1002/cne.21382; Zelano J, 2009, J COMP NEUROL, V517, P670, DOI 10.1002/cne.22186	76	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88449	10.1371/journal.pone.0088449	http://dx.doi.org/10.1371/journal.pone.0088449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523897	gold, Green Submitted, Green Published			2022-12-27	WOS:000331258100046
J	Nishida, N; Sawai, H; Kashiwase, K; Minami, M; Sugiyama, M; Seto, WK; Yuen, MF; Posuwan, N; Poovorawan, Y; Ahn, SH; Han, KH; Matsuura, K; Tanaka, Y; Kurosaki, M; Asahina, Y; Izumi, N; Kang, JH; Hige, S; Ide, T; Yamamoto, K; Sakaida, I; Murawaki, Y; Itoh, Y; Tamori, A; Orito, E; Hiasa, Y; Honda, M; Kaneko, S; Mita, E; Suzuki, K; Hino, K; Tanaka, E; Mochida, S; Watanabe, M; Eguchi, Y; Masaki, N; Murata, K; Korenaga, M; Mawatari, Y; Ohashi, J; Kawashima, M; Tokunaga, K; Mizokami, M				Nishida, Nao; Sawai, Hiromi; Kashiwase, Koichi; Minami, Mutsuhiko; Sugiyama, Masaya; Seto, Wai-Kay; Yuen, Man-Fung; Posuwan, Nawarat; Poovorawan, Yong; Ahn, Sang Hoon; Han, Kwang-Hyub; Matsuura, Kentaro; Tanaka, Yasuhito; Kurosaki, Masayuki; Asahina, Yasuhiro; Izumi, Namiki; Kang, Jong-Hon; Hige, Shuhei; Ide, Tatsuya; Yamamoto, Kazuhide; Sakaida, Isao; Murawaki, Yoshikazu; Itoh, Yoshito; Tamori, Akihiro; Orito, Etsuro; Hiasa, Yoichi; Honda, Masao; Kaneko, Shuichi; Mita, Eiji; Suzuki, Kazuyuki; Hino, Keisuke; Tanaka, Eiji; Mochida, Satoshi; Watanabe, Masaaki; Eguchi, Yuichiro; Masaki, Naohiko; Murata, Kazumoto; Korenaga, Masaaki; Mawatari, Yoriko; Ohashi, Jun; Kawashima, Minae; Tokunaga, Katsushi; Mizokami, Masashi			New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC HEPATITIS-B; VIRUS CLEARANCE; POLYMORPHISM; VARIANTS; LOCUS	Previous studies have revealed the association between SNPs located on human leukocyte antigen (HLA) class II genes, including HLA-DP and HLA-DQ, and chronic hepatitis B virus (HBV) infection, mainly in Asian populations. HLA-DP alleles or haplotypes associated with chronic HBV infection or disease progression have not been fully identified in Asian populations. We performed trans-ethnic association analyses of HLA-DPA1, HLA-DPB1 alleles and haplotypes with hepatitis B virus infection and disease progression among Asian populations comprising Japanese, Korean, Hong Kong, and Thai subjects. To assess the association between HLA-DP and chronic HBV infection and disease progression, we conducted high-resolution (4-digit) HLA-DPA1 and HLA-DPB1 genotyping in a total of 3,167 samples, including HBV patients, HBV-resolved individuals and healthy controls. Trans-ethnic association analyses among Asian populations identified a new risk allele HLA-DPB1*09:01 (P = 1.36 x 10(-6); OR = 1.97; 95% CI, 1.50-2.59) and a new protective allele DPB1*02:01 (P = 5.22 x 10(-6); OR = 0.68; 95% CI, 0.58-0.81) to chronic HBV infection, in addition to the previously reported alleles. Moreover, DPB1*02:01 was also associated with a decreased risk of disease progression in chronic HBV patients among Asian populations (P = 1.55 x 10(-7); OR = 0.50; 95% CI, 0.39-0.65). Trans-ethnic association analyses identified Asian-specific associations of HLA-DP alleles and haplotypes with HBV infection or disease progression. The present findings will serve as a base for future functional studies of HLA-DP molecules in order to understand the pathogenesis of HBV infection and the development of hepatocellular carcinoma.	[Nishida, Nao; Sugiyama, Masaya; Masaki, Naohiko; Murata, Kazumoto; Korenaga, Masaaki; Mawatari, Yoriko; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan; [Nishida, Nao; Sawai, Hiromi; Kawashima, Minae; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo, Japan; [Kashiwase, Koichi; Minami, Mutsuhiko] Japanese Red Cross Kanto Koshinetsu Block Blood C, HLA Lab, Koutou Ku, Tokyo, Japan; [Seto, Wai-Kay; Yuen, Man-Fung] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Posuwan, Nawarat; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Kurosaki, Masayuki; Izumi, Namiki] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Musashino, Tokyo, Japan; [Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Liver Dis Control, Bunkyo Ku, Tokyo, Japan; [Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo, Japan; [Kang, Jong-Hon] Teine Keijinkai Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan; [Hige, Shuhei] Hokkaido Univ, Grad Sch Med, Dept Internal Med, Sapporo, Hokkaido, Japan; [Ide, Tatsuya] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka 830, Japan; [Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan; [Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Murawaki, Yoshikazu] Tottori Univ, Fac Med, Tottori 680, Japan; [Itoh, Yoshito] Kyoto Prefectural Univ Med, Kyoto, Japan; [Tamori, Akihiro] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Orito, Etsuro] Nagoya Daini Red Cross Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Hiasa, Yoichi] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Ehime, Japan; [Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Mita, Eiji] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Japan; [Suzuki, Kazuyuki] Iwate Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Morioka, Iwate 020, Japan; [Hino, Keisuke] Kawasaki Med Coll, Div Hepatol & Pancreatol, Kurashiki, Okayama, Japan; [Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 390, Japan; [Mochida, Satoshi] Saitama Med Univ, Div Gastroenterol & Hepatol, Iruma, Saitama, Japan; [Watanabe, Masaaki] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan; [Eguchi, Yuichiro] Saga Med Sch, Dept Internal Med, Saga, Japan; [Ohashi, Jun] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Hong Kong; Chulalongkorn University; Yonsei University; Yonsei University Health System; Nagoya City University; Nagoya City University; Musashino RedCross Hospital; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Teine Keijinkai Hospital; Hokkaido University; Kurume University; Okayama University; Yamaguchi University; Tottori University; Kyoto Prefectural University of Medicine; Osaka Metropolitan University; Japanese Red Cross Nagoya Daini Hospital; Ehime University; Kanazawa University; Osaka National Hospital; Iwate Medical University; Kawasaki Medical School; Shinshu University; Saitama Medical University; Kitasato University; Saga University; University of Tsukuba	Nishida, N (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan.	nishida-75@umin.ac.jp; mmizokami@hospk.ncgm.go.jp	Korenaga, Masaaki/AAE-7479-2020; SETO, Wai-Kay/H-4452-2012; OHASHI, JUN/G-5907-2015; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Hiasa, Yoichi/ABD-2759-2021	SETO, Wai-Kay/0000-0002-9012-313X; Hiasa, Yoichi/0000-0003-4117-339X; Poovorawan, Yong/0000-0002-2337-6807; Han, Kwang-Hyub/0000-0003-3960-6539; Tanaka, Yasuhito/0000-0002-2473-6966; Ahn, Sang Hoon/0000-0002-3629-4624	Ministry of Health, Labour, and Welfare of Japan [H24-Bsou-kanen-ippan-011, H24-kanen-ippan-004, H23-kanen-005, H25-kanen-wakate-013, H25-kanen-wakate-012]; Ministry of Education, Culture, Sports, Science of Japan [22133008, 24790728, 25870178];  [22-shi-302];  [24-shi-107]; Grants-in-Aid for Scientific Research [23590985, 24790728, 24590960, 22133008] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan H24-Bsou-kanen-ippan-011 and H24-kanen-ippan-004 to Masashi Mizokami, H23-kanen-005 to Katsushi Tokunaga, H25-kanen-wakate-013 to Nao Nishida, and H25-kanen-wakate-012 to Hiromi Sawai. This work was also supported by The Grant for National Center for Global Health and Medicine 22-shi-302 to Masashi Mizokami and 24-shi-107 to Nao Nishida. Partial support by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science of Japan [grant number 22133008] for Scientific Research on Innovative Areas to Katsushi Tokunaga, [grant number 24790728] for Young Scientists (B) to Nao Nishida, and [grant number 25870178] for Young Scientists (B) to Hiromi Sawai, is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Chandanayingyong D, 1997, HUM IMMUNOL, V53, P174, DOI 10.1016/S0198-8859(96)00284-4; CHANDANAYINGYONG D, 1994, HUM IMMUNOL, V40, P20, DOI 10.1016/0198-8859(94)90017-5; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Maneemaroj Ratchaneewan, 1997, Journal of the Medical Association of Thailand, V80, pS20; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Sawai H, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-47; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Vermehren J, 2012, PLOS ONE, V7; Wu TW, 2013, HUM GENET; Zidan A, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6894	21	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e86449	10.1371/journal.pone.0086449	http://dx.doi.org/10.1371/journal.pone.0086449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520320	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600011
J	Skinner, MD; Lahmek, P; Pham, H; Aubin, HJ				Skinner, Marilyn D.; Lahmek, Pierre; Pham, Heloise; Aubin, Henri-Jean			Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis	PLOS ONE			English	Article							TRIAL COMPARING DISULFIRAM; FUNCTIONAL SOCIAL SUPPORT; COCAINE ABUSERS; OUTPATIENT TREATMENT; NALTREXONE; PLACEBO; MAINTENANCE; ACAMPROSATE; ABSTINENCE; CONCURRENT	Background: Despite its success with compliant or supervised patients, disulfiram has been a controversial medication in the treatment of alcoholism. Often, study designs did not recognize a pivotal factor in disulfiram research, the importance of an open-label design. Our objectives are: (1) to analyze the efficacy and safety of disulfiram in RCTs in supporting abstinence and (2) to compare blind versus open-label studies, hypothesizing that blinded studies would show no difference between disulfiram and control groups because the threat would be evenly spread across all groups. Methods and Findings: We searched PubMed, EMBASE and the Cochrane Central Register for RCTs on disulfiram use with alcoholics in comparison to any alcoholic control group. The primary outcome was defined by the authors of each trial. Additional analyses included: blind vs. open-label, with or without supervision, cocaine study or not, and type of control. Overall, the 22 included studies showed a higher success rate of disulfiram compared to controls Hedges'g =.58 (95% CI =.35-.82). When comparing blind and open-label RCTs, only open-label trials showed a significant superiority over controls g =.70 (95% CI =.46-.93). RCTs with blind designs showed no efficacy of disulfiram compared to controls. Disulfiram was also more effective than the control condition when compared to naltrexone g =.77, 95% CI =.52-1.02, to acamprosate g =.76, 95% CI =.04-1.48, and to the no disulfiram groups g =.43, 95% CI =.17-.69. Limits include: (1) a population of 89% male subjects and (2) a high but unavoidable heterogeneity of the studies with a substantial I-square in most subgroups of studies. Conclusions: Blinded studies were incapable of distinguishing a difference between treatment groups and thus are incompatible with disulfiram research. Based on results with open-label studies, disulfiram is a safe and efficacious treatment compared to other abstinence supportive pharmacological treatments or to no disulfiram in supervised studies for problems of alcohol abuse or dependence.	[Skinner, Marilyn D.] Hop Emile Roux, AP HP, INSERM, Ctr Traitement Addict,U669, Limeil Brevannes, France; [Lahmek, Pierre] Hop Emile Roux, AP HP, Ctr Traitement Addict, Limeil Brevannes, France; [Pham, Heloise] Ctr Med Marmottan Paris, Paris, France; [Aubin, Henri-Jean] Univ Paris 11, Ctr Enseignement Rech & Traitement Addict, Hop Paul Brousse, AP HP,INSERM,U669, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Emile-Roux - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Emile-Roux - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Skinner, MD (corresponding author), Hop Emile Roux, AP HP, INSERM, Ctr Traitement Addict,U669, Limeil Brevannes, France.	marilyn.skinner@erx.aphp.fr	, Aubin/AAT-9739-2021; Aubin, Henri-Jean/AAP-8605-2021	Aubin, Henri-Jean/0000-0002-6604-6672				Alharbi FF, 2013, ADDICT DISORD TREAT, V12, P140, DOI 10.1097/ADT.0b013e3182625beb; Anton RF, 2001, J CLIN PSYCHIAT, V62, P11; AZRIN NH, 1982, J BEHAV THER EXP PSY, V13, P105, DOI 10.1016/0005-7916(82)90050-7; Beattie MC, 1999, ADDICT BEHAV, V24, P593, DOI 10.1016/S0306-4603(98)00120-8; BREWER C, 1986, ALCOHOL ALCOHOLISM, V21, P385; Brewer C, 2000, CNS DRUGS, V14, P329, DOI 10.2165/00023210-200014050-00001; Brewer C, 2001, PRIMARY CARE NEW AUT, P227; Brewer Colin, 2003, Subst Abus, V24, P157, DOI 10.1023/A:1025010227511; Carroll C, 1993, AM J ADDICTION, V2, P77; Carroll KM, 2004, ARCH GEN PSYCHIAT, V61, P264, DOI 10.1001/archpsyc.61.3.264; CARROLL KM, 1993, J STUD ALCOHOL, V54, P199, DOI 10.15288/jsa.1993.54.199; Carroll KM, 1998, ADDICTION, V93, P713, DOI 10.1046/j.1360-0443.1998.9357137.x; CHICK J, 1992, BRIT J PSYCHIAT, V161, P84, DOI 10.1192/bjp.161.1.84; Closser M H, 1992, Recent Dev Alcohol, V10, P115; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Sousa A, 2005, ALCOHOL ALCOHOLISM, V40, P545, DOI 10.1093/alcalc/agh187; De Sousa A, 2004, ALCOHOL ALCOHOLISM, V39, P528, DOI 10.1093/alcalc/agh104; De Sousa A, 2009, J PULP PAP SCI, V6, P85; De Sousa A, 2008, J SUBST USE, V13, P382, DOI 10.1080/14659890802305861; De Sousa AA, 2008, J SUBST ABUSE TREAT, V34, P460, DOI 10.1016/j.jsat.2007.05.012; Diehl A, 2010, ALCOHOL ALCOHOL; Dobkin PL, 2002, ADDICTION, V97, P347, DOI 10.1046/j.1360-0443.2002.00083.x; Fuller RK, 2004, ADDICTION, V99, P21, DOI 10.1111/j.1360-0443.2004.00597.x; FULLER RK, 1986, JAMA-J AM MED ASSOC, V256, P1449, DOI 10.1001/jama.256.11.1449; FULLER RK, 1979, ANN INTERN MED, V90, P901, DOI 10.7326/0003-4819-90-6-901; Gaval-Cruz M, 2009, MOL INTERV, V9, P175, DOI 10.1124/mi.9.4.6; GERREIN JR, 1973, ARCH GEN PSYCHIAT, V28, P798; Gossop M, 2006, ALCOHOL ALCOHOLISM, V41, P119, DOI 10.1093/alcalc/agl003; GRANT BF, 1990, DRUG ALCOHOL DEPEN, V25, P97, DOI 10.1016/0376-8716(90)90147-7; Grassi MC, 2007, PHARMACOL RES, V55, P117, DOI 10.1016/j.phrs.2006.11.005; Higgins JP, 2008, COCHRANE HDB SYSEMAT; Hughes JC, 1997, ADDICTION, V92, P381; IBER FL, 1987, ALCOHOL CLIN EXP RES, V11, P301, DOI 10.1111/j.1530-0277.1987.tb01312.x; Johnson BA, 2008, BIOCHEM PHARMACOL, V75, P34, DOI 10.1016/j.bcp.2007.08.005; Johnson BA, 2010, AM J PSYCHIAT, V167, P630, DOI 10.1176/appi.ajp.2010.08101500; Jorgensen CH, 2011, ALCOHOL CLIN EXP RES; Khalsa H, 1992, Recent Dev Alcohol, V10, P7; Laaksonen E, 2008, ALCOHOL ALCOHOLISM, V43, P53, DOI 10.1093/alcalc/agm136; LING W, 1983, ARCH GEN PSYCHIAT, V40, P851; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Malcolm R, 2008, EXPERT OPIN DRUG SAF, V7, P459, DOI [10.1517/14740338.7.4.459, 10.1517/14740338.7.4.459 ]; MCCANCEKATZ EF, 1993, PSYCHOPHARMACOLOGY, V111, P39, DOI 10.1007/BF02257405; Mutschler J, 2013, AM J DRUG ALCOHOL AB, V39, P44, DOI 10.3109/00952990.2012.677889; Mutschler J, 2010, ALCOHOL ALCOHOLISM, V45, P214, DOI 10.1093/alcalc/agp093; Nava F, 2006, J PSYCHOACTIVE DRUGS, V38, P211, DOI 10.1080/02791072.2006.10399846; Niederhofer H, 2003, DRUG ALCOHOL REV, V22, P295, DOI 10.1080/0959523031000154436; Oliveto A, 2011, DRUG ALCOHOL DEPEN, V113, P184, DOI 10.1016/j.drugalcdep.2010.07.022; Pani PP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007024.pub2; Petrakis IL, 2005, BIOL PSYCHIAT, V57, P1128, DOI 10.1016/j.biopsych.2005.02.016; Petrakis IL, 2000, ADDICTION, V95, P219, DOI 10.1046/j.1360-0443.2000.9522198.x; Pettinati HM, 2008, ADDICT BEHAV, V33, P651, DOI 10.1016/j.addbeh.2007.11.011; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Schuckit MA, 1996, J CONSULT CLIN PSYCH, V64, P669; Skinner M, 2010, DRUG ALCOHOL DEPEND; STOCKWELL T, 1979, BRIT J ADDICT, V74, P79; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Swift RM, 1999, NEW ENGL J MED, V340, P1482, DOI 10.1056/NEJM199905133401907; Tonnesen H, 1999, BMJ-BRIT MED J, V318, P1311, DOI 10.1136/bmj.318.7194.1311; Ulrichsen J, 2010, NORD J PSYCHIAT, V64, P356, DOI 10.3109/08039481003686180; von Bardeleben U, 1999, BIBL PSYCHIAT, P45; Weinshenker D, 2010, NAT MED, V16, P969, DOI 10.1038/nm0910-969; WEISS RD, 1988, J NERV MENT DIS, V176, P719, DOI 10.1097/00005053-198812000-00004; WILSON A, 1984, J CLIN PSYCHIAT, V45, P242; WRIGHT C, 1990, AM J MED, V88, P647, DOI 10.1016/0002-9343(90)90534-K; Yao LN, 2010, NAT MED, V16, P1024, DOI 10.1038/nm.2200	65	141	145	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87366	10.1371/journal.pone.0087366	http://dx.doi.org/10.1371/journal.pone.0087366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520330	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600021
J	Tong, ZY; Xie, C; Ma, L; Liu, LP; Jin, YS; Dong, JL; Wang, T				Tong, Zongyong; Xie, Can; Ma, Lei; Liu, Liping; Jin, Yongsheng; Dong, Jiangli; Wang, Tao			Co-Expression of Bacterial Aspartate Kinase and Adenylylsulfate Reductase Genes Substantially Increases Sulfur Amino Acid Levels in Transgenic Alfalfa (Medicago sativa L.)	PLOS ONE			English	Article							CYSTATHIONINE GAMMA-SYNTHASE; 5'-ADENYLYLSULFATE REDUCTASE; SULFATE REDUCTION; LYSINE METABOLISM; NUTRITIVE-VALUE; ENHANCED LEVELS; PAPS-REDUCTASE; O-ACETYLSERINE; METHIONINE; PLANTS	Alfalfa (Medicago sativa L.) is one of the most important forage crops used to feed livestock, such as cattle and sheep, and the sulfur amino acid (SAA) content of alfalfa is used as an index of its nutritional value. Aspartate kinase (AK) catalyzes the phosphorylation of aspartate to Asp-phosphate, the first step in the aspartate family biosynthesis pathway, and adenylylsulfate reductase (APR) catalyzes the conversion of activated sulfate to sulfite, providing reduced sulfur for the synthesis of cysteine, methionine, and other essential metabolites and secondary compounds. To reduce the feedback inhibition of other metabolites, we cloned bacterial AK and APR genes, modified AK, and introduced them into alfalfa. Compared to the wild-type alfalfa, the content of cysteine increased by 30% and that of methionine increased substantially by 60%. In addition, a substantial increase in the abundance of essential amino acids (EAAs), such as aspartate and lysine, was found. The results also indicated a close connection between amino acid metabolism and the tricarboxylic acid (TCA) cycle. The total amino acid content and the forage biomass tested showed no significant changes in the transgenic plants. This approach provides a new method for increasing SAAs and allows for the development of new genetically modified crops with enhanced nutritional value.	[Tong, Zongyong; Xie, Can; Ma, Lei; Liu, Liping; Jin, Yongsheng; Dong, Jiangli; Wang, Tao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Wang, T (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	wangt@cau.edu.cn	liu, li/HGC-0900-2022		Hi-Tech Research and Development (863) Program of China [2009AA10Z108, 2011AA100209]	Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China)	was supported by the Hi-Tech Research and Development (863) Program of China (2009AA10Z108 and 2011AA100209) (http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelovici R, 2009, PLANT PHYSIOL, V151, P2058, DOI 10.1104/pp.109.145631; AOAC, 2006, OFFICIAL METHODS ANA; Avraham T, 2005, PLANT BIOTECHNOL J, V3, P71, DOI 10.1111/j.1467-7652.2004.00102.x; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; Beauregard M, 2006, PLANT BIOTECHNOL J, V4, P561, DOI 10.1111/j.1467-7652.2006.00204.x; Berndt C, 2004, J BIOL CHEM, V279, P7850, DOI 10.1074/jbc.M309332200; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Bick JA, 1998, P NATL ACAD SCI USA, V95, P8404, DOI 10.1073/pnas.95.14.8404; BIRD PR, 1972, AUST J BIOL SCI, V25, P835, DOI 10.1071/BI9720835; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunold Christian, 1997, Progress in Botany, V58, P164; Bryan J. K., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P403; Curien G, 2005, J BIOL CHEM, V280, P41178, DOI 10.1074/jbc.M509324200; DECLERCQ A, 1990, PLANT PHYSIOL, V94, P970, DOI 10.1104/pp.94.3.970; Di R, 2003, J AGR FOOD CHEM, V51, P5695, DOI 10.1021/jf030148c; Dong JL, 2005, VIROLOGY, V339, P153, DOI 10.1016/j.virol.2005.06.004; Dumas R, 2012, ARCH BIOCHEM BIOPHYS, V519, P186, DOI 10.1016/j.abb.2011.10.016; FALCO SC, 1995, BIO-TECHNOL, V13, P577, DOI 10.1038/nbt0695-577; FRANKARD V, 1992, PLANT PHYSIOL, V99, P1285, DOI 10.1104/pp.99.4.1285; Frankard V, 1997, PLANT MOL BIOL, V34, P233, DOI 10.1023/A:1005863128558; GALILI G, 1995, PLANT CELL, V7, P899, DOI 10.2307/3870045; Galili G, 2013, PLANT BIOTECHNOL J, V11, P211, DOI 10.1111/pbi.12025; Galili S, 2000, TRANSGENIC RES, V9, P137, DOI 10.1023/A:1008991625001; Hacham Y, 2002, PLANT PHYSIOL, V128, P454, DOI 10.1104/pp.010819; Hacham Y, 2008, PLANT J, V54, P260, DOI 10.1111/j.1365-313X.2008.03415.x; Hacham Y, 2007, PLANT J, V51, P850, DOI 10.1111/j.1365-313X.2007.03184.x; Harlow E., 1988, ANTIBODIES LAB MANUA; Harms K, 2000, PLANT J, V22, P335, DOI 10.1046/j.1365-313x.2000.00743.x; Hesse H, 2003, TRENDS PLANT SCI, V8, P259, DOI 10.1016/S1360-1385(03)00107-9; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubberten HM, 2012, PLANT J, V70, P666, DOI 10.1111/j.1365-313X.2012.04905.x; KARCHI H, 1993, PLANT J, V3, P721, DOI 10.1111/j.1365-313X.1993.00721.x; Kikuchi Y, 1999, FEMS MICROBIOL LETT, V173, P211, DOI 10.1111/j.1574-6968.1999.tb13504.x; Kim H, 1999, PLANTA, V209, P282, DOI 10.1007/s004250050634; Kim J, 2002, PLANT PHYSIOL, V128, P95, DOI 10.1104/pp.101801; Kopriva S, 2001, J BIOL CHEM, V276, P42881, DOI 10.1074/jbc.M107424200; Koprivova A, 2000, PLANT PHYSIOL, V122, P737, DOI 10.1104/pp.122.3.737; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Lu DY, 2000, SCI CHINA SER C, V43, P387, DOI 10.1007/BF02879303; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019883; Martin MN, 2005, PHOTOSYNTH RES, V86, P309, DOI 10.1007/s11120-005-9006-z; MERTZ ET, 1952, ARCH BIOCHEM BIOPHYS, V38, P139, DOI 10.1016/0003-9861(52)90017-9; Molvig L, 1997, P NATL ACAD SCI USA, V94, P8393, DOI 10.1073/pnas.94.16.8393; Mugford SG, 2011, PLANT J, V65, P96, DOI 10.1111/j.1365-313X.2010.04410.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scheible WR, 1997, PLANT J, V11, P671, DOI 10.1046/j.1365-313X.1997.11040671.x; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; SCHWENN JD, 1988, ARCH MICROBIOL, V150, P313, DOI 10.1007/BF00408300; SCHWENN JD, 1987, Z NATURFORSCH C, V42, P93; SHAUL O, 1992, PLANT PHYSIOL, V100, P1157, DOI 10.1104/pp.100.3.1157; Sirko A, 2004, J EXP BOT, V55, P1881, DOI 10.1093/jxb/erh151; Smith FW, 1997, PLANT J, V12, P875, DOI 10.1046/j.1365-313X.1997.12040875.x; Suter M, 2000, J BIOL CHEM, V275, P930, DOI 10.1074/jbc.275.2.930; Tabe L, 2010, J EXP BOT, V61, P721, DOI 10.1093/jxb/erp338; Tabe LM, 2002, PLANT PHYSIOL, V128, P1137, DOI 10.1104/pp.010935; TABE LM, 1995, J ANIM SCI, V73, P2752; THOMAS MR, 1990, PLANT SCI, V69, P189, DOI 10.1016/0168-9452(90)90117-7; Tsakraklides G, 2002, PLANT J, V32, P879, DOI 10.1046/j.1365-313X.2002.01477.x; Tzchori IBT, 1996, PLANT MOL BIOL, V32, P727, DOI 10.1007/BF00020213; WAGNER W, 1978, Z NATURFORSCH C, V33, P517; Zhao Qian, 2004, Journal of Agricultural Biotechnology, V12, P247; Zhu XH, 2004, PLANT PHYSIOL, V135, P129, DOI 10.1104/pp.103.037168	63	7	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88310	10.1371/journal.pone.0088310	http://dx.doi.org/10.1371/journal.pone.0088310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520364	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600055
J	Zhang, J; Li, YQ; Gu, ZH; Yu, ZL				Zhang, Jun; Li, Yuanqing; Gu, Zhenghui; Yu, Zhu Liang			Recoverability Analysis for Modified Compressive Sensing with Partially Known Support	PLOS ONE			English	Article							SIGNAL RECONSTRUCTION; RECOVERY	The recently proposed modified-compressive sensing (modified-CS), which utilizes the partially known support as prior knowledge, significantly improves the performance of recovering sparse signals. However, modified-CS depends heavily on the reliability of the known support. An important problem, which must be studied further, is the recoverability of modified-CS when the known support contains a number of errors. In this letter, we analyze the recoverability of modified-CS in a stochastic framework. A sufficient and necessary condition is established for exact recovery of a sparse signal. Utilizing this condition, the recovery probability that reflects the recoverability of modified-CS can be computed explicitly for a sparse signal with l nonzero entries. Simulation experiments have been carried out to validate our theoretical results.	[Zhang, Jun] Guangdong Univ Technol, Coll Informat Engn, Guangzhou, Guangdong, Peoples R China; [Li, Yuanqing; Gu, Zhenghui; Yu, Zhu Liang] S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou, Guangdong, Peoples R China	Guangdong University of Technology; South China University of Technology	Li, YQ (corresponding author), S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou, Guangdong, Peoples R China.	auyqli@scut.edu.cn		Zhang, Jun/0000-0002-9647-0941	National High-tech R&D Program of China (863 Program) [2012AA011601]; National Natural Science Foundation of China [91120305, 61105121, 61175114]; Natural Science Foundation of Guangdong [S2012020010945]; Excellent Youth Development Project of Universities in Guangdong Province [2012LYM 0057]	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Excellent Youth Development Project of Universities in Guangdong Province	This work was supported by the National High-tech R&D Program of China (863 Program) under grant 2012AA011601, the National Natural Science Foundation of China under grants 91120305, 61105121 and 61175114, the Natural Science Foundation of Guangdong under grant S2012020010945 and the Excellent Youth Development Project of Universities in Guangdong Province under grant 2012LYM 0057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2005, IEEE T INFORM THEORY, V51, P4203, DOI 10.1109/TIT.2005.858979; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Chen SSB, 2001, SIAM REV, V43, P129, DOI 10.1137/S1064827596304010; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Friedlander M, 2010, IEEE T INF IN PRESS; Fuchs JJ, 2005, IEEE T INFORM THEORY, V51, P3601, DOI 10.1109/TIT.2005.855614; Guo W, 2010, TR1002 RIC U DEP COM; Jacques L, 2010, SIGNAL PROCESS, V90, P3308, DOI 10.1016/j.sigpro.2010.05.025; Khajehnejad MA, 2011, IEEE T SIGNAL PROCES, V59, P1985, DOI 10.1109/TSP.2011.2107904; Li YQ, 2006, IEEE T INFORM THEORY, V52, P3139, DOI 10.1109/TIT.2006.876348; LU W, 2009, P IEEE INT C IM PROC, P3009; Mamaghanian H, 2011, IEEE T BIO-MED ENG, V58, P2456, DOI 10.1109/TBME.2011.2156795; Miosso CJ, 2009, IEEE T SIGNAL PROCES, V57, P2424, DOI 10.1109/TSP.2009.2016889; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Qiu CL, 2009, INT CONF ACOUST SPEE, P393, DOI 10.1109/ICASSP.2009.4959603; Vaswani N, 2010, IEEE T SIGNAL PROCES, V58, P4595, DOI 10.1109/TSP.2010.2051150; Vaswani N, 2009, IEEE INT SYMP INFO, P488, DOI 10.1109/ISIT.2009.5205717; von Borries R, 2007, 2007 2ND IEEE INTERNATIONAL WORKSHOP ON COMPUTATIONAL ADVANCES IN MULTI-SENSOR ADAPTIVE PROCESSING, P157; Wang YL, 2010, SIAM J IMAGING SCI, V3, P462, DOI 10.1137/090772447	20	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87985	10.1371/journal.pone.0087985	http://dx.doi.org/10.1371/journal.pone.0087985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520341	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600032
J	Lamb, JS; Chadwick, RS				Lamb, Jessica S.; Chadwick, Richard S.			Phase of Shear Vibrations within Cochlear Partition Leads to Activation of the Cochlear Amplifier	PLOS ONE			English	Article							HAIR CELL MOTILITY; TECTORIAL MEMBRANE; BASILAR-MEMBRANE; TRAVELING-WAVES; MODEL; MECHANICS; EAR; SUBPARTITIONS; AMPLIFICATION; TRANSDUCTION	Since Georg von Bekesy laid out the place theory of the hearing, researchers have been working to understand the remarkable properties of mammalian hearing. Because access to the cochlea is restricted in live animals, and important aspects of hearing are destroyed in dead ones, models play a key role in interpreting local measurements. Wentzel-Kramers-Brillouin (WKB) models are attractive because they are analytically tractable, appropriate to the oblong geometry of the cochlea, and can predict wave behavior over a large span of the cochlea. Interest in the role the tectorial membrane (TM) plays in cochlear tuning led us to develop models that directly interface the TM with the cochlear fluid. In this work we add an angled shear between the TM and reticular lamina (RL), which serves as an input to a nonlinear active force. This feature plus a novel combination of previous work gives us a model with TM-fluid interaction, TM-RL shear, a nonlinear active force and a second wave mode. The behavior we get leads to the conclusion the phase between the shear and basilar membrane (BM) vibration is critical for amplification. We show there is a transition in this phase that occurs at a frequency below the cutoff, which is strongly influenced by TM stiffness. We describe this mechanism of sharpened BM velocity profile, which demonstrates the importance of the TM in overall cochlear tuning and offers an explanation for the response characteristics of the Tectb mutant mouse.	[Lamb, Jessica S.; Chadwick, Richard S.] NIDCD, Sect Auditory Mech, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Chadwick, RS (corresponding author), NIDCD, Sect Auditory Mech, Bethesda, MD 20892 USA.	chadwick@helix.nih.gov			National Institute on Deafness and other Communication Disorders [DC00033]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000033] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the intramural program project DC00033 in the National Institute on Deafness and other Communication Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1993, J ACOUST SOC AM, V94, P809, DOI 10.1121/1.408182; ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chadwick RS, 1998, P NATL ACAD SCI USA, V95, P14594, DOI 10.1073/pnas.95.25.14594; Chadwick RS, 1996, P NATL ACAD SCI USA, V93, P2564, DOI 10.1073/pnas.93.6.2564; Chen FY, 2011, NAT NEUROSCI, V14, P770, DOI 10.1038/nn.2827; Dallos P., 1996, SPRINGER HDB AUDITOR, V8; DEBOER E, 1990, LECT NOTES BIOMATH, V87, P333; Dong W, 2013, BIOPHYS J, V105, P1067, DOI 10.1016/j.bpj.2013.06.049; Elliott SJ, 2011, AIP CONF PROC, V1403, DOI 10.1063/1.3658149; Elliott SJ, 2013, J ACOUST SOC AM, V133, P1535, DOI 10.1121/1.4790350; Gavara N, 2010, NAT METHODS, V7, P650, DOI [10.1038/NMETH.1474, 10.1038/nmeth.1474]; Ghaffari R, 2007, P NATL ACAD SCI USA, V104, P16510, DOI 10.1073/pnas.0703665104; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; Hemmert W, 2000, BIOPHYS J, V78, P2285, DOI 10.1016/S0006-3495(00)76775-0; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Keiler S, 2001, HEARING RES, V162, P91, DOI 10.1016/S0378-5955(01)00374-4; Lamb JS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.088101; Lukashkin AN, 2010, HEARING RES, V266, P26, DOI 10.1016/j.heares.2009.10.005; Manoussaki D, 2008, P NATL ACAD SCI USA, V105, P6162, DOI 10.1073/pnas.0710037105; Meaud J, 2010, J ACOUST SOC AM, V127, P1411, DOI 10.1121/1.3290995; Nilsen KE, 2000, P NATL ACAD SCI USA, V97, P11751, DOI 10.1073/pnas.97.22.11751; Richardson GP, 2008, CURR OPIN OTOLARYNGO, V16, P458, DOI 10.1097/MOO.0b013e32830e20c4; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; RUSSELL IJ, 1992, PHILOS T ROY SOC B, V336, P317, DOI 10.1098/rstb.1992.0064; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; SAUNDERS JC, 1982, J COMP PHYSIOL, V146, P517, DOI 10.1007/BF00609448; STEELE CR, 1979, J ACOUST SOC AM, V65, P1001, DOI 10.1121/1.382569; Watts L, 2000, J ACOUST SOC AM, V108, P2266, DOI 10.1121/1.1310194; ZWISLOCKI JJ, 1979, SCIENCE, V204, P639, DOI 10.1126/science.432671; ZWISLOCKI JJ, 1986, HEARING RES, V22, P155, DOI 10.1016/0378-5955(86)90091-2	34	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e85969	10.1371/journal.pone.0085969	http://dx.doi.org/10.1371/journal.pone.0085969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551037	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500006
J	Renaud, HJ; Cui, JLY; Lu, H; Klaassen, CD				Renaud, Helen J.; Cui, Julia Y.; Lu, Hong; Klaassen, Curtis D.			Effect of Diet on Expression of Genes Involved in Lipid Metabolism, Oxidative Stress, and Inflammation in Mouse Liver-Insights into Mechanisms of Hepatic Steatosis	PLOS ONE			English	Article							CALORIE RESTRICTION; ACID; CHOLESTEROL; FAT; DISEASE; MICE; RECEPTOR; STEATOHEPATITIS; CARBOHYDRATE; RESISTANCE	Nutritional intake is a fundamental determinant of health. Many studies have correlated excess caloric intake, as well as a high ratio of n-6:n-3 fatty acids, with detrimental health outcomes, such as the metabolic syndrome. In contrast, low-calorie diets have beneficial health effects. Despite these associations, our understanding of the causal relationship between diet and health remains largely elusive. The present study examined the molecular changes elicited by nine diets with varying fat, sugar, cholesterol, omega-3 fatty acids, omega-6 fatty acids, and calories in C57BL/6 male mice. Microarray analyses were conducted on liver samples from three mice per diet and detected 20,449 genes of which 3,734 were responsive to changes in dietary components. Principal component analysis showed that diet restriction correlated the least with the other diets and also affected more genes than any other diet. Interestingly, Gene Set Enrichment Analysis (GSEA) identified gene sets involved in glutathione metabolism, immune response, fatty acid metabolism, cholesterol metabolism, ABC transporters, and oxidative phosphorylation as being highly responsive to changes in diet composition. On the gene level, this study reveals novel findings such as the induction of the drug efflux pump Abcb1a (p-glycoprotein) by diet restriction and an atherogenic diet, as well as the suppression of the rate limiting step of bile acid synthesis, Cyp7a1, by a high fructose diet. This study provides considerable insight into the molecular changes incurred by a variety of diets and furthers our understanding of the causal relationships between diet and health.	[Renaud, Helen J.; Cui, Julia Y.; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA; [Lu, Hong] SUNY Syracuse, Dept Pharmacol, Syracuse, NY USA	University of Kansas; University of Kansas Medical Center; State University of New York (SUNY) System	Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA.	cklaasse@kumc.edu			NIH [ES009649]; Canadian Institutes of Health Research Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant ES009649. Helen J Renaud is supported by a Canadian Institutes of Health Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatston AS, 2005, CLEV CLIN J MED, V72, P946, DOI 10.3949/ccjm.72.10.946; Allard JP, 2008, J HEPATOL, V48, P300, DOI 10.1016/j.jhep.2007.09.009; Arteel Gavin E, 2012, Hepatology, V55, P2030, DOI 10.1002/hep.25721; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; BEHER WT, 1963, J NUTR, V79, P523, DOI 10.1093/jn/79.4.523; Bu LM, 2011, DIABETES RES CLIN PR, V92, P82, DOI 10.1016/j.diabres.2011.01.005; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cordain L, 2003, COMP BIOCHEM PHYS A, V136, P95, DOI 10.1016/S1095-6433(03)00011-4; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Desai MS, 2008, J LEUKOCYTE BIOL, V83, P1336, DOI 10.1189/jlb.0607390; Desmots F, 2002, FREE RADICAL BIO MED, V32, P93, DOI 10.1016/S0891-5849(01)00767-5; Enjoji M, 2010, WORLD J GASTROENTERO, V16, P800, DOI 10.3748/wjg.v16.i7.800; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; FRIEND PS, 1978, LAB INVEST, V38, P629; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haynes Paul, 2004, Clin Liver Dis, V8, P535, DOI 10.1016/j.cld.2004.04.007; Hoekstra M, 2006, J LIPID RES, V47, P2198, DOI 10.1194/jlr.M600095-JLR200; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Larson-Meyer DE, 2008, OBESITY, V16, P1355, DOI 10.1038/oby.2008.201; Leonard MO, 2006, FASEB J, V20, P2624, DOI 10.1096/fj.06-5097fje; Levant B, 2006, J NUTR, V136, P2236, DOI 10.1093/jn/136.8.2236; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Moussavi N, 2008, OBESITY, V16, P7, DOI 10.1038/oby.2007.14; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; NISHINA PM, 1990, J LIPID RES, V31, P859; OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609; OKA K, 1994, EUR J BIOCHEM, V224, P975, DOI 10.1111/j.1432-1033.1994.00975.x; Poudyal H, 2012, AM J PHYSIOL-ENDOC M, V302, pE1472, DOI 10.1152/ajpendo.00102.2012; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reilich P, 2011, J NEUROL, V258, P1987, DOI 10.1007/s00415-011-6055-4; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Saadeh S, 2007, NUTR CLIN PRACT, V22, P1, DOI 10.1177/011542650702200101; Salt William B 2nd, 2004, J Insur Med, V36, P27; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Sun DX, 2004, CELL IMMUNOL, V228, P54, DOI 10.1016/j.cellimm.2004.04.001; Tang WQ, 2011, BBA-MOL CELL BIOL L, V1811, P549, DOI 10.1016/j.bbalip.2011.05.013; Thornton SJ, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-21; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Walsh ME, 2013, FREE RADIC BIOL MED; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039006; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298	60	60	62	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88584	10.1371/journal.pone.0088584	http://dx.doi.org/10.1371/journal.pone.0088584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551121	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500049
J	Bammann, K; Peplies, J; De Henauw, S; Hunsberger, M; Molnar, D; Moreno, LA; Tornaritis, M; Veidebaum, T; Ahrens, W; Siani, A				Bammann, Karin; Peplies, Jenny; De Henauw, Stefaan; Hunsberger, Monica; Molnar, Denes; Moreno, Luis A.; Tornaritis, Michael; Veidebaum, Toomas; Ahrens, Wolfgang; Siani, Alfonso		IDEFICS Consortium	Early Life Course Risk Factors for Childhood Obesity: The IDEFICS Case-Control Study	PLOS ONE			English	Article							BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; MATERNAL RECALL; BIRTH-WEIGHT; FOLLOW-UP; OVERWEIGHT; PREGNANCY; CHILDREN; COHORT; AGE	Background: The early life course is assumed to be a critical phase for childhood obesity; however the significance of single factors and their interplay is not well studied in childhood populations. Objectives: The investigation of pre-, peri- and postpartum risk factors on the risk of obesity at age 2 to 9. Methods: A case-control study with 1,024 1: 1-matched case-control pairs was nested in the baseline survey (09/2007-05/2008) of the IDEFICS study, a population-based intervention study on childhood obesity carried out in 8 European countries in pre- and primary school settings. Conditional logistic regression was used for identification of risk factors. Results: For many of the investigated risk factors, we found a raw effect in our study. In multivariate models, we could establish an effect for gestational weight gain (adjusted OR = 1.02; 95% CI 1.00-1.04), smoking during pregnancy (adjusted OR = 1.48; 95% CI 1.08-2.01), Caesarian section (adjusted OR = 1.38; 95% CI 1.10-1.74), and breastfeeding 4 to 11 months (adjusted OR = 0.77; 95% CI 0.62-0.96). Birth weight was related to lean mass rather than to fat mass, the effect of smoking was found only in boys, but not in girls. After additional adjustment for parental BMI and parental educational status, only gestational weight gain remained statistically significant. Both, maternal as well as paternal BMI were the strongest risk factors in our study, and they confounded several of the investigated associations. Conclusions: Key risk factors of childhood obesity in our study are parental BMI and gestational weight gain; consequently prevention approaches should target not only children but also adults. The monitoring of gestational weight seems to be of particular importance for early prevention of childhood obesity.	[Bammann, Karin] Univ Bremen, Inst Publ Hlth & Nursing Res IPP, D-28359 Bremen, Germany; [Bammann, Karin; Peplies, Jenny; Ahrens, Wolfgang] BIPS Inst Prevent Res & Epidemiol, Bremen, Germany; [De Henauw, Stefaan] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [De Henauw, Stefaan] Univ Gothenburg, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Molnar, Denes] Univ Pecs, Dept Pediat, Pecs, Hungary; [Moreno, Luis A.] Univ Zaragoza, Growth Exercise Nutr & Dev GENUD Res Grp, Zaragoza, Spain; [Tornaritis, Michael] Res & Educ Fdn Child Hlth, Strovolos, Cyprus; [Veidebaum, Toomas] Natl Inst Hlth Dev, Dept Chron Dis, Tallinn, Estonia; [Siani, Alfonso] CNR, Inst Food Sci, Unit Epidemiol & Populat Genet, Avellino, Italy	University of Bremen; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Ghent University; University of Gothenburg; University of Pecs; University of Zaragoza; National Institute for Health Development - Estonia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Bammann, K (corresponding author), Univ Bremen, Inst Publ Hlth & Nursing Res IPP, D-28359 Bremen, Germany.	bammann@uni-bremen.de	Akkal, Maureen/P-6919-2014; Molnár, Dénes/AAB-6820-2022; Moreno, Luis/S-1780-2019; Siani, Alfonso/B-7925-2015; Ahrens, Wolfgang/A-2740-2012	Moreno, Luis/0000-0003-0454-653X; Hunsberger, Monica/0000-0003-1779-1286; Ahrens, Wolfgang/0000-0003-3777-570X; Bammann, Karin/0000-0002-5623-8160	European Community [016181]	European Community(European Commission)	This work was done as part of the IDEFICS Study (www.idefics.eu). We gratefully acknowledge the financial support of the European Community within the Sixth RTD Framework Programme Contract No. 016181 (FOOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; Amir Lisa Helen, 2003, Breastfeed Rev, V11, P19; Bammann K, 2013, PEDIATR OBES, V8, P1, DOI 10.1111/j.2047-6310.2012.00075.x; BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x; Bartok CJ, 2009, INT J PEDIATR OBES, V4, P196, DOI 10.3109/17477160902763309; Beyerlein A, 2011, AM J CLIN NUTR, V94, p1772S, DOI 10.3945/ajcn.110.000547; Bleich SN, 2011, INT J OBESITY, V35, P1, DOI 10.1038/ijo.2010.252; Blustein J, 2013, INT J OBESITY, V37, P900, DOI 10.1038/ijo.2013.49; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Brophy S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-467; Chen AM, 2006, INT J EPIDEMIOL, V35, P121, DOI 10.1093/ije/dyi218; Chen K, 1999, BIOMETRIKA, V86, P755, DOI 10.1093/biomet/86.4.755; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dieu HTT, 2007, INT J PEDIATR OBES, V2, P40, DOI 10.1080/17477160601103922; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Durmus B, 2013, PEDIATR OBES, V8, P339, DOI 10.1111/j.2047-6310.2012.00114.x; Durmus B, 2010, CLIN ENDOCRINOL, V72, P633, DOI 10.1111/j.1365-2265.2009.03708.x; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; Fiese BH, 2013, TRENDS ENDOCRIN MET, V24, P375, DOI 10.1016/j.tem.2013.01.009; Fleten C, 2012, AM J EPIDEMIOL, V176, P83, DOI 10.1093/aje/kws134; Fruhbeck G, 2013, OBESITY FACTS, V6, P117, DOI 10.1159/000350627; Gibbs BG, 2013, PEDIAT OBES     0402, V2, DOI [10.1111/j.2047-6310.2013.00155.x, DOI 10.1111/J.2047-6310.2013.00155.X.]; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Herring SJ, 2012, DIABETES OBES METAB, V14, P195, DOI 10.1111/j.1463-1326.2011.01489.x; HOUTKOOPER LB, 1989, J APPL PHYSIOL, V66, P814, DOI 10.1152/jappl.1989.66.2.814; Howe LD, 2012, INT J EPIDEMIOL, V41, P722, DOI 10.1093/ije/dys025; Huh SY, 2011, PEDIATRICS, V127, pE544, DOI 10.1542/peds.2010-0740; Jaspers M, 2010, J CLIN EPIDEMIOL, V63, P185, DOI 10.1016/j.jclinepi.2009.05.003; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kim SY, 2012, CURR OPIN OBSTET GYN, V24, P376, DOI 10.1097/GCO.0b013e328359f0f4; Kramer MS, 2009, J NUTR, V139, p417S, DOI 10.3945/jn.108.097675; Labayen I, 2006, J NUTR, V136, P147, DOI 10.1093/jn/136.1.147; LAUNER LJ, 1992, J EPIDEMIOL COMMUN H, V46, P203, DOI 10.1136/jech.46.3.203; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; Moore VM, 2004, J NUTR, V134, P1820, DOI 10.1093/jn/134.7.1820; Neutzling MB, 2009, INT J PEDIATR OBES, V4, P143, DOI 10.1080/17477160802453530; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Phelan S, 2011, EXP DIABETES RES, DOI 10.1155/2011/985139; Poskitt EME, 2012, NUTR METAB CARDIOVAS, V22, P819, DOI 10.1016/j.numecd.2012.08.005; Poston L, 2012, CURR OPIN CLIN NUTR, V15, P252, DOI 10.1097/MCO.0b013e3283527cf2; Promislow JHE, 2005, AM J EPIDEMIOL, V161, P289, DOI 10.1093/aje/kwi044; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal A, 2004, LANCET, V363, P1571, DOI 10.1016/S0140-6736(04)16198-9; Thompson AL, 2012, AM J HUM BIOL, V24, P350, DOI 10.1002/ajhb.22254; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Tounian P, 2011, ANN NUTR METAB, V58, P30, DOI 10.1159/000328038; UNESCO, 2006, ISCED 1997; Verier C, 2010, DIABETES CARE, V33, P190, DOI 10.2337/dc09-1459; Walton KA, 2000, EUR J EPIDEMIOL, V16, P793, DOI 10.1023/A:1007625030509; Wasser H, 2011, PEDIATRICS, V127, P229, DOI 10.1542/peds.2010-0166; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x	59	63	65	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e86914	10.1371/journal.pone.0086914	http://dx.doi.org/10.1371/journal.pone.0086914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551043	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000006
J	Miller, JK; Buchner, N; Timms, L; Tam, S; Luo, XM; Brown, AMK; Pasternack, D; Bristow, RG; Fraser, M; Boutros, PC; McPherson, JD				Miller, Jessica K.; Buchner, Nicholas; Timms, Lee; Tam, Shirley; Luo, Xuemei; Brown, Andrew M. K.; Pasternack, Danielle; Bristow, Robert G.; Fraser, Michael; Boutros, Paul C.; McPherson, John D.			Use of Sequenom Sample ID Plus (R) SNP Genotyping in Identification of FFPE Tumor Samples	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PARAFFIN-EMBEDDED TISSUE; DNA EXTRACTION; CELL-LINES; FORMALIN FIXATION; MULTIPLEX PCR; DEGRADED DNA; ASSAY; MISIDENTIFICATION; PRIMER	Short tandem repeat (STR) analysis, such as the AmpFlSTR (R) Identifiler (R) Plus kit, is a standard, PCR-based human genotyping method used in the field of forensics. Misidentification of cell line and tissue DNA can be costly if not detected early; therefore it is necessary to have quality control measures such as STR profiling in place. A major issue in large-scale research studies involving archival formalin-fixed paraffin embedded (FFPE) tissues is that varying levels of DNA degradation can result in failure to correctly identify samples using STR genotyping. PCR amplification of STRs of several hundred base pairs is not always possible when DNA is degraded. The Sample ID Plus (R) panel from Sequenom allows for human DNA identification and authentication using SNP genotyping. In comparison to lengthy STR amplicons, this multiplexing PCR assay requires amplification of only 76-139 base pairs, and utilizes 47 SNPs to discriminate between individual samples. In this study, we evaluated both STR and SNP genotyping methods of sample identification, with a focus on paired FFPE tumor/normal DNA samples intended for next-generation sequencing (NGS). The ability to successfully validate the identity of FFPE samples can enable cost savings by reducing rework.	[Miller, Jessica K.; Buchner, Nicholas; Timms, Lee; Tam, Shirley; Luo, Xuemei; Brown, Andrew M. K.; Pasternack, Danielle; McPherson, John D.] Ontario Inst Canc Res, Dept Genome Technol, Toronto, ON, Canada; [Bristow, Robert G.; Fraser, Michael] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Bristow, Robert G.; Boutros, Paul C.; McPherson, John D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto	Miller, JK (corresponding author), Ontario Inst Canc Res, Dept Genome Technol, Toronto, ON, Canada.	jessica.miller@oicr.on.ca	McPherson, John D/D-2633-2017	McPherson, John D/0000-0001-8049-9347; Boutros, Paul/0000-0003-0553-7520; Bristow, Robert/0000-0002-8553-9544	Canadian Prostate Cancer Genome Network (CPC-GENE); Prostate Cancer Canada; Movember Foundation; Ontario Institute for Cancer Research (OICR); Ontario Ministry of Research and Innovation	Canadian Prostate Cancer Genome Network (CPC-GENE); Prostate Cancer Canada; Movember Foundation; Ontario Institute for Cancer Research (OICR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was partially funded by a grant to the Canadian Prostate Cancer Genome Network (CPC-GENE) by Prostate Cancer Canada with monies from the Movember Foundation and the Ontario Institute for Cancer Research (OICR). The OICR receives funds from the Ontario Ministry of Research and Innovation. [websites: http://www.prostatecancer.ca/, http://ca.movember.com/?home, http://oicr.on.ca/, http://www.ontario.ca/ministry-research-innovation]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JM, 2003, J FORENSIC SCI, V48, P1054; BUTLER JM, 2004, CURR PROTOC HUM GENE, V14; Capes-Davis A, 2012, INT J CANC, V000, P000; Capes-Davis A, 2010, INT J CANC, V000, P000; Chakraborty R, 1999, ELECTROPHORESIS, V20, P1682; Chung JY, 2012, ANAL BIOCHEM, V425, P128, DOI 10.1016/j.ab.2012.03.012; Demichelis F, 2008, NUCLEIC ACIDS RES, V36, P2446, DOI 10.1093/nar/gkn089; Frankel A, 2012, ANZ J SURG, V82, P395, DOI 10.1111/j.1445-2197.2012.06092.x; Funabashi KS, 2012, PATHOL RES PRACT, V208, P584, DOI 10.1016/j.prp.2012.07.001; Gabriel S, 2009, CURR PROT HUMAN GENE, V60, P2; Gilbert MTP, 2007, ELECTROPHORESIS, V28, P2361, DOI 10.1002/elps.200600589; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Johansen P, 2013, FORENSIC SCI INT-GEN, V7, P482, DOI 10.1016/j.fsigen.2013.04.009; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Locke JA, 2012, CLIN CANCER RES, V18, P308, DOI 10.1158/1078-0432.CCR-11-2147; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nims RW, 2010, IN VITRO CELL DEV-AN, V46, P811, DOI 10.1007/s11626-010-9352-9; Opel KL, 2006, J FORENSIC SCI, V51, P351, DOI 10.1111/j.1556-4029.2006.00077.x; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Somaschini A, 2013, GENET TEST MOL BIOMA, V17, P254, DOI 10.1089/gtmb.2012.0359; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Thompson R, 2012, METHODS MOL BIOL, V830, P3, DOI 10.1007/978-1-61779-461-2_1; Tracey M, 2001, CROAT MED J, V42, P233; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Van Neste L, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-16	28	11	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88163	10.1371/journal.pone.0088163	http://dx.doi.org/10.1371/journal.pone.0088163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551080	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000023
J	Kawano, M; Nakayama, M; Aoshima, Y; Nakamura, K; Ono, M; Nishiya, T; Nakamura, S; Takeda, Y; Dobashi, A; Takahashi, A; Endo, M; Ito, A; Ueda, K; Sato, N; Higuchi, S; Kondo, T; Hashimoto, S; Watanabe, M; Watanabe, M; Takahashi, T; Sasaki, K; Nakamura, M; Sasazuki, T; Narushima, T; Suzuki, R; Ogasawara, K				Kawano, Mitsuko; Nakayama, Masafumi; Aoshima, Yusuke; Nakamura, Kyohei; Ono, Mizuho; Nishiya, Tadashi; Nakamura, Syou; Takeda, Yuri; Dobashi, Akira; Takahashi, Akiko; Endo, Misato; Ito, Akiyo; Ueda, Kyosuke; Sato, Naoki; Higuchi, Shigehito; Kondo, Takeru; Hashimoto, Suguru; Watanabe, Masamichi; Watanabe, Makoto; Takahashi, Tetsu; Sasaki, Keiichi; Nakamura, Masanori; Sasazuki, Takehiko; Narushima, Takayuki; Suzuki, Ryuji; Ogasawara, Kouetsu			NKG2D(+) IFN-gamma(+) CD8(+) T Cells Are Responsible for Palladium Allergy	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CONTACT HYPERSENSITIVITY; IN-VITRO; IMMUNE-RESPONSE; IFN-GAMMA; NOD MICE; NICKEL; DERMATITIS; RECEPTOR; TH2-TYPE	Nickel, cobalt, and chromium are well known to be causal agents of allergic contact dermatitis. Palladium (Pd) can also cause allergic disease and exposure results from wide use of this metal in dental restorations and jewelry. Metal allergy is categorized as a delayed-type hypersensitivity, and metal-responsive T cell clones have been isolated from allergic patients. However, compared to nickel, little is known about the pathology of allergic disease mediated by Pd, and pathogenic T cells are poorly understood. To identify the pathogenic T cells that are responsible for onset of Pd allergy, we enriched metal-responsive lymphocytes by sequential adoptive transfer of involved lymph node cells. Here we show that sequential adoptive transfer gradually increased the incidence and the intensity of Pd allergy, and CD8(+) T cells are responsible for the disease as CD8(+) T cell-depleted mice and beta 2-microglobulin-deficient mice did not develop Pd allergy. In addition, we found that draining lymph node cells skewed toward CD8(+) T cells in response to Pd challenge in 8th adoptive transferred recipient mice. The CD8(+) T cells expressed NKG2D, a costimulatory molecule involved in the production of IFN-gamma. NKG2D ligand was also induced in Pd-injected tissues. Furthermore, both NKG2D ligand-transgenic mice, where NKG2D is downmodulated, and IFN-gamma-deficient mice showed impaired Pd allergy. Taken together, these results indicate that IFN-gamma-producing NKG2D(+) CD8(+) T cells are responsible for Pd allergy and suggest that NKG2D is a potential therapeutic target for treatment of metal allergy.	[Kawano, Mitsuko; Nakayama, Masafumi; Aoshima, Yusuke; Nakamura, Kyohei; Ono, Mizuho; Nakamura, Syou; Takeda, Yuri; Dobashi, Akira; Takahashi, Akiko; Endo, Misato; Ito, Akiyo; Sato, Naoki; Higuchi, Shigehito; Kondo, Takeru; Hashimoto, Suguru; Watanabe, Masamichi; Ogasawara, Kouetsu] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Aoba Ku, Sendai, Miyagi 980, Japan; [Aoshima, Yusuke; Ueda, Kyosuke; Narushima, Takayuki] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Aoba Ku, Sendai, Miyagi 980, Japan; [Nishiya, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Takeda, Yuri; Watanabe, Masamichi; Watanabe, Makoto; Takahashi, Tetsu] Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 980, Japan; [Nakamura, Masanori] Showa Univ, Grad Sch Dent, Shinagawa Ku, Tokyo, Japan; [Sasazuki, Takehiko] Kyushu Univ, Inst Adv Study, Higashi Ku, Fukuoka 812, Japan; [Suzuki, Ryuji] Sagamihara Natl Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Dept Rheumatol & Clin Immunol,Minami Ku, Sagamihara, Kanagawa, Japan	Tohoku University; Tohoku University; Okayama University; Tohoku University; Showa University; Kyushu University	Ogasawara, K (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Aoba Ku, Sendai, Miyagi 980, Japan.	ogasawara@idac.tohoku.ac.jp	Ogasawara, Kouetsu/G-9892-2011; Ueda, Kyosuke/T-6747-2019; Nakamura, Kyohei/AAH-4823-2019; Narushima, Takayuki/T-4322-2019	Ueda, Kyosuke/0000-0001-7166-8727; Nakamura, Kyohei/0000-0002-6631-9028; Nakayama, Masafumi/0000-0002-9839-7143; Narushima, Takayuki/0000-0002-2461-5785	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan [H22-meneki-ippan-004]; Grants-in-Aid for Scientific Research [25118703] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to MK and KO). Additional funding was provided by and by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan H22-meneki-ippan-004 (to KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bordignon V, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-19; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Budinger L, 2001, J IMMUNOL, V167, P6038, DOI 10.4049/jimmunol.167.10.6038; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Cristaudo A, 2009, INT J IMMUNOPATH PH, V22, P605, DOI 10.1177/039463200902200306; de Vos G, 2007, IMMUNOPHARM IMMUNOT, V29, P537, DOI 10.1080/08923970701690993; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Faurschou A, 2011, CONTACT DERMATITIS, V64, P185, DOI 10.1111/j.1600-0536.2011.01878.x; Filon F. L, 2003, AM J CONTACT DERMAT, V14, P78; Friedmann-Morvinski D, 2005, BLOOD, V105, P3087, DOI 10.1182/blood-2004-09-3737; Gamerdinger K, 2003, J EXP MED, V197, P1345, DOI 10.1084/jem.20030121; Gorbachev AV, 2001, J IMMUNOL, V166, P2323, DOI 10.4049/jimmunol.166.4.2323; Grinberg-Bleyer Y, 2010, J CLIN INVEST, V120, P4558, DOI 10.1172/JCI42945; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Hashizume H, 2008, J IMMUNOL, V181, P8096, DOI 10.4049/jimmunol.181.11.8096; Hazlett LD, 2001, J IMMUNOL, V166, P1292, DOI 10.4049/jimmunol.166.2.1292; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Kehren J, 1999, J EXP MED, V189, P779, DOI 10.1084/jem.189.5.779; Kish DD, 2007, J LEUKOCYTE BIOL, V82, P85, DOI 10.1189/jlb.0207089; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; Minang JT, 2006, CLIN EXP IMMUNOL, V146, P417, DOI 10.1111/j.1365-2249.2006.03226.x; Minang JT, 2006, CLIN EXP IMMUNOL, V143, P494, DOI 10.1111/j.1365-2249.2006.03018.x; Minang JT, 2005, SCAND J IMMUNOL, V62, P289, DOI 10.1111/j.1365-3083.2005.01673.x; Niiyama S, 2010, INT ARCH ALLERGY IMM, V153, P303, DOI 10.1159/000314372; Ogasawara K, 2005, NAT IMMUNOL, V6, P938, DOI 10.1038/ni1236; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767; Pittet MJ, 2000, J IMMUNOL, V164, P1148, DOI 10.4049/jimmunol.164.3.1148; Raap U, 2009, CONTACT DERMATITIS, V60, P339, DOI 10.1111/j.1600-0536.2009.01524.x; Saint-Mezard P, 2005, J INVEST DERMATOL, V124, P562, DOI 10.1111/j.0022-202X.2005.23567.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Silvennoinen-Kassinen S, 1998, SCAND J IMMUNOL, V48, P99, DOI 10.1046/j.1365-3083.1998.00367.x; SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Summer B, 2010, CONTACT DERMATITIS, V63, P15, DOI 10.1111/j.1600-0536.2010.01744.x; Teixeira MM, 2001, J LEUKOCYTE BIOL, V69, P353; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; Vilarinho S, 2007, P NATL ACAD SCI USA, V104, P18187, DOI 10.1073/pnas.0708968104; Warnecke G, 2007, TRANSPLANTATION, V84, P392, DOI 10.1097/01.tp.0000269705.94545.3a; Wataha JC, 2010, EXPERT REV MED DEVIC, V7, P489, DOI 10.1586/ERD.10.25; Werfel T, 1997, J IMMUNOL, V158, P2500; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Wong SC, 2009, CELL IMMUNOL, V256, P64, DOI 10.1016/j.cellimm.2009.01.009; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yoshida S, 2012, J IMMUNOL, V188, P3972, DOI 10.4049/jimmunol.1102886	51	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e86810	10.1371/journal.pone.0086810	http://dx.doi.org/10.1371/journal.pone.0086810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533050	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600008
J	Porsmoguer, SB; Banaru, D; Bearez, P; Dekeyser, I; Fornelino, MM; Boudouresque, CF				Porsmoguer, Sebastian Biton; Banaru, Daniela; Bearez, Philippe; Dekeyser, Ivan; Fornelino, Manuel Merchan; Boudouresque, Charles F.			Unexpected Headless and Tailless Fish in the Stomach Content of Shortfin Mako Isurus oxyrinchus	PLOS ONE			English	Article							SHARK; FOOD	The stomach content of 113 individuals of shortfin mako Isurus oxyrinchus was analyzed. Individuals were sampled at landing in Vigo (Spain) and captured by sea-surface long-liners in the vicinity of the Azores Archipelago and between Azores and the Iberian Peninsula, in March and October 2012, and March 2013. Teleosts constituted the dominant item, mainly Atlantic saury Scomberesox saurus (87% of teleost prey). Among them, 94% were deprived of both head and the caudal fin, while the flesh and bones of the body were preserved. The presence of eye's lenses, the number of which was consistent with the number of fish remains, likely rules out the elimination of the heads before ingestion. There is no obvious explanation for this unexpected and unrecorded pattern of digestion.	[Porsmoguer, Sebastian Biton; Banaru, Daniela; Dekeyser, Ivan; Boudouresque, Charles F.] Aix Marseille Univ, MIO, UM 110, Marseille, France; [Porsmoguer, Sebastian Biton; Fornelino, Manuel Merchan] Asociac CHELONIA, Madrid, Spain; [Bearez, Philippe] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR 7209, F-75231 Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Porsmoguer, SB (corresponding author), Aix Marseille Univ, MIO, UM 110, Campus Luminy,Case 901, Marseille, France.	sebastien.biton@univ-amu.fr	Béarez, Philippe/D-2383-2012; BANARU, Daniela/ABC-8603-2021; BITON-PORSMOGUER, Sebastian/P-8306-2017	Béarez, Philippe/0000-0003-0397-2393; BANARU, Daniela/0000-0002-8126-4328; BITON-PORSMOGUER, Sebastian/0000-0002-0251-8271	Spanish Ministerio de Medio Ambiente y Medio Rural y Marino [23.09.456C.484]; Ministerio de Agricultura, Alimentacion y Medio ambiente (Fundacion Biodiversidad)	Spanish Ministerio de Medio Ambiente y Medio Rural y Marino(Spanish Government); Ministerio de Agricultura, Alimentacion y Medio ambiente (Fundacion Biodiversidad)	This work was supported by the Spanish Ministerio de Medio Ambiente y Medio Rural y Marino (aplicacion presupuestaria 23.09.456C.484) and Ministerio de Agricultura, Alimentacion y Medio ambiente (Fundacion Biodiversidad; resolucion del 28/12/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop SDH, 2006, MAR FRESHWATER RES, V57, P143, DOI 10.1071/MF05077; Bowman RE, 2000, 155 NOAA NMFSNE, P138; Cailliet GM, 2009, IUCN RED LIST THREAT; CITES, 2013, CONV INT TRAD END SP; Clarke M.R., 1996, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V14A, P41; CLIFF G, 1990, S AFR J MARINE SCI, V9, P115; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Ferenbaught J, 2007, ELEMENTAL ANAL OTOLI; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Gorni GR, 2012, INT COMM CONS ATL CO, V68, P1933; JONES BC, 1977, J FISH RES BOARD CAN, V34, P2067, DOI 10.1139/f77-274; Karepvitch A., 1937, Zool J Moscow, V16, P28; Lopez S, 2009, REV BIOL MAR OCEANOG, V44, P439; Mahler B, 2013, BIOCHEMISTRY-US, V52, P3579, DOI 10.1021/bi400151c; Maia A, 2006, ENVIRON BIOL FISH, V77, P157, DOI 10.1007/s10641-006-9067-7; MEDVED RJ, 1985, J FISH BIOL, V26, P239, DOI 10.1111/j.1095-8649.1985.tb04263.x; Moreno J.A., 2004, GUIA TIBURONES AGUAS; Movillo J, 1971, B MUSEO NACL HIST NA, V29, P290; Mucientes Sandoval GR, 2008, REV INVEST MAR, V29, P145; Muss BJ, 2006, GUIDE POISSONS MER P; Papastamatiou YP, 2005, COMP BIOCHEM PHYS A, V141, P210, DOI 10.1016/j.cbpb.2005.05.041; Pinkas L., 1971, CALIF DEP FISH GAME, V152, P1, DOI DOI 10.1201/B18714-2; Rosecchi E., 1987, REV I PECHES MARIT, V49, P111; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; STILLWELL CE, 1982, CAN J FISH AQUAT SCI, V39, P407, DOI 10.1139/f82-058; Vaske-Junior Teodoro, 1998, Revista Brasileira de Biologia, V58, P445; Velasco Tarelo M, 2005, THESIS I POLITECNICO; Wetherbee BM, 2012, CRC MAR BIOL SER, P239; ZANDER C D, 1982, Vie et Milieu, V32, P1	29	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88488	10.1371/journal.pone.0088488	http://dx.doi.org/10.1371/journal.pone.0088488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533093	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600051
J	Tamari, Z; Rosin, D; Voichek, Y; Barkai, N				Tamari, Zvi; Rosin, Dalia; Voichek, Yoav; Barkai, Naama			Coordination of Gene Expression and Growth-Rate in Natural Populations of Budding Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; STRESS-RESPONSE; TRANSCRIPTOME; EVOLUTION; XYLULOSE; CELLS	Cells adapt to environmental changes through genetic mutations that stabilize novel phenotypes. Often, this adaptation involves regulatory changes which modulate gene expression. In the budding yeast, ribosomal-related gene expression correlates with cell growth rate across different environments. To examine whether the same relationship between gene expression and growth rate is observed also across natural populations, we measured gene expression, growth rate and ethanol production of twenty-four wild type yeast strains originating from diverse habitats, grown on the pentose sugar xylulose. We found that expression of ribosome-related genes did not correlate with growth rate. Rather, growth rate was correlated with the expression of amino acid biosynthesis genes. Searching other databases, we observed a similar correlation between growth rate and amino-acid biosyntehsis genes in a library of gene deletions. We discuss the implications of our results for understanding how cells coordinate their translation capacity with available nutrient resources.	[Tamari, Zvi; Rosin, Dalia; Voichek, Yoav; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il		Voichek, Yoav/0000-0001-8460-7018	NIH [P50GM068763]; European Research Council; Israel Science Foundation; Helen and Martin Kimmel Award for Innovative Investigations; Israeli Ministry of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel Award for Innovative Investigations; Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (P50GM068763), the European Research Council, the Israel Science Foundation, and the Helen and Martin Kimmel Award for Innovative Investigations. N.B. is the incumbent of the Lorna Greenberg Scherzer Professorial Chair, and the Minerva Foundation. Z.T. is supported by the Israeli Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hodgins-Davis A, 2012, GENOME BIOL EVOL, V4, P1061, DOI 10.1093/gbe/evs084; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lai LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-627; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Milo R, 2007, P NATL ACAD SCI USA, V104, P16998, DOI 10.1073/pnas.0707673104; OLSSON L, 1994, ENZYME MICROB TECH, V16, P388, DOI 10.1016/0141-0229(94)90153-8; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Richard P, 2000, FEMS MICROBIOL LETT, V190, P39, DOI 10.1016/S0378-1097(00)00312-8; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; Strassburg K, OMICS, V14, P249; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	24	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88801	10.1371/journal.pone.0088801	http://dx.doi.org/10.1371/journal.pone.0088801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533150	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600108
J	Toyonaga, K; Miyake, Y; Yamasaki, S				Toyonaga, Kenji; Miyake, Yasunobu; Yamasaki, Sho			Characterization of the Receptors for Mycobacterial Cord Factor in Guinea Pig	PLOS ONE			English	Article							ACTIVATING RECEPTOR; PATHOGENIC FUNGUS; RECOGNITION; MINCLE; RECOMBINANT; INFECTION; RESPONSES; DECTIN-2; MODELS	Guinea pig is a widely used animal for research and development of tuberculosis vaccines, since its pathological disease process is similar to that present in humans. We have previously reported that two C-type lectin receptors, Mincle (macrophage inducible C-type lectin, also called Clec4e) and MCL (macrophage C-type lectin, also called Clec4d), recognize the mycobacterial cord factor, trehalose-6,6'-dimycolate (TDM). Here, we characterized the function of the guinea pig homologue of Mincle (gpMincle) and MCL (gpMCL). gpMincle directly bound to TDM and transduced an activating signal through ITAM-bearing adaptor molecule, FcR gamma. Whereas, gpMCL lacked C-terminus and failed to bind to TDM. mRNA expression of gpMincle was detected in the spleen, lymph nodes and peritoneal macrophages and it was strongly upregulated upon stimulation of zymosan and TDM. The surface expression of gpMincle was detected on activated macrophages by a newly established monoclonal antibody that also possesses a blocking activity. This antibody potently suppressed TNF production in BCG-infected macrophages. Collectively, gpMincle is the TDM receptor in the guinea pig and TDM-Mincle axis is involved in host immune responses against mycobacteria.	[Toyonaga, Kenji; Miyake, Yasunobu; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 812, Japan; [Miyake, Yasunobu; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Res Ctr Adv Immunol, Fukuoka 812, Japan	Kyushu University; Kyushu University	Miyake, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 812, Japan.	ymiyake@bioreg.kyushu-u.ac.jp; yamasaki@bioreg.kyushu-u.ac.jp			Funding Program for Next Generation World-Leading Researchers (NEXT Program); Takeda Science Foundation; Uehara Memorial foundation	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial foundation(Uehara Memorial Foundation)	This work was supported by Funding Program for Next Generation World-Leading Researchers (NEXT Program), Takeda Science Foundation, the Uehara Memorial foundation, Grant-in-Aid for Young Scientists (B) and the Uehara Memorial foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; BEKIERKUNST A, 1969, J BACTERIOL, V100, P95, DOI 10.1128/JB.100.1.95-102.1969; Black GF, 2003, CLIN DIAGN LAB IMMUN, V10, P602, DOI 10.1128/CDLI.10.4.602-611.2003; Botha T, 2003, J IMMUNOL, V171, P3110, DOI 10.4049/jimmunol.171.6.3110; Cho H, 2005, INFECT IMMUN, V73, P1367, DOI 10.1128/IAI.73.3.1367-1376.2005; Dascher CC, 1999, J IMMUNOL, V163, P5478; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; HAZEKI K, 1994, FEBS LETT, V342, P29, DOI 10.1016/0014-5793(94)80578-4; Hiromatsu K, 2002, IMMUNOLOGY, V106, P159, DOI 10.1046/j.1365-2567.2002.01422.x; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Lobato-Pascual A, 2013, EUR J IMMUNOL, V43, P3167, DOI 10.1002/eji.201343752; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Masumoto M, 1999, J IMMUNOL, V163, P5039; McMurray DN, 2005, TUBERCULOSIS, V85, P295, DOI 10.1016/j.tube.2005.08.012; McMurray DN, 2001, SCAND J INFECT DIS, V33, P175, DOI 10.1080/00365540151060743; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Moody DB, 2001, IMMUNOLOGY, V104, P243, DOI 10.1046/j.1365-2567.2001.01326.x; Nalamothu V, 2009, CLIN DERMATOL, V27, pS41, DOI 10.1016/j.clindermatol.2009.09.003; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Orme IM, 2005, TUBERCULOSIS, V85, P13, DOI 10.1016/j.tube.2004.08.001; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; World Health Organization, GLOB TUB REP 2013; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	34	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88747	10.1371/journal.pone.0088747	http://dx.doi.org/10.1371/journal.pone.0088747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533147	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600105
J	Weldy, CS; Liu, YG; Liggitt, HD; Chin, MT				Weldy, Chad S.; Liu, Yonggang; Liggitt, H. Denny; Chin, Michael T.			In Utero Exposure to Diesel Exhaust Air Pollution Promotes Adverse Intrauterine Conditions, Resulting in Weight Gain, Altered Blood Pressure, and Increased Susceptibility to Heart Failure in Adult Mice	PLOS ONE			English	Article							LONG-TERM EXPOSURE; ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL-CELL ACTIVATION; GROWTH-RETARDED RAT; PKC-EPSILON GENE; UTEROPLACENTAL INSUFFICIENCY; CARDIOVASCULAR-DISEASE; GESTATIONAL-AGE; GLUTATHIONE GSH; BIRTH-WEIGHT	Exposure to fine particulate air pollution (PM2.5) is strongly associated with cardiovascular morbidity and mortality. Exposure to PM2.5 during pregnancy promotes reduced birthweight, and the associated adverse intrauterine conditions may also promote adult risk of cardiovascular disease. Here, we investigated the potential for in utero exposure to diesel exhaust (DE) air pollution, a major source of urban PM2.5, to promote adverse intrauterine conditions and influence adult susceptibility to disease. We exposed pregnant female C57Bl/6J mice to DE (approximate to 300 mu g/m(3) PM2.5, 6 hrs/day, 5 days/week) from embryonic day (E) 0.5 to 17.5. At E17.5 embryos were collected for gravimetric analysis and assessed for evidence of resorption. Placental tissues underwent pathological examination to assess the extent of injury, inflammatory cell infiltration, and oxidative stress. In addition, some dams that were exposed to DE were allowed to give birth to pups and raise offspring in filtered air (FA) conditions. At 10-weeks of age, body weight and blood pressure were measured. At 12-weeks of age, cardiac function was assessed by echocardiography. Susceptibility to pressure overload-induced heart failure was then determined after transverse aortic constriction surgery. We found that in utero exposure to DE increases embryo resorption, and promotes placental hemorrhage, focal necrosis, compaction of labyrinth vascular spaces, inflammatory cell infiltration and oxidative stress. In addition, we observed that in utero DE exposure increased body weight, but counterintuitively reduced blood pressure without any changes in baseline cardiac function in adult male mice. Importantly, we observed these mice to have increased susceptibility to pressure-overload induced heart failure, suggesting this in utero exposure to DE 'reprograms' the heart to a heightened susceptibility to failure. These observations provide important data to suggest that developmental exposure to air pollution may strongly influence adult susceptibility to cardiovascular disease.	[Weldy, Chad S.; Liu, Yonggang; Chin, Michael T.] Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Weldy, Chad S.; Chin, Michael T.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Liggitt, H. Denny] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chin, MT (corresponding author), Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA.	mtchin@u.washington.edu		Weldy, Chad/0000-0003-4652-6422	NIEHS DISCOVER Center [P50 ES015915]; Experimental Pathology of Cardiovascular Disease Training Grant [T32HL007312]; NIEHS Center for Ecogenetics and Environmental Health [P30ES007033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, P50ES015915] Funding Source: NIH RePORTER	NIEHS DISCOVER Center; Experimental Pathology of Cardiovascular Disease Training Grant; NIEHS Center for Ecogenetics and Environmental Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	YL and MTC were supported by NIEHS DISCOVER Center grant P50 ES015915 and CSW was supported by the Experimental Pathology of Cardiovascular Disease Training Grant (T32HL007312). Additional support was provided by the NIEHS Center for Ecogenetics and Environmental Health though a pilot project award funded by grant P30ES007033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160; Auten RL, 2012, AM J RESP CELL MOL, V46, P454, DOI 10.1165/rcmb.2011-0256OC; Bae S, 2005, J PHYSIOL-LONDON, V565, P149, DOI 10.1113/jphysiol.2005.082701; Bae S, 2005, BRIT J PHARMACOL, V144, P900, DOI 10.1038/sj.bjp.0706129; Bagley HN, 2013, J OBES, V2013, DOI 10.1155/2013/312153; Bai N, 2011, ATHEROSCLEROSIS, V216, P299, DOI 10.1016/j.atherosclerosis.2011.02.019; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; BUSSEY ME, 1985, PEDIATR RES, V19, P363, DOI 10.1203/00006450-198519040-00010; Campen MJ, 2010, TOXICOL APPL PHARM, V242, P310, DOI 10.1016/j.taap.2009.10.021; Channell MM, 2012, TOXICOL SCI, V127, P179, DOI 10.1093/toxsci/kfs084; Cherng TW, 2011, ENVIRON HEALTH PERSP, V119, P98, DOI 10.1289/ehp.1002286; Cherng TW, 2009, AM J PHYSIOL-REG I, V297, pR640, DOI 10.1152/ajpregu.90899.2008; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575; Dorr J, 2011, ADV EXP MED BIOL, V704, P909, DOI 10.1007/978-94-007-0265-3_47; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V160, P385, DOI 10.1016/0002-9378(89)90453-5; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V161, P1004, DOI 10.1016/0002-9378(89)90772-2; Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790; Fariss MW, 2013, TOXICOL SCI, V132, P253, DOI 10.1093/toxsci/kft001; Feldt K, 2007, J HUM HYPERTENS, V21, P401, DOI 10.1038/sj.jhh.1002176; Godfrey K M, 2001, Public Health Nutr, V4, P611; Gould T, 2008, INHAL TOXICOL, V20, P49, DOI [10.1080/08958370701758478, 10.1080/08958370701758478 ]; Hazari MS, 2011, ENVIRON HEALTH PERSP, V119, P951, DOI 10.1289/ehp.1003200; Janssen BG, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-22; Janssen BG, 2012, ENVIRON HEALTH PERSP, V120, P1346, DOI 10.1289/ehp.1104458; Kampfrath T, 2011, CIRC RES, P1; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Knuckles TL, 2008, TOXICOL APPL PHARM, V230, P346, DOI 10.1016/j.taap.2008.03.010; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Lane RH, 2001, PEDIATR RES, V50, P83, DOI 10.1203/00006450-200107000-00016; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu YG, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-49; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; MARTYN CN, 1995, BRIT HEART J, V73, P116; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; OGATA ES, 1986, METABOLISM, V35, P970, DOI 10.1016/0026-0495(86)90064-8; OGATA ES, 1985, PEDIATR RES, V19, P32, DOI 10.1203/00006450-198501000-00010; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Quan CL, 2010, INHAL TOXICOL, V22, P738, DOI 10.3109/08958371003728057; Shaw CA, 2011, AM J RESP CELL MOL, V44, P840, DOI 10.1165/rcmb.2010-0011OC; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967; Torres SM, 2010, CARDIOVASC TOXICOL, V10, P87, DOI 10.1007/s12012-010-9065-z; Torres SM, 2010, CARDIOVASC TOXICOL, V10, P37, DOI 10.1007/s12012-010-9061-3; Tsirka AE, 2001, J ENDOCRINOL, V169, P373, DOI 10.1677/joe.0.1690373; VIJAYAKUMAR M, 1995, BRIT HEART J, V73, P363; Wagner JG, 2013, ENVIRON HEALTH PERSP, V122, P27; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; Ward JM, 2012, VET PATHOL, V49, P71, DOI 10.1177/0300985811429811; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; Weldy CS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-59; Weldy CS, 2013, INHAL TOXICOL, V25, P444, DOI 10.3109/08958378.2013.801004; Weldy CS, 2012, FREE RADICAL BIO MED, V53, P1264, DOI 10.1016/j.freeradbiomed.2012.07.006; Weldy CS, 2011, TOXICOL IN VITRO, V25, P2064, DOI 10.1016/j.tiv.2011.08.008; Wendler CC, 2009, FASEB J, V23, P1272, DOI 10.1096/fj.08-124941; Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580; Xiao DL, 2009, HYPERTENSION, V54, P1123, DOI 10.1161/HYPERTENSIONAHA.109.138024; Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552; Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008; Yu M, 2009, OMICS, V13, P501, DOI 10.1089/omi.2009.0086	67	67	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88582	10.1371/journal.pone.0088582	http://dx.doi.org/10.1371/journal.pone.0088582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533117	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600075
J	Kim, JI; Lee, I; Park, S; Lee, S; Hwang, MW; Bae, JY; Heo, J; Kim, D; Jang, SI; Kim, K; Park, MS				Kim, Jin Il; Lee, Ilseob; Park, Sehee; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Donghwan; Jang, Seok-Il; Kim, Kabsu; Park, Man-Seong			Phylogenetic Analysis of a Swine Influenza A(H3N2) Virus Isolated in Korea in 2012	PLOS ONE			English	Article							A VIRUSES; GENETIC-CHARACTERIZATION; HUMAN INFECTIONS; VARIANT VIRUS; UNITED-STATES; H1N1; EVOLUTION; EMERGENCE; ORIGIN; PIGS	Influenza A virus (IAV) can infect avian and mammalian species, including humans. The genome nature of IAVs may contribute to viral adaptation in different animal hosts, resulting in gene reassortment and the reproduction of variants with optimal fitness. As seen again in the 2009 swine-origin influenza A H1N1 pandemic, pigs are known to be susceptible to swine, avian, and human IAVs and can serve as a 'mixing vessel' for the generation of novel IAV variants. To this end, the emergence of swine influenza viruses must be kept under close surveillance. Herein, we report the isolation and phylogenetic study of a swine IAV, A/swine/Korea/PL01/2012 (swPL01, H3N2 subtype). After screening nasopharyngeal samples from pigs in the Gyeongsangnam-do region of Korea from December 2011 to May 2012, we isolated the swPL01 virus and sequenced its all of 8 genome segments (polymerase basic 2, PB2; polymerase basic 1, PB1; polymerase acidic, PA; hemagglutinin, HA; nucleocapsid protein, NP; neuraminidase, NA; matrix protein, M; and nonstructural protein, NS). The phylogenetic study, analyzed with reference strains registered in the National Center for Biotechnology Information (NCBI) database, indicated that the swPL01 virus was similar to the North American triple-reassortant swine strains and that the HA gene of the swPL01 virus was categorized into swine H3 cluster IV. The swPL01 virus had the M gene of the triple-reassortant swine H3N2 viruses, whereas that of other contemporary strains in Korea was transferred from the 2009 pandemic H1N1 virus. These data suggest the possibility that various swine H3N2 viruses may co-circulate in Korea, which underlines the importance of a sustained surveillance system against swine IAVs.	[Kim, Jin Il; Lee, Ilseob; Park, Sehee; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Donghwan; Jang, Seok-Il; Park, Man-Seong] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, Gangwon Do, South Korea; [Kim, Jin Il; Lee, Ilseob; Park, Sehee; Lee, Sangmoo; Hwang, Min-Woong; Bae, Joon-Yong; Heo, Jun; Kim, Donghwan; Jang, Seok-Il; Park, Man-Seong] Hallym Univ, Coll Med, Ctr Med Sci Res, Chunchon, Gangwon Do, South Korea; [Kim, Kabsu] Cheju Halla Univ, Sch Equine Sci, Cheju, Jeju Do, South Korea	Hallym University; Hallym University	Park, MS (corresponding author), Hallym Univ, Coll Med, Dept Microbiol, Chunchon, Gangwon Do, South Korea.	manseong.park@gmail.com	Park, Man-Seong/AAF-1207-2020; Kim, Young-jin/GSD-3168-2022	Kim, Jin Il/0000-0001-8833-2138	Korea Healthcare Technology R&D Project of the Ministry of Health and Welfare [A103001, A084411]; Hallym University Specialization Fund [HRF-S-41]	Korea Healthcare Technology R&D Project of the Ministry of Health and Welfare; Hallym University Specialization Fund	This study was supported by grants from the Korea Healthcare Technology R&D Project of the Ministry of Health and Welfare (Grant No. A103001, A084411) and the Hallym University Specialization Fund (HRF-S-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggerstaff M, 2013, CLIN INFECT DIS, V57, pS12, DOI 10.1093/cid/cit273; Brockwell-Staats C, 2009, INFLUENZA OTHER RESP, V3, P207, DOI 10.1111/j.1750-2659.2009.00096.x; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V60, P1741; Choi YK, 2013, CURR TOP MICROBIOL, V370, P147, DOI 10.1007/82_2011_195; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epperson S, 2013, CLIN INFECT DIS, V57, pS4, DOI 10.1093/cid/cit272; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng ZX, 2013, J VIROL, V87, P7655, DOI 10.1128/JVI.00804-13; 이일섭, 2013, Journal of Bacteriology and Virology, V43, P9, DOI 10.4167/jbv.2013.43.1.9; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Kim JI, 2013, J VIROL, V87, P7539, DOI 10.1128/JVI.00373-13; Kim JI, 2012, BMB REP, V45, P653, DOI 10.5483/BMBRep.2012.45.11.137; Kim SH, 2013, ARCH VIROL; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Lee JH, 2009, J VIROL, V83, P4205, DOI [10.1128/JVI.02403-08, 10.1128/JVI.02403-09]; Loving CL, 2013, J VIROL; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Nei M., 2000, MOL EVOLUTION PHYLOG; Nelson MI, 2012, J VIROL, V86, P8872, DOI 10.1128/JVI.00259-12; Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077; Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; Pappaioanou M, 2010, ILAR J, V51, P268, DOI 10.1093/ilar.51.3.268; Pascua PNQ, 2012, P NATL ACAD SCI USA, V109, P15900, DOI 10.1073/pnas.1205576109; Pascua PNQ, 2008, VIRUS RES, V138, P43, DOI 10.1016/j.virusres.2008.08.005; Pascua PN, 2013, INFLUENZA OTHER RESP; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Richt JA, 2003, J CLIN MICROBIOL, V41, P3198, DOI 10.1128/JCM.41.7.3198-3205.2003; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Takemae N, 2013, ARCH VIROL, V158, P859, DOI 10.1007/s00705-013-1616-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trebbien R, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-290; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Vincent A., 2013, ZOONOSES PUBLIC HLTH; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; Webster RG, 2004, REV SCI TECH OIE, V23, P453, DOI 10.20506/rst.23.2.1493; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	46	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88782	10.1371/journal.pone.0088782	http://dx.doi.org/10.1371/journal.pone.0088782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523938	gold, Green Submitted, Green Published			2022-12-27	WOS:000331258100087
J	Mahdi, A; Meshkat, N; Sullivant, S				Mahdi, Adam; Meshkat, Nicolette; Sullivant, Seth			Structural Identifiability of Viscoelastic Mechanical Systems	PLOS ONE			English	Article							MODELS; REPRESENTATION; CHECK	We solve the local and global structural identifiability problems for viscoelastic mechanical models represented by networks of springs and dashpots. We propose a very simple characterization of both local and global structural identifiability based on identifiability tables, with the purpose of providing a guideline for constructing arbitrarily complex, identifiable spring-dashpot networks. We illustrate how to use our results in a number of examples and point to some applications in cardiovascular modeling.	[Mahdi, Adam; Meshkat, Nicolette; Sullivant, Seth] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Mahdi, A (corresponding author), N Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA.	amahdi@ncsu.edu	Sullivant, Seth/AAL-7095-2020	Sullivant, Seth/0000-0002-5883-8768	VPR project under NIH-NIGMS [1P50GM094503- 01A0]; David and Lucille Packard Foundation; US National Science Foundation (DMS) [0954865]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM094503] Funding Source: NIH RePORTER	VPR project under NIH-NIGMS; David and Lucille Packard Foundation(The David & Lucile Packard Foundation); US National Science Foundation (DMS)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Adam Mahdi was partially supported by the VPR project under NIH-NIGMS grant # 1P50GM094503- 01A0 sub-award to NCSU. Nicolette Meshkat was partially supported by the David and Lucille Packard Foundation. Seth Sullivant was partially supported by the David and Lucille Packard Foundation and the US National Science Foundation (DMS 0954865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley EJ, 2013, MED PHYS, V40, DOI 10.1118/1.4788643; AKYILDIZ F, 1990, RHEOL ACTA, V29, P482, DOI 10.1007/BF01376800; Alfrey KD, 2000, THESIS RICE U HOUSTO; Anand L, 2006, INT J PLASTICITY, V22, P1123, DOI 10.1016/j.ijplas.2005.07.006; BELLMAN R, 1970, Mathematical Biosciences, V7, P329, DOI 10.1016/0025-5564(70)90132-X; Bland D, 1965, THEORY LINEAR VISCOE; Bugenhagen Scott M, 2010, Physiol Genomics, V42, P23, DOI 10.1152/physiolgenomics.00027.2010; Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755; Christensen R.M., 1971, THEORY VISCOELASTICI; Cox D. A., 2005, GRADUATE TEXTS MATH, V185, DOI 10.1007/b138611; Denis-Vidal L, 2001, MATH COMPUT SIMULAT, V57, P35, DOI 10.1016/S0378-4754(01)00274-9; Denis-Vidal L, 2000, IEEE T AUTOMAT CONTR, V45, P768, DOI 10.1109/9.847119; Dietrich L, 1998, ACTA MECH, V126, P153, DOI 10.1007/BF01172805; Ekpenyong AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045237; Flugge W, 1975, VISCOELASTICITY; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gandhi F, 1996, SMART MATER STRUCT, V5, P517, DOI 10.1088/0964-1726/5/5/002; HASAN Z, 1983, J NEUROPHYSIOL, V49, P989, DOI 10.1152/jn.1983.49.4.989; HOUK JC, 1966, J THEOR BIOL, V12, P196, DOI 10.1016/0022-5193(66)90113-5; Kalita P, 2008, ARCH COMPUT METHOD E, V15, P1, DOI 10.1007/s11831-007-9015-5; LEAROYD BM, 1966, CIRC RES, V18, P278, DOI 10.1161/01.RES.18.3.278; Little MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008915; Mahdi A, 2012, P 1 INT WORKSH INN S, P75; Mahdi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003384; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Ottesen JT, 2011, SYST BIO, V2, P97, DOI 10.1007/978-1-4419-6956-9_6; ROSCOE R, 1950, BRIT J APPL PHYS, V1, P171, DOI 10.1088/0508-3443/1/7/302; Terzopoulos D., 1988, Computer Graphics, V22, P269, DOI 10.1145/378456.378522	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e86411	10.1371/journal.pone.0086411	http://dx.doi.org/10.1371/journal.pone.0086411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523860	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100009
J	Pandey, AK; Lu, L; Wang, XS; Homayouni, R; Williams, RW				Pandey, Ashutosh K.; Lu, Lu; Wang, Xusheng; Homayouni, Ramin; Williams, Robert W.			Functionally Enigmatic Genes: A Case Study of the Brain Ignorome	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CANDIDATE GENE; EXPRESSION; PROTEIN; MOUSE; IDENTIFICATION; TRANSCRIPTOME; PLEIOTROPHIN; DUPLICATION; ANNOTATION	What proportion of genes with intense and selective expression in specific tissues, cells, or systems are still almost completely uncharacterized with respect to biological function? In what ways do these functionally enigmatic genes differ from well-studied genes? To address these two questions, we devised a computational approach that defines so-called ignoromes. As proof of principle, we extracted and analyzed a large subset of genes with intense and selective expression in brain. We find that publications associated with this set are highly skewed-the top 5% of genes absorb 70% of the relevant literature. In contrast, approximately 20% of genes have essentially no neuroscience literature. Analysis of the ignorome over the past decade demonstrates that it is stubbornly persistent, and the rapid expansion of the neuroscience literature has not had the expected effect on numbers of these genes. Surprisingly, ignorome genes do not differ from well-studied genes in terms of connectivity in coexpression networks. Nor do they differ with respect to numbers of orthologs, paralogs, or protein domains. The major distinguishing characteristic between these sets of genes is date of discovery, early discovery being associated with greater research momentum-a genomic bandwagon effect. Finally we ask to what extent massive genomic, imaging, and phenotype data sets can be used to provide high-throughput functional annotation for an entire ignorome. In a majority of cases we have been able to extract and add significant information for these neglected genes. In several cases-ELMOD1, TMEM88B, and DZANK1-we have exploited sequence polymorphisms, large phenome data sets, and reverse genetic methods to evaluate the function of ignorome genes.	[Pandey, Ashutosh K.; Lu, Lu; Wang, Xusheng; Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, UT Ctr Integrat & Translat Genom, Memphis, TN 38163 USA; [Pandey, Ashutosh K.; Lu, Lu; Wang, Xusheng; Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Wang, Xusheng] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Homayouni, Ramin] Univ Memphis, Dept Biol Sci, Bioinformat Program, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Memphis	Pandey, AK (corresponding author), Univ Tennessee, Ctr Hlth Sci, UT Ctr Integrat & Translat Genom, Memphis, TN 38163 USA.	apandey1@uthsc.edu	Homayouni, Ramin/U-2837-2019; Homayouni, Ramin/B-3547-2009; Williams, Robert W./H-8789-2016	Homayouni, Ramin/0000-0003-0186-5076; Homayouni, Ramin/0000-0003-0186-5076; Williams, Robert W./0000-0001-8924-4447	Integrative Neuroscience Initiative on Alcoholism [U01AA016662, U01AA13499, U24AA13513, U01AA014425]; University of Memphis Bioinformatics Program; Assisi Foundation of Memphis; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA014425, U01AA016662, U01AA013499] Funding Source: NIH RePORTER	Integrative Neuroscience Initiative on Alcoholism; University of Memphis Bioinformatics Program; Assisi Foundation of Memphis; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Integrative Neuroscience Initiative on Alcoholism grants U01AA016662, U01AA13499, U24AA13513, U01AA014425 (RWW), University of Memphis Bioinformatics Program and the Assisi Foundation of Memphis (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RC, 1996, NEUROPSYCHOPHARMACOL, V15, P484, DOI 10.1016/S0893-133X(96)00058-9; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bocciardi R, 2005, HUM MUTAT, V26, P426, DOI 10.1002/humu.20235; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chadwick BP, 2000, MAMM GENOME, V11, P81, DOI 10.1007/s003350010017; Chen NS, 2004, GENOME RES, V14, P2155, DOI 10.1101/gr.2521304; Chesler EJ, 2004, INT REV NEUROBIOL, V60, P59; Ciobanu DC, 2010, GENETICS, V184, P119, DOI 10.1534/genetics.109.107474; Demarest K, 1999, J NEUROSCI, V19, P549; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Floris C, 2008, EUR J HUM GENET, V16, P696, DOI 10.1038/ejhg.2008.7; Geisert EE, 2009, MOL VIS, V15, P1730; Guo J, 2003, CYTOGENET GENOME RES, V103, P58, DOI 10.1159/000076290; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Lehmann W, 2004, BONE, V35, P1247, DOI 10.1016/j.bone.2004.08.017; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012181; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Mulder N.J., 2008, CURR PROTOC BIOINFOR, V2, P2, DOI DOI 10.1002/0471250953.BI0207S21; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Pfeiffer T, 2007, P NATL ACAD SCI USA, V104, P12052, DOI 10.1073/pnas.0701315104; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; Redfern RE, 2010, PROTEIN SCI, V19, P1948, DOI 10.1002/pro.483; Reif A, 2011, NEUROPSYCHOPHARMACOL, V36, P2318, DOI 10.1038/npp.2011.120; Risinger FO, 2000, NEUROTOXICOL TERATOL, V22, P667, DOI 10.1016/S0892-0362(00)00085-4; Roberts AJ, 1995, BEHAV NEUROSCI, V109, P1199, DOI 10.1037/0735-7044.109.6.1199; Schmitt WB, 2005, NAT NEUROSCI, V8, P270, DOI 10.1038/nn1412; Sehgal AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-220; Shimizu A, 2003, BIOCHEM BIOPH RES CO, V309, P143, DOI 10.1016/S0006-291X(03)01555-9; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Su AI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-404; Tang YT, 2004, GENOMICS, V83, P727, DOI 10.1016/j.ygeno.2003.10.006; Tare RS, 2002, BIOCHEM BIOPH RES CO, V298, P324, DOI 10.1016/S0006-291X(02)02456-7; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang SI, 1997, CANCER RES, V57, P4183; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11; Wu CC, 2004, BIOINFORMATICS, V20, P3691, DOI 10.1093/bioinformatics/bth428; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamada K, 2008, BIOCHEM BIOPH RES CO, V369, P426, DOI 10.1016/j.bbrc.2008.02.041; Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343; Yue Y, 2006, J MED GENET, V43, P143, DOI 10.1136/jmg.2004.029660	57	54	55	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88889	10.1371/journal.pone.0088889	http://dx.doi.org/10.1371/journal.pone.0088889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523945	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100094
J	Tsuang, D; Esterberg, M; Braff, D; Calkins, M; Cadenhead, K; Dobie, D; Freedman, R; Green, MF; Greenwood, T; Gur, R; Gur, R; Horan, W; Lazzeroni, LC; Light, GA; Millard, SP; Olincy, A; Nuechterlein, K; Seidman, L; Siever, L; Silverman, J; Stone, W; Sprock, J; Sugar, C; Swerdlow, N; Tsuang, M; Turetsky, B; Radant, A				Tsuang, Debby; Esterberg, Michelle; Braff, David; Calkins, Monica; Cadenhead, Kristin; Dobie, Dorcas; Freedman, Robert; Green, Michael F.; Greenwood, Tiffany; Gur, Raquel; Gur, Ruben; Horan, William; Lazzeroni, Laura C.; Light, Gregory A.; Millard, Steven P.; Olincy, Ann; Nuechterlein, Keith; Seidman, Larry; Siever, Larry; Silverman, Jeremy; Stone, William; Sprock, Joyce; Sugar, Catherine; Swerdlow, Neal; Tsuang, Ming; Turetsky, Bruce; Radant, Allen			Is There an Association between Advanced Paternal Age and Endophenotype Deficit Levels in Schizophrenia?	PLOS ONE			English	Article							PARENTAL AGE; NEUROCOGNITIVE ENDOPHENOTYPES; ANTISACCADE PERFORMANCE; RISK; CONSORTIUM; GENETICS; DISORDER; AUTISM; MULTISITE; RELATIVES	The children of older fathers have increased risks of developing schizophrenia spectrum disorders, and among those who develop these disorders, those with older fathers present with more severe clinical symptoms. However, the influence of advanced paternal age on other important domains related to schizophrenia, such as quantitative endophenotype deficit levels, remains unknown. This study investigated the associations between paternal age and level of endophenotypic impairment in a well-characterized family-based sample from the Consortium on the Genetics of Schizophrenia (COGS). All families included at least one affected subject and one unaffected sibling. Subjects met criteria for schizophrenia (probands; n = 293) or were unaffected first-degree siblings of those probands (n = 382). Paternal age at the time of subjects' birth was documented. Subjects completed a comprehensive clinical assessment and a battery of tests that measured 16 endophenotypes. After controlling for covariates, potential paternal age-endophenotype associations were analyzed using one model that included probands alone and a second model that included both probands and unaffected siblings. Endophenotype deficits in the Identical Pairs version of the 4-digit Continuous Performance Test and in the Penn Computerized Neurocognitive Battery verbal memory test showed significant associations with paternal age. However, after correcting for multiple comparisons, no endophenotype was significantly associated with paternal age. These findings suggest that factors other than advanced paternal age at birth may account for endophenotypic deficit levels in schizophrenia.	[Tsuang, Debby] VA Puget Sound Hlth Care Syst, VISN Geriatr Res Educ & Clin Ctr 20, Seattle, WA 98108 USA; [Tsuang, Debby; Esterberg, Michelle; Dobie, Dorcas; Radant, Allen] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Braff, David; Light, Gregory A.] VA San Diego Healthcare Syst, VISN Mental Illness Res Educ & Clin Ctr 22, San Diego, CA USA; [Braff, David; Cadenhead, Kristin; Greenwood, Tiffany; Light, Gregory A.; Sprock, Joyce; Swerdlow, Neal; Tsuang, Ming] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Calkins, Monica; Gur, Raquel; Gur, Ruben; Turetsky, Bruce] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Dobie, Dorcas; Millard, Steven P.] VA Puget Sound Hlth Care Syst, VISN Mental Illness Res Educ & Clin Ctr 20, Seattle, WA USA; [Freedman, Robert; Olincy, Ann] Univ Colorado, Hlth Sci Ctr, Dept Psychiat, Denver, CO 80262 USA; [Green, Michael F.; Horan, William; Nuechterlein, Keith; Sugar, Catherine] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Geffen Sch Med, Los Angeles, CA 90024 USA; [Green, Michael F.; Horan, William; Sugar, Catherine] VA Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; [Lazzeroni, Laura C.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Seidman, Larry; Stone, William] Harvard Univ, Beth Israel Deaconess Med Ctr, Massachusetts Mental Hlth Ctr Publ, Psychiat Div,Med Sch,Dept Psychiat, Boston, MA 02215 USA; [Siever, Larry; Silverman, Jeremy] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Siever, Larry; Silverman, Jeremy] James J Peters VA Med Ctr, VISN Mental Illness Res Educ & Clin Ctr 3, New York, NY USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Tsuang, D (corresponding author), VA Puget Sound Hlth Care Syst, VISN Geriatr Res Educ & Clin Ctr 20, Seattle, WA 98108 USA.	dwt1@uw.edu	Swerdlow, Neal/AAU-4912-2020; Tsuang, Debby/L-7234-2016; Greenwood, Tiffany/F-6356-2012; Light, Gregory/AAA-5696-2020; Nuechterlein, Keith H/K-8654-2012; Gur, Ruben/K-1999-2019; Silverman, Jeremy M./AAO-4268-2020; Lazzeroni, Laura/F-2903-2010; Horan, William/V-7495-2019	Tsuang, Debby/0000-0002-4716-1894; Greenwood, Tiffany/0000-0002-6080-6503; Gur, Ruben/0000-0002-9657-1996; Lazzeroni, Laura/0000-0002-1846-6920; Freedman, Robert/0000-0002-2181-2898; Light, Gregory/0000-0003-4730-8646	Office of Research and Development Medical Research Service, Department of Veterans Affairs; NIMH [R01 MH65571, R01 MH042228, R01 MH65588, R01 MH65562, R01 MH65707, R01 MH65554, R01 MH65578, R01 MH086135, R01 MH65558]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065588, R01MH065707, R01MH086135, R01MH042228, R01MH065562, R01MH065558, R01MH065578, R01MH065554, R01MH065571] Funding Source: NIH RePORTER	Office of Research and Development Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This material is based upon work supported (or supported in part) by the Office of Research and Development Medical Research Service, Department of Veterans Affairs. This study was supported by NIMH grants R01 MH65571, R01 MH042228, R01 MH65588, R01 MH65562, R01 MH65707, R01 MH65554, R01 MH65578, R01 MH086135, and R01 MH65558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Balding DJ, 2004, APPL LONGITUDINAL AN; Bates D., 2011, PACKAGE LME4 LINEAR; Blehar MC, 1994, ARCH GEN PSYCHIAT, V51, P63; Braff D, 2007, AM J PSYCHIAT, V164, P705, DOI 10.1176/appi.ajp.164.5.705; Braff DL, 2007, SCHIZOPHRENIA BULL, V33, P21, DOI 10.1093/schbul/sbl049; Brown AS, 2002, AM J PSYCHIAT, V159, P1528, DOI 10.1176/appi.ajp.159.9.1528; Buizer-Voskamp JE, 2011, SCHIZOPHR RES, V129, P128, DOI 10.1016/j.schres.2011.03.021; Byrne M, 2003, ARCH GEN PSYCHIAT, V60, P673, DOI 10.1001/archpsyc.60.7.673; Calkins ME, 2007, SCHIZOPHRENIA BULL, V33, P33, DOI 10.1093/schbul/sbl044; Cantor RM, 2007, MOL PSYCHIATR, V12, P419, DOI 10.1038/sj.mp.4001966; Dalman C, 2002, AM J PSYCHIAT, V159, P1591, DOI 10.1176/appi.ajp.159.9.1591; El-Saadi O, 2004, SCHIZOPHR RES, V67, P227, DOI 10.1016/S0920-9964(03)00100-2; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; Gur RE, 2007, AM J PSYCHIAT, V164, P813, DOI 10.1176/appi.ajp.164.5.813; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; HOLM S, 1979, SCAND J STAT, V6, P65; Horan WP, 2008, SCHIZOPHR RES, V103, P218, DOI 10.1016/j.schres.2008.02.014; Hultman CM, 2010, MOL PSYCHIAT; Jastak S, 1993, WIDE RANGE ACHIEVEME; JAYASEKARA R, 1978, J BIOSOC SCI, V10, P255, DOI 10.1017/S002193200001172X; Lee H, 2011, SCHIZOPHR RES, V128, P143, DOI 10.1016/j.schres.2011.02.006; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Maxwell M., 1992, FAMILY INTERVIEW GEN; Menezes PR, 2010, PSYCHOL MED, V40, P477, DOI 10.1017/S003329170999064X; Naserbakht M, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-15; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radant AD, 2007, SCHIZOPHR RES, V89, P320, DOI 10.1016/j.schres.2006.08.010; Radant AD, 2010, PSYCHOPHYSIOLOGY, V47, P846, DOI 10.1111/j.1469-8986.2010.01004.x; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rosenfield PJ, 2010, SCHIZOPHR RES, V116, P191, DOI 10.1016/j.schres.2009.10.020; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Sipos A, 2004, BMJ-BRIT MED J, V329, P1070, DOI 10.1136/bmj.38243.672396.55; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Stone WS, 2011, SCHIZOPHR RES, V128, P102, DOI 10.1016/j.schres.2011.01.005; Swerdlow NR, 2007, SCHIZOPHR RES, V92, P237, DOI 10.1016/j.schres.2007.01.012; Vestergaard M, 2005, EUR J EPIDEMIOL, V20, P1003, DOI 10.1007/s10654-005-4250-2; Weiser M, 2008, SCHIZOPHRENIA BULL, V34, P1042, DOI 10.1093/schbul/sbn109; Wohl M, 2007, EUR PSYCHIAT, V22, P22, DOI 10.1016/j.eurpsy.2006.08.007; [No title captured], DOI DOI 10.1093/SCHBUL/SBQ011	46	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88379	10.1371/journal.pone.0088379	http://dx.doi.org/10.1371/journal.pone.0088379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523888	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100037
J	Chen, Y; Ayaru, L; Mathew, S; Morris, E; Pereira, SP; Behboudi, S				Chen, Yuan; Ayaru, Lakshmana; Mathew, Sanju; Morris, Emma; Pereira, Stephen P.; Behboudi, Shahriar			Expansion of Anti-Mesothelin Specific CD4(+) and CD8(+) T Cell Responses in Patients with Pancreatic Carcinoma	PLOS ONE			English	Article							CANCER STATISTICS; ALPHA-FETOPROTEIN; SERUM MESOTHELIN; POOLED ANALYSIS; RISK; LYMPHOCYTES; CYTOKINES; DIAGNOSIS; SURVIVAL; TARGET	We aimed to assess the status of naturally occurring CD4(+) and CD8(+) T cell responses to a tumour associated antigen, Mesothelin, in patients with pancreatic carcinoma and study the effects of elevated IL-10 on Mesothelin-specific T cell responses. For that sake, short term T cell lines were generated from PBMCs of 16 healthy controls, 15 patients with benign pancreatic diseases and 25 patients with pancreatic carcinoma and Mesothelin-specific CD4(+) and CD8(+) T cell responses were analysed using intracellular cytokine assays for IFN-gamma. Plasma levels of IL-10 and Mesothelin were measured using cytometric bead array and ELISA assay, respectively. The blocking assays were performed to assess the effects of IL-10 on Mesothelin-specific T cell responses. Here, we demonstrate that the plasma levels of Mesothelin and IL-10 are significantly increased in patients with pancreatic carcinoma. Additionally, we found that (a) Mesothelin-specific T cell responses are significantly expanded in cancer patients (p = 0.0053), (b) the multifunctional CD4(+) T cell response is directed toward a broad repertoire of epitopes within the Mesothelin protein. (c) Mesothelin-specific CD4+ T cell response is directly inhibited by elevated IL-10 in cancer patients. These data provides evidence for the use of Mesothelin as an immunogen for tumourspecific T cell response.	[Chen, Yuan; Pereira, Stephen P.; Behboudi, Shahriar] UCL, Inst Liver & Digest Hlth, London, England; [Ayaru, Lakshmana; Mathew, Sanju] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Chen, Yuan; Morris, Emma] UCL, Inst Immun & Transplantat, London, England; [Chen, Yuan; Morris, Emma] Royal Free London NHS Fdn Trust, London, England	University of London; University College London; Imperial College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust	Pereira, SP (corresponding author), UCL, Inst Liver & Digest Hlth, London, England.	Stephen.pereira@ucl.ac.uk	Pereira, Stephen P/C-5639-2009	Pereira, Stephen P/0000-0003-0821-1809; behboudi, shahriar/0000-0001-6455-4086; Morris, Emma/0000-0003-4834-1130	National Institutes of Health [P01 CA84203]; UCLH/UCL Comprehensive Biomedical Centre; Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; NATIONAL CANCER INSTITUTE [P01CA084203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLH/UCL Comprehensive Biomedical Centre; Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SPP was a recipient of National Institutes of Health grant P01 CA84203. The work was partly supported by the UCLH/UCL Comprehensive Biomedical Centre which receives a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme. None of these organisations were involved in the statistical analysis, interpretation of the results or the writing of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch DK, 2012, NAT REV GASTRO HEPAT, V9, P445, DOI 10.1038/nrgastro.2012.111; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chua YJ, 2008, ANN ONCOL, V19, P1224, DOI 10.1093/annonc/mdn063; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cress RD, 2006, CANCER CAUSE CONTROL, V17, P403, DOI 10.1007/s10552-005-0539-4; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Dima SO, 2012, PANCREAS, V41, P1001, DOI 10.1097/MPA.0b013e3182546e13; Dobrzanski MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00063; Duell EJ, 2012, ANN ONCOL, V23, P2964, DOI 10.1093/annonc/mds140; Elena JW, 2013, CANCER CAUSE CONTROL, V24, P13, DOI 10.1007/s10552-012-0078-8; Emmerich J, 2012, CANCER RES, V72, P3570, DOI 10.1158/0008-5472.CAN-12-0721; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Hamilton SR, 2000, WHO CLASSIFICATION T; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Herlyn D, 1999, ANN MED, V31, P66, DOI 10.3109/07853899909019264; Huang CY, 2006, ANTICANCER RES, V26, P4721; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao L, 2010, CANCER CAUSE CONTROL, V21, P1305, DOI 10.1007/s10552-010-9558-x; Johnston FM, 2009, CLIN CANCER RES, V15, P6511, DOI 10.1158/1078-0432.CCR-09-0565; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Maisonneuve P, 2010, DIGEST DIS, V28, P645, DOI 10.1159/000320068; Malvezzi M, 2011, ANN ONCOL, V22, P947, DOI 10.1093/annonc/mdq774; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; O'Reilly EM, 2012, CANCER J, V18, P609, DOI 10.1097/PPO.0b013e3182758e27; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Ordonez NG, 2003, MODERN PATHOL, V16, P192, DOI 10.1097/01.MP.0000056981.16578.C3; Sato K, 1998, ONCOL REP, V5, P355; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Thimme R, 2008, HEPATOLOGY, V48, P1821, DOI 10.1002/hep.22535; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Vulfovich M, 2008, EXPERT REV ANTICANC, V8, P993, DOI 10.1586/14737140.8.6.993; Yokokawa J, 2005, CLIN CANCER RES, V11, P6342, DOI 10.1158/1078-0432.CCR-05-0596; Zhang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068303	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88133	10.1371/journal.pone.0088133	http://dx.doi.org/10.1371/journal.pone.0088133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520352	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600043
J	Hainfeld, JF; O'Connor, MJ; Lin, P; Qian, LP; Slatkin, DN; Smilowitz, HM				Hainfeld, James F.; O'Connor, Michael J.; Lin, Ping; Qian, Luping; Slatkin, Daniel N.; Smilowitz, Henry M.			Infrared-Transparent Gold Nanoparticles Converted by Tumors to Infrared Absorbers Cure Tumors in Mice by Photothermal Therapy	PLOS ONE			English	Article							CANCER-CELLS; OPTICAL-PROPERTIES; HYPERTHERMIA; DELIVERY; IMMUNOCYTOCHEMISTRY; NANOSHELLS; PARTICLES; EFFICACY; SURGERY; AGENTS	Gold nanoparticles (AuNPs) absorb light and can be used to heat and ablate tumors. The "tissue window'' at,800 nm (near infrared, NIR) is optimal for best tissue penetration of light. Previously, large, 50-150 nm, gold nanoshells and nanorods that absorb well in the NIR have been used. Small AuNPs that may penetrate tumors better unfortunately barely absorb at 800 nm. We show that small AuNPs conjugated to anti-tumor antibodies are taken up by tumor cells that catalytically aggregate them (by enzyme degradation of antibodies and pH effects), shifting their absorption into the NIR region, thus amplifying their photonic absorption. The AuNPs are NIR transparent until they accumulate in tumor cells, thus reducing background heating in blood and non-targeted cells, increasing specificity, in contrast to constructs that are always NIR-absorptive. Treatment of human squamous cell carcinoma A431 which overexpresses epidermal growth factor receptor (EGFr) in subcutaneous murine xenografts with anti-EGFr antibodies conjugated to 15 nm AuNPs and NIR resulted in complete tumor ablation in most cases with virtually no normal tissue damage. The use of targeted small AuNPs therefore provides a potent new method of selective NIR tumor therapy.	[Hainfeld, James F.; O'Connor, Michael J.; Lin, Ping; Qian, Luping; Slatkin, Daniel N.] Nanoprobes Inc, Yaphank, NY USA; [Smilowitz, Henry M.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA	University of Connecticut	Hainfeld, JF (corresponding author), Nanoprobes Inc, Yaphank, NY USA.	hainfeld@nanoprobes.com			NIH [R44CA130225]; NATIONAL CANCER INSTITUTE [R44CA130225] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Studies were funded by grants from NIH (R44CA130225) and the Dr. med. h.c. Erwin Braun Stiftung Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan VP, 2011, ANGEW CHEM INT EDIT, V50, P11417, DOI 10.1002/anie.201104449; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; CONNOR WG, 1977, RADIOLOGY, V123, P497, DOI 10.1148/123.2.497; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; FUCHS S, 2004, GER MED SCI, V2; Hainfeld JF, 2008, US Patent Application, Patent No. 20080279946; Hartel M, 2006, BRIT J SURG, V93, P952, DOI 10.1002/bjs.5429; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; HOFFMANN G, 1994, ADV EXP MED BIOL, V345, P181; Hong R, 2006, J AM CHEM SOC, V128, P1078, DOI 10.1021/ja056726i; Huang XH, 2006, PHOTOCHEM PHOTOBIOL, V82, P412, DOI 10.1562/2005-12-14-RA-754; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Kampinga HH, 2006, INT J HYPERTHER, V22, P191, DOI 10.1080/02656730500532028; Kawai N, 2005, PROSTATE, V64, P373, DOI 10.1002/pros.20253; Khlebtsov B, 2006, NANOTECHNOLOGY, V17, P5167, DOI 10.1088/0957-4484/17/20/022; Kong G, 2000, CANCER RES, V60, P4440; Ku G, 2005, OPT LETT, V30, P507, DOI 10.1364/OL.30.000507; Lee H, 2011, INT J HYPERTHER, V27, P698, DOI 10.3109/02656736.2011.608217; Liu YL, 2007, ANAL CHEM, V79, P2221, DOI 10.1021/ac061578f; Loo C, 2004, TECHNOL CANCER RES T, V3, P33, DOI 10.1177/153303460400300104; Melling AC, 2001, LANCET, V358, P876, DOI 10.1016/S0140-6736(01)06071-8; Mercer JB, 2008, GER MED SCI, V6; Mukherjee Priyabrata, 2007, Journal of Nanobiotechnology, V5, P4, DOI 10.1186/1477-3155-5-4; Nam J, 2009, J AM CHEM SOC, V131, P13639, DOI 10.1021/ja902062j; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Oldenburg SJ, 1999, APPL PHYS LETT, V75, P2897, DOI 10.1063/1.125183; Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Rechberger W, 2003, OPT COMMUN, V220, P137, DOI 10.1016/S0030-4018(03)01357-9; Robinson JM, 2000, J HISTOCHEM CYTOCHEM, V48, P487, DOI 10.1177/002215540004800406; Shen YQ, 2009, NANOMED-NANOTECHNOL, V5, P192, DOI 10.1016/j.nano.2008.09.003; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Souza GR, 2006, P NATL ACAD SCI USA, V103, P1215, DOI 10.1073/pnas.0509739103; Stern JM, 2007, J ENDOUROL, V21, P939, DOI 10.1089/end.2007.0437; Su KH, 2003, NANO LETT, V3, P1087, DOI 10.1021/nl034197f; TAKIZAWA T, 1994, J HISTOCHEM CYTOCHEM, V42, P1615, DOI 10.1177/42.12.7983362; von Maltzahn G, 2009, CANCER RES, V69, P3892, DOI 10.1158/0008-5472.CAN-08-4242; Wolff JA, 2008, MOL THER, V16, P8, DOI 10.1038/sj.mt.6300326; Yanase S, 2009, PHOTOMED LASER SURG, V27, P791, DOI 10.1089/pho.2008.2329	40	47	48	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88414	10.1371/journal.pone.0088414	http://dx.doi.org/10.1371/journal.pone.0088414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520385	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600076
J	Jayaraman, D; Valdes-Lopez, O; Kaspar, CW; Ane, JM				Jayaraman, Dhileepkumar; Valdes-Lopez, Oswaldo; Kaspar, Charles W.; Ane, Jean-Michel			Response of Medicago truncatula Seedlings to Colonization by Salmonella enterica and Escherichia coli O157:H7	PLOS ONE			English	Article							RHIZOGENES-TRANSFORMED ROOTS; ALFALFA SEEDS; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; CHEMICAL TREATMENTS; INSERTIONAL MUTAGENESIS; BACTERIAL-COLONIZATION; PATHOGENIC BACTERIA; GENE-EXPRESSION; TOMATO PLANTS	Disease outbreaks due to the consumption of legume seedlings contaminated with human enteric bacterial pathogens like Escherichia coli O157: H7 and Salmonella enterica are reported every year. Besides contaminations occurring during food processing, pathogens present on the surface or interior of plant tissues are also responsible for such outbreaks. In the present study, surface and internal colonization of Medicago truncatula, a close relative of alfalfa, by Salmonella enterica and Escherichia coli O157: H7 were observed even with inoculum levels as low as two bacteria per plant. Furthermore, expression analyses revealed that approximately 30% of Medicago truncatula genes were commonly regulated in response to both of these enteric pathogens. This study highlights that very low inoculum doses trigger responses from the host plant and that both of these human enteric pathogens may in part use similar mechanisms to colonize legume seedlings.	[Jayaraman, Dhileepkumar; Valdes-Lopez, Oswaldo; Ane, Jean-Michel] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Kaspar, Charles W.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ane, JM (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	jane@wisc.edu	Ané, Jean-Michel/G-5921-2010; Valdés-López, Oswaldo/K-8695-2019; Jayaraman, Dhileepkumar/A-1205-2011	Ané, Jean-Michel/0000-0002-3128-9439; Valdés-López, Oswaldo/0000-0002-4760-048X; Jayaraman, Dhileepkumar/0000-0001-5364-5900	Joint Institute for Food Safety and Applied Nutrition	Joint Institute for Food Safety and Applied Nutrition	This work was supported by a research grant from the Joint Institute for Food Safety and Applied Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badalucco L, 2001, RHIZOSPHERE BIOCH OR; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2002, APPL ENVIRON MICROB, V68, P4758, DOI 10.1128/AEM.68.10.4758-4763.2002; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Batz M.B., 2011, RANKING RISKS TOP 10; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Brelles-Marino G., 2008, NITROGEN FIXATION RE; Cantu D, 2008, TRENDS PLANT SCI, V13, P610, DOI 10.1016/j.tplants.2008.09.002; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Chabaud M, 2003, PLANT CELL REP, V22, P46, DOI 10.1007/s00299-003-0649-y; Chaintreuil C, 2000, APPL ENVIRON MICROB, V66, P5437, DOI 10.1128/AEM.66.12.5437-5447.2000; Constantin GD, 2008, MOL PLANT MICROBE IN, V21, P720, DOI 10.1094/MPMI-21-6-0720; Constantin GD, 2004, PLANT J, V40, P622, DOI 10.1111/j.1365-313X.2004.02233.x; Cook DR, 1999, CURR OPIN PLANT BIOL, V2, P301, DOI 10.1016/S1369-5266(99)80053-3; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Deering AJ, 2012, FOOD RES INT, V45, P567, DOI 10.1016/j.foodres.2011.06.058; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edwards Jode W., 2005, Functional & Integrative Genomics, V5, P32, DOI 10.1007/s10142-004-0123-0; Fett WF, 2005, FOOD MICROBIOL, V22, P253, DOI 10.1016/j.fm.2004.03.004; Franz E, 2007, FOOD MICROBIOL, V24, P106, DOI 10.1016/j.fm.2006.03.002; Gandhi M, 2001, J FOOD PROTECT, V64, P1891, DOI 10.4315/0362-028X-64.12.1891; Gould L. Hannah, 2011, Morbidity and Mortality Weekly Report, V60, P1197; Hao LY, 2012, APPL ENVIRON MICROB, V78, P4561, DOI 10.1128/AEM.07867-11; He ZH, 1999, PLANT MOL BIOL, V39, P1189, DOI 10.1023/A:1006197318246; Hernandez-Reyes C, 2013, FEMS MICROBIOL LETT, V343, P1, DOI 10.1111/1574-6968.12127; Holliday SL, 2001, J FOOD PROTECT, V64, P1489, DOI 10.4315/0362-028X-64.10.1489; Hora R, 2005, J FOOD PROTECT, V68, P2506, DOI 10.4315/0362-028X-68.12.2506; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Kulikova O, 2004, CHROMOSOMA, V113, P276, DOI 10.1007/s00412-004-0315-3; Kulikova O, 2001, PLANT J, V27, P49, DOI 10.1046/j.1365-313x.2001.01057.x; Limpens E, 2004, J EXP BOT, V55, P983, DOI 10.1093/jxb/erh122; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Meng FH, 2013, ENVIRON MICROBIOL, V15, P2418, DOI 10.1111/1462-2920.12113; Messinese E, 2007, MOL PLANT MICROBE IN, V20, P912, DOI 10.1094/MPMI-20-8-0912; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mohle-Boetani JC, 2009, EPIDEMIOL INFECT, V137, P357, DOI 10.1017/S0950268808000411; Neetoo H, 2011, FOOD MICROBIOL, V28, P119, DOI 10.1016/j.fm.2010.09.004; Pollack S., 2001, EXAMPLE EC RES SERVI; Rediers H, 2003, APPL ENVIRON MICROB, V69, P6864, DOI 10.1128/AEM.69.11.6864-6874.2003; Riely BK, 2006, MOL PLANT PATHOL, V7, P197, DOI [10.1111/j.1364-3703.2006.00328.x, 10.1111/J.1364-3703.2006.00328.X]; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Rose RJ, 2008, FUNCT PLANT BIOL, V35, P253, DOI 10.1071/FP07297; Roy D, 2013, PHYTOPATHOLOGY, V103, P326, DOI 10.1094/PHYTO-09-12-0230-FI; Schikora A, 2012, TRENDS PLANT SCI, V17, P245, DOI 10.1016/j.tplants.2012.03.007; Schikora A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024112; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Sharma M, 2009, J FOOD PROTECT, V72, P1513, DOI 10.4315/0362-028X-72.7.1513; Shirron N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018855; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Tadege M, 2005, TRENDS PLANT SCI, V10, P229, DOI 10.1016/j.tplants.2005.03.009; Tadege M, 2008, PLANT J, V54, P335, DOI 10.1111/j.1365-313X.2008.03418.x; Teplitski M, 2012, FOOD RES INT, V45, P576, DOI 10.1016/j.foodres.2011.06.020; Teplitski M, 2011, TRENDS MICROBIOL, V19, P121, DOI 10.1016/j.tim.2010.11.007; Teplitski M, 2009, CURR OPIN BIOTECH, V20, P166, DOI 10.1016/j.copbio.2009.03.002; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thoquet Philippe, 2002, BMC Plant Biology, V2, P1, DOI 10.1186/1471-2229-2-1; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Tyler HL, 2008, ANNU REV PHYTOPATHOL, V46, P53, DOI 10.1146/annurev.phyto.011708.103102; Ukuku DO, 2007, FOOD MICROBIOL, V24, P288, DOI 10.1016/j.fm.2006.04.007; Uppalapati SR, 2009, MOL PLANT MICROBE IN, V22, P7, DOI 10.1094/MPMI-22-1-0007; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.010331; Verica JA, 2003, PLANT PHYSIOL, V133, P1732, DOI 10.1104/pp.103.028530; Wachtel MR, 2002, J FOOD PROTECT, V65, P465, DOI 10.4315/0362-028X-65.3.465; Warriner K, 2003, J APPL MICROBIOL, V95, P719, DOI 10.1046/j.1365-2672.2003.02037.x; Weissinger WR, 2000, J FOOD PROTECT, V63, P1475, DOI 10.4315/0362-028X-63.11.1475; Weissinger WR, 2001, J FOOD PROTECT, V64, P442, DOI 10.4315/0362-028X-64.4.442; Weissinger WR, 2000, INT J FOOD MICROBIOL, V62, P123, DOI 10.1016/S0168-1605(00)00415-3; Yadav RKP, 2005, MICROB ECOL, V50, P185, DOI 10.1007/s00248-004-0171-y; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zheng J, 2013, APPL ENVIRON MICROB, V79, P2494, DOI 10.1128/AEM.03704-12; Zimmerli L, 2004, PLANT J, V40, P633, DOI 10.1111/j.1365-313X.2004.02236.x	80	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87970	10.1371/journal.pone.0087970	http://dx.doi.org/10.1371/journal.pone.0087970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551073	Green Published, Green Submitted, gold			2022-12-27	WOS:000331271500026
J	Gerasch, A; Faber, D; Kuntzer, J; Niermann, P; Kohlbacher, O; Lenhof, HP; Kaufmann, M				Gerasch, Andreas; Faber, Daniel; Kuentzer, Jan; Niermann, Peter; Kohlbacher, Oliver; Lenhof, Hans-Peter; Kaufmann, Michael			BiNA: A Visual Analytics Tool for Biological Network Data	PLOS ONE			English	Article							GENE; VISUALIZATION; WEB; CYTOSCAPE; KEGG	Interactive visual analysis of biological high-throughput data in the context of the underlying networks is an essential task in modern biomedicine with applications ranging from metabolic engineering to personalized medicine. The complexity and heterogeneity of data sets require flexible software architectures for data analysis. Concise and easily readable graphical representation of data and interactive navigation of large data sets are essential in this context. We present BiNA - the Biological Network Analyzer - a flexible open-source software for analyzing and visualizing biological networks. Highly configurable visualization styles for regulatory and metabolic network data offer sophisticated drawings and intuitive navigation and exploration techniques using hierarchical graph concepts. The generic projection and analysis framework provides powerful functionalities for visual analyses of high-throughput omics data in the context of networks, in particular for the differential analysis and the analysis of time series data. A direct interface to an underlying data warehouse provides fast access to a wide range of semantically integrated biological network databases. A plugin system allows simple customization and integration of new analysis algorithms or visual representations. BiNA is available under the 3-clause BSD license at http://bina.unipax.info/.	[Gerasch, Andreas; Faber, Daniel; Kaufmann, Michael] Univ Tubingen, Dept Comp Sci, Tubingen, Germany; [Gerasch, Andreas; Niermann, Peter; Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, Quantitat Biol Ctr, Tubingen, Germany; [Lenhof, Hans-Peter] Univ Saarland, Ctr Bioinformat, D-66123 Saarbrucken, Germany; [Kuentzer, Jan] Roche Diagnost GmbH, Penzberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Saarland University; Roche Holding	Gerasch, A (corresponding author), Univ Tubingen, Dept Comp Sci, Tubingen, Germany.	gerasch@informatik.uni-tuebingen.de	Kohlbacher, Oliver/B-7310-2008; Kohlbacher, Oliver/AAF-3297-2021	Kohlbacher, Oliver/0000-0003-1739-4598; Kohlbacher, Oliver/0000-0003-1739-4598	Deutsche Forschungsgemeinschaft [BIZ4: 1-4]; Deutsche Forschungsgemeinschaft ('Scalable Visual Analytics') [SPP 1335]; Landesforschungsschwerpunktprogramm des Landes Baden-Wurttemberg; Klaus Tschira Foundation; German Cancer Aid [107342]; BMBF [01GI1104A]; EU [236215]; PRIME-XS [262067]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft ('Scalable Visual Analytics')(German Research Foundation (DFG)); Landesforschungsschwerpunktprogramm des Landes Baden-Wurttemberg; Klaus Tschira Foundation; German Cancer Aid(Deutsche Krebshilfe); BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); PRIME-XS	The work is supported in parts by: Deutsche Forschungsgemeinschaft (BIZ4: 1-4) http://www.dfg.de/, Deutsche Forschungsgemeinschaft (SPP 1335 'Scalable Visual Analytics') http://www. dfg. de/, Landesforschungsschwerpunktprogramm des Landes Baden-Wurttemberg, Klaus Tschira Foundation, German Cancer Aid (grant 107342), BMBF (grant number 01GI1104A), EU FP7 grants MARINA (contract no. 236215), PRIME-XS (contract no. 262067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2009, INT S GRAPH DRAW, P256; [Anonymous], 2010, R LANG ENV STAT COMP; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Backes C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1227; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BioCarta Website, CHART PATHW LIF; BioPAX Website, BIOL PATHW EXCH FORM; Blum T, 2007, GERM C BIOINF GI, P30; Blum T, 2008, J COMPUT BIOL, V15, P565, DOI 10.1089/cmb.2008.0044; Boehringer Mannheim GmbH - Biochemica Website, ROCH BIOCH PATHW CHA; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Docking Frames Website, DOCKINGFRAMES LIB VE; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Griss J, 2013, MZTAB DATA IN PRESS; Hu ZJ, 2009, NUCLEIC ACIDS RES, V37, pW115, DOI 10.1093/nar/gkp406; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; HUPO Proteomics Standards Initiative Website, MOL INT XML FORM VER; Ingenuity Systems Website, ING PATHW AN; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jones AR, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014381; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keller A, 2009, BIOINFORMATICS, V25, P2787, DOI 10.1093/bioinformatics/btp510; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; Klukas C, 2007, BIOINFORMATICS, V23, P344, DOI 10.1093/bioinformatics/btl611; Klukas C, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-112; Kuntzer J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-367; Laczny C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-36; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Michal G, 1998, BIOCH PATHWAYS ATLAS; Nagasaki Masao, 2003, Appl Bioinformatics, V2, P181; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; O'Donoghue SI, 2010, NAT METHODS, V7, pS2, DOI 10.1038/nmeth.f.301; Pavlopoulos GA, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-12; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spellman PT, 2002, GENOME BIOL, V3; Stockel D, 2013, BIOINFORMATICS, V29, P1702, DOI 10.1093/bioinformatics/btt204; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; The OSGi Alliance Website, OSGI SERV PLATF REL; Thomson Reuters Website, METACORE PATHW AN DA; TIBSHIRANI R, 1988, J AM STAT ASSOC, V83, P394, DOI 10.2307/2288855; Walzer M, 2013, MOL CELL PROTEOMICS, V12, P2332, DOI 10.1074/mcp.O113.028506; Wiese R, 2002, 11 S GRAPH DRAW GD 0, P588	48	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87397	10.1371/journal.pone.0087397	http://dx.doi.org/10.1371/journal.pone.0087397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551056	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000013
J	Ward, HL; Ransome, RD; Jones, G; Rossiter, SJ				Ward, Helen L.; Ransome, Roger D.; Jones, Gareth; Rossiter, Stephen J.			Determinants and Patterns of Reproductive Success in the Greater Horseshoe Bat during a Population Recovery	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; MICROSATELLITE LOCI; RHINOLOPHUS-FERRUMEQUINUM; MATING SUCCESS; PATERNITY SKEW; BODY-SIZE; EARED BAT; SELECTION; PARENTAGE; CHIROPTERA	An individual's reproductive success will depend on traits that increase access to mates, as well as the number of mates available. In most well-studied mammals, males are the larger sex, and body size often increases success in intra-sexual contests and thus paternity. In comparison, the determinants of male success in species with reversed sexual size dimorphism (RSD) are less well understood. Greater horseshoe bats (Rhinolophus ferrumequinum) exhibit RSD and females appear to exert mate choice when they visit and copulate with males in their underground territories. Here we assessed putative determinants of reproductive success in a colony of greater horseshoe bats during a 19-year period of rapid population growth. We genotyped 1080 bats with up to 40 microsatellite loci and assigned maternity to 99.5% of pups, and paternity to 76.8% of pups. We found that in spite of RSD, paternity success correlated positively with male size, and, consistent with our previous findings, also with age. Female reproductive success, which has not previously been studied in this population, was also age-related and correlated positively with individual heterozygosity, but not with body size. Remarkable male reproductive skew was detected that initially increased steadily with population size, possibly coinciding with the saturation of suitable territories, but then levelled off suggesting an upper limit to a male's number of partners. Our results illustrate that RSD can occur alongside intense male sexual competition, that male breeding success is density-dependent, and that male and female greater horseshoe bats are subject to different selective pressures.	[Ward, Helen L.; Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Ransome, Roger D.; Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of London; Queen Mary University London; University of Bristol	Rossiter, SJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	s.j.rossiter@qmul.ac.uk		Rossiter, Stephen/0000-0002-3881-4515	NERC [NE/H525089/1]; Natural Environment Research Council [NBAF010001] Funding Source: researchfish; NERC [NBAF010001] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a studentship awarded by the Natural Environment Research Council (UK). The NERC Grant number is NE/H525089/1 (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; [Anonymous], 1994, SEXUAL SELECTION; Bates D, 2012, LME4 LINEAR MIXED EF; Bisazza A, 1997, J FISH BIOL, V50, P397, DOI 10.1006/jfbi.1996.0303; Burland TM, 1999, P ROY SOC B-BIOL SCI, V266, P975, DOI 10.1098/rspb.1999.0732; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Clutton-Brock T.H., 1988, P325; Clutton-Brock T.H., 2004, SOAY SHEEP DYNAMICS; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1977, NATURE, V269, P797, DOI 10.1038/269797a0; Coulon A, 2010, MOL ECOL RESOUR, V10, P167, DOI 10.1111/j.1755-0998.2009.02731.x; Dawson DA, 2004, MOL ECOL NOTES, V4, P96, DOI 10.1046/j.1471-8286.2003.00580.x; Dechmann DKN, 2005, BEHAV ECOL SOCIOBIOL, V58, P316, DOI 10.1007/s00265-005-0913-y; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; Gagliardi C, 2007, REPRODUCTION, V133, P819, DOI 10.1530/REP-06-0323; Goodall J., 1986, CHIMPANZEES GOMBE PA; HAKKARAINEN H, 1991, OIKOS, V61, P337, DOI 10.2307/3545241; Hernandez MIM, 1998, ANIM BEHAV, V56, P533, DOI 10.1006/anbe.1998.0840; Hodge SJ, 2008, J ANIM ECOL, V77, P92, DOI 10.1111/j.1365-2656.2007.01318.x; Hosken DJ, 1998, J ZOOL, V245, P93, DOI 10.1017/S0952836998005111; Hua PY, 2009, CONSERV GENET, V10, P597, DOI 10.1007/s10592-008-9586-1; Isaac JL, 2003, BEHAV ECOL, V14, P818, DOI 10.1093/beheco/arg076; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kervinen M, 2012, BEHAV ECOL, V23, P1209, DOI 10.1093/beheco/ars104; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kruuk LEB, 2008, P ROY SOC B-BIOL SCI, V275, P593, DOI 10.1098/rspb.2007.1689; Lindenfors P, 2002, BEHAV ECOL SOCIOBIOL, V52, P188, DOI 10.1007/s00265-002-0507-x; Liu WC, 2009, MOL ECOL RESOUR, V9, P183, DOI 10.1111/j.1755-0998.2008.02434.x; Mao XG, 2009, CONSERV GENET, V10, P709, DOI 10.1007/s10592-008-9625-y; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; MCLACHLAN AJ, 1987, OIKOS, V48, P11, DOI 10.2307/3565681; Monnet JM, 2002, P ROY SOC B-BIOL SCI, V269, P2301, DOI 10.1098/rspb.2002.2170; Muniz L, 2010, AM J PRIMATOL, V72, P1118, DOI 10.1002/ajp.20876; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Nonacs P., 2003, SKEW CALCULATOR 2003; Nussey DH, 2009, AM NAT, V174, P342, DOI 10.1086/603615; Olano-Marin J, 2011, EVOLUTION, V65, P3175, DOI 10.1111/j.1558-5646.2011.01369.x; PART T, 1989, J ANIM ECOL, V58, P305, DOI 10.2307/5002; R Core Team, 2012, R LANG ENV STAT COMP; Raihani G, 2006, ANIM BEHAV, V71, P833, DOI 10.1016/j.anbehav.2005.06.013; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; Ransome R., 1990, NATURAL HIST HIBERNA; Ransome R.D., 1991, P88; RANSOME RD, 1968, J ZOOL, V154, P77; RANSOME RD, 1989, BIOL J LINN SOC, V38, P71, DOI 10.1111/j.1095-8312.1989.tb01564.x; Ransome RD, 1995, PHILOS T ROY SOC B, V350, P153, DOI 10.1098/rstb.1995.0149; RANSOME RD, 1994, ZOOL J LINN SOC-LOND, V112, P337, DOI 10.1006/zjls.1994.1046; Rawlins RG., 1986, CAYO SANTIAGO MACAQU; Rossiter SJ, 2000, P ROY SOC B-BIOL SCI, V267, P545, DOI 10.1098/rspb.2000.1035; Rossiter SJ, 1999, MOL ECOL, V8, P1959, DOI 10.1046/j.1365-294x.1999.00778-2.x; Rossiter SJ, 2001, P ROY SOC B-BIOL SCI, V268, P1055, DOI 10.1098/rspb.2001.1612; Rossiter SJ, 2006, MOL ECOL, V15, P3035, DOI 10.1111/j.1365-294X.2006.02987.x; Rughetti M, 2011, J ZOOL, V284, P257, DOI 10.1111/j.1469-7998.2011.00800.x; Say L, 2003, MOL ECOL, V12, P2793, DOI 10.1046/j.1365-294X.2003.01945.x; SCHLUTER D, 1986, EVOLUTION, V40, P221, DOI 10.1111/j.1558-5646.1986.tb00465.x; Schulte-Hostedde AI, 2004, BEHAV ECOL, V15, P351, DOI 10.1093/beheco/arh021; Serrano-Meneses MA, 2008, J EVOLUTION BIOL, V21, P1259, DOI 10.1111/j.1420-9101.2008.01567.x; Shine R, 2000, BEHAV ECOL, V11, P239, DOI 10.1093/beheco/11.3.239; Smith J.N.M., 2006, CONSERVATION BIOL SM; Spong GF, 2008, MOL ECOL, V17, P2287, DOI 10.1111/j.1365-294X.2008.03734.x; Stevens RD, 2013, ACTA CHIROPTEROL, V15, P163, DOI 10.3161/150811013X667966; Strier KB, 2011, P NATL ACAD SCI USA, V108, P18915, DOI 10.1073/pnas.1116737108; Szulkin M, 2008, P R SOC B, V275, P703, DOI 10.1098/rspb.2007.0989; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Voigt CC, 2005, BEHAV ECOL SOCIOBIOL, V57, P457, DOI 10.1007/s00265-004-0874-6; Walling CA, 2010, MOL ECOL, V19, P1914, DOI 10.1111/j.1365-294X.2010.04604.x; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666; Willisch CS, 2012, EVOL ECOL, V26, P187, DOI 10.1007/s10682-011-9486-6	70	10	11	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87199	10.1371/journal.pone.0087199	http://dx.doi.org/10.1371/journal.pone.0087199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551052	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000010
J	Brooke, HL; Corder, K; Griffin, SJ; van Sluijs, EMF				Brooke, Hannah L.; Corder, Kirsten; Griffin, Simon J.; van Sluijs, Esther M. F.			Physical Activity Maintenance in the Transition to Adolescence: A Longitudinal Study of the Roles of Sport and Lifestyle Activities in British Youth	PLOS ONE			English	Article							EPOCH LENGTH; CHILDREN; ACCELEROMETERS; DETERMINANTS; VALIDITY; ISSUES	Background: Promoting physical activity in youth is important for health, but existing physical activity interventions have had limited success. We aimed to inform intervention design by i) describing drop-out, continuation and uptake of specific activities over the transition to adolescence; and ii) examining Variety (number of different activities/week) and Frequency (number of activity session/week) of activity participation and their associations with changes in objectively measured physical activity from childhood to adolescence. Methods: At age 10.2 +/- 0.3 and 14.2 +/- 0.3 years, 319 children in the SPEEDY study (46% boys) wore GT1M Actigraph accelerometers for 7 days and provided self-reported participation (never, once, 2 to 3 times or four or more times, over the last 7 days) in 23 leisure-time activities. Associations of change in moderate-to-vigorous intensity PA (MVPA) (>= 2000 counts/minute) and change in total physical activity (TPA) (average accelerometer counts/minute) with exposure variables Z-score transformed (change in) Variety and Frequency were examined using multilevel linear regression, clustered by school, in simple and adjusted models. Results: The number of children ever reporting a specific activity ranged from 30 ('Hockey') to 279 ('Running or jogging'). Some activities were susceptible to drop-out (e.g. 'Skipping') but others were commonly continued or taken up (e.g. 'Household chores'). Overall, Variety and Frequency declined (mean +/- SD Delta Variety -3.1 +/- 4.4 activities/week; Delta Frequency -7.2 +/- 12.0 session/week). Delta MVPA and Delta TPA were not associated with Variety or Frequency at baseline, nor with Delta Variety or Delta Frequency (p>0.29 in all models). Conclusions: Popularity of specific activities as well as drop-out, continuation and uptake should be considered in future intervention development. Activities that are commonly continued or taken up may be more valuable to encourage in interventions than those with low participation or high drop-out. We did not find evidence to support the idea that Variety and Frequency may be key elements to include in future interventions.	[Brooke, Hannah L.; Corder, Kirsten; Griffin, Simon J.; van Sluijs, Esther M. F.] Univ Cambridge, Sch Clin Med, MRC, UKCRC Ctr Diet & Act Res CEDAR,Epidemiol Unit, Cambridge, England; [Corder, Kirsten; Griffin, Simon J.; van Sluijs, Esther M. F.] Univ Cambridge, Sch Clin Med, MRC, Epidemiol Unit, Cambridge, England	University of Cambridge; University of Cambridge	Corder, K (corresponding author), Univ Cambridge, Sch Clin Med, MRC, UKCRC Ctr Diet & Act Res CEDAR,Epidemiol Unit, Cambridge, England.	klc29@medschl.cam.ac.uk	; Griffin, Simon/K-3106-2013	van Sluijs, Esther/0000-0001-9141-9082; Griffin, Simon/0000-0002-2157-4797; Brooke, Hannah/0000-0002-7085-1551	National Prevention Research Initiative; British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Health and Social Care Research and Development Office for the Northern Ireland; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government; World Cancer Research Fund; Medical Research Council [MC_UU_12015/7, MC_UU_12015/4]; Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research: Centre of Excellence; National Institute for Health Research; Wellcome Trust under UK Clinical Research Collaboration; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12015/7, MR/K023187/1, G0501294, MC_U106179474, MC_UU_12015/4, MC_UP_1001/2] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [G0501294, MC_U106179474, MR/K023187/1, MC_UP_1001/2] Funding Source: researchfish	National Prevention Research Initiative(Diabetes UK); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health and Social Care Research and Development Office for the Northern Ireland; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research: Centre of Excellence; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The SPEEDY study is funded by the National Prevention Research Initiative http://www.npri.org.uk), consisting of the following Funding Partners: British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Health and Social Care Research and Development Office for the Northern Ireland; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government and World Cancer Research Fund. This work was also supported by the Medical Research Council [Unit Programme numbers MC_UU_12015/7 and MC_UU_12015/4] and the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research: Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron DJ, 2002, ARCH PEDIAT ADOL MED, V156, P1075, DOI 10.1001/archpedi.156.11.1075; Belanger M, 2009, AM J PREV MED, V37, P41, DOI 10.1016/j.amepre.2009.04.002; Bradley CB, 2000, MED SCI SPORT EXER, V32, P2071, DOI 10.1097/00005768-200012000-00017; Brockman R, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-15; Brooke HL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-761; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corder K, 2009, AM J CLIN NUTR, V89, P862, DOI 10.3945/ajcn.2008.26739; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; Department of Health PA Health Improvement and Protection, 2011, START ACT STAY ACT R, V59; Dorsey K, 2009, RES Q EXERCISE SPORT, V80, P460, DOI 10.5641/027013609X13088500159200; Dovey SM, 1998, BRIT J SPORT MED, V32, P53, DOI 10.1136/bjsm.32.1.53; Dumith SC, 2012, PEDIATR EXERC SCI, V24, P58, DOI 10.1123/pes.24.1.58; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Eiberg S, 2005, BRIT J SPORT MED, V39, P725, DOI 10.1136/bjsm.2004.015230; Ekelund U, 2004, AM J CLIN NUTR, V80, P584; Ekelund U, 2011, BRIT J SPORT MED, V45, P859, DOI 10.1136/bjsports-2011-090190; Harrison F, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-47; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kjonniksen L, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-69; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Pate Russell R, 2007, J Phys Act Health, V4, P3; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Sallis JF., 1999, PHYS ACTIVITY BEHAV, Vvol. 3; Telford A, 2005, PEDIATR EXERC SCI, V17, P266, DOI 10.1123/pes.17.3.266; Telford A, 2004, PEDIATR EXERC SCI, V16, P64, DOI 10.1123/pes.16.1.64; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Wareham NJ, 1998, INT J OBESITY, V22, pS30	36	26	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89028	10.1371/journal.pone.0089028	http://dx.doi.org/10.1371/journal.pone.0089028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533167	Green Published, gold			2022-12-27	WOS:000331262600129
J	Campbell, JTP; Bray, BD; Hoffman, AM; Kavanagh, SJ; Rudd, AG; Tyrrell, PJ				Campbell, James T. P.; Bray, Benjamin D.; Hoffman, Alex M.; Kavanagh, Sara J.; Rudd, Anthony G.; Tyrrell, Pippa J.		Intercollegiate Stroke Working	The Effect of Out of Hours Presentation with Acute Stroke on Processes of Care and Outcomes: Analysis of Data from the Stroke Improvement National Audit Programme (SINAP)	PLOS ONE			English	Article							WEEKDAY ADMISSION; CASE-FATALITY; WEEKEND; MORTALITY; ASSOCIATION; CENTERS; COHORT; TIME	Background: There is inconsistent evidence that patients with stroke admitted to hospital out of regular working hours (such as weekends) experience worse outcomes. We aimed to identify if inequalities in the quality of care and mortality exist in contemporary stroke care in England. Methods: SINAP is a prospective database of acute stroke patients, documenting details of processes of care over the first 72 hours. We compared quality of care indicators and mortality at 72 hours, 7 days and 30 days, for patients who arrived within normal hours (Monday-Friday 8am to 6pm) and for those who arrived out of hours, using multivariable logistic and Cox proportional hazard models. Quality of care was defined according to time from arrival at hospital to interventions (e.g., brain scan), and whether the patient received therapeutic interventions (such as thrombolysis). Results: 45,726 stroke patients were admitted to 130 hospitals in England between 1 April 2010 and 31 January 2012. Patients admitted out of hours (n = 23779) had more features indicative of worse prognosis (haemorrhagic stroke, reduced consciousness, pre stroke dependency). Out of hours admission was significantly associated with longer delays in receiving a CT scan or being admitted to a stroke unit, and reduced odds of receiving thrombolysis. After adjusting for casemix, there was no consistent evidence of higher mortality for patients admitted out of hours, but patients admitted at the weekends had a higher risk of 30 day mortality (OR 1.14, 95% CI 1.06-1.21) Conclusion: Inequalities in the provision of stroke care for people admitted out of regular hours persist in contemporary stroke in England. The association with mortality is small and largely attributable to higher illness severity in patients admitted out of hours.	[Campbell, James T. P.; Hoffman, Alex M.; Kavanagh, Sara J.] Royal Coll Physicians, London NW1 4LE, England; [Bray, Benjamin D.; Rudd, Anthony G.] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Rudd, Anthony G.] Guys & St Thomas NHS Fdn Trust, Comprehens Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Tyrrell, Pippa J.] Univ Manchester MAHSC, Salford Royal NHS Fdn Trust, Salford, Lancs, England	Royal College of Physicians; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Salford Royal NHS Foundation Trust	Campbell, JTP (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	james.campbell@rcplondon.ac.uk			Intercollegiate Stroke Working Party	Intercollegiate Stroke Working Party	The authors would like to thank the many hundreds of individuals who have contributed to SINAP. The audits would not be possible without their hard work and dedication. We would also like to thank the Intercollegiate Stroke Working Party for their guidance and work to support SINAP.	Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Albright KC, 2012, CEREBROVASC DIS, V34, P424, DOI 10.1159/000345077; Albright KC, 2009, CEREBROVASC DIS, V27, P107, DOI 10.1159/000177916; Aujesky D, 2009, CIRCULATION, V119, P962, DOI 10.1161/CIRCULATIONAHA.108.824292; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Crowley RW, 2009, J NEUROSURG, V111, P60, DOI 10.3171/2008.11.JNS081038; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Marco J, 2010, AM J MED QUAL, V25, P312, DOI 10.1177/1062860610366031; Office for National Statistics, 2016, 2011 CENS REL FEM MA; Ogbu UC, 2011, J NEUROL NEUROSUR PS, V82, P8, DOI 10.1136/jnnp.2009.202176; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Reeves MJ, 2009, STROKE, V40, P569, DOI 10.1161/STROKEAHA.108.519355; Rudd AG, 2007, AGE AGEING, V36, P247, DOI 10.1093/ageing/afm007; Sharp AL, 2013, AM J EMERG MED, V31, P835, DOI 10.1016/j.ajem.2013.01.006; Stroke Unit Trailists' Collaboration, 2007, COCHRANE DB SYST REV; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Wong HJ, 2011, J GEN INTERN MED, V26, P1050, DOI 10.1007/s11606-011-1715-8	20	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87946	10.1371/journal.pone.0087946	http://dx.doi.org/10.1371/journal.pone.0087946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533063	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600021
J	Carlsen, JF; Ewertsen, C; Saftoiu, A; Lonn, L; Nielsen, MB				Carlsen, Jonathan Frederik; Ewertsen, Caroline; Saftoiu, Adrian; Lonn, Lars; Nielsen, Michael Bachmann			Accuracy of Visual Scoring and Semi-Quantification of Ultrasound Strain Elastography - A Phantom Study	PLOS ONE			English	Article							REAL-TIME ELASTOGRAPHY; MALIGNANT LYMPH-NODES; THYROID-NODULES; DIFFERENTIAL-DIAGNOSIS; CLINICAL-APPLICATION; PANCREATIC MASSES; US ELASTOGRAPHY; BREAST-LESIONS; LIVER FIBROSIS; BENIGN	Purpose: The aim of this study was to evaluate the performance of strain elastography in an elasticity phantom and to assess which factors influenced visual scoring, strain histograms and strain ratios. Furthermore this study aimed to evaluate the effect of observer experience on visual scorings. Materials and Methods: Two operators examined 20 targets of various stiffness and size (16.7 to 2.5 mm) in an elasticity phantom at a depth of 3.5 cm with a 5-18 MHz transducer. Two pre-settings were used yielding 80 scans. Eight evaluators, four experienced, four inexperienced, performed visual scorings. Cut-offs for semi-quantitative methods were established for prediction of target stiffness. Data was pooled in two categories allowing calculations of sensitivity and specificity. Statistical tests chi-square test and linear regression as relevant. Results: Strain ratios and strain histograms were superior to visual scorings of both experienced and inexperienced observers (p = 0.025, strain histograms vs. experienced observers, p<0.001, strain histograms vs. inexperienced observers, p = 0.044 strain ratios vs. experienced observers and p = 0.002 strain ratios vs. inexperienced observers). No significant difference in predicting target stiffness between strain ratios and strain histograms (p = 0.83) nor between experienced and inexperienced observers (p = 0.054) was shown when using four categories. When pooling data in two groups (80 kPa/45 kPa vs. 14/8 kPa) the difference between the observers became significant(p<0.001). Target size had a significant influence on strain ratios measurements (p = 0.017) and on visual scorings (p<0.001) but not on the strain histograms(p = 0.358). Observer experience had significant effect on visual scorings(p = 0.003). Conclusion: Strain ratios and strain histograms are superior to visual scoring in assessing target stiffness in a phantom. Target size had a significant impact on strain ratios and visual scoring, but not on strain histograms. Experience influenced visual scorings but the difference between experienced and inexperienced observers was only significant when looking at two classes of target stiffness.	[Carlsen, Jonathan Frederik; Ewertsen, Caroline; Lonn, Lars; Nielsen, Michael Bachmann] Rigshosp Copenhagen Univ Hosp, Dept Radiol, Copenhagen, Denmark; [Saftoiu, Adrian] Univ Med & Pharm, Res Ctr Gastroenterol & Hepatol, Craiova, Romania; [Saftoiu, Adrian] Copenhagen Univ Hosp Herlev, Dept Endoscopy, Gastrointestinal Unit, Herlev, Denmark; [Lonn, Lars] Rigshosp Copenhagen Univ Hosp, Dept Vasc Surg, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Medicine & Pharmacy of Craiova; University of Copenhagen; Rigshospitalet; University of Copenhagen	Carlsen, JF (corresponding author), Rigshosp Copenhagen Univ Hosp, Dept Radiol, Copenhagen, Denmark.	jonathan.carlsen@gmail.com	Saftoiu, Adrian/C-2792-2011; Nielsen, Michael Bachmann/U-2749-2018	Saftoiu, Adrian/0000-0001-7993-8269; Nielsen, Michael Bachmann/0000-0002-9380-1688; Lonn (Lonn), Lars/0000-0003-2089-5211				Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Bhatia KSS, 2010, ULTRASOUND MED BIOL, V36, P1990, DOI 10.1016/j.ultrasmedbio.2010.08.016; Bhatia KSS, 2010, ULTRASOUND MED BIOL, V36, P1644, DOI 10.1016/j.ultrasmedbio.2010.07.010; Carlsen JF, 2013, DIAGNOSTICS, V3, P117, DOI 10.3390/diagnostics3010117; Chang S, 2013, ULTRASCHALL MED, V34, P260, DOI 10.1055/s-0032-1313008; Cho N, 2012, RADIOLOGY, V262, P80, DOI 10.1148/radiol.11110886; Chung SY, 2010, ACTA RADIOL, V51, P9, DOI 10.3109/02841850903273966; Dietrich CF, 2012, ULTRASCHALL MED, V33, P411, DOI 10.1055/s-0032-1325384; Frey H, 2003, RADIOLOGE, V43, P850, DOI 10.1007/s00117-003-0943-2; Fu LN, 2011, CHINESE MED J-PEKING, V124, P2384, DOI 10.3760/cma.j.issn.0366-6999.2011.15.024; Garra BS, 1997, RADIOLOGY, V202, P79, DOI 10.1148/radiology.202.1.8988195; Gong X, 2011, BREAST CANCER RES TR, V130, P11, DOI 10.1007/s10549-011-1745-2; Havre RF, 2012, ULTRASCHALL MED, V33, P559, DOI 10.1055/s-0031-1273247; Havre RF, 2008, ULTRASOUND MED BIOL, V34, P1638, DOI 10.1016/j.ultrasmedbio.2008.03.009; Hu DM, 2013, DIGEST DIS SCI, V58, P1125, DOI 10.1007/s10620-012-2428-5; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Itokawa F, 2011, J GASTROENTEROL, V46, P843, DOI 10.1007/s00535-011-0399-5; KOSSOFF G, 1973, J ACOUST SOC AM, V53, P1730, DOI 10.1121/1.1913526; Kumm TR, 2010, CANCER CONTROL, V17, P156, DOI 10.1177/107327481001700303; Lee JH, 2011, ACAD RADIOL, V18, P74, DOI 10.1016/j.acra.2010.07.014; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Park SH, 2009, AM J ROENTGENOL, V193, pW416, DOI 10.2214/AJR.09.2541; Ragazzoni F, 2012, ULTRASOUND MED BIOL, V38, P1154, DOI 10.1016/j.ultrasmedbio.2012.02.025; Rasband WS, 2012, ASTROPHYS SOURCE COD, V1, P06013; Saftoiu A, 2006, ULTRASCHALL MED, V27, P535, DOI 10.1055/s-2006-927117; Saftoiu A, 2011, ENDOSCOPY, V43, P596, DOI 10.1055/s-0030-1256314; Saftoiu A, 2007, AM J ROENTGENOL, V189, pW232, DOI 10.2214/AJR.07.2571; Saftoiu A, 2007, GASTROINTEST ENDOSC, V66, P291, DOI 10.1016/j.gie.2006.12.039; Thomas A, 2010, ACAD RADIOL, V17, P558, DOI 10.1016/j.acra.2009.12.006; Tozaki M, 2011, JPN J RADIOL, V29, P598, DOI 10.1007/s11604-011-0591-9; Wojcinski S, 2010, ULTRASCHALL MED, V31, P484, DOI 10.1055/s-0029-1245282; Xie LM, 2012, J ULTRAS MED, V31, P1053; Zhang Y, 2012, EUR J RADIOL, V81, P857, DOI 10.1016/j.ejrad.2011.02.037; Zhi H, 2010, ACAD RADIOL, V17, P1227, DOI 10.1016/j.acra.2010.05.004	35	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88699	10.1371/journal.pone.0088699	http://dx.doi.org/10.1371/journal.pone.0088699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533138	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600096
J	Hart, Y; Noy, L; Feniger-Schaal, R; Mayo, AE; Alon, U				Hart, Yuval; Noy, Lior; Feniger-Schaal, Rinat; Mayo, Avraham E.; Alon, Uri			Individuality and Togetherness in Joint Improvised Motion	PLOS ONE			English	Article							INTERPERSONAL COORDINATION; BRAIN; GENERATION; MOVEMENTS; DYNAMICS; BODIES; SIDE; FMRI	Actors, dancers and musicians that improvise together report special moments of togetherness: high performance and synchrony, seemingly without a leader and a follower. Togetherness seems to conflict with individuality-the idiosyncratic character of each person's performance. To understand the relation of individuality and togetherness, we employed the mirror game paradigm in which two players are asked to mirror each other and create interesting synchronized motion, with and without a designated leader. The mirror game enables quantitative characterization of moments of togetherness in which complex motion is generated with high synchrony. We find that each person as a leader does basic strokes of motion with a characteristic signature, in terms of the shape of their velocity profile between two stopping events. In moments of togetherness both players change their signature to a universal stroke shape. This universal velocity profile resembles a half-period of a sine wave, and is therefore symmetric and maximally smooth. Thus, instead of converging to an intermediate motion signature, or having one player dominate, players seem to shift their basic motion signatures to a shape that is altogether different from their individually preferred shapes; the resulting motion may be easier to predict and to agree on. The players then build complex motion by using such smooth elementary strokes.	[Hart, Yuval; Noy, Lior; Mayo, Avraham E.; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Hart, Yuval; Noy, Lior; Feniger-Schaal, Rinat; Mayo, Avraham E.; Alon, Uri] Weizmann Inst Sci, Theatre Lab, IL-76100 Rehovot, Israel; [Feniger-Schaal, Rinat] Univ Haifa, Ctr Study Child Dev, Grad Sch Creat Arts Therapies, IL-31999 Haifa, Israel	Weizmann Institute of Science; Weizmann Institute of Science; University of Haifa	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	Hart, Yuval/HGD-6424-2022; mayo, avi/N-3756-2019	mayo, avi/0000-0002-4479-3423	Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science	Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science	We thank the Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science (http://www.weizmann.ac.il/pages/research-institutes-institute-wide), for support. Uri Alon is the incumbent of the Abisch-Frenkel Professorial Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baess P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00083; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Chaminade T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00179; Csikszentmihalyi M, 1992, Nebr Symp Motiv, V40, P57; D'Agostino RB, 1986, GOODNESS OF FIT TECH; de Rugy A, 2006, BIOL CYBERN, V94, P427, DOI 10.1007/s00422-006-0059-7; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fleishman EA, 1967, LEARN INDIVID DIFFER, P165; Fogel A., 1993, DEV RELATIONSHIPS OR; Hari R, 2013, TRENDS COGN SCI, V17, P105, DOI 10.1016/j.tics.2013.01.003; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; HOGAN N, 1987, TRENDS NEUROSCI, V10, P170, DOI 10.1016/0166-2236(87)90043-9; Hogan N, 2007, EXP BRAIN RES, V181, P13, DOI 10.1007/s00221-007-0899-y; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Kelso S., 1995, DYNAMIC PATTERNS SEL; King AC, 2012, NEUROSCI LETT, V529, P144, DOI 10.1016/j.neulet.2012.08.014; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Sacheli LM, 2013, EXP BRAIN RES, V226, P473, DOI 10.1007/s00221-013-3459-7; Sawyer R.K., 2003, GROUP CREATIVITY MUS; schechner richard, 1973, ENV THEATER; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Schmidt RC, 1989, ADV PSYCHOL, P123, DOI DOI 10.1016/S0166-4115(08)60020-5; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Seham A., 2001, WHOSE IMPROV IS IT A; Spolin V, 1999, IMPROVISATION THEATE; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Turner Victor W., 1995, RITUAL PROCESS STRUC; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Vesper C, 2011, EXP BRAIN RES, V211, P517, DOI 10.1007/s00221-011-2706-z; Vesper C, 2010, NEURAL NETWORKS, V23, P998, DOI 10.1016/j.neunet.2010.06.002; Watanabe T, 2012, J ADV MECH DES SYST, V6, P1307, DOI 10.1299/jamdsm.6.1307; Wikioo, 2021, THINKING JAZZ INFINI; Yun K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00959	44	58	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87213	10.1371/journal.pone.0087213	http://dx.doi.org/10.1371/journal.pone.0087213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7FJ	24533054	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600012
J	Joshi, VS; Reinhardt, JM; Garvin, MK; Abramoff, MD				Joshi, Vinayak S.; Reinhardt, Joseph M.; Garvin, Mona K.; Abramoff, Michael D.			Automated Method for Identification and Artery-Venous Classification of Vessel Trees in Retinal Vessel Networks	PLOS ONE			English	Article							COLOR FUNDUS PHOTOGRAPHS; DIABETIC-RETINOPATHY; SYSTEM; BIFURCATIONS; POPULATION; EXTRACTION; TRACKING; DISEASE	The separation of the retinal vessel network into distinct arterial and venous vessel trees is of high interest. We propose an automated method for identification and separation of retinal vessel trees in a retinal color image by converting a vessel segmentation image into a vessel segment map and identifying the individual vessel trees by graph search. Orientation, width, and intensity of each vessel segment are utilized to find the optimal graph of vessel segments. The separated vessel trees are labeled as primary vessel or branches. We utilize the separated vessel trees for arterial-venous (AV) classification, based on the color properties of the vessels in each tree graph. We applied our approach to a dataset of 50 fundus images from 50 subjects. The proposed method resulted in an accuracy of 91.44% correctly classified vessel pixels as either artery or vein. The accuracy of correctly classified major vessel segments was 96.42%.	[Joshi, Vinayak S.; Reinhardt, Joseph M.; Abramoff, Michael D.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Garvin, Mona K.; Abramoff, Michael D.] Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; [Garvin, Mona K.] Iowa City VA Hlth Care Syst, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA; [Abramoff, Michael D.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Abramoff, Michael D.] Iowa City Vet Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Abramoff, MD (corresponding author), Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.	michael-abramoff@uiowa.edu	Abramoff, Michael D/A-5836-2009	Abramoff, Michael D/0000-0002-3490-0037; Reinhardt, Joseph/0000-0003-3526-3591	National Eye Institute [R01 EY017066]; Research to Prevent Blindness; Department of Veteran Affairs; NATIONAL EYE INSTITUTE [R01EY017066] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (R01 EY017066), Research to Prevent Blindness, and the Department of Veteran Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2005, TELEMED J E-HEALTH, V11, P668, DOI 10.1089/tmj.2005.11.668; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; AKITA K, 1982, PATTERN RECOGN, V15, P431, DOI 10.1016/0031-3203(82)90022-X; Al-Diri B, 2008, IEEE INT C BIOINF BI, P847; Aylward SR, 2005, LECT NOTES COMPUT SC, V3749, P59; Chapman N, 2002, CLIN SCI, V103, P111; Chrstek R, 2002, P IAPR WORKSH MACH V; Faber DJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.028102; Grisan E, 2004, P ANN INT IEEE EMBS, V26, P1620; Grisan E, 2003, P ANN INT IEEE EMBS, V25, P890, DOI 10.1109/IEMBS.2003.1279908; Joshi V, 2011, P SIE MED IMAGING CO, V7963; Joshi V, 2012, P SPIE MED IMAGING, V8315; Joshi VS, 2011, I S BIOMED IMAGING, P1416, DOI 10.1109/ISBI.2011.5872665; Kochner B, 1998, P SOC PHOTO-OPT INS, V3338, P755, DOI 10.1117/12.310955; Kondermann C, 2007, PROC SPIE, V6512, DOI 10.1117/12.708469; Koreen Susan, 2007, Ophthalmology, V114, pe59, DOI 10.1016/j.ophtha.2007.10.006; Lau QP, 2013, IEEE T BIO-MED ENG, V60, P1851, DOI 10.1109/TBME.2013.2243447; Lee S, 2008, SPIE P, P6914; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Niemeijer M, 2011, IEEE T MED IMAGING, V30, P1941, DOI 10.1109/TMI.2011.2159619; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rockett P, 2005, IEEE T PATTERN ANAL, V27; Rothaus K, 2009, IMAGE VISION COMPUT, V27, P864, DOI 10.1016/j.imavis.2008.02.013; Sasongko MB, 2010, DIABETES CARE, V33, P1331, DOI 10.2337/dc10-0055; Sukkaew L, 2008, IEICE T INF SYST, V12; Sun Y, 1990, SPIE P, p[1233, 257]; Tramontan L, 2008, IEEE ENG MED BIO, P3550, DOI 10.1109/IEMBS.2008.4649972; Vazquez SG, 2010, COMPUTING, V90, P197, DOI 10.1007/s00607-010-0114-z; Vickerman M, 2009, ANAT REC, V292; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; ZAMIR M, 1979, J GEN PHYSIOL, V74, P537, DOI 10.1085/jgp.74.4.537; ZHOU LA, 1994, IEEE T MED IMAGING, V13, P619, DOI 10.1109/42.363106	32	48	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88061	10.1371/journal.pone.0088061	http://dx.doi.org/10.1371/journal.pone.0088061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533066	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600024
J	Tang, CB; Wang, Z; Li, X				Tang, Changbing; Wang, Zhen; Li, Xiang			Moderate Intra-Group Bias Maximizes Cooperation on Interdependent Populations	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; NETWORK RECIPROCITY; EVOLUTIONARY GAMES; COMPLEX NETWORKS; INDIVIDUALS; EMERGENCE; DYNAMICS; IMPACT	Evolutionary game theory on spatial structures has received increasing attention during the past decades. However, the majority of these achievements focuses on single and static population structures, which is not fully consistent with the fact that real structures are composed of many interactive groups. These groups are interdependent on each other and present dynamical features, in which individuals mimic the strategy of neighbors and switch their partnerships continually. It is however unclear how the dynamical and interdependent interactions among groups affect the evolution of collective behaviors. In this work, we employ the prisoner's dilemma game to investigate how the dynamics of structure influences cooperation on interdependent populations, where populations are represented by group structures. It is found that the more robust the links between cooperators (or the more fragile the links between cooperators and defectors), the more prevalent of cooperation. Furthermore, theoretical analysis shows that the intra-group bias can favor cooperation, which is only possible when individuals are likely to attach neighbors within the same group. Yet, interestingly, cooperation can be even inhibited for large intra-group bias, allowing the moderate intra-group bias maximizes the cooperation level.	[Tang, Changbing; Li, Xiang] Fudan Univ, Dept Elect Engn, Adapt Networks & Control Lab, Shanghai 200433, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Kowloon Tong, Hong Kong, Peoples R China	Fudan University; Hong Kong Baptist University; Hong Kong Baptist University; Hong Kong Baptist University	Li, X (corresponding author), Fudan Univ, Dept Elect Engn, Adapt Networks & Control Lab, Shanghai 200433, Peoples R China.	lix@fudan.edu.cn	Li, Xiang/C-4127-2009; Li, Xiang/AAB-4134-2020; li, xiang/GWM-6319-2022	Li, Xiang/0000-0002-6482-2535; 	National Key Basic Research and Development Program [2010CB731403]; National Natural Science Foundation [61273223]; Research Fund for the Doctoral Program of Higher Education [20120071110029]; key Project of National Social Science Fund of China [12ZD18]; Academic New Artist Ministry of Education Doctoral Post Graduate of China [JFH1232003]	National Key Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); key Project of National Social Science Fund of China; Academic New Artist Ministry of Education Doctoral Post Graduate of China	Funding: This work was partly supported by the National Key Basic Research and Development Program (No. 2010CB731403), the National Natural Science Foundation (No. 61273223), the Research Fund for the Doctoral Program of Higher Education (No. 20120071110029) and the key Project of National Social Science Fund (No. 12&ZD18) of China. C.B.T. also acknowledges the financial support by the Academic New Artist Ministry of Education Doctoral Post Graduate (No. JFH1232003) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2013, NAT PHYS, V9, P230, DOI 10.1038/NPHYS2556; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Chen XJ, 2012, PHYS REV E, V80; Dugatkin L.A., 1997, COOPERATION ANIMALS; Durrett R., 2005, PROBABILITY THEORY E; Fu F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00460; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gomez-Gardenes J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056113; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Jiang LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02483; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Kim BJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021907; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Parshani R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048701; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pierre B, 2012, PHYS REV E, V86; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Radicchi F, 2013, NAT PHYS; Roca CP, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48005; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026101; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; SEGBROECK SV, 2009, PHYS REV LETT, V102; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Tanabe S, 2012, J THEOR BIOL, V293, P151, DOI 10.1016/j.jtbi.2011.10.020; Tang CB, 2012, J THEOR BIOL, V306, P1, DOI 10.1016/j.jtbi.2012.04.024; Tanimoto J, 2011, SOCIOBIOLOGY, V58, P315; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021126; Taylor C, 2007, EVOLUTION, V61, P2281, DOI 10.1111/j.1558-5646.2007.00196.x; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021905; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a; Vincent T. L., 2005, EVOLUTIONARY GAME TH; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01468; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wu B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046111; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Xia CY, 2011, PHYSICA A, V390, P4602, DOI 10.1016/j.physa.2011.06.064; Yamauchi A, 2010, BIOSYSTEMS, V102, P82, DOI 10.1016/j.biosystems.2010.07.017; Zhang HF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03292; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118	63	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88412	10.1371/journal.pone.0088412	http://dx.doi.org/10.1371/journal.pone.0088412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533084	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600042
J	Wojewoda, M; Kmiecik, K; Ventura-Clapier, R; Fortin, D; Onopiuk, M; Jakubczyk, J; Sitek, B; Fedorowicz, A; Majerczak, J; Kaminski, K; Chlopicki, S; Zoladz, JA				Wojewoda, Marta; Kmiecik, Katarzyna; Ventura-Clapier, Renee; Fortin, Dominique; Onopiuk, Marta; Jakubczyk, Justyna; Sitek, Barbara; Fedorowicz, Andrzej; Majerczak, Joanna; Kaminski, Karol; Chlopicki, Stefan; Zoladz, Jerzy Andrzej			Running Performance at High Running Velocities Is Impaired but V'O-2max and Peripheral Endothelial Function Are Preserved in IL-6(-/-) Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID TRANSPORTERS; SKELETAL-MUSCLE; ENDURANCE EXERCISE; AMPK ACTIVITY; POWER OUTPUT; SINGLE BOUT; INTERLEUKIN-6; IL-6; INCREASES	It has been reported that IL-6 knockout mice (IL-6(-/-)) possess lower endurance capacity than wild type mice (WT), however the underlying mechanism is poorly understood. The aim of the present work was to examine whether reduced endurance running capacity in IL-(6-/-) mice is linked to impaired maximal oxygen uptake (V'O-2max), decreased glucose tolerance, endothelial dysfunction or other mechanisms. Maximal running velocity during incremental running to exhaustion was significantly lower in IL-(6-/-) mice than in WT mice (13.00 +/- 0.97 m.min(-1) vs. 16.89 +/- 1.15 m.min(-1), P<0.02, respectively). Moreover, the time to exhaustion during running at 12 m.min(-1) in IL-6(-/-) mice was significantly shorter (P<0.05) than in WT mice. V'O-2max in IL-6(-/-) (n = 20) amounting to 108.3 +/- 2.8 ml.kg(-1.)min(-1) was similar as in WT mice (n = 22) amounting to 113.0 +/- 1.8 ml.kg(-1).min(-1), (P = 0.16). No difference in maximal COX activity between the IL-6(-/-) and WT mice in m. soleus and m. gastrocnemius was found. Moreover, no impairment of peripheral endothelial function or glucose tolerance was found in IL-6(-/-) mice. Surprisingly, plasma lactate concentration during running at 8 m.min(-1) as well at maximal running velocity in IL-6(-/-) mice was significantly lower (P<0.01) than in WT mice. Interestingly, IL-6(-/-) mice displayed important adaptive mechanisms including significantly lower oxygen cost of running at a given speed accompanied by lower expression of sarcoplasmic reticulum Ca2+-ATPase and lower plasma lactate concentrations during running at submaximal and maximal running velocities. In conclusion, impaired endurance running capacity in IL-6(-/-) mice could not be explained by reduced V'O-2max, endothelial dysfunction or impaired muscle oxidative capacity. Therefore, our results indicate that IL-6 cannot be regarded as a major regulator of exercise capacity but rather as a modulator of endurance performance. Furthermore, we identified important compensatory mechanism limiting reduced exercise performance in IL-6(-/-) mice.	[Wojewoda, Marta; Kmiecik, Katarzyna; Sitek, Barbara; Fedorowicz, Andrzej; Chlopicki, Stefan] Jagiellonian Univ, JCET, Krakow, Poland; [Majerczak, Joanna; Zoladz, Jerzy Andrzej] Univ Sch Phys Educ, Dept Muscle Physiol, Krakow, Poland; [Ventura-Clapier, Renee; Fortin, Dominique] Univ Paris 11, INSERM, U769, Chatenay Malabry, France; [Kaminski, Karol] Med Univ Bialystok, Dept Cardiol, Bialystok, Poland; [Onopiuk, Marta; Jakubczyk, Justyna] Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland	Jagiellonian University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Medical University of Bialystok; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Chlopicki, S (corresponding author), Jagiellonian Univ, JCET, Krakow, Poland.	stefan.chlopicki@jcet.eu; Jerzy.Zoladz@awf.krakow.pl	Majerczak, Joanna/V-7492-2019; Kaminski, Karol A./J-4515-2014	Majerczak, Joanna/0000-0003-0898-1707; Kaminski, Karol A./0000-0002-9465-2581; Chlopicki, Stefan/0000-0002-2878-3858; Kmiecik, Katarzyna/0000-0002-9579-9091; Fedorowicz, Andrzej/0000-0002-3795-7506; Zoladz, Jerzy A./0000-0002-1143-5590; Smeda, Marta/0000-0002-0219-2574; Ventura-Clapier, Renee/0000-0002-7488-4123; Rog, JUSTYNA/0000-0001-5718-2536	European Union [POIG.01.01.02-00-069/09]	European Union(European Commission)	This work was supported by the European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme (grant coordinated by JCET-UJ, No. POIG.01.01.02-00-069/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benrick A, 2012, EXP PHYSIOL, V97, P1224, DOI 10.1113/expphysiol.2012.065508; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Cacicedo JM, 2011, AM J PHYSIOL-HEART C, V301, pH1255, DOI 10.1152/ajpheart.01279.2010; Chabowski A, 2008, J PHYSIOL PHARMACOL, V59, P105; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chlopicki S, 2012, PHARMACOL REP, V64, P369; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Feghali CA, 1997, FRONT BIOSCI, V2, P1912; Fernstrom M, 2004, J PHYSIOL-LONDON, V554, P755, DOI 10.1113/jphysiol.2003.055202; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Fritsche L, 2010, DIABETOLOGIA, V53, P1732, DOI 10.1007/s00125-010-1754-4; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Helge JW, 2011, EXP PHYSIOL, V96, P590, DOI 10.1113/expphysiol.2010.056424; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Knab AM, 2009, PHYSIOL BEHAV, V98, P433, DOI 10.1016/j.physbeh.2009.07.006; Li L, 2011, BASIC RES CARDIOL, V106, P1221, DOI 10.1007/s00395-011-0213-9; Lukaszuk B, 2012, LIPIDS, V47, P763, DOI 10.1007/s11745-012-3678-x; Majerczak J, 2008, J PHYSIOL PHARMACOL, V59, P589; Majerczak J, 2012, EXP PHYSIOL, V97, P386, DOI 10.1113/expphysiol.2011.062992; McBride A, 2009, ACTA PHYSIOL, V196, P99, DOI 10.1111/j.1748-1716.2009.01975.x; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Ruderman NB, 2006, DIABETES, V55, pS48, DOI 10.2337/db06-S007; Schrader LI, 2007, ARTERIOSCL THROM VAS, V27, P2576, DOI 10.1161/ATVBAHA.107.153080; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; WASSERMAN K, 1986, MED SCI SPORT EXER, V18, P344, DOI 10.1249/00005768-198606000-00017; ZOLADZ JA, 1995, J PHYSIOL-LONDON, V488, P211, DOI 10.1113/jphysiol.1995.sp020959; ZOLADZ JA, 1993, EUR J APPL PHYSIOL O, V67, P71, DOI 10.1007/BF00377708; Zoladz JA, 2008, J APPL PHYSIOL, V105, P575, DOI 10.1152/japplphysiol.01129.2007; Zoladz JA, 2013, EXP PHYSIOL, V98, P883, DOI 10.1113/expphysiol.2012.069443	36	10	10	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88333	10.1371/journal.pone.0088333	http://dx.doi.org/10.1371/journal.pone.0088333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533077	Green Published, gold			2022-12-27	WOS:000331262600035
J	Miah, S; Goel, RK; Dai, CL; Kalra, N; Beaton-Brown, E; Bagu, ET; Bonham, K; Lukong, KE				Miah, Sayem; Goel, Raghuveera Kumar; Dai, Chenlu; Kalra, Natasha; Beaton-Brown, Erika; Bagu, Edward T.; Bonham, Keith; Lukong, Kiven E.			BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration	PLOS ONE			English	Article							NONRECEPTOR TYROSINE KINASE; MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR; MEMBRANE RECRUITMENT; PROTEIN; EXPRESSION; PHOSPHORYLATION; GROWTH; P62(DOK); CANCER	Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosine kinase overexpressed in more that 60% of human breast carcinomas. The overexpression of BRK has been shown to sensitize mammary epithelial cells to mitogenic signaling and to promote cell proliferation and tumor formation. The molecular mechanisms of BRK have been unveiled by the identification and characterization of BRK target proteins. Downstream of tyrosine kinases 1 or Dok1 is a scaffolding protein and a substrate of several tyrosine kinases. Herein we show that BRK interacts with and phosphorylates Dok1 specifically on Y362. We demonstrate that this phosphorylation by BRK significantly downregulates Dok1 in a ubiquitin-proteasome-mediated mechanism. Together, these results suggest a novel mechanism of action of BRK in the promotion of tumor formation, which involves the targeting of tumor suppressor Dok1 for degradation through the ubiquitin proteasomal pathway.	[Miah, Sayem; Goel, Raghuveera Kumar; Dai, Chenlu; Kalra, Natasha; Beaton-Brown, Erika; Bagu, Edward T.; Bonham, Keith; Lukong, Kiven E.] Univ Saskatchewan, Coll Med, Dept Biochem, Saskatoon, SK S7N 0W0, Canada; [Beaton-Brown, Erika; Bagu, Edward T.; Bonham, Keith] Saskatchewan Canc Agcy, Hlth Res Div, Canc Res Unit, Saskatoon, SK, Canada; [Beaton-Brown, Erika; Bagu, Edward T.; Bonham, Keith] Univ Saskatchewan, Coll Med, Div Oncol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Lukong, KE (corresponding author), Univ Saskatchewan, Coll Med, Dept Biochem, Saskatoon, SK S7N 0W0, Canada.	Kiven.lukong@usuask.ca		Goel, Raghuveera/0000-0001-7348-3996	Department of Biochemistry at the U of S	Department of Biochemistry at the U of S	This work was supported by startup funds awarded to KEL by the Department of Biochemistry at the U of S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubele M, 2007, BRIT J CANCER, V96, P801, DOI 10.1038/sj.bjc.6603613; Balassiano K, 2011, CANCER LETT, V311, P85, DOI 10.1016/j.canlet.2011.06.038; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Brauer PM, 2010, CELL CYCLE, V9, P4190, DOI 10.4161/cc.9.20.13518; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Dai ZH, 1998, GENE DEV, V12, P1415, DOI 10.1101/gad.12.10.1415; DECLUE JE, 1993, MOL CELL BIOL, V13, P6799, DOI 10.1128/MCB.13.11.6799; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Di Cristofano A, 2001, J EXP MED, V194, P275, DOI 10.1084/jem.194.3.275; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Gao YW, 2012, J BIOL CHEM, V287, P20904, DOI 10.1074/jbc.M111.334144; Gerard A, 2004, ONCOGENE, V23, P1594, DOI 10.1038/sj.onc.1207283; Goel RK, 2013, FEBS J, V280, P4539, DOI 10.1111/febs.12420; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hosooka T, 2001, MOL CELL BIOL, V21, P5437, DOI 10.1128/MCB.21.16.5437-5446.2001; Ikeda O, 2010, J BIOL CHEM, V285, P38093, DOI 10.1074/jbc.M110.162388; Ikeda O, 2009, BIOCHEM BIOPH RES CO, V384, P71, DOI 10.1016/j.bbrc.2009.04.076; INABA T, 1991, LEUKEMIA, V5, P719; Janas JA, 2011, MOL CELL BIOL, V31, P2552, DOI 10.1128/MCB.05045-11; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kang SA, 2012, BIOCH J; Kang SA, 2013, BIOCHEM BIOPH RES CO, V431, P734, DOI 10.1016/j.bbrc.2013.01.046; Kang SA, 2010, J BIOL CHEM, V285, P26013, DOI 10.1074/jbc.M109.088971; Kasprzycka M, 2006, AM J PATHOL, V168, P1631, DOI 10.2353/ajpath.2006.050521; Kawamata A, 2011, J CELL PHYSIOL, V226, P3087, DOI 10.1002/jcp.22909; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Lee S, 2004, ONCOGENE, V23, P2287, DOI 10.1038/sj.onc.1207385; Lee S-K, 1993, P59FYN TYROSINE KINA; Li X, 2012, ONCOGENE; Liang XQ, 2002, J BIOL CHEM, V277, P13732, DOI 10.1074/jbc.M200277200; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lofgren KA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2946; Ludyga N, 2011, MOL BIOSYST; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lukong KE, 2008, CELL SIGNAL, V20, P432, DOI 10.1016/j.cellsig.2007.11.003; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Mashima R, 2010, LAB INVEST, V90, P1357, DOI 10.1038/labinvest.2010.121; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Mercier PL, 2011, MOL ONCOL, V5, P438, DOI 10.1016/j.molonc.2011.07.003; Miah S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.11; Miao L, 2003, EUR J BIOCHEM, V270, P2721, DOI 10.1046/j.1432-1033.2003.03639.x; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Murakami H, 2002, J BIOL CHEM, V277, P32781, DOI 10.1074/jbc.M202336200; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Nelms K, 1998, GENOMICS, V53, P243, DOI 10.1006/geno.1998.5514; Nemorin JG, 2000, J BIOL CHEM, V275, P14590, DOI 10.1074/jbc.275.19.14590; Niki M, 2004, J EXP MED, V200, P1689, DOI 10.1084/jem.20041306; Niu Y, 2006, MOL CELL BIOL, V26, P4288, DOI 10.1128/MCB.01817-05; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; Oki S, 2005, CELL CYCLE, V4, P310; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Petro BJ, 2004, ORAL ONCOL, V40, P1040, DOI 10.1016/j.oraloncology.2004.05.010; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Saulnier A, 2012, INT J CANCER, V130, P2484, DOI 10.1002/ijc.26299; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Serfas MS, 2003, ONCOL RES, V13, P409; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Siouda M, 2012, MOL CELL BIOL, V32, P4877, DOI 10.1128/MCB.01050-12; Takeda H, 2010, J PROTEOME RES, V9, P5982, DOI 10.1021/pr100773t; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; YOFFE G, 1990, J PEDIATR-US, V116, P114, DOI 10.1016/S0022-3476(05)81658-0; Yu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029450; Yuan YF, 2001, CANCER RES, V61, P5558; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200; Zhao MM, 2001, J EXP MED, V194, P265, DOI 10.1084/jem.194.3.265	92	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e87684	10.1371/journal.pone.0087684	http://dx.doi.org/10.1371/journal.pone.0087684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523872	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100021
J	Jan, C; Lee, M; Roa, R; Herrera, V; Politis, M; Motta, J				Jan, Carmen; Lee, Marcos; Roa, Reina; Herrera, Victor; Politis, Michael; Motta, Jorge			The Association of Tobacco Control Policies and the Risk of Acute Myocardial Infarction Using Hospital Admissions Data	PLOS ONE			English	Article							SMOKE-FREE LEGISLATION; CIGARETTE TAXES; IMPACT; CONSUMPTION; HEALTH; BANS; LAWS; US	Objective: To evaluate the association of a nationwide comprehensive smoking ban (CSB) and tobacco tax increase (TTI) on the risk of acute myocardial infarctions (AMI) in Panama for the period of 2006 - 2010 using hospital admissions data. Methods: Data of AMI cases was gathered from public and private hospitals in the country for the period of January 1, 2006 to December 31, 2010. The number of AMI cases was calculated on a monthly basis. The risk of AMI was estimated for the pre-CSB period (January 2006 to April 2008) and was used as a reference point. Three post-intervention periods were examined: (1) post-CSB from May 2008 to April 2009 (12 months); (2) post-CSB from May 2009 to November 2009 (7 months); and (3) post-TTI from December 2009 to December 2010 (13 months). Relative risks (RR) of AMI were estimated for each post intervention periods by using a Poisson regression model. Mortality registries for the country attributed to myocardial infarction (MI) were obtained from January 2001 to December 2012. The annual percentage change (APC) of the number of deaths from MI was calculated using Joinpoint regression analysis. Results: A total sample size of 2191 AMI cases was selected (monthly mean number of cases 36.52 +/- 8.24 SD). Using the pre-CSB as a reference point (RR = 1.00), the relative risk of AMI during the first CSB period, the second CSB period and post-TTI were 0.982, 1.049, and 0.985, respectively. The APC of deaths from MI from January 2001 to April 2008 was 0.5%. From January 2001 to June 2010 the APC trend was 0.47% and from July 2010 to December 2012 the APC was -0.3%. Conclusions: The implementation of a CSB and TTI in Panama were associated with a decrease in tobacco consumption and a reduction of the RR of AMI.	[Jan, Carmen; Lee, Marcos; Herrera, Victor; Politis, Michael; Motta, Jorge] Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Roa, Reina] Minist Hlth, Panama City, Panama	Instituto Conmemorativo Gorgas de Estudios de la Salud; Ministerio de Salud de la Republica de Panama	Motta, J (corresponding author), Gorgas Mem Inst Hlth Studies, Panama City, Panama.	drjmotta@gmail.com	Motta, Jorge Alejandro/ABI-6006-2020	Roa, Reina/0000-0002-6332-0584	Roswell Park Cancer Institute; Gorgas Memorial Institute of Health Studies	Roswell Park Cancer Institute; Gorgas Memorial Institute of Health Studies	This study was funded in part by Roswell Park Cancer Institute and the Gorgas Memorial Institute of Health Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2008, PUBLIC HEALTH, V122, P3, DOI 10.1016/j.puhe.2007.02.020; Alemu Rahel, 2011, ISRN Cardiol, V2011, P174358, DOI 10.5402/2011/174358; Barnett R, 2009, AUST NZ J PUBL HEAL, V33, P515, DOI 10.1111/j.1753-6405.2009.00446.x; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Barr CD, 2012, AM J EPIDEMIOL, V176, P642, DOI 10.1093/aje/kws267; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; de Korte-de Boer D, 2012, HEART, V98, P995, DOI 10.1136/heartjnl-2012-301702; DeCicca P, 2008, J HEALTH ECON, V27, P918, DOI 10.1016/j.jhealeco.2007.11.005; Desalu OO, 2011, ANN AFR MED, V10, P103, DOI 10.4103/1596-3519.82069; Gasparrini A, 2009, EUR J EPIDEMIOL, V24, P597, DOI 10.1007/s10654-009-9377-0; Glantz SA, 2008, PREV MED, V47, P452, DOI 10.1016/j.ypmed.2008.06.007; Goerre S, 2007, INT J CARDIOL, V118, P36, DOI 10.1016/j.ijcard.2006.06.015; Hahn EJ, 2011, PUBLIC HEALTH REP, V126, P826, DOI 10.1177/003335491112600608; Instituto Conmemorativo Gorgas de Estudios en Salud website, 2000, AN DEM TAB PAN CONTR; Instituto Conmemorativo Gorgas de Estudios en Salud website, PREV FACT RIESG AS E; Instituto Conmemorativo Gorgas de Estudios en Salud website, ENC NAC SAL CAL VID; Jimenez-Ruiz JA, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.021030; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kuo MC, 2003, ALCOHOL CLIN EXP RES, V27, P720, DOI [10.1097/01.ALC.0000065064.61199.79, 10.1111/j.1530-0277.2003.tb04410.x]; Lazuras L, 2009, TOB CONTROL, V18, P127, DOI 10.1136/tc.2008.025841; Lemstra M, 2008, CAN J PUBLIC HEALTH, V99, P62, DOI 10.1007/BF03403743; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Liu Echu, 2008, J Health Care Finance, V34, P91; Pan American Health Organization (PAHO) website, GLOB AD TOB SURV GAT; Pechacek TF, 2004, BRIT MED J, V328, P980, DOI 10.1136/bmj.328.7446.980; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Ravara SB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-134; Rodu B, 2012, J COMMUN HEALTH, V37, P468, DOI 10.1007/s10900-011-9464-5; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; Salloum RG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-534; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Schroeder SA, 2009, J AM COLL CARDIOL, V54, P1256, DOI 10.1016/j.jacc.2009.08.006; Seguret F., 2013, EUR J PREV CARDIOL; Showalter MH, 1998, AM J PUBLIC HEALTH, V88, P1118, DOI 10.2105/AJPH.88.7.1118; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Stallings-Smith S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062063; Villalbi JR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000067; Warren CW, 2012, EUR J PUBLIC HEALTH, V22, P712, DOI 10.1093/eurpub/ckr157; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	42	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88784	10.1371/journal.pone.0088784	http://dx.doi.org/10.1371/journal.pone.0088784			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520421	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600112
J	McAllan, L; Skuse, P; Cotter, PD; O' Connor, P; Cryan, JF; Ross, RP; Fitzgerald, G; Roche, HM; Nilaweera, KN				McAllan, Liam; Skuse, Peter; Cotter, Paul D.; O' Connor, Paula; Cryan, John F.; Ross, R. Paul; Fitzgerald, Gerald; Roche, Helen M.; Nilaweera, Kanishka N.			Protein Quality and the Protein to Carbohydrate Ratio within a High Fat Diet Influences Energy Balance and the Gut Microbiota In C57BL/6J Mice	PLOS ONE			English	Article							ALPHA-LACTALBUMIN INCREASES; MILK-DERIVED LACTOFERRIN; NEUTRAL AMINO-ACIDS; BODY-WEIGHT GAIN; WHEY-PROTEIN; INDUCED OBESITY; ANTIBACTERIAL ACTIVITY; NEXT-GENERATION; NATIVE WHEY; STRESS	Macronutrient quality and composition are important determinants of energy balance and the gut microbiota. Here, we investigated how changes to protein quality (casein versus whey protein isolate; WPI) and the protein to carbohydrate (P/C) ratio within a high fat diet (HFD) impacts on these parameters. Mice were fed a low fat diet (10% kJ) or a high fat diet (HFD; 45% kJ) for 21 weeks with either casein (20% kJ, HFD) or WPI at 20%, 30% or 40% kJ. In comparison to casein, WPI at a similar energy content normalised energy intake, increased lean mass and caused a trend towards a reduction in fat mass (P = 0.08), but the protein challenge did not alter oxygen consumption or locomotor activity. WPI reduced HFD-induced plasma leptin and liver triacylglycerol, and partially attenuated the reduction in adipose FASN mRNA in HFD-fed mice. High throughput sequence-based analysis of faecal microbial populations revealed microbiota in the HFD-20% WPI group clustering closely with HFD controls, although WPI specifically increased Lactobacillaceae/Lactobacillus and decreased Clostridiaceae/Clostridium in HFD-fed mice. There was no effect of increasing the P/C ratio on energy intake, but the highest ratio reduced HFD-induced weight gain, fat mass and plasma triacylglycerol, non-esterified fatty acids, glucose and leptin levels, while it increased lean mass and oxygen consumption. Similar effects were observed on adipose mRNA expression, where the highest ratio reduced HFD-associated expression of UCP-2, TNF alpha and CD68 and increased the diet-associated expression of beta 3-AR, LPL, IR, IRS-1 and GLUT4. The P/C ratio also impacted on gut microbiota, with populations in the 30/ 40% WPI groups clustering together and away from the 20% WPI group. Taken together, our data show that increasing the P/C ratio has a dramatic effect on energy balance and the composition of gut microbiota, which is distinct from that caused by changes to protein quality.	[McAllan, Liam; Skuse, Peter; Cotter, Paul D.; O' Connor, Paula; Ross, R. Paul; Nilaweera, Kanishka N.] TEAGASC, Food Biosci Dept, Fermoy, Cork, Ireland; [McAllan, Liam] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [Skuse, Peter; Fitzgerald, Gerald] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Cotter, Paul D.; Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [Roche, Helen M.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	Teagasc; University College Cork; University College Cork; University College Cork; University College Cork; University College Dublin	Nilaweera, KN (corresponding author), TEAGASC, Food Biosci Dept, Fermoy, Cork, Ireland.	kanishka.nilaweera@teagasc.ie	Cotter, Paul/AAX-5449-2021; Ross, Paul/A-7584-2015; Cotter, Paul/B-7781-2008; Cryan, John F./A-6950-2013; Roche, Helen M/AAF-4164-2019; STANTON, CATHERINE/A-9549-2015	Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Cryan, John F./0000-0001-5887-2723; Roche, Helen M/0000-0002-0628-3318; STANTON, CATHERINE/0000-0002-6724-7011; McAllan, Liam/0000-0002-6215-4289; Nilaweera, Kanishka/0000-0002-6074-9457; O'Connor, Paula M./0000-0001-6462-2077	Teagasc Vision Programme on Obesity; Teagasc PhD Walsh Fellowship; SFI PI [11/PI/1119]	Teagasc Vision Programme on Obesity; Teagasc PhD Walsh Fellowship; SFI PI(Science Foundation Ireland)	KN is supported by the Teagasc Vision Programme on Obesity, which also funded the work detailed in this manuscript. LM is supported by a Teagasc PhD Walsh Fellowship. HMR is supported by SFI PI (11/PI/1119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson KJ, 2011, AM J CLIN NUTR, V93, P525, DOI 10.3945/ajcn.110.005850; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Belobrajdic DP, 2004, J NUTR, V134, P1454, DOI 10.1093/jn/134.6.1454; Bender DA, 2012, BRIT J NUTR, V108, pS113, DOI 10.1017/S0007114512002292; Blatt AD, 2011, J AM DIET ASSOC, V111, P290, DOI 10.1016/j.jada.2010.10.047; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Buchenauer T, 2009, PHYSIOL BEHAV, V98, P563, DOI 10.1016/j.physbeh.2009.09.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caterson ID, 2004, CIRCULATION, V110, pE476, DOI 10.1161/01.CIR.0000140114.83145.59; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; Collins S, 1999, INT J OBESITY, V23, P669, DOI 10.1038/sj.ijo.0800894; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freedman DJ, 1998, J INFECT DIS, V177, P662, DOI 10.1086/514227; Freudenberg A, 2012, J NUTR BIOCHEM, V23, P1524, DOI 10.1016/j.jnutbio.2011.10.005; Garlick PJ, 1999, EUR J CLIN NUTR, V53, pS34, DOI 10.1038/sj.ejcn.1600742; Ghosal S, 2013, PHYSIOL BEHAV, V122, P201, DOI 10.1016/j.physbeh.2013.04.003; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamad EM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-57; Harris RBS, 1998, AM J PHYSIOL-REG I, V275, pR1928, DOI 10.1152/ajpregu.1998.275.6.R1928; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hoek KS, 1997, ANTIMICROB AGENTS CH, V41, P54, DOI 10.1128/AAC.41.1.54; Hulsey MG, 1998, PHYSIOL BEHAV, V65, P445, DOI 10.1016/S0031-9384(98)00180-2; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kamemori N, 2004, BRAIN RES, V1029, P34, DOI 10.1016/j.brainres.2004.09.015; Kanda A, 2013, BRIT J NUTR, V110, P981, DOI 10.1017/S0007114512006174; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Markus CR, 2002, AM J CLIN NUTR, V75, P1051, DOI 10.1093/ajcn/75.6.1051; Markus CR, 2000, AM J CLIN NUTR, V71, P1536; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAllan L, 2013, BRIT J NUTR, V110, P2114, DOI 10.1017/S0007114513001396; McAllan L, 2013, J PHYSIOL BIOCHEM, V69, P155, DOI 10.1007/s13105-012-0170-2; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Mortensen LS, 2009, AM J CLIN NUTR, V90, P41, DOI 10.3945/ajcn.2008.27281; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Norton LE, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-67; Norton LE, 2006, J NUTR, V136, p533S, DOI 10.1093/jn/136.2.533S; Ouwehand AC, 1999, INT DAIRY J, V9, P43, DOI 10.1016/S0958-6946(99)00043-6; Pal S, 2010, ATHEROSCLEROSIS, V212, P339, DOI 10.1016/j.atherosclerosis.2010.05.032; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; PECKHAM SC, 1962, J NUTR, V77, P187, DOI 10.1093/jn/77.2.187; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Pichon L, 2006, J NUTR, V136, P1256, DOI 10.1093/jn/136.5.1256; Pichon L, 2008, BRIT J NUTR, V99, P739, DOI 10.1017/S0007114507831709; Pilvi TK, 2008, WORLD J GASTROENTERO, V14, P4462, DOI 10.3748/wjg.14.4462; Pilvi TK, 2007, BRIT J NUTR, V98, P900, DOI 10.1017/S0007114507764760; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rea MC, 2011, P NATL ACAD SCI USA, V108, P4639, DOI 10.1073/pnas.1001224107; Rieu I, 2007, NUTRITION, V23, P323, DOI 10.1016/j.nut.2006.12.013; Ryan KK, 2012, CELL METAB, V15, P137, DOI 10.1016/j.cmet.2011.12.013; Saegusa Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE685, DOI 10.1152/ajpendo.00121.2011; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047303; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sclafani A, 1993, Obes Res, V1, P173; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Shertzer HG, 2011, J NUTR, V141, P582, DOI 10.3945/jn.110.133736; Shi J, 2012, J FUNCT FOODS, V4, P440, DOI 10.1016/j.jff.2012.02.002; Shi J, 2011, INT DAIRY J, V21, P513, DOI 10.1016/j.idairyj.2011.03.006; Shin K, 2000, J NUTR BIOCHEM, V11, P94, DOI 10.1016/S0955-2863(99)00082-0; Sonoyama K, 2009, APPL ENVIRON MICROB, V75, P6451, DOI 10.1128/AEM.00692-09; Sousa DZ, 2007, FEMS MICROBIOL ECOL, V60, P252, DOI 10.1111/j.1574-6941.2007.00291.x; Sprong RC, 2010, J DAIRY SCI, V93, P1364, DOI 10.3168/jds.2009-2397; Takeuchi T, 2003, BRAIN RES, V979, P216, DOI 10.1016/S0006-8993(03)02941-X; Tipton KD, 2007, AM J PHYSIOL-ENDOC M, V292, pE71, DOI 10.1152/ajpendo.00166.2006; Tranberg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071439; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Vekovischeva OY, 2013, BRIT J NUTR, V110, P1336, DOI 10.1017/S0007114513000238; Viau V, 1999, J NEUROSCI, V19, P6684; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; West DB, 1998, AM J CLIN NUTR, V67, p505S, DOI 10.1093/ajcn/67.3.505S; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yamada C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/792940; YAMAUCHI K, 1993, INFECT IMMUN, V61, P719, DOI 10.1128/IAI.61.2.719-728.1993; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123; Zhou J, 1999, AM J PHYSIOL-REG I, V277, pR757, DOI 10.1152/ajpregu.1999.277.3.R757	88	63	66	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88904	10.1371/journal.pone.0088904	http://dx.doi.org/10.1371/journal.pone.0088904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520424	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600115
J	Meyrand, P; Bem, T				Meyrand, Pierre; Bem, Tiaza			Variety of Alternative Stable Phase-Locking in Networks of Electrically Coupled Relaxation Oscillators	PLOS ONE			English	Article							GAP-JUNCTIONS; SPINAL MOTONEURONS; HORIZONTAL CELLS; MULTI-STABILITY; SPIKING NEURONS; NMDA RECEPTORS; IN-PHASE; ADULT; EXPRESSION; ANTIPHASE	We studied the dynamics of a large-scale model network comprised of oscillating electrically coupled neurons. Cells are modeled as relaxation oscillators with short duty cycle, so they can be considered either as models of pacemaker cells, spiking cells with fast regenerative and slow recovery variables or firing rate models of excitatory cells with synaptic depression or cellular adaptation. It was already shown that electrically coupled relaxation oscillators exhibit not only synchrony but also anti-phase behavior if electrical coupling is weak. We show that a much wider spectrum of spatiotemporal patterns of activity can emerge in a network of electrically coupled cells as a result of switching from synchrony, produced by short external signals of different spatial profiles. The variety of patterns increases with decreasing rate of neuronal firing (or duty cycle) and with decreasing strength of electrical coupling. We study also the effect of network topology - from all-to-all - to pure ring connectivity, where only the closest neighbors are coupled. We show that the ring topology promotes anti-phase behavior as compared to all-to-all coupling. It also gives rise to a hierarchical organization of activity: during each of the main phases of a given pattern cells fire in a particular sequence determined by the local connectivity. We have analyzed the behavior of the network using geometric phase plane methods and we give heuristic explanations of our findings. Our results show that complex spatiotemporal activity patterns can emerge due to the action of stochastic or sensory stimuli in neural networks without chemical synapses, where each cell is equally coupled to others via gap junctions. This suggests that in developing nervous systems where only electrical coupling is present such a mechanism can lead to the establishment of proto-networks generating premature multiphase oscillations whereas the subsequent emergence of chemical synapses would later stabilize generated patterns.	[Meyrand, Pierre] Univ Bordeaux, IMN, UMR 5293, Bordeaux, France; [Meyrand, Pierre] CNRS, IMN, UMR 5293, Bordeaux, France; [Bem, Tiaza] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences	Meyrand, P (corresponding author), Univ Bordeaux, IMN, UMR 5293, Bordeaux, France.	pierre.meyrand@u-bordeaux2.fr	Bem, Tiaza/N-1841-2016		Polish Academy of Sciences	Polish Academy of Sciences	This work was supported by the status grant of the Polish Academy of Sciences (TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam H, 2005, NAT NEUROSCI, V8, P1720, DOI 10.1038/nn1588; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Bem T, 2005, EUR J NEUROSCI, V22, P2661, DOI 10.1111/j.1460-9568.2005.04405.x; Bem T, 2002, J NEUROPHYSIOL, V87, P538, DOI 10.1152/jn.00372.2001; Bem T, 2004, J NEUROPHYSIOL, V91, P693, DOI 10.1152/jn.00783.2003; Bem T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003830; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Blankenship AG, 2011, J NEUROSCI, V31, P9998, DOI 10.1523/JNEUROSCI.5640-10.2011; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; Chow CC, 2000, NEURAL COMPUT, V12, P1643, DOI 10.1162/089976600300015295; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; Curtin KD, 2002, J CELL SCI, V115, P3379; Dodla R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058922; Ducret E, 2006, EUR J NEUROSCI, V24, P3119, DOI 10.1111/j.1460-9568.2006.05209.x; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Haas JS, 2011, SCIENCE, V334, P389, DOI 10.1126/science.1207502; Hartveit E, 2012, BRAIN RES, V1487, P160, DOI 10.1016/j.brainres.2012.05.060; He SG, 2000, J COMP NEUROL, V418, P33, DOI 10.1002/(SICI)1096-9861(20000228)418:1<33::AID-CNE3>3.0.CO;2-J; Lee E, 2013, J APPL DYN SYST, V12, P8211; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Mentis GZ, 2002, J PHYSIOL-LONDON, V544, P757, DOI 10.1113/jphysiol.2002.028159; Mercer A, 2012, BRAIN RES, V1487, P192, DOI 10.1016/j.brainres.2012.03.069; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Ostaszewski H, 2010, BIOCYBERN BIOMED ENG, V30, P3; Ostojic S, 2009, J COMPUT NEUROSCI, V26, P369, DOI 10.1007/s10827-008-0117-3; Pastor AM, 2003, J NEUROPHYSIOL, V89, P793, DOI 10.1152/jn.00498.2002; PEINADO A, 1993, CEREB CORTEX, V3, P488, DOI 10.1093/cercor/3.5.488; Pereda AE, 2013, BBA-BIOMEMBRANES, V1828, P134, DOI 10.1016/j.bbamem.2012.05.026; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; PICCOLINO M, 1984, J NEUROSCI, V4, P2477; Starich TA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-16; Szabo TM, 2007, BRAIN RES, V1129, P63, DOI 10.1016/j.brainres.2006.09.112; Szabo TM, 2010, BRAIN RES, V1349, P21, DOI 10.1016/j.brainres.2010.06.025; Tabak J, 2006, J COMPUT NEUROSCI, V21, P307, DOI 10.1007/s10827-006-8862-7; Terman D, 2011, SIAM J APPL DYN SYST, V10, P1127, DOI 10.1137/100813774; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Xin DY, 2000, VISUAL NEUROSCI, V17, P799, DOI 10.1017/S0952523800175133; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zsiros V, 2008, J NEUROSCI, V28, P1804, DOI 10.1523/JNEUROSCI.4616-07.2008	44	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e86572	10.1371/journal.pone.0086572	http://dx.doi.org/10.1371/journal.pone.0086572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520321	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600012
J	Wang, ZY; Zhao, KK; Zheng, JW; Rossmiller, B; Ildefonso, C; Biswal, M; Zhao, PQ				Wang, Zhao-Yang; Zhao, Keke; Zheng, Jingwei; Rossmiller, Brian; Ildefonso, Cristhian; Biswal, Manas; Zhao, Pei-quan			Systematic Review and Meta-Analysis of the Association between Complement Factor H I62V Polymorphism and Risk of Polypoidal Choroidal Vasculopathy in Asian Populations	PLOS ONE			English	Review							MACULAR DEGENERATION; CFH; VARIANTS; PHENOTYPE; SUBTYPES; ARMS2; GENE	Purpose: To investigate whether the polymorphism rs800292 (184G>A, I62V) in the complement factor H gene is associated with polypoidal choroidal vasculopathy (PCV) and the genetic difference between PCV and neovascular age-related macular degeneration (nAMD), in Asian populations. Methods: A comprehensive literature search was performed in PubMed, Medline, Web of Science, and reference lists. A system review and meta-analysis of the association between I62V and PCV and/or nAMD were performed from 8 studies involving 5,062 subjects. The following data from individual studies were extracted and analyzed: 1) comparison of I62V polymorphisms between PCV and controls; 2) comparison of I62V polymorphisms between PCV and nAMD. Summary odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using fixed-effects models. The Q-statistic test was used to assess heterogeneity, and Egger's test was used to evaluate publication bias. Sensitivity analysis and cumulative meta-analysis were also performed. Results: The I62V polymorphism showed a significant summary OR1 for genotype GA+GG versus homozygous genotype AA was 3.18 (95% CI, 2.51-4.04, P<0.00001), the OR2 of heterozygous genotype GA versus AA was 2.29 (95% CI: 1.79-2.94, P<0.00001), the OR3 of homozygous genotype GG versus AA was 4.42 (95% CI: 3.45-5.67, P<0.00001), and the OR4 of allele G versus A was 2.04 (95% CI: 1.85-2.26, P<0.00001). Sensitivity analysis indicated the robustness of our findings, and evidence of publication bias was not observed in our meta-analysis. Cumulative meta-analysis revealed that the summary ORs were stable. There was no significant difference in every genetic model between PCV and nAMD (n = 5, OR1 = 0.92, OR2 = 0.96, OR3 = 0.90, OR4 = 0.94). Conclusions: Our analysis provides evidence that the I62V polymorphism is associated with an increased risk of PCV. The variant of I62V could be a promising genetic biomarker of PCV in Asian populations.	[Wang, Zhao-Yang; Zhao, Pei-quan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Wang, Zhao-Yang; Zhao, Keke; Rossmiller, Brian; Ildefonso, Cristhian; Biswal, Manas] Univ Florida, Dept Mol Genet, Gainesville, FL USA; [Zheng, Jingwei] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; State University System of Florida; University of Florida; Wenzhou Medical University	Zhao, PQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China.	zhaokekewzy@hotmail.com	Ildefonso, Cristhian/AAC-3576-2021	Biswal, Manas/0000-0002-9685-2923; Ildefonso, Cristhian/0000-0001-6179-720X	National Natural Science Funds of China [81371040, 81070760, 81100677]; Shanghai Rising-Star Program [12QA1402200]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This study was supported by Project of the National Natural Science Funds of China (No. 81371040, 81070760 and No. 81100677), and Shanghai Rising-Star Program (No. 12QA1402200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessho H, 2011, MOL VIS, V17, P977; Byeon SH, 2008, JPN J OPHTHALMOL, V52, P57, DOI 10.1007/s10384-007-0498-2; Chantaren P, 2012, CLIN OPHTHALMOL, V6, P465, DOI 10.2147/OPTH.S30529; Chen HY, 2012, MOL VIS, V18, P816; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Gotoh N, 2008, CLIN EXP OPHTHALMOL, V36, P437, DOI 10.1111/j.1442-9071.2008.01791.x; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Lim TH, 2010, EYE, V24, P483, DOI 10.1038/eye.2009.323; Lima LH, 2010, OPHTHALMOLOGY, V117, P1567, DOI 10.1016/j.ophtha.2009.12.018; Liu K, 2013, OPHTHALMOLOGY, V120, P837, DOI 10.1016/j.ophtha.2012.10.003; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Miki A, 2013, OPHTHALMIC GENET, V34, P146, DOI 10.3109/13816810.2012.749288; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Nakata I, 2012, INVEST OPHTH VIS SCI, V53, P794, DOI 10.1167/iovs.11-8468; Okubo A, 2002, BRIT J OPHTHALMOL, V86, P1093, DOI 10.1136/bjo.86.10.1093; Sakurada Y, 2011, OPHTHALMOLOGY, V118, P1402, DOI 10.1016/j.ophtha.2010.12.010; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Takahashi Kanji, 2008, Nippon Ganka Gakkai Zasshi, V112, P1076; Tanaka K, 2011, MOL VIS, V17, P2751; Ueda-Arakawa N, 2013, AM J OPHTHALMOL, V155, P260, DOI 10.1016/j.ajo.2012.08.011; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yuan DQ, 2013, MOL VIS, V19, P374; Zhang XZ, 2013, EXP EYE RES, V108, P16, DOI 10.1016/j.exer.2012.12.005	33	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88324	10.1371/journal.pone.0088324	http://dx.doi.org/10.1371/journal.pone.0088324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520367	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600058
J	Chang, PC; Wang, TY; Chang, YT; Chu, CY; Lee, CL; Hsu, HW; Zhou, TA; Wu, ZJ; Kim, RH; Desai, SJ; Liu, SQ; Kung, HJ				Chang, Pei-Ching; Wang, Tao-Yeuan; Chang, Yi-Ting; Chu, Cheng-Ying; Lee, Chin-Ling; Hsu, Hung-Wei; Zhou, Tyng-An; Wu, Zhaoju; Kim, Randie H.; Desai, Sonal J.; Liu, Shangqin; Kung, Hsing-Jien			Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NEURAL STEM-CELLS; ANDROGEN DEPRIVATION; GENE-TRANSCRIPTION; IN-VITRO; INTERLEUKIN-6; TARGET; TRANSDIFFERENTIATION; SURVIVAL; REST	Prostate cancer (PCa) cells undergoing neuroendocrine differentiation (NED) are clinically relevant to the development of relapsed castration-resistant PCa. Increasing evidences show that autophagy involves in the development of neuroendocrine (NE) tumors, including PCa. To clarify the effect of autophagy on NED, androgen-sensitive PCa LNCaP cells were examined. Treatment of LNCaP cells with IL-6 resulted in an induction of autophagy. In the absence of androgen, IL-6 caused an even stronger activation of autophagy. Similar result was identified in NED induction. Inhibition of autophagy with chloroquine (CQ) markedly decreased NED. This observation was confirmed by beclin1 and Atg5 silencing experiments. Further supporting the role of autophagy in NED, we found that LC3 was up-regulated in PCa tissue that had relapsed after androgen-deprivation therapy when compared with their primary tumor counterpart. LC3 staining in relapsed PCa tissue showed punctate pattern similar to the staining of chromogranin A (CgA), a marker for NED cells. Moreover, autophagy inhibition induced the apoptosis of IL-6 induced NE differentiated PCa cells. Consistently, inhibition of autophagy by knockdown of beclin1 or Atg5 sensitized NE differentiated LNCaP cells to etoposide, a chemotherapy drug. To identify the mechanisms, phosphorylation of IL-6 downstream targets was analyzed. An increase in phospho-AMPK and a decrease in phospho-mTOR were found, which implies that IL-6 regulates autophagy through the AMPK/mTOR pathway. Most important to this study is the discovery of REST, a neuronal gene-specific transcriptional repressor that is involved in autophagy activation. REST was down-regulated in IL-6 treatment. Knockdown experiments suggest that REST is critical to NED and autophagy activation by IL-6. Together, our studies imply that autophagy is involved in PCa progression and plays a cytoprotective role when NED is induced in PCa cells by IL-6 treatment. These results reveal the potential of targeting autophagy as part of a combined therapeutic regime for NE tumors.	[Chang, Pei-Ching; Chang, Yi-Ting; Hsu, Hung-Wei; Zhou, Tyng-An] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wang, Tao-Yeuan; Lee, Chin-Ling] Mackay Med Coll, Dept Pathol, New Taipei City, Taiwan; [Wang, Tao-Yeuan; Lee, Chin-Ling] Mackay Mem Hosp, New Taipei City, Taiwan; [Wang, Tao-Yeuan; Lee, Chin-Ling] Mackay Jr Coll Med Nursing & Management, New Taipei City, Taiwan; [Chu, Cheng-Ying; Kung, Hsing-Jien] Taipei Med Univ, Coll Med Sci & Technol, Inst Translat Med, Taipei, Taiwan; [Wu, Zhaoju; Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Wu, Zhaoju; Kung, Hsing-Jien] Univ Calif Davis, UC Davis Canc Ctr, Davis, CA 95616 USA; [Kim, Randie H.] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Liu, Shangqin] Wuhan Univ, Zhongnan Hosp, Dept Hematl, Wuhan 430072, Peoples R China; [Kung, Hsing-Jien] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Miaoli County, Taiwan	National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University; University of California System; University of California Davis; University of California System; University of California Davis; New York University; Wuhan University; National Health Research Institutes - Taiwan	Chang, PC (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	pcchang@ym.edu.tw; hkung@nhri.org.tw	Kung, Hsing-Jien/C-7651-2013	Kim, Randie/0000-0003-0365-5961	NSC [NSC 101-2320-B-010-047-MY3]; MMH [MMH10194]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	NSC(Ministry of Science and Technology, Taiwan); MMH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by NSC grants (NSC 101-2320-B-010-047-MY3) and by MMH grants (MMH10194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Amorino GP, 2004, CRIT REV EUKAR GENE, V14, P287, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.40; Arvisais E, 2010, MOL ENDOCRINOL, V24, P632, DOI 10.1210/me.2009-0312; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Boutin B, 2013, PROSTATE, V73, P1090, DOI 10.1002/pros.22658; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Chhipa RR, 2011, CELL SIGNAL, V23, P1466, DOI 10.1016/j.cellsig.2011.04.008; Chhipa RR, 2010, CELL SIGNAL, V22, P1554, DOI 10.1016/j.cellsig.2010.05.024; Chin TY, 2010, AUTOPHAGY, V6, P1139, DOI 10.4161/auto.6.8.13564; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Ciarlo M, 2012, INT J CANCER, V131, P582, DOI 10.1002/ijc.26402; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Deeble PD, 2007, CANCER RES, V67, P3663, DOI 10.1158/0008-5472.CAN-06-2616; Deeble PD, 2001, MOL CELL BIOL, V21, P8471, DOI 10.1128/MCB.21.24.8471-8482.2001; Delk NA, 2012, AUTOPHAGY, V8, P650, DOI 10.4161/auto.19226; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Holmes D, 2011, NAT REV DRUG DISCOV, V10, P563, DOI 10.1038/nrd3527; ISAACS JT, 1984, PROSTATE, V5, P1, DOI 10.1002/pros.2990050102; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jiborn T, 1998, UROLOGY, V51, P585, DOI 10.1016/S0090-4295(97)00684-5; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Komiya A, 2009, INT J UROL, V16, P37, DOI 10.1111/j.1442-2042.2008.02175.x; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li MQ, 2008, AUTOPHAGY, V4, P54, DOI 10.4161/auto.5209; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Marcu M, 2010, ROM J MORPHOL EMBRYO, V51, P7; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ruderman NB, 2006, DIABETES, V55, pS48, DOI 10.2337/db06-S007; Schaeffer V, 2012, AUTOPHAGY, V8, P1686, DOI 10.4161/auto.21488; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Spiotto MT, 2000, PROSTATE, V42, P186, DOI 10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E; Svensson C, 2013, NUCL ACIDS RES; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tawadros T, 2005, CELL SIGNAL, V17, P929, DOI 10.1016/j.cellsig.2004.11.013; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vazquez P, 2012, AUTOPHAGY, V8, P187, DOI 10.4161/auto.8.2.18535; Wang CR, 2013, NAT NEUROSCI, V16, P532, DOI 10.1038/nn.3365; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; Wu CY, 2007, J BIOL CHEM, V282, P3571, DOI 10.1074/jbc.M608487200; Wu Zhaoju, 2010, Genes Cancer, V1, P40, DOI 10.1177/1947601909358324; Xi HB, 2013, BIOCHEM PHARMACOL, V85, P1463, DOI 10.1016/j.bcp.2013.02.037; Xie SZ, 2004, PROSTATE, V60, P61, DOI 10.1002/pros.20048; Yang XZ, 2005, CANCER RES, V65, P5263, DOI 10.1158/0008-5472.CAN-05-0162; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Zeng M, 2008, CELL SIGNAL, V20, P659, DOI 10.1016/j.cellsig.2007.11.015; Zhao Y, 2012, MAR DRUGS, V10, P1345, DOI 10.3390/md10061345	63	43	46	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88556	10.1371/journal.pone.0088556	http://dx.doi.org/10.1371/journal.pone.0088556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551118	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500046
J	Wu, N; Dacres, H; Anderson, A; Trowell, SC; Zhu, YG				Wu, Nan; Dacres, Helen; Anderson, Alisha; Trowell, Stephen C.; Zhu, Yonggang			Comparison of Static and Microfluidic Protease Assays Using Modified Bioluminescence Resonance Energy Transfer Chemistry	PLOS ONE			English	Article							TRANSFER BRET; PROTEOLYTIC CLEAVAGE; ON-CHIP; FLUORESCENCE; THROMBIN; BIOSENSORS; TISSUES; SYSTEM; CELLS	Background: Fluorescence and bioluminescence resonance energy transfer (F/BRET) are two forms of Forster resonance energy transfer, which can be used for optical transduction of biosensors. BRET has several advantages over fluorescence-based technologies because it does not require an external light source. There would be benefits in combining BRET transduction with microfluidics but the low luminance of BRET has made this challenging until now. Methodology: We used a thrombin bioprobe based on a form of BRET (BRETH), which uses the BRET1 substrate, native coelenterazine, with the typical BRET2 donor and acceptor proteins linked by a thrombin target peptide. The microfluidic assay was carried out in a Y-shaped microfluidic network. The dependence of the BRETH ratio on the measurement location, flow rate and bioprobe concentration was quantified. Results were compared with the same bioprobe in a static microwell plate assay. Principal Findings: The BRETH thrombin bioprobe has a lower limit of detection (LOD) than previously reported for the equivalent BRET1-based version but it is substantially brighter than the BRET2 version. The normalised BRETH ratio of the bioprobe changed 32% following complete cleavage by thrombin and 31% in the microfluidic format. The LOD for thrombin in the microfluidic format was 27 pM, compared with an LOD of 310 pM, using the same bioprobe in a static microwell assay, and two orders of magnitude lower than reported for other microfluidic chip-based protease assays. Conclusions: These data demonstrate that BRET based microfluidic assays are feasible and that BRETH provides a useful test bed for optimising BRET-based microfluidics. This approach may be convenient for a wide range of applications requiring sensitive detection and/or quantification of chemical or biological analytes.	[Wu, Nan] CSIRO Mat Sci & Engn & Food Futures Flagship, Clayton, Vic, Australia; [Dacres, Helen; Anderson, Alisha; Trowell, Stephen C.; Zhu, Yonggang] CSIRO Ecosyst Sci & Food Futures Flagship, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhu, YG (corresponding author), CSIRO Ecosyst Sci & Food Futures Flagship, Canberra, ACT, Australia.	yonggang.zhu@csiro.au	Zhu, Yonggang/ABC-6992-2021; Zhu, Yonggang/B-3362-2012; Trowell, Stephen C/B-8043-2008; Anderson, Alisha R/C-1499-2008; Dacres, Helen/C-1858-2008; Trowell, Stephen/AAG-8943-2019; Anderson, Alisha/AAC-3505-2021	Zhu, Yonggang/0000-0002-5419-9508; Zhu, Yonggang/0000-0002-5419-9508; Trowell, Stephen C/0000-0002-0505-8741; Anderson, Alisha R/0000-0001-7013-116X; Dacres, Helen/0000-0002-8993-1906; Anderson, Alisha/0000-0001-7013-116X	CSIRO Food Futures Flagship	CSIRO Food Futures Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The CSIRO Food Futures Flagship provided internal funding for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andou T, 2011, SENSOR ACTUAT B-CHEM, V152, P277, DOI 10.1016/j.snb.2010.12.020; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Dacres H, 2010, ANAL CHEM, V82, P432, DOI 10.1021/ac9022956; Dacres H, 2009, BIOSENS BIOELECTRON, V24, P1164, DOI 10.1016/j.bios.2008.07.021; Dacres H, 2011, BIOSENS BIOELECTRON, V29, P119, DOI 10.1016/j.bios.2011.08.004; Dacres H, 2009, ANAL BIOCHEM, V385, P194, DOI 10.1016/j.ab.2008.10.040; de Stefano L, 2013, SENSOR ACTUAT B-CHEM, V179, P157, DOI 10.1016/j.snb.2012.11.055; Dragulescu-Andrasi A, 2011, P NATL ACAD SCI USA, V108, P12060, DOI 10.1073/pnas.1100923108; Eltoukhy H, 2006, IEEE J SOLID-ST CIRC, V41, P651, DOI 10.1109/JSSC.2006.869785; Fang S, 2005, ANAL CHEM, V77, P6528, DOI 10.1021/ac051283m; Filanoski B, 2008, LUMINESCENCE, V23, P22, DOI 10.1002/bio.1011; Haruyama T, 2006, ANAL CHIM ACTA, V568, P211, DOI 10.1016/j.aca.2005.10.026; Kim JH, 2006, ANAL CHIM ACTA, V577, P171, DOI 10.1016/j.aca.2006.06.058; Liu YC, 2008, ANAL BIOCHEM, V378, P53, DOI 10.1016/j.ab.2008.02.018; Maehana K, 2006, ANAL CHIM ACTA, V560, P24, DOI 10.1016/j.aca.2005.12.034; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; Meddahi S, 2004, THROMB RES, V114, P51, DOI 10.1016/j.thromres.2004.04.014; Milligan G, 2004, EUR J PHARM SCI, V21, P397, DOI 10.1016/j.ejps.2003.11.010; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Rea I, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3626008; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Sapsford KE, 2009, SENSOR ACTUAT B-CHEM, V139, P13, DOI 10.1016/j.snb.2008.07.026; Turner APF, 2013, CHEM SOC REV, V42, P3184, DOI 10.1039/c3cs35528d; Varghese SS, 2010, LAB CHIP, V10, P1355, DOI 10.1039/b924271f; Xia ZY, 2009, CURR OPIN BIOTECH, V20, P37, DOI 10.1016/j.copbio.2009.01.001; Xu XD, 2007, P NATL ACAD SCI USA, V104, P10264, DOI 10.1073/pnas.0701987104; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	30	10	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88399	10.1371/journal.pone.0088399	http://dx.doi.org/10.1371/journal.pone.0088399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551097	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500036
J	Anda, S; Boye, E; Grallert, B				Anda, Silje; Boye, Erik; Grallert, Beata			Cell-Cycle Analyses Using Thymidine Analogues in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; IN-VIVO; CHECKPOINT; REPAIR; MUTAGENESIS; DAMAGE	Thymidine analogues are powerful tools when studying DNA synthesis including DNA replication, repair and recombination. However, these analogues have been reported to have severe effects on cell-cycle progression and growth, the very processes being investigated in most of these studies. Here, we have analyzed the effects of 5-ethynyl-2'-deoxyuridine (EdU) and 5-Chloro-2'-deoxyuridine (CldU) using fission yeast cells and optimized the labelling procedure. We find that both analogues affect the cell cycle, but that the effects can be mitigated by using the appropriate analogue, short pulses of labelling and low concentrations. In addition, we report sequential labelling of two consecutive S phases using EdU and 5-bromo- 2'-deoxyuridine (BrdU). Furthermore, we show that detection of replicative DNA synthesis is much more sensitive than DNA-measurements by flow cytometry.	[Anda, Silje; Boye, Erik; Grallert, Beata] Oslo Univ Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Montebello, Norway	University of Oslo	Grallert, B (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Montebello, Norway.	beata.grallert@rr-research.no			Research Council of Norway; Norwegian Cancer Society; South-Eastern Norway Regional Health Authority; Radium Hospital Legacy	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; Radium Hospital Legacy	This work was supported by the Research Council of Norway, the Norwegian Cancer Society, the South-Eastern Norway Regional Health Authority and the Radium Hospital Legacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Boe CA, 2012, P NATL ACAD SCI USA, V109, P9911, DOI 10.1073/pnas.1204901109; Breunig JJ, 2007, CELL STEM CELL, V1, P612, DOI 10.1016/j.stem.2007.11.008; Chabes A, 2007, P NATL ACAD SCI USA, V104, P1183, DOI 10.1073/pnas.0610585104; Green Marc D., 2009, V521, P463, DOI [10.1007/978-1-60327-817-5_26, 10.1007/978-1-60327-815-7_26]; Hakansson P, 2006, J BIOL CHEM, V281, P1778, DOI 10.1074/jbc.M511716200; Harper Jane V., 2004, V296, P157; Hodson JA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng134; Hua H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr063; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Knutsen JHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017175; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; LASKEN RS, 1984, J BIOL CHEM, V259, P1491; Lebofsky Ronald, 2003, Briefings in Functional Genomics & Proteomics, V1, P385, DOI 10.1093/bfgp/1.4.385; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; McCready SJ, 2000, MUTAT RES-FUND MOL M, V451, P197, DOI 10.1016/S0027-5107(00)00050-6; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nilssen EA, 2003, P NATL ACAD SCI USA, V100, P10758, DOI 10.1073/pnas.1833769100; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Rhind Nicholas, 2009, V521, P509, DOI [10.1007/978-1-60327-817-5_29, 10.1007/978-1-60327-815-7_29]; Sabatinos SA, 2013, GENETICS, V193, P143, DOI 10.1534/genetics.112.145730; Sabatinos SA, 2012, MOL CELL BIOL, V32, P4986, DOI 10.1128/MCB.01060-12; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; SHIBUI S, 1989, J HISTOCHEM CYTOCHEM, V37, P1007, DOI 10.1177/37.7.2659659; SIPICZKI M, 1993, J CELL SCI, V104, P485; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Terasawa M, 2007, P NATL ACAD SCI USA, V104, P5965, DOI 10.1073/pnas.0611490104; Tuttle AH, 2010, J VIS EXP; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Verdoodt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030227; Yonemasu R, 1997, NUCLEIC ACIDS RES, V25, P1553, DOI 10.1093/nar/25.8.1553	32	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88629	10.1371/journal.pone.0088629	http://dx.doi.org/10.1371/journal.pone.0088629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551125	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000047
J	Mesa, F; O'Valle, F; Rizzo, M; Cappello, F; Donos, N; Parkar, M; Chaudhary, N; Carini, F; Munoz, R; Nibali, L				Mesa, Francisco; O'Valle, Francisco; Rizzo, Manfredi; Cappello, Francesco; Donos, Nikos; Parkar, Mohamed; Chaudhary, Navidah; Carini, Francesco; Munoz, Ricardo; Nibali, Luigi			Association between COX-2 rs 6681231 Genotype and Interleukin-6 in Periodontal Connective Tissue. A Pilot Study	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; AGGRESSIVE PERIODONTITIS; PROMOTER POLYMORPHISMS; GENE POLYMORPHISMS; IL-6 HAPLOTYPES; CYCLOOXYGENASE-2; DISEASE; RISK; SUSCEPTIBILITY; INFLAMMATION	Objectives: The aim of this pilot study was to investigate associations between IL-6 and COX-2 expression in gingival biopsies and both clinical diagnosis and genotypes in the IL-6 and COX-2 genes. Design: A case-control study included 41 gingival biopsies obtained from Caucasian patients grouped according to clinical diagnosis of gingival health (n = 10), gingivitis (n = 15) or chronic periodontitis (n = 16). Immunohistochemistry analyses were performed to determine COX-2 expression in lamina propria, IL-6 expression in lamina propria and gingival epithelium and level of inflammatory cell infiltrate. Individual DNA was extracted and genotyped by real-time PCR for IL6 SNPs rs 2069827 and rs 2069825 and for COX-2 rs 6681231. Results: The percentage of cellular COX-2 expression was associated with the extent of periodontal disease (Arbes index p = 0.026) and inflammatory infiltrate (p<0.0001). No association was observed between IL6 haplotypes and cells positive to IL-6 or COX-2 in gingival tissues. The COX-2 rs 6681231 was associated with cells positive to IL-6 in the connective tissue (p = 0.032). Conclusions: COX-2 expression in gingival tissues may be a marker of periodontal disease severity. COX-2 rs 6681231 may be associated with IL-6 local production in gingival tissues.	[Mesa, Francisco] Univ Granada, Sch Dent, Dept Periodont, Granada, Spain; [O'Valle, Francisco] Univ Granada, Sch Med & Biopathol, Dept Pathol, Granada, Spain; [O'Valle, Francisco] Univ Granada, Med Regenerat Inst IBIMER, Granada, Spain; [Rizzo, Manfredi] Univ Palermo, Dept Internal Med, Palermo, Italy; [Cappello, Francesco; Carini, Francesco] Univ Palermo, Dept Expt Med & Clin Neurosci, Sect Human Anat, Palermo, Italy; [Donos, Nikos; Parkar, Mohamed; Chaudhary, Navidah; Nibali, Luigi] UCL, Eastman Dent Inst & Hosp, Periodontol Unit, London, England; [Donos, Nikos; Parkar, Mohamed; Chaudhary, Navidah; Nibali, Luigi] UCL, Eastman Dent Inst & Hosp, Dept Clin Res, London, England; [Rizzo, Manfredi; Cappello, Francesco] Euro Mediterranean Inst Sci & Technol, Palermo, Italy; [Munoz, Ricardo] Andalusian Serv Publ Hlth, Granada, Spain	University of Granada; University of Granada; University of Granada; University of Palermo; University of Palermo; University of London; University College London; University of London; University College London	Nibali, L (corresponding author), UCL, Eastman Dent Inst & Hosp, Periodontol Unit, London, England.	l.nibali@ucl.ac.uk	OValle, Francisco/AAA-9151-2019; Mesa, Francisco/L-9712-2018; Cappello, Francesco/F-9153-2012	Mesa, Francisco/0000-0002-8293-2527; Cappello, Francesco/0000-0001-9288-1148; RIZZO, Manfredi/0000-0002-9549-8504; carini, francesco/0000-0001-9442-1671	Department of Health's National Institute of Health Research (NIHR) Biomedical Research Centres funding scheme	Department of Health's National Institute of Health Research (NIHR) Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	This study was partially undertaken at the UCL Eastman Dental Institute, which received a proportion of funding from the Department of Health's National Institute of Health Research (NIHR) Biomedical Research Centres funding scheme. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, J PERIODONTOL, V77, P1515, DOI 10.1902/jop.2006.050427; AINAMO J, 1975, INT DENT J, V25, P229; Arbes SJ, 1999, J DENT RES, V78, P1777, DOI 10.1177/00220345990780120301; Bennermo M, 2004, ATHEROSCLEROSIS, V174, P157, DOI 10.1016/j.atherosclerosis.2004.01.019; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Fife MS, 2005, GENES IMMUN, V6, P367, DOI 10.1038/sj.gene.6364186; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Hill MR, 2006, AM J RESP CRIT CARE, V174, P915, DOI 10.1164/rccm.200512-1839OC; Ho YP, 2008, J CLIN PERIODONTOL, V35, P1, DOI 10.1111/j.1600-051X.2007.01167.x; Holla LI, 2004, J PERIODONTOL, V75, P30, DOI 10.1902/jop.2004.75.1.30; Jansson H, 2006, SWED DENT J, V30, P17; Kalburgi Nagaraj B, 2010, J Oral Sci, V52, P431; Laine ML, 2010, INT J DENT, V2010, DOI 10.1155/2010/324719; Loo WTY, 2011, ARCH ORAL BIOL, V56, P1081, DOI 10.1016/j.archoralbio.2011.03.011; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Mesa F, 2012, J PERIODONTOL, V83, P1538, DOI 10.1902/jop.2012.110561; Morton RS, 2001, J PERIODONTOL, V72, P461, DOI 10.1902/jop.2001.72.4.461; Nibali L, 2013, CLIN ORAL INVEST, V17, P1235, DOI 10.1007/s00784-012-0804-3; Nibali L, 2010, J PERIODONTOL, V81, P1814, DOI 10.1902/jop.2010.100084; Nibali L, 2009, CYTOKINE, V45, P50, DOI 10.1016/j.cyto.2008.10.016; Nibali L, 2008, J PERIODONTAL RES, V43, P627, DOI 10.1111/j.1600-0765.2007.01039.x; Nikolopoulos GK, 2008, J CLIN PERIODONTOL, V35, P754, DOI 10.1111/j.1600-051X.2008.01298.x; OFFENBACHER S, 1989, J PERIODONTAL RES, V24, P63, DOI 10.1111/j.1600-0765.1989.tb00859.x; Ol KK, 2011, GENET MOL RES, V10, P810, DOI 10.4238/vol10-2gmr967; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; Schaefer AS, 2010, J DENT RES, V89, P384, DOI 10.1177/0022034509359575; Shao MY, 2009, J ZHEJIANG UNIV-SC B, V10, P920, DOI 10.1631/jzus.B0920279; Shi D, 2008, J PERIODONTOL, V79, P2340, DOI [10.1902/jop.2008.080192, 10.1902/jop.2008.080192 ]; Tipton DA, 2003, J PERIODONTOL, V74, P1754, DOI 10.1902/jop.2003.74.12.1754; Trevilatto PC, 2003, J CLIN PERIODONTOL, V30, P438, DOI 10.1034/j.1600-051X.2003.20016.x; Van Dyke Thomas E, 2005, J Int Acad Periodontol, V7, P3; Woods A, 2000, EUR HEART J, V21, P1574, DOI 10.1053/euhj.1999.2207; Xie CJ, 2009, J CLIN PERIODONTOL, V36, P198, DOI 10.1111/j.1600-051X.2008.01366.x	34	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87023	10.1371/journal.pone.0087023	http://dx.doi.org/10.1371/journal.pone.0087023			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551049	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000009
J	Ally, D; Wiss, VR; Deckert, GE; Green, D; Roychoudhury, P; Wichman, HA; Brown, CJ; Krone, SM				Ally, Dilara; Wiss, Valorie R.; Deckert, Gail E.; Green, Danielle; Roychoudhury, Pavitra; Wichman, Holly A.; Brown, Celeste J.; Krone, Stephen M.			The Impact of Spatial Structure on Viral Genomic Diversity Generated during Adaptation to Thermal Stress	PLOS ONE			English	Article							BENEFICIAL MUTATIONS; EVOLUTION; BIODIVERSITY; POPULATIONS; SELECTION; INVASION; FITNESS; MODEL	Background: Most clinical and natural microbial communities live and evolve in spatially structured environments. When changes in environmental conditions trigger evolutionary responses, spatial structure can impact the types of adaptive response and the extent to which they spread. In particular, localized competition in a spatial landscape can lead to the emergence of a larger number of different adaptive trajectories than would be found in well-mixed populations. Our goal was to determine how two levels of spatial structure affect genomic diversity in a population and how this diversity is manifested spatially. Methodology/Principal Findings: We serially transferred bacteriophage populations growing at high temperatures (40 degrees C) on agar plates for 550 generations at two levels of spatial structure. The level of spatial structure was determined by whether the physical locations of the phage subsamples were preserved or disrupted at each passage to fresh bacterial host populations. When spatial structure of the phage populations was preserved, there was significantly greater diversity on a global scale with restricted and patchy distribution. When spatial structure was disrupted with passaging to fresh hosts, beneficial mutants were spread across the entire plate. This resulted in reduced diversity, possibly due to clonal interference as the most fit mutants entered into competition on a global scale. Almost all substitutions present at the end of the adaptation in the populations with disrupted spatial structure were also present in the populations with structure preserved. Conclusions/Significance: Our results are consistent with the patchy nature of the spread of adaptive mutants in a spatial landscape. Spatial structure enhances diversity and slows fixation of beneficial mutants. This added diversity could be beneficial in fluctuating environments. We also connect observed substitutions and their effects on fitness to aspects of phage biology, and we provide evidence that some substitutions exclude each other.	[Ally, Dilara; Wiss, Valorie R.; Deckert, Gail E.; Green, Danielle; Wichman, Holly A.; Brown, Celeste J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Ally, Dilara; Wiss, Valorie R.; Deckert, Gail E.; Roychoudhury, Pavitra; Wichman, Holly A.; Brown, Celeste J.; Krone, Stephen M.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Deckert, Gail E.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Roychoudhury, Pavitra; Krone, Stephen M.] Univ Idaho, Dept Math, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Washington State University; Idaho; University of Idaho	Krone, SM (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.	krone@uidaho.edu	Roychoudhury, Pavitra/K-8841-2012	Roychoudhury, Pavitra/0000-0002-4567-8232; Green, Danielle/0000-0001-6924-3797	National Center for Research Resources [5P20RR016448-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103397-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103397] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Center for Research Resources (5P20RR016448-10) and the National Institute of General Medical Sciences (8 P20 GM103397-10) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Brown CJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-66; Bull JJ, 2000, MOL BIOL EVOL, V17, P942, DOI 10.1093/oxfordjournals.molbev.a026375; Bull JJ, 1997, GENETICS, V147, P1497; Campos PRA, 2008, EVOLUTION, V62, P1390, DOI 10.1111/j.1558-5646.2008.00380.x; Coberly LC, 2009, AM NAT, V173, pE121, DOI 10.1086/597226; De Visser JAGM, 2005, J EVOLUTION BIOL, V18, P779, DOI 10.1111/j.1420-9101.2005.00879.x; Dennehy JJ, 2007, EVOLUTION, V61, P2516, DOI 10.1111/j.1558-5646.2007.00205.x; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Fane B., 2006, BACTERIOPHAGES, P129; Gallet R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-241; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; Gordo I, 2006, GENETICA, V127, P217, DOI 10.1007/s10709-005-4012-9; Habets MGJL, 2007, P ROY SOC B-BIOL SCI, V274, P2139, DOI 10.1098/rspb.2007.0529; Habets MGJL, 2006, ECOL LETT, V9, P1041, DOI 10.1111/j.1461-0248.2006.00955.x; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Kryazhimskiy S, 2012, EVOLUTION, V66, P1931, DOI 10.1111/j.1558-5646.2011.01569.x; Lee KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025640; Martens EA, 2011, GENETICS, V189, P1045, DOI 10.1534/genetics.111.130112; Miller CR, 2011, GENETICS, V187, P185, DOI 10.1534/genetics.110.121400; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Perfeito L, 2008, BIOL LETTERS, V4, P57, DOI 10.1098/rsbl.2007.0481; Ralph P, 2010, GENETICS, V186, P647, DOI 10.1534/genetics.110.119594; Rokyta DR, 2009, J MOL EVOL, V69, P229, DOI 10.1007/s00239-009-9267-9; Rokyta DR, 2006, J BACTERIOL, V188, P1134, DOI 10.1128/JB.188.3.1134-1142.2006; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Ruboyianes MV, 2009, J VIROL, V83, P9952, DOI 10.1128/JVI.01077-09; Saxer G, 2009, P R SOC B, V276, P2065, DOI 10.1098/rspb.2008.1827; Wei W, 2005, J THEOR BIOL, V236, P335, DOI 10.1016/j.jtbi.2005.03.016; Wichman HA, 2005, GENETICS, V170, P19, DOI 10.1534/genetics.104.034488; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wichman HA, 2010, PHILOS T R SOC B, V365, P2495, DOI 10.1098/rstb.2010.0053	37	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88702	10.1371/journal.pone.0088702	http://dx.doi.org/10.1371/journal.pone.0088702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533140	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600098
J	Arason, AJ; Jonsdottir, HR; Halldorsson, S; Benediktsdottir, BE; Bergthorsson, JT; Ingthorsson, S; Baldursson, O; Sinha, S; Gudjonsson, T; Magnusson, MK				Arason, Ari Jon; Jonsdottir, Hulda R.; Halldorsson, Skarphedinn; Benediktsdottir, Berglind Eva; Bergthorsson, Jon Thor; Ingthorsson, Saevar; Baldursson, Olafur; Sinha, Satrajit; Gudjonsson, Thorarinn; Magnusson, Magnus K.			deltaNp63 Has a Role in Maintaining Epithelial Integrity in Airway Epithelium	PLOS ONE			English	Article							CELL LUNG-CANCER; STEM-CELLS; BASAL-CELLS; P63; DIFFERENTIATION; EXPRESSION; PROLIFERATION; DELTA-NP63-ALPHA; ESOPHAGEAL; MIGRATION	The upper airways are lined with a pseudostratified bronchial epithelium that forms a barrier against unwanted substances in breathing air. The transcription factor p63, which is important for stratification of skin epithelium, has been shown to be expressed in basal cells of the lungs and its Delta N isoform is recognized as a key player in squamous cell lung cancer. However, the role of p63 in formation and maintenance of bronchial epithelia is largely unknown. The objective of the current study was to determine the expression pattern of the Delta N and TA isoforms of p63 and the role of p63 in the development and maintenance of pseudostratified lung epithelium in situ and in culture. We used a human bronchial epithelial cell line with basal cell characteristics (VA10) to model bronchial epithelium in an air-liquid interface culture (ALI) and performed a lentiviral-based silencing of p63 to characterize the functional and phenotypic consequences of p63 loss. We demonstrate that Delta Np63 is the major isoform in the human lung and its expression was exclusively found in the basal cells lining the basement membrane of the bronchial epithelium. Knockdown of p63 affected proliferation and migration of VA10 cells and facilitated cellular senescence. Expression of p63 is critical for epithelial repair as demonstrated by wound healing assays. Importantly, generation of pseudostratified VA10 epithelium in the ALI setup depended on p63 expression and goblet cell differentiation, which can be induced by IL-13 stimulation, was abolished by the p63 knockdown. After knockdown of p63 in primary bronchial epithelial cells they did not proliferate and showed marked senescence. We conclude that these results strongly implicate p63 in the formation and maintenance of differentiated pseudostratified bronchial epithelium.	[Arason, Ari Jon; Bergthorsson, Jon Thor; Ingthorsson, Saevar; Gudjonsson, Thorarinn; Magnusson, Magnus K.] Univ Iceland, Fac Med, Stem Cell Res Unit, Biomed Ctr, Reykjavik, Iceland; [Benediktsdottir, Berglind Eva] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland; [Magnusson, Magnus K.] Univ Iceland, Fac Med, Dept Pharmacol & Toxicol, Reykjavik, Iceland; [Halldorsson, Skarphedinn] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Arason, Ari Jon; Ingthorsson, Saevar; Gudjonsson, Thorarinn; Magnusson, Magnus K.] Landspitali Univ Hosp, Dept Lab Hematol, Reykjavik, Iceland; [Baldursson, Olafur] Landspitali Univ Hosp, Dept Pulm Med, Reykjavik, Iceland; [Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14214 USA; [Jonsdottir, Hulda R.] Kantonal Hosp, Inst Immunobiol, St Gallen, Switzerland	University of Iceland; University of Iceland; University of Iceland; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Kantonsspital St. Gallen	Magnusson, MK (corresponding author), Univ Iceland, Fac Med, Stem Cell Res Unit, Biomed Ctr, Reykjavik, Iceland.	magnuskm@hi.is	Benediktsdottir, Berglind/L-5266-2015; Halldórsson, Skarphéðinn/AAD-7217-2019	Benediktsdottir, Berglind Eva/0000-0002-1044-5113; Bergthorsson, Jon Thor/0000-0002-0560-2639; Ingthorsson, Saevar/0000-0001-8480-9680; Gudjonsson, Thorarinn/0000-0001-9645-9665; Jonsdottir, Hulda R./0000-0001-7509-5970; Magnusson, Magnus Karl/0000-0001-8593-4934	Icelandic Research Fund [120423021]; Landspitali University Hospital Research Fund; University of Iceland Research Fund; Eimskip University Fund	Icelandic Research Fund; Landspitali University Hospital Research Fund; University of Iceland Research Fund; Eimskip University Fund	This work was supported by grants from Icelandic Research Fund (grant number 120423021), Landspitali University Hospital Research Fund, University of Iceland Research Fund and Eimskip University Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri CE, 2003, J BIOL CHEM, V278, P51408, DOI 10.1074/jbc.M309943200; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Choi HR, 2002, HUM PATHOL, V33, P158, DOI 10.1053/hupa.2002.30722; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; DeCastro AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.37; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Franzdottir SR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-162; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Glickman JN, 2001, HUM PATHOL, V32, P1157, DOI 10.1053/hupa.2001.28951; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gu XL, 2008, CANCER LETT, V263, P26, DOI 10.1016/j.canlet.2007.12.011; Halldorsson S, 2007, IN VITRO CELL DEV-AN, V43, P283, DOI 10.1007/s11626-007-9050-4; Halldorsson S, 2010, AM J RESP CELL MOL, V42, P62, DOI 10.1165/rcmb.2008-0357OC; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kettunen E, 2000, CANCER GENET CYTOGEN, V117, P66, DOI 10.1016/S0165-4608(99)00146-6; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Konigshoff M, 2011, RESPIRATION, V81, P353, DOI 10.1159/000326299; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lechner JF, 1985, J TISSUE CULTURE MET, V9; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ooi AT, 2010, CANCER RES, V70, P6639, DOI 10.1158/0008-5472.CAN-10-0455; Park JJ, 2000, AM J SURG PATHOL, V24, P1414, DOI 10.1097/00000478-200010000-00012; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Petitjean Audrey, 2006, Bull Cancer, V93, pE126; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; RANDELL SH, 1991, AM J RESP CELL MOL, V4, P544, DOI 10.1165/ajrcmb/4.6.544; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Thavagnanam S, 2011, PEDIATR RES, V69, P95, DOI 10.1203/PDR.0b013e318204edb5; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Wang H, 2012, NEOPLASMA, V59, P416, DOI 10.4149/neo_2012_054; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	50	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88683	10.1371/journal.pone.0088683	http://dx.doi.org/10.1371/journal.pone.0088683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533135	Green Published, gold			2022-12-27	WOS:000331262600093
J	Corbin, JA; Bhaskar, V; Goldfine, ID; Bedinger, DH; Lau, A; Michelson, K; Gross, LM; Maddux, BA; Kuan, HF; Tran, C; Lao, L; Handa, M; Watson, SR; Narasimha, AJ; Zhu, S; Levy, R; Webster, L; Wijesuriya, SD; Liu, NC; Wu, XR; Chemla-Vogel, D; Lee, SR; Wong, S; Wilcock, D; White, ML				Corbin, John A.; Bhaskar, Vinay; Goldfine, Ira D.; Bedinger, Daniel H.; Lau, Angela; Michelson, Kristen; Gross, Lisa M.; Maddux, Betty A.; Kuan, Hua F.; Tran, Catarina; Lao, Llewelyn; Handa, Masahisa; Watson, Susan R.; Narasimha, Ajay J.; Zhu, Shirley; Levy, Raphael; Webster, Lynn; Wijesuriya, Sujeewa D.; Liu, Naichi; Wu, Xiaorong; Chemla-Vogel, David; Lee, Steve R.; Wong, Steve; Wilcock, Diane; White, Mark L.			Improved Glucose Metabolism In Vitro and In Vivo by an Allosteric Monoclonal Antibody That Increases Insulin Receptor Binding Affinity	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; RESISTANCE; KINASE; CELLS; ANALOGS; AUTOANTIBODIES; HYPOGLYCEMIA; MODULATORS; PATIENT; DISEASE	Previously we reported studies of XMetA, an agonist antibody to the insulin receptor (INSR). We have now utilized phage display to identify XMetS, a novel monoclonal antibody to the INSR. Biophysical studies demonstrated that XMetS bound to the human and mouse INSR with picomolar affinity. Unlike monoclonal antibody XMetA, XMetS alone had little or no agonist effect on the INSR. However, XMetS was a strong positive allosteric modulator of the INSR that increased the binding affinity for insulin nearly 20-fold. XMetS potentiated insulin-stimulated INSR signaling, similar to 15-fold or greater including; autophosphorylation of the INSR, phosphorylation of Akt, a major enzyme in the metabolic pathway, and phosphorylation of Erk, a major enzyme in the growth pathway. The enhanced signaling effects of XMetS were more pronounced with Akt than with Erk. In cultured cells, XMetS also enhanced insulin-stimulated glucose transport. In contrast to its effects on the INSR, XMetS did not potentiate IGF-1 activation of the IGF-1 receptor. We studied the effect of XMetS treatment in two mouse models of insulin resistance and diabetes. The first was the diet induced obesity mouse, a hyperinsulinemic, insulin resistant animal, and the second was the multi-low dose streptozotocin/high-fat diet mouse, an insulinopenic, insulin resistant animal. In both models, XMetS normalized fasting blood glucose levels and glucose tolerance. In concert with its ability to potentiate insulin action at the INSR, XMetS reduced insulin and C-peptide levels in both mouse models. XMetS improved the response to exogenous insulin without causing hypoglycemia. These data indicate that an allosteric monoclonal antibody can be generated that markedly enhances the binding affinity of insulin to the INSR. These data also suggest that an INSR monoclonal antibody with these characteristics may have the potential to both improve glucose metabolism in insulinopenic type 2 diabetes mellitus and correct compensatory hyperinsulinism in insulin resistant conditions.	[Corbin, John A.; Bhaskar, Vinay; Bedinger, Daniel H.; Lau, Angela; Michelson, Kristen; Gross, Lisa M.; Kuan, Hua F.; Tran, Catarina; Lao, Llewelyn; Handa, Masahisa; Watson, Susan R.; Narasimha, Ajay J.; Zhu, Shirley; Levy, Raphael; Webster, Lynn; Wijesuriya, Sujeewa D.; Liu, Naichi; Wu, Xiaorong; Chemla-Vogel, David; Lee, Steve R.; Wong, Steve; Wilcock, Diane; White, Mark L.] Xoma Corp, Dept Preclin Res, Berkeley, CA 94710 USA; [Goldfine, Ira D.; Maddux, Betty A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco	Corbin, JA (corresponding author), Xoma Corp, Dept Preclin Res, Berkeley, CA 94710 USA.	corbinjohn@gmail.com		Bedinger, Daniel/0000-0001-5009-9369	XOMA Corporation	XOMA Corporation	This research was funded by XOMA Corporation. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken R, 2001, ANTIBODY PHAGE DISPL; Arioglu E, 2002, MEDICINE, V81, P87, DOI 10.1097/00005792-200203000-00001; Arulmozhi DK, 2008, J PHARM PHARMACOL, V60, P1167, DOI 10.1211/jpp.60.9.0008; Authier F, 1998, BIOCHEM J, V332, P421, DOI 10.1042/bj3320421; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bhaskar V, 2012, DIABETES OBES METAB; Bhaskar V, 2012, DIABETES, V61, P1263, DOI 10.2337/db11-1578; BRUNETTI A, 1989, BIOCHEM BIOPH RES CO, V165, P212, DOI 10.1016/0006-291X(89)91056-5; Cazorla M, 2011, BRIT J PHARMACOL, V162, P947, DOI 10.1111/j.1476-5381.2010.01094.x; Centers for Disease Control and Prevention (CDC), 2011, NAT DIAB FACT SHEET; CHEN YDI, 1988, J CLIN INVEST, V82, P21, DOI 10.1172/JCI113572; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Colquhoun D, 2007, TRENDS PHARMACOL SCI, V28, P608, DOI 10.1016/j.tips.2007.09.011; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; DEPIRRO R, 1984, DIABETES, V33, P301, DOI 10.2337/diabetes.33.3.301; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; FLIER JS, 1975, SCIENCE, V190, P63, DOI 10.1126/science.170678; FORSAYETH JR, 1987, P NATL ACAD SCI USA, V84, P3448, DOI 10.1073/pnas.84.10.3448; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Goldfine I D, 1986, Horiz Biochem Biophys, V8, P471; Hansen BF, 1996, BIOCHEM J, V315, P271; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; KADOWAKI T, 1988, SCIENCE, V240, P787, DOI 10.1126/science.2834824; KAHN CR, 1977, J CLIN INVEST, V60, P1094, DOI 10.1172/JCI108861; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; KOLTERMAN OG, 1981, J CLIN INVEST, V68, P957, DOI 10.1172/JCI110350; Koschubs T, 2012, BIOCHEM J, V442, P483, DOI 10.1042/BJ20111317; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lupsa BC, 2009, MEDICINE, V88, P141, DOI 10.1097/MD.0b013e3181a5b42e; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; MARCHANDBRUSTEL YL, 1978, DIABETOLOGIA, V14, P311, DOI 10.1007/BF01223022; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MORGAN DO, 1986, BIOCHEMISTRY-US, V25, P1364, DOI 10.1021/bi00354a026; Rathanaswami P, 2008, ANAL BIOCHEM, V373, P52, DOI 10.1016/j.ab.2007.08.014; Reaven G M, 1978, Adv Metab Disord, V9, P313; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ryan CJ, 2008, PROSTATE, V68, P1232, DOI 10.1002/pros.20789; SCHILD HO, 1947, BRIT J PHARM CHEMOTH, V2, P189, DOI 10.1111/j.1476-5381.1947.tb00336.x; Sciacca Laura, 2012, Front Endocrinol (Lausanne), V3, P21, DOI 10.3389/fendo.2012.00021; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SIDDLE K, 1987, BIOCHEM SOC T, V15, P47, DOI 10.1042/bst0150047; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257; Ussar S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003447; Vigneri R, 2012, DIABETES, V61, P984, DOI 10.2337/db12-0192; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Xie L, 2005, J IMMUNOL METHODS, V304, P1, DOI 10.1016/j.jim.2005.04.009; ZICK Y, 1984, J BIOL CHEM, V259, P4396; Zloza A, 2003, BLOOD, V102, P2156, DOI 10.1182/blood-2002-07-1972	59	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88684	10.1371/journal.pone.0088684	http://dx.doi.org/10.1371/journal.pone.0088684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533136	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600094
J	Domokos, G; Jerolmack, DJ; Sipos, AA; Torok, A				Domokos, Gabor; Jerolmack, Douglas J.; Sipos, Andras A.; Toeroek, Akos			How River Rocks Round: Resolving the Shape-Size Paradox	PLOS ONE			English	Article							ABRASION; PEBBLES; GRAVEL; MODEL; PARTICLES; TRANSPORT; TOOLBOX	River-bed sediments display two universal downstream trends: fining, in which particle size decreases; and rounding, where pebble shapes evolve toward ellipsoids. Rounding is known to result from transport-induced abrasion; however many researchers argue that the contribution of abrasion to downstream fining is negligible. This presents a paradox: downstream shape change indicates substantial abrasion, while size change apparently rules it out. Here we use laboratory experiments and numerical modeling to show quantitatively that pebble abrasion is a curvature-driven flow problem. As a consequence, abrasion occurs in two well-separated phases: first, pebble edges rapidly round without any change in axis dimensions until the shape becomes entirely convex; and second, axis dimensions are then slowly reduced while the particle remains convex. Explicit study of pebble shape evolution helps resolve the shape-size paradox by reconciling discrepancies between laboratory and field studies, and enhances our ability to decipher the transport history of a river rock.	[Domokos, Gabor; Sipos, Andras A.] Budapest Univ Technol & Econ, Dept Mech Mat & Struct, Budapest, Hungary; [Jerolmack, Douglas J.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Toeroek, Akos] Budapest Univ Technol & Econ, Dept Construct Mat & Engn Geol, Budapest, Hungary	Budapest University of Technology & Economics; University of Pennsylvania; Budapest University of Technology & Economics	Jerolmack, DJ (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	sediment@sas.upenn.edu	Sipos, Andras A./H-1370-2012; Torok, Akos/H-9136-2012; Török, Ákos/P-4167-2019	Sipos, Andras A./0000-0003-0440-2165; Torok, Akos/0000-0002-5394-4510; Török, Ákos/0000-0002-5394-4510	OTKA [T104601]; NSF [EAR-1224943]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NSF(National Science Foundation (NSF))	The authors gratefully acknowledge support for this work through OTKA grant T104601 to GD and AS, and NSF agreement EAR-1224943 to DJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1979, SCIENCE, V203, P171, DOI 10.1126/science.203.4376.171; ANDERSON RS, 1986, GEOL SOC AM BULL, V97, P1270, DOI 10.1130/0016-7606(1986)97<1270:EPDTPE>2.0.CO;2; Attal M, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2009JF001328; Bloore F, 1977, MATH GEOL, P113, DOI [DOI 10.1007/BF02312507, 10.1007/8E02312507]; Blott SJ, 2008, SEDIMENTOLOGY, V55, P31, DOI 10.1111/j.1365-3091.2007.00892.x; Boggs Jr S, 2006, SEDIMENTOLOGY STRATI; COLMAN SM, 1983, SCIENCE, V221, P263, DOI 10.1126/science.221.4607.263; Domokos G, 2012, P ROY SOC A-MATH PHY, V468, P3059, DOI 10.1098/rspa.2011.0562; Domokos G, 2009, ASTROPHYS J LETT, V699, pL13, DOI 10.1088/0004-637X/699/1/L13; Domokos G., 2013, GEOMETRICAL PHYS MOD; Domokos G., 2009, PERIOD POL ARCH, V40, P3, DOI [DOI 10.3311/PP.AR.2009-1.01, 10.3311/pp.ar.2009-1.01]; Durian D, 2006, PHYS REV LETT, V97, DOI [10.1103/PhysRev-Lett.97.028001, DOI 10.1103/PHYSREV-LETT.97.028001]; Ferguson R, 1996, GEOLOGY, V24, P179, DOI 10.1130/0091-7613(1996)024<0179:FEFRDF>2.3.CO;2; FIREY WJ, 1974, MATHEMATIKA, V21, P1, DOI 10.1112/S0025579300005714; Fourier M, 1822, THEORIE ANALITIQUE C; Giga Y., 2006, SURFACE EVOLUTION EQ; Hamilton R. S., 1994, TRIBUTE ILYA BAKELMA, V3, P69; Hoey TB, 1999, J SEDIMENT RES, V69, P40, DOI 10.2110/jsr.69.40; Jerolmack DJ, 2013, SCIENCE, V340, P1055, DOI 10.1126/science.1239343; Jerolmack DJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001821; Jerolmack DJ, 2010, GEOLOGY, V38, P719, DOI 10.1130/G30922.1; John F, 1986, PARTIAL DIFFERENTIAL; KARDAR M, 1986, PHYS REV LETT, V56, P889, DOI 10.1103/PhysRevLett.56.889; KODAMA Y, 1994, J SEDIMENT RES A, V64, P76, DOI 10.2110/jsr.64.76; Krapivsky PL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031119; Krumbein WC, 1941, J GEOL, V49, P482, DOI 10.1086/624985; Krynine P. D., 1960, GEOL SOC AM BULL, V71, P1721, DOI DOI 10.1130/0016-7606(1960)71[1721:OTAOSA]2.0.CO;2; KUENEN PH, 1956, J GEOL, V64, P336, DOI 10.1086/626370; Lewin J, 2002, EARTH SURF PROC LAND, V27, P145, DOI 10.1002/esp.306; Mitchell IM, 2008, J SCI COMPUT, V35, P300, DOI 10.1007/s10915-007-9174-4; Morris PH, 1999, EARTH SURF PROC LAND, V24, P835, DOI 10.1002/(SICI)1096-9837(199908)24:9<835::AID-ESP15>3.0.CO;2-G; PAOLA C, 1992, SCIENCE, V258, P1757, DOI 10.1126/science.258.5089.1757; PARKER G, 1991, J HYDRAUL ENG-ASCE, V117, P131, DOI 10.1061/(ASCE)0733-9429(1991)117:2(131); Roth AE, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031303; Seal R, 1997, J HYDRAUL ENG-ASCE, V123, P874, DOI 10.1061/(ASCE)0733-9429(1997)123:10(874); Sternberg H., 1875, Z BAUWESEN, V25, P483; Szabo T, 2013, J GEOPHYS RES-EARTH, V118, P2059, DOI 10.1002/jgrf.20142; Torok A, 2002, GEOL SOC SPEC PUBL, V205, P363, DOI 10.1144/GSL.SP.2002.205.01.26; Varkonyi PL, 2011, IMA J APPL MATH, V76, P47, DOI 10.1093/imamat/hxq066; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298; Wang ZT, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031304; Wentworth CK, 1919, J GEOL, V27, P507, DOI 10.1086/622676; Williams RME, 2013, SCIENCE, V340, P1068, DOI 10.1126/science.1237317; Zingg Theodor., 1935, SCHWEIZ MINER PETROG, V15, P39, DOI DOI 10.3929/ETHZ-A-000103455	45	55	56	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88657	10.1371/journal.pone.0088657	http://dx.doi.org/10.1371/journal.pone.0088657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533132	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600090
J	Duran-Aniotz, C; Morales, R; Moreno-Gonzalez, I; Hu, PP; Fedynyshyn, J; Soto, C				Duran-Aniotz, Claudia; Morales, Rodrigo; Moreno-Gonzalez, Ines; Hu, Ping Ping; Fedynyshyn, Joseph; Soto, Claudio			Aggregate-Depleted Brain Fails to Induce A beta Deposition in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID DEPOSITION; PRION DISEASES; PROTEIN; TRANSMISSION; PATHOGENESIS; MECHANISMS; PATHOLOGY; OLIGOMERS	Recent studies in animal models of Alzheimer's disease (AD) show that amyloid-beta (A beta) misfolding can be transmissible; however, the mechanisms by which this process occurs have not been fully explored. The goal of this study was to analyze whether depletion of aggregates from an AD brain suppresses its in vivo "seeding'' capability. Removal of aggregates was performed by using the Aggregate Specific Reagent 1 (ASR1) compound which has been previously described to specifically bind misfolded species. Our results show that pre-treatment with ASR1-coupled magnetic beads reduces the in vivo misfolding inducing capability of an AD brain extract. These findings shed light respect to the active principle responsible for the prion-like spreading of Alzheimer's amyloid pathology and open the possibility of using seeds-capturing reagents as a promising target for AD treatment.	[Duran-Aniotz, Claudia; Morales, Rodrigo; Moreno-Gonzalez, Ines; Hu, Ping Ping; Soto, Claudio] Univ Texas Houston, Sch Med, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77004 USA; [Duran-Aniotz, Claudia] Univ Los Andes, Fac Med, Santiago, Chile; [Hu, Ping Ping] Southwest Univ, Coll Life Sci, Educ Minist, Key Lab Luminescence & Real Time Anal, Chongqing, Peoples R China; [Fedynyshyn, Joseph] Novartis Vaccines & Diagnost, Emeryville, CA USA	University of Texas System; University of Texas Health Science Center Houston; Universidad de los Andes - Chile; Southwest University - China; Novartis	Soto, C (corresponding author), Univ Texas Houston, Sch Med, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77004 USA.	Claudio.Soto@uth.tmc.edu	Moreno-Gonzalez, Ines/AAO-1694-2021; Morales, Rodrigo/K-7173-2015; Moreno-Gonzalez, Ines/AAA-2222-2019	Moreno-Gonzalez, Ines/0000-0003-3875-0889; Duran-Aniotz, Claudia/0000-0003-2503-8366	Novartis Vaccines and Diagnostics; Alzheimer's Association [MNIRGD-12-243075]	Novartis Vaccines and Diagnostics; Alzheimer's Association(Alzheimer's Association)	This work was funded by a grant from Novartis Vaccines and Diagnostics to CS and a grant from the Alzheimer's Association (MNIRGD-12-243075) to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cohen AD, 2009, LETT DRUG DES DISCOV, V6, P437, DOI 10.2174/157018009789057526; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Duran-Aniotz C, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-76; Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64; Estrada LD, 2007, CURR TOP MED CHEM, V7, P115, DOI 10.2174/156802607779318262; Estus S, 2002, J ALZHEIMERS DIS, V4, P133, DOI 10.3233/JAD-2002-4302; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Gomez-Isla Teresa, 2008, Handb Clin Neurol, V89, P233, DOI 10.1016/S0072-9752(07)01222-5; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Heikenwalder M, 2007, J NEUROSCI RES, V85, P2714, DOI 10.1002/jnr.21246; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Moore BD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt121; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Murray AN, 2013, PROTEIN SCI, DOI [10.1002/pro.2339, DOI 10.1002/PR0.2339]; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rosen RF, 2012, J NEUROCHEM, V120, P660, DOI 10.1111/j.1471-4159.2011.07551.x; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Yam AY, 2011, BIOCHEMISTRY-US, V50, P4322, DOI 10.1021/bi200215j	34	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89014	10.1371/journal.pone.0089014	http://dx.doi.org/10.1371/journal.pone.0089014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533166	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600126
J	Khushi, M; Liddle, C; Clarke, CL; Graham, JD				Khushi, Matloob; Liddle, Christopher; Clarke, Christine L.; Graham, J. Dinny			Binding Sites Analyser (BiSA): Software for Genomic Binding Sites Archiving and Overlap Analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CHIP-SEQ; ELEMENTS; SYSTEM	Genome-wide mapping of transcription factor binding and histone modification reveals complex patterns of interactions. Identifying overlaps in binding patterns by different factors is a major objective of genomic studies, but existing methods to archive large numbers of datasets in a personalised database lack sophistication and utility. Therefore we have developed transcription factor DNA binding site analyser software (BiSA), for archiving of binding regions and easy identification of overlap with or proximity to other regions of interest. Analysis results can be restricted by chromosome or base pair overlap between regions or maximum distance between binding peaks. BiSA is capable of reporting overlapping regions that share common base pairs; regions that are nearby; regions that are not overlapping; and average region sizes. BiSA can identify genes located near binding regions of interest, genomic features near a gene or locus of interest and statistical significance of overlapping regions can also be reported. Overlapping results can be visualized as Venn diagrams. A major strength of BiSA is that it is supported by a comprehensive database of publicly available transcription factor binding sites and histone modifications, which can be directly compared to user data. The documentation and source code are available on http://bisa.sourceforge.net	[Khushi, Matloob; Clarke, Christine L.; Graham, J. Dinny] Univ Sydney, Sydney Med Sch, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Khushi, Matloob; Liddle, Christopher; Clarke, Christine L.; Graham, J. Dinny] Westmead Millennium Inst, Westmead, NSW, Australia; [Liddle, Christopher] Univ Sydney, Sydney Med Sch, Storr Liver Unit, Westmead, NSW 2145, Australia; [Khushi, Matloob] Univ Sydney, Sydney Med Sch, Australian Breast Canc Tissue Bank, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Khushi, M (corresponding author), Univ Sydney, Sydney Med Sch, Westmead Inst Canc Res, Westmead, NSW 2145, Australia.	mkhushi@uni.sydney.edu.au	Khushi, Matloob/H-2725-2019	Clarke, Christine/0000-0001-7568-111X; Khushi, Matloob/0000-0001-7792-2327; Graham, Dinny/0000-0002-0269-0493	Australian Postgraduate Award (APA); Westmead Medical Research Foundation (WMRF) Top-Up Grant	Australian Postgraduate Award (APA)(Australian Government); Westmead Medical Research Foundation (WMRF) Top-Up Grant	MK is supported by Australian Postgraduate Award (APA) and Westmead Medical Research Foundation (WMRF) Top-Up Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Frietze S, 2010, J BIOL CHEM, V285, P1393, DOI 10.1074/jbc.M109.063032; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Khushi M, 2012, BIOPRESERV BIOBANK, V10, P37, DOI 10.1089/bio.2011.0038; Khushi M, 2012, CELL TISSUE BANK, V13, P9, DOI 10.1007/s10561-011-9240-x; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Meyer CA, 2012, MOL ENDOCRINOL, V26, P1651, DOI 10.1210/me.2012-1150; Microsoft, 2013, SQL SERV EXPR ED; MinGW, 2013, MINGW MIN GNU WIND; Motallebipour M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r129; Project C, 2013, NUCL REC CISTR; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Renaud G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026715; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823	22	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87301	10.1371/journal.pone.0087301	http://dx.doi.org/10.1371/journal.pone.0087301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533055	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600013
J	Lin, L; Shen, Q; Xue, T; Duan, XN; Fu, X; Yu, CL				Lin, Lin; Shen, Qi; Xue, Tao; Duan, Xiaoning; Fu, Xin; Yu, Changlong			Sonic Hedgehog Improves Redifferentiation of Dedifferentiated Chondrocytes for Articular Cartilage Repair	PLOS ONE			English	Article							HUMAN OSTEOARTHRITIC CARTILAGE; CHONDROGENIC PROGENITOR CELLS; LONG-TERM CULTURE; SOMITIC CHONDROGENESIS; FEEDBACK LOOP; LIMB BUD; COLLAGEN; GROWTH; EXPRESSION; PROTEIN	Sonic hedgehog (Shh) is involved in the induction of early cartilaginous differentiation of mesenchymal cells in the limb. We investigated whether Shh could promote redifferentiation of dedifferentiated chondrocytes and have a favorable effect on the regeneration of cartilage. Articular chondrocytes of rats were separated and cultured. The redifferentiation of dedifferentiated chondrocytes transfected with Shh was evaluated using monolayer and pellet culture system. The signaling molecules (Ptc 1, Gli 1 and Sox9) of the hedgehog pathway were investigated. A rat model of articular cartilage defect was used to evaluate cartilage repair after transplantation with dedifferentiated chondrocytes. After Shh gene transfer, the hedgehog pathway was upregulated in dedifferentiated chondrocytes. Real time-PCR and western blot analysis verified the stronger expression of Ptc1, Gli1 and Sox9 in Shh transfected cells. Shh upregulates the Shh signaling pathway and multiple cytokines (bone morphogenetic protein 2 and insulin-like growth factor 1) in dedifferentiated chondrocytes. After transplantation in the joint, histologic analysis of the regenerative tissues revealed that significantly better cartilage repair in rats transplanted with Shh transfected cells. These data suggest that Shh could induce redifferentiation of dedifferentiated chondrocytes through up-regulating Shh signaling pathway, and have considerable therapeutic potential in cartilage repair.	[Lin, Lin; Xue, Tao; Duan, Xiaoning; Fu, Xin; Yu, Changlong] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China; [Shen, Qi] Peking Univ, Hosp 1, Inst Urol, Beijing 100871, Peoples R China	Peking University; Peking University	Lin, L (corresponding author), Peking Univ, Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China.	simon.lin2003@163.com			National Natural Scientific Foundation of China [30900711]; Beijing NOVA Program [2008B04]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVA Program(Beijing Municipal Science & Technology Commission)	This research was supported by the National Natural Scientific Foundation of China (30900711) and the Beijing NOVA Program (2008B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 1999, ARTHRITIS RHEUM, V42, P1443, DOI 10.1002/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO;2-A; AIGNER T, 1993, J CLIN INVEST, V91, P829, DOI 10.1172/JCI116303; Aigner T, 1997, OSTEOARTHR CARTILAGE, V5, P183, DOI 10.1016/S1063-4584(97)80013-1; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Enomoto-Iwamoto M, 2000, J BONE MINER RES, V15, P1659, DOI 10.1359/jbmr.2000.15.9.1659; Gelse K, 2003, ARTHRITIS RHEUM-US, V48, P430, DOI 10.1002/art.10759; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; Iwakura T, 2013, ARTHRITIS RHEUM-US, V65, P408, DOI 10.1002/art.37768; Kawai S, 2001, BONE, V29, P54, DOI 10.1016/S8756-3282(01)00470-7; Kellner K, 2002, TISSUE ENG, V8, P561, DOI 10.1089/107632702760240481; Koelling S, 2010, ARTHRITIS RHEUM-US, V62, P1077, DOI 10.1002/art.27311; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Lin L, 2008, ARTHRITIS RHEUM-US, V58, P1067, DOI 10.1002/art.23380; Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sailor LZ, 1996, J ORTHOPAED RES, V14, P937, DOI 10.1002/jor.1100140614; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Stott NS, 1997, J CELL SCI, V110, P2691; Tavella S, 2004, J BONE MINER RES, V19, P1678, DOI 10.1359/JBMR.040706; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002	30	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88550	10.1371/journal.pone.0088550	http://dx.doi.org/10.1371/journal.pone.0088550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533105	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600063
J	Miao, JR; Niu, JK; Wang, KH; Xiao, YL; Du, Y; Zhou, LF; Duan, LP; Li, S; Yang, G; Chen, LF; Tong, MX; Miao, YL				Miao, Jiarong; Niu, Junkun; Wang, Kunhua; Xiao, Yuliang; Du, Yan; Zhou, Lifeng; Duan, Liping; Li, Shuan; Yang, Gang; Chen, Lifang; Tong, Mingxia; Miao, Yinglei			Heat Shock Factor 2 Levels Are Associated with the Severity of Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BIOMARKERS; INHIBITION; MICROBIOTA	Background and Aims: The morbidity of ulcerative colitis (UC) is increasing in China every year. In addition, there is a lack of accurate diagnostic indices with which to evaluate the activity of the disease. The aim of this study was to identify UC-associated proteins as biomarkers for the diagnosis, and objective assessment of disease activity. Methods: Differential expression of serum proteins from UC patients compared to normal controls was analyzed by two-dimensional electrophoresis (2-DE) and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF-MS). The expression of heat shock factor 2(HSF2) in colonic mucosa in Crohn's disease, Behcet's disease, ulcerative colitis, intestinal tuberculosis, infective enteritis, intestinal lymphoma, and normal controls was investigated by immunohistochemistry (IHC). The expression of the HSF2 in colonic mucosa of UC subjects with varying severity of disease was measured by real time-PCR and Western Blots. The expression of HSF2 was inhibited by HSF2 small interfering RNA (siRNA) transfection in Caco-2 cells. The concentrations of HSF2, IL-1 beta, and TNF-alpha in serum and IL-1 beta, and TNF-alpha in the supernatants of transfected Caco-2 cells were determined by ELISA. Results: HSF2 was differentially expressed in UC patients compared to normal controls. HSF2 expression was significantly higher in the intestinal mucosa of UC patients compared to other six groups. The results of immunohistochemistry, real time-PCR, Western Blots, and ELISA showed that the expression of HSF2 increased in parallel with the severity of UC. The serum concentration of HSF2 also positively correlated with levels of IL-1 beta and TNF-alpha. After down-regulation expression of HSF2 in Caco-2 cells by RNA interference, the productions of IL-1 beta and TNF-alpha stimulated by lipopolysaccharide (LPS) increased dramatically. Conclusions: HSF2 appears to be a potential novel molecular marker for UC activity, and may provide a basis for studies on the pathogenesis and novel therapeutic targets for UC.	[Miao, Jiarong; Niu, Junkun; Xiao, Yuliang; Zhou, Lifeng; Duan, Liping; Li, Shuan; Yang, Gang; Chen, Lifang; Tong, Mingxia; Miao, Yinglei] Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Peoples R China; [Wang, Kunhua] Kunming Med Univ, Affiliated Hosp 1, Dept Gen Surg, Kunming, Peoples R China; [Du, Yan] Kunming Med Univ, Affiliated Hosp 1, Dept Clin Lab, Kunming, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University	Miao, YL (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Peoples R China.	myldu@sina.com		Niu, Junkun/0000-0001-9458-0138	National Natural Science Foundation of China [81260074/H0310, 81160055/H0310]; Confederative Special Foundation of Science & Technology Department of Yunnan Province and Kunming Medical College [2011FB183, 2007C0010R]; Medical academic leader of Yunnan Provincial Bureau of Health [D-201215]; Social development of science and technology projects of Yunnan Province [2013CA021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Confederative Special Foundation of Science & Technology Department of Yunnan Province and Kunming Medical College; Medical academic leader of Yunnan Provincial Bureau of Health; Social development of science and technology projects of Yunnan Province	This work was supported by National Natural Science Foundation of China (81260074/H0310, 81160055/H0310), Confederative Special Foundation of Science & Technology Department of Yunnan Province and Kunming Medical College (2011FB183, 2007C0010R), Medical academic leader of Yunnan Provincial Bureau of Health (D-201215) and Social development of science and technology projects of Yunnan Province (2013CA021). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Braus NA, 2009, CLIN IMMUNOL, V132, P1, DOI 10.1016/j.clim.2009.02.006; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Calligaris D, 2011, J PROTEOMICS, V74, P920, DOI 10.1016/j.jprot.2011.03.030; Chen Z, 2010, GENES IMMUN, V11, P573, DOI 10.1038/gene.2010.16; Chubet RG, 1996, BIOTECHNIQUES, V20, P136; Fan NJ, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-45; Florholmen J, 2011, SCAND J GASTROENTERO, V46, P1407, DOI 10.3109/00365521.2011.627449; Geboes K, 2008, INFLAMM BOWEL DIS, V14, pS168, DOI 10.1002/ibd.20598; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034349; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hatsugai M, 2010, J GASTROENTEROL, V45, P488, DOI 10.1007/s00535-009-0183-y; Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001; Judd TA, 2011, J GASTROEN HEPATOL, V26, P1493, DOI 10.1111/j.1440-1746.2011.06846.x; Koboziev I, 2010, ANN NY ACAD SCI, V1207, pE86, DOI 10.1111/j.1749-6632.2010.05711.x; Lemmens B, 2013, INFLAMM BOWEL DIS, V19, P1194, DOI 10.1097/MIB.0b013e318280e75f; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Malago JJ, 2002, CELL STRESS CHAPERON, V7, P191, DOI 10.1379/1466-1268(2002)007<0191:THSRAC>2.0.CO;2; Millares P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033590; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Nielsen MM, 2005, J INSECT PHYSIOL, V51, P1320, DOI 10.1016/j.jinsphys.2005.08.002; Ouyang Q, 2005, CURR OPIN GASTROEN, V21, P408; Perrier C, 2011, IMMUNOTHERAPY-UK, V3, P1341, DOI [10.2217/imt.11.122, 10.2217/IMT.11.122]; Shimp SK, 2012, INFLAMM RES, V61, P521, DOI 10.1007/s00011-012-0442-x; Sokol H, 2010, WORLD J GASTROENTERO, V16, P583, DOI 10.3748/wjg.v16.i5.583; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Terada T, 2013, INT J CLIN EXP PATHO, V6, P349; Thompson AI, 2011, INFLAMM BOWEL DIS, V17, P831, DOI 10.1002/ibd.21375; Tomasello G, 2011, EUR J HISTOCHEM, V55, P210, DOI 10.4081/ejh.2011.e38; Wang JP, 2006, EUR J PHARMACOL, V553, P297, DOI 10.1016/j.ejphar.2006.08.087	32	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88822	10.1371/journal.pone.0088822	http://dx.doi.org/10.1371/journal.pone.0088822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533153	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600111
J	Kim, YR; Kim, JH; Kim, MJ; Treasure, J				Kim, Youl-Ri; Kim, Jeong-Hyun; Kim, Mi Jeong; Treasure, Janet			Differential Methylation of the Oxytocin Receptor Gene in Patients with Anorexia Nervosa: A Pilot Study	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; EPIGENETIC DOWN-REGULATION; AUTISM SPECTRUM DISORDERS; MESSENGER-RNA EXPRESSION; EATING-DISORDERS; DNA METHYLATION; PROMOTER; FEMALES; BULIMIA; PSYCHOPATHOLOGY	Background and Aim: Recent studies in patients with anorexia nervosa suggest that oxytocin may be involved in the pathophysiology of anorexia nervosa. We examined whether there was evidence of variation in methylation status of the oxytocin receptor (OXTR) gene in patients with anorexia nervosa that might account for these findings. Methods: We analyzed the methylation status of the CpG sites in a region from the exon 1 to the MT2 regions of the OXTR gene in buccal cells from 15 patients and 36 healthy women using bisulfite sequencing. We further examined whether methylation status was associated with markers of illness severity or form. Results: We identified six CpG sites with significant differences in average methylation levels between the patient and control groups. Among the six differentially methylated CpG sites, five showed higher than average methylation levels in patients than those in the control group (64.9-88.8% vs. 6.6-45.0%). The methylation levels of these five CpG sites were negatively associated with body mass index (BMI). BMI, eating disorders psychopathology, and anxiety were identified in a regression analysis as factors affecting the methylation levels of these CpG sites with more variation accounted for by BMI. Conclusions: Epigenetic misregulation of the OXTR gene may be implicated in anorexia nervosa, which may either be a mechanism linking environmental adversity to risk or may be a secondary consequence of the illness.	[Kim, Youl-Ri] Inje Univ, Seoul Paik Hosp, Dept Psychiat, Seoul, South Korea; [Kim, Jeong-Hyun; Kim, Mi Jeong] Inje Univ, Indang Inst Mol Biol, Seoul, South Korea; [Kim, Jeong-Hyun] Inje Univ, Sch Biol Sci, Gimhae, South Korea; [Treasure, Janet] Kings Coll London, Sect Eating Disorders, Dept Psychol Med, Inst Psychiat, London, England	Inje University; Inje University; Inje University; University of London; King's College London	Kim, YR (corresponding author), Inje Univ, Seoul Paik Hosp, Dept Psychiat, Seoul, South Korea.	youlri.kim@paik.ac.kr	Kim, Youl-Ri/AAE-5170-2021	Treasure, Janet/0000-0003-0871-4596; Kim, Youl-Ri/0000-0002-5538-7180	National Research Foundation of Korea [2011-0030914]; Swiss Anorexia Nervosa Foundation; National Institute for Health Research (NIHR); Mental Health Biomedical Research Centre at South London; Maudsley NHS Foundation Trust and King's College London	National Research Foundation of Korea(National Research Foundation of Korea); Swiss Anorexia Nervosa Foundation; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Mental Health Biomedical Research Centre at South London; Maudsley NHS Foundation Trust and King's College London	This study was supported under the framework of the International Cooperation Program managed by the National Research Foundation of Korea (2011-0030914) to YK. The Swiss Anorexia Nervosa Foundation supported the work of JT in part. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JT received salary support from the National Institute for Health Research (NIHR), Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Akkermann K, 2012, J PSYCHIATR RES, V46, P38, DOI 10.1016/j.jpsychires.2011.09.013; Allen KL, 2013, INT J EAT DISORDER, V46, P669, DOI 10.1002/eat.22147; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-24; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Cagar-Nazai HP, 2014, NEUROSCI BIOBEHAV R, V42, P55, DOI 10.1016/j.neubiorev.2013.12.002; Choi SW, 2013, ADV NUTR, V4, P530, DOI 10.3945/an.113.004168; Courty A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-222; Dadds MR, 2014, DEV PSYCHOPATHOL, V26, P33, DOI 10.1017/S0954579413000497; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEMITRACK MA, 1990, AM J PSYCHIAT, V147, P882; Ehrlich S, 2010, J PSYCHIATR RES, V44, P827, DOI 10.1016/j.jpsychires.2010.01.011; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; First MB, 2002, STRUCTURED CLIN INTE; Frieling H, 2008, EUR NEUROPSYCHOPHARM, V18, pS13, DOI 10.1016/S0924-977X(08)70015-4; Frieling H, 2007, MOL PSYCHIATR, V12, P229, DOI 10.1038/sj.mp.4001931; Frieling H, 2008, NEUROPSYCHOPHARMACOL, V33, P2605, DOI 10.1038/sj.npp.1301662; Frieling H, 2010, INT J EAT DISORDER, V43, P577, DOI 10.1002/eat.20745; GILLBERG CL, 1992, J CHILD PSYCHOL PSYC, V33, P813, DOI 10.1111/j.1469-7610.1992.tb01959.x; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Groleau P, 2012, J PSYCHIATR RES, V46, P1139, DOI 10.1016/j.jpsychires.2012.05.018; Hambrook D, 2008, BRIT J CLIN PSYCHOL, V47, P335, DOI 10.1348/014466507X272475; Heijmans BT, 2012, INT J EPIDEMIOL, V41, P74, DOI 10.1093/ije/dyr225; Huke V, 2013, EUR EAT DISORD REV, V21, P345, DOI 10.1002/erv.2244; Hwang CK, 2007, MOL CELL BIOL, V27, P4720, DOI 10.1128/MCB.00073-07; Jack A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00280; Jacobi C, 2011, PSYCHOL MED, V41, P1939, DOI 10.1017/S0033291710002631; Karwautz AFK, 2011, MOL PSYCHIATR, V16, P590, DOI 10.1038/mp.2010.125; Krueger F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00004; Krug I, 2013, PHYSIOL BEHAV, V109, P51, DOI 10.1016/j.physbeh.2012.11.003; Kumsta R, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00083; Kusui C, 2001, BIOCHEM BIOPH RES CO, V289, P681, DOI 10.1006/bbrc.2001.6024; Lawson EA, 2012, J CLIN ENDOCR METAB, V97, pE1898, DOI 10.1210/jc.2012-1702; Lawson EA, 2011, J CLIN PSYCHIAT, V72, P1546, DOI 10.4088/JCP.10m06617; Loth E, 2013, BIOL PSYCHIAT, DOI [10.1016/j.biopsych.2013.1007.1043, DOI 10.1016/J.BIOPSYCH.2013.1007.1043]; Maguire S, 2013, EUR EAT DISORD REV, V21, P475, DOI 10.1002/erv.2252; Mecawi AS, 2011, AM J PHYSIOL-REG I, V301, pR905, DOI 10.1152/ajpregu.00800.2010; Menzel JE, 2010, BODY IMAGE, V7, P261, DOI 10.1016/j.bodyim.2010.05.004; Niculescu MD, 2013, EPIGENOMICS-UK, V5, P13, DOI [10.2217/EPI.12.70, 10.2217/epi.12.70]; Oldershaw A, 2011, NEUROSCI BIOBEHAV R, V35, P970, DOI 10.1016/j.neubiorev.2010.11.001; Pjetri E, 2012, CURR OPIN CLIN NUTR, V15, P330, DOI 10.1097/MCO.0b013e3283546fd3; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Sabatier N, 2007, BIOCHEM SOC T, V35, P1247, DOI 10.1042/BST0351247; Saffrey R, 2014, INT J EAT DISORDER, V47, P206, DOI 10.1002/eat.22200; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Schober I, 2013, EUR EAT DISORD REV, V21, P374, DOI 10.1002/erv.2243; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steiger H, 2013, INT J EAT DISORDER, V46, P246, DOI 10.1002/eat.22113; Stoltenberg SF, 2012, INT J EAT DISORDER, V45, P492, DOI 10.1002/eat.20976; Taborelli E, 2013, COGNITIVE THER RES, V37, P820, DOI 10.1007/s10608-012-9518-8; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; Toyokawa S, 2012, SOC SCI MED, V74, P67, DOI 10.1016/j.socscimed.2011.09.036; Trace SE, 2013, ANNU REV CLIN PSYCHO, V9, P589, DOI 10.1146/annurev-clinpsy-050212-185546; Treasure J, 2013, J EAT DISOR IN PRESS; Treasure J, 2013, NORD J PSYCHIAT, V67, P38, DOI 10.3109/08039488.2012.674554; Treasure J, 2012, EUR EAT DISORD REV, V20, P429, DOI 10.1002/erv.2211; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Zucker NL, 2007, PSYCHOL BULL, V133, P976, DOI 10.1037/0033-2909.133.6.976	62	52	55	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88673	10.1371/journal.pone.0088673	http://dx.doi.org/10.1371/journal.pone.0088673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523928	gold, Green Submitted, Green Published			2022-12-27	WOS:000331258100077
J	Lopes, LC; Spencer, FA; Neumann, I; Ventresca, M; Ebrahim, S; Zhou, Q; Bhatnagar, N; Schulman, S; Eikelboom, J; Guyatt, G				Lopes, Luciane Cruz; Spencer, Frederick A.; Neumann, Ignacio; Ventresca, Matthew; Ebrahim, Shanil; Zhou, Qi; Bhatnagar, Neera; Schulman, Sam; Eikelboom, John; Guyatt, Gordon			Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants	PLOS ONE			English	Review							ANTITHROMBOTIC THERAPY; CHADS(2) SCORE; WARFARIN; ASPIRIN; STROKE; POPULATION; PREVENTION; SAFETY; MANAGEMENT; HEMORRHAGE	Background: Patients with atrial fibrillation considering use of anticoagulants must balance stroke reduction against bleeding risk. Knowledge of bleeding risk without the use of anticoagulants may help inform this decision. Purpose: To determine the rate of major bleeding reported in observational studies of atrial fibrillation patients not receiving Vitamin K antagonists (VKA). Data Sources: We searched MEDLINE, EMBASE and CINAHL to October 2011 and examined reference lists of eligible studies and related reviews. Study Selection: All longitudinal cohort studies that included over 100 adult patients with atrial fibrillation not receiving VKA. Data Extraction: Teams of two reviewers independently and in duplicate adjudicated eligibility, assessed risk of bias and abstracted study characteristics and outcomes. Data Synthesis: Twenty-one eligible studies included 96,448 patients. Major bleeding rates varied widely, from 0 to 4.69 events per 100 patient-years. The pooled estimate in 13 studies with 78839 patients was 1.59 with a 99% confidence interval of 1.10 to 2.3 and median 1.42 (interquartile range 0.62-2.70). Pooled estimates for fatal bleeding and non-fatal bleeding from 4 studies that reported these outcomes were, respectively, 0.40 (0.34 to 0.46) and 1.18 (0.30 to 4.56) per 100 patient-years. In 9 randomized controlled trials (RCTs) the median rate of major bleeding in patients not receiving either anticoagulant or antiplatelet therapy was 0.6 (interquartile 0.2 to 0.90), and in 12 RCTs the median rate of major bleeding in patients receiving a single antiplatelet agent was 0.75 (interquartile 0.4 to 1.4). Conclusion: Results suggest that patients with atrial fibrillation not receiving VKA enrolled in observational studies represent a population on average at higher risk of bleeding.	[Lopes, Luciane Cruz] Univ Sorocaba, Pharmaceut Sci Postgrad Course, Sao Paulo, Brazil; [Spencer, Frederick A.] McMaster Univ, Dept Med, Div Cardiol, Hamilton, ON, Canada; [Neumann, Ignacio] Pontificia Univ Catolica Chile, Sch Med, Dept Internal Med, Santiago, Chile; [Neumann, Ignacio; Ventresca, Matthew; Ebrahim, Shanil; Zhou, Qi; Schulman, Sam; Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Ebrahim, Shanil] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Ebrahim, Shanil] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Bhatnagar, Neera] McMaster Univ, Hlth Sci Lib, Hamilton, ON, Canada; [Schulman, Sam] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Eikelboom, John] McMaster Univ, Dept Med, Div Hematol & Thromboembolism, Hamilton, ON, Canada	Universidade de Sorocaba; McMaster University; Pontificia Universidad Catolica de Chile; McMaster University; McMaster University; Stanford University; McMaster University; McMaster University; McMaster University	Lopes, LC (corresponding author), Univ Sorocaba, Pharmaceut Sci Postgrad Course, Sao Paulo, Brazil.	luslopes@terra.com.br	Zhou, Qi/GSM-9583-2022; Lopes, Luciane Cruz/H-3159-2019; LOPES, LUCIANE CRUZ/H-1168-2012; Schulman, Sam/I-7559-2019; Eikelboom, John/AAG-6117-2019; Neumann, Ignacio/ABB-5013-2020	Lopes, Luciane Cruz/0000-0002-3684-3275; LOPES, LUCIANE CRUZ/0000-0002-3684-3275; Schulman, Sam/0000-0002-8512-9043; Eikelboom, John/0000-0003-4126-1285; 	FAPESP Brazil [2009/5308431]; Canadian Institutes of Health Research Fellowship Award; MITACS Elevate Award	FAPESP Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Canadian Institutes of Health Research Fellowship Award(Canadian Institutes of Health Research (CIHR)); MITACS Elevate Award	This study was supported by FAPESP Brazil (Process N. 2009/5308431). Shanil Ebrahim is supported by a Canadian Institutes of Health Research Fellowship Award and a MITACS Elevate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFASAK, 1989, LANCET, V333, P175; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; Boccuzzi SJ, 2009, CURR MED RES OPIN, V25, P2853, DOI 10.1185/03007990903196422; Boulanger L, 2006, ANN PHARMACOTHER, V40, P1024, DOI 10.1345/aph.1G408; Burton C, 2006, BRIT J GEN PRACT, V56, P697; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Currie CJ, 2006, HEART, V92, P196, DOI 10.1136/hrt.2004.058339; Darkow T, 2005, CURR MED RES OPIN, V21, P1583, DOI 10.1185/030079905X61956; Edvardsson N, 2003, J INTERN MED, V254, P95, DOI 10.1046/j.1365-2796.2003.01159.x; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Friberg L, 2010, EUR HEART J, V31, P967, DOI 10.1093/eurheartj/ehn599; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gullov AL, 1999, ARCH INTERN MED, V159, P1322, DOI 10.1001/archinte.159.12.1322; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hellemons BSP, 1997, CEREBROVASC DIS, V7, P11; Hu Da-yi, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P295; Jackson SL, 2001, INTERN MED J, V31, P329, DOI 10.1046/j.1445-5994.2001.00071.x; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Lai HM, 2009, INT J NEPHROLOGY REN, V2; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lee BH, 2010, J CARDIOVASC ELECTR, V21, P501, DOI 10.1111/j.1540-8167.2009.01661.x; Leung C. S., 2003, Hong Kong Medical Journal, V9, P179; Lopes LC, 2013, CLIN PHARM THER; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Meiltz A, 2008, EUROPACE, V10, P674, DOI 10.1093/europace/eun086; Morocutti C, 1997, STROKE, V28, P1015, DOI 10.1161/01.STR.28.5.1015; NASPEAF, 2004, J AM COLL CARDIOL, V44, P1557; Parkash R, 2007, CAN J CARDIOL, V23, P457, DOI 10.1016/S0828-282X(07)70784-5; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ortiz MR, 2010, CARDIOLOGY, V115, P200, DOI 10.1159/000284450; Sam C, 2004, AM J CARDIOL, V94, P947, DOI 10.1016/j.amjcard.2004.06.038; Sato H, 2006, STROKE, V37, P447, DOI 10.1161/01.STR.0000198839.61112.ee; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Wess ML, 2008, J GEN INTERN MED, V23, P411, DOI 10.1007/s11606-007-0477-9; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88131	10.1371/journal.pone.0088131	http://dx.doi.org/10.1371/journal.pone.0088131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523876	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100025
J	Rivers, JW; Johnson, JM; Haig, SM; Schwarz, CJ; Glendening, JW; Burnett, LJ; George, D; Grantham, J				Rivers, James W.; Johnson, J. Matthew; Haig, Susan M.; Schwarz, Carl J.; Glendening, John W.; Burnett, L. Joseph; George, Daniel; Grantham, Jesse			Resource Selection by the California Condor (Gymnogyps californianus) Relative to Terrestrial-Based Habitats and Meteorological Conditions	PLOS ONE			English	Article							WIND ENERGY; FLIGHT BEHAVIOR; MIGRATION; BIRDS; MOVEMENT; PATTERNS; CONVECTION; MORTALITY; EAGLES	Condors and vultures are distinct from most other terrestrial birds because they use extensive soaring flight for their daily movements. Therefore, assessing resource selection by these avian scavengers requires quantifying the availability of terrestrial-based habitats, as well as meteorological variables that influence atmospheric conditions necessary for soaring. In this study, we undertook the first quantitative assessment of habitat-and meteorological-based resource selection in the endangered California condor (Gymnogyps californianus) within its California range and across the annual cycle. We found that condor use of terrestrial areas did not change markedly within the annual cycle, and that condor use was greatest for habitats where food resources and potential predators could be detected and where terrain was amenable for taking off from the ground in flight (e.g., sparse habitats, coastal areas). Condors originating from different release sites differed in their use of habitat, but this was likely due in part to variation in habitats surrounding release sites. Meteorological conditions were linked to condor use of ecological subregions, with thermal height, thermal velocity, and wind speed having both positive (selection) and negative (avoidance) effects on condor use in different areas. We found little evidence of systematic effects between individual characteristics (i.e., sex, age, breeding status) or components of the species management program (i.e., release site, rearing method) relative to meteorological conditions. Our findings indicate that habitat type and meteorological conditions can interact in complex ways to influence condor resource selection across landscapes, which is noteworthy given the extent of anthropogenic stressors that may impact condor populations (e.g., lead poisoning, wind energy development). Additional studies will be valuable to assess small-scale condor movements in light of these stressors to help minimize their risk to this critically endangered species.	[Rivers, James W.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Johnson, J. Matthew; Haig, Susan M.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Schwarz, Carl J.] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada; [Burnett, L. Joseph] Ventana Wildlife Soc, Salinas, CA USA; [George, Daniel] Pinnacles Natl Pk, Natl Pk Serv, Paicines, CA USA; [Grantham, Jesse] US Fish & Wildlife Serv, Calif Condor Recovery Program, Ventura, CA USA	Oregon State University; United States Department of the Interior; United States Geological Survey; Simon Fraser University; United States Department of the Interior; United States Department of the Interior; US Fish & Wildlife Service	Rivers, JW (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	jim.rivers@oregonstate.edu			National Fish and Wildlife Foundation, Wildlife Encounters, Inc., William R. Hearst III, The Oregon Zoo Foundation, Pacific Gas and Electric, and J. Glendening	National Fish and Wildlife Foundation, Wildlife Encounters, Inc., William R. Hearst III, The Oregon Zoo Foundation, Pacific Gas and Electric, and J. Glendening	Funding came from the National Fish and Wildlife Foundation, Wildlife Encounters, Inc., William R. Hearst III, The Oregon Zoo Foundation, Pacific Gas and Electric, and J. Glendening. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; BEYER HL, 2005, HAWTHS ANAL TOOLS AR; Bildstein KL, 2009, IBIS, V151, P382, DOI 10.1111/j.1474-919X.2009.00919.x; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Burnett LJ, 2013, CONDOR, V115, P477, DOI 10.1525/cond.2013.110150; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Buskirk SW, 2006, J WILDLIFE MANAGE, V70, P358, DOI 10.2193/0022-541X(2006)70[358:MFSORS]2.0.CO;2; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; Cleland D.T., 2007, WO76 USDA; Cline BB, 2011, AUK, V128, P543, DOI 10.1525/auk.2011.10217; Comer P., 2003, ECOLOGICAL SYSTEMS U; de Lucas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048092; Diehl RH, 2013, TRENDS ECOL EVOL, V28, P377, DOI 10.1016/j.tree.2013.02.015; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Erickson W. P., 2001, RADIO TRACKING ANIMA, P211; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Garratt JR, 1992, METEOROLOGICAL BOUND; Getz WM, 2008, P NATL ACAD SCI USA, V105, P19066, DOI 10.1073/pnas.0801732105; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Horn JW, 2008, J WILDLIFE MANAGE, V72, P123, DOI 10.2193/2006-465; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Janjic Z, 2010, CARTN477STR NCAR; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Koford C. B., 1953, CALIFORNIA CONDOR; Kutner M., 2004, APPL LINEAR STAT MOD; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Madders M, 2006, IBIS, V148, P43, DOI 10.1111/j.1474-919X.2006.00506.x; Mandel JT, 2011, ECOL APPL, V21, P2258, DOI 10.1890/10-1651.1; Manly B.F.J., 2002, RESOURCE SELECTION A; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; McCullagh P, 1989, GEN LINEAR MODELS; MCGAHAN J, 1973, J EXP BIOL, V58, P225; MERETSKY VJ, 1992, CONDOR, V94, P313, DOI 10.2307/1369205; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; PENNYCUICK CJ, 1969, IBIS, V111, P525, DOI 10.1111/j.1474-919X.1969.tb02566.x; PENNYCUICK CJ, 1984, IBIS, V126, P253, DOI 10.1111/j.1474-919X.1984.tb08005.x; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Pennycuick CJ, 1998, J AVIAN BIOL, V29, P33, DOI 10.2307/3677338; Piorkowski MD, 2012, J WILDLIFE MANAGE, V76, P451, DOI 10.1002/jwmg.327; Renewable Energy Action Team, 2010, BEST MAN PRACT GUID; Rideout BA, 2012, J WILDLIFE DIS, V48, P95, DOI 10.7589/0090-3558-48.1.95; Rivers JW, 2014, BIRD CONSER IN PRESS, V24; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Shamoun-Baranes J, 2003, CONDOR, V105, P208, DOI 10.1650/0010-5422(2003)105[0208:DUOTCB]2.0.CO;2; Shannon HD, 2002, CONDOR, V104, P679, DOI 10.1650/0010-5422(2002)104[0679:AWPSFT]2.0.CO;2; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Silverman B.W., 1986, DENSITY ESTIMATION S; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Snyder NF, 2002, CALIFORNIA CONDOR GY; Spaar R, 1996, J AVIAN BIOL, V27, P289, DOI 10.2307/3677260; Thomas PJ, 2011, J WILDLIFE MANAGE, V75, P805, DOI 10.1002/jwmg.119; TUCKER VA, 1988, J EXP BIOL, V140, P325; U.S. Fish and Wildlife Service, 1996, CAL COND REC PLAN; Walters JR, 2010, AUK, V127, P969, DOI 10.1525/auk.2010.127.4.969; White G. C., 1990, ANAL WILDLIFE RADIOT; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; YOUNG GS, 1988, EARTH-SCI REV, V25, P179, DOI 10.1016/0012-8252(88)90020-7	64	7	7	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88430	10.1371/journal.pone.0088430	http://dx.doi.org/10.1371/journal.pone.0088430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523893	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100042
J	Yan, W; Zhou, HT; Luo, YZ; Hu, J; Hickford, JGH				Yan, Wei; Zhou, Huitong; Luo, Yuzhu; Hu, Jiang; Hickford, Jon G. H.			Identification of More Than Two Paternal Haplotypes of the Ovine Fatty Acid-Binding Protein 4 (FABP4) Gene in Half-Sib Families: Evidence of Intragenic Meiotic Recombination	PLOS ONE			English	Article							FATTY-ACID-BINDING-PROTEIN-4 GENE; HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; FISSION YEAST; POLYMORPHISM; HOTSPOTS; DNA; DIVERSITY; SEQUENCE; MUSCLE	The fatty acid binding protein 4 (FABP4) plays an important role in the regulation of lipid metabolism in mammals. In this study, two regions of ovine FABP4 spanning exon 2-intron 2 and exon 3-intron 3 were investigated in four hundred and twenty lambs derived from seven sires that were previously typed as having heterozygous genotypes in both these regions of the gene. These regions have been shown to be variable, with three SNPs plus one indel and four SNPs respectively constituting five and four allele variants in the two regions. Across these regions, fourteen haplotypes have been identified. The lambs were typed using a Polymerase Chain Reaction Single-Stranded Conformational Polymorphism (PCR-SSCP) method to identify the haplotypes inherited from the sires. Between three and four paternally-derived haplotypes were identified in the progeny of six of the seven sires, suggesting that meiotic recombination occurs within ovine FABP4. A number of sequence motifs associated with recombination "hotspots'' were detected in the two regions of the gene that were analyzed and these may facilitate the recombination.	[Yan, Wei; Luo, Yuzhu; Hu, Jiang] Gansu Agr Univ, Fac Anim Sci & Technol, Gansu Key Lab Herbivorous Anim Biotechnol, Lanzhou, Peoples R China; [Zhou, Huitong; Hickford, Jon G. H.] Lincoln Univ, Fac Agr & Life Sci, Gene Marker Lab, Lincoln, New Zealand	Gansu Agricultural University; Lincoln University - New Zealand	Luo, YZ (corresponding author), Gansu Agr Univ, Fac Anim Sci & Technol, Gansu Key Lab Herbivorous Anim Biotechnol, Lanzhou, Peoples R China.	luoyz@gsau.edu.cn; jon.hickford@lincoln.ac.nz	Zhou, Huitong/B-7212-2008; Hickford, Jon GH/C-3807-2009; Hickford, Jonathan/E-7995-2019	Zhou, Huitong/0000-0001-7620-3160; Hickford, Jon GH/0000-0001-9313-761X; Hickford, Jonathan/0000-0001-9313-761X; Yan, Wei/0000-0002-1641-4860	Chinese International Cooperation and Exchanges Program; Gansu Province Creative Research Groups Program; Lincoln University Gene-Marker Laboratory	Chinese International Cooperation and Exchanges Program; Gansu Province Creative Research Groups Program; Lincoln University Gene-Marker Laboratory	This work is funded by the Chinese International Cooperation and Exchanges Program, the Gansu Province Creative Research Groups Program and the Lincoln University Gene-Marker Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barendse W, 2009, ANIM GENET, V40, P770, DOI 10.1111/j.1365-2052.2009.01913.x; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Byun SO, 2009, ANAL BIOCHEM, V385, P174, DOI 10.1016/j.ab.2008.10.024; Byun SO, 2008, MOL CELL PROBE, V22, P69, DOI 10.1016/j.mcp.2007.08.005; Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Giordano M, 1997, HUM GENET, V100, P249, DOI 10.1007/s004390050500; Hickford JGH, 2004, J ANIM SCI, V82, P1553; Kon N, 1997, P NATL ACAD SCI USA, V94, P13756; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lee SH, 2010, ANIM GENET, V41, P442, DOI 10.1111/j.1365-2052.2010.02024.x; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; MORITA T, 1993, P NATL ACAD SCI USA, V90, P6577, DOI 10.1073/pnas.90.14.6577; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Ojeda A, 2006, GENETICS, V174, P2119, DOI 10.1534/genetics.106.063057; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; SMITH GR, 1994, EXPERIENTIA, V50, P234, DOI 10.1007/BF01924006; Smith WJM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-27; Steiner WW, 2009, GENETICS, V182, P459, DOI 10.1534/genetics.109.101253; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Yan W, 2012, MOL BIOL REP, V39, P10621, DOI 10.1007/s11033-012-1951-y; Zhou H, 2000, VET MICROBIOL, V76, P163, DOI 10.1016/S0378-1135(00)00233-9; Zhou H, 2006, ANAL BIOCHEM, V354, P159, DOI 10.1016/j.ab.2006.03.042; Zhou H, 2005, J ANIM SCI, V83, P745	28	0	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88691	10.1371/journal.pone.0088691	http://dx.doi.org/10.1371/journal.pone.0088691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523930	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100079
J	Bandeiras, C; Trovoada, MJ; Goncalves, LA; Marinho, CRF; Turner, L; Hviid, L; Penha-Goncalves, C; Gomes, MGM				Bandeiras, Catia; Trovoada, Maria Jesus; Goncalves, Ligia A.; Marinho, Claudio R. F.; Turner, Louise; Hviid, Lars; Penha-Goncalves, Carlos; Gomes, M. Gabriela M.			Modeling Malaria Infection and Immunity against Variant Surface Antigens in Principe Island, West Africa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; TRANSMISSION; INTERVENTIONS; ERYTHROCYTES; ANTIBODIES; RESISTANCE; DIVERSITY; SELECTION; BURDEN	After remarkable success of vector control campaigns worldwide, concerns about loss of immunity against Plasmodium falciparum due to lack of exposure to the parasite are relevant since an increase of severe cases in less immune individuals is expected. We present a mathematical model to investigate the impact of reducing exposure to the parasite on the immune repertoire against P. falciparum erythrocyte membrane protein 1 ( PfEMP1) variants. The model was parameterized with data from Principe Island, West Africa, and applied to simulate two alternative transmission scenarios: one where control measures are continued to eventually drive the system to elimination; and another where the effort is interrupted after 6 years of its initiation and the system returns to the initial transmission potential. Population dynamics of parasite prevalence predict that in a few years infection levels return to the pre-control values, while the re-acquisition of the immune repertoire against PfEMP1 is slower, creating a window for increased severity. The model illustrates the consequences of loss of immune repertoire against PfEMP1 in a given setting and can be applied to other regions where similar data may be available.	[Bandeiras, Catia; Trovoada, Maria Jesus; Goncalves, Ligia A.; Marinho, Claudio R. F.; Penha-Goncalves, Carlos; Gomes, M. Gabriela M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Turner, Louise; Hviid, Lars] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark; [Turner, Louise; Hviid, Lars] Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark	Instituto Gulbenkian de Ciencia; University of Copenhagen; Rigshospitalet; University of Copenhagen	Gomes, MGM (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	ggomes@igc.gulbenkian.pt	Gonçalves, Lígia Antunes/F-6242-2014; Gomes, Gabriela/H-7218-2014; Penha-Goncalves, Carlos/F-4640-2012; Hviid, Lars/G-3705-2012; Marinho, Claudio Romero Farias/F-7507-2012; Bandeiras, Catia/K-9158-2013	Gonçalves, Lígia Antunes/0000-0001-9804-6899; Gomes, Gabriela/0000-0002-1454-4979; Hviid, Lars/0000-0002-1698-4927; Marinho, Claudio Romero Farias/0000-0002-1227-3845; Penha-Goncalves, Carlos/0000-0001-7225-1907; Bandeiras, Catia/0000-0001-6959-3746; Turner, Louise/0000-0003-4494-2289	Portuguese Foundation for Science and Technology (FCT); European Commission [EC-ICT-231807, 242095]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre)	Research supported by the Portuguese Foundation for Science and Technology (FCT) and by the European Commission [grants EC-ICT-231807 (Epiwork) and 242095 (EVIMalaR)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006627; Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; ANDERSON R M, 1991; Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326; Bretscher MT, 2011, EPIDEMICS-NETH, V3, P109, DOI 10.1016/j.epidem.2011.03.002; Buckee CO, 2009, P ROY SOC B-BIOL SCI, V276, P477, DOI 10.1098/rspb.2008.1122; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Carlton JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001160; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Eckhoff P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044950; Felger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045542; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; Fine P., 1975, TROPICAL DISEASES B, V72, P475; Gatton ML, 2004, INFECT IMMUN, V72, P6538, DOI 10.1128/IAI.72.11.6538-6545.2004; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; HOMMEL M, 1983, J EXP MED, V157, P1137, DOI 10.1084/jem.157.4.1137; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Kern SE, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-210; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Maude RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037166; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Pinkevych M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002729; Piper KP, 1999, INFECT IMMUN, V67, P6369; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007; Sambo MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011141; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; van Noort SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009778; WHO, WORLD MAL REP 2011	42	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88110	10.1371/journal.pone.0088110	http://dx.doi.org/10.1371/journal.pone.0088110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520349	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600040
J	Ramadan, A; Sabir, JSM; Alakilli, SYM; Shokry, AM; Gadalla, NO; Edris, S; Al-Kordy, MA; Al-Zahrani, HS; El-Domyati, FM; Bahieldin, A; Baker, NR; Willmitzer, L; Irgang, S				Ramadan, Ahmed; Sabir, Jamal S. M.; Alakilli, Saleha Y. M.; Shokry, Ahmed M.; Gadalla, Nour O.; Edris, Sherif; Al-Kordy, Magdy A.; Al-Zahrani, Hassan S.; El-Domyati, Fotouh M.; Bahieldin, Ahmed; Baker, Neil R.; Willmitzer, Lothar; Irgang, Susann			Metabolomic Response of Calotropis procera Growing in the Desert to Changes in Water Availability	PLOS ONE			English	Article							DROUGHT STRESS; DESICCATION TOLERANCE; LIPID-METABOLISM; YIELD; ARABIDOPSIS; INSIGHTS; MAIZE	Water availability is a major limitation for agricultural productivity. Plants growing in severe arid climates such as deserts provide tools for studying plant growth and performance under extreme drought conditions. The perennial species Calotropis procera used in this study is a shrub growing in many arid areas which has an exceptional ability to adapt and be productive in severe arid conditions. We describe the results of studying the metabolomic response of wild C procera plants growing in the desert to a one time water supply. Leaves of C. procera plants were taken at three time points before and 1 hour, 6 hours and 12 hours after watering and subjected to a metabolomics and lipidomics analysis. Analysis of the data reveals that within one hour after watering C. procera has already responded on the metabolic level to the sudden water availability as evidenced by major changes such as increased levels of most amino acids, a decrease in sucrose, raffinose and maltitol, a decrease in storage lipids (triacylglycerols) and an increase in membrane lipids including photosynthetic membranes. These changes still prevail at the 6 hour time point after watering however 12 hours after watering the metabolomics data are essentially indistinguishable from the prewatering state thus demonstrating not only a rapid response to water availability but also a rapid response to loss of water. Taken together these data suggest that the ability of C. procera to survive under the very harsh drought conditions prevailing in the desert might be associated with its rapid adjustments to water availability and losses.	[Ramadan, Ahmed; Sabir, Jamal S. M.; Alakilli, Saleha Y. M.; Shokry, Ahmed M.; Gadalla, Nour O.; Edris, Sherif; Al-Kordy, Magdy A.; Al-Zahrani, Hassan S.; El-Domyati, Fotouh M.; Bahieldin, Ahmed] KAU, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Ramadan, Ahmed; Shokry, Ahmed M.] ARC, AGERI, Giza, Egypt; [Gadalla, Nour O.; Al-Kordy, Magdy A.] Natl Res Ctr, Genet & Cytol Dept, Genet Engn & Biotechnol Div, Dokki, Egypt; [Edris, Sherif; El-Domyati, Fotouh M.; Bahieldin, Ahmed] Ain Shams Univ, Fac Agr, Dept Genet, Cairo, Egypt; [Willmitzer, Lothar; Irgang, Susann] Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany; [Baker, Neil R.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Ain Shams University; Max Planck Society; University of Essex	Willmitzer, L (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany.	Willmitzer@mpimp-golm.mpg.de	gadalla, nour eldin o/J-3140-2012; Ramadan, Ahmed/I-8241-2012; Edris, Sherif/I-8070-2012; Edris, Sherif/GXZ-9995-2022; bahieldin, ahmed/I-9186-2012; Sabir, Jamal S M/C-8102-2014	Ramadan, Ahmed/0000-0002-2502-9921; Edris, Sherif/0000-0002-2810-3736; Edris, Sherif/0000-0002-2810-3736; Al-kordy, Magdy/0000-0002-0838-0445; Bahieldin, Ahmed/0000-0002-6496-7881; Gadalla, Nour/0000-0002-1622-6763	Deanship of Scientific research (DSR), King Abdulaziz University, Jeddah [2-3-1432/HiCi]; DSR	Deanship of Scientific research (DSR), King Abdulaziz University, Jeddah; DSR	The project was funded by the Deanship of Scientific research (DSR), King Abdulaziz University, Jeddah, under Grant no 2-3-1432/HiCi. The authors therefore acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2011, PLANT SIGNAL BEHAV, V6, P243, DOI 10.4161/psb.6.2.14317; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Gechev TS, 2012, CELL MOL LIFE SCI, V69, P3175, DOI 10.1007/s00018-012-1088-0; Giavalisco P, 2011, PLANT J, V68, P364, DOI 10.1111/j.1365-313X.2011.04682.x; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lopes MS, 2011, J EXP BOT, V62, P3135, DOI 10.1093/jxb/err105; Swamy BPM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-319; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Messina CD, 2011, J EXP BOT, V62, P855, DOI 10.1093/jxb/erq329; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Skirycz A, 2010, CURR OPIN BIOTECH, V21, P197, DOI 10.1016/j.copbio.2010.03.002; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Torres-Franklin ML, 2007, PHYSIOL PLANTARUM, V131, P201, DOI 10.1111/j.1399-3054.2007.00943.x; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Yobi A, 2013, MOL PLANT, V6, P369, DOI 10.1093/mp/sss155; Yobi A, 2012, PLANT J, V72, P983, DOI 10.1111/tpj.12008	25	18	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87895	10.1371/journal.pone.0087895	http://dx.doi.org/10.1371/journal.pone.0087895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520340	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000331254600031
J	Li, ZC; Xiao, J; Peng, JL; Chen, JW; Ma, T; Cheng, GQ; Dong, YQ; Wang, WL; Liu, ZD				Li, Zhan-Chun; Xiao, Jie; Peng, Jin-Liang; Chen, Jian-Wei; Ma, Tao; Cheng, Guang-Qi; Dong, Yu-Qi; Wang, Wei-li; Liu, Zu-De			Functional Annotation of Rheumatoid Arthritis and Osteoarthritis Associated Genes by Integrative Genome-Wide Gene Expression Profiling Analysis	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; SYNOVIAL FIBROBLASTS; PATHWAYS; ACTIVATION; MEDIATORS; CARTILAGE; LYMPHOMA; RISK; TOOL	Background: Rheumatoid arthritis (RA) and osteoarthritis (OA) are two major types of joint diseases that share multiple common symptoms. However, their pathological mechanism remains largely unknown. The aim of our study is to identify RA and OA related-genes and gain an insight into the underlying genetic basis of these diseases. Methods: We collected 11 whole genome-wide expression profiling datasets from RA and OA cohorts and performed a meta-analysis to comprehensively investigate their expression signatures. This method can avoid some pitfalls of single dataset analyses. Results and Conclusion: We found that several biological pathways (i.e., the immunity, inflammation and apoptosis related pathways) are commonly involved in the development of both RA and OA. Whereas several other pathways (i.e., vasopressin-related pathway, regulation of autophagy, endocytosis, calcium transport and endoplasmic reticulum stress related pathways) present significant difference between RA and OA. This study provides novel insights into the molecular mechanisms underlying this disease, thereby aiding the diagnosis and treatment of the disease.	[Li, Zhan-Chun; Chen, Jian-Wei; Ma, Tao; Cheng, Guang-Qi; Dong, Yu-Qi; Wang, Wei-li; Liu, Zu-De] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Xiao, Jie] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Peng, Jin-Liang] Shanghai Jiao Tong Univ, MED X Res Inst, Sch Biomed Engn, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, ZD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	zudeliu001@163.com		Xiao, Jie/0000-0001-5416-4754	Shanghai Natural Science Foundation, China [13ZR1424900]; Medical-Engineering Joint Fund of Shanghai Jiao Tong University [YG2011MS41]	Shanghai Natural Science Foundation, China(Natural Science Foundation of Shanghai); Medical-Engineering Joint Fund of Shanghai Jiao Tong University	This study was supported by Shanghai Natural Science Foundation, China (No. 13ZR1424900) and Medical-Engineering Joint Fund of Shanghai Jiao Tong University (No. YG2011MS41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2013, J INTERF CYTOK RES, V33, P297, DOI 10.1089/jir.2012.0107; Albano SA, 2001, SEMIN ARTHRITIS RHEU, V31, P146, DOI 10.1053/sarh.2001.27719; Alvarez-Lafuente R, 2005, ANN RHEUM DIS, V64, P1357, DOI 10.1136/ard.2004.033514; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Balandraud N, 2004, AUTOIMMUN REV, V3, P362, DOI 10.1016/j.autrev.2004.02.002; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008; Brandt KD, 2009, MED CLIN N AM, V93, P1, DOI 10.1016/j.mcna.2008.08.009; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Collins-Racie LA, 2009, OSTEOARTHR CARTILAGE, V17, P832, DOI 10.1016/j.joca.2008.12.011; Daouti S, 2005, OSTEOARTHR CARTILAGE, V13, P508, DOI 10.1016/j.joca.2005.02.003; De Filippo K, 2013, BLOOD; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Franklin J, 2006, ANN RHEUM DIS, V65, P617, DOI 10.1136/ard.2005.044784; Fraser A, 2003, ARTHRITIS RHEUM, V48, P3085, DOI 10.1002/art.11331; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Harty LC, 2012, ANN RHEUM DIS, V71, P582, DOI 10.1136/annrheumdis-2011-200245; Heruth DP, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-43; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Ishikawa S, 2009, ANN RHEUM DIS, V68, P264, DOI 10.1136/ard.2007.079533; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Kingsbury Sarah R, 2012, Prim Health Care Res Dev, V13, P373, DOI 10.1017/S1463423612000072; Kudryavtseva E, 2012, ARTHRITIS RHEUM-US, V64, P1057, DOI 10.1002/art.33414; Kumarasinghe DD, 2012, OSTEOARTHR CARTILAGE, V20, P1357, DOI 10.1016/j.joca.2012.07.005; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; Lee J, 2011, SCAND J RHEUMATOL, V40, P334, DOI 10.3109/03009742.2010.547871; Lee J, 2012, INFLAMMATION, V35, P633, DOI 10.1007/s10753-011-9355-z; Li CY, 2012, SCI CHINA LIFE SCI, V55, P1057, DOI 10.1007/s11427-012-4418-4; Petersson M, 2006, OSTEOARTHR CARTILAGE, V14, P652, DOI 10.1016/j.joca.2006.01.003; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Reedquist Kris A, 2012, Open Rheumatol J, V6, P259, DOI 10.2174/1874312901206010259; Robier C, 2013, CLIN RHEUMATOL, V32, P671, DOI 10.1007/s10067-012-2147-5; Scaife S, 2004, RHEUMATOLOGY, V43, P1346, DOI 10.1093/rheumatology/keh347; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Shahrara S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2318; Sikora KA, 2012, ARTHRITIS RHEUM-US, V64, P3799, DOI 10.1002/art.34604; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Takada K, 2011, INT J EXP PATHOL, V92, P232, DOI 10.1111/j.1365-2613.2010.00758.x; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wen HY, 2011, JCR-J CLIN RHEUMATOL, V17, P102, DOI 10.1097/RHU.0b013e31820edd18; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29; Zhang RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032356	51	22	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e85784	10.1371/journal.pone.0085784	http://dx.doi.org/10.1371/journal.pone.0085784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551036	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500005
J	Wajanga, BK; Peck, RN; Kalluvya, S; Fitzgerald, DW; Smart, LR; Downs, JA				Wajanga, BahatiM. K.; Peck, Robert N.; Kalluvya, Samuel; Fitzgerald, Daniel W.; Smart, Luke R.; Downs, Jennifer A.			Healthcare Worker Perceived Barriers to Early Initiation of Antiretroviral and Tuberculosis Therapy among Tanzanian Inpatients	PLOS ONE			English	Article							HIV CARE; TB; INTEGRATION; MORTALITY; PROGRAMS; ADULTS	Setting: Clinical trials have shown that early initiation of antiretroviral therapy in HIV-infected patients with tuberculosis saves lives, but models for implementation of this new strategy have been under-studied in real-world settings. Objective: To identify the barriers and possible solutions for implementing concurrent early treatment with antiretroviral and anti-tuberculosis therapy in a large East African referral hospital where the prevalence of both infections is high. Design: In-depth interviews among hospital administrators, laboratory technicians, nurses, pharmacists, and physicians. Results: Twenty-six hospital staff identified six key barriers and corresponding solutions to promote rapid initiation of antiretroviral therapy in HIV-infected inpatients with tuberculosis. These include revising systems of medication delivery, integrating care between inpatient and outpatient systems, training hospital nurses to counsel and initiate medications in inpatients, and cultivating a team approach to consistent guideline implementation. Conclusion: Most barriers identified by hospital staff were easily surmountable with reorganization, training, and policy changes at minimal cost. Efforts to reduce mortality for HIV and tuberculosis co-infected patients in accordance with new World Health Organization guidelines are currently hampered by implementation barriers in real-world settings. Our findings suggest that these can be overcome with strategic enactment of simple, realistic interventions to promote early dual treatment for HIV/tuberculosis co-infected patients.	[Wajanga, BahatiM. K.; Peck, Robert N.; Kalluvya, Samuel; Smart, Luke R.; Downs, Jennifer A.] Bugando Med Ctr, Dept Internal Med, Mwanza, Tanzania; [Wajanga, BahatiM. K.; Peck, Robert N.; Kalluvya, Samuel; Smart, Luke R.; Downs, Jennifer A.] Catholic Univ Hlth & Allied Sci Bugando, Dept Internal Med, Mwanza, Tanzania; [Peck, Robert N.; Fitzgerald, Daniel W.; Smart, Luke R.; Downs, Jennifer A.] Weill Cornell Med Coll, Dept Med, Ctr Global Hlth, New York, NY USA	Cornell University	Wajanga, BK (corresponding author), Bugando Med Ctr, Dept Internal Med, Mwanza, Tanzania.	wajangabmk@yahoo.com		Downs, Jennifer/0000-0001-9537-204X; Smart, Luke/0000-0003-4083-0060; Peck, Robert/0000-0002-4526-2480	United States National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI098627]; National Institutes of Health Fogarty International Center [TW 00018]; United States Agency for International Development (USAID) leadership training program; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI098627] Funding Source: NIH RePORTER	United States National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); United States Agency for International Development (USAID) leadership training program(United States Agency for International Development (USAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part by grants from the United States National Institutes of Health/National Institute of Allergy and Infectious Diseases (AI098627), the National Institutes of Health Fogarty International Center (TW 00018) and a United States Agency for International Development (USAID) leadership training program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064622; Chapman E, 2002, J HEALTH PSYCHOL, V7, P125, DOI 10.1177/1359105302007002397; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Conseil A, 2010, HEALTH POLICY PLANN, V25, pi32, DOI 10.1093/heapol/czq055; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P287; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Nansera D, 2010, AFR HEALTH SCI, V10, P312; Palacios E, 2012, INT J TUBERC LUNG D, V16, P348, DOI 10.5588/ijtld.11.0473; Peck RN, 2012, INT J TUBERC LUNG D, V16, P1047, DOI 10.5588/ijtld.11.0772; Peck RN, 2013, J HYPERTENS, V31, P1806, DOI 10.1097/HJH.0b013e328362bad7; Sandelowski M, 2003, QUAL HEALTH RES, V13, P905, DOI 10.1177/1049732303253488; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Schuchat A, 2012, J INFECT DIS, V205, pS1, DOI 10.1093/infdis/jir801; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; The United Republic of Tanzania, 2012, REPORT LAW MARRIAGE; Vijay S, 2009, PLOS ONE, V4, pe7899, DOI [10.1371/journal.pone.0007899, DOI 10.1371/J0URNAL.P0NE.0007899]; Wandwalo Eliud, 2004, Afr Health Sci, V4, P109; World Health Organization, 2012, WHO POL COLL TB HIV	20	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87584	10.1371/journal.pone.0087584	http://dx.doi.org/10.1371/journal.pone.0087584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551061	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500019
J	Naveh, ZMH; Malliavin, TE; Maragliano, L; Cottone, G; Ciccotti, G				Naveh, Zeynab Mohammad Hosseini; Malliavin, Therese E.; Maragliano, Luca; Cottone, Grazia; Ciccotti, Giovanni			Conformational Changes in Acetylcholine Binding Protein Investigated by Temperature Accelerated Molecular Dynamics	PLOS ONE			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURE; FREE-ENERGY; RECEPTOR; ACHBP; MECHANISM; NICOTINE; ACTIVATION	Despite the large number of studies available on nicotinic acetylcholine receptors, a complete account of the mechanistic aspects of their gating transition in response to ligand binding still remains elusive. As a first step toward dissecting the transition mechanism by accelerated sampling techniques, we study the ligand-induced conformational changes of the acetylcholine binding protein (AChBP), a widely accepted model for the full receptor extracellular domain. Using unbiased Molecular Dynamics (MD) and Temperature Accelerated Molecular Dynamics (TAMD) simulations we investigate the AChBP transition between the apo and the agonist-bound state. In long standard MD simulations, both conformations of the native protein are stable, while the agonist-bound structure evolves toward the apo one if the orientation of few key sidechains in the orthosteric cavity is modified. Conversely, TAMD simulations initiated from the native conformations are able to produce the spontaneous transition. With respect to the modified conformations, TAMD accelerates the transition by at least a factor 10. The analysis of some specific residue-residue interactions points out that the transition mechanism is based on the disruption/formation of few key hydrogen bonds. Finally, while early events of ligand dissociation are observed already in standard MD, TAMD accelerates the ligand detachment and, at the highest TAMD effective temperature, it is able to produce a complete dissociation path in one AChBP subunit.	[Naveh, Zeynab Mohammad Hosseini; Cottone, Grazia; Ciccotti, Giovanni] Univ Coll Dublin, Sch Phys, Dublin 2, Ireland; [Malliavin, Therese E.] Inst Pasteur, Paris, France; [Malliavin, Therese E.] CNRS, UMR 3528, Unite Bioinformat Struct, Paris, France; [Maragliano, Luca] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Cottone, Grazia] Univ Palermo, Dept Chem & Phys, Palermo, Italy; [Ciccotti, Giovanni] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	University College Dublin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Istituto Italiano di Tecnologia - IIT; University of Palermo; Sapienza University Rome	Cottone, G (corresponding author), Univ Coll Dublin, Sch Phys, Dublin 2, Ireland.	grazia.cottone@unipa.it	Cottone, Grazia/E-8734-2012; Maragliano, Luca/A-8294-2010	Cottone, Grazia/0000-0001-6923-6394; Maragliano, Luca/0000-0002-5705-6967; Malliavin, Therese/0000-0002-3276-3366	SFI-Science Foundation of Ireland [08-IN.1-I1869]; Istituto Italiano di Tecnologia (IIT) [N.259SIMBEDD]; CNRS; Institut Pasteur	SFI-Science Foundation of Ireland(Science Foundation Ireland); Istituto Italiano di Tecnologia (IIT)(Istituto Italiano di Tecnologia - IIT); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission)	This work was supported by SFI-Science Foundation of Ireland (grant 08-IN.1-I1869) and Istituto Italiano di Tecnologia (IIT, seed project grant N.259SIMBEDD). TM acknowledges CNRS and Institut Pasteur for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams CF, 2012, CHEM PHYS LETT, V547, P114, DOI 10.1016/j.cplett.2012.07.064; Abrams CF, 2010, P NATL ACAD SCI USA, V107, P4961, DOI 10.1073/pnas.0914540107; Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; Amiri S, 2007, PROTEIN ENG DES SEL, V20, P353, DOI 10.1093/protein/gzm029; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bourne Y, 2006, J MOL NEUROSCI, V30, P103, DOI 10.1385/JMN:30:1:103; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Briggs CA, 1998, NEUROPHARMACOLOGY, V37, P1095, DOI 10.1016/S0028-3908(98)00110-5; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Changeux JP, 2005, NICOTIMIC ACETYLCHOL; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; Ciccotti G, 2011, PHYS CHEM CHEM PHYS, V13, P5952, DOI 10.1039/c0cp01335h; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Edink E, 2011, J AM CHEM SOC, V133, P5363, DOI 10.1021/ja110571r; FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hansen SB, 2005, EMBO J, V24, P2625; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Liu XL, 2008, J PHYS CHEM B, V112, P4087, DOI 10.1021/jp0716738; Liu XL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040019; Lucid J, 2013, J PHYS CHEM C, V117, P774, DOI 10.1021/jp309038n; Maragliano L, 2006, CHEM PHYS LETT, V426, P168, DOI 10.1016/j.cplett.2006.05.062; Maragliano L, 2010, J AM CHEM SOC, V132, P1010, DOI 10.1021/ja905671x; Maragliano L, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2907241; Miller DK, 2000, NEUROPHARMACOLOGY, V39, P2654, DOI 10.1016/S0028-3908(00)00140-4; Monteferrante M, 2009, MOL SIMULAT, V35, P1116, DOI 10.1080/08927020903051598; Monteferrante M, 2008, SCI MODEL SIMUL, V15, P187, DOI 10.1007/s10820-008-9097-x; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samson AO, 2008, BIOCHEMISTRY-US, V47, P4065, DOI 10.1021/bi702272j; Sander T, 2010, J MOL GRAPH MODEL, V29, P415, DOI 10.1016/j.jmgm.2010.08.004; Scarpazza DP, 2013, INT PARALL DISTRIB P, P933, DOI 10.1109/IPDPS.2013.93; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; Shi C, 2008, J MOL MODEL, V105, P8280; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Sterpone F, 2012, J PHYS CHEM C, V116, P19636, DOI 10.1021/jp3019588; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Taly A, 2011, J MOL GRAPH MODEL, V30, P100, DOI 10.1016/j.jmgm.2011.06.008; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Terry AV, 1998, NEUROPHARMACOLOGY, V37, P93, DOI 10.1016/S0028-3908(97)00142-1; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Ulens C, 2009, J MED CHEM, V52, P2372, DOI 10.1021/jm801400g; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Vashisth H, 2012, J PHYS CHEM LETT, V3, P3379, DOI 10.1021/jz301650q; Vashisth H, 2013, ACS CHEM BIOL, V8, P2778, DOI 10.1021/cb400568g; Vashisth H, 2013, J PHYS CHEM B, V117, P3738, DOI 10.1021/jp3126297; Vashisth H, 2012, STRUCTURE, V20, P1453, DOI 10.1016/j.str.2012.08.007; Vashisth H, 2012, BIOPHYS J, V102, P1979, DOI 10.1016/j.bpj.2012.03.031; Wang HL, 2009, BIOPHYS J, V96, P3582, DOI 10.1016/j.bpj.2009.02.020; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whatley VJ, 1996, INT REV NEUROBIOL, V39, P113, DOI 10.1016/S0074-7742(08)60665-0; Yi MG, 2008, P NATL ACAD SCI USA, V105, P8280, DOI 10.1073/pnas.0710530105; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u; Zheng WJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001046; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	88	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88555	10.1371/journal.pone.0088555	http://dx.doi.org/10.1371/journal.pone.0088555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551117	Green Submitted, gold, Green Published			2022-12-27	WOS:000331266000045
J	Palmer, ND; Ng, MCY; Hicks, PJ; Mudgal, P; Langefeld, CD; Freedman, BI; Bowden, DW				Palmer, Nicholette D.; Ng, Maggie C. Y.; Hicks, Pamela J.; Mudgal, Poorva; Langefeld, Carl D.; Freedman, Barry I.; Bowden, Donald W.			Evaluation of Candidate Nephropathy Susceptibility Genes in a Genome-Wide Association Study of African American Diabetic Kidney Disease	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; VARIANTS; SCAN; PREVALENCE; ADMIXTURE	Type 2 diabetes (T2D)-associated end-stage kidney disease (ESKD) is a complex disorder resulting from the combined influence of genetic and environmental factors. This study contains a comprehensive genetic analysis of putative nephropathy loci in 965 African American (AA) cases with T2D-ESKD and 1029 AA population-based controls extending prior findings. Analysis was based on 4,341 directly genotyped and imputed single nucleotide polymorphisms (SNPs) in 22 nephropathy candidate genes. After admixture adjustment and correction for multiple comparisons, 37 SNPs across eight loci were significantly associated (1.6E-05<P-emp<0.049). Among these, variants in MYH9 were the most significant (1.6E05< P-emp<0.049), followed by additional chromosome 22 loci (APOL1, SFI1, and LIMK2). Nominal signals were observed in AGTR1, RPS12, CHN2 and CNDP1. Additional adjustment for APOL1 G1/G2 risk variants attenuated association at MYH9 (P-emp = 0.00026-0.043) while marginally improving significance of other APOL1 SNPs (rs136161, rs713753, and rs767855; P-emp = 0.0060-0.037); association at other loci was markedly reduced except for CHN2 (chimerin; rs17157914, P-emp = 0.029). In addition, SNPs in other candidate loci (FRMD3 and TRPC6) trended toward association with T2D-ESKD (P-emp<0.05). These results suggest that risk contributed by putative nephropathy genes is shared across populations of African and European ancestry.	[Palmer, Nicholette D.; Hicks, Pamela J.; Bowden, Donald W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27106 USA; [Palmer, Nicholette D.; Ng, Maggie C. Y.; Freedman, Barry I.; Bowden, Donald W.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Palmer, Nicholette D.; Ng, Maggie C. Y.; Mudgal, Poorva; Freedman, Barry I.; Bowden, Donald W.] Wake Forest Sch Med, Diabet Res Ctr, Winston Salem, NC USA; [Langefeld, Carl D.] Wake Forest Sch Med, Ctr Publ Hlth Genom, Winston Salem, NC USA; [Langefeld, Carl D.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Freedman, Barry I.; Bowden, Donald W.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Palmer, ND (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27106 USA.	nallred@wakehealth.edu			Center for Inherited Disease Research (CIDR); National Institutes of Health (NIH) [HHSC268200782096C]; NIH [K99 DK081350, R01 DK066358, R01 DK053591, R01 HL56266, R01 DK 070941, R01 DK 084149]; General Clinical Research Center of the Wake Forest School of Medicine [M01 RR07122]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084149, K99DK081350, R01DK066358, R01DK053591, R01DK070941] Funding Source: NIH RePORTER	Center for Inherited Disease Research (CIDR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Center of the Wake Forest School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Genotyping services were provided by the Center for Inherited Disease Research (CIDR), which is fully funded through a federal contract from the National Institutes of Health (NIH) to The Johns Hopkins University, contract number HHSC268200782096C. This work was supported by NIH grants K99 DK081350 (NDP), R01 DK066358 (DWB), R01 DK053591 (DWB), R01 HL56266 (BIF), R01 DK 070941 (BIF), R01 DK 084149 (BIF) and in part by a grant from the General Clinical Research Center of the Wake Forest School of Medicine, M01 RR07122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, USRDS 2013 ANN DAT R; [Anonymous], 2007, NATURE, V447, P661; Bowden DW, 2004, KIDNEY INT, V66, P1517, DOI 10.1111/j.1523-1755.2004.00915.x; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Freedman BI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002150; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Iyengar SK, 2007, DIABETES, V56, P1577, DOI 10.2337/db06-1154; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; Keene KL, 2008, HUM GENET, V124, P147, DOI 10.1007/s00439-008-0532-6; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; McDonough CW, 2011, KIDNEY INT, V79, P563, DOI 10.1038/ki.2010.467; Palmer ND, 2012, CURR DIABETES REP, V12, P423, DOI 10.1007/s11892-012-0279-2; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; System URD, 2010, USRDS 2010 ANN DAT R; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Vardarli I, 2002, KIDNEY INT, V62, P2176, DOI 10.1046/j.1523-1755.2002.00663.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	24	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88273	10.1371/journal.pone.0088273	http://dx.doi.org/10.1371/journal.pone.0088273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551085	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000026
J	Cabeen, MT				Cabeen, Matthew T.			Stationary Phase-Specific Virulence Factor Overproduction by a IasR Mutant of Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; QUORUM-SENSING HIERARCHY; GENE-EXPRESSION; QUINOLONE SIGNAL; LASR MUTANTS; INFECTIONS; REGULATOR; LUNG; GROWTH; RSAL	Secreted virulence factors of the human pathogen Pseudomonas aeruginosa are often under quorum sensing control. Cells lacking the quorum-sensing regulator LasR show reduced virulence factor production under typical laboratory conditions and are hypo-virulent in short-term animal infection models, yet lasR mutants are frequently associated with long-term infection in cystic fibrosis patients. Here, I show that in stationary-phase or slow-growth conditions, lasR cells continuously and strongly produce the important virulence factor pyocyanin while wild-type cells do not. Pyocyanin overproduction by lasR cells is permitted by loss of repression by RsaL, a LasR-dependent negative regulator. lasR cells also contribute pyocyanin in mixed cultures, even under "cheating'' conditions where they depend on their wild-type neighbors for nutrients. Finally, some clinical P. aeruginosa isolates with lasR mutations can overproduce pyocyanin in the laboratory. These results imply that slow-growing clinical populations of lasR cells in chronic infections may contribute to virulence by producing pyocyanin under conditions where IasR(+) cells do not.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Cabeen, MT (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	cabeen@fas.harvard.edu			BASF Advanced Research Initiative at Harvard University [5366005-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568] Funding Source: NIH RePORTER	BASF Advanced Research Initiative at Harvard University(BASF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the BASF (www.basf.com) Advanced Research Initiative at Harvard University, Grant 5366005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; De Kievit T, 1999, J BACTERIOL, V181, P2175, DOI 10.1128/JB.181.7.2175-2184.1999; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Foley I, 1999, J ANTIMICROB CHEMOTH, V43, P164, DOI 10.1093/jac/43.1.164; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Jensen V, 2006, J BACTERIOL, V188, P8601, DOI 10.1128/JB.01378-06; Lee J, 2013, NAT CHEM BIOL; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; Rampioni G, 2007, J BACTERIOL, V189, P1922, DOI 10.1128/JB.01552-06; Rampioni G, 2009, FEMS MICROBIOL LETT, V301, P210, DOI 10.1111/j.1574-6968.2009.01817.x; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Rutherford ST, 2012, COLD SPRING HARB PER, V2; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Van Delden C, 1998, INFECT IMMUN, V66, P4499; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu KD, 2001, FEMS MICROBIOL LETT, V199, P67	38	42	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88743	10.1371/journal.pone.0088743	http://dx.doi.org/10.1371/journal.pone.0088743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533146	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600104
J	Bauch, C; Koliwer, J; Buck, F; Honck, HH; Kreienkamp, HJ				Bauch, Carola; Koliwer, Judith; Buck, Friedrich; Hoenck, Hans-Hinrich; Kreienkamp, Hans-Juergen			Subcellular Sorting of the G-Protein Coupled Mouse Somatostatin Receptor 5 by a Network of PDZ-Domain Containing Proteins	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PLASMA-MEMBRANE EXPRESSION; TRAFFICKING; SECRETION; PIST; SUBTYPE-5; COMPLEXES; PARTNERS; PATHWAY; INSULIN	PSD-95/discs large/ZO-1 (PDZ) domain proteins integrate many G-protein coupled receptors (GPCRs) into membrane associated signalling complexes. Additional PDZ proteins are involved in intracellular receptor trafficking. We show that three PDZ proteins (SNX27, PIST and NHERF1/3) regulate the mouse somatostatin receptor subtype 5 (SSTR5). Whereas the PDZ ligand motif of SSTR5 is not necessary for plasma membrane targeting or internalization, it protects the SSTR5 from postendocytic degradation. Under conditions of lysosomal inhibition, recycling of the SSTR5 to the plasma membrane does not depend on the PDZ ligand. However, recycling of the wild type receptor carrying the PDZ binding motif depends on SNX27 which interacts and colocalizes with the receptor in endosomal compartments. PIST, implicated in lysosomal targeting of some membrane proteins, does not lead to degradation of the SSTR5. Instead, overexpressed PIST retains the SSTR5 at the Golgi. NHERF family members release SSTR5 from retention by PIST, allowing for plasma membrane insertion. Our data suggest that PDZ proteins act sequentially on the GPCR at different stages of its subcellular trafficking.	[Bauch, Carola; Koliwer, Judith; Hoenck, Hans-Hinrich; Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Buck, Friedrich] Univ Klinikum Hamburg Eppendorf, Inst Klin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kreienkamp, HJ (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany.	Kreienkamp@uke.de		Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	Deutsche Forschungsgemeinschaft (Graduiertenkolleg) [GRK1459]	Deutsche Forschungsgemeinschaft (Graduiertenkolleg)(German Research Foundation (DFG))	This work was financially supported by Deutsche Forschungsgemeinschaft (Graduiertenkolleg GRK1459; to H.-J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen AN, 2012, J COMP NEUROL, V520, P889, DOI 10.1002/cne.22774; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Christenn M, 2007, FEBS LETT, V581, P5173, DOI 10.1016/j.febslet.2007.10.003; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Guggino William B, 2004, Proc Am Thorac Soc, V1, P28, DOI 10.1513/pats.2306011; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Kim JK, 2012, J BIOL CHEM; Kokkola T, 2011, FEBS LETT, V585, P2665, DOI 10.1016/j.febslet.2011.07.028; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Liew CW, 2009, FEBS LETT, V583, P49, DOI 10.1016/j.febslet.2008.11.048; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; Madsen KL, 2012, J BIOL CHEM, V287, P12293, DOI 10.1074/jbc.M111.294702; Sarret P, 2004, J BIOL CHEM, V279, P8029, DOI 10.1074/jbc.M310792200; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Strowski MZ, 2000, ENDOCRINOLOGY, V141, P111, DOI 10.1210/en.141.1.111; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Turvy D N, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1807s36; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wente W, 2005, FEBS LETT, V579, P6305, DOI 10.1016/j.febslet.2005.10.009; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Xu ZG, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-80	35	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88529	10.1371/journal.pone.0088529	http://dx.doi.org/10.1371/journal.pone.0088529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523912	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100061
J	Flatters, I; Hill, LJB; Williams, JHG; Barber, SE; Mon-Williams, M				Flatters, Ian; Hill, Liam J. B.; Williams, Justin H. G.; Barber, Sally E.; Mon-Williams, Mark			Manual Control Age and Sex Differences in 4 to 11 Year Old Children	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; FINE MOTOR-SKILLS; GENDER-DIFFERENCES; PERFORMANCE; HAND; MOVEMENT; CHILDHOOD; EYE; PRESCHOOL; DEFICITS	To what degree does being male or female influence the development of manual skills in pre-pubescent children? This question is important because of the emphasis placed on developing important new manual skills during this period of a child's education (e.g. writing, drawing, using computers). We investigated age and sex-differences in the ability of 422 children to control a handheld stylus. A task battery deployed using tablet PC technology presented interactive visual targets on a computer screen whilst simultaneously recording participant's objective kinematic responses, via their interactions with the on-screen stimuli using the handheld stylus. The battery required children use the stylus to: (i) make a series of aiming movements, (ii) trace a series of abstract shapes and (iii) track a moving object. The tasks were not familiar to the children, allowing measurement of a general ability that might be meaningfully labelled 'manual control', whilst minimising culturally determined differences in experience (as much as possible). A reliable interaction between sex and age was found on the aiming task, with girls' movement times being faster than boys in younger age groups (e.g. 4-5 years) but with this pattern reversing in older children (10-11 years). The improved performance in older boys on the aiming task is consistent with prior evidence of a male advantage for gross-motor aiming tasks, which begins to emerge during adolescence. A small but reliable sex difference was found in tracing skill, with girls showing a slightly higher level of performance than boys irrespective of age. There were no reliable sex differences between boys and girls on the tracking task. Overall, the findings suggest that prepubescent girls are more likely to have superior manual control abilities for performing novel tasks. However, these small population differences do not suggest that the sexes require different educational support whilst developing their manual skills.	[Flatters, Ian; Hill, Liam J. B.; Mon-Williams, Mark] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Williams, Justin H. G.] Univ Aberdeen, Royal Cornhill Hosp, Dept Mental Hlth, Aberdeen, Scotland; [Barber, Sally E.] Bradford Teaching Hosp NHS Fdn Trust, Bradford Inst Hlth Res, Bradford, W Yorkshire, England	University of Leeds; University of Aberdeen	Hill, LJB (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	L.J.Hill@leeds.ac.uk	Williams, Justin/AAE-5903-2020	Hill, Liam/0000-0002-4069-5121; Flatters, Ian John/0000-0002-3789-0487; Mon-Williams, Mark/0000-0001-7595-8545	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) for LYB (Leeds, York and Bradford); Waterloo Foundation (TWF) [1285/1986]; MRC Centenary Career Development Award	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) for LYB (Leeds, York and Bradford); Waterloo Foundation (TWF); MRC Centenary Career Development Award	The authors acknowledge funding from the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) for LYB (Leeds, York and Bradford). They also acknowledge support from an MRC Centenary Career Development Award and from a grant from the Waterloo Foundation (TWF reference: 1285/1986). These sources each generously contributed to supporting the research at different points. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D, 2010, CHILD NEUROPSYCHOL, V16, P32, DOI 10.1080/09297040903049061; Barnett LM, 2010, RES Q EXERCISE SPORT, V81, P162; Beech JR, 2005, PERS INDIV DIFFER, V39, P459, DOI 10.1016/j.paid.2005.01.024; BERNINGER VW, 1992, J SCHOOL PSYCHOL, V30, P363, DOI 10.1016/0022-4405(92)90004-O; Blank R, 2000, NEUROSCI LETT, V295, P89, DOI 10.1016/S0304-3940(00)01592-5; Butterfield SA, 2012, PERCEPT MOTOR SKILL, V114, P261, DOI 10.2466/10.11.25.PMS.114.1.261-274; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2009, J HEAD TRAUMA REHAB, V24, P363, DOI 10.1097/HTR.0b013e3181af0810; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cools W, 2009, J SPORT SCI MED, V8, P154; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Dinehart L, 2013, EARLY EDUC DEV, V24, P138, DOI 10.1080/10409289.2011.636729; Dorffierger S, 2009, BEHAV BRAIN RES, V198, P165, DOI 10.1016/j.bbr.2008.10.033; Eliot L, 2011, NEURON, V72, P895, DOI 10.1016/j.neuron.2011.12.001; Feder KP, 2007, DEV MED CHILD NEUROL, V49, P312, DOI 10.1111/j.1469-8749.2007.00312.x; Field A.P., 2020, DISCOVERING STAT USI, V4th; Genna M, 2012, IFMBE PROC, V37, P141; Gowen E, 2006, HUM MOVEMENT SCI, V25, P568, DOI 10.1016/j.humov.2006.06.005; Grissmer D, 2010, DEV PSYCHOL, V46, P1008, DOI 10.1037/a0020104; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Halpern Diane F, 2007, Psychol Sci Public Interest, V8, P1, DOI 10.1111/j.1529-1006.2007.00032.x; Hellinckx T, 2013, RES AUTISM SPECT DIS, V7, P176, DOI 10.1016/j.rasd.2012.08.009; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Huang C-T, 2012, PLOS ONE, V8; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Junaid Kathryn A, 2006, Phys Occup Ther Pediatr, V26, P5; Kadesjo B, 1999, J AM ACAD CHILD PSY, V38, P820, DOI 10.1097/00004583-199907000-00011; Kerstjens JM, 2009, EARLY HUM DEV, V85, P443, DOI 10.1016/j.earlhumdev.2009.03.001; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lingam Raghu, 2009, Pediatrics, V123, pe693, DOI 10.1542/peds.2008-1770; Lingam R, 2010, PEDIATRICS, V126, pE1109, DOI 10.1542/peds.2009-2789; Lissek S, 2007, NEUROIMAGE, V37, P912, DOI 10.1016/j.neuroimage.2007.05.037; Lorson KM, 2008, RES Q EXERCISE SPORT, V79, P174; Lung FW, 2011, RES DEV DISABIL, V32, P100, DOI 10.1016/j.ridd.2010.09.004; Malina R. M., 2004, GROWTH MATURATION PH, DOI DOI 10.5040/9781492596837; Miller L T, 2001, Can J Occup Ther, V68, P5; Missiuna C, 2011, RES DEV DISABIL, V32, P549, DOI 10.1016/j.ridd.2010.12.025; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; Pieters S, 2012, CHILD CARE HLTH DEV, V38, P139, DOI 10.1111/j.1365-2214.2011.01225.x; Poole Janet L, 2005, J Hand Ther, V18, P348, DOI 10.1197/j.jht.2005.04.003; Prunty MM, 2013, RES DEV DISABIL, V34, P2927, DOI 10.1016/j.ridd.2013.06.005; Raudsepp L, 1995, PEDIATR EXERC SCI, V7, P294; Raw RK, Q J EXPT PSYCH UNPUB; Rivet TT, 2011, RES AUTISM SPECT DIS, V5, P957, DOI 10.1016/j.rasd.2010.12.003; Roivainen E, 2011, LEARN INDIVID DIFFER, V21, P145, DOI 10.1016/j.lindif.2010.11.021; Rueckriegel SM, 2008, INT J DEV NEUROSCI, V26, P655, DOI 10.1016/j.ijdevneu.2008.07.015; Sanders G, 2007, EVOLUTIONARY PSYCHOL, V5, P653; Schulz J, 2011, RES DEV DISABIL, V32, P1361, DOI 10.1016/j.ridd.2011.01.032; Strand S, 2006, BRIT J EDUC PSYCHOL, V76, P463, DOI 10.1348/000709905X50906; Sugden DA, 2003, BRIT J EDUC PSYCHOL, V73, P545, DOI 10.1348/000709903322591235; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Terlecki M, 2011, CURR PSYCHOL, V30, P22, DOI 10.1007/s12144-010-9095-5; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Tottenham LS, 2005, PERCEPT MOTOR SKILL, V101, P3, DOI 10.2466/pms.101.1.3-12; Tsai CL, 2012, DEV MED CHILD NEUROL, V54, P1114, DOI [10.1111/j.1469-8749.2012.04408.x, 10.1111/j.1469-8749.2012.04427.x]; van Mier H, 2006, HUM MOVEMENT SCI, V25, P657, DOI 10.1016/j.humov.2006.06.004; Van Waelvelde H, 2012, PHYS OCCUP THER PEDI, V32, P306, DOI 10.3109/01942638.2012.678971; Wang TN, 2009, DEV MED CHILD NEUROL, V51, P817, DOI 10.1111/j.1469-8749.2009.03271.x; Zwicker JG, 2010, PEDIATRICS, V126, pE678, DOI 10.1542/peds.2010-0059	61	46	47	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88692	10.1371/journal.pone.0088692	http://dx.doi.org/10.1371/journal.pone.0088692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523931	Green Accepted, Green Published, gold			2022-12-27	WOS:000331258100080
J	Lu, M; Tian, H; Yue, WM; Li, L; Li, SH; Qi, L; Hu, WS; Gao, C; Si, LB				Lu, Ming; Tian, Hui; Yue, Weiming; Li, Lin; Li, Shuhai; Qi, Lei; Hu, Wensi; Gao, Cun; Si, Libo			TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis	PLOS ONE			English	Article							RNA-POLYMERASE-III; TRANSCRIPTION; MAF1; SURVIVAL	Background: The aim of this study was to examine BRF2 expression in patients with non-small cell lung cancer (NSCLC) and explore the relationship of BRF2 protein with clinicopathologic factors, tumor angiogenesis and prognosis. Methods: Both BRF2 protein and intratumoral microvessels were examined by immunohistochemical staining in 107 non-small cell lung cancer patients. Intratumoral m icrovessel density (MVD) was measured by counting CD-34 positive immunostained endothelial cells. Western blot and RT-PCR analyses were utilized to investigate the BRF2 expression status in tissues Results: A notably higher level of BRF2 expression was found in NSCLC tissues at protein levels. In addition, univariate and multivariate analysis demonstrated that BRF2 protein over-expression and high MVD were significantly associated with tumor relapse. Although BRF2 overexpression and high MVD indicated poor 5-year overall survival (p = 0.004 and p = 0.019, respectively), multivariate analysis demonstrated that only BRF2 overexpression was an independent prognostic factor for unfavorable overall survival (P = 0.021). Conclusions: BRF2 is a promising biomarker to identify individuals with poor prognostic potential and a possible target for anti-angiogenic therapy for patients with early-stage NSCLC.	[Lu, Ming; Tian, Hui; Yue, Weiming; Li, Lin; Li, Shuhai; Qi, Lei; Hu, Wensi; Gao, Cun; Si, Libo] Shandong Univ, Qilu Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China	Shandong University	Tian, H (corresponding author), Shandong Univ, Qilu Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China.	tianhuiql@126.com			National Natural Science Foundation of China [30571844]; Science and Technology Development Foundation of Shandong Province [2009GG10002007]; National Natural Science Foundation of Shandong Province [ZR2009CM090]; Wu Jie Ping Foundation [320.6750.12393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Foundation of Shandong Province; National Natural Science Foundation of Shandong Province; Wu Jie Ping Foundation	Project supported by the National Natural Science Foundation of China (No. 30571844), and the Science and Technology Development Foundation of Shandong Province (No. 2009GG10002007), and the National Natural Science Foundation of Shandong Province (No. ZR2009CM090), and the Wu Jie Ping Foundation (No. 320.6750.12393). Sponsors had no involvement in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. The funders had no role in study design, data collection and analysis.	Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brognard J, 2001, CANCER RES, V61, P3986; Cabarcas S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-47; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; FLEHINGER BJ, 1992, CHEST, V101, P1013, DOI 10.1378/chest.101.4.1013; Fry WA, 1999, CANCER, V86, P1867, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Jacob J, 2007, BIOCHEM BIOPH RES CO, V360, P778, DOI 10.1016/j.bbrc.2007.06.114; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Li SH, 2011, ANN SURG ONCOL, V18, P2048, DOI 10.1245/s10434-010-1510-5; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lu ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0664-y; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Ren HN, 2004, J CLIN ONCOL, V22, P3230, DOI 10.1200/JCO.2004.02.080; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rollins J, 2007, INT J BIOL SCI, V3, P292; Rooney C, 2011, RESPIRATION, V81, P89, DOI 10.1159/000323946; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; Wang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043268; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244	24	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88032	10.1371/journal.pone.0088032	http://dx.doi.org/10.1371/journal.pone.0088032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523874	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100023
J	Pullen, N; Morris, RJ				Pullen, Nick; Morris, Richard J.			Bayesian Model Comparison and Parameter Inference in Systems Biology Using Nested Sampling	PLOS ONE			English	Article							MONTE-CARLO METHODS; BIOCHEMICAL PATHWAYS; SELECTION; OPTIMIZATION; EFFICIENT	Inferring parameters for models of biological processes is a current challenge in systems biology, as is the related problem of comparing competing models that explain the data. In this work we apply Skilling's nested sampling to address both of these problems. Nested sampling is a Bayesian method for exploring parameter space that transforms a multi-dimensional integral to a 1D integration over likelihood space. This approach focusses on the computation of the marginal likelihood or evidence. The ratio of evidences of different models leads to the Bayes factor, which can be used for model comparison. We demonstrate how nested sampling can be used to reverse-engineer a system's behaviour whilst accounting for the uncertainty in the results. The effect of missing initial conditions of the variables as well as unknown parameters is investigated. We show how the evidence and the model ranking can change as a function of the available data. Furthermore, the addition of data from extra variables of the system can deliver more information for model comparison than increasing the data from one variable, thus providing a basis for experimental design.	[Pullen, Nick; Morris, Richard J.] John Innes Ctr, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Pullen, N (corresponding author), John Innes Ctr, Norwich, Norfolk, England.	nick.pullen@jic.ac.uk		Morris, Richard/0000-0003-3080-2613	UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC Systems Biology PhD studentship; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000611, 982530] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Systems Biology PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The John Innes Centre is grant-aided by the UK Biotechnology and Biological Sciences Research Council (BBSRC). NP was supported by a BBSRC Systems Biology PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-72; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alon U., 2006, CHAPMAN HALL CRC MAT; Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; [Anonymous], 2002, MATH BIOL; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Ashyraliyev M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-83; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; BLUMER A, 1987, INFORM PROCESS LETT, V24, P377, DOI 10.1016/0020-0190(87)90114-1; Brewer BJ, 2011, STAT COMPUT, V21, P649, DOI 10.1007/s11222-010-9198-8; Brooks S, 2011, CH CRC HANDB MOD STA, pXIX; Burkoff NS, 2012, BIOPHYS J, V102, P878, DOI 10.1016/j.bpj.2011.12.053; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Calderhead B, 2011, INTERFACE FOCUS, V1, P821, DOI 10.1098/rsfs.2011.0051; Calderhead B, 2009, COMPUT STAT DATA AN, V53, P4028, DOI 10.1016/j.csda.2009.07.025; Chou I, 2006, THEOR BIOL MED MODEL, V19, P3; Dalchau N, 2012, NEW PHYTOL, V193, P852, DOI 10.1111/j.1469-8137.2011.04004.x; Edelstein-Keshet L., 1988, RANDOM HOUSE BIRKHAU; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Eydgahi H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.69; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; Feroz F, 2008, MON NOT R ASTRON SOC, V384, P449, DOI 10.1111/j.1365-2966.2007.12353.x; Feroz F, 2009, MON NOT R ASTRON SOC, V398, P1601, DOI 10.1111/j.1365-2966.2009.14548.x; Feroz F, 2013, ARXIV13062144; Floudas CA, 2009, J GLOBAL OPTIM, V45, P3, DOI 10.1007/s10898-008-9332-8; Friel N, 2012, STAT NEERL, V66, P288, DOI 10.1111/j.1467-9574.2011.00515.x; Gonzalez OR, 2007, BIOINFORMATICS, V23, P480, DOI 10.1093/bioinformatics/btl522; Goodwin B.C, 1963, TEMPORAL ORG CELLS D; Granqvist E, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-97; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Han C, 2001, J AM STAT ASSOC, V96, P1122, DOI 10.1198/016214501753208780; Heuett WJ, 2012, BIOPHYS J, V102, P399, DOI 10.1016/j.bpj.2011.12.046; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Jaynes E.T., 2003, PROBABILITY THEORY L; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kirk P, 2013, CURRENT OPINION BIOT; Kirk PDW, 2008, BIOPHYS J, V95, P540, DOI 10.1529/biophysj.107.126086; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Liepe J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002888; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; MacKay D. J. C., 2003, INFORM THEORY INFERE; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Mitsos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050085; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Mukherjee P, 2006, ASTROPHYS J, V638, pL51, DOI 10.1086/501068; Murray I., 2007, THESIS U COLL LONDON; Neal R. M., 1996, LECT NOTES STAT; Partay LB, 2010, J PHYS CHEM B, V114, P10502, DOI 10.1021/jp1012973; Patil A, 2010, J STAT SOFTW, V35, P1; Pokhilko A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.6; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Press W. H., 1992, ART SCI COMPUTING; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rasmussen CE, 2001, ADV NEUR IN, V13, P294; Schmidl D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-95; SCHNAKENBERG J, 1979, J THEOR BIOL, V81, P389, DOI 10.1016/0022-5193(79)90042-0; Schwaab M, 2008, CHEM ENG SCI, V63, P1542, DOI 10.1016/j.ces.2007.11.024; Scott P, 2012, EUR PHYS J PLUS, V127, DOI 10.1140/epjp/i2012-12138-3; Sivia Devinderjit, 2006, DATA ANAL BAYESIAN T, DOI DOI 10.1007/10201161_90; Skilling J, 2006, BAYESIAN ANAL, V1, P833, DOI 10.1214/06-BA127; Toni T, 2010, METHODS MOL BIOL, V673, P283, DOI 10.1007/978-1-60761-842-3_18; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; VOLTERRA VITO, 1926, MEM R ACCAD NAZ LINCEI CL FIS MAT E NAT, V2, P31; Vyshemirsky V, 2008, BIOINFORMATICS, V24, P833, DOI 10.1093/bioinformatics/btm607; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkinson DJ, 2007, BRIEF BIOINFORM, V8, P109, DOI 10.1093/bib/bbm007; Zhan CJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-14	80	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88419	10.1371/journal.pone.0088419	http://dx.doi.org/10.1371/journal.pone.0088419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523891	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100040
J	Schmid, E; Yan, J; Nurbaeva, MK; Russo, A; Yang, WT; Faggio, C; Shumilina, E; Lang, F				Schmid, Evi; Yan, Jing; Nurbaeva, Meerim K.; Russo, Antonella; Yang, Wenting; Faggio, Caterina; Shumilina, Ekaterina; Lang, Florian			Decreased Store Operated Ca2+ Entry in Dendritic Cells Isolated from Mice Expressing PKB/SGK-Resistant GSK3	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NA+/CA2+ EXCHANGER; MAMMALIAN TARGET; PHOSPHORYLATION; ACTIVATION; RECEPTOR; INHIBITION; RAPAMYCIN; HORMONE; RELEASE	Dendritic cells (DCs), key players of immunity, are regulated by glycogen synthase kinase GSK3. GSK3 activity is suppressed by PKB/Akt and SGK isoforms, which are in turn stimulated by the PI3K pathway. Exposure to bacterial lipopolysaccharides increases cytosolic Ca2+-concentration ([Ca (2+)](i)), an effect augmented in DCs isolated from mutant mice expressing PKB/SGK-resistant GSK3 alpha, beta (gsk3(KI)). Factors affecting [Ca2+](i) include Ca2+-release from intracellular stores (CRIS), store-operated Ca(2+-)entry (SOCE) through STIM1/STIM2-regulated Orai1, K+-dependent Na+/Ca2+-exchangers (NCKX), K+-independent Na+/Ca(2+-)exchangers (NCX) and calbindin-D28k. The present study explored whether PKB/SGK-dependent GSK3 alpha, beta-activity impacts on CRIS, SOCE, NCKX, NCX or calbindin. DCs were isolated from gsk3(KI) mice and respective wild-type mice (gsk3(WT)), [Ca2+](i) estimated from Fura2 fluorescence, Orai1, STIM1, STIM2 as well as calbindin-D28k protein abundance determined by Western blotting and mRNA levels quantified by real time PCR. As a result, thapsigargin-induced CRIS and SOCE were significantly blunted by GSK3-inhibitors SB216763 (1-10 mu M, 30 min) or GSK-XIII (10 mu M, 30 min) but were significantly lower in gsk3(WT) than in gsk3(KI) DCs. Orai1, STIM1 and STIM2 protein abundance was significantly lower and calbindin-D28k abundance significantly higher in gsk3(KI) than in gsk3(WT) DCs. Activity of NCKX and NCX was significantly higher in gsk3(KI) than in gsk3(WT) DCs and was significantly increased by SB216763(1 mu M, 30 min) or GSK-XIII (10 mu M, 30 min). Treatment of gsk3(WT) DCs with SB216763(1 mu M, 4-24 h) or GSK-XIII (10 mu M, 4-24 h) did not significantly modify the protein abundance of Orai1, STIM1 and STIM2. The present observations point to a dual role of GSK3 in the regulation of Ca2+ in DCs. Acute inhibition of GSK3 blunted the increase of [Ca2+](i) following CRIS and SOCE and stimulated NCKX/NCX activity. However, expression of PKB/SGK-resistant GSK3 alpha, beta downregulated the increase of [Ca2+](i) following CRIS and SOCE, an effect at least partially due to downregulation of Orai1, STIM1 and STIM2 expression as well as upregulation of Na+/Ca2+-exchanger activity and calbindin D28k expression.	[Schmid, Evi; Yan, Jing; Nurbaeva, Meerim K.; Russo, Antonella; Yang, Wenting; Shumilina, Ekaterina; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Faggio, Caterina] Univ Messina, Dept Biol & Environm Sci, Sant Agata Di Messina, Italy	Eberhard Karls University of Tubingen; University of Messina	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Tubingen, Germany.	florian.lang@uni-tuebingen.de		faggio, caterina/0000-0002-0066-2421	Deutsche Forschungsgemeinschaft [GK 1302]; Open Access Publishing Fund of Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This study was supported by the Deutsche Forschungsgemeinschaft (GK 1302) (http://www.dfg.de/) and the Open Access Publishing Fund of Tuebingen University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann TF, 2010, CELL PHYSIOL BIOCHEM, V25, P775, DOI 10.1159/000315097; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bandyopadhyay BC, 2011, J LEUKOCYTE BIOL, V89, P57, DOI 10.1189/jlb.0610381; Beurel E, 2010, NEUROSCIENCE, V169, P1063, DOI 10.1016/j.neuroscience.2010.05.044; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Beurel E, 2011, J IMMUNOL, V186, P1391, DOI 10.4049/jimmunol.1003511; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bhavsar SK, 2012, BIOCHEM BIOPH RES CO, V425, P6, DOI 10.1016/j.bbrc.2012.07.030; Boini KM, 2008, PFLUG ARCH EUR J PHY, V456, P1207, DOI 10.1007/s00424-008-0483-8; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS HR, 1995, MAGNET RESON MED, V34, P673, DOI 10.1002/mrm.1910340505; De Sarno P, 2008, J IMMUNOL, V181, P338, DOI 10.4049/jimmunol.181.1.338; Dubsky P, 2005, J CLIN IMMUNOL, V25, P551, DOI 10.1007/s10875-005-8216-7; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Felix R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061595; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Geng S, 2012, INT IMMUNOPHARMACOL, V12, P358, DOI 10.1016/j.intimp.2011.12.008; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Heise N, 2011, AM J PHYSIOL-CELL PH, V300, pC1306, DOI 10.1152/ajpcell.00396.2010; Hofmann C, 2010, INFLAMM BOWEL DIS, V16, P1850, DOI 10.1002/ibd.21294; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; HUGHES K, 1992, BIOCHEM J, V288, P309, DOI 10.1042/bj2880309; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Koros E, 2007, DRUG NEWS PERSPECT, V20, P437, DOI 10.1358/dnp.2007.20.7.1149632; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Martin DR, 2005, AM J PHYSIOL-ENDOC M, V289, pE729, DOI 10.1152/ajpendo.00065.2005; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nurbaeva MK, 2012, FASEB J, V26, P3049, DOI 10.1096/fj.12-204024; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Ono T, 2007, IMMUNOLOGY, V122, P189, DOI 10.1111/j.1365-2567.2007.02627.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce AC, 2005, J MED CHEM, V48, P1278, DOI 10.1021/jm0492249; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Rotte A, 2010, J GASTROENTEROL; Russo A, 2013, BIOCH BIOPHYS RES CO; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schmid E, 2012, CELL PHYSIOL BIOCHEM, V30, P1423, DOI 10.1159/000343330; Schutz SV, 2010, J CELL BIOCHEM, V109, P1192, DOI 10.1002/jcb.22500; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Shumilina E, 2013, AM J PHYSIOL-CELL PH, V305, pC70, DOI 10.1152/ajpcell.00355.2012; Shumilina E, 2011, AM J PHYSIOL-CELL PH, V300, pC1205, DOI 10.1152/ajpcell.00039.2011; Siraskar B, 2011, PFLUG ARCH EUR J PHY, V462, P811, DOI 10.1007/s00424-011-1006-6; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Wang HZ, 2011, J IMMUNOL, V186, P675, DOI 10.4049/jimmunol.1001473; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Wyatt AW, 2006, CELL PHYSIOL BIOCHEM, V17, P137, DOI 10.1159/000092075	54	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88637	10.1371/journal.pone.0088637	http://dx.doi.org/10.1371/journal.pone.0088637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523925	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100074
J	Skinner, JPJ; Keown, AA; Chong, MMW				Skinner, Jarrod P. J.; Keown, Ashleigh A.; Chong, Mark M. W.			The miR-17 similar to 92a Cluster of MicroRNAs Is Required for the Fitness of Foxp3(+) Regulatory T Cells	PLOS ONE			English	Article							RNA-INTERFERENCE; TARGET GENES; DIFFERENTIATION; TRANSCRIPTION; T(H)17; DICER; ENTEROPATHY; DISRUPTION; EXPRESSION; ENHANCER	By genetic inactivation of key microRNA biogenesis enzymes, we and others have previously demonstrated the critical requirement of the microRNA pathway for the differentiation and function of Foxp3(+) regulatory T cells. In this study, we identified members of the miR-17 similar to 92a cluster of microRNAs to be enriched in regulatory T cells. To investigate the function of this microRNA cluster, we deleted the gene specifically in Foxp3(+) cells in mice. We found that miR-17 similar to 92a is required for the fitness of regulatory T cells, and deficiency impacted at the level of apoptosis and proliferation of these cells. This led to a loss of Foxp3(+) cells over time, particularly in competitive settings, and culminated in a range of immunologic perturbations. Thus, miR-17 similar to 92a-target interactions are part of the essential microRNA networks that safeguard the regulatory T cell lineage.	[Skinner, Jarrod P. J.; Keown, Ashleigh A.; Chong, Mark M. W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Chong, Mark M. W.] Univ Melbourne, Dept Med St Vincents, Fitzroy, Vic 3065, Australia	St. Vincent's Institute of Medical Research; University of Melbourne	Chong, MMW (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	mchong@svi.edu.au	Chong, Mark/H-6684-2016	Chong, Mark/0000-0002-3701-7397	National Health and Medical Research Council, Australia [637338, 1004541]; Juvenile Diabetes Research Foundation [5-2011-100]; Diabetes Australia Research Trust [Y13G-CHOM]; Australian Research Council QEII Fellow	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes Australia Research Trust; Australian Research Council QEII Fellow(Australian Research Council)	This work was funded by grants from the National Health and Medical Research Council, Australia (#637338 and #1004541), Juvenile Diabetes Research Foundation (5-2011-100) and the Diabetes Australia Research Trust (Y13G-CHOM). MMWC is an Australian Research Council QEII Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Chong MMW, 2010, GENE DEV, V24, P659, DOI 10.1101/gad.1901610; de Kouchkovsky D, 2013, J IMMUNOL, V191, P1594, DOI 10.4049/jimmunol.1203567; Dupont C, 2013, CURR OPIN CELL BIOL, V25, P314, DOI 10.1016/j.ceb.2013.03.001; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Katoh H, 2011, MOL CELL, V44, P770, DOI 10.1016/j.molcel.2011.10.012; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	36	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88997	10.1371/journal.pone.0088997	http://dx.doi.org/10.1371/journal.pone.0088997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523948	Green Published, gold			2022-12-27	WOS:000331258100097
J	Xiong, Q; Li, ZL; Li, ZH; Zhu, Y; Abdulhalim, S; Wang, P; Cai, XJ				Xiong, Qi; Li, Zhiliang; Li, Zhaohui; Zhu, Yi; Abdulhalim, Sancar; Wang, Ping; Cai, Xiaojun			Anti-VEGF Agents with or without Antimetabolites in Trabeculectomy for Glaucoma: A Meta-Analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUBCONJUNCTIVAL BEVACIZUMAB; FILTERING SURGERY; SCAR FORMATION; MITOMYCIN-C; 5-FLUOROURACIL; INJECTION; ENDOPHTHALMITIS; FIBROBLASTS; FILTRATION	We aimed to evaluate the intraoperative application of antimetabolites compared with anti-vascular endothelial growth factor (VEGF) agents with or without antimetabolites in trabeculectomy (Trab) for glaucoma. Methods: Relevant studies were selected through extensive search using PubMed, EMBASE, the Cochrane Library, and Web of Science databases in August 2013. The primary efficacy estimate was measured using weighted mean difference of the percentage of intraocular pressure reduction (IOPR%) from baseline to end-point, and the secondary efficacy estimates were odds ratio (OR) and 95% confidence interval (CI) for complete success rate and qualified success rate. ORs were also used to measure the tolerability estimate for adverse events. Meta-analyses of fixed or random effects models were conducted using RevMan software 5.2 to pool the results of the studies included. Heterogeneity was assessed using Chi(2) test and the I-2 measure. Results: Nine studies enrolling a total of 349 patients were included. The weighted mean difference of IOPR% from baseline was 7.23 (95% CI: 2.57-11.89) for antimetabolites vs. anti-VEGF agents and 3.96 (95% CI: 24.18-12.10) for antimetabolites vs. anti-VEGF agents plus antimetabolites. The pooled ORs comparing antimetabolites with anti-VEGF agents were 2.37 (95% CI: 0.78, 7.21) for the complete success rate and 1.93 (95% CI: 0.52, 7.16) for qualified success rate. The pooled ORs comparing antimetabolites with anti-VEGF agents plus antimetabolites were 1.43 (95% CI: 0.48, 4.29) for the complete success rate and 2.11 (95% CI: 0.12, 37.72) for qualified success rate. The rates of adverse events did not significantly differ between antimetabolites and anti-VEGF agents, with pooled ORs of 0.86 (0.28-2.69) for bleb leakage, 3.01 (0.45-20.10) for choroidal effusion, 0.96 (0.23-3.98) for flat anterior chamber, and 0.90 (0.12-6.60) for hypotony. Further, the rates of adverse events were similar between antimetabolites and anti-VEGF agents plus antimetabolites, with pooled ORs of 0.40 (0.082.00) and 8.00 (0.93-68.59) for bleb leakage and hypotony, respectively. Conclusions: In comparison with anti-VEGF agents, antimetabolites were more effective in lowering IOP in Trab, while the intraoperative application of these two types of agents did not indicate	[Xiong, Qi; Li, Zhaohui; Zhu, Yi; Abdulhalim, Sancar; Wang, Ping; Cai, Xiaojun] Wuhan Univ, Dept Ophthalmol, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China; [Li, Zhiliang] Huazhong Univ Sci & Technol, Dept Orthped, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Cai, XJ (corresponding author), Wuhan Univ, Dept Ophthalmol, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China.	xiaojuncai168@163.com						ADDICKS EM, 1983, ARCH OPHTHALMOL-CHIC, V101, P795; Akkan JU, 2013, J GLAUCOMA; Bao Philip, 2009, J Surg Res, V153, P347, DOI 10.1016/j.jss.2008.04.023; Burr J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004399.pub3; CAIRNS JE, 1968, AM J OPHTHALMOL, V66, P673, DOI 10.1016/0002-9394(68)91288-9; Choritz L, 2010, GRAEF ARCH CLIN EXP, V248, P197, DOI 10.1007/s00417-009-1221-4; Chua BE, 2012, CLIN EXP OPHTHALMOL, V40, P773, DOI 10.1111/j.1442-9071.2012.02798.x; Coote MA, 2008, J GLAUCOMA, V17, P517, DOI 10.1097/IJG.0b013e31815f5345; Deeks J, 2008, COCHRANE HDB SYSTEMA; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Freiberg FJ, 2013, CLIN OPHTHALMOL, V7, P1211, DOI 10.2147/OPTH.S41750; Greenfield DS, 1996, ARCH OPHTHALMOL-CHIC, V114, P943, DOI 10.1001/archopht.1996.01100140151007; Grewal DS, 2008, OPHTHALMOLOGY, V115, P2141, DOI 10.1016/j.ophtha.2008.06.009; Heatley G, 2004, GENE THER, V11, P949, DOI 10.1038/sj.gt.3302253; Hitchings R, 1998, ARCH OPHTHALMOL-CHIC, V116, P241; HITCHINGS RA, 1983, T OPHTHAL SOC UK, V103, P84; Jonas JB, 2007, OPHTHAL RES, V39, P121, DOI 10.1159/000099248; Jurkowska-Dudzinska J, 2012, CLIN EXP OPHTHALMOL, V40, pE135, DOI 10.1111/j.1442-9071.2011.02608.x; Kahook MY, 2010, AM J OPHTHALMOL, V150, P399, DOI 10.1016/j.ajo.2010.03.025; Kahook MY, 2006, OPHTHAL SURG LAS IM, V37, P148, DOI 10.3928/1542-8877-20060301-12; Lama PJ, 2003, SURV OPHTHALMOL, V48, P314, DOI 10.1016/S0039-6257(03)00038-9; Li ZQ, 2009, INVEST OPHTH VIS SCI, V50, P5217, DOI 10.1167/iovs.08-2662; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nakamura-Shibasaki M, 2013, CELL BIOCHEM FUNCT, V31, P482, DOI 10.1002/cbf.2923; Nilforushan N, 2012, AM J OPHTHALMOL, V153, P352, DOI 10.1016/j.ajo.2011.08.005; Nissen NN, 1998, AM J PATHOL, V152, P1445; Pakravan Mohammad, 2011, J Ophthalmic Vis Res, V6, P78; Parrish R, 1996, OPHTHALMOLOGY, V103, P1167, DOI 10.1016/S0161-6420(96)30527-7; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Rulli E, 2013, JAMA OPHTHALMOL, V131, P1573, DOI 10.1001/jamaophthalmol.2013.5059; Seah S K, 1995, J Glaucoma, V4, P73; Sengupta S, 2012, J GLAUCOMA, V21, P450, DOI 10.1097/IJG.0b013e31821826b2; Simsek T, 2012, J OCUL PHARMACOL TH, V28, P542, DOI 10.1089/jop.2012.0035; SKUTA GL, 1987, SURV OPHTHALMOL, V32, P149, DOI 10.1016/0039-6257(87)90091-9; Suh W, 2013, J OCUL PHARMACOL TH, V29, P646, DOI 10.1089/jop.2012.0250; Vogel R, 2007, OPHTHALMOLOGY, V114, P1822, DOI 10.1016/j.ophtha.2007.03.050; Wang X, 2013, CLIN EXPT OPHTHALMOL, V14; Yu J, 2007, INVEST OPHTH VIS SCI, V48, P4815	39	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88403	10.1371/journal.pone.0088403	http://dx.doi.org/10.1371/journal.pone.0088403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523890	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100039
J	Bart, IY; Schabos, Y; van Hout, RWNM; Leenders, ACAP; de Vries, E				Bart, Ingeborg Y.; Schabos, Yvonne; van Hout, Roeland W. N. M.; Leenders, Alexander C. A. P.; de Vries, Esther			Pediatric Acute Q Fever Mimics Other Common Childhood Illnesses	PLOS ONE			English	Article							CHILDREN; OSTEOMYELITIS; DIAGNOSIS; HEPATITIS	Knowledge of Q fever has increased over the last decades, but research has mainly focused on adults. Data in children are scarce, and current knowledge is mostly based on case reports. The aim of this study was to determine predictors for acute Q fever in children in the general population. We retrospectively studied all children tested for Coxiella burnetii by serology and/or PCR upon request of their general practitioner in the regional laboratory for Medical Microbiology of the Jeroen Bosch during the Q fever outbreak in the Netherlands between 2007 and 2011. A total of 1061 patients was analyzed. Influenza-like illness and respiratory tract infection were the most common presentations of acute Q fever, mimicking other common childhood illnesses. None of the reported symptoms was significantly related to a positive test outcome and therefore presenting signs or symptoms have no predictive value in diagnosing Q-fever in children. Only diagnostic tests are reliable. As the infection generally follows a mild and uncomplicated course, we question if the difficulty of recognizing pediatric Q fever is a problem worth solving.	[van Hout, Roeland W. N. M.] Radboud Univ Nijmegen, Dept Linguist, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen		e.d.vries@jbz.nl		de Vries, Esther/0000-0003-4311-3550				[Anonymous], 2008, EURO SURVEILL; Ariga T, 2000, PEDIATR INT, V42, P711, DOI 10.1046/j.1442-200x.2000.01290.x; Baquero-Artigao F, 2002, PEDIATR INFECT DIS J, V21, P705, DOI 10.1097/00006454-200207000-00021; Barralet JH, 2004, MED J AUSTRALIA, V180, P596, DOI 10.5694/j.1326-5377.2004.tb06106.x; Cohn A, 2012, PEDIATR INFECT DIS J, V31, P525, DOI 10.1097/INF.0b013e3182468f0e; DRANCOURT M, 1991, EUR J EPIDEMIOL, V7, P134; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Georgiev M, 2013, EURO SURVEILL, V18; Hervas JA, 2000, PEDIATR INFECT DIS J, V19, P1104, DOI 10.1097/00006454-200011000-00019; Kuroiwa Y, 2007, PEDIATR INFECT DIS J, V26, P763, DOI 10.1097/INF.0b013e3180f60bfe; Maltezou HC, 2004, AM J TROP MED HYG, V70, P540, DOI 10.4269/ajtmh.2004.70.540; Maltezou HC, 2002, LANCET INFECT DIS, V2, P686, DOI 10.1016/S1473-3099(02)00440-1; Maltezou HC, 2001, PEDIATR INFECT DIS J, V20, P811, DOI 10.1097/00006454-200108000-00021; Meekelenkamp JCE, 2012, EUR J CLIN MICROBIOL, V31, P1267, DOI 10.1007/s10096-011-1438-0; Nourse C, 2004, CLIN INFECT DIS, V39, pE61, DOI 10.1086/424014; Ohgimi Chikara, 2009, Kansenshogaku Zasshi, V83, P245; Parker N, 2010, AUST NZ J PUBL HEAL, V34, P79, DOI 10.1111/j.1753-6405.2010.00478.x; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Ravid S, 2008, PEDIATR NEUROL, V38, P44, DOI 10.1016/j.pediatrneurol.2007.09.004; Richardus J H, 1984, Ned Tijdschr Geneeskd, V128, P2253; RICHARDUS JH, 1985, PEDIATR INFECT DIS J, V4, P369, DOI 10.1097/00006454-198507000-00007; RUIZCONTRERAS J, 1993, AM J DIS CHILD, V147, P300, DOI 10.1001/archpedi.1993.02160270062019; Schimmer B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042364; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; Tasher D, 2012, PEDIATR CARDIOL, V33, P831, DOI 10.1007/s00246-012-0215-x; Tellez A, 1998, J INFECTION, V37, P79, DOI 10.1016/S0163-4453(98)91034-9; Terheggen Ulrich, 2007, Travel Med Infect Dis, V5, P159, DOI 10.1016/j.tmaid.2006.06.001; van Hensbroek MB, 2000, PEDIATR INFECT DIS J, V19, P358, DOI 10.1097/00006454-200004000-00021; Wegdam-Blans M. C. A., 2010, Nederlands Tijdschrift voor Geneeskunde, V154, P1725; Neth OW, 2011, PEDIATR INFECT DIS J, V30, P810, DOI 10.1097/INF.0b013e31821487f5	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88677	10.1371/journal.pone.0088677	http://dx.doi.org/10.1371/journal.pone.0088677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520412	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600103
J	Jiang, X; Yang, XJ; Zhang, YH; Wang, BX; Sun, LJ; Shang, L				Jiang, Xun; Yang, Xianjun; Zhang, Yuhai; Wang, Baoxi; Sun, Lijun; Shang, Lei			Development and Preliminary Validation of Chinese Preschoolers' Eating Behavior Questionnaire	PLOS ONE			English	Article							NORMAL-WEIGHT; FACTORIAL VALIDATION; RELATIVE WEIGHT; FIT INDEXES; CHILDREN; OBESITY; ASSOCIATION; ADOLESCENTS; PATTERNS; AGE	Background: The objective of this study was to develop a questionnaire for caregivers to assess the eating behavior of Chinese preschoolers. Methods: To assess children's eating behaviors, 152 items were derived from a broad review of the literature related to epidemiology surveys and the assessment of children's eating behaviors. All of these items were reviewed by 50 caregivers of preschoolers and 10 experienced pediatricians. Seventy-seven items were selected for use in a primary questionnaire. After conducting an exploratory factor analysis and a variability analysis on the data from 313 preschoolers used to evaluate this primary questionnaire, we deleted 39 of these 77 items. A Chinese Preschoolers' Eating Behavior Questionnaire (CPEBQ) was finally established from the remaining 38 items. The structure of this questionnaire was explored by factor analysis, and its reliability, validity and discriminative ability were evaluated with data collected from caregivers of 603 preschoolers. Results: The CPEBQ consisted of 7 dimensions and 38 items. The 7 dimensions were food fussiness, food responsiveness, eating habit, satiety responsiveness, exogenous eating, emotional eating and initiative eating. The Cronbach's a coefficient for the questionnaire was 0.92, and the test-retest reliability was 0.72. There were significant differences between the scores of normal-weight, overweight and obese preschoolers when it was referred to food fussiness, food responsiveness, eating habits, satiety responsiveness and emotional eating (p<0.05). Differences in caregiver's education levels also had significant effects on scores for food fussiness, eating habits and exogenous eating (p<0.05). Conclusions: The CPEBQ satisfies the conditions of reliability and validity, in accordance with psychometric demands. The questionnaire can be employed to evaluate the characteristics of Chinese preschoolers' eating behaviors; therefore, it can be used in child health care practice and research.	[Jiang, Xun; Wang, Baoxi] Fourth Mil Med Univ, Tangdu Hosp, Dept Pediat, Xian 710032, Shaanxi, Peoples R China; [Yang, Xianjun; Zhang, Yuhai; Sun, Lijun; Shang, Lei] Fourth Mil Med Univ, Sch Publ Hlth, Dept Hlth Stat, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Jiang, X (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Pediat, Xian 710032, Shaanxi, Peoples R China.	jiangx@fmmu.edu.cn; shanglei@fmmu.edu.cn	Yang, Xian/GVU-9087-2022	Jiang, Xun/0000-0002-3344-4797	National Natural Science Funds [81273175]; Social Development Research Funds of Shaanxi Province [2011K12-31]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Social Development Research Funds of Shaanxi Province	This study was supported by National Natural Science Funds (No. 81273175) and Social Development Research Funds of Shaanxi Province (No. 2011K12-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER LA, 1991, J PEDIATR PSYCHOL, V16, P629, DOI 10.1093/jpepsy/16.5.629; Banos RM, 2011, NUTR HOSP, V26, P890, DOI [10.3305/nh.2011.26.4.5238, 10.1590/S0212-16112011000400032]; BARKELING B, 1992, INT J OBESITY, V16, P355; Birch LL, 2009, INT J OBESITY, V33, pS74, DOI 10.1038/ijo.2009.22; Cao YT, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-5; Carnell S, 2008, P NUTR SOC, V67, P343, DOI 10.1017/S0029665108008641; Carruth BR, 2000, J AM COLL NUTR, V19, P771, DOI 10.1080/07315724.2000.10718077; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; DiSantis KI, 2011, INT J OBESITY, V35, P480, DOI 10.1038/ijo.2011.3; Dubois L, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-9; Farrow C, 2012, APPETITE, V58, P151, DOI 10.1016/j.appet.2011.09.005; Hao Y, 2009, CHINESE J HLTH STAT, V21, P209; Health. NCfWsaCs, 2008, CHIN J PEDIAT, V46, P179; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jin X. M., 2009, CHINESE J CHILD HLTH, V17, P387; Jing XM, 2010, CHIN J CHILD HLTH CA, V18, P537; Lewinsohn PM, 2005, INT J EAT DISORDER, V38, P208, DOI 10.1002/eat.20175; Li F, 2010, CHIN J EVID BASED PE, V5, P320; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P493; Lindgren AC, 2000, J PEDIATR-US, V137, P50, DOI 10.1067/mpd.2000.106563; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; NAKAO H, 1990, APPETITE, V14, P45, DOI 10.1016/0195-6663(90)90053-B; Ogden CL, 2010, PREVALENCE OBESITY C; Pheasant ST, 1986, BODYSPACE ANTHROPOME, P72; Ren YJ, 2011, HLTH READING J, V4, P360; Russell DW, 2002, PERS SOC PSYCHOL B, V28, P1629, DOI 10.1177/014616702237645; Scaglioni S, 2011, AM J CLIN NUTR, V94, p2006S, DOI 10.3945/ajcn.110.001685; SCHACHTER S, 1968, SCIENCE, V161, P751, DOI 10.1126/science.161.3843.751; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Spence JC, 2011, INT J PEDIATR OBES, V6, pE501, DOI 10.3109/17477166.2010.512087; Sun J, 2008, MED WORLD, V9, P66; Svensson V, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-134; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; Viana V, 2008, BRIT J NUTR, V100, P445, DOI 10.1017/S0007114508894391; WARDLE J, 1992, APPETITE, V18, P167, DOI 10.1016/0195-6663(92)90195-C; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661; Webb SM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-97; Zhang XM, 2011, CHIN J CHILD HLTH CA, V19, P275; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	43	13	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88255	10.1371/journal.pone.0088255	http://dx.doi.org/10.1371/journal.pone.0088255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520359	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600050
J	Soto, IM; Carreira, VP; Corio, C; Padro, J; Soto, EM; Hasson, E				Soto, Ignacio M.; Carreira, Valeria P.; Corio, Cristian; Padro, Julian; Soto, Eduardo M.; Hasson, Esteban			Differences in Tolerance to Host Cactus Alkaloids in Drosophila koepferae and D. buzzatii	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; CACTOPHILIC DROSOPHILA; REPRODUCTIVE ISOLATION; FLUCTUATING ASYMMETRY; SECONDARY METABOLITES; DEVELOPMENTAL TIME; SPECIES COMPLEX; WING MORPHOLOGY; SONORAN DESERT; NATURAL HOSTS	The evolution of cactophily in the genus Drosophila was a major ecological transition involving over a hundred species in the Americas that acquired the capacity to cope with a variety of toxic metabolites evolved as feeding deterrents in Cactaceae. D. buzzatii and D. koepferae are sibling cactophilic species in the D. repleta group. The former is mainly associated with the relatively toxic-free habitat offered by prickly pears (Opuntia sulphurea) and the latter has evolved the ability to use columnar cacti of the genera Trichocereus and Cereus that contain an array of alkaloid secondary compounds. We assessed the effects of cactus alkaloids on fitness-related traits and evaluated the ability of D. buzzatii and D. koepferae to exploit an artificial novel toxic host. Larvae of both species were raised in laboratory culture media to which we added increasing doses of an alkaloid fraction extracted from the columnar cactus T. terschekii. In addition, we evaluated performance on an artificial novel host by rearing larvae in a seminatural medium that combined the nutritional quality of O. sulphurea plus amounts of alkaloids found in fresh T. terschekii. Performance scores in each rearing treatment were calculated using an index that took into account viability, developmental time, and adult body size. Only D. buzzatii suffered the effects of increasing doses of alkaloids and the artificial host impaired viability in D. koepferae, but did not affect performance in D. buzzatii. These results provide the first direct evidence that alkaloids are key determinants of host plant use in these species. However, the results regarding the artificial novel host suggest that the effects of alkaloids on performance are not straightforward as D. koepferae was heavily affected. We discuss these results in the light of patterns of host plan evolution in the Drosophila repleta group.	[Soto, Ignacio M.; Carreira, Valeria P.; Corio, Cristian; Padro, Julian; Soto, Eduardo M.; Hasson, Esteban] Consejo Nacl Invest Cient & Tecn, Inst Ecol Genet & Evoluc Buenos Aires, RA-1033 Buenos Aires, DF, Argentina; [Soto, Ignacio M.; Carreira, Valeria P.; Corio, Cristian; Padro, Julian; Soto, Eduardo M.; Hasson, Esteban] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Soto, IM (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Ecol Genet & Evoluc Buenos Aires, RA-1033 Buenos Aires, DF, Argentina.	soto@ege.fcen.uba.ar	Carreira, Valeria/AAG-2196-2020	Padro, Julian/0000-0002-9068-5685; Soto, Eduardo M./0000-0001-6500-5978; Soto, Ignacio/0000-0003-2589-826X; Hasson, Esteban/0000-0003-3326-9877	ANPCyT; CONICET; Universidad de Buenos Aires (UBA)	ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	This work was supported by grants from ANPCyT, CONICET and Universidad de Buenos Aires (UBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Bush G.L., 1975, P187; BUSH GL, 1969, EVOLUTION, V23, P237, DOI 10.1111/j.1558-5646.1969.tb03508.x; Carreira VP, 2006, J EVOLUTION BIOL, V19, P1275, DOI 10.1111/j.1420-9101.2005.01078.x; Carreira VP, 2014, HASELTONIA, P38, DOI 10.2985/026.019.0106; Corio C, 2013, BIOL J LINN SOC, V109, P342, DOI 10.1111/bij.12036; Cortese MD, 2002, EVOLUTION, V56, P2541, DOI 10.1111/j.0014-3820.2002.tb00179.x; Dambroski HR, 2005, EVOLUTION, V59, P1953, DOI 10.1111/j.0014-3820.2005.tb01065.x; Dieckmann U, 2004, ADAPTIVE SPECIATION, P488; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Dryden IL, 1998, STAT SHAPE ANAL; Efron B, 1993, INTRO BOOTSTRAP, Vxvi, P436; Etges WJ, 2006, J CHEM ECOL, V32, P2629, DOI 10.1007/s10886-006-9187-8; ETGES WJ, 1990, ECOLOGICAL EVOLUTION, P121; Fanara JJ, 2006, J EVOLUTION BIOL, V19, P900, DOI 10.1111/j.1420-9101.2006.01084.x; Fanara JJ, 2001, EVOLUTION, V55, P2615, DOI 10.1111/j.0014-3820.2001.tb00774.x; Fanara JJ, 1999, EVOL ECOL, V13, P173, DOI 10.1023/A:1006636025623; Fogleman J.C., 1990, P121; FOGLEMAN JC, 1981, AM NAT, V118, P541, DOI 10.1086/283846; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; Fogleman JC, 1989, INTERACTIONS PLANTS, P1; FONTDEVILA A, 1988, ANN ENTOMOL SOC AM, V81, P380, DOI 10.1093/aesa/81.3.380; Funk DJ, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P117; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Harley K L, 1967, CAN J ZOOL, V45, P315; HASSON E, 1992, REV CHIL HIST NAT, V65, P319; Hasson Esteban, 2009, P89; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Heed W.G., 1986, P311; HEED WB, 1965, SCIENCE, V149, P758, DOI 10.1126/science.149.3685.758; Hood GM, 2008, POPTOOLS VERS 3 0 3; Hurtado J, 2012, EVOL ECOL, V26, P733, DOI 10.1007/s10682-011-9529-z; Iriarte PF, 2000, EVOLUTION, V54, P1295, DOI 10.1554/0014-3820(2000)054[1295:TROTUO]2.0.CO;2; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jaureguy LM, 2007, EVOL ECOL RES, V9, P91; Jones CD, 2004, HEREDITY, V92, P235, DOI 10.1038/sj.hdy.6800401; Jones CD, 1998, GENETICS, V149, P1899; Kircher H.W., 1982, P143; KIRCHER HW, 1967, J INSECT PHYSIOL, V13, P1869, DOI 10.1016/0022-1910(67)90023-6; KREBS RA, 1991, AUST J ZOOL, V39, P579, DOI 10.1071/ZO9910579; Lang M, 2012, SCIENCE, V337, P1658, DOI 10.1126/science.1224829; Manfrin MH, 2006, GENETICA, V126, P57, DOI 10.1007/s10709-005-1432-5; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; McBride CS, 2007, P NATL ACAD SCI USA, V104, P4996, DOI 10.1073/pnas.0608424104; MEYER JM, 1987, J CHEM ECOL, V13, P2069, DOI 10.1007/BF01012872; Mitter C., 1983, P427; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; Narberhaus I, 2005, CHEMOECOLOGY, V15, P121, DOI 10.1007/s00049-005-0302-z; Nyffeler R, 2002, AM J BOT, V89, P312, DOI 10.3732/ajb.89.2.312; Ogunbodede O, 2010, J ETHNOPHARMACOL, V131, P356, DOI 10.1016/j.jep.2010.07.021; Oliveira DCSG, 2012, MOL PHYLOGENET EVOL, V64, P533, DOI 10.1016/j.ympev.2012.05.012; Padro J, 2013, J PROF ASSOC CACTUS, V15, P1; Pennanec'h M, 1997, J INSECT PHYSIOL, V43, P1111, DOI 10.1016/S0022-1910(97)00082-6; Powell JR, 1997, PROGR PROSPECTS EVOL, P576; Ray AM, 2009, J CHEM ECOL, V35, P96, DOI 10.1007/s10886-008-9576-2; RETI L, 1951, J AM CHEM SOC, V73, P1767, DOI 10.1021/ja01148a097; RKHA S, 1991, P NATL ACAD SCI USA, V88, P1835, DOI 10.1073/pnas.88.5.1835; Roff DA, 2000, J EVOLUTION BIOL, V13, P434, DOI 10.1046/j.1420-9101.2000.00186.x; Rohlf JF, 2003, MORPHOMETRICS TPSDIG; Rova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014628; RUIZ A, 1988, J ANIM ECOL, V57, P237, DOI 10.2307/4775; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schoonhoven LM, 2005, INSECT PLANT BIOL, P421; Schreiber K., 1958, Entomologia Experimentalis et Applicata, V1, P28, DOI 10.1007/BF00338571; Sgro CM, 2004, HEREDITY, V93, P241, DOI 10.1038/sj.hdy.6800532; Soto EM, 2008, ENTOMOL EXP APPL, V126, P18, DOI 10.1111/j.1570-7458.2007.00631.x; Soto EM, 2012, EVOL ECOL, V26, P975, DOI 10.1007/s10682-011-9531-5; Soto IM, 2008, J EVOLUTION BIOL, V21, P598, DOI 10.1111/j.1420-9101.2007.01474.x; Soto IM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-77; Starmer WT, 1990, EVOL BIOL, V24, P115; StatSoft, 2001, STATISTICA DAT AN SO; Stintzing FC, 2005, MOL NUTR FOOD RES, V49, P175, DOI 10.1002/mnfr.200400071; Tabachnick BG, 2007, USING MULTIVARIATE S, P1008; THOMAS CD, 1987, EVOLUTION, V41, P892, DOI 10.1111/j.1558-5646.1987.tb05862.x; Throckmorton L.H., 1982, Genetics and Biology of Drosophila, V3b, P227; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225; VILELA C R, 1983, Revista Brasileira de Entomologia, V27, P1; Wasserman M., 1982, Genetics and Biology of Drosophila, V3b, P61; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Woods RE, 1999, EVOLUTION, V53, P493, DOI [10.2307/2640785, 10.1111/j.1558-5646.1999.tb03784.x]	81	33	34	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88370	10.1371/journal.pone.0088370	http://dx.doi.org/10.1371/journal.pone.0088370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520377	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600068
J	Suzuki, M; Nagaishi, T; Yamazaki, M; Onizawa, M; Watabe, T; Sakamaki, Y; Ichinose, S; Totsuka, M; Oshima, S; Okamoto, R; Shimonaka, M; Yagita, H; Nakamura, T; Watanabe, M				Suzuki, Masahiro; Nagaishi, Takashi; Yamazaki, Motomi; Onizawa, Michio; Watabe, Taro; Sakamaki, Yuriko; Ichinose, Shizuko; Totsuka, Mamoru; Oshima, Shigeru; Okamoto, Ryuichi; Shimonaka, Motoyuki; Yagita, Hideo; Nakamura, Tetsuya; Watanabe, Mamoru			Myosin Light Chain Kinase Expression Induced via Tumor Necrosis Factor Receptor 2 Signaling in the Epithelial Cells Regulates the Development of Colitis-Associated Carcinogenesis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; FACTOR-ALPHA; ULCERATIVE-COLITIS; MAINTENANCE THERAPY; BARRIER DYSFUNCTION; INTERFERON-GAMMA; CANCER; MODEL; INFLIXIMAB	It has been suggested that prolonged inflammatory bowel diseases (IBD) may lead to colitis-associated carcinogenesis (CAC). We previously observed that the NF-kappa B activation in colonic epithelial cells is associated with increased tumor necrosis factor receptor 2 (TNFR2) expression in CAC development. However, the mechanism by which epithelial NF-kappa B activation leading to CAC is still unclear. Myosin light chain kinase (MLCK) has been reported to be responsible for the epithelial permeability associated with TNF signaling. Therefore we focused on the role of MLCK expression via TNFR2 signaling on CAC development. Pro-tumorigenic cytokines such as IL-1 beta, IL-6 and MIP-2 production as well as INF-gamma and TNF production at the lamina propria were increased in the setting of colitis, and further in tumor tissues in associations with up-regulated TNFR2 and MLCK expressions in the epithelial cells of a CAC model. The up-regulated MLCK expression was observed in TNF-stimulated colonic epithelial cells in a dose-dependent fashion in association with up-regulation of TNFR2. Silencing TNFR2, but not TNFR1, resulted in restoration of epithelial tight junction (TJ) associated with decreased MLCK expression. Antibody-mediated blockade of TNF signaling also resulted in restoration of TJ in association with suppressed MLCK expression, and interestingly, similar results were observed with suppressing TNFR2 and MLCK expressions by inhibiting MLCK in the epithelial cells. Silencing of MLCK also resulted in suppressed TNFR2, but not TNFR1, expression, suggesting that the restored TJ leads to reduced TNFR2 signaling. Such suppression of MLCK as well as blockade of TNFR2 signaling resulted in restored TJ, decreased pro-tumorigenic cytokines and reduced CAC development. These results suggest that MLCK may be a potential target for the prevention of IBD-associated tumor development.	[Suzuki, Masahiro; Nagaishi, Takashi; Onizawa, Michio; Watabe, Taro; Oshima, Shigeru; Okamoto, Ryuichi; Nakamura, Tetsuya; Watanabe, Mamoru] Tokyo Med & Dent Univ, Grad Sch Med Sci, Dept Gastroenterol, Tokyo, Japan; [Yamazaki, Motomi] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Sakamaki, Yuriko; Ichinose, Shizuko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Tokyo, Japan; [Totsuka, Mamoru] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Shimonaka, Motoyuki] Tokyo Univ Sci, Dept Chem, Tokyo 162, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Tokyo Medical & Dental University (TMDU); Nihon University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo University of Science; Juntendo University	Nagaishi, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med Sci, Dept Gastroenterol, Tokyo, Japan.	tnagaishi.gast@tmd.ac.jp; mamoru.gast@tmd.ac.jp	Oshima, Shigeru/C-9865-2015; Okamoto, Ryuichi/I-1130-2019; Watanabe, Mamoru/AHE-0489-2022	Oshima, Shigeru/0000-0003-1186-9177; Okamoto, Ryuichi/0000-0002-7047-571X; 	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labor and Welfare; Japan Medical Association; Japan Foundation for Applied Enzymology; Japan Health Sciences Foundation; Memorial Fund of Nihon Univ. Medical Alumni Association; Abbott Japan Allergy Research Award; Foundation for Advancement of International Science; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25293170] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Medical Association; Japan Foundation for Applied Enzymology; Japan Health Sciences Foundation; Memorial Fund of Nihon Univ. Medical Alumni Association; Abbott Japan Allergy Research Award; Foundation for Advancement of International Science(Foundation for Advancement of International Science (FAIS)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research (T. Nagaishi, T. Nakamura and MW), Scientific Research on Priority Areas (MW), Exploratory Research and Creative Scientific Research (MW) from the Japanese Ministry of Education, Culture, Sports, Science and Technology; the Japanese Ministry of Health, Labor and Welfare (MW); the Japan Medical Association (MW); Japan Foundation for Applied Enzymology (MO); Japan Health Sciences Foundation (MO); Memorial Fund of Nihon Univ. Medical Alumni Association (T. Nagaishi); Abbott Japan Allergy Research Award (T. Nagaishi); Foundation for Advancement of International Science (T. Nagaishi); Takeda Science Foundation (T. Nagaishi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DERKX B, 1993, LANCET, V342, P173, DOI 10.1016/0140-6736(93)91375-V; DRISCOLL KE, 1995, J LEUKOCYTE BIOL, V58, P359, DOI 10.1002/jlb.58.3.359; ECKMANN L, 1993, GASTROENTEROLOGY, V105, P1689, DOI 10.1016/0016-5085(93)91064-O; EKBOM A, 1992, GASTROENTEROLOGY, V103, P954, DOI 10.1016/0016-5085(92)90029-X; EKBOM A, 1990, LANCET, V336, P357, DOI 10.1016/0140-6736(90)91889-I; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fish SM, 1999, GUT, V45, P191, DOI 10.1136/gut.45.2.191; Graham WV, 2006, J BIOL CHEM, V281, P26205, DOI 10.1074/jbc.M602164200; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Ichinose S, 2010, LAB INVEST, V90, P210, DOI 10.1038/labinvest.2009.125; IKEBE M, 1985, J BIOL CHEM, V260, P4547; Iwamoto T, 2011, BIOSCI BIOTECH BIOCH, V75, P925, DOI 10.1271/bbb.100887; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; LAHM H, 1992, EUR J CANCER, V28A, P1894, DOI 10.1016/0959-8049(92)90031-V; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Liu XC, 2013, DIGEST DIS SCI, V58, P107, DOI 10.1007/s10620-012-2304-3; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Mizoguchi E, 2008, GASTROENTEROLOGY, V134, P470, DOI 10.1053/j.gastro.2007.11.055; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Ohno Y, 1997, P NATL ACAD SCI USA, V94, P10279, DOI 10.1073/pnas.94.19.10279; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Prakash R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027046; PULLMAN WE, 1992, GASTROENTEROLOGY, V102, P529, DOI 10.1016/0016-5085(92)90100-D; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Taylor CT, 1998, GASTROENTEROLOGY, V114, P657, DOI 10.1016/S0016-5085(98)70579-7; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; WANG M, 1995, J IMMUNOL, V154, P4685; Yamaji O, 2012, J IMMUNOL, V188, P2524, DOI 10.4049/jimmunol.1100371; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Ye D, 2008, J CELL MOL MED, V12, P1331, DOI 10.1111/j.1582-4934.2008.00302.x	44	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88369	10.1371/journal.pone.0088369	http://dx.doi.org/10.1371/journal.pone.0088369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520376	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600067
J	Megchelenbrink, W; Huynen, M; Marchiori, E				Megchelenbrink, Wout; Huynen, Martijn; Marchiori, Elena			optGpSampler: An Improved Tool for Uniformly Sampling the Solution-Space of Genome-Scale Metabolic Networks	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; CONVERGENCE; MODELS	Constraint-based models of metabolic networks are typically underdetermined, because they contain more reactions than metabolites. Therefore the solutions to this system do not consist of unique flux rates for each reaction, but rather a space of possible flux rates. By uniformly sampling this space, an estimated probability distribution for each reaction's flux in the network can be obtained. However, sampling a high dimensional network is time-consuming. Furthermore, the constraints imposed on the network give rise to an irregularly shaped solution space. Therefore more tailored, efficient sampling methods are needed. We propose an efficient sampling algorithm (called optGpSampler), which implements the Artificial Centering Hit-and-Run algorithm in a different manner than the sampling algorithm implemented in the COBRA Toolbox for metabolic network analysis, here called gpSampler. Results of extensive experiments on different genome-scale metabolic networks show that optGpSampler is up to 40 times faster than gpSampler. Application of existing convergence diagnostics on small network reconstructions indicate that optGpSampler converges roughly ten times faster than gpSampler towards similar sampling distributions. For networks of higher dimension (i. e. containing more than 500 reactions), we observed significantly better convergence of optGpSampler and a large deviation between the samples generated by the two algorithms. Availability: optGpSampler for Matlab and Python is available for non-commercial use at: http://cs.ru.nl/similar to wmegchel/optGpSampler/.	[Megchelenbrink, Wout; Marchiori, Elena] Radboud Univ Nijmegen, ICIS, NL-6525 ED Nijmegen, Netherlands; [Megchelenbrink, Wout; Huynen, Martijn] Radboud Univ Nijmegen, Med Ctr, CMBI, NL-6525 ED Nijmegen, Netherlands; [Megchelenbrink, Wout; Huynen, Martijn; Marchiori, Elena] Radboud Univ Nijmegen, Med Ctr, CSBB, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Megchelenbrink, W (corresponding author), Radboud Univ Nijmegen, ICIS, NL-6525 ED Nijmegen, Netherlands.	w.megchelenbrink@cs.ru.nl; elenam@cs.ru.nl	Huynen, Martijn A/A-1530-2014; Huijnen, M.A./H-8051-2014	Huynen, Martijn A/0000-0001-6189-5491; 	Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMW)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organisation for Scientific Research (NWO) and The Netherlands Organisation for Health Research and Development (ZonMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cowles MK, 1996, J AM STAT ASSOC, V91, P883, DOI 10.2307/2291683; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Gorard S, 2005, BRIT J EDUC STUD, V53, P417, DOI 10.1111/j.1467-8527.2005.00304.x; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Price ND, 2003, J THEOR BIOL, V225, P185, DOI 10.1016/S0022-5193(03)00237-6; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Sanderson C., 2010, TECHNICAL REPORT; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; SMITH RL, 1984, OPER RES, V32, P1296, DOI 10.1287/opre.32.6.1296; Suthers PF, 2007, METAB ENG, V9, P387, DOI 10.1016/j.ymben.2007.05.005; Varma A, 1994, BIOTECHNOLOGY, V12; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; Winston WL, 2004, OPERATIONS RES APPL	20	73	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e86587	10.1371/journal.pone.0086587	http://dx.doi.org/10.1371/journal.pone.0086587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551039	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500008
J	Feliciano, DM; Zhang, SL; Nasrallah, CM; Lisgo, SN; Bordey, A				Feliciano, David M.; Zhang, Shiliang; Nasrallah, Carole M.; Lisgo, Steven N.; Bordey, Angelique			Embryonic Cerebrospinal Fluid Nanovesicles Carry Evolutionarily Conserved Molecules and Promote Neural Stem Cell Amplification	PLOS ONE			English	Article							MEMBRANE-PARTICLES; TRANSFERRIN RECEPTOR; EXOSOME ISOLATION; PROGENITORS; RELEASE; MUTATIONS; MECHANISM; PROTEINS; VESICLES	During brain development, neural stem cells (NSCs) receive on-or-off signals important for regulating their amplification and reaching adequate neuron density. However, how a coordinated regulation of intracellular pathways and genetic programs is achieved has remained elusive. Here, we found that the embryonic (e) CSF contains 10(12) nanoparticles/ml (77 nm diameter), some of which were identified as exosome nanovesicles that contain evolutionarily conserved molecules important for coordinating intracellular pathways. eCSF nanovesicles collected from rodent and human embryos encapsulate protein and microRNA components of the insulin-like growth factor (IGF) signaling pathway. Supplementation of eCSF nanovesicles to a mixed culture containing eNSCs activated the IGF-mammalian target of rapamycin complex 1 (mTORC1) pathway in eNSCs and expanded the pool of proliferative eNSCs. These data show that the eCSF serves as a medium for the distribution of nanovesicles, including exosomes, and the coordinated transfer of evolutionary conserved molecules that regulate eNSC amplification during corticogenesis.	[Feliciano, David M.; Zhang, Shiliang; Nasrallah, Carole M.; Bordey, Angelique] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Feliciano, David M.; Zhang, Shiliang; Nasrallah, Carole M.; Bordey, Angelique] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Lisgo, Steven N.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Yale University; Yale University; Newcastle University - UK	Bordey, A (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	angelique.bordey@yale.edu	Feliciano, David/ADM-6724-2022	Lisgo, Steven/0000-0001-5186-3971; Feliciano, David/0000-0001-5985-9109	National Institute of Health NRSA [10668225]; CT Stem Cell initiative grant; Medical Research Council [G0700089, MC_PC_15004] Funding Source: researchfish; MRC [G0700089, MC_PC_15004] Funding Source: UKRI	National Institute of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CT Stem Cell initiative grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported a National Institute of Health NRSA 10668225 (D.M.F; url: http://www.nichd.nih.gov) and CT Stem Cell initiative grant (A.B., URL: http://www.ct.gov/dph/cwp/view.asp?a=3142&q=389700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Buschow SI, 2010, IMMUNOL CELL BIOL, V88, P851, DOI 10.1038/icb.2010.64; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Currle D Spencer, 2007, J Vis Exp, P152, DOI 10.3791/152; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Dziegielewska KM, 2001, MICROSC RES TECHNIQ, V52, P5, DOI 10.1002/1097-0029(20010101)52:1<5::AID-JEMT3>3.3.CO;2-A; Gercel-Taylor C, 2012, ANAL BIOCHEM, V428, P44, DOI 10.1016/j.ab.2012.06.004; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grapp M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3123; Hartman NW, 2013, CELL REP, V5, P433, DOI 10.1016/j.celrep.2013.09.017; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Huttner HB, 2012, EPILEPSY RES, V99, P101, DOI 10.1016/j.eplepsyres.2011.10.029; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Li YF, 2010, ONCOL REP, V24, P1443, DOI 10.3892/or_00001004; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; MATHEW A, 1995, BIOCHEM J, V308, P823, DOI 10.1042/bj3080823; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; ORAHILLY R, 1994, HE EMBRYONIC HUMAN B; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pathania M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038174; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Ye P, 2006, J NEUROSCI RES, V83, P1, DOI 10.1002/jnr.20688; Zappaterra MD, 2007, J PROTEOME RES, V6, P3537, DOI 10.1021/pr070247w; Zappaterra MW, 2013, JOVE-J VIS EXP, DOI 10.3791/50333	37	59	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88810	10.1371/journal.pone.0088810	http://dx.doi.org/10.1371/journal.pone.0088810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533152	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600110
J	Jacquot, M; Bisseux, M; Abrial, D; Marsot, M; Ferquel, E; Chapuis, JL; Vourc'h, G; Bailly, X				Jacquot, Maude; Bisseux, Maxime; Abrial, David; Marsot, Maud; Ferquel, Elisabeth; Chapuis, Jean-Louis; Vourc'h, Gwenael; Bailly, Xavier			High-Throughput Sequence Typing Reveals Genetic Differentiation and Host Specialization among Populations of the Borrelia burgdorferi Species Complex that Infect Rodents	PLOS ONE			English	Article							INTRODUCED SIBERIAN CHIPMUNKS; NATIVE BANK VOLES; SENSU-LATO; EVOLUTION; DIVERSITY; ALGORITHM; ACCURATE; TICKS	Lyme disease is a zoonosis caused by various species belonging to the Borrelia burgdorferi bacterial species complex. These pathogens are transmitted by ticks and infect multiple, taxonomically distinct, host species. From an epidemiological perspective, it is important to determine whether genetic variants within the species complex are able to spread freely through the whole host community or, instead, if certain variants are restricted to particular hosts. To this end, we characterized the genotypes of members of the B. burgdorferi species complex; the bacteria were isolated from more than two hundred individuals captured in the wild and belonging to three different rodent host species. For each individual, we used a high-throughput approach to amplify and sequence rplB, a housekeeping gene, and ospC, which is involved in infection. This approach allowed us to evaluate the genetic diversity both within and among species in the B. burgdorferi species complex. Strong evidence of genetic differentiation among host species was revealed by both genes, even though they are, a priori, not constrained by the same selective pressures. These data are discussed in the context of the advancements made possible by multi-locus high-throughput sequencing and current knowledge of Lyme disease epidemiology.	[Jacquot, Maude; Bisseux, Maxime; Abrial, David; Marsot, Maud; Vourc'h, Gwenael; Bailly, Xavier] INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France; [Marsot, Maud; Chapuis, Jean-Louis] MNHN CNRS P6, UMR Conservat Especes Restaurat & Suivi Populat 7, Paris, France; [Ferquel, Elisabeth] Inst Pasteur, CNR Borrelia, Paris, France	INRAE; Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jacquot, M (corresponding author), INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France.	maude.jacquot@gmail.com	Jacquot, Maude/T-7584-2019; Marsot, Maud/ABF-8575-2021; Bailly, Xavier/C-6254-2011	Jacquot, Maude/0000-0001-5945-4689; Bailly, Xavier/0000-0001-6959-7974; Marsot, Maud/0000-0002-2307-8957	French National Institute for Agricultural Research (INRA); French Ministry of Higher Education and Research (MESR); 'Tick and Tick-Borne Diseases' (TMT) group	French National Institute for Agricultural Research (INRA); French Ministry of Higher Education and Research (MESR)(Ministry of Research, France); 'Tick and Tick-Borne Diseases' (TMT) group	This work was funded by the French National Institute for Agricultural Research (INRA) through the 'AIP Bioressources 2011' program. Maude Jacquot is supported by a PhD fellowship from the French Ministry of Higher Education and Research (MESR). Interactions between members of the INRA and the Pasteur Institute are funded by the 'Tick and Tick-Borne Diseases' (TMT) group, which is part of the Research Consortium on Biological Interactions (GdR REID). Field sampling was conducted with the financial support of the Conseil Regional d'Ile-de-France and the Office National des Forets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boers SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039630; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Chapuis JL., 2011, DATASHEET TAMIAS SIB; Christova I, 2003, EUR J CLIN MICROBIOL, V22, P535, DOI 10.1007/s10096-003-0988-1; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; EXCOFFIER L, 1992, GENETICS, V131, P479; GU X, 1995, MOL BIOL EVOL, V12, P546; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haven J, 2011, GENETICS, V189, P951, DOI 10.1534/genetics.111.130773; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Marsot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055377; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pisanu B, 2010, INT J PARASITOL, V40, P1277, DOI 10.1016/j.ijpara.2010.03.012; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Qiu WG, 2004, P NATL ACAD SCI USA, V101, P14150, DOI 10.1073/pnas.0402745101; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; Rudenko N, 2013, APPL ENVIRON MICROB, V79, P1444, DOI 10.1128/AEM.02749-12; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tavare S., 1986, LECT MATH LIFE SCI; THEISEN M, 1995, J BACTERIOL, V177, P3036, DOI 10.1128/jb.177.11.3036-3044.1995; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	36	23	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88581	10.1371/journal.pone.0088581	http://dx.doi.org/10.1371/journal.pone.0088581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533116	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000331262600074
J	Jensen, HS; Nichol, K; Lee, D; Ebert, B				Jensen, Henrik Sindal; Nichol, Kathryn; Lee, Deborah; Ebert, Bjarke			Clobazam and Its Active Metabolite N-desmethylclobazam Display Significantly Greater Affinities for alpha(2)- versus alpha(1)-GABA(A)-Receptor Complexes	PLOS ONE			English	Article							GABA(A) RECEPTOR SUBTYPES; LENNOX-GASTAUT SYNDROME; REFRACTORY EPILEPSY; CLONAZEPAM; DRUGS; BENZODIAZEPINES; PRIMATES	Clobazam (CLB), a 1,5-benzodiazepine (BZD), was FDA-approved in October 2011 for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years and older. BZDs exert various CNS effects through allosteric modulation of GABA(A) receptors. The structurally distinct, 1,4-BZD clonazepam (CLN) is also approved to treat LGS. The precise mechanisms of action and clinical efficacy of both are unknown. Data show that the GABAA alpha 1-subunit-selective compound zolpidem [ZOL] exhibits hypnotic/sedative effects. Conversely, data from knock-in mice carrying BZD binding site mutations suggest that the alpha(2) subunit mediates anticonvulsant effects, without sedative actions. Hence, the specific pattern of interactions across the GABAA receptor complexes of BZDs might be reflected in their clinical efficacies and adverse effect profiles. In this study, GABA(A)-receptor binding affinities of CLB, N-desmethylclobazam (N-CLB, the major metabolite of CLB), CLN, and ZOL were characterized with native receptors from rat-brain homogenates and on cloned receptors from HEK293 cells transfected with combinations of a (alpha 1, alpha 2, alpha 3, or alpha 5), beta 2, and gamma 2 subtypes. Our results demonstrate that CLB and N-CLB have significantly greater binding affinities for alpha(2)-vs. alpha(1)-receptor complexes, a difference not observed for CLN, for which no distinction between alpha(2) and alpha(1) receptors was observed. Our experiments with ZOL confirmed the high preference for alpha(1) receptors. These results provide potential clues to a new understanding of the pharmacologic modes of action of CLB and N-CLB.	[Jensen, Henrik Sindal] H Lundbeck & Co AS, Neurosci Drug Discovery, Synapt Transmiss, Valby, Denmark; [Nichol, Kathryn] Lundbeck LLC, Med Affairs, Deerfield, IL USA; [Lee, Deborah] Lundbeck LLC, Clin Affairs, Deerfield, IL USA; [Ebert, Bjarke] H Lundbeck & Co AS, Dept Electrophysiol, Valby, Denmark	Lundbeck Corporation; Lundbeck Corporation	Jensen, HS (corresponding author), H Lundbeck & Co AS, Neurosci Drug Discovery, Synapt Transmiss, Valby, Denmark.	hsin@lundbeck.com			Lundbeck	Lundbeck(Lundbeck Corporation)	The authors have read the journal's policy and have the following conflicts: This work was conducted and fully funded by Lundbeck. All authors were full-time Lundbeck employees at the time the analyses were conducted. Clobazam (Onfi) is a Lundbeck product. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ARENDT RM, 1987, PSYCHOPHARMACOLOGY, V93, P72, DOI 10.1007/BF02439589; Arzimanoglou A, 2009, LANCET NEUROL, V8, P82, DOI 10.1016/S1474-4422(08)70292-8; Atack JR, 2006, J PHARMACOL EXP THER, V316, P410, DOI 10.1124/jpet.105.089920; Fradley RL, 2007, J PSYCHOPHARMACOL, V21, P384, DOI 10.1177/0269881106067255; *GEN, 2010, KLON CLON; HAIGH JRM, 1987, BRIT J CLIN PHARMACO, V23, P213, DOI 10.1111/j.1365-2125.1987.tb03032.x; Huang Q, 2000, J MED CHEM, V43, P71, DOI 10.1021/jm990341r; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kosaki K, 2004, BRAIN DEV-JPN, V26, P530, DOI 10.1016/j.braindev.2004.02.010; *LLC, 2013, ONF CLOB; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Miura Y, 2002, EPILEPSY RES, V49, P189, DOI 10.1016/S0920-1211(02)00032-3; Mohler H, 2004, BIOCHEM PHARMACOL, V68, P1685, DOI 10.1016/j.bcp.2004.07.025; Ng YT, 2011, NEUROLOGY, V77, P1473, DOI 10.1212/WNL.0b013e318232de76; Nutt DJ, 2010, J PSYCHOPHARMACOL, V24, P1601, DOI 10.1177/0269881109106927; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; Rowlett JK, 2005, P NATL ACAD SCI USA, V102, P915, DOI 10.1073/pnas.0405621102; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SANGER DJ, 1994, NEUROSCI BIOBEHAV R, V18, P355, DOI 10.1016/0149-7634(94)90049-3; Sankar R, 2012, CNS DRUGS, V26, P229, DOI 10.2165/11599020-000000000-00000; Skolnick P., 2007, HDB CONT NEUROPHARMA; STERU L, 1986, EPILEPSIA S1, pS14; STEWART JA, 1991, EPILEPSIA, V32, P407; Tolbert D, 2013, EPILEPSY CURRENTS S1, V13; *US LLC, 2013, AMB ZOLP; van Rijnsoever C, 2004, J NEUROSCI, V24, P6785, DOI 10.1523/JNEUROSCI.1067-04.2004; VANDERMEYDEN CH, 1989, EUR J CLIN PHARMACOL, V37, P365, DOI 10.1007/BF00558501; Vuilleumier PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0043896; Walzer M, 2012, PHARMACOTHERAPY, V32, P340, DOI 10.1002/j.1875-9114.2012.01028.x; WILDIN JD, 1990, BRIT J CLIN PHARMACO, V29, P169, DOI 10.1111/j.1365-2125.1990.tb03616.x; Yamamoto Y, 2013, THER DRUG MONIT, V35, P305, DOI 10.1097/FTD.0b013e318283b49a	33	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88456	10.1371/journal.pone.0088456	http://dx.doi.org/10.1371/journal.pone.0088456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533090	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600048
J	Fares, F; Azzam, N; Fares, B; Larsen, S; Lindkaer-Jensen, S				Fares, Fuad; Azzam, Naiel; Fares, Basem; Larsen, Stig; Lindkaer-Jensen, Steen			Benzene-Poly-Carboxylic Acid Complex, a Novel Anti-Cancer Agent Induces Apoptosis in Human Breast Cancer Cells	PLOS ONE			English	Article							ETS TRANSCRIPTION FACTORS; NF-KAPPA B; CISPLATIN; FAMILY; DISEASE; EPIDEMIOLOGY; PREVENTION; RESISTANCE; PLATINUM; SURVIVAL	Some cases of breast cancer are composed of clones of hormonal-independent growing cells, which do not respond to therapy. In the present study, the effect of Benzene-Poly-Carboxylic Acid Complex (BP-C1) on growth of human breast-cancer cells was tested. BP-C1 is a novel anti-cancer complex of benzene-poly-carboxylic acids with a very low concentration of cis-diammineplatinum (II) dichloride. Human breast cancer cells, MCF-7 and T47D, were used. Cell viability was detected by XTT assay and apoptosis was detected by Flow Cytometry and by annexin V/FITC/PI assay. Caspases were detected by western blot analysis and gene expression was measured by using the Applied Biosystems (R) TaqMan (R) Array Plates. The results showed that exposure of the cells to BP-C1 for 48 h, significantly (P < 0.001) reduced cell viability, induced apoptosis and activated caspase 8 and caspace 9. Moreover, gene expression experiments indicated that BP-C1 increased the expression of pro-apoptotic genes (CASP8AP1, TNFRSF21, NFkB2, FADD, BCL10 and CASP8) and lowered the level of mRNA transcripts of inhibitory apoptotic genes (BCL2L11, BCL2L2 and XIAP. These findings may lead to the development of new therapeutic strategies for treatment of human cancer using BP-C1 analog.	[Fares, Fuad; Azzam, Naiel; Fares, Basem] Univ Haifa, Fac Nat Sci, Dept Human Biol, IL-31999 Haifa, Israel; [Fares, Fuad; Azzam, Naiel; Fares, Basem] Carmel Hosp, Dept Mol Genet, Haifa, Israel; [Larsen, Stig] Univ Life Sci, Dept Controlled Clin Studies & Biostat, Oslo, Norway; [Lindkaer-Jensen, Steen] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	University of Haifa; Clalit Health Services; Carmel Medical Center; Norwegian University of Life Sciences; Imperial College London	Fares, F (corresponding author), Univ Haifa, Fac Nat Sci, Dept Human Biol, IL-31999 Haifa, Israel.	ffares@sci.haifa.ac.il			Meabco LTD Copenhagen, Denmark	Meabco LTD Copenhagen, Denmark	This work was supported by Meabco LTD Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2010, MODERN PATHOL, V23, pS52, DOI 10.1038/modpathol.2010.55; Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; BOREK C, 1986, P NATL ACAD SCI USA, V83, P1490, DOI 10.1073/pnas.83.5.1490; BOREK C, 1991, FREE RADICAL RES COM, V12-3, P745; Borek C., 1997, SCI MED, V4, P51; BRADFIELD CA, 1987, J AGR FOOD CHEM, V35, P46, DOI 10.1021/jf00073a010; Chen F, 1999, CLIN CHEM, V45, P7; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; GUTTERIDGE JMC, 1993, FREE RADICAL RES COM, V19, P141, DOI 10.3109/10715769309111598; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Kadouri L, 2007, J MED GENET, V44, P467, DOI 10.1136/jmg.2006.048173; Khan N, 2010, ENDOCR-RELAT CANCER, V17, pR39, DOI 10.1677/ERC-09-0262; Khanzode SS, 2004, FREE RADICAL RES, V38, P81, DOI 10.1080/01411590310001637066; KNOX RJ, 1986, CANCER RES, V46, P1972; Koenig BA, 1998, J WOMENS HEALTH, V7, P531, DOI 10.1089/jwh.1998.7.531; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LEVI JA, 1981, BRIT MED J, V282, P2003, DOI 10.1136/bmj.282.6281.2003; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Marianneau P, 1997, J VIROL, V71, P3244, DOI 10.1128/JVI.71.4.3244-3249.1997; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Milosavljevic N, 2010, CANCER RES, V70, P7514, DOI 10.1158/0008-5472.CAN-10-1253; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Moran JH, 1996, J PHARMACOL TOXICOL, V36, P41, DOI 10.1016/1056-8719(96)00071-8; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Pruefer FG, 2008, J CHEMOTHERAPY, V20, P348, DOI 10.1179/joc.2008.20.3.348; Sana M., 2012, RES CANC TUMOR, V1, P1; Sheikh MS, 2003, CELL CYCLE, V2, P346, DOI 10.4161/cc.2.4.421; Shi XK, 2012, ANTIOXID REDOX SIGN, V16, P1215, DOI 10.1089/ars.2012.4529; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Stordal B, 2007, CANCER TREAT REV, V33, P688, DOI 10.1016/j.ctrv.2007.07.013; Stordal B, 2007, IUBMB LIFE, V59, P696, DOI 10.1080/15216540701636287; Stupack DG, 2013, CANCER LETT, V332, P133, DOI 10.1016/j.canlet.2010.07.022; Thomas LR, 2002, J BIOL CHEM, V277, P34343, DOI 10.1074/jbc.M204169200; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Windsor RE, 2012, CANCER-AM CANCER SOC, V118, P1856, DOI 10.1002/cncr.26472; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; Zambonin L, 2012, OXID MED CELL LONGEV, V2012, P1; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	49	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e85156	10.1371/journal.pone.0085156	http://dx.doi.org/10.1371/journal.pone.0085156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523856	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100005
J	Guillemot, J; Guerin, M; Thouennon, E; Montero-Hadjadje, M; Leprince, J; Lefebvre, H; Klein, M; Muresan, M; Anouar, Y; Yon, L				Guillemot, Johann; Guerin, Marlene; Thouennon, Erwan; Montero-Hadjadje, Maite; Leprince, Jerome; Lefebvre, Herve; Klein, Marc; Muresan, Mihaela; Anouar, Youssef; Yon, Laurent			Characterization and Plasma Measurement of the WE-14 Peptide in Patients with Pheochromocytoma	PLOS ONE			English	Article							SERUM CHROMOGRANIN-A; II-DERIVED PEPTIDE; SECRETOGRANIN-II; MOLECULAR-PROPERTIES; ALPHA-SUBUNIT; DIAGNOSIS; MARKER; CARCINOMA; EM66; SECRETION	Granins and their derived peptides are valuable circulating biological markers of neuroendocrine tumors. The aim of the present study was to investigate the tumoral chromogranin A (CgA)-derived peptide WE-14 and the potential advantage to combine plasma WE-14 detection with the EM66 assay and the existing current CgA assay for the diagnosis of pheochromocytoma. Compared to healthy volunteers, plasma WE-14 levels were 5.4-fold higher in patients with pheochromocytoma, but returned to normal values after surgical resection of the tumor. Determination of plasma CgA and EM66 concentrations in the same group of patients revealed that the test assays for these markers had an overall 84% diagnostic sensitivity, which is identical to that determined for WE-14. However, we found that WE-14 measurement improved the diagnostic sensitivity when combined with the results of CgA or EM66 assays. By combining the results of the three assays, the sensitivity for the diagnosis of pheochromocytoma was increased to 95%. In fact, the combination of WE-14 with either CgA or EM66 test assays achieved 100% sensitivity for the diagnosis of paragangliomas and sporadic or malignant pheochromocytomas if taken separately to account for the heterogeneity of the tumor. These data indicate that WE-14 is produced in pheochromocytoma and secreted into the general circulation, and that elevated plasma WE-14 levels are correlated with the occurrence of this chromaffin cell tumor. In addition, in association with other biological markers, such as CgA and/or EM66, WE-14 measurement systematically improves the diagnostic sensitivity for pheochromocytoma. These findings support the notion that granin-processing products may represent complementary tools for the diagnosis of neuroendocrine tumors.	[Guillemot, Johann; Guerin, Marlene; Thouennon, Erwan; Montero-Hadjadje, Maite; Leprince, Jerome; Lefebvre, Herve; Anouar, Youssef; Yon, Laurent] INSERM, U982, Mont St Aignan, France; [Guillemot, Johann; Guerin, Marlene; Thouennon, Erwan; Montero-Hadjadje, Maite; Leprince, Jerome; Lefebvre, Herve; Anouar, Youssef; Yon, Laurent] Normandy Univ, Normandy, France; [Guillemot, Johann; Guerin, Marlene; Thouennon, Erwan; Montero-Hadjadje, Maite; Leprince, Jerome; Lefebvre, Herve; Anouar, Youssef; Yon, Laurent] Univ Rouen, Lab Neuronal & Neuroendocrine Differentiat & Comm, IRIB, Mont St Aignan, France; [Guillemot, Johann] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Lefebvre, Herve] Rouen Univ Hosp, Dept Endocrinol Diabet & Metab Dis, Bois Guillaume, France; [Klein, Marc] Univ Nancy, Hop Brabois, Dept Endocrinol, Nancy, France; [Muresan, Mihaela] Hop Notre Dame de Bon Secours, Unit Endocrinol, Metz, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; CHU de Rouen; CHU de Nancy; Universite de Lorraine; CHR Metz-Thionville	Yon, L (corresponding author), INSERM, U982, Mont St Aignan, France.	laurent.yon@univ-rouen.fr	Yon, Laurent/E-1981-2016; Anouar, Youssef/F-9683-2017; Guillemot, Johann/O-1066-2013; Leprince, Jerome/N-9083-2017; Montero-Hadjadje, Maite/AAC-5692-2019	Yon, Laurent/0000-0002-5420-5779; Guillemot, Johann/0000-0002-5902-9188; Montero-Hadjadje, Maite/0000-0001-8859-893X; Klein, Marc/0000-0002-1037-4220; Lefebvre, Herve/0000-0002-6181-9648; Leprince, Jerome/0000-0002-7814-9927	INSERM [U982]; Conseil Regional de Haute-Normandie; Centre d'Investigation Clinique of Rouen hospital INSERM [U204]; Fondation pour la Recherche Medicale; Federation des Maladies Orphelines; Ligue de Recherche Contre le Cancer de Haute-Normandie; Institut National de la Sante et de la Recherche Medicale and Ministere Delegue a la Recherche et aux Nouvelles Technologies for the COMETE Network [PHRC AOM 06179]; Association pour la Recherche sur le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conseil Regional de Haute-Normandie(Region Normandie); Centre d'Investigation Clinique of Rouen hospital INSERM; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation des Maladies Orphelines; Ligue de Recherche Contre le Cancer de Haute-Normandie; Institut National de la Sante et de la Recherche Medicale and Ministere Delegue a la Recherche et aux Nouvelles Technologies for the COMETE Network; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by INSERM U982, Conseil Regional de Haute-Normandie, the Centre d'Investigation Clinique of Rouen hospital INSERM U204, Fondation pour la Recherche Medicale, Federation des Maladies Orphelines, Ligue de Recherche Contre le Cancer de Haute-Normandie, Association pour la Recherche sur le Cancer, and the grant PHRC AOM 06179 from Institut National de la Sante et de la Recherche Medicale and Ministere Delegue a la Recherche et aux Nouvelles Technologies for the COMETE Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Andersen KF, 2011, CANCER TREAT REV, V37, P111, DOI 10.1016/j.ctrv.2010.07.002; Anouar Y, 1996, FEBS LETT, V394, P295, DOI 10.1016/0014-5793(96)00976-3; Anouar Y, 1998, J CLIN ENDOCR METAB, V83, P2944, DOI 10.1210/jc.83.8.2944; Baudin E, 2001, ANN ONCOL, V12, pS79, DOI 10.1093/annonc/12.suppl_2.S79; Borch K, 1997, SCAND J GASTROENTERO, V32, P198, DOI 10.3109/00365529709000194; CONLON JM, 1992, PEPTIDES, V13, P639, DOI 10.1016/0196-9781(92)90167-2; Cunningham RT, 1999, J PATHOL, V187, P321; Curry W. J., 2004, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V4, P213, DOI 10.2174/1568013043357581; CURRY WJ, 1992, FEBS LETT, V301, P319, DOI 10.1016/0014-5793(92)80266-J; d'Herbomez M, 2007, EUR J ENDOCRINOL, V156, P569, DOI 10.1530/EJE-06-0640; Darr R, 2014, CLIN ENDOCRINOL, V80, P478, DOI 10.1111/cen.12327; Eder U, 1998, NEUROSCI LETT, V253, P17, DOI 10.1016/S0304-3940(98)00588-6; Ferrari L, 1999, ANTICANCER RES, V19, P3415; FISCHERCOLBRIE R, 1995, PROG NEUROBIOL, V46, P49, DOI 10.1016/0301-0082(94)00060-U; Gleeson CM, 1996, J ENDOCRINOL, V151, P409, DOI 10.1677/joe.0.1510409; Guerin M, 2010, REGUL PEPTIDES, V165, P21, DOI 10.1016/j.regpep.2010.06.003; Guignat L, 2001, BRIT J CANCER, V84, P808, DOI 10.1054/bjoc.2000.1677; Guillemot J, 2006, INT J CANCER, V118, P2003, DOI 10.1002/ijc.21571; Guillemot J, 2012, J MOL ENDOCRINOL, V48, P115, DOI 10.1530/JME-11-0077; Guillemot J, 2006, REGUL PEPTIDES, V137, P79, DOI 10.1016/j.regpep.2006.04.023; Guillemot J, 2009, ENDOCR-RELAT CANCER, V16, P281, DOI 10.1677/ERC-08-0190; Hanna FWF, 1997, J ENDOCRINOL, V152, P275, DOI 10.1677/joe.0.1520275; Heaney A P, 2000, Pituitary, V3, P67, DOI 10.1023/A:1009949623054; Helle KB, 2004, BIOL REV, V79, P769, DOI 10.1017/S146479310400644X; Ischia R, 2000, J UROLOGY, V163, P1161, DOI 10.1016/S0022-5347(05)67714-2; Ischia R, 2000, J CLIN ENDOCR METAB, V85, P355, DOI 10.1210/jc.85.1.355; Karasek D, 2010, CURR HYPERTENS REP, V12, P456, DOI 10.1007/s11906-010-0151-1; Kim YW, 2012, ONCOL REP, V28, P585, DOI 10.3892/or.2012.1829; Leprince J, 1998, J MED CHEM, V41, P4433, DOI 10.1021/jm980275d; Loo BM, 2011, SCAND J CLIN LAB INV, V71, P221, DOI 10.3109/00365513.2011.554996; Montero-Hadjadje M, 2003, J HISTOCHEM CYTOCHEM, V51, P1083, DOI 10.1177/002215540305100812; Montero-Hadjadje M, 2002, CELL TISSUE RES, V310, P223, DOI 10.1007/s00441-002-0625-9; Neumann HP, 2002, JAMA-J AM MED ASSOC, V288, P315; Neumann HPH, 2002, JAMA-J AM MED ASSOC, V288, P314, DOI 10.1001/jama.288.3.314; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Nobels FRE, 1997, J CLIN ENDOCR METAB, V82, P2622, DOI 10.1210/jc.82.8.2622; OCONNOR DT, 1986, NEW ENGL J MED, V314, P1145, DOI 10.1056/NEJM198605013141803; ROSA P, 1994, J ENDOCRINOL INVEST, V17, P207, DOI 10.1007/BF03347721; Sanduleanu S, 2001, EUR J CLIN INVEST, V31, P802, DOI 10.1046/j.1365-2362.2001.00890.x; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P2859, DOI 10.1210/jc.2003-031127; SEKIYA K, 1989, J CLIN INVEST, V83, P1834, DOI 10.1172/JCI114089; Spadaro A, 2005, WORLD J GASTROENTERO, V11, P1987; Stridsberg M, 2003, J ENDOCRINOL, V177, P337, DOI 10.1677/joe.0.1770337; STRIDSBERG M, 1995, J ENDOCRINOL, V144, P49, DOI 10.1677/joe.0.1440049; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Thouennon Erwan, 2009, Expert Rev Endocrinol Metab, V4, P45, DOI 10.1586/17446651.4.1.45; Vicha A, 2013, CURR OPIN ENDOCRINOL, V20, P186, DOI 10.1097/MED.0b013e32835fcc45; VIEAU D, 1991, CLIN ENDOCRINOL, V35, P319, DOI 10.1111/j.1365-2265.1991.tb03543.x; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; YASUDA D, 1993, HORM METAB RES, V25, P593, DOI 10.1055/s-2007-1002184; Yon L, 2003, J CLIN ENDOCR METAB, V88, P2579, DOI 10.1210/jc.2002-021748; Zhao E, 2009, GEN COMP ENDOCR, V164, P161, DOI 10.1016/j.ygcen.2009.01.011	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88698	10.1371/journal.pone.0088698	http://dx.doi.org/10.1371/journal.pone.0088698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523932	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100081
J	Zhang, Y; Casas-Tinto, S; Rincon-Limas, DE; Fernandez-Funez, P				Zhang, Yan; Casas-Tinto, Sergio; Rincon-Limas, Diego E.; Fernandez-Funez, Pedro			Combined Pharmacological Induction of Hsp70 Suppresses Prion Protein Neurotoxicity in Drosophila	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; MOLECULAR CHAPERONES; HUNTINGTONS-DISEASE; STRESS-PROTEINS; MOUSE MODEL; LIFE-SPAN; IN-VIVO; HEAT-SHOCK-PROTEIN-70; TRANSCRIPTION; EXPRESSION	Prion diseases are rare and aggressive neurodegenerative disorders caused by the accumulation of misfolded, toxic conformations of the prion protein (PrP). Therapeutic strategies directed at reducing the levels of PrP offer the best chance of delaying or halting disease progression. The challenge, though, is to define pharmacologic targets that result in reduced PrP levels. We previously reported that expression of wild type hamster PrP in flies induces progressive locomotor dysfunction and accumulation of pathogenic PrP conformations, while co-expression of human Hsp70 delayed these changes. To validate the therapeutic potential of Hsp70, we treated flies with drugs known to induce Hsp70 expression, including the Hsp90 inhibitor 17-DMAG and the glucocorticoid dexamethasone. Although the individual treatment with these compounds produced no significant benefits, their combination significantly increased the level of inducible Hsp70, decreased the level of total PrP, reduced the accumulation of pathogenic PrP conformers, and improved locomotor activity. Thus, the combined action of two pharmacological activators of Hsp70 with distinct targets results in sustained high levels of inducible Hsp70 with improved behavioral output. These findings can have important therapeutic applications for the devastating prion diseases and other related proteinopathies.	[Zhang, Yan; Rincon-Limas, Diego E.; Fernandez-Funez, Pedro] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32611 USA; [Casas-Tinto, Sergio] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain; [Rincon-Limas, Diego E.; Fernandez-Funez, Pedro] Genet Inst Inc, Dept Neurosci, Gainesville, FL USA; [Rincon-Limas, Diego E.; Fernandez-Funez, Pedro] Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Fernandez-Funez, Pedro] Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA	State University System of Florida; University of Florida; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Rincon-Limas, DE (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32611 USA.	diego.rincon@neurology.ufl.edu; pedro.fernandez@neurology.ufl.edu	Casas-Tinto, Sergio/G-8220-2015	Casas-Tinto, Sergio/0000-0002-9589-9981; Rincon-Limas, Diego/0000-0003-3099-0642	NIH [DP2 OD002721-01]; department of Neurology at University of Florida; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); department of Neurology at University of Florida; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded in part by the NIH grant DP2 OD002721-01 to PFF and start-up funds to PFF and DERL from the department of Neurology at University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2003, J NEUROSCI, V23, P2203; Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dickey Chad A., 2005, Current Alzheimer Research, V2, P231, DOI 10.2174/1567205053585927; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Du J, 2000, J BIOL CHEM, V275, P19661, DOI 10.1074/jbc.M907258199; Egorin MJ, 2002, CANCER CHEMOTH PHARM, V49, P7, DOI 10.1007/s00280-001-0380-8; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Golde TE, 2013, J CLIN INVEST, V123, P1847, DOI 10.1172/JCI66029; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; Hernandez-Espinosa D, 2009, J THROMB HAEMOST, V7, P1128, DOI 10.1111/j.1538-7836.2009.03449.x; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; KENWARD N, 1994, J NEUROCHEM, V62, P1870; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kovacs GG, 2001, NEUROBIOL DIS, V8, P881, DOI 10.1006/nbdi.2001.0418; LEBOURG E, 1992, GERONTOLOGY, V38, P59; Marinovic AC, 2007, AM J PHYSIOL-RENAL, V292, pF660, DOI 10.1152/ajprenal.00178.2006; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rincon-Limas DE, 2010, PRION, V4, P1; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Shyu WC, 2000, J NEUROL, V247, P929, DOI 10.1007/s004150070048; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Steele AD, 2008, P NATL ACAD SCI USA, V105, P13626, DOI 10.1073/pnas.0806319105; Sun L, 2000, AM J PHYSIOL-HEART C, V278, pH1091, DOI 10.1152/ajpheart.2000.278.4.H1091; TBARKA N, 1993, FEBS LETT, V322, P125, DOI 10.1016/0014-5793(93)81551-A; Wadekar SA, 2004, MOL ENDOCRINOL, V18, P500, DOI 10.1210/me.2003-0215; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Zhao YM, 2005, J EXP BIOL, V208, P697, DOI 10.1242/jeb.01439; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	49	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88522	10.1371/journal.pone.0088522	http://dx.doi.org/10.1371/journal.pone.0088522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523910	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100059
J	Zhang, Y; Hou, F; Liu, X; Ma, DX; Zhang, YZ; Kong, BH; Cui, BX				Zhang, Yan; Hou, Fei; Liu, Xin; Ma, Daoxin; Zhang, Youzhong; Kong, Beihua; Cui, Baoxia			Tc17 Cells in Patients with Uterine Cervical Cancer	PLOS ONE			English	Article							CD8(+) T-CELLS; CUTTING EDGE; TH17 CELLS; GROWTH; IMMUNITY; SUBSET; DIFFERENTIATION; ANGIOGENESIS; EOMESODERMIN; LYMPHOCYTES	Background: The existence of Tc17 cells was recently shown in several types of infectious and autoimmune diseases, but their distribution and functions in uterine cervical cancer (UCC) have not been fully elucidated. Methods: The frequency of Tc17 cells in peripheral blood samples obtained from UCC patients, cervical intraepithelial neoplasia (CIN) patients and healthy controls was determined by flow cytometry. Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining. Results: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues. Besides, the increased level of Tc17 in UCC patients was associated with the status of pelvic lymph node metastases and increased microvessel density. Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues. Conclusions: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.	[Zhang, Yan; Hou, Fei; Zhang, Youzhong; Kong, Beihua; Cui, Baoxia] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Zhang, Yan; Liu, Xin] Peoples Hosp, Dept Obstet & Gynecol, Weifang City, Shandong, Peoples R China; [Hou, Fei] Jinan Matern & Childrens Hosp, Jinan, Shandong, Peoples R China; [Ma, Daoxin] Shandong Univ, Qilu Hosp, Haematol Oncol Ctr, Jinan 250100, Shandong, Peoples R China; [Zhang, Yan; Zhang, Youzhong; Kong, Beihua; Cui, Baoxia] Shandong Univ, Qilu Hosp, Gynecol Oncol Key Lib Shandong Prov, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Cui, BX (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China.	cuibaoxia@sdu.edu.cn			National Natural Science Foundation of China [81172486, 81170515, 81072122]; Shandong Technological Development Project [2006BS03060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project	This study was supported by grants from the National Natural Science Foundation of China (Nos. 81172486, 81170515, and 81072122) and the Shandong Technological Development Project (No. 2006BS03060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2007, GUT, V56, P1572, DOI 10.1136/gut.2006.117812; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Chen ZF, 2012, EUR J GYNAECOL ONCOL, V33, P502; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Delgado FG, 2009, IMMUNOLOGY, V126, P523, DOI 10.1111/j.1365-2567.2008.02912.x; Dwivedi VP, 2012, J BIOL CHEM, V287, P2943, DOI 10.1074/jbc.C111.327627; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Henriques A, 2010, CELL IMMUNOL, V264, P97, DOI 10.1016/j.cellimm.2010.05.004; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Hirahara N, 2001, ONCOLOGY-BASEL, V61, P79, DOI 10.1159/000055357; Hou F, 2012, CLIN CHIM ACTA, V413, P1848, DOI 10.1016/j.cca.2012.07.012; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kuang DM, 2010, J IMMUNOL, V185, P1544, DOI 10.4049/jimmunol.0904094; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Roberts SJ, 2007, P NATL ACAD SCI USA, V104, P6770, DOI 10.1073/pnas.0604982104; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Sheu BC, 2007, J OBSTET GYNAECOL RE, V33, P103, DOI 10.1111/j.1447-0756.2007.00492.x; Shi QF, 2013, RADIAT RES, V179, P584, DOI 10.1667/RR3155.1; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Wei S, 2005, CANCER RES, V65, P5020, DOI 10.1158/0008-5472.CAN-04-4043; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Yu Y, 2013, J IMMUNOL, V190, P1873, DOI 10.4049/jimmunol.1201989; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhang Y, 2011, CLIN CHIM ACTA, V412, P894, DOI 10.1016/j.cca.2011.01.015; Zhu XJ, 2010, J CLIN IMMUNOL, V30, P253, DOI 10.1007/s10875-009-9353-1; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	40	11	12	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e86812	10.1371/journal.pone.0086812	http://dx.doi.org/10.1371/journal.pone.0086812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523865	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100014
J	Bjornlie, DD; Van Manen, FT; Ebinger, MR; Haroldson, MA; Thompson, DJ; Costello, CM				Bjornlie, Daniel D.; Van Manen, Frank T.; Ebinger, Michael R.; Haroldson, Mark A.; Thompson, Daniel J.; Costello, Cecily M.			Whitebark Pine, Population Density, and Home-Range Size of Grizzly Bears in the Greater Yellowstone Ecosystem	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; FLORIDA BLACK BEARS; UTILIZATION DISTRIBUTIONS; PEROMYSCUS-MANICULATUS; NATIONAL-PARK; BROWN BEARS; FOOD; ORGANIZATION; ECOLOGY; KERNEL	Changes in life history traits of species can be an important indicator of potential factors influencing populations. For grizzly bears (Ursus arctos) in the Greater Yellowstone Ecosystem (GYE), recent decline of whitebark pine (WBP; Pinus albicaulis), an important fall food resource, has been paired with a slowing of population growth following two decades of robust population increase. These observations have raised questions whether resource decline or density-dependent processes may be associated with changes in population growth. Distinguishing these effects based on changes in demographic rates can be difficult. However, unlike the parallel demographic responses expected from both decreasing food availability and increasing population density, we hypothesized opposing behavioral responses of grizzly bears with regard to changes in home-range size. We used the dynamic changes in food resources and population density of grizzly bears as a natural experiment to examine hypotheses regarding these potentially competing influences on grizzly bear home-range size. We found that home-range size did not increase during the period of whitebark pine decline and was not related to proportion of whitebark pine in home ranges. However, female home-range size was negatively associated with an index of population density. Our data indicate that home-range size of grizzly bears in the GYE is not associated with availability of WBP, and, for female grizzly bears, increasing population density may constrain home-range size.	[Bjornlie, Daniel D.; Thompson, Daniel J.] Wyoming Game & Fish Dept, Large Carnivore Sect, Lander, WY USA; [Van Manen, Frank T.; Haroldson, Mark A.] US Geol Survey, Northern Rocky Mt Sci Ctr, Interagcy Grizzly Bear Study Team, Bozeman, MT USA; [Ebinger, Michael R.; Costello, Cecily M.] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA	United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana	Bjornlie, DD (corresponding author), Wyoming Game & Fish Dept, Large Carnivore Sect, Lander, WY USA.	dan.bjornlie@wyo.gov	Bjornlie, Dan/AAD-3034-2019	T. van Manen, Frank/0000-0001-5340-8489	U.S. Fish & Wildlife Service	U.S. Fish & Wildlife Service(US Fish & Wildlife Service)	Data collection for this work is part of Interagency Grizzly Bear Study Team (IGBST) routine monitoring of the Greater Yellowstone grizzly bear population. The authors are employed by IGBST member agencies. Funding for this work was also provided by the U.S. Fish & Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambramsky Z, 1980, OIKOS, V34, P347; Beyer, 2018, GEOSPATIAL MODELING; Bjornlie DD, 2014, WILDLIFE SOC B, V38, P182, DOI 10.1002/wsb.368; Bockino N, 2011, WHITEBARK PINE STRAT; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; BOYCE M.S., 2001, INT ASS BEAR RES MAN, V4; Brockwell P., 1996, INTRO TIME SERIES FO; Brodeur V, 2008, CAN J ZOOL, V86, P1307, DOI 10.1139/Z08-118; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARPENTER SR, 1990, ECOLOGY, V71, P2038, DOI 10.2307/1938617; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Dahle B, 2006, J MAMMAL, V87, P859, DOI 10.1644/05-MAMM-A-352R1.1; Dobey S, 2005, WILDLIFE MONOGR, P1; Eberhardt LL, 1996, J WILDLIFE MANAGE, V60, P416, DOI 10.2307/3802244; Fortin JK, 2013, J WILDLIFE MANAGE, V77, P270, DOI 10.1002/jwmg.483; GARSHELIS DL, 1981, J WILDLIFE MANAGE, V45, P912, DOI 10.2307/3808099; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Greater Yellowstone Whitebark Pine Monitoring Working Group, 2014, SUMM PREL STEP TREND; HAROLDSON M. A, 2013, YELLOWSTONE GRIZZLY, P11; Haroldson M. A., 2012, YELLOWSTONE GRIZZLY, P39; Interagency Grizzly Bear Study Team, 2012, UPD EV APPR EST POP; Jonkel J.J., 1993, MANUAL HANDLING BEAR; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Koike S, 2012, MAMM STUDY, V37, P21, DOI 10.3106/041.037.0103; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lichti NI, 2011, J WILDLIFE MANAGE, V75, P413, DOI 10.1002/jwmg.48; Macfarlane WW, 2010, USING LANDSCAPE ASSE; MARES MA, 1982, ECOLOGY, V63, P267, DOI 10.2307/1938940; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; McLoughlin PD, 2000, ECOSCIENCE, V7, P123, DOI 10.1080/11956860.2000.11682580; Moyer MA, 2007, J MAMMAL, V88, P468, DOI 10.1644/06-MAMM-A-165R1.1; NAGY JAS, 1990, INT C BEAR, V8, P227; Nilsen EB, 2005, ECOSCIENCE, V12, P68, DOI 10.2980/i1195-6860-12-1-68.1; Oli Madan K., 2002, Journal for Nature Conservation (Jena), V10, P87, DOI 10.1078/1617-1381-00010; Said S, 2005, J ZOOL, V267, P301, DOI 10.1017/S0952836905007454; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Schwartz CC, 2014, J WILDLIFE MANAGE, V78, P68, DOI 10.1002/jwmg.633; Stradiotto A, 2009, J MAMMAL, V90, P704, DOI 10.1644/08-MAMM-A-120R1.1; TAITT MJ, 1981, J ANIM ECOL, V50, P111, DOI 10.2307/4035; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; VINCENT JP, 1995, J ZOOL, V236, P371, DOI 10.1111/j.1469-7998.1995.tb02719.x; Wauters LA, 2005, EVOL ECOL, V19, P375, DOI 10.1007/s10682-005-8311-5; WOLFF JO, 1985, CAN J ZOOL, V63, P2657, DOI 10.1139/z85-397; [No title captured]	49	18	18	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88160	10.1371/journal.pone.0088160	http://dx.doi.org/10.1371/journal.pone.0088160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520354	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600045
J	Blom, H; Marschark, M; Vervloed, MPJ; Knoors, H				Blom, Helen; Marschark, Marc; Vervloed, Mathijs P. J.; Knoors, Harry			Finding Friends Online: Online Activities by Deaf Students and Their Well-Being	PLOS ONE			English	Article							FACE-TO-FACE; INTERNET USE; ADOLESCENTS; CHILDREN; QUALITY; PEER; OFFLINE; COMMUNICATION; ADJUSTMENT; ACCEPTANCE	Generally, deaf and hard of hearing (D/HH) children have fewer friends than hearing peers and their friendships are of a lower quality. The research hypothesis was that using the computer to communicate with new online friends through social network sites or playing games with offline friends is associated with D/HH friendship qualities, because it removes certain communication barriers D/HH face in offline communication settings. With online questionnaires the relation between computer use and online, mixed (offline friend who you also speak in online settings), and offline friendship quality of D/HH and hearing students (18-25 years) was compared in both the Netherlands (n = 100) and the United States (n = 122). In addition, the study examined whether the different friendship qualities were related to the participants' well-being. Results showed that, in general, D/HH students' friendship qualities and levels of well-being were similar to their hearing peers. The quality of the mixed friendships was positively related to well-being. Furthermore, the frequency of pc use with both online and offline friends was positively related to friendships qualities in both hearing and D/HH students. A combination of the online and offline friendship seems to be the most important friendship type for both hearing and D/HH students and it is worthwhile to encourage this friendship type.	[Blom, Helen; Vervloed, Mathijs P. J.; Knoors, Harry] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Marschark, Marc] Rochester Inst Technol, Natl Tech Inst Deaf, Rochester, NY 14623 USA; [Blom, Helen; Knoors, Harry] Royal Dutch Kentalis, Nijmegen, Netherlands	Radboud University Nijmegen; Rochester Institute of Technology	Blom, H (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	hel.blom@kentalis.nl	Vervloed, Mathijs/D-6094-2012; vervloed, mathijs/HHN-4013-2022; Knoors, Harry E.T./D-6170-2012	Vervloed, Mathijs/0000-0002-0123-3557; Knoors, Harry E.T./0000-0002-1709-052X				Antheunis M.L., 2012, CYBERPSYCHOLOGY, V6, DOI 10.5817/CP2012-3-6; Barak A, 2008, COMPUT HUM BEHAV, V24, P1802, DOI 10.1016/j.chb.2008.02.007; Bargh JA, 2004, ANNU REV PSYCHOL, V55, P573, DOI 10.1146/annurev.psych.55.090902.141922; Bat-Chava Y, 2005, J CHILD PSYCHOL PSYC, V46, P1287, DOI 10.1111/j.1469-7610.2005.01426.x; Berndt TJ, 2002, CURR DIR PSYCHOL SCI, V11, P7, DOI 10.1111/1467-8721.00157; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Chan DKS, 2004, J SOC PERS RELAT, V21, P305, DOI 10.1177/0265407504042834; Dammeyer J, 2010, J DEAF STUD DEAF EDU, V15, P50, DOI 10.1093/deafed/enp024; Gierveld JD, 2006, RES AGING, V28, P582, DOI 10.1177/0164027506289723; Demir M., 2007, J HAPPINESS STUD, V8, P181, DOI [10.1007/s10902-006-9012-7, DOI 10.1007/S10902-006-9012-7, DOI 10.1007/S10902-006-9034-1]; Desjarlais M, 2010, COMPUT HUM BEHAV, V26, P896, DOI 10.1016/j.chb.2010.02.004; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Gierveld JD, 2006, RES AGING, V28, P730, DOI 10.1177/0164027506291873; Gross EF, 2002, J SOC ISSUES, V58, P75, DOI 10.1111/1540-4560.00249; Hintermair M, 2007, AM ANN DEAF, V152, P320, DOI 10.1353/aad.2007.0028; Ho SS, 2008, COMMUN RES, V35, P190, DOI 10.1177/0093650207313159; HOLLINGER F, 1990, EUROPEAN SOCIOLOGICA, V0006; Kingery JN, 2011, MERRILL PALMER QUART, V57, P215; Kouwenberg M., 2013, SOCIAL EMOTIONAL FAC; Ladd GW, 1996, CHILD DEV, V67, P1103, DOI 10.2307/1131882; Mathur R, 2006, J EARLY ADOLESCENCE, V26, P365, DOI 10.1177/0272431606288553; Moeller MP, 2007, EAR HEARING, V28, P740, DOI 10.1097/AUD.0b013e318157f07f; PARKER JG, 1987, PSYCHOL BULL, V102, P357, DOI 10.1037/0033-2909.102.3.357; PARKER JG, 1993, DEV PSYCHOL, V29, P611, DOI 10.1037/0012-1649.29.4.611; Parks MR, 1996, J COMMUN, V46, P80, DOI 10.1111/j.1460-2466.1996.tb01462.x; Piso F, 2009, VHZ, V5, P10; Powdthavee N., 2008, J SOCIO-ECON, V37, P1459, DOI [DOI 10.1016/j.socec.2007.04.004, 10.1016/j.socec.2007.04.004, DOI 10.1016/J.SOCEC.2007.04.004]; Raacke J, 2008, CYBERPSYCHOL BEHAV, V11, P169, DOI 10.1089/cpb.2007.0056; Reich SM, 2012, DEV PSYCHOL, V48, P356, DOI 10.1037/a0026980; Stinson M. S., 1992, EFFECTIVE PUBLIC SCH, P149; Subrahmanyam K, 2008, FUTURE CHILD, V18, P119, DOI 10.1353/foc.0.0006; Subrahmanyam K, 2008, J APPL DEV PSYCHOL, V29, P420, DOI 10.1016/j.appdev.2008.07.003; Valkenburg PM, 2007, J COMPUT-MEDIAT COMM, V12, P1169, DOI 10.1111/j.1083-6101.2007.00368.x; Valkenburg PM, 2007, MEDIA PSYCHOL, V9, P43, DOI 10.1080/15213260709336802; Valkenburg PM, 2009, CURR DIR PSYCHOL SCI, V18, P1, DOI 10.1111/j.1467-8721.2009.01595.x; Vitak J., 2012, KEEPING CONNECTED FA; Wolters N, 2012, J DEAF STUD DEAF EDU, V17, P463, DOI 10.1093/deafed/ens021	37	16	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88351	10.1371/journal.pone.0088351	http://dx.doi.org/10.1371/journal.pone.0088351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520373	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600064
J	Choi, J; Ababon, MR; Soliman, M; Lin, Y; Brzustowicz, LM; Matteson, PG; Millonig, JH				Choi, Jiyeon; Ababon, Myka R.; Soliman, Mai; Lin, Yong; Brzustowicz, Linda M.; Matteson, Paul G.; Millonig, James H.			Autism Associated Gene, ENGRAILED2, and Flanking Gene Levels Are Altered in Post-Mortem Cerebellum	PLOS ONE			English	Article							HOMEOBOX-TRANSCRIPTION-FACTOR; SPECTRUM-DISORDER; SONIC HEDGEHOG; NORADRENERGIC NEURONS; SEROTONERGIC NEURONS; INFANTILE-AUTISM; BLOOD SEROTONIN; PURKINJE-CELLS; RETINAL AXONS; EXPRESSION	Background: Previous genetic studies demonstrated association between the transcription factor ENGRAILED2 (EN2) and Autism Spectrum Disorder (ASD). Subsequent molecular analysis determined that the EN2 ASD-associated haplotype (rs1861972-rs1861973 A-C) functions as a transcriptional activator to increase gene expression. EN2 is flanked by 5 genes, SEROTONIN RECEPTOR5A (HTR5A), INSULIN INDUCED GENE1 (INSIG1), CANOPY1 HOMOLOG (CNPY1), RNA BINDING MOTIF PROTEIN33 (RBM33), and SONIC HEDGEHOG (SHH). These flanking genes are co-expressed with EN2 during development and coordinate similar developmental processes. To investigate if mRNA levels for these genes are altered in individuals with autism, post-mortem analysis was performed. Methods: qRT-PCR quantified mRNA levels for EN2 and the 5 flanking genes in 78 post-mortem cerebellar samples. mRNA levels were correlated with both affection status and rs1861972-rs1861973 genotype. Molecular analysis investigated whether EN2 regulates flanking gene expression. Results: EN2 levels are increased in affected A-C/G-T individuals (p =.0077). Affected individuals also display a significant increase in SHH and a decrease in INSIG1 levels. Rs1861972-rs1861973 genotype is correlated with significant increases for SHH (A-C/G-T) and CNPY1 (G-T/G-T) levels. Human cell line over-expression and knock-down as well as mouse knock-out analysis are consistent with EN2 and SHH being co-regulated, which provides a possible mechanism for increased SHH postmortem levels. Conclusions: EN2 levels are increased in affected individuals with an A-C/G-T genotype, supporting EN2 as an ASD susceptibility gene. SHH, CNPY1, and INSIG1 levels are also significantly altered depending upon affection status or rs1861972-rs1861973 genotype. Increased EN2 levels likely contribute to elevated SHH expression observed in the postmortem samples	[Choi, Jiyeon; Ababon, Myka R.; Soliman, Mai; Matteson, Paul G.; Millonig, James H.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Lin, Yong] Canc Inst New Jersey, Piscataway, NJ USA; [Millonig, James H.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Brzustowicz, Linda M.; Millonig, James H.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Millonig, JH (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	Millonig@CABM.rutgers.edu			National Institutes of Health [R01 MH076624, R01 MH076435, RC1 MH088288]; New Jersey Governor's Council on Autism Research; National Alliance for Autism Research; Autism Speaks; National Alliance for Research on Schizophrenia and Depression Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076435, R01MH076624, RC1MH088288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Governor's Council on Autism Research; National Alliance for Autism Research; Autism Speaks; National Alliance for Research on Schizophrenia and Depression Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (R01 MH076624), New Jersey Governor's Council on Autism Research, National Alliance for Autism Research, Autism Speaks, and National Alliance for Research on Schizophrenia and Depression Young Investigator Award to JHM; National Institutes of Health (R01 MH076435, RC1 MH088288) to LMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2006, STEM CELL REV, V2, P5, DOI 10.1385/SCR:2:1:5; Baader SL, 1998, J NEUROSCI, V18, P1763; Baader SL, 1999, J NEUROSCI, V19, P5370; Benayed R, 2005, AM J HUM GENET, V77, P851, DOI 10.1086/497705; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brune CW, 2007, AM J MED GENETICS B; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; CAMPBELL M, 1975, INT PHARMACOPSYCHIAT, V10, P213, DOI 10.1159/000468197; Choi J, 2012, HUM MOL GENET, V21, P1566, DOI 10.1093/hmg/ddr594; COOK EH, 1992, J AM ACAD CHILD PSY, V31, P739, DOI 10.1097/00004583-199207000-00024; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; DECELIS JF, 1995, DEVELOPMENT, V121, P3467; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; GUILLEN I, 1995, DEVELOPMENT, V121, P3447; Harwell CC, 2012, NEURON, V73, P1116, DOI 10.1016/j.neuron.2012.02.009; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Lam CS, 2003, MOL CELL NEUROSCI, V22, P501, DOI 10.1016/S1044-7431(03)00031-9; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Liu H, 2008, J EXP MED, V205, P1843, DOI 10.1084/jem.20072102; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; McDougle CJ, 1996, ARCH GEN PSYCHIAT, V53, P993; Millen KJ, 1995, DEVELOPMENT, V121, P3935; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; PETIT E, 1995, J MED GENET, V32, P269, DOI 10.1136/jmg.32.4.269; Porter FD, 2008, EUR J HUM GENET, V16, P535, DOI 10.1038/ejhg.2008.10; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; RITVO ER, 1970, ARCH GEN PSYCHIAT, V23, P566; Rossman IT, 2008, CURR CLIN NEUROL, P3, DOI 10.1007/978-1-60327-489-0_1; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Sen B, 2010, GENES BRAIN BEHAV, V9, P248, DOI 10.1111/j.1601-183X.2009.00556.x; Sillitoe RV, 2009, NEUROSCIENCE, V162, P574, DOI 10.1016/j.neuroscience.2008.12.025; Sillitoe RV, 2010, J NEUROSCI, V30, P10015, DOI 10.1523/JNEUROSCI.0653-10.2010; Sillitoe RV, 2008, J NEUROSCI, V28, P12150, DOI 10.1523/JNEUROSCI.2059-08.2008; Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Tripathi PP, 2009, NEUROSCIENCE, V159, P842, DOI 10.1016/j.neuroscience.2009.01.007; Vaccarino FM, 2009, J AUTISM DEV DISORD, V39, P511, DOI 10.1007/s10803-008-0653-8; Wang LF, 2008, AM J MED GENET B, V147B, P434, DOI 10.1002/ajmg.b.30623; Wass S, 2011, BRAIN COGNITION, V75, P18, DOI 10.1016/j.bandc.2010.10.005; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; Yang PC, 2008, NEUROPSYCHOBIOLOGY, V57, P3, DOI 10.1159/000123115; Yang PC, 2010, NEUROPSYCHOBIOLOGY, V62, P104, DOI 10.1159/000315441; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; ZECCA M, 1995, DEVELOPMENT, V121, P2265	55	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87208	10.1371/journal.pone.0087208	http://dx.doi.org/10.1371/journal.pone.0087208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520327	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600018
J	Faure, C; Dupont, C; Baraibar, MA; Ladouce, R; Cedrin-Durnerin, I; Wolf, JP; Levy, R				Faure, Celine; Dupont, Charlotte; Baraibar, Martin A.; Ladouce, Romain; Cedrin-Durnerin, Isabelle; Wolf, Jean Philippe; Levy, Rachel			In Subfertile Couple, Abdominal Fat Loss in Men Is Associated with Improvement of Sperm Quality and Pregnancy: A Case-Series	PLOS ONE			English	Article							BODY-MASS INDEX; SEMEN QUALITY; BIOIMPEDANCE ANALYSIS; AROMATASE EXPRESSION; DNA INTEGRITY; WEIGHT-LOSS; OBESE MEN; RISK; IMPACT; INFERTILITY	Background: The impact of overweight among men of reproductive-age may affect fertility. Abdominal fat, more than body mass index, is an indicator of higher metabolic risk, which seems to be involved in decreasing sperm quality. This study aims to assess the relationship between abdominal fat and sperm DNA fragmentation and the effect of abdominal fat loss, among 6 men in subfertile couples. Methods: Sperm DNA fragmentation, abdominal fat and metabolic and hormonal profiles were measured in the 6 men before and after dietary advices. Seminal oxidative stress and antioxidant markers were determined. Results: After several months of a lifestyle program, all 6 men lost abdominal fat (patient 1: loss of 3 points of abdominal fat, patient 2: loss of 3 points, patient 3: loss of 2 points, patient 4: loss of 1 point, patient 5: loss of 4 points and patient 6: loss of 13 points). At the same time, their rate of sperm DNA fragmentation decreased: 9.5% vs 31%, 24% vs 43%, 18% vs 47%, 26.3% vs 66%, 25.4% vs 35% and 1.7% vs 25%. Also, an improvement in both metabolic (significant decrease in triglycerides and total cholesterol; p = 0.0139) and hormonal (significant increase in testosterone/oestradiol ratio; p = 0.0139) blood profiles was observed after following the lifestyle program. In seminal plasma, the amount of SOD2 has significantly increased (p = 0.0139) while in parallel carbonylated proteins have decreased. Furthermore, all spouses got pregnant. All pregnancies were brought to term. Conclusion: This study shows specifically that sperm DNA fragmentation among men in subfertile couples could be affected by abdominal fat, but improvement of lifestyle factor may correct this alteration. The effect of specific abdominal fat loss on sperm quality needs further investigation. The reduction of oxidative stress may be a contributing factor.	[Faure, Celine; Dupont, Charlotte; Levy, Rachel] Hop Jean Verdier, AP HP, Serv Histol Embryol Cytogenet CECO, Bondy, France; [Faure, Celine; Dupont, Charlotte; Cedrin-Durnerin, Isabelle; Levy, Rachel] Univ Paris 13, Unite Rech Epidemiol Nutr, INSERM, INRA,CNAM,CRNH IdF,U557, Bobigny, France; [Dupont, Charlotte] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Baraibar, Martin A.; Ladouce, Romain] Univ Paris 06, Lab Biol Cellulaire Vieillissement, Paris 05, France; [Cedrin-Durnerin, Isabelle] Univ Paris 13, Hop Jean Verdier, AP HP, Serv Med Reprod, Bondy, France; [Wolf, Jean Philippe] Univ Paris 05, Hop Cochin, Serv Histol Embryol Biol Reprod, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Faure, C (corresponding author), Hop Jean Verdier, AP HP, Serv Histol Embryol Cytogenet CECO, Bondy, France.	c.faure@uren.smbh.univ-paris13.fr	Dupont, Charlotte/AAL-8780-2020	Andersson, Anders/0000-0002-3627-6899	National Biomedical Research: ALIFERT	National Biomedical Research: ALIFERT	This study was supported by National Biomedical Research: ALIFERT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727, DOI 10.1016/S1472-6483(10)60676-1; Alkan I, 1997, J UROLOGY, V157, P140, DOI 10.1016/S0022-5347(01)65307-2; ALVAREZ JG, 1987, J ANDROL, V8, P338; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Baraibar MA, 2013, J PROTEOMICS; Blumer CG, 2008, FERTIL STERIL, V90, P1716, DOI 10.1016/j.fertnstert.2007.09.007; Bungum M, 2007, HUM REPROD, V22, P174, DOI 10.1093/humrep/del326; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Cocuzza Marcello, 2007, Int. braz j urol., V33, P603, DOI 10.1590/S1677-55382007000500002; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Davi G, 2005, LUPUS, V14, P760, DOI 10.1191/0961203305lu2216oa; de la Calle JFV, 2008, FERTIL STERIL, V90, P1792, DOI 10.1016/j.fertnstert.2007.09.021; Derby CA, 2006, CLIN ENDOCRINOL, V65, P125, DOI 10.1111/j.1365-2265.2006.02560.x; Duits FH, 2010, FERTIL STERIL, V94, P1356, DOI 10.1016/j.fertnstert.2009.05.075; Dupont C, 2013, ASIAN J ANDROL, V15, P622, DOI 10.1038/aja.2013.65; Ebisch IMW, 2006, HUM REPROD, V21, P1725, DOI 10.1093/humrep/del081; Ebisch IMW, 2008, FERTIL STERIL, V90, P2340, DOI 10.1016/j.fertnstert.2007.10.026; Fariello RM, BJU INT; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; Gautier A, 2013, CLIN ENDOCRINOL, V78, P373, DOI 10.1111/j.1365-2265.2012.04401.x; GORCZYCA W, 1993, CANCER RES, V53, P1945; Hakonsen LB, REPROD HLTH, V8, P24; Hakonsen LB, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-24; Hammiche F, 2012, HUM REPROD; Heber D, 2010, AM J CLIN NUTR, V91, p280S, DOI 10.3945/ajcn.2009.28473B; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Kaukua J, 2003, OBES RES, V11, P689, DOI 10.1038/oby.2003.98; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Kuchenbecker WKH, 2011, HUM REPROD, V26, P2505, DOI 10.1093/humrep/der229; La Vignera S, 2011, J ANDROL, V33, P53, DOI 10.2164/jandrol.110.012120; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Li YF, 2009, HUM REPROD, V24, P459, DOI 10.1093/humrep/den399; Niskanen L, 2004, DIABETES OBES METAB, V6, P208, DOI 10.1111/j.1462-8902.2004.00335.x; Nunez C, 1997, MED SCI SPORT EXER, V29, P524; Pasquali R, 2006, BJOG-INT J OBSTET GY, V113, P1148, DOI 10.1111/j.1471-0528.2006.00990.x; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; Santiso R, 2010, FERTIL STERIL, V93, P314, DOI 10.1016/j.fertnstert.2009.07.969; Sermondade N, 2012, HUM REPROD UPDATE; Sermondade N, 2012, ARCH INTERN MED, V172, P440, DOI 10.1001/archinternmed.2011.1382; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Thomson RL, 2008, J CLIN ENDOCR METAB, V93, P3373, DOI 10.1210/jc.2008-0751; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x; Wong WY, 2000, FERTIL STERIL, V73, P435, DOI 10.1016/S0015-0282(99)00551-8; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484; Zain MM, 2008, WOMENS HEALTH, V4, P183, DOI 10.2217/17455057.4.2.183; Zhao Y, 1997, J STEROID BIOCHEM, V61, P203, DOI 10.1016/S0960-0760(97)80013-1	51	43	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e86300	10.1371/journal.pone.0086300	http://dx.doi.org/10.1371/journal.pone.0086300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520319	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600009
J	Okada, Y; Diogo, D; Greenberg, JD; Mouassess, F; Achkar, WAL; Fulton, RS; Denny, JC; Gupta, N; Mirel, D; Gabriel, S; Li, G; Kremer, JM; Pappas, DA; Carroll, RJ; Eyler, AE; Trynka, G; Stahl, EA; Cui, J; Saxena, R; Coenen, MJH; Guchelaar, HJ; Huizinga, TWJ; Dieude, P; Mariette, X; Barton, A; Canhao, H; Fonseca, JE; de Vries, N; Tak, PP; Moreland, LW; Bridges, SL; Miceli-Richard, C; Choi, HK; Kamatani, Y; Galan, P; Lathrop, M; Raj, T; De Jager, PL; Raychaudhuri, S; Worthington, J; Padyukov, L; Klareskog, L; Siminovitch, KA; Gregersen, PK; Mardis, ER; Arayssi, T; Kazkaz, LA; Plenge, RM				Okada, Yukinori; Diogo, Dorothee; Greenberg, Jeffrey D.; Mouassess, Faten; Achkar, Walid A. L.; Fulton, Robert S.; Denny, Joshua C.; Gupta, Namrata; Mirel, Daniel; Gabriel, Stacy; Li, Gang; Kremer, Joel M.; Pappas, Dimitrios A.; Carroll, Robert J.; Eyler, Anne E.; Trynka, Gosia; Stahl, Eli A.; Cui, Jing; Saxena, Richa; Coenen, Marieke J. H.; Guchelaar, Henk-Jan; Huizinga, Tom W. J.; Dieude, Philippe; Mariette, Xavier; Barton, Anne; Canhao, Helena; Fonseca, Joao E.; de Vries, Niek; Tak, Paul P.; Moreland, Larry W.; Bridges, S. Louis, Jr.; Miceli-Richard, Corinne; Choi, Hyon K.; Kamatani, Yoichiro; Galan, Pilar; Lathrop, Mark; Raj, Towfique; De Jager, Philip L.; Raychaudhuri, Soumya; Worthington, Jane; Padyukov, Leonid; Klareskog, Lars; Siminovitch, Katherine A.; Gregersen, Peter K.; Mardis, Elaine R.; Arayssi, Thurayya; Kazkaz, Layla A.; Plenge, Robert M.			Integration of Sequence Data from a Consanguineous Family with Genetic Data from an Outbred Population Identifies PLB1 as a Candidate Rheumatoid Arthritis Risk Gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; AMERICAN-COLLEGE; COMMON VARIANTS; RARE; CRITERIA; DNA; CLASSIFICATION; METHOTREXATE; ETANERCEPT	Integrating genetic data from families with highly penetrant forms of disease together with genetic data from outbred populations represents a promising strategy to uncover the complete frequency spectrum of risk alleles for complex traits such as rheumatoid arthritis (RA). Here, we demonstrate that rare, low-frequency and common alleles at one gene locus, phospholipase B1 (PLB1), might contribute to risk of RA in a 4-generation consanguineous pedigree (Middle Eastern ancestry) and also in unrelated individuals from the general population (European ancestry). Through identity-by-descent (IBD) mapping and whole-exome sequencing, we identified a non-synonymous c.2263G. C (p.G755R) mutation at the PLB1 gene on 2q23, which significantly co-segregated with RA in family members with a dominant mode of inheritance (P = 0.009). We further evaluated PLB1 variants and risk of RA using a GWAS meta-analysis of 8,875 RA cases and 29,367 controls of European ancestry. We identified significant contributions of two independent non-coding variants near PLB1 with risk of RA (rs116018341 [MAF = 0.042] and rs116541814 [MAF = 0.021], combined P = 3.26 x 10(-6)). Finally, we performed deep exon sequencing of PLB1 in 1,088 RA cases and 1,088 controls (European ancestry), and identified suggestive dispersion of rare protein-coding variant frequencies between cases and controls (P = 0.049 for C-alpha test and P = 0.055 for SKAT). Together, these data suggest that PLB1 is a candidate risk gene for RA. Future studies to characterize the full spectrum of genetic risk in the PLB1 genetic locus are warranted.	[Okada, Yukinori; Diogo, Dorothee; Li, Gang; Trynka, Gosia; Cui, Jing; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA; [Okada, Yukinori; Diogo, Dorothee; Trynka, Gosia; Raj, Towfique; De Jager, Philip L.; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med, Boston, MA 02115 USA; [Okada, Yukinori; Diogo, Dorothee; Gupta, Namrata; Mirel, Daniel; Gabriel, Stacy; Trynka, Gosia; Raj, Towfique; De Jager, Philip L.; Raychaudhuri, Soumya; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Okada, Yukinori] Tokyo Med & Dent Univ, Dept Human Genet & Dis Divers, Grad Sch Med & Dent Sci, Tokyo, Japan; [Okada, Yukinori; Kamatani, Yoichiro] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Greenberg, Jeffrey D.] NYU, Hosp Joint Dis, New York, NY USA; [Mouassess, Faten; Achkar, Walid A. L.] Mol Biol & Biotechnol Dept, Div Human Genet, Damascus, Syria; [Fulton, Robert S.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Denny, Joshua C.; Carroll, Robert J.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Kremer, Joel M.] Albany Med Ctr, Dept Med, Albany, NY USA; [Kremer, Joel M.] Ctr Rheumatol, Albany, NY USA; [Pappas, Dimitrios A.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Rheumatol,Presbyterian Hosp, New York, NY USA; [Eyler, Anne E.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Stahl, Eli A.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Saxena, Richa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Coenen, Marieke J. H.] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Guchelaar, Henk-Jan] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands; [Huizinga, Tom W. J.] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands; [Dieude, Philippe] Hop Bichat Claude Bernard, AP HP, Serv Rhumatol, F-75877 Paris 18, France; [Dieude, Philippe] Hop Bichat Claude Bernard, AP HP, INSERM, U699, F-75877 Paris 18, France; [Dieude, Philippe] Univ Paris 07, Paris, France; [Mariette, Xavier; Miceli-Richard, Corinne] Univ Paris 11, Hop Univ Paris Sud, AP HP, INSERM,U1012, Le Kremlin Bicetre, France; [Barton, Anne; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Musculoskeletal Res, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Rheumatol Res Unit, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal; [Canhao, Helena; Fonseca, Joao E.] Santa Maria Hosp CHLN, Dept Rheumatol, Lisbon, Portugal; [de Vries, Niek; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Niek] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Tak, Paul P.] GlaxoSmithKline, Stevenage, Herts, England; [Moreland, Larry W.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA; [Bridges, S. Louis, Jr.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Choi, Hyon K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Choi, Hyon K.] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA; [Choi, Hyon K.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Kamatani, Yoichiro] CEPH, Paris, France; [Galan, Pilar] Univ Paris 13, Sorbonne Paris Cite, UREN, Inserm,Inra,Cnam,U557,U1125, Bobigny, France; [Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Raj, Towfique; De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed, Res Unit, Cent Manchester NHS Fdn Trust, Manchester, Lancs, England; [Worthington, Jane] Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res, Manchester Musculoskeletal Biomed Res Unit, Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester, Lancs, England; [Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Rheumatol Unit, Dept Med Solna, Stockholm, Sweden; [Siminovitch, Katherine A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON, Canada; [Siminovitch, Katherine A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Arayssi, Thurayya] Weill Cornell Med Coll Qatar, Doha, Qatar; [Kazkaz, Layla A.] Tishreen Hosp, Damascus, Syria; [Kazkaz, Layla A.] Syrian Assoc Rheumatol, Damascus, Syria	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tokyo Medical & Dental University (TMDU); RIKEN; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Washington University (WUSTL); Vanderbilt University; Albany Medical College; Columbia University; NewYork-Presbyterian Hospital; Vanderbilt University; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Massachusetts General Hospital; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Manchester; Universidade de Lisboa; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; GlaxoSmithKline; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; Boston University; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; McGill University; Harvard University; Brigham & Women's Hospital; University of Manchester; University of Manchester; Karolinska Institutet; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Northwell Health; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Plenge, RM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA.	robert.plenge@merck.com	Arayssi, Thurayya/S-1725-2019; Mardis, Elaine/W-2202-2019; Raj, Towfique/ABD-7620-2021; Canhao, Helena/C-9611-2018; Worthington, Jane/M-9770-2014; Kamatani, Yoichiro/N-5513-2015; Coenen, Marieke/A-2159-2010; Saxena, Richa/AAG-7279-2020; Siminovitch, Katherine/K-1475-2013; Denny, Josh/AAL-3359-2021; guchelaar, henk-jan/AAP-1381-2021; Padyukov, Leonid/A-4890-2009; de Vries, Niek/J-9348-2013; Barton, Anne/N-2053-2014	Arayssi, Thurayya/0000-0003-2469-0272; Canhao, Helena/0000-0003-1894-4870; Worthington, Jane/0000-0003-0544-042X; Coenen, Marieke/0000-0001-8796-2031; Denny, Josh/0000-0002-3049-7332; Raychaudhuri, Soumya/0000-0002-1901-8265; Saxena, Richa/0000-0003-2233-1065; Padyukov, Leonid/0000-0003-2950-5670; DIOGO, DOROTHEE/0000-0003-2913-5913; de Vries, Niek/0000-0002-6257-8604; Guchelaar, Henk-Jan/0000-0002-7085-1383; Dieude, Philippe/0000-0002-4814-0307; Barton, Anne/0000-0003-3316-2527; Klareskog, Lars/0000-0001-9601-6186	National Institutes of Health (NIH) [R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648]; Burroughs Wellcome Fund; Japan Society of the Promotion of Science (JSPS); Japan Science and Technology Agency (JST); Netherlands Organization for Scientific Research (NOW); NIH (NIAMS) [R01-AR056291, R01-AR065944, P60 AR047785, R21 AR056042]; NIH [R01AR063759-01A1, K08-KAR055688A]; European Research Council (ERC); Canada Research Chair; Sherman Family Chair in Genomic Medicine; Ontario Research Fund [RE01-061]; Canadian Institutes of Health Research [MOP79321]; Qatar National Research Fund (QNRF) [4-344-3-105]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785, R01AR063759, R01AR056291, R01AR059648, R21AR056042, R01AR056768, R01AR065944, R01AR057108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM097119, U01GM092691] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Japan Society of the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Netherlands Organization for Scientific Research (NOW)(Netherlands Organization for Scientific Research (NWO)); NIH (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)European Commission); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Sherman Family Chair in Genomic Medicine; Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.M.P. is supported by National Institutes of Health (NIH) grants R01-AR057108, R01-AR056768, U01-GM092691, and R01-AR059648 and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. Y.O. is supported by grants from the Japan Society of the Promotion of Science (JSPS) and the Japan Science and Technology Agency (JST). G.T. is supported by the Rubicon grant from the Netherlands Organization for Scientific Research (NOW). H. K. C. is supported by NIH (NIAMS) grants R01-AR056291, R01-AR065944, P60 AR047785, and R21 AR056042. S. R. is supported by NIH grants R01AR063759-01A1 and K08-KAR055688A. L.P. and L.K. are supported by a senior investigator grant from the European Research Council (ERC). K.A.S is supported by a Canada Research Chair, the Sherman Family Chair in Genomic Medicine and by grants from the Ontario Research Fund (RE01-061) and the Canadian Institutes of Health Research (MOP79321). This research was generously supported by the Qatar National Research Fund (QNRF), NPRP # 4-344-3-105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andres AM, 1998, COMPUT STAT DATA AN, V29, P107, DOI 10.1016/S0167-9473(98)90179-7; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Carroll Robert J, 2011, AMIA Annu Symp Proc, V2011, P189; Chibnik LB, 2009, J RHEUMATOL, V36, P706, DOI 10.3899/jrheum.080895; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Duan R, 2010, ANN RHEUM DIS, V69, P1724, DOI 10.1136/ard.2009.111690; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fisher MC, 2012, J RHEUMATOL, V39, P904, DOI 10.3899/jrheum.110852; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kazkaz L, 2007, ANN RHEUM DIS, V66, P195, DOI 10.1136/ard.2004.033829; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leibon G, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1340; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2013, ARTHRITIS RHEUM-US, V65, P1975, DOI 10.1002/art.38011; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; TEITSSON I, 1985, SCAND J RHEUMATOL, V14, P109, DOI 10.3109/03009748509165492; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thomas A, 2010, GENET EPIDEMIOL, V34, P119, DOI 10.1002/gepi.20440; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	63	20	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87645	10.1371/journal.pone.0087645	http://dx.doi.org/10.1371/journal.pone.0087645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520335	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600026
J	Villarreal, FD; Das, GK; Abid, A; Kennedy, IM; Kultz, D				Villarreal, Fernando D.; Das, Gautom Kumar; Abid, Aamir; Kennedy, Ian M.; Kueltz, Dietmar			Sublethal Effects of CuO Nanoparticles on Mozambique Tilapia (Oreochromis mossambicus) Are Modulated by Environmental Salinity	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; METAL-OXIDE NANOPARTICLES; INDUCED OXIDATIVE STRESS; CARP CYPRINUS-CARPIO; FUNDULUS-HETEROCLITUS; SILVER NANOPARTICLES; RAINBOW-TROUT; MANUFACTURED NANOPARTICLES; ONCORHYNCHUS-MYKISS; COPPER TOXICITY	The increasing use of manufactured nanoparticles (NP) in different applications has triggered the need to understand their putative ecotoxicological effects in the environment. Copper oxide nanoparticles (CuO NP) are toxic, and induce oxidative stress and other pathophysiological conditions. The unique properties of NP can change depending on the characteristics of the media they are suspended in, altering the impact on their toxicity to aquatic organisms in different environments. Here, Mozambique tilapia (O. mossambicus) were exposed to flame synthesized CuO NP (0.5 and 5 mg.L-1) in two environmental contexts: (a) constant freshwater (FW) and (b) stepwise increase in environmental salinity (SW). Sublethal effects of CuO NP were monitored and used to dermine exposure endpoints. Fish exposed to 5 mg.L-1 CuO in SW showed an opercular ventilation rate increase, whereas fish exposed to 5 mg(.)L(-1) in FW showed a milder response. Different effects of CuO NP on antioxidant enzyme activities, accumulation of transcripts for metal-responsive genes, GSH:GSSG ratio, and Cu content in fish gill and liver also demonstrate that additive osmotic stress modulates CuO NP toxicity. We conclude that the toxicity of CuO NP depends on the particular environmental context and that salinity is an important factor for modulating NP toxicity in fish.	[Villarreal, Fernando D.; Kueltz, Dietmar] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Das, Gautom Kumar; Abid, Aamir; Kennedy, Ian M.] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Villarreal, FD (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	fvillarreal@ucdavis.edu	, DK/AAU-3163-2021	Villarreal, Fernando/0000-0002-4034-1243	National Institute of Environmental Health Sciences [P42ES004699]; W. M. Keck Foundation; Division Of Integrative Organismal Systems [1049780] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); W. M. Keck Foundation(W.M. Keck Foundation); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for this study was provided by the National Institute of Environmental Health Sciences, Award Number P42ES004699 and W. M. Keck Foundation research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid AD, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-1; Aitken RJ, 2006, OCCUP MED-OXFORD, V56, P300, DOI 10.1093/occmed/kql051; Akaighe N, 2012, SCI TOTAL ENVIRON, V441, P277, DOI 10.1016/j.scitotenv.2012.09.055; [Anonymous], 2006, ASTME2456062012; Anushia C., 2012, International Journal of Pharmaceutical Research and Bio-Science, V1, P371; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Atkinson MJ, 1998, J AQUARICULTURE AQUA, V8, P39; Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Barreto RE, 2011, J BIOSCIENCES, V36, P851, DOI 10.1007/s12038-011-9111-4; Batley GE, 2013, ACCOUNTS CHEM RES, V46, P854, DOI 10.1021/ar2003368; Belinky PA, 2003, APPL ENVIRON MICROB, V69, P6500, DOI 10.1128/AEM.69.11.6500-6506.2003; Bielmyer GK, 2013, ENVIRON TOXICOL CHEM, V32, P1354, DOI 10.1002/etc.2185; Bielmyer GK, 2012, INTEGR COMP BIOL, V52, P753, DOI 10.1093/icb/ics045; Bilberg K, 2010, AQUAT TOXICOL, V96, P159, DOI 10.1016/j.aquatox.2009.10.019; Blanchard J, 2006, AQUAT TOXICOL, V80, P131, DOI 10.1016/j.aquatox.2006.08.001; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Boxall A, 2007, CURRENT FUTURE PREDI, P70; Brant J, 2005, J NANOPART RES, V7, P545, DOI 10.1007/s11051-005-4884-8; Buffet PE, 2013, ENVIRON SCI TECHNOL, V47, P1620, DOI 10.1021/es303513r; Carnes CL, 2003, J MOL CATAL A-CHEM, V194, P227, DOI 10.1016/S1381-1169(02)00525-3; Ceyhun SB, 2011, BIOL TRACE ELEM RES, V144, P781, DOI 10.1007/s12011-011-9068-z; Chang YN, 2012, MATERIALS, V5, P2850, DOI 10.3390/ma5122850; Cheung APL, 2010, AQUAT TOXICOL, V99, P42, DOI 10.1016/j.aquatox.2010.03.017; Costa-Pierce BA, 1997, FARMERS FISHERS DEV; Costa-Pierce BA, 2003, BIOL INVASIONS, V5, P71, DOI 10.1023/A:1024094606326; Crocker CE, 1998, J COMP PHYSIOL B, V168, P50, DOI 10.1007/s003600050120; Dai PC, 2000, NATURE, V406, P965, DOI 10.1038/35023094; Dang ZC, 1999, AM J PHYSIOL-REG I, V277, pR320, DOI 10.1152/ajpregu.1999.277.1.R320; Das GK, 2010, J BIOMED MATER RES A, V93A, P337, DOI 10.1002/jbm.a.32533; Diamond JM, 2009, ENVIRON TOXICOL CHEM, V9, P3; Dosev D, 2006, J AEROSOL SCI, V37, P402, DOI 10.1016/j.jaerosci.2005.08.009; Evans TG, 2010, J FISH BIOL, V76, P1903, DOI 10.1111/j.1095-8649.2010.02590.x; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Fiol DF, 2011, BBA-GEN SUBJECTS, V1810, P439, DOI 10.1016/j.bbagen.2010.11.005; Gaiser BK, 2012, ENVIRON TOXICOL CHEM, V31, P144, DOI 10.1002/etc.703; Geiger SP, 2000, ENVIRON BIOL FISH, V59, P181, DOI 10.1023/A:1007640132059; Gottschalk F, 2011, ENVIRON POLLUT, V159, P3439, DOI 10.1016/j.envpol.2011.08.023; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Govindasamy R, 2012, J ENVIRON SCI, V24, P1091, DOI 10.1016/S1001-0742(11)60845-0; GRIFFITH RW, 1974, COPEIA, P319; Griffitt RJ, 2007, ENVIRON SCI TECHNOL, V41, P8178, DOI 10.1021/es071235e; Grosell M, 2007, AQUAT TOXICOL, V84, P162, DOI 10.1016/j.aquatox.2007.03.026; HAMILTON SJ, 1986, T AM FISH SOC, V115, P596, DOI 10.1577/1548-8659(1986)115<596:MIF>2.0.CO;2; Handy RD, 2011, J FISH BIOL, V79, P821, DOI 10.1111/j.1095-8649.2011.03080.x; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Hao LH, 2013, ECOTOX ENVIRON SAFE, V91, P52, DOI 10.1016/j.ecoenv.2013.01.007; Janczewski D, 2011, MICROSC RES TECHNIQ, V74, P563, DOI 10.1002/jemt.20912; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Kaegi R, 2010, ENVIRON POLLUT, V158, P2900, DOI 10.1016/j.envpol.2010.06.009; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kalbassi M. R., 2011, IRAN J TOXICOL, V5, P436; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Karthigarani M., 2012, INT J SCI TECHNOL RE, V1, P13, DOI DOI 10.1371/J0URNAL.P0NE.0088723; Kashiwada S, 2006, ENVIRON HEALTH PERSP, V114, P1697, DOI 10.1289/ehp.9209; Keenleyside M.H.A., 1991, PARENTAL CARE; Kim CI, 2004, MAR ENVIRON RES, V58, P125, DOI 10.1016/j.marenvres.2004.03.006; Kultz D, 2012, PHYSIOLOGY, V27, P259, DOI 10.1152/physiol.00014.2012; Lanone S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-14; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Li HC, 2009, ECOTOX ENVIRON SAFE, V72, P684, DOI 10.1016/j.ecoenv.2008.09.027; Lin SJ, 2011, ACS NANO, V5, P7284, DOI 10.1021/nn202116p; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Luther EM, 2012, NEUROCHEM RES, V37, P1639, DOI 10.1007/s11064-012-0767-4; Mahapatra O, 2008, J EXP NANOSCI, V3, P185, DOI 10.1080/17458080802395460; MALLATT J, 1985, CAN J FISH AQUAT SCI, V42, P630, DOI 10.1139/f85-083; Marshall WS, 2012, FISH PHYSIOL, P395; Martinez-Alvarez RM, 2002, J EXP BIOL, V205, P3699; McDonald D, 1993, FISH ECOPHYSIOLOGY, V9, P300; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; NONNOTTE G, 1993, RESP PHYSIOL, V91, P71, DOI 10.1016/0034-5687(93)90090-W; Osborne OJ, 2013, NANOTOXICOLOGY, V7, P1315, DOI 10.3109/17435390.2012.737484; Ouattara N, 2009, AQUACULTURE, V290, P155, DOI 10.1016/j.aquaculture.2009.01.025; Paital B, 2010, COMP BIOCHEM PHYS C, V151, P142, DOI 10.1016/j.cbpc.2009.09.007; Pang CF, 2013, ENVIRON TOXICOL CHEM, V32, P1561, DOI 10.1002/etc.2216; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poole C., 2003, INTRO NANOTECHNOLOGY; Qiu JR, 2013, MOL BIOL REP, V40, P3321, DOI 10.1007/s11033-012-2407-0; Reeves JF, 2008, MUTAT RES-FUND MOL M, V640, P113, DOI 10.1016/j.mrfmmm.2007.12.010; Reis-Henriques M.A., 1998, AQUACULTURE HDB, P135; Roberts SD, 2005, J COMP PHYSIOL B, V175, P1, DOI 10.1007/s00360-004-0453-1; Roberts SD, 2003, COMP BIOCHEM PHYS A, V134, P525, DOI 10.1016/S1095-6433(02)00327-6; Rudin T, 2011, J NANOPART RES, V13, P2715, DOI 10.1007/s11051-010-0206-x; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanchez W, 2005, ENVIRON TOXICOL PHAR, V19, P177, DOI 10.1016/j.etap.2004.07.003; Schultz ET, 2012, EURYHALINE FISHES FI, P477, DOI [10.1016/B978-0-12-396951-4.00010-4, DOI 10.1016/B978-0-12-396951-4.00010-4]; Scown TM, 2010, ENVIRON CHEM, V7, P36, DOI 10.1071/EN09125; Scown TM, 2009, TOXICOL SCI, V109, P372, DOI 10.1093/toxsci/kfp064; Setyawati MI, 2013, J BIOMED MATER RES A, V101, P633, DOI 10.1002/jbm.a.34363; Shaw BJ, 2011, ENVIRON INT, V37, P1083, DOI 10.1016/j.envint.2011.03.009; Sheader DL, 2006, MAR ENVIRON RES, V62, P33, DOI 10.1016/j.marenvres.2006.03.001; Shi JY, 2011, ENVIRON POLLUT, V159, P1277, DOI 10.1016/j.envpol.2011.01.028; Smith CJ, 2007, AQUAT TOXICOL, V82, P94, DOI 10.1016/j.aquatox.2007.02.003; STICKNEY RR, 1986, PROG FISH CULT, V48, P161, DOI 10.1577/1548-8640(1986)48&lt;161:TTOSW&gt;2.0.CO;2; Treuel L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0939; Tytler P., 1985, FISH ENERGETICS NEW; Uno T, 2012, ENVIRON TOXICOL PHAR, V34, P1, DOI 10.1016/j.etap.2012.02.004; vanRooij JM, 1996, MAR ECOL PROG SER, V132, P31, DOI 10.3354/meps132031; Wang DW, 2011, ACS NANO, V5, P530, DOI 10.1021/nn1025252; WHEATLY MG, 1988, AM ZOOL, V28, P65; Wong CKC, 2000, AQUAT TOXICOL, V48, P517, DOI 10.1016/S0166-445X(99)00060-0; Woo S, 2009, COMP BIOCHEM PHYS C, V149, P289, DOI 10.1016/j.cbpc.2008.08.002; Wu Y, 2012, ENV TOXICOLOGY CHEM; Xu RL, 2007, CARBON, V45, P2806, DOI 10.1016/j.carbon.2007.09.010; Xu ZR, 2007, ECOTOX ENVIRON SAFE, V67, P89, DOI 10.1016/j.ecoenv.2006.04.006; Yan B, 2012, MOL BIOL REP, P1; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang JT, 2006, CHEM MATER, V18, P867, DOI 10.1021/cm052256f; Zhao J, 2011, J HAZARD MATER, V197, P304, DOI 10.1016/j.jhazmat.2011.09.094	113	35	37	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88723	10.1371/journal.pone.0088723	http://dx.doi.org/10.1371/journal.pone.0088723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520417	Green Submitted, gold, Green Published			2022-12-27	WOS:000331254600108
J	Llop-Guevara, A; Chu, DK; Walker, TD; Goncharova, S; Fattouh, R; Silver, JS; Moore, CL; Xie, JL; O'Byrne, PM; Coyle, AJ; Kolbeck, R; Humbles, AA; Stampfli, MR; Jordana, M				Llop-Guevara, Alba; Chu, Derek K.; Walker, Tina D.; Goncharova, Susanna; Fattouh, Ramzi; Silver, Jonathan S.; Moore, Cheryl Lynn; Xie, Juliana L.; O'Byrne, Paul M.; Coyle, Anthony J.; Kolbeck, Roland; Humbles, Alison A.; Staempfli, Martin R.; Jordana, Manel			A GM-CSF/IL-33 Pathway Facilitates Allergic Airway Responses to Sub-Threshold House Dust Mite Exposure	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; GM-CSF; TRANSGENE EXPRESSION; MURINE MODEL; IL-33; CYTOKINE; ASTHMA; RECEPTOR; INFLAMMATION; LUNG	Allergic asthma is a chronic immune-inflammatory disease of the airways. Despite aeroallergen exposure being universal, allergic asthma affects only a fraction of individuals. This is likely related, at least in part, to the extent of allergen exposure. Regarding house dust mite (HDM), we previously identified the threshold required to elicit allergic responses in BALB/c mice. Here, we investigated the impact of an initial immune perturbation on the response to sub-threshold HDM exposure. We show that transient GM-CSF expression in the lung facilitated robust eosinophilic inflammation, long-lasting antigen-specific Th2 responses, mucus production and airway hyperresponsiveness. This was associated with increased IL-33 levels and activated CD11b(+) DCs expressing OX40L. GM-CSF-driven allergic responses were significantly blunted in IL-33-deficient mice. IL-33 was localized on alveolar type II cells and in vitro stimulation of human epithelial cells with GM-CSF enhanced intracellular IL-33 independently of IL-1 alpha. Likewise, GM-CSF administration in vivo resulted in increased levels of IL-33 but not IL-1 alpha. These findings suggest that exposures to environmental agents associated with GM-CSF production, including airway infections and pollutants, may decrease the threshold of allergen responsiveness and, hence, increase the susceptibility to develop allergic asthma through a GM-CSF/IL-33/OX40L pathway.	[Llop-Guevara, Alba; Chu, Derek K.; Walker, Tina D.; Goncharova, Susanna; Fattouh, Ramzi; Moore, Cheryl Lynn; Xie, Juliana L.; Coyle, Anthony J.; Staempfli, Martin R.; Jordana, Manel] McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Silver, Jonathan S.; Kolbeck, Roland; Humbles, Alison A.] MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD USA; [O'Byrne, Paul M.; Staempfli, Martin R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Coyle, Anthony J.] Pfizer, Cambridge, MA USA	McMaster University; AstraZeneca; Medimmune; McMaster University; Pfizer	Jordana, M (corresponding author), McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada.	jordanam@mcmaster.ca	T, E/HII-8943-2022	Stampfli, Martin/0000-0003-4918-5889; Llop-Guevara, Alba/0000-0002-7913-9472; O'Byrne, Paul/0000-0003-0979-281X; Fattouh, Ramzi/0000-0001-6573-6367; Chu, Derek/0000-0001-8269-4496	Canadian Institute of Health Research (CIHR) [87517]; LaCaixa-ICCS scholarship; Fundacion Caja Madrid doctoral scholarship (Spain); CIHR Vanier scholar	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); LaCaixa-ICCS scholarship; Fundacion Caja Madrid doctoral scholarship (Spain); CIHR Vanier scholar(Canadian Institutes of Health Research (CIHR))	This work was partially supported by a grant from the Canadian Institute of Health Research (CIHR, grant number 87517). AL-G was initially supported by a LaCaixa-ICCS scholarship and then a Fundacion Caja Madrid doctoral scholarship (Spain); DKC is a CIHR Vanier scholar; and MJ holds a Senior Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellanger AP, 2009, J MED MICROBIOL, V58, P174, DOI 10.1099/jmm.0.005488-0; Boland S, 1999, AM J PHYSIOL-LUNG C, V276, pL604, DOI 10.1152/ajplung.1999.276.4.L604; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; DeMaio L, 2009, AM J PHYSIOL-LUNG C, V296, pL1051, DOI 10.1152/ajplung.00021.2009; Fattouh Ramzi, 2008, Inflammation & Allergy Drug Targets, V7, P224, DOI 10.2174/187152808786848388; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; He JQ, 2003, CHEST, V123, p438S, DOI 10.1378/chest.123.3_suppl.438S; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Johnson JR, 2007, AM J PHYSIOL-LUNG C, V293, pL730, DOI 10.1152/ajplung.00056.2007; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kabesch M, 2007, ALLERGY, V62, P423, DOI 10.1111/j.1398-9995.2006.01300.x; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Lei XF, 1998, CLIN EXP IMMUNOL, V113, P157; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; Llop-Guevara A, 2011, INFLAMMATION AND ALLERGY DRUG DESIGN, P187; Llop-Guevara A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002426; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nelson MP, 2011, J IMMUNOL, V186, P2372, DOI 10.4049/jimmunol.1002558; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Sunyer J, 2004, J ALLERGY CLIN IMMUN, V114, P1033, DOI 10.1016/j.jaci.2004.05.072; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Trimble NJ, 2009, AM J RESP CELL MOL, V40, P38, DOI 10.1165/rcmb.2008-0107OC; Whitesides GM, 1999, SCIENCE, V284, P89, DOI 10.1126/science.284.5411.89; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Xiang ZG, 2010, IMMUNOL LETT, V131, P159, DOI 10.1016/j.imlet.2010.04.005; Yamaya M, 2012, PULM MED, V2012, DOI 10.1155/2012/834826; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109	45	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88714	10.1371/journal.pone.0088714	http://dx.doi.org/10.1371/journal.pone.0088714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551140	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500056
J	Oberzaucher, E; Grammer, K				Oberzaucher, Elisabeth; Grammer, Karl			The Case of Moulay Ismael - Fact or Fancy?	PLOS ONE			English	Article							MENSTRUAL-CYCLE; STILLBIRTH RATES; RISK-FACTORS; FERTILITY; POPULATION; CONCEPTION; SURVIVAL; AGE	Textbooks on evolutionary psychology and biology cite the case of the Sharifian Emperor of Morocco, Moulay Ismael the Bloodthirsty (1672-1727) who was supposed to have sired 888 children. This example for male reproduction has been challenged and led to a still unresolved discussion. The scientific debate is shaped by assumptions about reproductive constraints which cannot be tested directly-and the figures used are sometimes arbitrary. Therefore we developed a computer simulation which tests how many copulations per day were necessary to reach the reported reproductive outcome. We based our calculations on a report dating 1704, thus computing whether it was possible to have 600 sons in a reproductive timespan of 32 years. The algorithm is based on three different models of conception and different social and biological constraints. In the first model we used a random mating pool with unrestricted access to females. In the second model we used a restricted harem pool. The results indicate that Moulay Ismael could have achieved this high reproductive success. A comparison of the three conception models highlights the necessity to consider female sexual habits when assessing fertility across the cycle. We also show that the harem size needed is far smaller than the reported numbers.	[Oberzaucher, Elisabeth; Grammer, Karl] Univ Vienna, Dept Anthropol, Vienna, Austria	University of Vienna	Oberzaucher, E (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	elisabeth.oberzaucher@univie.ac.at	oberzaucher, elisabeth/A-5702-2011	oberzaucher, elisabeth/0000-0003-0083-3160				Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; BARRETT JC, 1969, POP STUD-J DEMOG, V23, P455, DOI 10.1080/00324728.1969.10405297; Busnot D, 1712, HIST REGNE MOULAY IS; CHIAZZE L, 1968, J AMER MED ASSOC, V203, P377, DOI 10.1001/jama.203.6.377; Einon D, 1995, EHB, V19, P413; Fehring RJ, 2002, CONTRACEPTION, V66, P231, DOI 10.1016/S0010-7824(02)00355-4; FRANCE JT, 1992, INT J FERTIL, V37, P244; FREUND M, 1963, J REPROD FERTIL, V6, P269; Garcia-Enguidanos A, 2002, EUR J OBSTET GYN R B, V102, P111, DOI 10.1016/S0301-2115(01)00613-3; Gould RG, 2000, EVOL HUM BEHAV, V21, P295, DOI 10.1016/S1090-5138(00)00043-X; JOCHLE W, 1973, CONTRACEPTION, V7, P523, DOI 10.1016/0010-7824(73)90023-1; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lee AC, 2011, INT J GYNECOL OBSTET, V113, P199, DOI 10.1016/j.ijgo.2010.12.015; Oberzaucher E, 2013, IN PRESS; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Ruttimann D, 2012, HOMO, V63, P50, DOI 10.1016/j.jchb.2011.11.001; Sharman A, 1951, BRIT J OBSTET GYNAEC, V58, P440; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Strassmann BI, 1997, CURR ANTHROPOL, V38, P123, DOI 10.1086/204592; WEINBERG CR, 1995, BIOMETRICS, V51, P405, DOI 10.2307/2532929; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhengwei Y, 2006, HUMAN NATURE, V17, P434; Zhou HB, 1996, BIOMETRICS, V52, P945, DOI 10.2307/2533055; Ziomkiewicz A, 2006, HUM NATURE-INT BIOS, V17, P419, DOI 10.1007/s12110-006-1004-0	26	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e85292	10.1371/journal.pone.0085292	http://dx.doi.org/10.1371/journal.pone.0085292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551034	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500004
J	Ochi, A; Mori, K; Emoto, M; Nakatani, S; Morioka, T; Motoyama, K; Fukumoto, S; Imanishi, Y; Koyama, H; Ishimura, E; Inaba, M				Ochi, Akinobu; Mori, Katsuhito; Emoto, Masanori; Nakatani, Shinya; Morioka, Tomoaki; Motoyama, Koka; Fukumoto, Shinya; Imanishi, Yasuo; Koyama, Hidenori; Ishimura, Eiji; Inaba, Masaaki			Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; TYPE-2 DIABETES-MELLITUS; FATTY LIVER; GLYCOPROTEIN/FETUIN-A; RECEPTOR; ASSOCIATION; ADIPONECTIN; STEATOSIS; DISEASE; HUMANS	Fetuin-A, a circulating glycoprotein synthesized in the liver, is involved in insulin resistance and type 2 diabetes. However, regulation of fetuin-A synthesis has remained obscure. We previously reported that pioglitazone treatment significantly reduced serum fetuin-A levels in patients with type 2 diabetes. To clarify whether pioglitazone can directory inhibit hepatic fetuin-A synthesis, we investigated the effects of pioglitazone on fetuin-A expression both in vitro and in vivo. Pioglitazone treatment suppressed mRNA and protein expression of fetuin-A in Fao hepatoma cells. Interestingly, rosiglitazone but not metformin, also inhibited fetuin-A expression. In addition, GW 9662, an inhibitor of peroxisome proliferator-activated receptor (PPAR) gamma, reversed pioglitazone-induced suppression of fetuin-A, suggesting that thiazolidinedione derivatives may have common characteristics with regard to fetuin-A suppression, possibly through PPAR gamma activation. Finally, oral administration of pioglitazone to mice for 8 weeks resulted in suppression of hepatic fetuin-A mRNA. These findings suggest that pioglitazone may partially ameliorate insulin resistance through its direct inhibitory effects on fetuin-A expression in the liver.	[Ochi, Akinobu; Mori, Katsuhito; Emoto, Masanori; Nakatani, Shinya; Morioka, Tomoaki; Motoyama, Koka; Fukumoto, Shinya; Imanishi, Yasuo; Ishimura, Eiji; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan; [Koyama, Hidenori] Hyogo Coll Med, Div Endocrinol & Metab, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Osaka Metropolitan University; Hyogo College of Medicine	Mori, K (corresponding author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan.	ktmori@med.osaka-cu.ac.jp	Koyama, Hidenori/AAU-2346-2020; Ochi, Akinobu/K-5380-2019	Koyama, Hidenori/0000-0001-7930-2228; OCHI, AKINOBU/0000-0001-6809-8399	Japan Society for the Promotion of Science [25461250]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by a Grant-in-Aid for Scientific Research (C) (No.25461250) from the Japan Society for the Promotion of Science (to Mori). No additional funding was received for this study. The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6; BACKER JM, 1989, J BIOL CHEM, V264, P1694; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Derosa G, 2010, DRUGS, V70, P1945, DOI 10.2165/11538100-000000000-00000; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Haukeland JW, 2012, EUR J ENDOCRINOL, V166, P503, DOI 10.1530/EJE-11-0864; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Ix JH, 2008, JAMA-J AM MED ASSOC, V300, P182, DOI 10.1001/jama.300.2.182; Jiang QJ, 2010, J INVEST DERMATOL, V130, P1288, DOI 10.1038/jid.2009.423; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Monden M, 2013, DIABETES, V62, P478, DOI 10.2337/db11-1116; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Mori K, 2005, MOL CELL ENDOCRINOL, V230, P39, DOI 10.1016/j.mce.2004.11.004; Mori K, 2008, METABOLISM, V57, P1248, DOI 10.1016/j.metabol.2008.04.019; Mori K, 2012, ADV CLIN CHEM, V56, P175, DOI 10.1016/B978-0-12-394317-0.00010-8; Mori K, 2011, RECENT PATENTS ENDOC, V5, P124, DOI 10.2174/187221411799015372; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2013, NAT MED, V19, P394, DOI 10.1038/nm.3116; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Takata H, 2009, J ATHEROSCLER THROMB, V16, P448, DOI 10.5551/jat.No950; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797	28	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88704	10.1371/journal.pone.0088704	http://dx.doi.org/10.1371/journal.pone.0088704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551137	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000056
J	Zeng, FG; Tang, Q; Lu, T				Zeng, Fan-Gang; Tang, Qing; Lu, Thomas			Abnormal Pitch Perception Produced by Cochlear Implant Stimulation	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; AUDITORY-NERVE; FREQUENCY DISCRIMINATION; IMPAIRED LISTENERS; SPEECH RECOGNITION; MELODY RECOGNITION; MUSIC PERCEPTION; NORMAL-HEARING; TEMPORAL CUES; ELECTRODE	Contemporary cochlear implants with multiple electrode stimulation can produce good speech perception but poor music perception. Hindered by the lack of a gold standard to quantify electric pitch, relatively little is known about the nature and extent of the electric pitch abnormalities and their impact on cochlear implant performance. Here we overcame this obstacle by comparing acoustic and electric pitch perception in 3 unilateral cochlear-implant subjects who had functionally usable acoustic hearing throughout the audiometric frequency range in the non-implant ear. First, to establish a baseline, we measured and found slightly impaired pure tone frequency discrimination and nearly perfect melody recognition in all 3 subjects' acoustic ear. Second, using pure tones in the acoustic ear to match electric pitch induced by an intra-cochlear electrode, we found that the frequency-electrode function was not only 1-2 octaves lower, but also 2 times more compressed in frequency range than the normal cochlear frequency-place function. Third, we derived frequency difference limens in electric pitch and found that the equivalent electric frequency discrimination was 24 times worse than normal-hearing controls. These 3 abnormalities are likely a result of a combination of broad electric field, distant intra-cochlear electrode placement, and non-uniform spiral ganglion cell distribution and survival, all of which are inherent to the electrode-nerve interface in contemporary cochlear implants. Previous studies emphasized on the "mean'' shape of the frequency-electrode function, but the present study indicates that the large "variance'' of this function, reflecting poor electric pitch discriminability, is the main factor limiting contemporary cochlear implant performance.	[Zeng, Fan-Gang] Univ Calif Irvine, Dept Anat & Neurobiol, Ctr Hearing Res, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Biomed Engn, Ctr Hearing Res, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Cognit Sci, Ctr Hearing Res, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Ctr Hearing Res, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Zeng, FG (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Ctr Hearing Res, Irvine, CA 92717 USA.	fzeng@uci.edu			National Institutes of Health [RO1-DC008858, P30-DC008369]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC008369, R01DC008858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (RO1-DC008858 and P30-DC008369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASA, 1994, S111994 ASA ANSI; Baumann U, 2006, HEARING RES, V213, P34, DOI 10.1016/j.heares.2005.12.010; BEKESY GEORG v., 1952, ACTA OTO LARYNGOL, V42, P197, DOI 10.3109/00016485209120346; Blamey PJ, 1996, HEARING RES, V99, P139, DOI 10.1016/S0378-5955(96)00095-0; Boex C, 2006, JARO-J ASSOC RES OTO, V7, P110, DOI 10.1007/s10162-005-0027-2; Bonham BH, 2008, HEARING RES, V242, P141, DOI 10.1016/j.heares.2008.03.006; Carlyon RP, 2010, JARO-J ASSOC RES OTO, V11, P625, DOI 10.1007/s10162-010-0222-7; Collins LM, 1997, J ACOUST SOC AM, V101, P440, DOI 10.1121/1.417989; de Cheveigne A, 1998, J ACOUST SOC AM, V103, P1261, DOI 10.1121/1.423232; Dorman MF, 2007, JARO-J ASSOC RES OTO, V8, P234, DOI 10.1007/s10162-007-0071-1; DYNES SBC, 1992, HEARING RES, V58, P79, DOI 10.1016/0378-5955(92)90011-B; Eddington D K, 1978, Ann Otol Rhinol Laryngol, V87, P1; FREYMAN RL, 1991, J SPEECH HEAR RES, V34, P1371, DOI 10.1044/jshr.3406.1371; Galvin JJ, 2007, EAR HEARING, V28, P302, DOI 10.1097/01.aud.0000261689.35445.20; Gfeller K, 2007, EAR HEARING, V28, P412, DOI 10.1097/AUD.0b013e3180479318; Green T, 2012, INT J AUDIOL, V51, P389, DOI 10.3109/14992027.2011.642010; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HARTMANN R, 1990, ACTA OTO-LARYNGOL, P128; Izzo AD, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714296; JESTEADT W, 1980, PERCEPT PSYCHOPHYS, V28, P85, DOI 10.3758/BF03204321; Kang R, 2009, EAR HEARING, V30, P411, DOI 10.1097/AUD.0b013e3181a61bc0; Kong YY, 2004, EAR HEARING, V25, P173, DOI 10.1097/01.AUD.0000120365.97792.2F; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LICKLIDER JCR, 1951, EXPERIENTIA, V7, P128, DOI 10.1007/BF02156143; McDermott HJ, 1997, J ACOUST SOC AM, V101, P1622, DOI 10.1121/1.418177; McDermott H, 2009, AUDIOL NEURO-OTOL, V14, P2, DOI 10.1159/000206489; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; McKay CM, 1996, J ACOUST SOC AM, V99, P1079, DOI 10.1121/1.414594; Meddis R, 1997, J ACOUST SOC AM, V102, P1811, DOI 10.1121/1.420088; Middlebrooks JC, 2008, HEARING RES, V242, P52, DOI 10.1016/j.heares.2008.04.001; Middlebrooks JC, 2010, J NEUROSCI, V30, P1937, DOI 10.1523/JNEUROSCI.4949-09.2010; NELSON DA, 1995, J ACOUST SOC AM, V98, P1987, DOI 10.1121/1.413317; Oxenham AJ, 2004, P NATL ACAD SCI USA, V101, P1421, DOI 10.1073/pnas.0306958101; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; PIJL S, 1995, HEARING RES, V89, P203, DOI 10.1016/0378-5955(95)00138-9; Reiss LAJ, 2007, JARO-J ASSOC RES OTO, V8, P241, DOI 10.1007/s10162-007-0077-8; SCHOUTEN JF, 1962, J ACOUST SOC AM, V34, P517, DOI 10.1121/1.1918160; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shower EG, 1931, J ACOUST SOC AM, V3, P275, DOI 10.1121/1.1915561; Singh S, 2009, EAR HEARING, V30, P160, DOI 10.1097/AUD.0b013e31819342b9; Spahr AJ, 2008, J SPEECH LANG HEAR R, V51, P1599, DOI 10.1044/1092-4388(2008/07-0254); Stakhovskaya O, 2007, JARO-J ASSOC RES OTO, V8, P220, DOI 10.1007/s10162-007-0076-9; Tang Q, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046029; VANDENHONERT C, 1987, HEARING RES, V29, P195, DOI 10.1016/0378-5955(87)90167-5; Vermeire K, 2013, HEARING RES, V306, P29, DOI 10.1016/j.heares.2013.09.004; Vermeire K, 2008, HEARING RES, V245, P98, DOI 10.1016/j.heares.2008.09.003; Vollmer M, 2007, J NEUROPHYSIOL, V98, P2588, DOI 10.1152/jn.00011.2007; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; Woolsey CN, 1942, B JOHNS HOPKINS HOSP, V71, P315; Xu J, 2000, AM J OTOL, V21, P49, DOI 10.1016/S0196-0709(00)80112-X; Zeng FG, 2011, HEARING RES, V277, P61, DOI 10.1016/j.heares.2011.03.010; Zeng Fan-Gang, 2008, IEEE Rev Biomed Eng, V1, P115, DOI 10.1109/RBME.2008.2008250; ZENG FG, 1991, Q J EXP PSYCHOL-A, V43, P565, DOI 10.1080/14640749108400987; Zeng FG, 2005, J NEUROPHYSIOL, V93, P3050, DOI 10.1152/jn.00985.2004; Zeng FG, 2002, HEARING RES, V174, P101, DOI 10.1016/S0378-5955(02)00644-5; Zeng FG, 2004, COCHLEAR IMPLANTS AU; ZWICKER E, 1961, J ACOUST SOC AM, V33, P248, DOI 10.1121/1.1908630	57	51	53	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88662	10.1371/journal.pone.0088662	http://dx.doi.org/10.1371/journal.pone.0088662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551131	Green Published, gold			2022-12-27	WOS:000331266000051
J	Deng, B; Gao, F; Liu, FF; Zhao, XH; Yu, CY; Ju, G; Xu, LX; Wang, J				Deng, Bin; Gao, Fei; Liu, Fang-Fang; Zhao, Xiang-Hui; Yu, Cai-Yong; Ju, Gong; Xu, Li-Xian; Wang, Jian			Two Monoclonal Antibodies Recognising aa 634-668 and aa 1026-1055 of NogoA Enhance Axon Extension and Branching in Cultured Neurons	PLOS ONE			English	Article							SPINAL-CORD-INJURY; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; CERVICAL LESION; ADULT PRIMATES; MESSENGER-RNA; RECEPTOR; REGENERATION; PROTEIN; MYELIN	In a previous study, we generated two monoclonal antibodies (mAbs) in mice, aNogoA-N and aNogo-66 mAb, which were raised against recombinant N-terminal fragments of rat NogoA and Nogo-66, respectively. When compared with the commercial rabbit anti-rat NogoA polyclonal antibody (pAb), which can specifically recognise NogoA, the two mAbs were also specific for the NogoA antigen in immunofluorescence histochemical (IHC) staining and Western blot (WB) analysis. Serial truncations of NogoA covering the N-terminal region of NogoA (aa 570-691) and Nogo-66 (aa 1026-1091) were expressed in E. coli. The epitopes recognised by aNogoA-N and aNogo-66 are located in the aa 634-668 and aa 1026-1055 regions of NogoA, respectively. Both mAbs remarkably enhanced the axon growth and branching of cultured hippocampal neurons in vitro. These results suggest that the antibodies that bind to aa 634-668 and aa 1026-1055 of NogoA may have stimulatory effects on axon growth and branching. Additionally, the two mAbs that we generated are specific for NogoA and significantly block NogoA function. In conclusion, two sites in NogoA located within aa 634-668 and aa 1026-1055 are recognised by our two antibodies and are novel and potentially promising targets for repair after central nervous system (CNS) injury.	[Deng, Bin; Liu, Fang-Fang; Zhao, Xiang-Hui; Yu, Cai-Yong; Ju, Gong; Wang, Jian] Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China; [Deng, Bin; Xu, Li-Xian] Fourth Mil Med Univ, Stomatol Coll, Dept Anesthesiol, Xian 710032, Peoples R China; [Gao, Fei] Peoples Liberat Army, Hosp 174, Dept Clin Lab, Xiamen, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Xu, LX (corresponding author), Fourth Mil Med Univ, Stomatol Coll, Dept Anesthesiol, Xian 710032, Peoples R China.	xlx116@fmmu.edu.cn; jwangfm@fmmu.edu.cn		yu, caiyong/0000-0002-4482-2319	National Natural Science Foundation of China [30371763, 81071060, 81070997, 31100785]; Natural Science Foundation of Shaanxi Province [2006C254, 2011KJXX67]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by the National Natural Science Foundation of China (Grant No. 30371763, No. 81071060, No. 81070997, No. 31100785), and in part by the Natural Science Foundation of Shaanxi Province (Grant No. 2006C254, No. 2011KJXX67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareyre FM, 2002, J NEUROSCI, V22, P7097; Borrie SC, 2012, CELL TISSUE RES, V349, P105, DOI 10.1007/s00441-012-1332-9; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng G, 2009, NEUROSCI LETT, V451, P105, DOI 10.1016/j.neulet.2008.12.045; Craveiro LM, 2008, EUR J NEUROSCI, V28, P1808, DOI 10.1111/j.1460-9568.2008.06473.x; Deng B, 2013, BIOMATERIALS, V34, P8786, DOI 10.1016/j.biomaterials.2013.07.076; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2002, PROG BRAIN RES, V137, P361; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Freund P, 2009, EUR J NEUROSCI, V29, P983, DOI 10.1111/j.1460-9568.2009.06642.x; Gao Y, 2009, NEUROSCI LETT, V458, P132, DOI 10.1016/j.neulet.2009.04.034; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Guo F, 2013, CNS NEUROSCI THER, V19, P319, DOI 10.1111/cns.12083; Hocquemiller M, 2010, J NEUROSCI RES, V88, P202, DOI 10.1002/jnr.22190; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Huber AB, 2002, J NEUROSCI, V22, P3553; Kaneda M, 2010, ADV EXP MED BIOL, V664, P97, DOI 10.1007/978-1-4419-1399-9_12; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Leu BG, 2010, DEV NEUROBIOL, V70, P897, DOI 10.1002/dneu.20829; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Mi YJ, 2012, CELL DEATH DIFFER, V19, P1175, DOI 10.1038/cdd.2011.206; Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200; Nash M, 2009, MOL NEUROBIOL, V40, P224, DOI 10.1007/s12035-009-8083-y; Oertle T, 2003, J NEUROSCI, V23, P5393; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Richard M, 2005, EUR J NEUROSCI, V22, P2145, DOI 10.1111/j.1460-9568.2005.04418.x; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Song Chao-jun, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P567; Wang XX, 2002, J NEUROSCI, V22, P5505; Zhao XH, 2011, NEUROSCI LETT, V499, P32, DOI 10.1016/j.neulet.2011.05.026	39	5	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88554	10.1371/journal.pone.0088554	http://dx.doi.org/10.1371/journal.pone.0088554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533107	Green Submitted, gold, Green Published			2022-12-27	WOS:000331262600065
J	Imaizumi, K; Nishishita, N; Muramatsu, M; Yamamoto, T; Takenaka, C; Kawamata, S; Kobayashi, K; Nishikawa, SI; Akuta, T				Imaizumi, Keitaro; Nishishita, Naoki; Muramatsu, Marie; Yamamoto, Takako; Takenaka, Chiemi; Kawamata, Shin; Kobayashi, Kenichiro; Nishikawa, Shin-ichi; Akuta, Teruo			A Simple and Highly Effective Method for Slow-Freezing Human Pluripotent Stem Cells Using Dimethyl Sulfoxide, Hydroxyethyl Starch and Ethylene Glycol	PLOS ONE			English	Article							EFFICIENT CRYOPRESERVATION METHOD; RECOVERY; SURVIVAL; MOUSE	Vitrification and slow-freezing methods have been used for the cryopreservation of human pluripotent stem cells (hPSCs). Vitrification requires considerable skill and post-thaw recovery is low. Furthermore, it is not suitable for cryopreservation of large numbers of hPSCs. While slow-freezing methods for hPSCs are easy to perform, they are usually preceded by a complicated cell dissociation process that yields poor post-thaw survival. To develop a robust and easy slow-freezing method for hPSCs, several different cryopreservation cocktails were prepared by modifying a commercially available freezing medium (CP-1((TM))) containing hydroxyethyl starch (HES), and dimethyl sulfoxide (DMSO) in saline. The new freezing media were examined for their cryopreservation efficacy in combination with several different cell detachment methods. hPSCs in cryopreservation medium were slowly cooled in a conventional -80 degrees C freezer and thawed rapidly. hPSC colonies were dissociated with several proteases. Ten percent of the colonies were passaged without cryopreservation and another 10% were cryopreserved, and then the recovery ratio was determined by comparing the number of Alkaline Phosphatase-positive colonies after thawing at day 5 with those passaged without cryopreservation at day 5. We found that cell detachment with Pronase/EDTA followed by cryopreservation using 6% HES, 5% DMSO, and 5% ethylene glycol (EG) in saline (termed CP-5E) achieved post-thaw recoveries over 80%. In summary, we have developed a new cryopreservation medium free of animal products for slow-freezing. This easy and robust cryopreservation method could be used widely for basic research and for clinical application.	[Imaizumi, Keitaro; Nishishita, Naoki; Takenaka, Chiemi; Kawamata, Shin; Kobayashi, Kenichiro; Nishikawa, Shin-ichi; Akuta, Teruo] RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kobe, Hyogo, Japan; [Imaizumi, Keitaro; Akuta, Teruo] RIKEN Cell Tech Co Ltd, Kobe Off, Chuo Ku, Kobe, Hyogo, Japan; [Nishishita, Naoki; Muramatsu, Marie; Yamamoto, Takako; Takenaka, Chiemi; Kawamata, Shin] Fdn Biomed Res & Innovat, Div Cell Therapy, Chuo Ku, Kobe, Hyogo, Japan; [Kobayashi, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Setagaya Ku, Tokyo, Japan	RIKEN; Institute for Biomedical Research & Innovation (IBRI); National Center for Child Health & Development - Japan	Kawamata, S (corresponding author), RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kobe, Hyogo, Japan.	kawamata@fbri.org; t.akuta@kyokutoseiyaku.co.jp		Yamamoto, Takako/0000-0002-1877-0359; kawamata, shin/0000-0001-5148-1949	RIKEN Cell Tech Co., Ltd.; Japanese governmental research fund JST "Safety test for iPSC-derived cell products.''	RIKEN Cell Tech Co., Ltd.; Japanese governmental research fund JST "Safety test for iPSC-derived cell products.''	This study was funded by RIKEN Cell Tech Co., Ltd. and Japanese governmental research fund JST "Safety test for iPSC-derived cell products.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2010, NAT PROTOC, V5, P588, DOI 10.1038/nprot.2009.247; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Clapisson G, 1999, ELECT J ONCOL, V1, P97; Fujioka T, 2004, INT J DEV BIOL, V48, P1149, DOI 10.1387/ijdb.041852tf; GROUT B, 1990, TRENDS BIOTECHNOL, V8, P293, DOI 10.1016/0167-7799(90)90201-8; Ha SY, 2005, HUM REPROD, V20, P1779, DOI 10.1093/humrep/deh854; Hasegawa K, 2006, STEM CELLS, V24, P2649, DOI 10.1634/stemcells.2005-0657; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Holm F, 2010, HUM REPROD, V25, P1271, DOI 10.1093/humrep/deq040; Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; JUNKER BH, 1992, CYTOTECHNOLOGY, V9, P173, DOI 10.1007/BF02521745; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Li XY, 2008, STEM CELLS DEV, V17, P1079, DOI 10.1089/scd.2007.0247; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Li Y, 2010, FERTIL STERIL, V93, P999, DOI 10.1016/j.fertnstert.2008.10.052; LIONETTI FJ, 1978, TRANSFUSION, V18, P685, DOI 10.1046/j.1537-2995.1978.18679077950.x; Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316; Martin-Ibanez R, 2012, IN TECH, P139; Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x; Mollamohammadi S, 2009, HUM REPROD, V24, P2468, DOI 10.1093/humrep/dep244; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; NOMOTO M, 1960, J BIOCHEM-TOKYO, V48, P593, DOI 10.1093/oxfordjournals.jbchem.a127207; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Richards M, 2004, STEM CELLS, V22, P779, DOI 10.1634/stemcells.22-5-779; SHAW JM, 1995, HUM REPROD, V10, P396, DOI 10.1093/oxfordjournals.humrep.a135951; STIFF PJ, 1987, BLOOD, V70, P974; Stolzing A, 2012, TRANSFUS APHER SCI, V46, P137, DOI 10.1016/j.transci.2012.01.007; T'Joen V, 2012, STEM CELLS DEV, V21, P1716, DOI 10.1089/scd.2011.0374; T'Joen V, 2012, STEM CELLS DEV, V21, P721, DOI 10.1089/scd.2011.0192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu X, 2010, BIOTECHNOL PROGR, V26, P781, DOI 10.1002/btpr.358; Zhang XB, 2003, TRANSFUSION, V43, P265, DOI 10.1046/j.1537-2995.2003.00301.x; Zhou CQ, 2004, CHINESE MED J-PEKING, V117, P1050	39	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88696	10.1371/journal.pone.0088696	http://dx.doi.org/10.1371/journal.pone.0088696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533137	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600095
J	Izumi, H; Kosaka, N; Shimizu, T; Sekine, K; Ochiya, T; Takase, M				Izumi, Hirohisa; Kosaka, Nobuyoshi; Shimizu, Takashi; Sekine, Kazunori; Ochiya, Takahiro; Takase, Mitsunori			Time-Dependent Expression Profiles of microRNAs and mRNAs in Rat Milk Whey	PLOS ONE			English	Article							GENE-EXPRESSION; IMMUNE-SYSTEM; BREAST-MILK; CELL-DIFFERENTIATION; BACTERIAL-INFECTION; INSULIN SENSITIVITY; EXOSOMES; LACTATION; INNATE; PLASMA	Functional RNAs, such as microRNA (miRNA) and mRNA, are present in milk, but their roles are unknown. To clarify the roles of milk RNAs, further studies using experimental animals such as rats are needed. However, it is unclear whether rat milk also contains functional RNAs and what their time dependent expression profiles are. Thus, we prepared total RNA from whey isolated from rat milk collected on days 2, 9, and 16 postpartum and analyzed using microarrays and quantitative PCR. The concentration of RNA in colostrum whey (day 2) was markedly higher than that in mature milk whey (days 9 and 16). Microarray analysis detected 161 miRNAs and 10,948 mRNA transcripts. Most of the miRNAs and mRNA transcripts were common to all tested milks. Finally, we selected some immune- and development-related miRNAs and mRNAs, and analysed them by quantitative PCR (in equal sample volumes) to determine their time-dependent changes in expression in detail. Some were significantly more highly expressed in colostrum whey than in mature milk whey, but some were expressed equally. And mRNA expression levels of some cytokines and hormones did not reflect the protein levels. It is still unknown whether RNAs in milk play biological roles in neonates. However, our data will help guide future in vivo studies using experimental animals such as rats.	[Izumi, Hirohisa; Shimizu, Takashi; Sekine, Kazunori; Takase, Mitsunori] Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Zama, Kanagawa, Japan; [Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo 104, Japan	Morinaga Milk Industry Company, Ltd; National Cancer Center - Japan	Izumi, H (corresponding author), Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Zama, Kanagawa, Japan.	h-izumi@morinagamilk.co.jp	Izumi, Hirohisa/AAW-1526-2021; Ochiya, Takahiro/AAH-7585-2019	Izumi, Hirohisa/0000-0002-8855-4774; 	Morinaga Milk Industry Co., Ltd.	Morinaga Milk Industry Co., Ltd.	This work was funded by Morinaga Milk Industry Co., Ltd. H. Izumi, T. Shimizu, K. Sekine and M. Takase are employees of Morinaga Milk Industry Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; An MJ, 2009, NUTR RES, V29, P275, DOI 10.1016/j.nutres.2009.03.011; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Bottcher MF, 2003, PEDIATR ALLERGY IMMU, V14, P35, DOI 10.1034/j.1399-3038.2003.02120.x; Brenaut P, 2012, J DAIRY SCI, V95, P6130, DOI 10.3168/jds.2012-5604; Burrin DG, 2002, CLIN PERINATOL, V29, P65, DOI 10.1016/S0095-5108(03)00065-4; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Flynt AS, 2010, MOL CELL, V38, P900, DOI 10.1016/j.molcel.2010.06.014; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Ge Q, 2012, ENDOCRINOLOGY, V153, P5285, DOI 10.1210/en.2012-1623; Goldman AS, 2007, BREASTFEED MED, V2, P195, DOI 10.1089/bfm.2007.0024; GRIGOR MR, 1990, BIOCHEM J, V267, P815, DOI 10.1042/bj2670815; GRUSBY MJ, 1990, P NATL ACAD SCI USA, V87, P6897, DOI 10.1073/pnas.87.17.6897; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Haas JM, 2011, TLS-TIMES LIT SUPPL, P6; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Hennessy E, 2010, BIOCHEM BIOPH RES CO, V396, P457, DOI 10.1016/j.bbrc.2010.04.116; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Izumi Hirohisa, 2013, Methods Mol Biol, V1024, P191, DOI 10.1007/978-1-62703-453-1_15; Jensen RG, 1995, HDB MILK COMPOSITION; KEEN CL, 1981, J NUTR, V111, P226, DOI 10.1093/jn/111.2.226; Khudayberdiev Sharof, 2009, Commun Integr Biol, V2, P411; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; Melo SA, 2011, CELL CYCLE, V10, P922, DOI 10.4161/cc.10.6.15119; Moore KJ, 2010, TRENDS ENDOCRIN MET, V21, P699, DOI 10.1016/j.tem.2010.08.008; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Newburg DS, 2010, J PEDIATR-US, V156, pS41, DOI 10.1016/j.jpeds.2009.11.020; Niu YN, 2011, IMMUNOLOGY, V133, P8, DOI 10.1111/j.1365-2567.2010.03374.x; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Papetti M, 2011, AM J PHYSIOL-GASTR L, V301, pG508, DOI 10.1152/ajpgi.00066.2011; Ramirez CM, 2011, ARTERIOSCL THROM VAS, V31, P2707, DOI 10.1161/ATVBAHA.111.232066; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; SHULMAN RJ, 1990, PEDIATR RES, V28, P171, DOI 10.1203/00006450-199028020-00018; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sira MM, 2009, INT IMMUNOL, V21, P1013, DOI 10.1093/intimm/dxp067; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vordenbaumen S, 2011, J IMMUNOL, V186, P592, DOI 10.4049/jimmunol.1001461; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Warg LA, 2012, AM J PHYSIOL-LUNG C, V303, pL391, DOI 10.1152/ajplung.00369.2011; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	59	51	57	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88843	10.1371/journal.pone.0088843	http://dx.doi.org/10.1371/journal.pone.0088843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533154	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600112
J	Jing, RY; Liu, JJ; Yu, ZH; Liu, XB; Wang, GH				Jing, Ruiyong; Liu, Junjie; Yu, Zhenhua; Liu, Xiaobing; Wang, Guanghua			Phylogenetic Distribution of the Capsid Assembly Protein Gene (g20) of Cyanophages in Paddy Floodwaters in Northeast China	PLOS ONE			English	Article							FRESH-WATER CYANOPHAGES; T4-TYPE BACTERIOPHAGES; RICE FIELDS; CYANOBACTERIAL DIVERSITY; MARINE; PHAGE; VIRUSES; SOILS; COMMUNITIES; POPULATIONS	Numerous studies have revealed the high diversity of cyanophages in marine and freshwater environments, but little is currently known about the diversity of cyanophages in paddy fields, particularly in Northeast (NE) China. To elucidate the genetic diversity of cyanophages in paddy floodwaters in NE China, viral capsid assembly protein gene (g20) sequences from five floodwater samples were amplified with the primers CPS1 and CPS8. Denaturing gradient gel electrophoresis (DGGE) was applied to distinguish different g20 clones. In total, 54 clones differing in g20 nucleotide sequences were obtained in this study. Phylogenetic analysis showed that the distribution of g20 sequences in this study was different from that in Japanese paddy fields, and all the sequences were grouped into Clusters alpha, beta, gamma and epsilon. Within Clusters alpha and beta, three new small clusters (PFW-VII similar to-IX) were identified. UniFrac analysis of g20 clone assemblages demonstrated that the community compositions of cyanophage varied among marine, lake and paddy field environments. In paddy floodwater, community compositions of cyanophage were also different between NE China and Japan.	[Jing, Ruiyong; Liu, Junjie; Yu, Zhenhua; Liu, Xiaobing; Wang, Guanghua] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Mollisols Agroecol, Harbin, Peoples R China; [Jing, Ruiyong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Jing, Ruiyong] Heilongjiang BaYi Agr Univ, Coll Life & Sci Technol, Daqing, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Heilongjiang Bayi Agricultural University	Wang, GH (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Mollisols Agroecol, Harbin, Peoples R China.	guanghuawang@hotmail.com	Liu, Xiaobing/AAQ-3881-2020; 于, 镇华/AAR-6878-2021; Wang, Guanghua/ADE-3570-2022	Wang, Guanghua/0000-0003-4737-8126	Chinese Academy of Sciences for the Hundred Talents Program; National Natural Science Foundation of China [41271262, 31300425]	Chinese Academy of Sciences for the Hundred Talents Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Chinese Academy of Sciences for the Hundred Talents Program and the National Natural Science Foundation of China (41271262, 31300425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AC, 2006, APPL ENVIRON MICROB, V72, P5713, DOI 10.1128/AEM.00270-06; CANTERLUND H, 1995, FRESHWATER ALGAE THE, P194; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Crosbie ND, 2003, APPL ENVIRON MICROB, V69, P5716, DOI 10.1128/AEM.69.9.5716-5721.2003; Deng L, 2008, FRESHWATER BIOL, V53, P1240, DOI 10.1111/j.1365-2427.2007.01947.x; Dorigo U, 2004, APPL ENVIRON MICROB, V70, P1017, DOI 10.1128/AEM.70.2.1017-1022.2004; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2501; Hambly E, 2005, CURR OPIN MICROBIOL, V8, P444, DOI 10.1016/j.mib.2005.06.005; HENNES KP, 1995, APPL ENVIRON MICROB, V61, P3623, DOI 10.1128/AEM.61.10.3623-3627.1995; HU NT, 1981, VIROLOGY, V114, P236, DOI 10.1016/0042-6822(81)90269-5; Jameson E, 2011, ISME J, V5, P1713, DOI 10.1038/ismej.2011.54; Kimura M, 2005, SOIL SCI PLANT NUTR, V51, P159, DOI 10.1111/j.1747-0765.2005.tb00021.x; Kimura M, 2008, SOIL SCI PLANT NUTR, V54, P1, DOI 10.1111/j.1747-0765.2007.00197.x; Kumari N, 2012, J MICROBIOL BIOTECHN, V22, P1, DOI 10.4014/jmb.1106.06016; Liu JJ, 2012, SOIL SCI PLANT NUTR, V58, P435, DOI 10.1080/00380768.2012.703610; Liu JJ, 2011, SOIL BIOL BIOCHEM, V43, P1980, DOI 10.1016/j.soilbio.2011.05.005; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Marston MF, 2003, APPL ENVIRON MICROB, V69, P4639, DOI 10.1128/AEM.69.8.4639-4647.2003; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Paul JH, 2005, CURR OPIN BIOTECH, V16, P299, DOI 10.1016/j.copbio.2005.03.007; Paul JH, 2002, COMP BIOCHEM PHYS B, V133, P463, DOI 10.1016/S1096-4959(02)00168-9; Prasanna Radha, 2007, Wetlands Ecology and Management, V15, P127, DOI 10.1007/s11273-006-9018-2; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; SAFFERMAN RS, 1963, SCIENCE, V140, P679, DOI 10.1126/science.140.3567.679; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; SINGH PK, 1973, ARCH MIKROBIOL, V89, P169, DOI 10.1007/BF00425031; Song TY, 2005, FEMS MICROBIOL ECOL, V54, P131, DOI 10.1016/j.femsec.2005.03.008; Sullivan MB, 2008, ENVIRON MICROBIOL, V10, P2810, DOI 10.1111/j.1462-2920.2008.01702.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang GH, 2011, FEMS MICROBIOL ECOL, V76, P352, DOI 10.1111/j.1574-6941.2011.01052.x; Wang GH, 2010, BIOL FERT SOILS, V46, P93, DOI 10.1007/s00374-009-0410-y; Wang G, 2009, SOIL BIOL BIOCHEM, V41, P423, DOI 10.1016/j.soilbio.2008.11.012; Wang K, 2004, AQUAT MICROB ECOL, V34, P105, DOI 10.3354/ame034105; Wang K, 2008, ENVIRON MICROBIOL, V10, P300, DOI 10.1111/j.1462-2920.2007.01452.x; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Wilhelm SW, 2006, APPL ENVIRON MICROB, V72, P4957, DOI 10.1128/AEM.00349-06; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zhong X, 2013, APPL ENVIRON MICROB, V79, P7169, DOI 10.1128/AEM.01914-13; Zhong Y, 2002, APPL ENVIRON MICROB, V68, P1576, DOI 10.1128/AEM.68.4.1576-1584.2002	45	11	19	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88634	10.1371/journal.pone.0088634	http://dx.doi.org/10.1371/journal.pone.0088634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533125	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600083
J	Ramirez-Franco, J; Bartolome-Martin, D; Alonso, B; Torres, M; Sanchez-Prieto, J				Ramirez-Franco, Jorge; Bartolome-Martin, David; Alonso, Beatris; Torres, Magdalena; Sanchez-Prieto, Jose			Cannabinoid Type 1 Receptors Transiently Silence Glutamatergic Nerve Terminals of Cultured Cerebellar Granule Cells	PLOS ONE			English	Article							LONG-TERM DEPRESSION; ENHANCES NEUROTRANSMITTER RELEASE; ENDOCANNABINOID RELEASE; PROTEIN-KINASE; RIM PROTEINS; ACTIVE ZONE; ENDOGENOUS CANNABINOIDS; PRESYNAPTIC CYTOMATRIX; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL SYNAPSES	Cannabinoid receptors are the most abundant G protein-coupled receptors in the brain and they mediate retrograde short-term inhibition of neurotransmitter release, as well as long-term depression of synaptic transmission at many excitatory synapses. The induction of presynaptically silent synapses is a means of modulating synaptic strength, which is important for synaptic plasticity. Persistent activation of cannabinoid type 1 receptors (CB1Rs) mutes GABAergic terminals, although it is unclear if CB1Rs can also induce silencing at glutamatergic synapses. Cerebellar granule cells were transfected with VGLUT1-pHluorin to visualise the exo-endocytotic cycle. We found that prolonged stimulation (10 min) of cannabinoid receptors with the agonist HU-210 induces the silencing of previously active synapses. However, the presynaptic silencing induced by HU-210 is transient as it reverses after 20 min. cAMP with forskolin prevented CB1R-induced synaptic silencing, via activation of the Exchange Protein directly Activated by cAMP (Epac). Furthermore, Epac activation accelerated awakening of already silent boutons. Electron microscopy revealed that silencing was associated with synaptic vesicle (SV) redistribution within the nerve terminal, which diminished the number of vesicles close to the active zone of the plasma membrane. Finally, by combining functional and immunocytochemical approaches, we observed a strong correlation between the release capacity of the nerve terminals and RIM1 alpha protein content, but not that of Munc13-1 protein. These results suggest that prolonged stimulation of cannabinoid receptors can transiently silence glutamatergic nerve terminals.	[Ramirez-Franco, Jorge; Bartolome-Martin, David; Alonso, Beatris; Torres, Magdalena; Sanchez-Prieto, Jose] Univ Complutense, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain	Complutense University of Madrid	Torres, M (corresponding author), Univ Complutense, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain.	mitorres@vet.ucm.es; jsprieto@vet.ucm.es	Ramirez-Franco, Jorge/J-1082-2018; Martín, David Bartolomé/AAX-5855-2020; Torres, Magdalena/E-6150-2017	Ramirez-Franco, Jorge/0000-0002-2426-6140; Martín, David Bartolomé/0000-0003-0258-7477; Torres, Magdalena/0000-0002-3893-8569; Sanchez-Prieto, Jose/0000-0002-8513-3501	Spanish MINECO [BFU2010-16947, BFU2009-07092]; Instituto de Salud Carlos III [RD06/0026]; Comunidad de Madrid [CAM-I2M2 2011-BMD-2349]	Spanish MINECO(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was financed by grants from the Spanish MINECO (BFU2010-16947 to JS-P and BFU2009-07092 to MT), the 'Instituto de Salud Carlos III' RD06/0026 and the 'Comunidad de Madrid' (CAM-I2M2 2011-BMD-2349 to J S-P and MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger BE, 2002, PROG NEUROBIOL, V68, P247; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bartolome-Martin D, 2012, J CELL SCI, V125, P422, DOI 10.1242/jcs.090878; Bergsman JB, 2006, J NEUROSCI METH, V152, P32, DOI 10.1016/j.jneumeth.2005.08.008; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CHARPIER S, 1995, P NATL ACAD SCI USA, V92, P117, DOI 10.1073/pnas.92.1.117; Cousin MA, 2011, J PHYSIOL-LONDON, V589, P1943, DOI 10.1113/jphysiol.2010.200477; Crawford DC, 2012, NEUROSCIENTIST, V18, P216, DOI 10.1177/1073858411418525; Crawford DC, 2011, J NEUROSCI, V31, P979, DOI 10.1523/JNEUROSCI.4960-10.2011; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Dimova K, 2006, BBA-MOL CELL RES, V1763, P1256, DOI 10.1016/j.bbamcr.2006.09.017; FABER DS, 1991, ANN NY ACAD SCI, V627, P151; Fernandez-Busnadiego R, 2010, J CELL BIOL, V188, P145, DOI 10.1083/jcb.200908082; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Godino MD, 2005, NEUROPHARMACOLOGY, V48, P547, DOI 10.1016/j.neuropharm.2004.11.012; Guo J, 2004, MOL PHARMACOL, V65, P665, DOI 10.1124/mol.65.3.665; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Huang Y, 2008, J NEUROSCI, V28, P7074, DOI 10.1523/JNEUROSCI.0899-08.2008; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jiang XP, 2010, J NEUROSCI, V30, P1798, DOI 10.1523/JNEUROSCI.4965-09.2010; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Lopez-Jimenez ME, 2009, CELL DEATH DIFFER, V16, P1266, DOI 10.1038/cdd.2009.57; Losi G, 2002, J NEUROPHYSIOL, V87, P1263, DOI 10.1152/jn.00633.2001; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin R, 2010, J BIOL CHEM, V285, P17907, DOI 10.1074/jbc.M109.080838; Millan C, 2002, J BIOL CHEM, V277, P14092, DOI 10.1074/jbc.M109044200; Mittelstaedt T, 2010, BIOL CHEM, V391, P599, DOI 10.1515/BC.2010.064; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Moulder KL, 2006, J NEUROSCI, V26, P6618, DOI 10.1523/JNEUROSCI.5498-05.2006; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; VOGEL Z, 1993, J NEUROCHEM, V61, P352, DOI 10.1111/j.1471-4159.1993.tb03576.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Yang Y, 2012, NEURON, V73, P774, DOI 10.1016/j.neuron.2012.02.003; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yasuda H, 2008, P NATL ACAD SCI USA, V105, P3106, DOI 10.1073/pnas.0708349105	73	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88594	10.1371/journal.pone.0088594	http://dx.doi.org/10.1371/journal.pone.0088594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533119	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600077
J	Chiviacowsky, S; Drews, R				Chiviacowsky, Suzete; Drews, Ricardo			Effects of Generic versus Non-Generic Feedback on Motor Learning in Children	PLOS ONE			English	Article							SELF-CONTROLLED FEEDBACK; IMPLICIT THEORIES; MOTIVATION; KNOWLEDGE; ABILITY; CONCEPTIONS; EFFICACY	Non-generic feedback refers to a specific event and implies that performance is malleable, while generic feedback implies that task performance reflects an inherent ability. The present study examined the influences of generic versus non-generic feedback on motor performance and learning in 10-year-old children. In the first experiment, using soccer ball kicking at a target as a task, providing participants with generic feedback resulted in worse performance than providing non-generic feedback, after both groups received negative feedback. The second experiment measured more permanent effects. Results of a retention test, performed one day after practicing a throwing task, showed that participants who received non-generic feedback during practice outperformed the generic feedback group, after receiving a negative feedback statement. The findings demonstrate the importance of the wording of feedback. Even though different positive feedback statements may not have an immediate influence on performance, they can affect performance, and presumably individuals' motivation, when performance is (purportedly) poor. Feedback implying that performance is malleable, rather than due to an inherent ability, seems to have the potential to inoculate learners against setbacks - a situation frequently encountered in the context of motor performance and learning.	[Chiviacowsky, Suzete; Drews, Ricardo] Univ Fed Pelotas, Sch Phys Educ, Pelotas, RS, Brazil	Universidade Federal de Pelotas	Chiviacowsky, S (corresponding author), Univ Fed Pelotas, Sch Phys Educ, Pelotas, RS, Brazil.	schivi@terra.com.br	Chiviacowsky, Suzete/AAL-8462-2021; Drews, Ricardo/ABK-5086-2022	Chiviacowsky, Suzete/0000-0002-3641-0779; Drews, Ricardo/0000-0003-3121-0134				Allen JB, 1998, J SPORT EXERCISE PSY, V20, P280; AMES C, 1988, J EDUC PSYCHOL, V80, P260, DOI 10.1037/0022-0663.80.3.260; Amorose AJ, 2000, J SPORT EXERCISE PSY, V22, P63, DOI 10.1123/jsep.22.1.63; Avila LTG, 2012, PSYCHOL SPORT EXERC, V13, P849, DOI 10.1016/j.psychsport.2012.07.001; Badami R, 2011, RES Q EXERCISE SPORT, V82, P360; Burnette JL, 2013, PSYCHOL BULL, V139, P655, DOI 10.1037/a0029531; CARVER CS, 1978, J PERS SOC PSYCHOL, V36, P324, DOI 10.1037/0022-3514.36.3.324; Chiviacowsky S, 2005, RES Q EXERCISE SPORT, V76, P42; Chiviacowsky S, 2002, RES Q EXERCISE SPORT, V73, P408, DOI 10.1080/02701367.2002.10609040; Chiviacowsky S, 2008, RES Q EXERCISE SPORT, V79, P405; Chiviacowsky S, 2007, RES Q EXERCISE SPORT, V78, P40, DOI 10.1080/02701367.2007.10599402; Chiviacowsky S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00458; Chiviacowsky S, 2009, RES Q EXERCISE SPORT, V80, P663; Cimpian A, 2007, PSYCHOL SCI, V18, P314, DOI 10.1111/j.1467-9280.2007.01896.x; Clark SE, 2007, J SPORT SCI, V25, P577, DOI 10.1080/02640410600947090; Drews R., 2013, J MOTOR LEARNING DEV, V1, P38, DOI DOI 10.1123/JMLD.1.2.38; Dweck C. S., 2002, DEV ACHIEVEMENT MOTI, P57, DOI [10.1016/B978-012750053-9/50005-X, DOI 10.1016/B978-012750053-9/50005-X]; Dweck C. S, 1999, SELF THEORIES THEIR; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037/0033-295X.95.2.256; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; Fairbrother JT, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00323; Gelman SA, 1999, PSYCHOL SCI, V10, P489, DOI 10.1111/1467-9280.00194; Hong YY, 1999, J PERS SOC PSYCHOL, V77, P588, DOI 10.1037/0022-3514.77.3.588; JOURDEN FJ, 1991, J SPORT EXERCISE PSY, V13, P213, DOI 10.1123/jsep.13.3.213; Kamins ML, 1999, DEV PSYCHOL, V35, P835, DOI 10.1037/0012-1649.35.3.835; Koka A., 2003, KINESIOLOGY, V35, P86; Lewthwaite R, 2010, Q J EXP PSYCHOL, V63, P738, DOI 10.1080/17470210903111839; MARTOCCHIO JJ, 1994, J APPL PSYCHOL, V79, P819, DOI 10.1037/0021-9010.79.6.819; Mouratidis A, 2008, J SPORT EXERCISE PSY, V30, P240, DOI 10.1123/jsep.30.2.240; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Patterson JT, 2010, HUM MOVEMENT SCI, V29, P214, DOI 10.1016/j.humov.2009.12.003; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; Saemi E, 2012, PSYCHOL SPORT EXERC, V13, P378, DOI 10.1016/j.psychsport.2011.12.008; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Wulf G., 2011, BRAZILIAN J PHYS ED, V25, P671, DOI DOI 10.1590/S1807-55092011000400011; Wulf G, 2009, J MOTOR BEHAV, V41, P461, DOI 10.3200/35-08-083	36	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88989	10.1371/journal.pone.0088989	http://dx.doi.org/10.1371/journal.pone.0088989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523947	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100096
J	Pu, WX; Su, Y; Li, JX; Li, CH; Yang, ZQ; Deng, HP; Ni, CX				Pu, WanXia; Su, Yang; Li, JianXi; Li, ChunHui; Yang, ZhiQiang; Deng, HaiPing; Ni, ChunXia			High Incidence of Oxacillin-Susceptible mecA-Positive Staphylococcus aureus (OS-MRSA) Associated with Bovine Mastitis in China	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ANTIMICROBIAL RESISTANCE; INFECTIONS	Staphylococcus aureus is a main cause of bovine mastitis and a major pathogen affecting human health. The emergence and spread of methicillin-resistant Staphylococcus aureus (MRSA) has become a significant concern for both animal health and public health. This study investigated the incidence of MRSA in milk samples collected from dairy cows with clinical mastitis and characterized the MRSA isolates using antimicrobial susceptibility tests and genetic typing methods. In total, 103 S. aureus isolates were obtained from dairy farms in 4 different provinces in China, including Gansu, Shanghai, Sichuan, and Guizhou. Antimicrobial susceptibility testing of these isolates revealed that the resistance rates to penicillin and sulfamethoxazole were high, while the resistance rates to ciprofloxacin and vancomycin were low. Among the 103 isolates, 49 (47.6%) were found to be mecA-positive, indicating the high incidence of MRSA. However, 37 of the 49 mecA-positive isolates were susceptible to oxacillin as determined by antimicrobial susceptibility assays and were thus classified as oxacillin-susceptible mecA-positive S. aureus (OS-MRSA). These isolates could be misclassified as methicillin susceptible Staphylococcus aureus (MSSA) if genetic detection of mecA was not performed. Molecular characterization of selected mecA-positive isolates showed that they were all negative with Panton-Valentine leukocidin (PVL), but belonged to different spa types and SCCmec types. These results indicate that OS-MRSA is common in bovine mastitis in China and underscore the need for genetic methods (in addition to phenotypic tests) to accurately identify MRSA.	[Pu, WanXia; Su, Yang; Li, JianXi; Li, ChunHui; Yang, ZhiQiang; Deng, HaiPing; Ni, ChunXia] CAAS, Key Lab New Anim Drug Project, Key Lab Vet Pharmaceut Dev, Minist Agr,Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Pu, WX (corresponding author), CAAS, Key Lab New Anim Drug Project, Key Lab Vet Pharmaceut Dev, Minist Agr,Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Peoples R China.	wanxiapu@aliyun.com		pu, wanxia/0000-0002-4607-5855	Science and Technology Project Funds of GanSu Province [1304WCG172]; China Agriculture Research System In Dairy Cow [CARS-37]	Science and Technology Project Funds of GanSu Province; China Agriculture Research System In Dairy Cow	This study was funded by grants from the Science and Technology Project Funds of GanSu Province (1304WCG172, http://www.gsstc.gov.cn/Guide/detail.php?n_no=86734&dir=/), and China Agriculture Research System In Dairy Cow (CARS-37; http//119.253.58.231/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Bai LX, 2010, CHIN QING HAI J ANIM, V5, P45; Bannerman TM, 2003, MANUAL CLIN MICROBIO, P384; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Cao LT, 2010, J ANHUI AGR SCI, V38, P19541; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; *CLIN LAB STAND I, 2011, M100S21 CLSI; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; DEVRIESE LA, 1972, ZENTRALB VET RIEHE B, V19, P598; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Galdiero E, 2003, EUR J EPIDEMIOL, V18, P139, DOI 10.1023/A:1023067930211; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Giannouli S, 2010, J ANTIMICROB CHEMOTH, V65, P626, DOI 10.1093/jac/dkq039; Hendriksen RS, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-28; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Holmes MA, 2011, J MAMMARY GLAND BIOL, V16, P373, DOI 10.1007/s10911-011-9237-x; Hososaka Yasuko, 2007, Journal of Infection and Chemotherapy, V13, P79, DOI 10.1007/s10156-006-0502-7; Huber H, 2010, EURO SURVEILL, V15; Ikonomidis A, 2008, ANTIMICROB AGENTS CH, V52, P3905, DOI 10.1128/AAC.00653-08; Jannati E, 2013, AM J INFECT CONTROL, V41, P1122, DOI 10.1016/j.ajic.2013.02.012; Jin YZ, 2011, ANIM HUSB VET MED, V43, P64; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Labrou M, 2012, ANTIMICROB AGENTS CH, V56, P3388, DOI 10.1128/AAC.00103-12; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Nam HM, 2011, FOODBORNE PATHOG DIS, V8, P231, DOI 10.1089/fpd.2010.0661; Paterson GK, 2013, J ANTIMICROB CHEMOTH; Saeed K, 2010, J HOSP INFECT, V76, P267, DOI 10.1016/j.jhin.2010.03.004; Saini V, 2013, J DAIRY SCI, V96, P4965, DOI 10.3168/jds.2012-5713; Sakoulas G, 2001, J CLIN MICROBIOL, V39, P3946, DOI 10.1128/JCM.39.11.3946-3951.2001; Sharff KA, 2012, J CLIN MICROBIOL, V50, P4151, DOI 10.1128/JCM.01564-12; Su Yang, 2012, Scientia Agricultura Sinica, V45, P3602; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; Tokajian S, 2011, ISRN MICROBIOL; Turk DC, 1978, SHORT TXB MED MICROB; Turkyilmaz S, 2010, ZOONOSES PUBLIC HLTH, V57, P197, DOI 10.1111/j.1863-2378.2009.01257.x; Turutoglu H, 2006, B VET I PULAWY, V50, P41; Turutoglu H, 2009, VET RES COMMUN, V33, P945, DOI 10.1007/s11259-009-9313-5; [王登峰 Wang Dengfeng], 2011, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V42, P1416; Zecconi A, 2006, MICROB PATHOGENESIS, V40, P177, DOI 10.1016/j.micpath.2006.01.001; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang Wanjiang, 2011, Vet J, V190, pe125, DOI 10.1016/j.tvjl.2011.02.006	46	73	79	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88134	10.1371/journal.pone.0088134	http://dx.doi.org/10.1371/journal.pone.0088134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523877	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100026
J	Hayashi, T; Yamaguchi, T; Sakakibara, Y; Taguchi, K; Maeda, M; Kuzuya, M; Hattori, Y				Hayashi, Toshio; Yamaguchi, Tomoe; Sakakibara, Yasufumi; Taguchi, Kumiko; Maeda, Morihiko; Kuzuya, Masafumi; Hattori, Yuichi			eNOS-Dependent Antisenscence Effect of a Calcium Channel Blocker in Human Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CELLULAR SENESCENCE; HIGH GLUCOSE; HUMAN PLASMA; IN-VIVO; NIFEDIPINE; ATHEROSCLEROSIS; ACTIVATION; DISEASE; ASSOCIATION	Senescence of vascular endothelial cells is an important contributor to the pathogenesis of age-associated vascular disorders such as atherosclerosis. We investigated the effects of antihypertensive agents on high glucose-induced cellular senescence in human umbilical venous endothelial cells (HUVECs). Exposure of HUVECs to high glucose (22 mM) for 3 days increased senescence-associated-beta-galactosidase (SA-beta-gal) activity, a senescence marker, and decreased telomerase activity, a replicative senescence marker. The calcium channel blocker nifedipine, but not the beta 1-adrenergic blocking agent atenolol or the angiotensin-converting enzyme inhibitor perindopril, reduced SA-beta-gal positive cells and prevented a decrease in telomerase activity in a high-glucose environment. This beneficial effect of nifedipine was associated with reduced reactive oxygen species (ROS) and increased endothelial nitric oxide synthase (eNOS) activity. Thus, nifedipine prevented high glucose-induced ROS generation and increased basal eNOS phosphorylation level at Ser-1177. Treatment with N-G-nitro-L-arginine (L-NAME) and transfection of small interfering RNA (siRNA) targeting eNOS eliminated the anti-senscence effect of nifedipine. These results demonstrate that nifedipine can prevent endothelial cell senescence in an eNOS-dependent manner. The anti-senescence action of nifedipine may represent a novel mechanism by which it protects against atherosclerosis.	[Hayashi, Toshio; Yamaguchi, Tomoe; Sakakibara, Yasufumi; Maeda, Morihiko; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4648601, Japan; [Taguchi, Kumiko; Hattori, Yuichi] Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama, Japan	Nagoya University	Hayashi, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4648601, Japan.	hayashi@med.nagoya-u.ac.jp	Hayashi, Toshio/I-7346-2014; Kuzuya, Masafumi/I-1583-2012	Hayashi, Toshio/0000-0002-7711-2700; Sakakibara, Yasufumi/0000-0002-7459-1611	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24590881] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Chandra J, 2003, BLOOD, V102, P4512, DOI 10.1182/blood-2003-02-0562; Chen LY, 1997, J AM COLL CARDIOL, V30, P569, DOI 10.1016/S0735-1097(97)00158-7; Chen R, 2013, Drug Res (Stuttg), V63, P38, DOI 10.1055/s-0032-1331713; Christ M, 2002, DIABETES, V51, P2648, DOI 10.2337/diabetes.51.8.2648; Cristofori P, 2000, J HYPERTENS, V18, P1429, DOI 10.1097/00004872-200018100-00010; Croom KF, 2006, DRUGS, V66, P497, DOI 10.2165/00003495-200666040-00007; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Edo MD, 2005, CARDIOVASC RES, V66, P213, DOI 10.1016/j.cardiores.2004.09.007; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; Hayashi T, 2008, PHARMACOL THERAPEUT, V120, P333, DOI 10.1016/j.pharmthera.2008.09.002; HENRY PD, 1981, J CLIN INVEST, V68, P1366, DOI 10.1172/JCI110384; Hernandez Rafael Hernandez, 2003, Am J Ther, V10, P409, DOI 10.1097/00045391-200311000-00006; Ishii N, 2012, J ATHEROSCLER THROMB, V19, P693; Kurz DJ, 2000, J CELL SCI, V113, P3613; Kyselovic J, 2005, J PHARMACOL EXP THER, V315, P320, DOI 10.1124/jpet.105.089847; LICHTLEN PR, 1990, LANCET, V335, P1109, DOI 10.1016/0140-6736(90)91121-P; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Miyazaki-Akita A, 2007, J PHARMACOL EXP THER, V320, P591, DOI 10.1124/jpet.106.111641; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Nakano K, 2008, ATHEROSCLEROSIS, V196, P172, DOI 10.1016/j.atherosclerosis.2007.03.036; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; Simionescu M, 2007, ARTERIOSCL THROM VAS, V27, P266, DOI 10.1161/01.ATV.0000253884.13901.e4; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Vasile E, 2001, FASEB J, V15, P458, DOI 10.1096/fj.00-0051com; Versari D, 2009, EXP PHYSIOL, V94, P317, DOI 10.1113/expphysiol.2008.043356; Voelker R, 2008, JAMA-J AM MED ASSOC, V299, P2611, DOI 10.1001/jama.299.22.2611; Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X; Wang D, 2011, J CHROMATOGR B, V879, P1827, DOI 10.1016/j.jchromb.2011.04.034; WATERS D, 1990, CIRCULATION, V82, P1940, DOI 10.1161/01.CIR.82.6.1940; WILLIS AL, 1985, ARTERIOSCLEROSIS, V5, P250, DOI 10.1161/01.ATV.5.3.250; Yildiz G, 2007, ANN NY ACAD SCI, V1100, P353, DOI 10.1196/annals.1395.038; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607	37	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88391	10.1371/journal.pone.0088391	http://dx.doi.org/10.1371/journal.pone.0088391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520379	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600070
J	Huang, HL; Lamikanra, AA; Alkaitis, MS; Thezenas, ML; Ramaprasad, A; Moussa, E; Roberts, DJ; Casals-Pascual, C				Huang, Honglei; Lamikanra, Abigail A.; Alkaitis, Matthew S.; Thezenas, Marie L.; Ramaprasad, Abhinay; Moussa, Ehab; Roberts, David J.; Casals-Pascual, Climent			Interleukin-10 Regulates Hepcidin in Plasmodium falciparum Malaria	PLOS ONE			English	Article							IRON; ANEMIA; FERROPORTIN; IL-10	Background: Acute malarial anemia remains a major public health problem. Hepcidin, the major hormone controlling the availability of iron, is raised during acute and asymptomatic parasitemia. Understanding the role and mechanism of raised hepcidin and so reduced iron availability during infection is critical to establish evidence-based guidelines for management of malaria anemia. Our recent clinical evidence suggests a potential role of IL-10 in the regulation of hepcidin in patients with acute P. falciparum malaria. Methods: We have measured secretion of hepcidin by primary macrophages and the hepatoma cell line HepG2 stimulated with IL-10, IL-6 and Plasmodium falciparum-infected erythrocytes. Findings: We have observed that IL-10 and IL-6 production increased in primary macrophages when these cells were cocultured with Plasmodium falciparum-infected erythrocytes. We found that IL-10 induced hepcidin secretion in primary macrophages in a dose-dependent manner but not in HepG2 cells. These effects were mediated through signal transducer and activator of transcription (STAT) 3-phosphorylation and completely abrogated by a specific STAT3 inhibitor. Conclusion: IL-10 can directly regulate hepcidin in primary macrophages but not in HepG2 cells. This effect can be modulated by Plasmodium falciparum. The results are consistent with a role for IL-10 in modulating iron metabolism during acute phase of infection.	[Huang, Honglei; Thezenas, Marie L.; Ramaprasad, Abhinay; Moussa, Ehab; Casals-Pascual, Climent] Wellcome Trust Ctr Human Genet, Oxford, England; [Lamikanra, Abigail A.; Alkaitis, Matthew S.; Roberts, David J.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Lamikanra, Abigail A.; Alkaitis, Matthew S.; Roberts, David J.] John Radcliffe Hosp, Natl Hlth Serv Blood & Transplant, Oxford OX3 9DU, England; [Alkaitis, Matthew S.] NIAID, Lab Malaria & Vector Res, Rockville, MD USA; [Ramaprasad, Abhinay; Moussa, Ehab] King Abdullah Univ Sci & Technol, Jeddah, Saudi Arabia	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; NHS Blood & Transplant (NHSBT); University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); King Abdullah University of Science & Technology	Casals-Pascual, C (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	ccasals@well.ox.ac.uk	Lamikanra, Abigail/AAD-9603-2019; Ramaprasad, Abhinay/D-1181-2013; Casals-Pascual, Climent/N-7692-2018; Ramaprasad, Abhinay/X-1235-2019	Ramaprasad, Abhinay/0000-0001-9372-5526; Casals-Pascual, Climent/0000-0002-0867-8954; Ramaprasad, Abhinay/0000-0001-9372-5526; Roberts, David/0000-0003-0648-6585	Medical research Council [G0701885]; National Blood Service; National Institute for Health Research; Wellcome Trust Centre for Human Genetics (Oxford, UK) [077383/Z/05/Z]; National Health Service Blood and Transplant - Oxford Centre; Medical Research Council [G0701885] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish; MRC [G0701885] Funding Source: UKRI	Medical research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Blood Service; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust Centre for Human Genetics (Oxford, UK); National Health Service Blood and Transplant - Oxford Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CC-P is supported by the Medical research Council (Clinician Scientist Fellowship: G0701885). DJR is supported by the National Blood Service, and the National Institute for Health Research. The research was carried out at the Wellcome Trust Centre for Human Genetics (Oxford, UK) [077383/Z/05/Z], and the National Health Service Blood and Transplant - Oxford Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WORLDW PREV AN 1993; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Armitage AE, 2009, BRIT J HAEMATOL, V147, P769, DOI 10.1111/j.1365-2141.2009.07880.x; Bastin J, 2006, BRIT J HAEMATOL, V134, P532, DOI 10.1111/j.1365-2141.2006.06216.x; Burte F, 2013, BLOOD, V121, P3016, DOI 10.1182/blood-2012-10-461418; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Casals-Pascual C, 2012, HAEMATOL-HEMATOL J, V97, P1695, DOI 10.3324/haematol.2012.065854; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Drakesmith H, 2005, P NATL ACAD SCI USA, V102, P11017, DOI 10.1073/pnas.0504823102; FINCH C, 1994, BLOOD, V84, P1697; Kossodo S, 1997, IMMUNOLOGY, V91, P536, DOI 10.1046/j.1365-2567.1997.00290.x; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nweneka CV, 2010, T ROY SOC TROP MED H, V104, P175, DOI 10.1016/j.trstmh.2009.08.007; Oliveras-Verges A, 2008, MED HYPOTHESES, V70, P630, DOI 10.1016/j.mehy.2007.07.021; Piperno A, 2011, BLOOD, V117, P2953, DOI 10.1182/blood-2010-08-299859; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Schimanski LM, 2008, BLOOD CELL MOL DIS, V40, P360, DOI 10.1016/j.bcmd.2007.09.007; Tilg H, 2002, J IMMUNOL, V169, P2204, DOI 10.4049/jimmunol.169.4.2204; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840	26	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88408	10.1371/journal.pone.0088408	http://dx.doi.org/10.1371/journal.pone.0088408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520384	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600075
J	Kim, Y; Yoon, S; Lee, SB; Han, HW; Oh, H; Lee, WJ; Lee, SM				Kim, Yunhye; Yoon, Sun; Lee, Sun Bok; Han, Hye Won; Oh, Hayoun; Lee, Wu Joo; Lee, Seung-Min			Fermentation of Soy Milk via Lactobacillus plantarum Improves Dysregulated Lipid Metabolism in Rats on a High Cholesterol Diet	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LACTIC-ACID BACTERIA; ISOFLAVONE AGLYCONES; LDL-CHOLESTEROL; GENE-EXPRESSION; VLDL RECEPTOR; FATTY LIVER; DISEASE; PLASMA; REDUCTASE	We aimed to investigate whether in vitro fermentation of soy with L. plantarum could promote its beneficial effects on lipids at the molecular and physiological levels. Rats were fed an AIN76A diet containing 50% sucrose (w/w) (CTRL), a modified AIN76A diet supplemented with 1% (w/w) cholesterol (CHOL), or a CHOL diet where 20% casein was replaced with soy milk (SOY) or fermented soy milk (FSOY). Dietary isoflavone profiles, serum lipids, hepatic and fecal cholesterol, and tissue gene expression were examined. The FSOY diet had more aglycones than did the SOY diet. Both the SOY and FSOY groups had lower hepatic cholesterol and serum triglyceride (TG) than did the CHOL group. Only FSOY reduced hepatic TG and serum free fatty acids and increased serum HDL-CHOL and fecal cholesterol. Compared to CHOL, FSOY lowered levels of the nuclear forms of SREBP-1c and SREBP-2 and expression of their target genes, including FAS, SCD1, LDLR, and HMGCR. On the other hand, FSOY elevated adipose expression levels of genes involved in TG-rich lipoprotein uptake (ApoE, VLDLR, and Lrp1), fatty acid oxidation (PPARa, CPT1a, LCAD, CYP4A1, UCP2, and UCP3), HDL-biogenesis (ABCA1, ApoA1, and LXRa), and adiponectin signaling (AdipoQ, AdipoR1, and AdipoR2), as well as levels of phosphorylated AMPK and ACC. SOY conferred a similar expression profile in both liver and adipose tissues but failed to reach statistical significance in many of the genes tested, unlike FSOY. Our data indicate that fermentation may be a way to enhance the beneficial effects of soy on lipid metabolism, in part via promoting a reduction of SREBP-dependent cholesterol and TG synthesis in the liver, and enhancing adiponectin signaling and PPARa-induced expression of genes involved in TG-rich lipoprotein clearance, fatty acid oxidation, and reverse cholesterol transport in adipose tissues.	[Kim, Yunhye; Yoon, Sun; Lee, Sun Bok; Han, Hye Won; Oh, Hayoun; Lee, Wu Joo; Lee, Seung-Min] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Seoul 120749, South Korea	Yonsei University	Lee, SM (corresponding author), Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Seoul 120749, South Korea.	leeseungmin@yonsei.ac.kr			National Research Foundation of Korea (NRF); Korean government [20110003704]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government(Korean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (No. 20110003704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; Ascencio C, 2004, J NUTR, V134, P522, DOI 10.1093/jn/134.3.522; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Chambers CM, 1997, BIOCHEM BIOPH RES CO, V232, P278, DOI 10.1006/bbrc.1997.6288; Chien HL, 2006, FOOD MICROBIOL, V23, P772, DOI 10.1016/j.fm.2006.01.002; DEWAEL J, 1977, CLIN CHIM ACTA, V79, P465, DOI 10.1016/0009-8981(77)90443-0; Di Cagno R, 2010, J AGR FOOD CHEM, V58, P10338, DOI 10.1021/jf101513r; Field FJ, 2001, J LIPID RES, V42, P1687; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fukui K, 2002, J AGR FOOD CHEM, V50, P5717, DOI 10.1021/jf025642f; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; HAGLUND O, 1991, J NUTR, V121, P165, DOI 10.1093/jn/121.2.165; Hoie LH, 2005, EUR J NUTR, V44, P65, DOI 10.1007/s00394-004-0492-0; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Izumi T, 2000, J NUTR, V130, P1695, DOI 10.1093/jn/130.7.1695; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kano M, 2006, J NUTR, V136, P2291, DOI 10.1093/jn/136.9.2291; Khoo KL, 2003, ATHEROSCLEROSIS, V169, P1, DOI 10.1016/S0021-9150(03)00009-1; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lewis GF, 1997, CURR OPIN LIPIDOL, V8, P146, DOI 10.1097/00041433-199706000-00004; Lin YG, 2004, J NUTR, V134, P143, DOI 10.1093/jn/134.1.143; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rossmeisl M, 2005, OBES RES, V13, P835, DOI 10.1038/oby.2005.96; Santo SMSE, 2005, J LIPID RES, V46, P1097, DOI 10.1194/jlr.C500007-JLR200; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882; Tacken PJ, 2000, J LIPID RES, V41, P2055; Taku K, 2007, AM J CLIN NUTR, V85, P1148, DOI 10.1093/ajcn/85.4.1148; Torre-Villalvazo I, 2008, J NUTR, V138, P462, DOI 10.1093/jn/138.3.462; Yasutake K, 2009, SCAND J GASTROENTERO, V44, P471, DOI 10.1080/00365520802588133	33	25	32	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88231	10.1371/journal.pone.0088231	http://dx.doi.org/10.1371/journal.pone.0088231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520358	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600049
J	Oseguera, CAV; Spencer, JV				Oseguera, Cendy A. Valle; Spencer, Juliet V.			cmvIL-10 Stimulates the Invasive Potential of MDA-MB-231 Breast Cancer Cells	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; INTERLEUKIN-10; APOPTOSIS; EXPRESSION; HOMOLOG; PROTEIN; IL-10; HOST	Cancer is the result of unregulated cell growth that leads to tumor formation, and in many cases, metastases. Although there are several risk factors associated with cancer, one area that remains poorly understood is the impact of infectious disease. Human cytomegalovirus ( HCMV) is a member of the herpesvirus family that is highly prevalent in the population. HCMV usually causes clinical disease only in immune compromised individuals, but recent evidence suggests that HCMV may be strongly associated with some forms of cancer, particularly glioblastoma and breast cancer. We investigated the possibility that cmvIL-10, a viral cytokine with homology to human IL-10 that is secreted from infected cells, could act in a paracrine manner to alter the tumor microenvironment, induce cell signaling, and increase the invasive potential of cancer cells. We found that human MDA-MB-231 breast cancer cells express the IL-10 receptor and that exposure to cmvIL-10 results in activation of Stat3, a transcription factor strongly associated with enhanced metastatic potential and chemoresistance. In addition, cmvIL-10 stimulated an increase in DNA synthesis and cell proliferation, protected MDA-MB-231 cells from etoposide-induced apoptosis, and also greatly enhanced chemotaxis toward epidermal growth factor (EGF). These results suggest a significant and wide-ranging role for cmvIL-10 in the progression of breast cancer and could have broad implications for the diagnosis and treatment of cancer in HCMV-positive patients.	[Oseguera, Cendy A. Valle; Spencer, Juliet V.] Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA	University of San Francisco	Spencer, JV (corresponding author), Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA.	jspencer@usfca.edu			National Institutes of Health [R15CA158767]; USF Faculty Development Funds; NATIONAL CANCER INSTITUTE [R15CA158767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USF Faculty Development Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (www.nih.gov) grant R15CA158767 and USF Faculty Development Funds (www.usfca.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althwani AN, 2011, J FM BAGHDAD, V53, P289; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Blaheta RA, 2004, NEOPLASIA, V6, P323, DOI 10.1593/neo.03418; Blaheta RA, 2006, NEOPLASIA, V8, P807, DOI 10.1593/neo.06379; Cobbs CS, 2007, J NEURO-ONCOL, V85, P271, DOI 10.1007/s11060-007-9423-2; Cobbs CS, 2002, CANCER RES, V62, P3347; Damato EG, 2002, JOGNN-J OBST GYN NEO, V31, P86, DOI 10.1111/j.1552-6909.2002.tb00026.x; de la Hoz RE, 2002, J CLIN VIROL, V25, pS1, DOI 10.1016/S1386-6532(02)00091-4; Deng JY, 2010, WORLD J GASTROENTERO, V16, P5380, DOI 10.3748/wjg.v16.i42.5380; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Llanes-Fernandez L, 2006, BREAST, V15, P482, DOI 10.1016/j.breast.2005.09.012; McCormick AL, 2008, CURR TOP MICROBIOL, V325, P281; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Sanchez V, 2008, CURR TOP MICROBIOL, V325, P243; Scalzo AA, 2007, IMMUNOL CELL BIOL, V85, P46, DOI 10.1038/sj.icb.7100013; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Spencer JV, 2008, VIROLOGY, V374, P164, DOI 10.1016/j.virol.2007.11.031; Spencer JV, 2007, J VIROL, V81, P2083, DOI 10.1128/JVI.01655-06; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Taher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056795; Wilkins-Port CE, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/85208; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zeng L, 2009, CYTOKINE; Zhang XL, 2010, CANCER GENET CYTOGEN, V197, P46, DOI 10.1016/j.cancergencyto.2009.10.004; Zheng MZ, 2007, CANCER IMMUNOL IMMUN, V56, P205, DOI 10.1007/s00262-006-0175-1	37	22	22	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88708	10.1371/journal.pone.0088708	http://dx.doi.org/10.1371/journal.pone.0088708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520416	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600107
J	Samy, RP; Kandasamy, M; Gopalakrishnakone, P; Stiles, BG; Rowan, EG; Becker, D; Shanmugam, MK; Sethi, G; Chow, VTK				Samy, Ramar Perumal; Kandasamy, Matheswaran; Gopalakrishnakone, Ponnampalam; Stiles, Bradley G.; Rowan, Edward G.; Becker, David; Shanmugam, Muthu K.; Sethi, Gautam; Chow, Vincent T. K.			Wound Healing Activity and Mechanisms of Action of an Antibacterial Protein from the Venom of the Eastern Diamondback Rattlesnake (Crotalus adamanteus)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MYOTOXIC PHOSPHOLIPASES A(2); TERRIFICUS SNAKE-VENOM; NF-KAPPA-B; ANTIMICROBIAL ACTIVITY; PHARMACOLOGICAL-PROPERTIES; TGF-BETA; PEPTIDE; EXPRESSION; ANGIOGENESIS	Basic phospholipase A(2) was identified from the venom of the eastern diamondback rattlesnake. The Crotalus adamanteus toxin-II (CaTx-II) induced bactericidal effects (7.8 mu g/ml) on Staphylococcus aureus, while on Burkholderia pseudomallei (KHW), and Enterobacter aerogenes were killed at 15.6 mu g/ml. CaTx-II caused pore formation and membrane damaging effects on the bacterial cell wall. CaTx-II was not cytotoxic on lung (MRC-5), skin fibroblast (HEPK) cells and in mice. CaTx-II-treated mice showed significant wound closure and complete healing by 16 days as compared to untreated controls (**P<0.01). Histological examination revealed enhanced collagen synthesis and neovascularization after treatment with CaTx-II versus 2% Fusidic Acid ointment (FAO) treated controls. Measurement of tissue cytokines revealed that interleukin-1 beta (IL-1 beta) expression in CaTx-II treated mice was significantly suppressed versus untreated controls. In contrast, cytokines involved in wound healing and cell migration i.e., monocyte chemotactic protein-1 (MCP-1), fibroblast growth factor-basic (FGF-b), chemokine (KC), granulocyte-macrophage colony-stimulating factor (GM-CSF) were significantly enhanced in CaTx-II treated mice, but not in the controls. CaTx-II also modulated nuclear factor-kappa B (NF-kappa B) activation during skin wound healing. The CaTx-II protein highlights distinct snake proteins as a potential source of novel antimicrobial agents with significant therapeutic application for bacterial skin infections.	[Samy, Ramar Perumal; Gopalakrishnakone, Ponnampalam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Venom & Toxin Res Programme, Singapore 117595, Singapore; [Samy, Ramar Perumal; Chow, Vincent T. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Infect Dis Programme, Singapore 117595, Singapore; [Kandasamy, Matheswaran] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Brenner Ctr Mol Med, Infect Immun Programme, Singapore, Singapore; [Stiles, Bradley G.] US Army Med Res, Integrated Toxicol Div, Inst Infect Dis, Ft Detrick, MD USA; [Rowan, Edward G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Becker, David] UCL, Dept Anat & Dev Biol, London, England; [Shanmugam, Muthu K.; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Clin Res Ctr, Dept Pharmacol, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); United States Department of Defense; United States Army; University of Strathclyde; University of London; University College London; National University of Singapore	Samy, RP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Venom & Toxin Res Programme, Singapore 117595, Singapore.	rperumalsamy@yahoo.co.uk	Becker, David Laurence/GZL-4411-2022; R., Ponalagusamy/B-5250-2014; Sethi, Gautam/F-2372-2011	R., Ponalagusamy/0000-0002-9868-3764; Sethi, Gautam/0000-0002-8677-8475; Kandasamy, Matheswaran/0000-0001-7734-4600; Rowan, Edward/0000-0002-9960-3308; Chow, Vincent/0000-0003-2634-6213	Economic Development Board (EDB), Singapore [R-181-000-110-144]; MOE Tier I	Economic Development Board (EDB), Singapore; MOE Tier I	The authors thank Dr. Naidu for providing cells (skin fibroblast) and technical support in performing the cytotoxicity assay. The authors are thankful to the Economic Development Board (EDB), Singapore, for financial support by Proof of Concept (Grant No: R-181-000-110-144). This work was also supported in part by a grant from MOE Tier I to Dr. Gautam Sethi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragao EA, 2008, TOXICON, V51, P538, DOI 10.1016/j.toxicon.2007.11.004; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Behler JL, 1979, AUDUBON SOC FIELD GU, P743; Calvete JJ, 2010, J PROTEOME RES, V9, P528, DOI 10.1021/pr9008749; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Desbois AP, 2010, INT J ANTIMICROB AG, V35, P559, DOI 10.1016/j.ijantimicag.2010.01.016; Elcin YM, 2001, ARTIF ORGANS, V25, P558, DOI 10.1046/j.1525-1594.2001.025007558.x; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; FLETCHER JE, 1980, BIOCHEM PHARMACOL, V29, P1565, DOI 10.1016/0006-2952(80)90609-7; FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galbusera E, 2011, ANTIMICROB AGENTS CH, V55, P1008, DOI 10.1128/AAC.00720-10; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; Hara T, 2001, BIOPOLYMERS, V58, P437, DOI 10.1002/1097-0282(20010405)58:4<437::AID-BIP1019>3.3.CO;2-9; Hernandez-Oliveira S, 2005, PROTEIN J, V24, P233, DOI 10.1007/s10930-005-6718-z; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598; Jikia D, 2005, CLIN EXP DERMATOL, V30, P23, DOI 10.1111/j.1365-2230.2004.01600.x; Vargas LJ, 2012, COMP BIOCHEM PHYS B, V161, P341, DOI 10.1016/j.cbpb.2011.12.010; JOYCE CYC, 2001, AM J PATHOL, V159, P1681; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kirby A, 2011, INFECTION, V39, P277, DOI 10.1007/s15010-011-0103-y; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Liu Q, 2003, J BIOL CHEM, V278, P41400, DOI 10.1074/jbc.M305210200; Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008; LOMONTE B, 1994, J BIOL CHEM, V269, P29867; Lomonte B, 2009, PROTEIN PEPTIDE LETT, V16, P860, DOI 10.2174/092986609788923356; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mann A, 2001, J INVEST DERMATOL, V117, P1382, DOI 10.1046/j.0022-202x.2001.01600.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Masson P., 1929, J TECH METHODS, V12, P75; McFarland KL, 2008, WOUND REPAIR REGEN, V16, P534, DOI 10.1111/j.1524-475X.2008.00401.x; Micek ST, 2007, CLIN INFECT DIS, V45, pS184, DOI 10.1086/519471; Milheirico C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-76; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Murillo LA, 2007, REV ESP QUIM, V20, P330; Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318; Nakagawa T, 2004, AM J PHYSIOL-RENAL, V287, pF658, DOI 10.1152/ajprenal.00040.2004; Nevalainen TJ, 2008, BBA-MOL CELL BIOL L, V1781, P1, DOI 10.1016/j.bbalip.2007.12.001; Oguiura N, 2011, J ANTIBIOT, V64, P327, DOI 10.1038/ja.2011.10; Oono T, 2003, BRIT J DERMATOL, V148, P188, DOI 10.1046/j.1365-2133.2003.509915.x; Paramo L, 1998, EUR J BIOCHEM, V253, P452, DOI 10.1046/j.1432-1327.1998.2530452.x; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Pereira HA, 2006, CURR PHARM BIOTECHNO, V7, P229; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Reinholz M, 2012, ANN DERMATOL, V24, P126, DOI 10.5021/ad.2012.24.2.126; Ren Ha-tao, 2005, Zhonghua Shao Shang Za Zhi, V21, P356; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Rouault M, 2006, BIOCHEMISTRY-US, V45, P5800, DOI 10.1021/bi060217r; Sampaio SC, 2003, TOXICON, V41, P899, DOI 10.1016/S0041-0101(03)00069-2; Samy RP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-100; Samy RP, 2007, J APPL MICROBIOL, V102, P650, DOI 10.1111/j.1365-2672.2006.03161.x; Samy RP, 2008, J CELL PHYSIOL, V216, P54, DOI 10.1002/jcp.21373; Samy RP, 2010, BIOCHIMIE, V92, P1854, DOI 10.1016/j.biochi.2010.07.012; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Santamaria C, 2005, TOXICON, V45, P807, DOI 10.1016/j.toxicon.2004.09.012; Santamaria C, 2005, ANTIMICROB AGENTS CH, V49, P1340, DOI [10.1128/AAC.49.4.1340-1345.2005, 10.1128/AAc.49.4.1340-1345.2005]; Shanmugam MK, 2011, J MOL MED, V89, P713, DOI 10.1007/s00109-011-0746-2; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Soares AM, 2001, INT J BIOCHEM CELL B, V33, P877, DOI 10.1016/S1357-2725(01)00065-6; Soares AM, 2001, ARCH BIOCHEM BIOPHYS, V387, P188, DOI 10.1006/abbi.2000.2244; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; STOCKER JF, 1986, J APPL BACTERIOL, V61, P383, DOI 10.1111/j.1365-2672.1986.tb04300.x; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takamiya Masataka, 2009, Legal Medicine, V11, P186, DOI 10.1016/j.legalmed.2009.03.010; TALAN DA, 1991, J INFECT DIS, V164, P195, DOI 10.1093/infdis/164.1.195; Toyama MH, 2003, TOXICON, V41, P1033, DOI 10.1016/S0041-0101(03)00085-0; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	78	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e80199	10.1371/journal.pone.0080199	http://dx.doi.org/10.1371/journal.pone.0080199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551028	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000331271500001
J	Strandkvist, C; Juul, J; Bendtsen, KM				Strandkvist, Charlotte; Juul, Jeppe; Bendtsen, Kristian Moss			Asymmetric Segregation of Damaged Cellular Components in Spatially Structured Multicellular Organisms	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; AGE ASYMMETRY; FISSION YEAST; STEM-CELLS; INHERITANCE; NUCLEOIDS; PROTEINS; MOTHER; ACCUMULATION; DIVISION	The asymmetric distribution of damaged cellular components has been observed in species ranging from fission yeast to humans. To study the potential advantages of damage segregation, we have developed a mathematical model describing ageing mammalian tissue, that is, a multicellular system of somatic cells that do not rejuvenate at cell division. To illustrate the applicability of the model, we specifically consider damage incurred by mutations to mitochondrial DNA, which are thought to be implicated in the mammalian ageing process. We show analytically that the asymmetric distribution of damaged cellular components reduces the overall damage level and increases the longevity of the cell population. Motivated by the experimental reports of damage segregation in human embryonic stem cells, dividing symmetrically with respect to cell-fate, we extend the model to consider spatially structured systems of cells. Imposing spatial structure reduces, but does not eliminate, the advantage of asymmetric division over symmetric division. The results suggest that damage partitioning could be a common strategy for reducing the accumulation of damage in a wider range of cell types than previously thought.	[Strandkvist, Charlotte] UCL, London, England; [Juul, Jeppe; Bendtsen, Kristian Moss] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	University of London; University College London; University of Copenhagen; Niels Bohr Institute	Juul, J (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	jeppesj@nbi.dk			Danish national research foundation	Danish national research foundation(Danmarks Grundforskningsfond)	This work was supported by the Danish national research foundation, http://dg.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Bendtsen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036018; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Erjavec N, 2008, P NATL ACAD SCI USA, V105, P18764, DOI 10.1073/pnas.0804550105; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Evans SN, 2007, THEOR POPUL BIOL, V71, P473, DOI 10.1016/j.tpb.2007.02.004; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Klinger H, 2010, EXP GERONTOL, V45, P533, DOI 10.1016/j.exger.2010.03.016; Kowald A, 2000, J THEOR BIOL, V202, P145, DOI 10.1006/jtbi.1999.1046; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lai CY, 2002, GENETICS, V162, P73; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Minois N, 2006, BIOGERONTOLOGY, V7, P261, DOI 10.1007/s10522-006-9025-y; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Ouellet J, 2012, J CELL BIOL, V196, P305, DOI 10.1083/jcb.201102078; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Rashidi A, 2012, SUBCELL BIOCHEM, V57, P315, DOI 10.1007/978-94-007-2561-4_14; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Simon VR, 1997, CELL MOTIL CYTOSKEL, V37, P199, DOI 10.1002/(SICI)1097-0169(1997)37:3<199::AID-CM2>3.0.CO;2-2; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103	34	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87917	10.1371/journal.pone.0087917	http://dx.doi.org/10.1371/journal.pone.0087917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551071	Green Published, gold, Green Submitted			2022-12-27	WOS:000331266000020
J	Zhou, JM; Cui, XT; Jin, XJ; Zhou, J; Zhang, HY; Tang, BX; Fu, M; Herlitz, H; Cui, J; Zhu, HM; Sun, AJ; Hu, K; Ge, JB				Zhou, Jingmin; Cui, Xiaotong; Jin, Xuejuan; Zhou, Jun; Zhang, Hanying; Tang, Bixiao; Fu, Michael; Herlitz, Hans; Cui, Jie; Zhu, Hongmin; Sun, Aijun; Hu, Kai; Ge, Junbo			Association of Renal Biochemical Parameters with Left Ventricular Diastolic Dysfunction in a Community-Based Elderly Population in China: A Cross-Sectional Study	PLOS ONE			English	Article							URINARY ALBUMIN EXCRETION; CHRONIC HEART-FAILURE; BLOOD UREA NITROGEN; GLOMERULAR-FILTRATION-RATE; BRAIN NATRIURETIC PEPTIDE; CHRONIC KIDNEY-DISEASE; ENDOTHELIAL DYSFUNCTION; EUROPEAN-SOCIETY; OLDER PATIENTS; TASK-FORCE	Background: Relationship of left ventricular diastolic dysfunction (LVDD) with parameters that could provide more information than hemodynamic renal indexes has not been clarified. We aimed to explore the association of comprehensive renal parameters with LVDD in a community-based elderly population. Methods: 1,166 community residents (aged >= 65 years, 694 females) participating in the Shanghai Heart Health Study with complete data of renal parameters were investigated. Echocardiography was used to evaluate diastolic function with conventional and tissue Doppler imaging techniques. Serum urea, creatinine, urea-to-creatinine ratio, estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR) were analyzed on their associations with LVDD. Results: The prevalence of LVDD increased in proportion to increasing serum urea, urea-to-creatinine ratio and UACR. These three renal parameters were found negatively correlated to peak early (E) to late (A) diastolic velocities ratio (E/A), and positively to left atrial volume index; UACR also positively correlated with E to peak early (E') diastolic mitral annular velocity ratio (E/E'). Serum urea, urea-to-creatinine ratio and UACR correlated with LVDD in logistic univariate regression analysis, and urea-to-creatinine ratio remained independently correlated to LVDD [ Odds ratio (OR) 2.82, 95% confidence interval (CI) 1.34-5.95] after adjustment. Serum urea (OR 1.18, 95%CI 1.03-1.34), creatinine (OR 6.53, 95%CI 1.70-25.02), eGFR (OR 0.22, 95%CI 0.07-0.65) and UACR (OR 2.15, 95%CI 1.42-3.24) were revealed independent correlates of advanced (moderate and severe) LVDD. Conclusions: Biochemical parameters of renal function were closely linked with LVDD. This finding described new cardiorenal relationship in the elderly population.	[Zhou, Jingmin; Cui, Xiaotong; Jin, Xuejuan; Zhou, Jun; Cui, Jie; Zhu, Hongmin; Sun, Aijun; Hu, Kai; Ge, Junbo] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Zhang, Hanying; Tang, Bixiao] Fengjing Community Hlth Ctr, Shanghai, Peoples R China; [Fu, Michael] Univ Gothenburg, Cardiol Sect, Dept Med, Sahlgrenska Univ Hosp,Ostra Hosp, Gothenburg, Sweden; [Herlitz, Hans] Univ Gothenburg, Nephrol Sect, Dept Med, Sahlgrenska Univ Hosp,Ostra Hosp, Gothenburg, Sweden	Fudan University; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Ge, JB (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China.	jbge@zs-hospital.sh.cn			Key Projects in the National Science & Technology Pillar Program in the Eleventh [2006BAI01A04]; Twelfth Five-year Plan Period of China [2011BAI11B10]; Exchange Program Fund of Doctoral Student under the Fudan University Graduate School	Key Projects in the National Science & Technology Pillar Program in the Eleventh; Twelfth Five-year Plan Period of China; Exchange Program Fund of Doctoral Student under the Fudan University Graduate School	This study is funded by grants from the Key Projects in the National Science & Technology Pillar Program in the Eleventh (2006BAI01A04) and Twelfth (2011BAI11B10) Five-year Plan Period of China, and the Exchange Program Fund of Doctoral Student under the Fudan University Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafiz AH, 2011, NEPHRON EXP NEPHROL, V119, pE6, DOI 10.1159/000328015; Abhayaratna WP, 2006, AM HEART J, V152, P941, DOI 10.1016/j.ahj.2006.05.007; Ahmed A, 2007, AM J CARDIOL, V99, P393, DOI 10.1016/j.amjcard.2006.08.042; Aronson D, 2004, AM J MED, V116, P466, DOI 10.1016/j.amjmed.2003.11.014; Bess RL, 2006, ECHOCARDIOGR-J CARD, V23, P332, DOI 10.1111/j.1540-8175.2006.00215.x; Bruch C, 2007, INT J CARDIOL, V118, P375, DOI 10.1016/j.ijcard.2006.06.066; Cecil RLF., 2008, CECIL MED; DeFilippi C, 2008, AM J CARDIOL, V101, p82A, DOI 10.1016/j.amjcard.2007.11.029; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas M, 2010, KIDNEY INT, V78, P14, DOI 10.1038/ki.2010.123; Elesber AA, 2007, AM HEART J, V153, P1081, DOI 10.1016/j.ahj.2007.03.007; Emery WT, 2008, EUR J ECHOCARDIOGR, V9, P685, DOI 10.1093/ejechocard/jen137; Feola M, 2005, AM J CARDIOL, V96, P705, DOI 10.1016/j.amjcard.2005.04.049; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Grewal J, 2008, EUR J HEART FAIL, V10, P252, DOI 10.1016/j.ejheart.2008.01.017; Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Kerzner R, 2003, AM HEART J, V146, P286, DOI 10.1016/S0002-8703(03)00151-0; Kloch-Badelek M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-10; Lin HJ, 2009, CLIN RES CARDIOL, V98, P487, DOI 10.1007/s00392-009-0025-1; Ma LN, 2000, INT J CARDIOL, V72, P275, DOI 10.1016/S0167-5273(99)00203-X; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Malik AR, 2007, J HUM HYPERTENS, V21, P231, DOI 10.1038/sj.jhh.1002143; McKie PM, 2011, J AM COLL CARDIOL, V58, P2095, DOI 10.1016/j.jacc.2011.07.042; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nishio M, 2008, HYPERTENS RES, V31, P1865, DOI 10.1291/hypres.31.1865; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Palatini P, 1996, AM J HYPERTENS, V9, P334, DOI 10.1016/0895-7061(95)00391-6; Panteghini Mauro, 2004, Clin Lab, V50, P325; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Post WS, 2000, AM J HYPERTENS, V13, P1168, DOI 10.1016/S0895-7061(00)01181-X; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Sato B, 2013, AM J CARDIOL, V111, P712, DOI 10.1016/j.amjcard.2012.11.025; SCHMIEDER RE, 1990, JAMA-J AM MED ASSOC, V264, P2775, DOI 10.1001/jama.264.21.2775; Schrier RW, 2008, CIRC-HEART FAIL, V1, P2, DOI 10.1161/CIRCHEARTFAILURE.108.770834; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Schrier RW, 2006, J AM COLL CARDIOL, V47, P1, DOI 10.1016/j.jacc.2005.07.067; Shenkman HJ, 2007, AM J CARDIOL, V99, P1143, DOI 10.1016/j.amjcard.2006.11.050; Smith GL, 2006, ARCH INTERN MED, V166, P1134, DOI 10.1001/archinte.166.10.1134; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Tschope C, 2005, EUR HEART J, V26, P2277, DOI 10.1093/eurheartj/ehi406; van Kimmenade RRJ, 2009, J AM COLL CARDIOL, V53, P884, DOI 10.1016/j.jacc.2008.11.032; Vickery S, 2005, AM J KIDNEY DIS, V46, P610, DOI 10.1053/j.ajkd.2005.06.017; Zhang Y, 2010, AM HEART J, V160, P471, DOI 10.1016/j.ahj.2010.06.027; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zizek B, 2007, BLOOD PRESSURE, V16, P36, DOI 10.1080/08037050701189941; 葛均波, 2012, [上海医学, Shanghai Medical Journal], V35, P1	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88638	10.1371/journal.pone.0088638	http://dx.doi.org/10.1371/journal.pone.0088638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533126	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600084
J	Heiden, S; Vignon-Zellweger, N; Masuda, S; Yagi, K; Nakayama, K; Yanagisawa, M; Emoto, N				Heiden, Susi; Vignon-Zellweger, Nicolas; Masuda, Shigeru; Yagi, Keiko; Nakayama, Kazuhiko; Yanagisawa, Masashi; Emoto, Noriaki			Vascular Endothelium Derived Endothelin-1 Is Required for Normal Heart Function after Chronic Pressure Overload in Mice	PLOS ONE			English	Article							IDIOPATHIC-DILATED CARDIOMYOPATHY; NATRIURETIC-PEPTIDE RECEPTOR; ANGIOTENSIN-II; BLOOD-PRESSURE; THERAPEUTIC TARGET; INDUCED APOPTOSIS; CARDIAC-FUNCTION; SEX-DIFFERENCES; PENTOXIFYLLINE; FAILURE	Background: Endothelin-1 participates in the pathophysiology of heart failure. The reasons for the lack of beneficial effect of endothelin antagonists in heart failure patients remain however speculative. The anti-apoptotic properties of ET-1 on cardiomyocytes could be a reasonable explanation. We therefore hypothesized that blocking the pro-apoptotic TNF-alpha pathway using pentoxifylline could prevent the deleterious effect of the lack of ET-1 in a model for heart failure. Methods: We performed transaortic constriction (TAC) in vascular endothelial cells specific ET-1 deficient (VEETKO) and wild type (WT) mice (n = 5-9) and treated them with pentoxifylline for twelve weeks. Results: TAC induced a cardiac hypertrophy in VEETKO and WT mice but a reduction of fractional shortening could be detected by echocardiography in VEETKO mice only. Cardiomyocyte diameter was significantly increased by TAC in VEETKO mice only. Pentoxifylline treatment prevented cardiac hypertrophy and reduction of fractional shortening in VEETKO mice but decreased fractional shortening in WT mice. Collagen deposition and number of apoptotic cells remained stable between the groups as did TNF-alpha, caspase-3 and caspase-8 messenger RNA expression levels. TAC surgery enhanced ANP, BNP and bcl2 expression. Pentoxifylline treatment reduced expression levels of BNP, bcl2 and bax. Conclusions: Lack of endothelial ET-1 worsened the impact of TAC-induced pressure overload on cardiac function, indicating the crucial role of ET-1 for normal cardiac function under stress. Moreover, we put in light a TNF-alpha-independent beneficial effect of pentoxifylline in the VEETKO mice suggesting a therapeutic potential for pentoxifylline in a subpopulation of heart failure patients at higher risk.	[Heiden, Susi; Vignon-Zellweger, Nicolas; Yagi, Keiko; Nakayama, Kazuhiko; Emoto, Noriaki] Kobe Pharmaceut Univ, Dept Clin Pharm, Kobe, Hyogo 658, Japan; [Masuda, Shigeru; Emoto, Noriaki] Kobe Univ, Dept Internal Med, Grad Sch Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Kobe Pharmaceutical University; Kobe University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Emoto, N (corresponding author), Kobe Pharmaceut Univ, Dept Clin Pharm, Kobe, Hyogo 658, Japan.	n-emoto@kobepharma-u.ac.jp		Emoto, Noriaki/0000-0001-6673-2616; Heiden, Susi/0000-0001-8993-7120; Vignon-Zellweger, Nicolas/0000-0001-6918-0183	Takeda Science Foundation, Japan; Japan Society for the Promotion of Science KAKEHNI;  [22-00811]	Takeda Science Foundation, Japan(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science KAKEHNI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This study was supported by a grant from the Takeda Science Foundation, Japan and by the Japan Society for the Promotion of Science KAKEHNI, Grant-in-Aid for JSPS fellow 22-00811 to Susi Heiden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiarto S, 2012, LIFE SCI, V91, P651, DOI 10.1016/j.lfs.2012.02.006; Anand I, 2004, LANCET, V364, P347, DOI 10.1016/S0140-6736(04)16723-8; Bahrmann P, 2004, EUR J HEART FAIL, V6, P195, DOI 10.1016/j.ejheart.2003.09.005; Bryan PM, 2007, AM J PHYSIOL-RENAL, V292, pF1636, DOI 10.1152/ajprenal.00418.2006; Chen Q M, 2001, Cardiovasc Toxicol, V1, P267, DOI 10.1385/CT:1:4:267; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; Dickey DM, 2007, ENDOCRINOLOGY, V148, P3518, DOI 10.1210/en.2007-0081; Fantin M, 2006, EUR J PHARMACOL, V535, P301, DOI 10.1016/j.ejphar.2006.02.017; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Gahlot S, 2010, BIOCHEM PHARMACOL, V80, P1650, DOI 10.1016/j.bcp.2010.08.018; Gomez-Contreras PC, 2006, CHEMOTHERAPY, V52, P308, DOI 10.1159/000096003; Gray GA, 1996, PHARMACOL THERAPEUT, V72, P109, DOI 10.1016/S0163-7258(96)00101-5; Hocher B, 1999, HYPERTENSION, V33, P816, DOI 10.1161/01.HYP.33.3.816; Kakita T, 2001, CIRC RES, V88, P1239, DOI 10.1161/hh1201.091794; Kedzierski RM, 2003, MOL CELL BIOL, V23, P8226, DOI 10.1128/MCB.23.22.8226-8232.2003; Kirkby NS, 2008, BRIT J PHARMACOL, V153, P1105, DOI 10.1038/sj.bjp.0707516; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; Kittikulsuth W, 2013, CLIN EXP PHARMACOL P, V40, P362, DOI 10.1111/1440-1681.12084; Kittikulsuth W, 2011, HYPERTENSION, V58, P212, DOI 10.1161/HYPERTENSIONAHA.111.172734; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; LERMAN A, 1992, J AM COLL CARDIOL, V20, P849, DOI 10.1016/0735-1097(92)90183-N; LOFFLER BM, 1993, J MOL CELL CARDIOL, V25, P407, DOI 10.1006/jmcc.1993.1047; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Moorjani N, 2007, INT J CARDIOL, V116, P27, DOI 10.1016/j.ijcard.2006.04.037; Mulder P, 1998, CARDIOVASC RES, V39, P600, DOI 10.1016/S0008-6363(98)00159-X; Nicklasson M, 2002, CHIRALITY, V14, P643, DOI 10.1002/chir.10121; Nisi A, 2012, J CLIN PHARM; O'Connor CM, 2003, J AM COLL CARDIOL, V41, P1452, DOI 10.1016/S0735-1097(03)00194-3; Ogata Y, 2003, HYPERTENSION, V41, P1156, DOI 10.1161/01.HYP.0000064342.30653.24; Osterreicher J, 2001, Acta Medica (Hradec Kralove), V44, P125; POLDERMAN KH, 1993, ANN INTERN MED, V118, P429, DOI 10.7326/0003-4819-118-6-199303150-00006; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; Shaw SM, 2009, EUR J HEART FAIL, V11, P113, DOI 10.1093/eurjhf/hfn040; Shimojo N, 2006, EXP BIOL MED, V231, P932; Shohet RV, 2004, P NATL ACAD SCI USA, V101, P2088, DOI 10.1073/pnas.0307159101; Skudicky D, 2001, CIRCULATION, V103, P1083, DOI 10.1161/01.CIR.103.8.1083; Sliwa K, 2004, EUR J HEART FAIL, V6, P731, DOI 10.1016/j.ejheart.2003.11.006; Sliwa K, 2004, CIRCULATION, V109, P750, DOI 10.1161/01.CIR.0000112568.48837.60; Sliwa K, 2002, EUR J HEART FAIL, V4, P305, DOI 10.1016/S1388-9842(02)00008-9; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Vignon-Zellweger N, 2011, J HYPERTENS, V29, P961, DOI 10.1097/HJH.0b013e3283450770; Wann BP, 2006, BIOL PSYCHIAT, V59, P430, DOI 10.1016/j.biopsych.2005.07.018; Wei H, 2012, P NATL ACAD SCI USA, V109, pE841, DOI 10.1073/pnas.1202081109; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Zhao XS, 2006, CIRCULATION, V114, P830, DOI 10.1161/CIRCULATIONAHA.105.577288	47	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88730	10.1371/journal.pone.0088730	http://dx.doi.org/10.1371/journal.pone.0088730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523936	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100085
J	Nagpure, BV; Bian, JS				Nagpure, Bhushan Vijay; Bian, Jin-Song			Hydrogen Sulfide Inhibits A2A Adenosine Receptor Agonist Induced beta-Amyloid Production in SH-SY5Y Neuroblastoma Cells via a cAMP Dependent Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GAMMA-SECRETASE; NERVOUS-SYSTEM; BRAIN; EXPRESSION; APP; PATHOPHYSIOLOGY	Alzheimer's disease (AD) is the leading cause of senile dementia in today's society. Its debilitating symptoms are manifested by disturbances in many important brain functions, which are influenced by adenosine. Hence, adenosinergic system is considered as a potential therapeutic target in AD treatment. In the present study, we found that sodium hydrosulfide (NaHS, an H2S donor, 100 mu M) attenuated HENECA (a selective A2A receptor agonist, 10-200 nM) induced beta-amyloid (1-42) (A beta 42) production in SH-SY5Y cells. NaHS also interfered with HENECA-stimulated production and post-translational modification of amyloid precursor protein (APP) by inhibiting its maturation. Measurement of the C-terminal APP fragments generated from its enzymatic cleavage by beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) showed that NaHS did not have any significant effect on beta-secretase activity. However, the direct measurements of HENECA-elevated gamma-secretase activity and mRNA expressions of presenilins suggested that the suppression of A beta 42 production in NaHS pretreated cells was mediated by inhibiting gamma-secretase. NaHS induced reductions were accompanied by similar decreases in intracellular cAMP levels and phosphorylation of cAMP responsive element binding protein (CREB). NaHS significantly reduced the elevated cAMP and A beta 42 production caused by forskolin (an adenylyl cyclase, AC agonist) alone or forskolin in combination with IBMX (a phosphodiesterase inhibitor), but had no effect on those caused by IBMX alone. Moreover, pretreatment with NaHS significantly attenuated HENECA-elevated AC activity and mRNA expressions of various AC isoforms. These data suggest that NaHS may preferentially suppress AC activity when it was stimulated. In conclusion, H2S attenuated HENECA induced A beta 42 production in SH-SY5Y neuroblastoma cells through inhibiting gamma-secretase via a cAMP dependent pathway.	[Nagpure, Bhushan Vijay; Bian, Jin-Song] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	National University of Singapore	Bian, JS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	phcbjs@nus.edu.sg		Bian, Jinsong/0000-0002-7741-598X	Singapore National Medical Research Council [1183/2008]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This work is supported by a research grant from the Singapore National Medical Research Council (1183/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 1999, ANN NY ACAD SCI, V890, P79, DOI 10.1111/j.1749-6632.1999.tb07983.x; Abe K, 1996, J NEUROSCI, V16, P1066; Albasanz JL, 2008, BRAIN PATHOL, V18, P211, DOI 10.1111/j.1750-3639.2007.00112.x; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; BALLARD FJ, 1970, BIOCHEM J, V117, P231, DOI 10.1042/bj1170231; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Blum D, 2003, LANCET NEUROL, V2, P366, DOI 10.1016/S1474-4422(03)00411-3; Boison D, 2006, TRENDS PHARMACOL SCI, V27, P652, DOI 10.1016/j.tips.2006.10.008; Canals M, 2005, J NEUROCHEM, V92, P337, DOI 10.1111/j.1471-4159.2004.02856.x; Canas PM, 2009, J NEUROSCI, V29, P14741, DOI 10.1523/JNEUROSCI.3728-09.2009; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Chen Y, 2012, LIFE SCI, V91, P271, DOI 10.1016/j.lfs.2012.07.026; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; Cummings JL, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.1_Suppl_1.S2; Cummings JL, 1998, NEUROLOGY, V51, pS65, DOI 10.1212/WNL.51.1_Suppl_1.S65; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dall'lgna OP, 2003, BRIT J PHARMACOL, V138, P1207, DOI 10.1038/sj.bjp.0705185; de Mendoncca A, 2001, DRUG DEVELOP RES, V52, P283, DOI 10.1002/ddr.1125; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Decking UKM, 1997, CIRC RES, V81, P154, DOI 10.1161/01.RES.81.2.154; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Fuxe K, 2010, CNS NEUROSCI THER, V16, pe18, DOI 10.1111/j.1755-5949.2009.00126.x; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HEADRICK JP, 1990, AM J PHYSIOL, V258, pH617, DOI 10.1152/ajpheart.1990.258.3.H617; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Jeong SO, 2006, BIOCHEM BIOPH RES CO, V345, P938, DOI 10.1016/j.bbrc.2006.05.002; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Klein AM, 1999, ANN NY ACAD SCI, V893, P314, DOI 10.1111/j.1749-6632.1999.tb07845.x; Kolachala V, 2005, J BIOL CHEM, V280, P4048, DOI 10.1074/jbc.M409577200; Kumar A, 1999, NEUROCHEM RES, V24, P1209, DOI 10.1023/A:1020912704404; Lee RKK, 1997, P NATL ACAD SCI USA, V94, P5422, DOI 10.1073/pnas.94.10.5422; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lim JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1261, DOI 10.1152/ajpcell.00195.2008; Lu M, 2012, AM J PHYSIOL-CELL PH, V302, pC59, DOI 10.1152/ajpcell.00341.2010; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Mackay K, 2001, CARDIOVASC RES, V50, P65, DOI 10.1016/S0008-6363(00)00322-9; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; NORDSTEDT C, 1991, P NATL ACAD SCI USA, V88, P8910, DOI 10.1073/pnas.88.20.8910; Pan TT, 2008, AM J PHYSIOL-CELL PH, V294, pC169, DOI 10.1152/ajpcell.00282.2007; Park J., 2013, ADENOSINE, P23, DOI DOI 10.1007/978-1-4614-3903-5_2; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; Satoh JI, 1999, NEUROPATH APPL NEURO, V25, P492; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Su Y, 2003, FEBS LETT, V546, P407, DOI 10.1016/S0014-5793(03)00645-8; Takahashi RN, 2008, FRONT BIOSCI-LANDMRK, V13, P2614, DOI 10.2741/2870; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yamada K, 2005, J MOL CELL CARDIOL, V38, P945, DOI 10.1016/j.yjmcc.2004.11.020; Yang HY, 2013, ANTIOXID REDOX SIGNA; Yong QC, 2008, J MOL CELL CARDIOL, V44, P701, DOI 10.1016/j.yjmcc.2008.01.007; Yong QC, 2010, NEUROCHEM INT, V56, P508, DOI 10.1016/j.neuint.2009.12.011; Zhang H, 2011, NEUROCHEM INT, V58, P169, DOI 10.1016/j.neuint.2010.11.010	67	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88508	10.1371/journal.pone.0088508	http://dx.doi.org/10.1371/journal.pone.0088508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523906	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100055
J	Ursano, RJ; McKibben, JBA; Reissman, DB; Liu, X; Wang, LM; Sampson, RJ; Fullerton, CS				Ursano, Robert J.; McKibben, Jodi B. A.; Reissman, Dori B.; Liu, Xian; Wang, Leming; Sampson, Robert J.; Fullerton, Carol S.			Posttraumatic Stress Disorder and Community Collective Efficacy following the 2004 Florida Hurricanes	PLOS ONE			English	Article							MENTAL-HEALTH; PTSD CHECKLIST; DEPRESSION; SYMPTOMS; DISASTER; VETERANS; CONTEXT; WORKERS; SAFETY	There is a paucity of research investigating the relationship of community-level characteristics such as collective efficacy and posttraumatic stress following disasters. We examine the association of collective efficacy with probable posttraumatic stress disorder and posttraumatic stress disorder symptom severity in Florida public health workers (n = 2249) exposed to the 2004 hurricane season using a multilevel approach. Anonymous questionnaires were distributed electronically to all Florida Department of Health personnel nine months after the 2004 hurricane season. The collected data were used to assess posttraumatic stress disorder and collective efficacy measured at both the individual and zip code levels. The majority of participants were female (80.42%), and ages ranged from 20 to 78 years (median = 49 years); 73.91% were European American, 13.25% were African American, and 8.65% were Hispanic. Using multi-level analysis, our data indicate that higher community-level and individual-level collective efficacy were associated with a lower likelihood of having posttraumatic stress disorder (OR = 0.93, CI = 0.88-0.98; and OR = 0.94, CI = 0.92-0.97, respectively), even after adjusting for individual sociodemographic variables, community socioeconomic characteristic variables, individual injury/damage, and community storm damage. Higher levels of community-level collective efficacy and individual-level collective efficacy were also associated with significantly lower posttraumatic stress disorder symptom severity (b = -0.22, p<0.01; and b = -0.17, p<0.01, respectively), after adjusting for the same covariates. Lower rates of posttraumatic stress disorder are associated with communities with higher collective efficacy. Programs enhancing community collective efficacy may be an important part of prevention practices and possibly lead to a reduction in the rate of posttraumatic stress disorder post-disaster.	[Ursano, Robert J.; McKibben, Jodi B. A.; Liu, Xian; Wang, Leming; Fullerton, Carol S.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Reissman, Dori B.] NIOSH, Off Director, Washington, DC USA; [Sampson, Robert J.] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA	Uniformed Services University of the Health Sciences - USA; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Harvard University	Fullerton, CS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA.	cfullert@erols.com	Sampson, Robert J./AAB-7369-2020; Ursano, Robert J/ABE-6533-2020	Ursano, Robert/0000-0002-1861-9173	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by funds from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno Ron, 2007, Am J Public Health, V97 Suppl 1, pS103, DOI 10.2105/AJPH.2006.087007; Aiken L. S., 1991, MULTIPLE REGRESSION; Akbayrak N, 2005, MIL MED, V170, P125; [Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; [Anonymous], 2006, SAS MIXED MODELS; Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Benedek DM, 2007, ANNU REV PUBL HEALTH, V28, P55, DOI 10.1146/annurev.publhealth.28.021406.144037; Benight CC, 2004, ANXIETY STRESS COPIN, V17, P401, DOI 10.1080/10615800512331328768; Bills CB, 2008, MT SINAI J MED, V75, P115, DOI 10.1002/msj.20026; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Bryant RA, 1996, J TRAUMA STRESS, V9, P51, DOI 10.1007/BF02116833; Carson MA, 2000, J CONSULT CLIN PSYCH, V68, P890, DOI 10.1037/0022-006X.68.5.890; Cieslak R, 2013, J NERV MENT DIS, V201, P917, DOI 10.1097/NMD.0000000000000034; Cohen DA, 2006, SOC SCI MED, V62, P769, DOI 10.1016/j.socscimed.2005.06.033; Cohen DA, 2003, SOC SCI MED, V57, P1631, DOI 10.1016/S0277-9536(03)00015-7; Coleman J., 1990, FDN SOCIAL THEORY; FEMA, 2010, FEMAS PUBL ASS PROGR; Fontana A, 1997, AM J PSYCHIAT, V154, P758; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Gapen M, 2011, AM J ORTHOPSYCHIAT, V81, P31, DOI 10.1111/j.1939-0025.2010.01069.x; Grieger TA, 2003, PSYCHIAT SERV, V54, P1383, DOI 10.1176/appi.ps.54.10.1383; Hembree C, 2005, HEALTH PLACE, V11, P147, DOI 10.1016/j.healthplace.2004.02.005; Hobfoll SE, 2006, J TRAUMA STRESS, V19, P867, DOI 10.1002/jts.20166; Jack K, 2002, J URBAN HEALTH, V79, P332, DOI 10.1093/jurban/79.3.332; Kerasiotis Bernadina, 2004, Int J Emerg Ment Health, V6, P121; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; McCarroll JE, 1996, AM J PSYCHIAT, V153, P778; National Oceanic and Atmospheric Administration NWS National Hurricane Center, 2005, ATL HURR SEAS; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Odgers CL, 2009, DEV PSYCHOL, V45, P942, DOI 10.1037/a0016162; Raudenbush S. W., 2002, HIERARCHIAL LINEAR M; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sapouna M, 2010, J INTERPERS VIOLENCE, V25, P1912, DOI 10.1177/0886260509354509; *SAS I INC, 2006, SAS STAT SOFTW VERS; Schoenbaum M, 2009, ARCH GEN PSYCHIAT, V66, P906, DOI 10.1001/archgenpsychiatry.2009.77; Shah S. A., 2010, EMERGENCY PUBLIC HLT, P493; Siegel CE, 2004, AM J PUBLIC HEALTH, V94, P582, DOI 10.2105/AJPH.94.4.582; Tanieliean TL, 2008, INVISIBLE WOUNDS WAR; Vaeth PAC, 2010, J INTERPERS VIOLENCE, V25, P771, DOI 10.1177/0886260509336957; van Kamp I, 2006, EUR J PUBLIC HEALTH, V16, P252, DOI 10.1093/eurpub/cki188; Walker EA, 2002, GEN HOSP PSYCHIAT, V24, P375, DOI 10.1016/S0163-8343(02)00203-7; Wang J., 2009, MULTILEVEL MODELS AP; Weathers F.W., 1996, MEASUREMENT STRESS T, P250; Xue YG, 2005, ARCH GEN PSYCHIAT, V62, P554, DOI 10.1001/archpsyc.62.5.554	45	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88467	10.1371/journal.pone.0088467	http://dx.doi.org/10.1371/journal.pone.0088467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7DT	24523900	gold, Green Published, Green Submitted			2022-12-27	WOS:000331258100049
J	Amorim, R; Costa, SM; Cavaleiro, NP; da Silva, EE; da Costa, LJ				Amorim, Raquel; Costa, Sara Mesquita; Cavaleiro, Nathalia Pereira; da Silva, Edson Elias; da Costa, Luciana Jesus			HIV-1 Transcripts Use IRES-Initiation under Conditions Where Cap-Dependent Translation Is Restricted by Poliovirus 2A Protease	PLOS ONE			English	Article							RIBOSOME ENTRY SEGMENT; MESSENGER-RNA; CELL-CYCLE; VIRAL SUBVERSION; BINDING-PROTEIN; CLEAVAGE; 2A(PRO); INHIBITION; EXPRESSION; PROTEOLYSIS	The 30 different species of mRNAs synthesized during the HIV-1 replication cycle are all capped and polyadenilated. Internal ribosome entry sites have been recognized in the 59 untranslated region of some mRNA species of HIV-1, which would contribute to an alternative mechanism of initiation of mRNA translation. However, the Cap-dependent translation is assumed to be the main mechanism driving the initiation of HIV-1 protein synthesis. In this work, we describe a cell system in which lower to higher levels of transient expression of the poliovirus 2A protease strongly inhibited cellular Capdependent translation with no toxic effect to the cells during a 72-hour time frame. In this system, the synthesis of HIV-1 proteins was inhibited in a temporal dose-dependent way. Higher levels of 2A protease expression severely inhibited HIV-1 protein synthesis during the first 24 hours of infection consequently inhibiting viral production and infectivity. Intermediate to lower levels of 2A Protease expression caused the inhibition of viral protein synthesis only during the first 48 hours of viral replication. After this period both protein synthesis and viral release were recovered to the control levels. However, the infectivity of viral progeny was still partially inhibited. These results indicate that two mechanisms of mRNA translation initiation contribute to the synthesis of HIV-1 proteins; during the first 24-48 hours of viral replication HIV-1 protein synthesis is strongly dependent on Cap-initiation, while at later time points IRES-driven translation initiation is sufficient to produce high amounts of viral particles.	[Amorim, Raquel; Costa, Sara Mesquita; Cavaleiro, Nathalia Pereira; da Costa, Luciana Jesus] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, BR-21941 Rio De Janeiro, Brazil; [da Silva, Edson Elias] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Enterovirus, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	da Costa, LJ (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, BR-21941 Rio De Janeiro, Brazil.	ljcosta@micro.ufrj.br	Costa, Luciana J/B-7878-2013; Amorim, Raquel/M-8161-2013	Amorim, Raquel/0000-0002-1605-0702	CNPq; CAPES; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported with grants from CNPq, CAPES and FAPERJ. RA was supported with a Ph.D. scholarship from CAPES. The funders had no role in the study, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aldabe R, 1995, FEBS LETT, V377, P1, DOI 10.1016/0014-5793(95)01269-9; Barco A, 2000, J VIROL, V74, P2383, DOI 10.1128/JVI.74.5.2383-2392.2000; Berkhout B, 2011, NUCLEIC ACIDS RES, V39, P5232, DOI 10.1093/nar/gkr113; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Calandria C, 2004, VIRUS RES, V104, P39, DOI 10.1016/j.virusres.2004.02.042; Camerini V, 2008, J VIROL, V82, P3574, DOI 10.1128/JVI.02038-07; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; Chamond N, 2010, BIOCHEM SOC T, V38, P1548, DOI 10.1042/BST0381548; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chase AJ, 2012, FUTURE VIROL, V7, P179, DOI 10.2217/FVL.12.2; de Breyne S, 2012, FEBS J, V279, P3098, DOI 10.1111/j.1742-4658.2012.08689.x; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HAMBIDGE SJ, 1991, J VIROL, V65, P6312, DOI 10.1128/JVI.65.11.6312-6315.1991; JANG SK, 1990, ENZYME, V44, P292, DOI 10.1159/000468766; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Jurgens CK, 2006, VIROLOGY, V345, P346, DOI 10.1016/j.virol.2005.09.067; Kempf BJ, 2008, J VIROL, V82, P5847, DOI 10.1128/JVI.01514-07; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; LEIBOWITZ R, 1971, J VIROL, V8, P661, DOI 10.1128/JVI.8.5.661-668.1971; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lloyd RE, 2006, VIRUS RES, V119, P76, DOI 10.1016/j.virusres.2005.10.016; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Monette A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068108; Muramatsu M, 1963, QUANTITATIVE ASPECTS; Ochs K, 2003, J VIROL, V77, P115, DOI 10.1128/JVI.77.1.115-122.2003; Ohlmann T, 2000, J BIOL CHEM, V275, P11899, DOI 10.1074/jbc.275.16.11899; Plank TDM, 2013, NUCLEIC ACIDS RES, V41, P6698, DOI 10.1093/nar/gkt358; Reineke LC, 2011, CURR OPIN VIROL, V1, P363, DOI 10.1016/j.coviro.2011.10.009; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schindler M, 2005, HUMAN IMMUNODEFICIEN; Sharma A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002612; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Soto-Rifo R, 2012, NUCLEIC ACIDS RES, V40, P2653, DOI 10.1093/nar/gkr1093; Svitkin YV, 1999, J VIROL, V73, P3467, DOI 10.1128/JVI.73.4.3467-3472.1999; Thierry S, 2004, J VIROL, V78, P12198, DOI 10.1128/JVI.78.22.12198-12206.2004; Vallejos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035031; Vallejos M, 2011, NUCLEIC ACIDS RES, V39, P6186, DOI 10.1093/nar/gkr189; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	50	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88619	10.1371/journal.pone.0088619	http://dx.doi.org/10.1371/journal.pone.0088619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520405	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600096
J	Alguacil, MD; Torrecillas, E; Lozano, Z; Torres, MP; Roldan, A				del Mar Alguacil, Maria; Torrecillas, Emma; Lozano, Zenaida; Pilar Torres, Maria; Roldan, Antonio			Prunus persica Crop Management Differentially Promotes Arbuscular Mycorrhizal Fungi Diversity in a Tropical Agro-Ecosystem	PLOS ONE			English	Article							CONVENTIONAL FARMING SYSTEMS; LONG-TERM FERTILIZATION; VITIS-VINIFERA; SOIL; COMMUNITIES; ROOTS; COLONIZATION; ABUNDANCE; IMPACT; PHYLUM	Due to the important role of arbuscular mycorrhizal fungi (AMF) in ecosystem functioning, determination of the effect of management practices on the AMF diversity in agricultural soils is essential for the sustainability of these agro-ecosystems. The objective of this study was to compare the AMF diversity in Prunus persica roots under two types of fertilisation (inorganic, with or without manure) combined with integrated or chemical pest management in a Venezuelan agro-ecosystem. The AM fungal small-subunit (SSU) rRNA genes were subjected to PCR, cloning, sequencing and phylogenetic analyses. Twenty-one different phylotypes were identified: 15 belonged to the genus Glomus, one to Claroideoglomus, two to Paraglomus, one to Acaulospora, one to Scutellospora and one to Archaeospora. The distribution of the AMF community composition differed as a consequence of the treatment effects. The treatment combining organic and inorganic fertilisation with chemical pest control had the highest AMF richness and the treatment combining inorganic fertilisation with chemical pest had the lowest. The real causes and effects of these differences in the AMF community are very difficult to establish, since the crop management regimes tested were composed of several interacting factors. In conclusion, the crop management practices can exert a significant influence on the populations of AMF. The treatment combining organic and inorganic fertilisation with chemical pest control appears to be the most suitable agricultural management strategy with respect to improving the AMF diversity in this crop under tropical conditions, and thus for maintaining the agricultural and environmental sustainability of this agro-ecosystem.	[del Mar Alguacil, Maria; Torrecillas, Emma; Roldan, Antonio] CSIC, Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Murcia, Spain; [Lozano, Zenaida] UCV, Fac Agron, Inst Edafol, Maracay, Venezuela; [Pilar Torres, Maria] Univ Miguel Hernandez, Area Bot, Dept Biol Aplicada, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Central Venezuela; Universidad Miguel Hernandez de Elche	Alguacil, MD (corresponding author), CSIC, Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Campus Espinardo, Murcia, Spain.	mmalguacil@cebas.csic.es	Roldan, Antonio/F-6241-2013; caputo, carlo/N-3747-2014; del Mar Alguacil, Maria/M-3859-2014	del Mar Alguacil, Maria/0000-0001-8495-8707; Roldan, Antonio/0000-0002-2610-7784	Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain)	Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain)(German Research Foundation (DFG))	This research was supported by funding from Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain). MM Alguacil was supported by the Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avilan L, 1990, SUELOS FERTILIZANTES; Balestrini R, 2010, ENV MICROBIOL REP, V2, P594, DOI 10.1111/j.1758-2229.2010.00160.x; Beauregard MS, 2010, MICROB ECOL, V59, P379, DOI 10.1007/s00248-009-9583-z; Bhadalung NN, 2005, PLANT SOIL, V270, P371, DOI 10.1007/s11104-004-1829-4; Bharadwaj DP, 2007, APPL SOIL ECOL, V35, P213, DOI 10.1016/j.apsoil.2006.04.003; Borriello R, 2012, BIOL FERT SOILS, V48, P911, DOI 10.1007/s00374-012-0683-4; Bradley K, 2006, SOIL BIOL BIOCHEM, V38, P1583, DOI 10.1016/j.soilbio.2005.11.011; Caravaca F, 2003, FOREST ECOL MANAG, V182, P49, DOI 10.1016/S0378-1127(03)00067-7; Cesaro P, 2008, APPL ENVIRON MICROB, V74, P5776, DOI 10.1128/AEM.00719-08; Colwell RK, 2013, ESTIMATES STAT ESTIM; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; Alguacil MD, 2011, APPL ENVIRON MICROB, V77, P8656, DOI 10.1128/AEM.05577-11; Alguacil MD, 2010, SOIL BIOL BIOCHEM, V42, P1114, DOI 10.1016/j.soilbio.2010.03.012; Alguacil MD, 2009, APPL ENVIRON MICROB, V75, P4254, DOI 10.1128/AEM.00316-09; Galvan GA, 2009, MYCORRHIZA, V19, P317, DOI 10.1007/s00572-009-0237-2; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; Gosling P, 2010, AGR ECOSYST ENVIRON, V139, P273, DOI 10.1016/j.agee.2010.08.013; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; Joner EJ, 2000, BIOL FERT SOILS, V32, P435, DOI 10.1007/s003740000279; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lumini E, 2011, ECOL APPL, V21, P1696, DOI 10.1890/10-1542.1; Mader P, 2000, BIOL FERT SOILS, V31, P150, DOI 10.1007/s003740050638; Martinez-Medina A, 2011, APPL SOIL ECOL, V47, P98, DOI 10.1016/j.apsoil.2010.11.010; Martinez-Medina A, 2009, J SCI FOOD AGR, V89, P1843, DOI 10.1002/jsfa.3660; Mathimaran N, 2007, AGR ECOSYST ENVIRON, V119, P22, DOI 10.1016/j.agee.2006.06.004; Nicholas KB., 1997, GENEDOC TOOL EDITING; Oehl F, 2005, NEW PHYTOL, V165, P273, DOI 10.1111/j.1469-8137.2004.01235.x; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oehl F, 2010, SOIL BIOL BIOCHEM, V42, P724, DOI 10.1016/j.soilbio.2010.01.006; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; Querejeta JI, 2007, FUNCT PLANT BIOL, V34, P683, DOI 10.1071/FP07061; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos-Gonzalez JC, 2011, MICROB ECOL, V62, P25, DOI 10.1007/s00248-011-9834-7; Sasvari Z, 2011, BIOL FERT SOILS, V47, P167, DOI 10.1007/s00374-010-0519-z; Schreiner RP, 2009, MYCOLOGIA, V101, P599, DOI 10.3852/08-169; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Soil Survey Staff (SSS), 2010, KEYS SOIL TAX; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2002, PAUP PHYL AN US PARS; ter Braak C.F.J., 2004, CANOCO REFERENCE MAN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toljander JF, 2008, FEMS MICROBIOL ECOL, V65, P323, DOI 10.1111/j.1574-6941.2008.00512.x; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Verbruggen E, 2012, MOL ECOL, V21, P2341, DOI 10.1111/j.1365-294X.2012.05534.x; Verbruggen E, 2010, NEW PHYTOL, V186, P968, DOI 10.1111/j.1469-8137.2010.03230.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x	57	3	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88454	10.1371/journal.pone.0088454	http://dx.doi.org/10.1371/journal.pone.0088454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520389	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600080
J	Levine, M; Crimmins, E				Levine, Morgan; Crimmins, Eileen			Not All Smokers Die Young: A Model for Hidden Heterogeneity within the Human Population	PLOS ONE			English	Article							ADVANCED GLYCATION ENDPRODUCTS; OXIDATIVE STRESS; CIGARETTE-SMOKING; LIFE-SPAN; SUPEROXIDE-DISMUTASE; STATIONARY-PHASE; GENE-EXPRESSION; HUMAN LONGEVITY; NULL MUTATION; CELL COUNT	The ability of some individuals to reach extreme old age in the presence of clearly high exposure to damaging factors may signal an innate biological advantage. For this study we used data on 4,655 current and never smokers, ages 50 and above, from NHANES III to examine whether long-lived smokers represent a biologically resilient phenotype that could facilitate our understanding of heterogeneity in the aging process. Using a proportional hazards model, our results showed that while smoking significantly increased mortality in most age groups, it did not increase the mortality risk for those who were age 80 and over at baseline. Additionally when comparing the adjusted means of biomarkers between never and current smokers, we found that long-lived smokers (80+) had similar inflammation, HDL, and lung function levels to never smokers. Given that factors which allow some individuals to withstand smoking may also enable others to cope with everyday biological stressors, the investigation of long-lived smokers may eventually allow us to identify molecular and genetic mechanisms which enable longevity extension.	[Levine, Morgan; Crimmins, Eileen] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA	University of Southern California	Levine, M (corresponding author), Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA.	canon@usc.edu			National Institute on Aging [P30AG017265, T32AG0037]; NATIONAL INSTITUTE ON AGING [P30AG017265, T32AG000037] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging, Grants P30AG017265 and T32AG0037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Balistreri CR, 2004, JAMA-J AM MED ASSOC, V292, P2339, DOI 10.1001/jama.292.19.2339; Barbieri M, 2003, EXP GERONTOL, V38, P137, DOI 10.1016/S0531-5565(02)00153-5; Barter PJ, 2013, ENDOCRINOL METAB, V28, P169, DOI 10.3803/EnM.2013.28.3.169; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barzilai N, 2010, J AM GERIATR SOC, V49, P1; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Conen D, 2013, J HUM HYPERTENS, V27, P71, DOI 10.1038/jhh.2012.7; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Del Turco S, 2012, BIOFACTORS, V38, P266, DOI 10.1002/biof.1018; Duttaroy A, 2003, GENETICS, V165, P2295; El-Gohary A, 2013, APPL MATH MODEL, V37, P13, DOI 10.1016/j.apm.2011.05.017; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2010, AGING CELL, V9, P519, DOI 10.1111/j.1474-9726.2010.00578.x; Flouris AD, 2012, FOOD CHEM TOXICOL, V50, P3600, DOI 10.1016/j.fct.2012.07.025; Fragoso CAV, 2012, AM J MED, V125, P79, DOI 10.1016/j.amjmed.2011.06.024; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2005, MECH AGEING DEV, V126, P351, DOI 10.1016/j.mad.2004.08.028; Gan WQ, 2005, CHEST, V127, P558, DOI 10.1378/chest.127.2.558; GARRISON RJ, 1978, ATHEROSCLEROSIS, V30, P17, DOI 10.1016/0021-9150(78)90149-1; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hubbard RE, 2009, AGE AGEING, V38, P115, DOI 10.1093/ageing/afn252; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Lithgow CJ, 2000, BIOESSAYS, V22, P410, DOI 10.1002/(SICI)1521-1878(200005)22:5<410::AID-BIES2>3.0.CO;2-C; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; McGrowder D, 2011, CHOLESTEROL, DOI 10.1155/2011/496925; Nicholl ID, 1998, CELL MOL BIOL, V44, P1025; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Puri BK, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-S1-S4; Rahilly-Tierney C, 2012, CIRC-CARDIOVASC QUAL, V5, P381, DOI 10.1161/CIRCOUTCOMES.111.963850; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Santos S, 2004, VASC MED, V9, P171, DOI 10.1191/1358863x04vm543oa; Smith MR, 2003, ATHEROSCLEROSIS, V169, P331, DOI 10.1016/S0021-9150(03)00200-4; Unlu ES, 2007, ANN NY ACAD SCI, V1100, P505, DOI 10.1196/annals.1395.055; US Department of Health and Human Services (DHHS) National Center for Health Statistics, 2001, 3 NAT HLTH NUTR EX S; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Walter M, 2009, ARTERIOSCL THROM VAS, V29, P1244, DOI 10.1161/ATVBAHA.108.181438; Watson J, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e454; Wawryn J, 1999, ACTA BIOCHIM POL, V46, P249, DOI 10.18388/abp.1999_4158; YASHIN AI, 1985, THEOR POPUL BIOL, V27, P154, DOI 10.1016/0040-5809(85)90008-5; Yin DZ, 2005, EXP GERONTOL, V40, P455, DOI 10.1016/j.exger.2005.03.012	64	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87403	10.1371/journal.pone.0087403	http://dx.doi.org/10.1371/journal.pone.0087403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520332	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600023
J	Nakamura, A; Maess, B; Knosche, TR; Friederici, AD				Nakamura, Akinori; Maess, Burkhard; Knoesche, Thomas R.; Friederici, Angela D.			Different Hemispheric Roles in Recognition of Happy Expressions	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; EVENT-RELATED POTENTIALS; EMOTIONAL FACIAL EXPRESSIONS; POSITRON-EMISSION-TOMOGRAPHY; HUMAN NEURAL SYSTEM; FACE PERCEPTION; HUMAN AMYGDALA; HUMAN BRAIN; TEMPORAL CORTEX; TIME-COURSE	The emotional expression of the face provides an important social signal that allows humans to make inferences about other people's state of mind. However, the underlying brain mechanisms are complex and still not completely understood. Using magnetoencephalography (MEG), we analyzed the spatiotemporal structure of regional electrical brain activity in human adults during a categorization task (faces or hands) and an emotion discrimination task (happy faces or neutral faces). Brain regions that are specifically important for different aspects of processing emotional facial expressions showed interesting hemispheric dominance patterns. The dorsal brain regions showed a right predominance when participants paid attention to facial expressions: The right parietofrontal regions, including the somatosensory, motor/premotor, and inferior frontal cortices showed significantly increased activation in the emotion discrimination task, compared to in the categorization task, in latencies of 350 to 550 ms, while no activation was found in their left hemispheric counterparts. Furthermore, a left predominance of the ventral brain regions was shown for happy faces, compared to neutral faces, in latencies of 350 to 550 ms within the emotion discrimination task. Thus, the present data suggest that the right and left hemispheres play different roles in the recognition of facial expressions depending on cognitive context.	[Nakamura, Akinori] Natl Ctr Geriatr & Gerontol, Dept Clin & Expt Neuroimaging, Obu, Japan; [Nakamura, Akinori; Maess, Burkhard] Max Planck Inst Human Cognit & Brain Sci, Method & Dev Grp MEG & EEG Signal Anal & Modellin, Leipzig, Germany; [Knoesche, Thomas R.] Max Planck Inst Human Cognit & Brain Sci, Method & Dev Grp Cort Networks & Cognit Funct, Leipzig, Germany; [Friederici, Angela D.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany	National Center for Geriatrics & Gerontology; Max Planck Society; Max Planck Society; Max Planck Society	Nakamura, A (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Clin & Expt Neuroimaging, Obu, Japan.	nakamura@ncgg.go.jp		Nakamura, Akinori/0000-0002-4259-1297; Maess, Burkhard/0000-0002-7857-291X				Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 1996, J NEUROSCI, V16, P7678; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; AHERN GL, 1979, NEUROPSYCHOLOGIA, V17, P693, DOI 10.1016/0028-3932(79)90045-9; Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; BOTZEL K, 1995, EXP BRAIN RES, V104, P135, DOI 10.1007/BF00229863; BOWERS D, 1985, BRAIN COGNITION, V4, P258, DOI 10.1016/0278-2626(85)90020-X; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Clark VP, 1996, NEUROIMAGE, V4, P1, DOI 10.1006/nimg.1996.0025; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; DEKOSKY ST, 1980, BRAIN LANG, V9, P206, DOI 10.1016/0093-934X(80)90141-8; Dien J, 1998, BRAIN TOPOGR, V11, P43, DOI 10.1023/A:1022218503558; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; ELLIS AW, 1990, Q J EXP PSYCHOL-A, V42, P495, DOI 10.1080/14640749008401234; ETCOFF NL, 1984, NEUROPSYCHOLOGIA, V22, P281, DOI 10.1016/0028-3932(84)90075-7; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Graham R, 2001, NEUROREPORT, V12, P245, DOI 10.1097/00001756-200102120-00013; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Herrmann MJ, 2002, INT J PSYCHOPHYSIOL, V45, P241, DOI 10.1016/S0167-8760(02)00033-8; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Ioannides AA, 2000, HUM BRAIN MAPP, V11, P77, DOI 10.1002/1097-0193(200010)11:2<77::AID-HBM20>3.0.CO;2-0; Ioannides AA, 2004, NEUROIMAGE, V23, P473, DOI 10.1016/j.neuroimage.2004.06.023; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klopp J, 2000, HUM BRAIN MAPP, V11, P286, DOI 10.1002/1097-0193(200012)11:4<286::AID-HBM80>3.3.CO;2-I; Knosche T, 1996, ELECTROEN CLIN NEURO, V99, P183, DOI 10.1016/0013-4694(96)95648-5; Knosche TR, 1997, SOLUTIONS NEUROELECT; Krolak-Salmon P, 2001, EUR J NEUROSCI, V13, P987, DOI 10.1046/j.0953-816x.2001.01454.x; Kujala MV, 2009, HUM BRAIN MAPP, V30, P3910, DOI 10.1002/hbm.20816; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Liu BC, 1999, BRAIN TOPOGR, V11, P291, DOI 10.1023/A:1022258620435; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; Martinez A., 1998, AR FACE DATABASE CVC; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Monroe JF, 2013, HUM BRAIN MAPP, V34, P1, DOI 10.1002/hbm.21406; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Munte TF, 1998, NEUROSCI RES, V30, P25, DOI 10.1016/S0168-0102(97)00118-1; Nakamura A, 2004, NEUROIMAGE, V23, P25, DOI 10.1016/j.neuroimage.2004.04.034; Nakamura A, 2001, NEUROSCI LETT, V312, P13, DOI 10.1016/S0304-3940(01)02168-1; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1610, DOI 10.1152/jn.1999.82.3.1610; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Puce A, 1998, J NEUROSCI, V18, P2188; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; Sams M, 1997, NEUROSCIENCE, V77, P49, DOI 10.1016/S0306-4522(96)00419-8; Sato N, 1999, NEUROREPORT, V10, P3633, DOI 10.1097/00001756-199911260-00031; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2003, NEUROSCI LETT, V342, P101, DOI 10.1016/S0304-3940(03)00274-X; Streit M, 2000, NEUROSCI LETT, V278, P13, DOI 10.1016/S0304-3940(99)00884-8; Talairach J., 1988, COPLANAR STEREOTAXIC; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Watanabe S, 1999, COGNITIVE BRAIN RES, V8, P125, DOI 10.1016/S0926-6410(99)00013-0; WEDDING D, 1985, INT J NEUROSCI, V27, P277, DOI 10.3109/00207458509149773; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009; YOUNG AW, 1986, PSYCHOL RES-PSYCH FO, V48, P63, DOI 10.1007/BF00309318	87	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88628	10.1371/journal.pone.0088628	http://dx.doi.org/10.1371/journal.pone.0088628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520407	gold, Green Submitted, Green Published			2022-12-27	WOS:000331254600098
J	Sontag, TJ; Reardon, CA				Sontag, Timothy J.; Reardon, Catherine A.			Polymorphisms of Mouse Apolipoprotein A-II Alter Its Physical and Functional Nature	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOA-I; INCREASED ATHEROSCLEROSIS; MICE LACKING; DIETARY-FAT; DEFICIENCY; BINDING; EXPRESSION; RISK; HYPERTRIGLYCERIDEMIA	ApoA-II is the second most abundant protein on HDL making up similar to 20% of the total protein but its functions have still only been partially characterized. Recent methodological improvements have allowed for the recombinant expression and characterization of human apoA-II which shares only 55% sequence homology with murine apoA-II. Here we describe the purification of the two most common polymorphic variants of apoA-II found in inbred mouse strains, differing at 3 amino acid sites. C57BL/6 mice having variant apoA-II a have lower plasma HDL levels than FVB/N mice that have variant apoA-IIb. Characterization of the helical structure of these two variants reveals a more alpha-helical structure for the FVB/N apoA-II. These changes do not alter the lipid or HDL binding of the two apoA-II variants, but significantly increase the ability of the FVB/N variant to promote both ABCA1 and ABCG1 mediated cellular cholesterol efflux. These differences may be differentially altering plasma HDL apoA-II levels. In vivo, neither C57 nor FVB apoA-II protein levels are affected by the absence of apoE, while an apoE/apoA-I double deficiency results in a 50% decrease of plasma FVB apoA-II but results in undetectable levels of C57 apoA-II in the plasma. FVB apoA-II is able to form an HDL particle in the absence of apoE or apoA-I.	[Sontag, Timothy J.; Reardon, Catherine A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Sontag, TJ (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	tsontag@bsd.uchicago.edu						Birjmohun RS, 2007, CIRCULATION, V116, P2029, DOI 10.1161/CIRCULATIONAHA.107.704031; Boden WE, 2000, AM J CARDIOL, V86, p19L; Cabana VG, 2004, J LIPID RES, V45, P317, DOI 10.1194/jlr.M300414-JLR200; Chou CY, 2006, J BIOL CHEM, V281, P13333, DOI 10.1074/jbc.M511077200; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; DEEB SS, 1990, AM J HUM GENET, V46, P822; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380; Duverger N, 1996, CIRCULATION, V94, P713, DOI 10.1161/01.CIR.94.4.713; EISENBERG S, 1984, J LIPID RES, V25, P1017; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Hedrick CC, 2001, J LIPID RES, V42, P563; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kitagawa K, 2003, AMYLOID, V10, P207, DOI 10.3109/13506120309041737; LOPEZ J, 1994, EUR J BIOCHEM, V225, P1141, DOI 10.1111/j.1432-1033.1994.1141b.x; Lund-Katz S, 2010, J LIPID RES, V51, P606, DOI 10.1194/jlr.M002055; MILLER CG, 1987, J LIPID RES, V28, P311; Moore RE, 2005, CIRC RES, V97, P763, DOI 10.1161/01.RES.0000185320.82962.F7; Moore RE, 2003, ARTERIOSCL THROM VAS, V23, P1914, DOI 10.1161/01.ATV.0000092328.66882.F5; Natarajan P, 2004, J BIOL CHEM, V279, P24044, DOI 10.1074/jbc.M400561200; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; OSADA J, 1994, ATHEROSCLEROSIS, V108, P83, DOI 10.1016/0021-9150(94)90039-6; PASZTY C, 1994, J CLIN INVEST, V94, P899, DOI 10.1172/JCI117412; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Sankaranarayanan S, 2009, J LIPID RES, V50, P275, DOI 10.1194/jlr.M800362-JLR200; Smith LE, 2012, J LIPID RES, V53, P1708, DOI 10.1194/jlr.D028043; Smith LE, 2010, BBA-MOL CELL BIOL L, V1801, P64, DOI 10.1016/j.bbalip.2009.09.012; Sontag TJ, 2012, J LIPID RES, V53, P951, DOI 10.1194/jlr.M021154; SORCITHOMAS M, 1989, J LIPID RES, V30, P1397; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Voyiaziakis E, 1998, J LIPID RES, V39, P313; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; Wang YY, 2011, J LIPID RES, V52, P1461, DOI 10.1194/jlr.M013235; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Winkler K, 2008, CLIN CHEM, V54, P1405, DOI 10.1373/clinchem.2008.103929; Wool GD, 2008, J LIPID RES, V49, P1268, DOI 10.1194/jlr.M700552-JLR200; ZHONG SB, 1994, J CLIN INVEST, V94, P2457, DOI 10.1172/JCI117614	40	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88705	10.1371/journal.pone.0088705	http://dx.doi.org/10.1371/journal.pone.0088705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520415	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600106
J	Tang, YK; Wen, XF; Sun, XM; Wang, HM				Tang, Yakun; Wen, Xuefa; Sun, Xiaomin; Wang, Huimin			Interannual Variation of the Bowen Ratio in a Subtropical Coniferous Plantation in Southeast China, 2003-2012	PLOS ONE			English	Article							SOIL RESPIRATION; CARBON-DIOXIDE; PRIMARY PRODUCTIVITY; FLUX MEASUREMENTS; DECIDUOUS FOREST; PINE PLANTATION; GROWING-SEASON; MIXED FOREST; HEAT FLUXES; ENERGY	The interannual variation of the Bowen ratio, through its effect on the warming extent of available energy to the ecosystem land surface air, heavily influences the ecosystem microclimate and affects the hydrological cycle at both regional and global scales. Although the precipitation amount in southeast China is not expected to change greatly as a result of climate change, the precipitation frequency may be altered in the future. We explored the interannual variation of the Bowen ratio and its affecting mechanisms based on eddy covariance measurements in a subtropical plantation in southeast China during 2003-2012. The results indicated that the annual mean Bowen ratio was 0.3560.06, with a range of 0.29-0.45. The Bowen ratio during the dry season (July-October) positively correlated with the annual Bowen ratio (R-2 = 0.85, p<0.001). The effective precipitation frequency during the dry season, through its positive effect on shallow soil water content, indirectly and negatively affected the annual Bowen ratio. Between 2003 and 2012, the annual Bowen ratio exhibited a marginally significant decreasing trend (p = 0.061), meanwhile the effective precipitation frequency and shallow soil water content during the dry season increased significantly (p<0.001). The annual Bowen ratio may decrease further if the effective precipitation frequency and shallow soil water content during the dry season follow similar trends in the future. The warming effect of available energy to the surface air of our studied plantation may decline with the decreasing annual Bowen ratio.	[Tang, Yakun; Wen, Xuefa; Sun, Xiaomin; Wang, Huimin] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Tang, Yakun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wen, XF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	wenxf@igsnrr.ac.cn; sunxm@igsnrr.ac.cn	wang, huimin/HDM-8421-2022		Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences [XDA05050601]; National Natural Science Foundation of China [31070408]; Strategic Program of Knowledge Innovation of Chinese Academy of Sciences [KZCX2-EW-QN305]	Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Program of Knowledge Innovation of Chinese Academy of Sciences	This study was supported by the Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences (grant XDA05050601), the National Natural Science Foundation of China (grant 31070408), and the Strategic Program of Knowledge Innovation of Chinese Academy of Sciences (grant KZCX2-EW-QN305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi D, 2000, GLOBAL CHANGE BIOL, V6, P69, DOI 10.1046/j.1365-2486.2000.06014.x; Baldocchi D, 2001, AGR FOREST METEOROL, V107, P1, DOI 10.1016/S0168-1923(00)00228-8; Beringer J, 2005, AGR FOREST METEOROL, V131, P143, DOI 10.1016/j.agrformet.2005.05.006; Black TA, 2000, GEOPHYS RES LETT, V27, P1271, DOI 10.1029/1999GL011234; Borken W, 2006, GLOBAL CHANGE BIOL, V12, P177, DOI 10.1111/j.1365-2486.2005.001058.x; Bracho R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000469; Budyko M.I., 1974, CLIMATE LIFE; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Concilio A, 2009, CLIMATIC CHANGE, V92, P109, DOI 10.1007/s10584-008-9475-0; da Rocha HR, 2004, ECOL APPL, V14, pS22; Epron D, 2004, ANN FOREST SCI, V61, P499, DOI 10.1051/forest:2004044; Falge E, 2001, AGR FOREST METEOROL, V107, P71, DOI 10.1016/S0168-1923(00)00235-5; FAO, 2020, GLOBAL FOREST RESOUR; Fisher JB, 2009, GLOBAL CHANGE BIOL, V15, P2694, DOI 10.1111/j.1365-2486.2008.01813.x; Goldstein AH, 2000, AGR FOREST METEOROL, V101, P113, DOI 10.1016/S0168-1923(99)00168-9; Grunwald T, 2007, TELLUS B, V59, P387, DOI 10.1111/j.1600-0889.2007.00259.x; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Humphreys ER, 2003, AGR FOREST METEOROL, V115, P109, DOI 10.1016/S0168-1923(02)00171-5; Jassal RS, 2009, AGR FOREST METEOROL, V149, P1168, DOI 10.1016/j.agrformet.2009.02.004; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kosugi Y, 2007, J HYDROL, V337, P269, DOI 10.1016/j.jhydrol.2007.01.039; Lamarque JF, 2013, GEOSCI MODEL DEV, V6, P179, DOI 10.5194/gmd-6-179-2013; Launiainen S, 2010, BIOGEOSCIENCES, V7, P3921, DOI 10.5194/bg-7-3921-2010; Law BE, 2000, GLOBAL CHANGE BIOL, V6, P613, DOI 10.1046/j.1365-2486.2000.00339.x; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Li ZH, 2010, HYDROL PROCESS, V24, P2405, DOI 10.1002/hyp.7643; Matsumoto K, 2008, AGR FOREST METEOROL, V148, P1978, DOI 10.1016/j.agrformet.2008.09.008; MCCAUGHEY JH, 1985, BOUND-LAY METEOROL, V31, P89, DOI 10.1007/BF00120036; MCNAUGHTON KG, 1986, BOUND-LAY METEOROL, V34, P243, DOI 10.1007/BF00122381; Oliphant AJ, 2004, AGR FOREST METEOROL, V126, P185, DOI 10.1016/j.agrformet.2004.07.003; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Ross I, 2012, BIOGEOSCIENCES, V9, P1007, DOI 10.5194/bg-9-1007-2012; Roupsard O, 2006, AGR FOREST METEOROL, V139, P252, DOI 10.1016/j.agrformet.2006.07.006; Ryu Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009263; Saigusa N, 2010, BIOGEOSCIENCES, V7, P641, DOI 10.5194/bg-7-641-2010; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun G, 2010, FOREST ECOL MANAG, V259, P1299, DOI 10.1016/j.foreco.2009.09.016; Tang YK, 2014, ADV ATMOS S IN PRESS, V31; Wang YD, 2012, CAN J FOREST RES, V42, P657, DOI [10.1139/x2012-017, 10.1139/X2012-017]; Wang YD, 2011, CAN J FOREST RES, V41, P1897, DOI [10.1139/X11-105, 10.1139/x11-105]; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wen XF, 2010, BIOGEOSCIENCES, V7, P357, DOI 10.5194/bg-7-357-2010; Wickham JD, 2013, GLOBAL ECOL BIOGEOGR, V22, P620, DOI 10.1111/geb.12013; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Wilson KB, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000989; Wilson KB, 2000, AGR FOREST METEOROL, V100, P1, DOI 10.1016/S0168-1923(99)00088-X; Wu CY, 2011, REMOTE SENS ENVIRON, V115, P3424, DOI 10.1016/j.rse.2011.08.006; Wu JB, 2007, HYDROL PROCESS, V21, P2425, DOI 10.1002/hyp.6395; Zhang WJ, 2011, BIOGEOSCIENCES, V8, P1667, DOI 10.5194/bg-8-1667-2011	53	91	93	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88267	10.1371/journal.pone.0088267	http://dx.doi.org/10.1371/journal.pone.0088267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520360	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600051
J	Garcia, A; Leonardi, D; Salazar, MO; Lamas, MC				Garcia, Agustina; Leonardi, Dario; Oscar Salazar, Mario; Celina Lamas, Maria			Modified beta-Cyclodextrin Inclusion Complex to Improve the Physicochemical Properties of Albendazole. Complete In Vitro Evaluation and Characterization	PLOS ONE			English	Article							MASS-SPECTROMETRY; ORAL BIOAVAILABILITY; DRUG; MICROPARTICLES; SOLUBILIZATION; CHITOSAN	The potential use of natural cyclodextrins and their synthetic derivatives have been studied extensively in pharmaceutical research and development to modify certain properties of hydrophobic drugs. The ability of these host molecules of including guest molecules within their cavities improves notably the physicochemical properties of poorly soluble drugs, such as albendazole, the first chosen drug to treat gastrointestinal helminthic infections. Thus, the aim of this work was to synthesize a beta cyclodextrin citrate derivative, to analyze its ability to form complexes with albendazole and to evaluate its solubility and dissolution rate. The synthesis progress of the cyclodextrin derivative was followed by electrospray mass spectrometry and the acid-base titration of the product. The derivative exhibited an important drug affinity. Nuclear magnetic resonance experiments demonstrated that the tail and the aromatic ring of the drug were inside the cavity of the cyclodextrin derivative. The inclusion complex was prepared by spray drying and full characterized. The drug dissolution rate displayed exceptional results, achieving 100% drug release after 20 minutes. The studies indicated that the inclusion complex with the cyclodextrin derivative improved remarkably the physicochemical properties of albendazole, being a suitable excipient to design oral dosage forms.	[Garcia, Agustina; Leonardi, Dario; Celina Lamas, Maria] UNR, Fac Ciencias Bioquim & Farmaceut, IQUIR CONICET, Rosario, Santa Fe, Argentina; [Garcia, Agustina; Leonardi, Dario; Celina Lamas, Maria] UNR, Fac Ciencias Bioquim & Farmaceut, Area Tecn Farmaceut, Rosario, Santa Fe, Argentina; [Oscar Salazar, Mario] UNR, Fac Ciencias Bioquim & Farmaceut, Area Farmacognosia, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; National University of Rosario	Leonardi, D (corresponding author), UNR, Fac Ciencias Bioquim & Farmaceut, IQUIR CONICET, Rosario, Santa Fe, Argentina.	leonardi@iquir-conicet.gov.ar; mlamas@fbioyf.unr.edu.ar	Salazar, Mario/AAR-6723-2021	Leonardi, Dario/0000-0003-2292-3570; /0000-0001-6738-1918	CONICET; National University of Rosario; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 112-201001-00194]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National University of Rosario; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	A.G. is grateful to CONICET for a Doctoral Fellowship. The National University of Rosario and CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, Project No. PIP 112-201001-00194) are gratefully acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzouqi AH, 2009, J PHARMACEUT BIOMED, V49, P227, DOI 10.1016/j.jpba.2008.10.032; Carrier RL, 2007, J CONTROL RELEASE, V123, P78, DOI 10.1016/j.jconrel.2007.07.018; Castillo JA, 1999, DRUG DEV IND PHARM, V25, P1241, DOI 10.1081/DDC-100102294; CECH NB, 2010, SELECTIVITY ELECTROS, P49; Chaleawlert-Umpon S, 2011, CARBOHYD POLYM, V84, P186, DOI 10.1016/j.carbpol.2010.11.017; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Correia I, 2002, J PHYS ORG CHEM, V15, P647, DOI 10.1002/poc.528; Daniel-Mwambete K, 2004, INT J PHARMACEUT, V272, P29, DOI 10.1016/j.ijpharm.2003.11.030; de Freitas MR, 2012, CARBOHYD POLYM, V89, P1095, DOI 10.1016/j.carbpol.2012.03.072; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; di Cagno M, 2011, J PHARMACEUT BIOMED, V55, P446, DOI 10.1016/j.jpba.2011.02.022; Dotsikas Y, 2003, J AM SOC MASS SPECTR, V14, P1123, DOI 10.1016/S1044-0305(03)00451-3; El-Tahlawy K, 2006, CARBOHYD POLYM, V63, P385, DOI 10.1016/j.carbpol.2005.08.057; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Kim Y, 2011, MACROMOL BIOSCI, V11, P219, DOI 10.1002/mabi.201000293; Kumar MP, 2008, CURR NANOSCI, V4, P53; Kwon S, 2009, J MOL STRUCT, V938, P192, DOI 10.1016/j.molstruc.2009.09.025; Leonardi D, 2008, J PHARMACEUT BIOMED, V48, P802, DOI 10.1016/j.jpba.2008.08.006; Li HH, 2006, J AM SOC MASS SPECTR, V17, P9, DOI 10.1016/j.jasms.2005.08.011; LIN SF, 1983, J PHARM SCI, V72, P1333, DOI 10.1002/jps.2600721124; Linde GA, 2010, FOOD RES INT, V43, P187, DOI 10.1016/j.foodres.2009.09.025; Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b; Lopez ML, 1997, CHEMOTHERAPY, V43, P430, DOI 10.1159/000239602; Loukas YL, 1997, J PHARMACEUT BIOMED, V16, P275, DOI 10.1016/S0731-7085(97)00050-2; Menezes PP, 2012, THERMOCHIM ACTA, V548, P45, DOI 10.1016/j.tca.2012.08.023; Palomares-Alonso F, 2010, ACTA TROP, V113, P56, DOI 10.1016/j.actatropica.2009.09.006; Panwar P, 2010, INT J NANOMED, V5, P101; Rawden HC, 2000, BRIT J CLIN PHARMACO, V49, P313, DOI 10.1046/j.1365-2125.2000.00170.x; Salustio PJ, 2009, EUR J PHARM BIOPHARM, V71, P377, DOI 10.1016/j.ejpb.2008.09.027; SELVA A, 1993, ORG MASS SPECTROM, V28, P983, DOI 10.1002/oms.1210280909; Sobrinho JLS, 2011, QUIM NOVA, V34, P1534, DOI 10.1590/S0100-40422011000900010; SZEJTLI J, 1994, MED RES REV, V14, P353, DOI 10.1002/med.2610140304; Tommasini S, 2005, J PHARMACEUT BIOMED, V39, P572, DOI 10.1016/j.jpba.2005.05.009; United States Pharmacopeial Convention, 2012, US PHARM; Wang SY, 2013, CARBOHYD POLYM, V92, P1960, DOI 10.1016/j.carbpol.2012.11.079; Wong SM, 2006, INT J PHARM, V317, P61, DOI 10.1016/j.ijpharm.2006.03.001; Yanez C, 2004, J PHARMACEUT BIOMED, V35, P51, DOI 10.1016/j.jpba.2003.12.015; Yang CQ, 2000, TEXT RES J, V70, P615, DOI 10.1177/004051750007000709	38	56	57	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88234	10.1371/journal.pone.0088234	http://dx.doi.org/10.1371/journal.pone.0088234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551084	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500032
J	Loke, LHL; Jachowski, NR; Bouma, TJ; Ladle, RJ; Todd, PA				Loke, Lynette H. L.; Jachowski, Nicholas R.; Bouma, Tjeerd J.; Ladle, Richard J.; Todd, Peter A.			Complexity for Artificial Substrates (CASU): Software for Creating and Visualising Habitat Complexity	PLOS ONE			English	Article							COASTAL DEFENSE STRUCTURES; RECONCILIATION ECOLOGY; INTERTIDAL SEAWALLS; ROCKY SHORES; PATCH SIZE; LANDSCAPE; DIVERSITY; BIODIVERSITY; URBAN; RESTORATION	Physical habitat complexity regulates the structure and function of biological communities, although the mechanisms underlying this relationship remain unclear. Urbanisation, pollution, unsustainable resource exploitation and climate change have resulted in the widespread simplification (and loss) of habitats worldwide. One way to restore physical complexity to anthropogenically simplified habitats is through the use of artificial substrates, which also offer excellent opportunities to explore the effects of different components (variables) of complexity on biodiversity and community structure that would be difficult to separate in natural systems. Here, we describe a software program (CASU) that enables users to visualise static, physical complexity. CASU also provides output files that can be used to create artificial substrates for experimental and/or restoration studies. It has two different operational modes: simple and advanced. In simple mode, users can adjust the five main variables of informational complexity (i.e. the number of object types, relative abundance of object types, density of objects, variability and range in the objects' dimensions, and their spatial arrangement) and visualise the changes as they do so. The advanced mode allows users to design artificial substrates by fine-tuning the complexity variables as well as alter object-specific parameters. We illustrate how CASU can be used to create tiles of different designs for application in a marine environment. Such an ability to systematically influence physical complexity could greatly facilitate ecological restoration by allowing conservationists to rebuild complexity in degraded and simplified habitats.	[Loke, Lynette H. L.; Todd, Peter A.] Natl Univ Singapore, Dept Biol Sci, Expt Marine Ecol Lab, Singapore 117548, Singapore; [Jachowski, Nicholas R.] Natl Univ Singapore, Dept Geog, Singapore 117548, Singapore; [Bouma, Tjeerd J.] Deltares, Delft, Netherlands; [Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res NIOZ Yerseke, Yerseke, Netherlands; [Ladle, Richard J.] Univ Fed Alagoas, Inst Biol & Hlth Sci, Maceio, Brazil; [Ladle, Richard J.] Univ Oxford, Sch Geog & Environm, Oxford, England	National University of Singapore; National University of Singapore; Deltares; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universidade Federal de Alagoas; University of Oxford	Todd, PA (corresponding author), Natl Univ Singapore, Dept Biol Sci, Expt Marine Ecol Lab, Singapore 117548, Singapore.	dbspat@nus.edu.sg	Ladle, Richard/E-4228-2014; Bouma, Tjeerd J/A-9841-2011; Todd, Peter A/H-8410-2012	Ladle, Richard/0000-0003-3200-3946; Loke, Lynette/0000-0002-3649-1046; Bouma, Tjeerd/0000-0001-7824-7546	Singapore Delft Water Alliance (SDWA) [R-303-001-021-414, R-303-001-020-414]	Singapore Delft Water Alliance (SDWA)	This work was supported by the Singapore Delft Water Alliance (SDWA) JBE Part B grant number R-303-001-021-414 and JBE Part A grant number R-303-001-020-414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, ECOL COMPLEX, V1, P3; [Anonymous], 2009, FRESHW ECOL S; Bell SS, 1997, RESTOR ECOL, V5, P318, DOI 10.1046/j.1526-100X.1997.00545.x; Borsje BW, 2011, ECOL ENG, V37, P113, DOI 10.1016/j.ecoleng.2010.11.027; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P8204, DOI 10.1021/es201924b; Bulleri F, 2005, MAR ENVIRON RES, V60, P355, DOI 10.1016/j.marenvres.2004.12.002; Bulleri F, 2004, MAR ECOL PROG SER, V281, P121, DOI 10.3354/meps281121; Bulleri F, 2004, MAR BIOL, V145, P381, DOI 10.1007/s00227-004-1316-8; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Chapman MG, 2006, J MOLLUS STUD, V72, P247, DOI 10.1093/mollus/eyi069; Chapman MG, 2011, J EXP MAR BIOL ECOL, V400, P302, DOI 10.1016/j.jembe.2011.02.025; Chapman MG, 2009, OECOLOGIA, V161, P625, DOI 10.1007/s00442-009-1393-y; Chapman MG, 2003, LANDSCAPE URBAN PLAN, V62, P159, DOI 10.1016/S0169-2046(02)00148-2; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; DOBKIN DS, 1987, OECOLOGIA, V71, P161, DOI 10.1007/BF00377280; Firth LB, 2013, DIVERS DISTRIB, V19, P1275, DOI 10.1111/ddi.12079; FLEISHMAN E, 2000, J RES LEPIDOPTERA, V36, P31; Gacia E, 2007, SCI MAR, V71, P259, DOI 10.3989/scimar.2007.71n2259; Guest J., 2010, REEF REHABILITATION, P73; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Hovel KA, 2001, ECOLOGY, V82, P1814; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Ihara S., 1993, INFORM THEORY CONTIN; Johnson MP, 2003, ECOL LETT, V6, P126, DOI 10.1046/j.1461-0248.2003.00404.x; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Kovalenko KE, 2010, J APPL ECOL, V47, P318, DOI 10.1111/j.1365-2664.2009.01768.x; Larkin Daniel, 2006, P142; Ludwig JA, 1996, RESTOR ECOL, V4, P398, DOI 10.1111/j.1526-100X.1996.tb00192.x; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; Matias MG, 2010, ECOLOGY, V91, P1908, DOI 10.1890/09-1083.1; May Robert M., 2007, P205; MILLER RI, 1987, BIOL CONSERV, V39, P255, DOI 10.1016/0006-3207(87)90128-5; Mitchell M., 2009, COMPLEXITY GUIDED TO; Moore EC, 2010, OIKOS, V119, P1299, DOI 10.1111/j.1600-0706.2009.17909.x; Moschella PS, 2005, COAST ENG, V52, P1053, DOI 10.1016/j.coastaleng.2005.09.014; Pianka E. R., 2000, EVOLUTIONARY ECOLOGY; PIANKA ER, 1966, ECOLOGY, V47, P1055, DOI 10.2307/1935656; Pickering H, 1997, FISH RES, V31, P39, DOI 10.1016/S0165-7836(97)00019-2; Pister B, 2009, MAR BIOL, V156, P861, DOI 10.1007/s00227-009-1130-4; Rosenzweig ML, 2003, ORYX, V37, P194, DOI 10.1017/S0030605303000371; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Spanhoff B, 2007, RESTOR ECOL, V15, P317, DOI 10.1111/j.1526-100X.2007.00216.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x	46	39	39	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87990	10.1371/journal.pone.0087990	http://dx.doi.org/10.1371/journal.pone.0087990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551074	Green Submitted, Green Published, gold			2022-12-27	WOS:000331271500027
J	Devaere, L; Clausen, S; Alvaro, JJ; Peel, JS; Vachard, D				Devaere, Lea; Clausen, Sebastien; Javier Alvaro, J.; Peel, John S.; Vachard, Daniel			Terreneuvian Orthothecid (Hyolitha) Digestive Tracts from Northern Montagne Noire, France; Taphonomic, Ontogenetic and Phylogenetic Implications	PLOS ONE			English	Article							SHALE-TYPE PRESERVATION; SMALL SHELLY FOSSILS; CAMBRIAN HYOLITHS; FECAL PELLETS; MORPHOLOGY; REVISION; BIOLOGY	More than 285 specimens of Conotheca subcurvata with three-dimensionally preserved digestive tracts were recovered from the Terreneuvian (early Cambrian) Heraultia Limestone of the northern Montagne Noire, southern France. They represent one of the oldest occurrences of such preserved guts. The newly discovered operculum of some complete specimens provides additional data allowing emendation of the species diagnosis. Infestation of the U-shaped digestive tracts by smooth uniseriate, branching to anastomosing filaments along with isolated botryoidal coccoids attests to their early, microbially mediated phosphatisation. Apart from taphonomic deformation, C. subcurvata exhibits three different configurations of the digestive tract: (1) anal tube and gut parallel, straight to slightly undulating; (2) anal tube straight and loosely folded gut; and (3) anal tube straight and gut straight with local zigzag folds. The arrangement of the digestive tracts and its correlation with the mean apertural diameter of the specimens are interpreted as ontogenetically dependent. The simple U-shaped gut, usually considered as characteristic of the Hyolithida, developed in earlier stages of C. subcurvata, whereas the more complex orthothecid type-3 only appears in largest specimens. This growth pattern suggests a distinct phylogenetic relationship between these two hyolith orders through heterochronic processes.	[Devaere, Lea; Clausen, Sebastien; Vachard, Daniel] Univ Lille 1, UMR Geosyst CNRS 8217, F-59655 Villeneuve Dascq, France; [Javier Alvaro, J.] CSIC, Inst Nacl Tecn Aeroespacial, Ctr Astrobiol, Torrejon De Ardoz, Spain; [Peel, John S.] Uppsala Univ, Dept Earth Sci Palaeobiol, Uppsala, Sweden	Universite de Lille - ISITE; Universite de Lille; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Uppsala University	Devaere, L (corresponding author), Univ Lille 1, UMR Geosyst CNRS 8217, F-59655 Villeneuve Dascq, France.	lea.devaere@ed.univ-lille1.fr	CLAUSEN, Sebastien/H-3141-2017	CLAUSEN, Sebastien/0000-0002-2476-1512; Devaere, Lea/0000-0001-7109-8066	Freie Universitat Berlin; DAAD (German Academic Exchange Service); Spanish MICINN [CGL2010-19491]; EU-FEDER	Freie Universitat Berlin; DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU-FEDER(European Commission)	LD benefited from a research fellowship conducted at the Freie Universitat Berlin, funded by the DAAD (German Academic Exchange Service). This paper is a contribution to project CGL2010-19491 from Spanish MICINN and EU-FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro JJ, 2010, GEOBIOLOGY, V8, P89, DOI 10.1111/j.1472-4669.2009.00229.x; Alvaro JJ, STRATIGRAPH IN PRESS; BABCOCK L E, 1988, University of Kansas Paleontological Contributions Paper, P1; Bengston S., 1992, Topics in Geobiology, V10, P447; Bengtson S., 1990, Memoir of the Association of Australasian Palaeontologists, V9, P1; Bergeron J, 1887, CR HEBD ACAD SCI, V104, P530; BRIGGS DEG, 1993, SCIENCE, V259, P1439, DOI 10.1126/science.259.5100.1439; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Butterfield N.J., 2001, P40, DOI 10.1002/9780470999295.ch7; Butterfield NJ, 2003, INTEGR COMP BIOL, V43, P166, DOI 10.1093/icb/43.1.166; Butterfield NJ, 1996, J PALEONTOL, V70, P893, DOI 10.1017/S0022336000038579; Chen Jun-Yuan, 1997, Records of the Australian Museum, V49, P1; Clausen S, 2007, GEOL SOC SPEC PUBL, V275, P17, DOI 10.1144/GSL.SP.2007.275.01.02; Cobbold E. S., 1935, Annals & Magazine of Natural History Series 10, V16, P25; Cutler E. B, 1994, SIPUNCULA THEIR SYST; Demange M, 1998, GEOL FRANCE, V4, P3; Devaere L, PALAEONTOLO IN PRESS; Duan C, 1984, B TIANJIN I GEOLOGY, V7, P141; DZIK J, 1978, LETHAIA, V11, P293, DOI 10.1111/j.1502-3931.1978.tb01884.x; Edmonds SJ, 1962, CAH BIOL MAR, V3, P183; Geze B., 1949, MEMOIRES SOC GEOLOGI, V62, P1; Guerange-Lozes J., 1990, GEOLOGIE FRANCE, V3-4, P71; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horny RJ, 1998, J NATL MUSEUM PRAGUE, V167, P95; HOUBRICK RS, 1988, LETHAIA, V21, P395, DOI 10.1111/j.1502-3931.1988.tb01768.x; Huang DY, 2004, P ROY SOC B-BIOL SCI, V271, P1671, DOI 10.1098/rspb.2004.2774; JOHANNES RE, 1966, LIMNOL OCEANOGR, V11, P191, DOI 10.4319/lo.1966.11.2.0191; JUMARS PA, 1990, PHILOS T R SOC A, V331, P85, DOI 10.1098/rsta.1990.0058; KERBER M, 1988, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V202, P127; Kouchinsky A, 2012, GEOL MAG, V149, P221, DOI 10.1017/S0016756811000720; Kouchinsky AV, 2000, ALCHERINGA, V24, P65, DOI 10.1080/03115510008619525; Kruse PD, 2002, ALCHERINGA, V26, P353, DOI 10.1080/03115510208619263; Kruse PD, 1996, LETHAIA, V29, P213, DOI 10.1111/j.1502-3931.1996.tb01651.x; Lerosey-Aubril R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032934; Lin JP, 2010, PALAIOS, V25, P463, DOI 10.2110/palo.2009.p09-145r; Luo H., 1982, SINIAN CAMBRIAN BOUN; Maeda H, 2011, PALAIOS, V26, P225, DOI 10.2110/palo.2010.p10-042r; Malinky JM, 2004, ACTA PALAEONTOL POL, V49, P551; Malinky JM, 2003, J PALEONTOL, V77, P625, DOI 10.1666/0022-3360(2003)077<0625:OASHAG>2.0.CO;2; MALINKY JM, 1987, J PALEONTOL, V61, P942, DOI 10.1017/S0022336000029310; Malinky JM, 1999, PALAEONTOLOGY, V42, P25, DOI 10.1111/1475-4983.00061; Malinky John M., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P521; Mao Jia-Ren, 1992, Acta Micropalaeontologica Sinica, V9, P257; Marek L., 1967, Sb geol ved (P), V9, P51; MAREK L, 1976, LETHAIA, V9, P65, DOI 10.1111/j.1502-3931.1976.tb00952.x; MAREK L, 1964, SCIENCE, V146, P1674, DOI 10.1126/science.146.3652.1674; Marek L., 1966, Casopis Narodniho Musea, V135, P89; Marek L., 1963, SBORNIK GEOLOGICKYCH, V1, P53; Marek Ladislav, 1997, Vestnik Ceskeho Geologickeho Ustavu, V72, P351; Meshkova N.P., 1974, T I GEOLOGII GEOFIZI, V97, P1; Meshkova NP, 1981, PHANEROZOIC PROBLEMA, V481, P82; Mus MM, 2007, PALAEONTOLOGY, V50, P1231, DOI 10.1111/j.1475-4983.2007.00700.x; Pojeta J. Jr, 1987, P436; Qian Y., 1989, FOSS STRAT, V24, P156; Qian Yi, 2000, Acta Micropalaeontologica Sinica, V17, P404; Qian Yi, 2001, Acta Palaeontologica Sinica, V40, P31; Reed F.R.C, 1909, EARTH ENV SCI T R SO, V47, P203; Rozanov A.Y., 1969, T GEOLOGICESKOGO INS, V206, P1; RUNNEGAR B, 1975, LETHAIA, V8, P181, DOI 10.1111/j.1502-3931.1975.tb01311.x; RUNNEGAR B, 1980, LETHAIA, V13, P21, DOI 10.1111/j.1502-3931.1980.tb01025.x; RUNNEGAR B, 1982, LETHAIA, V15, P199, DOI 10.1111/j.1502-3931.1982.tb00645.x; Skovsted CB, 2007, ACTA PALAEONTOL POL, V52, P729; SYSOEV VA, 1957, DOKL AKAD NAUK SSSR+, V116, P304; Sysoev VA, 1960, P USSR ACAD SCI, V131, P1156; SYSOYEV V.A., 1968, STRATIGRAFIA HIOLITY, P1; Thoral M, 1935, CONTRIBUTION ETUDE P; Valkov AK, 1983, PHYLUM HYOLITHOZOES, V558, P54; Vannier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052200; Wilson L, 2003, PALAEONTOLOGICAL ASS, V54, P190; Wilson L, 2006, FOOD THOUGHT MORPHOL; YOCHELSON EL, 1961, J PALEONTOL, V35, P152; YOCHELSON EL, 1984, MALACOLOGIA, V25, P255; Yu W., 1974, HDB STRATIGRAPHIC PA, P111; Zhang ZF, 2013, SCI REP-UK, V3, DOI [10.1038/srep01066, 10.1038/srep01327]	74	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88583	10.1371/journal.pone.0088583	http://dx.doi.org/10.1371/journal.pone.0088583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533118	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600076
J	Scholze, M; Silva, E; Kortenkamp, A				Scholze, Martin; Silva, Elisabete; Kortenkamp, Andreas			Extending the Applicability of the Dose Addition Model to the Assessment of Chemical Mixtures of Partial Agonists by Using a Novel Toxic Unit Extrapolation Method	PLOS ONE			English	Article							SCREEN; POLLUTANT	Dose addition, a commonly used concept in toxicology for the prediction of chemical mixture effects, cannot readily be applied to mixtures of partial agonists with differing maximal effects. Due to its mathematical features, effect levels that exceed the maximal effect of the least efficacious compound present in the mixture, cannot be calculated. This poses problems when dealing with mixtures likely to be encountered in realistic assessment situations where chemicals often show differing maximal effects. To overcome this limitation, we developed a pragmatic solution that extrapolates the toxic units of partial agonists to effect levels beyond their maximal efficacy. We extrapolated different additivity expectations that reflect theoretically possible extremes and validated this approach with a mixture of 21 estrogenic chemicals in the E-Screen. This assay measures the proliferation of human epithelial breast cancers. We found that the dose-response curves of the estrogenic agents exhibited widely varying shapes, slopes and maximal effects, which made it necessary to extrapolate mixture responses above 14% proliferation. Our toxic unit extrapolation approach predicted all mixture responses accurately. It extends the applicability of dose addition to combinations of agents with differing saturating effects and removes an important bottleneck that has severely hampered the use of dose addition in the past.	[Scholze, Martin; Silva, Elisabete; Kortenkamp, Andreas] Brunel Univ, Inst Environm, Uxbridge UB8 3PH, Middx, England	Brunel University	Scholze, M (corresponding author), Brunel Univ, Inst Environm, Uxbridge UB8 3PH, Middx, England.	martin.scholze@brunel.ac.uk			European Commission [QLRT-CT2002-00603]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors are grateful for funding by the European Commission (Contract numbers: QLRT-CT2002-00603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz RG, 2008, SCI TOTAL ENVIRON, V404, P77, DOI 10.1016/j.scitotenv.2008.06.008; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bodeker W., 1990, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V42, P70; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Faust M, 2001, AQUAT TOXICOL, V56, P13, DOI 10.1016/S0166-445X(01)00187-4; Hestermann EV, 2000, TOXICOL APPL PHARM, V168, P160, DOI 10.1006/taap.2000.9026; Howard GJ, 2010, ENVIRON HEALTH PERSP, V118, P666, DOI 10.1289/ehp.0901312; Howard GJ, 2009, J THEOR BIOL, V259, P469, DOI 10.1016/j.jtbi.2009.03.030; Kortenkamp A., 2009, 0703072007485103ETUD; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P106, DOI 10.1289/ehp.9358; LOEWE S., 1926, ARCH EXP PATH U PHARMAKOL, V114, P313, DOI 10.1007/BF01952257; Olmstead AW, 2005, INTEGR ENVIRON ASSES, V1, P114, DOI 10.1897/IEAM_2004-005R.1; Orton F, 2014, TOXICOL APPL PHARM, V278, P201, DOI 10.1016/j.taap.2013.09.008; Peters AK, 2006, TOXICOL LETT, V165, P230, DOI 10.1016/j.toxlet.2006.04.005; Rajapakse N, 2004, ENVIRON SCI TECHNOL, V38, P6343, DOI 10.1021/es049681e; Scholze M, 2001, ENVIRON TOXICOL CHEM, V20, P448, DOI 10.1002/etc.5620200228; Silva E, 2007, ENVIRON HEALTH PERSP, V115, P91, DOI 10.1289/ehp.9363; Silva E, 2011, TOXICOL SCI, V122, P383, DOI 10.1093/toxsci/kfr103; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Vonesh E., 1996, LINEAR NONLINEAR MOD; Yueh MF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037705, 10.1371/journal.pone.0043606]	22	39	39	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88808	10.1371/journal.pone.0088808	http://dx.doi.org/10.1371/journal.pone.0088808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533151	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600109
J	Wojewodka, G; De Sanctis, JB; Bernier, J; Berube, J; Ahlgren, HG; Gruber, J; Landry, J; Lands, LC; Nguyen, D; Rousseau, S; Benedetti, A; Matouk, E; Radzioch, D				Wojewodka, Gabriella; De Sanctis, Juan B.; Bernier, Joanie; Berube, Julie; Ahlgren, Heather G.; Gruber, Jim; Landry, Jennifer; Lands, Larry C.; Dao Nguyen; Rousseau, Simon; Benedetti, Andrea; Matouk, Elias; Radzioch, Danuta			Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients	PLOS ONE			English	Article							CLINICAL SCORING SYSTEM; FATTY-ACIDS; ANTIBIOTIC-THERAPY; ADULT PATIENTS; RESPIRATORY EXACERBATIONS; PSEUDOMONAS-AERUGINOSA; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; CERAMIDE DEFICIENCY; LIPID-PEROXIDATION	Introduction: Pulmonary exacerbations (PEs) cause significant morbidity and can severely impact disease progression in cystic fibrosis (CF) lung disease, especially in patients who suffer from recurrent PEs. The assessments able to predict a future PE or a recurrent PE are limited. We hypothesized that combining clinical, molecular and patient reported data could identify patients who are at risk of PE. Methods: We prospectively followed a cohort of 53 adult CF patients for 24 months. Baseline values for spirometry, clinical status using the Matouk Disease Score, quality of life (QOL), inflammatory markers (C-reactive protein (CRP), interleukins (IL)1 beta, -6, -8, -10, macrophage inflammatory protein (MIP)-1 beta, tumor necrosis factor (TNF) and vascular endothelial growth factor (VEGF)), polyunsaturated fatty acids and lipid peroxidation in blood plasma were collected for all patients during periods of stable disease, and patients were monitored for PE requiring PO/IV antibiotic treatment. Additionally, we closely followed 13 patients during PEs collecting longitudinal data on changes in markers from baseline values. We assessed whether any markers were predictors of future PE at baseline and after antibiotic treatment. Results: Out of 53 patients, 37 experienced PEs during our study period. At baseline, we found that low lung function, clinical scoring and QOL values were associated with increased risk of PE events. PEs were associated with increased inflammatory markers at Day 1, and these biomarkers improved with treatment. The imbalance in arachidonic acid and docosahexaenoic acid levels improved with treatment which coincided with reductions in lipid peroxidation. High levels of inflammatory markers CRP and IL-8 were associated with an early re-exacerbation. Conclusion: Our results demonstrate that worse clinical and QOL assessments during stable disease are potential markers associated with a higher risk of future PEs, while higher levels of inflammatory markers at the end of antibiotic treatment may be associated with early re-exacerbation.	[Wojewodka, Gabriella; Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [De Sanctis, Juan B.] Cent Univ Venezuela, Inst Immunol, Caracas, Venezuela; [Bernier, Joanie; Gruber, Jim; Landry, Jennifer; Matouk, Elias] McGill Univ, Ctr Hlth, Montreal Chest Inst, Adult Cyst Fibrosis Clin, Montreal, PQ, Canada; [Berube, Julie] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Ahlgren, Heather G.; Dao Nguyen; Rousseau, Simon; Benedetti, Andrea; Radzioch, Danuta] McGill Univ, Dept Med, Montreal, PQ, Canada; [Lands, Larry C.] McGill Univ, Montreal Childrens Hosp, Res Inst, Div Pediat Resp Med,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Benedetti, Andrea] McGill Univ, Ctr Hlth, Montreal Chest Inst, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University; University of Central Venezuela; McGill University; McGill University; McGill University; McGill University; McGill University	Radzioch, D (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	danuta.radzioch@mcgill.ca	caputo, carlo/N-3747-2014; De Sanctis, Juan B./H-5050-2019	De Sanctis, Juan B./0000-0002-5480-4608; Radzioch, Danuta/0000-0002-1601-2757; Rousseau, Simon/0000-0002-8773-575X	Frederick Banting; Canadian Institutes of Health Research; FONACIT [G2005000389]; Ministere du Developpement Economique, de l'Innovation et de l'Exportation (MDEIE/MESRST); MSBi Valorisation and Cystic Fibrosis Canada	Frederick Banting; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FONACIT; Ministere du Developpement Economique, de l'Innovation et de l'Exportation (MDEIE/MESRST); MSBi Valorisation and Cystic Fibrosis Canada	GW received funding from the Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award from the Canadian Institutes of Health Research. JBdS received funding from FONACIT (G2005000389). DR received funding from Ministere du Developpement Economique, de l'Innovation et de l'Exportation (MDEIE/MESRST), MSBi Valorisation and Cystic Fibrosis Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breen L., 2012, COCHRANE DB SYST REV, V7; CANTIN A, 1993, J CLIN INVEST, V91, P38, DOI 10.1172/JCI116196; Chiron R, 2008, J CYST FIBROS, V7, P463, DOI 10.1016/j.jcf.2008.04.002; Colombo C, 2005, PEDIATR PULM, V40, P15, DOI 10.1002/ppul.20237; de Boer K, 2011, THORAX, V66, P680, DOI 10.1136/thx.2011.161117; Downey DG, 2007, PEDIATR PULM, V42, P729, DOI 10.1002/ppul.20646; Durieu I, 2007, EUR RESPIR J, V29, P958, DOI 10.1183/09031936.00000906; Durieu I, 2007, J CYST FIBROS, V6, P320, DOI 10.1016/j.jcf.2006.12.005; Elborn JS, 2000, THORAX, V55, P355, DOI 10.1136/thorax.55.5.355; Etherington C, 2013, J CYST FIBROS; Farhat SCL, 2013, CHEST, V144, P1186, DOI 10.1378/chest.12-2414; FINKELSTEIN SM, 1992, PEDIATR PULM, V12, P3, DOI 10.1002/ppul.1950120104; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; GILLJAM H, 1986, SCAND J CLIN LAB INV, V46, P511, DOI 10.3109/00365518609083706; Gray RD, 2010, J CYST FIBROS, V9, P193, DOI 10.1016/j.jcf.2010.01.005; Guilbault C, 2008, AM J RESP CELL MOL, V38, P47, DOI 10.1165/rcmb.2007-0036OC; Guilbault C, 2009, AM J RESP CELL MOL, V41, P100, DOI 10.1165/rcmb.2008-0279OC; Gziut M, 2013, BRIT J PHARMACOL, V168, P1165, DOI 10.1111/bph.12018; Hakimi Shoki A, 2013, CHEST; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Hoek RAS, 2013, SCAND J INFECT DIS, V45, P65, DOI 10.3109/00365548.2012.708942; Horsley AR, 2013, THORAX, V68, P532, DOI 10.1136/thoraxjnl-2012-202538; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KONSTAN MW, 1993, AM REV RESPIR DIS, V148, P896, DOI 10.1164/ajrccm/148.4_Pt_1.896; LAWRENCE RH, 1994, CLIN EXP IMMUNOL, V98, P12; Lechtzin N, 2013, CONTEMP CLIN TRIALS, V36, P460, DOI 10.1016/j.cct.2013.09.004; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Liou TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042748; Lloyd-Still JD, 2006, NUTRITION, V22, P36, DOI 10.1016/j.nut.2005.05.006; Lucidi V, 2008, FREE RADICAL BIO MED, V45, P913, DOI 10.1016/j.freeradbiomed.2008.06.026; Matouk E, 1999, EUR RESPIR J, V13, P552, DOI 10.1183/09031936.99.13355299; Matouk E, 1997, EUR RESPIR J, V10, P2004, DOI 10.1183/09031936.97.10092004; McColley SA, 2000, AM J RESP CRIT CARE, V161, P1877, DOI 10.1164/ajrccm.161.6.9905022; McGrath LT, 1999, THORAX, V54, P518, DOI 10.1136/thx.54.6.518; Mutoh A, 2013, LIFE SCI, V92, P984, DOI 10.1016/j.lfs.2013.03.019; Nir M, 1996, THORAX, V51, P1023, DOI 10.1136/thx.51.10.1023; Nixon LS, 1998, AM J RESP CRIT CARE, V157, P1764, DOI 10.1164/ajrccm.157.6.9704086; Oborna I, 2010, HUM REPROD, V25, P308, DOI 10.1093/humrep/dep416; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; Quittner AL, 2000, J PEDIATR PSYCHOL, V25, P403, DOI 10.1093/jpepsy/25.6.403; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Sawicki GS, 2013, PEDIATR PULM, V48, P954, DOI 10.1002/ppul.22741; SCHLENK H, 1960, ANAL CHEM, V32, P1412, DOI 10.1021/ac60167a011; Sequeiros IM, 2012, CHRON RESP DIS, V9, P213, DOI 10.1177/1479972312445903; Sequeiros IM, 2012, CHRON RESP DIS, V9, P9, DOI 10.1177/1479972311433575; SOCIETY AT, 1987, AM REV RESPIR DIS, V136, P1285; STRANDVIK B, 1988, SCAND J GASTROENTERO, V23, P1, DOI 10.3109/00365528809090205; Sutton S, 2013, PEDIAT PULMONOL; SZAFF M, 1983, ACTA PAEDIATR SCAND, V72, P651, DOI 10.1111/j.1651-2227.1983.tb09789.x; Waters V, 2012, EUR RESPIR J, V40, P61, DOI 10.1183/09031936.00159111; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003	54	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88567	10.1371/journal.pone.0088567	http://dx.doi.org/10.1371/journal.pone.0088567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533110	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600068
J	Kamboj, M; Babady, NE; Marsh, JW; Schlackman, JL; Son, C; Sun, J; Eagan, J; Tang, YW; Sepkowitz, K				Kamboj, Mini; Babady, N. Esther; Marsh, Jane W.; Schlackman, Jessica L.; Son, Crystal; Sun, Janet; Eagan, Janet; Tang, Yi-Wei; Sepkowitz, Kent			Estimating Risk of C. difficile Transmission from PCR Positive but Cytotoxin Negative Cases	PLOS ONE			English	Article							MULTILOCUS VARIABLE-NUMBER; TANDEM-REPEAT ANALYSIS; RESTRICTION-ENDONUCLEASE ANALYSIS; CLOSTRIDIUM-DIFFICILE; HEALTHY INFANTS; INFECTION; CHILDREN; STRAINS; RATES; HOSPITALS	Background: The use of molecular methods to diagnose Clostridium difficile infection (CDI) has improved diagnostic yield compared to conventional methods. However, PCR testing can detect colonization and has introduced several practical challenges pertaining to need for treatment and isolation of cases. Methods: For all new cases detected by real-time PCR, concurrent cytotoxin assay was performed and genetic characterization with MLVA (multi-locus variable number tandem repeat analysis) was done to determine relatedness. We used PCR cycle threshold (Ct) of detection as surrogate marker for bacterial burden in stool. Results: Overall, 54 cases of CDI were detected during the study period. 42 were concurrently tested by CYT and characterized by MLVA. MLVA analysis revealed marked genetic diversity with no ongoing outbreaks; four cases were due to NAP1 strain. CYT -/PCR + cases had a higher median Ct value of detection compared to CYT+/PCR + cases (28.2 vs 22.5; p = 0.01). Among 25 strains that were genetically related, 9/11 isolates in this dominant cluster were positive by CYT compared to 4/14 in non-dominant clusters (p = 0.02). Conclusion: CYT-/PCR+ cases contribute to hospital based transmission. However, the risk of transmission of C. difficile from CYT +/PCR+ cases may be higher than those that are CYT-/PCR+.	[Kamboj, Mini; Son, Crystal; Eagan, Janet; Sepkowitz, Kent] Mem Sloan Kettering Canc Ctr, Infect Control Program, New York, NY 10021 USA; [Kamboj, Mini; Sun, Janet; Tang, Yi-Wei; Sepkowitz, Kent] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA; [Babady, N. Esther; Tang, Yi-Wei] Mem Sloan Kettering Canc Ctr, Dept Lab Med, Clin Microbiol Serv, New York, NY 10021 USA; [Marsh, Jane W.; Schlackman, Jessica L.] Univ Pittsburgh, Div Infect Dis, Pittsburgh, PA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kamboj, M (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Control Program, 1275 York Ave, New York, NY 10021 USA.	kambojm@mskcc.org		Tang, Yi-Wei/0000-0003-4888-6771; KAMBOJ, MINI/0000-0002-3122-6374	Source NIH/NIAID [K23 AI083880]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI083880] Funding Source: NIH RePORTER	Source NIH/NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant K23 AI083880 [Source NIH/NIAID] awarded to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOL MICROBIOLOGY; Babady NE, 2010, J CLIN MICROBIOL, V48, P4519, DOI 10.1128/JCM.01648-10; BRETTLE RP, 1982, LANCET, V1, P1193; Bryant K, 2009, PEDIATR INFECT DIS J, V28, P145, DOI 10.1097/INF.0b013e318198c984; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; Eyre DW, 2013, J CLIN MICROBIOL, V51, P4141, DOI 10.1128/JCM.01095-13; HOLST E, 1981, SCAND J INFECT DIS, V13, P41, DOI 10.1080/00365548.1981.11690365; Kaltsas A, 2012, J CLIN MICROBIOL, V50, P1303, DOI 10.1128/JCM.05711-11; Kamboj M, 2012, INFECT CONT HOSP EP, V33, P1162, DOI 10.1086/668023; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kim J, 2012, PEDIATR INFECT DIS J, V31, P134, DOI 10.1097/INF.0b013e3182352e2c; Kim J, 2008, PEDIATRICS, V122, P1266, DOI 10.1542/peds.2008-0469; Longtin Y, 2013, CLIN INFECT DIS, V56, P67, DOI 10.1093/cid/cis840; Marsh JW, 2006, J CLIN MICROBIOL, V44, P2558, DOI 10.1128/JCM.02364-05; Marsh JW, 2010, J CLIN MICROBIOL, V48, P412, DOI 10.1128/JCM.01315-09; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Rousseau C, 2012, CLIN INFECT DIS, V55, P1209, DOI 10.1093/cid/cis637; Rousseau C, 2011, J MED MICROBIOL, V60, P1112, DOI 10.1099/jmm.0.029736-0; STARK PL, 1982, INFECT IMMUN, V35, P895, DOI 10.1128/IAI.35.3.895-899.1982; Tai E, 2011, PEDIATR INFECT DIS J, V30, P610, DOI 10.1097/INF.0b013e31820970d1; Toltzis P, 2009, J PEDIATR-US, V154, P607, DOI 10.1016/j.jpeds.2008.10.016; VISCIDI R, 1981, GASTROENTEROLOGY, V81, P5; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Zahariadis G, 2002, AM J GASTROENTEROL, V97, P2929	24	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88262	10.1371/journal.pone.0088262	http://dx.doi.org/10.1371/journal.pone.0088262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523882	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000331258100031
J	Walde, M; Monypenny, J; Heintzmann, R; Jones, GE; Cox, S				Walde, Marie; Monypenny, James; Heintzmann, Rainer; Jones, Gareth E.; Cox, Susan			Vinculin Binding Angle in Podosomes Revealed by High Resolution Microscopy	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; LOCALIZATION MICROSCOPY; SEALING ZONE; SUPERRESOLUTION; INVADOPODIA; PAXILLIN; LIMIT; TALIN	Podosomes are highly dynamic actin-rich adhesive structures formed predominantly by cells of the monocytic lineage, which degrade the extracellular matrix. They consist of a core of F-actin and actin-regulating proteins, surrounded by a ring of adhesion-associated proteins such as vinculin. We have characterised the structure of podosomes in macrophages, particularly the structure of the ring, using three super-resolution fluorescence microscopy techniques: stimulated emission depletion microscopy, structured illumination microscopy and localisation microscopy. Rather than being round, as previously assumed, we found the vinculin ring to be created from relatively straight strands of vinculin, resulting in a distinctly polygonal shape. The strands bind preferentially at angles between 116 degrees and 135 degrees. Furthermore, adjacent vinculin strands are observed nucleating at the corners of the podosomes, suggesting a mechanism for podosome growth.	[Walde, Marie; Monypenny, James; Heintzmann, Rainer; Jones, Gareth E.; Cox, Susan] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Walde, Marie; Heintzmann, Rainer] Univ Jena, Inst Phys Chem, Abbe Ctr Photon, D-07743 Jena, Germany; [Heintzmann, Rainer] Leibniz Inst Photon Technol, Jena, Germany	University of London; King's College London; Friedrich Schiller University of Jena; Leibniz Institut fur Photonische Technologien	Walde, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	marie.walde@uni-jena.de; susan.cox@kcl.ac.uk	Heintzmann, Rainer/AAY-4849-2020; Jones, Gareth E/H-2282-2012	Heintzmann, Rainer/0000-0002-4950-1936; Jones, Gareth E/0000-0001-5879-3048; Walde, Marie/0000-0002-4071-7677; Cox, Susan/0000-0001-8322-1981	British Heart Foundation [CH/08/001]; Wellcome Trust [80373]; MRC [G0401026, G0100152]; EU [215597]; Medical Research Council [G1100041, G0401026, G0100152, MR/K015664/1] Funding Source: researchfish; MRC [MR/K015664/1, G1100041] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The STED system was purchased with funding from the British Heart Foundation, grant number CH/08/001. Additional funding was received from the Wellcome Trust (GEJ, grant number 80373, SC, VIP Fellowship), the MRC (GEJ, grant numbers G0401026 and G0100152) and EU FP7 GA 215597 (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Bowman AW, 1997, APPL SMOOTHING TECHN; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Calle Y, 2008, J MICROSC-OXFORD, V231, P494, DOI 10.1111/j.1365-2818.2008.02062.x; Cox S, 2012, NAT METHODS, V9, P195, DOI [10.1038/NMETH.1812, 10.1038/nmeth.1812]; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; DEPASQUALE JA, 1991, J CELL BIOL, V113, P1351, DOI 10.1083/jcb.113.6.1351; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Dougherty E.R., 1992, TUTORIAL TEXTS OPTIC; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Heintzmann Rainer, 2006, Briefings in Functional Genomics & Proteomics, V5, P289, DOI 10.1093/bfgp/ell036; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Meddens MBM, 2013, MICROSC MICROANAL, V19, P180, DOI 10.1017/S1431927612014018; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; van den Dries K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2402; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wicker K, 2013, OPT EXPRESS, V21, P2032, DOI 10.1364/OE.21.002032	36	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88251	10.1371/journal.pone.0088251	http://dx.doi.org/10.1371/journal.pone.0088251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523880	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100029
J	Fucinos, C; Fucinos, P; Miguez, M; Katime, I; Pastrana, LM; Rua, ML				Fucinos, Clara; Fucinos, Pablo; Miguez, Martin; Katime, Issa; Pastrana, Lorenzo M.; Rua, Maria L.			Temperature-and pH-Sensitive Nanohydrogels of Poly(N-Isopropylacrylamide) for Food Packaging Applications: Modelling the Swelling-Collapse Behaviour	PLOS ONE			English	Article							POLY N-ISOPROPYLACRYLAMIDE; VOLUME PHASE-TRANSITION; ANTIMICROBIAL ACTIVITY; MICROGEL PARTICLES; CONTROLLED-RELEASE; POTASSIUM SORBATE; HEAT-CAPACITY; COPOLYMERS; NATAMYCIN; HYDROGELS	Temperature-sensitive poly(N-isopropylacrylamide) (PNIPA) nanohydrogels were synthesized by nanoemulsion polymerization in water-in-oil systems. Several cross-linking degrees and the incorporation of acrylic acid as comonomer at different concentrations were tested to produce nanohydrogels with a wide range of properties. The physicochemical properties of PNIPA nanohydrogels, and their relationship with the swelling-collapse behaviour, were studied to evaluate the suitability of PNIPA nanoparticles as smart delivery systems (for active packaging). The swelling-collapse transition was analyzed by the change in the optical properties of PNIPA nanohydrogels using ultraviolet-visible spectroscopy. The thermodynamic parameters associated with the nanohydrogels collapse were calculated using a mathematical approach based on the van't Hoff analysis, assuming a two-state equilibrium (swollen to collapsed). A mathematical model is proposed to predict both the thermally induced collapse, and the collapse induced by the simultaneous action of two factors (temperature and pH, or temperature and organic solvent concentration). Finally, van't Hoff analysis was compared with differential scanning calorimetry. The results obtained allow us to solve the problem of determining the molecular weight of the structural repeating unit in cross-linked NIPA polymers, which, as we show, can be estimated from the ratio of the molar heat capacity (obtained from the van't Hoff analysis) to the specific heat capacity (obtained from calorimetric measurements).	[Fucinos, Clara; Miguez, Martin; Pastrana, Lorenzo M.; Rua, Maria L.] Univ Vigo, Dept Quim Analit & Alimentaria, Grp Bioquim, Orense, Spain; [Fucinos, Pablo] Inst Invest Marinas CSIC, Grp Reciclado & Valorizac Mat Residuales REVAL, Vigo, Spain; [Katime, Issa] Univ Basque Country, Dept Quim Fis, Grp Nuevos Mat & Espectroscopia Supramol, Leioa, Spain	Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Basque Country	Fucinos, C (corresponding author), Univ Vigo, Dept Quim Analit & Alimentaria, Grp Bioquim, Orense, Spain.	clarafg@gmail.com	Rua, ML/L-7086-2014; Miguez, Martin/E-8382-2016; Fuciños, Clara/L-9941-2014; Castro, Lorenzo Miguel Pastrana/K-8331-2014; Pastrana, Lorenzo/AAZ-9606-2020; Fuciños, Pablo/D-1137-2015; Pastrana, Lorenzo M/Y-8162-2018	Rua, ML/0000-0001-5952-2442; Miguez, Martin/0000-0001-6402-5248; Fuciños, Clara/0000-0003-3430-630X; Pastrana, Lorenzo/0000-0002-6637-3462; Fuciños, Pablo/0000-0002-4502-1660; Rua, Maria Luisa/0000-0001-5194-4034	"Ministerio de Educacion y Ciencia'' (Spain) [MAT 2006-11662-CO3-CO2-C01/MAT 2010-21509-C03-01/EUI 2008-00115]; University of Vigo (Spain)	"Ministerio de Educacion y Ciencia'' (Spain)(Spanish Government); University of Vigo (Spain)	This work was funded by grant (MAT 2006-11662-CO3-CO2-C01/MAT 2010-21509-C03-01/EUI 2008-00115) from the "Ministerio de Educacion y Ciencia'' (Spain). Clara Fucinos was funded by a predoctoral scholarship from University of Vigo (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alf ME, 2011, LANGMUIR, V27, P10691, DOI 10.1021/la201935r; Basile MA, 2010, BIORESOURCE TECHNOL, V101, P4386, DOI 10.1016/j.biortech.2010.01.061; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Caykara T, 2006, J APPL POLYM SCI, V101, P1756, DOI 10.1002/app.23513; Cerqueira MA, 2012, FOOD HYDROCOLLOID, V27, P175, DOI 10.1016/j.foodhyd.2011.07.007; Chearuil FN, 2009, INT J PHARMACEUT, V366, P21, DOI 10.1016/j.ijpharm.2008.08.036; CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0; Chen HY, 2008, J MATER SCI-MATER M, V19, P651, DOI 10.1007/s10856-007-3019-4; Chen H, 2008, ADV FUNCT MATER, V18, P95, DOI 10.1002/adfm.200600452; Choi JH, 2005, LWT-FOOD SCI TECHNOL, V38, P417, DOI 10.1016/j.lwt.2004.07.004; Coehn A., 1898, ANN PHYS-NEW YORK, V300, P217; Coronado R, 2011, POLYM BULL, V67, P101, DOI 10.1007/s00289-010-0407-6; Coughlan DC, 2008, J PHARM SCI-US, V97, P318, DOI 10.1002/jps.21095; Crowther HM, 1998, COLLOID POLYM SCI, V276, P46, DOI 10.1007/s003960050207; DAMODARAN S., 1997, FOOD PROTEINS THEIR, P7; Diez-Pena E, 2004, AAPS PHARMSCITECH, V5; Diez-Pena E, 2004, MACROMOL CHEM PHYS, V205, P438, DOI 10.1002/macp.200300074; Diez-Pena E, 2002, POLYMER, V43, P4341, DOI 10.1016/S0032-3861(02)00270-7; Blanco MD, 2012, POLYM INT, V61, P1202, DOI 10.1002/pi.4200; Eeckman F, 2004, INT J PHARMACEUT, V273, P109, DOI 10.1016/j.ijpharm.2003.12.013; Eeckman F, 2001, INT J PHARM, V222, P259, DOI 10.1016/S0378-5173(01)00716-5; ELIMELECH M, 1994, DESALINATION, V95, P269, DOI 10.1016/0011-9164(94)00064-6; Elsaeed SM, 2012, J APPL POLYM SCI, V124, P1947, DOI 10.1002/app.34912; Fajardo P, 2010, J FOOD ENG, V101, P349, DOI 10.1016/j.jfoodeng.2010.06.029; FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016; Fucinos C, 2012, J FOOD SCI, V77, pN21, DOI 10.1111/j.1750-3841.2012.02781.x; Fundueanu G, 2009, J MATER SCI-MATER M, V20, P2465, DOI 10.1007/s10856-009-3807-0; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Guerra NP, 2005, J FOOD PROTECT, V68, P1012, DOI 10.4315/0362-028X-68.5.1012; Howard KA, 2007, SMALL, V3, P54, DOI 10.1002/small.200600328; Jaiswal MK, 2010, COLLOID SURFACE B, V81, P185, DOI 10.1016/j.colsurfb.2010.07.009; Kamal JKA, 2003, J BIOL CHEM, V278, P16451; Kato E, 2005, J APPL POLYM SCI, V97, P405, DOI 10.1002/app.21764; Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2; LI Y, 1992, ANNU REV MATER SCI, V22, P243; Lin CL, 2006, J POLYM SCI POL CHEM, V44, P356, DOI 10.1002/pola.21134; Malonne H, 2005, EUR J PHARM BIOPHARM, V61, P188, DOI 10.1016/j.ejpb.2005.05.007; Milasinovic N, 2010, REACT FUNCT POLYM, V70, P807, DOI 10.1016/j.reactfunctpolym.2010.07.017; Milasinovic N, 2010, INT J PHARMACEUT, V383, P53, DOI 10.1016/j.ijpharm.2009.09.001; Mohanraj V. J., 2006, Tropical Journal of Pharmaceutical Research, V5, P561; Nayak S, 2012, J PHYS CHEM C, V116, P30, DOI 10.1021/jp209048g; OTAKE K, 1990, MACROMOLECULES, V23, P283, DOI 10.1021/ma00203a049; Ouattara B, 2000, J FOOD SCI, V65, P768, DOI 10.1111/j.1365-2621.2000.tb13584.x; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Pace CN, 2000, PROTEINS, P1; Pranoto Y, 2005, LWT-FOOD SCI TECHNOL, V38, P859, DOI 10.1016/j.lwt.2004.09.014; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Saunders BR, 1997, MACROMOLECULES, V30, P482, DOI 10.1021/ma961277f; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; Serrano-Medina A, 2012, J COLLOID INTERF SCI, V369, P82, DOI 10.1016/j.jcis.2011.12.045; Shibayama M, 1996, MACROMOLECULES, V29, P2019, DOI 10.1021/ma951390q; Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w; Tapeinos C, 2013, J MATER CHEM B, V1, P194, DOI 10.1039/c2tb00013j; Tauer K, 2009, COLLOID POLYM SCI, V287, P299, DOI 10.1007/s00396-008-1984-x; TIKTOPULO EI, 1994, MACROMOLECULES, V27, P2879, DOI 10.1021/ma00088a031; Ture H, 2011, INT J FOOD SCI TECH, V46, P154, DOI 10.1111/j.1365-2621.2010.02465.x; Vartiainen J, 2003, PACKAG TECHNOL SCI, V16, P223, DOI 10.1002/pts.629; Weiss J, 2006, J FOOD SCI, V71, pR107, DOI 10.1111/j.1750-3841.2006.00195.x; Wu JY, 2005, J CONTROL RELEASE, V102, P361, DOI 10.1016/j.jconrel.2004.10.008; Yoo MK, 2000, POLYMER, V41, P5713, DOI 10.1016/S0032-3861(99)00779-X; Zhang XZ, 2002, INT J PHARMACEUT, V235, P43, DOI 10.1016/S0378-5173(01)00976-0; Zhu PW, 1996, J COLLOID INTERF SCI, V177, P343, DOI 10.1006/jcis.1996.0042	62	52	52	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2								10.1371/journal.pone.0087190	http://dx.doi.org/10.1371/journal.pone.0087190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520326	Green Published, gold			2022-12-27	WOS:000331254600017
J	Njenga, SM; Ng'ang'a, PM; Mwanje, MT; Bendera, FS; Bockarie, MJ				Njenga, Sammy M.; Ng'ang'a, Paul M.; Mwanje, Mariam T.; Bendera, Fatuma S.; Bockarie, Moses J.			A School-Based Cross-Sectional Survey of Adverse Events following Co-Administration of Albendazole and Praziquantel for Preventive Chemotherapy against Urogenital Schistosomiasis and Soil-Transmitted Helminthiasis in Kwale County, Kenya	PLOS ONE			English	Article							HAEMATOBIUM INFECTION; EFFICACY; MORBIDITY; MANSONI; SCHOOLCHILDREN; CHILDREN; EPIDEMIOLOGY; DYNAMICS; SAFETY	Background: Soil-transmitted helminths and schistosomiasis are mostly prevalent in developing countries due to poor sanitation and lack of adequate clean water. School-age children tend to be the target of chemotherapy-based control programmes because they carry the heaviest worm and egg burdens. The present study examines adverse events (AEs) experienced following co-administration of albendazole and praziquantel to school-age children in a rural area in Kwale County, Kenya. Methods: Children were treated with single doses of albendazole and praziquantel tablets and then interviewed using a questionnaire for post treatment AEs. Results: Overall, 752 children, 47.6% boys, participated in the study. Their median (interquartile range) age was 12.0 (10.0-14.0) years. A total of 190 (25.3%) children reportedly experienced at least one AE. In total, 239 cases of AEs were reported with the most frequent being abdominal pains (46.3%), dizziness (33.2%) and nausea (21.1%). Majority of the reported AEs (80.8%) resolved themselves while 12.1% and 6.3% were countered by, respectively, self-medication and visiting a nearby health facility. More girls (60.5%) than boys (39.5%) reported AEs (P = 0.027). Conclusions: The AEs were mild and transient, and were no worse than those expected following monotherapy. The current study adds to the evidence base that dual administration of albendazole and praziquantel in school-based mass drug administration is safe with only mild adverse events noted.	[Njenga, Sammy M.] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya; [Ng'ang'a, Paul M.; Mwanje, Mariam T.] Minist Hlth, Div Vector Borne Dis & Neglected Trop Dis DVBD NT, Nairobi, Kenya; [Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Kenya Medical Research Institute; Liverpool School of Tropical Medicine; University of Liverpool	Njenga, SM (corresponding author), Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Mbagathi Rd, Nairobi, Kenya.	snjenga@kemri.org	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021	Njenga, Sammy/0000-0001-6309-476X	European Foundations Initiative of Neglected Tropical Diseases (EFINTD) through a postdoctoral fellowship [I/84000]; MRC [G1001337] Funding Source: UKRI; Medical Research Council [G1001337] Funding Source: researchfish	European Foundations Initiative of Neglected Tropical Diseases (EFINTD) through a postdoctoral fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support for this study was provided by the European Foundations Initiative of Neglected Tropical Diseases (EFINTD) through a postdoctoral fellowship (Grant No. I/84000) awarded to Prof. Njenga (http://www.europeanfoundations.eu/content/Pages/European-Foundations-Initiative-for-AfricanResearch-into-Neglected-Tropical-Diseases-(EFINTD).aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoubryn KD, 2012, MED SANTE TROP, V22, P170, DOI 10.1684/mst.2012.0048; ANDERSON RM, 1985, ADV PARASIT, V24, P1, DOI 10.1016/S0065-308X(08)60561-8; [Anonymous], 2006, PREV CHEM HUM HELM C; Berhe N, 1999, ACTA TROP, V72, P53, DOI 10.1016/S0001-706X(98)00084-9; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Erko Berhanu, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P235, DOI 10.1016/S2221-1691(12)60049-5; Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005; Horton J, 2000, PARASITOLOGY, V121, pS113, DOI 10.1017/S0031182000007290; Jaoko WG, 1996, E AFR MED J, V73, P499; Kabatereine NB, 2007, B WORLD HEALTH ORGAN, V85, P91, DOI 10.2471/BLT.06.030353; Kabatereine NB, 2006, T ROY SOC TROP MED H, V100, P208, DOI 10.1016/j.trstmh.2005.03.015; Kenya National Bureau of Statistics, 2010, 2009 KEN POP HOUS CE; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; Makau JK, 2004, 25 AFR HLTH SCI C NA; Mohammed KA, 2008, PLOS NEGLECT TROP D, V2, P4; Montresor A., 2002, HELMINTH CONTROL SCH; Muchiri EM, 1996, AM J TROP MED HYG, V55, P127, DOI 10.4269/ajtmh.1996.55.127; N'Goran EK, 2003, ANN TROP MED PARASIT, V97, P37, DOI 10.1179/000349803125002553; Njenga SM, 2011, PARASITE VECTOR, V4, P3; Njomo DW, 2010, AFRICAN J HLTH SCI, V17, P3; Olds GR, 1999, J INFECT DIS, V179, P996, DOI 10.1086/314686; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, P4; Raso G, 2004, T ROY SOC TROP MED H, V98, P18, DOI 10.1016/S0035-9203(03)00003-8; Southgate VR, 2005, J HELMINTHOL, V79, P181, DOI 10.1079/JOH2005307; Stothard JR, 2009, T ROY SOC TROP MED H, V103, P1031, DOI 10.1016/j.trstmh.2009.03.024; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wiest PM, 1996, PARASITOL TODAY, V12, P215, DOI 10.1016/0169-4758(96)10019-3; World Health Organization, 2002, WHO TECHN REP SER; World Health Organization UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2015, MICR DET ID QUANT MA	29	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88315	10.1371/journal.pone.0088315	http://dx.doi.org/10.1371/journal.pone.0088315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520365	Green Published, Green Accepted, gold			2022-12-27	WOS:000331254600056
J	Pietraszewski, D; Cosmides, L; Tooby, J				Pietraszewski, David; Cosmides, Leda; Tooby, John			The Content of Our Cooperation, Not the Color of Our Skin: An Alliance Detection System Regulates Categorization by Coalition and Race, but Not Sex	PLOS ONE			English	Article							SOCIAL CATEGORIZATION; PERSON MEMORY; ACCESSIBILITY; INFORMATION; EVOLUTION; PARADIGM; SALIENCE; THINKING; MARKERS; GENDER	Humans in all societies form and participate in cooperative alliances. To successfully navigate an alliance-laced world, the human mind needs to detect new coalitions and alliances as they emerge, and predict which of many potential alliance categories are currently organizing an interaction. We propose that evolution has equipped the mind with cognitive machinery that is specialized for performing these functions: an alliance detection system. In this view, racial categories do not exist because skin color is perceptually salient; they are constructed and regulated by the alliance system in environments where race predicts social alliances and divisions. Early tests using adversarial alliances showed that the mind spontaneously detects which individuals are cooperating against a common enemy, implicitly assigning people to rival alliance categories based on patterns of cooperation and competition. But is social antagonism necessary to trigger the categorization of people by alliance-that is, do we cognitively link A and B into an alliance category only because they are jointly in conflict with C and D? We report new studies demonstrating that peaceful cooperation can trigger the detection of new coalitional alliances and make race fade in relevance. Alliances did not need to be marked by team colors or other perceptually salient cues. When race did not predict the ongoing alliance structure, behavioral cues about cooperative activities up-regulated categorization by coalition and down-regulated categorization by race, sometimes eliminating it. Alliance cues that sensitively regulated categorization by coalition and race had no effect on categorization by sex, eliminating many alternative explanations for the results. The results support the hypothesis that categorizing people by their race is a reversible product of a cognitive system specialized for detecting alliance categories and regulating their use. Common enemies are not necessary to erase important social boundaries; peaceful cooperation can have the same effect.	[Pietraszewski, David; Cosmides, Leda; Tooby, John] Univ Calif Santa Barbara, Ctr Evolutionary Psychol, Santa Barbara, CA 93106 USA; [Pietraszewski, David; Cosmides, Leda] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Tooby, John] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Pietraszewski, D (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	davidpietraszewski@gmail.com			National Institutes of Health Director's Pioneer Award [DPI OD000516]; John Templeton Foundation Grant [29468]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000516] Funding Source: NIH RePORTER	National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by a National Institutes of Health Director's Pioneer Award (# DPI OD000516 (http://commonfund.nih.gov/pioneer/) to L.C., and a John Templeton Foundation Grant (# 29468) to J.T. & L.C.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Barden J, 2004, J PERS SOC PSYCHOL, V87, P5, DOI 10.1037/0022-3514.87.1.5; Bennett M, 2003, BRIT J DEV PSYCHOL, V21, P99, DOI 10.1348/026151003321164645; Blanz M, 1999, EUR J SOC PSYCHOL, V29, P43, DOI 10.1002/(SICI)1099-0992(199902)29:1<43::AID-EJSP913>3.0.CO;2-Z; Brewer M., 1988, ADV SOCIAL COGNITION, P1; Bruner J. S., 1956, STUDY THINKING; Chagnon Napoleon., 1992, YANOMAMO LAST DAYS E; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; Crisp R.J., 1999, GROUP PROCESS INTERG, V2, P307, DOI [10.1177/1368430299024001, DOI 10.1177/1368430299024001]; Delton AW, 2012, J PERS SOC PSYCHOL, V102, P1252, DOI 10.1037/a0027026; DESCHAMPS JC, 1977, EUR J SOC PSYCHOL, V7, P517, DOI 10.1002/ejsp.2420070410; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; GILBERT DT, 1991, J PERS SOC PSYCHOL, V60, P509, DOI 10.1037/0022-3514.60.4.509; Harcourt AH., 1992, COALITIONS ALLIANCES; HEWSTONE M, 1991, EUR J SOC PSYCHOL, V21, P517, DOI 10.1002/ejsp.2420210606; Hirschfeld L.A., 1996, RACE MAKING COGNITIO; Keeley LH., 1996, WAR CIVILIZATION; Klauer KC, 1998, J PERS SOC PSYCHOL, V75, P1155, DOI 10.1037/0022-3514.75.5.1155; Klein SB, 2002, PSYCHOL REV, V109, P306, DOI 10.1037//0033-295X.109.2.306; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Lieberman D, 2008, EUR J SOC PSYCHOL, V38, P998, DOI 10.1002/ejsp.528; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; Oakes Penelope J., 1987, REDISCOVERING SOCIAL, P117, DOI DOI 10.2307/2073157; OAKES PJ, 1991, BRIT J SOC PSYCHOL, V30, P125, DOI 10.1111/j.2044-8309.1991.tb00930.x; Payne BK, 2002, J EXP SOC PSYCHOL, V38, P384, DOI 10.1016/S0022-1031(02)00006-9; Perry S, 2004, ANIM BEHAV, V67, P165, DOI 10.1016/j.anbehav.2003.04.005; Pietraszewski D., 2013, NAVIGATING SOCIAL WO, P253, DOI [10.1093/acprof:oso/9780199890712.003.0046, DOI 10.1093/ACPROF:OSO/9780199890712.003.0046]; Pietraszewski D, 2013, COGNITION, V126, P352, DOI 10.1016/j.cognition.2012.10.009; Quine W., 1969, ONT REAL OTH ESS, DOI 10.7312/quin92204; Rhodes M, 2013, PSYCHOL SCI, V24, P999, DOI 10.1177/0956797612466267; RIPS LJ, 1973, J VERB LEARN VERB BE, V12, P1, DOI 10.1016/S0022-5371(73)80056-8; Sack JD, 2005, DISS ABSTR INT, V66, P3469; Sani F, 2005, SCAND J PSYCHOL, V46, P83, DOI 10.1111/j.1467-9450.2005.00438.x; Sengupta S., 2001, NY TIMES; Sidanius J., 1999, SOCIAL DOMINANCE INT; Smuts B. B., 1987, PRIMATE SOC; SPEARS R, 1997, SOCIAL PSYCHOL STERE, P171; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Staddon J.E.R., 1988, P59; STANGOR C, 1992, J PERS SOC PSYCHOL, V62, P207, DOI 10.1037/0022-3514.62.2.207; Susskind JE, 2007, BRIT J DEV PSYCHOL, V25, P213, DOI 10.1348/026151006X103654; TAYLOR SE, 1978, J PERS SOC PSYCHOL, V36, P778, DOI 10.1037/0022-3514.36.7.778; Telles E., 2004, RACE ANOTHER AM SIGN, DOI [10.1515/9781400837434, 10.2307/j.ctt6wpzpb]; Tooby J., 1988, 881 I EV STUD; Tooby J, 2006, MANAG DECIS ECON, V27, P103, DOI 10.1002/mde.1287; Turner J.C., 1981, INTERGROUP BEHAV, P66; Van Twuyver M, 1998, EUR J SOC PSYCHOL, V28, P531; von Rueden C, 2008, EVOL HUM BEHAV, V29, P402, DOI 10.1016/j.evolhumbehav.2008.05.001; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wrangham R., 1996, DEMONIC MALES; Yamagishi T, 1999, ADV GROUP, V16, P161	55	74	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88534	10.1371/journal.pone.0088534	http://dx.doi.org/10.1371/journal.pone.0088534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520394	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600085
J	Donastorg, Y; Barrington, C; Perez, M; Kerrigan, D				Donastorg, Yeycy; Barrington, Clare; Perez, Martha; Kerrigan, Deanna			Abriendo Puertas: Baseline Findings from an Integrated Intervention to Promote Prevention, Treatment and Care among FSW Living with HIV in the Dominican Republic	PLOS ONE			English	Article							FEMALE SEX WORKERS; ANTIRETROVIRAL THERAPY; RISK BEHAVIOR; DEVELOPING-COUNTRIES; HIV/AIDS STIGMA; CONDOM USE; IMPACT; ADHERENCE; HEALTH; MEN	Female sex workers (FSW) are often the focus of primary HIV prevention efforts. However, little attention has been paid to the prevention, treatment, and care needs of FSW living with HIV. Based on formative research, we developed an integrated model to promote prevention and care for FSW living with HIV in Santo Domingo, Dominican Republic, including (1) individual counseling and education; (2) peer navigation; (3) clinical provider training; and (4) community mobilization. We enrolled 268 FSW living with HIV into the intervention and conducted socio-behavioral surveys, sexually transmitted infection (STI) testing, and viral load (VL) assessments. We used multivariate logistic regression to identify behavioral and socio-demographic factors associated with detectable VL (>50 copies/mL) and STI prevalence. Over half of all participants (51.9%) had a detectable VL, even though most received HIV-related care in the last 6 months (85.1%) and were currently on anti-retroviral treatment (ART) (72.4%). Factors positively associated with a detectable VL included being 18-35 years of age (Adjusted Odds Ratio [AOR] 2.46, 95% CI 1.31-4.60), having ever used drugs (AOR 2.34, 95% CI 1.14-4.79), and having ever interrupted ART (AOR 3.09, 95% CI 1.44-6.59). Factors protective against having a detectable VL included being single (AOR 0.45, 95% 0.20-0.98) and being currently on ART (AOR 0.17, 95% CI 0.07-0.41). Nearly one-quarter (23.1%) had an STI, which was associated with being single (AOR 3.21, 95% CI 1.27-8.11) and using drugs in the last 6 months (AOR 3.54, 95% CI 1.32-9.45). Being on ART was protective against STI (AOR 0.51, 95% CI 0.26-1.00). Baseline findings indicate significant barriers to VL suppression and STI prevention among FSW living with HIV and highlight gaps in the continuum of HIV care and treatment. These findings have important implications for both the individual health of FSW and population-level HIV transmission dynamics.	[Donastorg, Yeycy; Perez, Martha] Inst Dermatal & Cirugia Piel Dr Humberto Bogart D, HIV Vaccine Res Unit, Santo Domingo, Dominican Rep; [Barrington, Clare] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Kerrigan, Deanna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kerrigan, D (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.	dkerriga@jhsph.edu	Barrington, Clare/AAM-4909-2021		U.S. Agency for International Development [GHH-I-00-07-00032-00]; President's Emergency Plan for AIDS Relief; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	U.S. Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded by the U.S. Agency for International Development (http://www. usaid. gov/) under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Amuri M, 2011, AIDS CARE, V23, P378, DOI 10.1080/09540121.2010.507739; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-36; Barrington C, 2009, SOC SCI MED, V68, P2037, DOI 10.1016/j.socscimed.2009.03.009; BASTOS FIP, 2009, PUBLIC HLTH ASPECTS, P629; Beattie TSH, 2012, J EPIDEMIOL COMMUN H, V66, pII42, DOI 10.1136/jech-2011-200475; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Beyrer C, 2011, JAIDS-J ACQ IMM DEF, V57, pS96, DOI 10.1097/QAI.0b013e31821db944; Celum C, 2013, J INFECT DIS, V208, P189, DOI 10.1093/infdis/jit154; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; *COPRESIDA, 2008, LER ENC VIG COMP VIN; Cornish F, 2009, AM J COMMUN PSYCHOL, V44, P123, DOI 10.1007/s10464-009-9254-8; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Diabate S, 2011, WORLD J AIDS, V1, P94, DOI [10.4236/wja.2011.13014, DOI 10.4236/WJA.2011.13014]; *EMP WOM SHE, STRONG HIV POS; Forsyth AD, 2012, CURR OPIN HIV AIDS, V7, P111, DOI 10.1097/COH.0b013e32834fcff6; GHIMIRE L, 2009, GLOBAL J HLTH SCI, V1, pP12; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hadland SE, 2012, AIDS PATIENT CARE ST, V26, P274, DOI 10.1089/apc.2011.0196; Halperin DT, 2009, JAIDS-J ACQ IMM DEF, V51, pS52, DOI 10.1097/QAI.0b013e3181a267e4; Hodgson I, 2012, AIDS CARE, V24, P1204, DOI 10.1080/09540121.2012.658755; Holtgrave DR, 2012, AIDS BEHAV, V16, P1085, DOI 10.1007/s10461-012-0186-1; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Kennedy C, 2007, AIDS CARE, V19, P707, DOI 10.1080/09540120701203261; Kennedy C., 2013, EXPLORING POSITIVE H; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D., 2001, Culture, Health & Sexuality, V3, P221, DOI 10.1080/136910501750153049; KERRIGAN D, 2009, PUBLIC HLTH ASPECTS, P655; KERRIGAN D, 2013, LANCET; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; McClelland L, 2011, AIDS EDUC PREV, V23, P299, DOI 10.1521/aeap.2011.23.4.299; McClelland RS, 2010, AIDS, V24, P891, DOI 10.1097/QAD.0b013e32833616c7; Murray L, 2007, AIDS BEHAV, V11, P463, DOI 10.1007/s10461-006-9184-5; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Reidpath DD, 2005, AIDS CARE, V17, P425, DOI 10.1080/09540120412331319769; Scambler G, 2008, SOC SCI MED, V66, P1848, DOI 10.1016/j.socscimed.2008.01.002; UNAIDS, 2009, UNAIDS GUID NOT HIV; *UNAIDS, 2002, UNAIDS TECHN UPD SEX; Wariki WMV, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005272.pub3; World Health Organization, 2011, PREV HIV SEX WORK SU; World Health Organization, 2004, WORLD HLTH REP 2004; Zelaya CE, 2008, AIDS BEHAV, V12, P781, DOI 10.1007/s10461-007-9331-7	48	40	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88157	10.1371/journal.pone.0088157	http://dx.doi.org/10.1371/journal.pone.0088157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551079	Green Published, gold			2022-12-27	WOS:000331271500030
J	Yoon, G; Lee, M; Kim, JI; Na, S; Eom, K				Yoon, Gwonchan; Lee, Myeongsang; Kim, Jae In; Na, Sungsoo; Eom, Kilho			Role of Sequence and Structural Polymorphism on the Mechanical Properties of Amyloid Fibrils	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; SOLID-STATE NMR; AROMATIC INTERACTIONS; PROTEIN STRUCTURES; NANOMECHANICS; STRENGTH; LENGTH; MODEL; NANOCONFINEMENT; FLEXIBILITY	Amyloid fibrils playing a critical role in disease expression, have recently been found to exhibit the excellent mechanical properties such as elastic modulus in the order of 10 GPa, which is comparable to that of other mechanical proteins such as microtubule, actin filament, and spider silk. These remarkable mechanical properties of amyloid fibrils are correlated with their functional role in disease expression. This suggests the importance in understanding how these excellent mechanical properties are originated through self-assembly process that may depend on the amino acid sequence. However, the sequence-structure-property relationship of amyloid fibrils has not been fully understood yet. In this work, we characterize the mechanical properties of human islet amyloid polypeptide (hIAPP) fibrils with respect to their molecular structures as well as their amino acid sequence by using all-atom explicit water molecular dynamics (MD) simulation. The simulation result suggests that the remarkable bending rigidity of amyloid fibrils can be achieved through a specific self-aggregation pattern such as antiparallel stacking of beta strands (peptide chain). Moreover, we have shown that a single point mutation of hIAPP chain constituting a hIAPP fibril significantly affects the thermodynamic stability of hIAPP fibril formed by parallel stacking of peptide chain, and that a single point mutation results in a significant change in the bending rigidity of hIAPP fibrils formed by antiparallel stacking of b strands. This clearly elucidates the role of amino acid sequence on not only the equilibrium conformations of amyloid fibrils but also their mechanical properties. Our study sheds light on sequence-structure-property relationships of amyloid fibrils, which suggests that the mechanical properties of amyloid fibrils are encoded in their sequence-dependent molecular architecture.	[Yoon, Gwonchan; Lee, Myeongsang; Kim, Jae In; Na, Sungsoo] Korea Univ, Dept Mech Engn, Seoul, South Korea; [Yoon, Gwonchan] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; [Eom, Kilho] Sungkyunkwan Univ, Coll Sport Sci, Biomech Lab, Suwon, South Korea	Korea University; Boston University; Sungkyunkwan University (SKKU)	Na, S (corresponding author), Korea Univ, Dept Mech Engn, Seoul, South Korea.	nass@korea.ac.kr; kilhoeom@skku.edu	Kim, Jae In/A-2799-2010; Lee, Myeongsang/F-8292-2012; Eom, Kilho/B-1552-2008	Eom, Kilho/0000-0001-5135-8473; Lee, Myeongsang/0000-0003-2078-6023	National Research Foundation of Korea (NRF) [2012R1A1A2008616, NRF-2010-0026223]; NRF [2011-0007272, 2011-0029477, 2012-0000785]; Korea University Grant	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NRF; Korea University Grant	K.E. appreciates the financial support from the National Research Foundation of Korea (NRF) under Grant No. 2012R1A1A2008616 and NRF-2010-0026223. S.N. gratefully acknowledges the financial support from NRF under Grant No. 2011-0007272, 2011-0029477, and 2012-0000785. G.Y. and S.N. are grateful to Korea University Grant for the financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Adamcik J, 2010, NAT NANOTECHNOL, V5, P423, DOI [10.1038/nnano.2010.59, 10.1038/NNANO.2010.59]; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Berryman JT, 2011, BIOPHYS J, V100, P2234, DOI 10.1016/j.bpj.2011.02.060; Berryman JT, 2009, BIOPHYS J, V97, P1, DOI 10.1016/j.bpj.2009.03.062; Buehler MJ, 2008, PROG MATER SCI, V53, P1101, DOI 10.1016/j.pmatsci.2008.06.002; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Buehler MJ, 2010, REV MOD PHYS, V82, P1459, DOI 10.1103/RevModPhys.82.1459; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Clark A, 2007, PROTEIN MISFOLDING A; Colby DW, 2011, NAT REV MICROBIOL, V9, P771, DOI 10.1038/nrmicro2650; Cui Q., 2005, NORMAL MODE ANAL THE; Deriu MA, 2010, BIOPHYS J, V99, P2190, DOI 10.1016/j.bpj.2010.06.070; Drago D, 2007, J ALZHEIMERS DIS, V11, P33; Eom K, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021904; Eom K, 2003, J PHYS CHEM B, V107, P8730, DOI 10.1021/jp035178x; Eom K, 2007, J COMPUT CHEM, V28, P1400, DOI 10.1002/jcc.20672; Eom K, 2011, PHYS REP, V503, P115, DOI 10.1016/j.physrep.2011.03.002; Eom K, 2010, J COMPUT THEOR NANOS, V7, P1210, DOI 10.1166/jctn.2010.1475; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P10976, DOI 10.1073/pnas.1309690110; Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t; Golji J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000389; Gosline JM, 1999, J EXP BIOL, V202, P3295; HAYWARD S, 1995, ANNU REV PHYS CHEM, V46, P223, DOI 10.1146/annurev.pc.46.100195.001255; Hollander PA, 2003, DIABETES CARE, V26, P784, DOI 10.2337/diacare.26.3.784; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Jang H, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3282447; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kawahara M, 2001, BRAIN RES BULL, V55, P211, DOI 10.1016/S0361-9230(01)00475-0; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Kim JI, 2009, J CHEM THEORY COMPUT, V5, P1931, DOI 10.1021/ct900027h; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kumar S, 2010, PHYS REP, V486, P1, DOI 10.1016/j.physrep.2009.11.001; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lara C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.238101; Lee G, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4739494; Liu FF, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3702195; Liu XJ, 2012, BIOPHYS J, V102, P1793, DOI 10.1016/j.bpj.2012.02.046; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Madine J, 2008, J AM CHEM SOC, V130, P14990, DOI 10.1021/ja802483d; Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Meirovitch L., 1967, ANAL METHODS VIBRATI; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/nchem.1293, 10.1038/NCHEM.1293]; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Ndlovu H, 2012, BIOPHYS J, V102, P587, DOI 10.1016/j.bpj.2011.12.047; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P2118, DOI 10.1002/anie.200804198; Pampaloni F, 2006, P NATL ACAD SCI USA, V103, P10248, DOI 10.1073/pnas.0603931103; Paparcone R, 2010, BIOCHEMISTRY-US, V49, P8967, DOI 10.1021/bi100953t; Paparcone R, 2010, J BIOMECH, V43, P1196, DOI 10.1016/j.jbiomech.2009.11.026; Park J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000492; Parthasarathy S, 2011, J AM CHEM SOC, V133, P3390, DOI 10.1021/ja1072178; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rapezzi C, 2010, NAT REV CARDIOL, V7, P398, DOI 10.1038/nrcardio.2010.67; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sachse C, 2010, ANGEW CHEM INT EDIT, V49, P1321, DOI 10.1002/anie.200904781; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sherwood P, 2008, CURR OPIN STRUC BIOL, V18, P630, DOI 10.1016/j.sbi.2008.07.003; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Staple DB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248301; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Tracz SM, 2004, BIOCHEMISTRY-US, V43, P15901, DOI 10.1021/bi048812l; Valdman D, 2012, BIOPHYS J, V102, P1144, DOI 10.1016/j.bpj.2012.01.045; vandenAkker CC, 2011, J AM CHEM SOC, V133, P18030, DOI 10.1021/ja206513r; Voth Gregory A., 2009, P1; Wang JC, 2002, J MOL BIOL, V315, P601, DOI 10.1006/jmbi.2001.5130; Wells DB, 2010, BIOPHYS J, V99, P629, DOI 10.1016/j.bpj.2010.04.038; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Xu ZP, 2010, BIOPHYS J, V98, P2053, DOI 10.1016/j.bpj.2009.12.4317; Yoon G, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774296; Yoon G, 2011, ADV FUNCT MATER, V21, P3454, DOI 10.1002/adfm.201002493; Yoon G, 2009, J COMPUT CHEM, V30, P873, DOI 10.1002/jcc.21107; Zatta P., 2003, METAL IONS NEURODEGE	87	43	44	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88502	10.1371/journal.pone.0088502	http://dx.doi.org/10.1371/journal.pone.0088502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551113	gold, Green Submitted, Green Published			2022-12-27	WOS:000331271500044
J	Ippolito, JE; Piwnica-Worms, D				Ippolito, Joseph E.; Piwnica-Worms, David			A Fluorescence-Coupled Assay for Gamma Aminobutyric Acid (GABA) Reveals Metabolic Stress-Induced Modulation of GABA Content in Neuroendocrine Cancer	PLOS ONE			English	Article							SMALL-CELL CARCINOMA; INTRACELLULAR PH; EXTRACELLULAR PH; SKELETAL-MUSCLE; L-GLUTAMATE; PROSTATE; DIFFERENTIATION; EXPRESSION; GROWTH; QUANTIFICATION	Pathways involved in the synthesis of the neurotransmitter gamma-aminobutyric acid (GABA) have been implicated in the pathogenesis of high grade neuroendocrine (NE) neoplasms as well as neoplasms from a non-NE lineage. Using The Cancer Genome Atlas, overexpression of the GABA synthetic enzyme, glutamate decarboxylase 1 (GAD1), was found to be associated with decreased disease free-survival in prostate adenocarcinoma and decreased overall survival in clear cell renal cell carcinomas. Furthermore, GAD1 was found to be expressed in castrate-resistant prostate cancer cell lines, but not androgen-responsive cell lines. Using a novel fluorescence-coupled enzymatic microplate assay for GABA mediated through reduction of resazurin in a prostate neuroendocrine carcinoma (PNEC) cell line, acid microenvironment-induced stress increased GABA levels while alkaline microenvironment-induced stress decreased GABA through modulation of GAD1 and glutamine synthetase (GLUL) activities. Moreover, glutamine but not glucose deprivation decreased GABA through modulation of GLUL. Consistent with evidence in prokaryotic and eukaryotic organisms that GABA synthesis mediated through GAD1 may play a crucial role in surviving stress, GABA may be an important mediator of stress survival in neoplasms. These findings identify GABA synthesis and metabolism as a potentially important pathway for regulating cancer cell stress response as well as a potential target for therapeutic strategies.	[Ippolito, Joseph E.; Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO USA; [Ippolito, Joseph E.] Washington Univ, Sch Med, Dept Genet, St Louis, MO USA; [Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	Ippolito, JE (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA.	ippolitoj@mir.wustl.edu; dpiwnica-worms@mdanderson.org			Radiological Society of North America [RR1031]; National Institutes of Health [P50 CA94056]; Siteman Cancer Center [P30 CA091842]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA094056] Funding Source: NIH RePORTER	Radiological Society of North America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants from the Radiological Society of North America (RR1031; http://www.rsna.org) and the National Institutes of Health (P50 CA94056). The HTS core is supported in part by a grant to the Siteman Cancer Center (P30 CA091842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO;2-S; Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Azuma H, 2003, CANCER RES, V63, P8090; Babin E, 2006, J LARYNGOL OTOL, V120, P289, DOI 10.1017/S0022215106000594; Bacac M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000032; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P109, DOI 10.1677/erc.1.00876; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman J, 1999, ANAL CHIM ACTA, V402, P47, DOI 10.1016/S0003-2670(99)00533-4; Cheville JC, 2002, CANCER-AM CANCER SOC, V95, P1028, DOI 10.1002/cncr.10788; CORREA JG, 1993, FREE RADICAL RES COM, V19, P303, DOI 10.3109/10715769309056519; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLellis R A, 2001, Am J Clin Pathol, V115 Suppl, pS5; Demellawy Dina El, 2006, Ann Diagn Pathol, V10, P162, DOI 10.1016/j.anndiagpath.2005.09.008; diSantAgnese PA, 1996, CANCER, V78, P357, DOI 10.1002/(SICI)1097-0142(19960715)78:2<357::AID-CNCR27>3.0.CO;2-U; DISANTAGNESE PA, 1992, HUM PATHOL, V23, P287; Edwards LJ, 1998, MOL REPROD DEV, V50, P434, DOI 10.1002/(SICI)1098-2795(199808)50:4<434::AID-MRD7>3.3.CO;2-S; Feehily C, 2012, J APPL MICROBIOL; Feehily C, 2012, APPL ENV MICROBIOL; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Gillies R. J., 2013, CANC RES; Hashim AI, 2011, CLIN EXP METASTAS, V28, P841, DOI 10.1007/s10585-011-9415-7; Hausler RE, 2000, ANAL BIOCHEM, V281, P1, DOI 10.1006/abio.2000.4556; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Hu Y, 2002, J BIOL CHEM, V11, P11; Ibrahim-Hashim A, 2012, J UROLOGY, V188, P624, DOI 10.1016/j.juro.2012.03.113; Ippolito JE, 2005, P NATL ACAD SCI USA, V102, P9901, DOI 10.1073/pnas.0500756102; Ippolito JE, 2006, P NATL ACAD SCI USA, V103, P12505, DOI 10.1073/pnas.0605207103; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; KARNES HT, 1991, PHARMACEUT RES, V8, P421, DOI 10.1023/A:1015882607690; Kim YG, 2009, EMBO J, V28, P959, DOI 10.1038/emboj.2009.40; Kobayashi S, 2001, J NEUROCHEM, V76, P1935, DOI 10.1046/j.1471-4159.2001.00214.x; KOVACEVIC Z, 1971, BIOCHEM J, V125, P757, DOI 10.1042/bj1250757; Kwan YW, 1996, BRIT J PHARMACOL, V118, P755, DOI 10.1111/j.1476-5381.1996.tb15464.x; Liu Y, 2008, WORLD J GASTROENTERO, V14, P7175, DOI 10.3748/wjg.14.7175; LOSCHER W, 1980, N-S ARCH PHARMACOL, V315, P119, DOI 10.1007/BF00499254; Madry C, 2008, P NATL ACAD SCI USA, V105, P12563, DOI 10.1073/pnas.0805624105; Marin-Valencia I, 2012, NMR BIOMED, V25, P1177, DOI 10.1002/nbm.2787; MILLER RE, 1978, P NATL ACAD SCI USA, V75, P1418, DOI 10.1073/pnas.75.3.1418; Montie JE, 2006, J UROLOGY, V175, P2070; Naves T, 2013, BIOCH PHARM; O'Byrne CP, 2011, J MICROBIOL METH, V84, P137, DOI 10.1016/j.mimet.2010.10.017; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; PASSONEAU JV, 1993, ENZYMATIC ANAL PRACT; PUSATERI ME, 1984, J NEUROCHEM, V42, P1269, DOI 10.1111/j.1471-4159.1984.tb02782.x; Quek ML, 2006, UROLOGY, V67, P1247, DOI 10.1016/j.urology.2005.12.009; Roberts SS, 2009, PATHOL ONCOL RES, V15, P645, DOI 10.1007/s12253-009-9165-x; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Saxena S, 2012, TOXICOL APPL PHARM, V264, P324, DOI 10.1016/j.taap.2012.08.033; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Shinji S, 2006, INT J ONCOL, V29, P357; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Sorensen Morten, 1998, Current Opinion in Oncology, V10, P133, DOI 10.1097/00001622-199803000-00009; Takayama N, 2012, ANAL BIOCHEM, V425, P114, DOI 10.1016/j.ab.2012.03.011; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tretter L, 2000, J NEUROSCI, V20, P8972; Tsunoda S, 2005, INT J GYNECOL CANCER, V15, P295, DOI 10.1111/j.1525-1438.2005.15219.x; Valero E, 2004, BIOPHYS J, V86, P3598, DOI 10.1529/biophysj.103.035956; Vermeir S, 2007, J AGR FOOD CHEM, V55, P3240, DOI 10.1021/jf0637022; Wafa LA, 2007, HUM PATHOL, V38, P161, DOI 10.1016/j.humpath.2006.07.003; Wick MR, 2000, AM J CLIN PATHOL, V113, P331, DOI 10.1309/ETJ3-QBUK-13QD-J8FP; WICK MR, 2002, CURR DIAGN PATHOL, V8, P102, DOI DOI 10.1054/CDIP.2001.0102; WOLF R, 1991, ANAL BIOCHEM, V192, P78, DOI 10.1016/0003-2697(91)90187-X; Xue QW, 2013, CHEM COMMUN, V49, P2640, DOI 10.1039/c3cc39064k; Yamamoto N, 2006, ANAL BIOCHEM, V351, P139, DOI 10.1016/j.ab.2005.12.011; Yao JL, 2006, AM J SURG PATHOL, V30, P705, DOI 10.1097/00000478-200606000-00005; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009; Zhu CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047584	79	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88667	10.1371/journal.pone.0088667	http://dx.doi.org/10.1371/journal.pone.0088667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551133	Green Submitted, Green Published, gold			2022-12-27	WOS:000331266000053
J	Williams, KA; Terry, KL; Tworoger, SS; Vitonis, AF; Titus, LJ; Cramer, DW				Williams, Kristina A.; Terry, Kathryn L.; Tworoger, Shelley S.; Vitonis, Allison F.; Titus, Linda J.; Cramer, Daniel W.			Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival	PLOS ONE			English	Article							GENETIC-VARIATION; GASTRIC-CANCER; OVEREXPRESSION; ASSOCIATION; EXPRESSION; CARCINOMA; TUMORIGENESIS; PROTEIN; TUMORS; CELLS	Objective: To examine single nucleotide polymorphism (SNPs) in MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival. Methods: We genotyped germline variants of MUC16 (rs2547065, rs1559168, rs12984471, rs2121133) and MUC1 (rs2070803, rs4072037, rs1045253) using samples collected from 758 ovarian cancer cases and 788 controls enrolled in the New England Case-Control Study between 2003 and 2008. We calculated age-adjusted odds ratios (OR) and 95% confidence intervals (CIs) for disease risk using unconditional and polytomous logistic regression and hazard ratios (HR) for survival using Cox proportional hazard ratios. In a subset of cases, we compared log-normalized CA125 values by genotype using generalized linear models. Results: Cases homozygous for the variant allele of MUC16 SNP, rs12984471, had poorer overall survival (log-rank p = 0.03) and higher CA125 levels, especially cases over age 65 (p = 0.01). For MUC1 SNP, rs4072037, women homozygous for the G variant had a non-significantly decreased risk for serous invasive types but elevated risk for serous borderline tumors, mucinous borderline and invasive tumors, and endometrioid tumors. Women with the variant allele of MUC16 SNP, rs2547065, especially those who were homozygous had an elevated risk for ovarian cancer; but this association was not confirmed in an independent dataset. Conclusion: This targeted screen of seven polymorphisms of MUC16 and MUC1 genes failed to identify and confirm effects on ovarian cancer risk overall. However, there may be effects of MUC16 rs12984471 on survival and MUC1 rs4072037 on risk for histologic types of ovarian cancer other than invasive serous. Further study is warranted.	[Williams, Kristina A.; Terry, Kathryn L.; Vitonis, Allison F.; Cramer, Daniel W.] Brigham & Womens Hosp, Dept Obstet & Gynecol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Williams, Kristina A.; Terry, Kathryn L.; Tworoger, Shelley S.; Cramer, Daniel W.] Harvard Univ, Sch Med, Boston, MA USA; [Terry, Kathryn L.; Tworoger, Shelley S.; Cramer, Daniel W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Tworoger, Shelley S.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Titus, Linda J.] Dartmouth Hitchcock Med Ctr, Dept Pediat, Dept Community & Family Med, Lebanon, NH 03766 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Dartmouth College	Cramer, DW (corresponding author), Brigham & Womens Hosp, Dept Obstet & Gynecol, Obstet & Gynecol Epidemiol Ctr, 75 Francis St, Boston, MA 02115 USA.	dcramer@partners.org		Tworoger, Shelley/0000-0002-6986-7046	NIH [R01CA054419, P50CA105009, R01CA49449, R01CA67272, R01CA50383, UM1 CA176726, P01CA87969]; Department of Defense [W81XWH-10-1-0280]; Scholars in Medicine Office at Harvard Medical School; Department of Obstetrics and Gynecology at Brigham and Women's Hospital; NATIONAL CANCER INSTITUTE [P50CA105009, R01CA054419, R01CA049449, UM1CA176726, P01CA087969] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Scholars in Medicine Office at Harvard Medical School; Department of Obstetrics and Gynecology at Brigham and Women's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported by NIH grant numbers R01CA054419, P50CA105009, R01CA49449, R01CA67272, R01CA50383, UM1 CA176726, and P01CA87969; Department of Defense grant number W81XWH-10-1-0280 and the Scholars in Medicine Office at Harvard Medical School and the Department of Obstetrics and Gynecology at Brigham and Women's Hospital. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bieche I, 1997, CANCER GENET CYTOGEN, V98, P75, DOI 10.1016/S0165-4608(96)00410-4; Bon GG, 1999, HUM REPROD, V14, P566, DOI 10.1093/humrep/14.2.566; Bouanene H, 2011, PATHOL ONCOL RES, V17, P295, DOI 10.1007/s12253-010-9314-2; BULLER RE, 1992, GYNECOL ONCOL, V47, P87, DOI 10.1016/0090-8258(92)90082-T; CARRAWAY KL, 1989, BIOESSAYS, V10, P117, DOI 10.1002/bies.950100406; Cramer DW, 2010, GYNECOL ONCOL, V119, P462, DOI 10.1016/j.ygyno.2010.08.028; Feng H, 2002, JPN J CLIN ONCOL, V32, P525, DOI 10.1093/jjco/hyf111; Giuntoli RL, 1998, CANCER RES, V58, P5546; Goode EL, 2010, CLIN CANCER RES, V16, P995, DOI 10.1158/1078-0432.CCR-09-2553; Harris HR, 2012, INT J CANCER, V131, pE518, DOI 10.1002/ijc.26455; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Horimasu Y, 2012, RESP MED, V106, P1756, DOI 10.1016/j.rmed.2012.09.001; Lacunza E, 2010, CANCER GENET CYTOGEN, V201, P102, DOI 10.1016/j.cancergencyto.2010.05.015; Li FX, 2012, MOL BIOL REP, V39, P9557, DOI 10.1007/s11033-012-1820-8; Marin F, 2012, CARCINOGENESIS, V33, P1072, DOI 10.1093/carcin/bgs119; Micci F, 2009, GENE CHROMOSOME CANC, V48, P184, DOI 10.1002/gcc.20628; Myllykangas S, 2008, INT J CANCER, V123, P817, DOI 10.1002/ijc.23574; Ng W, 2008, BRIT J CANCER, V99, P978, DOI 10.1038/sj.bjc.6604617; Palmer AJ, 2012, EUR J CANCER PREV, V21, P541, DOI 10.1097/CEJ.0b013e3283529b79; PEJOVIC T, 1992, GENE CHROMOSOME CANC, V4, P58, DOI 10.1002/gcc.2870040108; Phelan CM, 2010, CANCER EPIDEM BIOMAR, V19, P600, DOI 10.1158/1055-9965.EPI-09-0861; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Sellers TA, 2008, CANCER EPIDEM BIOMAR, V17, P397, DOI 10.1158/1055-9965.EPI-07-0565; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Skates SJ, 2011, CANCER PREV RES, V4, P1401, DOI 10.1158/1940-6207.CAPR-10-0402; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Takano M, 2004, ONCOL REP, V12, P1177; TASHIRO Y, 1994, HUM PATHOL, V25, P364, DOI 10.1016/0046-8177(94)90144-9; Terry KL, 2010, INT J MOL EPIDEMIOL, V1, P272; Theriault C, 2011, GYNECOL ONCOL, V121, P434, DOI 10.1016/j.ygyno.2011.02.020; THOMPSON FH, 1994, GENE CHROMOSOME CANC, V10, P262, DOI 10.1002/gcc.2870100407; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tworoger SS, 2009, CANCER RES, V69, P1885, DOI 10.1158/0008-5472.CAN-08-3515; Vitonis AF, 2011, OBSTET GYNECOL, V117, P1042, DOI 10.1097/AOG.0b013e318212fcb7; Waltz MR, 1998, CANCER GENET CYTOGEN, V100, P63, DOI 10.1016/S0165-4608(97)00015-0; Wang L, 2007, GYNECOL ONCOL, V105, P695, DOI 10.1016/j.ygyno.2007.02.004; Wreesmann VB, 2004, CANCER RES, V64, P3780, DOI 10.1158/0008-5472.CAN-03-1460	40	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88334	10.1371/journal.pone.0088334	http://dx.doi.org/10.1371/journal.pone.0088334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551091	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000029
J	Chen, S; Zhu, ZG; Klebe, D; Bian, HT; Krafft, PR; Tang, JP; Zhang, JM; Zhang, JH				Chen, Sheng; Zhu, Zhigang; Klebe, Damon; Bian, Hetao; Krafft, Paul R.; Tang, Jiping; Zhang, Jianmin; Zhang, John H.			Role of P2X Purinoceptor 7 in Neurogenic Pulmonary Edema after Subarachnoid Hemorrhage in Rats	PLOS ONE			English	Article							AIRWAY INFLAMMATION; LUNG INFLAMMATION; EXTRACELLULAR ATP; RECEPTOR; CELLS; INJURY; MODEL; MICE; LIPOPOLYSACCHARIDE; ACTIVATION	Introduction: Neurogenic pulmonary edema (NPE) is an acute and serious complication after subarachnoid hemorrhage (SAH) with high mortality. The present study aimed to test the therapeutic potential of brilliant blue G (BBG), a selective P2X purinoceptor 7 (P2X7R) antagonist, on NPE in a rat SAH model. Methods: SAH was induced by endovascular perforation. 86 Sprague-Dawley rats were randomly divided into sham, vehicle-, or BBG-treatment groups. Mortality, body weight, SAH grading, neurological deficits, NPE clinical symptoms, and pulmonary index were measured at 24 hours following SAH. Western blot, gelatin zymography, lung histopathology, and immunofluorescence staining were performed in the left lung lobe to explore the underlying mechanisms at 24 hours post-surgery. Results: The incidence of clinical symptoms was correlated with pulmonary index. P2X7R and the marker of alveolar type I epithelial cells (the mucin-type glycoprotein T1-alpha) immunoreactivities were generally co-localized. BBG administration decreased mature interleukin-1 beta, myeloperoxidase, and matrix metallopeptidase-9 activation, but increased tight junction proteins, such as ZO-1 and occludin, which ameliorated pulmonary edema via anti-inflammation and improved neurological deficits. Conclusion: P2X7R inhibition prevented NPE after SAH by attenuating inflammation. Thus, BBG is a potential therapeutic application for NPE after SAH and warrants further research.	[Chen, Sheng; Zhu, Zhigang; Zhang, Jianmin] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Chen, Sheng; Klebe, Damon; Bian, Hetao; Krafft, Paul R.; Tang, Jiping; Zhang, John H.] Loma Linda Univ, Dept Physiol & Pharmacol, Loma Linda, CA 92350 USA	Zhejiang University; Loma Linda University	Zhang, JM (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	zjm135@vip.sina.com; johnzhang3910@yahoo.com		chen, sheng/0000-0002-8374-136X	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study is supported by NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Barth K, 2009, FEBS J, V276, P341, DOI 10.1111/j.1742-4658.2008.06795.x; Berta T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-18; Beynon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039576; BORZELLECA JF, 1990, FOOD CHEM TOXICOL, V28, P221, DOI 10.1016/0278-6915(90)90034-K; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brathwaite S, 2013, TRANSL STROKE RES, DOI [10.1007/s12975-013-0316-8, DOI 10.1007/S12975-013-0316-8.PMID:24338266]; Chen S, 2013, PROG NEUROBIOL, DOI [10.1016/j.pneurobio.2013.09.002, DOI 10.1016/J.PNEUR0BI0.2013.09.002.PMID:24076160]; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; Cobelens PM, 2010, CRIT CARE, V14, DOI 10.1186/cc9232; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Dekali S, 2013, NANOTOXICOLOGY, V7, P1302, DOI 10.3109/17435390.2012.735269; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Fischer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059952; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Greenhalgh AD, 2012, TRANSL STROKE RES, V3, P164, DOI 10.1007/s12975-011-0124-y; He YD, 2012, TRANSL STROKE RES, V3, pS180, DOI 10.1007/s12975-012-0171-z; Huang XJ, 2013, J NEUROTRAUM, V30, P39, DOI 10.1089/neu.2012.2508; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Kim WI, 2013, NEUROL RES, V35, P369, DOI 10.1179/1743132812Y.0000000137; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Lok J, 2012, TRANSL STROKE RES, V3, pS119, DOI 10.1007/s12975-012-0157-x; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Mutoh T, 2012, J NEUROSURG ANESTH, V24, P203, DOI 10.1097/ANA.0b013e318242e52e; Piazza O, 2011, PANMINERVA MED, V53, P203; Qin WW, 2012, J ENDOCRINOL, V214, P145, DOI 10.1530/JOE-12-0147; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Sedy J, 2012, J APPL PHYSIOL, V112, P1, DOI 10.1152/japplphysiol.00574.2011; Simard JM, 2012, TRANSL STROKE RES, V3, pS155, DOI 10.1007/s12975-012-0166-9; Steinberg J, 2005, SHOCK, V24, P348, DOI 10.1097/01.shk.0000180619.06317.2c; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Sun CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061886; Suzuki H, 2009, STROKE, V40, P3872, DOI 10.1161/STROKEAHA.109.566109; Urrutia A, 2013, NEUROBIOL DIS, V50, P49, DOI 10.1016/j.nbd.2012.10.006; Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008; Wong GKC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059946	40	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89042	10.1371/journal.pone.0089042	http://dx.doi.org/10.1371/journal.pone.0089042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533168	gold, Green Submitted, Green Published			2022-12-27	WOS:000331262600130
J	Govindan, J; Iovine, MK				Govindan, Jayalakshmi; Iovine, M. Kathryn			Hapln1a Is Required for Connexin43-Dependent Growth and Patterning in the Regenerating Fin Skeleton	PLOS ONE			English	Article							CARTILAGE LINK PROTEIN; ACID-BINDING REGION; HYALURONIC-ACID; INTERCELLULAR COMMUNICATION; CRANIOFACIAL ABNORMALITIES; CELL-PROLIFERATION; GENETIC-ANALYSIS; CARCINOMA-CELLS; ZEBRAFISH FINS; EXPRESSION	Cell-cell communication, facilitating the exchange of small metabolites, ions and second messengers, takes place via aqueous proteinaceous channels called gap junctions. Connexins (cx) are the subunits of a gap junction channel. Mutations in zebrafish cx43 produces the short fin (sofb(123)) phenotype and is characterized by short fins due to reduced segment length of the bony fin rays and reduced cell proliferation. Previously established results from our lab demonstrate that Cx43 plays a dual role regulating both cell proliferation (growth) and joint formation (patterning) during the process of skeletal morphogenesis. In this study, we show that Hapln1a (Hyaluronan and Proteoglycan Link Protein 1a) functions downstream of cx43. Hapln1a belongs to the family of link proteins that play an important role in stabilizing the ECM by linking the aggregates of hyaluronan and proteoglycans. We validated that hapln1a is expressed downstream of cx43 by in situ hybridization and quantitative RT-PCR methods. Moreover, in situ hybridization at different time points revealed that hapln1a expression peaks at 3 days post amputation. Expression of hapln1a is located in the medial mesenchyme and the in the lateral skeletal precursor cells. Furthermore, morpholino mediated knock-down of hapln1a resulted in reduced fin regenerate length, reduced bony segment length and reduced cell proliferation, recapitulating all the phenotypes of cx43 knock-down. Moreover, Hyaluronic Acid (HA) levels are dramatically reduced in hapln1a knock-down fins, attesting the importance of Hapln1a in stabilizing the ECM. Attempts to place hapln1a in our previously defined cx43-sema3d pathway suggest that hapln1a functions in a parallel genetic pathway. Collectively, our data suggest that Cx43 mediates independent Sema3d and Hapln1a pathways in order to coordinate skeletal growth and patterning.	[Govindan, Jayalakshmi; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Iovine, MK (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	mki3@lehigh.edu			National Institutes of Health [HD047737]; National Science Foundation [IOS 1145582]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was funded by the National Institutes of Health (HD047737) and National Science Foundation (IOS 1145582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Andreasen EA, 2007, TOXICOL SCI, V95, P215, DOI 10.1093/toxsci/kfl119; Bai SX, 2005, REPRODUCTION, V129, P103, DOI 10.1530/rep.1.00283; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Becker DL, 1999, DEV GENET, V24, P33, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<33::AID-DVG5>3.0.CO;2-F; BINETTE F, 1994, J BIOL CHEM, V269, P19116; Contreras EG, 2009, DEVELOPMENT, V136, P2987, DOI 10.1242/dev.035501; Czipri M, 2003, J BIOL CHEM, V278, P39214, DOI 10.1074/jbc.M303329200; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; GARDELL S, 1980, BIOCHEM BIOPH RES CO, V95, P1823, DOI 10.1016/S0006-291X(80)80111-2; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Hoptak-Solga AD, 2007, FEBS LETT, V581, P3297, DOI 10.1016/j.febslet.2007.06.030; Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Iovine MK, 2000, GENETICS, V155, P1321; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kang JS, 2008, ZOOL SCI, V25, P912, DOI 10.2108/zsj.25.912; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Law LY, 2002, DEV GROWTH DIFFER, V44, P537; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Li YC, 2007, DEV BIOL, V305, P411, DOI 10.1016/j.ydbio.2007.02.023; LOHMANDER LS, 1980, J BIOL CHEM, V255, P6084; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Nagahata M, 2004, BIOCHEM BIOPH RES CO, V315, P603, DOI 10.1016/j.bbrc.2004.01.098; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; Oyamada M, 2005, BBA-BIOMEMBRANES, V1719, P6, DOI 10.1016/j.bbamem.2005.11.002; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Prince CW, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-12; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Richardson RR, 2004, J MED GENET, V41, P60, DOI 10.1136/jmg.2003.012005; RIPELLINO JA, 1989, J CELL BIOL, V108, P1899, DOI 10.1083/jcb.108.5.1899; SANTAMARIA JA, 1991, J ANAT, V176, P9; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Slevin M, 2004, INT J CANCER, V109, P793, DOI 10.1002/ijc.20059; Slevin M, 1998, LAB INVEST, V78, P987; Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034; Stains JP, 2003, J BIOL CHEM, V278, P24377, DOI 10.1074/jbc.M212554200; STIRPE NS, 1990, DEV BIOL, V137, P419, DOI 10.1016/0012-1606(90)90266-L; Sun GW, 2002, J ENDOCRINOL, V175, P505, DOI 10.1677/joe.0.1750505; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Ton QV, 2012, DEV BIOL, V366, P195, DOI 10.1016/j.ydbio.2012.03.020; Urano T, 2011, EUR SPINE J, V20, P572, DOI 10.1007/s00586-010-1598-0; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WEST DC, 1989, CIBA F SYMP, V143, P187; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wirrig EE, 2007, DEV BIOL, V310, P291, DOI 10.1016/j.ydbio.2007.07.041; Ya J, 1998, CIRC RES, V82, P360, DOI 10.1161/01.RES.82.3.360	59	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88574	10.1371/journal.pone.0088574	http://dx.doi.org/10.1371/journal.pone.0088574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533114	Green Published, gold			2022-12-27	WOS:000331262600072
J	Van Ryswyk, L; Simonson, L; Eisen, JS				Van Ryswyk, Liesl; Simonson, Levi; Eisen, Judith S.			The Role of inab in Axon Morphology of an Identified Zebrafish Motoneuron	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; ALPHA-INTERNEXIN; SPINAL-CORD; GENE-EXPRESSION; MESSENGER-RNA; GROWTH CONES; GEFILTIN; NEURONS; SPECIFICATION; CELLS	The ability of an animal to move and to interact with its environment requires that motoneurons correctly innervate specific muscles. Although many genes that regulate motoneuron development have been identified, our understanding of motor axon branching remains incomplete. We used transcriptional expression profiling to identify potential candidate genes involved in development of zebrafish identified motoneurons. Here we focus on inab, an intermediate filament encoding gene dynamically expressed in a subset of motoneurons as well as in an identified interneuron. We show that inab is necessary for proper axon morphology of a specific motoneuron subtype.	[Van Ryswyk, Liesl; Simonson, Levi; Eisen, Judith S.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Eisen, JS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	eisen@uoneuro.uoregon.edu			NIH [NS23915, HD007348]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023915, R56NS023915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by NIH grant NS23915, URL http://www.ninds.nih.gov; NIH grant HD007348, URL http://www.nichd.nih.gov/Pages/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 1998, DEVELOPMENT, V125, P371; Appel B, 1995, DEVELOPMENT, V121, P4117; Asch WS, 1998, J NEUROCHEM, V71, P20; Beattie CE, 1997, DEVELOPMENT, V124, P713; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Ching GY, 1999, J NEUROSCI, V19, P2974; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; COCHARD P, 1984, J NEUROSCI, V4, P2080; Cornell RA, 2000, DEVELOPMENT, V127, P2873; EISEN JS, 1990, J NEUROSCI, V10, P34; EISEN JS, 1992, NEURON, V8, P231, DOI 10.1016/0896-6273(92)90290-T; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Eisen JS, 2001, NAT NEUROSCI, V4, P1065, DOI 10.1038/nn742; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; GLASGOW E, 1994, EMBO J, V13, P297, DOI 10.1002/j.1460-2075.1994.tb06262.x; Hale L, 2011, PLOS ONE, V6; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Hutchinson SA, 2007, DEVELOPMENT, V134, P1671, DOI 10.1242/dev.02826; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura Y, 2008, DEVELOPMENT, V135, P3001, DOI 10.1242/dev.024802; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; KUWADA JY, 1990, J NEUROSCI, V10, P1299; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langhammer CG, 2010, CYTOM PART A, V77A, P1160, DOI 10.1002/cyto.a.20954; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Leake D, 1999, DIFFERENTIATION, V65, P181, DOI 10.1046/j.1432-0436.1999.6540181.x; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LENTH RV, 1989, J R STAT SOC C-APPL, V38, P185; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; Lewis KE, 2001, DEVELOPMENT, V128, P3485; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Niloff MS, 1998, MOL BRAIN RES, V61, P78, DOI 10.1016/S0169-328X(98)00204-6; NIXON RA, 1992, CELL MOTIL CYTOSKEL, V22, P81, DOI 10.1002/cm.970220202; PACHTER JS, 1985, J CELL BIOL, V101, P1316, DOI 10.1083/jcb.101.4.1316; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; Sato-Maeda M, 2008, DEVELOPMENT, V135, P323, DOI 10.1242/dev.007559; Seredick SD, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-35; Tallafuss A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-18; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Wang P, 2006, J CELL BIOCHEM, V97, P275, DOI 10.1002/jcb.20643; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhao YG, 1997, J COMP NEUROL, V377, P351, DOI 10.1002/(SICI)1096-9861(19970120)377:3<351::AID-CNE4>3.0.CO;2-1	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88631	10.1371/journal.pone.0088631	http://dx.doi.org/10.1371/journal.pone.0088631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533123	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600081
J	Joe, YH; Yoon, KY; Hwang, J				Joe, Yun Haeng; Yoon, Ki Young; Hwang, Jungho			Methodology for Modeling the Microbial Contamination of Air Filters	PLOS ONE			English	Article							ESCHERICHIA-COLI; GROWTH; BACTERIAL; MEDIA; AEROSOLS; EFFICACY; MICROORGANISMS; NANOPARTICLES; COLONIZATION; BIOAEROSOLS	In this paper, we propose a theoretical model to simulate microbial growth on contaminated air filters and entrainment of bioaerosols from the filters to an indoor environment. Air filter filtration and antimicrobial efficiencies, and effects of dust particles on these efficiencies, were evaluated. The number of bioaerosols downstream of the filter could be characterized according to three phases: initial, transitional, and stationary. In the initial phase, the number was determined by filtration efficiency, the concentration of dust particles entering the filter, and the flow rate. During the transitional phase, the number of bioaerosols gradually increased up to the stationary phase, at which point no further increase was observed. The antimicrobial efficiency and flow rate were the dominant parameters affecting the number of bioaerosols downstream of the filter in the transitional and stationary phase, respectively. It was found that the nutrient fraction of dust particles entering the filter caused a significant change in the number of bioaerosols in both the transitional and stationary phases. The proposed model would be a solution for predicting the air filter life cycle in terms of microbiological activity by simulating the microbial contamination of the filter.	[Joe, Yun Haeng; Hwang, Jungho] Yonsei Univ, Sch Mech Engn, Seoul 120749, South Korea; [Yoon, Ki Young] Hyundai Motor Co, Exhaust Emiss Engn Team, Hwaseong, South Korea	Yonsei University; Hyundai Kia Motors	Hwang, J (corresponding author), Yonsei Univ, Sch Mech Engn, Seoul 120749, South Korea.	hwangjh@yonsei.ac.kr		Hwang, Jungho/0000-0002-0304-7360	Future-based Technology Development Program (Green Nanotechnology Development Program) through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2013-0030206]	Future-based Technology Development Program (Green Nanotechnology Development Program) through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Future-based Technology Development Program (Green Nanotechnology Development Program) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant No. 2013-0030206). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DG, 1997, CURR MICROBIOL, V35, P305, DOI 10.1007/s002849900259; American Society of Heating Refrigerating and Air Conditioning Engineers, 2007, 5222007 ASHRAE; Brown R.C, 1993, AIR FILTRATION; Chao HJ, 2002, ENVIRON HEALTH PERSP, V110, P777, DOI 10.1289/ehp.02110777; Corradini MG, 2005, J APPL MICROBIOL, V99, P187, DOI 10.1111/j.1365-2672.2005.02570.x; Davies CN., 1973, AIR FILTRATION; Foarde KK, 2000, ASHRAE J, V42, P52; Fujikawa H, 2005, APPL ENVIRON MICROB, V71, P7920, DOI 10.1128/AEM.71.12.7920-7926.2005; Fujikawa H, 2004, FOOD MICROBIOL, V21, P501, DOI 10.1016/j.fm.2004.01.007; Gorny RL, 1999, ANN AGR ENV MED, V6, P105; Gospavic R, 2008, INT J FOOD MICROBIOL, V127, P290, DOI 10.1016/j.ijfoodmicro.2008.07.022; Griffiths WD, 2005, J HOSP INFECT, V61, P242, DOI 10.1016/j.jhin.2005.03.004; Hinds W.C., 1999, AEROSOL TECHNOLOGY; Jankowska E, 2000, J AEROSOL SCI, V31, P969, DOI 10.1016/S0021-8502(00)00017-3; Joe YH, 2013, AEROSOL AIR QUAL RES, V13, P1009, DOI 10.4209/aaqr.2012.07.0191; Juneja VK, 2011, FOOD MICROBIOL, V28, P791, DOI 10.1016/j.fm.2010.05.013; Ko G, 2002, ENVIRON HEALTH PERSP, V110, P95, DOI 10.1289/ehp.0211095; Kowalski W., 1999, ASHRAE T, V105, P4; Lee JH, 2008, J APPL MICROBIOL, V105, P1318, DOI 10.1111/j.1365-2672.2008.03855.x; Liu BYH, 1986, ASTM, VI; Longhi DA, 2013, J THEOR BIOL, V335, P88, DOI 10.1016/j.jtbi.2013.06.030; Main CE, 2003, ENVIRON INT, V29, P347, DOI 10.1016/S0160-4120(03)00012-6; Maus R, 2001, ATMOS ENVIRON, V35, P105, DOI 10.1016/S1352-2310(00)00280-6; Park CW, 2013, J HAZARD MATER, V244, P421, DOI 10.1016/j.jhazmat.2012.12.006; Park JH, 2009, J MECH SCI TECHNOL, V23, P1846, DOI 10.1007/s12206-009-0613-z; Perrier JCB, 2008, INT J CHEM REACT ENG, V6; Schmid S, 2013, J HAZARD MATER, V256, P76, DOI 10.1016/j.jhazmat.2013.04.021; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; STOLWIJK JAJ, 1991, ENVIRON HEALTH PERSP, V95, P99, DOI 10.2307/3431114; Vadasz AS, 2001, INT J FOOD MICROBIOL, V71, P219, DOI 10.1016/S0168-1605(01)00618-3; Verdenelli MC, 2003, J APPL MICROBIOL, V94, P9, DOI 10.1046/j.1365-2672.2003.01820.x; WHITBY KT, 1978, ATMOS ENVIRON, V12, P135, DOI 10.1016/0004-6981(78)90196-8; Woo MH, 2012, APPL ENVIRON MICROB, V78, P5781, DOI 10.1128/AEM.00465-12; Yoon KY, 2008, ENVIRON SCI TECHNOL, V42, P1251, DOI 10.1021/es0720199; Yoon KY, 2008, ENVIRON ENG SCI, V25, P289, DOI 10.1089/ees.2007.0003	35	9	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88514	10.1371/journal.pone.0088514	http://dx.doi.org/10.1371/journal.pone.0088514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523908	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100057
J	Carlson, JM; Alderson, DL; Stromberg, SP; Bassett, DS; Craparo, EM; Guiterrez-Villarreal, F; Otani, T				Carlson, Jean M.; Alderson, David L.; Stromberg, Sean P.; Bassett, Danielle S.; Craparo, Emily M.; Guiterrez-Villarreal, Francisco; Otani, Thomas			Measuring and Modeling Behavioral Decision Dynamics in Collective Evacuation	PLOS ONE			English	Article							NEURAL MECHANISMS; SPREAD; DOMAIN; PREFERENCES; DRIVEN; MEDIA; SCALE	Identifying and quantifying factors influencing human decision making remains an outstanding challenge, impacting the performance and predictability of social and technological systems. In many cases, system failures are traced to human factors including congestion, overload, miscommunication, and delays. Here we report results of a behavioral network science experiment, targeting decision making in a natural disaster. In a controlled laboratory setting, our results quantify several key factors influencing individual evacuation decision making in a controlled laboratory setting. The experiment includes tensions between broadcast and peer-to-peer information, and contrasts the effects of temporal urgency associated with the imminence of the disaster and the effects of limited shelter capacity for evacuees. Based on empirical measurements of the cumulative rate of evacuations as a function of the instantaneous disaster likelihood, we develop a quantitative model for decision making that captures remarkably well the main features of observed collective behavior across many different scenarios. Moreover, this model captures the sensitivity of individual- and population-level decision behaviors to external pressures, and systematic deviations from the model provide meaningful estimates of variability in the collective response. Identification of robust methods for quantifying human decisions in the face of risk has implications for policy in disasters and other threat scenarios, specifically the development and testing of robust strategies for training and control of evacuations that account for human behavior and network topologies.	[Carlson, Jean M.; Stromberg, Sean P.; Bassett, Danielle S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Alderson, David L.; Craparo, Emily M.; Guiterrez-Villarreal, Francisco; Otani, Thomas] Naval Postgrad Sch, Monterey, CA USA; [Bassett, Danielle S.] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; United States Department of Defense; United States Navy; Naval Postgraduate School; University of California System; University of California Santa Barbara	Carlson, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	carlson@physics.ucsb.edu			David and Lucile Packard Foundation; Office of Naval Research; MURI [N000140810747, 0001408WR20242]; Institute for Collaborative Biotechnologies through from the U.S. Army Research Office [W911NF-09-D-0001]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Office of Naval Research(Office of Naval Research); MURI(MURI); Institute for Collaborative Biotechnologies through from the U.S. Army Research Office	This work was supported by the David and Lucile Packard Foundation, the Office of Naval Research, MURI grants N000140810747 and 0001408WR20242, and the Institute for Collaborative Biotechnologies through contract no. W911NF-09-D-0001 from the U.S. Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Ball D, 2011, HURRICANE EARTHQUAKE; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Banos RA, 2013, ROLE HIDDEN INFLUENT; Barahona M, 2012, P 2012 C COLL INT; Barnsby RE, 2012, THESIS ARMY COMMAND; Bassett D, 2012, PHYS REV E, V86; Bayati M, 2010, ALGORITHMICA, V58, P860, DOI 10.1007/s00453-009-9340-1; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Bettencourt LMA, 2006, PHYSICA A, V364, P513, DOI 10.1016/j.physa.2005.08.083; Bevington P. R., 2002, DATA REDUCTION ERROR; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; Borge-Holthoefer J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066123; Borge-Holthoefer J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026116; Bosse T, 2012, AUTON AGENT MULTIAGE, P1; BURT RS, 1987, AM J SOCIOL, V92, P1287, DOI 10.1086/228667; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chang SWC, 2012, BIOL PSYCHIAT, V72, P101, DOI 10.1016/j.biopsych.2012.02.017; Chen TM, 2011, IEEE NETWORK, V25, P2; Chib VS, 2012, NEURON, V74, P582, DOI 10.1016/j.neuron.2012.02.038; Church RL, 2002, MODELING SMALL AREA, P1; Conneally T, 2011, VIRGINIA EARTHQUAKE; Crews J, 2012, THESIS NAVAL POSTGRA; Dabner N, 2012, INTERNET HIGH EDUC, V15, P69, DOI 10.1016/j.iheduc.2011.06.001; Dash N., 2007, NAT HAZARDS REV, V8, P69, DOI [10.1061/(asce)1527-6988(2007)8:3(69), DOI 10.1061/(ASCE)1527-6988(2007)8:3(69)]; Diaz-Aviles E., 2012, EPIDEMIC INTELLIGENC; Dodds PS, 2005, J THEOR BIOL, V232, P587, DOI 10.1016/j.jtbi.2004.09.006; Doer B, 2012, COMMUN ACM, V55, P70, DOI 10.1145/2184319.2184338; Drabek T.E., 1986, HUMAN SYSTEM RESPONS, P509, DOI [10.1007/978-1-4612-4960-3, DOI 10.1007/978-1-4612-4960-3]; Easley D, 2010, NETWORKS CROWDS MARK; Edelson M, 2011, SCIENCE, V333, P108, DOI 10.1126/science.1203557; Edwards JA, 2012, RISK ANAL, V32, P2055, DOI 10.1111/j.1539-6924.2012.01839.x; Farrell H, 2012, ANNU REV POLIT SCI, V15, P35, DOI 10.1146/annurev-polisci-030810-110815; Gigerenzer G, 2002, CALCULATED RISKS KNO; Glimcher PW, 2004, BRADFORD BOOKS; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Guille A., 2013, PREDICTING TEMPORAL; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Hartley CA, 2012, BIOL PSYCHIAT, V72, P113, DOI 10.1016/j.biopsych.2011.12.027; Hastie T., 2009, UNSUPERVISED LEARNIN; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Howard PN, 2011, COMMUN REV, V14, P216, DOI 10.1080/10714421.2011.597254; Huang L, 2011, THESIS FIU, P1; John O, 1991, BIG 5 INVENTORY VERS; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Judd S, 2011, P NATL ACAD SCI USA, V108, P6689, DOI 10.1073/pnas.1104351108; Kearns M, 2006, SCIENCE, V313, P824, DOI 10.1126/science.1127207; Kearns M, 2012, COMMUN ACM, V55, P56, DOI 10.1145/2347736.2347753; Kearns M, 2009, P NATL ACAD SCI USA, V106, P1347, DOI 10.1073/pnas.0808147106; Khondker HH, 2011, GLOBALIZATIONS, V8, P675, DOI 10.1080/14747731.2011.621287; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Langford W, 2011, THESIS NAVAL POSTGRA; Lerman K, 2010, ICWSM, V10, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431; Leskovec J, 2009, P 15 ACM SIGKDD; Leskovec J, 2007, SIAM P S; Li C, 2013, EPIDEMIC THRESHOLD D; Lindell MK, 2006, EMERGENCY MANAGEMENT; Lorenz J, 2011, P NATL ACAD SCI USA; Lotan G, 2011, INT J COMMUN-US, V5, P1375; MACY MW, 1991, AM SOCIOL REV, V56, P730, DOI 10.2307/2096252; Mason W, 2012, P NATL ACAD SCI USA, V109, P764, DOI 10.1073/pnas.1110069108; Mavrodiev P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01360; McCaffrey S, 2004, SOC NATUR RESOUR, V17, P509, DOI 10.1080/08941920490452445; Melnik S, 2013, CHAOS, V23, DOI 10.1063/1.4790836; Myers SA, 2012, INFORM DIFFUSION EXT; Nedic A, 2012, P IEEE, V100, P713, DOI 10.1109/JPROC.2011.2166437; NOAA/National Weather Service, 2012, SAND GRAPH ARCH ONLI; OLIVER P, 1985, AM J SOCIOL, V91, P522, DOI 10.1086/228313; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Oswald E, 2011, NEW YORKERS SAW DC Q; Otto SP, 2007, BIOL GUIDE MATH MODE; Press W. H., 1992, ART SCI COMPUTING; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Regnier E, 2008, MANAGE SCI, V54, P16, DOI 10.1287/mnsc.1070.0764; Sano Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012805; Shafiq MZ, 2013, MODELING MORPHOLOGY; SHULER ML, 2001, BIOPROCESS ENG BASIC; Simmons MP, 2011, P 5 INT AAAI C WEBL, P353; Soane E, 2005, PERS INDIV DIFFER, V38, P1781, DOI 10.1016/j.paid.2004.10.005; Sood V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041121; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Sweeny K, 2008, PSYCHOL BULL, V134, P61, DOI 10.1037/0033-2909.134.1.61; US Department of Transportation and US Department of Homeland Security, 2006, REP C CAT HURR EV PL; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Zhang YC, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032133; Zhao JC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016105	97	11	11	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87380	10.1371/journal.pone.0087380	http://dx.doi.org/10.1371/journal.pone.0087380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520331	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600022
J	Kuitunen, K; Kovalev, A; Gorb, SN				Kuitunen, Katja; Kovalev, Alexander; Gorb, Stanislav N.			Sex-Related Effects in the Superhydrophobic Properties of Damselfly Wings in Young and Old Calopteryx splendens	PLOS ONE			English	Article							CRYSTALLINE WAX COVERAGE; HIERARCHICAL STRUCTURES; WATER-REPELLENT; SURFACE; LEGS; WETTABILITY; CUTICLE; OVIPOSITION; LOCOMOTION; BEHAVIOR	Numerous sex-related morphological adaptations are connected to reproductive behavior in animals. For example, females of some insect species can submerge during oviposition, which may lead to sex-related adaptations in the hydrophobicity (water-repellency) due to specialization of certain morphological structures. On the other hand, ageing can cause changes in hydrophobicity of the surface, because the morphological structures can wear with age. Here, we investigated sex-and age-related differences in wing hydrophobicity and in morphology (spine density, wax cover characteristics, size of females' pseudopterostigma) potentially related to hydrophobicity of Calopteryx splendens damselflies. Hydrophobicity was measured with two methods, by measuring the contact angle (CA) between a wing and water droplet, and by dipping a wing into water and measuring forces needed to submerge, withdraw, and pull-out a wing from water. We found that C. splendens wings are superhydrophobic, having mean CAs of 161 degrees. The only sex and age related difference in the hydrophobicity measurements was that young females had stronger amplitude of force fluctuations during withdrawal of wings from water than young males. This suggests that young females may form less uniform air pockets on their wings while submerged. From the morphological structures measured here, the only sex related finding was that old females had denser spine cover than young females in their wing veins. The difference may be explained by better survival of females with denser spine cover. The most important morphological character that predicted superhydrophobicity was the prevalence of long wax rods on wing veins. In addition, female pseudopterostigma area (a trait present only in females) was negatively related to pull-out force, suggesting that large pseudopterostigmas might help females to emerge from water following oviposition. The subtle sex-related differences in hydrophobicity could be explained by the fact that both sexes must resist rain, and males are occasionally in contact with water.	[Kuitunen, Katja] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kuitunen, Katja; Kovalev, Alexander; Gorb, Stanislav N.] Univ Kiel, Inst Zool, Dept Funct Morphol & Biomech, D-24098 Kiel, Germany	University of Jyvaskyla; University of Kiel	Kuitunen, K (corresponding author), Univ Jyvaskyla, Dept Math Informat Technol, Jyvaskyla, Finland.	katja.m.m.kuitunen@jyu.fi			Academy of Finland [127447]; German Science Foundation [GO 995/10-2, SPP 1420]	Academy of Finland(Academy of Finland); German Science Foundation(German Research Foundation (DFG))	The study has been funded by Academy of Finland (#127447) to KK and German Science Foundation (DFG project GO 995/10-2 in the framework of the special priority program SPP 1420) to SNG. Websites: Academy of Finalnd: http://www.aka.fi/en-GB/A/. German Research Foundation: http://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHLOTT W, 2010, ADV MATER, V22, P2325, DOI DOI 10.1002/adma.200904411; Bhushan B, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976635; Bobji MS, 2009, LANGMUIR, V25, P12120, DOI 10.1021/la902679c; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Borodich FM, 2010, APPL PHYS A-MATER, V100, P63, DOI 10.1007/s00339-010-5794-x; Byun D, 2009, J BIONIC ENG, V6, P63, DOI 10.1016/S1672-6529(08)60092-X; Carre A, 2009, SUPERHYDROPHOBIC SURFACES, pIX; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Cordero A, 1999, J INSECT BEHAV, V12, P27, DOI 10.1023/A:1020972913683; Cordero Rivera A., 2002, Journal of Insect Science (Tucson), V2, P1; Dorrer C, 2009, SOFT MATTER, V5, P51, DOI 10.1039/b811945g; DORSET DL, 1983, BIOCHIM BIOPHYS ACTA, V760, P136, DOI 10.1016/0304-4165(83)90134-4; Feng XQ, 2007, LANGMUIR, V23, P4892, DOI 10.1021/la063039b; Fielden LJ, 2011, J INSECT PHYSIOL, V57, P21, DOI 10.1016/j.jinsphys.2010.08.009; Flynn MR, 2008, J FLUID MECH, V608, P275, DOI 10.1017/S0022112008002048; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; GIBBONS DW, 1992, J ANIM ECOL, V61, P283, DOI 10.2307/5321; Goodwyn PJP, 2008, J BIONIC ENG, V5, P121, DOI 10.1016/S1672-6529(08)60015-3; Goodwyn PP, 2009, NATURWISSENSCHAFTEN, V96, P781, DOI 10.1007/s00114-009-0531-z; Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7; Gorb SN, 2009, INT J ODONATOL, V12, P205, DOI 10.1080/13887890.2009.9748340; Hirayama H, 2008, ANIM BEHAV, V76, P1919, DOI 10.1016/j.anbehav.2008.08.013; Hosoda N, 2012, P ROY SOC B-BIOL SCI, V279, P4236, DOI 10.1098/rspb.2012.1297; Hu HMS, 2011, J EXP BIOL, V214, P915, DOI 10.1242/jeb.051128; Jackson LL, 1976, CHEM BIOCH NATURAL W, P201; Kuitunen K, 2011, ZOOLOGY, V114, P129, DOI 10.1016/j.zool.2011.01.003; Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6; Lee YW, 2007, ADV MATER, V19, P2330, DOI 10.1002/adma.200700820; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Marmur A, 2006, LANGMUIR, V22, P1400, DOI 10.1021/la052802j; Marmur A, 2004, LANGMUIR, V20, P2317; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; Nguyen SHT, 2013, COLLOID SURFACE B, V106, P126, DOI 10.1016/j.colsurfb.2013.01.042; Outomuro D, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6101; Sun MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046710; Sun MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035056; Sun MX, 2009, J EXP BIOL, V212, P3148, DOI 10.1242/jeb.033373; Svensson EI, 2006, EVOLUTION, V60, P1242; Tsubaki Y, 2006, J INSECT PHYSIOL, V52, P499, DOI 10.1016/j.jinsphys.2006.01.009; Tynkkynen K, 2009, J EVOLUTION BIOL, V22, P2512, DOI 10.1111/j.1420-9101.2009.01870.x; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Wagner T, 1996, ACTA ZOOL-STOCKHOLM, V77, P213, DOI 10.1111/j.1463-6395.1996.tb01265.x; Watson GS, 2010, ACTA BIOMATER, V6, P4060, DOI 10.1016/j.actbio.2010.04.016; Watson GS, 2010, ACS NANO, V4, P129, DOI 10.1021/nn900869b; Watson GS, 2010, J STRUCT BIOL, V171, P44, DOI 10.1016/j.jsb.2010.03.008; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024	46	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88627	10.1371/journal.pone.0088627	http://dx.doi.org/10.1371/journal.pone.0088627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520406	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600097
J	Levy-Sakin, M; Berger, O; Feibish, N; Sharon, N; Schnaider, L; Shmul, G; Amir, Y; Buzhansky, L; Gazit, E				Levy-Sakin, Michal; Berger, Or; Feibish, Nir; Sharon, Noa; Schnaider, Lee; Shmul, Guy; Amir, Yaniv; Buzhansky, Ludmila; Gazit, Ehud			The Influence of Chemical Chaperones on Enzymatic Activity under Thermal and Chemical Stresses: Common Features and Variation among Diverse Chemical Families	PLOS ONE			English	Article							TRIMETHYLAMINE-N-OXIDE; ORGANIC OSMOLYTES; STABILIZATION; STABILITY; PROTEINS; DENATURATION; LYSOZYME; UREA; MECHANISM; PEPTIDE	Molecular and chemical chaperones are key components of the two main mechanisms that ensure structural stability and activity under environmental stresses. Yet, chemical chaperones are often regarded only as osmolytes and their role beyond osmotic regulation is not fully understood. Here, we systematically studied a large group of chemical chaperones, representatives of diverse chemical families, for their protective influence under either thermal or chemical stresses. Consistent with previous studies, we observed that in spite of the structural similarity between sugars and sugar alcohols, they have an apparent difference in their protective potential. Our results support the notion that the protective activity is mediated by the solvent and the presence of water is essential. In the current work we revealed that i) polyols and sugars have a completely different profile of protective activity toward trifluoroethanol and thermal stress; ii) minor changes in solvent composition that do not affect enzyme activity, yet have a great effect on the ability of osmolytes to act as protectants and iii) increasing the number of active groups of carbohydrates makes them better protectants while increasing the number of active groups of methylamines does not, as revealed by attempts to synthesize de novo designed methylamines with multiple functional groups.	[Levy-Sakin, Michal; Berger, Or; Feibish, Nir; Sharon, Noa; Schnaider, Lee; Shmul, Guy; Amir, Yaniv; Buzhansky, Ludmila; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Gazit, E (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	ehudg@post.tau.ac.il	Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/C-3715-2011; Feibish, Nir/Z-6346-2019	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Berger, Or/0000-0002-3840-9704	German-Israeli Foundation for Scientific Research and Development	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	This research was sponsored by the German-Israeli Foundation for Scientific Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P169, DOI 10.1016/0003-9861(83)90201-1; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Attri P, 2010, INFLUENCE OSMOLYTES; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Auton M, 2007, METHOD ENZYMOL, V428, P397, DOI 10.1016/S0076-6879(07)28023-1; Auton M, 2011, BIOPHYS CHEM, V159, P90, DOI 10.1016/j.bpc.2011.05.012; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bonincontro A, COLLOIDS SURFACES B, V10, P7; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Chattopadhyay MK, 2004, J BACTERIOL, V186, P8149, DOI 10.1128/JB.186.23.8149-8152.2004; Cope AC, 1959, ORG SYNTH, V39, P40; de Oliveira OV, 2007, J MOL STRUC-THEOCHEM, V808, P93, DOI 10.1016/j.theochem.2006.12.039; De Santi C, 2012, BIOTECHNOL PROGR, V28, P946, DOI 10.1002/btpr.1574; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Foglia F, 2008, J THERM ANAL CALORIM, V91, P67, DOI 10.1007/s10973-007-8555-0; GEKKO K, 1981, J BIOCHEM-TOKYO, V90, P1643, DOI 10.1093/oxfordjournals.jbchem.a133639; GEKKO K, 1983, J BIOCHEM-TOKYO, V94, P199, DOI 10.1093/oxfordjournals.jbchem.a134330; GEKKO K, 1981, J BIOCHEM-TOKYO, V90, P51, DOI 10.1093/oxfordjournals.jbchem.a133469; Gekko K, 1982, CALORIMETRIC STUDY T, V1204, P1197; GERLSMA SY, 1972, INT J PEPT PROT RES, V4, P377; Gilman-Politi R, 2011, J CHEM THEORY COMPUT, V7, P3816, DOI 10.1021/ct200455n; Giugliarelli A, 2013, J PHYS CHEM B, V117, P2645, DOI 10.1021/jp311268x; GOODMAN M, 1962, J AM CHEM SOC, V84, P3770, DOI 10.1021/ja00878a036; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Holthauzen LMF, 2007, PROTEIN SCI, V16, P293, DOI 10.1110/ps.062610407; Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552; Kaushik JK, 1998, J PHYS CHEM B, V102, P7058, DOI 10.1021/jp981119l; Kelly RH, 1999, BIOL BULL, V196, P18, DOI 10.2307/1543162; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; Kumar R, 2005, ARCH BIOCHEM BIOPHYS, V436, P78, DOI 10.1016/j.abb.2005.01.008; Kumar V, 2012, AM PHARM REV; Kumar V, 2011, INT J PHARMACEUT, V413, P19, DOI 10.1016/j.ijpharm.2011.04.011; Larini L, 2013, J PHYS CHEM B, V117, P13268, DOI 10.1021/jp403635g; Levy-Sakin M, 2012, PROTEIN PEPTIDE FOLD, DOI [10.1002/9781118183373, DOI 10.1002/9781118183373]; Lin TY, 1996, PROTEIN SCI, V5, P372; Liu FF, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3453713; LIU YF, 1995, BIOCHEMISTRY-US, V34, P12884, DOI 10.1021/bi00039a051; MACMILLEN RE, 1967, SCIENCE, V158, P383, DOI 10.1126/science.158.3799.383; Martinez A, 2008, PROG MOL BIOL TRANSL, V83, P89, DOI 10.1016/S0079-6603(08)00603-X; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V258, P356, DOI 10.1016/0003-9861(87)90355-9; Mehta AD, 2005, J ENZYM INHIB MED CH, V20, P199, DOI 10.1080/14756360400020538; Moeser B, 2013, UNIFIED DESCRIPTION, DOI [10.1021/jp409934q, DOI 10.1021/JP409934Q]; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Niebuhr M, 2005, BIOPHYS J, V89, P1978, DOI 10.1529/biophysj.105.063859; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Palmer HR, 2013, DOMINANANT OSMOLYTES; Politi R, 2010, CHEM COMMUN, V46, P6449, DOI 10.1039/c0cc01763a; Politi R, 2009, J PHYS CHEM A, V113, P7548, DOI 10.1021/jp9010026; PREISER H, 1975, CLIN CHIM ACTA, V59, P169, DOI 10.1016/0009-8981(75)90025-X; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Rodrigues JV, 2012, CURR TOP MED CHEM, V12, P2546; Rosgen J, 2005, BIOPHYS J, V89, P2988, DOI [10.1529/biophysj.105.067330, 10.1529/biophsyj.105.067330]; Rosgen J, 2007, PROTEIN SCI, V16, P733, DOI 10.1110/ps.062671607; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; Sasahara K, 2006, PROTEINS, V63, P127, DOI 10.1002/prot.20782; Sassi P, 2011, J MOL LIQ, V159, P112, DOI 10.1016/j.molliq.2010.12.008; Shao Q, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3692801; Singh LR, 2011, LIFE SCI, V88, P117, DOI 10.1016/j.lfs.2010.10.020; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Tiwari A, 2006, BIOPHYS CHEM, V124, P90, DOI 10.1016/j.bpc.2006.06.003; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; Yancey Paul H., 2004, Science Progress, V87, P1, DOI 10.3184/003685004783238599; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yancey PH, 1980, METHY LAMINE OSMOREG, P213	70	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88541	10.1371/journal.pone.0088541	http://dx.doi.org/10.1371/journal.pone.0088541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520396	Green Submitted, Green Published, gold			2022-12-27	WOS:000331254600087
J	Pava, MJ; den Hartog, CR; Blanco-Centurion, C; Shiromani, PJ; Woodward, JJ				Pava, Matthew J.; den Hartog, Carolina R.; Blanco-Centurion, Carlos; Shiromani, Priyattam J.; Woodward, John J.			Endocannabinoid Modulation of Cortical Up-States and NREM Sleep	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM DEPRESSION; CANNABINOID RECEPTOR; PREFRONTAL CORTEX; ENDOGENOUS CANNABINOIDS; PYRAMIDAL NEURONS; IN-VIVO; GLUTAMATERGIC NEURONS; VANILLOID RECEPTORS; PERSISTENT ACTIVITY	Up-/down-state transitions are a form of network activity observed when sensory input into the cortex is diminished such as during non-REM sleep. Up-states emerge from coordinated signaling between glutamatergic and GABAergic synapses and are modulated by systems that affect the balance between inhibition and excitation. We hypothesized that the endocannabinoid (EC) system, a neuromodulatory system intrinsic to the cortical microcircuitry, is an important regulator of up-states and sleep. To test this hypothesis, up-states were recorded from layer V/VI pyramidal neurons in organotypic cultures of wild-type or CB1R knockout (KO) mouse prefrontal cortex. Activation of the cannabinoid 1 receptor (CB1) with exogenous agonists or by blocking metabolism of endocannabinoids, anandamide or 2-arachidonoyl glycerol, increased up-state amplitude and facilitated action potential discharge during up-states. The CB1 agonist also produced a layer II/IIIselective reduction in synaptic GABAergic signaling that may underlie its effects on up-state amplitude and spiking. Application of CB1 antagonists revealed that an endogenous EC tone regulates up-state duration. Paradoxically, the duration of up-states in CB1 KO cultures was increased suggesting that chronic absence of EC signaling alters cortical activity. Consistent with increased cortical excitability, CB1 KO mice exhibited increased wakefulness as a result of reduced NREM sleep and NREM bout duration. Under baseline conditions, NREM delta (0.5-4 Hz) power was not different in CB1 KO mice, but during recovery from forced sleep deprivation, KO mice had reduced NREM delta power and increased sleep fragmentation. Overall, these findings demonstrate that the EC system actively regulates cortical up-states and important features of NREM sleep such as its duration and low frequency cortical oscillations.	[Pava, Matthew J.; den Hartog, Carolina R.; Woodward, John J.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Pava, Matthew J.; den Hartog, Carolina R.; Woodward, John J.] Med Univ S Carolina, Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA; [Blanco-Centurion, Carlos; Shiromani, Priyattam J.; Woodward, John J.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Blanco-Centurion, Carlos; Shiromani, Priyattam J.] Ralph H Johnson VA Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Woodward, JJ (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	woodward@musc.edu		Pava, Matthew/0000-0002-9867-4577; Blanco-Centurion, Carlos/0000-0002-3344-1713	National Institutes of Health [P50 AA010761, F31 AA018908, MH055772, NS052287, NS079940]; Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052287, R21NS079940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA010761, R37AA009986, F31AA018908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants P50 AA010761 (RC3; Charleston Alcohol Research Center; JJW), F31 AA018908 (MJP), MH055772 (PJM), NS052287 (PJM), NS079940 (PJM), and Medical Research Service of the Department of Veterans Affairs (PJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hayani A, 2001, NEUROPHARMACOLOGY, V41, P1000, DOI 10.1016/S0028-3908(01)00145-9; Ali AB, 2010, EUR J NEUROSCI, V31, P1196, DOI 10.1111/j.1460-9568.2010.07165.x; Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; [Anonymous], ALCOHOL CLIN EXP RES, V33, P2134; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Bacci A, 2004, NATURE, V431, P312, DOI 10.1038/nature02913; Beltramo R, 2013, NAT NEUROSCI, V16, P227, DOI 10.1038/nn.3306; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Breivogel CS, 2001, MOL PHARMACOL, V60, P155, DOI 10.1124/mol.60.1.155; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Durstewitz D, 2006, NEUROSCIENCE, V139, P119, DOI 10.1016/j.neuroscience.2005.06.094; Ferretjans R, 2012, REV BRAS PSIQUIATR, V34, pS163, DOI 10.1016/j.rbp.2012.07.003; Fortin DA, 2004, J NEUROPHYSIOL, V92, P2105, DOI 10.1152/jn.00351.2004; Fortin DA, 2007, CEREB CORTEX, V17, P163, DOI 10.1093/cercor/bhj133; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; FUJIMORI M, 1973, PHYSIOL BEHAV, V11, P291, DOI 10.1016/0031-9384(73)90003-6; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Institute for Laboratory Animal Research, 2011, GUID CAR US LAB AN; Johnson HA, 2007, J NEUROSCI, V27, P5915, DOI 10.1523/JNEUROSCI.0447-07.2007; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kawaguchi Y, 2001, J NEUROSCI, V21, P7261, DOI 10.1523/JNEUROSCI.21-18-07261.2001; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kroener S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006507; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Lambe EK, 2006, NEUROPSYCHOPHARMACOL, V31, P1682, DOI 10.1038/sj.npp.1300944; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Luk T, 2004, BRIT J PHARMACOL, V142, P495, DOI 10.1038/sj.bjp.0705792; Mann EO, 2009, J NEUROSCI, V29, P7513, DOI 10.1523/JNEUROSCI.6162-08.2009; Marinelli S, 2008, J NEUROSCI, V28, P13532, DOI 10.1523/JNEUROSCI.0847-08.2008; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mathur BN, 2013, NAT NEUROSCI, V16, P1275, DOI 10.1038/nn.3478; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monti JM, 2004, SLEEP MED REV, V8, P133, DOI 10.1016/S1087-0792(02)00158-2; MORETON JE, 1973, NEUROPHARMACOLOGY, V12, P897, DOI 10.1016/0028-3908(73)90042-7; Murillo-Rodriguez E, 2008, NEUROSCIENCE, V157, P1, DOI 10.1016/j.neuroscience.2008.08.056; Murillo-Rodriguez E, 2003, SLEEP, V26, P943, DOI 10.1093/sleep/26.8.943; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pava MJ, 2012, ALCOHOL, V46, P185, DOI 10.1016/j.alcohol.2012.01.002; PIVIK RT, 1972, CLIN PHARMACOL THER, V13, P426; Roberto M, 2010, NEUROPSYCHOPHARMACOL, V35, P1962, DOI 10.1038/npp.2010.70; Ruiu S, 2003, J PHARMACOL EXP THER, V306, P363, DOI 10.1124/jpet.103.049924; Sagar DR, 2010, EUR J NEUROSCI, V31, P1414, DOI 10.1111/j.1460-9568.2010.07162.x; Sales-Carbonell C, 2013, P NATL ACAD SCI USA, V110, P719, DOI 10.1073/pnas.1217144110; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Santucci V, 1996, LIFE SCI, V58, pPL103, DOI 10.1016/0024-3205(95)02319-4; Seamans JK, 2003, CEREB CORTEX, V13, P1242, DOI 10.1093/cercor/bhg094; Shiromani PJ, 2000, MOL BRAIN RES, V80, P75, DOI 10.1016/S0169-328X(00)00123-6; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sugiura T, 2009, BIOFACTORS, V35, P88, DOI 10.1002/biof.18; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Trettel J, 2004, J PHYSIOL-LONDON, V556, P95, DOI 10.1113/jphysiol.2003.058198; Trettel J, 2003, J NEUROPHYSIOL, V89, P2334, DOI 10.1152/jn.01037.2002; Trettel J, 2002, J NEUROPHYSIOL, V88, P534, DOI 10.1152/jn.2002.88.1.534; Tu Y, 2007, J NEUROSCI, V27, P4765, DOI 10.1523/JNEUROSCI.5378-06.2007; Wang J, 2009, PROSTAG OTH LIPID M, V89, P112, DOI 10.1016/j.prostaglandins.2008.12.002; Watson S, 2008, MOL CELL NEUROSCI, V38, P89, DOI 10.1016/j.mcn.2008.02.001; Wedzony K, 2007, J PHYSIOL PHARMACOL, V58, P611; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Woodward JJ, 2012, ALCOHOL CLIN EXP RES, V36, P780, DOI 10.1111/j.1530-0277.2011.01674.x; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	70	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88672	10.1371/journal.pone.0088672	http://dx.doi.org/10.1371/journal.pone.0088672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520411	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600102
J	Qiu, WQ; Wallack, M; Dean, M; Liebson, E; Mwamburi, M; Zhu, HH				Qiu, Wei Qiao; Wallack, Max; Dean, Michael; Liebson, Elizabeth; Mwamburi, Mkaya; Zhu, Haihao			Association between Amylin and Amyloid-beta Peptides in Plasma in the Context of Apolipoprotein E4 Allele	PLOS ONE			English	Article							WHITE-MATTER LESIONS; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; INSULIN; RAT; RISK; POLYPEPTIDE; DEGRADATION	Amylin, a pancreatic peptide that readily crosses the blood brain barrier (BBB), and amyloid-beta peptide (A beta), the main component of amyloid plaques and a major component of Alzheimer's disease (AD) pathology in the brain, share several features. These include having similar b-sheet secondary structures, binding to the same receptor, and being degraded by the same protease. Thus, amylin may be associated with Ab, but the nature of their relationship remains unclear. In this study, we used human samples to study the relationship between plasma amylin and Ab in the context of the apolipoprotein E alleles (ApoE). We found that concentrations of A beta 1-42 (p<0.0001) and A beta 1-40 (P<0.0001) increased with each quartile increase of amylin. Using multivariate regression analysis, the study sample showed that plasma amylin was associated with A beta 1-42 (beta= +0.149, SE = 0.025, P<0.0001) and A beta 1-40 (beta = +0.034, SE = 0.016, P = 0.04) as an outcome after adjusting for age, gender, ethnicity, ApoE4, BMI, diabetes, stroke, kidney function and lipid profile. This positive association between amylin and A beta 1-42 in plasma was found regardless of the ApoE genotype. In contrast, the relationship between amylin and A beta 1-40 in plasma seen in ApoE4 non-carriers disappeared in the presence of ApoE4. Using AD mouse models, our recent study demonstrates that intraperitoneal (i. p.) injection of synthetic amylin enhances the removal of A beta from the brain into blood, thus resulting in increased blood levels of both amylin and A beta. The positive association between amylin and Ab, especially A beta 1-42, in human blood samples is probably relevant to the findings in the AD mouse models. The presence of ApoE4 may attenuate amylin's capacity to remove A beta, especially A beta 1-40, from the AD brain.	[Qiu, Wei Qiao] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Qiu, Wei Qiao; Wallack, Max; Dean, Michael; Zhu, Haihao] Boston Univ, Sch Med, Boston, MA 02118 USA; [Qiu, Wei Qiao; Wallack, Max] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Liebson, Elizabeth] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA USA; [Mwamburi, Mkaya] Tufts Univ, Dept Publ Hlth & Family Med, Boston, MA 02111 USA	Boston University; Boston University; Boston University; Harvard University; McLean Hospital; Tufts University	Qiu, WQ (corresponding author), Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA.	wqiu67@bu.edu	Dean, Michael/G-8172-2012	Dean, Michael/0000-0003-2234-0631	National Institute on Aging [AG-022476]; Ignition Award (WQQ); BU ADC pilot grant (HZ); NATIONAL INSTITUTE ON AGING [K23AG022476, R01AG031171, P30AG013846] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ignition Award (WQQ); BU ADC pilot grant (HZ); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Institute on Aging, AG-022476 and Ignition Award (WQQ) and BU ADC pilot grant (HZ). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Edvinsson Lars, 2001, TheScientificWorld, V1, P168; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu W, 2012, J BIOL CHEM, V287, P18820, DOI 10.1074/jbc.M111.331181; Geary N, 1999, NEUROPEPTIDES, V33, P400, DOI 10.1054/npep.1999.0046; Golpon HA, 2001, REGUL PEPTIDES, V102, P81, DOI 10.1016/S0167-0115(01)00300-7; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Gurol ME, 2006, NEUROLOGY, V66, P23, DOI 10.1212/01.wnl.0000191403.95453.6a; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoogwerf BJ, 2008, VASC HEALTH RISK MAN, V4, P355, DOI 10.2147/VHRM.S1978; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Hou XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024815; Jackson K, 2013, ANN NEUROL, V74, P517, DOI 10.1002/ana.23956; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Lahoz C, 1996, CLIN CHEM, V42, P1817; Le Bastard N, 2009, NEUROCHEM INT, V55, P820, DOI 10.1016/j.neuint.2009.08.006; Lim YA, 2008, FEBS LETT, V582, P2188, DOI 10.1016/j.febslet.2008.05.006; Lutz Thomas Alexander, 2012, Handb Exp Pharmacol, P231, DOI 10.1007/978-3-642-24716-3_10; Makimattila S, 2000, J CLIN ENDOCR METAB, V85, P2822, DOI 10.1210/jc.85.8.2822; MITSUKAWA T, 1992, DIABETES RES CLIN PR, V15, P131, DOI 10.1016/0168-8227(92)90016-K; Olsson M, 2007, PEPTIDES, V28, P1416, DOI 10.1016/j.peptides.2007.06.011; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; PIEBER TR, 1994, AM J PHYSIOL, V267, pE156, DOI 10.1152/ajpendo.1994.267.1.E156; Qiu WQ, 2007, INT J GERIATR PSYCH, V22, P536, DOI 10.1002/gps.1710; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; ROSES AD, 1994, LANCET, V343, P1564, DOI 10.1016/S0140-6736(94)92960-2; Roth JD, 2013, CURR OPIN ENDOCRINOL, V20, P8, DOI 10.1097/MED.0b013e32835b896f; Sagare AP, 2012, COLD SPRING HARB PER, V2; Scott TM, 2006, INT J GERIATR PSYCH, V21, P519, DOI 10.1002/gps.1503; Selkoe DJ, 2006, NAT MED, V12, P758, DOI 10.1038/nm0706-758; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sun XY, 2008, ARCH GEN PSYCHIAT, V65, P542, DOI 10.1001/archpsyc.65.5.542; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Tanzi RE, 1999, J CLIN INVEST, V104, P1175, DOI 10.1172/JCI8593; Trevaskis JL, 2010, ENDOCRINOLOGY, V151, P5657, DOI 10.1210/en.2010-0590; Uenaka K, 2012, CLIN NEUROPHARMACOL, V35, P25, DOI 10.1097/WNF.0b013e31823a13d3; van Dijk EJ, 2004, ANN NEUROL, V55, P570, DOI 10.1002/ana.20050; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; WESTFALL TC, 1995, J CARDIOVASC PHARM, V26, P932, DOI 10.1097/00005344-199512000-00012; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	46	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88063	10.1371/journal.pone.0088063	http://dx.doi.org/10.1371/journal.pone.0088063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520345	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600036
J	Roucher, C; Rogier, C; Sokhna, C; Tall, A; Trape, JF				Roucher, Clementine; Rogier, Christophe; Sokhna, Cheikh; Tall, Adama; Trape, Jean-Francois			A 20-Year Longitudinal Study of Plasmodium ovale and Plasmodium malariae Prevalence and Morbidity in a West African Population	PLOS ONE			English	Article							HOLOENDEMIC AREA; CLINICAL MALARIA; PARASITE; INFECTION; SENEGAL; IDENTIFICATION; TRANSMISSION; IMMUNITY; CRITERIA; SAVANNA	Background: Plasmodium ovale and Plasmodium malariae have long been reported to be widely distributed in tropical Africa and in other major malaria-endemic areas of the world. However, little is known about the burden caused by these two malaria species. Methods and Findings: We did a longitudinal study of the inhabitants of Dielmo village, Senegal, between June, 1990, and December, 2010. We monitored the inhabitants for fever during this period and performed quarterly measurements of parasitemia. We analyzed parasitological and clinical data in a random-effect logistic regression model to investigate the relationship between the level of parasitemia and the risk of fever and to establish diagnostic criteria for P. ovale and P. malariae clinical attacks. The prevalence of P. ovale and P. malariae infections in asymptomatic individuals were high during the first years of the project but decreased after 2004 and almost disappeared in 2010 in relation to changes in malaria control policies. The average incidence densities of P. ovale and P. malariae clinical attacks were 0.053 and 0.093 attacks per person per year in children <15 years and 0.024 and 0.009 attacks per person per year in adults >= 15 years, respectively. These two malaria species represented together 5.9% of the malaria burden. Conclusions: P. ovale and P. malariae were a common cause of morbidity in Dielmo villagers until the recent dramatic decrease of malaria that followed the introduction of new malaria control policies. P. ovale and P. malariae may constitute an important cause of morbidity in many areas of tropical Africa.	[Roucher, Clementine; Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal; [Rogier, Christophe; Tall, Adama] Inst Pasteur, Unite Epidemiol, Dakar, Senegal; [Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo, Madagascar	Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Trape, JF (corresponding author), Inst Rech Dev, Lab Paludol & Zool Med, Dakar, Senegal.	jean-francois.trape@ird.fr			Institut Pasteur of Paris; Institut Pasteur of Dakar; Institut de Recherche pour le Developpement (IRD); Ministry of Cooperation; Ministry of Research (France)	Institut Pasteur of Paris; Institut Pasteur of Dakar; Institut de Recherche pour le Developpement (IRD); Ministry of Cooperation; Ministry of Research (France)(Ministry of Research, France)	The Dielmo project was funded by the Institut Pasteur of Paris, the Institut Pasteur of Dakar, the Institut de Recherche pour le Developpement (IRD, formerly ORSTOM) and received grants from the Ministry of Cooperation and the Ministry of Research (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armstrong Schellenberg J. R. M., 1994, Parasitology Today, V10, P439; Bonnet S, 2002, TROP MED INT HEALTH, V7, P249, DOI 10.1046/j.1365-3156.2002.00861.x; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Ehrich JHH, 2007, PEDIATR NEPHROL, V22, P626, DOI 10.1007/s00467-006-0332-y; FACER CA, 1991, LANCET, V338, P896, DOI 10.1016/0140-6736(91)91562-9; Faye FBK, 1998, T ROY SOC TROP MED H, V92, P522, DOI 10.1016/S0035-9203(98)90900-2; Faye FBK, 2002, J INFECT DIS, V186, P690, DOI 10.1086/342395; Garnham PCC., 1966, MALARIA PARASITES OT; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Habluetzel A, 1999, TROP MED INT HEALTH, V4, P557, DOI 10.1046/j.1365-3156.1999.00455.x; Hedelius R, 2011, J TRAVEL MED, V18, P288, DOI 10.1111/j.1708-8305.2011.00526.x; Lau YL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-389; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; McKenzie FE, 1999, J PARASITOL, V85, P12, DOI 10.2307/3285692; Miller MJ, 1958, T R SOC TROP MED HYG, V79, P435; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Ndiaye F, 1998, SITUATION DEMOGRAPHI, P118; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Snounou G, 1996, Methods Mol Biol, V50, P263; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P435, DOI 10.1016/0035-9203(85)90054-9; TRAPE JF, 1987, B SOC PATHOL EXOT, V80, P520; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123	32	65	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87169	10.1371/journal.pone.0087169	http://dx.doi.org/10.1371/journal.pone.0087169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520325	Green Published, Green Submitted			2022-12-27	WOS:000331254600016
J	Busch, M; Westhofen, TC; Koch, M; Lutz, MB; Zernecke, A				Busch, Martin; Westhofen, Thilo C.; Koch, Miriam; Lutz, Manfred B.; Zernecke, Alma			Dendritic Cell Subset Distributions in the Aorta in Healthy and Atherosclerotic Mice	PLOS ONE			English	Article							CHRONIC INFLAMMATION; IN-VIVO; MACROPHAGES; MONOCYTE; HETEROGENEITY	Dendritic cells (DCs) can be sub-divided into various subsets that play specialized roles in priming of adaptive immune responses. Atherosclerosis is regarded as a chronic inflammatory disease of the vessel wall and DCs can be found in non-inflamed and diseased arteries. We here performed a systematic analyses of DCs subsets during atherogenesis. Our data indicate that distinct DC subsets can be localized in the vessel wall. In C57BL/6 and low density lipoprotein receptor-deficient (Ldlr(-/-)) mice, CD11c(+) MHCII+ DCs could be discriminated into CD103(-) CD11b(+) F4/80(+), CD11b(+) F4/80(-) and CD11b(-) F4/80(-) DCs and CD103(+) CD11b(-) F4/80(-) DCs. Except for CD103(-) CD11b(-) F4/80(-) DCs, these subsets expanded in high fat diet-fed Ldlr(-/-) mice. Signal-regulatory protein (Sirp)-alpha was detected on aortic macrophages, CD11b(+) DCs, and partially on CD103(-) CD11b(-) F4/80(-) but not on CD103(+) DCs. Notably, in FMS-like tyrosine kinase 3-ligand-deficient (Flt3l(-/-)) mice, a specific loss of CD103(+) DCs but also CD103(-) CD11b(+) F4/80(-) DCs was evidenced. Aortic CD103(+) and CD11b(+) F4/80(-) CD103(-) DCs may thus belong to conventional rather than monocyte-derived DCs, given their dependence on Flt3L-signalling. CD64, postulated to distinguish macrophages from DCs, could not be detected on DC subsets under physiological conditions, but appeared in a fraction of CD103(-) CD11b(+) F4/80(-) and CD11b(+) F4/80(+) cells in atherosclerotic Ldlr(-/-) mice. The emergence of CD64 expression in atherosclerosis may indicate that CD11b(+) F4/80(-) DCs similar to CD11b(+) F4/80(+) DCs are at least in part derived from immigrated monocytes during atherosclerotic lesion formation. Our data advance our knowledge about the presence of distinct DC subsets and their accumulation characteristics in atherosclerosis, and may help to assist in future studies aiming at specific DC-based therapeutic strategies for the treatment of chronic vascular inflammation.	[Busch, Martin; Westhofen, Thilo C.; Koch, Miriam] Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Koch, Miriam; Zernecke, Alma] Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiocchem, Wurzburg, Germany; [Lutz, Manfred B.] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Zernecke, Alma] Tech Univ Munich, Klinikum Rechts Isar, Dept Vasc Surg, D-80290 Munich, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; Technical University of Munich	Zernecke, A (corresponding author), Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiocchem, Wurzburg, Germany.	alma.zernecke@uni-wuerzburg.de		Lutz, Manfred B./0000-0001-9193-1772	Deutsche Forschungsgemeinschaft [FOR809, ZE827/1-2, ZE827/4-1, SFB688 TPA12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FOR809, ZE827/1-2 and ZE827/4-1, SFB688 TPA12) to A.Z. The authors have no conflicting financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Lahoud MH, 2006, J IMMUNOL, V177, P372, DOI 10.4049/jimmunol.177.1.372; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lewis KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007401; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; Manthey HD, 2011, THROMB HAEMOSTASIS, V106, P772, DOI 10.1160/TH11-05-0296; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Sun JS, 2010, CIRCULATION, V122, P808, DOI 10.1161/CIRCULATIONAHA.109.891887; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001	28	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88452	10.1371/journal.pone.0088452	http://dx.doi.org/10.1371/journal.pone.0088452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551105	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500039
J	Zhang, H; Zhang, YR; Hamoudi, R; Yan, GY; Chen, XG; Zhou, YP				Zhang, Hao; Zhang, Yanru; Hamoudi, Rifat; Yan, Guiyun; Chen, Xiaoguang; Zhou, Yuanping			Spatiotemporal Characterizations of Dengue Virus in Mainland China: Insights into the Whole Genome from 1978 to 2011	PLOS ONE			English	Article							WEST-NILE-VIRUS; PHYLOGENETIC ANALYSIS; MOLECULAR EPIDEMIOLOGY; BLOOD-DONORS; INFECTIONS; EMERGENCE; EVOLUTION; SEQUENCES; FEVER	Temporal-Spatial of dengue virus (DENV) analyses have been performed in previous epidemiological studies in mainland China, but few studies have examined the whole genome of the DENV. Herein, 40 whole genome sequences of DENVs isolated from mainland China were downloaded from GenBank. Phylogenetic analyses and evolutionary distances of the dengue serotypes 1 and 2 were calculated using 14 maximum likelihood trees created from individual genes and whole genome. Amino acid variations were also analyzed in the 40 sequences that included dengue serotypes 1, 2, 3 and 4, and they were grouped according to temporal and spatial differences. The results showed that none of the phylogenetic trees created from each individual gene were similar to the trees created using the complete genome and the evolutionary distances were variable with each individual gene. The number of amino acid variations was significantly different (p = 0.015) between DENV-1 and DENV-2 after 2001; seven mutations, the N290D, L402F and A473T mutations in the E gene region and the R101K, G105R, D340E and L349M mutations in the NS1 region of DENV-1, had significant substitutions, compared to the amino acids of DENV-2. Based on the spatial distribution using Guangzhou, including Foshan, as the indigenous area and the other regions as expanding areas, significant differences in the number of amino acid variations in the NS3 (p = 0.03) and NS1 (p = 0.024) regions and the NS2B (p = 0.016) and NS3 (p = 0.042) regions were found in DENV-1 and DENV-2. Recombination analysis showed no inter-serotype recombination events between the DENV-1 and DENV-2, while six and seven breakpoints were found in DENV-1 and DENV-2. Conclusively, the individual genes might not be suitable to analyze the evolution and selection pressure isolated in mainland China; the mutations in the amino acid residues in the E, NS1 and NS3 regions may play important roles in DENV-1 and DENV-2 epidemics.	[Zhang, Hao; Zhang, Yanru; Zhou, Yuanping] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Zhang, Hao; Chen, Xiaoguang] Soothern Med Guangzhou, Sch Publ Hlth & Trop Med, Key Lab Prevent & Control Emerging Infect Dis Gua, Guangzhou, Guangdong, Peoples R China; [Hamoudi, Rifat] UCL, Rockefeller Bldg, Dept Pathol, London, England; [Hamoudi, Rifat] UCL, Paul O Gorman Bldg, UCL Canc Inst, London, England; [Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	Southern Medical University - China; University of London; University College London; University of London; University College London; University of California System; University of California Irvine	Chen, XG (corresponding author), Soothern Med Guangzhou, Sch Publ Hlth & Trop Med, Key Lab Prevent & Control Emerging Infect Dis Gua, Guangzhou, Guangdong, Peoples R China.	xgchen2001@hotmail.com; yuanpingzhou@163.com		Hamoudi, Rifat/0000-0002-1402-0868	National Science Foundation of China [30771899]; National Institutes of Health [R01AI083202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083202] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Science Foundation of China (30771899) to YP Zhou, and National Institutes of Health grant R01AI083202 to XG Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437; Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459; Anoop M, 2012, VIRUS GENES, V45, P1, DOI 10.1007/s11262-012-0756-3; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Carney J, 2012, ARCH VIROL, V157, P75, DOI 10.1007/s00705-011-1143-4; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; Fan J, 2013, EPIDEMIOL INFECT, V142, P1; Grinev A, 2008, EMERG INFECT DIS, V14, P436, DOI 10.3201/eid1403.070463; Herring BL, 2007, VIROLOGY, V363, P220, DOI 10.1016/j.virol.2007.01.019; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Jiang Li-yun, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P1273; Jiang LY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-4; Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12; Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021; Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lemmon AR, 2002, P NATL ACAD SCI USA, V99, P10516, DOI 10.1073/pnas.162224399; Li ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-132; Liang W, 2007, S CHINA J PREV MED, V33, P4; Luo Huiming, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P427; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; Mohammed MAF, 2011, INFECT GENET EVOL, V11, P855, DOI 10.1016/j.meegid.2011.01.020; Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83; QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Rodriguez-Roche R, 2012, INFECT GENET EVOL, V12, P332, DOI 10.1016/j.meegid.2011.12.005; Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732; Sotelo E, 2009, VIROLOGY, V395, P289, DOI 10.1016/j.virol.2009.09.013; Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x; Tang WF, 2010, INFECT GENET EVOL, V10, P329, DOI 10.1016/j.meegid.2009.12.005; Wang C, 2013, ASIA-PAC POWER ENERG; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322; Zehender G, 2011, INFECT GENET EVOL, V11, P646, DOI 10.1016/j.meegid.2011.02.003; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	37	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87630	10.1371/journal.pone.0087630	http://dx.doi.org/10.1371/journal.pone.0087630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551062	Green Published, gold			2022-12-27	WOS:000331271500020
J	Sarvari, M; Kallo, I; Hrabovszky, E; Solymosi, N; Liposits, Z				Sarvari, Miklos; Kallo, Imre; Hrabovszky, Erik; Solymosi, Norbert; Liposits, Zsolt			Ovariectomy and Subsequent Treatment with Estrogen Receptor Agonists Tune the Innate Immune System of the Hippocampus in Middle-Aged Female Rats	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALTERNATIVE COMPLEMENT PATHWAY; INFLAMMATORY RESPONSE; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; FRONTAL-CORTEX; MICROGLIA; EXPRESSION; BRAIN; BETA	The innate immune system including microglia has a major contribution to maintenance of the physiological functions of the hippocampus by permanent monitoring of the neural milieu and elimination of tissue-damaging threats. The hippocampus is vulnerable to age-related changes ranging from gene expression to network connectivity. The risk of hippocampal deterioration increases with the decline of gonadal hormone supply. To explore the impact of hormone milieu on the function of the innate immune system in middle-aged female rats, we compared mRNA expression in the hippocampus after gonadal hormone withdrawal, with or without subsequent estrogen replacement using estradiol and isotype-selective estrogen receptor (ER) agonists. Targeted profiling assessed the status of the innate immune system (macrophage-associated receptors, complement, inhibitory neuronal ligands), local estradiol synthesis (P450 aromatase) and estrogen reception (ER). Results established upregulation of macrophage-associated (Cd45, Iba1, Cd68, Cd11b, Cd18, Fcgr1a, Fcgr2b) and complement (C3, factor B, properdin) genes in response to ovariectomy. Ovariectomy upregulated Cd22 and downregulated semaphorin3A (Sema3a) expression, indicating altered neuronal regulation of microglia. Ovariectomy also led to downregulation of aromatase and upregulation of ER alpha gene. Of note, analogous changes were observed in the hippocampus of postmenopausal women. In ovariectomized rats, estradiol replacement attenuated Iba1, Cd11b, Fcgr1a, C3, increased mannose receptor Mrc1, Cd163 and reversed Sema3a expression. In contrast, reduced expression of aromatase was not reversed by estradiol. While the effects of ER alpha agonist closely resembled those of estradiol, ER beta agonist was also capable of attenuating the expression of several macrophage-associated and complement genes. These data together indicate that the innate immune system of the aging hippocampus is highly responsive to the gonadal hormone milieu. In ovariectomized female rats, estradiol replacement exerts potent immunomodulatory effects including attenuation of microglia sensitization, initiation of M2-like activation and modulation of complement expression by targeting hippocampal neurons and glial cells through ER alpha and ER beta.	[Sarvari, Miklos; Kallo, Imre; Hrabovszky, Erik; Liposits, Zsolt] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Kallo, Imre; Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary; [Solymosi, Norbert] Eotvos Lorand Univ, Dept,Phys Complex Syst, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand University	Sarvari, M (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	sarvari@koki.hu	Liposits, Zsolt/K-8145-2019; Solymosi, Norbert/B-5428-2012; Kalló, Imre/C-6262-2016	Kalló, Imre/0000-0003-3412-4100; Hrabovszky, Erik/0000-0001-6927-0015; Solymosi, Norbert/0000-0003-1783-2041; Liposits, Zsolt/0000-0002-3508-2750	Hungarian Scientific Research Fund [OTKA K100722]; National Development Agency of Hungary [NFU-BONUS- HU08/2-2011-0006]; European Community [245009]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency of Hungary; European Community(European Commission)	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA K100722), the National Development Agency of Hungary (NFU-BONUS- HU08/2-2011-0006) and the European Community's Seventh Framework Programme (FP7/2007-2013, No. 245009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2002, J NEUROSCI, V22, P3608; Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Barha CK, 2011, NEUROBIOL AGING, V32, P2091, DOI 10.1016/j.neurobiolaging.2009.12.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Daniel JM, 2006, ENDOCRINOLOGY, V147, P607, DOI 10.1210/en.2005-0998; Dominguez R, 2009, J NEUROSCI, V29, P4228, DOI 10.1523/JNEUROSCI.0550-09.2009; Downer EJ, 2010, NEUROBIOL AGING, V31, P118, DOI 10.1016/j.neurobiolaging.2008.03.017; Engler-Chiurazzi E, 2011, NEUROBIOL AGING, V32, P680, DOI 10.1016/j.neurobiolaging.2009.09.005; Epperson CN, 2013, J CLIN ENDOCR METAB, V98, P3829, DOI 10.1210/jc.2013-1808; FEARON DT, 1975, P NATL ACAD SCI USA, V72, P3220, DOI 10.1073/pnas.72.8.3220; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; GOTZE O, 1971, J EXP MED, V134, pS90; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Hillisch A, 2004, MOL ENDOCRINOL, V18, P1599, DOI 10.1210/me.2004-0050; Ji K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056293; Jurgens HA, 2012, EXP NEUROL, V233, P40, DOI 10.1016/j.expneurol.2010.11.014; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lewis DK, 2008, J NEUROIMMUNOL, V195, P47, DOI 10.1016/j.jneuroim.2008.01.006; Loram LC, 2012, PSYCHONEUROENDOCRINO, V37, P1688, DOI 10.1016/j.psyneuen.2012.02.018; LOY R, 1988, DEV BRAIN RES, V39, P245, DOI 10.1016/0165-3806(88)90028-4; Lynch AM, 2010, AGING DIS, V1, P262; Majed HH, 2006, J NEUROSCI, V26, P1730, DOI 10.1523/JNEUROSCI.0702-05.2006; McEwen BS, 2012, BEHAV NEUROSCI, V126, P4, DOI 10.1037/a0026708; MCKINLAY SM, 1992, MATURITAS, V14, P103, DOI 10.1016/0378-5122(92)90003-M; Minghetti L, 2005, BRAIN RES REV, V48, P251, DOI 10.1016/j.brainresrev.2004.12.015; Mott RT, 2004, GLIA, V46, P369, DOI 10.1002/glia.20009; Mukai H, 2010, BBA-GEN SUBJECTS, V1800, P1030, DOI 10.1016/j.bbagen.2009.11.002; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Prange-Kiel J, 2013, PROG HISTOCHEM CYTO, V48, P49, DOI 10.1016/j.proghi.2013.07.002; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Reichwald J, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-35; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Sarvari M, 2010, ENDOCRINOLOGY, V151, P3847, DOI 10.1210/en.2010-0375; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229, DOI 10.1007/s004010050792; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shughrue PJ, 2000, NEUROSCIENCE, V99, P605, DOI 10.1016/S0306-4522(00)00242-6; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sun J, 2003, MOL ENDOCRINOL, V17, P247, DOI 10.1210/me.2002-0341; Tabatadze N, 2013, ENDOCRINOLOGY, V154, P819, DOI 10.1210/en.2012-1870; Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Waters EM, 2008, J COMP NEUROL, V511, P34, DOI 10.1002/cne.21826; Weber MT, 2013, MENOPAUSE, V20, P511, DOI [10.1097/GME.0b013e31827655e5, 10.1097/gme.0b013e31827655e5]; Witty CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051385; Wong AM, 2005, NEUROSCI LETT, V390, P76, DOI 10.1016/j.neulet.2005.07.058; Wu WF, 2013, P NATL ACAD SCI USA, V110, P3543, DOI 10.1073/pnas.1300313110; Wu WW, 2013, J NEUROSCI, V33, P16158, DOI 10.1523/JNEUROSCI.2001-13.2013; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamane M, 2012, BIOCHEM BIOPH RES CO, V422, P333, DOI 10.1016/j.bbrc.2012.05.003; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhao LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031267	77	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88540	10.1371/journal.pone.0088540	http://dx.doi.org/10.1371/journal.pone.0088540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551115	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000331266000043
J	Chary, M; Park, EH; McKenzie, A; Sun, J; Manini, AF; Genes, N				Chary, Michael; Park, Emily H.; McKenzie, Andrew; Sun, Julia; Manini, Alex F.; Genes, Nicholas			Signs & Symptoms of Dextromethorphan Exposure from YouTube	PLOS ONE			English	Article							ABUSE; DEXTRORPHAN; RECEPTOR	Detailed data on the recreational use of drugs are difficult to obtain through traditional means, especially for substances like Dextromethorphan (DXM) which are available over-the-counter for medicinal purposes. In this study, we show that information provided by commenters on YouTube is useful for uncovering the toxicologic effects of DXM. Using methods of computational linguistics, we were able to recreate many of the clinically described signs and symptoms of DXM ingestion at various doses, using information extracted from YouTube comments. Our study shows how social networks can enhance our understanding of recreational drug effects.	[Chary, Michael; McKenzie, Andrew; Sun, Julia] Icahn Sch Med Mt Sinai, New York, NY USA; [Park, Emily H.] Rutgers New Jersey Med Sch, Newark, NJ USA; [Manini, Alex F.] Icahn Sch Med Mt Sinai, Div Med Toxicol, New York, NY USA; [Genes, Nicholas] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Genes, N (corresponding author), Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA.	nicholas.genes@mountsinai.org		Sun, Julia/0000-0001-9768-4362; Genes, Nicholas/0000-0002-9836-2477; Chary, Michael/0000-0002-9000-1765				Anderson I, 2013, DEXTROMETHORPHAN ABU; [Anonymous], 2011, J ADDICT DIS, V30, P243; Ball J. K., 2006, NEW DAWN REP, V32, P1; Banerji S, 2001, AM J HEALTH-SYST PH, V58, P1811, DOI 10.1093/ajhp/58.19.1811; Bobo WV, 2004, AM J EMERG MED, V22, P624, DOI 10.1016/j.ajem.2004.09.011; Boyer EW, 2007, CYBERPSYCHOL BEHAV, V10, P1, DOI 10.1089/cpb.2006.9999; Boyer EW, 2004, PEDIATR EMERG CARE, V20, P858, DOI 10.1097/01.pec.0000148039.14588.d0; Bronstein AC, 2012, CLIN TOXICOL, V50, P911, DOI 10.3109/15563650.2012.746424; Bryner JK, 2006, ARCH PEDIAT ADOL MED, V160, P1217, DOI 10.1001/archpedi.160.12.1217; Casselman I, 2011, J ETHNOPHARMACOL, V138, P662, DOI 10.1016/j.jep.2011.07.065; Chou YC, 1999, BRAIN RES, V821, P516, DOI 10.1016/S0006-8993(99)01125-7; Daniulaityte R, 2012, DRUG ALCOHOL DEPENDE; GINSKI MJ, 1994, PSYCHOPHARMACOLOGY, V114, P573, DOI 10.1007/BF02244987; Lange JE, 2010, DRUG ALCOHOL DEPEN, V108, P138, DOI 10.1016/j.drugalcdep.2009.11.010; Manning P, 2012, DRUGS ED PREVENTION, P1; Miller G., 1990, INT J LEXICOGR, V3, P235, DOI DOI 10.1093/IJL/3.4.235; Mitkov, 2002, OXFORD HDB COMPUTATI; Murff HJ, 2011, JAMA-J AM MED ASSOC, V306, P848, DOI 10.1001/jama.2011.1204; Murphy PN, 2011, HUM PSYCHOPHARM CLIN, V26, P460, DOI 10.1002/hup.1228; Pham T, 2010, TECHNICAL REPORT; Price LH, 2000, AM J PSYCHIAT, V157, P304, DOI 10.1176/appi.ajp.157.2.304; RAMACHANDER G, 1977, J PHARM SCI, V66, P1047, DOI 10.1002/jps.2600660740; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Substance Abuse and Mental Health Services Administration (SAMHSA), 2007, NSDUH REP MIS OV THE; Trugenberger CA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-51; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; Wilson MD, 2011, CLIN TOXICOL, V49, P409, DOI 10.3109/15563650.2011.585429; Zack M, 2004, NEUROPSYCHOPHARMACOL, V29, P195, DOI 10.1038/sj.npp.1300333	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e82452	10.1371/journal.pone.0082452	http://dx.doi.org/10.1371/journal.pone.0082452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533044	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600002
J	Blancato, J; Graves, A; Rashidi, B; Moroni, M; Tchobe, L; Ozdemirli, M; Kallakury, B; Makambi, KH; Marian, C; Mueller, SC				Blancato, Jan; Graves, Ashley; Rashidi, Banafsheh; Moroni, Maria; Tchobe, Leopold; Ozdemirli, Metin; Kallakury, Bhaskar; Makambi, Kepher H.; Marian, Catalin; Mueller, Susette C.			SYK Allelic Loss and the Role of Syk-Regulated Genes in Breast Cancer Survival	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; MATRIX-METALLOPROTEINASE; TUMOR-SUPPRESSOR; CELL-MIGRATION; IN-SITU; ALPHA-5-BETA-1 INTEGRIN; RAB GTPASES; E-CADHERIN; CORTACTIN; METHYLATION	Heterozygotic loss of SYK, a non-receptor tyrosine kinase, gives rise to mouse mammary tumor formation where Syk protein levels are reduced by about half; loss of SYK mRNA is correlated with invasive cell behavior in in vitro models; and SYK loss has been correlated with distant metastases in patients. Here, allelic loss of the SYK gene was explored in breast ductal carcinoma in situ (DCIS) using fluorescence in situ hybridization and pyrosequencing, respectively, and in infiltrating ductal carcinoma (IDC) using genomic data from The Cancer Genome Atlas (TCGA). Allelic loss was present in a subset of DCIS cases where adjacent IDC was present. SYK copy number loss was found in about 26% of 1002 total breast cancer cases and 30% of IDC cases. Quantitative immunofluorescence revealed Syk protein to be six-fold higher in infiltrating immune cells compared with epithelial cells. This difference distorted tumor cell mRNA and protein levels in extracts. 20% of 1002 IDC cases contained elevated immune cell infiltration as estimated by elevated immune-specific mRNAs. In cases without immune cell infiltration, loss of SYK copy number was associated with a significant reduction of SYK mRNA. Here we define a 55 Gene Set consisting of Syk interacting, motility-and invasion-related genes. We found that overall survival was significantly reduced in IDC and Luminal A+B cases where copy number and mutations of these 55 genes were affected (Kaplan-Meier, Logrank test p-value 0.007141 and Logrank test p-value 0.001198, respectively). We conclude that reduction in Syk expression and contributions of genomic instability to copy number and mutations in the 55 Syk interacting genes significantly contribute to poorer overall patient survival. A closer examination of the role of Syk interacting motility and invasion genes and their prognostic and/or causative association with metastatic disease and patient outcome is warranted.	[Blancato, Jan; Graves, Ashley; Tchobe, Leopold; Mueller, Susette C.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Rashidi, Banafsheh; Ozdemirli, Metin; Kallakury, Bhaskar] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Moroni, Maria] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA; [Tchobe, Leopold] Univ Dist Columbia Lombardi Comprehens Canc Ctr P, Washington, DC USA; [Makambi, Kepher H.] Georgetown Univ, Med Ctr, Dept Biostat & Bioinformat, Washington, DC 20007 USA; [Marian, Catalin] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Marian, Catalin] Univ Med & Farm Timisoara, Dept Biochem, Timisoara, Romania	Georgetown University; Georgetown University; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Georgetown University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Victor Babes University of Medicine & Pharmacy, Timisoara	Mueller, SC (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA.	muellers@georgetown.edu	Marian, Catalin/P-2885-2019; Marian, Catalin/B-1750-2012	Marian, Catalin/0000-0002-7749-1384; 	Lombardi Comprehensive Cancer Center Microscopy & Imaging, Histopathology & Tissue, Tissue Culture & Biorepository for Cell Lines and Biofluids; U.S. Public Health Service [2P30-CA-51008, 1S10 RR15768-01, 1 S10 RR019291-01A2];  [9R01 CA112673]; NATIONAL CANCER INSTITUTE [U56CA101563, R01CA112673, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015768, S10RR019291] Funding Source: NIH RePORTER	Lombardi Comprehensive Cancer Center Microscopy & Imaging, Histopathology & Tissue, Tissue Culture & Biorepository for Cell Lines and Biofluids; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the Lombardi Comprehensive Cancer Center Microscopy & Imaging, Histopathology & Tissue, Tissue Culture & Biorepository for Cell Lines and Biofluids, and the Genomics & Epigenomics Shared Resources funded by U.S. Public Health Service Grant 2P30-CA-51008, 1S10 RR15768-01, and 1 S10 RR019291-01A2; and 9R01 CA112673 to SCM. No additional funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Al-Sahaf O, 2010, ANN SURG, V252, P1037, DOI 10.1097/SLA.0b013e3181efc635; Aloisi AL, 2013, HISTOL HISTOPATHOL, V28, P839, DOI 10.14670/HH-28.839; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Artym VV, 2011, EUR J CELL BIOL, V90, P172, DOI 10.1016/j.ejcb.2010.06.006; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cohen AL, 2010, J NATL COMPR CANC NE, V8, P1211, DOI 10.6004/jnccn.2010.0088; Conklin MW, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-14; Coopman PJ, 2006, CANCER LETT, V241, P159, DOI 10.1016/j.canlet.2005.11.004; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Courtneidge SA, 2012, BIOCHEM SOC T, V40, P129, DOI 10.1042/BST20110685; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Dong SW, 2011, NEOPLASMA, V58, P89, DOI 10.4149/neo_2011_01_89; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Huderson BP, 2012, ENDOCRINOLOGY, V153, P4144, DOI 10.1210/en.2011-2001; Inayat U, 2012, POL J PATHOL, V63, P106; Jenkins RB, 1997, CANCER RES, V57, P524; Kanwal S, 2012, MOL BIOL REP, V39, P8345, DOI 10.1007/s11033-012-1684-y; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kreiseder B, 2013, INT J CANCER, V132, P521, DOI 10.1002/ijc.27698; Kunze E, 2006, INT J MOL MED, V18, P547; Larive RM, 2009, ONCOGENE, V28, P2337, DOI 10.1038/onc.2009.99; Layton T, 2009, AM J PATHOL, V175, P2625, DOI 10.2353/ajpath.2009.090543; Lee HS, 2009, CLIN CANCER RES, V15, P812, DOI 10.1158/1078-0432.CCR-08-0266; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Ma L, 2010, CLIN LAB, V56, P407; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P6209, DOI 10.1074/jbc.M208905200; Maruyama S, 1996, J BIOL CHEM, V271, P6631, DOI 10.1074/jbc.271.12.6631; Mascarello JT, 2011, GENET MED, V13, P667, DOI 10.1097/GIM.0b013e3182227295; Mills GB, 2009, J CLIN INVEST, V119, P2123, DOI 10.1172/JCI40256; Minobe K, 1998, JPN J CANCER RES, V89, P916, DOI 10.1111/j.1349-7006.1998.tb00649.x; Mitra S, 2012, BIOCHEM SOC T, V40, P1404, DOI 10.1042/BST20120249; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mueller Susette C., 2008, P403, DOI 10.1007/978-0-387-69057-5_21; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Neuhaus B, 2011, CELL MOL LIFE SCI, V68, P3757, DOI 10.1007/s00018-011-0676-8; Nishimura N, 2008, J MED INVESTIG, V55, P9, DOI 10.2152/jmi.55.9; Ogane S, 2009, INT J CANCER, V124, P2651, DOI 10.1002/ijc.24237; Ortiz RM, 2004, GENE CHROMOSOME CANC, V41, P366, DOI 10.1002/gcc.20102; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ruschel A, 2004, CELL SIGNAL, V16, P1249, DOI 10.1016/j.cellsig.2004.03.007; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; Schuuring E, 1991, CANCER RES, V51, P4028; Sibony-Benyamini H, 2012, EUR J CELL BIOL, V91, P896, DOI 10.1016/j.ejcb.2012.04.001; Struckhoff AP, 2011, FRONT BIOSCI-LANDMRK, V16, P1915, DOI 10.2741/3830; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312; Sung YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007445; Tang BL, 2009, CELL MOTIL CYTOSKEL, V66, P365, DOI 10.1002/cm.20376; Tennis M, 2006, CANCER EPIDEM BIOMAR, V15, P80, DOI 10.1158/1055-9965.EPI-05-0444; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tsou JA, 2007, LUNG CANCER, V58, P220, DOI 10.1016/j.lungcan.2007.06.015; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Rossum AGSH, 2006, EXP CELL RES, V312, P1658, DOI 10.1016/j.yexcr.2006.01.033; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver V, 2007, DEV CELL, V13, P462, DOI 10.1016/j.devcel.2007.09.013; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yuan YF, 2005, INT J CANCER, V113, P654, DOI 10.1002/ijc.20628; Yuan YF, 2001, CANCER RES, V61, P5558; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622; Zhang XY, 2009, MOL CANCER RES, V7, P634, DOI 10.1158/1541-7786.MCR-08-0371; Zhong JL, 2008, MOL CANCER RES, V6, P383, DOI 10.1158/1541-7786.MCR-07-2028; Zitka O, 2010, CURR MED CHEM, V17, P3751, DOI 10.2174/092986710793213724	84	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e87610	10.1371/journal.pone.0087610	http://dx.doi.org/10.1371/journal.pone.0087610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523870	Green Submitted, gold, Green Published			2022-12-27	WOS:000331258100019
J	Campa, D; Barrdahl, M; Tsilidis, KK; Severi, G; Diver, WR; Siddiq, A; Chanock, S; Hoover, RN; Ziegler, RG; Berg, CD; Buys, SS; Haiman, CA; Henderson, BE; Schumacher, FR; Le Marchand, L; Flesch-Janys, D; Lindstrom, S; Hunter, DJ; Hankinson, SE; Willett, WC; Kraft, P; Cox, DG; Khaw, KT; Tjonneland, A; Dossus, L; Trichopoulos, D; Panico, S; van Gils, CH; Weiderpass, E; Barricarte, A; Sund, M; Gaudet, MM; Giles, G; Southey, M; Baglietto, L; Chang-Claude, J; Kaaks, R; Canzian, F				Campa, Daniele; Barrdahl, Myrto; Tsilidis, Konstantinos K.; Severi, Gianluca; Diver, W. Ryan; Siddiq, Afshan; Chanock, Stephen; Hoover, Robert N.; Ziegler, Regina G.; Berg, Christine D.; Buys, Saundra S.; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick R.; Le Marchand, Loic; Flesch-Janys, Dieter; Lindstroem, Sara; Hunter, David J.; Hankinson, Susan E.; Willett, Walter C.; Kraft, Peter; Cox, David G.; Khaw, Kay-Tee; Tjonneland, Anne; Dossus, Laure; Trichopoulos, Dimitrios; Panico, Salvatore; van Gils, Carla H.; Weiderpass, Elisabete; Barricarte, Aurelio; Sund, Malin; Gaudet, Mia M.; Giles, Graham; Southey, Melissa; Baglietto, Laura; Chang-Claude, Jenny; Kaaks, Rudolf; Canzian, Federico			A Genome-Wide "Pleiotropy Scan'' Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer	PLOS ONE			English	Article							COMPLEX DISEASES; ASSOCIATION; METAANALYSIS; RISK	Approximately 15-30% of all breast cancer tumors are estrogen receptor negative (ER-). Compared with ER- positive (ER+) disease they have an earlier age at onset and worse prognosis. Despite the vast number of risk variants identified for numerous cancer types, only seven loci have been unambiguously identified for ER- negative breast cancer. With the aim of identifying new susceptibility SNPs for this disease we performed a pleiotropic genome-wide association study (GWAS). We selected 3079 SNPs associated with a human complex trait or disease at genome-wide significance level (P<5x10(-8)) to perform a secondary analysis of an ER- negative GWAS from the National Cancer Institute's Breast and Prostate Cancer Cohort Consortium (BPC3), including 1998 cases and 2305 controls from prospective studies. We then tested the top ten associations (i.e. with the lowest P-values) using three additional populations with a total sample size of 3509 ER+ cases, 2543 ER- cases and 7031 healthy controls. None of the 3079 selected variants in the BPC3 ER- GWAS were significant at the adjusted threshold. 186 variants were associated with ER- breast cancer risk at a conventional threshold of P<0.05, with P-values ranging from 0.049 to 2.3 x 10(-4). None of the variants reached statistical significance in the replication phase. In conclusion, this study did not identify any novel susceptibility loci for ER-breast cancer using a "pleiotropic approach''.	[Campa, Daniele; Barrdahl, Myrto; Chang-Claude, Jenny; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Tsilidis, Konstantinos K.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Severi, Gianluca; Giles, Graham; Southey, Melissa; Baglietto, Laura] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Severi, Gianluca; Giles, Graham; Southey, Melissa; Baglietto, Laura] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Diver, W. Ryan; Gaudet, Mia M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Siddiq, Afshan; Cox, David G.] Univ London Imperial Coll Sci Technol & Med, London, England; [Chanock, Stephen; Hoover, Robert N.; Ziegler, Regina G.; Berg, Christine D.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Buys, Saundra S.] Univ Utah, Sch Med, Div Oncol, Huntsman Canc Inst, Salt Lake City, UT USA; [Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick R.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Flesch-Janys, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometr & Epidemiol, Hamburg, Germany; [Lindstroem, Sara; Hunter, David J.; Hankinson, Susan E.; Willett, Walter C.; Kraft, Peter; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hankinson, Susan E.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Hankinson, Susan E.] Harvard Univ, Sch Med, Boston, MA USA; [Hankinson, Susan E.] Univ Massachusetts, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Cox, David G.] Univ Lyon 1, F-69365 Lyon, France; [Cox, David G.] Ctr Rech Cancerol Lyon, Inst Natl Sante & Rech Med, U1052, Lyon, France; [Cox, David G.] Ctr Rech Cancerol Lyon, Ctr Natl Rech Sci, UMR5286, Lyon, France; [Cox, David G.] Ctr Leon Berard, F-69373 Lyon, France; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Dossus, Laure] Hormones & Womens Hlth Team, Inst Natl Sante & Rech Med, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Dossus, Laure] Univ Paris 11, UMRS 1018, Villejuif, France; [Dossus, Laure] Inst Gustave Roussy, F-94805 Villejuif, France; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Panico, Salvatore] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy; [van Gils, Carla H.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Weiderpass, Elisabete] Arctic Univ Tromso, Dept Community Med, Fac Hlth Sci, Univ Tromso, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland; [Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Barricarte, Aurelio] CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain; [Sund, Malin] Umea Univ Hosp, Dept Surg, S-90185 Umea, Sweden; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford; University of Ioannina; Cancer Council Victoria; University of Melbourne; American Cancer Society; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; University of Cambridge; Danish Cancer Society; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Academy of Athens; University of Naples Federico II; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Samfundet Folkhalsan; Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Umea University; Helmholtz Association; German Cancer Research Center (DKFZ)	Campa, D (corresponding author), German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.	d.campa@dkfz.de	Weiderpass, Elisabete/M-4029-2016; Cox, David/ABA-7454-2020; Berg, Christine/K-1047-2014; Severi, Gianluca/H-3774-2018; Cox, David G/A-2023-2009; Baglietto, Laura/AAB-9051-2019; Dossus, Laure/AAW-9097-2021; Diver, Ryan/AAG-3469-2019; Weiderpass, Elisabete/AAP-2747-2021; Khaw, Kay-Tee/AAZ-3209-2021; Schumacher, Fredrick/R-6043-2019; Severi, Gianluca/Q-1824-2019; Campa, Daniele/K-1617-2016; Canzian, Federico/I-2804-2014	Weiderpass, Elisabete/0000-0003-2237-0128; Severi, Gianluca/0000-0001-7157-419X; Cox, David G/0000-0002-2152-9259; Dossus, Laure/0000-0003-2716-5748; Diver, Ryan/0000-0002-5418-9000; Weiderpass, Elisabete/0000-0003-2237-0128; Schumacher, Fredrick/0000-0002-3073-7463; Severi, Gianluca/0000-0001-7157-419X; Campa, Daniele/0000-0003-3220-9944; Panico, Salvatore/0000-0002-5498-8312; Siddiq, Afshan/0000-0002-9110-1434; Baglietto, Laura/0000-0002-8193-7529; Canzian, Federico/0000-0002-4261-4583; Tjonneland, Anne/0000-0003-4385-2097; Barrdahl, Myrto/0000-0001-8680-8729; Tsilidis, Konstantinos/0000-0002-8452-8472; Giles, Graham/0000-0003-4946-9099; Southey, Melissa/0000-0002-6313-9005; Cox, David/0000-0003-2047-4687	US National Institutes of Health, National Cancer Institute [U01-CA98233-07, U01CA98710-06, U01-CA98216-06, U01-CA98758-07]; Intramural Research Program of National Institutes of Health; National Cancer Institute, Division of Cancer Epidemiology and Genetics; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA098233, U01CA098216, U01CA098710, U01CA098758] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health, National Cancer Institute (cooperative agreements U01-CA98233-07 to D.J.H.; U01CA98710-06 to M.J.T.; U01-CA98216-06 to E.R. and R.K.; and U01-CA98758-07 to B.E.H.); and Intramural Research Program of National Institutes of Health and National Cancer Institute, Division of Cancer Epidemiology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chu KC, 2002, BREAST CANCER RES TR, V74, P199, DOI 10.1023/A:1016361932220; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Giles G G, 2002, IARC Sci Publ, V156, P69; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hindorff LA, 2011, CARCINOGENESIS, V32, P945, DOI 10.1093/carcin/bgr056; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hunter DJ, 2005, NAT REV CANCER, V5, P977, DOI 10.1038/nrc1754; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Pierce BL, 2011, CANCER RES, V71, P4352, DOI 10.1158/0008-5472.CAN-11-0124; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vineis P, 2008, MUTAGENESIS, V23, P439, DOI 10.1093/mutage/gen042; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609	30	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e85955	10.1371/journal.pone.0085955	http://dx.doi.org/10.1371/journal.pone.0085955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523857	Green Published, gold			2022-12-27	WOS:000331258100006
J	Carellos, EVM; de Andrade, GMQ; Vasconcelos-Santos, DV; Januario, JN; Romanelli, RMC; Abreu, MNS; da Silva, FM; Loures, IRC; de Andrade, JQ; Caiaffa, WT				Machado Carellos, Ericka Viana; Queiroz de Andrade, Glaucia Manzan; Vasconcelos-Santos, Daniel Vitor; Januario, Jose Nelio; Castro Romanelli, Roberta Maia; Silva Abreu, Mery Natali; da Silva, Fabiana Maria; Coelho Loures, Ivy Rosa; de Andrade, Juliana Queiroz; Caiaffa, Waleska Teixeira		UFMG-CTBG	Adverse Socioeconomic Conditions and Oocyst-Related Factors Are Associated with Congenital Toxoplasmosis in a Population-Based Study in Minas Gerais, Brazil	PLOS ONE			English	Article							PREGNANT-WOMEN; RISK-FACTORS; GONDII INFECTION; ANIMALS; PARANA; SEROPOSITIVITY; EXPOSURE; REGION; STATE; WATER	Objective: Congenital toxoplasmosis is a public health problem in Brazil. This study aimed to determine risk factors associated with congenital toxoplasmosis in Minas Gerais which is the second largest Brazilian State based on number of inhabitants, and its territorial extension is larger than that of France. Methods: Population-based case-control study to assess the association between congenital toxoplasmosis and maternal exposure to infection risk factors. The study included mothers/children participating in the Minas Gerais Newborn Screening Program. The cases consisted of 175 mothers of infected children, and the controls consisted of 278 mothers of children without suspected infection. The associations were assessed through binomial logistic regression with p <= 0.05. Results: The variables associated with lower probability of toxoplasmosis were: older mother age (OR = 0.89; CI95% = 0.85-0.93), higher level of education (OR = 0.85; CI95% = 0.78-0.92), access to potable water (OR = 0.21; CI95% = 0.08-0.51), and home with flush toilet (OR = 0.18; CI95% = 0.04-078). The variables associated with higher probability of infection were: cats in the neighborhood (OR = 2.27; CI95% = 1.27-4.06), owning or visiting homes with domestic cats (OR = 1.90; CI95% = 1.09-3.31), handling the soil (OR = 2.29; CI95% = 1.32-3.96), and eating fresh meat not previously frozen (OR = 3.97; CI95% = 2.17-7.25). After stratification according region of residence (rural or urban/peri-urban), home with flush toilet and consumption of treated water were protective against the disease only in the rural stratum. Conclusions: In Minas Gerais, congenital toxoplasmosis has been associated with poor socioeconomic conditions. Considering maternal exposure to sources of Toxoplasma gondii, the predominating risk factors were those related to the ingestion of oocysts. It is expected that these results will contribute to development of a program for prevention of congenital toxoplasmosis adapted to the reality of the population of Minas Gerais. The differences between populations living in rural and urban areas regarding the main risk factors for toxoplasmosis point to the need of considering regional specificities in planning strategies to control congenital toxoplasmosis.	[Machado Carellos, Ericka Viana; Queiroz de Andrade, Glaucia Manzan; Castro Romanelli, Roberta Maia] Univ Fed Minas Gerais, Dept Pediat, Sch Med, Belo Horizonte, MG, Brazil; [Vasconcelos-Santos, Daniel Vitor] Univ Fed Minas Gerais, Dept Ophthalmol, Sch Med, Belo Horizonte, MG, Brazil; [Januario, Jose Nelio] Univ Fed Minas Gerais, Ctr Newborn Screening & Genet Diag, Sch Med, Belo Horizonte, MG, Brazil; [Silva Abreu, Mery Natali] Univ Fed Minas Gerais, Sch Nursing, Belo Horizonte, MG, Brazil; [da Silva, Fabiana Maria; Coelho Loures, Ivy Rosa] Fundacao Hosp Estado Minas Gerais, Hosp Infantil Joao Paulo 2, Belo Horizonte, MG, Brazil; [de Andrade, Juliana Queiroz] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Dept Prevent & Social Med, Observ Urban Hlth, Sch Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Carellos, EVM (corresponding author), Univ Fed Minas Gerais, Dept Pediat, Sch Med, Belo Horizonte, MG, Brazil.	ericka.carellos@gmail.com	Romanelli, Roberta/H-4124-2018; Carellos, Ericka Viana Machado/AAW-4620-2021; Januario, Jose Nelio/Y-7825-2019; Vasconcelos-Santos, Daniel V/D-3576-2013	Romanelli, Roberta/0000-0002-1660-0751; Carellos, Ericka Viana Machado/0000-0002-3319-7597; Januario, Jose Nelio/0000-0002-0912-3782; Vasconcelos-Santos, Daniel V/0000-0002-6747-2024	Fundacao de Amparo a Pesquisa do estado de Minas Gerais [APQ-00058-09]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are thankful to Fundacao de Amparo a Pesquisa do estado de Minas Gerais for the grant awarded (Process N. APQ-00058-09). http://www.fapemig.br/. They are also thankful to Nucleo de Acoes e Pesquisa em Apoio Diagnostico -Universidade Federal de Minas Gerais and Secretaria De Estado De Saude De Minas Gerais for the support to carry out the study. http://www.nupad.medicina.ufmg.br/. WTC has been awarded with a productivity grant by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avelino Mariza Martins, 2004, Braz J Infect Dis, V8, P164, DOI 10.1590/S1413-86702004000200007; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; Barbosa IR, 2009, T ROY SOC TROP MED H, V103, P377, DOI 10.1016/j.trstmh.2008.11.025; Baril L, 1999, SCAND J INFECT DIS, V31, P305, DOI 10.1080/00365549950163626; Bojar I, 2010, ANN AGR ENV MED, V17, P209; Buffolano W, 1996, EPIDEMIOL INFECT, V116, P347, DOI 10.1017/S0950268800052675; Carellos EV, 2013, EPIDEMIOL INFECT, P1; Carmo ELd, 2010, REV PAN AMAZONICA SA, P61; CONYNVANSPAENDONCK MAE, 1992, SCAND J INFECT DIS, P51; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Costa FF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-73; Dias RCF, 2011, REV INST MED TROP SP, V53, P185, DOI 10.1590/S0036-46652011000400002; Bittencourt LHFD, 2012, REV BRAS GINECOL OBS, V34, P63, DOI 10.1590/S0100-72032012000200004; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jones JL, 2006, EMERG INFECT DIS, V12, P582; Lass A, 2012, EUR J CLIN MICROBIOL, V31, P1101, DOI 10.1007/s10096-011-1414-8; Lebech M, 1996, EUR J CLIN MICROBIOL, V15, P799, DOI 10.1007/BF01701522; Lopes FMR, 2009, MEM I OSWALDO CRUZ, V104, P378, DOI 10.1590/S0074-02762009000200036; Olariu TR, 2011, PEDIATR INFECT DIS J, V30, P1056, DOI 10.1097/INF.0b013e3182343096; Pawlowski ZS, 2001, HEALTH EDUC RES, V16, P493, DOI 10.1093/her/16.4.493; Lopes-Mori FMR, 2011, REV ASSOC MED BRAS, V57, P594, DOI 10.1590/S0104-42302011000500021; Sartori AL, 2011, REV BRAS GINECOL OBS, V33, P93, DOI 10.1590/S0100-72032011000200007; Spalding SM, 2005, REV SOC BRAS MED TRO, V38, P173, DOI 10.1590/S0037-86822005000200009; Sroka J, 2006, ANN AGR ENV MED, V13, P169; Sroka J, 2010, ANN AGR ENV MED, V17, P125; Sroka S, 2010, AM J TROP MED HYG, V83, P528, DOI 10.4269/ajtmh.2010.10-0082; Szklo M., 2007, EPIDEMIOLOGY BASICS; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tenter AM, 2009, MEM I OSWALDO CRUZ, V104, P364, DOI 10.1590/S0074-02762009000200033	29	22	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88588	10.1371/journal.pone.0088588	http://dx.doi.org/10.1371/journal.pone.0088588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523920	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100069
J	Hettwer, S; Lin, S; Kucsera, S; Haubitz, M; Oliveri, F; Fariello, RG; Ruegg, MA; Vrijbloed, JW				Hettwer, Stefan; Lin, Shuo; Kucsera, Stefan; Haubitz, Monika; Oliveri, Filippo; Fariello, Ruggero G.; Ruegg, Markus A.; Vrijbloed, Jan W.			Injection of a Soluble Fragment of Neural Agrin (NT-1654) Considerably Improves the Muscle Pathology Caused by the Disassembly of the Neuromuscular Junction	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PROTEOLYTIC CLEAVAGE; SKELETAL-MUSCLE; DISTINCT ROLES; ISOFORMS; MUSK; NEUROTRYPSIN; DIFFER; NERVE	Treatment of neuromuscular diseases is still an unsolved problem. Evidence over the last years strongly indicates the involvement of malformation and dysfunction of neuromuscular junctions in the development of such medical conditions. Stabilization of NMJs thus seems to be a promising approach to attenuate the disease progression of muscle wasting diseases. An important pathway for the formation and maintenance of NMJs is the agrin/Lrp4/MuSK pathway. Here we demonstrate that the agrin biologic NT-1654 is capable of activating the agrin/Lrp4/MuSK system in vivo, leading to an almost full reversal of the sarcopenia-like phenotype in neurotrypsin-overexpressing (SARCO) mice. We also show that injection of NT-1654 accelerates muscle re-innervation after nerve crush. This report demonstrates that a systemically administered agrin fragment has the potential to counteract the symptoms of neuromuscular disorders.	[Hettwer, Stefan; Kucsera, Stefan; Haubitz, Monika; Fariello, Ruggero G.; Vrijbloed, Jan W.] Neurotune AG, Zurich, Switzerland; [Lin, Shuo; Oliveri, Filippo; Ruegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Hettwer, S (corresponding author), Neurotune AG, Zurich, Switzerland.	stefan.hettwer@neurotune.com	Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Haubitz, Monika/0000-0001-7660-401X; Lin, Shuo/0000-0003-2317-0339	Swiss Commission for Technology and Innovation (CTI) [12887.1]	Swiss Commission for Technology and Innovation (CTI)	This work was supported by the Swiss Commission for Technology and Innovation (CTI), project number 12887.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bogdanik LP, 2011, HUM MOL GENET, V20, P4617, DOI 10.1093/hmg/ddr396; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; Butikofer L, 2011, FASEB J, V25, P4378, DOI 10.1096/fj.11-191262; Burden SJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009167; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Cenacchi G, 2011, J NEUROL, V258, P746, DOI 10.1007/s00415-010-5823-x; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Deschenes MR, 2010, EXP GERONTOL, V45, P389, DOI 10.1016/j.exger.2010.03.007; Deschenes MR, 2004, SPORTS MED, V34, P809, DOI 10.2165/00007256-200434120-00002; Dupuis L, 2010, CURR DRUG TARGETS, V11, P1250, DOI 10.2174/1389450111007011250; Eusebio A, 2003, NEUROMUSCULAR DISORD, V13, P408, DOI 10.1016/S0960-8966(03)00036-1; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Hettwer S, 2013, EXP GERONTOL, V48, P69, DOI 10.1016/j.exger.2012.03.002; Ko IK, 2013, BIOMATERIALS, VS0142-9612; Koneczny I, 2013, J ANAT, DOI [10.1111/joa. 12034, DOI 10.1111/J0A.12034]; Krakora D, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/379657; Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Motomura Masakatsu, 2013, Brain Nerve, V65, P433; Murray LM, 2013, NEUROBIOL DIS, V49, P57, DOI 10.1016/j.nbd.2012.08.019; NOVIKOFF AB, 1980, J HISTOCHEM CYTOCHEM, V28, P1036, DOI 10.1177/28.9.7410815; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006; Perez-Garcia MJ, 2012, CELL REPORTS, V2, P497, DOI 10.1016/j.celrep.2012.08.004; Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, P31; Punga AR, 2011, EUR J NEUROSCI, V33, P890, DOI 10.1111/j.1460-9568.2010.07569.x; Reif R, 2008, PROTEIN EXPRES PURIF, V61, P13, DOI 10.1016/j.pep.2008.06.003; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; Samuel MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046663; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; TSUJI S, 1984, HISTOCHEMISTRY, V81, P129, DOI 10.1007/BF00490105; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033	42	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88739	10.1371/journal.pone.0088739	http://dx.doi.org/10.1371/journal.pone.0088739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520420	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000331254600111
J	Li, SH; Wang, ZJ; Chang, TT				Li, Shihong; Wang, Zheng Jim; Chang, Ting-Tung			Temperature Oscillation Modulated Self-Assembly of Periodic Concentric Layered Magnesium Carbonate Microparticles	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; FT-IR ANALYSIS; NONCLASSICAL NUCLEATION; TRANSFORMATION; HYDROMAGNESITE; NESQUEHONITE; SYSTEM; CLUSTERS; OOIDS; CACO3	Intriguing patterns of periodic, concentric, layered, mineral microstructure are present in nature and organisms, yet they have elusive geneses. We hypothesize temperature oscillation can be an independent factor that causes the self-assembly of such patterns in mineral phases synthesized in solution. Static experiments verify that rhythmic concentric multi-layered magnesium carbonate microhemispheres can be synthesized from bicarbonate solution by temperature oscillation, without use of a chemical template, additive or gel-diffusion system. Appropriate reactant concentration and initial pH value can restrain the competitive growth of other mineral generations. Polarized light microscopy images indicate the microhemispheres are crystalline and the crystallinity increases with incubation time. The thickness of a single mineral layer of microhemisphere in microscale is precisely controlled by the waveform parameters of the temperature oscillation, while the layer number, which can reach tens to about one hundred, is constrained by the temperature oscillation period number. FT-IR spectra show that these microhemispheres synthesized under different conditions can be identified as the basic form of magnesium carbonate, hydromagnesite (Mg-5(CO3)(4)(OH)(2) center dot 4H(2)O). SEM images exhibit the characteristic microscopic texture of the alternating dark and light rings of these microhemispheres. TEM images and ED patterns suggest the nanoflakes of microhemispheres are present in polycrystalline form with some degree of oriented assembly. The temperature oscillation modulated self-assembly may offer a new mechanism to understand the formation of layered microstructure of minerals in solution, and provide a non-invasive and programmable means to synthesize hierarchically ordered materials.	[Li, Shihong; Wang, Zheng Jim; Chang, Ting-Tung] Van Andel Res Inst, Small Anim Imaging Facil, Lab Translat Imaging, Grand Rapids, MI USA	Van Andel Institute	Li, SH (corresponding author), Van Andel Res Inst, Small Anim Imaging Facil, Lab Translat Imaging, Grand Rapids, MI USA.	shihongli.email@gmail.com; Anthony.Chang@vai.org						Ball P., 1999, SELF MADE TAPESTRY P; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Bathurst R., 1979, CARBONATE SEDIMENTS; Botha A, 2003, J THERM ANAL CALORIM, V71, P987, DOI 10.1023/A:1023355016208; Botha A, 2001, HYDROMETALLURGY, V62, P175, DOI 10.1016/S0304-386X(01)00197-9; CAMPANA SE, 1984, CAN J ZOOL, V62, P1507, DOI 10.1139/z84-219; Chen SF, 2006, CHEM MATER, V18, P115, DOI 10.1021/cm0519028; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; DAVIES PJ, 1978, SEDIMENTOLOGY, V25, P703, DOI 10.1111/j.1365-3091.1978.tb00326.x; DAVIES PJ, 1973, CHEM GEOL, V12, P289, DOI 10.1016/0009-2541(73)90006-5; Demichelis R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1604; Dong M, 2008, J CHEM ENG DATA, V53, P2586, DOI 10.1021/je800438p; Du J, 2013, TURK J CHEM, V37, P228, DOI 10.3906/kim-1204-21; Duguid SMA, 2010, J SEDIMENT RES, V80, P236, DOI 10.2110/jsr.2010.027; Folk RL, 2001, SEDIMENTOLOGY, V48, P215, DOI 10.1046/j.1365-3091.2001.00354.x; Gebauer D, 2011, NANO TODAY, V6, P564, DOI 10.1016/j.nantod.2011.10.005; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Gilbert B, 2007, J COLLOID INTERF SCI, V313, P152, DOI 10.1016/j.jcis.2007.04.038; Grzybowski BA, 2005, SOFT MATTER, V1, P114, DOI 10.1039/b501769f; Hanchen M, 2008, CHEM ENG SCI, V63, P1012, DOI 10.1016/j.ces.2007.09.052; Henisch H. K., 1988, CRYSTALS GELS LIESEG; Hopkinson L, 2008, J GEOL, V116, P387, DOI 10.1086/588834; Jiang JX, 2012, J AM CERAM SOC, V95, P3735, DOI 10.1111/jace.12077; Jiang J, 2009, CHEM COMMUN, P5853, DOI 10.1039/b911219g; Keith HD, 1996, MACROMOLECULES, V29, P7776, DOI 10.1021/ma960634j; Kleiner Oleg, 2002, BMC Gastroenterol, V2, P3, DOI 10.1186/1471-230X-2-3; Liu YY, 2013, CRYST GROWTH DES, V13, P59, DOI 10.1021/cg3008206; Mann S, 2009, NAT MATER, V8, P781, DOI [10.1038/NMAT2496, 10.1038/nmat2496]; Marion GM, 2001, GEOCHIM COSMOCHIM AC, V65, P1883, DOI 10.1016/S0016-7037(00)00588-3; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Niles PB, 2013, SPACE SCI REV, V174, P301, DOI 10.1007/s11214-012-9940-y; Oelkers EH, 2005, CHEM GEOL, V217, P183, DOI 10.1016/j.chemgeo.2004.12.006; Pacton M, 2012, GEOLOGY, V40, P547, DOI 10.1130/G32846.1; Politi Y, 2010, CHEM MATER, V22, P161, DOI 10.1021/cm902674h; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Radha AV, 2012, GEOCHIM COSMOCHIM AC, V90, P83, DOI 10.1016/j.gca.2012.04.056; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Russell MJ, 1999, J GEOL SOC LONDON, V156, P869, DOI 10.1144/gsjgs.156.5.0869; SAWADA Y, 1978, THERMOCHIM ACTA, V27, P45, DOI 10.1016/0040-6031(78)85020-5; Sear RP, 2012, INT MATER REV, V57, P328, DOI 10.1179/1743280411Y.0000000015; Sipala J, 2008, 20081 AB AK U FAC TE, P1; Tong H, 2008, J STRUCT BIOL, V163, P1, DOI 10.1016/j.jsb.2008.03.012; Truitt B, 2009, HDB PHARM EXCIPIENTS, P397; TUUR SM, 1987, AM J SURG PATHOL, V11, P598, DOI 10.1097/00000478-198708000-00003; Verch A, 2012, Z KRIST-CRYST MATER, V227, P718, DOI 10.1524/zkri.2012.1529; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; WHITE WB, 1971, AM MINERAL, V56, P46; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Xiong YL, 2008, APPL GEOCHEM, V23, P1634, DOI 10.1016/j.apgeochem.2007.12.035; Yuwono VM, 2010, J AM CHEM SOC, V132, P2163, DOI 10.1021/ja909769a; Zhang Q, 2009, J MATER CHEM, V19, P191, DOI 10.1039/b807760f; Zhang ZP, 2006, J PHYS CHEM B, V110, P12969, DOI 10.1021/jp061261j; Zhao L, 2013, GEOCHIM COSMOCHIM AC, V106, P192, DOI 10.1016/j.gca.2012.12.029	53	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88648	10.1371/journal.pone.0088648	http://dx.doi.org/10.1371/journal.pone.0088648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520410	gold, Green Published, Green Submitted			2022-12-27	WOS:000331254600101
J	Li, YF; Yan, JC; Wu, C; Wang, ZQ; Yuan, W; Wang, DQ				Li, Yuefeng; Yan, Jinchuan; Wu, Chao; Wang, Zhongqun; Yuan, Wei; Wang, Dongqing			CD137-CD137L Interaction Regulates Atherosclerosis via Cyclophilin A in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							CD137; CYTOKINE; LIGAND; CELLS; CD40	Background: Our previous studies showed that increased levels of cyclophilin A (CyPA) may be a valuable marker for predicting the severity of acute coronary syndromes and that interruption of CD137-CD137L interactions diminished the formation and progression of atherosclerosis in apolipoprotein E-deficient (ApoE-/- ) mice. Here, we sought to determine whether the proinflammatory factor CyPA is involved in atherosclerosis regulated by CD137-CD137L interactions. Methods and Results: A constrictive collar was placed around the right carotid arteries of ApoE-/- mice that were fed a high-fat diet to induce atherosclerotic plaque formation. After that, the mice were intraperitoneally injected with anti-CD137 or anti-CD137L in the presence or absence of the recombinant lentiviral vectors LVTHM-CyPA or pGC-FU-CyPA, respectively. Interestingly, activation of CD137-CD137L was negatively correlated with CyPA expression in vivo and in vitro. Stimulating CD137-CD137L interaction significantly increased CyPA, which was concurrent with the upregulation of proinflammatory cytokines, chemokines and matrix metalloproteinases and resulted in the promotion of atherosclerosis in ApoE-/-mice. Silencing CyPA could eliminate these effects, and restoration of CyPA effectively and consistently attenuated the atherosclerotic suppression phenotypes elicited by the blockade of CD137-CD137L. Conclusion: These observations suggest that CD137-CD137L interactions mediated via regulation of CyPA contribute to the progression of atherosclerosis.	[Li, Yuefeng; Yan, Jinchuan; Wu, Chao; Wang, Zhongqun; Yuan, Wei] Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Peoples R China; [Li, Yuefeng; Wang, Dongqing] Jiangsu Univ, Affiliated Hosp, Dept Radiol, Zhenjiang, Peoples R China	Jiangsu University; Jiangsu University	Yan, JC (corresponding author), Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Peoples R China.	yanjinchuan@hotmail.com	LI, Yue/GRS-8071-2022		Natural Foundation and the Development Health Engineering Foundation in Jiangsu Province [BK2011486, LJ201116]; National Natural Science Foundation of China [81170279, 81370409, 81301194]; Social Development in Zhenjiang [SS2012002, SH2013025]; Clinical Development in Jiangsu University [JLY2010152]	Natural Foundation and the Development Health Engineering Foundation in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development in Zhenjiang; Clinical Development in Jiangsu University	This project was supported by the Natural Foundation and the Development Health Engineering Foundation in Jiangsu Province (BK2011486, LJ201116), the National Natural Science Foundation of China (81170279, 81370409, 81301194), the Social Development in Zhenjiang (SS2012002, SH2013025) and Clinical Development in Jiangsu University (JLY2010152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Nigro P, 2011, J EXP MED, V208, P53, DOI 10.1084/jem.20101174; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Satoh K, 2011, ARTERIOSCL THROM VAS, V31, P1116, DOI 10.1161/ATVBAHA.110.214601; Satoh K, 2010, CIRC J, V74, P2249, DOI 10.1253/circj.CJ-10-0904; Schonbeck U, 2001, CIRC RES, V89, P1092, DOI 10.1161/hh2401.101272; Soe NN, 2013, ARTERIOSCLER THROMB; Vinay DS, 1999, IMMUNOBIOLOGY, V200, P246, DOI 10.1016/S0171-2985(99)80074-6; Wang BA, 2013, INT J CARDIOL, V163, P34, DOI 10.1016/j.ijcard.2011.05.053; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Wei YA, 2010, ATHEROSCLEROSIS, V213, P415, DOI 10.1016/j.atherosclerosis.2010.09.033; Yan JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060854; Yan JC, 2013, CLINICS, V68, P193, DOI [10.6061/CLINICS/2013(02)OA12, 10.6061/clinics/2013(02)OA12]; Yan JC, 2012, INT J CARDIOL, V157, P134, DOI 10.1016/j.ijcard.2012.03.039; Yan JC, 2011, CLIN CHIM ACTA, V412, P993, DOI 10.1016/j.cca.2011.02.038	18	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88563	10.1371/journal.pone.0088563	http://dx.doi.org/10.1371/journal.pone.0088563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520398	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600089
J	Fernandes, R; Millard, AR; Brabec, M; Nadeau, MJ; Grootes, P				Fernandes, Ricardo; Millard, Andrew R.; Brabec, Marek; Nadeau, Marie-Josee; Grootes, Pieter			Food Reconstruction Using Isotopic Transferred Signals ( FRUITS): A Bayesian Model for Diet Reconstruction	PLOS ONE			English	Article							STABLE-ISOTOPES; BONE-COLLAGEN; PROTEIN; CARBON; NITROGEN; ARCHAEOLOGY; MARINE; RATIOS; VALUES; TOO	Human and animal diet reconstruction studies that rely on tissue chemical signatures aim at providing estimates on the relative intake of potential food groups. However, several sources of uncertainty need to be considered when handling data. Bayesian mixing models provide a natural platform to handle diverse sources of uncertainty while allowing the user to contribute with prior expert information. The Bayesian mixing model FRUITS (Food Reconstruction Using Isotopic Transferred Signals) was developed for use in diet reconstruction studies. FRUITS incorporates the capability to account for dietary routing, that is, the contribution of different food fractions (e. g. macronutrients) towards a dietary proxy signal measured in the consumer. FRUITS also provides relatively straightforward means for the introduction of prior information on the relative dietary contributions of food groups or food fractions. This type of prior may originate, for instance, from physiological or metabolic studies. FRUITS performance was tested using simulated data and data from a published controlled animal feeding experiment. The feeding experiment data was selected to exemplify the application of the novel capabilities incorporated into FRUITS but also to illustrate some of the aspects that need to be considered when handling data within diet reconstruction studies. FRUITS accurately predicted dietary intakes, and more precise estimates were obtained for dietary scenarios in which expert prior information was included. FRUITS represents a useful tool to achieve accurate and precise food intake estimates in diet reconstruction studies within different scientific fields (e. g. ecology, forensics, archaeology, and dietary physiology).	[Fernandes, Ricardo; Nadeau, Marie-Josee] Univ Kiel, Leibniz Lab Radiometr Dating & Isotope Res, Kiel, Germany; [Fernandes, Ricardo; Nadeau, Marie-Josee; Grootes, Pieter] Univ Kiel, Grad Sch Human Dev Landscapes, Kiel, Germany; [Millard, Andrew R.] Univ Durham, Dept Archaeol, Durham, England; [Brabec, Marek] Acad Sci Czech Republ, Inst Comp Sci, Dept Nonlinear Modeling, Prague 8, Czech Republic; [Grootes, Pieter] Univ Kiel, Inst Ecosyst Res, Kiel, Germany	University of Kiel; University of Kiel; Durham University; Czech Academy of Sciences; Institute of Computer Science of the Czech Academy of Sciences; University of Kiel	Fernandes, R (corresponding author), Univ Kiel, Leibniz Lab Radiometr Dating & Isotope Res, Kiel, Germany.	rfernandes@gshdl.uni-kiel.de	Brabec, Marek/F-9816-2012; Nadeau, Marie-Josee/B-5084-2010	Nadeau, Marie-Josee/0000-0001-9616-5632; Brabec, Marek/0000-0001-6367-5791; Grootes, Pieter/0000-0003-4265-3168	German Research Foundation (Deutsche Forschungsgemeinschaft) [SPP 1400]; Graduate School "Human Development in Landscapes'' of the German Excellence Initiative	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Graduate School "Human Development in Landscapes'' of the German Excellence Initiative	Research funding is provided by the German Research Foundation (Deutsche Forschungsgemeinschaft) within the frame of the Priority Program SPP 1400 and the Graduate School "Human Development in Landscapes'' of the German Excellence Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN LH, 1979, AM J CLIN NUTR, V32, P741, DOI 10.1093/ajcn/32.4.741; Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Ambrose S.H., 2002, BIOGEOCHEMICAL APPRO, P243, DOI DOI 10.1007/0-306-47194-9_12; [Anonymous], 2012, BAYESIAN STAT INTRO; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Bilsborough S, 2006, INT J SPORT NUTR EXE, V16, P129, DOI 10.1123/ijsnem.16.2.129; Bohning D, 2007, COMPUT STAT DATA AN, V51, P5205, DOI 10.1016/j.csda.2006.10.025; BURTON JH, 1990, J ARCHAEOL SCI, V17, P547, DOI 10.1016/0305-4403(90)90035-4; Codron D, 2011, CAN J ZOOL, V89, P453, DOI [10.1139/Z11-010, 10.1139/z11-010]; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Deniro MJ., 1976, GEOL SOC AM ABS PROG, V8, P834; Fernandes R, 2012, FRUHE MONUMENTALITAT, V2, P87; Fernandes R, 2012, ARCHAEOL ANTHROP SCI, V4, P291, DOI 10.1007/s12520-012-0102-7; Gilks W.R., 1996, MARKOV CHAIN MONTE C; HARE PE, 1991, J ARCHAEOL SCI, V18, P277; Howland MR, 2003, INT J OSTEOARCHAEOL, V13, P54, DOI 10.1002/oa.658; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; Katzenberg MA, 1997, J ARCHAEOL RES, V5, P265, DOI 10.1007/BF02229154; Lemon PWR, 1996, NUTR REV, V54, pS169; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Meyers LD, 2006, DRI DIETARY REFERENC; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Morrison DJ, 2000, RAPID COMMUN MASS SP, V14, P1321, DOI 10.1002/1097-0231(20000815)14:15<1321::AID-RCM946>3.0.CO;2-8; National Grain & Feed Association, 2013, SPEC LINKS; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Phillips DL, 2001, OECOLOGIA, V127, P166, DOI 10.1007/s004420000571; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SETHURAMAN J, 1994, STAT SINICA, V4, P639; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; Tome D, 2000, J NUTR, V130, p1868S, DOI 10.1093/jn/130.7.1868S; USDA. Agricultural Research Service United States Department of Agriculture, 2013, NAT NUTR DAT STAND R; van der Merwe N.J., 1983, AFR ARCHAEOL REV, V1, P33, DOI DOI 10.1007/BF01116771; Warinner C, 2010, AM J PHYS ANTHROPOL, V141, P486, DOI 10.1002/ajpa.21222; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0	41	228	228	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e87436	10.1371/journal.pone.0087436	http://dx.doi.org/10.1371/journal.pone.0087436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551057	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000014
J	Hsu, WL; Chen, CL; Huang, SW; Wu, CC; Chen, IH; Nadar, M; Su, YP; Tsai, CH				Hsu, Wei-Li; Chen, Chung-Lun; Huang, Shi-Wei; Wu, Chia-Chen; Chen, I-Hsuan; Nadar, Muthukumar; Su, Yin-Peng; Tsai, Ching-Hsiu			The Untranslated Regions of Classic Swine Fever Virus RNA Trigger Apoptosis	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; VIRAL-DIARRHEA-VIRUS; INTERNUCLEOSOMAL DNA FRAGMENTATION; TRANSLATION INITIATION-FACTOR; CELL-DEATH; N-PRO; LYMPHOCYTE APOPTOSIS; INTERFERON SYNTHESIS; MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS	Classical swine fever virus (CSFV) causes a broad range of disease in pigs, from acute symptoms including high fever and hemorrhages, to chronic disease or unapparent infection, depending on the virus strain. CSFV belongs to the genus Pestivirus of the family Flaviviridae. It carries a single-stranded positive-sense RNA genome. An internal ribosomal entry site (IRES) in the 5' untranslated region (UTR) drives the translation of a single open reading frame encoding a 3898 amino acid long polypeptide chain. The open reading frame is followed by a 3' UTR comprising four highly structured stem-loops. In the present study, a synthetic RNA composed of the 5' and 3' UTRs of the CSFV genome devoid of any viral coding sequence and separated by a luciferase gene cassette (designated 5'UTR-Luc-3'UTR) triggered apoptotic cell death as early as 4 h post-transfection. The apoptosis was measured by DNA laddering analysis, TUNEL assay, annexin-V binding determined by flow cytometry, and by analysis of caspase activation. Contrasting with this, only trace DNA laddering was observed in cells transfected with the individual 5' or 3' UTR RNA; even when the 5' UTR and 3' UTR were co-transfected as separate RNA molecules, DNA laddering did not reach the level induced by the chimeric 5'UTR-Luc-3'UTR RNA. Interestingly, RNA composed of the 5'UTR and of stem-loop I of the 3'UTR triggered much stronger apoptosis than the 5' or 3'UTR alone. These results indicate that the 5' and 3' UTRs act together in cis induce apoptosis. We furthered obtained evidence that the UTR-mediated apoptosis required double-stranded RNA and involved translation shutoff possibly through activation of PKR.	[Hsu, Wei-Li; Wu, Chia-Chen; Su, Yin-Peng] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan; [Chen, Chung-Lun; Huang, Shi-Wei; Chen, I-Hsuan; Tsai, Ching-Hsiu] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Nadar, Muthukumar] Karunya Univ, Sch Biotechnol & Hlth Sci, Dept Biotechnol, Coimbatore, Tamil Nadu, India	National Chung Hsing University; National Chung Hsing University; Karunya Institute of Technology & Sciences	Tsai, CH (corresponding author), Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan.	chtsai1@dragon.nchu.edu.tw	Hsu, Wei-Li/CAF-3821-2022	Hsu, Wei-Li/0000-0002-1392-163X	National Science Council, Taiwan [101-2321-B-005-005, NSC-96-2311-B-005-004-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was partly supported by National Science Council, Taiwan (101-2321-B-005-005 and NSC-96-2311-B-005-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensaude E, 2004, J GEN VIROL, V85, P1029, DOI 10.1099/vir.0.19637-0; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Choi C, 2004, ARCH VIROL, V149, P875, DOI 10.1007/s00705-003-0275-6; Chon SK, 1998, VIROLOGY, V251, P370, DOI 10.1006/viro.1998.9425; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COHEN GM, 1992, BIOCHEM J, V286, P331, DOI 10.1042/bj2860331; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Harris D, 2006, MOL CELL PROTEOMICS, V5, P1006, DOI 10.1074/mcp.M500429-MCP200; Huang SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033764; Johns HL, 2010, J GEN VIROL, V91, P1038, DOI 10.1099/vir.0.016576-0; Johns HL, 2010, J GEN VIROL, V91, P2677, DOI 10.1099/vir.0.022897-0; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kolupaeva VG, 2000, RNA, V6, P1791, DOI 10.1017/S1355838200000662; LEE JY, 1994, VIROLOGY, V200, P307, DOI 10.1006/viro.1994.1192; Linfert DR, 1997, CLIN CHEM, V43, P2431; Majde JA, 2000, J INTERF CYTOK RES, V20, P259, DOI 10.1089/107999000312397; MEYERS G, 1989, VIROLOGY, V171, P555, DOI 10.1016/0042-6822(89)90625-9; Meyers G, 1996, J VIROL, V70, P8606, DOI 10.1128/JVI.70.12.8606-8613.1996; Meyers G, 1996, ADV VIRUS RES, V47, P53, DOI 10.1016/S0065-3527(08)60734-4; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Renson P, 2010, VET RES, V41, DOI 10.1051/vetres/2009055; Rijnbrand R, 1997, J VIROL, V71, P451, DOI 10.1128/JVI.71.1.451-457.1997; Romero-Lopez C, 2009, RNA, V15, P1740, DOI 10.1261/rna.1680809; Ruggli N, 2005, VIROLOGY, V340, P265, DOI 10.1016/j.virol.2005.06.033; Ruggli N, 2003, J VIROL, V77, P7645, DOI 10.1128/JVI.77.13.7645-7654.2003; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Schweizer M, 2001, J VIROL, V75, P4692, DOI 10.1128/JVI.75.10.4692-4698.2001; Summerfield A, 1998, J VIROL, V72, P1853, DOI 10.1128/JVI.72.3.1853-1861.1998; Summerfield A, 2001, J GEN VIROL, V82, P1309, DOI 10.1099/0022-1317-82-6-1309; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tang QH, 2011, VIRUS GENES, V42, P355, DOI 10.1007/s11262-011-0582-z; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; TOMEI LD, 1993, P NATL ACAD SCI USA, V90, P853, DOI 10.1073/pnas.90.3.853; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Xu H, 2007, INTERVIROLOGY, V50, P433, DOI 10.1159/000113467; Yamane D, 2006, J GEN VIROL, V87, P2961, DOI 10.1099/vir.0.81820-0	37	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88863	10.1371/journal.pone.0088863	http://dx.doi.org/10.1371/journal.pone.0088863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533157	gold, Green Published, Green Submitted			2022-12-27	WOS:000331262600115
J	Hu, X; Li, SB; Yang, GY; Liu, H; Boden, G; Li, L				Hu, Xin; Li, Shengbing; Yang, Gangyi; Liu, Hua; Boden, Guenther; Li, Ling			Efficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CLINICAL-TRIALS; PONALRESTAT; EPALRESTAT; QUALITY	Background: Aldose reductase inhibitors (ARIs) can block the metabolism of the polyol pathway, and have been used to slow or reverse the progression of diabetic cardiovascular autonomic neuropathy (DCAN). The purpose of this study was to review the effectiveness and safety of ARIs in the treatment of DCAN as determined by five cardiac autonomic neuropathy function tests. Methods: CENTRAL, MEDLINE, EMBASE, Scopus databases (inception to May 2012) were searched to identify randomized controlled trials (RCTs) and non-randomized controlled trials (non-RCTs) investigating ARIs for the treatment of DCAN with an English-language restriction. The data were analyzed using RevMan 5.0, and the heterogeneity between the trials was evaluated using the Cochrane's Q-test as well as the I 2 test. The type of model (random or fixed) used for analysis was based on heterogeneity. Weighted mean differences (WMD) with 95% confidence intervals (CI) were computed for the five cardiac automatic neuropathy function tests to evaluate the effects. Results: Ten articles met the prerequisites for this review. Analysis of the results showed that ARIs significantly improved function in at least three of the five automatic neuropathy tests, including the resting heart rate variation coefficients (WMD = 0.25, 95% CI 0.02 to 0.48, P = 0.040); the 30: 15 ratio (WMD = 0.06, 95% CI 0.01 to 0.10, P = 0.010) and the postural systolic blood pressure change (WMD = -5.94, 95% CI -7.31 to -4.57, P = 0.001). The expiration/inspiration ratio showed a marginally significant benefit (WMD = 0.05, 95% CI 0.00 to 0.09, P = 0.040). Glycaemic control was not significantly affected by ARIs. Adverse effects of ARIs except for Tolerestat were minimal. Conclusions: Based on these results, we conclude that ARIs could ameliorate cardiac automatic neuropathy especially mild or asymptomatic DCAN but need further investigation.	[Hu, Xin; Li, Shengbing; Li, Ling] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China; [Hu, Xin; Li, Shengbing; Li, Ling] Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Chongqing, Peoples R China; [Yang, Gangyi] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China; [Liu, Hua] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Boden, Guenther] Temple Univ, Sch Med, Div Endocrinol Diabet Metab, Philadelphia, PA 19122 USA; [Boden, Guenther] Temple Univ, Sch Med, Clin Res Ctr, Philadelphia, PA 19122 USA	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of Mississippi; University of Mississippi Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Li, L (corresponding author), Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China.	liling31@hotmail.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Yang, Gangyi/0000-0002-6458-6747	National Natural Science Foundation of China [30871199, 81270913, 81070640, 30971388, 30771037]; Doctoral Fund of Ministry of Education of China [20105503110002]; Natural Science Foundation Key Project of CQ cstc [cstc2012 jjB10022]; American Diabetes Association [1-10-Ct-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation Key Project of CQ cstc(Natural Science Foundation Project of CQ CSTC); American Diabetes Association(American Diabetes Association)	This work was supported by research grants from the National Natural Science Foundation of China (30871199, 81270913, 81070640, 30971388 and 30771037), Doctoral Fund of Ministry of Education of China (20105503110002) and Natural Science Foundation Key Project of CQ cstc (cstc2012 jjB10022) and the American Diabetes Association (1-10-Ct-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff M, 1996, NEUROLOGY, V46, P873; Chalk C, 2007, COCHRANE DB SYST REV, V17; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; El-Kabbani O, 2004, CELL MOL LIFE SCI, V61, P750, DOI 10.1007/s00018-003-3403-2; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; FAES TJC, 1993, J NEUROL, V240, P156, DOI 10.1007/BF00857521; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; GILL JS, 1990, DIABETES METAB, V16, P296; GIUGLIANO D, 1995, DIABETES CARE, V18, P536, DOI 10.2337/diacare.18.4.536; Giugliano D, 1993, TOLRESTAT MILD DIABE; GOTO Y, 1995, BIOMED PHARMACOTHER, V49, P269, DOI 10.1016/0753-3322(96)82642-4; Hamada Yoji, 2004, Treat Endocrinol, V3, P245, DOI 10.2165/00024677-200403040-00006; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hotta N, 2006, DIABETES CARE, V29, P1538, DOI 10.2337/dc05-2370; Ikeda T, 1999, DIABETES RES CLIN PR, V43, P193, DOI 10.1016/S0168-8227(99)00015-7; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnson BF, 2004, DIABETES CARE, V27, P448, DOI 10.2337/diacare.27.2.448; KAHN R, 1992, DIABETES CARE, V15, P1095; Karayannis G, 2012, EXPERT REV CARDIOVAS, V10, P747, DOI [10.1586/erc.12.53, 10.1586/ERC.12.53]; Kelkar P, 2005, SEMIN NEUROL, V25, P168, DOI 10.1055/s-2005-871325; KRENTZ AJ, 1992, DIABETIC MED, V9, P463, DOI 10.1111/j.1464-5491.1992.tb01818.x; Laudadio C, 1998, J DIABETES COMPLICAT, V12, P121, DOI 10.1016/S1056-8727(97)00074-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maser RE, 2005, J CLIN ENDOCR METAB, V90, P5896, DOI 10.1210/jc.2005-0754; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nakayama M, 2001, DIABETES CARE, V24, P1093, DOI 10.2337/diacare.24.6.1093; Oates PJ, 2002, INT REV NEUROBIOL, V50, P325; OHARE JP, 1988, DIABETIC MED, V5, P537, DOI 10.1111/j.1464-5491.1988.tb01047.x; Pacher P, 2002, DIABETES, V51, P514, DOI 10.2337/diabetes.51.2.514; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Schonauer M, 2008, DIABETES VASC DIS RE, V5, P336, DOI 10.3132/dvdr.2008.047; Scott Lynda A, 2004, J Nucl Med Technol, V32, P66; Spallone V, 2011, NUTR METAB CARDIOVAS, V21, P69, DOI 10.1016/j.numecd.2010.07.005; Sundkvist Goran, 1992, Journal of Diabetes and its Complications, V6, P123, DOI 10.1016/1056-8727(92)90023-E; van Gerven J M, 1992, J Diabetes Complications, V6, P45, DOI 10.1016/1056-8727(92)90048-P; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Voulgari C, 2011, EXP DIABETES RES, DOI 10.1155/2011/687624; Weimer LH, 2010, NEUROLOGIST, V16, P215, DOI 10.1097/NRL.0b013e3181cf86ab; ZIEGLER D, 1991, DIABETES RES CLIN PR, V14, P63, DOI 10.1016/0168-8227(91)90054-H	44	24	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e87096	10.1371/journal.pone.0087096	http://dx.doi.org/10.1371/journal.pone.0087096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533052	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600010
J	Lang, JD; Smith, AB; Brandon, A; Bradley, KM; Liu, YL; Li, W; Crowe, DR; Jhala, NC; Cross, RC; Frenette, L; Martay, K; Vater, YL; Vitin, AA; Dembo, GA; DuBay, DA; Bynon, JS; Szychowski, JM; Reyes, JD; Halldorson, JB; Rayhill, SC; Dick, AA; Bakthavatsalam, R; Brandenberger, J; Broeckel-Elrod, JA; Sissons-Ross, L; Jordan, T; Chen, LY; Siriussawakul, A; Eckhoff, DE; Patel, RP				Lang, John D., Jr.; Smith, Alvin B.; Brandon, Angela; Bradley, Kelley M.; Liu, Yuliang; Li, Wei; Crowe, D. Ralph; Jhala, Nirag C.; Cross, Richard C.; Frenette, Luc; Martay, Kenneth; Vater, Youri L.; Vitin, Alexander A.; Dembo, Gregory A.; DuBay, Derek A.; Bynon, J. Steven; Szychowski, Jeff M.; Reyes, Jorge D.; Halldorson, Jeffrey B.; Rayhill, Stephen C.; Dick, Andre A.; Bakthavatsalam, Ramasamy; Brandenberger, Jared; Broeckel-Elrod, Jo Ann; Sissons-Ross, Laura; Jordan, Terry; Chen, Lucinda Y.; Siriussawakul, Arunotai; Eckhoff, Devin E.; Patel, Rakesh P.			A Randomized Clinical Trial Testing the Anti-Inflammatory Effects of Preemptive Inhaled Nitric Oxide in Human Liver Transplantation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; SYSTEMIC OXYGEN PERSUFFLATION; ISCHEMIA/REPERFUSION INJURY; RAT-LIVER; NO; DELIVERY; BLOOD; LUNG; CELL; VASODILATION	Decreases in endothelial nitric oxide synthase derived nitric oxide (NO) production during liver transplantation promotes injury. We hypothesized that preemptive inhaled NO (iNO) would improve allograft function (primary) and reduce complications post-transplantation (secondary). Patients at two university centers (Center A and B) were randomized to receive placebo (n = 20/center) or iNO (80 ppm, n = 20/center) during the operative phase of liver transplantation. Data were analyzed at set intervals for up to 9-months post-transplantation and compared between groups. Patient characteristics and outcomes were examined with the Mann-Whitney U test, Student t-test, logistic regression, repeated measures ANOVA, and Cox proportional hazards models. Combined and site stratified analyses were performed. MELD scores were significantly higher at Center B (22.5 vs. 19.5, p<0.0001), surgical times were greater at Center B (7.7 vs. 4.5 hrs, p<0.001) and warm ischemia times were greater at Center B (95.4 vs. 69.7 min, p<0.0001). No adverse metabolic or hematologic effects from iNO occurred. iNO enhanced allograft function indexed by liver function tests (Center B, p<0.05; and p<0.03 for ALT with center data combined) and reduced complications at 9-months (Center A and B, p = 0.0062, OR = 0.15, 95% CI (0.04, 0.59)). ICU (p = 0.47) and hospital length of stay (p = 0.49) were not decreased. iNO increased concentrations of nitrate (p<0.001), nitrite (p<0.001) and nitrosylhemoglobin (p<0.001), with nitrite being postulated as a protective mechanism. Mean costs of iNO were $ 1,020 per transplant. iNO was safe and improved allograft function at one center and trended toward improving allograft function at the other. ClinicalTrials.gov with registry number 00582010 and the following URL:http://clinicaltrials.gov/show/NCT00582010.	[Lang, John D., Jr.; Liu, Yuliang; Martay, Kenneth; Vater, Youri L.; Vitin, Alexander A.; Dembo, Gregory A.; Broeckel-Elrod, Jo Ann; Sissons-Ross, Laura; Jordan, Terry; Chen, Lucinda Y.] Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Reyes, Jorge D.; Rayhill, Stephen C.; Dick, Andre A.; Bakthavatsalam, Ramasamy; Brandenberger, Jared] Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA; [Li, Wei] Jilin Univ, China Japan Union Hosp, Dept Hepatobiliary Pancreat Surg, Changchun 130023, Peoples R China; [Smith, Alvin B.; Cross, Richard C.; Frenette, Luc] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Brandon, Angela; Bradley, Kelley M.; Crowe, D. Ralph; Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [DuBay, Derek A.; Szychowski, Jeff M.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Eckhoff, Devin E.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Jhala, Nirag C.] Ruth & Raymond Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA; [Bynon, J. Steven] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Div Immunol & Organ Transplantat, Houston, TX 77030 USA; [Halldorson, Jeffrey B.] Univ Calif San Diego Hlth Care Syst, Dept Surg, San Diego, CA USA; [Siriussawakul, Arunotai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok 10700, Thailand	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Jilin University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health Science Center Houston; Mahidol University	Lang, JD (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	jdlang@uw.edu		VATER, YOURI/0000-0001-5497-2081; Szychowski, Jeff/0000-0002-1727-1662; Patel, Rakesh/0000-0002-1526-4303	Ikaria and University of Washington Department of Anesthesiology research funds	Ikaria and University of Washington Department of Anesthesiology research funds	This study was funded in part by Ikaria and University of Washington Department of Anesthesiology research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, ARCH BIOCHEM BIOPHYS, V484, P232, DOI 10.1016/j.abb.2008.10.006; Bacha EA, 1997, TRANSPLANTATION, V63, P1380, DOI 10.1097/00007890-199705270-00002; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Blok JJ, 2012, LIVER TRANSPLANT, V18, P113, DOI 10.1002/lt.22447; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Cameron Andrew M, 2005, Hepatobiliary Pancreat Dis Int, V4, P495; Cannon RO, 2001, J CLIN INVEST, V108, P279, DOI 10.1172/JCI12761; Crawford JH, 2004, BLOOD, V104, P1375, DOI 10.1182/blood-2004-03-0880; Creagh-Brown BC, 2009, CRIT CARE, V13, DOI 10.1186/cc7734; de Rougemont O, 2010, CURR OPIN ORGAN TRAN, V15, P183, DOI 10.1097/MOT.0b013e3283373ced; DIODATI JG, 1993, THROMB HAEMOSTASIS, V70, P654; Duranski MR, 2006, AM J PHYSIOL-HEART C, V291, pH2980, DOI 10.1152/ajpheart.01173.2005; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Fox-Robichaud A, 1998, J CLIN INVEST, V101, P2497, DOI 10.1172/JCI2736; Gianetti J, 2004, J THORAC CARDIOV SUR, V127, P44, DOI 10.1016/j.jtcvs.2002.08.001; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Gries A, 2000, THROMB HAEMOSTASIS, V83, P309; Hataishi R, 2006, AM J PHYSIOL-HEART C, V291, pH379, DOI 10.1152/ajpheart.01172.2005; IJtsma AJC, 2009, LIVER TRANSPLANT, V15, P1050, DOI 10.1002/lt.21791; Katsumi H, 2008, TRANSPLANTATION, V85, P264, DOI 10.1097/TP.0b013e31815e902b; Kobayashi H, 1995, J SURG RES, V59, P772, DOI 10.1006/jsre.1995.1238; Koken T, 1999, CLIN CHIM ACTA, V288, P55, DOI 10.1016/S0009-8981(99)00138-2; Kupiec-Weglinski JW, 2005, TRANSPL P, V37, P1653, DOI 10.1016/j.transproceed.2005.03.134; Lang JD, 2007, J CLIN INVEST, V117, P2583, DOI 10.1172/JCI31892; Li W, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/635179; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Mathru M, 2007, ANESTHESIOLOGY, V106, P275, DOI 10.1097/00000542-200702000-00015; McMahon Timothy J, 2006, Proc Am Thorac Soc, V3, P153, DOI 10.1513/pats.200507-066BG; Nagai K, 2013, TRANSPLANTATION, V95, P78, DOI 10.1097/TP.0b013e318277e2d1; Ng ESM, 2004, CIRC RES, V94, P559, DOI 10.1161/01.RES.0000117771.63140.D6; Shi YJ, 2010, LIVER TRANSPLANT, V16, P1267, DOI 10.1002/lt.22148; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Sibulesky L, 2011, TRANSPL P, V43, P1760, DOI 10.1016/j.transproceed.2010.12.057; Siriussawakul A, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/819382; Siriussawakul A, 2010, WORLD J GASTROENTERO, V16, P6079, DOI 10.3748/wjg.v16.i48.6079; Srinivasan PK, 2012, LIVER TRANSPLANT, V18, P219, DOI 10.1002/lt.22442; Szabo C, 1996, SHOCK, V6, P79, DOI 10.1097/00024382-199608000-00001; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Troncy E, 1997, CAN J ANAESTH, V44, P973, DOI 10.1007/BF03011970; Waisman D, 2005, SHOCK, V23, P150, DOI 10.1097/01.shk.0000148056.12387.ce; Wang XD, 2006, J BIOL CHEM, V281, P26994, DOI 10.1074/jbc.M603953200; Washburn WK, 2009, LIVER TRANSPLANT, V15, P1570, DOI 10.1002/lt.21858; WESSEL DL, 1994, CRIT CARE MED, V22, P930, DOI 10.1097/00003246-199406000-00009; Yamashita H, 2004, ANN THORAC SURG, V78, P292, DOI 10.1016/j.athoracsur.2003.12.025	46	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e86053	10.1371/journal.pone.0086053	http://dx.doi.org/10.1371/journal.pone.0086053			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533048	Green Published, Green Submitted, gold			2022-12-27	WOS:000331262600006
J	Mach, N; Berri, M; Esquerre, D; Chevaleyre, C; Lemonnier, G; Billon, Y; Lepage, P; Oswald, IP; Dore, J; Rogel-Gaillard, C; Estelle, J				Mach, Nuria; Berri, Mustapha; Esquerre, Diane; Chevaleyre, Claire; Lemonnier, Gaetan; Billon, Yvon; Lepage, Patricia; Oswald, Isabelle P.; Dore, Joel; Rogel-Gaillard, Claire; Estelle, Jordi			Extensive Expression Differences along Porcine Small Intestine Evidenced by Transcriptome Sequencing	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; RNA-SEQ EXPERIMENTS; NECROTIZING ENTEROCOLITIS; EXTREME PHENOTYPES; BINDING PROTEIN; P-GLYCOPROTEIN; PIGS; GENE; MICROBIOTA; TISSUES	The aim of this study was to analyse gene expression along the small intestine (duodenum, jejunum, ileum) and in the ileal Peyer's patches in four young pigs with no clinical signs of disease by transcriptome sequencing. Multidimensional scaling evidenced that samples clustered by tissue type rather than by individual, thus prefiguring a relevant scenario to draw tissue-specific gene expression profiles. Accordingly, 1,349 genes were found differentially expressed between duodenum and jejunum, and up to 3,455 genes between duodenum and ileum. Additionally, a considerable number of differentially expressed genes were found by comparing duodenum (7,027 genes), jejunum (6,122 genes), and ileum (6,991 genes) with ileal Peyer's patches tissue. Functional analyses revealed that most of the significant differentially expressed genes along small intestinal tissues were involved in the regulation of general biological processes such as cell development, signalling, growth and proliferation, death and survival or cell function and maintenance. These results suggest that the intrinsic large turnover of intestinal tissues would have local specificities at duodenum, ileum and jejunum. In addition, in concordance with their biological function, enteric innate immune pathways were overrepresented in ileal Peyer's patches. The reported data provide an expression map of the cell pathway variation in the different small intestinal tissues. Furthermore, expression levels measured in healthy individuals could help to understand changes in gene expression that occur in dysbiosis or pathological states.	[Mach, Nuria; Lemonnier, Gaetan; Rogel-Gaillard, Claire; Estelle, Jordi] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Mach, Nuria; Lemonnier, Gaetan; Rogel-Gaillard, Claire; Estelle, Jordi] AgroParisTech, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Mach, Nuria; Lemonnier, Gaetan; Rogel-Gaillard, Claire; Estelle, Jordi] CEA, DSV iRCM SREIT LREG, Jouy En Josas, France; [Mach, Nuria; Lepage, Patricia; Dore, Joel] INRA, MICALIS UMR1319, Jouy En Josas, France; [Mach, Nuria; Lepage, Patricia; Dore, Joel] AgroParisTech, MICALIS UMR1319, Jouy En Josas, France; [Berri, Mustapha; Chevaleyre, Claire] INRA, ISP UMR1282, F-37380 Nouzilly, France; [Berri, Mustapha; Chevaleyre, Claire] Univ Tours, ISP UMR1282, Tours, France; [Esquerre, Diane] INRA, LGC Plateforme GET UMR444, F-31326 Castanet Tolosan, France; [Billon, Yvon] INRA, GEPA UE967, Le Magneraud, France; [Oswald, Isabelle P.] INRA, TOXALIM UMR1331, F-31931 Toulouse, France; [Oswald, Isabelle P.] Univ Toulouse 3, TOXALIM INP UMR1331, F-31062 Toulouse, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Tours; INRAE; INRAE; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Mach, N (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	nuria.mach@jouy.inra.fr	Dore, Joel/ABA-8921-2020; OSWALD, Isabelle P/A-8497-2013; Estellé, Jordi/A-7976-2008; Mach, Núria/C-5985-2012; Lepage, Patricia/D-4362-2014; OSWALD, Isabelle/GPP-1123-2022	OSWALD, Isabelle P/0000-0001-9918-277X; Estellé, Jordi/0000-0002-6241-1732; Mach, Núria/0000-0002-8001-6314; Lepage, Patricia/0000-0002-9501-6771; OSWALD, Isabelle/0000-0001-9918-277X; ROGEL-GAILLARD, Claire/0000-0002-2174-1962	French National Agency (SUS_FLORA project, ANR Genomique); Animal Genetics Division of INRA (PigMuNome project, AAP-GA)	French National Agency (SUS_FLORA project, ANR Genomique)(French National Research Agency (ANR)); Animal Genetics Division of INRA (PigMuNome project, AAP-GA)	This work was supported by grants from the French National Agency (SUS_FLORA project, ANR Genomique 2011-2014) and the Animal Genetics Division of INRA (PigMuNome project, AAP-GA-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey M, 2009, DEV COMP IMMUNOL, V33, P375, DOI 10.1016/j.dci.2008.07.003; Berggren S, 2007, MOL PHARM, V4, P252, DOI 10.1021/mp0600687; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Burkey TE, 2007, VET IMMUNOL IMMUNOP, V115, P309, DOI 10.1016/j.vetimm.2006.11.012; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cano PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053647; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chowdhury Shankar R, 2007, BMC Genomics, V8, P215, DOI 10.1186/1471-2164-8-215; Cilieborg MS, 2011, PEDIATR RES, V69, P10, DOI 10.1203/PDR.0b013e3181ff2a89; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Freeman TC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-90; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gao JL, 2007, J IMMUNOL, V178, P1450, DOI 10.4049/jimmunol.178.3.1450; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Glebov OK, 2003, CANCER EPIDEM BIOMAR, V12, P755; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Klostermeier UC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-305; Lammert F, 2005, GASTROENTEROLOGY, V129, P718, DOI [10.1053/j.gastro.2004.11.017, 10.1016/j.gastro.2004.11.017]; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Lehner F, 2010, WORLD J GASTROENTERO, V16, P3919, DOI 10.3748/wjg.v16.i31.3919; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Machado JG, 2005, MAMM GENOME, V16, P599, DOI 10.1007/s00335-005-0008-0; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mei J, 2005, BRIT J NUTR, V93, P37, DOI 10.1079/BJN20041302; Menheniott TR, 2010, GASTROENTEROLOGY, V138, P1823, DOI 10.1053/j.gastro.2010.01.050; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouly S, 2003, PHARM RES-DORDR, V20, P1595, DOI 10.1023/A:1026183200740; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Nabuurs MJA, 1998, VET QUART, V20, pS42; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Pedersen R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-30; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Perez-Montarelo D, 2014, PHYSIOL GENOMICS, V46, P195, DOI 10.1152/physiolgenomics.00151.2013; Pluske JR, 1997, LIVEST PROD SCI, V51, P215, DOI 10.1016/S0301-6226(97)00057-2; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ringseis R, 2007, INFLAMM RES, V56, P118, DOI 10.1007/s00011-006-6122-y; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson MD, 2010, GENOME BIOL, V11, P25, DOI DOI 10.1186/GB-2010-11-3-R25.ACCESSED; Samborski A, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112177; Samborski A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107870; San Roman AK, 2011, EXP CELL RES, V317, P2711, DOI 10.1016/j.yexcr.2011.07.011; Siggers RH, 2008, J NUTR, V138, P1437, DOI 10.1093/jn/138.8.1437; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thorn HA, 2011, EUR J PHARM SCI, V43, P89, DOI 10.1016/j.ejps.2011.03.008; Tohno M, 2005, BIOCHEM BIOPH RES CO, V330, P547, DOI 10.1016/j.bbrc.2005.03.017; Tohno M, 2006, VET RES, V37, P791, DOI 10.1051/vetres:2006036; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilfart A, 2007, J ANIM SCI, V85, P976, DOI 10.2527/jas.2006-431	58	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88515	10.1371/journal.pone.0088515	http://dx.doi.org/10.1371/journal.pone.0088515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533095	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600053
J	Parr, EB; Camera, DM; Areta, JL; Burke, LM; Phillips, SM; Hawley, JA; Coffey, VG				Parr, Evelyn B.; Camera, Donny M.; Areta, Jose L.; Burke, Louise M.; Phillips, Stuart M.; Hawley, John A.; Coffey, Vernon G.			Alcohol Ingestion Impairs Maximal Post-Exercise Rates of Myofibrillar Protein Synthesis following a Single Bout of Concurrent Training	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; NEW-ZEALAND SPORTSPEOPLE; RESISTANCE EXERCISE; HAZARDOUS DRINKING; GENE-EXPRESSION; MESSENGER-RNA; RAG GTPASES; AMINO-ACIDS; MTOR; PHOSPHORYLATION	Introduction: The culture in many team sports involves consumption of large amounts of alcohol after training/ competition. The effect of such a practice on recovery processes underlying protein turnover in human skeletal muscle are unknown. We determined the effect of alcohol intake on rates of myofibrillar protein synthesis (MPS) following strenuous exercise with carbohydrate (CHO) or protein ingestion. Methods: In a randomized cross-over design, 8 physically active males completed three experimental trials comprising resistance exercise (865 reps leg extension, 80% 1 repetition maximum) followed by continuous (30 min, 63% peak power output (PPO)) and high intensity interval (10x30 s, 110% PPO) cycling. Immediately, and 4 h post-exercise, subjects consumed either 500 mL of whey protein (25 g; PRO), alcohol (1.5 g center dot kg body mass(-1), 12 +/- 2 standard drinks) co-ingested with protein (ALC-PRO), or an energy-matched quantity of carbohydrate also with alcohol (25 g maltodextrin; ALC-CHO). Subjects also consumed a CHO meal (1.5 g CHO center dot kg body mass(-1)) 2 h post-exercise. Muscle biopsies were taken at rest, 2 and 8 h post-exercise. Results: Blood alcohol concentration was elevated above baseline with ALC-CHO and ALC-PRO throughout recovery (P<0.05). Phosphorylation of mTOR(Sper2448) 2 h after exercise was higher with PRO compared to ALC-PRO and ALC-CHO (P<0.05), while p70S6K phosphorylation was higher 2 h post-exercise with ALC-PRO and PRO compared to ALC-CHO (P<0.05). Rates of MPS increased above rest for all conditions (similar to 29-109%, P<0.05). However, compared to PRO, there was a hierarchical reduction in MPS with ALC-PRO (24%, P<0.05) and with ALC-CHO (37%, P, 0.05). Conclusion: We provide novel data demonstrating that alcohol consumption reduces rates of MPS following a bout of concurrent exercise, even when co-ingested with protein. We conclude that alcohol ingestion suppresses the anabolic response in skeletal muscle and may therefore impair recovery and adaptation to training and/or subsequent performance.	[Parr, Evelyn B.; Camera, Donny M.; Areta, Jose L.] RMIT Univ, Sch Med Sci, Exercise & Nutr Res Grp, Bundoora, Vic, Australia; [Burke, Louise M.] Australian Inst Sport, Dept Sports Nutr, Canberra, ACT, Australia; [Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada; [Hawley, John A.] Australian Catholic Univ, Sch Exercise Sci, Exercise & Nutr Res Grp, Fitzroy, Vic, Australia; [Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Coffey, Vernon G.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Kelvin Grove, Qld, Australia; [Coffey, Vernon G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	Royal Melbourne Institute of Technology (RMIT); Australian Institute of Sport; McMaster University; Australian Catholic University; Liverpool John Moores University; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Hawley, JA (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Exercise & Nutr Res Grp, Fitzroy, Vic, Australia.	john.hawley@acu.edu.au	Burke, Louise/X-3127-2019; Hawley, John A/U-3814-2018; Burke, Louise/ABC-5691-2020; Camera, Donny/J-1571-2018; Phillips, Stuart/B-2343-2009; Parr, Evelyn/J-1576-2018; Areta, José L/H-8216-2019	Burke, Louise/0000-0001-8866-5637; Hawley, John A/0000-0002-0886-9881; Camera, Donny/0000-0002-6494-9472; Phillips, Stuart/0000-0002-1956-4098; Parr, Evelyn/0000-0003-1710-6381; Areta, José L/0000-0001-6918-1223	Australian Sports Commission	Australian Sports Commission	This study was, in part, funded by a grant from the Australian Sports Commission to LMB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	Areta JL, 2013, J PHYSIOL-LONDON, V591, P2319, DOI 10.1113/jphysiol.2012.244897; ASP S, 1995, J PHYSIOL-LONDON, V482, P705, DOI 10.1113/jphysiol.1995.sp020553; Atherton PJ, 2010, AM J CLIN NUTR, V92, P1080, DOI 10.3945/ajcn.2010.29819; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Barnes MJ, 2011, EUR J APPL PHYSIOL, V111, P725, DOI 10.1007/s00421-010-1655-8; Barnes MJ, 2010, EUR J APPL PHYSIOL, V108, P1009, DOI 10.1007/s00421-009-1311-3; Burd NA, 2012, METABOLISM, V61, P931, DOI 10.1016/j.metabol.2011.11.004; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Burke LM, 2003, J APPL PHYSIOL, V95, P983, DOI 10.1152/japplphysiol.00115.2003; BURKE LM, 1988, CAN J SPORT SCI, V13, P15; Burke LM, 2011, J SPORT SCI, V29, pS17, DOI 10.1080/02640414.2011.585473; Camera DM, 2012, J APPL PHYSIOL, V113, P206, DOI 10.1152/japplphysiol.00395.2012; Coffey VG, 2011, EUR J APPL PHYSIOL, V111, P1473, DOI 10.1007/s00421-010-1768-0; Coffey VG, 2009, AM J PHYSIOL-REG I, V297, pR1441, DOI 10.1152/ajpregu.00351.2009; Deldicque L, 2012, EXERC SPORT SCI REV, V40, P43, DOI 10.1097/JES.0b013e3182355e8c; Dreyer HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE392, DOI 10.1152/ajpendo.00582.2007; Fernandez-Sola J, 2007, ALCOHOL CLIN EXP RES, V31, P1953, DOI 10.1111/j.1530-0277.2007.00530.x; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; Hawley JA, 2011, J APPL PHYSIOL, V110, P834, DOI 10.1152/japplphysiol.00949.2010; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Koopman R, 2007, SPORTS MED, V37, P895, DOI 10.2165/00007256-200737100-00005; Kumar V, 2002, AM J PHYSIOL-ENDOC M, V283, pE917, DOI 10.1152/ajpendo.00181.2002; Kumar V, 2009, J PHYSIOL-LONDON, V587, P211, DOI 10.1113/jphysiol.2008.164483; Lang CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE268, DOI 10.1152/ajpendo.1999.277.2.E268; Lang CH, 2000, ALCOHOL CLIN EXP RES, V24, P322, DOI 10.1097/00000374-200003000-00010; Lang CH, 2004, ALCOHOL CLIN EXP RES, V28, P1758, DOI 10.1097/01.ALC.0000145787.66405.59; Lang CH, 2004, AM J PHYSIOL-ENDOC M, V286, pE916, DOI 10.1152/ajpendo.00554.2003; Lang CH, 2003, AM J PHYSIOL-ENDOC M, V285, pE1205, DOI 10.1152/ajpendo.00177.2003; Lang CH, 2008, ALCOHOL CLIN EXP RES, V32, P796, DOI 10.1111/j.1530-0277.2008.00637.x; Lang CH, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Martens MP, 2006, J SUBST ABUSE TREAT, V31, P305, DOI 10.1016/j.jsat.2006.05.004; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; O'Brien KS, 2007, ALCOHOL ALCOHOLISM, V42, P376, DOI 10.1093/alcalc/agm035; O'Brien KS, 2005, ALCOHOL ALCOHOLISM, V40, P239, DOI 10.1093/alcalc/agh145; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; OBRIEN CP, 1993, SPORTS MED, V15, P71, DOI 10.2165/00007256-199315020-00001; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Phillips SM, 2006, APPL PHYSIOL NUTR ME, V31, P647, DOI 10.1139/h06-035; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Stellingwerff T, 2011, J SPORT SCI, V29, pS79, DOI 10.1080/02640414.2011.589469; Vary TC, 2008, AM J PHYSIOL-REG I, V294, pR1777, DOI 10.1152/ajpregu.00056.2008; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Watten RG, 1995, SCAND J MED SCI SPOR, V5, P364; West DWD, 2011, AM J CLIN NUTR, V94, P795, DOI 10.3945/ajcn.111.013722; Yang YF, 2006, J APPL PHYSIOL, V101, P1442, DOI 10.1152/japplphysiol.00438.2006; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	50	58	58	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88384	10.1371/journal.pone.0088384	http://dx.doi.org/10.1371/journal.pone.0088384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533082	Green Published, gold, Green Submitted			2022-12-27	WOS:000331262600040
J	Wang, Q; Zhou, SB; Wang, LJ; Lei, MM; Wang, Y; Miao, C; Jin, YZ				Wang, Qi; Zhou, Shao-Bo; Wang, Li-Jie; Lei, Ming-Ming; Wang, Yong; Miao, Chi; Jin, Yuan-Zhe			Seven Functional Polymorphisms in the CETP Gene and Myocardial Infarction Risk: A Meta-Analysis and Meta-Regression	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; STATIN-TREATED PATIENTS; CORONARY-HEART-DISEASE; HDL-CHOLESTEROL; CARDIOVASCULAR-DISEASE; TAQIB POLYMORPHISM; HETEROGENEITY; ASSOCIATION; THERAPY	Objective: This meta-analysis aims to evaluate the relationships between seven functional polymorphisms in the CETP gene and myocardial infarction (MI) risk. Method: The PubMed, CISCOM, CINAHL, Web of Science, Google Scholar, EBSCO, Cochrane Library, and CBM databases were searched for relevant articles published before March 1st, 2013 without any language restrictions. Meta-analysis was conducted using the STATA 12.0 software. Results: Nine case-control studies with a total 8,623 MI cases and 8,564 healthy subjects met the inclusion criteria. The results of our meta-analysis suggested that CETP rs708272 (C>T) polymorphism might be correlated with an increased risk of MI, especially among Caucasians. Furthermore, we observed that CETP rs1800775 (C>A) polymorphism might increase the risk of MI. Nevertheless, no similar findings were found for CETP rs5882 (A. G), rs2303790 (A>G), rs1800776 (C>A), rs12149545 (G. A), and rs4783961 (G. A) polymorphisms. Conclusion: The current meta-analysis suggests that CETP rs708272 (C>T) and rs1800775 (C>A) polymorphisms may contribute to MI susceptibility, especially among Caucasians. Thus, CETP rs708272 and rs1800775 polymorphisms may be promising and potential biomarkers for early diagnosis of MI.	[Wang, Qi; Zhou, Shao-Bo; Wang, Li-Jie; Lei, Ming-Ming; Wang, Yong; Miao, Chi; Jin, Yuan-Zhe] China Med Univ, Affiliated Hosp 4, Dept Cardiol, Shenyang, Peoples R China	China Medical University	Jin, YZ (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Cardiol, Shenyang, Peoples R China.	cmu4h_jyz@163.com	Miao, Chiyuan/E-6036-2011	Miao, Chiyuan/0000-0001-6413-7020; WANG, LIJIE/0000-0001-8674-3128; Wang, Qi/0000-0003-2458-8569	Tianqing Research Foundation [TQGB20120101]	Tianqing Research Foundation	This work was supported by a grant from the Tianqing Research Foundation (No. TQGB20120101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos GK, 2004, HEART, V90, P1336, DOI 10.1136/hrt.2003.019067; Ansell BJ, 2004, REV ENDOCR METAB DIS, V5, P351, DOI 10.1023/B:REMD.0000045107.71895.b2; Banka CL, 1996, CURR OPIN LIPIDOL, V7, P139, DOI 10.1097/00041433-199606000-00005; Barn K, 2010, TRANSPL INT, V23, P574, DOI 10.1111/j.1432-2277.2009.01021.x; Barter P, 2000, ARTERIOSCL THROM VAS, V20, P2029, DOI 10.1161/01.ATV.20.9.2029; Boekholdt SM, 2013, CIRCULATION, V128, P1504, DOI 10.1161/CIRCULATIONAHA.113.002670; Canto JG, 2011, JAMA-J AM MED ASSOC, V306, P2120, DOI 10.1001/jama.2011.1654; Cooney MT, 2009, ATHEROSCLEROSIS, V206, P611, DOI 10.1016/j.atherosclerosis.2009.02.041; Dachet C, 2000, ARTERIOSCL THROM VAS, V20, P507, DOI 10.1161/01.ATV.20.2.507; de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B; DRAYNA D, 1987, NATURE, V327, P632, DOI 10.1038/327632a0; Dullaart RPF, 2008, PHARMACOGENOMICS, V9, P747, DOI 10.2217/14622416.9.6.747; Eiriksdottir G, 2001, ATHEROSCLEROSIS, V159, P187, DOI 10.1016/S0021-9150(01)00489-0; Enquobahrie DA, 2008, AM J CARDIOL, V101, P1683, DOI 10.1016/j.amjcard.2008.02.052; Holzmann MJ, 2012, ANN MED, V44, P262, DOI 10.3109/07853890.2010.532153; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Keavney B, 2004, INT J EPIDEMIOL, V33, P1002, DOI 10.1093/ije/dyh275; Li Y, 1999, CHIN CIRCUL J, P16; Licastro F, 2010, CURR PHARM DESIGN, V16, P783, DOI 10.2174/138161210790883543; Liu S, 2002, ATHEROSCLEROSIS, V161, P469, DOI 10.1016/S0021-9150(01)00673-6; Manrique-Garcia E, 2011, J EPIDEMIOL COMMUN H, V65, P301, DOI 10.1136/jech.2009.104075; Masson D, 2009, J LIPID RES, V50, pS201, DOI 10.1194/jlr.R800061-JLR200; Meiner V, 2008, ANN HUM GENET, V72, P732, DOI 10.1111/j.1469-1809.2008.00464.x; Mohrschladt MF, 2005, EUR J HUM GENET, V13, P877, DOI 10.1038/sj.ejhg.5201426; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Ordovas JM, 2000, CLIN CHEM LAB MED, V38, P945, DOI 10.1515/CCLM.2000.139; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Poss J, 2011, CURR PHARM DESIGN, V17, P861, DOI 10.2174/138161211795428858; Qian YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064395; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rich MW, 2009, J INTERV CARD ELECTR, V25, P3, DOI 10.1007/s10840-008-9337-8; Ridker PM, 2009, CIRC-CARDIOVASC GENE, V2, P26, DOI 10.1161/CIRCGENETICS.108.817304; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Serre D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001382; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tall AR, 2010, J CLIN LIPIDOL, V4, P389, DOI 10.1016/j.jacl.2010.08.006; TENKANEN H, 1991, HUM GENET, V87, P574; Thompson JF, 2005, ATHEROSCLEROSIS, V181, P45, DOI 10.1016/j.atherosclerosis.2005.01.015; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.014; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; van Venrooij FV, 2003, DIABETES CARE, V26, P1216, DOI 10.2337/diacare.26.4.1216; Vinueza R, 2010, PREV MED, V50, P106, DOI 10.1016/j.ypmed.2009.12.011; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Von Eckardstein A, 2010, EXPERT REV CARDIOVAS, V8, P345, DOI 10.1586/ERC.10.6; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wu JH, 2001, ATHEROSCLEROSIS, V159, P451, DOI 10.1016/S0021-9150(01)00524-X; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Zee RYL, 2006, J THROMB HAEMOST, V4, P341, DOI 10.1111/j.1538-7836.2006.01754.x; [张国兵 Zhang Guobing], 2005, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V13, P88; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]; Zhuang YY, 2002, CHINESE MED J-PEKING, V115, P371; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	55	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88118	10.1371/journal.pone.0088118	http://dx.doi.org/10.1371/journal.pone.0088118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24533069	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600027
J	Dierkes, R; Warnking, K; Liedmann, S; Seyer, R; Ludwig, S; Ehrhardt, C				Dierkes, Ruediger; Warnking, Kathrin; Liedmann, Swantje; Seyer, Roman; Ludwig, Stephan; Ehrhardt, Christina			The Rac1 Inhibitor NSC23766 Exerts Anti-Influenza Virus Properties by Affecting the Viral Polymerase Complex Activity	PLOS ONE			English	Article							N-TERMINAL KINASE; INFLUENZA-A VIRUS; ANTIVIRAL ACTIVITY; RHO-GTPASES; ACTIVATION; HOST; PROTEIN	The frequent emergence of new influenza viruses in the human population underlines the urgent need for antiviral therapeutics in addition to the preventative vaccination against the seasonal flu. To circumvent the development of resistance, recent antiviral approaches target cellular proteins needed by the virus for efficient replication. We investigated the contribution of the small GTPase Rac1 to the replication of influenza viruses. Inhibition of Rac1 by NSC23766 resulted in impaired replication of a wide variety of influenza viruses, including a human virus strain of the pandemic from 2009 as well as highly pathogenic avian virus strains. Furthermore, we identified a crucial role of Rac1 for the activity of the viral polymerase complex. The antiviral potential of NSC23766 was confirmed in mouse experiments, identifying Rac1 as a new cellular target for therapeutic treatment of influenza virus infections.	[Dierkes, Ruediger; Warnking, Kathrin; Liedmann, Swantje; Seyer, Roman; Ludwig, Stephan; Ehrhardt, Christina] Univ Munster, Inst Mol Virol, Ctr Mol Virol ZMBE, D-48149 Munster, Germany	University of Munster	Ehrhardt, C (corresponding author), Univ Munster, Inst Mol Virol, Ctr Mol Virol ZMBE, D-48149 Munster, Germany.	ehrhardc@uni-muenster.de		Liedmann, Swantje/0000-0002-3945-9148; Ludwig, Stephan/0000-0003-4490-3052	Deutsche Forschungsgemeinschaft [DFG EH 235 1/2, DFG Graduate School 1409, SFB1009]; FluResearchNet; Federal Ministry of Education and Research (BMBF); Aventis Foundation; Deutsche Forschungsgemeinschaft; University of Muenster; fund 'Innovative Medical Research of the University of Muenster Medical School [EH1 2 10 03]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FluResearchNet; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Aventis Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster; fund 'Innovative Medical Research of the University of Muenster Medical School	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG EH 235 1/2, DFG Graduate School 1409, SFB1009) (http://www.dfg.de), the fund 'Innovative Medical Research (EH1 2 10 03)' of the University of Muenster Medical School (http://campus.uni-muenster.de/19.0.html) and the FluResearchNet (http://www.campus.uni-muenster.de/fluresearchnet.html), a nationwide research network to study zoonotic influenza sponsored by the Federal Ministry of Education and Research (BMBF), and the Aventis Foundation (http://www.aventis-foundation.org/). Further, the authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Ehrhardt C, 2013, CELL MICROBIOL, V15, P1198, DOI 10.1111/cmi.12108; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Lee SMY, 2012, ANTIVIR RES, V96, P391, DOI 10.1016/j.antiviral.2012.09.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Ludwig S, 2001, J BIOL CHEM, V276, P10990, DOI 10.1074/jbc.M009902200; Ludwig S, 2011, BIOL CHEM, V392, P837, DOI 10.1515/BC.2011.121; Marjuki H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-134; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Nacken W, 2012, BIOL CHEM, V393, P525, DOI 10.1515/hsz-2011-0270; Quetglas JI, 2012, J VIROL, V86, P1758, DOI 10.1128/JVI.05666-11; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Wang JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000809; Warren JC, 2007, CELL MOTIL CYTOSKEL, V64, P675, DOI 10.1002/cm.20215	30	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88520	10.1371/journal.pone.0088520	http://dx.doi.org/10.1371/journal.pone.0088520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523909	Green Submitted, Green Published, gold			2022-12-27	WOS:000331258100058
J	Hessel, A; Savidis-Dacho, H; Coulibaly, S; Portsmouth, D; Kreil, TR; Crowe, BA; Schwendinger, MG; Pilz, A; Barrett, PN; Falkner, FG; Schafer, B				Hessel, Annett; Savidis-Dacho, Helga; Coulibaly, Sogue; Portsmouth, Daniel; Kreil, Thomas R.; Crowe, Brian A.; Schwendinger, Michael G.; Pilz, Andreas; Barrett, P. Noel; Falkner, Falko G.; Schaefer, Birgit			MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses	PLOS ONE			English	Article							RECOMBINANT VACCINIA VIRUS; CD4(+) T-CELLS; A VACCINE; PANDEMIC INFLUENZA; UNIVERSAL VACCINES; HUMAN INFECTION; M2 PROTEIN; ANKARA; HEMAGGLUTININ; IMMUNITY	Background: The availability of a universal influenza vaccine able to induce broad cross-reactive immune responses against diverse influenza viruses would provide an alternative to currently available strain-specific vaccines. We evaluated the ability of vectors based on modified vaccinia virus Ankara (MVA) expressing conserved influenza proteins to protect mice against lethal challenge with multiple influenza subtypes. Methods: Mice were immunized with MVA vectors expressing H5N1-derived nucleoprotein (NP), the stem region of hemagglutinin (HA), matrix proteins 1 and 2 (M1 and M2), the viral polymerase basic protein 1 (PB1), or the HA stem fused to a quadrivalent matrix protein 2 extracellular domain (M2e). Immunized mice were challenged with lethal doses of H5N1, H7N1 or H9N2 virus and monitored for disease symptoms and weight loss. To investigate the influence of previous exposure to influenza virus on protective immune responses induced by conserved influenza proteins, mice were infected with pandemic H1N1 virus (H1N1pdm09) prior to immunization and subsequently challenged with H5N1 virus. Antibody and T cell responses were assessed by ELISA and flow cytometry, respectively. Results: MVA vectors expressing NP alone, or co-expressed with other conserved influenza proteins, protected mice against lethal challenge with H5N1, H7N1 or H9N2 virus. Pre-exposure to H1N1pdm09 increased protective efficacy against lethal H5N1 challenge. None of the other conserved influenza proteins provided significant levels of protection against lethal challenge. NP-expressing vectors induced high numbers of influenza-specific CD4(+) and CD8(+) T cells and high titer influenza-specific antibody responses. Higher influenza-specific CD4(+) T cell responses and NP-specific CD8(+) T cell responses were associated with increased protective efficacy. Conclusions: MVA vectors expressing influenza NP protect mice against lethal challenge with H5N1, H7N1 and H9N2 viruses by a mechanism involving influenza-specific CD4(+) and CD8(+) T cell responses.	[Hessel, Annett; Portsmouth, Daniel; Crowe, Brian A.; Schwendinger, Michael G.; Pilz, Andreas; Barrett, P. Noel; Schaefer, Birgit] Baxter Biosci, Vaccine R&D, Orth, Austria; [Savidis-Dacho, Helga; Coulibaly, Sogue] Baxter Biosci, Pharmacol, Orth, Austria; [Kreil, Thomas R.] Baxter Biosci, Global Pathogen Safety, Vienna, Austria; [Falkner, Falko G.] Baxter Biosci, Biol R&D, Orth, Austria		Falkner, FG (corresponding author), Baxter Biosci, Biol R&D, Orth, Austria.	falko_falkner@baxter.com		Pilz, Andreas/0000-0002-6394-3845	Baxter	Baxter	This study was funded by Baxter. Baxter employees were responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Amato RJ, 2010, CLIN CANCER RES, V16, P5539, DOI 10.1158/1078-0432.CCR-10-2082; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Boyd AC, 2013, VACCINE, V31, P670, DOI 10.1016/j.vaccine.2012.11.047; Brewoo JN, 2013, VACCINE, V31, P1848, DOI 10.1016/j.vaccine.2013.01.038; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Chang HY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-197; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Couch RB, 2013, J INFECT DIS, V207, P974, DOI 10.1093/infdis/jis935; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Donis RO, 2011, CLIN INFECT DIS, V52, P1010, DOI 10.1093/cid/cir129; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; ENDO A, 1991, J GEN VIROL, V72, P699, DOI 10.1099/0022-1317-72-3-699; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Hashem AM, 2012, HUM VACC IMMUNOTHER, V8, P425, DOI 10.4161/hv.19109; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Hessel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012217; JAKEMAN KJ, 1989, J GEN VIROL, V70, P1523, DOI 10.1099/0022-1317-70-6-1523; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; Kheiri MT, 2012, ANTIVIR RES, V95, P229, DOI 10.1016/j.antiviral.2012.07.003; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kosik I, 2012, ARCH VIROL, V157, P811, DOI 10.1007/s00705-012-1238-6; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Kreijtz JHCM, 2009, J INFECT DIS, V199, P405, DOI 10.1086/595984; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; Kreijtz JHCM, 2010, J GEN VIROL, V91, P2745, DOI 10.1099/vir.0.024885-0; Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X; Lambe T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01443; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; McKinstry KK, 2011, J INTERN MED, V269, P507, DOI 10.1111/j.1365-2796.2011.02367.x; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Mullarkey CE, 2013, EUR J IMMUNOL, V43, P1940, DOI 10.1002/eji.201242922; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Pascutti MF, 2011, J VIROL, V85, P5532, DOI 10.1128/JVI.02267-10; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Reber A, 2013, EXPERT REV VACCINES, V12, P519, DOI [10.1586/erv.13.35, 10.1586/ERV.13.35]; Ricci PS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-529; Rimmelzwaan GF, 2009, EXPERT REV VACCINES, V8, P447, DOI 10.1586/ERV.09.4; Sagawa H, 1996, J GEN VIROL, V77, P1483, DOI 10.1099/0022-1317-77-7-1483; Schafer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024505; Scheiflinger F, 1998, ARCH VIROL, V143, P467, DOI 10.1007/s007050050303; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Subbarao K, 2013, TRENDS MICROBIOL, V21, P350, DOI 10.1016/j.tim.2013.04.003; SUTTER G, 1994, VACCINE, V12, P1032, DOI 10.1016/0264-410X(94)90341-7; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Verheust C, 2012, VACCINE, V30, P2623, DOI 10.1016/j.vaccine.2012.02.016; Vitelli A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055435; Wang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052488; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wodal W, 2012, VACCINE, V30, P4625, DOI 10.1016/j.vaccine.2012.04.102; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-151; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zhou DM, 2010, MOL THER, V18, P2182, DOI 10.1038/mt.2010.202	75	52	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88340	10.1371/journal.pone.0088340	http://dx.doi.org/10.1371/journal.pone.0088340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523886	Green Published, Green Submitted, gold			2022-12-27	WOS:000331258100035
J	Krut, JJ; Mellberg, T; Price, RW; Hagberg, L; Fuchs, D; Rosengren, L; Nilsson, S; Zetterberg, H; Gisslen, M				Krut, Jan Jessen; Mellberg, Tomas; Price, Richard W.; Hagberg, Lars; Fuchs, Dietmar; Rosengren, Lars; Nilsson, Staffan; Zetterberg, Henrik; Gisslen, Magnus			Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NEUROFILAMENT PROTEIN NFL; AIDS DEMENTIA COMPLEX; NEUROCOGNITIVE DISORDERS; CD4 NADIR; INFECTION; CSF; IMPAIRMENT; SYSTEM; PREDICTOR	Background: Prevalence of neurocognitive impairment in HIV-1 infected patients is reported to be high. Whether this is result of active HIV-related neurodegeneration is unclear. We examined axonal injury in HIV-1 patients by measuring the light subunit of neurofilament protein (NFL) in CSF with a novel, sensitive method. Methods: With a cross-sectional design, CSF concentrations of neurofilament protein light (NFL) (marker of neuronal injury), neopterin (intrathecal immunoactivation) and CSF/Plasma albumin ratio (blood-brain barrier integrity) were analyzed on CSF from 252 HIV-infected patients, subdivided into untreated neuroasymptomatics (n = 200), HIV-associated dementia HAD) (n = 14) and on combinations antiretroviral treatment (cART) (n = 85), and healthy controls (n = 204). 46 HIV-infected patients were included in both treated and untreated groups, but sampled at different timepoints. Furthermore, 78 neuroasymptomatic patients were analyzed before and after treatment initiation. Results: While HAD patients had the highest NFL concentrations, elevated CSF NFL was also found in 33% of untreated neuroasymptomatic patients, mainly in those with blood CD4+ cell counts below 250 cells/mu L. CSF NFL concentrations in the untreated neuroasymptomatics and treated groups were equivalent to controls 18.5 and 3.9 years older, respectively. Neopterin correlated with NFL levels in untreated groups while the albumin ratio correlated with NFL in both untreated and treated groups. Conclusions: Increased CSF NFL indicates ongoing axonal injury in many neuroasymptomatic patients. Treatment decreases NFL, but treated patients retain higher levels than controls, indicating either continued virus-related injury or an aging-like effect of HIV infection. NFL correlates with neopterin and albumin ratio, suggesting an association between axonal injury, neuroinflammation and blood-brain barrier permeability. NFL appears to be a sensitive biomarker of subclinical and clinical brain injury in HIV and warrants further assessment for broader clinical use.	[Krut, Jan Jessen; Mellberg, Tomas; Hagberg, Lars; Gisslen, Magnus] Univ Gothenburg, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria; [Rosengren, Lars] Univ Gothenburg, Inst Neurosci & Physiol, Dept Neurol, Sahlgrenska Acad, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers, S-41296 Gothenburg, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England	University of Gothenburg; University of California System; University of California San Francisco; Medical University of Innsbruck; University of Gothenburg; Chalmers University of Technology; University of Gothenburg; University of London; University College London	Mellberg, T (corresponding author), Univ Gothenburg, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.	tomas.mellberg@infect.gu.se	Fuchs, Dietmar/AAL-8011-2021; Gisslen, Magnus/D-7454-2015	Fuchs, Dietmar/0000-0003-1627-9563; Gisslen, Magnus/0000-0002-2357-1020; Nilsson, Staffan/0000-0003-4748-0446; Rosengren, Lars/0000-0003-0505-8896	Sahlgrenska Academy at the University of Gothenburg [ALFGBG-141741, ALFGBG-144341]; G oteborg Medical Society; United States National Institutes of Health [R21MH096619, P01MH094177, R01MH62701]; UCSF-CTSI [UL1 RR024131]; Swedish Research Council [K2008-58P-20930-04-1, K2008-58X-20931-01-1, K2010-63P-21562-01-4, K2011-61X-20401-05-6]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH094177, R01MH062701, R21MH096619] Funding Source: NIH RePORTER	Sahlgrenska Academy at the University of Gothenburg; G oteborg Medical Society; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF-CTSI; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Swedish Research Council (K2008-58P-20930-04-1, K2008-58X-20931-01-1, K2010-63P-21562-01-4, K2011-61X-20401-05-6), the Sahlgrenska Academy at the University of Gothenburg (ALFGBG-141741 and ALFGBG-144341) and the G oteborg Medical Society. Additional support was from the United States National Institutes of Health (R21MH096619, P01MH094177, R01MH62701 and UCSF-CTSI Grant Number UL1 RR024131); the contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulle S, 2007, J NEUROL, V254, P1026, DOI 10.1007/s00415-006-0481-8; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; CASTRO KG, 1993, CLIN INFECT DIS, V17, P802, DOI 10.1093/clinids/17.4.802; Cysique LA, 2009, NEUROLOGY, V73, P342, DOI 10.1212/WNL.0b013e3181ab2b3b; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Gisslen M, 1999, J ACQ IMMUN DEF SYND, V21, P271, DOI 10.1097/00126334-199908010-00003; Gisslen M, 2011, BMC INFECT DIS, V11, P356; Gisslen M, 2007, J NEUROIMMUNE PHARM, V2, P112, DOI 10.1007/s11481-006-9035-1; Gisslen M, 2007, J INFECT DIS, V195, P1774, DOI 10.1086/518043; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Lescure FX, 2011, CLIN INFECT DIS, V52, P235, DOI 10.1093/cid/ciq041; MCARTHUR JC, 1992, NEUROLOGY, V42, P1707, DOI 10.1212/WNL.42.9.1707; Mellgren A, 2007, NEUROLOGY, V69, P1536, DOI 10.1212/01.wnl.0000277635.05973.55; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; PORTEGIES P, 1989, BRIT MED J, V299, P819, DOI 10.1136/bmj.299.6703.819; POWER C, 1993, ANN NEUROL, V34, P339, DOI 10.1002/ana.410340307; Robertson KR, 2004, JAIDS-J ACQ IMM DEF, V36, P562, DOI 10.1097/00126334-200405010-00003; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Scherling CS, 2013, ANN NEUROL; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Tibbling G, 1977, SCAND J CLIN LAB INV, V37, P385; Tozzi V, 1999, AIDS, V13, P1889, DOI 10.1097/00002030-199910010-00011; Valcour V, 2006, J NEUROVIROL, V12, P387, DOI 10.1080/13550280600915339; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Waldo ML, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-54	33	96	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88591	10.1371/journal.pone.0088591	http://dx.doi.org/10.1371/journal.pone.0088591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523921	Green Published, gold			2022-12-27	WOS:000331258100070
J	Perez-Munuzuri, A; Couce-Pico, ML; Bana-Souto, A; Lopez-Suarez, O; Iglesias-Deus, A; Blanco-Teijeiro, J; Fernandez-Lorenzo, JR; Fraga-Bermudez, JM				Perez-Munuzuri, Alejandro; Luz Couce-Pico, Ma; Bana-Souto, Ana; Lopez-Suarez, Olalla; Iglesias-Deus, Alicia; Blanco-Teijeiro, Jose; Ramon Fernandez-Lorenzo, Jose; Maria Fraga-Bermudez, Jose			Preclinical Screening for Retinopathy of Prematurity Risk Using IGF1 Levels at 3 Weeks Post-Partum	PLOS ONE			English	Article							SCORE; PREDICTOR	Following current recommendations for preventing retinopathy of prematurity (ROP) involves screening a large number of patients. We performed a prospective study to establish a useful screening system for ROP prediction and we have determined that measuring serum levels of IGF1 at week three and the presence of sepsis have a high predictive value for the subsequent development of ROP. A total of 145 premature newborn, with birthweight <1500 g and/or <32 weeks gestational age, were enrolled. 26.9% of them showed some form of retinopathy. A significant association was found between the development of retinopathy and each of the following variables: early gestational age, low birthweight, requiring mechanical ventilation, oxygen treatment, intracranial haemorrhage, sepsis during the first three weeks, bronchopulmonary dysplasia, the need for erythrocyte transfusion, erythropoietin treatment, and low levels of serum IGF1 in the third week. A multiple logistic regression analysis was used to obtain curves for the probability of developing ROP, based on the main factors linked with ROP, namely serum levels of IGF1 and presence of sepsis. Such preclinical screening has the ability to identify patients with high-risk of developing retinopathy and should lead to better prediction for ROP, while at the same time optimising the use of clinical resources, both human and material.	[Perez-Munuzuri, Alejandro; Luz Couce-Pico, Ma; Bana-Souto, Ana; Lopez-Suarez, Olalla; Iglesias-Deus, Alicia; Ramon Fernandez-Lorenzo, Jose; Maria Fraga-Bermudez, Jose] Univ Santiago de Compostela, Clin Hosp, Dept Paediat, Serv Neonatol, Santiago De Compostela, Spain; [Blanco-Teijeiro, Jose] Univ Santiago de Compostela, Clin Hosp, Ophthalmol Serv, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Perez-Munuzuri, A (corresponding author), Univ Santiago de Compostela, Clin Hosp, Dept Paediat, Serv Neonatol, Santiago De Compostela, Spain.	apmunuzuri@yahoo.es		fraga, jose m/0000-0001-8897-3621; Couce, Maria Luz/0000-0003-4861-9905; Fernandez-Lorenzo, Jose Ramon/0000-0002-0559-6240; Perez-Munuzuri, Alejandro/0000-0003-1434-7470				BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Binenbaum G, 2011, PEDIATRICS, V127, pE607, DOI 10.1542/peds.2010-2240; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Eckert GU, 2012, EYE, V26, P400, DOI 10.1038/eye.2011.334; Ells A, 2005, EYE, V19, P138, DOI 10.1038/sj.eye.6701437; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Hellstrom A, 2001, P NATL ACAD SCI USA, V98, P5804, DOI 10.1073/pnas.101113998; Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016; Ho SF, 2005, J AAPOS, V9, P584, DOI 10.1016/j.jaapos.2005.07.007; Jefferies AL, 2010, PAED CHILD HEALT-CAN, V15, P667, DOI 10.1093/pch/15.10.667; Lee SK, 2001, ARCH PEDIAT ADOL MED, V155, P387, DOI 10.1001/archpedi.155.3.387; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; PALMER EA, 1988, ARCH OPHTHALMOL-CHIC, V106, P471; Perez-Munuzuri A, 2010, ACTA PAEDIATR, V99, P519, DOI 10.1111/j.1651-2227.2009.01677.x; Schiariti V, 2008, J PERINATOL, V28, P566, DOI 10.1038/jp.2008.34; Sears JE, 2009, OPHTHALMOLOGY, V116, P513, DOI 10.1016/j.ophtha.2008.09.051; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Tolsma KW, 2011, ARCH OPHTHALMOL-CHIC, V129, P1555, DOI 10.1001/archophthalmol.2011.319; Turner D, 2006, ACTA PAEDIATR, V95, P1571, DOI 10.1080/08035250600767811; VanderVeen DK, 2006, J AAPOS, V10, P445, DOI 10.1016/j.jaapos.2006.04.010; Wu C, 2010, ARCH OPHTHALMOL-CHIC, V128, P443, DOI 10.1001/archophthalmol.2010.31	25	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2014	9	2							e88781	10.1371/journal.pone.0088781	http://dx.doi.org/10.1371/journal.pone.0088781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7DT	24523937	Green Published, gold, Green Submitted			2022-12-27	WOS:000331258100086
J	Azuma, K; Tsukui, T; Ikeda, K; Shiba, S; Nakagawa, K; Okano, T; Urano, T; Horie-Inoue, K; Ouchi, Y; Ikawa, M; Inoue, S				Azuma, Kotaro; Tsukui, Tohru; Ikeda, Kazuhiro; Shiba, Sachiko; Nakagawa, Kimie; Okano, Toshio; Urano, Tomohiko; Horie-Inoue, Kuniko; Ouchi, Yasuyoshi; Ikawa, Masahito; Inoue, Satoshi			Liver-Specific gamma-Glutamyl Carboxylase-Deficient Mice Display Bleeding Diathesis and Short Life Span	PLOS ONE			English	Article							BONE-MINERAL DENSITY; VITAMIN-K; HEMOPHILIA-B; GENE; PROTEIN; MUTATION; HEART; IDENTIFICATION; PROTHROMBIN; MENAQUINONE	Vitamin K is a fat-soluble vitamin that plays important roles in blood coagulation and bone metabolism. One of its functions is as a co-factor for gamma-glutamyl carboxylase (Ggcx). Conventional knockout of Ggcx causes death shortly after birth in homozygous mice. We created Ggcx-floxed mice by inserting loxP sequences at the sites flanking exon 6 of Ggcx. By mating these mice with albumin-Cre mice, we generated Ggcx-deficient mice specifically in hepatocytes (Ggcx (Delta liver/Delta liver) mice). In contrast to conventional Ggcx knockout mice, Ggcx(Delta liver/Delta liver) mice had very low activity of Ggcx in the liver and survived several weeks after birth. Furthermore, compared with heterozygous mice (Ggcx(+/Delta liver)), Ggcx(Delta liver/Delta liver) mice had shorter life spans. Ggcx(Delta liver/Delta liver) mice displayed bleeding diathesis, which was accompanied by decreased activity of coagulation factors II and IX. Ggcx-floxed mice can prove useful in examining Ggcx functions in vivo.	[Azuma, Kotaro; Ouchi, Yasuyoshi; Inoue, Satoshi] Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Tsukui, Tohru; Ikeda, Kazuhiro; Shiba, Sachiko; Horie-Inoue, Kuniko; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Saitama, Japan; [Nakagawa, Kimie; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 658, Japan; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo, Japan; [Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan	University of Tokyo; Saitama Medical University; Kobe Pharmaceutical University; University of Tokyo; Osaka University	Inoue, S (corresponding author), Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Bunkyo Ku, Tokyo, Japan.	INOUE-GER@h.u-tokyo.ac.jp	Urano, Tomohiko/AFS-9574-2022; ikawa, masahito/A-5315-2009	ikawa, masahito/0000-0001-9859-6217	Cell Innovation Program; Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour, and Welfare; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation	Cell Innovation Program; Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by grants from Cell Innovation Program, Grants-in-Aid, and Support Project of Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid from the Ministry of Health, Labour, and Welfare, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2009, ENDOCR J, V56, P843, DOI 10.1507/endocrj.K09E-108; Berkner KL, 1998, P NATL ACAD SCI USA, V95, P466, DOI 10.1073/pnas.95.2.466; Brenner B, 1998, BLOOD, V92, P4554, DOI 10.1182/blood.V92.12.4554.424k42_4554_4559; Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Dewerchin M, 2000, THROMB HAEMOSTASIS, V83, P185, DOI 10.1055/s-0037-1613783; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Gast GCM, 2009, NUTR METAB CARDIOVAS, V19, P504, DOI 10.1016/j.numecd.2008.10.004; Gatewood JD, 2006, J NEUROSCI, V26, P2335, DOI 10.1523/JNEUROSCI.3743-05.2006; Geleijnse JM, 2004, J NUTR, V134, P3100, DOI 10.1093/jn/134.11.3100; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Kinoshita H, 2007, BONE, V40, P451, DOI 10.1016/j.bone.2006.08.007; Kulman JD, 1997, P NATL ACAD SCI USA, V94, P9058, DOI 10.1073/pnas.94.17.9058; Kulman JD, 2001, P NATL ACAD SCI USA, V98, P1370, DOI 10.1073/pnas.98.4.1370; Kundu RK, 1998, BLOOD, V92, P168, DOI 10.1182/blood.V92.1.168.413k06_168_174; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; MATSCHINER JT, 1974, J NUTR, V104, P660, DOI 10.1093/jn/104.6.660; Mullins ES, 2009, BLOOD, V113, P696, DOI 10.1182/blood-2008-07-169003; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Neogi T, 2006, ARTHRITIS RHEUM, V54, P1255, DOI 10.1002/art.21735; Presse N, 2008, J AM DIET ASSOC, V108, P2095, DOI 10.1016/j.jada.2008.09.013; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Rosen ED, 2005, THROMB HAEMOSTASIS, V94, P493, DOI 10.1160/TH05-05-0337; Rosen ED, 1997, NATURE, V390, P290, DOI 10.1038/36862; Rosendaal FR, 2002, ARTERIOSCL THROM VAS, V22, P201, DOI 10.1161/hq0202.102318; Shiraki M, 2000, J BONE MINER RES, V15, P515, DOI 10.1359/jbmr.2000.15.3.515; Spronk HMH, 2000, BLOOD, V96, P3650; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Viegas CSB, 2008, J BIOL CHEM, V283, P36655, DOI 10.1074/jbc.M802761200; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Wang LL, 1997, P NATL ACAD SCI USA, V94, P11563, DOI 10.1073/pnas.94.21.11563; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Wong JH, 2008, J CLIN INVEST, V118, P2969, DOI 10.1172/JCI34957; WORCESTER EM, 1993, CALCIFIED TISSUE INT, V53, P242, DOI 10.1007/BF01320909; Zhu AH, 2007, BLOOD, V109, P5270, DOI 10.1182/blood-2006-12-064188	41	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88643	10.1371/journal.pone.0088643	http://dx.doi.org/10.1371/journal.pone.0088643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520408	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600099
J	Forsblom, E; Aittoniemi, J; Ruotsalainen, E; Helmijoki, V; Huttunen, R; Jylhava, J; Hurme, M; Jarvinen, A				Forsblom, Erik; Aittoniemi, Janne; Ruotsalainen, Eeva; Helmijoki, Visa; Huttunen, Reetta; Jylhava, Juulia; Hurme, Mikko; Jarvinen, Asko			High Cell-Free DNA Predicts Fatal Outcome among Staphylococcus aureus Bacteraemia Patients with Intensive Care Unit Treatment	PLOS ONE			English	Article							FREE PLASMA DNA; ANTIMICROBIAL SUSCEPTIBILITY; INFECTIVE ENDOCARDITIS; ANTIBIOTIC-TREATMENT; LATIN-AMERICA; MORTALITY; SEPSIS; PROCALCITONIN; INFLAMMATION; RECURRENCE	Introduction Among patients with bacteraemia or sepsis the plasma cell-free DNA (cf-DNA) biomarker has prognostic value and Pitt bacteraemia scores predict outcome. We evaluated the prognostic value of plasma cf-DNA in patients with Staphylococcus aureus bacteraemia (SAB) treated in the ICU or in the general ward. Methods: 418 adult patients with positive blood culture for S. aureus were prospectively followed for 90 days. SAB patients were grouped according to ICU treatment: 99 patients were treated in ICU within 7 days of documented SAB whereas 319 patients were managed outside ICU. Pitt bacteraemia scores were assessed at hospital arrival and cf-DNA was measured at days 3 and 5 from positive blood culture. Results: SAB patients with high Pitt bacteraemia scores and ICU treatment presented higher cf-DNA values as compared to SAB patients with low Pitt bacteraemia scores and non-ICU treatment at both days 3 and 5. Among ICU patients cf-DNA >1.99 mu g/ml at day 3 predicted death with a sensitivity of 67% and a specificity of 77% and had an AUC in receiver operating characteristic analysis of 0.71 (p<0.01). The cut-off cf-DNA >1.99 mu g/ml value demonstrated a strong association to high Pitt bacteraemia scores (>= 4 points) (p<0.000). After controlling for all prognostic markers, Pitt bacteraemia scores >= 4 points at hospital admission (OR 4.47, p<0.000) and day 3 cf-DNA (OR 3.56, p, 0.001) were the strongest factors significantly predicting outcome in ICU patients. cf-DNA at day 5 did not predict fatal outcome. Conclusion: High cf-DNA concentrations were observed among patients with high Pitt bacteraemia scores and ICU treatment. Pitt bacteraemia scores (>= 4 points) and cf-DNA at day 3 from positive blood culture predicted death among SAB patients in ICU and were found to be independent prognostic markers. cf-DNA had no prognostic value among non-ICU patients.	[Forsblom, Erik; Ruotsalainen, Eeva; Jarvinen, Asko] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland; [Aittoniemi, Janne; Helmijoki, Visa; Hurme, Mikko] Fimlab Labs, Dept Clin Microbiol, Tampere, Finland; [Helmijoki, Visa; Jylhava, Juulia; Hurme, Mikko] Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland; [Huttunen, Reetta] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland	University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University; Tampere University Hospital	Forsblom, E (corresponding author), Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland.	erik.forsblom@helsinki.fi		Hurme, Mikko/0000-0002-8614-1044; Jylhava, Juulia/0000-0003-0250-4491	State Research Financing of the Expert Responsibility Area of Tampere University Hospital [Fimlab X50000]; Medical Society of Finland; National Graduate School of Clinical Investigation of Helsinki University Central Hospital	State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Medical Society of Finland; National Graduate School of Clinical Investigation of Helsinki University Central Hospital	This study was financially supported by the State Research Financing of the Expert Responsibility Area of Tampere University Hospital (Fimlab X50000) and by grants from The Medical Society of Finland and The National Graduate School of Clinical Investigation of Helsinki University Central Hospital (www.fls.fi; www.vktk.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09; Cohen J, 2004, CRIT CARE MED, V32, P1510, DOI [10.1097/01.CCM.0000129973.13104.2D, 10.1097/01.CCM.0000145917.89975.F5]; Conterno LO, 1998, INFECT CONT HOSP EP, V19, P32; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cuculi F, 2008, EUR J CLIN MICROBIOL, V27, P1145, DOI 10.1007/s10096-008-0541-3; Devlin RK, 2004, CURR OPIN CARDIOL, V19, P134, DOI 10.1097/00001573-200403000-00012; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Dwivedi DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11466; Fowler VG, 1999, CLIN INFECT DIS, V28, P106; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021700; Jahr S, 2001, CANCER RES, V61, P1659; Kaech C, 2006, CLIN MICROBIOL INFEC, V12, P345, DOI 10.1111/j.1469-0691.2005.01359.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lodise TP, 2003, CLIN INFECT DIS, V36, P1418, DOI 10.1086/375057; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Martins GA, 2000, ANN NY ACAD SCI, V906, P134; McBean M, 2001, J INFECT DIS, V183, P596, DOI 10.1086/318526; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Moreira VG, 2006, CLIN CHEM LAB MED, V44, P1410, DOI 10.1515/CCLM.2006.252; Okkonen M, 2011, CRIT CARE, V15, DOI 10.1186/cc10357; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Pfaller MA, 1999, DIAGN MICR INFEC DIS, V33, P283, DOI 10.1016/S0732-8893(98)00149-7; Price James, 2010, Int J Microbiol, V2010, P654858, DOI 10.1155/2010/654858; Rhee JY, 2009, SHOCK, V31, P146, DOI 10.1097/SHK.0b013e318182f98f; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Rose WE, 2012, J INFECT DIS, V206, P1604, DOI 10.1093/infdis/jis552; Ruotsalainen E, 2006, J INTERN MED, V259, P179, DOI 10.1111/j.1365-2796.2005.01598.x; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Saukkonen K, 2007, INTENS CARE MED, V33, P1624, DOI 10.1007/s00134-007-0686-z; Siegman-Igra Y, 2005, SCAND J INFECT DIS, V37, P572, DOI 10.1080/00365540510038488; TSUMITA T, 1963, NATURE, V198, P1088, DOI 10.1038/1981088a0; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wijeratne S, 2004, ANN NY ACAD SCI, V1022, P232, DOI 10.1196/annals.1318.036; Wisplinghoff H, 2001, CLIN INFECT DIS, V33, P733, DOI 10.1086/322610; Wu TL, 2002, CLIN CHIM ACTA, V321, P77, DOI 10.1016/S0009-8981(02)00091-8; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95	45	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e87741	10.1371/journal.pone.0087741	http://dx.doi.org/10.1371/journal.pone.0087741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520336	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600027
J	Herr, N; Mauler, M; Witsch, T; Stallmann, D; Schmitt, S; Mezger, J; Bode, C; Duerschmied, D				Herr, Nadine; Mauler, Maximilian; Witsch, Thilo; Stallmann, Daniela; Schmitt, Stefanie; Mezger, Julius; Bode, Christoph; Duerschmied, Daniel			Acute Fluoxetine Treatment Induces Slow Rolling of Leukocytes on Endothelium in Mice	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; INTERFERON-GAMMA; IN-VIVO; SEROTONIN; INFLAMMATION; PLATELETS; RELEASE; STIMULATION	Objective: Activated platelets release serotonin at sites of inflammation where it acts as inflammatory mediator and enhances recruitment of neutrophils. Chronic treatment with selective serotonin reuptake inhibitors (SSRI) depletes the serotonin storage pool in platelets, leading to reduced leukocyte recruitment in murine experiments. Here, we examined the direct and acute effects of SSRI on leukocyte recruitment in murine peritonitis. Methods: C57Bl/6 and Tph1-/- (Tryptophan hydroxylase1) mice underwent acute treatment with the SSRI fluoxetine or vehicle. Serotonin concentrations were measured by ELISA. Leukocyte rolling and adhesion on endothelium was analyzed by intravital microscopy in mesentery venules with and without lipopolysaccharide challenge. Leukocyte extravasation in sterile peritonitis was measured by flow cytometry of abdominal lavage fluid. Results: Plasma serotonin levels were elevated 2 hours after fluoxetine treatment (0.70 +/- 0.1 mu g/ml versus 0.27 +/- 0.1, p = 0.03, n = 14), while serum serotonin did not change. Without further stimulation, acute fluoxetine treatment increased the number of rolling leukocytes (63 +/- 8 versus 165 +/- 17/0.04 mm(2)min(-1)) and decreased their velocity (61 +/- 6 versus 28 +/- 1 mu m/s, both p<0.0001, n = 10). In Tph1-/- mice leukocyte rolling was not significantly influenced by acute fluoxetine treatment. Stimulation with lipopolysaccharide decreased rolling velocity and induced leukocyte adhesion, which was enhanced after fluoxetine pretreatment (27 +/- 3 versus 36 +/- 2/0.04 mm(2), p = 0.008, n = 10). Leukocyte extravasation in sterile peritonitis, however, was not affected by acute fluoxetine treatment. Conclusions: Acute fluoxetine treatment increased plasma serotonin concentrations and promoted leukocyte-endothelial interactions in-vivo, suggesting that serotonin is a promoter of acute inflammation. E-selectin was upregulated on endothelial cells in the presence of serotonin, possibly explaining the observed increase in leukocyte-endothelial interactions. However transmigration of neutrophils in sterile peritonitis was not affected by higher serotonin concentrations, indicating that the effect of fluoxetine was restricted to early steps in the leukocyte recruitment. Whether SSRI use in humans alters leukocyte recruitment remains to be investigated.	[Herr, Nadine; Mauler, Maximilian; Witsch, Thilo; Stallmann, Daniela; Schmitt, Stefanie; Mezger, Julius; Bode, Christoph; Duerschmied, Daniel] Univ Freiburg, Dept Cardiol & Angiol 1, Ctr Heart, D-79106 Freiburg, Germany; [Mauler, Maximilian; Schmitt, Stefanie] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg	Duerschmied, D (corresponding author), Univ Freiburg, Dept Cardiol & Angiol 1, Ctr Heart, Hugstetter Str 55, D-79106 Freiburg, Germany.	daniel.duerschmied@universitaets-herzzentrum.de	Duerschmied, D./AAB-5139-2021; Duerschmied, D./K-8182-2015	Duerschmied, D./0000-0001-5249-4012; Duerschmied, D./0000-0001-5249-4012	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 1999, EUR NEUROPSYCHOPHARM, V10, P31, DOI 10.1016/S0924-977X(99)00048-6; Bakish D, 1997, BIOL PSYCHIAT, V41, P184, DOI 10.1016/S0006-3223(96)00040-6; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Bianchi M, 2002, EXP BRAIN RES, V143, P191, DOI 10.1007/s00221-001-0979-3; Blardi P, 2002, J CLIN PSYCHOPHARM, V22, P131, DOI 10.1097/00004714-200204000-00005; Bourdeaux R, 1998, J PHARM PHARMACOL, V50, P1387, DOI 10.1111/j.2042-7158.1998.tb03364.x; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Chauhan AK, 2008, J EXP MED, V205, P2065, DOI 10.1084/jem.20080130; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; Durk T, 2013, AM J RESP CRIT CARE, V187, P476, DOI 10.1164/rccm.201208-1440OC; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Eddahibi S, 1999, CIRC RES, V84, P329, DOI 10.1161/01.RES.84.3.329; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; FINOCCHIARO LME, 1988, J INTERFERON RES, V8, P705, DOI 10.1089/jir.1988.8.705; IKEN K, 1995, CELL IMMUNOL, V163, P1, DOI 10.1006/cimm.1995.1092; Kawano H, 2001, BLOOD, V97, P1697, DOI 10.1182/blood.V97.6.1697; Kushnir-Sukhov NM, 2007, J ALLERGY CLIN IMMUN, V119, P498, DOI 10.1016/j.jaci.2006.09.003; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; PALMER DS, 1994, THROMB HAEMOSTASIS, V72, P132; Roumestan C, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-35; Sauer WH, 2003, CIRCULATION, V108, P32, DOI 10.1161/01.CIR.0000079172.43229.CD; Schluter T, 1999, BIOCHEM PHARMACOL, V57, P1191, DOI 10.1016/S0006-2952(99)00011-8; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104	31	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e88316	10.1371/journal.pone.0088316	http://dx.doi.org/10.1371/journal.pone.0088316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520366	Green Submitted, gold, Green Published			2022-12-27	WOS:000331254600057
J	Liu, L; Hao, ZZ; Liu, YY; Wei, XX; Cun, YZ; Wang, XQ				Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan; Wei, Xiao-Xin; Cun, Yu-Zhi; Wang, Xiao-Quan			Phylogeography of Pinus armandii and Its Relatives: Heterogeneous Contributions of Geography and Climate Changes to the Genetic Differentiation and Diversification of Chinese White Pines	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; POPULATION-GROWTH; MITOCHONDRIAL; PINACEAE; CHLOROPLAST; PHYLOGENY; HISTORY; DIVERGENCE; SOFTWARE; IMPRINTS	Geographic barriers and Quaternary climate changes are two major forces driving the evolution, speciation, and genetic structuring of extant organisms. In this study, we used Pinus armandii and eleven other Asian white pines (subsection Strobus, subgenus Pinus) to explore the influences of geographic factors and Pleistocene climatic oscillations on species in South China, a region known to be centers of plant endemism and biodiversity hotspots. Range-wide patterns of genetic variation were investigated using chloroplast and mitochondrial DNA markers, with extensive sampling throughout the entire range of P. armandii. Both cpDNA and mtDNA revealed that P. armandii exhibits high levels of genetic diversity and significant population differentiation. Three geographically distinct subdivisions corresponding to the Qinling-Daba Mountains (QDM), Himalaya-Hengduan Mountains (HHM) and Yungui Plateau (YGP) were revealed in mainland China by cpDNA. Their break zone was located in the southeastern margin of the Qinghai-Tibetan Plateau (QTP). A series of massive mountains, induced by the QTP uplift, imposed significant geographic barriers to genetic exchange. The disjunct distribution patterns of ancestral haplotypes suggest that a large continuous population of the white pines may have existed from southwest to subtropical China. Repeated range shifts in response to the Pleistocene glaciations led to the isolation and diversification of the subtropical species. The two Taiwanese white pines share a common ancestor with the species in mainland China and obtain their chloroplasts via long-distance pollen dispersal from North Asian pines. Distinct genetic patterns were detected in populations from the Qinling-Daba Mountains, Yungui Plateau, Himalaya-Hengduan Mountains, and subtropical China, indicating significant contributions of geographic factors to the genetic differentiation in white pines. Our study depicts a clear picture of the evolutionary history of Chinese white pines and highlights the heterogeneous contributions of geography and Pleistocene climatic fluctuations to the extremely high plant species diversity and endemism in South China.	[Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan; Wei, Xiao-Xin; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Liu, Liu; Hao, Zhen-Zhen; Liu, Yan-Yan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cun, Yu-Zhi] Dali Univ, Dali, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dali University	Wei, XX (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	weixx@ibcas.ac.cn			National Natural Science Foundation of China [31270422, 30730010, 31160047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant nos. 31270422, 30730010, 31160047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2007, MOL ECOL, V16, P3393, DOI 10.1111/j.1365-294X.2007.03391.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Businsky Roman, 2004, Willdenowia, V34, P209, DOI 10.3372/wi.34.34120; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; [陈之端 Chen Zhiduan], 2012, [植物学报, Chinese Bulletin of Botany], V47, P551; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; CRITCHFIELD WB, 1984, P 8 N AM FOR BIOL WO, P70; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duminil J, 2002, MOL ECOL NOTES, V2, P428, DOI 10.1046/j.1471-8286.2002.00263.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farjon A, 2001, WORLD CHECKLIST BIBL; Fu L.G., 1999, FLORA CHINA, V4; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; Jia GD, 2003, GEOLOGY, V31, P1093, DOI 10.1130/G19992.1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ma C. G., 1992, S SEL OPT SEED SOURC; Ma XF, 2006, MOL BIOL EVOL, V23, P807, DOI 10.1093/molbev/msj100; Mayr E, 1942, SYSTEMATICS ORIGIN S; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Nylander JAA., 2004, BIOINFORMATICS; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056243; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Syring J, 2007, SYST BIOL, V56, P163, DOI 10.1080/10635150701258787; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian S, 2008, ANN BOT-LONDON, V102, P69, DOI 10.1093/aob/mcn068; Tian S, 2010, PLANT SYST EVOL, V284, P219, DOI 10.1007/s00606-009-0246-9; Tsutsui K, 2009, J PLANT RES, V122, P509, DOI 10.1007/s10265-009-0246-4; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang H., 2004, USDA SERV P RMRS P, V32, P73; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Wang XQ, 2000, MOL BIOL EVOL, V17, P773, DOI 10.1093/oxfordjournals.molbev.a026356; Wei XX, 2011, TREE GENET GENOMES, V7, P1025, DOI 10.1007/s11295-011-0392-4; WILLYARD A, 2006, MOL BIOL EVOL, V23, P1; Wu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055315; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhang DC, 2009, NORD J BOT, V27, P405, DOI 10.1111/j.1756-1051.2008.00235.x	66	53	60	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85920	10.1371/journal.pone.0085920	http://dx.doi.org/10.1371/journal.pone.0085920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24533149	gold, Green Published, Green Submitted			2022-12-27	WOS:000330244500144
J	Song, Y; Liang, CL; Wang, W; Fang, J; Sun, NN; Jia, XD; Li, N				Song, Yan; Liang, Chunlai; Wang, Wei; Fang, Jin; Sun, Nana; Jia, Xudong; Li, Ning			Immunotoxicological Evaluation of Corn Genetically Modified with Bacillus thuringiensis Cry1Ah Gene by a 30-Day Feeding Study in BALB/c Mice	PLOS ONE			English	Article							IMMUNE-RESPONSE; TOXIN; MAIZE; L.	This study was to investigate the immunotoxicological potential of corn genetically modified (GM) with Bacillus thuringiensis (Bt) Cry1Ah gene in BALB/c mice. Female BALB/c mice were randomly assigned to one of the four groups: the negative control group, the parental corn group, the GM corn group and the positive control group with 10 mice per group. Mice in the GM corn group and the parental corn group were fed with diets containing 70% corresponding corn for 30 days. Mice in the negative control group and the positive control group were fed with AIN93G diet, administered with saline or 200 mg/kg of cyclophosphamide (CY) via intraperitoneal injection 24 h before the termination of the study, respectively. At the end of the study, the immunotoxicological effects of the GM corn were evaluated through immunopathology parameters including body and organ weights, hematology and clinical chemistry parameters, histological examination, peripheral blood lymphocytes phenotype; humoral immunity including antibody plaque-forming cell, serum immunoglobulin, cytokine and half hemolysis value; cellular immunity such as mitogen-induced splenocyte proliferation, cytotoxic T-lymphocyte reaction, delayed-type hypersensitivity reaction; non-specific immunity including phagocytic activities of phagocytes, natural killer cell activity. A single dose of cyclophosphamide (200 mg/kg bw) was found to have significant adverse effects on immunopathology, cellular immunity, and humoral immunity in mice. The corn genetically modified with Bt Cry1Ah gene is considered consistent with the parental corn in terms of immunopathology, humoral immunity, cellular immunity and non-specific immunity. No adverse immunotoxicological effects of GM corn with Bt Cry1Ah gene were found when feeding mice for 30 days.	[Song, Yan; Liang, Chunlai; Wang, Wei; Fang, Jin; Sun, Nana; Jia, Xudong; Li, Ning] China Natl Ctr Food Safety Risk Assessment, Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China		Li, N (corresponding author), China Natl Ctr Food Safety Risk Assessment, Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.	lining_65@126.com			Special Fund for China Agro-scientific Research in the Public Interest [200903054-06]; China National GMO Cultivation Major Project of New Varieties [2008ZX08011-005, 2011ZX08011-005]	Special Fund for China Agro-scientific Research in the Public Interest; China National GMO Cultivation Major Project of New Varieties	The work was financially supported by Special Fund for China Agro-scientific Research in the Public Interest (200903054-06) and China National GMO Cultivation Major Project of New Varieties (2008ZX08011-005 and 2011ZX08011-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEGLE CC, 1992, CAN ENTOMOL, V124, P587, DOI 10.4039/Ent124587-4; Bernstein IL, 1999, ENVIRON HEALTH PERSP, V107, P575, DOI 10.2307/3434400; Bertoni G, 2005, VET RES COMMUN, V29, P13, DOI 10.1007/s11259-005-0004-6; Bin-Hafeez B, 2003, INT IMMUNOPHARMACOL, V3, P257, DOI 10.1016/S1567-5769(02)00292-8; CUNNINGHAM AJ, 1965, NATURE, V207, P1106, DOI 10.1038/2071106a0; European Commission, 1997, OFF J EUR COMMUN L, VL253, P1; FAO/WHO Codex Alimentarius Commission, 2001, EXPERT CONSULTATION, P1; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Harlander SK, 2002, J AM COLL NUTR, V21, p161S, DOI 10.1080/07315724.2002.10719260; Huang Qiong, 2007, Zhongguo Yaolixue Yu Dulixue Zazhi, V21, P140; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; LUSTER MI, 1988, FUND APPL TOXICOL, V10, P2, DOI 10.1016/0272-0590(88)90247-3; Marmiroli N, 2005, VET RES COMMUN, V29, P1, DOI 10.1007/s11259-005-0002-8; Mateo R, 2006, AM J TROP MED HYG, V75, P356, DOI 10.4269/ajtmh.2006.75.356; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Qi Lijuan, 2010, Wei Sheng Yan Jiu, V39, P313; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sagstad A, 2007, J FISH DIS, V30, P201, DOI 10.1111/j.1365-2761.2007.00808.x; Seralinil GE, 2011, ENV SCI EUROPE; Sheng XL, 2007, WORLD J GASTROENTERO, V13, P5944, DOI 10.3748/wjg.v13.i44.5944; The Ministry of Health, 2003, TECHN STAND TEST ASS, P28; Thompson M A, 1995, Genet Eng (N Y), V17, P99; US EPA, 1998, IMMUNOTOXICITY, P1; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Yoon HS, 2010, J MICROBIOL BIOTECHN, V20, P438, DOI 10.4014/jmb.0905.05058; Yue TongQing, 2010, Journal of Agricultural Biotechnology, V18, P638; Zhu YZ, 2004, ARCH ANIM NUTR, V58, P295, DOI 10.1080/00039420412331273277	27	44	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e78566	10.1371/journal.pone.0078566	http://dx.doi.org/10.1371/journal.pone.0078566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520311	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600001
J	Burns, DA; Woodruff, LG; Bradley, PM; Cannon, WF				Burns, Douglas A.; Woodruff, Laurel G.; Bradley, Paul M.; Cannon, William F.			Mercury in the Soil of Two Contrasting Watersheds in the Eastern United States	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; ATMOSPHERIC DEPOSITION; METHYL MERCURY; UPLAND FOREST; BULK-DENSITY; PATTERNS; METHYLMERCURY; DYNAMICS; CARBON; SEQUESTRATION	Soil represents the largest store of mercury (Hg) in terrestrial ecosystems, and further study of the factors associated with soil Hg storage is needed to address concerns about the magnitude and persistence of global environmental Hg bioaccumulation. To address this need, we compared total Hg and methyl Hg concentrations and stores in the soil of different landscapes in two watersheds in different geographic settings with similar and relatively high methyl Hg concentrations in surface waters and biota, Fishing Brook, Adirondack Mountains, New York, and McTier Creek, Coastal Plain, South Carolina. Median total Hg concentrations and stores in organic and mineral soil samples were three-fold greater at Fishing Brook than at McTier Creek. Similarly, median methyl Hg concentrations were about two-fold greater in Fishing Brook soil than in McTier Creek soil, but this difference was significant only for mineral soil samples, and methyl Hg stores were not significantly different among these watersheds. In contrast, the methyl Hg/total Hg ratio was significantly greater at McTier Creek suggesting greater climate-driven methylation efficiency in the Coastal Plain soil than that of the Adirondack Mountains. The Adirondack soil had eight-fold greater soil organic matter than that of the Coastal Plain, consistent with greater total Hg stores in the northern soil, but soil organic matter - total Hg relations differed among the sites. A strong linear relation was evident at McTier Creek (r(2) = 0.68; p<0.001), but a linear relation at Fishing Brook was weak (r(2) = 0.13; p<0.001) and highly variable across the soil organic matter content range, suggesting excess Hg binding capacity in the Adirondack soil. These results suggest greater total Hg turnover time in Adirondack soil than that of the Coastal Plain, and that future declines in stream water Hg concentrations driven by declines in atmospheric Hg deposition will be more gradual and prolonged in the Adirondacks.	[Burns, Douglas A.] US Geol Survey, Troy, NY 12180 USA; [Woodruff, Laurel G.] US Geol Survey, Mountain View, CA USA; [Bradley, Paul M.] US Geol Survey, Columbia, SC USA; [Cannon, William F.] US Geol Survey, Reston, VA 22092 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Burns, DA (corresponding author), US Geol Survey, Troy, NY 12180 USA.	daburns@usgs.gov	Burns, Douglas/A-7507-2009; Spencer, Thomas/AAD-6434-2020; Bradley, Paul M./AAC-2451-2020; navakanitworakul, raphatphorn/T-5948-2017	Bradley, Paul M./0000-0001-7522-8606; navakanitworakul, raphatphorn/0000-0001-6408-0079; Spencer, Thomas/0000-0003-2815-766X; Burns, Douglas/0000-0001-6516-2869; Burns, Gregory/0000-0003-0021-4319	United States Environmental Protection Agency; National Water Quality Assessment Program of the United States Geological Survey; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061580] Funding Source: NIH RePORTER	United States Environmental Protection Agency(United States Environmental Protection Agency); National Water Quality Assessment Program of the United States Geological Survey; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this work was provided by the United States Environmental Protection Agency and the National Water Quality Assessment Program of the United States Geological Survey. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WA, 1973, J SOIL SCI, V24, P10, DOI 10.1111/j.1365-2389.1973.tb00737.x; Aelion CM, 2009, SCI TOTAL ENVIRON, V407, P2216, DOI 10.1016/j.scitotenv.2008.11.033; Akerblom S, 2008, WATER AIR SOIL POLL, V189, P239, DOI 10.1007/s11270-007-9571-1; [Anonymous], WATER AIR SOIL POLLU; Arfstrom C, 2000, WATER AIR SOIL POLL, V121, P133, DOI 10.1023/A:1005214908516; ASHWAL LD, 1982, AM MINERAL, V67, P14; Bradley PM, 2013, ENVIRON POLLUT, V172, P42, DOI 10.1016/j.envpol.2012.08.008; Bradley PM, 2011, ENVIRON SCI TECHNOL, V45, P2048, DOI 10.1021/es103923j; BROADBENT FE, 1953, ADV AGRON, V5, P153, DOI 10.1016/S0065-2113(08)60229-1; Brown Z.A., 2002, ANAL METHODS CHEM AN, P1; Burns DA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001812; Burns DA, 2013, BIOGEOCHEMISTRY, V113, P451, DOI 10.1007/s10533-012-9773-5; Burt R, 2003, J ENVIRON QUAL, V32, P2109, DOI 10.2134/jeq2003.2109; Bushey JT, 2008, ATMOS ENVIRON, V42, P6905, DOI 10.1016/j.atmosenv.2008.05.043; Chen X, 2010, ENVIRON POLLUT, V158, P48, DOI 10.1016/j.envpol.2009.08.028; Dahl T.E., 2009, DATA COLLECTION REQU; De Vos B, 2005, SOIL SCI SOC AM J, V69, P500, DOI 10.2136/sssaj2005.0500; Demers JD, 2007, ECOL APPL, V17, P1341, DOI 10.1890/06-1697.1; Demers JD, 2013, J GEOPHYS RES-BIOGEO, V118, P825, DOI 10.1002/jgrg.20066; Desaules A, 2012, ENVIRON MONIT ASSESS, V184, P487, DOI 10.1007/s10661-011-1982-1; DeWild JF, 2004, 5A7 US GEOL SURV; Duffera M, 2007, GEODERMA, V137, P327, DOI 10.1016/j.geoderma.2006.08.018; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; FEDERER CA, 1993, CAN J FOREST RES, V23, P1026, DOI 10.1139/x93-131; Fu XW, 2010, ENVIRON POLLUT, V158, P2324, DOI 10.1016/j.envpol.2010.01.032; Gabriel MC, 2004, ENVIRON GEOCHEM HLTH, V26, P421, DOI 10.1007/s10653-004-1308-0; Gerbig C., 2012, ENV CHEM TOXICOLOGY, DOI [10.1002/9781118146644.ch8, DOI 10.1002/9781118146644.CH8]; Grigal DF, 2003, J ENVIRON QUAL, V32, P393, DOI 10.2134/jeq2003.0393; Guo YY, 2006, SOIL SCI SOC AM J, V70, P601, DOI 10.2136/sssaj2005.0163; Harrison RB, 2003, SOIL SCI SOC AM J, V67, P1602, DOI 10.2136/sssaj2003.1602; Helsel D. R., 2005, NONDETECTS DATA ANAL; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Journey CA, 2012, 20125173 US GEOL SUR; Kiernan BD, 2003, ENVIRON POLLUT, V123, P347, DOI 10.1016/S0269-7491(03)00023-X; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LaPoint S. D., 2004, WETLANDS EFFECTS DAT; Lindqvist O, 1994, WATER AIR SOIL POLL, V55, P1; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Markewich H. W., 1990, Geomorphology, V3, P417, DOI 10.1016/0169-555X(90)90015-I; McGee GG, 2007, J TORREY BOT SOC, V134, P253, DOI 10.3159/1095-5674(2007)134[253:RAFACA]2.0.CO;2; Mitchell CPJ, 2008, ENVIRON SCI TECHNOL, V42, P1010, DOI 10.1021/es0704986; NATER EA, 1992, NATURE, V358, P139, DOI 10.1038/358139a0; Obrist D, 2011, ENVIRON SCI TECHNOL, V45, P3974, DOI 10.1021/es104384m; Obrist D, 2012, ENVIRON SCI TECHNOL, V46, P5921, DOI 10.1021/es2045579; Park JH, 2005, ENVIRON SCI TECHNOL, V39, P6993, DOI 10.1021/es048301m; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Ravichandran M, 2004, CHEMOSPHERE, V55, P319, DOI 10.1016/j.chemosphere.2003.11.011; Richardson G. Mark, 2003, Environmental Reviews, V11, P17, DOI 10.1139/a03-004; Richardson JB, 2013, ENVIRON POLLUT, V182, P127, DOI 10.1016/j.envpol.2013.07.011; Riva-Murray K, 2011, ECOTOXICOLOGY, V9, P1; Rogers VA, 1985, SOIL SURVEY AIKEN CO; Schelker J, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001330; Schwesig D, 1999, WATER AIR SOIL POLL, V113, P141, DOI 10.1023/A:1005080922234; Scudder BC, 2009, 20095109 US GEOL SUR; Scudder Eikenberry BC, 2012, 20111318 US GEOL SUR; Selin NE, 2009, ANNU REV ENV RESOUR, V34, P43, DOI 10.1146/annurev.environ.051308.084314; SHANLEY JB, 2002, EOS T, V83, P45, DOI DOI 10.1029/2002E0000031; Silverman M. H., 2006, SOIL SURVEY HAMILTON; Skyllberg U, 2003, BIOGEOCHEMISTRY, V64, P53, DOI 10.1023/A:1024904502633; Smith DB, 2009, APPL GEOCHEM, V24, P1357, DOI 10.1016/j.apgeochem.2009.04.008; Smith-Downey NV, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001124; Tipping E, 2011, ENVIRON POLLUT, V159, P3721, DOI 10.1016/j.envpol.2011.07.011; Tjerngren I, 2012, BIOGEOCHEMISTRY, V108, P335, DOI 10.1007/s10533-011-9603-1; WANG W, 1995, ENVIRON SCI TECHNOL, V29, P2261, DOI 10.1021/es00009a016; Wiener JG, 2006, ENVIRON SCI TECHNOL, V40, P6261, DOI 10.1021/es060822h; Woodruff LG, 2010, ENVIRON SCI TECHNOL, V44, P5371, DOI 10.1021/es100544d; Woodruff LG, 2009, APPL GEOCHEM, V24, P1369, DOI 10.1016/j.apgeochem.2009.04.009; Woodruff LG, 2010, 516 US GEOL SURV	68	176	184	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e86855	10.1371/journal.pone.0086855	http://dx.doi.org/10.1371/journal.pone.0086855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24614226	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500010
J	Yang, F; Ning, K; Chang, XZ; Yuan, X; Tu, QC; Yuan, T; Deng, Y; Hemme, CL; Van Nostrand, J; Cui, XP; He, ZL; Chen, ZG; Guo, DW; Yu, JB; Zhang, Y; Zhou, JZ; Xu, J				Yang, Fang; Ning, Kang; Chang, Xingzhi; Yuan, Xiao; Tu, Qichao; Yuan, Tong; Deng, Ye; Hemme, Christopher L.; Van Nostrand, Joy; Cui, Xinping; He, Zhili; Chen, Zhenggang; Guo, Dawei; Yu, Jiangbo; Zhang, Yue; Zhou, Jizhong; Xu, Jian			Saliva Microbiota Carry Caries-Specific Functional Gene Signatures	PLOS ONE			English	Article							WHOLE-SALIVA; STREPTOCOCCI; COMMUNITY; ASSOCIATION; EXPERIENCE; TOOL	Human saliva microbiota is phylogenetically divergent among host individuals yet their roles in health and disease are poorly appreciated. We employed a microbial functional gene microarray, HuMiChip 1.0, to reconstruct the global functional profiles of human saliva microbiota from ten healthy and ten caries-active adults. Saliva microbiota in the pilot population featured a vast diversity of functional genes. No significant distinction in gene number or diversity indices was observed between healthy and caries-active microbiota. However, co-presence network analysis of functional genes revealed that caries-active microbiota was more divergent in non-core genes than healthy microbiota, despite both groups exhibited a similar degree of conservation at their respective core genes. Furthermore, functional gene structure of saliva microbiota could potentially distinguish caries-active patients from healthy hosts. Microbial functions such as Diaminopimelate epimerase, Prephenate dehydrogenase, Pyruvate-formate lyase and N-acetylmuramoyl-L-alanine amidase were significantly linked to caries. Therefore, saliva microbiota carried disease-associated functional signatures, which could be potentially exploited for caries diagnosis.	[Yang, Fang; Yuan, Xiao; Chen, Zhenggang; Guo, Dawei; Yu, Jiangbo; Zhang, Yue] Qingdao Municipal Hosp, Oral Res Ctr, Qingdao, Shandong, Peoples R China; [Ning, Kang; Chang, Xingzhi; Xu, Jian] Chinese Acad Sci, CAS Key Lab Biofuels, Shandong Key Lab Energy Genet, Qingdao, Shandong, Peoples R China; [Ning, Kang; Chang, Xingzhi; Xu, Jian] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, BioEnergy Genome Ctr, Qingdao, Shandong, Peoples R China; [Tu, Qichao; Yuan, Tong; Deng, Ye; Hemme, Christopher L.; Van Nostrand, Joy; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Cui, Xinping] Univ Calif Riverside, Dept Stat, Riverside, CA 92521 USA	Qingdao Municipal Hospital; Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Riverside	Zhou, JZ (corresponding author), Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.	jzhou@ou.edu; xujian@qibebt.ac.cn	He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Xu, Jian/G-8430-2012; Zhang, Qiang/B-6233-2012; Deng, Ye/X-4358-2019; Van Nostrand, Joy D/F-1740-2016; Ning, Kang/ABD-3446-2020	He, Zhili/0000-0001-8225-7333; Xu, Jian/0000-0002-0548-8477; Deng, Ye/0000-0002-7584-0632; Van Nostrand, Joy D/0000-0001-9548-6450; Tu, Qichao/0000-0002-3245-7545; Ning, Kang/0000-0003-3325-5387; Yang, Fulin/0000-0002-5530-0954; YANG, Fang/0000-0002-6783-972X	Ministry of Science and Technology of China [2011IM030100, 2009AA02Z310]; National Science Foundation of China [31271410, 31300424]; Qingdao [2011-WSZD029, KJZD-12-16-nsh, VII2013W002]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qingdao	This work was supported in part by grants 2011IM030100 and 2009AA02Z310 from Ministry of Science and Technology of China, grants 31271410 and 31300424 from National Science Foundation of China, and grants 2011-WSZD029, KJZD-12-16-nsh and VII2013W002 from Qingdao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amerongen AV, 2004, CARIES RES, V38, P247, DOI 10.1159/000077762; Baldini C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3523; Baum B J, 2011, Adv Dent Res, V23, P360, DOI 10.1177/0022034511420433; Bergandi L, 2007, EUR J ORAL SCI, V115, P93, DOI 10.1111/j.1600-0722.2007.00437.x; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brinkmann O, 2011, ORAL ONCOL, V47, P51, DOI 10.1016/j.oraloncology.2010.10.009; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Doel JJ, 2004, EUR J ORAL SCI, V112, P424, DOI 10.1111/j.1600-0722.2004.00153.x; Farrell JJ, 2011, GUT; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Fonteles CSR, 2009, ARCH ORAL BIOL, V54, P80, DOI 10.1016/j.archoralbio.2008.07.011; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He Z, 2012, CURR OPIN BIOTECHNOL; He ZL, 2012, CURR OPIN BIOTECH, V23, P49, DOI 10.1016/j.copbio.2011.11.001; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Holgerson PL, 2005, ACTA ODONTOL SCAND, V63, P233, DOI 10.1080/00016350510019883; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang Q, 2012, MOL CELL BIOCH; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Ku HK, 2011, INT J BIOL MACROMOL, V49, P761, DOI 10.1016/j.ijbiomac.2011.07.009; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Martínez-Pabón María C, 2010, Acta odontol. latinoam., V23, P249; Mirzaii-Dizgah Iraj, 2011, J Contemp Dent Pract, V12, P114; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; MORMANN JE, 1983, CARIES RES, V17, P353; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Qi X, 2008, 3 NATL SAMPLING EPID; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Smith AMV, 2007, CARIES RES, V41, P445, DOI 10.1159/000107930; Takahashi-Abbe S, 2003, ORAL MICROBIOL IMMUN, V18, P293, DOI 10.1034/j.1399-302X.2003.00081.x; Tao RC, 2005, ANTIMICROB AGENTS CH, V49, P3883, DOI 10.1128/AAC.49.9.3883-3888.2005; Thanyasrisung P, 2009, ORAL MICROBIOL IMMUN, V24, P451, DOI 10.1111/j.1399-302X.2009.00536.x; Thomadaki K, 2011, J DENT RES, V90, P1325, DOI 10.1177/0022034511420721; VANWUYCKHUYSE BC, 1995, J DENT RES, V74, P686, DOI 10.1177/00220345950740021001; Xiao H, 2011, MOL CELL PROTEOMICS; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Yamamoto Y, 2000, INFECT IMMUN, V68, P4773, DOI 10.1128/IAI.68.8.4773-4777.2000; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zahir S, 2006, J Indian Soc Pedod Prev Dent, V24, P27; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang Q, 2007, J DENT, V35, P177, DOI 10.1016/j.jdent.2006.07.004	47	98	102	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e76458	10.1371/journal.pone.0076458	http://dx.doi.org/10.1371/journal.pone.0076458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24941017	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600001
J	Sun, ZK; He, X; Brancaccio, VF; Yuan, J; Riedel, CU				Sun, Zhongke; He, Xiang; Brancaccio, Vincenzo F.; Yuan, Jing; Riedel, Christian U.			Bifidobacteria Exhibit LuxS-Dependent Autoinducer 2 Activity and Biofilm Formation	PLOS ONE			English	Article							VIBRIO-HARVEYI; LISTERIA-MONOCYTOGENES; EXPRESSION PROFILES; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; GENOME SEQUENCE; LONGUM NCC2705; BACTERIA; LUMINESCENCE; METABOLISM	Autoinducer-2 (AI-2) molecules are one class of signalling molecules involved in gene regulation dependent on population density in a mechanism commonly referred to as quorum sensing (QS). AI-2 is produced by the methylthioadenosine/S-adenosyl-homocysteine nucleosidase LuxS. In the present study, we characterise the function of bifidobacterial LuxS proteins to address the question whether these economically important bacteria are able to perform QS communication. All publically available genome sequences of bifidobacteria harbour putative luxS genes. The deduced amino acid sequences are well conserved in the genus and show good homology to the LuxS protein of the prototypical AI-2 producer Vibrio harveyi. The luxS genes of three bifidobacterial strains were successfully expressed in AI-2-negative Escherichia coli DH5 alpha. Supernatants of these recombinant E. coli strains contained significant AI-2 activity. In initial experiments, we failed to detect AI-2 activity in supernatants of bifidobacteria grown in MRSc. High concentration of glucose as well as acidic pH had strong inhibitory effects on AI-2 activity. AI-2 activity could be detected when lower volumes of supernatants were used in the assay. Homologous overexpression of luxS in Bifidobacterium longum NCC2705 increased AI-2 levels in the supernatant. Furthermore, over-expression of luxS or supplementation with AI-2-containing supernatants enhanced biofilm formation of B. longum NCC2705. Collectively, these results suggest that bifidobacteria indeed harbour functional luxS genes that are involved in the production of AI-2-like molecules. To the best of our knowledge, this represents the first report on AI-2 activity produced by bifidobacteria. Self-produced AI-2 activity as well as AI-2-like molecules of other bacteria of the intestinal tract may have a regulatory function in biofilm formation and host colonization by bifidobacteria.	[Sun, Zhongke; Brancaccio, Vincenzo F.; Riedel, Christian U.] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany; [He, Xiang; Yuan, Jing] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China	Ulm University; Academy of Military Medical Sciences - China	Yuan, J (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	yuanjing6216@163.com; christian.riedel@uni-ulm.de	Sun, Zhongke/AAF-5743-2020; Sun, Zhongke/R-2274-2019	Sun, Zhongke/0000-0002-9784-9769; Riedel, Christian U./0000-0001-7134-7085	German Academic Exchange Service/Federal Ministry of Education and Research [D/09/04778]; German Academic Exchange Service	German Academic Exchange Service/Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)Deutscher Akademischer Austausch Dienst (DAAD)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This study was partially funded by the German Academic Exchange Service/Federal Ministry of Education and Research (grant D/09/04778) to CUR. ZS was supported by a PhD fellowship of the German Academic Exchange Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Belval SC, 2006, APPL ENVIRON MICROB, V72, P2644, DOI 10.1128/AEM.72.4.2644-2650.2006; Brancaccio VF, 2013, BIOENGINEERED, V4, P197, DOI 10.4161/bioe.23381; DeKeersmaecker SCJ, 2003, MICROBIOL-SGM, V149, P1953, DOI 10.1099/mic.0.C0117-0; Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006; Hardie KR, 2003, MICROBIOL-SGM, V149, P715, DOI 10.1099/mic.0.25853-0; Klijn A, 2006, APPL ENVIRON MICROB, V72, P7401, DOI 10.1128/AEM.01611-06; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Leahy SC, 2005, J APPL MICROBIOL, V98, P1303, DOI 10.1111/j.1365-2672.2005.02600.x; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Mijakovic I, 2012, FEMS MICROBIOL REV, V36, P877, DOI 10.1111/j.1574-6976.2011.00314.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Riedel CU, 2006, INT J FOOD MICROBIOL, V110, P62, DOI 10.1016/j.ijfoodmicro.2006.01.040; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela S, 2006, APPL ENVIRON MICROB, V72, P5653, DOI 10.1128/AEM.00048-06; SHENG Y, 1995, NUCLEIC ACIDS RES, V23, P1990, DOI 10.1093/nar/23.11.1990; Soufi B, 2012, CURR OPIN MICROBIOL, V15, P357, DOI 10.1016/j.mib.2012.05.003; Taga Michiko E, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01c01s00; Turovskiy Y, 2006, J MICROBIOL METH, V66, P497, DOI 10.1016/j.mimet.2006.02.001; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vilchez R, 2007, ANAL BIOANAL CHEM, V387, P489, DOI 10.1007/s00216-006-0824-4; Wilson CM, 2012, J BACTERIOL, V194, P1743, DOI 10.1128/JB.06318-11; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yuan J, 2008, J PROTEOME RES, V7, P375, DOI 10.1021/pr0704940; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zhurina D, 2011, J BACTERIOL, V193, P301, DOI 10.1128/JB.01180-10	36	55	66	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88260	10.1371/journal.pone.0088260	http://dx.doi.org/10.1371/journal.pone.0088260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24520369	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200156
J	Burns, G; Brooks, K; Wildung, M; Navakanitworakul, R; Christenson, LK; Spencer, TE				Burns, Gregory; Brooks, Kelsey; Wildung, Mark; Navakanitworakul, Raphatphorn; Christenson, Lane K.; Spencer, Thomas E.			Extracellular Vesicles in Luminal Fluid of the Ovine Uterus	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; ENDOGENOUS RETROVIRUSES; INTERFERON-TAU; EXOSOMES; PREGNANCY; EXPRESSION; MICRORNAS; PROTEIN; GENES; RNA	Microvesicles and exosomes are nanoparticles released from cells and can contain small RNAs, mRNA and proteins that affect cells at distant sites. In sheep, endogenous beta retroviruses (enJSRVs) are expressed in the endometrial epithelia of the uterus and can be transferred to the conceptus trophectoderm. One potential mechanism of enJSRVs transfer from the uterus to the conceptus is via exosomes/microvesicles. Therefore, studies were conducted to evaluate exosomes in the uterine luminal fluid (ULF) of sheep. Exosomes/microvesicles (hereafter referred to as extracellular vesicles) were isolated from the ULF of day 14 cyclic and pregnant ewes using ExoQuick-TC. Transmission electron microscopy and nanoparticle tracking analysis found the isolates contained vesicles that ranged from 50 to 200 nm in diameter. The isolated extracellular vesicles were positive for two common markers of exosomes (CD63 and HSP70) by Western blot analysis. Proteins in the extracellular vesicles were determined by mass spectrometry and Western blot analysis. Extracellular vesicle RNA was analyzed for small RNAs by sequencing and enJSRVs RNA by RT-PCR. The ULF extracellular vesicles contained a large number of small RNAs and miRNAs including 81 conserved mature miRNAs. Cyclic and pregnant ULF extracellular vesicles contained enJSRVs env and gag RNAs that could be delivered to heterologous cells in vitro. These studies support the hypothesis that ULF extracellular vesicles can deliver enJSRVs RNA to the conceptus, which is important as enJSRVs regulate conceptus trophectoderm development. Importantly, these studies support the idea that extracellular vesicles containing select miRNAs, RNAs and proteins are present in the ULF and likely have a biological role in conceptus-endometrial interactions important for the establishment and maintenance of pregnancy.	[Burns, Gregory; Brooks, Kelsey; Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Wildung, Mark] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Navakanitworakul, Raphatphorn; Christenson, Lane K.] Univ Kansas, Dept Mol & Integrat Physiol, Sch Med, Kansas City, KS USA	Washington State University; Washington State University; University of Kansas; University of Kansas Medical Center	Spencer, TE (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	thomas.spencer@wsu.edu	Burns, Douglas/A-7507-2009; Spencer, Thomas/AAD-6434-2020; Bradley, Paul M./AAC-2451-2020; navakanitworakul, raphatphorn/T-5948-2017	Bradley, Paul M./0000-0001-7522-8606; navakanitworakul, raphatphorn/0000-0001-6408-0079; Spencer, Thomas/0000-0003-2815-766X; Burns, Douglas/0000-0001-6516-2869; Burns, Gregory/0000-0003-0021-4319	USDA National Institute of Food and Agriculture [2012-67015-30173]; National Institute of Health [HD061580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061580] Funding Source: NIH RePORTER	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported in part by AFRI Competitive Grant 2012-67015-30173 (TES) from the USDA National Institute of Food and Agriculture and HD061580 (LKC) from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Black SG, 2010, J VIROL, V84, P9078, DOI 10.1128/JVI.00950-10; Dorniak P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097063; Dorniak P, 2011, BIOL REPROD, V84, P1119, DOI 10.1095/biolreprod.110.089979; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FLECHON JE, 1986, REPROD NUTR DEV, V26, P1017, DOI 10.1051/rnd:19860609; Forbes K, 2012, PLACENTA, V33, P581, DOI 10.1016/j.placenta.2012.03.006; Forde N, 2010, PHYSIOL GENOMICS, V41, P53, DOI 10.1152/physiolgenomics.00162.2009; Frangsmyr L, 2005, MOL HUM REPROD, V11, P35, DOI 10.1093/molehr/gah129; FRASER M, 1994, ENDOCRINOLOGY, V135, P2440, DOI 10.1210/en.135.6.2440; Gifford CA, 2007, J DAIRY SCI, V90, P274, DOI 10.3168/jds.S0022-0302(07)72628-0; GIRAUD A, 1994, ENDOCRINOLOGY, V135, P2806, DOI 10.1210/en.135.6.2806; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; GUILLOMOT M, 1995, J REPROD FERTIL, P39; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Racicot K, 2012, AM J REPROD IMMUNOL, V67, P498, DOI 10.1111/j.1600-0897.2012.01109.x; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Simmons RM, 2010, BIOL REPROD, V82, P35, DOI 10.1095/biolreprod.109.079608; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Song G, 2007, PLACENTA, V28, P1091, DOI 10.1016/j.placenta.2007.04.004; Song GH, 2005, ENDOCRINOLOGY, V146, P4825, DOI 10.1210/en.2005-0768; Song G, 2008, BIOL REPROD, V79, P376, DOI 10.1095/biolreprod.108.068403; Spencer T E, 2007, Soc Reprod Fertil Suppl, V64, P379; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102; Spencer TE, 2012, J REPROD DEVELOP, V58, P33, DOI 10.1262/jrd.2011-026; Spencer Thomas E, 2004, Reprod Biol Endocrinol, V2, P49, DOI 10.1186/1477-7827-2-49; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Urnovitz HB, 1996, CLIN MICROBIOL REV, V9, P72, DOI 10.1128/CMR.9.1.72; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	61	176	184	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90913	10.1371/journal.pone.0090913	http://dx.doi.org/10.1371/journal.pone.0090913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614226	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300053
J	Shen, Y; Honma, N; Kobayashi, K; Jia, LN; Hosono, T; Shindo, K; Ariga, T; Seki, T				Shen, Yan; Honma, Natsumi; Kobayashi, Katsuya; Jia, Liu Nan; Hosono, Takashi; Shindo, Kazutoshi; Ariga, Toyohiko; Seki, Taiichiro			Cinnamon Extract Enhances Glucose Uptake in 3T3-L1 Adipocytes and C2C12 Myocytes by Inducing LKB1-AMP-Activated Protein Kinase Signaling	PLOS ONE			English	Article							HUMAN HEPG2 CELLS; INSULIN SENSITIVITY; DIABETES-MELLITUS; MUSCLE-CELLS; IN-VIVO; ACTIVATION; TYPE-2; METFORMIN; LKB1; AMPK	We previously demonstrated that cinnamon extract (CE) ameliorates type 1 diabetes induced by streptozotocin in rats through the up-regulation of glucose transporter 4 (GLUT4) translocation in both muscle and adipose tissues. This present study was aimed at clarifying the detailed mechanism(s) with which CE increases the glucose uptake in vivo and in cell culture systems using 3T3-L1 adipocytes and C2C12 myotubes in vitro. Specific inhibitors of key enzymes in insulin signaling and AMP-activated protein kinase (AMPK) signaling pathways, as well as small interference RNA, were used to examine the role of these kinases in the CE-induced glucose uptake. The results showed that CE stimulated the phosphorylation of AMPK and acetyl-CoA carboxylase. An AMPK inhibitor and LKB1 siRNA blocked the CE-induced glucose uptake. We also found for the first time that insulin suppressed AMPK activation in the adipocyte. To investigate the effect of CE on type 2 diabetes in vivo, we further performed oral glucose tolerance tests and insulin tolerance tests in type 2 diabetes model rats administered with CE. The CE improved glucose tolerance in oral glucose tolerance tests, but not insulin sensitivity in insulin tolerance test. In summary, these results indicate that CE ameliorates type 2 diabetes by inducing GLUT4 translocation via the AMPK signaling pathway. We also found insulin antagonistically regulates the activation of AMPK.	[Shen, Yan; Honma, Natsumi; Kobayashi, Katsuya; Hosono, Takashi; Ariga, Toyohiko; Seki, Taiichiro] Nihon Univ, Coll Bioresource Sci, Grad Sch Bioresource Sci, Dept Chem & Life Sci, Fujisawa, Kanagawa, Japan; [Jia, Liu Nan] Nihon Univ, Sch Pharm, Chiba, Japan; [Shindo, Kazutoshi] Japan Womens Univ, Dept Food & Nutr, Tokyo 112, Japan	Nihon University; Nihon University; Japan Womens University	Hosono, T (corresponding author), Nihon Univ, Coll Bioresource Sci, Grad Sch Bioresource Sci, Dept Chem & Life Sci, Fujisawa, Kanagawa, Japan.	hosono.takashi@nihon-u.ac.jp			Nihon University; Japan Science and Technology Agency (JST) A-STEP program; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Nihon University; Japan Science and Technology Agency (JST) A-STEP program; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Nihon University individual research grant program (to T. S.). This work was also supported by grants from the Japan Science and Technology Agency (JST) A-STEP program (to T. H.). Y.S. is supported by a Fellowship from the Academic Frontier Project from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Amitani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053913; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; Babu PS, 2007, PHYTOMEDICINE, V14, P15, DOI 10.1016/j.phymed.2006.11.005; Beauloye C, 2001, FEBS LETT, V505, P348, DOI 10.1016/S0014-5793(01)02788-0; BERRIO LF, 1992, HORM RES, V37, P225, DOI 10.1159/000182317; Blevins SM, 2007, DIABETES CARE, V30, P2236, DOI 10.2337/dc07-0098; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheng BC., 1983, ZHONG CAO YAO, V14, P134; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gamble J, 1997, METABOLISM, V46, P1270, DOI 10.1016/S0026-0495(97)90229-8; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang YP, 2013, J NUTR BIOCHEM, V24, P1469, DOI 10.1016/j.jnutbio.2012.12.006; Hwang YP, 2013, MOL NUTR FOOD RES, V57, P471, DOI 10.1002/mnfr.201200529; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kannappan S., 2006, SMJ Singapore Medical Journal, V47, P858; Kim SH, 2006, J ETHNOPHARMACOL, V104, P119, DOI 10.1016/j.jep.2005.08.059; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Leverve XM, 2003, DIABETES METAB, V29, pS88; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mang B, 2006, EUR J CLIN INVEST, V36, P340, DOI 10.1111/j.1365-2362.2006.01629.x; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Onderoglu S, 1999, J PHARM PHARMACOL, V51, P1305, DOI 10.1211/0022357991776886; Pham AQ, 2007, PHARMACOTHERAPY, V27, P595, DOI 10.1592/phco.27.4.595; Qin B, 2004, HORM METAB RES, V36, P119, DOI 10.1055/s-2004-814223; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Ragolia L, 1997, ENDOCRINOLOGY, V138, P2398, DOI 10.1210/en.138.6.2398; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Riddle MC, 1999, AM FAM PHYSICIAN, V60, P2613; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Seki T, 2001, J CELL PHYSIOL, V189, P72, DOI 10.1002/jcp.1140; Sewter C, 2002, DIABETES OBES METAB, V4, P239, DOI 10.1046/j.1463-1326.2002.00187.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2418, DOI 10.1271/bbb.100453; Suppapitiporn S, 2006, J MED ASS THAI S3, V89, pS200; Vanschoonbeek K, 2006, J NUTR, V136, P977, DOI 10.1093/jn/136.4.977; Verspohl EJ, 2005, PHYTOTHER RES, V19, P203, DOI 10.1002/ptr.1643; Wang JG, 2007, FERTIL STERIL, V88, P240, DOI 10.1016/j.fertnstert.2006.11.082; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	50	82	86	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e87894	10.1371/journal.pone.0087894	http://dx.doi.org/10.1371/journal.pone.0087894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24748132	Green Published, gold, Green Submitted			2022-12-27	WOS:000331271500023
J	Yang, FL; Zhang, Q; Wang, RY; Zhou, J				Yang, Fulin; Zhang, Qiang; Wang, Runyuan; Zhou, Jing			Evapotranspiration Measurement and Crop Coefficient Estimation over a Spring Wheat Farmland Ecosystem in the Loess Plateau	PLOS ONE			English	Article							WATER-VAPOR; WINTER-WHEAT; MAIZE; TRANSPIRATION; MODEL; HEAT; FLUX; GRASSLAND; EXCHANGE; REGION	Evapotranspiration (ET) is an important component of the surface energy balance and hydrological cycle. In this study, the eddy covariance technique was used to measure ET of the semi-arid farmland ecosystem in the Loess Plateau during 2010 growing season (April to September). The characteristics and environmental regulations of ET and crop coefficient (Kc) were investigated. The results showed that the diurnal variation of latent heat flux (LE) was similar to single-peak shape for each month, with the largest peak value of LE occurring in August (151.4 W m(-2)). The daily ET rate of the semi-arid farmland in the Loess Plateau also showed clear seasonal variation, with the maximum daily ET rate of 4.69 mm day(-1). Cumulative ET during 2010 growing season was 252.4 mm, and lower than precipitation. Radiation was the main driver of farmland ET in the Loess Plateau, which explained 88% of the variances in daily ET (p<0.001). The farmland Kc values showed the obvious seasonal fluctuation, with the average of 0.46. The correlation analysis between daily Kc and its major environmental factors indicated that wind speed (Ws), relative humidity (RH), soil water content (SWC), and atmospheric vapor pressure deficit (VPD) were the major environmental regulations of daily Kc. The regression analysis results showed that Kc exponentially decreased with Ws increase, an exponentially increased with RH, SWC increase, and a linearly decreased with VPD increase. An experiential Kc model for the semi-arid farmland in the Loess Plateau, driven by Ws, RH, SWC and VPD, was developed, showing a good consistency between the simulated and the measured Kc values.	[Yang, Fulin; Zhang, Qiang; Wang, Runyuan] CMA, Inst Arid Meteorol, Key Open Lab Arid Climat Change & Disaster Reduct, Key Lab Arid Climat Change & Reducing Disaster Ga, Lanzhou, Peoples R China; [Zhou, Jing] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China	China Meteorological Administration; Lanzhou University	Zhang, Q (corresponding author), CMA, Inst Arid Meteorol, Key Open Lab Arid Climat Change & Disaster Reduct, Key Lab Arid Climat Change & Reducing Disaster Ga, Lanzhou, Peoples R China.	zhangqiang@cma.gov.cn	He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Xu, Jian/G-8430-2012; Zhang, Qiang/B-6233-2012; Deng, Ye/X-4358-2019; Van Nostrand, Joy D/F-1740-2016; Ning, Kang/ABD-3446-2020	He, Zhili/0000-0001-8225-7333; Xu, Jian/0000-0002-0548-8477; Deng, Ye/0000-0002-7584-0632; Van Nostrand, Joy D/0000-0001-9548-6450; Tu, Qichao/0000-0002-3245-7545; Ning, Kang/0000-0003-3325-5387; Yang, Fulin/0000-0002-5530-0954; YANG, Fang/0000-0002-6783-972X	National Basic Research Program of China [2012CB955304, 2013CB430206]; National Natural Science Foundation of China [31300376, 40830957, 41275118, 41305134]; Natural Science Foundation of Gansu province [1208RJYA025]; China Postdoctoral Science Foundation [2012M512044]; Meteorological Research Program of Gansu Provincial Meteorological Service; Science Research Foundation for Drought Meteorology [IAM201312]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Meteorological Research Program of Gansu Provincial Meteorological Service; Science Research Foundation for Drought Meteorology	This research was jointly supported by National Basic Research Program of China (2012CB955304, 2013CB430206), National Natural Science Foundation of China (31300376, 40830957, 41275118, 41305134), Natural Science Foundation of Gansu province (1208RJYA025), China Postdoctoral Science Foundation (2012M512044), Meteorological Research Program of Gansu Provincial Meteorological Service (2012-15), and Science Research Foundation for Drought Meteorology (IAM201312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[张永强 Zhang Yongqiang], 2002, [地理学报, Acta Geographica Sinica], V57, P333; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Baldocchi D, 1998, AGR FOREST METEOROL, V90, P1, DOI 10.1016/S0168-1923(97)00072-5; Burba GG, 2005, AGR FOREST METEOROL, V135, P190, DOI 10.1016/j.agrformet.2005.11.017; Ding RS, 2013, AGR FOREST METEOROL, V168, P140, DOI 10.1016/j.agrformet.2012.08.003; Falge E, 2001, AGR FOREST METEOROL, V107, P71, DOI 10.1016/S0168-1923(00)00235-5; [郭家选 GUO JiaXuan], 2006, [生态学报, Acta Ecologica Sinica], V26, P130; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kang SZ, 2003, AGR WATER MANAGE, V59, P239, DOI 10.1016/S0378-3774(02)00150-6; Kimura R, 2006, ACTA OECOL, V29, P45, DOI 10.1016/j.actao.2005.07.003; Kite G, 2000, J HYDROL, V229, P59, DOI 10.1016/S0022-1694(99)00199-7; Lei HM, 2010, AGR FOREST METEOROL, V150, P581, DOI 10.1016/j.agrformet.2010.01.022; Li SG, 2005, HYDROL PROCESS, V19, P517, DOI 10.1002/hyp.5673; Li Yi-Jun, 2007, Zhiwu Shengtai Xuebao, V31, P1132; Li YL, 2003, AGR WATER MANAGE, V61, P1, DOI 10.1016/S0378-3774(02)00177-4; [李志 Li Zhi], 2012, [生态学报, Acta Ecologica Sinica], V32, P4139; Li Zhi, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P106; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Lockwood JG, 1999, CLIMATIC CHANGE, V41, P193, DOI 10.1023/A:1005469416067; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Pauwels VRN, 2006, AGR WATER MANAGE, V82, P1, DOI 10.1016/j.agwat.2005.06.001; Qin Z, 2004, SCI CHINA SER D, V34, P183; Suyker AE, 2008, AGR FOREST METEOROL, V148, P417, DOI 10.1016/j.agrformet.2007.10.005; Trezza R, 2013, REMOTE SENS-BASEL, V5, P5397, DOI 10.3390/rs5105397; Villalobos FJ, 2013, AGR FOREST METEOROL, V171, P93, DOI 10.1016/j.agrformet.2012.11.010; Wang GY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013372; Wang KC, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000373; Wang YouQi, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P6; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Xuan SL, 2011, ADV ATMOS SCI, V28, P387, DOI 10.1007/s00376-010-0111-3; Yang FL, 2011, J HYDROL, V396, P139, DOI 10.1016/j.jhydrol.2010.11.001; Yang K, 2008, SCI CHINA SER D, V51, P721, DOI 10.1007/s11430-008-0036-1; [杨晓光 Yang Xiaohua], 2003, [中国生态农业学报, Chinese journal of eco-agriculture], V11, P66; Yu GR, 2006, AGR FOREST METEOROL, V137, P125, DOI 10.1016/j.agrformet.2006.02.011; Yu WY, 2008, ACTA ECOL SINICA, V28, P4894; Zhang BZ, 2013, IRRIGATION SCI, V31, P1303, DOI 10.1007/s00271-013-0405-1; Zhang Q, 2011, CHINESE J GEOPHYS-CH, V54, P1727, DOI 10.3969/j.issn.0001-5733.2011.07.005; 信忠保, 2007, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V37, P1504	38	98	102	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100031	10.1371/journal.pone.0100031	http://dx.doi.org/10.1371/journal.pone.0100031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941017	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200068
J	Fretwell, PT; Trathan, PN; Wienecke, B; Kooyman, GL				Fretwell, Peter T.; Trathan, Phil N.; Wienecke, Barbara; Kooyman, Gerald L.			Emperor Penguins Breeding on Iceshelves	PLOS ONE			English	Article							ANTARCTIC PENINSULA; SOUTHERN-OCEAN; CLIMATE-CHANGE; VARIABILITY; RESPONSES	We describe a new breeding behaviour discovered in emperor penguins; utilizing satellite and aerial-survey observations four emperor penguin breeding colonies have been recorded as existing on ice-shelves. Emperors have previously been considered as a sea-ice obligate species, with 44 of the 46 colonies located on sea-ice (the other two small colonies are on land). Of the colonies found on ice-shelves, two are newly discovered, and these have been recorded on shelves every season that they have been observed, the other two have been recorded both on ice-shelves and sea-ice in different breeding seasons. We conduct two analyses; the first using synthetic aperture radar data to assess why the largest of the four colonies, for which we have most data, locates sometimes on the shelf and sometimes on the sea-ice, and find that in years where the sea-ice forms late, the colony relocates onto the ice-shelf. The second analysis uses a number of environmental variables to test the habitat marginality of all emperor penguin breeding sites. We find that three of the four colonies reported in this study are in the most northerly, warmest conditions where sea-ice is often sub-optimal. The emperor penguin's reliance on sea-ice as a breeding platform coupled with recent concerns over changed sea-ice patterns consequent on regional warming, has led to their designation as "near threatened'' in the IUCN red list. Current climate models predict that future loss of sea-ice around the Antarctic coastline will negatively impact emperor numbers; recent estimates suggest a halving of the population by 2052. The discovery of this new breeding behaviour at marginal sites could mitigate some of the consequences of sea-ice loss; potential benefits and whether these are permanent or temporary need to be considered and understood before further attempts are made to predict the population trajectory of this iconic species.	[Fretwell, Peter T.; Trathan, Phil N.] British Antarctic Survey, Cambridge CB3 0ET, England; [Wienecke, Barbara] Australian Antarctic Div, Hobart, Tas, Australia; [Kooyman, Gerald L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian Antarctic Division; University of California System; University of California San Diego; Scripps Institution of Oceanography	Fretwell, PT (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	ptf@bas.ac.uk		Staniland, Iain/0000-0003-2736-9134; , gerald/0000-0002-8872-2950	BAS-NERC ecosystems programme; NERC [bas0100025, bas010011] Funding Source: UKRI; Natural Environment Research Council [bas0100025, bas010011] Funding Source: researchfish	BAS-NERC ecosystems programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this study came internally from BAS-NERC ecosystems programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Barbraud C, 2011, ANTARCT SCI, V23, P461, DOI 10.1017/S0954102011000356; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; IUCN, 2013, IUCN RED LIST THREAT; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; KLAGES N, 1989, POLAR BIOL, V9, P385, DOI 10.1007/BF00442529; KOOYMAN GL, 1993, ANTARCT SCI, V5, P143, DOI 10.1017/S0954102093000203; Larsen C., 1894, GEOGR J, V4, P333, DOI [DOI 10.2307/1773537, 10.2307/1773537]; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Morris EM, 2003, ANTARCT RES SER, V79, P61; Rack W, 2004, ANN GLACIOL-SER, V39, P505, DOI 10.3189/172756404781814005; Serrezer MC, 2007, SCIENCE, V315, P5818; Sime LC, 2009, NATURE, V462, P342, DOI 10.1038/nature08564; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Trathan PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014738; Turner J., 2009, ANTARCTIC CLIMATE CH; van Lipzig NPM, 2002, INT J CLIMATOL, V22, P1197, DOI 10.1002/joc.798; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Wienecke B, 2012, POLAR BIOL, V35, P1289, DOI 10.1007/s00300-012-1172-9; Wienecke B, 2010, POLAR REC, V46, P271, DOI 10.1017/S0032247409990283	29	56	63	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85285	10.1371/journal.pone.0085285	http://dx.doi.org/10.1371/journal.pone.0085285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24533131	Green Published, Green Accepted, gold			2022-12-27	WOS:000329862500234
J	Zhang, YG; Qiu, L; Li, SJ; Xiang, YC; Chen, JY; Ren, YG				Zhang, Yiguo; Qiu, Lu; Li, Shaojun; Xiang, Yuancai; Chen, Jiayu; Ren, Yonggang			The C-Terminal Domain of Nrf1 Negatively Regulates the Full-Length CNC-bZIP Factor and Its Shorter Isoform LCR-F1/Nrf1 beta; Both Are Also Inhibited by the Small Dominant-Negative Nrf1 gamma/delta Isoforms that Down-Regulate ARE-Battery Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF1; TNF-ALPHA PROMOTER; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; EMBRYONIC LETHALITY; BINDING DOMAIN; BETA-TRCP; KEAP1	The C-terminal domain (CTD, aa 686-741) of nuclear factor-erythroid 2 p45-related factor 1 (Nrf1) shares 53% amino acid sequence identity with the equivalent Neh3 domain of Nrf2, a homologous transcription factor. The Neh3 positively regulates Nrf2, but whether the Neh3-like (Neh3L) CTD of Nrf1 has a similar role in regulating Nrf1-target gene expression is unknown. Herein, we report that CTD negatively regulates the full-length Nrf1 (i.e. 120-kDa glycoprotein and 95-kDa deglycoprotein) and its shorter isoform LCR-F1/Nrf1 beta (55-kDa). Attachment of its CTD-adjoining 112-aa to the C-terminus of Nrf2 yields the chimaeric Nrf2-C112(Nrf1) factor with a markedly decreased activity. Live-cell imaging of GFP-CTD reveals that the extra-nuclear portion of the fusion protein is allowed to associate with the endoplasmic reticulum (ER) membrane through the amphipathic Neh3L region of Nrf1 and its basic c-tail. Thus removal of either the entire CTD or the essential Neh3L portion within CTD from Nrf1, LCR-F1/Nrf1 beta and Nrf2-C112(Nrf1), results in an increase in their transcriptional ability to regulate antioxidant response element (ARE)-driven reporter genes. Further examinations unravel that two smaller isoforms, 36-kDa Nrf1 gamma and 25-kDa Nrf1 delta, act as dominant-negative inhibitors to compete against Nrf1, LCR-F1/Nrf1 beta and Nrf2. Relative to Nrf1, LCR-F1/Nrf1 beta is a weak activator, that is positively regulated by its Asn/Ser/Thr-rich (NST) domain and acidic domain 2 (AD2). Like AD1 of Nrf1, both AD2 and NST domain of LCR-F1/Nrf1 beta fused within two different chimaeric contexts to yield Gal4D:Nrf1 beta(607) and Nrf1 beta:C270(Nrf2), positively regulate their transactivation activity of cognate Gal4- and Nrf2-target reporter genes. More importantly, differential expression of endogenous ARE-battery genes is attributable to up-regulation by Nrf1 and LCR-F1/Nrf1 beta and down-regulation by Nrf1 gamma and Nrf1 delta.	[Zhang, Yiguo] Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China; Chongqing Univ, Fac Life Sci, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Zhang, YG (corresponding author), Chongqing Univ, Coll Med Bioengn, Lab Cell Biochem & Gene Regulat, Chongqing 630044, Peoples R China.	yiguozhang@cqu.edu.cn		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	National Natural Science Foundation of China [91129703, 31270879]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (key program 91129703 and project 31270879) awarded to Prof. Yiguo Zhang (University of Chongqing, China). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; Grimberg KB, 2011, MOL CELL BIOL, V31, P897, DOI 10.1128/MCB.00799-10; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Husberg C, 2001, J BIOL CHEM, V276, P17641, DOI 10.1074/jbc.M007951200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; Koch A, 2011, CELL CYCLE, V10, P1200, DOI 10.4161/cc.10.8.15327; Kusunoki H, 2002, NAT STRUCT BIOL, V9, P252, DOI 10.1038/nsb771; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwong EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048404; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Li X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002119; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prieschl EE, 1998, NUCLEIC ACIDS RES, V26, P2291, DOI 10.1093/nar/26.10.2291; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rupert PB, 1998, NAT STRUCT BIOL, V5, P484, DOI 10.1038/nsb0698-484; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAKURAI A, 1990, MOL ENDOCRINOL, V4, P1988, DOI 10.1210/mend-4-12-1988; Schultz MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087204; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2013, MOL CELL BIOL, V33, P3461, DOI 10.1128/MCB.01271-12; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Wang HY, 2013, CANCER RES, V73, P3097, DOI 10.1158/0008-5472.CAN-12-3386; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wu JL, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-9; Xiao H, 2013, CURR CHEM BIOL, V7, P151, DOI [DOI 10.2174/2212796811307020008, 10.2174/2212796811307020008]; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang Y, 2014, MS1305858; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093458; Zhang YG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02006; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575; Zhang Y, 2009, J BIOL CHEM, V284, P3195, DOI 10.1074/jbc.M805337200; [张玉台 Zhang Yutai], 2009, [管理世界, Management World], P1; Zhong YW, 2012, J BIOL CHEM, V287, P28057, DOI 10.1074/jbc.M112.381798	71	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2014	9	10							e109159	10.1371/journal.pone.0109159	http://dx.doi.org/10.1371/journal.pone.0109159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ4VK	25290918	Green Published, gold, Green Submitted			2022-12-27	WOS:000342798000041
J	Zhang, YJ; Wang, DM; Yang, LN; Zhou, D; Zhang, JF				Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang			Purification and Characterization of Flavonoids from the Leaves of Zanthoxylum bungeanum and Correlation between Their Structure and Antioxidant Activity	PLOS ONE			English	Article							ALDOSE REDUCTASE; DNA-DAMAGE; EXTRACTS; ALKYLAMIDES; PROTECTION; PERICARPS; QUERCETIN; CHROMATOGRAPHY; CONSTITUENTS; INHIBITION	Nine flavonoids were isolated and characterized from the leaves of Zanthoxylum bungeanum. Their structures were elucidated by spectroscopic techniques as quercetin (1), afzelin (2), quercitrin (3), trifolin (4), quercetin-3-O-beta-D-glucoside (5), isorhamnetin 3-O-alpha-L-rhamnoside (6), hyperoside (7), vitexin (8) and rutin (9). All compounds were isolated from the leaves of Z. bungeanum for the first time. Five compounds (2, 4, 5, 6 and 8) were found for the first time in the genus Zanthoxylum. To learn the mechanisms underlying its health benefits, in vitro (DPPH, ABTS, FRAP and lipid peroxidation inhibition assays) and in vivo (protective effect on Escherichia coli under peroxide stress) antioxidant activities of the nine flavonoids were measured. Quercetin and quercetin glycosides (compounds 1, 3, 5, 7, 9) showed the highest antioxidant activity. Structure-activity relationships indicated that the -OH in 49 position on the B ring and the -OH in 7 position on the A ring possessed high antioxidant activity; B ring and/or A ring with adjacent -OH groups could greatly increase their antioxidant ability. Also, due to the different structures of various flavonoids, they will certainly exhibit different antioxidant capacity when the reactions occur in solution or in oil-in-water emulsion. These findings suggest that Z. bungeanum leaves may have health benefits when consumed. It could become a useful supplement for pharmaceutical products and functional food ingredients in both nutraceutical and food industries as a potential source of natural antioxidants.	[Zhang, Yujuan; Wang, Dongmei; Yang, Lina; Zhou, Dan; Zhang, Jingfang] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China	Northwest A&F University - China	Wang, DM (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.	dmwli@163.com		Jia, Jianping/0000-0003-4624-0336; Zhang, Yujuan/0000-0002-3243-1644; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548	Special Fund for Forestry Scientific Research in the Public Interest of China [201304811]; Fundamental Research Funds for the Central Universities [ZD2013010]	Special Fund for Forestry Scientific Research in the Public Interest of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to the research fund from the Special Fund for Forestry Scientific Research in the Public Interest of China (201304811) and the Fundamental Research Funds for the Central Universities (ZD2013010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Azimova SS, 2013, PHYSICOCHEMCIAL PHAR; Bauer R, 2011, CURR CLIN UROL, P191, DOI 10.1007/978-1-60327-420-3_10; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bourassa P, 2013, J PHOTOCH PHOTOBIO B, V128, P43, DOI 10.1016/j.jphotobiol.2013.07.021; Chang ZQ, 1981, ACTA PHARM SINICA, V16, P394; Costantino L, 1997, EXPERT OPIN THER PAT, V7, P843, DOI 10.1517/13543776.7.8.843; de Freitas V, 2001, J AGR FOOD CHEM, V49, P940, DOI 10.1021/jf000981z; Decker EA, 2005, J AGR FOOD CHEM, V53, P4303, DOI 10.1021/jf058012x; [邓振义 Deng Zhenyi], 2005, [西北林学院学报, Journal of Northwest Forestry College], V20, P179; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Dorman H. J. D., 1995, Journal of Essential Oil Research, V7, P645; Dubeau S, 2010, FOOD CHEM, V122, P539, DOI 10.1016/j.foodchem.2010.03.005; Duke J. A., 1985, MED PLANTS CHINA, P705; Ferrali M, 1997, FEBS LETT, V416, P123, DOI 10.1016/S0014-5793(97)01182-4; GALVEZ J, 1993, J PHARM PHARMACOL, V45, P157, DOI 10.1111/j.2042-7158.1993.tb03706.x; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HUANG XL, 1993, PHYTOTHER RES, V7, P41, DOI 10.1002/ptr.2650070111; Ibrahim LF, 2002, MOLECULES, V7, P245; Jung HA, 2011, FOOD CHEM TOXICOL, V49, P376, DOI 10.1016/j.fct.2010.11.012; KIMUYA Y, 1981, CHEM PHARM BULL, V29, P2610; Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w; Li H, 2012, FOOD CHEM, V135, P2942, DOI 10.1016/j.foodchem.2012.07.048; Li Y, 2001, Zhong Yao Cai, V24, P572; Ma XF, 2005, J CHROMATOGR A, V1070, P211, DOI 10.1016/j.chroma.2005.02.052; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Miguel G, 2004, FOOD CHEM, V86, P183, DOI 10.1016/j.foodchem.2003.08.031; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2362, DOI 10.1248/cpb.36.2362; Nassar M. I., 2010, Revista Latinoamericana de Quimica, V38, P103; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; OSHIMA R, 1982, CARBOHYD RES, V107, P169, DOI 10.1016/S0008-6215(00)80536-4; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1151, DOI 10.1016/S0968-0896(00)00052-3; Ren L, 1981, XAOXUE XUEBAO, V16, P672; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez P, 2010, FITOTERAPIA, V81, P1220, DOI 10.1016/j.fitote.2010.08.007; Smirnova GV, 2010, WORLD J MICROB BIOT, V26, P2269, DOI 10.1007/s11274-010-0417-4; Smirnova GV, 2009, FREE RADICAL BIO MED, V46, P759, DOI 10.1016/j.freeradbiomed.2008.11.017; Tachakittirungrod S, 2007, FOOD CHEM, V103, P381, DOI 10.1016/j.foodchem.2006.07.034; Tirillini B., 1994, Journal of Essential Oil Research, V6, P249; TK Lim, 2012, ZANTHOXYLUM SIMULANS, P904; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Wang DM, 2013, ALLELOPATHY J, V32, P67; Wang S, 2011, J LIQ CHROMATOGR R T, V34, P2640, DOI 10.1080/10826076.2011.593219; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; XIONG QB, 1995, PHYTOCHEMISTRY, V39, P723, DOI 10.1016/0031-9422(94)00965-V; Xiong QB, 1997, PHYTOCHEMISTRY, V46, P1123, DOI 10.1016/S0031-9422(97)84398-1; Xu HR, 2010, TEXTBOOK OF PERINATAL EPIDEMIOLOGY, P111; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Yeung H., 1985, HDB CHINESE HERBS FO, VVolume 1; Zhou X, 2005, J CHROMATOGR A, V1092, P216, DOI 10.1016/j.chroma.2005.07.064	56	446	470	16	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2014	9	8							e105725	10.1371/journal.pone.0105725	http://dx.doi.org/10.1371/journal.pone.0105725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JK	25290918	Green Submitted, Green Published, gold			2022-12-27	WOS:000341303200055
